Citrus Sinensis ID: 047009

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480--
Protein Sequence
MVSSQLPGLTKTCMHKPLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVPVQDSPEVSYGDLVNAVSAAADASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECVDGLTVKEIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADFSYVRPAASFLQSNSPLC
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEcccccccccccccccccHHHHHHHHccccHHHHHHHHcccccccccccccccccccccccccccccccccEEEEEEcccccEEEEEEEcccccEEEEEEccHHHHHcHHHHHHHHHHHHHHHHccccEEEcccccccccccEEEEEEEccccHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEEccccccccccccccccccccccccHHHHcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHccccccccccccccHHHHHcccccccccHHHHHccccccccccccccccccccccHHccccccccccccccccccccccccEEEcccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccHHHccccccccEEcccccccccccccccEcccccccccccccccccccccccccccccccccEccccccEEEEEcccccccccccccHHHHHccccHHHHHHHHHHccccccccccccccccccccccccccccccccHHHEEEEEEEEEccccEEEEEEEcccccEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccEcEccccccHHHccHHHHHcccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHcHHHccccHHHHHccccccccccccccccccccccHHHcccccccccccccHHcHHHccccEEccccccccccccccc
Coil and Loop (DISEMBL)
mvssqlpgltktcmhkplqtqlffpvsppddvvsdsleldfsdvfgpvpvqdspevsygDLVNAVSAaadaseiiyedpviicnrshslvgpsscvsesskLTKLILRESEDAEELLECVdgltvkeidessidenvkgdsvTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLhangimhrdlkpenillgadghvmltdfglakqfdentrsnsmigtveymapeivlgkghnkaaDWWSVGILLYEmltgkppfiggnrAKIQQKIVKDklrlpaflSSEAHSLLKGLlqkepgkrlgagpkgseeikshkwfkpinwkkleareiqpgfcpevagkhCIANFEkkwtdmplsdspaatpknntnpfadfsyvrpaasflqsnsplc
Flexible Loop (DISEMBL)
mvssqlpgltktcmhkPLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVPVQDSPEVSYGDLVNAVSAAADASEIIYEDPVIICNRSHslvgpsscvsesSKLTKLILRESEDAEELLECVDGLTVKeidessidenvkgdsVTVCCVGIEDFEVLKVvgqgafgrvyqvrkkntseiyamkvmrkdkiveKNHAEYMKAERdiltkidhpFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKgllqkepgkrlgagpkgseeikshkwfkpiNWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADFSYVRPAAsflqsnsplc
Low Complexity Region (SEG)
MVSSQLPGLTKTCMHKPLQTQLFFpvsppddvvsdsLELDFSDVFGPVPVQDSPEVSYGDLVNAVSAAADASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECVDGLTVKEIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADFSYVRPAASFLQSNSPLC
Disordered region (IsUnstruct)
************CMHKPLQTQLFFPVS***DVVSDSLELDFSDVFGPVPVQDSPEVSYGDLVNAVSAAADASEIIYEDPVIICNRSHSLVGPS*C******LTKLILR****AEELLECVDGLTVKEIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSS****L*************************HKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWT***************************************
Disordered Region (DISOPRED)
*************************************ELDFSDVFG******************************EDPVIICNRSH**************************************************************EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLS***********NPFADFSYVRPAAS*********
Disordered Region (DISEMBL)
MVSSQLPGLTKTCMHKPLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVPVQDSPEVSYGDLVNAVSAAADASEIIYEDPVIICNRSHSL***********KLTKLILRESEDAEELLECVDGLTVKEIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADFSYVRPAAS*********
Disordered Region (DISPRO)
****************PLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVP**DSPEVSYGDLVNAVSAAADASEIIYEDPVIICNRSHSLVG*****SESS**TK**LRESED*********************************CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADFSYVRPA***********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVSSQLPGLTKTCMHKPLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVPVQDSPEVSYGDLVNAVSAAADASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECVDGLTVKEIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADFSYVRPAASFLQSNSPLC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	482	2.2.26 [Sep-21-2011]
Q39030	471	Serine/threonine-protein	yes	no	0.960	0.983	0.690	0.0
P42818	465	Serine/threonine-protein	no	no	0.943	0.978	0.657	1e-178
Q6TJY3	527	Ribosomal protein S6 kina	yes	no	0.701	0.641	0.465	5e-87
P67998	525	Ribosomal protein S6 kina	yes	no	0.701	0.643	0.463	1e-86
P28178	479	Protein kinase 2 OS=Dicty	yes	no	0.657	0.661	0.481	1e-86
P23443	525	Ribosomal protein S6 kina	yes	no	0.701	0.643	0.463	1e-86
Q8BSK8	525	Ribosomal protein S6 kina	yes	no	0.701	0.643	0.463	1e-86
Q8MYF1	456	Probable serine/threonine	no	no	0.665	0.703	0.474	2e-86
P67999	525	Ribosomal protein S6 kina	yes	no	0.701	0.643	0.463	2e-86
Q9Z1M4	485	Ribosomal protein S6 kina	no	no	0.721	0.717	0.436	2e-83

>sp|Q39030|KPK2_ARATH Serine/threonine-protein kinase AtPK2/AtPK19 OS=Arabidopsis thaliana GN=ATPK2 PE=1 SV=2

 Score =  684 bits (1764), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 334/484 (69%), Positives = 387/484 (79%), Gaps = 21/484 (4%)

Query: 1   MVSSQLPGLTKTCMHKPLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVPVQDSPEVSYGD 60
           MVSSQ     K    KP Q  L   +SPP  V+ D+LEL FSDVFGP+P  +S E     
Sbjct: 1   MVSSQCSVANKNQTGKPFQKHLSLSISPPKSVLGDNLELQFSDVFGPMPEANSEE----- 55

Query: 61  LVNAVSAAADASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECV 120
                     A ++ Y++P ++ +RSHSLVGPS  VS S K+ KL LRE+ED+ +L+ECV
Sbjct: 56  ----------ACDVAYDEPAVVYSRSHSLVGPSLVVSHSLKMNKLTLRETEDSVDLVECV 105

Query: 121 DGLTVKEIDESSIDENV---KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEI 177
           +G ++KE DE S +++    K        VGIEDFEVLKVVGQGAFG+VYQVRKK+TSEI
Sbjct: 106 EGESIKENDEFSGNDDTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQVRKKDTSEI 165

Query: 178 YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL 237
           YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF+VQLKYSFQTKYRLYLVLDFINGGHL
Sbjct: 166 YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHL 225

Query: 238 FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA 297
           FFQLYH GLFREDLAR+Y AEIVSAVSHLH  GIMHRDLKPENIL+  DGHVMLTDFGLA
Sbjct: 226 FFQLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDVDGHVMLTDFGLA 285

Query: 298 KQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKI 357
           K+F+ENTRSNSM GT EYMAPEIV GKGH+KAADWWSVGILLYEMLTGKPPF+ G++ KI
Sbjct: 286 KEFEENTRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGKPPFL-GSKGKI 344

Query: 358 QQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLE 417
           QQKIVKDK++LP FLS+EAH+LLKGLLQKEP +RLG+GP G+EEIK HKWFK INWKKLE
Sbjct: 345 QQKIVKDKIKLPQFLSNEAHALLKGLLQKEPERRLGSGPSGAEEIKKHKWFKAINWKKLE 404

Query: 418 AREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNN--TNPFADFSYVRPAASFL 475
           ARE+QP F P V+G+ CIANF+K WTDM + DSPA++P ++   NPF +F+YVRP  SFL
Sbjct: 405 AREVQPSFKPAVSGRQCIANFDKCWTDMSVLDSPASSPNSDAKANPFTNFTYVRPPHSFL 464

Query: 476 QSNS 479
              +
Sbjct: 465 HRTT 468

Downstream effector of TOR signaling pathway. May be involved in adaptation of plant to cold or high-salt conditions.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P42818|KPK1_ARATH Serine/threonine-protein kinase AtPK1/AtPK6 OS=Arabidopsis thaliana GN=ATPK1 PE=1 SV=1

 Score =  624 bits (1608), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 323/491 (65%), Positives = 386/491 (78%), Gaps = 36/491 (7%)

Query: 1   MVSSQLPGLTKTCMHKPLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVPVQDSPEVSYGD 60
           MVSSQ P   K      +Q Q +  +SP + V+ D +EL+FSDVFGP+P           
Sbjct: 1   MVSSQRPVPNK------IQKQQYLSISPSNSVLKDDVELEFSDVFGPLP----------- 43

Query: 61  LVNAVSAAADASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECV 120
                    +A++I Y++P ++ +RSHSLVGP S  S S KLTKL L E+ED+ +L+EC+
Sbjct: 44  --------EEANDIAYDEPAVVYSRSHSLVGPCSLDSHSLKLTKLTLLETEDSIDLVECL 95

Query: 121 DGLTVKEIDESSIDEN------VKGDSVTVC-CVGIEDFEVLKVVGQGAFGRVYQVRKKN 173
           +G ++KE D+ S +++      ++GD V V   VGI+DFEV+KVVG+GAFG+VYQVRKK 
Sbjct: 96  EGESLKENDDFSGNDDSDNEKALEGDLVKVSGVVGIDDFEVMKVVGKGAFGKVYQVRKKE 155

Query: 174 TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFIN 233
           TSEIYAMKVMRKD I+EKNHAEYMKAERDILTKIDHPF+VQLKYSFQTKYRLYLVLDFIN
Sbjct: 156 TSEIYAMKVMRKDHIMEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFIN 215

Query: 234 GGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTD 293
           GGHLFFQLYH GLFREDLAR+Y AEIVSAVSHLH  GIMHRDLKPENIL+  DGHVMLTD
Sbjct: 216 GGHLFFQLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDTDGHVMLTD 275

Query: 294 FGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
           FGLAK+F+ENTRSNSM GT EYMAPEIV GKGH+KAADWWSVGILLYEMLTGKPPF+ G+
Sbjct: 276 FGLAKEFEENTRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGKPPFL-GS 334

Query: 354 RAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW 413
           + KIQQKIVKDK++LP FLS+EAH++LKGLLQKEP +RLG+G  G+EEIK HKWFK INW
Sbjct: 335 KGKIQQKIVKDKIKLPQFLSNEAHAILKGLLQKEPERRLGSGLSGAEEIKQHKWFKGINW 394

Query: 414 KKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPL--SDSPAATPKNNTNPFADFSYVRPA 471
           KKLEARE+ P F PEV+G+ CIANF+K WTDM +  S + + +     NPF +F+YVRP 
Sbjct: 395 KKLEAREVMPSFKPEVSGRQCIANFDKCWTDMSVLDSPASSPSSDPKANPFTNFTYVRPP 454

Query: 472 ASFL-QSNSPL 481
            SFL QS + L
Sbjct: 455 PSFLHQSTTTL 465

Downstream effector of TOR signaling pathway involved in osmotic stress response. Could be involved in the control of plant growth and development. Phosphorylates the ribosomal proteins P14, P16 and S6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6TJY3|KS6B1_BOVIN Ribosomal protein S6 kinase beta-1 OS=Bos taurus GN=RPS6KB1 PE=2 SV=1

 Score =  322 bits (825), Expect = 5e-87,   Method: Compositional matrix adjust.
 Identities = 164/352 (46%), Positives = 235/352 (66%), Gaps = 14/352 (3%)

Query: 127 EIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVM 183
           EI E+S+  N   + +   C     FE+L+V+G+G +G+V+QVRK    NT +I+AMKV+
Sbjct: 73  EISETSV--NRGPEKIRPEC-----FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL 125

Query: 184 RKDKIVEK-NHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY 242
           +K  IV       + KAER+IL ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL 
Sbjct: 126 KKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE 185

Query: 243 HHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FD 301
             G+F ED A  Y AEI  A+ HLH  GI++RDLKPENI+L   GHV LTDFGL K+   
Sbjct: 186 REGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 245

Query: 302 ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI 361
           + T +++  GT+EYMAPEI++  GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI
Sbjct: 246 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 305

Query: 362 VKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREI 421
           +K KL LP +L+ EA  LLK LL++    RLGAGP  + E+++H +F+ INW++L AR++
Sbjct: 306 LKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKV 365

Query: 422 QPGFCPEVAGKHCIANFEKKWTDMPLSDSP--AATPKNNTNPFADFSYVRPA 471
           +P F P +  +  ++ F+ K+T     DSP  +A  ++    F  F+YV P+
Sbjct: 366 EPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSALSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P67998|KS6B1_RABIT Ribosomal protein S6 kinase beta-1 OS=Oryctolagus cuniculus GN=RPS6KB1 PE=2 SV=1

 Score =  320 bits (821), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 163/352 (46%), Positives = 234/352 (66%), Gaps = 14/352 (3%)

Query: 127 EIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVM 183
           EI E+S+  N   + +   C     FE+L+V+G+G +G+V+QVRK    NT +I+AMKV+
Sbjct: 73  EISETSV--NRGPEKIRPEC-----FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL 125

Query: 184 RKDKIVEK-NHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY 242
           +K  IV       + KAER+IL ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL 
Sbjct: 126 KKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE 185

Query: 243 HHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FD 301
             G+F ED A  Y AEI  A+ HLH  GI++RDLKPENI+L   GHV LTDFGL K+   
Sbjct: 186 REGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 245

Query: 302 ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI 361
           + T +++  GT+EYMAPEI++  GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI
Sbjct: 246 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 305

Query: 362 VKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREI 421
           +K KL LP +L+ EA  LLK LL++    RLGAGP  + E+++H +F+ INW++L AR++
Sbjct: 306 LKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKV 365

Query: 422 QPGFCPEVAGKHCIANFEKKWTDMPLSDSP--AATPKNNTNPFADFSYVRPA 471
           +P F P +  +  ++ F+ K+T     DSP  +   ++    F  F+YV P+
Sbjct: 366 EPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28178|PK2_DICDI Protein kinase 2 OS=Dictyostelium discoideum GN=pkgB PE=1 SV=2

 Score =  320 bits (821), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 156/324 (48%), Positives = 216/324 (66%), Gaps = 7/324 (2%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE+L V+G+G+FG+V QV+KK   +I+AMKV+RKD I+ +    + K+E+ IL  I H
Sbjct: 151 DDFELLNVIGKGSFGKVMQVKKKGEDKIFAMKVLRKDAIIARKQVNHTKSEKTILQCISH 210

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF+V L Y+FQTK +LY+VLDF+NGG LFF L   G F E   +IYAAEIVSA+ HLH  
Sbjct: 211 PFIVNLHYAFQTKDKLYMVLDFVNGGELFFHLKREGRFSEPRVKIYAAEIVSALDHLHKQ 270

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKA 329
            I++RDLKPENILL ++GH+ +TDFGL+K+ +    + +  GT EY+APE++ G GH  A
Sbjct: 271 DIVYRDLKPENILLDSEGHICITDFGLSKKIETTDGTFTFCGTPEYLAPEVLNGHGHGCA 330

Query: 330 ADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPG 389
            DWWS+G LLYEMLTG PPF   N + + QKI+  +L++P ++S EA SLL+GLL +E  
Sbjct: 331 VDWWSLGTLLYEMLTGLPPFYSQNVSTMYQKILNGELKIPTYISPEAKSLLEGLLTREVD 390

Query: 390 KRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWT-----D 444
           KRLG   KG  E+K H WFK I+W+KL+ +E++  F P+V     I+  +  +T     D
Sbjct: 391 KRLGT--KGGGEVKQHPWFKNIDWEKLDRKEVEVHFKPKVKSGTDISQIDPVFTQERPMD 448

Query: 445 MPLSDSPAATPKNNTNPFADFSYV 468
             +  S           F  F+YV
Sbjct: 449 SLVETSALGDAMGKDTSFEGFTYV 472

Required for morphogenesis during multicellular development. Phosphorylates talB, gefN, gefS, PI4P 5-kinase and gacQ.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P23443|KS6B1_HUMAN Ribosomal protein S6 kinase beta-1 OS=Homo sapiens GN=RPS6KB1 PE=1 SV=2

 Score =  320 bits (820), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 163/352 (46%), Positives = 234/352 (66%), Gaps = 14/352 (3%)

Query: 127 EIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVM 183
           EI E+S+  N   + +   C     FE+L+V+G+G +G+V+QVRK    NT +I+AMKV+
Sbjct: 73  EISETSV--NRGPEKIRPEC-----FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL 125

Query: 184 RKDKIVEK-NHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY 242
           +K  IV       + KAER+IL ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL 
Sbjct: 126 KKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE 185

Query: 243 HHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FD 301
             G+F ED A  Y AEI  A+ HLH  GI++RDLKPENI+L   GHV LTDFGL K+   
Sbjct: 186 REGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 245

Query: 302 ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI 361
           + T +++  GT+EYMAPEI++  GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI
Sbjct: 246 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 305

Query: 362 VKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREI 421
           +K KL LP +L+ EA  LLK LL++    RLGAGP  + E+++H +F+ INW++L AR++
Sbjct: 306 LKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKV 365

Query: 422 QPGFCPEVAGKHCIANFEKKWTDMPLSDSP--AATPKNNTNPFADFSYVRPA 471
           +P F P +  +  ++ F+ K+T     DSP  +   ++    F  F+YV P+
Sbjct: 366 EPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial URI1 leading to dissociation of a URI1-PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8BSK8|KS6B1_MOUSE Ribosomal protein S6 kinase beta-1 OS=Mus musculus GN=Rps6kb1 PE=1 SV=2

 Score =  320 bits (820), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 163/352 (46%), Positives = 234/352 (66%), Gaps = 14/352 (3%)

Query: 127 EIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVM 183
           EI E+S+  N   + +   C     FE+L+V+G+G +G+V+QVRK    NT +I+AMKV+
Sbjct: 73  EISETSV--NRGPEKIRPEC-----FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL 125

Query: 184 RKDKIVEK-NHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY 242
           +K  IV       + KAER+IL ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL 
Sbjct: 126 KKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE 185

Query: 243 HHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FD 301
             G+F ED A  Y AEI  A+ HLH  GI++RDLKPENI+L   GHV LTDFGL K+   
Sbjct: 186 REGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 245

Query: 302 ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI 361
           + T +++  GT+EYMAPEI++  GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI
Sbjct: 246 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 305

Query: 362 VKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREI 421
           +K KL LP +L+ EA  LLK LL++    RLGAGP  + E+++H +F+ INW++L AR++
Sbjct: 306 LKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKV 365

Query: 422 QPGFCPEVAGKHCIANFEKKWTDMPLSDSP--AATPKNNTNPFADFSYVRPA 471
           +P F P +  +  ++ F+ K+T     DSP  +   ++    F  F+YV P+
Sbjct: 366 EPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8MYF1|Y2070_DICDI Probable serine/threonine-protein kinase DDB_G0277449 OS=Dictyostelium discoideum GN=DDB_G0277449 PE=3 SV=1

 Score =  320 bits (820), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 155/327 (47%), Positives = 217/327 (66%), Gaps = 6/327 (1%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + + +F +  +VG+G FG+V+QV   +T ++YA+KV++K+ I+ K       AE+DIL K
Sbjct: 123 INLSNFIIKHLVGKGGFGKVFQVVHVDTQKVYALKVIKKNHIIAKKSVVNTLAEKDILKK 182

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           I HPF+V L Y+FQ + +LYLV+DF+NGG LF+ L    +F ED  R Y AE++ A+ HL
Sbjct: 183 ISHPFIVNLHYAFQNEKKLYLVMDFVNGGQLFYHLQKEAIFSEDQVRFYMAELILALEHL 242

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAK-QFDENTRSNSMIGTVEYMAPEIVLGKG 325
           H + I+HRDLKPENILL + GH +LTDFGLAK +   N  + S  GT+EYMAPE++    
Sbjct: 243 HDSNIVHRDLKPENILLDSQGHCILTDFGLAKLEVKTNNETFSFAGTLEYMAPEMIQHAT 302

Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
             KA DWWS+GIL+Y+M+ GKPPF   NRA +Q+KI+ +K + P F+SS A SL+ GLL 
Sbjct: 303 CGKAVDWWSIGILMYDMMIGKPPFEHKNRALMQEKIISEKAKFPKFVSSSARSLINGLLT 362

Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDM 445
           K+P KRLGA   G+ EIK H +FK I W+K+E +EI P F P   G   I+NF+      
Sbjct: 363 KDPTKRLGAN--GAIEIKRHPFFKSIQWRKIENKEITPPFVPSTKGIDDISNFDHASLKA 420

Query: 446 PLSDSPAATPKNNTNP---FADFSYVR 469
              DS + +P  +++    F  FS+VR
Sbjct: 421 HQRDSFSTSPTLSSSQQAYFDGFSFVR 447

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P67999|KS6B1_RAT Ribosomal protein S6 kinase beta-1 OS=Rattus norvegicus GN=Rps6kb1 PE=1 SV=1

 Score =  320 bits (820), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 163/352 (46%), Positives = 234/352 (66%), Gaps = 14/352 (3%)

Query: 127 EIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVM 183
           EI E+S+  N   + +   C     FE+L+V+G+G +G+V+QVRK    NT +I+AMKV+
Sbjct: 73  EISETSV--NRGPEKIRPEC-----FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL 125

Query: 184 RKDKIVEK-NHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY 242
           +K  IV       + KAER+IL ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL 
Sbjct: 126 KKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE 185

Query: 243 HHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FD 301
             G+F ED A  Y AEI  A+ HLH  GI++RDLKPENI+L   GHV LTDFGL K+   
Sbjct: 186 REGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 245

Query: 302 ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI 361
           + T +++  GT+EYMAPEI++  GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI
Sbjct: 246 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 305

Query: 362 VKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREI 421
           +K KL LP +L+ EA  LLK LL++    RLGAGP  + E+++H +F+ INW++L AR++
Sbjct: 306 LKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKV 365

Query: 422 QPGFCPEVAGKHCIANFEKKWTDMPLSDSP--AATPKNNTNPFADFSYVRPA 471
           +P F P +  +  ++ F+ K+T     DSP  +   ++    F  F+YV P+
Sbjct: 366 EPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9Z1M4|KS6B2_MOUSE Ribosomal protein S6 kinase beta-2 OS=Mus musculus GN=Rps6kb2 PE=1 SV=1

 Score =  310 bits (793), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 158/362 (43%), Positives = 229/362 (63%), Gaps = 14/362 (3%)

Query: 117 LECVDGLTVKEIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRK---KN 173
           LE V      E+ ESS+  N+  + +   C     FE+L V+G+G +G+V+QVRK    N
Sbjct: 39  LETVGHYEEVELTESSV--NLGPERIGPHC-----FELLSVLGKGGYGKVFQVRKVQGTN 91

Query: 174 TSEIYAMKVMRKDKIV-EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFI 232
             +IYAMKV+RK KIV       + +AER+IL  + HPF+V+L Y+FQT  +LYL+L+ +
Sbjct: 92  LGKIYAMKVLRKAKIVCSAKDTAHTRAERNILESVKHPFIVELAYAFQTGGKLYLILECL 151

Query: 233 NGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLT 292
           +GG LF  L   G+F ED A  Y AEI  A+ HLH++GI++RDLKPENI+L + GH+ LT
Sbjct: 152 SGGELFTHLEREGIFLEDTACFYLAEITLALGHLHSHGIIYRDLKPENIMLSSQGHIKLT 211

Query: 293 DFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIG 351
           DFGL K+   E   +++  GT+EYMAPEI++  GHN+A DWWS+G L+Y+MLTG PPF  
Sbjct: 212 DFGLCKESIHEGAITHTFCGTIEYMAPEILVRTGHNRAVDWWSLGALMYDMLTGSPPFTA 271

Query: 352 GNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
            NR K   KI+K KL LP +L+ +A  L K  L++ P +R+G G   + +++ H +F+ I
Sbjct: 272 ENRKKTMDKIIKGKLVLPPYLTPDARDLAKKFLKRNPTQRIGGGLGDAADVQRHPFFRHI 331

Query: 412 NWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSP--AATPKNNTNPFADFSYVR 469
           NW  L AR + P F P +  +  ++ F+ ++T     DSP   A  ++    F  F+YV 
Sbjct: 332 NWDDLLARRVDPPFRPSLQSEEDVSQFDARFTRQTPVDSPDDTALSESANQAFLGFTYVA 391

Query: 470 PA 471
           P+
Sbjct: 392 PS 393

Phosphorylates specifically ribosomal protein S6.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	482
255575604	481	ribosomal protein S6 kinase, putative [R	0.970	0.972	0.775	0.0
225439717	489	PREDICTED: serine/threonine-protein kina	0.995	0.981	0.748	0.0
224139384	475	predicted protein [Populus trichocarpa]	0.968	0.983	0.765	0.0
224087877	475	predicted protein [Populus trichocarpa]	0.966	0.981	0.748	0.0
356532147	479	PREDICTED: serine/threonine-protein kina	0.973	0.979	0.739	0.0
297735529	446	unnamed protein product [Vitis vinifera]	0.923	0.997	0.729	0.0
363806700	479	uncharacterized protein LOC100805922 [Gl	0.973	0.979	0.721	0.0
297833618	471	ATPK19/ATPK2 [Arabidopsis lyrata subsp.	0.960	0.983	0.690	0.0
15231959	471	serine/threonine protein kinase 2 [Arabi	0.960	0.983	0.690	0.0
867995	471	ribosomal-protein S6 kinase homolog [Ara	0.960	0.983	0.683	0.0

>gi|255575604|ref|XP_002528702.1| ribosomal protein S6 kinase, putative [Ricinus communis] gi|223531874|gb|EEF33691.1| ribosomal protein S6 kinase, putative [Ricinus communis]

 Score =  767 bits (1980), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 379/489 (77%), Positives = 418/489 (85%), Gaps = 21/489 (4%)

Query: 1   MVSSQLPGLTKTCMHKPLQTQLFFPVSPP--DDVVSDSLELDFSDVFGPVPVQDSPEVSY 58
           MVSSQ   L+K  M KP ++QL F  +PP  D +VSD +ELDF+DVFGP+PVQ S EV+ 
Sbjct: 1   MVSSQFSELSKAHMCKPFRSQLLFTENPPPPDALVSD-VELDFADVFGPLPVQTSTEVNS 59

Query: 59  GDLVNAVSAAADASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLE 118
           GDL N +S A D +E+IY+DPV+I NRSHSLVGPSS VS S KL KL L E+ED+ ELLE
Sbjct: 60  GDLANPLSGA-DVTELIYDDPVVIHNRSHSLVGPSSFVSHSLKLNKLTLHETEDSMELLE 118

Query: 119 CVDGLTVKEIDESSIDEN--------VKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVR 170
                    +DESS+D++        V GD++ V  VGIEDFEVLKVVGQGAFG+VYQV+
Sbjct: 119 ---------LDESSLDDDNSEKATDDVSGDALEVRSVGIEDFEVLKVVGQGAFGKVYQVK 169

Query: 171 KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD 230
           KK TSEIYAMKVMRKDKIVEKNH EYMKAERDILTK+DHPF+VQLKYSFQTKYRLYL+LD
Sbjct: 170 KKGTSEIYAMKVMRKDKIVEKNHVEYMKAERDILTKVDHPFIVQLKYSFQTKYRLYLILD 229

Query: 231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVM 290
           FINGGHLFFQLYH GLFREDLARIYAAEIVSAV HLHANGIMHRDLKPENILL ADGHVM
Sbjct: 230 FINGGHLFFQLYHQGLFREDLARIYAAEIVSAVCHLHANGIMHRDLKPENILLDADGHVM 289

Query: 291 LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFI 350
           LTDFGLAKQFDENTRSNSM GTVEYMAPEIVLG+GH+KAADWWSVG+LLYEMLTGKPPFI
Sbjct: 290 LTDFGLAKQFDENTRSNSMCGTVEYMAPEIVLGRGHDKAADWWSVGVLLYEMLTGKPPFI 349

Query: 351 GGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP 410
           GGNR KIQQKIVKDK++LPAFLSSEAHSLLKGLLQK+  KRLG GP G EEIK HKW KP
Sbjct: 350 GGNREKIQQKIVKDKMKLPAFLSSEAHSLLKGLLQKDVSKRLGNGPTGGEEIKRHKWLKP 409

Query: 411 INWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADFSYVRP 470
           INWKKL+AREIQP F P+VAGKHCIANFEK+WTDMPLSDSPAA+PK+N NPF +FSYVRP
Sbjct: 410 INWKKLDAREIQPSFRPQVAGKHCIANFEKRWTDMPLSDSPAASPKSNVNPFVNFSYVRP 469

Query: 471 AASFLQSNS 479
           AA FLQ NS
Sbjct: 470 AAFFLQKNS 478

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225439717|ref|XP_002273012.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Vitis vinifera]

 Score =  763 bits (1970), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/489 (74%), Positives = 424/489 (86%), Gaps = 9/489 (1%)

Query: 1   MVSSQLPGLTKTCMHKPLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVPVQDSPEVSYGD 60
           MV S +PGLTKT M KP+Q QL FP++P D V  D +ELDF+DVFGP+PVQ   E++ GD
Sbjct: 1   MVFSDVPGLTKTRMCKPIQNQLLFPMNPTDIVPLDHVELDFADVFGPLPVQTPSEMNPGD 60

Query: 61  LVNAVSAAADASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECV 120
             ++VSAA D +++IY DPV+I +RSHSLVGPS+C+S+S KL+KL L E ED+EEL+EC+
Sbjct: 61  SGDSVSAA-DTNDLIYGDPVVIYSRSHSLVGPSTCLSQSLKLSKLALHEIEDSEELVECL 119

Query: 121 DGLTVKEIDESSID--------ENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKK 172
               VKE+  +S          E++  DS TV  VG+EDFEV+K+VGQGAFG+V+QVRK+
Sbjct: 120 HEEAVKELQRTSSSDDISEKSFEDIDSDSTTVETVGLEDFEVMKLVGQGAFGKVFQVRKR 179

Query: 173 NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFI 232
           NTSEIYAMKVMRKDKI+EK+HAEYMKAERDILTK+DHPF+VQL+YSFQTKYRLYLVLDF+
Sbjct: 180 NTSEIYAMKVMRKDKIMEKDHAEYMKAERDILTKVDHPFIVQLRYSFQTKYRLYLVLDFV 239

Query: 233 NGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLT 292
           NGGHLFFQLY+HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL ADGH MLT
Sbjct: 240 NGGHLFFQLYNHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLDADGHAMLT 299

Query: 293 DFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG 352
           DFGLAK+FDENTRSNSM GTVEYM+PEI LGKGH+KAADWWSVGILL+EMLTGKPPFIGG
Sbjct: 300 DFGLAKEFDENTRSNSMCGTVEYMSPEIFLGKGHDKAADWWSVGILLFEMLTGKPPFIGG 359

Query: 353 NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN 412
           NR KIQQKI+KDK++LPAFLSS+AHS+LKGLLQK+P KRLG+GP G +EIK HKWFKPIN
Sbjct: 360 NRQKIQQKIIKDKIKLPAFLSSDAHSVLKGLLQKDPSKRLGSGPLGIDEIKHHKWFKPIN 419

Query: 413 WKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADFSYVRPAA 472
           W+KLEAREIQP F PEV GK CIANFEK+WTDMPL+DSPAA+PK N N F  F+YVRPAA
Sbjct: 420 WRKLEAREIQPSFRPEVDGKLCIANFEKRWTDMPLADSPAASPKANGNIFTGFTYVRPAA 479

Query: 473 SFLQSNSPL 481
           SFL+ NSPL
Sbjct: 480 SFLRRNSPL 488

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139384|ref|XP_002323086.1| predicted protein [Populus trichocarpa] gi|222867716|gb|EEF04847.1| predicted protein [Populus trichocarpa]

 Score =  758 bits (1958), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 375/490 (76%), Positives = 418/490 (85%), Gaps = 23/490 (4%)

Query: 1   MVSSQLPGLTKTCMHKPLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVPVQDSPEVSYGD 60
           MVSSQLPGLTK         +L FPV+P D VVSD +ELDF+DVFGP+P   S +V+ GD
Sbjct: 1   MVSSQLPGLTKN--------RLLFPVNPSDTVVSDHVELDFTDVFGPLP---SIDVNCGD 49

Query: 61  LVNAVSAAADASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECV 120
            +    +  D SE+IY+DPV++ NRSHSLVGPSS VS+S KL+KL L+E+ED+ EL+ECV
Sbjct: 50  PL----SVGDGSELIYDDPVVVHNRSHSLVGPSSYVSQSLKLSKLNLQETEDSLELVECV 105

Query: 121 DGLTVKEIDESSID--------ENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKK 172
              T+KE++ES ID        E+V GD+  V  VGIEDFEVLKVVGQGAFG+VYQVRKK
Sbjct: 106 LDETIKELEESFIDDDAVEKDMEDVSGDTSKVQTVGIEDFEVLKVVGQGAFGKVYQVRKK 165

Query: 173 NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFI 232
            T EIYAMKVMRKD+IVEKNH EYM+ ERDILTKIDHPF+VQLKYSFQTKYRLYLVLDFI
Sbjct: 166 GTPEIYAMKVMRKDRIVEKNHVEYMRGERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFI 225

Query: 233 NGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLT 292
           NGGHLFFQLY+HGLFREDLA IYAAEI SAVSHLHANGIMHRDLKPENILL +DGH MLT
Sbjct: 226 NGGHLFFQLYNHGLFREDLACIYAAEIASAVSHLHANGIMHRDLKPENILLDSDGHAMLT 285

Query: 293 DFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG 352
           DFGLAK+FDENTRSNSM GTVEYMAPEIV GKGH+KAADWWSVGILLYEMLTGKPPFIGG
Sbjct: 286 DFGLAKEFDENTRSNSMCGTVEYMAPEIVQGKGHDKAADWWSVGILLYEMLTGKPPFIGG 345

Query: 353 NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN 412
           NR KIQQKIVKDK++LP+FLSSEAHSLLKGLL K+  KRLG+G  GSEEIK HKWFKPIN
Sbjct: 346 NRNKIQQKIVKDKIKLPSFLSSEAHSLLKGLLNKDAAKRLGSGSLGSEEIKRHKWFKPIN 405

Query: 413 WKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADFSYVRPAA 472
           WKKL+AREIQP F PEVAGKHCIANF+K WTDM LSDSPAA+PK NTNPF +F+YVRPAA
Sbjct: 406 WKKLDAREIQPSFRPEVAGKHCIANFDKCWTDMKLSDSPAASPKTNTNPFVNFTYVRPAA 465

Query: 473 SFLQSNSPLC 482
           SFL+ NSPLC
Sbjct: 466 SFLKQNSPLC 475

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224087877|ref|XP_002308257.1| predicted protein [Populus trichocarpa] gi|222854233|gb|EEE91780.1| predicted protein [Populus trichocarpa]

 Score =  740 bits (1910), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/489 (74%), Positives = 414/489 (84%), Gaps = 23/489 (4%)

Query: 1   MVSSQLPGLTKTCMHKPLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVPVQDSPEVSYGD 60
           MVSSQLPG TK         +L FPV+  D  VSD +ELDF+DVFGP+P   S +V+ GD
Sbjct: 1   MVSSQLPGSTKN--------RLLFPVNSLDTEVSDHVELDFTDVFGPLP---SIDVNCGD 49

Query: 61  LVNAVSAAADASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECV 120
            +    +  D SE+IY++PV+I NRSHSLVGPSS VS+S KL+KL L E+ED+ EL++CV
Sbjct: 50  PL----SVGDGSELIYDNPVVIHNRSHSLVGPSSYVSQSLKLSKLNLNETEDSMELVKCV 105

Query: 121 DGLTVKEIDESSID--------ENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKK 172
              T+KE++E SID        E V GD++ V  VGIEDFEVLKVVGQGAFG+VYQVRKK
Sbjct: 106 LDETIKELEECSIDDDAIEKDVEGVSGDTLEVQTVGIEDFEVLKVVGQGAFGKVYQVRKK 165

Query: 173 NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFI 232
            T EIYAMKVMRKD+IVEKNH +YM+ ERDILTKI HPF+VQLKYSFQTKYRLYLVLDFI
Sbjct: 166 GTPEIYAMKVMRKDRIVEKNHVDYMRGERDILTKIAHPFIVQLKYSFQTKYRLYLVLDFI 225

Query: 233 NGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLT 292
           NGGHLFFQLY+HGLFREDLARIYAAEIVSAV HLHANGIMHRDLKPENILL +DGHVMLT
Sbjct: 226 NGGHLFFQLYNHGLFREDLARIYAAEIVSAVCHLHANGIMHRDLKPENILLDSDGHVMLT 285

Query: 293 DFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG 352
           DFGLAKQFDENTRSNSM GTVEYMAPEIV G+GH+KAADWWSVGILLYEMLTGKPPF+GG
Sbjct: 286 DFGLAKQFDENTRSNSMCGTVEYMAPEIVQGRGHDKAADWWSVGILLYEMLTGKPPFVGG 345

Query: 353 NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN 412
           NR KIQQKIVKDK++LP+FL+SEAH+LLKGLL K+  KRLG+GP GSEEIK HKWFK IN
Sbjct: 346 NRDKIQQKIVKDKIKLPSFLTSEAHTLLKGLLNKDASKRLGSGPLGSEEIKRHKWFKAIN 405

Query: 413 WKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADFSYVRPAA 472
           WKKL+AREIQP F P+VAGKHCIANF+K WTDM LSDSPAA+PK NTNPF +F+YVRPAA
Sbjct: 406 WKKLDAREIQPSFRPDVAGKHCIANFDKCWTDMTLSDSPAASPKMNTNPFVNFTYVRPAA 465

Query: 473 SFLQSNSPL 481
           SFLQ +SPL
Sbjct: 466 SFLQQSSPL 474

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356532147|ref|XP_003534635.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Glycine max]

 Score =  731 bits (1888), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/488 (73%), Positives = 411/488 (84%), Gaps = 19/488 (3%)

Query: 1   MVSSQLPGLTKTCMHKPLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVPVQDSPEVSYGD 60
           MVSSQ  GLT    +KP QTQL FP + PD V ++ +ELDFSDVFGPV V         D
Sbjct: 1   MVSSQFSGLT-MAGYKPAQTQLLFPANLPDTVNTEHIELDFSDVFGPVTV---------D 50

Query: 61  LVNAVSAAAD----ASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEEL 116
           L N  S   +     +E++Y+DP +I  RSHSLVGPS+CVS+S KL KL + E+ED+ EL
Sbjct: 51  LNNIDSTTGEPLEEVNELVYDDPPVIYTRSHSLVGPSTCVSQSLKLGKLTIHETEDSLEL 110

Query: 117 LECVDGLTVKEIDESS-IDENVK---GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKK 172
           ++ V+G T+K+I +SS +D+++K   G+   +  V IEDFE+LKVVGQGAF +VYQVRKK
Sbjct: 111 VDHVNGETIKDIKDSSFVDKSLKDEDGNLKKIQRVSIEDFEILKVVGQGAFAKVYQVRKK 170

Query: 173 NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFI 232
            TSEIYAMKVMRKDKI+EKNHAEYMKAERDI TKI+HPFVVQL+YSFQTKYRLYLVLDF+
Sbjct: 171 GTSEIYAMKVMRKDKIMEKNHAEYMKAERDIWTKIEHPFVVQLRYSFQTKYRLYLVLDFV 230

Query: 233 NGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLT 292
           NGGHLFFQLYH GLFREDLARIY AEIV AVSHLH+NGIMHRDLKPENILL ADGHVMLT
Sbjct: 231 NGGHLFFQLYHQGLFREDLARIYTAEIVCAVSHLHSNGIMHRDLKPENILLDADGHVMLT 290

Query: 293 DFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG 352
           DFGLAKQF+E+TRSNSM GT+EYMAPEI+LGKGH+KAADWWSVGILL+EMLTGKPPF GG
Sbjct: 291 DFGLAKQFEESTRSNSMCGTLEYMAPEIILGKGHDKAADWWSVGILLFEMLTGKPPFCGG 350

Query: 353 NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN 412
           NR KIQQKIVKDK++LPAFLSSEAHSLLKGLLQKEPG+RLG GP+G EEIKSHKWFKPIN
Sbjct: 351 NRDKIQQKIVKDKIKLPAFLSSEAHSLLKGLLQKEPGRRLGCGPRGVEEIKSHKWFKPIN 410

Query: 413 WKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADFSYVRPAA 472
           W+KLEAREIQP F PEVAG  C+ANFEK+WTDMP+ DSPAA+P N  NPF DFSYVRPAA
Sbjct: 411 WRKLEAREIQPSFRPEVAGVQCVANFEKRWTDMPVVDSPAASP-NGGNPFKDFSYVRPAA 469

Query: 473 SFLQSNSP 480
           SFLQ NSP
Sbjct: 470 SFLQRNSP 477

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297735529|emb|CBI18023.3| unnamed protein product [Vitis vinifera]

 Score =  725 bits (1872), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/481 (72%), Positives = 404/481 (83%), Gaps = 36/481 (7%)

Query: 1   MVSSQLPGLTKTCMHKPLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVPVQDSPEVSYGD 60
           MV S +PGLTKT M KP+Q QL FP++P D V  D +ELDF+DVFGP+PVQ         
Sbjct: 1   MVFSDVPGLTKTRMCKPIQNQLLFPMNPTDIVPLDHVELDFADVFGPLPVQ--------- 51

Query: 61  LVNAVSAAADASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECV 120
                    D +++IY DPV+I +RSHSLVGPS+C+S+S KL+KL L E ED+EEL+EC+
Sbjct: 52  ------TPTDTNDLIYGDPVVIYSRSHSLVGPSTCLSQSLKLSKLALHEIEDSEELVECL 105

Query: 121 DGLTVKEIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAM 180
                   +E++              VG+EDFEV+K+VGQGAFG+V+QVRK+NTSEIYAM
Sbjct: 106 H-------EEAT--------------VGLEDFEVMKLVGQGAFGKVFQVRKRNTSEIYAM 144

Query: 181 KVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQ 240
           KVMRKDKI+EK+HAEYMKAERDILTK+DHPF+VQL+YSFQTKYRLYLVLDF+NGGHLFFQ
Sbjct: 145 KVMRKDKIMEKDHAEYMKAERDILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ 204

Query: 241 LYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF 300
           LY+HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL ADGH MLTDFGLAK+F
Sbjct: 205 LYNHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLDADGHAMLTDFGLAKEF 264

Query: 301 DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQK 360
           DENTRSNSM GTVEYM+PEI LGKGH+KAADWWSVGILL+EMLTGKPPFIGGNR KIQQK
Sbjct: 265 DENTRSNSMCGTVEYMSPEIFLGKGHDKAADWWSVGILLFEMLTGKPPFIGGNRQKIQQK 324

Query: 361 IVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEARE 420
           I+KDK++LPAFLSS+AHS+LKGLLQK+P KRLG+GP G +EIK HKWFKPINW+KLEARE
Sbjct: 325 IIKDKIKLPAFLSSDAHSVLKGLLQKDPSKRLGSGPLGIDEIKHHKWFKPINWRKLEARE 384

Query: 421 IQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADFSYVRPAASFLQSNSP 480
           IQP F PEV GK CIANFEK+WTDMPL+DSPAA+PK N N F  F+YVRPAASFL+ NSP
Sbjct: 385 IQPSFRPEVDGKLCIANFEKRWTDMPLADSPAASPKANGNIFTGFTYVRPAASFLRRNSP 444

Query: 481 L 481
           L
Sbjct: 445 L 445

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363806700|ref|NP_001242011.1| uncharacterized protein LOC100805922 [Glycine max] gi|255636025|gb|ACU18357.1| unknown [Glycine max]

 Score =  712 bits (1837), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 352/488 (72%), Positives = 404/488 (82%), Gaps = 19/488 (3%)

Query: 1   MVSSQLPGLTKTCMHKPLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVPVQDSPEVSYGD 60
           MVSSQ    T    +KP QTQL FP    D V ++ +ELDFSDVFGPV +         D
Sbjct: 1   MVSSQFSAFT-LAGYKPSQTQLLFPAKLVDTVNTEHIELDFSDVFGPVTL---------D 50

Query: 61  LVNAVSAAAD----ASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEEL 116
           L N  S  ++     +E++Y+DP +I  RSHSLVGPS+CVS+S K  KL + E+ED+ EL
Sbjct: 51  LNNIDSTTSEPMEEVNELVYDDPPVIYTRSHSLVGPSTCVSQSLKFGKLTIHETEDSLEL 110

Query: 117 LECVDGLTVKEIDESS-IDENVK---GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKK 172
           +E V+G  +K+I ESS ++E++K   G+ + +  V I+DFE+LKVVGQGAF +VYQVRKK
Sbjct: 111 VEHVNGEAIKDIKESSFVEESLKDEDGNLMKIHRVSIDDFEILKVVGQGAFAKVYQVRKK 170

Query: 173 NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFI 232
            TSEIYAMKVMRKDKI+EKNHAEYMKAERDI TKI+HPF VQL+YSFQTKYRLYLVLDF+
Sbjct: 171 GTSEIYAMKVMRKDKIMEKNHAEYMKAERDIWTKIEHPFGVQLRYSFQTKYRLYLVLDFV 230

Query: 233 NGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLT 292
           NGGHLFFQLYH GLFREDLARIY AEIVSAVSHLHANGIMHRDLKPENILL ADGHVMLT
Sbjct: 231 NGGHLFFQLYHQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLT 290

Query: 293 DFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG 352
           DFGLAKQF+E+TRSNSM GT+EYMAPEI+LGKGH+KAADWWSVG+LL+EMLTGKPPF GG
Sbjct: 291 DFGLAKQFEESTRSNSMCGTLEYMAPEIILGKGHDKAADWWSVGVLLFEMLTGKPPFCGG 350

Query: 353 NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN 412
           N  KIQQKIVKDK++LPAFLSSEAHSLLKGLLQKE  +RLG GP+G EEIKSHKWFKPIN
Sbjct: 351 NCDKIQQKIVKDKIKLPAFLSSEAHSLLKGLLQKEQARRLGCGPRGVEEIKSHKWFKPIN 410

Query: 413 WKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADFSYVRPAA 472
           W+KLEAREIQP F PEVAG HC+AN EK+WTDMP+ DSPAA+P N  NPF DFSYVRPAA
Sbjct: 411 WRKLEAREIQPSFRPEVAGVHCVANVEKRWTDMPVVDSPAASP-NGGNPFKDFSYVRPAA 469

Query: 473 SFLQSNSP 480
           SFLQ N+P
Sbjct: 470 SFLQRNNP 477

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297833618|ref|XP_002884691.1| ATPK19/ATPK2 [Arabidopsis lyrata subsp. lyrata] gi|297330531|gb|EFH60950.1| ATPK19/ATPK2 [Arabidopsis lyrata subsp. lyrata]

 Score =  689 bits (1777), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 334/484 (69%), Positives = 393/484 (81%), Gaps = 21/484 (4%)

Query: 1   MVSSQLPGLTKTCMHKPLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVPVQDSPEVSYGD 60
           MVSSQ P   K    KP Q QL+  +SPP  V++D+LEL+FSDVFGP+P  +S E     
Sbjct: 1   MVSSQCPVANKNQTGKPFQKQLYLSISPPKSVLNDNLELEFSDVFGPMPEANSGE----- 55

Query: 61  LVNAVSAAADASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECV 120
                     AS++ Y++P ++ +RSHSLVGPS  VS S KL KL LRE+ED+ +L+ECV
Sbjct: 56  ----------ASDVAYDEPAVVYSRSHSLVGPSLVVSHSLKLNKLTLRETEDSVDLVECV 105

Query: 121 DGLTVKEIDESSIDENVKGDSV---TVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEI 177
           +G ++KE DE   +++   D         VGIEDFEVLKVVGQGAFG+VYQVRKK+TSEI
Sbjct: 106 EGESIKENDEFFGNDDTDSDKALEEVSGVVGIEDFEVLKVVGQGAFGKVYQVRKKDTSEI 165

Query: 178 YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL 237
           YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF+VQLKYSFQTKYRLYLVLDFINGGHL
Sbjct: 166 YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHL 225

Query: 238 FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA 297
           FFQLYH GLFREDLAR+Y AEIVSAVSHLH  GIMHRDLKPENIL+  DGHVMLTDFGLA
Sbjct: 226 FFQLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDVDGHVMLTDFGLA 285

Query: 298 KQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKI 357
           K+F+ENTRSNSM GT EYMAPEI+ GKGH+KAADWWSVGILLYEMLTGKPPF+ G++ KI
Sbjct: 286 KEFEENTRSNSMCGTTEYMAPEIIHGKGHDKAADWWSVGILLYEMLTGKPPFL-GSKGKI 344

Query: 358 QQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLE 417
           QQKIVKDK++LP FLS+EAH+LLKGLLQKEP +RLG+GP G++EIK HKWFK INWKKLE
Sbjct: 345 QQKIVKDKIKLPQFLSNEAHALLKGLLQKEPERRLGSGPSGADEIKQHKWFKVINWKKLE 404

Query: 418 AREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNN--TNPFADFSYVRPAASFL 475
           ARE+QP F P V+G+ CIANF+K WT+M + DSPA++P ++   NPF++F+YVRP  SFL
Sbjct: 405 AREVQPSFKPAVSGRQCIANFDKCWTEMSVLDSPASSPNSDPKANPFSNFTYVRPPPSFL 464

Query: 476 QSNS 479
              +
Sbjct: 465 HRTT 468

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15231959|ref|NP_187484.1| serine/threonine protein kinase 2 [Arabidopsis thaliana] gi|30680612|ref|NP_850543.1| serine/threonine protein kinase 2 [Arabidopsis thaliana] gi|21431798|sp|Q39030.2|KPK2_ARATH RecName: Full=Serine/threonine-protein kinase AtPK2/AtPK19; AltName: Full=Ribosomal-protein S6 kinase homolog 2 gi|12322721|gb|AAG51345.1|AC012562_6 putative ribosomal-protein S6 kinase (ATPK19); 61330-59548 [Arabidopsis thaliana] gi|13272447|gb|AAK17162.1|AF325094_1 putative ribosomal-protein S6 kinase (ATPK19) [Arabidopsis thaliana] gi|111074206|gb|ABH04476.1| At3g08720 [Arabidopsis thaliana] gi|222422905|dbj|BAH19439.1| AT3G08720 [Arabidopsis thaliana] gi|332641148|gb|AEE74669.1| serine/threonine protein kinase 2 [Arabidopsis thaliana] gi|332641149|gb|AEE74670.1| serine/threonine protein kinase 2 [Arabidopsis thaliana]

 Score =  684 bits (1764), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 334/484 (69%), Positives = 387/484 (79%), Gaps = 21/484 (4%)

Query: 1   MVSSQLPGLTKTCMHKPLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVPVQDSPEVSYGD 60
           MVSSQ     K    KP Q  L   +SPP  V+ D+LEL FSDVFGP+P  +S E     
Sbjct: 1   MVSSQCSVANKNQTGKPFQKHLSLSISPPKSVLGDNLELQFSDVFGPMPEANSEE----- 55

Query: 61  LVNAVSAAADASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECV 120
                     A ++ Y++P ++ +RSHSLVGPS  VS S K+ KL LRE+ED+ +L+ECV
Sbjct: 56  ----------ACDVAYDEPAVVYSRSHSLVGPSLVVSHSLKMNKLTLRETEDSVDLVECV 105

Query: 121 DGLTVKEIDESSIDENV---KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEI 177
           +G ++KE DE S +++    K        VGIEDFEVLKVVGQGAFG+VYQVRKK+TSEI
Sbjct: 106 EGESIKENDEFSGNDDTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQVRKKDTSEI 165

Query: 178 YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL 237
           YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF+VQLKYSFQTKYRLYLVLDFINGGHL
Sbjct: 166 YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHL 225

Query: 238 FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA 297
           FFQLYH GLFREDLAR+Y AEIVSAVSHLH  GIMHRDLKPENIL+  DGHVMLTDFGLA
Sbjct: 226 FFQLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDVDGHVMLTDFGLA 285

Query: 298 KQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKI 357
           K+F+ENTRSNSM GT EYMAPEIV GKGH+KAADWWSVGILLYEMLTGKPPF+ G++ KI
Sbjct: 286 KEFEENTRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGKPPFL-GSKGKI 344

Query: 358 QQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLE 417
           QQKIVKDK++LP FLS+EAH+LLKGLLQKEP +RLG+GP G+EEIK HKWFK INWKKLE
Sbjct: 345 QQKIVKDKIKLPQFLSNEAHALLKGLLQKEPERRLGSGPSGAEEIKKHKWFKAINWKKLE 404

Query: 418 AREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNN--TNPFADFSYVRPAASFL 475
           ARE+QP F P V+G+ CIANF+K WTDM + DSPA++P ++   NPF +F+YVRP  SFL
Sbjct: 405 AREVQPSFKPAVSGRQCIANFDKCWTDMSVLDSPASSPNSDAKANPFTNFTYVRPPHSFL 464

Query: 476 QSNS 479
              +
Sbjct: 465 HRTT 468

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|867995|dbj|BAA07661.1| ribosomal-protein S6 kinase homolog [Arabidopsis thaliana] gi|914079|gb|AAB33196.1| ATPK19=ribosomal-protein S6 kinase homolog [Arabidopsis thaliana, Peptide, 471 aa]

 Score =  677 bits (1748), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/484 (68%), Positives = 385/484 (79%), Gaps = 21/484 (4%)

Query: 1   MVSSQLPGLTKTCMHKPLQTQLFFPVSPPDDVVSDSLELDFSDVFGPVPVQDSPEVSYGD 60
           MVSSQ     K    KP Q  L   +SPP  V+ D+LEL FSDVFGP+P  +S E     
Sbjct: 1   MVSSQCSVANKNQTGKPFQKHLSLSISPPKSVLGDNLELQFSDVFGPMPEANSEE----- 55

Query: 61  LVNAVSAAADASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECV 120
                     A ++ Y++P ++ +RSHSLVGPS  VS S K+ KL LRE+ED+ +L+ECV
Sbjct: 56  ----------ACDVAYDEPAVVYSRSHSLVGPSLVVSHSLKMNKLTLRETEDSVDLVECV 105

Query: 121 DGLTVKEIDESSIDENV---KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEI 177
           +G ++KE DE S +++    K        VGIEDFEVLKVVGQGAFG+VYQVRKK+TSEI
Sbjct: 106 EGESIKENDEFSGNDDTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQVRKKDTSEI 165

Query: 178 YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL 237
           YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF+VQLKYSFQTKYRLYLVLDFINGGHL
Sbjct: 166 YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHL 225

Query: 238 FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA 297
           FFQLYH GLFREDLAR+Y AEIVS VSHLH  GIMHRDLKPENIL+  DGHVMLTDFGLA
Sbjct: 226 FFQLYHQGLFREDLARVYTAEIVSVVSHLHEKGIMHRDLKPENILMDVDGHVMLTDFGLA 285

Query: 298 KQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKI 357
           K+F+ENTRSNSM GT EYMAPEIV GKGH+KAADWWSVGILLYEMLTGKPPF+ G++ KI
Sbjct: 286 KEFEENTRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGKPPFL-GSKGKI 344

Query: 358 QQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLE 417
           QQKIVKDK++LP F+ +EAH+LLKGLLQKEP +RLG+GP G+EEIK HKWFK INWKKLE
Sbjct: 345 QQKIVKDKIKLPQFVFNEAHALLKGLLQKEPERRLGSGPSGAEEIKKHKWFKAINWKKLE 404

Query: 418 AREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNN--TNPFADFSYVRPAASFL 475
           ARE+QP F P V+G+ CIANF+K WTDM + DSPA++P ++   NPF +F+YVRP  SFL
Sbjct: 405 AREVQPSFKPAVSGRQCIANFDKCWTDMSVLDSPASSPNSDAKANPFTNFTYVRPPHSFL 464

Query: 476 QSNS 479
              +
Sbjct: 465 HRTT 468

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	482
TAIR|locus:2077843	471	S6K2 "serine/threonine protein	0.952	0.974	0.685	2.1e-171
TAIR|locus:2077873	465	PK1 "protein-serine kinase 1"	0.921	0.954	0.668	1.3e-164
UNIPROTKB|F1MNP4	525	RPS6KB1 "Ribosomal protein S6	0.676	0.620	0.483	7.4e-82
UNIPROTKB|Q6TJY3	527	RPS6KB1 "Ribosomal protein S6	0.676	0.618	0.483	7.4e-82
UNIPROTKB|E2RMD8	525	RPS6KB1 "Uncharacterized prote	0.676	0.620	0.486	9.4e-82
UNIPROTKB|B4DLT4	472	RPS6KB1 "cDNA FLJ53847, highly	0.676	0.690	0.486	9.4e-82
UNIPROTKB|P23443	525	RPS6KB1 "Ribosomal protein S6	0.676	0.620	0.486	9.4e-82
UNIPROTKB|Q7Z721	451	RPS6KB1 "RPS6KB1 protein" [Hom	0.676	0.722	0.486	9.4e-82
UNIPROTKB|P67998	525	RPS6KB1 "Ribosomal protein S6	0.676	0.620	0.486	9.4e-82
MGI|MGI:1270849	525	Rps6kb1 "ribosomal protein S6	0.676	0.620	0.486	9.4e-82

TAIR|locus:2077843 S6K2 "serine/threonine protein kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1666 (591.5 bits), Expect = 2.1e-171, P = 2.1e-171
 Identities = 329/480 (68%), Positives = 378/480 (78%)

Query:     1 MVSSQLPGLTKTCMHKPLQTQLFFXXXXXXXXXXXXLELDFSDVFGPVPVQDSPEVSYGD 60
             MVSSQ     K    KP Q  L              LEL FSDVFGP+P  +S E     
Sbjct:     1 MVSSQCSVANKNQTGKPFQKHLSLSISPPKSVLGDNLELQFSDVFGPMPEANSEE----- 55

Query:    61 LVNAVSAAADASEIIYEDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECV 120
                       A ++ Y++P ++ +RSHSLVGPS  VS S K+ KL LRE+ED+ +L+ECV
Sbjct:    56 ----------ACDVAYDEPAVVYSRSHSLVGPSLVVSHSLKMNKLTLRETEDSVDLVECV 105

Query:   121 DGLTVKEIDESSIDENV---KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEI 177
             +G ++KE DE S +++    K        VGIEDFEVLKVVGQGAFG+VYQVRKK+TSEI
Sbjct:   106 EGESIKENDEFSGNDDTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQVRKKDTSEI 165

Query:   178 YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL 237
             YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF+VQLKYSFQTKYRLYLVLDFINGGHL
Sbjct:   166 YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHL 225

Query:   238 FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA 297
             FFQLYH GLFREDLAR+Y AEIVSAVSHLH  GIMHRDLKPENIL+  DGHVMLTDFGLA
Sbjct:   226 FFQLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDVDGHVMLTDFGLA 285

Query:   298 KQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKI 357
             K+F+ENTRSNSM GT EYMAPEIV GKGH+KAADWWSVGILLYEMLTGKPPF+G ++ KI
Sbjct:   286 KEFEENTRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGKPPFLG-SKGKI 344

Query:   358 QQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLE 417
             QQKIVKDK++LP FLS+EAH+LLKGLLQKEP +RLG+GP G+EEIK HKWFK INWKKLE
Sbjct:   345 QQKIVKDKIKLPQFLSNEAHALLKGLLQKEPERRLGSGPSGAEEIKKHKWFKAINWKKLE 404

Query:   418 AREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNT--NPFADFSYVRPAASFL 475
             ARE+QP F P V+G+ CIANF+K WTDM + DSPA++P ++   NPF +F+YVRP  SFL
Sbjct:   405 AREVQPSFKPAVSGRQCIANFDKCWTDMSVLDSPASSPNSDAKANPFTNFTYVRPPHSFL 464

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0009408 "response to heat" evidence=IEP

TAIR|locus:2077873 PK1 "protein-serine kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1602 (569.0 bits), Expect = 1.3e-164, P = 1.3e-164
 Identities = 317/474 (66%), Positives = 377/474 (79%)

Query:    18 LQTQLFFXXXXXXXXXXXXLELDFSDVFGPVPVQDSPEVSYGDLVNAVSAAADASEIIYE 77
             +Q Q +             +EL+FSDVFGP+P                    +A++I Y+
Sbjct:    12 IQKQQYLSISPSNSVLKDDVELEFSDVFGPLP-------------------EEANDIAYD 52

Query:    78 DPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECVDGLTVKEIDE-SSIDEN 136
             +P ++ +RSHSLVGP S  S S KLTKL L E+ED+ +L+EC++G ++KE D+ S  D++
Sbjct:    53 EPAVVYSRSHSLVGPCSLDSHSLKLTKLTLLETEDSIDLVECLEGESLKENDDFSGNDDS 112

Query:   137 -----VKGDSVTVC-CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE 190
                  ++GD V V   VGI+DFEV+KVVG+GAFG+VYQVRKK TSEIYAMKVMRKD I+E
Sbjct:   113 DNEKALEGDLVKVSGVVGIDDFEVMKVVGKGAFGKVYQVRKKETSEIYAMKVMRKDHIME 172

Query:   191 KNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRED 250
             KNHAEYMKAERDILTKIDHPF+VQLKYSFQTKYRLYLVLDFINGGHLFFQLYH GLFRED
Sbjct:   173 KNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHQGLFRED 232

Query:   251 LARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI 310
             LAR+Y AEIVSAVSHLH  GIMHRDLKPENIL+  DGHVMLTDFGLAK+F+ENTRSNSM 
Sbjct:   233 LARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDTDGHVMLTDFGLAKEFEENTRSNSMC 292

Query:   311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA 370
             GT EYMAPEIV GKGH+KAADWWSVGILLYEMLTGKPPF+G ++ KIQQKIVKDK++LP 
Sbjct:   293 GTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGKPPFLG-SKGKIQQKIVKDKIKLPQ 351

Query:   371 FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVA 430
             FLS+EAH++LKGLLQKEP +RLG+G  G+EEIK HKWFK INWKKLEARE+ P F PEV+
Sbjct:   352 FLSNEAHAILKGLLQKEPERRLGSGLSGAEEIKQHKWFKGINWKKLEAREVMPSFKPEVS 411

Query:   431 GKHCIANFEKKWTDMPLSDSPAATPKNN--TNPFADFSYVRPAASFL-QSNSPL 481
             G+ CIANF+K WTDM + DSPA++P ++   NPF +F+YVRP  SFL QS + L
Sbjct:   412 GRQCIANFDKCWTDMSVLDSPASSPSSDPKANPFTNFTYVRPPPSFLHQSTTTL 465

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IMP;IDA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

UNIPROTKB|F1MNP4 RPS6KB1 "Ribosomal protein S6 kinase beta-1" [Bos taurus (taxid:9913)]

 Score = 821 (294.1 bits), Expect = 7.4e-82, P = 7.4e-82
 Identities = 162/335 (48%), Positives = 229/335 (68%)

Query:   150 EDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEK-NHAEYMKAERDILT 205
             E FE+L+V+G+G +G+V+QVRK    NT +I+AMKV++K  IV       + KAER+IL 
Sbjct:    89 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query:   206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL   G+F ED A  Y AEI  A+ H
Sbjct:   149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query:   266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
             LH  GI++RDLKPENI+L   GHV LTDFGL K+   + T +++  GT+EYMAPEI++  
Sbjct:   209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query:   325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
             GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI+K KL LP +L+ EA  LLK LL
Sbjct:   269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query:   385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
             ++    RLGAGP  + E+++H +F+ INW++L AR+++P F P +  +  ++ F+ K+T 
Sbjct:   329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query:   445 MPLSDSP--AATPKNNTNPFADFSYVRPAASFLQS 477
                 DSP  +A  ++    F  F+YV P  S L+S
Sbjct:   389 QTPVDSPDDSALSESANQVFLGFTYVAP--SVLES 421

GO:0071363 "cellular response to growth factor stimulus" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0045931 "positive regulation of mitotic cell cycle" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

GO:0031929 "TOR signaling cascade" evidence=IEA

GO:0007281 "germ cell development" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q6TJY3 RPS6KB1 "Ribosomal protein S6 kinase beta-1" [Bos taurus (taxid:9913)]

 Score = 821 (294.1 bits), Expect = 7.4e-82, P = 7.4e-82
 Identities = 162/335 (48%), Positives = 229/335 (68%)

Query:   150 EDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEK-NHAEYMKAERDILT 205
             E FE+L+V+G+G +G+V+QVRK    NT +I+AMKV++K  IV       + KAER+IL 
Sbjct:    89 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query:   206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL   G+F ED A  Y AEI  A+ H
Sbjct:   149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query:   266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
             LH  GI++RDLKPENI+L   GHV LTDFGL K+   + T +++  GT+EYMAPEI++  
Sbjct:   209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query:   325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
             GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI+K KL LP +L+ EA  LLK LL
Sbjct:   269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query:   385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
             ++    RLGAGP  + E+++H +F+ INW++L AR+++P F P +  +  ++ F+ K+T 
Sbjct:   329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query:   445 MPLSDSP--AATPKNNTNPFADFSYVRPAASFLQS 477
                 DSP  +A  ++    F  F+YV P  S L+S
Sbjct:   389 QTPVDSPDDSALSESANQVFLGFTYVAP--SVLES 421

GO:0004672 "protein kinase activity" evidence=ISS

GO:0005739 "mitochondrion" evidence=ISS

GO:0071363 "cellular response to growth factor stimulus" evidence=ISS

GO:0043066 "negative regulation of apoptotic process" evidence=ISS

GO:0043005 "neuron projection" evidence=IEA

GO:0005741 "mitochondrial outer membrane" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0045931 "positive regulation of mitotic cell cycle" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0031929 "TOR signaling cascade" evidence=IEA

GO:0007281 "germ cell development" evidence=IEA

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA

GO:0045202 "synapse" evidence=IEA

GO:0030054 "cell junction" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E2RMD8 RPS6KB1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 820 (293.7 bits), Expect = 9.4e-82, P = 9.4e-82
 Identities = 163/335 (48%), Positives = 229/335 (68%)

Query:   150 EDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEK-NHAEYMKAERDILT 205
             E FE+L+V+G+G +G+V+QVRK    NT +I+AMKV++K  IV       + KAER+IL 
Sbjct:    89 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query:   206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL   G+F ED A  Y AEI  A+ H
Sbjct:   149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query:   266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
             LH  GI++RDLKPENI+L   GHV LTDFGL K+   + T +++  GT+EYMAPEI++  
Sbjct:   209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query:   325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
             GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI+K KL LP +L+ EA  LLK LL
Sbjct:   269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query:   385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
             ++    RLGAGP  + E+++H +F+ INW++L AR+++P F P +  +  ++ F+ K+T 
Sbjct:   329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query:   445 MPLSDSPA-ATPKNNTNP-FADFSYVRPAASFLQS 477
                 DSP  +T   + N  F  F+YV P  S L+S
Sbjct:   389 QTPVDSPDDSTLSESANQVFLGFTYVAP--SVLES 421

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

UNIPROTKB|B4DLT4 RPS6KB1 "cDNA FLJ53847, highly similar to Ribosomal protein S6 kinase beta-1 (EC 2.7.11.1)" [Homo sapiens (taxid:9606)]

 Score = 820 (293.7 bits), Expect = 9.4e-82, P = 9.4e-82
 Identities = 163/335 (48%), Positives = 229/335 (68%)

Query:   150 EDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEK-NHAEYMKAERDILT 205
             E FE+L+V+G+G +G+V+QVRK    NT +I+AMKV++K  IV       + KAER+IL 
Sbjct:    36 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 95

Query:   206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL   G+F ED A  Y AEI  A+ H
Sbjct:    96 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 155

Query:   266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
             LH  GI++RDLKPENI+L   GHV LTDFGL K+   + T +++  GT+EYMAPEI++  
Sbjct:   156 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 215

Query:   325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
             GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI+K KL LP +L+ EA  LLK LL
Sbjct:   216 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 275

Query:   385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
             ++    RLGAGP  + E+++H +F+ INW++L AR+++P F P +  +  ++ F+ K+T 
Sbjct:   276 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 335

Query:   445 MPLSDSPA-ATPKNNTNP-FADFSYVRPAASFLQS 477
                 DSP  +T   + N  F  F+YV P  S L+S
Sbjct:   336 QTPVDSPDDSTLSESANQVFLGFTYVAP--SVLES 368

GO:0005840 "ribosome" evidence=IEA

GO:0003009 "skeletal muscle contraction" evidence=IEA

GO:0004711 "ribosomal protein S6 kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0007281 "germ cell development" evidence=IEA

GO:0007568 "aging" evidence=IEA

GO:0007584 "response to nutrient" evidence=IEA

GO:0007616 "long-term memory" evidence=IEA

GO:0009408 "response to heat" evidence=IEA

GO:0009611 "response to wounding" evidence=IEA

GO:0009612 "response to mechanical stimulus" evidence=IEA

GO:0009636 "response to toxic substance" evidence=IEA

GO:0009749 "response to glucose stimulus" evidence=IEA

GO:0009986 "cell surface" evidence=IEA

GO:0014732 "skeletal muscle atrophy" evidence=IEA

GO:0014878 "response to electrical stimulus involved in regulation of muscle adaptation" evidence=IEA

GO:0014911 "positive regulation of smooth muscle cell migration" evidence=IEA

GO:0016477 "cell migration" evidence=IEA

GO:0032496 "response to lipopolysaccharide" evidence=IEA

GO:0032868 "response to insulin stimulus" evidence=IEA

GO:0032870 "cellular response to hormone stimulus" evidence=IEA

GO:0033574 "response to testosterone stimulus" evidence=IEA

GO:0033762 "response to glucagon stimulus" evidence=IEA

GO:0034612 "response to tumor necrosis factor" evidence=IEA

GO:0042277 "peptide binding" evidence=IEA

GO:0042493 "response to drug" evidence=IEA

GO:0043201 "response to leucine" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0045471 "response to ethanol" evidence=IEA

GO:0046324 "regulation of glucose import" evidence=IEA

GO:0046627 "negative regulation of insulin receptor signaling pathway" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0048633 "positive regulation of skeletal muscle tissue growth" evidence=IEA

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=IEA

GO:0051384 "response to glucocorticoid stimulus" evidence=IEA

UNIPROTKB|P23443 RPS6KB1 "Ribosomal protein S6 kinase beta-1" [Homo sapiens (taxid:9606)]

 Score = 820 (293.7 bits), Expect = 9.4e-82, P = 9.4e-82
 Identities = 163/335 (48%), Positives = 229/335 (68%)

Query:   150 EDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEK-NHAEYMKAERDILT 205
             E FE+L+V+G+G +G+V+QVRK    NT +I+AMKV++K  IV       + KAER+IL 
Sbjct:    89 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query:   206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL   G+F ED A  Y AEI  A+ H
Sbjct:   149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query:   266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
             LH  GI++RDLKPENI+L   GHV LTDFGL K+   + T +++  GT+EYMAPEI++  
Sbjct:   209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query:   325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
             GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI+K KL LP +L+ EA  LLK LL
Sbjct:   269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query:   385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
             ++    RLGAGP  + E+++H +F+ INW++L AR+++P F P +  +  ++ F+ K+T 
Sbjct:   329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query:   445 MPLSDSPA-ATPKNNTNP-FADFSYVRPAASFLQS 477
                 DSP  +T   + N  F  F+YV P  S L+S
Sbjct:   389 QTPVDSPDDSTLSESANQVFLGFTYVAP--SVLES 421

GO:0006915 "apoptotic process" evidence=IEA

GO:0030054 "cell junction" evidence=IEA

GO:0045202 "synapse" evidence=IEA

GO:0007281 "germ cell development" evidence=IEA

GO:0007568 "aging" evidence=IEA

GO:0007584 "response to nutrient" evidence=IEA

GO:0007616 "long-term memory" evidence=IEA

GO:0009408 "response to heat" evidence=IEA

GO:0009611 "response to wounding" evidence=IEA

GO:0009612 "response to mechanical stimulus" evidence=IEA

GO:0009636 "response to toxic substance" evidence=IEA

GO:0009749 "response to glucose stimulus" evidence=IEA

GO:0009986 "cell surface" evidence=IEA

GO:0014732 "skeletal muscle atrophy" evidence=IEA

GO:0014878 "response to electrical stimulus involved in regulation of muscle adaptation" evidence=IEA

GO:0014911 "positive regulation of smooth muscle cell migration" evidence=IEA

GO:0016477 "cell migration" evidence=IEA

GO:0032496 "response to lipopolysaccharide" evidence=IEA

GO:0033574 "response to testosterone stimulus" evidence=IEA

GO:0033762 "response to glucagon stimulus" evidence=IEA

GO:0034612 "response to tumor necrosis factor" evidence=IEA

GO:0042277 "peptide binding" evidence=IEA

GO:0042493 "response to drug" evidence=IEA

GO:0043201 "response to leucine" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0045471 "response to ethanol" evidence=IEA

GO:0046324 "regulation of glucose import" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0048633 "positive regulation of skeletal muscle tissue growth" evidence=IEA

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=IEA

GO:0051384 "response to glucocorticoid stimulus" evidence=IEA

GO:0003009 "skeletal muscle contraction" evidence=IEA

GO:0004711 "ribosomal protein S6 kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA;IDA

GO:0005741 "mitochondrial outer membrane" evidence=IEA

GO:0043005 "neuron projection" evidence=IEA

GO:0031929 "TOR signaling cascade" evidence=IDA

GO:0045727 "positive regulation of translation" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0045931 "positive regulation of mitotic cell cycle" evidence=IMP

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IMP

GO:0048015 "phosphatidylinositol-mediated signaling" evidence=TAS

GO:0005737 "cytoplasm" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0005739 "mitochondrion" evidence=IDA

GO:0043066 "negative regulation of apoptotic process" evidence=IMP

GO:0045948 "positive regulation of translational initiation" evidence=IMP

GO:0071363 "cellular response to growth factor stimulus" evidence=IDA

GO:0046627 "negative regulation of insulin receptor signaling pathway" evidence=IMP

GO:0007165 "signal transduction" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=IDA

UNIPROTKB|Q7Z721 RPS6KB1 "RPS6KB1 protein" [Homo sapiens (taxid:9606)]

 Score = 820 (293.7 bits), Expect = 9.4e-82, P = 9.4e-82
 Identities = 163/335 (48%), Positives = 229/335 (68%)

Query:   150 EDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEK-NHAEYMKAERDILT 205
             E FE+L+V+G+G +G+V+QVRK    NT +I+AMKV++K  IV       + KAER+IL 
Sbjct:    89 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query:   206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL   G+F ED A  Y AEI  A+ H
Sbjct:   149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query:   266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
             LH  GI++RDLKPENI+L   GHV LTDFGL K+   + T +++  GT+EYMAPEI++  
Sbjct:   209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query:   325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
             GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI+K KL LP +L+ EA  LLK LL
Sbjct:   269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query:   385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
             ++    RLGAGP  + E+++H +F+ INW++L AR+++P F P +  +  ++ F+ K+T 
Sbjct:   329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query:   445 MPLSDSPA-ATPKNNTNP-FADFSYVRPAASFLQS 477
                 DSP  +T   + N  F  F+YV P  S L+S
Sbjct:   389 QTPVDSPDDSTLSESANQVFLGFTYVAP--SVLES 421

GO:0007165 "signal transduction" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005840 "ribosome" evidence=IEA

UNIPROTKB|P67998 RPS6KB1 "Ribosomal protein S6 kinase beta-1" [Oryctolagus cuniculus (taxid:9986)]

 Score = 820 (293.7 bits), Expect = 9.4e-82, P = 9.4e-82
 Identities = 163/335 (48%), Positives = 229/335 (68%)

Query:   150 EDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEK-NHAEYMKAERDILT 205
             E FE+L+V+G+G +G+V+QVRK    NT +I+AMKV++K  IV       + KAER+IL 
Sbjct:    89 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query:   206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL   G+F ED A  Y AEI  A+ H
Sbjct:   149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query:   266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
             LH  GI++RDLKPENI+L   GHV LTDFGL K+   + T +++  GT+EYMAPEI++  
Sbjct:   209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query:   325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
             GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI+K KL LP +L+ EA  LLK LL
Sbjct:   269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query:   385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
             ++    RLGAGP  + E+++H +F+ INW++L AR+++P F P +  +  ++ F+ K+T 
Sbjct:   329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query:   445 MPLSDSPA-ATPKNNTNP-FADFSYVRPAASFLQS 477
                 DSP  +T   + N  F  F+YV P  S L+S
Sbjct:   389 QTPVDSPDDSTLSESANQVFLGFTYVAP--SVLES 421

GO:0004672 "protein kinase activity" evidence=ISS

GO:0005739 "mitochondrion" evidence=ISS

GO:0043066 "negative regulation of apoptotic process" evidence=ISS

GO:0046627 "negative regulation of insulin receptor signaling pathway" evidence=ISS

GO:0071363 "cellular response to growth factor stimulus" evidence=ISS

MGI|MGI:1270849 Rps6kb1 "ribosomal protein S6 kinase, polypeptide 1" [Mus musculus (taxid:10090)]

 Score = 820 (293.7 bits), Expect = 9.4e-82, P = 9.4e-82
 Identities = 163/335 (48%), Positives = 229/335 (68%)

Query:   150 EDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEK-NHAEYMKAERDILT 205
             E FE+L+V+G+G +G+V+QVRK    NT +I+AMKV++K  IV       + KAER+IL 
Sbjct:    89 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query:   206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL   G+F ED A  Y AEI  A+ H
Sbjct:   149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query:   266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
             LH  GI++RDLKPENI+L   GHV LTDFGL K+   + T +++  GT+EYMAPEI++  
Sbjct:   209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query:   325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
             GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI+K KL LP +L+ EA  LLK LL
Sbjct:   269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query:   385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
             ++    RLGAGP  + E+++H +F+ INW++L AR+++P F P +  +  ++ F+ K+T 
Sbjct:   329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query:   445 MPLSDSPA-ATPKNNTNP-FADFSYVRPAASFLQS 477
                 DSP  +T   + N  F  F+YV P  S L+S
Sbjct:   389 QTPVDSPDDSTLSESANQVFLGFTYVAP--SVLES 421

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=ISO

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=ISO;IMP;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004711 "ribosomal protein S6 kinase activity" evidence=ISO

GO:0005524 "ATP binding" evidence=ISO

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=ISO

GO:0005739 "mitochondrion" evidence=ISO;IDA

GO:0005741 "mitochondrial outer membrane" evidence=IEA

GO:0005840 "ribosome" evidence=IEA

GO:0006417 "regulation of translation" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;IMP;IDA

GO:0006915 "apoptotic process" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0007281 "germ cell development" evidence=IDA

GO:0009986 "cell surface" evidence=ISO

GO:0014911 "positive regulation of smooth muscle cell migration" evidence=ISO

GO:0016020 "membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030054 "cell junction" evidence=IEA

GO:0031929 "TOR signaling cascade" evidence=ISO

GO:0032868 "response to insulin stimulus" evidence=ISO

GO:0034612 "response to tumor necrosis factor" evidence=ISO

GO:0042277 "peptide binding" evidence=ISO

GO:0043005 "neuron projection" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=ISO;IMP

GO:0043491 "protein kinase B signaling cascade" evidence=IGI

GO:0045202 "synapse" evidence=IEA

GO:0045727 "positive regulation of translation" evidence=ISO

GO:0045931 "positive regulation of mitotic cell cycle" evidence=ISO

GO:0045948 "positive regulation of translational initiation" evidence=ISO

GO:0046324 "regulation of glucose import" evidence=ISO

GO:0046627 "negative regulation of insulin receptor signaling pathway" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0048633 "positive regulation of skeletal muscle tissue growth" evidence=ISO

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=ISO

GO:0071363 "cellular response to growth factor stimulus" evidence=ISO

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q39030	KPK2_ARATH	2, ., 7, ., 1, 1, ., 1	0.6900	0.9605	0.9830	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	482
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-147
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-129
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-119
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-112
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-111
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-108
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-106
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-105
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-104
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-104
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-103
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-102
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-100
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-98
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-97
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-96
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-95
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-93
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-93
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-93
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-92
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-92
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-92
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-91
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-90
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-89
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-89
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-89
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-87
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-86
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-86
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-85
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-84
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-84
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-84
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-83
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-83
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-82
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-81
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-81
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-79
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-79
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-75
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-75
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-75
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-74
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-74
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-74
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-72
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-72
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-71
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-71
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-70
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-69
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-67
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-66
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-66
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-66
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-65
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-64
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-64
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-64
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-63
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-63
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-61
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-60
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-59
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-59
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-59
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-59
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-58
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	9e-58
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-56
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-52
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-48
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-48
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-47
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-46
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-46
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-45
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-44
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-44
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-43
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-43
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-42
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-41
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-41
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-41
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-41
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-40
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-40
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-40
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-40
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-40
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	7e-40
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-39
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-39
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-38
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-38
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-37
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-37
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-37
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-36
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-36
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-36
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-36
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-35
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-34
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-34
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-34
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-33
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-33
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-33
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-32
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-32
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-32
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-31
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-31
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-31
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-31
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-31
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-31
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-31
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-30
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-30
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-30
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-30
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-30
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-30
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-30
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-30
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-29
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-29
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-29
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-29
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-29
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-29
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-29
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-28
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-28
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-28
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-28
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-28
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-28
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-28
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-28
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-28
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-28
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-28
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-28
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-27
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-27
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-27
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-27
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-27
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-26
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-26
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-26
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-26
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-25
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-25
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-25
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-25
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-24
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-24
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-24
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-24
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-24
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-23
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-23
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-23
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-23
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-22
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-22
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-22
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-21
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-21
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-21
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-21
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-21
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-21
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-21
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-21
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-20
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-20
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-20
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-20
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-20
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-20
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-20
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-19
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-19
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-19
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-19
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-19
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-19
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	9e-19
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-18
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-18
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-18
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-18
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-18
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-17
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-17
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-17
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-17
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-17
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-16
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-16
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-13
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	6e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-12
smart00133	64	smart00133, S_TK_X, Extension to Ser/Thr-type prot	5e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-12
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	9e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-09
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	9e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-06
PRK09188	365	PRK09188, PRK09188, serine/threonine protein kinas	4e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	6e-06
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	1e-05
pfam00433	47	pfam00433, Pkinase_C, Protein kinase C terminal do	1e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-05
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	4e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	5e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	6e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	1e-04
COG4248	637	COG4248, COG4248, Uncharacterized protein with pro	4e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-04

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  420 bits (1083), Expect = e-147
 Identities = 146/252 (57%), Positives = 197/252 (78%), Gaps = 3/252 (1%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+FG+V  VRKK+T ++YAMKV++K KI+++   E+   ER+IL++I+HPF+V+L Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           +FQT+ +LYLVL++  GG LF  L   G F E+ AR YAAEIV A+ +LH+ GI++RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 278 PENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
           PENILL ADGH+ LTDFGLAK+   E +R+N+  GT EY+APE++LGKG+ KA DWWS+G
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLG 180

Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGP 396
           +LLYEMLTGKPPF   +R +I +KI+KD LR P FLS EA  L+ GLLQK+P KRLG+G 
Sbjct: 181 VLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240

Query: 397 KGSEEIKSHKWF 408
             +EEIK+H +F
Sbjct: 241 --AEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  376 bits (968), Expect = e-129
 Identities = 135/291 (46%), Positives = 193/291 (66%), Gaps = 2/291 (0%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE +K +G G+FGRV  VR K + + YA+K++ K KIV+    E++  E+ IL  I H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF+V L  SFQ    LYLV++++ GG LF  L   G F E +AR YAA++V A+ +LH+ 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKA 329
            I++RDLKPEN+LL +DG++ +TDFG AK+    T   ++ GT EY+APEI+L KG+ KA
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILSKGYGKA 178

Query: 330 ADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPG 389
            DWW++GIL+YEML G PPF   N  +I +KI++ K+R P+F S +A  L++ LLQ +  
Sbjct: 179 VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLT 238

Query: 390 KRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEK 440
           KRLG    G  +IK+H WF  I+W  L  R+I+  F P+V G    +NF+ 
Sbjct: 239 KRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDD 289

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  352 bits (905), Expect = e-119
 Identities = 158/324 (48%), Positives = 220/324 (67%), Gaps = 9/324 (2%)

Query: 155 LKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIV--EKNHAEYMKAERDILTKIDH 209
           LKV+G+G +G+V+QVRK    +T +I+AMKV++K  IV  +K+ A + KAER+IL  + H
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTA-HTKAERNILEAVKH 59

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF+V L Y+FQT  +LYL+L++++GG LF  L   G+F ED A  Y +EI  A+ HLH  
Sbjct: 60  PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           GI++RDLKPENILL A GHV LTDFGL K+   E T +++  GT+EYMAPEI++  GH K
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGK 179

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWWS+G L+Y+MLTG PPF   NR K   KI+K KL LP +L+ EA  LLK LL++ P
Sbjct: 180 AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNP 239

Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLS 448
             RLGAGP  + E++SH +F+ +NW  L AR+++P F P +  +  ++ F+ K+T     
Sbjct: 240 SSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPV 299

Query: 449 DSPAAT--PKNNTNPFADFSYVRP 470
           DSP  +   ++    F  F+YV P
Sbjct: 300 DSPDDSTLSESANQIFLGFTYVAP 323

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  334 bits (858), Expect = e-112
 Identities = 154/319 (48%), Positives = 213/319 (66%), Gaps = 6/319 (1%)

Query: 155 LKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           LKV+GQG+FG+V+ VRK    +  ++YAMKV++K  +  ++     K ERDIL +++HPF
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHPF 59

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           +V+L Y+FQT+ +LYL+LDF+ GG LF +L    +F E+  + Y AE+  A+ HLH+ GI
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119

Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           ++RDLKPENILL  +GH+ LTDFGL+K+  D   ++ S  GTVEYMAPE+V  +GH ++A
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 179

Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGK 390
           DWWS G+L++EMLTG  PF G +R +    I+K KL +P FLS EA SLL+ L ++ P  
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPAN 239

Query: 391 RLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDS 450
           RLGAGP G EEIK H +F  I+W KL  REI+P F P V        F+ ++T     DS
Sbjct: 240 RLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDS 299

Query: 451 PAATPKNNTNP-FADFSYV 468
           P   P  N +  F  FS+V
Sbjct: 300 PGIPPSANAHQLFRGFSFV 318

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  329 bits (847), Expect = e-111
 Identities = 123/261 (47%), Positives = 170/261 (65%), Gaps = 11/261 (4%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +E+L+ +G+G+FG+VY  R K T ++ A+KV++K KI  K   E +  E  IL K+ HP 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           +V+L   F+ + +LYLV+++  GG LF  L   G   ED AR Y  +I+SA+ +LH+ GI
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           +HRDLKPENILL  DGHV L DFGLA+Q D   +  + +GT EYMAPE++LGKG+ KA D
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178

Query: 332 WWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDKLRLPAF---LSSEAHSLLKGLLQKE 387
            WS+G++LYE+LTGKPPF G     ++ +KI K K   P     +S EA  L++ LL K+
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKD 238

Query: 388 PGKRLGAGPKGSEEIKSHKWF 408
           P KRL A     EE   H +F
Sbjct: 239 PEKRLTA-----EEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  323 bits (830), Expect = e-108
 Identities = 152/332 (45%), Positives = 229/332 (68%), Gaps = 12/332 (3%)

Query: 151 DFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEKNH-AEYMKAERDILTK 206
           +FE+LKV+G GA+G+V+ VRK    +T ++YAMKV++K  +V+K    E+ + ER++L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 207 I-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
           +   PF+V L Y+FQT+ +L+L+LD+++GG +F  LY    F ED  R Y+ EI+ A+ H
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLG 323
           LH  GI++RD+K ENILL ++GHV+LTDFGL+K+F  +E  R+ S  GT+EYMAPEI+ G
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180

Query: 324 K-GHNKAADWWSVGILLYEMLTGKPPF-IGGNR---AKIQQKIVKDKLRLPAFLSSEAHS 378
           K GH KA DWWS+GIL++E+LTG  PF + G R   +++ ++I+K     P+F+  EA  
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240

Query: 379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANF 438
           LL  LL+K+P KRLGAGP+G+ EIK H +FK ++W+ L  R++ P F P +  +  + NF
Sbjct: 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNF 300

Query: 439 EKKWTDMPLSDSPAATPKNNTNPFADFSYVRP 470
            +++T++    SPA TP +    F  +S+V P
Sbjct: 301 AEEFTNLEPVYSPAGTPPSGARVFQGYSFVAP 332

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  319 bits (818), Expect = e-106
 Identities = 139/324 (42%), Positives = 205/324 (63%), Gaps = 12/324 (3%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK-IDHPFVVQ 214
           KV+G+G+FG+V   + K   + YA+KV++K  I++K   +++ AER++L K + HPF+V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L YSFQT  +LY VLD++NGG LFF L     F E  AR YAAEI SA+ +LH+  I++R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 275 DLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           DLKPENILL + GHV+LTDFGL K+  + +  +++  GT EY+APE++  + +++  DWW
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWW 180

Query: 334 SVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
            +G +LYEML G PPF   + A++   I+   LRL   +S  A  LL+GLLQK+  KRLG
Sbjct: 181 CLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLG 240

Query: 394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAA 453
           A      EIK+H +F  INW  L  ++I P F P V+G   + +F+ ++T+ P+ +S   
Sbjct: 241 AK-DDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGK 299

Query: 454 TPKNNT---------NPFADFSYV 468
           +P +           + F  FSY 
Sbjct: 300 SPDSVLVSASVKEADDAFLGFSYA 323

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  314 bits (806), Expect = e-105
 Identities = 126/267 (47%), Positives = 180/267 (67%), Gaps = 13/267 (4%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           + +GA+GRV+  +KK+T +IYA+KV++K  ++ KN  + +  ERDIL++   P+VV+L Y
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           SFQ K  LYLV++++ GG L   L + G   ED+ARIY AEIV A+ +LH+NGI+HRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 278 PENILLGADGHVMLTDFGLAK---------QFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           P+NIL+ ++GH+ LTDFGL+K           D+      ++GT +Y+APE++LG+GH+K
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF--LSSEAHSLLKGLLQK 386
             DWWS+G +LYE L G PPF G    +I Q I+  K+  P    +S EA  L+  LL  
Sbjct: 181 TVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP 240

Query: 387 EPGKRLGAGPKGSEEIKSHKWFKPINW 413
           +P KRLGA  K  EEIK+H +FK I+W
Sbjct: 241 DPEKRLGA--KSIEEIKNHPFFKGIDW 265

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  315 bits (808), Expect = e-104
 Identities = 142/356 (39%), Positives = 206/356 (57%), Gaps = 45/356 (12%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFEV+KV+G+GAFG V+ VR K+T ++YAMKV+RK  ++++N   +++AERDIL   D 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P++V+L YSFQ +  LYLV++++ GG L   L    +F E+ AR Y AE+V A+  +H  
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-------------------------- 303
           G +HRD+KP+NIL+ ADGH+ L DFGL K+ ++                           
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180

Query: 304 ----TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ 359
                R+NS +GT +Y+APE++ G  +    DWWS+G++LYEML G PPF      +   
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240

Query: 360 KIV--KDKLRLPAF--LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK 415
           KI+  K+ LR P    +S EA  L+  LL  +P  RLG+     EEIKSH +FK I+W+ 
Sbjct: 241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGS----FEEIKSHPFFKGIDWEN 295

Query: 416 LEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTN----PFADFSY 467
           L  RE +P F PE++     +NF+    D  LSD  +   K         F  F+Y
Sbjct: 296 L--RETKPPFVPELSSPLDTSNFDDFEDDKDLSDYLSQNSKKLNKGKQLAFVGFTY 349

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  312 bits (801), Expect = e-104
 Identities = 137/290 (47%), Positives = 201/290 (69%), Gaps = 15/290 (5%)

Query: 151 DFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEKNH-AEYMKAERDILTK 206
           +FE+L+V+G GA+G+V+ VRK    +  ++YAMKV++K  IV+K   AE+ + ER +L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 207 IDH-PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
           +   PF+V L Y+FQT  +L+L+LD++NGG LF  LY    F E   R+Y AEIV A+ H
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLG 323
           LH  GI++RD+K ENILL ++GHV+LTDFGL+K+F  +E  R+ S  GT+EYMAPE++ G
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180

Query: 324 K--GHNKAADWWSVGILLYEMLTGKPPF-IGGNR---AKIQQKIVKDKLRLPAFLSSEAH 377
              GH+KA DWWS+G+L +E+LTG  PF + G +   ++I ++I+K K   P  +S+EA 
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240

Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP 427
             ++ LL+K+P KRLGA   G++EIK+H +F+ I+W  L A+ I   F P
Sbjct: 241 DFIQKLLEKDPKKRLGAN--GADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  311 bits (799), Expect = e-103
 Identities = 132/318 (41%), Positives = 202/318 (63%), Gaps = 5/318 (1%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL-TKIDHPFVVQ 214
           KV+G+G+FG+V     K T E+YA+KV++KD I++ +  E    E+ +L     HPF+ Q
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   FQTK RL+ V++++NGG L F +   G F E  AR YAAEIV  +  LH  GI++R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 275 DLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           DLK +N+LL ++GH+ + DFG+ K+       +++  GT +Y+APEI+  + +  A DWW
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWW 180

Query: 334 SVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           ++G+LLYEML G+ PF G +  ++ Q I++D++R P +LS EA S+LK  L K P KRLG
Sbjct: 181 ALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLG 240

Query: 394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSP-- 451
             P G ++IK H +F+ I+W KLE +EI+P F P++ G+  ++NF+ ++T      +P  
Sbjct: 241 CLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPD 300

Query: 452 -AATPKNNTNPFADFSYV 468
            A     +   F  FSY+
Sbjct: 301 EAIIRNIDQEEFRGFSYI 318

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  308 bits (791), Expect = e-102
 Identities = 139/314 (44%), Positives = 206/314 (65%), Gaps = 6/314 (1%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+FG+V QVRK++T  IYA+K +RK  IV ++   +  AER +L +++ PF+V LK+
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           SFQ+  +LYLVL FINGG LF  L   G F    AR Y AE++ A+ +LH   +++RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 278 PENILLGADGHVMLTDFGLAK-QFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
           PENILL   GH+ L DFGL K    ++ ++N+  GT EY+APE++LG G+ KA DWW++G
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLG 180

Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGP 396
           +LLYEMLTG PPF   N  ++ +KI+++ LR P     +A  LL GLL ++P +RLG   
Sbjct: 181 VLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN- 239

Query: 397 KGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWT-DMPLSDSPAATP 455
            G++EIK+H +F  ++WKKL  + IQP F P V+     +NF++++T + P+      + 
Sbjct: 240 -GAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSVVDDSH 298

Query: 456 KNNT--NPFADFSY 467
            + T    F  +SY
Sbjct: 299 LSETVQQQFGGWSY 312

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  303 bits (777), Expect = e-100
 Identities = 127/316 (40%), Positives = 185/316 (58%), Gaps = 37/316 (11%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
            F+ +K++G+G  GRV+ VR K T +++A+KV+ K +++++N  + +  E++IL  +DHP
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLF--FQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           F+  L  SFQT+  L LV+D+  GG LF   Q        E++AR YAAE++ A+ +LH 
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-------------------------- 302
            GI++RDLKPENILL   GH+ML+DF L+KQ D                           
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181

Query: 303 ----NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ 358
               + RSNS +GT EY+APE++ G GH  A DWW++GILLYEML G  PF G NR +  
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241

Query: 359 QKIVKDKLRLP--AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKL 416
             I+K ++  P    +SS A  L++ LL K+P KRLG+  +G+ EIK H +F+ +NW  +
Sbjct: 242 SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK-RGAAEIKQHPFFRGVNWALI 300

Query: 417 EAREIQPGFCPEVAGK 432
             R   P   P     
Sbjct: 301 --RHTTPPIIPRPDDG 314

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  297 bits (763), Expect = 4e-98
 Identities = 137/328 (41%), Positives = 203/328 (61%), Gaps = 15/328 (4%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           DF  L V+G+G+FG+V    +K T E+YA+K+++KD I++ +  E    E+ +L     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 211 -FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
            F+ QL   FQT  RLY V++++NGG L + +   G F+E  A  YAAEI   +  LH+ 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQ--FDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           GI++RDLK +N++L A+GH+ + DFG+ K+  F   T + +  GT +Y+APEI+  + + 
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT-TRTFCGTPDYIAPEIIAYQPYG 179

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           K+ DWW+ G+LLYEML G+PPF G +  ++ Q I++  +  P  LS EA S+ KGLL K 
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH 239

Query: 388 PGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPL 447
           P KRLG GP G  +I+ H +F+ I+W+KLE REIQP F P+V G+    NF+K +T  P 
Sbjct: 240 PAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFFTREP- 298

Query: 448 SDSPAATP-------KNNTNPFADFSYV 468
              P  TP         + + F  FS+V
Sbjct: 299 ---PVLTPPDKLVIANIDQSEFQGFSFV 323

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  293 bits (752), Expect = 3e-97
 Identities = 110/262 (41%), Positives = 170/262 (64%), Gaps = 4/262 (1%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G FGRV  V+ K+ +  +A+K ++K  IVE    E++ +E++IL + +HPF+V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           +F+ K  +Y+++++  GG L+  L   GLF E  AR Y A +V A  +LH  GI++RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 278 PENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGI 337
           PEN+LL ++G+V L DFG AK+     ++ +  GT EY+APEI+L KG++ + D+WS+GI
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGI 180

Query: 338 LLYEMLTGKPPFIGGNRA--KIQQKIVK--DKLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           LLYE+LTG+PPF   +    +I   I+K   KL  P ++   A  L+K LL++ P +RLG
Sbjct: 181 LLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLG 240

Query: 394 AGPKGSEEIKSHKWFKPINWKK 415
               G ++IK HKWF   +W+ 
Sbjct: 241 NLKGGIKDIKKHKWFNGFDWEG 262

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  291 bits (747), Expect = 4e-96
 Identities = 117/290 (40%), Positives = 186/290 (64%), Gaps = 2/290 (0%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D E +K VG G FGRV+ VR + +   YA+KVM   +++     +++  E+ +L ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF+++L ++   +  LY++++++ GG LF  L + G F       YA+EIV A+ +LH+ 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKA 329
            I++RDLKPENILL  +GH+ LTDFG AK+  +  R+ ++ GT EY+APE++  KGHNKA
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--RTWTLCGTPEYLAPEVIQSKGHNKA 178

Query: 330 ADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPG 389
            DWW++GIL+YEML G PPF   N   I +KI+  KL  P  L   A  L+K LL  +  
Sbjct: 179 VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRT 238

Query: 390 KRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
           +RLG    G++++K+H+WFK ++W  +  R+++P   P+V+     +NF+
Sbjct: 239 RRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFD 288

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  291 bits (746), Expect = 2e-95
 Identities = 126/308 (40%), Positives = 187/308 (60%), Gaps = 3/308 (0%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           + DFE+ + +G G+FGRV   + K T E YA+K ++K +I++    +++  E+ IL ++ 
Sbjct: 17  LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HPF+V +  SFQ + R+Y +L+F+ GG LF  L   G F  D+A+ Y AE+V A  +LH+
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             I++RDLKPEN+LL   GHV +TDFG AK+  +  R+ ++ GT EY+APE++  KGH K
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--RTFTLCGTPEYLAPEVIQSKGHGK 194

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+LLYE + G PPF      +I +KI+  +L+ P +    A  L+KGLLQ + 
Sbjct: 195 AVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDH 254

Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLS 448
            KRLG    G  ++K+H +F   NW KL AR         V      +NFE K+ D P+ 
Sbjct: 255 TKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFE-KYPDSPVD 313

Query: 449 DSPAATPK 456
             P  T  
Sbjct: 314 RLPPLTAA 321

Length = 329

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  286 bits (734), Expect = 1e-93
 Identities = 123/331 (37%), Positives = 195/331 (58%), Gaps = 21/331 (6%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL---TKID 208
           F  L V+G+G FG+V     K T E+YA+K ++K  I+ ++  E +  E+ I        
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HPF+V L   FQT+  +  V+++  GG L   + H  +F E  A  YAA +V  + +LH 
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHE 119

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQ---FDENTRSNSMIGTVEYMAPEIVLGKG 325
           N I++RDLK +N+LL  +G V + DFGL K+   F +  R+++  GT E++APE++    
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETS 177

Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G+L+YEML G+ PF G +  ++   IV D++R P FLS EA S+++ LL+
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237

Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDM 445
           + P +RLG+G K +E++K   +F+ INW  L AR+I+P F P + G   ++NF++++T  
Sbjct: 238 RNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEEFT-- 295

Query: 446 PLSDSPAATPKNNTNP--------FADFSYV 468
             S++P  TP              F  F YV
Sbjct: 296 --SEAPVLTPPREPRLLTEEEQELFRGFDYV 324

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  286 bits (733), Expect = 2e-93
 Identities = 136/319 (42%), Positives = 194/319 (60%), Gaps = 14/319 (4%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI---DHPFVVQ 214
           +G+G FG+VYQVRKK+T  IYAMKV+ K +IV K    +   ER+IL +    + PF+V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           LK+SFQT   LYLV D+++GG LF+ L   G F ED A+ Y AE+V A+ HLH   I++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 275 DLKPENILLGADGHVMLTDFGLAK-QFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADW 332
           DLKPENILL A GH+ L DFGL+K    +N  +N+  GT EY+APE++L  KG+ K  D+
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180

Query: 333 WSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP-AFLSSEAHSLLKGLLQKEPGKR 391
           WS+G+L++EM  G  PF   +  ++ + I   K+R P   LS E    +KGLL + P  R
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240

Query: 392 LGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSD-- 449
           LGA  + + E+K H +F  I+W  L  ++I P F P V     ++NF+ ++T+  L +  
Sbjct: 241 LGA-HRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFTNSSLLNAG 299

Query: 450 -----SPAATPKNNTNPFA 463
                     P  N+ P +
Sbjct: 300 IVPWEDVPGLPGANSTPLS 318

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  284 bits (729), Expect = 7e-93
 Identities = 129/321 (40%), Positives = 202/321 (62%), Gaps = 10/321 (3%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           K++G+G FG+V  VR+K T + YAMK+++K+ I+ K+   +   E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           KYSFQT  RL  V+++ NGG LFF L    +F ED AR Y AEIVSA+ +LH+  +++RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 276 LKPENILLGADGHVMLTDFGLAKQ--FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           LK EN++L  DGH+ +TDFGL K+   D  T   +  GT EY+APE++    + +A DWW
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 334 SVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
            +G+++YEM+ G+ PF   +  K+ + I+ +++R P  LS EA SLL GLL+K+P +RLG
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239

Query: 394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSP-- 451
            GP+ ++EI  H++F  INW+ +  ++++P F P+V  +     F++++T   ++ +P  
Sbjct: 240 GGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQSITITPPD 299

Query: 452 ----AATPKNNTNP-FADFSY 467
                   +    P F  FSY
Sbjct: 300 RYDSLGLLQLEERPHFPQFSY 320

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  281 bits (721), Expect = 3e-92
 Identities = 139/290 (47%), Positives = 201/290 (69%), Gaps = 13/290 (4%)

Query: 151 DFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEK-NHAEYMKAERDILTK 206
           +FE+LKV+G GA+G+V+ VRK    ++ ++YAMKV++K  IV+K    E+ + ER +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 207 IDH-PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
           I   PF+V L Y+FQT  +L+L+LD+INGG LF  L     F+E   +IY+ EIV A+ H
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLG 323
           LH  GI++RD+K ENILL ++GHV+LTDFGL+K+F  DE  R+ S  GT+EYMAP+IV G
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180

Query: 324 --KGHNKAADWWSVGILLYEMLTGKPPF-IGGNR---AKIQQKIVKDKLRLPAFLSSEAH 377
              GH+KA DWWS+G+L+YE+LTG  PF + G +   A+I ++I+K +   P  +S+ A 
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240

Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP 427
            +++ LL K+P KRLG GP  ++EIK H +F+ INW  L A+++   F P
Sbjct: 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  279 bits (717), Expect = 5e-92
 Identities = 111/260 (42%), Positives = 166/260 (63%), Gaps = 6/260 (2%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           FE+L+V+G+GAFG+V  V+K++T +++AMK M K K VEK     +  ER IL +++HPF
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           +V L YSFQ +  +YLV+D + GG L + L     F E+  + +  EIV A+ +LH+ GI
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           +HRD+KP+NILL   GHV +TDF +A +   +T + S  GT  YMAPE++  +G++ A D
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVD 181

Query: 332 WWSVGILLYEMLTGKPPFIG---GNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           WWS+G+  YE L GK P+ G     R +I+ K     +  PA  S+EA   +  LL+++P
Sbjct: 182 WWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDP 241

Query: 389 GKRLGAGPKGSEEIKSHKWF 408
            KRLG   K   ++K+H +F
Sbjct: 242 QKRLGDNLK---DLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  280 bits (718), Expect = 8e-92
 Identities = 106/281 (37%), Positives = 170/281 (60%), Gaps = 23/281 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID- 208
           +DF+  K++G+G+F  V   ++K T++ YA+K++ K +++++   +Y+K E+++LT+++ 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +++L Y+FQ +  LY VL++   G L   +  +G   E   R YAAEI+ A+ +LH+
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---------------------TRSN 307
            GI+HRDLKPENILL  D H+ +TDFG AK  D N                      R  
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR 367
           S +GT EY++PE++  K   K++D W++G ++Y+MLTGKPPF G N     QKI+K +  
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240

Query: 368 LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
            P     +A  L++ LL  +P  RLG    G +E+K+H +F
Sbjct: 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNE-GYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  281 bits (720), Expect = 5e-91
 Identities = 133/367 (36%), Positives = 200/367 (54%), Gaps = 52/367 (14%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE +KV+G+GAFG V  V+KK+T  IYAMK +RK +++EK    +++AERDIL + D+
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P+VV+L YSFQ +  LYL+++++ GG +   L     F E+  R Y AE + A+  +H  
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN---------------------- 307
           G +HRD+KP+N+LL A GH+ L+DFGL     ++ R+                       
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 308 -----------------SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFI 350
                            S +GT +Y+APE+ L  G+NK  DWWS+G+++YEML G PPF 
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240

Query: 351 GGNRAKIQQKIV--KDKLRLP--AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHK 406
             N  +  +KI+  K+ L+ P    LS EA  L+K L   E  +RLG    G  EIKSH 
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN--NGVNEIKSHP 297

Query: 407 WFKPINWKKLEAREIQPGFCPEVAGKHCIANFEK-KWTDMPLSDSPAATPKNNTN---PF 462
           +FK ++W+ +  RE      PE+      +NF+  +  D+ +  SP        +    F
Sbjct: 298 FFKGVDWEHI--RERPAPIIPELKSITDTSNFDDFEEIDLDVPTSPGPPRGKIKSKDLAF 355

Query: 463 ADFSYVR 469
             ++Y R
Sbjct: 356 IGYTYKR 362

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  278 bits (713), Expect = 1e-90
 Identities = 140/326 (42%), Positives = 208/326 (63%), Gaps = 12/326 (3%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK-IDHPFVVQ 214
           KV+G+G+FG+V   R K   + YA+KV++K  I++K   +++ +ER++L K + HPF+V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L +SFQT  +LY VLD+INGG LF+ L     F E  AR YAAEI SA+ +LH+  I++R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 275 DLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           DLKPENILL + GH++LTDFGL K+  + N  +++  GT EY+APE++  + +++  DWW
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 180

Query: 334 SVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
            +G +LYEML G PPF   N A++   I+   L+L   +++ A  LL+GLLQK+  KRLG
Sbjct: 181 CLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLG 240

Query: 394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAA 453
           A      EIK+H +F PINW  L  ++I P F P V+G + + +F+ ++T+ P+ +S   
Sbjct: 241 A-KDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQ 299

Query: 454 TP---------KNNTNPFADFSYVRP 470
           +P         K     F  FSY  P
Sbjct: 300 SPDSILVTASVKEAAEAFLGFSYAPP 325

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  275 bits (704), Expect = 2e-89
 Identities = 136/321 (42%), Positives = 200/321 (62%), Gaps = 9/321 (2%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK-IDHPFVVQ 214
           KV+G+G+FG+V   ++K+    YA+KV++K  I++K    ++ AER++L K + HPF+V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L YSFQT  +LY VLD++NGG LFF L     F E  AR YAAE+ SA+ +LH+  I++R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 275 DLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           DLKPENILL + GHV+LTDFGL K+  +    +++  GT EY+APE++  + +++  DWW
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWW 180

Query: 334 SVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
            +G +LYEML G PPF   + +++   I+   L+LP   +  A  LL GLL K+  +RLG
Sbjct: 181 CLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLG 240

Query: 394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAA 453
           A      EIK+H +F PINW  L  + I P + P VAG   + +F+ ++T   +S S   
Sbjct: 241 A-KADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQ 299

Query: 454 TPKNN------TNPFADFSYV 468
           TP         ++ F  FSY 
Sbjct: 300 TPDLTASSSSASSAFLGFSYA 320

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  272 bits (698), Expect = 4e-89
 Identities = 110/266 (41%), Positives = 155/266 (58%), Gaps = 15/266 (5%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +E+L+ +G G+FG VY+ + K T +I A+K+++K     K        E  IL ++ HP 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPN 59

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           +V+L  +F+ K  LYLV+++  GG LF  L   G   ED A+  A +I+  + +LH+NGI
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI-GTVEYMAPEIVL-GKGHNKA 329
           +HRDLKPENILL  +G V + DFGLAK+  +++ S +   GT  YMAPE++L G G+   
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 330 ADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF-------LSSEAHSLLKG 382
            D WS+G++LYE+LTGKPPF G N     Q I +       F        S EA  L+K 
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWF 408
            L K+P KR  A     EEI  H WF
Sbjct: 240 CLNKDPSKRPTA-----EEILQHPWF 260

Length = 260

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  274 bits (703), Expect = 4e-89
 Identities = 126/324 (38%), Positives = 191/324 (58%), Gaps = 15/324 (4%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT-KIDHPFVVQ 214
           KV+G+G+FG+V     K T E+YA+KV++KD I++ +  +    E+ IL     HPF+  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   FQTK RL+ V++++NGG L FQ+     F E  +R YAAE+  A+  LH +G+++R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 275 DLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           DLK +NILL A+GH  L DFG+ K+       + +  GT +Y+APEI+    +  + DWW
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWW 180

Query: 334 SVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           ++G+L+YEM+ G+PPF   N   + + I+ D +  P +LS EA S+LK  + K P KRLG
Sbjct: 181 ALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLG 240

Query: 394 AGPK--GSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSP 451
                 G + IK H +FK I+W  LE R+I+P F P++  K  + NF++ +T     + P
Sbjct: 241 CVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFT----KEEP 296

Query: 452 AATPKN-------NTNPFADFSYV 468
             TP +       N   F  FS+ 
Sbjct: 297 VLTPVDPAVIKQINQEEFRGFSFF 320

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  270 bits (692), Expect = 2e-87
 Identities = 122/325 (37%), Positives = 195/325 (60%), Gaps = 19/325 (5%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT-KIDHPFVVQ 214
           KV+G+G+FG+V     K T+E +A+K ++KD ++E +  E    ER +L    +HPF+  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L  +FQTK  L+ V++++NGG L F +   G F E  AR YAAEI+  +  LH  GI++R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 275 DLKPENILLGADGHVMLTDFGLAK-QFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           DLK +N+LL  DGH+ + DFG+ K   +   ++++  GT +Y+APEI+ G+ +N++ DWW
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWW 180

Query: 334 SVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           S G+LLYEML G+ PF G +  ++   I+ D+   P ++S EA   L  L +++P KRLG
Sbjct: 181 SFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLG 240

Query: 394 -AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPA 452
             G      I+ H +F+ I+W++LE REI P F P+V      +NF++++T+    +   
Sbjct: 241 VDGD-----IRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTN----EKVR 291

Query: 453 ATPKN-------NTNPFADFSYVRP 470
            +P +       +   F  FS+  P
Sbjct: 292 LSPVDKKLLASMDQEQFRGFSFTNP 316

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  268 bits (685), Expect = 2e-86
 Identities = 120/298 (40%), Positives = 192/298 (64%), Gaps = 3/298 (1%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           K++G+G FG+V  VR+K T   YAMK++RK+ I+ K+   +   E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           KY+FQT  RL  V+++ NGG LFF L    +F E+ AR Y AEIVSA+ +LH+  +++RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 276 LKPENILLGADGHVMLTDFGLAKQ--FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           +K EN++L  DGH+ +TDFGL K+   D  T   +  GT EY+APE++    + +A DWW
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 334 SVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
            +G+++YEM+ G+ PF   +  ++ + I+ +++R P  LS EA SLL GLL+K+P +RLG
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239

Query: 394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSP 451
            GP  ++E+  H++F  INW+ +  +++ P F P+V  +     F+ ++T   ++ +P
Sbjct: 240 GGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITP 297

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  266 bits (682), Expect = 6e-86
 Identities = 134/327 (40%), Positives = 201/327 (61%), Gaps = 14/327 (4%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           DF  L V+G+G+FG+V    +K T E+YA+K+++KD +++ +  E    E+ +L   D P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 211 -FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
            F+ QL   FQT  RLY V++++NGG L + +   G F+E  A  YAAEI   +  LH  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           GI++RDLK +N++L ++GH+ + DFG+ K+   +   + +  GT +Y+APEI+  + + K
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGK 180

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           + DWW+ G+LLYEML G+PPF G +  ++ Q I++  +  P  LS EA S+ KGL+ K P
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP 240

Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLS 448
            KRLG GP+G  +I+ H +F+ I+W KLE REIQP F P+V GK    NF+K +T     
Sbjct: 241 SKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGKGA-ENFDKFFT----R 295

Query: 449 DSPAATPKN-------NTNPFADFSYV 468
             P  TP +       +   F  FSYV
Sbjct: 296 GQPVLTPPDQLVIANIDQADFEGFSYV 322

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  266 bits (680), Expect = 1e-85
 Identities = 129/327 (39%), Positives = 204/327 (62%), Gaps = 14/327 (4%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           DF  L V+G+G+FG+V    +K T E+YA+K+++KD +++ +  E    E+ +L     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 211 -FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
            F+ QL   FQT  RLY V++++NGG L +Q+   G F+E  A  YAAEI   +  LH+ 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           GI++RDLK +N++L ++GH+ + DFG+ K+   +   + +  GT +Y+APEI+  + + K
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           + DWW+ G+LLYEML G+ PF G +  ++ Q I++  +  P  +S EA ++ KGL+ K P
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 240

Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLS 448
           GKRLG GP+G  +IK H +F+ I+W+KLE +E+QP + P+  G+    NF+K +T  P  
Sbjct: 241 GKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACGRDA-ENFDKFFTRHP-- 297

Query: 449 DSPAATPKN-------NTNPFADFSYV 468
             P  TP +       + + F  FSYV
Sbjct: 298 --PVLTPPDQEVIMNLDQSEFEGFSYV 322

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  265 bits (678), Expect = 1e-84
 Identities = 138/376 (36%), Positives = 199/376 (52%), Gaps = 62/376 (16%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F  +K +G GAFG V  VRK +T+ +YAMK +RK  ++ +N A ++KAERDIL + D+ +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           VV+L YSFQ K  LY V+D+I GG +   L   G+F EDLAR Y AE+  A+  +H  G 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQF-----------DENTRSNSM----------- 309
           +HRD+KP+NIL+  DGH+ LTDFGL   F            ++ R +SM           
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 310 ----------------------IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKP 347
                                 +GT  Y+APE++L  G+ +  DWWSVG++LYEML G+P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 348 PFIGGNRAKIQQKIV--KDKLRLP--AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIK 403
           PF+    A+ Q K++  +  L +P  A LS EA  L+  L       RLG    G++EIK
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK--NGADEIK 299

Query: 404 SHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANF-----EKKWTD--MPLSDSPAATPK 456
           +H +FK I++  L  R  +  + P++      +NF     EK  +D     S      P 
Sbjct: 300 AHPFFKGIDFASL-IRRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDRNVKPN 358

Query: 457 NNTNP---FADFSYVR 469
           N       F +F++ R
Sbjct: 359 NRKRTEHAFYEFTFRR 374

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  262 bits (672), Expect = 3e-84
 Identities = 119/287 (41%), Positives = 177/287 (61%), Gaps = 17/287 (5%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           DF++L  VGQG +G+V+  +KK+T EI A+K M+K  + + N   ++  ERDILT     
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG 270
           ++V+L Y+FQ    LYL ++++ GG     L + G+  ED AR Y AE+  AV  LH  G
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 271 IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
            +HRDLKPEN L+ A GH+ LTDFGL+K     T +NS++G+ +YMAPE++ GKG++   
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGI--VTYANSVVGSPDYMAPEVLRGKGYDFTV 179

Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLP------AFLSSEAHSLLKG 382
           D+WS+G +LYE L G PPF G    +  + +   K+ L+ P        LS EA  L+  
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITK 239

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEV 429
           L+  +P +R G      E+IK+H +FK ++W +L  RE++P F PE+
Sbjct: 240 LIN-DPSRRFG----SLEDIKNHPFFKEVDWNEL--RELKPPFVPEL 279

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  261 bits (668), Expect = 8e-84
 Identities = 120/297 (40%), Positives = 192/297 (64%), Gaps = 1/297 (0%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           K++G+G FG+V  VR+K + + YAMK+++K+ I+ K+   +   E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           KYSFQTK RL  V++++NGG LFF L    +F ED  R Y AEIVSA+ +LH+  I++RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 276 LKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWS 334
           LK EN++L  DGH+ +TDFGL K+   +     +  GT EY+APE++    + +A DWW 
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 180

Query: 335 VGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGA 394
           +G+++YEM+ G+ PF   +  K+ + I+ + ++ P  LS++A SLL GLL K+P KRLG 
Sbjct: 181 LGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGG 240

Query: 395 GPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSP 451
           GP  ++EI  H +F  +NW+ +  +++ P F P+V  +     F++++T   ++ +P
Sbjct: 241 GPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQTITITP 297

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  259 bits (663), Expect = 4e-83
 Identities = 127/325 (39%), Positives = 197/325 (60%), Gaps = 9/325 (2%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           K++G+G FG+V  V++K T   YAMK+++K+ IV K+   +   E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN-GIMHR 274
           KYSFQT  RL  V+++ NGG LFF L    +F ED AR Y AEIVSA+ +LH+   +++R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 275 DLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           DLK EN++L  DGH+ +TDFGL K+   +     +  GT EY+APE++    + +A DWW
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 180

Query: 334 SVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
            +G+++YEM+ G+ PF   +  K+ + I+ +++R P  LS EA SLL GLL+K+P +RLG
Sbjct: 181 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLG 240

Query: 394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAA 453
            GP  ++EI  HK+F  I W+ +  +++ P F P+V  +     F++++T   ++ +P  
Sbjct: 241 GGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMITITPPD 300

Query: 454 TPKNNTN-------PFADFSYVRPA 471
              +           F  FSY   A
Sbjct: 301 QDDSMETVDNERRPHFPQFSYSASA 325

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  256 bits (655), Expect = 8e-83
 Identities = 114/264 (43%), Positives = 166/264 (62%), Gaps = 10/264 (3%)

Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL-TKIDHPFVV 213
           LK + +GAFG VY  +K++T + +A+KV++K  ++ KN    +KAER I+  + + P+V 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMH 273
           +L YSFQ+K  LYLV++++NGG     +   G   ED A+ Y AE+V  V  LH  GI+H
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120

Query: 274 RDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           RD+KPEN+L+   GH+ LTDFGL++   EN +    +GT +Y+APE +LG G +K +DWW
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKK---FVGTPDYLAPETILGVGDDKMSDWW 177

Query: 334 SVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKGLLQKEPG 389
           S+G +++E L G PPF       +   I+  ++  P     F S EA  L+  LL  +P 
Sbjct: 178 SLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA 237

Query: 390 KRLGAGPKGSEEIKSHKWFKPINW 413
           KRLGA   G +EIKSH +FK INW
Sbjct: 238 KRLGA--NGYQEIKSHPFFKSINW 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  256 bits (655), Expect = 6e-82
 Identities = 124/323 (38%), Positives = 190/323 (58%), Gaps = 14/323 (4%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT-KIDHPFVVQ 214
           +V+G+G+FG+V   R K +  +YA+KV++KD I++ +  E    E+ IL+   +HPF+ Q
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   FQT  RL+ V++F+NGG L F +     F E  AR YAAEI SA+  LH  GI++R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 275 DLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           DLK +N+LL  +GH  L DFG+ K+       +++  GT +Y+APEI+    +  + DWW
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWW 180

Query: 334 SVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           ++G+LLYEML G  PF   N   + + I+ D++  P +LS +A  +LK  + K P  RLG
Sbjct: 181 AMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLG 240

Query: 394 AGPKGSEE-IKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPA 452
           +   G EE I  H +FK ++W+KL  R+I+P F P +  +  ++NF+  +      + P 
Sbjct: 241 SLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFI----KEDPV 296

Query: 453 ATPKN-------NTNPFADFSYV 468
            TP         N + F +FSY 
Sbjct: 297 LTPIEESLLPMINQDEFRNFSYT 319

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  255 bits (652), Expect = 2e-81
 Identities = 135/326 (41%), Positives = 202/326 (61%), Gaps = 12/326 (3%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK-IDHPFVVQ 214
           KV+G+G+FG+V   ++K   + YA+KV++K  ++ +   +++ AER++L K + HPF+V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L YSFQT  +LY VLDF+NGG LFF L     F E  AR YAAEI SA+ +LH+  I++R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 275 DLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           DLKPENILL + GHV+LTDFGL K+   ++  + +  GT EY+APE++  + ++   DWW
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWW 180

Query: 334 SVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
            +G +LYEML G PPF   + A++   I+   L L    S  A S+L+ LL+K+  +RLG
Sbjct: 181 CLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLG 240

Query: 394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD--MP----L 447
           A  +   EI+ H +F+ ++W  LE ++I P F P V G   I+NF+  +T+  +P     
Sbjct: 241 A-KEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCF 299

Query: 448 SDSPA---ATPKNNTNPFADFSYVRP 470
           S   +   A+     + F  FSY  P
Sbjct: 300 SSDYSIVNASVLEADDAFVGFSYAPP 325

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  252 bits (645), Expect = 5e-81
 Identities = 101/277 (36%), Positives = 165/277 (59%), Gaps = 6/277 (2%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G FG V   + K T ++YA K + K ++ ++   +    E+ IL K+   F+V L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +F+TK  L LV+  +NGG L + +Y+ G   F E  A  YAA+I+  + HLH   I++RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 276 LKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSV 335
           LKPEN+LL   G+V ++D GLA +     +     GT  YMAPE++ G+ ++ + DW+++
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFAL 180

Query: 336 GILLYEMLTGKPPF----IGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           G  LYEM+ G+ PF        + +++++ ++  +  P   S EA  L + LLQK+P KR
Sbjct: 181 GCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240

Query: 392 LGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE 428
           LG     ++E++ H  FK +NW++LEA  ++P F P+
Sbjct: 241 LGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  250 bits (641), Expect = 1e-79
 Identities = 121/331 (36%), Positives = 204/331 (61%), Gaps = 21/331 (6%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL-TKIDHPFVVQ 214
           +V+G+G++ +V  V  K T  IYAMKV++K+ + +    ++++ E+ +  T  +HPF+V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   FQT+ RL+ V++F++GG L F +       E+ AR Y+AEI  A++ LH  GI++R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 275 DLKPENILLGADGHVMLTDFGLAKQFDENTR----SNSMIGTVEYMAPEIVLGKGHNKAA 330
           DLK +N+LL A+GH+ LTD+G+ K   E  R    +++  GT  Y+APEI+ G+ +  + 
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 331 DWWSVGILLYEMLTGKPPF--IGGNRAKIQ-------QKIVKDKLRLPAFLSSEAHSLLK 381
           DWW++G+L++EM+ G+ PF  +G +    Q       Q I++ ++R+P  LS +A S+LK
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237

Query: 382 GLLQKEPGKRLGAGPK-GSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEK 440
           G L K+P +RLG  P+ G  +IKSH +F+ I+W  LE +++ P + P +     + NF+ 
Sbjct: 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDP 297

Query: 441 KWTDMPLS---DSPAATPKNNTNPFADFSYV 468
           ++TD P+    D P    + + + F  F Y+
Sbjct: 298 QFTDEPVQLTPDDPDVIARIDQSEFEGFEYI 328

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  248 bits (635), Expect = 2e-79
 Identities = 115/284 (40%), Positives = 172/284 (60%), Gaps = 8/284 (2%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA-ERDILTKIDHP 210
           F   +V+G+G FG V   + + T ++YA K + K +I +K   E M   E+ IL K++  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKQILEKVNSR 60

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHA 268
           FVV L Y+++TK  L LVL  +NGG L F +Y+ G   F E+ A  YAAEI   +  LH 
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             I++RDLKPENILL   GH+ ++D GLA +  E       +GTV YMAPE+V  + +  
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180

Query: 329 AADWWSVGILLYEMLTGKPPFIGG----NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
           + DWW +G L+YEM+ GK PF        R ++++++ +D+       S  A S+ + LL
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL 240

Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE 428
            K+PG RLG   +G+EE+K+H +F+  N+K+LEA  ++P FCP+
Sbjct: 241 TKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  240 bits (614), Expect = 1e-75
 Identities = 126/317 (39%), Positives = 184/317 (58%), Gaps = 7/317 (2%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTS-EIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           EDF  ++ +G G+FGRV     KN      A+K   K KI+++   +++ +ER IL  I+
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HPF V L  SF+ +  LYLVL+F+ GG  F  L  +  F  D+   YAA+IV    +L +
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             I++RDLKPEN+LL  DG + +TDFG AK  D  TR+ ++ GT EY+APEI+L  GH K
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD--TRTYTLCGTPEYIAPEILLNVGHGK 207

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           AADWW++GI +YE+L G PPF       I QKI++  +  P FL +    L+K LL  + 
Sbjct: 208 AADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDL 267

Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLS 448
            KR G   KG++ +K H WF  I+W  L  + ++  + P+       +NFE+   D+ ++
Sbjct: 268 TKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFERVQEDLTIA 327

Query: 449 DSPAATPKNNTNPFADF 465
           D       N  +PF D+
Sbjct: 328 DKIT----NENDPFFDW 340

Length = 340

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  239 bits (610), Expect = 2e-75
 Identities = 121/324 (37%), Positives = 197/324 (60%), Gaps = 17/324 (5%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT-KIDHPFVVQ 214
           K++G+G+FG+V+    K T++ +A+K ++KD ++  +  E    E+ +L+   +HPF+  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L  +FQTK  L+ V++++NGG L F +     F    A  YAAEI+  +  LH+ GI++R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 275 DLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           DLK +NILL  DGH+ + DFG+ K+    + ++ +  GT +Y+APEI+LG+ +N + DWW
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWW 180

Query: 334 SVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           S G+LLYEML G+ PF G +  ++ Q I  D    P +L+ EA  +L  L  +EP +RLG
Sbjct: 181 SFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLG 240

Query: 394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAA 453
              KG  +I+ H +F+ I+W  LE REI+P F P+V   +  +NF+K++    L++ P  
Sbjct: 241 V--KG--DIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEF----LNEKPRL 292

Query: 454 TPKNNT-------NPFADFSYVRP 470
           +  +         N F +FS++ P
Sbjct: 293 SVTDRMLINSMDQNMFENFSFINP 316

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  237 bits (607), Expect = 6e-75
 Identities = 112/286 (39%), Positives = 175/286 (61%), Gaps = 21/286 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDFE +K++  GA+G VY VR K T + +AMK + K  ++ +N  + +  ERDILT  ++
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PFVV +  SF+TK  L +V++++ GG     L + G    D+AR+Y AE V A+ +LH  
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAK-------------QFDENTRS---NSMIGTV 313
           GI+HRDLKP+N+L+ + GH+ LTDFGL+K               +++TR      + GT 
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180

Query: 314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA--- 370
           EY+APE++L +G+ K  DWW++GI+LYE L G  PF G    ++  +++ D +  P    
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240

Query: 371 FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKL 416
            L ++A  L+  LL++ P +RLG G  G+ E+K H++F  ++W  L
Sbjct: 241 ALPADAQDLISRLLRQNPLERLGTG--GAFEVKQHRFFLGLDWNGL 284

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  237 bits (606), Expect = 1e-74
 Identities = 119/326 (36%), Positives = 202/326 (61%), Gaps = 13/326 (3%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQ 214
           +V+G+G++ +V  VR K   +IYAMKV++K+ + +    ++++ E+ +  +   +PF+V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   FQT  RL+LV++++NGG L F +       E+ AR YAAEI  A++ LH  GI++R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 275 DLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           DLK +N+LL ADGH+ LTD+G+ K+       +++  GT  Y+APEI+ G+ +  + DWW
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWW 180

Query: 334 SVGILLYEMLTGKPPF--IGGN-----RAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
           ++G+L++EM+ G+ PF  I  N        + Q I++  +R+P FLS +A  +LKG L K
Sbjct: 181 ALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNK 240

Query: 387 EPGKRLGAGPK-GSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDM 445
           +P +RLG  P+ G  +IKSH +F+ I+W  LE +++ P F P++   + + NF+ ++T  
Sbjct: 241 DPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFDTQFTSE 300

Query: 446 PLSDSP---AATPKNNTNPFADFSYV 468
           P+  +P       + + + F  F Y+
Sbjct: 301 PVQLTPDDEDVIKRIDQSEFEGFEYI 326

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  233 bits (597), Expect = 6e-74
 Identities = 85/247 (34%), Positives = 147/247 (59%), Gaps = 7/247 (2%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
            +E++K +G+G+FG+VY VR+K+  ++Y +K +    + EK   + +  E  IL K++HP
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHP 59

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFF----QLYHHGLFREDLARIYAAEIVSAVSHL 266
            +++   SF+ K +L +V+++ +GG L      Q      F E+    +  ++  A+ +L
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-NSMIGTVEYMAPEIVLGKG 325
           H+  I+HRD+KP+NI L ++G V L DFG++K          +++GT  Y++PE+   K 
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP 179

Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHSLLKGLL 384
           +N  +D WS+G +LYE+ T K PF G N  ++  KI+K     +P+  SSE  +L+  LL
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239

Query: 385 QKEPGKR 391
           QK+P +R
Sbjct: 240 QKDPEER 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  237 bits (605), Expect = 8e-74
 Identities = 124/332 (37%), Positives = 184/332 (55%), Gaps = 57/332 (17%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF  +KV+G+GAFG V  V+KK+T +IYAMK + K ++ +K+   ++KAERD+L + D 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P+VV L YSFQ    LYL+++F+ GG L   L  +  F ED+ R Y AE V A+  +H  
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLA----KQFDEN---------------------- 303
           G +HRD+KP+NIL+   GH+ L+DFGL+    KQ D                        
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 304 ------TRSN----------------SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYE 341
                 T S+                S +GT +Y+APEI L +G+ +  DWWS+G +++E
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240

Query: 342 MLTGKPPFIGGNRAKIQQKIV--KDKLRLP--AFLSSEAHSLLKGLLQKEPGKRLGAGPK 397
            L G PPF   N  +  +KI+  ++ L  P    LS EA  L++ L+      RLG G  
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRG-- 297

Query: 398 GSEEIKSHKWFKPINWKKLEAREIQPGFCPEV 429
           G+ EIKSH +F+ ++W  +  R+I+  F P++
Sbjct: 298 GAHEIKSHPFFRGVDWDTI--RQIRAPFIPQL 327

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  232 bits (592), Expect = 1e-72
 Identities = 120/325 (36%), Positives = 194/325 (59%), Gaps = 19/325 (5%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT-KIDHPFVVQ 214
           KV+G+G+FG+V     K   E +A+K ++KD ++  +  E    E+ +L    ++PF+  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L  +FQTK  L+ V++F+NGG L F +   G F    A  YAAEIV  +  LH+ GI++R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 275 DLKPENILLGADGHVMLTDFGLAKQ--FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADW 332
           DLK +N++L  DGH+ + DFG+ K+  F +N R+++  GT +Y+APEI+ G  +  + DW
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RASTFCGTPDYIAPEILQGLKYTFSVDW 179

Query: 333 WSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRL 392
           WS G+LLYEML G+ PF G +  ++ + I  D    P +++ E+  +L+ L +++P +RL
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRL 239

Query: 393 GAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSP- 451
           G        I+ H +FK INW  LE RE+ P F P+V      +NF++++    LS+ P 
Sbjct: 240 GV----VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREF----LSEKPR 291

Query: 452 -AATPKN-----NTNPFADFSYVRP 470
            + + KN     + + FA FS++ P
Sbjct: 292 LSYSDKNLIDSMDQSAFAGFSFINP 316

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  231 bits (590), Expect = 4e-72
 Identities = 119/338 (35%), Positives = 181/338 (53%), Gaps = 27/338 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DF+V  +VG+G FG V  VR+K T +IYAMKVM+K  ++ +    + + ERDIL+  + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL-YHHGLFREDLARIYAAEIVSAVSHLHA 268
           P++ QL+Y+FQ K  LYLV+++  GG L   L  +   F ED+A+ Y AE+V A+  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM--IGTVEYMAPEIVLG-KG 325
            G +HRD+KPEN+L+   GH+ L DFG A +   N   NS   +GT +Y+APE++    G
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180

Query: 326 HNKAA-----DWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLPAFL--SSEA 376
             K       DWWS+G++ YEM+ G+ PF  G  AK    I+  +  L+ P     SS+ 
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240

Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIA 436
             L++ LL     +RL     G E +  H +F  I+W  +  R   P F P +      +
Sbjct: 241 LDLIQSLLCG-QKERL-----GYEGLCCHPFFSKIDWNNI--RNSLPPFVPTLKSDDDTS 292

Query: 437 NFEKKWTDMPLSDSPAATPKNNTN------PFADFSYV 468
           NF++   +       + T            PF  FS++
Sbjct: 293 NFDEPEKNSTRRSQSSTTQLKPNGFSGKDLPFVGFSFI 330

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  230 bits (587), Expect = 3e-71
 Identities = 120/339 (35%), Positives = 190/339 (56%), Gaps = 24/339 (7%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +  EDF+V+KV+G+GAFG V  VR K++ ++YAMK++ K ++++++ + +   ERDI+  
Sbjct: 40  MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH 99

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
            +  ++VQL Y+FQ    LY+V++++ GG L   + ++ +  E  AR Y AE+V A+  +
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-PEKWARFYTAEVVLALDAI 158

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGK 324
           H+ G +HRD+KP+N+LL   GH+ L DFG   + D N   R ++ +GT +Y++PE++  +
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 325 GHN----KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLP--AFLSSEA 376
           G +    +  DWWSVG+ LYEML G  PF   +      KI+  K+ L  P    +S +A
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278

Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIA 436
             L+   L      RLG    G +EIKSH +FK   W     RE      PE++     +
Sbjct: 279 KDLICAFLTDRE-VRLGR--NGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTS 335

Query: 437 NFEKKWTDMPLSDSPAAT---PK---NNTNPFADFSYVR 469
           NF+    D+   D    T   PK    N  PF  F+Y +
Sbjct: 336 NFD----DIEDDDKNEETFPLPKAFAGNQLPFIGFTYSK 370

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  229 bits (586), Expect = 6e-71
 Identities = 137/382 (35%), Positives = 202/382 (52%), Gaps = 68/382 (17%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F  +K +G GAFG V   RK +T  +YAMK +RK  ++ +N   ++KAERDIL + D+ +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           VV+L YSFQ K  LY V+D+I GG +   L   G+F EDLAR Y AE+  AV  +H  G 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQF----------------------------DEN 303
           +HRD+KP+NIL+  DGH+ LTDFGL   F                              N
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 304 TR--------------------SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEML 343
            R                    ++S++GT  Y+APE++L  G+ +  DWWSVG++LYEML
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 344 TGKPPFIGGNRAKIQQKIVK--DKLRLP--AFLSSEAHSLLKGLLQKEPGKRLGAGPKGS 399
            G+PPF+     + Q K++     L +P  A LS EA  L+  L  + P  RLG    G+
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK--NGA 299

Query: 400 EEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANF-----EKKWTDMP----LSDS 450
           +EIK+H +FK I++   + R+    + P++      +NF     +K W+D      ++D+
Sbjct: 300 DEIKAHPFFKTIDFSS-DLRQQSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNVNDT 358

Query: 451 PAATPKNNTNP---FADFSYVR 469
                KN  +P   F +F++ R
Sbjct: 359 LNGWYKNGKHPEHAFYEFTFRR 380

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  226 bits (577), Expect = 3e-70
 Identities = 114/328 (34%), Positives = 205/328 (62%), Gaps = 15/328 (4%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQ 214
           +V+G+G++ +V  VR K T  IYAMKV++K+ + +    ++++ E+ +  +  +HPF+V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   FQT+ RL+ V++++NGG L F +       E+ AR Y+AEI  A+++LH  GI++R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 275 DLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           DLK +N+LL ++GH+ LTD+G+ K+       +++  GT  Y+APEI+ G+ +  + DWW
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 180

Query: 334 SVGILLYEMLTGKPPF--IGGNRAKIQ-------QKIVKDKLRLPAFLSSEAHSLLKGLL 384
           ++G+L++EM+ G+ PF  +G +    Q       Q I++ ++R+P  LS +A S+LK  L
Sbjct: 181 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL 240

Query: 385 QKEPGKRLGAGPK-GSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWT 443
            K+P +RLG  P+ G  +I+ H +F+ ++W  +E +++ P F P ++G+  + NF+ ++T
Sbjct: 241 NKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFDAQFT 300

Query: 444 DMPLS---DSPAATPKNNTNPFADFSYV 468
           + P+    D      K + + F  F Y+
Sbjct: 301 NEPVQLTPDDDDIVRKIDQSEFEGFEYI 328

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  224 bits (573), Expect = 1e-69
 Identities = 121/335 (36%), Positives = 184/335 (54%), Gaps = 22/335 (6%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE+LKV+G+GAFG V  V+ KNT ++YAMK++ K +++++      + ERD+L   D 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHA 268
            ++  L Y+FQ +  LYLV+D+  GG L   L        ED+AR Y AE+V A+  +H 
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFG--LAKQFDENTRSNSMIGTVEYMAPEIVL---- 322
            G +HRD+KP+N+LL  +GH+ L DFG  L    D   +SN  +GT +Y++PEI+     
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180

Query: 323 GKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLPAF---LSSEA 376
           GKG      DWWS+G+ +YEML G+ PF   +  +   KI+  K+  + P     +S EA
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240

Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIA 436
             L++ L+   P  RLG    G ++ K H +F+ I+W  +  R     + PEV+     +
Sbjct: 241 KDLIRRLICS-PETRLGRN--GLQDFKDHPFFEGIDWDNI--RNSTAPYVPEVSSPTDTS 295

Query: 437 NF---EKKWTDMP-LSDSPAATPKNNTNPFADFSY 467
           NF   +    +   L  S       N  PF  F+Y
Sbjct: 296 NFDVDDDDLRNTESLPPSSHGAFSGNHLPFVGFTY 330

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  216 bits (552), Expect = 4e-67
 Identities = 108/283 (38%), Positives = 169/283 (59%), Gaps = 6/283 (2%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F   +V+G+G FG V   + + T ++YA K + K +I ++        E+ IL K++  F
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHAN 269
           VV L Y+++TK  L LVL  +NGG L F +Y+ G   F E+ A  YAAEI+  +  LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKA 329
             ++RDLKPENILL   GH+ ++D GLA +  E       +GTV YMAPE++  + +  +
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181

Query: 330 ADWWSVGILLYEMLTGKPPFIGG----NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
            D+W +G L+YEM+ G+ PF G      R ++ +++++ +    A  S EA S+ K LL 
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241

Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE 428
           K+P +RLG   +G+ E+K H +F+ +N+K+LEA  + P F P+
Sbjct: 242 KDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  215 bits (548), Expect = 2e-66
 Identities = 108/283 (38%), Positives = 163/283 (57%), Gaps = 6/283 (2%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F   +V+G+G FG V   + + T ++YA K + K +I ++        E+ IL K++  F
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHAN 269
           VV L Y+++TK  L LVL  +NGG L F +Y+ G   F E  A  YAAE+   +  L   
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKA 329
            I++RDLKPENILL   GH+ ++D GLA Q  E       +GTV YMAPE++  + +  +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181

Query: 330 ADWWSVGILLYEMLTGKPPFIGG----NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
            DWW +G L+YEM+ G+ PF        R ++ +++ +D+       S +A S+ + LL 
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241

Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE 428
           K P +RLG    G+  +K H  FK IN+K+LEA  ++P FCP+
Sbjct: 242 KNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  214 bits (545), Expect = 4e-66
 Identities = 116/284 (40%), Positives = 167/284 (58%), Gaps = 8/284 (2%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F   +V+G+G FG V   + + T ++YA K + K +I ++        E+ IL K++  F
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHAN 269
           VV L Y+++TK  L LVL  +NGG L F +YH G   F E  A  YAAEI   +  LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKA 329
            I++RDLKPENILL   GH+ ++D GLA    E       +GTV YMAPE+V  + +  +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181

Query: 330 ADWWSVGILLYEMLTGKPPFIGGNRAKIQ----QKIVKD-KLRLPAFLSSEAHSLLKGLL 384
            DWW++G LLYEM+ G+ PF    + KI+    +++VK+ +       S +A SL K LL
Sbjct: 182 PDWWALGCLLYEMIAGQSPF-QQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240

Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE 428
            K+P +RLG    G+ E+K H  FK IN+K+LEA  ++P F P+
Sbjct: 241 CKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  212 bits (542), Expect = 7e-66
 Identities = 87/268 (32%), Positives = 144/268 (53%), Gaps = 18/268 (6%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           ++   +++G+G+FG VY    K+T E+ A+K +      E+      + E  IL+ + HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALER-EIRILSSLQHP 59

Query: 211 FVVQLKYSFQTKYR--LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            +V+   S + + +  L + L++++GG L   L   G   E + R Y  +I+  +++LH+
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKG 325
           NGI+HRD+K  NIL+ +DG V L DFG AK+  +      + S+ GT  +MAPE++ G+ 
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ---KIVKDKL--RLPAFLSSEAHSLL 380
           + +AAD WS+G  + EM TGKPP+             KI        +P  LS EA   L
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPW--SELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237

Query: 381 KGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
           +  L+++P KR  A     +E+  H + 
Sbjct: 238 RKCLRRDPKKRPTA-----DELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  210 bits (537), Expect = 6e-65
 Identities = 107/279 (38%), Positives = 170/279 (60%), Gaps = 10/279 (3%)

Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI---DHPFVV 213
           ++G+G FG VY  RK +T ++YAMK + K +I  K        ER +L+ +   D PF+V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMH 273
            + Y+F T  +L  +LD +NGG L + L  HG+F E   R YAAEI+  + H+H   +++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 274 RDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG--HNKAAD 331
           RDLKP NILL   GHV ++D GLA  F +  + ++ +GT  YMAPE VL KG  ++ +AD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPE-VLQKGVAYDSSAD 178

Query: 332 WWSVGILLYEMLTGKPPFIG---GNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           W+S+G +L+++L G  PF      ++ +I +  +   + LP   S E  SLL+GLLQ++ 
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 238

Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP 427
            +RLG   +G++E+K H +F+ ++W+ +  ++  P   P
Sbjct: 239 NRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIP 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  209 bits (534), Expect = 1e-64
 Identities = 98/262 (37%), Positives = 144/262 (54%), Gaps = 14/262 (5%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
            FE+L+ +G+G FG VY+ R K T +  A+KV+   K+  K   E +  E  IL K  HP
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCKHP 57

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            +V+   S+  K  L++V++F +GG L    +  +  L    +A +   E++  + +LH+
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYV-CKELLKGLEYLHS 116

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           NGI+HRD+K  NILL +DG V L DFGL+ Q  +    N+M+GT  +MAPE++ GK ++ 
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQ 385
            AD WS+GI   E+  GKPP+      K   KI  +    LR P   S E    LK  LQ
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236

Query: 386 KEPGKRLGAGPKGSEEIKSHKW 407
           K P KR  A     E++  H +
Sbjct: 237 KNPEKRPTA-----EQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  212 bits (540), Expect = 2e-64
 Identities = 129/352 (36%), Positives = 192/352 (54%), Gaps = 55/352 (15%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE LKV+G+GAFG V  V+KK+T  IYAMK++RK  ++EK    +++AERDIL + D 
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
            +VV++ YSFQ K  LYL+++F+ GG +   L       E+  + Y AE V A+  +H  
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGL--------------------------------- 296
           G +HRD+KP+N+LL A GHV L+DFGL                                 
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180

Query: 297 -AKQFDENTR--SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
            A+ + +N R  + S +GT +Y+APE+ +  G+NK  DWWS+G+++YEML G PPF    
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 354 RAKIQQKIV--KDKLRLP--AFLSSEAHSL-LKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
             +  +K++  K+ L  P    +S +A  L L+     E   R+G+   G EEIKSH +F
Sbjct: 241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSE--NRIGSN--GVEEIKSHPFF 296

Query: 409 KPINWKKLEAREIQPGFCP-EVAGKHCIANFEKKWTDMPLSDSPAATPKNNT 459
           + ++W  +  R   P   P E+      +NF+    + P SD     P  NT
Sbjct: 297 EGVDWGHIRER---PAAIPIEIKSIDDTSNFD----EFPESD--ILQPAENT 339

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  211 bits (539), Expect = 5e-64
 Identities = 123/381 (32%), Positives = 197/381 (51%), Gaps = 67/381 (17%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F  +K +G GAFG V    K +T  +YAMK +RK  ++ +N   ++KAERDIL + D+ +
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           VV+L YSFQ K  LY V+D+I GG +   L    +F E LAR Y AE+  A+  +H  G 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122

Query: 272 MHRDLKPENILLGADGHVMLTDFGL----------------------------------- 296
           +HRD+KP+NIL+  DGH+ LTDFGL                                   
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 297 -------------AKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEML 343
                        A +  +   ++S++GT  Y+APE++L KG+ +  DWWSVG++L+EML
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 344 TGKPPFIGGNRAKIQQKIV--KDKLRLPA--FLSSEAHSLLKGLLQKEPGKRLGAGPKGS 399
            G+PPF+     + Q K++  ++ L +P    LS EA  L+   L     +RLG    G+
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLI-TKLCCSAEERLGR--NGA 299

Query: 400 EEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPK--- 456
           ++IK+H +F  +++      +  P + P+++     +NF+    + P +D+   + +   
Sbjct: 300 DDIKAHPFFSEVDFSSDIRTQPAP-YVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWD 358

Query: 457 -----NNTNP---FADFSYVR 469
                N  +P   F +F++ R
Sbjct: 359 TLCSPNGKHPEHAFYEFTFRR 379

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  207 bits (527), Expect = 2e-63
 Identities = 106/278 (38%), Positives = 169/278 (60%), Gaps = 8/278 (2%)

Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI---DHPFVV 213
           ++G+G FG VY  RK +T ++YAMK + K +I  K        ER +L+ +   D PF+V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMH 273
            + Y+F T  +L  +LD +NGG L + L  HG+F E   R YA EI+  + H+H   +++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 274 RDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL-GKGHNKAADW 332
           RDLKP NILL   GHV ++D GLA  F +  + ++ +GT  YMAPE++  G  ++ +ADW
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGTAYDSSADW 179

Query: 333 WSVGILLYEMLTGKPPF---IGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPG 389
           +S+G +L+++L G  PF      ++ +I +  +   + LP   S E  SLL+GLLQ++  
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS 239

Query: 390 KRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP 427
           KRLG   +G++E+K H +FK I+W+++  ++  P   P
Sbjct: 240 KRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  208 bits (531), Expect = 4e-63
 Identities = 128/371 (34%), Positives = 197/371 (53%), Gaps = 61/371 (16%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDFE LKV+G+GAFG V  V+KK+T  +YAMK++RK  ++EK    +++AERDIL + D 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
            +VV++ YSFQ K  LYL+++F+ GG +   L       E+  + Y AE V A+  +H  
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGL--------------------------------- 296
           G +HRD+KP+N+LL + GHV L+DFGL                                 
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 297 -AKQFDENTR--SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
            A+ +  N R  + S +GT +Y+APE+ +  G+NK  DWWS+G+++YEML G PPF    
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 354 RAKIQQKIV--KDKLRLP--AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
             +  +K++  K+ L  P    +S +A  L+      E   R+GA   G EEIK++ +F+
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGA--PGVEEIKTNPFFE 297

Query: 410 PINWKKLEAREIQPGFCP-EVAGKHCIANFEKKWTDMPLSD--SPAATPKNNTNP----- 461
            ++W+ +  R   P   P E+      +NF+    + P SD   P     N+        
Sbjct: 298 GVDWEHIRER---PAAIPIEIKSIDDTSNFD----EFPDSDILKPTVATSNHPETDYKNK 350

Query: 462 ---FADFSYVR 469
              F +++Y R
Sbjct: 351 DWVFINYTYKR 361

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  202 bits (515), Expect = 1e-61
 Identities = 100/284 (35%), Positives = 167/284 (58%), Gaps = 17/284 (5%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G FG V   + + T ++YA K + K ++ ++   E    E+ IL K+   F+V L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMH 273
           +FQTK  L LV+  +NGG L + +Y+    +  F E  A  Y A+I+S + HLH   I++
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 274 RDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNKAADW 332
           RDLKPEN+LL  DG+V ++D GLA +  D  +++    GT  +MAPE++ G+ ++ + D+
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDY 180

Query: 333 WSVGILLYEMLTGKPPFIGGNRAK--------IQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
           +++G+ LYEM+  + PF    RA+        ++Q+I+ D +  P   S  + S  + LL
Sbjct: 181 FALGVTLYEMIAARGPF----RARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236

Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE 428
            K+P KRLG      + +++H  F+ +NW++LEA  + P F P+
Sbjct: 237 AKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  202 bits (514), Expect = 2e-60
 Identities = 116/331 (35%), Positives = 187/331 (56%), Gaps = 18/331 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ED+EV+KV+G+GAFG V  VR K+T ++YAMK++ K ++++++ + +   ERDI+   + 
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P+VVQL Y+FQ    LY+V++++ GG L   + ++ +  E  AR Y AE+V A+  +H+ 
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDAIHSM 161

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG-- 325
           G +HRD+KP+N+LL   GH+ L DFG   + ++    R ++ +GT +Y++PE++  +G  
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 326 --HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLP--AFLSSEAHSL 379
             + +  DWWSVG+ LYEML G  PF   +      KI+  K+ L  P    +S EA +L
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 281

Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
           +   L     + +  G  G EEIK H +FK   W     R+      P+++     +NF+
Sbjct: 282 ICAFLTD---REVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFD 338

Query: 440 KKWTDMPLSDSPAATPK---NNTNPFADFSY 467
               D    +     PK    N  PF  F+Y
Sbjct: 339 DIEEDKG-EEETFPIPKAFVGNQLPFVGFTY 368

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  200 bits (509), Expect = 1e-59
 Identities = 116/333 (34%), Positives = 187/333 (56%), Gaps = 18/333 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ED++V+KV+G+GAFG V  VR K++ ++YAMK++ K ++++++ + +   ERDI+   + 
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P+VVQL  +FQ    LY+V++++ GG L   + ++ +  E  A+ Y AE+V A+  +H+ 
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFYTAEVVLALDAIHSM 161

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG-- 325
           G++HRD+KP+N+LL   GH+ L DFG   + DE    R ++ +GT +Y++PE++  +G  
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 326 --HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLP--AFLSSEAHSL 379
             + +  DWWSVG+ L+EML G  PF   +      KI+  K+ L  P    +S  A +L
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNL 281

Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANF- 438
           +   L     + +  G  G EEIK H +FK   W     RE      PE++     +NF 
Sbjct: 282 ICAFLTD---REVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFD 338

Query: 439 --EKKWTDMPLSDSPAATPKNNTNPFADFSYVR 469
             E    D+     P A   N   PF  F+Y R
Sbjct: 339 DIEDDKGDVETFPIPKAFVGNQL-PFIGFTYYR 370

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  196 bits (500), Expect = 1e-59
 Identities = 85/254 (33%), Positives = 138/254 (54%), Gaps = 8/254 (3%)

Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLK 216
           ++G+GAFG VY+     T +  A+K +  +KI E+     M  E D+L  + HP +V+  
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIM-QEIDLLKNLKHPNIVKYI 65

Query: 217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDL 276
            S +T   LY++L++   G L   +   G F E L  +Y  +++  +++LH  G++HRD+
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDI 125

Query: 277 KPENILLGADGHVMLTDFGLAKQFDENTR-SNSMIGTVEYMAPEIVLGKGHNKAADWWSV 335
           K  NIL   DG V L DFG+A + ++ ++   S++GT  +MAPE++   G + A+D WS+
Sbjct: 126 KAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSL 185

Query: 336 GILLYEMLTGKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLKGLLQKEPGKRLGA 394
           G  + E+LTG PP+   N      +IV+D    LP  +S E    L    QK+P  R  A
Sbjct: 186 GCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTA 245

Query: 395 GPKGSEEIKSHKWF 408
                +++  H W 
Sbjct: 246 -----KQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  192 bits (491), Expect = 7e-59
 Identities = 89/252 (35%), Positives = 137/252 (54%), Gaps = 42/252 (16%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G FG VY  R K T +  A+K+++K+     +  E +  E +IL K++HP +V+L  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDL 276
            F+ +  LYLV+++  GG L   L  + G   ED       +I+  + +LH+NGI+HRDL
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 277 KPENILLGAD-GHVMLTDFGLAKQFDENTR-SNSMIGTVEYMAPEIVLGKGH-NKAADWW 333
           KPENILL +D G V L DFGL+K    +     +++GT  YMAPE++LGKG+ ++ +D W
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178

Query: 334 SVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           S+G++LYE+                                E   L++ +LQK+P KR  
Sbjct: 179 SLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPS 207

Query: 394 AGPKGSEEIKSH 405
           A     +EI  H
Sbjct: 208 A-----KEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  196 bits (500), Expect = 7e-59
 Identities = 116/338 (34%), Positives = 192/338 (56%), Gaps = 28/338 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE++KV+G+GAFG V  V+ K+T  IYAMK++ K +++++      + ER++L   D 
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHA 268
            ++  L Y+FQ +  LYLV+D+  GG L   L        ED+AR Y AE+V A+  +H 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFG--LAKQFDENTRSNSMIGTVEYMAPEIV----- 321
              +HRD+KP+N+LL  +GH+ L DFG  L    D   +S+  +GT +Y++PEI+     
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 322 -LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLPAFL---SSE 375
            +GK +    DWWS+G+ +YEML G+ PF   +  +   KI+  +++ + P+ +   S E
Sbjct: 181 GMGK-YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239

Query: 376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCI 435
           A  L++ L+     +RLG    G E+ K H +F+ I+W+ +  R ++  + P+V+     
Sbjct: 240 AKDLIQRLICSRE-RRLGQ--NGIEDFKKHAFFEGIDWENI--RNLEAPYIPDVSSPSDT 294

Query: 436 ANFEKKWTDMPLSDSPAATPKNNTN------PFADFSY 467
           +NF+    D  L +   A P ++T       PF  F+Y
Sbjct: 295 SNFDVD--DDVLRNPEIAPPSSHTGFSGLHLPFVGFTY 330

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  194 bits (494), Expect = 6e-58
 Identities = 120/337 (35%), Positives = 189/337 (56%), Gaps = 26/337 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDFE+LKV+G+GAFG V  V+ KN  +++AMK++ K +++++      + ERD+L   D+
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHA 268
            ++  L Y+FQ +  LYLV+D+  GG L   L        ED+AR Y AE+V A+  +H 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFG--LAKQFDENTRSNSMIGTVEYMAPEIVL---- 322
              +HRD+KP+NIL+  +GH+ L DFG  L    D   +S+  +GT +Y++PEI+     
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 323 GKG-HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLPAF---LSSEA 376
           GKG +    DWWS+G+ +YEML G+ PF   +  +   KI+  K++ + PA    +S +A
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240

Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIA 436
             L++ L+      RLG    G E+ K H +F  I+W  +  R  +  + PEV+     +
Sbjct: 241 KDLIRRLICSRE-HRLGQ--NGIEDFKQHPFFTGIDWDNI--RNCEAPYIPEVSSPTDTS 295

Query: 437 NFEKKWTDMPLSDSPAATPKNNTN------PFADFSY 467
           NF+    D  L +S    P ++T       PF  F+Y
Sbjct: 296 NFDVD--DDCLKNSETMPPPSHTAFSGHHLPFVGFTY 330

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  192 bits (488), Expect = 9e-58
 Identities = 94/278 (33%), Positives = 169/278 (60%), Gaps = 8/278 (2%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G FG V  V+ KNT ++YA K + K ++ +K+  +    E++IL K++ PF+V L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLHANGIMHRD 275
           +F++K  L LV+  +NGG L + +Y+ G    ++ R+  Y+A+I   + HLH+  I++RD
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 276 LKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSV 335
           +KPEN+LL   G+  L+D GLA +  +        GT  YMAPEI+  + ++   DW+++
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAM 180

Query: 336 GILLYEMLTGKPPFIGG----NRAKIQQKIVKDKLRLP-AFLSSEAHSLLKGLLQKEPGK 390
           G  +YEM+ G+ PF        + +++++ ++D+++      + E+  + +  L K+P  
Sbjct: 181 GCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPED 240

Query: 391 RLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE 428
           RLG+  K +++ + H++FK IN+ +LEA  I P F P+
Sbjct: 241 RLGSREK-NDDPRKHEFFKTINFPRLEAGLIPPPFVPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  191 bits (484), Expect = 4e-56
 Identities = 101/294 (34%), Positives = 153/294 (52%), Gaps = 31/294 (10%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
            + +L+ +G+G+FG VY  R +   ++ A+KV+ K    +    E    E  IL  ++HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 211 -FVVQLKYSFQTKYRLYLVLDFINGG---HLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             +V+L   FQ +  LYLV+++++GG    L  ++   G   E  A    A+I+SA+ +L
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 267 HANGIMHRDLKPENILLGADGH-VMLTDFGLAKQFDE-------NTRSNSMIGTVEYMAP 318
           H+ GI+HRD+KPENILL  DG  V L DFGLAK   +           ++ +GT  YMAP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 319 EIVLGKGH---NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK------------ 363
           E++LG      + ++D WS+GI LYE+LTG PPF G   +    + +K            
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 364 -DKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKL 416
                 P  +S  A  LLK LL K+P  RL +    S ++ +H   K  +   L
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDL 291

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  177 bits (450), Expect = 3e-52
 Identities = 96/269 (35%), Positives = 143/269 (53%), Gaps = 18/269 (6%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
            D E +KV+GQG+ G VY+VR K T +IYA+K +  D   E      +  E   L   + 
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ--LLRELKTLRSCES 58

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRED-LARIYAAEIVSAVSHLHA 268
           P+VV+   +F  +  + +VL++++GG L   L   G   E  LA I A +I+  + +LH 
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYI-ARQILKGLDYLHT 117

Query: 269 N-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR--SNSMIGTVEYMAPEIVLGKG 325
              I+HRD+KP N+L+ + G V + DFG++K   ENT    N+ +GTV YM+PE + G+ 
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL-ENTLDQCNTFVGTVTYMSPERIQGES 176

Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAK---IQQKIVK-DKLRLPA-FLSSEAHSLL 380
           ++ AAD WS+G+ L E   GK PF+   +     + Q I       LPA   S E    +
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236

Query: 381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
              LQK+P KR  A      E+  H + K
Sbjct: 237 SACLQKDPKKRPSA-----AELLQHPFIK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  166 bits (423), Expect = 2e-48
 Identities = 87/266 (32%), Positives = 139/266 (52%), Gaps = 20/266 (7%)

Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
              +G G FG+VY     +T E+ A+K +R      K   E +  E  +L  + HP +V+
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE-IADEMKVLELLKHPNLVK 63

Query: 215 LKYSFQT-KYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMH 273
             Y  +  + ++Y+ +++ +GG L   L H  +  E + R+Y  +++  +++LH++GI+H
Sbjct: 64  Y-YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122

Query: 274 RDLKPENILLGADGHVMLTDFGLAKQFDENTRS-----NSMIGTVEYMAPEIVLG---KG 325
           RD+KP NI L  +G + L DFG A +   NT +      S+ GT  YMAPE++ G   KG
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182

Query: 326 HNKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKI-VKDKLRLP--AFLSSEAHSLLK 381
           H +AAD WS+G ++ EM TGK P+    N  +I   +    K  +P    LS E    L 
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLD 242

Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKW 407
             L+ +P KR  A      E+  H +
Sbjct: 243 RCLESDPKKRPTA-----SELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  166 bits (423), Expect = 3e-48
 Identities = 83/255 (32%), Positives = 141/255 (55%), Gaps = 16/255 (6%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           D+EVL+ +G+G+FG V +VR+K+  +I   K +    + EK   + + +E +IL ++ HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHP 59

Query: 211 FVVQLKYSF--QTKYRLYLVLDFINGGHL--FFQLYH--HGLFREDLA-RIYAAEIVSAV 263
            +V+       ++   LY+V+++  GG L    Q          E+   RI   +++ A+
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-QLLLAL 118

Query: 264 SHLH-----ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSMIGTVEYMA 317
              H      N ++HRDLKP NI L A+ +V L DFGLAK    ++  + + +GT  YM+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEA 376
           PE +    +++ +D WS+G L+YE+    PPF   N+ ++  KI + K  R+P   SSE 
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238

Query: 377 HSLLKGLLQKEPGKR 391
           + ++K +L  +P KR
Sbjct: 239 NEVIKSMLNVDPDKR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  163 bits (415), Expect = 3e-47
 Identities = 81/246 (32%), Positives = 134/246 (54%), Gaps = 9/246 (3%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMR--KDKIVEKNHAEYMKAERDILTKIDHPFVV 213
           +++G G+FG VY+    +  + +A+K +    D    +   + ++ E  +L+K+ HP +V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMH 273
           Q   + + +  LY+ L+ + GG L   L  +G F E + R+Y  +I+  + +LH    +H
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125

Query: 274 RDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG-HNKAADW 332
           RD+K  NIL+  +G V L DFG+AKQ  E + + S  G+  +MAPE++  +G +  AAD 
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185

Query: 333 WSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVKDKL--RLPAFLSSEAHSLLKGLLQKEP 388
           WS+G  + EM TGKPP+       +    KI + K    +P  LS EA   +   LQ++P
Sbjct: 186 WSLGCTVLEMATGKPPW--SQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDP 243

Query: 389 GKRLGA 394
             R  A
Sbjct: 244 SLRPTA 249

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  163 bits (414), Expect = 1e-46
 Identities = 82/264 (31%), Positives = 136/264 (51%), Gaps = 16/264 (6%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           ++ L+ +G+GA G VY+   + T +  A+K MR    + K + E +  E  I+    HP 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLF--REDLARIYAAEIVSAVSHLHAN 269
           +V    S+     L++V+++++GG L   +  + +      +A +   E++  + +LH+ 
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVLQGLEYLHSQ 135

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNK 328
            ++HRD+K +NILL  DG V L DFG A Q   E ++ NS++GT  +MAPE++  K +  
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQ 385
             D WS+GI+  EM  G+PP++     +    I       L+ P   S E    L   L 
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255

Query: 386 KEPGKRLGAGPKGSEEIKSHKWFK 409
           K+P KR  A     EE+  H + K
Sbjct: 256 KDPEKRPSA-----EELLQHPFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  160 bits (408), Expect = 7e-46
 Identities = 95/295 (32%), Positives = 147/295 (49%), Gaps = 51/295 (17%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +E L+ +G+G +G VY+ R K T EI A+K +R D   E   +  ++ E  +L ++ HP 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPN 59

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-----HHGLFREDLARIYAAEIVSAVSHL 266
           +V+L     T+ +LYLV ++ +       L        G    +L +    +++  +++ 
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS-MIGTVEYMAPEIVLG-K 324
           H++ I+HRDLKP+NIL+  DG + L DFGLA+ F    R+ +  + T+ Y APEI+LG K
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK 174

Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK------------------D 364
            ++ A D WSVG +  EM+TGKP F G   ++I Q  KI +                   
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLFPG--DSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232

Query: 365 KLRLPAF-----------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
           K   P F           L  E   LL  +LQ  P KR+ A     +E   H +F
Sbjct: 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA-----KEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  158 bits (402), Expect = 2e-45
 Identities = 75/248 (30%), Positives = 133/248 (53%), Gaps = 7/248 (2%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           DF+VLK +G+G++G VY+V++ + ++ YA+K +    + +K   + +   R IL  ++HP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIR-ILASVNHP 59

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG----LFREDLARIYAAEIVSAVSHL 266
            ++  K +F    +L +V+++   G L   +        L  E        +++  +  L
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           H   I+HRDLK  NILL A+  V + D G++K   +   + + IGT  YMAPE+  G+ +
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVL-KKNMAKTQIGTPHYMAPEVWKGRPY 178

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLLKGLLQ 385
           +  +D WS+G LLYEM T  PPF   +   ++ K+ + K   +P   S +  + ++ +LQ
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238

Query: 386 KEPGKRLG 393
            +P  R  
Sbjct: 239 VKPKLRPN 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  154 bits (392), Expect = 7e-44
 Identities = 80/249 (32%), Positives = 138/249 (55%), Gaps = 14/249 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E F++L+ +G+G++G VY+   K T ++ A+KV+  ++ +++     +  E  IL + D 
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE-----IIKEISILKQCDS 57

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           P++V+   S+     L++V+++   G +    ++ +  L  E++A I   + +  + +LH
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI-LYQTLKGLEYLH 116

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGH 326
           +N  +HRD+K  NILL  +G   L DFG++ Q  D   + N++IGT  +MAPE++   G+
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGN--RA--KIQQKIVKDKLRLPAFLSSEAHSLLKG 382
           N  AD WS+GI   EM  GKPP+   +  RA   I  K     L  P   S E +  +K 
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK-PPPTLSDPEKWSPEFNDFVKK 235

Query: 383 LLQKEPGKR 391
            L K+P +R
Sbjct: 236 CLVKDPEER 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  154 bits (391), Expect = 9e-44
 Identities = 81/244 (33%), Positives = 134/244 (54%), Gaps = 5/244 (2%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +  ++V+G+GAFG     R+     +   K +   ++ EK   + +  E  IL+ + HP 
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN-EIVILSLLQHPN 60

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHAN 269
           ++     F     L + +++ NGG L+ ++      LF E++   Y  +IVSAVS++H  
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           GI+HRD+K  NI L   G + L DFG++K    E + + +++GT  YM+PE+  G  +N 
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV-KDKLRLPAFLSSEAHSLLKGLLQKE 387
            +D W++G +LYE+LT K  F   N   +  KIV  +   + +  SSE  SL+  LLQ++
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQD 240

Query: 388 PGKR 391
           P KR
Sbjct: 241 PEKR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  162 bits (412), Expect = 2e-43
 Identities = 68/150 (45%), Positives = 107/150 (71%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           IE+F ++K + +GAFG+VY  RKKN S++YA+KV++K  ++ KN    ++AERD L    
Sbjct: 3   IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V L YS Q+   +YLV++++ GG +   L+ +G F E++A  Y +E+  A+ +LH 
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAK 298
           +GI+HRDLKP+N+L+  +GH+ LTDFGL+K
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  152 bits (386), Expect = 4e-43
 Identities = 76/245 (31%), Positives = 137/245 (55%), Gaps = 5/245 (2%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           DFE+L  +G+G+FG V++V +K    +YAMK +   K+  +   E +   R +L K+D  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR-VLAKLDSS 59

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGG--HLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           ++++   SF  K +L +V+++   G  H   ++       ED    +  +I+  ++HLH+
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-SNSMIGTVEYMAPEIVLGKGHN 327
             I+HRD+K  N+ L A  +V + D G+AK   +NT  +N+++GT  Y++PE+   K +N
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN 179

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-LPAFLSSEAHSLLKGLLQK 386
           + +D W++G++LYE  TGK PF   N+  +  KI++     +    S +   L+   L K
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239

Query: 387 EPGKR 391
           +  +R
Sbjct: 240 DYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  150 bits (380), Expect = 6e-42
 Identities = 79/268 (29%), Positives = 137/268 (51%), Gaps = 21/268 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVM----RKDKIVEKNHAEYMKAERDILT 205
           E F +L+ +G+G+FG VY+   K T+++ A+KV+     +D+I      E ++ E   L+
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI------EDIQQEIQFLS 54

Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
           +   P++ +   SF    +L++++++  GG     L   G   E        E++  + +
Sbjct: 55  QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLDETYIAFILREVLLGLEY 113

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSNSMIGTVEYMAPEIVLGK 324
           LH  G +HRD+K  NILL  +G V L DFG++ Q     ++ N+ +GT  +MAPE++   
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS 173

Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK---DKLRLPAFLSSEAHSLLK 381
           G+++ AD WS+GI   E+  G+PP    +  ++   I K     L    F S      + 
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKF-SKPFKDFVS 232

Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
             L K+P +R  A     +E+  HK+ K
Sbjct: 233 LCLNKDPKERPSA-----KELLKHKFIK 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  149 bits (377), Expect = 1e-41
 Identities = 86/227 (37%), Positives = 124/227 (54%), Gaps = 18/227 (7%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIY-AMK-------VMRKDKIVEKNHAEYMKAERDI 203
           + VL+ +G GAFG VY+VRKKN  +   A+K          KDK         + +E  I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 204 LTK-IDHPFVVQLKYSFQTKYRLYLVLDFING---GHLFFQLYH-HGLFREDLARIYA-- 256
           + + + HP +V+   +F    RLY+V+D I G   G  F  L      F E+  RI+   
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE--RIWNIF 119

Query: 257 AEIVSAVSHLHANG-IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEY 315
            ++V A+ +LH    I+HRDL P NI+LG D  V +TDFGLAKQ    ++  S++GT+ Y
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 316 MAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV 362
             PEIV  + + + AD W+ G +LY+M T +PPF   N   +  KIV
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV 226

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  149 bits (377), Expect = 2e-41
 Identities = 91/299 (30%), Positives = 142/299 (47%), Gaps = 51/299 (17%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKI 207
             +EVL VVG+GA+G V + R K T EI A+K   K K  E +      A R++  L ++
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK---KFKESEDDEDVKKTALREVKVLRQL 57

Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL---YHHGLFREDLARIYAAEIVSAVS 264
            H  +V LK +F+ K RLYLV +++       +L      GL   D  R Y  +++ A++
Sbjct: 58  RHENIVNLKEAFRRKGRLYLVFEYV--ERTLLELLEASPGGL-PPDAVRSYIWQLLQAIA 114

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN--SMIGTVEYMAPEIVL 322
           + H++ I+HRD+KPENIL+   G + L DFG A+       S     + T  Y APE+++
Sbjct: 115 YCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174

Query: 323 GKG-HNKAADWWSVGILLYEMLTGKPPFIG--------------GNRAKIQQKI------ 361
           G   + K  D W++G ++ E+L G+P F G              G      Q++      
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234

Query: 362 --------VKD----KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
                          + R P  +SS A   LK  L+ +P +RL       +E+  H +F
Sbjct: 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC-----DELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  147 bits (373), Expect = 4e-41
 Identities = 81/247 (32%), Positives = 127/247 (51%), Gaps = 8/247 (3%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE--KNHAEYMKAERDILTKIDHPFVV 213
           K++GQGAFGRVY     +T    A+K +  D      K     ++ E  +L  + H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMH 273
           Q     +    L + ++++ GG +  QL  +G   E + R Y  +I+  V +LH+N I+H
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127

Query: 274 RDLKPENILLGADGHVMLTDFGLAKQFD----ENTRSNSMIGTVEYMAPEIVLGKGHNKA 329
           RD+K  NIL  + G+V L DFG +K+        T   S+ GT  +M+PE++ G+G+ + 
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK 187

Query: 330 ADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL--RLPAFLSSEAHSLLKGLLQKE 387
           AD WSVG  + EMLT KPP+          KI       +LP+ +S +A + L+    + 
Sbjct: 188 ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVEN 247

Query: 388 PGKRLGA 394
             KR  A
Sbjct: 248 AKKRPSA 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  147 bits (373), Expect = 9e-41
 Identities = 87/307 (28%), Positives = 145/307 (47%), Gaps = 70/307 (22%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD--------- 202
           +E +  +G+G +G+VY+ R K T E+ A+K +R            M+ E++         
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR------------MENEKEGFPITAIRE 48

Query: 203 --ILTKIDHPFVVQLKYSFQTKYR--LYLVLDFINGGHLFFQLYHHGLFREDLARI--YA 256
             +L K+ HP +V+LK    +K +  +Y+V ++++  H    L      +   ++I  Y 
Sbjct: 49  IKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD--HDLTGLLDSPEVKFTESQIKCYM 106

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTR--SNSMIGTV 313
            +++  + +LH+NGI+HRD+K  NIL+  DG + L DFGLA+ +   N+   +N +I T+
Sbjct: 107 KQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TL 165

Query: 314 EYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRA----KI----------- 357
            Y  PE++LG   +    D WSVG +L E+  GKP F G        KI           
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN 225

Query: 358 --------------QQKIVKDKLR--LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEE 401
                          +K  K +LR      +   A  LL  LL  +P KR+ A     ++
Sbjct: 226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA-----DQ 280

Query: 402 IKSHKWF 408
              H++F
Sbjct: 281 ALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  146 bits (369), Expect = 1e-40
 Identities = 84/248 (33%), Positives = 133/248 (53%), Gaps = 6/248 (2%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
            + VL+VVG+G+FGR   V+  N+ + YAMK +R  K    +  E  + E  +L K+ HP
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLF--FQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            +V  K SF+    LY+V+++ +GG L    +L    LF ED    +  ++   V H+H 
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHN 327
             ++HRD+K +NI L  +G V L DFG A+        + + +GT  Y+ PEI     +N
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-LPAFLSSEAHSLLKGLLQK 386
             +D WS+G +LYE+ T K PF   +   +  K+ +   + LP+  S E  SL+K + ++
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238

Query: 387 EPGKRLGA 394
            P  R  A
Sbjct: 239 NPRSRPSA 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  146 bits (371), Expect = 1e-40
 Identities = 80/265 (30%), Positives = 140/265 (52%), Gaps = 15/265 (5%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH-- 209
           ++ L+++G+GA+G VY+ +   T  + A+K++  D     +    ++ E  +L+++    
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD--TPDDDVSDIQREVALLSQLRQSQ 60

Query: 210 -PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            P + +   S+    RL++++++  GG +   L   G   E    +   E++ A+ ++H 
Sbjct: 61  PPNITKYYGSYLKGPRLWIIMEYAEGGSVR-TLMKAGPIAEKYISVIIREVLVALKYIHK 119

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS-MIGTVEYMAPEIVL-GKGH 326
            G++HRD+K  NIL+   G+V L DFG+A   ++N+   S  +GT  +MAPE++  GK +
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPA-FLSSEAHSLLKGLL 384
           +  AD WS+GI +YEM TG PP+   +  +    I K K  RL     S      +   L
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACL 239

Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFK 409
            +EP +RL A     EE+   KW K
Sbjct: 240 DEEPKERLSA-----EELLKSKWIK 259

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  145 bits (367), Expect = 2e-40
 Identities = 78/244 (31%), Positives = 132/244 (54%), Gaps = 5/244 (2%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +  +K +G+G+FG+   V+ K   + Y +K +   K+  K   E  K E  +L+ + HP 
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK-EVAVLSNMKHPN 60

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHAN 269
           +VQ + SF+    LY+V+D+  GG L+ ++      LF ED    +  +I  A+ H+H  
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-SNSMIGTVEYMAPEIVLGKGHNK 328
            I+HRD+K +NI L  DG + L DFG+A+  +     + + IGT  Y++PEI   + +N 
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN 180

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLLKGLLQKE 387
            +D W++G +LYEM T K  F  GN   +  KI++     + +  S +  +L+  L ++ 
Sbjct: 181 KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRN 240

Query: 388 PGKR 391
           P  R
Sbjct: 241 PRDR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  145 bits (367), Expect = 3e-40
 Identities = 79/257 (30%), Positives = 127/257 (49%), Gaps = 15/257 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ED+E+++ +G G +G VY+ R   T E+ A+KV+   K+   +  E ++ E  +L +  H
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRH 59

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH--HGLFREDLARIYAAEIVSAVSHLH 267
           P +V    S+  + +L++V+++  GG L   +Y    G   E        E +  +++LH
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSNSMIGTVEYMAPEIV---LG 323
             G +HRD+K  NILL  DG V L DFG++ Q      +  S IGT  +MAPE+      
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERK 178

Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-----KLRLPAFLSSEAHS 378
            G++   D W++GI   E+   +PP    +  +    I K      KL+     S   H 
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238

Query: 379 LLKGLLQKEPGKRLGAG 395
            +K  L K+P KR  A 
Sbjct: 239 FIKKCLTKDPKKRPTAT 255

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  145 bits (368), Expect = 4e-40
 Identities = 83/279 (29%), Positives = 135/279 (48%), Gaps = 41/279 (14%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKIDH 209
           ++ L  +G+G +G VY+ R K T EI A+K ++      ++      A R+I  L +++H
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLR---FESEGIPKTALREIKLLKELNH 57

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLH 267
           P +++L   F+ K  LYLV +F++     ++L         E L + Y  +++  ++  H
Sbjct: 58  PNIIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-NSMIGTVEYMAPEIVLG-KG 325
           ++GI+HRDLKPEN+L+  +G + L DFGLA+ F    R     + T  Y APE++LG KG
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNR-------------------AKIQQKIVKDKL 366
           ++   D WSVG +  E+L+ +P F G +                     K        K 
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235

Query: 367 RLPAF-----------LSSEAHSLLKGLLQKEPGKRLGA 394
             P              S +A  LL  +L  +P KR+ A
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA 274

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score =  143 bits (362), Expect = 7e-40
 Identities = 84/250 (33%), Positives = 126/250 (50%), Gaps = 18/250 (7%)

Query: 161 GAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH--PFVVQLKYS 218
           G   +V  V    T + + +K +RK     +            LT I H  P +V L   
Sbjct: 4   GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRER----------LTIIPHCVPNMVCLHKY 53

Query: 219 FQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKP 278
             ++  ++LVL    GG L+  +       E+  + +AAE+V A+  LH  GI+ RDL P
Sbjct: 54  IVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNP 113

Query: 279 ENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGIL 338
            NILL   GH+ LT F    + +++    ++     Y APE+       +A DWWS+G +
Sbjct: 114 NNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM--YCAPEVGGISEETEACDWWSLGAI 171

Query: 339 LYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKG 398
           L+E+LTGK   +  + + I        L +P ++S EA SLL+ LLQ  P +RLGAG  G
Sbjct: 172 LFELLTGK-TLVECHPSGINTHT---TLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAG 227

Query: 399 SEEIKSHKWF 408
            E+IKSH +F
Sbjct: 228 VEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  143 bits (362), Expect = 1e-39
 Identities = 83/246 (33%), Positives = 134/246 (54%), Gaps = 8/246 (3%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +E++K +G+G+FG++Y  + K+ SE   +K +   K+  K   E  K E  +L K+ HP 
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPN 60

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLF--FQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           +V    SFQ   RL++V+++ +GG L          LF ED    +  +I   + H+H  
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120

Query: 270 GIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTR-SNSMIGTVEYMAPEIVLGKGHN 327
            I+HRD+K +NI L  +G V  L DFG+A+Q +++   + + +GT  Y++PEI   + +N
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYN 180

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR--LPAFLSSEAHSLLKGLLQ 385
              D WS+G +LYE+ T K PF G N  ++  KI +       P F S +  SL+  L +
Sbjct: 181 NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNF-SRDLRSLISQLFK 239

Query: 386 KEPGKR 391
             P  R
Sbjct: 240 VSPRDR 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  143 bits (363), Expect = 1e-39
 Identities = 83/256 (32%), Positives = 134/256 (52%), Gaps = 15/256 (5%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           + +F++ K +G+G F  VY+        + A+K ++  ++++    +    E D+L ++D
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI-------YAAEIVS 261
           HP V++   SF     L +VL+  + G L   + H   F++    I       Y  ++ S
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKH---FKKQKRLIPERTIWKYFVQLCS 117

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSMIGTVEYMAPEI 320
           A+ H+H+  IMHRD+KP N+ + A G V L D GL + F   T  ++S++GT  YM+PE 
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGG--NRAKIQQKIVK-DKLRLPA-FLSSEA 376
           +   G+N  +D WS+G LLYEM   + PF G   N   + +KI K D   LPA   S E 
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237

Query: 377 HSLLKGLLQKEPGKRL 392
             L+   +  +P KR 
Sbjct: 238 RDLVSRCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  139 bits (353), Expect = 5e-38
 Identities = 88/278 (31%), Positives = 142/278 (51%), Gaps = 20/278 (7%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
            + +E++  +G GAFG+VY+ + K T    A K++   +I  +   E    E DIL++  
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECK 60

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           HP +V L  ++  + +L+++++F +GG L         GL  E   R    +++ A++ L
Sbjct: 61  HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGL-TEPQIRYVCRQMLEALNFL 119

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGL-AKQFDENTRSNSMIGTVEYMAPEIVL--- 322
           H++ ++HRDLK  NILL  DG V L DFG+ AK      + ++ IGT  +MAPE+V    
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179

Query: 323 --GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAH 377
                ++  AD WS+GI L E+   +PP    N  ++  KI+K     L  P+  SS  +
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239

Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK 415
             LK  L K+P  R  A      E+  H +    +  K
Sbjct: 240 DFLKSCLVKDPDDRPTAA-----ELLKHPFVSDQSDNK 272

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  139 bits (352), Expect = 6e-38
 Identities = 78/270 (28%), Positives = 132/270 (48%), Gaps = 19/270 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D E L  +G G  G V +V  + T +I A+K +R +             E DIL K + 
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR--ELDILHKCNS 58

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           P++V    +F     + + +++++GG L    +     +    L +I  A ++  +++LH
Sbjct: 59  PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA-VLKGLTYLH 117

Query: 268 AN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
               I+HRD+KP NIL+ + G + L DFG++ Q   N+ + + +GT  YMAPE + G  +
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTFVGTSSYMAPERIQGNDY 176

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ-----QKIVK-DKLRLPA-FLSSEAHSL 379
           +  +D WS+G+ L E+ TG+ P+   N          Q IV     RLP+   S +    
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236

Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           +   L K+P +R     K   E+  H + K
Sbjct: 237 VNLCLIKDPRER--PSYK---ELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  137 bits (348), Expect = 5e-37
 Identities = 82/300 (27%), Positives = 127/300 (42%), Gaps = 57/300 (19%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKIDH 209
           +E  K +G+G +  VY+ R K T  I A+K ++  +  E        A R+I  L ++ H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 210 PFVVQLKYSFQTKYRLYLVLDF--------INGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           P ++ L   F  K  + LV +F        I    +               + Y    + 
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD--------IKSYMLMTLR 113

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEI 320
            + +LH+N I+HRDLKP N+L+ +DG + L DFGLA+ F   N +    + T  Y APE+
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173

Query: 321 VLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK-----------DKL 366
           + G + +    D WSVG +  E+L   P   G +   I Q  KI +              
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS--DIDQLGKIFEALGTPTEENWPGVT 231

Query: 367 RLPAFL-----------------SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
            LP ++                 S +A  LL+ LL   P KR+ A      +   H +F 
Sbjct: 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITA-----RQALEHPYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  136 bits (344), Expect = 6e-37
 Identities = 80/274 (29%), Positives = 135/274 (49%), Gaps = 22/274 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D+E+++V+G GA   VY       +E  A+K +  +K       + ++ E   +++ +H
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS--VDELRKEVQAMSQCNH 58

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGG---HLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           P VV+   SF     L+LV+ +++GG    +    Y  G   E +      E++  + +L
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-----RSNSMIGTVEYMAPEIV 321
           H+NG +HRD+K  NILLG DG V + DFG++    +          + +GT  +MAPE++
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 322 -LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHS- 378
               G++  AD WS GI   E+ TG  P+      K+    ++ D   L      + +S 
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238

Query: 379 ----LLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
               ++   LQK+P KR    P   E +K HK+F
Sbjct: 239 SFRKMISLCLQKDPSKR----PTAEELLK-HKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  137 bits (346), Expect = 6e-37
 Identities = 86/295 (29%), Positives = 133/295 (45%), Gaps = 47/295 (15%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
            +++L  +G+GA G V++ + + T E  A+K +   + +E         E   L    HP
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVAL-RRLEGGIPNQALREIKALQACQHP 59

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHA 268
           +VV+L   F       LV++++       ++         E   + Y   ++  V+++HA
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYM--PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS--NSMIGTVEYMAPEIVLGKGH 326
           NGIMHRDLKP N+L+ ADG + + DFGLA+ F E      +  + T  Y APE++ G   
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 327 -NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK-------------------D 364
            +   D W+VG +  E+L G P F G N   I+Q   + +                   +
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGEN--DIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235

Query: 365 KLRLPA-----------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
           K+  P              S EA  LLKGLL  +P KRL A      E   H +F
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA-----AEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 2e-36
 Identities = 84/278 (30%), Positives = 139/278 (50%), Gaps = 29/278 (10%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-D 208
             FE+++V+G+G +G+VY+ R K T ++ A+K+M     + ++  E +K E +IL K  +
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSN 61

Query: 209 HPFVVQLKYSFQTK------YRLYLVLDFINGG---HLFFQLYHHG-LFREDLARIYAAE 258
           HP +     +F  K       +L+LV++   GG    L   L   G   +E+       E
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMA 317
            +  +++LH N ++HRD+K +NILL  +  V L DFG++ Q D    R N+ IGT  +MA
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181

Query: 318 PEIVLGKGHNKA-----ADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLP 369
           PE++       A     +D WS+GI   E+  GKPP    +  +   KI ++    L+ P
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241

Query: 370 AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKW 407
              S + +  +   L K   +R    P   EE+  H +
Sbjct: 242 ENWSKKFNDFISECLIKNYEQR----PF-MEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  134 bits (340), Expect = 4e-36
 Identities = 81/298 (27%), Positives = 127/298 (42%), Gaps = 52/298 (17%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAE--RDI-----L 204
           +E L  +G+GA+G VY+ R  NT    A+K     K+      E +     R+I     L
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALK-----KVRVPLSEEGIPLSTLREIALLKQL 55

Query: 205 TKIDHPFVVQLKYSFQTKYR-----LYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAE 258
              +HP +V+L              L LV + ++     +           +  +    +
Sbjct: 56  ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQ 115

Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           ++  V  LH++ I+HRDLKP+NIL+ +DG V + DFGLA+ +       S++ T+ Y AP
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAP 175

Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP--------- 369
           E++L   +    D WSVG +  E+   +P F G + A    KI  D + LP         
Sbjct: 176 EVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIF-DVIGLPSEEEWPRNV 234

Query: 370 -----AF--------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
                +F              +  E   LLK +L   P KR+ A      E   H +F
Sbjct: 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA-----FEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  134 bits (339), Expect = 5e-36
 Identities = 91/298 (30%), Positives = 139/298 (46%), Gaps = 56/298 (18%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKI-D 208
           ++V+K +G G FG VY  R K T E+ A+K M+K K    +  E M   R++  L K+ +
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKK-KF--YSWEECMN-LREVKSLRKLNE 56

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY---HHGLFREDLARIYAAEIVSAVSH 265
           HP +V+LK  F+    LY V +++ G    +QL        F E + R    +I+  ++H
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYMEGN--LYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN----SMIGTVEYMAPEIV 321
           +H +G  HRDLKPEN+L+     V + DFGLA++     RS       + T  Y APEI+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLARE----IRSRPPYTDYVSTRWYRAPEIL 170

Query: 322 LGKG-HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV------------------ 362
           L    ++   D W++G ++ E+ T +P F G +      KI                   
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230

Query: 363 -KDKLRLPAFL-----------SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
            K   R P F            S EA  L+K +L+ +P KR  A      +   H +F
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA-----SQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  133 bits (336), Expect = 6e-36
 Identities = 72/246 (29%), Positives = 133/246 (54%), Gaps = 9/246 (3%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +E ++VVG+GAFG V+  R+K   ++  +K +  +++ +       + E  +L  + HP 
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER-LAAQNECQVLKLLSHPN 60

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           +++   +F     L +V+++  GG L  + Q   + L  ED    +  +I+ A+ H+H  
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 270 GIMHRDLKPENILLGADGHVM---LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
            I+HRDLK +NILL  D H M   + DFG++K     +++ +++GT  Y++PE+  GK +
Sbjct: 121 LILHRDLKTQNILL--DKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPY 178

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-LPAFLSSEAHSLLKGLLQ 385
           N+ +D W++G +LYE+ + K  F   N   +  KI+      +    S +   L+  +L 
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLN 238

Query: 386 KEPGKR 391
            +P KR
Sbjct: 239 LDPSKR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  132 bits (335), Expect = 1e-35
 Identities = 75/256 (29%), Positives = 130/256 (50%), Gaps = 22/256 (8%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK-------AERDILTKID 208
           +++G+G +GRVY      T E+ A+K +     +   H    K       +E + L  +D
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  +VQ      T+  L + L+++ GG +   L  +G F E L R +  +++  +++LH+
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE---NTRSNSMIGTVEYMAPEIV--LG 323
            GI+HRDLK +N+L+ ADG   ++DFG++K+ D+   N ++ SM G+V +MAPE++    
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186

Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVKDKLRLP------AFLSSE 375
           +G++   D WS+G ++ EM  G+ P+   +   I    K+   +   P        LS  
Sbjct: 187 QGYSAKVDIWSLGCVVLEMFAGRRPW--SDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244

Query: 376 AHSLLKGLLQKEPGKR 391
           A   L       P  R
Sbjct: 245 ALDFLNACFTINPDNR 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  130 bits (327), Expect = 2e-34
 Identities = 92/253 (36%), Positives = 136/253 (53%), Gaps = 14/253 (5%)

Query: 150 EDF-EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           E+F E++  +G GAFG+VY+ + K T  + A KV+  D   E+   +YM  E DIL   D
Sbjct: 4   EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 60

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L  +F  +  L+++++F  GG +    L       E   R+   + + A+++LH
Sbjct: 61  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGL-AKQFDENTRSNSMIGTVEYMAPEIVL---- 322
            N I+HRDLK  NIL   DG + L DFG+ AK      R +S IGT  +MAPE+V+    
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 323 -GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHS 378
             + ++  AD WS+GI L EM   +PP    N  ++  KI K +   L  P+  SSE   
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240

Query: 379 LLKGLLQKEPGKR 391
            LK  L+K    R
Sbjct: 241 FLKKCLEKNVDAR 253

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  129 bits (325), Expect = 3e-34
 Identities = 79/265 (29%), Positives = 138/265 (52%), Gaps = 24/265 (9%)

Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA------EYMKAERDILTKIDHP 210
           ++G G+FG VY     ++ E+ A+K +    +   +        + +  E  +L ++ H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG 270
            +VQ   S      L + L+++ GG +   L ++G F E L R +  +I+  +++LH  G
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 271 IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN-------SMIGTVEYMAPEIVLG 323
           I+HRD+K  NIL+   G + ++DFG++K+ + N+ S        S+ G+V +MAPE+V  
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186

Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRA----KIQQKIVKDKLRLPAFLSSEAHSL 379
             + + AD WS+G L+ EMLTGK PF    +     KI +    +   +P+ +SSEA   
Sbjct: 187 TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE---IPSNISSEAIDF 243

Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKS 404
           L+   + +  KR    P  +E +K 
Sbjct: 244 LEKTFEIDHNKR----PTAAELLKH 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  129 bits (325), Expect = 5e-34
 Identities = 89/257 (34%), Positives = 140/257 (54%), Gaps = 17/257 (6%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E +E++  +G GAFG+VY+ + K T  + A KV+  +   E+   +YM  E +IL   +H
Sbjct: 12  EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYM-VEIEILATCNH 68

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGH---LFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           P++V+L  +F    +L+++++F  GG    +  +L   GL  E   ++   +++ A+ +L
Sbjct: 69  PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLEL-DRGL-TEPQIQVICRQMLEALQYL 126

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGL-AKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
           H+  I+HRDLK  N+LL  DG + L DFG+ AK      R +S IGT  +MAPE+V+ + 
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186

Query: 326 -----HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAH 377
                ++  AD WS+GI L EM   +PP    N  ++  KI K +   L  P+  S E  
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246

Query: 378 SLLKGLLQKEPGKRLGA 394
             LK  L K P  R  A
Sbjct: 247 DFLKTALDKHPETRPSA 263

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  127 bits (320), Expect = 2e-33
 Identities = 72/202 (35%), Positives = 110/202 (54%), Gaps = 3/202 (1%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           FEVL VVG+GA+G V + R K T EI A+K   KD    +   E    E  +L  +    
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           +V+LK +F+ + +LYLV +++    L            +  R Y  +++ A+   H N I
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121

Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN--SMIGTVEYMAPEIVLGKGHNKA 329
           +HRD+KPEN+L+  +  + L DFG A+   E + +N    + T  Y +PE++LG  + KA
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 330 ADWWSVGILLYEMLTGKPPFIG 351
            D WSVG +L E+  G+P F G
Sbjct: 182 VDMWSVGCILGELSDGQPLFPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  127 bits (320), Expect = 2e-33
 Identities = 78/251 (31%), Positives = 134/251 (53%), Gaps = 12/251 (4%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
              +    +G+G+ G V     K+T    A+K M    + ++   E +  E  I+    H
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRDYQH 75

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +V++  S+     L++V++F+ GG L   + H  +  E +A +  A ++ A+S LHA 
Sbjct: 76  PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLA-VLKALSFLHAQ 134

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSMIGTVEYMAPEIVLGKGHNK 328
           G++HRD+K ++ILL +DG V L+DFG   Q  +   R  S++GT  +MAPE++    +  
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQ-QKIVKD----KLRLPAFLSSEAHSLLKGL 383
             D WS+GI++ EM+ G+PP+   N   +Q  K ++D    KL+    +S    S L  +
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYF--NEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252

Query: 384 LQKEPGKRLGA 394
           L ++P +R  A
Sbjct: 253 LVRDPAQRATA 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  126 bits (318), Expect = 5e-33
 Identities = 96/298 (32%), Positives = 144/298 (48%), Gaps = 51/298 (17%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVM---RKDKIVEKNHAEYMKAERDI--L 204
           E +E L +VG+G++G V + + K T +I A+K       DK+V+K       A R+I  L
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKK------IAMREIRML 54

Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAV 263
            ++ H  +V L   F+ K RLYLV +F++   L   + Y +GL  E   R Y  +I+  +
Sbjct: 55  KQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGL-DESRVRKYLFQILRGI 113

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-NSMIGTVEYMAPEIVL 322
              H++ I+HRD+KPENIL+   G V L DFG A+            + T  Y APE+++
Sbjct: 114 EFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV 173

Query: 323 GK-GHNKAADWWSVGILLYEMLTGKPPFIG--------------GNRAKIQQKIVKDK-- 365
           G   + +A D W+VG L+ EMLTG+P F G              GN     Q+I +    
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233

Query: 366 ---LRLPAF------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
              +RLP              LS     L K  L+ +P  R    P  S+ +  H++F
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDR----PSSSQLLH-HEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  124 bits (314), Expect = 1e-32
 Identities = 79/260 (30%), Positives = 124/260 (47%), Gaps = 31/260 (11%)

Query: 161 GAFGRVYQVRKKNTSEIYAMKVMRKDK--IVEKNHAEYMKAERDILTKIDHPFVVQLKYS 218
           G FG+V  ++ K T +++  K+++      +E    + MK         D+P  ++L YS
Sbjct: 27  GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMK---------DNPNFIKLYYS 77

Query: 219 FQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKP 278
             T     L++D+I  G LF  L   G   E   +    ++V A++ LH + I+H D+K 
Sbjct: 78  VTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137

Query: 279 ENILL-GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGI 337
           EN+L   A   + L D+GL K     T S    GT++Y +PE + G  ++ + DWW+VG+
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCKI--IGTPS-CYDGTLDYFSPEKIKGHNYDVSFDWWAVGV 194

Query: 338 LLYEMLTGKPPFIGGNR--------AKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPG 389
           L YE+LTGK PF              K QQK    KL     +S  A+  ++ +L+    
Sbjct: 195 LTYELLTGKHPFKEDEDEELDLESLLKRQQK----KLPFIKNVSKNANDFVQSMLKYNIN 250

Query: 390 KRLGAGPKGSEEIKSHKWFK 409
            RL        EI  H + K
Sbjct: 251 YRL----TNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  125 bits (315), Expect = 2e-32
 Identities = 90/303 (29%), Positives = 142/303 (46%), Gaps = 50/303 (16%)

Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT 205
           C  ++++E L  + +G +G VY+ R K T EI A+K ++ +K  E      ++ E +IL 
Sbjct: 1   CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILL 59

Query: 206 KIDHPFVVQLKY----SFQTKYRLYLVLDFINGGHLFFQL--YHHGLFREDLARIYAAEI 259
           K+ HP +V +K     S   K  +Y+V++++   H    L       F +   +    ++
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDK--IYMVMEYVE--HDLKSLMETMKQPFLQSEVKCLMLQL 115

Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-NSMIGTVEYMAP 318
           +S V+HLH N I+HRDLK  N+LL   G + + DFGLA+++    +    ++ T+ Y AP
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAP 175

Query: 319 EIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD------------- 364
           E++LG    + A D WSVG +  E+LT KP F G +      KI K              
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235

Query: 365 ----------------KLR---LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH 405
                           +LR       LS     LL  LL  +P KR+ A     E+   H
Sbjct: 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA-----EDALKH 290

Query: 406 KWF 408
            +F
Sbjct: 291 PYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  124 bits (312), Expect = 3e-32
 Identities = 80/277 (28%), Positives = 142/277 (51%), Gaps = 37/277 (13%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++HP 
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 60

Query: 212 VVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG 270
           +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H++ 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 271 IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KGHNK 328
           ++HRDLKP+N+L+  +G + L DFGLA+ F    R+ +  + T+ Y APEI+LG K ++ 
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK------DKL-----RLPAF---- 371
           A D WS+G +  EM+T +  F G   ++I Q  +I +      + +      LP +    
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGD--SEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238

Query: 372 --------------LSSEAHSLLKGLLQKEPGKRLGA 394
                         L  +   LL  +L  +P KR+ A
Sbjct: 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA 275

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  122 bits (307), Expect = 1e-31
 Identities = 58/203 (28%), Positives = 112/203 (55%), Gaps = 9/203 (4%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVM---RKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           + +G GAF   YQ R   T  + A+K +   R     ++   E ++ E  ++ +++HP +
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 213 VQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIM 272
           +++  +        L ++++ GG +   L  +G F+E +   Y  +++  +S+LH N I+
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125

Query: 273 HRDLKPENILLGADGH-VMLTDFGLAKQFDEN-TRSN----SMIGTVEYMAPEIVLGKGH 326
           HRD+K  N+L+ + G  + + DFG A +     T +      ++GT+ +MAPE++ G+ +
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY 185

Query: 327 NKAADWWSVGILLYEMLTGKPPF 349
            ++ D WSVG ++ EM T KPP+
Sbjct: 186 GRSCDVWSVGCVIIEMATAKPPW 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  122 bits (307), Expect = 2e-31
 Identities = 81/294 (27%), Positives = 145/294 (49%), Gaps = 48/294 (16%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKIDH 209
           ++ ++ +G+G +G VY+ R K T EI A+K +R +   E   +    A R+I  L +++H
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPS---TAIREISLLKELNH 57

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGG--HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           P +V+L     ++ +LYLV +F++             GL    L + Y  +++  +++ H
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP-PLIKSYLYQLLQGIAYCH 116

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+ +  + T+ Y APEI+LG + 
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176

Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK-----------DKLRLPAF- 371
           ++   D WS+G +  EM+  +P F G   ++I Q  +I +               LP + 
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGD--SEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234

Query: 372 -----------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
                            L  +   LL  +L  +P KR+ A     +    H +F
Sbjct: 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA-----KAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  120 bits (302), Expect = 4e-31
 Identities = 81/256 (31%), Positives = 129/256 (50%), Gaps = 22/256 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDFE+++ +G G +G VY+ R  NT E+ A+KV+   K+        ++ E  ++    H
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKH 65

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHA 268
             +V    S+  + +L++ ++F  GG L   +YH  G   E      + E +  + +LH+
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQ-DIYHVTGPLSESQIAYVSRETLQGLYYLHS 124

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSNSMIGTVEYMAPEIVLGK--- 324
            G MHRD+K  NILL  +GHV L DFG++ Q      +  S IGT  +MAPE+   +   
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKG 184

Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIG---------GNRAKIQQKIVKDKLRLPAFLSSE 375
           G+N+  D W+VGI   E+   +PP              ++  Q   +KDK++     S+ 
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK----WSNS 240

Query: 376 AHSLLKGLLQKEPGKR 391
            H  +K  L K P KR
Sbjct: 241 FHHFVKMALTKNPKKR 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  120 bits (302), Expect = 5e-31
 Identities = 80/237 (33%), Positives = 122/237 (51%), Gaps = 12/237 (5%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEY--MKAERDILTKIDHPFVV 213
           K++GQGAFGRVY     +T    A+K ++ D    +   E   ++ E  +L  + H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 214 QLKYSF---QTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG 270
           Q  Y       +  L + ++ + GG +  QL  +G   E++ R Y  +I+  VS+LH+N 
Sbjct: 68  QY-YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126

Query: 271 IMHRDLKPENILLGADGHVMLTDFGLAKQFD----ENTRSNSMIGTVEYMAPEIVLGKGH 326
           I+HRD+K  NIL  + G+V L DFG +K+        T   S+ GT  +M+PE++ G+G+
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL--RLPAFLSSEAHSLLK 381
            + AD WSVG  + EMLT KPP+          KI        LP  +S      LK
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLK 243

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  120 bits (301), Expect = 7e-31
 Identities = 83/253 (32%), Positives = 133/253 (52%), Gaps = 11/253 (4%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK-DKIVEKNHAEYMKAERDILTKI 207
           + +F + K +G+G F  VY+          A+K ++  D +  K  A+ +K E D+L ++
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQL 59

Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG----LFREDLARIYAAEIVSAV 263
           +HP V++   SF     L +VL+  + G L   + H      L  E     Y  ++ SA+
Sbjct: 60  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVL 322
            H+H+  +MHRD+KP N+ + A G V L D GL + F  + T ++S++GT  YM+PE + 
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGG--NRAKIQQKIVK-DKLRLPA-FLSSEAHS 378
             G+N  +D WS+G LLYEM   + PF G   N   + +KI + D   LP+   S E   
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239

Query: 379 LLKGLLQKEPGKR 391
           L+   +  +P KR
Sbjct: 240 LVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  119 bits (301), Expect = 8e-31
 Identities = 69/247 (27%), Positives = 123/247 (49%), Gaps = 13/247 (5%)

Query: 155 LKVVGQGAFGRVYQ----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
            K +G+GAFG VY+     +        A+K +++D   E+   E+++ E  I+ K+DHP
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS-EQQIEEFLR-EARIMRKLDHP 61

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            VV+L      +  LY+V++++ GG L  + +     L   DL   +A +I   + +L +
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLS-FALQIARGMEYLES 120

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGH 326
              +HRDL   N L+G +  V ++DFGL++    D+  R       + +MAPE +     
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180

Query: 327 NKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLKGLL 384
              +D WS G+LL+E+ T G+ P+ G +  ++ + +     L  P     E + L+    
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCW 240

Query: 385 QKEPGKR 391
            ++P  R
Sbjct: 241 AEDPEDR 247

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 8e-31
 Identities = 78/248 (31%), Positives = 129/248 (52%), Gaps = 10/248 (4%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEY--MKAERDILTKI 207
            ++ + K++G+GAFG VY     +T    A+K +  D   ++   E   ++ E  +L  +
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61

Query: 208 DHPFVVQLKYSFQ--TKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
            H  +VQ     +   + +L + ++++ GG +  QL  +G   E++ R Y  +I+  VS+
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD----ENTRSNSMIGTVEYMAPEIV 321
           LH+N I+HRD+K  NIL  + G+V L DFG +K+        T   S+ GT  +M+PE++
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181

Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--KLRLPAFLSSEAHSL 379
            G+G+ + AD WSV   + EMLT KPP+          KI     K  LP  +S      
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241

Query: 380 LKGLLQKE 387
           LK +  +E
Sbjct: 242 LKQIFVEE 249

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  119 bits (301), Expect = 8e-31
 Identities = 62/224 (27%), Positives = 114/224 (50%), Gaps = 12/224 (5%)

Query: 155 LKVVGQGAFGRVYQ----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
            K +G+GAFG VY+     +        A+K +++D   E+   E+++ E  I+ K+DHP
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDAS-EQQIEEFLR-EARIMRKLDHP 61

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            +V+L      +  L +V++++ GG L  + +              +A +I   + +L +
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGH 326
              +HRDL   N L+G +  V ++DFGL++    D+  +       + +MAPE +     
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181

Query: 327 NKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
              +D WS G+LL+E+ T G+ P+ G + A++ +  +K   RLP
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEY-LKKGYRLP 224

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  120 bits (301), Expect = 1e-30
 Identities = 83/267 (31%), Positives = 135/267 (50%), Gaps = 10/267 (3%)

Query: 134 DENVKGDSVTVCCVGIEDFEVLKV--VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK 191
           DE +     T+  VG    +  +   +GQGA G VY      T +  A+K M   +  +K
Sbjct: 1   DEEILEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK 60

Query: 192 NHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDL 251
              E +  E  ++ +  HP +V    S+     L++V++++ GG L   +    +    +
Sbjct: 61  ---ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 117

Query: 252 ARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMI 310
           A +   E + A+  LH+N ++HRD+K +NILLG DG V LTDFG   Q   E ++ ++M+
Sbjct: 118 AAV-CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176

Query: 311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV---KDKLR 367
           GT  +MAPE+V  K +    D WS+GI+  EM+ G+PP++  N  +    I      +L+
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ 236

Query: 368 LPAFLSSEAHSLLKGLLQKEPGKRLGA 394
            P  LS+     L   L+ +  KR  A
Sbjct: 237 NPEKLSAIFRDFLNRCLEMDVEKRGSA 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  119 bits (300), Expect = 1e-30
 Identities = 78/294 (26%), Positives = 136/294 (46%), Gaps = 48/294 (16%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F+ L+ +G+G +  VY+ R + T EI A+K +  D   E+        E  ++ ++ H  
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHEN 59

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-----HHGLFREDLARIYAAEIVSAVSHL 266
           +V+L     T+ +L LV ++++      + Y       G    +  + +  +++  ++  
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKD---LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD--ENTRSNSMIGTVEYMAPEIVLG- 323
           H N ++HRDLKP+N+L+   G + L DFGLA+ F    NT SN ++ T+ Y AP+++LG 
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGS 175

Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRA-------------------------KIQ 358
           + ++ + D WSVG ++ EM+TG+P F G N                           + +
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235

Query: 359 QKIVKDKLRLPAFLSSEAH----SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
               +   +    L   A      LL  LLQ  P  R+ A      +   H WF
Sbjct: 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA-----HDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  119 bits (298), Expect = 2e-30
 Identities = 70/202 (34%), Positives = 113/202 (55%), Gaps = 8/202 (3%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEY--MKAERDILTKIDHPFVV 213
           K++GQGAFGRVY     +T    A K ++ D    +   E   ++ E  +L  + H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 214 QLKYSFQTKYR--LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           Q     + +    L + ++++ GG +  QL  +G   E + R Y  +I+  +S+LH+N I
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127

Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQFD----ENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +HRD+K  NIL  + G+V L DFG +K+        T   S+ GT  +M+PE++ G+G+ 
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG 187

Query: 328 KAADWWSVGILLYEMLTGKPPF 349
           + AD WS+G  + EMLT KPP+
Sbjct: 188 RKADVWSLGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  118 bits (296), Expect = 3e-30
 Identities = 75/244 (30%), Positives = 131/244 (53%), Gaps = 10/244 (4%)

Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVM--RKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           ++VVG+G++G V  VR +   + Y +K +  R     E+  AE    E  +L+++ HP +
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE---QEAQLLSQLKHPNI 61

Query: 213 VQLKYSFQTK-YRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHAN 269
           V  + S++ +   LY+V+ F  GG L+ +L      L  E+    +  +I  A+ +LH  
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNK 328
            I+HRDLK +N+ L     + + D G+A+  + +   ++++IGT  YM+PE+   K +N 
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY 181

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLLKGLLQKE 387
            +D W++G  +YEM T K  F   +   +  +I++ KL  +P   S E   L+  +L K 
Sbjct: 182 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKR 241

Query: 388 PGKR 391
           P KR
Sbjct: 242 PEKR 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  119 bits (301), Expect = 4e-30
 Identities = 84/263 (31%), Positives = 134/263 (50%), Gaps = 30/263 (11%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK----AERDIL 204
           + + E +  +G GA G VY+V  + T  +YA+KV      +  NH + ++     E +IL
Sbjct: 73  LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKV------IYGNHEDTVRRQICREIEIL 126

Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
             ++HP VV+    F     + ++L+F++GG L         F  D+AR    +I+S ++
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIA 182

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFG----LAKQFDENTRSNSMIGTVEYMAPEI 320
           +LH   I+HRD+KP N+L+ +  +V + DFG    LA+  D     NS +GT+ YM+PE 
Sbjct: 183 YLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPER 239

Query: 321 V-----LGKGHNKAADWWSVGILLYEMLTGKPPF-IG--GNRAKIQQKI-VKDKLRLPAF 371
           +      G     A D WS+G+ + E   G+ PF +G  G+ A +   I +      PA 
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT 299

Query: 372 LSSEAHSLLKGLLQKEPGKRLGA 394
            S E    +   LQ+EP KR  A
Sbjct: 300 ASREFRHFISCCLQREPAKRWSA 322

Length = 353

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  117 bits (296), Expect = 4e-30
 Identities = 74/255 (29%), Positives = 125/255 (49%), Gaps = 23/255 (9%)

Query: 156 KVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           K +G+GAFG VY+     K   +   A+K +++D   E+   +++K E  ++ K+ HP V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS-EEERKDFLK-EARVMKKLGHPNV 58

Query: 213 VQLKYSFQTKYR-LYLVLDFINGGHL----------FFQLYHHGLFREDLARIYAAEIVS 261
           V+L     T+   LYLVL+++ GG L          F       L  +DL    A +I  
Sbjct: 59  VRL-LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF-AIQIAK 116

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT---VEYMAP 318
            + +L +   +HRDL   N L+G D  V ++DFGL++   ++       G    + +MAP
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 319 EIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEA 376
           E +        +D WS G+LL+E+ T G  P+ G +  ++ + + K  +L  P +   E 
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDEL 236

Query: 377 HSLLKGLLQKEPGKR 391
           + L+    Q +P  R
Sbjct: 237 YELMLSCWQLDPEDR 251

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  117 bits (295), Expect = 4e-30
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 5/208 (2%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           + +F++ K +G+G F  VY+       +  A+K ++  ++++    +    E D+L +++
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG----LFREDLARIYAAEIVSAVS 264
           HP V++   SF     L +VL+  + G L   + +      L  E     Y  ++ SAV 
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLG 323
           H+H+  +MHRD+KP N+ + A G V L D GL + F  + T ++S++GT  YM+PE +  
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIG 351
            G+N  +D WS+G LLYEM   + PF G
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  117 bits (295), Expect = 6e-30
 Identities = 71/213 (33%), Positives = 114/213 (53%), Gaps = 19/213 (8%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           FE+++VVG G +G+VY+ R   T ++ A+KVM     V ++  E +K E ++L K  H  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73

Query: 212 VVQLKY-SFQTKY------RLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSA 262
            +   Y +F  K       +L+LV++F   G +    +       +ED       EI+  
Sbjct: 74  NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSMIGTVEYMAPEIV 321
           ++HLHA+ ++HRD+K +N+LL  +  V L DFG++ Q D    R N+ IGT  +MAPE++
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 322 L-----GKGHNKAADWWSVGILLYEMLTGKPPF 349
                    ++  +D WS+GI   EM  G PP 
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  120 bits (303), Expect = 1e-29
 Identities = 86/255 (33%), Positives = 134/255 (52%), Gaps = 23/255 (9%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE--KNHAEYMKAERDILTKIDHPFVV 213
           +V+G GA G V   ++ +  E +A+KV+  + + E  KN A+   AE   L   D   +V
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ---AEVCCLLNCDFFSIV 94

Query: 214 QLKYSFQTK--------YRLYLVLDFINGGHLFFQLYHHG----LFREDLARIYAAEIVS 261
           +    F  K          + LVLD+ N G L  ++         FRE  A +   +++ 
Sbjct: 95  KCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN----SMIGTVEYMA 317
           AV H+H+  ++HRD+K  NILL ++G V L DFG +K +   T S+    +  GT  Y+A
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY-AATVSDDVGRTFCGTPYYVA 213

Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-LPAFLSSEA 376
           PEI   K ++K AD +S+G+LLYE+LT K PF G N  ++  K +  +   LP  +S E 
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEM 273

Query: 377 HSLLKGLLQKEPGKR 391
             ++  LL  +P +R
Sbjct: 274 QEIVTALLSSDPKRR 288

Length = 496

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  115 bits (289), Expect = 3e-29
 Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 11/204 (5%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMR---KDKIVEKNHAEYMKAERDILTKIDHPFV 212
           +V+G+GA+G VY     N  ++ A+K +     + +  +   E ++ E D+L  + H  +
Sbjct: 6   EVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 213 VQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIM 272
           VQ   +      + + ++F+ GG +   L   G   E +   Y  +I+  V++LH N ++
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124

Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQFD----ENTRSN---SMIGTVEYMAPEIVLGKG 325
           HRD+K  N++L  +G + L DFG A++        T SN   SM GT  +MAPE++   G
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184

Query: 326 HNKAADWWSVGILLYEMLTGKPPF 349
           + + +D WS+G  ++EM TGKPP 
Sbjct: 185 YGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  115 bits (289), Expect = 5e-29
 Identities = 78/256 (30%), Positives = 133/256 (51%), Gaps = 13/256 (5%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQGA G VY      T +  A+K M    + ++   E +  E  ++ +  +P +V    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 83

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALDFLHSNQVIHRDIK 142

Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            +NILLG DG V LTDFG   Q   E ++ ++M+GT  +MAPE+V  K +    D WS+G
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           I+  EM+ G+PP++  N  +    I  +   +L+ P  LS+     L   L+ +  +R  
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGS 262

Query: 394 AGPKGSEEIKSHKWFK 409
           A     +E+  H + K
Sbjct: 263 A-----KELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  115 bits (291), Expect = 5e-29
 Identities = 83/320 (25%), Positives = 135/320 (42%), Gaps = 69/320 (21%)

Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM--KAERDI 203
           C  + D+E+L  +G+G FG VY+ R+  T  + A+K     KI+  N  +     A R+I
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREI 58

Query: 204 --LTKIDHPFVVQL--------KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLAR 253
             L K+ HP VV L          S + +  +Y+V  +++  H    L  +   +   ++
Sbjct: 59  KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD--HDLSGLLENPSVKLTESQ 116

Query: 254 I--YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-------- 303
           I  Y  +++  +++LH N I+HRD+K  NIL+   G + + DFGLA+ +D          
Sbjct: 117 IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 304 ----TRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ 358
                +  +++ T  Y  PE++LG + +  A D W +G +  EM T +P   G +     
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236

Query: 359 QKI-----------------------VKDKLRLPAFLSS-------EAHSLLKGLLQKEP 388
             I                       V      P  L         E   LL  LL  +P
Sbjct: 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296

Query: 389 GKRLGAGPKGSEEIKSHKWF 408
            KRL A      +   H +F
Sbjct: 297 YKRLTA-----SDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  116 bits (292), Expect = 7e-29
 Identities = 95/311 (30%), Positives = 146/311 (46%), Gaps = 71/311 (22%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE--KNHAEYMKAERDI--LTKI 207
           +E+L+ +G+GA+G V++   + T E+ A+K     KI +  +N  +  +  R+I  L ++
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALK-----KIFDAFRNATDAQRTFREIMFLQEL 63

Query: 208 -DHPFVVQLK--YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFR----EDLARIYAA-EI 259
            DHP +V+L      +    +YLV +++        L  H + R    ED+ + Y   ++
Sbjct: 64  GDHPNIVKLLNVIKAENDKDIYLVFEYMET-----DL--HAVIRANILEDVHKRYIMYQL 116

Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM------IGTV 313
           + A+ ++H+  ++HRDLKP NILL +D  V L DFGLA+   E   +         + T 
Sbjct: 117 LKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 314 EYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIV-------- 362
            Y APEI+LG   + K  D WSVG +L EML GKP F G   + + Q  KI+        
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG--TSTLNQLEKIIEVIGPPSA 234

Query: 363 --------------------KDKLRLPAFL---SSEAHSLLKGLLQKEPGKRLGAGPKGS 399
                               + +  L   L   S +A  LLK LL   P KRL A     
Sbjct: 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA----- 289

Query: 400 EEIKSHKWFKP 410
           EE   H +   
Sbjct: 290 EEALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  115 bits (288), Expect = 8e-29
 Identities = 78/256 (30%), Positives = 133/256 (51%), Gaps = 13/256 (5%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQGA G VY      T +  A++ M    + ++   E +  E  ++ +  +P +V    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143

Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            +NILLG DG V LTDFG   Q   E ++ ++M+GT  +MAPE+V  K +    D WS+G
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203

Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           I+  EM+ G+PP++  N  +    I  +   +L+ P  LS+     L   L  +  KR  
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS 263

Query: 394 AGPKGSEEIKSHKWFK 409
           A     +E+  H++ K
Sbjct: 264 A-----KELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  113 bits (286), Expect = 9e-29
 Identities = 73/254 (28%), Positives = 126/254 (49%), Gaps = 20/254 (7%)

Query: 152 FEVLKVVGQGAFGRVYQ----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            E+ K +G+GAFG VY+       + T    A+K + K+   E+   E+++ E  I+ K+
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLE-EASIMKKL 58

Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHG--LFREDLARIYAAEIVSAV 263
            HP +V+L         LY+V +++ GG L  F  L  HG  L  +DL +  A +I   +
Sbjct: 59  SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDF--LRKHGEKLTLKDLLQ-MALQIAKGM 115

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ---FDENTRSNSMIGTVEYMAPEI 320
            +L +   +HRDL   N L+  +  V ++DFGL++     D   +       +++MAPE 
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES 175

Query: 321 VLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL--PAFLSSEAH 377
           +        +D WS G+LL+E+ T G+ P+ G +  ++ + + +D  RL  P     E +
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELY 234

Query: 378 SLLKGLLQKEPGKR 391
            L+      +P  R
Sbjct: 235 ELMLQCWAYDPEDR 248

Length = 258

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  114 bits (286), Expect = 1e-28
 Identities = 77/254 (30%), Positives = 134/254 (52%), Gaps = 20/254 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D +  +++G G  G VY+     T  I A+KV+  D  VE    + + +E +IL K D 
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDS 58

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           P+++    +F  + R+ +  +F++GG L  + ++  H L R       A  +V  +++L 
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGR------IAVAVVKGLTYLW 112

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  I+HRD+KP N+L+   G V L DFG++ Q   N+ + + +GT  YMAPE + G+ + 
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTYVGTNAYMAPERISGEQYG 171

Query: 328 KAADWWSVGILLYEMLTGKPPF--IGGNRA-----KIQQKIV-KDKLRLPAFLSSEAH-S 378
             +D WS+GI   E+  G+ P+  I  N+      ++ Q IV +D   LP    SE    
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231

Query: 379 LLKGLLQKEPGKRL 392
            +   ++K+P +R 
Sbjct: 232 FITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  114 bits (286), Expect = 1e-28
 Identities = 78/242 (32%), Positives = 129/242 (53%), Gaps = 10/242 (4%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+ G V     K++ ++ A+K M   K   +   E +  E  I+    H  VV++  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   + H  +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLKALSVLHAQGVIHRDIK 143

Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R  S++GT  +MAPE++    +    D WS+G
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 203

Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKG----LLQKEPGKRL 392
           I++ EM+ G+PP+      K   K+++D L        +    LKG    LL ++P +R 
Sbjct: 204 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRA 262

Query: 393 GA 394
            A
Sbjct: 263 TA 264

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  113 bits (285), Expect = 1e-28
 Identities = 61/199 (30%), Positives = 110/199 (55%), Gaps = 4/199 (2%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F  L+ +G+G+FG VY+     T E+ A+K++  ++   ++  E ++ E  +L++ D P+
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           + +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+   
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERK 122

Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           +HRD+K  N+LL   G V L DFG+A Q  D   + N+ +GT  +MAPE++    ++  A
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182

Query: 331 DWWSVGILLYEMLTGKPPF 349
           D WS+GI   E+  G+PP 
Sbjct: 183 DIWSLGITAIELAKGEPPN 201

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  114 bits (287), Expect = 2e-28
 Identities = 87/317 (27%), Positives = 131/317 (41%), Gaps = 78/317 (24%)

Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD--- 202
           C  + +FE L  +G+G +G VY+ R   + EI A+K +R D             ERD   
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN------------ERDGIP 50

Query: 203 --------ILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL-------- 246
                   +L  + HP +V+LK     K+     LD I    L  +     L        
Sbjct: 51  ISSLREITLLLNLRHPNIVELKEVVVGKH-----LDSI---FLVMEYCEQDLASLLDNMP 102

Query: 247 --FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT 304
             F E   +    +++  + +LH N I+HRDLK  N+LL   G + + DFGLA+ +    
Sbjct: 103 TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162

Query: 305 RSNS-MIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV 362
           +  +  + T+ Y APE++LG   +  A D W+VG +L E+L  KP   G +  +    I+
Sbjct: 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222

Query: 363 K-------------------DKLRLPA-----------FLSSEAHSLLKGLLQKEPGKRL 392
           +                    K  LP            +LS     LL  LL  +P KR 
Sbjct: 223 QLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRA 282

Query: 393 GAGPKGSEEIKSHKWFK 409
            A     EE     +FK
Sbjct: 283 TA-----EEALESSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  113 bits (285), Expect = 2e-28
 Identities = 70/241 (29%), Positives = 131/241 (54%), Gaps = 8/241 (3%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+ G V   R+K++    A+K+M   K   +   E +  E  I+    H  VV++  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L+++++F+ GG L   +    L  E +A +  + ++ A+ +LH+ G++HRD+K
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCES-VLQALCYLHSQGVIHRDIK 144

Query: 278 PENILLGADGHVMLTDFGLAKQFDENT-RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            ++ILL  DG V L+DFG   Q  ++  +  S++GT  +MAPE++    +    D WS+G
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLG 204

Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           I++ EM+ G+PP+   +  +  +++      KL+    +S      L+ +L +EP +R  
Sbjct: 205 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERAT 264

Query: 394 A 394
           A
Sbjct: 265 A 265

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  113 bits (283), Expect = 3e-28
 Identities = 76/260 (29%), Positives = 133/260 (51%), Gaps = 10/260 (3%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E F  L+ +G+G+FG V++     T ++ A+K++  ++   ++  E ++ E  +L++ D 
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDS 61

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P+V +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 62  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+ +GT  +MAPE++    ++ 
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLKGLLQKE 387
            AD WS+GI   E+  G+PP    +  K+   I K+    L    S      ++  L KE
Sbjct: 181 KADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 240

Query: 388 PGKRLGAGPKGSEEIKSHKW 407
           P  R    P   E +K HK+
Sbjct: 241 PSFR----PTAKELLK-HKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 3e-28
 Identities = 89/330 (26%), Positives = 148/330 (44%), Gaps = 88/330 (26%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKN--TSEIYAMKVMRKDKIVEKNHAEY----MKAERDI-- 203
           +E+   +G+G +GRVY+ ++KN    + YA+K  + DK       +Y      A R+I  
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDK------EQYTGISQSACREIAL 55

Query: 204 LTKIDHPFVVQLKYSFQTKY--RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA---- 257
           L ++ H  VV L   F       +YL+ D+    H  +Q+      +     I  +    
Sbjct: 56  LRELKHENVVSLVEVFLEHADKSVYLLFDYAE--HDLWQIIKFH-RQAKRVSIPPSMVKS 112

Query: 258 ---EIVSAVSHLHANGIMHRDLKPENILLGADGH----VMLTDFGLAKQFDENTRS---- 306
              +I++ V +LH+N ++HRDLKP NIL+  +G     V + D GLA+ F+   +     
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 307 NSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ------- 358
           + ++ T+ Y APE++LG  H  KA D W++G +  E+LT +P F G   AKI+       
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE-AKIKKSNPFQR 231

Query: 359 ---QKIVK-----------DKLRLPAF--------------------------LSSEAHS 378
              ++I +           D  ++P +                            S+   
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291

Query: 379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
           LL+ LL+ +P KR+ A     EE   H +F
Sbjct: 292 LLRKLLEYDPTKRITA-----EEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  113 bits (283), Expect = 3e-28
 Identities = 75/243 (30%), Positives = 132/243 (54%), Gaps = 12/243 (4%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+ G V    +K+T +  A+K M    + ++   E +  E  I+    H  VV +  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM---DLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   + H  +  E +A +    ++ A+S+LH  G++HRD+K
Sbjct: 87  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV-CLSVLRALSYLHNQGVIHRDIK 145

Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            ++ILL +DG + L+DFG   Q   E  +  S++GT  +MAPE++    +    D WS+G
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLG 205

Query: 337 ILLYEMLTGKPPFIGGNRAKIQ-QKIVKDKLRLPAFLSSEAHSLLKGLLQ----KEPGKR 391
           I++ EM+ G+PP+   N   +Q  + ++D L      S +  S+L+G L     +EP +R
Sbjct: 206 IMVIEMIDGEPPYF--NEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQR 263

Query: 392 LGA 394
             A
Sbjct: 264 ATA 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  112 bits (282), Expect = 5e-28
 Identities = 80/256 (31%), Positives = 133/256 (51%), Gaps = 13/256 (5%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQGA G V+      T +  A+K +   K  +K   E +  E  ++ ++ +P +V    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---ELIINEILVMKELKNPNIVNFLD 83

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           SF     L++V++++ GG L   +    +    +A +   E + A+  LHAN ++HRD+K
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV-CRECLQALEFLHANQVIHRDIK 142

Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            +N+LLG DG V LTDFG   Q   E ++ ++M+GT  +MAPE+V  K +    D WS+G
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           I+  EM+ G+PP++  N  +    I  +   +L+ P  LS      L   L+ +  KR  
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS 262

Query: 394 AGPKGSEEIKSHKWFK 409
           A     +E+  H + K
Sbjct: 263 A-----KELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  112 bits (280), Expect = 6e-28
 Identities = 62/200 (31%), Positives = 112/200 (56%), Gaps = 4/200 (2%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E F  L+ +G+G+FG V++     T ++ A+K++  ++   ++  E ++ E  +L++ D 
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDS 61

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P+V +   S+    +L+++++++ GG     L   G F E        EI+  + +LH+ 
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+ +GT  +MAPE++    ++ 
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180

Query: 329 AADWWSVGILLYEMLTGKPP 348
            AD WS+GI   E+  G+PP
Sbjct: 181 KADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  115 bits (289), Expect = 7e-28
 Identities = 77/222 (34%), Positives = 121/222 (54%), Gaps = 15/222 (6%)

Query: 185 KDKIVEK-------NHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL 237
           K+K+V K         A Y ++E   L   DH  +V+    F++  +L L++++ +GG L
Sbjct: 93  KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDL 152

Query: 238 FFQ----LYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTD 293
             Q    L  H  F+E    +   +IV A+  +H+  +MHRDLK  NI L   G + L D
Sbjct: 153 NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGD 212

Query: 294 FGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFI 350
           FG +KQ+ ++     ++S  GT  Y+APE+   K ++K AD WS+G++LYE+LT   PF 
Sbjct: 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272

Query: 351 GGNRAKIQQKIVKDKLR-LPAFLSSEAHSLLKGLLQKEPGKR 391
           G ++ +I Q+++  K    P  +SS   +LL  LL K P  R
Sbjct: 273 GPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALR 314

Length = 478

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  111 bits (279), Expect = 7e-28
 Identities = 77/256 (30%), Positives = 130/256 (50%), Gaps = 22/256 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
            D+E+++ VG G +G VY+ R  +T E+ A+K++   K+   +    ++ E  ++ +  H
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECKH 65

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHA 268
             +V    S+ ++ +L++ +++  GG L   +YH  G   E        E +  +++LH+
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQ-DIYHVTGPLSELQIAYVCRETLQGLAYLHS 124

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSNSMIGTVEYMAPEIVL---GK 324
            G MHRD+K  NILL  +G V L DFG+A +      +  S IGT  +MAPE+       
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNG 184

Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIG---------GNRAKIQQKIVKDKLRLPAFLSSE 375
           G+N+  D W+VGI   E+   +PP             +++  Q   +KDK +     SS 
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK----WSST 240

Query: 376 AHSLLKGLLQKEPGKR 391
            H+ +K  L K P KR
Sbjct: 241 FHNFVKISLTKNPKKR 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  110 bits (277), Expect = 1e-27
 Identities = 71/246 (28%), Positives = 129/246 (52%), Gaps = 9/246 (3%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA--ERDILTKIDHPFVVQL 215
           +G+G+FG VY V+ K       +KV+++  + E N  E ++A  E  +L+K+DHP +V+ 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQL--YHHG--LFREDLARIYAAEIVSAVSHLHANGI 271
             SF  +    ++ ++  G  L  +L    H      E+    +  +++  V ++H   I
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127

Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-SNSMIGTVEYMAPEIVLGKGHNKAA 330
           +HRDLK +NI L  +  + + DFG+++    +   + +  GT  YM+PE +  +G++  +
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKS 186

Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHSLLKGLLQKEPG 389
           D WS+G +LYEM      F G N   +  +IV+     LP   S + +S+++ +L K+P 
Sbjct: 187 DIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPS 246

Query: 390 KRLGAG 395
            R  A 
Sbjct: 247 LRPSAA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  111 bits (280), Expect = 1e-27
 Identities = 85/305 (27%), Positives = 143/305 (46%), Gaps = 55/305 (18%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ F+++  +G+G +G+VY+ R K+T E+ A+K +R D   E      ++ E  IL +++
Sbjct: 6   VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLN 64

Query: 209 HPFVVQLK---------YSF-QTKYRLYLVLDFINGGHLFFQLYHHGL--FREDLARIYA 256
           H  +V LK           F + K   YLV ++++  H    L   GL  F ED  + + 
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD--HDLMGLLESGLVHFSEDHIKSFM 122

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR---SNSMIGTV 313
            +++  +++ H    +HRD+K  NILL   G + L DFGLA+ ++       +N +I T+
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TL 181

Query: 314 EYMAPEIVLGKG-HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK--------- 363
            Y  PE++LG+  +  A D WS G +L E+ T KP F         + I +         
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241

Query: 364 --DKLRLP-------------------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEI 402
             D ++LP                   +F+ + A  LL  +L  +P KR  A     EE 
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA-----EEA 296

Query: 403 KSHKW 407
            +  W
Sbjct: 297 LNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  110 bits (278), Expect = 3e-27
 Identities = 88/317 (27%), Positives = 142/317 (44%), Gaps = 68/317 (21%)

Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAE--YMKAERD- 202
           C  +  +E L  +GQG FG V++ R K T +I A+K     K++ +N  E   + A R+ 
Sbjct: 8   CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALREI 62

Query: 203 -ILTKIDHPFVVQL------KYSFQTKYR--LYLVLDFINGGHLFFQLYHHGLFREDLAR 253
            IL  + H  VV L      K +   +Y+   YLV +F    H    L  +   +  L+ 
Sbjct: 63  KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE--HDLAGLLSNKNVKFTLSE 120

Query: 254 IYAA--EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD--ENTRSNSM 309
           I      +++ + ++H N I+HRD+K  NIL+  DG + L DFGLA+ F   +N++ N  
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180

Query: 310 IG---TVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN------------ 353
                T+ Y  PE++LG + +    D W  G ++ EM T + P + GN            
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTLISQL 239

Query: 354 RAKI----------------------QQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
              I                      Q++ VK++L+ P      A  L+  LL  +P KR
Sbjct: 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLK-PYVKDPHALDLIDKLLVLDPAKR 298

Query: 392 LGAGPKGSEEIKSHKWF 408
           + A     +   +H +F
Sbjct: 299 IDA-----DTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  109 bits (275), Expect = 5e-27
 Identities = 77/257 (29%), Positives = 127/257 (49%), Gaps = 19/257 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ++ EVL  +G+G +G VY+V  + T    AMK +R +  ++++    +  E DIL K   
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRED-----LARIYAAEIVSAVS 264
           P++V    +F  +  +Y+ +++++ G L  +LY  G+  E      L RI  A +     
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGK 324
               + I+HRD+KP N+L+  +G V L DFG++      + + + IG   YMAPE +   
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNIGCQSYMAPERIKSG 176

Query: 325 GHNKA------ADWWSVGILLYEMLTGK---PPFIGGNRAKIQQKIVK-DKLRLPAFLSS 374
           G N+       +D WS+G+ + EM  G+   PP    N       IV  D   LP+  S 
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236

Query: 375 EAHSLLKGLLQKEPGKR 391
           +A   +   L K P +R
Sbjct: 237 DAQDFVAKCLNKIPNRR 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  109 bits (273), Expect = 5e-27
 Identities = 69/213 (32%), Positives = 110/213 (51%), Gaps = 19/213 (8%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           FE++++VG G +G+VY+ R   T ++ A+KVM     V  +  E +K E ++L K  H  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63

Query: 212 VVQLKYSFQTKY-------RLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSA 262
            +   Y    K        +L+LV++F   G +    +       +E+       EI+  
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSMIGTVEYMAPEIV 321
           +SHLH + ++HRD+K +N+LL  +  V L DFG++ Q D    R N+ IGT  +MAPE++
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183

Query: 322 LGKGHNKA-----ADWWSVGILLYEMLTGKPPF 349
               +  A     +D WS+GI   EM  G PP 
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  109 bits (274), Expect = 2e-26
 Identities = 75/276 (27%), Positives = 118/276 (42%), Gaps = 65/276 (23%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK---DKIVEKNHAEYMKAERDILTKID 208
           +E+LK +G GA+G V     K T    A+K +     D I     A+ +  E  +L  + 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI----DAKRILREIKLLRHLR 57

Query: 209 HPFVVQLK--------YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI------ 254
           H  ++ L           F     +Y+V +               L   DL ++      
Sbjct: 58  HENIIGLLDILRPPSPEDFND---VYIVTE---------------LMETDLHKVIKSPQP 99

Query: 255 ----------YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT 304
                     Y  +I+  + +LH+  ++HRDLKP NIL+ ++  + + DFGLA+  D + 
Sbjct: 100 LTDDHIQYFLY--QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157

Query: 305 RSNS-MIGTVE---YMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ 359
                +   V    Y APE++L    + KA D WSVG +  E+LT KP F G +   I Q
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY--IDQ 215

Query: 360 --KIVK-----DKLRLPAFLSSEAHSLLKGLLQKEP 388
              IV+      +  L    S +A + LK L +K  
Sbjct: 216 LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPK 251

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  108 bits (270), Expect = 2e-26
 Identities = 81/261 (31%), Positives = 132/261 (50%), Gaps = 23/261 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-D 208
           + +E+++ +G+G +G+V++V  K      A+K++  D I + +  E ++AE +IL  + D
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDID--EEIEAEYNILKALSD 73

Query: 209 HPFVVQL-----KYSFQTKYRLYLVLDFINGGH---LFFQLYHHGLFREDLARIYAA-EI 259
           HP VV+      K   +   +L+LVL+  NGG    L       G   E+    Y   E 
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAP 318
           +  + HLH N  +HRD+K  NILL  +G V L DFG++ Q      R N+ +GT  +MAP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193

Query: 319 EIV-----LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPA 370
           E++     L   ++   D WS+GI   E+  G PP    +  +   KI ++    L  P 
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE 253

Query: 371 FLSSEAHSLLKGLLQKEPGKR 391
             S+E +  ++  L K+  KR
Sbjct: 254 LWSNEFNDFIRKCLTKDYEKR 274

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  107 bits (268), Expect = 5e-26
 Identities = 82/288 (28%), Positives = 137/288 (47%), Gaps = 46/288 (15%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + +E L+ +G+G +G+VY+ R KNT ++ A+K  R +   E      ++ E  +L  +  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSE 59

Query: 210 -PFVVQLKYSFQT-----KYRLYLVLDFINGG-HLFFQLYHHGLFR---EDLARIYAAEI 259
             ++V+L           K  LYLV ++++     F      G  R       + +  ++
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSM-IGTVEYMA 317
           +  V+H H +G+MHRDLKP+N+L+     ++ + D GL + F    +S +  I T+ Y A
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179

Query: 318 PEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK----------- 363
           PE++LG  H +   D WSVG +  EM   +P F G   +++QQ   I K           
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG--DSELQQLLHIFKLLGTPTEQVWP 237

Query: 364 --DKLR----LPAF-----------LSSEAHSLLKGLLQKEPGKRLGA 394
              KLR     P +           LS E   LL+ +L+ +P KR+ A
Sbjct: 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA 285

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  107 bits (269), Expect = 9e-26
 Identities = 82/303 (27%), Positives = 129/303 (42%), Gaps = 60/303 (19%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK---DKIVEKNHAEYMKAERDILTKID 208
           ++ L  VG GA+G+V       T    A+K + +     I    HA+    E  +L  +D
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI----HAKRTYRELRLLKHMD 72

Query: 209 HPFVVQL------KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
           H  V+ L        S +    +YLV   +  G     +       +D  +    +I+  
Sbjct: 73  HENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQILRG 130

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE---YMAPE 319
           + ++H+ GI+HRDLKP NI +  D  + + DFGLA+  D+      M G V    Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 185

Query: 320 IVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNR-------------------AKIQQ 359
           I+L   H N+  D WSVG ++ E+LTGK  F G +                     KI  
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 360 KIVKDKLR-LP---------AFL--SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKW 407
           +  ++ ++ LP          F   +  A  LL+ +L  +P KR+ A      E  +H +
Sbjct: 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITA-----AEALAHPY 300

Query: 408 FKP 410
              
Sbjct: 301 LAE 303

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  105 bits (265), Expect = 1e-25
 Identities = 70/214 (32%), Positives = 112/214 (52%), Gaps = 23/214 (10%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM--KAERDI--LTK 206
           D+  ++ +G+G +G VY+ R K T +I AMK     KI  ++  E +   A R+I  L +
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMK-----KIRLESEEEGVPSTAIREISLLKE 55

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH-------GLFREDLARIYAAEI 259
           + HP +V L+     + RLYL+ +F     L   L  +            +L + Y  +I
Sbjct: 56  LQHPNIVCLQDVLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQI 110

Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAP 318
           +  +   H+  ++HRDLKP+N+L+   G + L DFGLA+ F    R  +  + T+ Y AP
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAP 170

Query: 319 EIVLGKG-HNKAADWWSVGILLYEMLTGKPPFIG 351
           E++LG   ++   D WS+G +  EM T KP F G
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  104 bits (261), Expect = 4e-25
 Identities = 78/283 (27%), Positives = 129/283 (45%), Gaps = 50/283 (17%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKIDH 209
           +++L  +G+G F  V + + + T + YA+K M+K    + + N+   ++A R  L+   H
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALR-RLS--PH 57

Query: 210 PFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLY-----HHGLFREDLARIYAAEIVS 261
           P +++L    +  +T  RL LV + ++       LY           E   + Y  +++ 
Sbjct: 58  PNILRLIEVLFDRKTG-RLALVFELMDM-----NLYELIKGRKRPLPEKRVKSYMYQLLK 111

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           ++ H+H NGI HRD+KPENIL+  D  + L DFG  +           I T  Y APE +
Sbjct: 112 SLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECL 170

Query: 322 LGKG-HNKAADWWSVGILLYEMLTGKPPFIGGNR---------------AKIQQKIVKDK 365
           L  G +    D W+VG + +E+L+  P F G N                A++ +K  K +
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230

Query: 366 LRLPAF--------------LSSEAHSLLKGLLQKEPGKRLGA 394
                F               S+E   LLK LL  +P +R+ A
Sbjct: 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA 273

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  104 bits (260), Expect = 6e-25
 Identities = 66/212 (31%), Positives = 120/212 (56%), Gaps = 15/212 (7%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ +E ++ +G+G +G VY+ R + T+E  A+K +R ++  E   +  ++ E  +L ++ 
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQ 59

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLAR------IYAAEIVSA 262
           H  +V+L+    ++ RLYLV ++++       L  H     D A+       Y  +I+  
Sbjct: 60  HGNIVRLQDVVHSEKRLYLVFEYLD-----LDLKKHMDSSPDFAKNPRLIKTYLYQILRG 114

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSM-IGTVEYMAPEI 320
           +++ H++ ++HRDLKP+N+L+    + + L DFGLA+ F    R+ +  + T+ Y APEI
Sbjct: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEI 174

Query: 321 VLGKGH-NKAADWWSVGILLYEMLTGKPPFIG 351
           +LG  H +   D WSVG +  EM+  KP F G
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206

Length = 294

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  103 bits (258), Expect = 7e-25
 Identities = 75/256 (29%), Positives = 122/256 (47%), Gaps = 29/256 (11%)

Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL--TKIDHPFVVQ 214
           V+G+G +G VY  R  +T    A+K     +I E++         +I   + + H  +VQ
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIK-----EIPERDSRYVQPLHEEIALHSYLKHRNIVQ 69

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFR---------EDLARIYAAEIVSAVSH 265
              S        + ++ + GG L        L R         E     Y  +I+  + +
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSL------SALLRSKWGPLKDNEQTIIFYTKQILEGLKY 123

Query: 266 LHANGIMHRDLKPENILLGA-DGHVMLTDFGLAKQFDE-NTRSNSMIGTVEYMAPEIVLG 323
           LH N I+HRD+K +N+L+    G V ++DFG +K+    N  + +  GT++YMAPE++  
Sbjct: 124 LHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183

Query: 324 --KGHNKAADWWSVGILLYEMLTGKPPFI---GGNRAKIQQKIVKDKLRLPAFLSSEAHS 378
             +G+   AD WS+G  + EM TGKPPFI       A  +  + K    +P  LS+EA +
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN 243

Query: 379 LLKGLLQKEPGKRLGA 394
            +    + +P KR  A
Sbjct: 244 FILRCFEPDPDKRASA 259

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  103 bits (259), Expect = 8e-25
 Identities = 81/284 (28%), Positives = 131/284 (46%), Gaps = 38/284 (13%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA---ERDILTK 206
           E    L  +G+GA G V + R KNT  I+A+K      I    + +  K    E +I   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKT-----ITTDPNPDLQKQILRELEINKS 55

Query: 207 IDHPFVVQLKYSFQTKY--RLYLVLDFINGGHLFFQLYHHGLFREDLARI-------YAA 257
              P++V+   +F  +    + + +++  GG L   +Y     ++   RI        A 
Sbjct: 56  CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIY--KKVKKRGGRIGEKVLGKIAE 112

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
            ++  +S+LH+  I+HRD+KP NILL   G V L DFG++ +   N+ + +  GT  YMA
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTFTGTSFYMA 171

Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFI---GGNRAKIQ--QKIV-------KDK 365
           PE + GK ++  +D WS+G+ L E+   + PF          I+    IV       KD+
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231

Query: 366 LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
                  S E    +K  L+K+P +R    P    ++  H W K
Sbjct: 232 PGNGIKWSEEFKDFIKQCLEKDPTRR--PTPW---DMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  103 bits (258), Expect = 1e-24
 Identities = 74/291 (25%), Positives = 136/291 (46%), Gaps = 42/291 (14%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKIDH 209
           +E L+ +G+G +G V++ + + T EI A+K +R D   + +      A R+I  L ++ H
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD---DDDEGVPSSALREICLLKELKH 58

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
             +V+L     +  +L LV ++ +     +    +G    ++ + +  +++  ++  H++
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KGHN 327
            ++HRDLKP+N+L+  +G + L DFGLA+ F    R  S  + T+ Y  P+++ G K ++
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 178

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL------------RLPAF---- 371
            + D WS G +  E+     P   GN    Q K +   L            +LP +    
Sbjct: 179 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238

Query: 372 --------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
                         L+S    LL+ LL   P +R+ A     EE   H +F
Sbjct: 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA-----EEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  102 bits (256), Expect = 2e-24
 Identities = 88/303 (29%), Positives = 143/303 (47%), Gaps = 61/303 (20%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK--AERDI--LT 205
           E +E L  +G+G++G V++ R + T +I A+K     K VE      +K  A R+I  L 
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLK 55

Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSAVS 264
           ++ HP +V L   F+ K +L+LV ++ +   L   +    G+  E L +    + + AV+
Sbjct: 56  QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGV-PEHLIKKIIWQTLQAVN 114

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAK----QFDENTRSNSMIGTVEYMAPEI 320
             H +  +HRD+KPENIL+   G + L DFG A+      D+ T     + T  Y APE+
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT---DYVATRWYRAPEL 171

Query: 321 VLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVKD------------- 364
           ++G   +    D W++G +  E+LTG+P + G  ++ + Q   I K              
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG--KSDVDQLYLIRKTLGDLIPRHQQIFS 229

Query: 365 -------------------KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH 405
                              + + P  +SS A S LKG LQ +P +RL       EE+  H
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERL-----SCEELLEH 283

Query: 406 KWF 408
            +F
Sbjct: 284 PYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  102 bits (255), Expect = 2e-24
 Identities = 79/234 (33%), Positives = 124/234 (52%), Gaps = 26/234 (11%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-D 208
           + +E+++ +G+G +G+VY+V  K    + A+K++  D I + +  E ++AE +IL  + +
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVD--EEIEAEYNILQSLPN 77

Query: 209 HPFVVQLKYSF--QTKY---RLYLVLDFINGG---HLFFQLYHHGLFREDLARI----YA 256
           HP VV+    F    K    +L+LVL+  NGG    L   L   G  R D A I    Y 
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISYILYG 136

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEY 315
           A +   + HLH N I+HRD+K  NILL  +G V L DFG++ Q      R N+ +GT  +
Sbjct: 137 ALL--GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 194

Query: 316 MAPEIVLGK-----GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD 364
           MAPE++  +      ++   D WS+GI   E+  G PP    +  K   KI ++
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  101 bits (253), Expect = 5e-24
 Identities = 70/264 (26%), Positives = 125/264 (47%), Gaps = 33/264 (12%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKV--------MRKDKIVEKNHAEYMKAER 201
           ED E +  +G G  G V +V+   T  + A KV        +RK +I+          E 
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK-QILR---------EL 54

Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            I+ +   P++V    +F  +  + + ++F++ G L       G    ++    A  +V 
Sbjct: 55  QIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVE 114

Query: 262 AVSHLH-ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
            +++L+  + IMHRD+KP NIL+ + G + L DFG++ +   N+ +++ +GT  YM+PE 
Sbjct: 115 GLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFVGTSTYMSPER 173

Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAK------------IQQKIVKDKLRL 368
           + G  +   +D WS+GI + E+  GK PF   N               +QQ + +   RL
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL 233

Query: 369 PA-FLSSEAHSLLKGLLQKEPGKR 391
           P+     +    +   L K+P +R
Sbjct: 234 PSSDFPEDLRDFVDACLLKDPTER 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score =  105 bits (264), Expect = 5e-24
 Identities = 66/235 (28%), Positives = 116/235 (49%), Gaps = 20/235 (8%)

Query: 174 TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK-YRLYLVLDFI 232
           T    A+K++R D   E++     + E  +  ++ HP +V L  S +     L+ V +++
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 233 NGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG---H 288
            G  L   L   G L   +  R+   +++ A++  H  GI+HRDLKP+NI++   G   H
Sbjct: 62  PGRTLREVLAADGALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 289 VMLTDFGL------AKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLY 340
             + DFG+       +  D    TR+  ++GT  Y APE + G+     +D ++ G++  
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180

Query: 341 EMLTGKPPFIGGNRAKI-QQKIVKDKLRLPAFLSSEAHSL---LKGLLQKEPGKR 391
           E LTG+    G + A+I  Q++    + LP ++    H L   L+  L K+P +R
Sbjct: 181 ECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI--AGHPLGQVLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  100 bits (251), Expect = 1e-23
 Identities = 72/252 (28%), Positives = 115/252 (45%), Gaps = 16/252 (6%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMR-KDKIVEKNHAEYMKAERDILTKIDHP 210
           F  L+ +G G+FG VY  R   T+E+ A+K M    K   +   + +K E   L ++ HP
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQQLRHP 75

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG 270
             ++ K  +  ++  +LV+++  G        H    +E          +  +++LH++ 
Sbjct: 76  NTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE 135

Query: 271 IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG--KGH-N 327
            +HRD+K  NILL   G V L DFG A        +NS +GT  +MAPE++L   +G  +
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVILAMDEGQYD 192

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSS-----EAHSLLKG 382
              D WS+GI   E+   KPP    N       I ++       LSS        + +  
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---SPTLSSNDWSDYFRNFVDS 249

Query: 383 LLQKEPGKRLGA 394
            LQK P  R  +
Sbjct: 250 CLQKIPQDRPSS 261

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  100 bits (250), Expect = 1e-23
 Identities = 84/276 (30%), Positives = 135/276 (48%), Gaps = 23/276 (8%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
             + D E L  +G G  G+VY++R K T  + A+K MR+    E+N    M  + D++ K
Sbjct: 12  ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILM--DLDVVLK 69

Query: 207 I-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH--HGLFREDLARIYAAEIVSAV 263
             D P++V+    F T   +++ ++ +       +L     G   ED+       IV A+
Sbjct: 70  SHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKAL 127

Query: 264 SHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPE-I 320
            +L    G++HRD+KP NILL A G+V L DFG++ +  D   ++ S  G   YMAPE I
Sbjct: 128 HYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA-GCAAYMAPERI 186

Query: 321 VLGKGHNK---AADWWSVGILLYEMLTGKPPFIGGNRA-KIQQKIVKD---KLRLPAFLS 373
                + K    AD WS+GI L E+ TG+ P+       ++  KI+++    L      S
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS 246

Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
            +  S +   L K+  KR    PK  E ++ H + +
Sbjct: 247 PDFCSFVDLCLTKDHRKR----PKYRELLQ-HPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 98.6 bits (245), Expect = 4e-23
 Identities = 71/226 (31%), Positives = 116/226 (51%), Gaps = 20/226 (8%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTK 206
           +E +  L  +G+G +  V++ R K T  + A+K +R    +E        A R++  L  
Sbjct: 4   LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKN 59

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSH 265
           + H  +V L     T+  L LV ++++   L   L + G L      +I+  +++  +S+
Sbjct: 60  LKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGL--AKQFDENTRSNSMIGTVEYMAPEIVLG 323
            H   I+HRDLKP+N+L+   G + L DFGL  AK     T SN ++ T+ Y  P+++LG
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 177

Query: 324 KG-HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL 368
              ++   D W VG +LYEM TG+P F G          VK++L L
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGST--------VKEELHL 215

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 98.6 bits (245), Expect = 5e-23
 Identities = 60/205 (29%), Positives = 109/205 (53%), Gaps = 6/205 (2%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + +E L+ +G+G++  VY+ + K   ++ A+KV+R  +  E+        E  +L  + H
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
             +V L     TK  L LV ++++     +   H G    +  +++  +++  +S++H  
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGL--AKQFDENTRSNSMIGTVEYMAPEIVLGKG-H 326
            I+HRDLKP+N+L+   G + L DFGL  AK    +T SN ++ T+ Y  P+++LG   +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEY 181

Query: 327 NKAADWWSVGILLYEMLTGKPPFIG 351
           +   D W VG +  EM+ G   F G
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAFPG 206

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 98.6 bits (246), Expect = 9e-23
 Identities = 67/304 (22%), Positives = 119/304 (39%), Gaps = 58/304 (19%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD-----ILTK 206
           ++ ++ +G GA+G V       + +  A+K     KI          A+R      IL  
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIP-HAFDVPTLAKRTLRELKILRH 60

Query: 207 IDHPFVVQLKYSFQTKYRL----YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
             H  ++ ++   +         Y+V+D +    L   ++      E+  R +  +++  
Sbjct: 61  FKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-----IGTVEYMA 317
           + ++H+  ++HRDLKP N+L+  D  + + DFG+A+    +   +       + T  Y A
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179

Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN----------------------- 353
           PE++L    +  A D WSVG +  EML  +  F G N                       
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239

Query: 354 -----RAKIQQKIVKDKLRLPAFL---SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH 405
                R  IQ    K  +         S EA  LL  +LQ +P +R+       E+   H
Sbjct: 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV-----EQALQH 294

Query: 406 KWFK 409
            +  
Sbjct: 295 PFLA 298

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 97.1 bits (241), Expect = 2e-22
 Identities = 76/262 (29%), Positives = 122/262 (46%), Gaps = 19/262 (7%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F  L+ +G G+FG VY  R   T+E+ A+K M           + +  E   L +I HP 
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE-DLARIYAAEIVSAVSHLHANG 270
            ++ K  +  ++  +LV+++  G        H    +E ++A I    +   +++LH++ 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL-QGLAYLHSHN 145

Query: 271 IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG---HN 327
           ++HRD+K  NILL   G V L DFG A      + +NS +GT  +MAPE++L      ++
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMDEGQYD 202

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL---- 383
              D WS+GI   E+   KPP    N       I +++   P   S+E     +      
Sbjct: 203 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--SPTLQSNEWSDYFRNFVDSC 260

Query: 384 LQKEPGKRLGAGPKGSEEIKSH 405
           LQK P  R       SEE+  H
Sbjct: 261 LQKIPQDR-----PTSEELLKH 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 78/290 (26%), Positives = 144/290 (49%), Gaps = 31/290 (10%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI-LTKID 208
           +D EV++ +G+GA+G V ++R   T  I A+K +R    V     + +  + DI +  +D
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRAT--VNSQEQKRLLMDLDISMRSVD 58

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG--HLFFQLYHHGLF-REDLARIYAAEIVSAVSH 265
            P+ V    +   +  +++ ++ ++      + ++Y  GL   ED+    A  IV A+ +
Sbjct: 59  CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118

Query: 266 LHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE-----YMAPE 319
           LH+   ++HRD+KP N+L+  +G V L DFG++         +S+  T++     YMAPE
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL-----VDSVAKTIDAGCKPYMAPE 173

Query: 320 IVLG----KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVKD-KLRLPA-F 371
            +      KG++  +D WS+GI + E+ TG+ P+    +   QQ  ++V++   +LPA  
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPY-DSWKTPFQQLKQVVEEPSPQLPAEK 232

Query: 372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREI 421
            S E    +   L+K   +R    P    E+  H +F+    K  +    
Sbjct: 233 FSPEFQDFVNKCLKKNYKER----PN-YPELLQHPFFELHLSKNTDVASF 277

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 80/323 (24%), Positives = 130/323 (40%), Gaps = 89/323 (27%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA-----------ERDIL 204
             +G+G +G+V +     T +I A+K ++  +I      +               E  I+
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            +I H  ++ L         +Y+  DFIN   L   +        DL ++   +I    S
Sbjct: 75  NEIKHENIMGLV-------DVYVEGDFIN---LVMDIMAS-----DLKKVVDRKIRLTES 119

Query: 265 H--------------LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---------- 300
                          LH    MHRDL P NI + + G   + DFGLA+++          
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 301 -DENTRSN----SMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNR 354
            DE  +      S + T+ Y APE+++G + ++ A D WSVG +  E+LTGKP F G N 
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239

Query: 355 AKIQQKIVK-----------DKLRLPAFL-----------------SSEAHSLLKGLLQK 386
                +I +              +LP +                  S +A  LL+ LL+ 
Sbjct: 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299

Query: 387 EPGKRLGAGPKGSEEIKSHKWFK 409
            P +R+ A     +E   H++FK
Sbjct: 300 NPLERISA-----KEALKHEYFK 317

Length = 335

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 95.9 bits (239), Expect = 4e-22
 Identities = 79/300 (26%), Positives = 128/300 (42%), Gaps = 52/300 (17%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA----ERDIL 204
           +E ++ L  +G+G++  VY+ R K T ++ A+K +R        H E        E  +L
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRL------EHEEGAPFTAIREASLL 57

Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
             + H  +V L     TK  L LV ++++     +     G       R++  +++  ++
Sbjct: 58  KDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGL--AKQFDENTRSNSMIGTVEYMAPEIVL 322
           + H   ++HRDLKP+N+L+   G + L DFGL  AK     T SN ++ T+ Y  P+++L
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLL 176

Query: 323 G-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ-QKIVK-----------DKLRLP 369
           G   ++ + D W VG + YEM TG+P F G    + Q  KI +                P
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236

Query: 370 AF---------------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
            F                            L    LQ EP KR+ A      E   H +F
Sbjct: 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA-----AEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 94.0 bits (234), Expect = 1e-21
 Identities = 64/255 (25%), Positives = 113/255 (44%), Gaps = 25/255 (9%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E+F + + +G G FG V++   KN   + A+K+++ D   +    +  + E   L ++ H
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSD---DLLKQQDFQKEVQALKRLRH 61

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--------YAAEIVS 261
             ++ L         +Y++ + +  G L          R    ++         A ++  
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSL------LAFLRSPEGQVLPVASLIDMACQVAE 115

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPE 319
            +++L     +HRDL   NIL+G D    + DFGLA+   E+    S+  I   ++ APE
Sbjct: 116 GMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-PYKWTAPE 174

Query: 320 IVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLS--SEA 376
                  +  +D WS GILLYEM T G+ P+ G N  ++  +I     R+P       E 
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCPAKCPQEI 233

Query: 377 HSLLKGLLQKEPGKR 391
           + ++      EP  R
Sbjct: 234 YKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 66/243 (27%), Positives = 127/243 (52%), Gaps = 12/243 (4%)

Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           LK +G G FG V+  + +   ++ A+K++R+  + E +  E    E  ++ K+ HP +VQ
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIE----EAKVMMKLSHPNLVQ 63

Query: 215 LKYSFQTKYR-LYLVLDFI-NGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIM 272
           L Y   TK R +++V +++ NG  L +     G    +      +++  A+ +L +NG +
Sbjct: 64  L-YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122

Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           HRDL   N L+G D  V ++DFGLA+    D+ T S      V++  PE+      +  +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182

Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D WS G+L++E+ + GK P+   + +++ + +    +L  P    +E ++++     ++P
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKP 242

Query: 389 GKR 391
             R
Sbjct: 243 EDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 64/208 (30%), Positives = 109/208 (52%), Gaps = 20/208 (9%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD------- 202
           +DFE L  +G G  G V +V  + +  I A K++         H E   A R+       
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLI---------HLEIKPAIRNQIIRELK 51

Query: 203 ILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRED-LARIYAAEIVS 261
           +L + + P++V    +F +   + + ++ ++GG L   L   G   E+ L +I  A ++ 
Sbjct: 52  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-VLR 110

Query: 262 AVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
            +++L     IMHRD+KP NIL+ + G + L DFG++ Q   ++ +NS +GT  YM+PE 
Sbjct: 111 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPER 169

Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPP 348
           + G  +   +D WS+G+ L EM  G+ P
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 20/215 (9%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEY-MKAERDI--LTK 206
             ++ L  +G+GA+G V     K T    A+K     KI    H  +  +  R+I  L +
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK-----KISPFEHQTFCQRTLREIKILRR 59

Query: 207 IDHP-----FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
             H        +    SF++   +Y+V + +    L+  +    L   D  + +  +I+ 
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHL-SNDHIQYFLYQILR 117

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL  +  + + DFGLA+  D            + T  Y A
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ KA D WSVG +L EML+ +P F G
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 77/238 (32%), Positives = 114/238 (47%), Gaps = 31/238 (13%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEY-MKAERDI-----LT 205
           +E +  +G GA+G VY+ R  ++    A+K +R    V+ N     +   R++     L 
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR----VQTNEDGLPLSTVREVALLKRLE 57

Query: 206 KIDHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHH-------GLFRE---DLA 252
             DHP +V+L     + +T     + L F    H+   L  +       GL  E   DL 
Sbjct: 58  AFDHPNIVRLMDVCATSRTDRETKVTLVF---EHVDQDLRTYLDKVPPPGLPAETIKDLM 114

Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
           R    + +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +        ++ T
Sbjct: 115 R----QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVT 170

Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA 370
           + Y APE++L   +    D WSVG +  EM   KP F G + A    KI  D + LP 
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF-DLIGLPP 227

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 97.5 bits (243), Expect = 2e-21
 Identities = 63/246 (25%), Positives = 118/246 (47%), Gaps = 38/246 (15%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKI 207
           ++ +++++++G+G  G VY       S   A+K +R+D          +++ E  I   +
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLR-EAKIAADL 59

Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFING---GHLFFQLYHHGLFREDLA---------RIY 255
            HP +V +         +Y  + +I G     L   ++      ++LA          I+
Sbjct: 60  IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK----------------- 298
             +I + + ++H+ G++HRDLKP+NILLG  G V++ D+G A                  
Sbjct: 120 H-KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 299 --QFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAK 356
              +   T    ++GT +YMAPE +LG   +++ D +++G++LY+MLT   P+    R K
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY----RRK 234

Query: 357 IQQKIV 362
             +KI 
Sbjct: 235 KGRKIS 240

Length = 932

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 93.6 bits (232), Expect = 4e-21
 Identities = 72/250 (28%), Positives = 120/250 (48%), Gaps = 14/250 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E F  L  +G G+FG VY     +T+E+ A+K M           + +  E   L ++ H
Sbjct: 21  EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH 80

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE-DLARIYAAEIVSAVSHLHA 268
           P  ++ K  +  ++  +LV+++  G        H    +E ++A I    +   +++LH+
Sbjct: 81  PNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL-QGLAYLHS 139

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG--- 325
           + ++HRD+K  NILL   G V L DFG A +   ++ +NS +GT  +MAPE++L      
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASK---SSPANSFVGTPYWMAPEVILAMDEGQ 196

Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL-- 383
           ++   D WS+GI   E+   KPP    N       I ++    P   S+E     +G   
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPTLQSNEWTDSFRGFVD 254

Query: 384 --LQKEPGKR 391
             LQK P +R
Sbjct: 255 YCLQKIPQER 264

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 95.1 bits (236), Expect = 5e-21
 Identities = 82/279 (29%), Positives = 134/279 (48%), Gaps = 51/279 (18%)

Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLK 216
           ++G G+FG VY+    +TSE  A+K + +D        +Y   E  I+  ++H  ++ LK
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQD-------PQYKNRELLIMKNLNHINIIFLK 125

Query: 217 -YSFQTKYR-------LYLVLDFI-NGGHLFFQLY---HHGLFREDLARIYAAEIVSAVS 264
            Y +   ++       L +V++FI    H + + Y   +H L    L ++Y+ ++  A++
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHAL-PLFLVKLYSYQLCRALA 184

Query: 265 HLHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG 323
           ++H+  I HRDLKP+N+L+  + H + L DFG AK      RS S I +  Y APE++LG
Sbjct: 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244

Query: 324 K-GHNKAADWWSVGILLYEMLTGKPPFIGG--------------------------NRAK 356
              +    D WS+G ++ EM+ G P F G                           N A 
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD 304

Query: 357 IQQKIVKDK-LR--LPAFLSSEAHSLLKGLLQKEPGKRL 392
           I+   VK K L+   P     +A + +   L+ EP KRL
Sbjct: 305 IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL 343

Length = 440

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 93.6 bits (232), Expect = 5e-21
 Identities = 60/201 (29%), Positives = 110/201 (54%), Gaps = 6/201 (2%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKD-KIVEKNHAEYMKAERDILTKID 208
           +DFE +  +G G  G V++V  K +  I A K++  + K   +N    +  E  +L + +
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ---IIRELQVLHECN 61

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL-H 267
            P++V    +F +   + + ++ ++GG L   L   G   E +    +  ++  +++L  
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
            + IMHRD+KP NIL+ + G + L DFG++ Q  + + +NS +GT  YM+PE + G  ++
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYS 180

Query: 328 KAADWWSVGILLYEMLTGKPP 348
             +D WS+G+ L EM  G+ P
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 91.8 bits (228), Expect = 6e-21
 Identities = 65/243 (26%), Positives = 123/243 (50%), Gaps = 12/243 (4%)

Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           +K +G G FG V+  + +   ++ A+K + +  + E++  E    E  ++ K+ HP +VQ
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQ 63

Query: 215 LKYSFQTKYR-LYLVLDFI-NGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIM 272
           L Y   T+ + LY+V +F+ NG  L +     G   +D+      ++   + +L  N  +
Sbjct: 64  L-YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122

Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           HRDL   N L+ + G V ++DFG+ +    DE T S+     V++  PE+     ++  +
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHSLLKGLLQKEP 388
           D WS G+L++E+ T GK PF   +  ++ + I +  +L  P   S   + ++     ++P
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKP 242

Query: 389 GKR 391
             R
Sbjct: 243 EGR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 91.3 bits (227), Expect = 8e-21
 Identities = 65/248 (26%), Positives = 119/248 (47%), Gaps = 15/248 (6%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIY---AMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           K +G G+FG V +     +       A+K ++ DK +     +++K E  I+  +DH  +
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK-LSDIMDDFLK-EAAIMHSLDHENL 58

Query: 213 VQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLHANG 270
           ++L Y     + L +V +    G L  +L    L    ++ +  YA +I + + +L +  
Sbjct: 59  IRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 271 IMHRDLKPENILLGADGHVMLTDFGLA---KQFDENTRSNSMIGT-VEYMAPEIVLGKGH 326
            +HRDL   NILL +D  V + DFGL     Q +++      +     + APE +  +  
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 327 NKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL--PAFLSSEAHSLLKGL 383
           + A+D W  G+ L+EM T G+ P+ G + ++I +KI K+  RL  P     + ++++   
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237

Query: 384 LQKEPGKR 391
               P  R
Sbjct: 238 WAHNPADR 245

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 91.3 bits (227), Expect = 8e-21
 Identities = 67/226 (29%), Positives = 120/226 (53%), Gaps = 17/226 (7%)

Query: 153 EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           ++L+ +G G FG V++    NT+ + A+K ++   +  K   +++ AE  I+ K+ HP +
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTMDPK---DFL-AEAQIMKKLRHPKL 63

Query: 213 VQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHHG---LFREDLARIYAAEIVSAVSHLHA 268
           +QL Y+  T    +Y+V + +  G L   L       L    L  + AA++ S +++L A
Sbjct: 64  IQL-YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM-AAQVASGMAYLEA 121

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT---VEYMAPEIVLGKG 325
              +HRDL   N+L+G +    + DFGLA+   E+    +  G    +++ APE  L   
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNR 180

Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPA 370
            +  +D WS GILL E++T G+ P+ G   A++ Q++ +   R+P 
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPC 225

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 95.6 bits (237), Expect = 1e-20
 Identities = 75/288 (26%), Positives = 143/288 (49%), Gaps = 52/288 (18%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           + ++EV+K +G G FG V+ V+ K T E +  K +    + E+  ++ +  E +++ ++ 
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQ-LVIEVNVMRELK 70

Query: 209 HPFVVQLKYSFQTK--YRLYLVLDFINGGHL----------FFQLYHHGLFREDLARIYA 256
           H  +V+    F  K   +LY++++F + G L          F ++  H +   D+ R   
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV--DITR--- 125

Query: 257 AEIVSAVSHLH-----ANG--IMHRDLKPENILLGAD----GHVM-------------LT 292
            +++ A+++ H      NG  ++HRDLKP+NI L       G +              + 
Sbjct: 126 -QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184

Query: 293 DFGLAKQFDENTRSNSMIGTVEYMAPEIVL--GKGHNKAADWWSVGILLYEMLTGKPPFI 350
           DFGL+K     + ++S +GT  Y +PE++L   K ++  +D W++G ++YE+ +GK PF 
Sbjct: 185 DFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF- 243

Query: 351 GGNRAKIQQKIVKDKLRLPAF----LSSEAHSLLKGLLQKEPGKRLGA 394
             ++A    +++ +  R P       S E + L+K LL     +R  A
Sbjct: 244 --HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSA 289

Length = 1021

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 10/208 (4%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTK 206
           +E +  L  +G+G +  VY+ R K T  + A+K +R    +E        A R++  L  
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKD 60

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           + H  +V L     T+  L LV ++++     +             +++  +++  +++ 
Sbjct: 61  LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGL--AKQFDENTRSNSMIGTVEYMAPEIVLGK 324
           H   ++HRDLKP+N+L+   G + L DFGL  AK     T SN ++ T+ Y  P+I+LG 
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGS 179

Query: 325 -GHNKAADWWSVGILLYEMLTGKPPFIG 351
             ++   D W VG + YEM TG+P F G
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPG 207

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 75/258 (29%), Positives = 124/258 (48%), Gaps = 36/258 (13%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSE-----------IYAMKVMRKDKIVEKNHAEYMKAE 200
           +E++K +GQGA+G V   R   TSE           +++ K++ K  + E     + +  
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 201 RDILTKIDHPFVVQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHHGLFREDL---ARIYA 256
           ++I    D   V      F   +  LYL  + +       Q+   G    D    + IY 
Sbjct: 62  KNITCLYDMDIV------FPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIY- 112

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS-----MIG 311
            +I+  + ++H+  ++HRDLKP N+L+ AD  + + DFGLA+ F EN   N+      + 
Sbjct: 113 -QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171

Query: 312 TVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DK 365
           T  Y APEI+L  + + KA D WSVG +L E+L  KP F G +      +I++     D+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231

Query: 366 LRLPAFLSSEAHSLLKGL 383
             L    S +A + ++ L
Sbjct: 232 ETLSRIGSPKAQNYIRSL 249

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 67/273 (24%), Positives = 126/273 (46%), Gaps = 38/273 (13%)

Query: 150 EDFEVLKVVGQGAFGRVY-----QVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
           +   + + +G+GAFG+V+      +  +N  E+ A+K + K+        ++ + E ++L
Sbjct: 5   DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFER-EAELL 62

Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG---------------LFRE 249
           T   H  +V+            +V +++  G L   L  HG               L   
Sbjct: 63  TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 250 DLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM 309
            L +I A +I S + +L +   +HRDL   N L+G D  V + DFG+++  D  T     
Sbjct: 123 QLLQI-AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTTDYYR 179

Query: 310 IG-----TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAK----IQQ 359
           +G      + +M PE ++ +     +D WS G++L+E+ T GK P+ G +  +    I Q
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239

Query: 360 KIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRL 392
             +   L+ P    SE + ++ G  +++P +R+
Sbjct: 240 GRL---LQRPRTCPSEVYDIMLGCWKRDPQQRI 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 62/221 (28%), Positives = 111/221 (50%), Gaps = 10/221 (4%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ ++ LK +G GA G V            A+K + +     + HA+    E  +L  ++
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 78

Query: 209 HPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
           H  ++ L   F  +  L      YLV++ ++      Q+ H  L  E ++ +   +++  
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLY-QMLCG 135

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    N      + T  Y APE++L
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195

Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           G G+ +  D WSVG ++ E++ G   F G +      K+++
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 236

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 90.5 bits (224), Expect = 4e-20
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 8/206 (3%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F  L+ +G G+FG VY  R    SE+ A+K M           + +  E   L K+ HP 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 212 VVQLKYSFQTKYRLYLVLDFING-GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG 270
            +Q +  +  ++  +LV+++  G      +++   L   ++A +    +   +++LH++ 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL-QGLAYLHSHN 135

Query: 271 IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG---HN 327
           ++HRD+K  NILL   G V L DFG A        +N  +GT  +MAPE++L      ++
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYD 192

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGN 353
              D WS+GI   E+   KPP    N
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMN 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 90.8 bits (225), Expect = 4e-20
 Identities = 72/224 (32%), Positives = 109/224 (48%), Gaps = 18/224 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + +  LK VG GA+G V     + T    A+K + +     +  A+    E  +L  + H
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKH 73

Query: 210 PFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV 263
             V+ L   F     L      YLV+ F+  G    +L  H    ED  +    +++  +
Sbjct: 74  ENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE---YMAPEI 320
            ++HA GI+HRDLKP N+ +  D  + + DFGLA+Q D     + M G V    Y APE+
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD-----SEMTGYVVTRWYRAPEV 186

Query: 321 VLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           +L   H  +  D WSVG ++ EMLTGKP F G +      +I+K
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK 230

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 89.7 bits (222), Expect = 7e-20
 Identities = 63/225 (28%), Positives = 112/225 (49%), Gaps = 18/225 (8%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTK 206
           +E +  L+ +G+G +  V++ R K T  + A+K +R    +E        A R++  L  
Sbjct: 5   METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKD 60

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           + H  +V L     T   L LV ++++     +      +      +I+  +I+  +++ 
Sbjct: 61  LKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGL--AKQFDENTRSNSMIGTVEYMAPEIVLGK 324
           H   ++HRDLKP+N+L+   G + L DFGL  AK     T SN ++ T+ Y  P+++LG 
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS 179

Query: 325 G-HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL 368
             ++   D W VG + +EM +G+P F G          V+D+L L
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGST--------VEDELHL 216

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 90.1 bits (223), Expect = 7e-20
 Identities = 58/201 (28%), Positives = 110/201 (54%), Gaps = 6/201 (2%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKD-KIVEKNHAEYMKAERDILTKID 208
           +DFE +  +G G  G V +V+ K +  I A K++  + K   +N    +  E  +L + +
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ---IIRELQVLHECN 61

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL-H 267
            P++V    +F +   + + ++ ++GG L   L       E++    +  ++  +++L  
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE 121

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
            + IMHRD+KP NIL+ + G + L DFG++ Q  + + +NS +GT  YM+PE + G  ++
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYS 180

Query: 328 KAADWWSVGILLYEMLTGKPP 348
             +D WS+G+ L E+  G+ P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 34/271 (12%)

Query: 152 FEVLKVV---GQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
              LK +   G+G FG+V   R      NT E  A+K +      E+ H    + E +IL
Sbjct: 3   KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG--EEQHRSDFEREIEIL 60

Query: 205 TKIDHPFVVQLKYSFQTKYR--LYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIV 260
             +DH  +V+ K   +      L L+++++  G L   L  H   + +L R+  ++++I 
Sbjct: 61  RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQIC 119

Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSMIGT-VEYM 316
             + +L +   +HRDL   NIL+ ++  V ++DFGLAK   +  +         + + + 
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179

Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT-----GKPP-----FIGGNRAKIQQ----KIV 362
           APE +     + A+D WS G+ LYE+ T       PP      IG  + ++      +++
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239

Query: 363 KDKLRL--PAFLSSEAHSLLKGLLQKEPGKR 391
           K+  RL  P     E + L+K   + EP  R
Sbjct: 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDR 270

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 30/215 (13%)

Query: 158 VGQGAFGRVYQVRKKNTSEI--YAMKVMRKDKIVEKNHAEYMKAERDI--LTKIDHPFVV 213
           VG+G +G VY+ ++K+  +   YA+K +    I        M A R+I  L ++ HP V+
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-------MSACREIALLRELKHPNVI 61

Query: 214 QLKYSF--QTKYRLYLVLDFINGGHLFFQLYHHG--------LFREDLARIYAAEIVSAV 263
            L+  F   +  +++L+ D+          +H               + +    +I+  +
Sbjct: 62  ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 264 SHLHANGIMHRDLKPENILLGAD----GHVMLTDFGLAKQFDENTRS----NSMIGTVEY 315
            +LHAN ++HRDLKP NIL+  +    G V + D G A+ F+   +     + ++ T  Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 316 MAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPF 349
            APE++LG  H  KA D W++G +  E+LT +P F
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 12/215 (5%)

Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           LK +G GA G V       T +  A+K + +       HA+    E  ++  ++H  ++ 
Sbjct: 21  LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSR-PFQNVTHAKRAYRELVLMKLVNHKNIIG 79

Query: 215 L------KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLAR-IYAAEIVSAVSHLH 267
           L      + S +    +YLV++ ++      Q+    L  E ++  +Y  +++  + HLH
Sbjct: 80  LLNVFTPQKSLEEFQDVYLVMELMD--ANLCQVIQMDLDHERMSYLLY--QMLCGIKHLH 135

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           + GI+HRDLKP NI++ +D  + + DFGLA+    +      + T  Y APE++LG G+ 
Sbjct: 136 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 195

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV 362
           +  D WSVG ++ EM+ G   F G +      KI+
Sbjct: 196 ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII 230

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 87.8 bits (217), Expect = 3e-19
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 21/217 (9%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRK-KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI----- 203
           + +E +  +G+GA+G+V++ R  KN     A+K +R   +        +   R++     
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 57

Query: 204 LTKIDHPFVVQL-------KYSFQTKYRLYLVLDFINGGHLFF--QLYHHGLFREDLARI 254
           L   +HP VV+L       +   +TK  L LV + ++     +  ++   G+  E +  +
Sbjct: 58  LETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 115

Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE 314
              +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +       S++ T+ 
Sbjct: 116 -MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW 174

Query: 315 YMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIG 351
           Y APE++L   +    D WSVG +  EM   KP F G
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 86.3 bits (213), Expect = 6e-19
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 12/240 (5%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 67

Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 68  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127

Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +KEP +R
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 85.8 bits (212), Expect = 6e-19
 Identities = 60/240 (25%), Positives = 124/240 (51%), Gaps = 14/240 (5%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           +++G+G FG V Q   + T +  A+K ++ D       A+    E  ++TK+ H  +V+L
Sbjct: 12  EIIGEGEFGAVLQ--GEYTGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRL 64

Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLHANGIMH 273
                    LY+V++ ++ G+L   L   G     + ++  ++ ++   + +L +  ++H
Sbjct: 65  -LGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVH 123

Query: 274 RDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           RDL   NIL+  DG   ++DFGLA+    +   ++    V++ APE +  K  +  +D W
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181

Query: 334 SVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S G+LL+E+ + G+ P+   +  ++++ + K  ++  P    ++ + L+    + EP KR
Sbjct: 182 SYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 86.6 bits (214), Expect = 6e-19
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 6/200 (3%)

Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           L+ +G+G++  VY+   +   ++ A+KV+      E+        E  +L  + H  +V 
Sbjct: 10  LEKLGEGSYATVYKGISRINGQLVALKVISMK--TEEGVPFTAIREASLLKGLKHANIVL 67

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L     TK  L  V ++++     + + H G       R++  +++  ++++H   I+HR
Sbjct: 68  LHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR 127

Query: 275 DLKPENILLGADGHVMLTDFGLA--KQFDENTRSNSMIGTVEYMAPEIVLGK-GHNKAAD 331
           DLKP+N+L+   G + L DFGLA  K     T S+ ++ T+ Y  P+++LG   ++ A D
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSALD 186

Query: 332 WWSVGILLYEMLTGKPPFIG 351
            W  G +  EML G+P F G
Sbjct: 187 IWGAGCIFIEMLQGQPAFPG 206

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 87.6 bits (217), Expect = 8e-19
 Identities = 56/193 (29%), Positives = 92/193 (47%), Gaps = 11/193 (5%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           + V+K +  G+ GRV+   K    +   +K+ +K   +          E  +L  ++HP 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           V+++K +  +     +VL   +     +          D A I   +I+  + +LHA  I
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRI 178

Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN-SMIGTVEYMAPEIVLGKGHNKAA 330
           +HRD+K ENI +     V + D G A QF     +   + GTVE  APE++    +N  A
Sbjct: 179 IHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKA 237

Query: 331 DWWSVGILLYEML 343
           D WS GI+L+EML
Sbjct: 238 DIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 86.6 bits (214), Expect = 9e-19
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 30/215 (13%)

Query: 158 VGQGAFGRVYQVRKKNTSEI--YAMKVMRKDKIVEKNHAEYMKAERDI--LTKIDHPFVV 213
           VG+G +G VY+ ++K+  +   YA+K +    I        M A R+I  L ++ HP V+
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-------MSACREIALLRELKHPNVI 61

Query: 214 QLKYSF--QTKYRLYLVLDFINGGHLFFQLYHHG--------LFREDLARIYAAEIVSAV 263
            L+  F      +++L+ D+          +H               + +    +I+  +
Sbjct: 62  SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 264 SHLHANGIMHRDLKPENILLGAD----GHVMLTDFGLAKQFDENTRS----NSMIGTVEY 315
            +LHAN ++HRDLKP NIL+  +    G V + D G A+ F+   +     + ++ T  Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 316 MAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPF 349
            APE++LG  H  KA D W++G +  E+LT +P F
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 15/208 (7%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +  ++ ++   +G+G FG V     +   +  A+K ++ D       A+   AE  ++T 
Sbjct: 3   INSKELKLGATIGKGEFGDVMLGDYRG--QKVAVKCLKDDS----TAAQAFLAEASVMTT 56

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG---LFREDLARIYAAEIVSAV 263
           + HP +VQL         LY+V +++  G L   L   G   +        +A ++   +
Sbjct: 57  LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQ-LGFALDVCEGM 115

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVL 322
            +L     +HRDL   N+L+  D    ++DFGLAK+  +   S  +   V++ APE +  
Sbjct: 116 EYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL--PVKWTAPEALRE 173

Query: 323 GKGHNKAADWWSVGILLYEMLT-GKPPF 349
            K   K +D WS GILL+E+ + G+ P+
Sbjct: 174 KKFSTK-SDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 86.9 bits (215), Expect = 1e-18
 Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           LK VG GA+G V     K T E  A+K + +    E   A+    E  +L  + H  V+ 
Sbjct: 20  LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAYRELTLLKHMQHENVIG 78

Query: 215 L------KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           L        S       YLV+ ++    L   + H     ED  +    +++  + ++H+
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKVQYLVYQMLCGLKYIHS 135

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE---YMAPEIVLGKG 325
            GI+HRDLKP N+ +  D  + + DFGLA+  D       M G V    Y APE++L   
Sbjct: 136 AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWM 190

Query: 326 H-NKAADWWSVGILLYEMLTGKPPFIG 351
           H N+  D WSVG ++ EMLTGK  F G
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKG 217

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 64/248 (25%), Positives = 125/248 (50%), Gaps = 12/248 (4%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  +++K +G G FG V+       +++ A+K ++   +  ++  E    E  I+ K+ H
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQIMKKLRH 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +VQL Y+  ++  +Y+V ++++ G L   L         L  +   AA++ + ++++ 
Sbjct: 61  DKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+G      + DFGLA+  ++N  T        +++ APE  L   
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G N  ++ +++ +  ++  P       H L+   
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQC 239

Query: 384 LQKEPGKR 391
            +K+P +R
Sbjct: 240 WKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 86.6 bits (214), Expect = 2e-18
 Identities = 58/221 (26%), Positives = 111/221 (50%), Gaps = 10/221 (4%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ ++ LK +G GA G V            A+K + +     + HA+    E  ++  ++
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81

Query: 209 HPFVVQL------KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
           H  ++ L      + S +    +Y+V++ ++      Q+    L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLY-QMLCG 138

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T  Y APE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198

Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           G G+ +  D WSVG ++ EM+ G   F G +      K+++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 17/229 (7%)

Query: 152 FEVLKVVGQGAFGRVYQ----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            E +KV+G GAFG VY+       +      A+KV+R++    K + E +  E  ++  +
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILD-EAYVMASV 66

Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHL 266
           DHP VV+L        ++ L+   +  G L   + +H           +  +I   +S+L
Sbjct: 67  DHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT-----VEYMAPEIV 321
               ++HRDL   N+L+    HV +TDFGLAK  D                +++MA E +
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIKWMALESI 183

Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
           L + +   +D WS G+ ++E++T G  P+ G    +I   +++   RLP
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD-LLEKGERLP 231

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 39/223 (17%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-D 208
           ED + L  +G+GAFG V ++  K +  I A+K +R    V++   + +  + D++ +  D
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRS--TVDEKEQKRLLMDLDVVMRSSD 61

Query: 209 HPFVVQ-----------------LKYSFQTKYRL-YLVLDFINGGHLFFQLYHHGLFRED 250
            P++V+                 +  S    Y+  Y VL                +  E+
Sbjct: 62  CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLK--------------SVIPEE 107

Query: 251 LARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM 309
           +    A   V A+++L     I+HRD+KP NILL  +G++ L DFG++ Q  ++      
Sbjct: 108 ILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD 167

Query: 310 IGTVEYMAPEIVL---GKGHNKAADWWSVGILLYEMLTGKPPF 349
            G   YMAPE +      G++  +D WS+GI LYE+ TGK P+
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 85.5 bits (211), Expect = 3e-18
 Identities = 60/221 (27%), Positives = 110/221 (49%), Gaps = 10/221 (4%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ ++ LK +G GA G V            A+K + +     + HA+    E  ++  ++
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74

Query: 209 HPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
           H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++ +   +++  
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLY-QMLCG 131

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T  Y APE++L
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           G G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 84.5 bits (209), Expect = 5e-18
 Identities = 78/290 (26%), Positives = 125/290 (43%), Gaps = 45/290 (15%)

Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           L+ VG GAFG V   R + T +  A+K + K        A+    E  +L  + H  ++ 
Sbjct: 15  LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVL-AKRTYRELKLLKHLRHENIIS 73

Query: 215 LKYSFQTKYR-LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMH 273
           L   F +    +Y V + +  G    +L       +   + +  +I+  + ++H+ G++H
Sbjct: 74  LSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVH 131

Query: 274 RDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADW 332
           RDLKP NIL+  +  + + DFGLA+  D   +    + T  Y APEI+L  + ++   D 
Sbjct: 132 RDLKPSNILINENCDLKICDFGLARIQD--PQMTGYVSTRYYRAPEIMLTWQKYDVEVDI 189

Query: 333 WSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA--------------FLSS---- 374
           WS G +  EML GKP F G +    Q  I+ D L  P               F+ S    
Sbjct: 190 WSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKR 248

Query: 375 --------------EAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP 410
                          A  LL+ +L  +P KR+ A      E  +H +  P
Sbjct: 249 EPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISA-----AEALAHPYLAP 293

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 83.2 bits (206), Expect = 6e-18
 Identities = 64/251 (25%), Positives = 124/251 (49%), Gaps = 13/251 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           ED  + + +G+G FG VYQ   +  +N     A+K  +       +  E    E  I+ +
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQ 63

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVS 264
            DHP +V+L     T+  +++V++    G L  + Q+  + L    L  +Y+ ++ +A++
Sbjct: 64  FDHPHIVKL-IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLI-LYSYQLSTALA 121

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMAPEIVL 322
           +L +   +HRD+   N+L+ +   V L DFGL++  ++ +   +  G   +++MAPE + 
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181

Query: 323 GKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHSLL 380
            +    A+D W  G+ ++E+L  G  PF G     +  +I   ++L +P       +SL+
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 241

Query: 381 KGLLQKEPGKR 391
                 +P KR
Sbjct: 242 TKCWAYDPSKR 252

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 83.4 bits (206), Expect = 7e-18
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 31/264 (11%)

Query: 155 LKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           ++V+G+G FG+V    Y      T E+ A+K ++++    + +    K E +IL  + H 
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHE 66

Query: 211 FVVQLK--YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            +V+ K   S Q    L L+++++  G L   L  H L    L  ++A +I   +++LH+
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL-LFAQQICEGMAYLHS 125

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYMAPEIVLG 323
              +HRDL   N+LL  D  V + DFGLAK   E       R +     V + A E +  
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD-SPVFWYAVECLKE 184

Query: 324 KGHNKAADWWSVGILLYEMLTG-----KPP-----FIGGNRAKIQQ----KIVKDKLRLP 369
              + A+D WS G+ LYE+LT       PP      IG  + ++      ++++  +RLP
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLP 244

Query: 370 A--FLSSEAHSLLKGLLQKEPGKR 391
                  E + L+K   + E   R
Sbjct: 245 CPKNCPQEVYILMKNCWETEAKFR 268

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 76/321 (23%), Positives = 137/321 (42%), Gaps = 64/321 (19%)

Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD--ILTKIDHPFV 212
           L+ +G G+ G V+     +  +  A+K     KIV  +      A R+  I+ ++DH  +
Sbjct: 10  LRPLGCGSNGLVFSAVDSDCDKRVAVK-----KIVLTDPQSVKHALREIKIIRRLDHDNI 64

Query: 213 VQL-------------KYSFQTKYR-LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAE 258
           V++                  T+   +Y+V +++        +   G   E+ AR++  +
Sbjct: 65  VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQ 122

Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMI--GTVE- 314
           ++  + ++H+  ++HRDLKP N+ +  +  V+ + DFGLA+  D +      +  G V  
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 315 -YMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK--------D 364
            Y +P ++L   +  KA D W+ G +  EMLTGKP F G +  +  Q I++        D
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242

Query: 365 KLRL----PAFL------------------SSEAHSLLKGLLQKEPGKRLGAGPKGSEEI 402
           +  L    P+F+                  + EA   L+ +L   P  RL A     EE 
Sbjct: 243 RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA-----EEA 297

Query: 403 KSHKWFKPINWKKLEAREIQP 423
             H +    +    E   + P
Sbjct: 298 LMHPYMSCYSCPFDEPVSLHP 318

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 82.2 bits (203), Expect = 1e-17
 Identities = 61/253 (24%), Positives = 124/253 (49%), Gaps = 22/253 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D   LK +G G FG V   + +   ++ A+K++++  + E    E    E  ++ K+ H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMKLSH 58

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS-------A 262
             +VQL      +  +Y+V ++++ G L   L      RE   R   ++++         
Sbjct: 59  EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL------REHGKRFQPSQLLEMCKDVCEG 112

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEI 320
           +++L +   +HRDL   N L+   G V ++DFGL++    DE T S      V +  PE+
Sbjct: 113 MAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172

Query: 321 VLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHS 378
           +L    +  +D W+ G+L++E+ + GK P+   N ++  +K+ +  +L  P   S + ++
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYA 232

Query: 379 LLKGLLQKEPGKR 391
           ++     ++  +R
Sbjct: 233 IMYSCWHEKAEER 245

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 84.9 bits (210), Expect = 2e-17
 Identities = 43/123 (34%), Positives = 69/123 (56%), Gaps = 10/123 (8%)

Query: 309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL 368
           ++GT +Y+APE++LGK H  A DWW++G+ L+E LTG PPF      ++ Q I+   +  
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPW 599

Query: 369 P---AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGF 425
           P     LS  A + ++ LL  +P KR G      +E+K H  F  ++W+ L+ +     F
Sbjct: 600 PEGEEKLSVNAQNAIEILLTMDPTKRAGL-----KELKQHPLFHGVDWENLQNQT--MPF 652

Query: 426 CPE 428
            P+
Sbjct: 653 IPQ 655

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 83.9 bits (207), Expect = 2e-17
 Identities = 71/232 (30%), Positives = 105/232 (45%), Gaps = 32/232 (13%)

Query: 127 EIDESSIDENVKGDSVTVCC---VGIED--FEVLKVVGQGAFGRVYQVRKKNTSEIYAMK 181
           + DES  D      S+ +C     GIE   F +L+    GA G  +      T E   +K
Sbjct: 69  DEDESDAD-----ASLALCAEARAGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIK 123

Query: 182 VMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL 241
             ++     + H         IL  I+HP ++QLK +F       L+L           L
Sbjct: 124 AGQRGGTATEAH---------ILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-----DL 169

Query: 242 YHHGLFREDLA--RIYAAE--IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA 297
           Y +   + ++A   I A E  ++ A+ +LH N I+HRD+K ENI +   G V L DFG A
Sbjct: 170 YCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-A 228

Query: 298 KQFDENTRSNSM---IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGK 346
             F  +  +N      GT+   APE++    +  A D WS GI+L+EM T  
Sbjct: 229 ACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 62/251 (24%), Positives = 134/251 (53%), Gaps = 14/251 (5%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           +++G+G FG V++   K+ + + A+K  ++D + ++   +++   R IL + DHP +V+L
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPV-AVKTCKED-LPQELKIKFLSEAR-ILKQYDHPNIVKL 57

Query: 216 KYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMH 273
                 +  +Y+V++ + GG    F +     L  + L + +A +  + +++L +   +H
Sbjct: 58  IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVK-FALDAAAGMAYLESKNCIH 116

Query: 274 RDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMAPEIVLGKGHNKAAD 331
           RDL   N L+G +  + ++DFG+++Q D+   S+S +    +++ APE +    ++  +D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 332 WWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPG 389
            WS GILL+E  + G  P+ G    + ++++ K  ++  P     + + +++     +P 
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE 236

Query: 390 KRLGAGPKGSE 400
            R    PK SE
Sbjct: 237 NR----PKFSE 243

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 82.0 bits (202), Expect = 5e-17
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 12/211 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E ++ L  VG GA+G V         +  A+K + +       HA     E  +L  + H
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKH 73

Query: 210 PFVVQL------KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV 263
             V+ L        S +    +YLV + +  G     +       ++  +    +++  +
Sbjct: 74  ENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGL 131

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG 323
            ++H+ GI+HRDLKP N+ +  D  + + DFGLA+Q D+       + T  Y APEI+L 
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM--TGYVATRWYRAPEIMLN 189

Query: 324 KGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
             H N+  D WSVG ++ E+L GK  F G +
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGND 220

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 82.8 bits (204), Expect = 6e-17
 Identities = 56/236 (23%), Positives = 106/236 (44%), Gaps = 21/236 (8%)

Query: 149 IEDFEVLKVVGQGAFGRVY--QVRKKNTSEIYAMKVMRKDKIVEKNH---AEYMKAERDI 203
           +  F V+  +  GAFG+++   +R           V   ++   K     A+ +KA    
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206

Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFR----EDL-------- 251
             ++++  +   + + +   ++  +L      ++  Q Y   L+     E          
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266

Query: 252 --ARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSN 307
              R    +++ AV ++H   ++HRD+K ENI L  DG ++L DFG A  F++       
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326

Query: 308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +GTV   +PEI+ G G+ +  D WS G++L +ML+     IG    K  ++++K
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382

Length = 501

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 81.2 bits (200), Expect = 7e-17
 Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 16/223 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 73

Query: 208 DHPFVVQL------KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L        S +    +YLV   +  G     +       +D  +    +I+ 
Sbjct: 74  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 131

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 189

Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           L   H N+  D WSVG ++ E+LTG+  F G +     + I++
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 73/267 (27%), Positives = 128/267 (47%), Gaps = 35/267 (13%)

Query: 155 LKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           ++ +G+G FG V    Y   + NT E+ A+K ++        H    + E +IL  + H 
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHD 65

Query: 211 FVVQLK---YSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSH 265
            +V+ K   YS   +  L LV++++  G L  + Q +   L    L  +YA++I   + +
Sbjct: 66  NIVKYKGVCYS-AGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL-LYASQICKGMEY 123

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YMAPEIV 321
           L +   +HRDL   NIL+ ++  V + DFGL K   ++     +    E    + APE +
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 322 LGKGHNKAADWWSVGILLYEMLT-----GKPP--FIG--GNRAKIQQ------KIVKDKL 366
                + A+D WS G++LYE+ T       PP  F+   GN  + Q       +++K+  
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243

Query: 367 RLPAFLS--SEAHSLLKGLLQKEPGKR 391
           RLPA     +E ++++K     +P +R
Sbjct: 244 RLPAPPGCPAEIYAIMKECWNNDPSQR 270

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 67/240 (27%), Positives = 120/240 (50%), Gaps = 12/240 (5%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+++ A+K ++   ++ +   +    E  I+ K+ H  +V L Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKLVPL-Y 67

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V +F+  G L   L         L ++   AA+I   ++++     +HRD
Sbjct: 68  AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127

Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E++T G+ P+ G  NR  ++Q     ++  P       H L+K   +K+P +R
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDER 247

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 63/243 (25%), Positives = 123/243 (50%), Gaps = 16/243 (6%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G +G VY+   K  S   A+K +++D +  +   E++K E  ++ +I HP +VQL  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLK-EAAVMKEIKHPNLVQLLG 69

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L   L      R+++  +     A +I SA+ +L     +H
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKNFIH 127

Query: 274 RDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT---VEYMAPEIVLGKGHNKAA 330
           RDL   N L+G +  V + DFGL++    +T + +  G    +++ APE +     +  +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKS 186

Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D W+ G+LL+E+ T G  P+ G + +++ + + K  ++  P     + + L++   Q  P
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNP 246

Query: 389 GKR 391
             R
Sbjct: 247 SDR 249

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 69/239 (28%), Positives = 115/239 (48%), Gaps = 34/239 (14%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKIDH 209
           +++ +V+G+G++G V      +T E  A+K +     V ++ ++  +  R+I  L  + H
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND---VFEHVSDATRILREIKLLRLLRH 58

Query: 210 PFVVQLKY-----SFQTKYRLYLVLDFINGG-HLFFQLY------HHGLFREDLARIYAA 257
           P +V++K+     S +    +Y+V + +    H   +        HH  F   L R    
Sbjct: 59  PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR---- 114

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS----NSMIGTV 313
               A+ ++H   + HRDLKP+NIL  AD  + + DFGLA+    +T +       + T 
Sbjct: 115 ----ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 314 EYMAPEIV---LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP 369
            Y APE+      K +  A D WS+G +  E+LTGKP F G N    Q  ++ D L  P
Sbjct: 171 WYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLLGTP 227

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 59/209 (28%), Positives = 107/209 (51%), Gaps = 21/209 (10%)

Query: 149 IEDFEVLKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
           +++ ++L+ +G+G FG V    Y+  K       A+K ++ D       A+   AE  ++
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYRGNK------VAVKCIKNDAT-----AQAFLAEASVM 53

Query: 205 TKIDHPFVVQL-KYSFQTKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVS 261
           T++ H  +VQL     + K  LY+V +++  G L   L   G  +   D    ++ ++  
Sbjct: 54  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           A+ +L AN  +HRDL   N+L+  D    ++DFGL K+      +  +   V++ APE +
Sbjct: 114 AMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEAL 171

Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPF 349
             K  +  +D WS GILL+E+ + G+ P+
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 63/251 (25%), Positives = 124/251 (49%), Gaps = 17/251 (6%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G FG VY+   K  +E+ A+K  R   +      ++++    IL + DHP +V+L  
Sbjct: 3   IGKGNFGDVYKGVLKGNTEV-AVKTCRST-LPPDLKRKFLQEAE-ILKQYDHPNIVKLIG 59

Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
               K  +Y+V++ + GG L  F +   + L  + L ++ + +  + + +L +   +HRD
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQM-SLDAAAGMEYLESKNCIHRD 118

Query: 276 LKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT----VEYMAPEIVLGKGHNKAAD 331
           L   N L+G +  + ++DFG++++ +    + S  G     +++ APE +    +   +D
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSD-GLKQIPIKWTAPEALNYGRYTSESD 177

Query: 332 WWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPG 389
            WS GILL+E  + G  P+ G +  + +++I    ++  P     E + L+      +P 
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPE 237

Query: 390 KRLGAGPKGSE 400
            R    P  SE
Sbjct: 238 NR----PSFSE 244

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 80.7 bits (199), Expect = 2e-16
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 32/214 (14%)

Query: 152 FEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + +L  +  G+ G V+   K      +   +K +   K   +        E DIL  I H
Sbjct: 94  YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR--------EIDILKTISH 145

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE-------DLARIYAAE--IV 260
             ++ L ++++ K  + +V+            Y   LF          L +    +  ++
Sbjct: 146 RAIINLIHAYRWKSTVCMVM----------PKYKCDLFTYVDRSGPLPLEQAITIQRRLL 195

Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS---MIGTVEYMA 317
            A+++LH  GI+HRD+K ENI L    + +L DFG A + D +  +       GT+E  +
Sbjct: 196 EALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNS 255

Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PE++    +    D WS G++L+EM        G
Sbjct: 256 PELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289

Length = 392

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 51/196 (26%), Positives = 99/196 (50%), Gaps = 9/196 (4%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G FG V+        ++ A+K +R+  + E    E    E  ++ K+ HP +VQL  
Sbjct: 12  IGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYG 66

Query: 218 SFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L  +     G F ++       ++   +++L ++ ++HRDL
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126

Query: 277 KPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWS 334
              N L+G +  V ++DFG+ +    D+ T S      V++ +PE+     ++  +D WS
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 335 VGILLYEMLT-GKPPF 349
            G+L++E+ + GK P+
Sbjct: 187 FGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 64/263 (24%), Positives = 119/263 (45%), Gaps = 31/263 (11%)

Query: 156 KVVGQGAFGRVYQVRKKN-----TSEI-YAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
             +G GAFG VY+    +     +  I  A+K +RK    ++   E++K E  +++  +H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLK-EAHLMSNFNH 58

Query: 210 PFVV-QLKYSFQTKYRLYLVLDFINGGHLFFQL--------YHHGLFREDLARIYAAEIV 260
           P +V  L      +   Y++++ + GG L   L            L  ++L  I   ++ 
Sbjct: 59  PNIVKLLGVCLLNE-PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI-CLDVA 116

Query: 261 SAVSHLHANGIMHRDLKPENILLGADGH-----VMLTDFGLAKQFDEN----TRSNSMIG 311
               +L     +HRDL   N L+   G+     V + DFGLA+   ++         ++ 
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL- 175

Query: 312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLP 369
            V +MAPE +L       +D WS G+L++E+LT G+ P+   N  ++ Q +    +L+ P
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP 235

Query: 370 AFLSSEAHSLLKGLLQKEPGKRL 392
                + + L+     ++P +R 
Sbjct: 236 ENCPDKIYQLMTNCWAQDPSERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 65/263 (24%), Positives = 112/263 (42%), Gaps = 22/263 (8%)

Query: 150 EDFEVLKVVGQGAFGRVY-----QVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
           E   +++ +GQG+FG VY      V K       A+K + ++  + +      +A   ++
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA--SVM 63

Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH--------GLFREDLARIY- 255
            + +   VV+L     T     +V++ +  G L   L           GL    L +   
Sbjct: 64  KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 256 -AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSMIG 311
            AAEI   +++L A   +HRDL   N ++  D  V + DFG+ +   + D   +    + 
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRLP 369
            V +MAPE +        +D WS G++L+EM T  + P+ G  N   ++  I    L LP
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLP 243

Query: 370 AFLSSEAHSLLKGLLQKEPGKRL 392
                +   L++   Q  P  R 
Sbjct: 244 ENCPDKLLELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 69/253 (27%), Positives = 124/253 (49%), Gaps = 21/253 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++ + +G G FG V+      T+++ A+K ++   +      E    E  I+ K+ H
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMKKLRH 60

Query: 210 PFVVQLKYSFQTKYR-LYLVLDFINGGHLFFQLYH---HGLFREDLARIYAAEIVSAVSH 265
             +VQL Y+  ++   +Y+V ++++ G L   L       L    L  + AA+I   +++
Sbjct: 61  DKLVQL-YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM-AAQIAEGMAY 118

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIGTVEYMAPEIVL 322
           L +   +HRDL   NIL+G +    + DFGLA+  +++    R  +    +++ APE   
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF-PIKWTAPEAAN 177

Query: 323 GKGHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRLP--AFLSSEAHS 378
                  +D WS GILL E++T G+ P+ G  NR  ++Q  V+   R+P       E + 
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ--VERGYRMPRPPNCPEELYD 235

Query: 379 LLKGLLQKEPGKR 391
           L+     K+P +R
Sbjct: 236 LMLQCWDKDPEER 248

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 78.2 bits (193), Expect = 7e-16
 Identities = 66/228 (28%), Positives = 110/228 (48%), Gaps = 45/228 (19%)

Query: 152 FEV------LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE--KNHAEYMKAERDI 203
           FEV      +K +G+GA+G V   +   T+E  A+K     KI     N  +  +  R+I
Sbjct: 1   FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIK-----KIANAFDNRIDAKRTLREI 55

Query: 204 --LTKIDHPFVVQLK--------YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFR----- 248
             L  +DH  V+ +K         +F   Y +Y ++D          L  H + R     
Sbjct: 56  KLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT--------DL--HQIIRSSQTL 105

Query: 249 -EDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN 307
            +D  + +  +++  + ++H+  ++HRDLKP N+LL A+  + + DFGLA+    + + +
Sbjct: 106 SDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGD 163

Query: 308 SM---IGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
            M   + T  Y APE++L    +  A D WSVG +  E+L  KP F G
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.7 bits (191), Expect = 8e-16
 Identities = 64/261 (24%), Positives = 125/261 (47%), Gaps = 21/261 (8%)

Query: 151 DFEVLKVVGQGAFGRVYQVR-KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-D 208
           D +   V+G+G FG+V + R KK+   + A     K+   + +H ++   E ++L K+  
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-AGELEVLCKLGH 66

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI-------------- 254
           HP ++ L  + + +  LYL +++   G+L   L    +   D A                
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 255 --YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
             +AA++   + +L     +HRDL   NIL+G +    + DFGL++  +   +       
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 186

Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPA 370
           V +MA E +    +   +D WS G+LL+E+++ G  P+ G   A++ +K+ +  +L  P 
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 246

Query: 371 FLSSEAHSLLKGLLQKEPGKR 391
               E + L++   +++P +R
Sbjct: 247 NCDDEVYDLMRQCWREKPYER 267

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 64/263 (24%), Positives = 129/263 (49%), Gaps = 23/263 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQVR-KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI- 207
           ED +   V+G+G FG+V +   KK+  ++ A   M K+   E +H ++   E ++L K+ 
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDF-AGELEVLCKLG 60

Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-------------HHG----LFRED 250
            HP ++ L  + + +  LY+ +++   G+L   L               HG    L  + 
Sbjct: 61  HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 251 LARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI 310
           L + +A+++ + + +L     +HRDL   N+L+G +    + DFGL++  +   +     
Sbjct: 121 LLQ-FASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGR 179

Query: 311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRL 368
             V +MA E +    +   +D WS G+LL+E+++ G  P+ G   A++ +K+ +  ++  
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK 239

Query: 369 PAFLSSEAHSLLKGLLQKEPGKR 391
           P     E + L++   +  P +R
Sbjct: 240 PRNCDDEVYELMRQCWRDRPYER 262

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 64/269 (23%), Positives = 122/269 (45%), Gaps = 31/269 (11%)

Query: 151 DFEVLKVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT 205
           D  + + +G+GAFG+V     Y +       + A+K ++   +  +      + E ++LT
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD---FQREAELLT 62

Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-----------------LFR 248
            + H  +V+          L +V +++  G L   L  HG                 L  
Sbjct: 63  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 249 EDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTR 305
             +  I A++I S + +L +   +HRDL   N L+GA+  V + DFG+++     D    
Sbjct: 123 SQMLHI-ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181

Query: 306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD 364
               +  + +M PE ++ +     +D WS G++L+E+ T GK P+   +  ++ + I + 
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241

Query: 365 K-LRLPAFLSSEAHSLLKGLLQKEPGKRL 392
           + L  P     E + ++ G  Q+EP +RL
Sbjct: 242 RVLERPRVCPKEVYDIMLGCWQREPQQRL 270

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 64/238 (26%), Positives = 111/238 (46%), Gaps = 33/238 (13%)

Query: 151 DFEVLKVVGQGAFGRVYQ----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +F+ +KV+G GAFG VY+       +      A+K +R +    K + E +  E  ++  
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILD-EAYVMAS 65

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLF----REDLARI-------Y 255
           +D+P V +L           L +   +   L  QL   G      RE    I       +
Sbjct: 66  VDNPHVCRL-----------LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 114

Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---T 312
             +I   +++L    ++HRDL   N+L+    HV +TDFGLAK    + +     G    
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
           +++MA E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 231

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 55/221 (24%), Positives = 106/221 (47%), Gaps = 14/221 (6%)

Query: 158 VGQGAFGRVYQ--VRKKNTSEI-YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           +G G FG V +     K+  E+  A+K ++++ I      E+++ E  ++ ++DHP +V+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA-GKKEFLR-EASVMAQLDHPCIVR 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L    + +  L LV++    G L   L           +  A ++   +++L +   +HR
Sbjct: 61  LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119

Query: 275 DLKPENILLGADGHVMLTDFGLAK--QFDENTRSNSMIGT--VEYMAPE-IVLGKGHNKA 329
           DL   N+LL       ++DFG+++      +    +  G   +++ APE I  GK  +K 
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK- 178

Query: 330 ADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
           +D WS G+ L+E  + G  P+     A++   +   + RLP
Sbjct: 179 SDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-RLP 218

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 58/243 (23%), Positives = 121/243 (49%), Gaps = 14/243 (5%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G FG V+  R +  +   A+K  R + +     A++++  R IL +  HP +V+L  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEAR-ILKQYSHPNIVRLIG 60

Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRD 275
               K  +Y+V++ + GG     L   G  L  ++L ++      + + +L +   +HRD
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM-VENAAAGMEYLESKHCIHRD 119

Query: 276 LKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG-----TVEYMAPEIVLGKGHNKAA 330
           L   N L+     + ++DFG++++ ++   +++  G      V++ APE +    ++  +
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYAST--GGMKQIPVKWTAPEALNYGRYSSES 177

Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D WS GILL+E  + G  P+   +  + ++ I +  +L  P       + L++   + +P
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237

Query: 389 GKR 391
           G+R
Sbjct: 238 GQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 29/206 (14%)

Query: 158 VGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV 213
           +G+G FG+V    Y     NT E  A+K ++ +     NH   +K E +IL  + H  +V
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 69

Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLAR-----------IYAAEIVSA 262
                   KY+     D  NG  L  +    G  +E L R            YA +I   
Sbjct: 70  --------KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKG 121

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEYMAP 318
           + +L +   +HRDL   N+L+ ++  V + DFGL K  + +    T  + +   V + AP
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181

Query: 319 EIVLGKGHNKAADWWSVGILLYEMLT 344
           E ++      A+D WS G+ LYE+LT
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 70/290 (24%), Positives = 121/290 (41%), Gaps = 54/290 (18%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKID 208
           D E  + +G GAFG V+ V      +  A+K M     V +N     +  R++  L    
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN---VFQNLVSCKRVFRELKMLCFFK 57

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFR---------EDLARIYAAEI 259
           H  V+      Q  +     +D     ++  +L    L +          D  +++  +I
Sbjct: 58  HDNVLSALDILQPPH-----IDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQI 112

Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK--QFDENTRSNSMIGTVEYMA 317
           +  + +LH+ GI+HRD+KP N+L+ ++  + + DFGLA+  + DE+      + T  Y A
Sbjct: 113 LRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172

Query: 318 PEIVLGKGH-NKAADWWSVGILLYEMLTGKPPF-----------------------IGGN 353
           PEI++G  H   A D WSVG +  E+L  +  F                       +   
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232

Query: 354 RAKIQQKIVKDKLRLPAF---------LSSEAHSLLKGLLQKEPGKRLGA 394
               +  I++   + P+           + EA  LL  +L  +P KR+ A
Sbjct: 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA 282

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 60/248 (24%), Positives = 125/248 (50%), Gaps = 12/248 (4%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  +++K +G G FG V+       +++ A+K +++  +      E   AE +++ ++ H
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQH 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
           P +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 61  PRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAK--QFDENTRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  + +E T        +++ APE +    
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 179

Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLC 239

Query: 384 LQKEPGKR 391
            +++P +R
Sbjct: 240 WKEKPEER 247

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 74.9 bits (184), Expect = 5e-15
 Identities = 74/259 (28%), Positives = 126/259 (48%), Gaps = 23/259 (8%)

Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTS--EIY-AMKVMRKDKIVEKNHAEYMKAERD 202
           C+ IE     KV+G G FG V   R K     EI  A+K + K    EK   +++ +E  
Sbjct: 5   CIKIE-----KVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFL-SEAS 57

Query: 203 ILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVS 261
           I+ + DHP ++ L+        + +V +++  G L  F   H G F           I S
Sbjct: 58  IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIAS 117

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYM 316
            + +L   G +HRDL   NIL+ ++    ++DFGL++  +++     T     I  + + 
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PIRWT 176

Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRLPAFLSS 374
           APE +  +    A+D WS GI+++E+++ G+ P+    N+  I  K +++  RLPA +  
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI--KAIEEGYRLPAPMDC 234

Query: 375 EA--HSLLKGLLQKEPGKR 391
            A  H L+    QK+  +R
Sbjct: 235 PAALHQLMLDCWQKDRNER 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 74.7 bits (184), Expect = 5e-15
 Identities = 67/260 (25%), Positives = 126/260 (48%), Gaps = 26/260 (10%)

Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIY---AMKVMRKDKIVEKNHAEYMKAERD 202
            V IE     KV+G G FG V + R K   +     A+K   K    +K   +++  E  
Sbjct: 5   YVTIE-----KVIGGGEFGEVCRGRLKLPGKKEIDVAIK-TLKAGSSDKQRLDFL-TEAS 57

Query: 203 ILTKIDHPFVVQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHH-GLFR-EDLARIYAAEI 259
           I+ + DHP +++L     TK R + ++ +++  G L   L  + G F    L  +    I
Sbjct: 58  IMGQFDHPNIIRL-EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM-LRGI 115

Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-----NTRSNSMIGTVE 314
            S + +L     +HRDL   NIL+ ++    ++DFGL+++ ++      T+   +   + 
Sbjct: 116 ASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIR 173

Query: 315 YMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLS 373
           + APE +  +    A+D WS GI+++E+++ G+ P+   +   + + + +D  RLP  + 
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMD 232

Query: 374 --SEAHSLLKGLLQKEPGKR 391
             S  + L+    QK+  +R
Sbjct: 233 CPSALYQLMLDCWQKDRNER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 74.9 bits (184), Expect = 5e-15
 Identities = 70/264 (26%), Positives = 130/264 (49%), Gaps = 23/264 (8%)

Query: 142 VTVCCVGIEDFEVLKVVGQGAFGRVYQVRKK--NTSEIY-AMKVMRKDKIVEKNHAEYMK 198
           + V CV IE+     V+G G FG V + R K     EI+ A+K + K    EK   +++ 
Sbjct: 1   IDVSCVKIEE-----VIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFL- 53

Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYA 256
           +E  I+ + DHP ++ L+        + ++ +F+  G L  F +  + G F         
Sbjct: 54  SEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGML 112

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGT 312
             I + + +L     +HRDL   NIL+ ++    ++DFGL++  +++    T ++S+ G 
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172

Query: 313 --VEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
             + + APE +  +    A+D WS GI+++E+++ G+ P+   +   +   I +D  RLP
Sbjct: 173 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRLP 231

Query: 370 AFL--SSEAHSLLKGLLQKEPGKR 391
             +   +  H L+    QK+   R
Sbjct: 232 PPMDCPTALHQLMLDCWQKDRNAR 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 74.6 bits (183), Expect = 7e-15
 Identities = 66/261 (25%), Positives = 121/261 (46%), Gaps = 32/261 (12%)

Query: 158 VGQGAFGRVYQVRKKNTSE-----IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           +G+GAFG+V+     N        + A+K +++     ++  +  + E ++LT + H  +
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTVLQHQHI 69

Query: 213 VQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHHG----------------LFREDLARIY 255
           V+  Y   T+ R L +V +++  G L   L  HG                L    +  I 
Sbjct: 70  VRF-YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI- 127

Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGT 312
           A++I S + +L +   +HRDL   N L+G    V + DFG+++     D        +  
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187

Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRLPA 370
           + +M PE +L +     +D WS G++L+E+ T GK P+    N   I+      +L  P 
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPR 247

Query: 371 FLSSEAHSLLKGLLQKEPGKR 391
               E +++++G  Q+EP +R
Sbjct: 248 TCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 73.6 bits (180), Expect = 1e-14
 Identities = 63/256 (24%), Positives = 124/256 (48%), Gaps = 23/256 (8%)

Query: 157 VVGQGAFGRVYQVR-KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQ 214
           V+G+G FG+V + R KK+   + A     K+   + +H ++   E ++L K+  HP ++ 
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-AGELEVLCKLGHHPNIIN 60

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLY-------------HHG----LFREDLARIYAA 257
           L  + + +  LYL +++   G+L   L               +     L  + L   +AA
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH-FAA 119

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           ++   + +L     +HRDL   NIL+G +    + DFGL++  +   +       V +MA
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 179

Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSE 375
            E +    +   +D WS G+LL+E+++ G  P+ G   A++ +K+ +  +L  P     E
Sbjct: 180 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDE 239

Query: 376 AHSLLKGLLQKEPGKR 391
            + L++   +++P +R
Sbjct: 240 VYDLMRQCWREKPYER 255

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 67/275 (24%), Positives = 131/275 (47%), Gaps = 46/275 (16%)

Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK--AERDILTKID 208
           K +G+G FG+V     ++++ +      A+K+++++     + +E     +E ++L +++
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQVN 61

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQL---------------YHHGLFREDL 251
           HP V++L  +      L L++++   G L  F +                    L   D 
Sbjct: 62  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121

Query: 252 ARI-------YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDEN 303
             +       +A +I   + +L    ++HRDL   N+L+ A+G  M ++DFGL++   E 
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVYEE 180

Query: 304 ----TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQ 358
                RS   I  V++MA E +    +   +D WS G+LL+E++T G  P+ G    ++ 
Sbjct: 181 DSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239

Query: 359 QKIVKDKLRL--PAFLSSEAHSLLKGLLQKEPGKR 391
             ++K   R+  P   S E ++L+    ++EP KR
Sbjct: 240 N-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKR 273

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 64/228 (28%), Positives = 115/228 (50%), Gaps = 13/228 (5%)

Query: 151 DFEVLKVVGQGAFGRVYQ---VRKKNTSEI-YAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + + +KV+G GAFG VY+   V +  T +I  A+K++  +    K + E+M  E  I+  
Sbjct: 8   ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL-NETTGPKANVEFMD-EALIMAS 65

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSH 265
           +DHP +V+L         + LV   +  G L   ++ H       L   +  +I   + +
Sbjct: 66  MDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMAPEIVL 322
           L    ++HRDL   N+L+ +  HV +TDFGLA+  + + +  +  G    +++MA E + 
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 323 GKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            +     +D WS G+ ++E++T G  P+ G    +I   + K + RLP
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLP 231

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 62/258 (24%), Positives = 118/258 (45%), Gaps = 28/258 (10%)

Query: 158 VGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           +G+GAFG+V     Y +  +    + A+K ++       N  +    E ++LT + H  +
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHI 69

Query: 213 VQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG--------------LFREDLARIYAAE 258
           V+          L +V +++  G L   L  HG              L +  +  I A +
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI-AQQ 128

Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEY 315
           I + + +L +   +HRDL   N L+G +  V + DFG+++     D        +  + +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 316 MAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAFLS 373
           M PE ++ +     +D WS+G++L+E+ T GK P+   +  ++ + I + + L+ P    
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCP 248

Query: 374 SEAHSLLKGLLQKEPGKR 391
            E + L+ G  Q+EP  R
Sbjct: 249 KEVYDLMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 57/226 (25%), Positives = 116/226 (51%), Gaps = 13/226 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  +++K +G G FG V+     N++++ A+K ++   +  +   E    E +++  + H
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAFLE----EANLMKTLQH 60

Query: 210 PFVVQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHL 266
             +V+L Y+  TK   +Y++ +++  G L   L      +  L ++  ++A+I   ++++
Sbjct: 61  DKLVRL-YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGK 324
                +HRDL+  N+L+       + DFGLA+  ++N  T        +++ APE +   
Sbjct: 120 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 179

Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
                +D WS GILLYE++T GK P+ G + + +    ++   R+P
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-LQRGYRMP 224

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 71.5 bits (175), Expect = 7e-14
 Identities = 64/261 (24%), Positives = 128/261 (49%), Gaps = 23/261 (8%)

Query: 152 FEVLKVVGQGAFGRVYQVRKK---NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           F + +++G+G FG V + + K    + +  A+K+++ D     +  E+++ E   + + D
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLR-EAACMKEFD 59

Query: 209 HPFVVQL---KYSFQTKYRL---YLVLDFINGG--HLFFQLYHHG-----LFREDLARIY 255
           HP V++L       + K RL    ++L F+  G  H F  +   G     L  + L R +
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR-F 118

Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGT 312
             +I S + +L +   +HRDL   N +L  +  V + DFGL+K+    D   +  +    
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178

Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPA 370
           V+++A E +    +   +D W+ G+ ++E++T G+ P+ G   ++I   ++K ++L+ P 
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238

Query: 371 FLSSEAHSLLKGLLQKEPGKR 391
               + + L+      EP  R
Sbjct: 239 DCLEDVYELMCQCWSPEPKCR 259

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 67/256 (26%), Positives = 123/256 (48%), Gaps = 28/256 (10%)

Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTKI 207
           K +G GAFG+V     Y + K +     A+K+++        H+   E + +E  I++ +
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK-----PTAHSSEREALMSELKIMSHL 95

Query: 208 -DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY---HHGLFREDLARIYAAEIVSAV 263
            +H  +V L  +      + ++ ++   G L   L       L  EDL   ++ ++   +
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS-FSYQVAKGM 154

Query: 264 SHLHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQF--DEN--TRSNSMIGTVEYMAP 318
           + L +   +HRDL   N+LL   G ++ + DFGLA+    D N   + N+ +  V++MAP
Sbjct: 155 AFLASKNCIHRDLAARNVLL-THGKIVKICDFGLARDIMNDSNYVVKGNARL-PVKWMAP 212

Query: 319 EIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL--PAFLSSE 375
           E +    +   +D WS GILL+E+ + G  P+ G        K++K+  R+  P    +E
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE 272

Query: 376 AHSLLKGLLQKEPGKR 391
            + ++K     +P KR
Sbjct: 273 IYDIMKTCWDADPLKR 288

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 33/234 (14%)

Query: 155 LKVVGQGAFGRVYQ----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           +KV+G GAFG VY+       +N     A+KV+R++   + N  + +  E  ++  +  P
Sbjct: 12  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 69

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLF----REDLARI-------YAAEI 259
           +V +L           L +   +   L  QL  +G      RE+  RI       +  +I
Sbjct: 70  YVCRL-----------LGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI 118

Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYM 316
              +S+L    ++HRDL   N+L+ +  HV +TDFGLA+  D +       G    +++M
Sbjct: 119 AKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178

Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
           A E +L +     +D WS G+ ++E++T G  P+ G    +I   + K + RLP
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-RLP 231

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 25/223 (11%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
           +   +L+ +G GAFG VY+               A+K + +    E++ ++++  E  I+
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLM-EALIM 63

Query: 205 TKIDHPFVVQL-KYSFQTKYRLYLVLDFINGGHLFFQLYHH--------GLFREDLARIY 255
           +K +H  +V+L   SF+   R +++L+ + GG L   L  +         L  +DL    
Sbjct: 64  SKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC- 121

Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQF---DENTRSNSM 309
           A ++     +L  N  +HRD+   N LL   G      + DFG+A+         +    
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181

Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG 351
           +  +++M PE  L        D WS G+LL+E+ + G  P+ G
Sbjct: 182 MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 56/213 (26%), Positives = 108/213 (50%), Gaps = 11/213 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++ K +G G FG V+       +++ A+K M+   +      E   AE +++  + H
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 61  DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+ A     + DFGLA+  ++N  T        +++ APE +    
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179

Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKI 357
               +D WS GILL E++T G+ P+ G +  ++
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 212

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 70.4 bits (172), Expect = 6e-13
 Identities = 66/239 (27%), Positives = 104/239 (43%), Gaps = 61/239 (25%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMR------KDKIVEKNHAEYMK-- 198
           V  + F++L ++G+G FG+V +   +   E  A+K++R      +D  +E    E ++  
Sbjct: 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQA 185

Query: 199 --AERDILTKIDHPF--------VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFR 248
             A+R  L KI   F        +V  KY          +LD+I           HG F 
Sbjct: 186 DPADRFPLMKIQRYFQNETGHMCIVMPKYG-------PCLLDWI---------MKHGPFS 229

Query: 249 EDLARIYAAEIV----SAVSHLHAN-GIMHRDLKPENILLGADG---------------- 287
                 + A+I+     A+ + H    +MH DLKPENIL+                    
Sbjct: 230 HR----HLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285

Query: 288 HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGK 346
            V + D G     DE     +++ T  Y +PE+VLG G   + D WS+G ++YE+ TGK
Sbjct: 286 RVRICDLGGC--CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 56/205 (27%), Positives = 106/205 (51%), Gaps = 21/205 (10%)

Query: 158 VGQGAFG----RVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV 213
           +G G FG     VY++RKK      A+KV++ +   EK+  + M  E +I+ ++D+P++V
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQID--VAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIV 58

Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS----HLHAN 269
           ++    + +  L LV++  +GG L   L      ++++      E++  VS    +L   
Sbjct: 59  RMIGVCEAE-ALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGK 114

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGT--VEYMAPEIVLGKG 325
             +HRDL   N+LL    +  ++DFGL+K    D++       G   +++ APE +  + 
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 326 HNKAADWWSVGILLYEMLT-GKPPF 349
            +  +D WS GI ++E  + G+ P+
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 55/269 (20%), Positives = 123/269 (45%), Gaps = 40/269 (14%)

Query: 155 LKVVGQGAFGRVYQ----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           ++ +G+ AFG++Y+    +   + +++ A+K ++   I         + E  ++ ++ HP
Sbjct: 10  MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAELHHP 67

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGG--HLFFQL--------------------YHHGLFR 248
            +V L      +  + ++ +++N G  H F  +                      HG F 
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 249 EDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----T 304
                  A +I + + +L ++  +H+DL   NIL+G   HV ++D GL+++         
Sbjct: 128 H-----IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182

Query: 305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK 363
           +  S++  + +M PE ++    +  +D WS G++L+E+ + G  P+ G +  ++ + + K
Sbjct: 183 QPKSLL-PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241

Query: 364 DK-LRLPAFLSSEAHSLLKGLLQKEPGKR 391
            + L          +SL+    Q+ P +R
Sbjct: 242 RQLLPCSEDCPPRMYSLMTECWQEGPSRR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 54/230 (23%), Positives = 108/230 (46%), Gaps = 31/230 (13%)

Query: 149 IEDFEVLKVVGQGAFGRVY-----QVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI 203
           +     L+ +G+GAFG+VY        ++ ++   A+K ++++    K   E+ + E ++
Sbjct: 4   LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-KVQQEF-RQEAEL 61

Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLF-FQLYH----------------HGL 246
           ++ + HP +V L      +    ++ +++  G L  F + +                  L
Sbjct: 62  MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121

Query: 247 FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--- 303
              D   I A +I + + +L ++  +HRDL   N L+G    V ++DFGL++        
Sbjct: 122 DCSDFLHI-AIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180

Query: 304 -TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG 351
             +S S++  V +M PE +L       +D WS G++L+E+ + G  P+ G
Sbjct: 181 RVQSKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG 229

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 61/240 (25%), Positives = 115/240 (47%), Gaps = 26/240 (10%)

Query: 158 VGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV 213
           +G G FG V    Y+++K  + +  A+K+++ D        E ++ E +++ ++D+P++V
Sbjct: 3   LGSGNFGTVKKGMYKMKK--SEKTVAVKILKNDNNDPALKDELLR-EANVMQQLDNPYIV 59

Query: 214 QLKYSFQTKYRLYLVLDFINGG--HLFFQLYHHGLFREDLARIYAAEIVSAVS----HLH 267
           ++    + +    LV++    G  + F Q   H      +      E+V  VS    +L 
Sbjct: 60  RMIGICEAE-SWMLVMELAELGPLNKFLQKNKH------VTEKNITELVHQVSMGMKYLE 112

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGT--VEYMAPEIVLG 323
               +HRDL   N+LL    +  ++DFGL+K    DEN       G   V++ APE +  
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172

Query: 324 KGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHSLLK 381
              +  +D WS G+L++E  + G+ P+ G    ++ Q I   +++  P     E + L+K
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMK 232

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 66/277 (23%), Positives = 120/277 (43%), Gaps = 36/277 (12%)

Query: 151 DFEVLKVVGQGAFGRVYQVRK-----KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT 205
           + E ++ +GQGAFGRV+Q R           + A+K M K++      A++ + E  ++ 
Sbjct: 6   NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALMA 63

Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH------HGLFREDL-ARIY--- 255
           + DHP +V+L         + L+ +++  G L   L H        L      AR     
Sbjct: 64  EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123

Query: 256 ------------AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--- 300
                       A ++ + +++L     +HRDL   N L+G +  V + DFGL++     
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183

Query: 301 DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQ 359
           D    S +    + +M PE +    +   +D W+ G++L+E+ + G  P+ G    ++  
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV-I 242

Query: 360 KIVKDK--LRLPAFLSSEAHSLLKGLLQKEPGKRLGA 394
             V+D   L  P     E ++L++    K P  R   
Sbjct: 243 YYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSF 279

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases

 Score = 60.8 bits (148), Expect = 5e-12
 Identities = 21/62 (33%), Positives = 33/62 (53%), Gaps = 3/62 (4%)

Query: 411 INWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP---KNNTNPFADFSY 467
           I+W KLE +EI+P F P++      +NF+ ++T+     +P  +P        PF  FSY
Sbjct: 3   IDWDKLENKEIEPPFVPKIKSPTDTSNFDPEFTEETPVLTPVDSPLSGGIQQEPFRGFSY 62

Query: 468 VR 469
           V 
Sbjct: 63  VF 64

Length = 64

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 68/274 (24%), Positives = 130/274 (47%), Gaps = 39/274 (14%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
           +   + K +G+GAFG+V +     +   N +   A+K M KD   EK+ ++ + +E +++
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVK-MLKDDATEKDLSDLV-SEMEMM 69

Query: 205 TKI-DHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FF-------QLYHHGLFREDLARI 254
             I  H  ++ L      +  LY+V+++   G+L  F        +       R     +
Sbjct: 70  KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129

Query: 255 YAAEIVS-------AVSHLHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDEN--- 303
              ++VS        +  L +   +HRDL   N+L+  + HVM + DFGLA+        
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT-EDHVMKIADFGLARDIHHIDYY 188

Query: 304 -TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQ-- 359
              +N  +  V++MAPE +  + +   +D WS G+LL+E+ T G  P+ G     +++  
Sbjct: 189 RKTTNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG---IPVEELF 244

Query: 360 KIVKDKLRL--PAFLSSEAHSLLKGLLQKEPGKR 391
           K++K+  R+  P   + E + L++    + P +R
Sbjct: 245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQR 278

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 65.0 bits (158), Expect = 9e-12
 Identities = 62/249 (24%), Positives = 125/249 (50%), Gaps = 18/249 (7%)

Query: 156 KVVGQGAFGRVYQ--VRKKNTSEI-YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           KV+G G FG V++  ++     E+  A+K + K    EK   +++ +E  I+ +  H  +
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQDFL-SEASIMGQFSHHNI 68

Query: 213 VQLKYSFQTKYR-LYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLHANG 270
           ++L+    TK++   ++ +++  G L  +   H G F           I + + +L    
Sbjct: 69  IRLE-GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127

Query: 271 IMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYMAPEIVLGKG 325
            +HRDL   NIL+ ++    ++DFGL++  +++     T S   I  + + APE +  + 
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI-PIRWTAPEAIAYRK 186

Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLS--SEAHSLLKG 382
              A+D WS GI+++E+++ G+ P+   +  ++  K + D  RLPA +   S  + L+  
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-MKAINDGFRLPAPMDCPSAVYQLMLQ 245

Query: 383 LLQKEPGKR 391
             Q++  +R
Sbjct: 246 CWQQDRARR 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 46/157 (29%), Positives = 80/157 (50%), Gaps = 7/157 (4%)

Query: 241 LYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF 300
           L+   L  EDL   Y+ ++   +  L +   +HRDL   NILL  +  V + DFGLA+  
Sbjct: 166 LWKSPLTMEDLI-CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224

Query: 301 DEN---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAK 356
            ++    R  S    +++MAPE +  K +   +D WS G+LL+E+ + G  P+ G    +
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284

Query: 357 IQQKIVKD--KLRLPAFLSSEAHSLLKGLLQKEPGKR 391
              + +KD  ++R P   + E + ++    Q +P +R
Sbjct: 285 EFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 7/98 (7%)

Query: 250 DLARIYAA--EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN 307
            LA++ A   +++SA+ ++H  GI+HRD+K EN+L+     + L DFG A  F   + S 
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWST 316

Query: 308 ----SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYE 341
                + GTV+  APE++ G  +  + D WS G++++E
Sbjct: 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 13/160 (8%)

Query: 241 LYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF 300
           LY   L  EDL   Y+ ++   +  L +   +HRDL   NILL  +  V + DFGLA+  
Sbjct: 171 LYKKVLTLEDLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229

Query: 301 DEN---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAK 356
            ++    R       +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    K
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VK 286

Query: 357 IQQKIVK-----DKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           I ++  +      ++R P + + E +  +      EP +R
Sbjct: 287 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 326

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 49/151 (32%), Positives = 81/151 (53%), Gaps = 11/151 (7%)

Query: 249 EDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQF--DEN-- 303
           +DL R +++++   +  L +   +HRD+   N+LL  DG V  + DFGLA+    D N  
Sbjct: 212 DDLLR-FSSQVAQGMDFLASKNCIHRDVAARNVLL-TDGRVAKICDFGLARDIMNDSNYV 269

Query: 304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIV 362
            + N+ +  V++MAPE +    +   +D WS GILL+E+ + GK P+ G        K+V
Sbjct: 270 VKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV 328

Query: 363 KD--KLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           K   ++  P F   E +S++K     EP +R
Sbjct: 329 KRGYQMSRPDFAPPEIYSIMKMCWNLEPTER 359

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 60/263 (22%), Positives = 111/263 (42%), Gaps = 35/263 (13%)

Query: 156 KVVGQGAFGRVYQVRKK---NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           K++G+G FG V + +      +    A+K M+ D        E++  E   +   DHP V
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLS-EAACMKDFDHPNV 63

Query: 213 VQL-KYSFQTKYRLYL-----VLDFINGGHLFFQLYHHGLFREDLARI-----------Y 255
           ++L    F+      +     +L F+  G L     H  L    L  +           +
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDL-----HSFLLYSRLGGLPEKLPLQTLLKF 118

Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-----FDENTRSNSMI 310
             +I   + +L     +HRDL   N +L  D  V + DFGL+K+     +    R   M 
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM- 177

Query: 311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRL 368
             V+++A E +  + +   +D W+ G+ ++E+ T G+ P+ G    +I   +   ++L+ 
Sbjct: 178 -PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236

Query: 369 PAFLSSEAHSLLKGLLQKEPGKR 391
           P     E + L+    + +P  R
Sbjct: 237 PEDCLDELYDLMYSCWRADPKDR 259

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 55/233 (23%), Positives = 105/233 (45%), Gaps = 19/233 (8%)

Query: 155 LKVVGQGAFGRVYQVRKKNTSE-----IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +  +G+G FG V+  + K   E     +  +K ++K K  ++N     + E D+  K+ H
Sbjct: 10  ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSH 67

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAV---- 263
             VV+L    +     Y++L++ + G L  F +       +     +   + V+      
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 264 ---SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAP 318
               HL     +HRDL   N L+ +   V ++   L+K     E  +  + +  + ++AP
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 319 EIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPA 370
           E V     +  +D WS G+L++E+ T G+ PF G +  ++  ++   KL LP 
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 7/158 (4%)

Query: 240 QLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ 299
           +LY   L  EDL   Y+ ++   +  L +   +HRDL   NILL  +  V + DFGLA+ 
Sbjct: 164 ELYKEPLTLEDLIS-YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD 222

Query: 300 FDEN---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRA 355
             ++    R       +++MAPE +  K +   +D WS G+LL+E+ + G  P+ G    
Sbjct: 223 IYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID 282

Query: 356 KIQQKIVKD--KLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           +   + +K+  ++R P + + E +S++       P  R
Sbjct: 283 EEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR 320

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 63/265 (23%), Positives = 120/265 (45%), Gaps = 31/265 (11%)

Query: 156 KVVGQGAFGRVYQVR-------KKNTSEIYAMKVMRKDK--------IVEKNHAEYMKAE 200
           K +G+G FG+V           K N     A+K+++ D         I E    + +   
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 201 RDILTKI-----DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH---HGLFREDLA 252
           ++I+  +     D P  V ++Y+ +   R YL      G    +         L  +DL 
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
              A ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ + 
Sbjct: 144 SC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+LL+E+ T G  P+ G    ++  K++K+  R+
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKLLKEGHRM 261

Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             P+  ++E + +++      P +R
Sbjct: 262 DKPSNCTNELYMMMRDCWHAVPSQR 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 63/267 (23%), Positives = 129/267 (48%), Gaps = 35/267 (13%)

Query: 156 KVVGQGAFGRVYQ-----VRKKNTSEIYAMKV-MRKDKIVEKNHAEYMKAERDILTKI-D 208
           K +G+G FG+V       + K    E   + V M KD   EK+ ++ + +E +++  I  
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 79

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL---------YHHGLFREDLARIYAAEI 259
           H  ++ L  +      LY+++++ + G+L   L         Y + + R    ++   ++
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 260 VS-------AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
           VS        + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ + 
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQ--KIVKDKL 366
              V++MAPE +  + +   +D WS G+L++E+ T G  P+ G     +++  K++K+  
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG---IPVEELFKLLKEGH 256

Query: 367 RL--PAFLSSEAHSLLKGLLQKEPGKR 391
           R+  PA  ++E + +++      P  R
Sbjct: 257 RMDKPANCTNELYMMMRDCWHAIPSHR 283

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 16/208 (7%)

Query: 155 LKVVGQGAFGRVYQ---VRKKNTSEI-YAMKVMRKDKIVEKNHA--EYMKAERDILTKID 208
           LK++G G FG V++   + + ++ +I  A+K ++     +      ++M A    +  +D
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA----MGSLD 67

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLH 267
           H ++V+L         L LV      G L   +  H           +  +I   + +L 
Sbjct: 68  HAYIVRL-LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGK 324
            + ++HR+L   NILL +D  V + DFG+A      D+    +     +++MA E +L  
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIG 351
            +   +D WS G+ ++EM++ G  P+ G
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAG 214

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 56/224 (25%), Positives = 107/224 (47%), Gaps = 30/224 (13%)

Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKV-MRKDKIVEKNHAEYMKAERDILTKID- 208
           K +G+G FG+V     Y + K    +   + V M KD   +K+ A+ + +E +++  I  
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLI-SEMELMKLIGK 76

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-----------------FFQLYHHGLFREDL 251
           H  ++ L      +  LY+++++   G+L                   ++    L  +DL
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 252 ARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNS 308
               A ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++++
Sbjct: 137 VSC-AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG 351
               V++MAPE +  + +   +D WS GIL++E+ T G  P+ G
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 68/267 (25%), Positives = 124/267 (46%), Gaps = 35/267 (13%)

Query: 156 KVVGQGAFGRVYQ-----VRKKNTSEIYAMKV-MRKDKIVEKN------HAEYMK---AE 200
           K +G+G FG+V       + K   ++   + V M KD   +K+        E MK     
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 201 RDILTKI-----DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFF---QLYHHGLFREDLA 252
           ++I+  +     D P  V ++Y+ +   R YL      G    F   +L    L  +DL 
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
              A ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ + 
Sbjct: 138 SC-AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQ--KIVKDKL 366
              V++MAPE +  + +   +D WS G+LL+E+ T G  P+ G     +++  K++K+  
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG---IPVEELFKLLKEGH 253

Query: 367 RL--PAFLSSEAHSLLKGLLQKEPGKR 391
           R+  PA  + E + +++      P +R
Sbjct: 254 RMDKPANCTHELYMIMRECWHAVPSQR 280

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 63.0 bits (153), Expect = 9e-11
 Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 11/151 (7%)

Query: 249 EDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS 308
           EDL   ++ ++   +S L +   +HRDL   NILL       + DFGLA+  D    SN 
Sbjct: 214 EDLLS-FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR--DIRNDSNY 270

Query: 309 MIG-----TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIV 362
           ++       V++MAPE +    +   +D WS GILL+E+ + G  P+ G        K++
Sbjct: 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330

Query: 363 KDKLRL--PAFLSSEAHSLLKGLLQKEPGKR 391
           K+  R+  P    SE + ++K     +P KR
Sbjct: 331 KEGYRMLSPECAPSEMYDIMKSCWDADPLKR 361

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 50/224 (22%), Positives = 104/224 (46%), Gaps = 33/224 (14%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHA-----EYMKA 199
           +   +  ++ +G FGR++       +     E++   V        K+HA       +  
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV--------KDHASEIQVTLLLQ 57

Query: 200 ERDILTKIDHPFVVQ-LKYSFQTKYRLYLVLDFINGGHL--FFQ-------LYHHGLFRE 249
           E  +L  + H  ++  L    +     +++  ++N G+L  F Q            L  +
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117

Query: 250 DLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRS 306
            L  + A +I   +S+LH  G++H+D+   N ++  +  V +TD  L++     D +   
Sbjct: 118 QLVHM-AIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176

Query: 307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPF 349
           ++    V++MA E ++ K ++ A+D WS G+LL+E++T G+ P+
Sbjct: 177 DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 66/258 (25%), Positives = 120/258 (46%), Gaps = 26/258 (10%)

Query: 156 KVVGQGAFGRVY--QVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV 213
           K +G+G FG V   Q+ + ++    A+K M K  I  ++  E   +E   + + DHP V+
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 214 QL-KYSFQTKYRL-----YLVLDFINGGHLF-FQLYHH------GLFREDLARIYAAEIV 260
           +L     QT          ++L F+  G L  F LY         L  + L + +  +I 
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIA 122

Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-----FDENTRSNSMIGTVEY 315
           S + +L +   +HRDL   N +L  + +V + DFGL+K+     +    R   M   V++
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKW 180

Query: 316 MAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLS 373
           +A E +  + +   +D WS G+ ++E+ T G+ P+ G   ++I   + + ++L+ P    
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCL 240

Query: 374 SEAHSLLKGLLQKEPGKR 391
              +SL+       P  R
Sbjct: 241 DGLYSLMSSCWLLNPKDR 258

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 59.1 bits (143), Expect = 9e-10
 Identities = 58/239 (24%), Positives = 109/239 (45%), Gaps = 33/239 (13%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKN-HAEYMKAERDILTK-------I 207
             +G G FG+V         E +    M K ++V K   A     E+ +  +       +
Sbjct: 1   DEIGNGWFGKVLL------GEAHRG--MSKARVVVKELRASATPDEQLLFLQEVQPYREL 52

Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL-----YHHGLFREDLARIYAAEIVSA 262
           +HP V+Q            LVL+F   G L   L         + ++D+ +  A E+ S 
Sbjct: 53  NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA-KQFDEN--TRSNSMIGTVEYMAPE 319
           +  LH    +H DL   N  L AD  V + D+GLA +Q+ E+     +     + ++APE
Sbjct: 113 LLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPE 172

Query: 320 IVLGKGHN-------KAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLP 369
           +V  +G +       K ++ WS+G+ ++E+ T    P+   +  ++ +++V+++ ++LP
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 51/224 (22%), Positives = 94/224 (41%), Gaps = 40/224 (17%)

Query: 158 VGQGAFGRVYQVR----------------KKNTSEIYAMKVMRKDKIVEKNHAEYMKAER 201
           +G+G FG V+                   +K    + A+K++R D    KN       E 
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD--ANKNARNDFLKEV 70

Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRED----------- 250
            IL+++  P +++L      +  L ++ +++  G L   L  H L  ++           
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130

Query: 251 --LARIY------AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-- 300
              A  Y      A +I S + +L +   +HRDL   N L+G +  + + DFG+++    
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190

Query: 301 -DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEML 343
            D        +  + +MA E +L      A+D W+ G+ L+E+L
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 56/251 (22%), Positives = 113/251 (45%), Gaps = 24/251 (9%)

Query: 156 KVVGQGAFGRVYQ--VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV 213
           +++G G FG + +  ++  +  E+       +    +K    ++ AE   L + DH  +V
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFL-AEALTLGQFDHSNIV 69

Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAE-------IVSAVSHL 266
           +L+        + +V ++++ G L          R+   ++ A +       + S + +L
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGAL------DSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG--TVEYMAPEIVLGK 324
              G +H+ L    +L+ +D    ++ F   ++        +M G   V + APE +   
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRLPAFLSSEA--HSLL 380
             + A+D WS GI+++E+++ G+ P+     +  I  K V+D  RLPA  +     H L+
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI--KAVEDGFRLPAPRNCPNLLHQLM 241

Query: 381 KGLLQKEPGKR 391
               QKE G+R
Sbjct: 242 LDCWQKERGER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.0 bits (137), Expect = 9e-09
 Identities = 42/143 (29%), Positives = 66/143 (46%), Gaps = 6/143 (4%)

Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSN-SMIG 311
           +  ++   +  L +   +HRDL   N+LL     V + DFGLA+    D N  S  S   
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL-- 368
            V++MAPE +    +   +D WS GILL+E+ + G  P+ G          +K   R+  
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK 361

Query: 369 PAFLSSEAHSLLKGLLQKEPGKR 391
           P   + E + ++      EP KR
Sbjct: 362 PDHATQEVYDIMVKCWNSEPEKR 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 56.5 bits (136), Expect = 9e-09
 Identities = 67/309 (21%), Positives = 124/309 (40%), Gaps = 73/309 (23%)

Query: 166 VYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL 225
           VY  R   T  +  +++   +   E+ H + ++ E  +     HP ++     F T   L
Sbjct: 16  VYLARHTPTGTLVTVRITDLENCTEE-HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74

Query: 226 YLVLDFINGG---HLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENIL 282
           +++  F+  G    L    +  G+  E L        +  +++LH NG +HR++K  +IL
Sbjct: 75  WVISPFMAYGSANSLLKTYFPEGM-SEALIGNILFGALRGLNYLHQNGYIHRNIKASHIL 133

Query: 283 LGADGHVMLTD----FGLAKQ-------FDENTRSNSMIGTVEYMAPEIVLGK--GHNKA 329
           +  DG V L+     + L +        +D    S S++    +++PE++     G+N  
Sbjct: 134 ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVL---PWLSPELLRQDLYGYNVK 190

Query: 330 ADWWSVGILLYEMLTGKPPFI---------------------------GGNRAK------ 356
           +D +SVGI   E+ TG+ PF                              +R K      
Sbjct: 191 SDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGV 250

Query: 357 ------------IQQKIVKDKLRLPA--FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEI 402
                       + Q +  ++LR P+    S    +L++  LQ++P KR  A       +
Sbjct: 251 DSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSAS-----SL 305

Query: 403 KSHKWFKPI 411
            SH +FK +
Sbjct: 306 LSHAFFKQV 314

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 35/218 (16%)

Query: 158 VGQGAFGRVYQVRKKNTSE--------------IYAMKVMRKDKIVEKNHAEYMKAERDI 203
           +G+G FG V+    +  +E              + A+K++R D  V K        E  I
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKI 70

Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLF-------------RED 250
           ++++ +P +++L     +   L ++ +++  G L   L    +                +
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 251 LARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSN 307
           L  + A +I S + +L +   +HRDL   N L+G    + + DFG+++     D      
Sbjct: 131 LLYM-AVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 308 SMIGTVEYMAPE-IVLGKGHNKAADWWSVGILLYEMLT 344
             +  + +MA E I+LGK    A+D W+ G+ L+EM T
Sbjct: 190 RAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 15/206 (7%)

Query: 156 KVVGQGAFGRVYQ--VRKKNTSEIY-AMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           +V+G+G FG VY   +   +  +I+ A+K +  ++I +    E    E  I+    HP V
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNV 58

Query: 213 VQL-KYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           + L      ++    +VL ++  G L  F +   H    +DL   +  ++   + +L + 
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG-FGLQVAKGMEYLASK 117

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLA-----KQFDENTRSNSMIGTVEYMAPEIVLGK 324
             +HRDL   N +L     V + DFGLA     K++            V++MA E +  +
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 325 GHNKAADWWSVGILLYEMLT-GKPPF 349
                +D WS G+LL+E++T G PP+
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 63/278 (22%), Positives = 109/278 (39%), Gaps = 54/278 (19%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMR-----KDKIVEKNHAEYMKA 199
           E   +L+ +GQG+FG VY+     + K       A+K +      +++I   N A  MK 
Sbjct: 6   EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 65

Query: 200 ERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----- 254
                            ++     RL  V+       +  +L  HG  +  L  +     
Sbjct: 66  -----------------FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAE 108

Query: 255 ---------------YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ 299
                           AAEI   +++L+A   +HRDL   N ++  D  V + DFG+ + 
Sbjct: 109 NNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 168

Query: 300 FDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRA 355
             E     +    +  V +MAPE +       ++D WS G++L+E+ +  + P+ G +  
Sbjct: 169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228

Query: 356 KIQQKIVKD--KLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           ++  K V D   L  P         L++   Q  P  R
Sbjct: 229 QV-LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMR 265

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 52/224 (23%), Positives = 99/224 (44%), Gaps = 21/224 (9%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAER 201
           V  E   + + +GQG+FG VY+     V K       A+K + +   + +   E++  E 
Sbjct: 3   VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-RERIEFLN-EA 60

Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY--------HHGLFREDLAR 253
            ++ + +   VV+L           ++++ +  G L   L         +       L +
Sbjct: 61  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 254 I--YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT---RSNS 308
           +   A EI   +++L+AN  +HRDL   N ++  D  V + DFG+ +   E     +   
Sbjct: 121 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG 351
            +  V +M+PE +        +D WS G++L+E+ T  + P+ G
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 224

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 46/215 (21%), Positives = 95/215 (44%), Gaps = 23/215 (10%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT--KID 208
              + K         + + +  NT     +  ++K  +   +  +    +++I+T  ++ 
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNT-----LVAVKKINLDSCSKEDLKLLQQEIITSRQLQ 57

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGH---LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
           HP ++    SF     LY+V   +  G    L    +  G   E        ++++A+ +
Sbjct: 58  HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDY 116

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN--------SMIGTVEYMA 317
           +H+ G +HR +K  +ILL  DG V+L+    +    ++ +          S +  + +++
Sbjct: 117 IHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176

Query: 318 PEIVLGK---GHNKAADWWSVGILLYEMLTGKPPF 349
           PE VL +   G+N+ +D +SVGI   E+  G  PF
Sbjct: 177 PE-VLQQNLQGYNEKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 53/235 (22%), Positives = 101/235 (42%), Gaps = 30/235 (12%)

Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID------HPF 211
           +G G FG+V        SEIY    + +  + E       K + + L + D      HP 
Sbjct: 3   IGNGWFGKVL------LSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPN 56

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRED-----LARIYAAEIVSAVSHL 266
           ++Q            LV ++   G L   L      R +     L R+ A EI + V+H+
Sbjct: 57  ILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM-ACEIAAGVTHM 115

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLA-KQFDEN--TRSNSMIGTVEYMAPEIV-- 321
           H +  +H DL   N  L +D  V + D+G+   ++ E+     +     + ++APE+V  
Sbjct: 116 HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 322 -----LGKGHNKAADWWSVGILLYEML-TGKPPFIGGNRAKIQQKIVKDK-LRLP 369
                +     K ++ W++G+ L+E+      P+   +  ++   ++KD+ ++L 
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF 230

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 4/99 (4%)

Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSN-SMIG 311
           ++ ++ + +  L +   +HRDL   N+L+     V + DFGLA+    D N  S  S   
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPF 349
            +++MAPE +    +   +D WS GILL+E+ T G  P+
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 29/77 (37%), Positives = 43/77 (55%), Gaps = 8/77 (10%)

Query: 273 HRDLKPENILLGADGHVMLTDFG-LAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           HR  K  NILL  DG + L   G +A +  E +R +       +MAPE++ G+ + + AD
Sbjct: 34  HRQAKSGNILLTWDGLLKL--DGSVAFKTPEQSRPDPY-----FMAPEVIQGQSYTEKAD 86

Query: 332 WWSVGILLYEMLTGKPP 348
            +S+GI LYE L  + P
Sbjct: 87  IYSLGITLYEALDYELP 103

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 36/126 (28%), Positives = 63/126 (50%), Gaps = 12/126 (9%)

Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSMIGT 312
           A EI   + HLH N  +H DL   N LL AD  V + D+GL+    + D     + +   
Sbjct: 106 ACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVP 165

Query: 313 VEYMAPEIV-------LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD 364
           + ++APE+V       L     K ++ WS+G+ ++E+   G  P+   +  ++    V++
Sbjct: 166 LRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE 225

Query: 365 -KLRLP 369
            +L+LP
Sbjct: 226 QQLKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 38/220 (17%)

Query: 158 VGQGAFGRVYQVR----------------KKNTSEIYAMKVMRKDKIVEKN-HAEYMKAE 200
           +G+G FG V+                     N   + A+K++R+D    KN   +++K E
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--ANKNARNDFLK-E 69

Query: 201 RDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLA-------- 252
             I++++  P +++L     T   L ++ +++  G L   L  H   +E           
Sbjct: 70  IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHE-PQEAAEKADVVTIS 128

Query: 253 ----RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTR 305
                  A +I S + +L +   +HRDL   N L+G +  + + DFG+++     D    
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 306 SNSMIGTVEYMAPE-IVLGKGHNKAADWWSVGILLYEMLT 344
               +  + +M+ E I+LGK    A+D W+ G+ L+E+LT
Sbjct: 189 QGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 24/64 (37%), Positives = 37/64 (57%), Gaps = 2/64 (3%)

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE--Y 315
           ++++ +  LH  GI+HRD+KPEN+L+  DG V + DFG A         N + G ++  Y
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376

Query: 316 MAPE 319
             PE
Sbjct: 377 SPPE 380

Length = 507

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 51/230 (22%), Positives = 100/230 (43%), Gaps = 36/230 (15%)

Query: 153 EVLKVVGQGAFGRVYQVRKKNTSEI----------------YAMKVMRKDKIVEKNHAEY 196
             ++ +G+G FG V+        +                  A+KV+R D   +    ++
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDF 66

Query: 197 MKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLAR--- 253
           +K E  IL+++  P + +L         L ++++++  G L   L  H      LA    
Sbjct: 67  LK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 254 -------IY-AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-- 303
                  +Y A +I S + +L +   +HRDL   N L+G +  + + DFG+++    +  
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185

Query: 304 --TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT--GKPPF 349
              +  + +  + +MA E VL       +D W+ G+ L+E+LT   + P+
Sbjct: 186 YRVQGRAPL-PIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 28/80 (35%), Positives = 34/80 (42%), Gaps = 8/80 (10%)

Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDL-KPENILLGA 285
           LV  +  G  L     H      D A   +A    A+  LH  GI H DL KP+N L+G 
Sbjct: 95  LVRGWTEGVPL-----HLARPHGDPAWFRSAH--RALRDLHRAGITHNDLAKPQNWLMGP 147

Query: 286 DGHVMLTDFGLAKQFDENTR 305
           DG   + DF LA  F     
Sbjct: 148 DGEAAVIDFQLASVFRRRGA 167

Length = 365

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 37/222 (16%)

Query: 153 EVLKVVGQG--AFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           E+L V+G+G      V   R K T E   ++ +  +         +++ E  +    +HP
Sbjct: 1   ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA-CTNEMVTFLQGELHVSKLFNHP 59

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGH---LFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            +V  + +F     L++V  F+  G    L    +  G+    +A I    ++ A+ ++H
Sbjct: 60  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQG-VLKALDYIH 118

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN-SMIG--------------- 311
             G +HR +K  +IL+  DG V L+  GL        RSN SMI                
Sbjct: 119 HMGYVHRSVKASHILISVDGKVYLS--GL--------RSNLSMINHGQRLRVVHDFPKYS 168

Query: 312 --TVEYMAPEIVLG--KGHNKAADWWSVGILLYEMLTGKPPF 349
              + +++PE++    +G++  +D +SVGI   E+  G  PF
Sbjct: 169 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 47.6 bits (114), Expect = 1e-05
 Identities = 42/193 (21%), Positives = 81/193 (41%), Gaps = 36/193 (18%)

Query: 127 EIDESSIDENVKGDSVTVCCVGIEDFEVLKV----VGQGAFGRVY--------QVRKKNT 174
           +I+++ ++ N + D V V  +  E+ +  K+    +G+GA   +          V K+  
Sbjct: 306 DIEDTRVNPNFRTDEVEVTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERV 365

Query: 175 SEIYAMKVMRKDKIVEKNHAEYMKAERDILTK-----IDHPFVVQLKYSFQTKYRLYLVL 229
            + Y     R  ++ E+   E  +AE  +L++     +  P +    Y         +V+
Sbjct: 366 PKGY-----RHPELDERLRTERTRAEARLLSEARRAGVPTPVI----YDV-DPEEKTIVM 415

Query: 230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHV 289
           ++I G  L        +   +   +   ++   V+ LH  GI+H DL   N ++  D  +
Sbjct: 416 EYIGGKDL------KDVLEGNPELVR--KVGEIVAKLHKAGIVHGDLTTSNFIVR-DDRL 466

Query: 290 MLTDFGLAKQFDE 302
            L DFGL K  D 
Sbjct: 467 YLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain

 Score = 42.2 bits (100), Expect = 1e-05
 Identities = 13/46 (28%), Positives = 20/46 (43%), Gaps = 3/46 (6%)

Query: 428 EVAGKHCIANFEKKWTDMPLSDSPAATP---KNNTNPFADFSYVRP 470
           +V      +NF+ ++T  P   SP  +      +   F  FSYV P
Sbjct: 1   KVKSPTDTSNFDPEFTSEPPKLSPPDSEVLSSIDQLEFRGFSYVNP 46

Length = 47

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 49/220 (22%), Positives = 100/220 (45%), Gaps = 29/220 (13%)

Query: 158 VGQGAFGRVYQVRKKNT-----SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           +G+  FG+VY+     T     ++  A+K + KDK  E    E  K E  + +++ HP +
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDK-AEGPLREEFKHEAMMRSRLQHPNI 70

Query: 213 VQLKYSFQTKYRLYLVLDFINGG--HLFFQLY--HHGLFREDLARIY------------A 256
           V L      +  L ++  + +    H F  +   H  +   D  +               
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE----NTRSNSMIGT 312
            +I + +  L ++ ++H+DL   N+L+    +V ++D GL ++           NS++  
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL-P 189

Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG 351
           + +M+PE ++    +  +D WS G++L+E+ + G  P+ G
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 27/200 (13%)

Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRK-DKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           V+ +G  G  Y+ +       + +K +   + I     A+          K+ HP +V+L
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADM--------GKLQHPNIVKL 748

Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN---GIM 272
               +++   YL+ ++I G +L   L    L  E   +I A  I  A+  LH      ++
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVL--RNLSWERRRKI-AIGIAKALRFLHCRCSPAVV 805

Query: 273 HRDLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +L PE I++  DG    H+ L+  GL               +  Y+APE    K   +
Sbjct: 806 VGNLSPEKIII--DGKDEPHLRLSLPGLL------CTDTKCFISSAYVAPETRETKDITE 857

Query: 329 AADWWSVGILLYEMLTGKPP 348
            +D +  G++L E+LTGK P
Sbjct: 858 KSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 37/155 (23%), Positives = 57/155 (36%), Gaps = 27/155 (17%)

Query: 155 LKVVGQGAFGRVYQVRKKNTSEIY---AMKVMRKDKIVEKNHAEYMKAERDILTK----- 206
           + ++ QGA   +Y         +      K  R  ++ EK   E  + E  IL K     
Sbjct: 1   MDLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAG 60

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI---YAAEIVSAV 263
           +  P V    Y         +V+++I G           L ++ L         E+   V
Sbjct: 61  VPVPIV----YDVDP-DNGLIVMEYIEGE----------LLKDALEEARPDLLREVGRLV 105

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK 298
             LH  GI+H DL   NI+L     +   DFGL +
Sbjct: 106 GKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139

Length = 204

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 34/148 (22%), Positives = 61/148 (41%), Gaps = 19/148 (12%)

Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH----- 209
           +K++  G   RVY +  K+    Y +K+               + E  IL  +       
Sbjct: 3   IKLLKGGLTNRVYLLGTKDED--YVLKINPSR-----EKGADREREVAILQLLARKGLPV 55

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P V+    S ++    YL++++I G  L          +ED+A   A E+++ +  L   
Sbjct: 56  PKVL---ASGESDGWSYLLMEWIEGETLDEV---SEEEKEDIAEQLA-ELLAKLHQLPLL 108

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLA 297
            + H DL P NIL+     + + D+  A
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 43.7 bits (104), Expect = 5e-05
 Identities = 21/48 (43%), Positives = 25/48 (52%), Gaps = 1/48 (2%)

Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE 302
              EI   V  LH  GI+H DL   NI++  D  + L DFGL K  DE
Sbjct: 95  LLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDK-LYLIDFGLGKYSDE 141

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 44/188 (23%), Positives = 80/188 (42%), Gaps = 46/188 (24%)

Query: 149 IEDFEVLKVVGQGAFGRVYQV----RKKNTSEIYAMKVMRKDKIVE------------KN 192
            +DF + K +G+GAFG VY+     ++      Y +K   +   VE             +
Sbjct: 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNS 190

Query: 193 HAEYMKAERD-ILTKIDHPFVVQLKYS--------FQTKYRLYLVLDFINGGHLFFQLYH 243
            A+++    + + +K +  + +  +Y          Q+K   Y V  ++ G     Q   
Sbjct: 191 CADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGK---VQDLP 247

Query: 244 HGLFRED-LARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE 302
            GL RE+ + +    +I+ A+  LH+ GI+HRD+KP+NI+                 F E
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII-----------------FSE 290

Query: 303 NTRSNSMI 310
            + S  +I
Sbjct: 291 GSGSFKII 298

Length = 566

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 33/167 (19%), Positives = 73/167 (43%), Gaps = 30/167 (17%)

Query: 156 KVVGQGAFGRVYQVRKKN---------------TSEIYAMKVMRKDKIVEKNH-AEYMKA 199
           K++G G FG VY+ +  +                +E   M+ +  + I + +  A +   
Sbjct: 18  KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN- 76

Query: 200 ERDILTKIDHPFVVQL----KYSFQTKYRLYLVLD--FINGGHLFFQLYHHGLFREDLAR 253
               +  IDH  + +      +     Y  +++L+    N   +F ++       + L +
Sbjct: 77  ----IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK---CKNKKLIK 129

Query: 254 IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF 300
               ++++ + ++H +GI H D+KPENI++  +    + D+G+A  F
Sbjct: 130 NIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176

Length = 294

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 26/72 (36%), Positives = 42/72 (58%), Gaps = 5/72 (6%)

Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           +V+++I G  L   +  +G+   +L+R    EI   V  LH+ GI+H DL   N++L + 
Sbjct: 76  IVMEYIEGEPLKDLINSNGMEELELSR----EIGRLVGKLHSAGIIHGDLTTSNMIL-SG 130

Query: 287 GHVMLTDFGLAK 298
           G + L DFGLA+
Sbjct: 131 GKIYLIDFGLAE 142

Length = 211

>gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 25/115 (21%), Positives = 46/115 (40%), Gaps = 6/115 (5%)

Query: 243 HHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE 302
            +     D     A  + SA + LH +G +  D+   + L+  D  V+L D    +    
Sbjct: 110 SYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN 169

Query: 303 NTRSNSMIGTVEYMAPE-----IVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG 351
            T     +G  E+  PE       +G       D + + +L++ +L  G+ P+ G
Sbjct: 170 GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224

Length = 637

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 54/257 (21%), Positives = 118/257 (45%), Gaps = 35/257 (13%)

Query: 158 VGQGAFGRVYQ-VRK--KNTSEIYAMKVMRKDKIVEKNHAEYMKA---ERDILTKIDHPF 211
           +GQG F ++++ +R+   +  E++  +V+ K  +++K+H  Y ++      +++++ H  
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLK--VLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI-YAAEIVSAVSHLHANG 270
           +V             +V +++  G L   L  +        ++  A ++  A+  L   G
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 271 IMHRDLKPENILLGADGH--------VMLTDFG-----LAKQFDENTRSNSMIGTVEYMA 317
           + H ++  +N+LL  +          + L+D G     L K+         ++  + ++ 
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--------LLERIPWVP 172

Query: 318 PEIVLGKGH-NKAADWWSVGILLYEMLTG--KPPFIGGNRAKIQQKIVKDKLRLPAFLSS 374
           PE +    + + AAD WS G  L+E+ +G  KP     ++ K+Q    +D+ +LPA   +
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ--FYEDRHQLPAPKWT 230

Query: 375 EAHSLLKGLLQKEPGKR 391
           E  +L+   +  EP  R
Sbjct: 231 ELANLINQCMDYEPDFR 247

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	482
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.98
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
PRK10345	210	hypothetical protein; Provisional	99.85
smart00090	237	RIO RIO-like kinase.	99.84
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.62
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.57
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.52
KOG1243	690	consensus Protein kinase [General function predict	99.51
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.5
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.46
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.22
KOG3087	229	consensus Serine/threonine protein kinase [General	99.17
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.13
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.06
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.99
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.98
COG4248	637	Uncharacterized protein with protein kinase and he	98.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.85
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.82
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.72
PRK09902	216	hypothetical protein; Provisional	98.67
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.58
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.54
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.52
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.51
PF01636	239	APH: Phosphotransferase enzyme family This family	98.38
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.37
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.17
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.17
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.16
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.12
smart00133	64	S_TK_X Extension to Ser/Thr-type protein kinases.	98.12
PLN02876	822	acyl-CoA dehydrogenase	98.04
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.99
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.99
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.89
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.78
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.76
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.61
KOG2270	520	consensus Serine/threonine protein kinase involved	97.58
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.51
PRK10593	297	hypothetical protein; Provisional	97.47
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.43
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.42
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.31
PRK05231	319	homoserine kinase; Provisional	97.27
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.23
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.9
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.89
PLN02236	344	choline kinase	96.69
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.61
PLN02756	418	S-methyl-5-thioribose kinase	96.53
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.49
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.42
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.4
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.26
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.24
PF00433	48	Pkinase_C: Protein kinase C terminal domain; Inter	95.93
PRK12396	409	5-methylribose kinase; Reviewed	95.86
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.76
PTZ00384	383	choline kinase; Provisional	95.61
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.42
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.25
PRK11768	325	serine/threonine protein kinase; Provisional	94.96
COG2334	331	Putative homoserine kinase type II (protein kinase	94.75
PTZ00296	442	choline kinase; Provisional	94.74

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-77  Score=583.19  Aligned_cols=325  Identities=55%  Similarity=0.959  Sum_probs=303.5

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      ....++|+++++||+|+||+||+++.++|++.||+|+++|..+...+..+...+|..||.+++||+||+++..||+.+++
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            45679999999999999999999999999999999999999999988999999999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccc-ccCCC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~-~~~~~  304 (482)
                      |||+||+.||+|+.+|++++.|+|+.+++|+++|+.||.|||++|||||||||+|||||.+||++|+|||+|+. ...+.
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999996 45667


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CCCccCChHHHHHHHHh
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~LI~~~  383 (482)
                      .+.++|||+.|||||++.+.+|+.++||||||+++|||++|.+||.+.+..+++++|.+++. ..|..++.++++||+++
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~L  260 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKL  260 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHH
Confidence            77889999999999999999999999999999999999999999999999999999999994 45556999999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC-C-------
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT-P-------  455 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~-~-------  455 (482)
                      |++||++|++ +..++.+|++||||+++||+++.++++.|||.|.+.+..|+++||.+++.+....++... +       
T Consensus       261 L~rdp~~RLg-~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~~Fd~eft~~~~~~~~~~~~~~~~~~~~  339 (357)
T KOG0598|consen  261 LKRDPRQRLG-GPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTSNFDNEFTSYTVDYSPVDSSPDMSAFTA  339 (357)
T ss_pred             hccCHHHhcC-CCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccccccccHHHHhccccCCccccCcccccccc
Confidence            9999999998 467889999999999999999999999999999999999999999999988666555531 1       


Q ss_pred             --CCCCCCccCeeeecCC
Q 047009          456 --KNNTNPFADFSYVRPA  471 (482)
Q Consensus       456 --~~~~~~f~~f~~~~~~  471 (482)
                        ......|.+|+|+.+.
T Consensus       340 ~~~~~~~~f~gft~~~~s  357 (357)
T KOG0598|consen  340 FSRTYNKIFPGFTYVASS  357 (357)
T ss_pred             cccccccccCCccccCCC
Confidence              2345779999998763

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-72  Score=581.47  Aligned_cols=326  Identities=40%  Similarity=0.778  Sum_probs=307.9

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCC
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKY  223 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  223 (482)
                      ...++++|.++++||+|.||+|++|..+.+++.||||+++|+.+...+..+..+.|.+|+...+ ||++++|+.+|++..
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            3578899999999999999999999999999999999999999999999999999999999885 999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc-cC
Q 047009          224 RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~-~~  302 (482)
                      ++|+||||+.||++ .++++.+.|++..+++|+++++.||.|||++||||||||.+|||||.+|++||+|||+++.. ..
T Consensus       443 ~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             eEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            99999999999994 45556688999999999999999999999999999999999999999999999999999984 46


Q ss_pred             CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHH
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKG  382 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~  382 (482)
                      +..+.++||||.|||||++.+..|+.++|||||||+|||||.|..||.+.+.+++.+.|+.....+|.++|.++.+++++
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~  601 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRR  601 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHH
Confidence            77889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCC
Q 047009          383 LLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP---KNNT  459 (482)
Q Consensus       383 ~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~---~~~~  459 (482)
                      +|.+||++|+++++.++.+|+.||||+.|+|++++.|+++|||+|.+.++.+.+|||+.++.+...-++....   ..+|
T Consensus       602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~~~~~~l~~~~q  681 (694)
T KOG0694|consen  602 LLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALTPSDPRPLTEEEQ  681 (694)
T ss_pred             HhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCCCccCCCCccccchhhH
Confidence            9999999999999899999999999999999999999999999999999999999999999887766653222   4678


Q ss_pred             CCccCeeeecCC
Q 047009          460 NPFADFSYVRPA  471 (482)
Q Consensus       460 ~~f~~f~~~~~~  471 (482)
                      .+|.||+|+.|.
T Consensus       682 ~~F~~Fs~~~~~  693 (694)
T KOG0694|consen  682 EAFRDFSFVAEW  693 (694)
T ss_pred             HHhcCccccCCC
Confidence            999999999874

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-71  Score=527.17  Aligned_cols=296  Identities=45%  Similarity=0.812  Sum_probs=286.0

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ..++||++++.||.|+||+|.+++.+.+|..||+|++.++.+..-.+.+...+|..+|+.+.||+++++++.|.+.+++|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            56799999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      +||||++||.|+.++++.++|++..+++|++||+.||+|||+++|++|||||||||||.+|++||+|||+|+.+...  +
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T  198 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999997644  7


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhcc
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~  386 (482)
                      .+.||||.|+|||++..++|+.++|||||||++|||+.|.+||.+.+...++++|+.+++.+|..++.++++||+++|+.
T Consensus       199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~v  278 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQV  278 (355)
T ss_pred             EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhh
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCcc-ccCCcccccCccccccC
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP-EVAGKHCIANFEKKWTD  444 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p-~~~~~~~~~~f~~~~~~  444 (482)
                      |-.+|.+...+|.++|++||||++++|.++..|.++|||.| .+.+..++++|+..-++
T Consensus       279 D~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gdtsnfd~y~e~  337 (355)
T KOG0616|consen  279 DLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGDTSNFDDYEEE  337 (355)
T ss_pred             hhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCcccccccccccc
Confidence            99999998778999999999999999999999999999998 88999999999876544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.9e-68  Score=535.81  Aligned_cols=323  Identities=42%  Similarity=0.767  Sum_probs=286.6

Q ss_pred             ccccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          144 VCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      ....+++||++++.||+|+||.||+|+.+.||+.||||+++|......++.+.++.|.+||...++|+||+|+++|++..
T Consensus       135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE  214 (550)
T ss_pred             cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence            34568899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-
Q 047009          224 RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-  302 (482)
                      ++||||||++||++..+|.+.+.|+++.+++|+++++.|++-||+.|+|||||||+|+|||..||+||+|||||+.+.. 
T Consensus       215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999964311 


Q ss_pred             -----------------------CC------------------------CCcccccCCCCCchhhhcCCCCCchhHHHHH
Q 047009          303 -----------------------NT------------------------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSV  335 (482)
Q Consensus       303 -----------------------~~------------------------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSl  335 (482)
                                             ..                        ...+.+|||.|||||++.+++|+..+|||||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                   00                        0134689999999999999999999999999


Q ss_pred             hHHHHHHhhCCCCCCCCchHHHHHHHHhcc--cCCCc--cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          336 GILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPA--FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       336 GvilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      ||||||||.|.+||.+.++.+++.+|...+  +.+|.  .++++++|||.+||. ||.+|++.  .|++||++||||++|
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~--~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS--KGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc--ccHHHHhcCCccccC
Confidence            999999999999999999999999999876  66775  478999999999999 99999985  789999999999999


Q ss_pred             ChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC--------------CCCCCCCccCeeeecCCc
Q 047009          412 NWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT--------------PKNNTNPFADFSYVRPAA  472 (482)
Q Consensus       412 ~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~--------------~~~~~~~f~~f~~~~~~~  472 (482)
                      +|+.+..+.  |||+|.+.+..++.+|++ |.+.......+..              ....+..|-||+|.+-..
T Consensus       452 ~W~~l~~~~--apfvP~v~~~~DT~yFdd-F~e~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~FvgfTyk~~~~  523 (550)
T KOG0605|consen  452 DWDHLREMP--APFVPQVNSELDTQYFDD-FPEEDSMTPTADKSGPSRKMLSMVDTNNSSKDINFVGFTYKNFDG  523 (550)
T ss_pred             CcchhhcCC--CCCCCCCCCccccccccc-CcccccCcccccccccchhhhhcccccCCcccccccceeeecccc
Confidence            999996554  999999999999999995 4332221111110              012346799999987655

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-68  Score=510.23  Aligned_cols=331  Identities=40%  Similarity=0.764  Sum_probs=312.6

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ..+.+++|+.+++||+|.||+|.+++.+.+++.||||+++|+-+..++....-..|-++|+..+||++..|.+.|++.++
T Consensus       163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr  242 (516)
T KOG0690|consen  163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR  242 (516)
T ss_pred             ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence            34678999999999999999999999999999999999999998888888888899999999999999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccc-ccCC
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~-~~~~  303 (482)
                      +|+||||++||.|+.+|.+...|+++.+++|.++|+.||.|||+++||+||||.+|+|||.+|++||+|||+|+. +..+
T Consensus       243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999997 5677


Q ss_pred             CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHh
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~  383 (482)
                      ..+.++||||.|+|||++....|+.++|||.+||+||||++|++||+..+...++.-|+...++||..++++++.|+..+
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGL  402 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGL  402 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHH
Confidence            78889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC-------C
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP-------K  456 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~-------~  456 (482)
                      |.+||++|++.++.++.||.+|+||.+++|+.+-.+++.|||+|++.+..++..||++|+.+++.-.|+...       .
T Consensus       403 L~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~EFT~q~v~lTPP~r~~~~~~~~~  482 (516)
T KOG0690|consen  403 LKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDEEFTSQPVTLTPPDRYGSTVDEDE  482 (516)
T ss_pred             hhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhhhhhcceeEecCCCCCCcccchhh
Confidence            999999999999999999999999999999999999999999999999999999999999998876665432       1


Q ss_pred             CCCCCccCeeeecCCcccc
Q 047009          457 NNTNPFADFSYVRPAASFL  475 (482)
Q Consensus       457 ~~~~~f~~f~~~~~~~~~~  475 (482)
                      ..+..|..|+|..-.++..
T Consensus       483 e~~~~FpQFsy~~~~~s~~  501 (516)
T KOG0690|consen  483 ERRPHFPQFSYSASMGSIN  501 (516)
T ss_pred             hhccCCcceeeecchhhhh
Confidence            2367899999987666433

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-65  Score=486.55  Aligned_cols=330  Identities=36%  Similarity=0.761  Sum_probs=309.7

Q ss_pred             cccccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeec
Q 047009          143 TVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQT  221 (482)
Q Consensus       143 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  221 (482)
                      ....+++++|.++++||+|+|++|.+++++.|.+.||+|+++|+-+.+.+..++++.|..+..+- +||++|.|+.+|++
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            34457889999999999999999999999999999999999999888888999999999999876 89999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccc-c
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-F  300 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~-~  300 (482)
                      +.++++|.||++||+|..+++++.+++++.+++|..+|+.||.|||++|||+||||.+|+|+|.+|++||+|+|+++. +
T Consensus       323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999999997 6


Q ss_pred             cCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCC--------CchHHHHHHHHhcccCCCccC
Q 047009          301 DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIG--------GNRAKIQQKIVKDKLRLPAFL  372 (482)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~--------~~~~~~~~~i~~~~~~~p~~~  372 (482)
                      ..+..+.++||||.|.|||+++|..|+.++|||+|||+|+||+.|+.||.-        .+..-+++.|+..++++|..+
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl  482 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL  482 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence            778888999999999999999999999999999999999999999999952        334567889999999999999


Q ss_pred             ChHHHHHHHHhhccCcCCcCCCCC-CChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCC
Q 047009          373 SSEAHSLLKGLLQKEPGKRLGAGP-KGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSP  451 (482)
Q Consensus       373 s~~~~~LI~~~L~~dP~~R~s~~~-~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~  451 (482)
                      |-.+..+++..|++||++|+++.+ .+..+++.|+||+.++|+.++++++.|||.|.+.+...+.+||.+|++++...+|
T Consensus       483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~qltp  562 (593)
T KOG0695|consen  483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPVQLTP  562 (593)
T ss_pred             ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCccccccccccCCcccCC
Confidence            999999999999999999999866 4889999999999999999999999999999999999999999999999988887


Q ss_pred             CCCC---CCCCCCccCeeeecCCc
Q 047009          452 AATP---KNNTNPFADFSYVRPAA  472 (482)
Q Consensus       452 ~~~~---~~~~~~f~~f~~~~~~~  472 (482)
                      ....   .-+|+.|.||.|++|..
T Consensus       563 dd~d~i~ridqsefegfeyinpl~  586 (593)
T KOG0695|consen  563 DDEDAIKRIDQSEFEGFEYINPLL  586 (593)
T ss_pred             CCHHHHHhcchhhcCcceecchhh
Confidence            7654   46899999999999875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-64  Score=495.82  Aligned_cols=327  Identities=40%  Similarity=0.778  Sum_probs=306.5

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCe
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  224 (482)
                      .+...||..+.+||+|+||+|.+|..+++.+.||||+++++-+...+..+.-..|.++|... +-|++++|+.+|++-++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            45678999999999999999999999999999999999999888878888778899998877 56899999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccc-ccCC
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~-~~~~  303 (482)
                      +|+||||+.||+|..++++-+.|.|..+.+|+++|+-||-+||++|||+||||.+|||||.+|++||+|||+++. +-.+
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999987 4456


Q ss_pred             CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHh
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~  383 (482)
                      ..+.++||||.|+|||++...+|+.++||||+||+||||+.|++||.+.+..++.+.|...+..+|..+|.++.++++.+
T Consensus       505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~  584 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGL  584 (683)
T ss_pred             cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHH
Confidence            67788999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP---KNNTN  460 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~---~~~~~  460 (482)
                      |.+.|.+|+++++.+.++|..||||+.|+|++++.++++|||+|.+....+..|||+.++..+....|...-   .-+|+
T Consensus       585 ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD~~v~~nldq~  664 (683)
T KOG0696|consen  585 LTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPTDLTPPDKLVMMNLDQS  664 (683)
T ss_pred             hhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCCCCCCchHHHHhcCchh
Confidence            999999999999999999999999999999999999999999999988888999999999877666554432   45789


Q ss_pred             CccCeeeecCCc
Q 047009          461 PFADFSYVRPAA  472 (482)
Q Consensus       461 ~f~~f~~~~~~~  472 (482)
                      .|.||||++|.-
T Consensus       665 eF~gFsfvNpef  676 (683)
T KOG0696|consen  665 EFEGFSFVNPEF  676 (683)
T ss_pred             hcCceeeeChhh
Confidence            999999999875

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-62  Score=496.95  Aligned_cols=267  Identities=39%  Similarity=0.720  Sum_probs=255.3

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  225 (482)
                      ....||..++.||.|+|++|++|+.+.+++.||||++.|..+...+..+++..|..+|.+| .||.|++|+..|+++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            4568999999999999999999999999999999999999999989999999999999999 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      |+|+||+++|+|..++.+.|.|++..+++|++||+.||+|||++|||||||||+|||||.||++||+|||.|+.+.....
T Consensus       150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998743211


Q ss_pred             --------------CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCcc
Q 047009          306 --------------SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF  371 (482)
Q Consensus       306 --------------~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~  371 (482)
                                    ..+++||..|.+||++.....+..+|+|+||||||+|+.|.+||.+.+...++++|.+-.+.||+.
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~  309 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG  309 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC
Confidence                          256899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhh
Q 047009          372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEA  418 (482)
Q Consensus       372 ~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~  418 (482)
                      +++.+++||+++|..||++|+|+     ++|++||||.+|+|+.+-.
T Consensus       310 fp~~a~dLv~KLLv~dp~~Rlt~-----~qIk~HpFF~~Vdw~nlw~  351 (604)
T KOG0592|consen  310 FPEDARDLIKKLLVRDPSDRLTS-----QQIKAHPFFEGVDWENLWQ  351 (604)
T ss_pred             CCHHHHHHHHHHHccCccccccH-----HHHhhCcccccCChhhhhh
Confidence            99999999999999999999999     9999999999999999643

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-61  Score=474.16  Aligned_cols=287  Identities=42%  Similarity=0.737  Sum_probs=263.2

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ..+.+++|++++.||+|.-|+||+|+.++++..+|+|++.++.+...+...+.+.|.+||+.++||++..||..|++...
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            45677899999999999999999999999999999999999998888888999999999999999999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-
Q 047009          225 LYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-  301 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-  301 (482)
                      .|+|||||+||+|..+++++  +.|++..+++|+++++.||+|||-.|||+|||||+||||.++|||.|+||.++.... 
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            99999999999999888775  569999999999999999999999999999999999999999999999999874321 


Q ss_pred             -----------------------------------C---------------------CCCCcccccCCCCCchhhhcCCC
Q 047009          302 -----------------------------------E---------------------NTRSNSMIGTVEYMAPEIVLGKG  325 (482)
Q Consensus       302 -----------------------------------~---------------------~~~~~~~~gt~~y~APE~l~~~~  325 (482)
                                                         .                     +.++++++||-.|+|||++.|.+
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                               0                     01234678999999999999999


Q ss_pred             CCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCc--cCChHHHHHHHHhhccCcCCcCCCCCCChHHHH
Q 047009          326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA--FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIK  403 (482)
Q Consensus       326 ~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil  403 (482)
                      ++.++|||+|||++||||.|..||.|.+..++..+|+...+.+|.  .++..++|||+++|.+||++|++. ..|+.||+
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~-~rGA~eIK  390 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGS-KRGAAEIK  390 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcc-ccchHHhh
Confidence            999999999999999999999999999999999999999999986  478999999999999999999997 57889999


Q ss_pred             hCcCCCCCChhhhhhccCCCCCccccCCccc
Q 047009          404 SHKWFKPINWKKLEAREIQPGFCPEVAGKHC  434 (482)
Q Consensus       404 ~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~  434 (482)
                      +||||++++|.  .-|-..||++|......+
T Consensus       391 ~HpFF~gVnWa--Lir~~~PP~iP~~~d~~~  419 (459)
T KOG0610|consen  391 RHPFFEGVNWA--LIRCARPPEIPKPVDGGL  419 (459)
T ss_pred             cCccccCCChh--heeccCCCcCCCccccCc
Confidence            99999999998  447789999998765543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-61  Score=470.05  Aligned_cols=263  Identities=35%  Similarity=0.583  Sum_probs=240.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh----hHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK----NHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      ...+.|.+.+.||+|+||.|.+|..+.||+.||||++++......    .....+.+|++||++|+|||||+++++|...
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            345678999999999999999999999999999999998876542    2344567999999999999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC---CceeEcccCcccc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD---GHVMLTDFGLAKQ  299 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~---g~vKL~DFGla~~  299 (482)
                      +..||||||++||+|++.+..++.+.++..+.+++|++.||.|||++||+||||||+|||+..+   ..+||+|||+|+.
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            9999999999999999999999999999999999999999999999999999999999999876   6899999999999


Q ss_pred             ccCCCCCcccccCCCCCchhhhcCCCC---CchhHHHHHhHHHHHHhhCCCCCCCCchHH-HHHHHHhcccCCC----cc
Q 047009          300 FDENTRSNSMIGTVEYMAPEIVLGKGH---NKAADWWSVGILLYEMLTGKPPFIGGNRAK-IQQKIVKDKLRLP----AF  371 (482)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~~~~~---~~~sDvwSlGvilyelltG~~PF~~~~~~~-~~~~i~~~~~~~p----~~  371 (482)
                      ..+...+.+.||||.|.|||++.++++   ..++|+||+||+||-+|+|.+||.+..... +.++|.++++.+-    ..
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~  408 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR  408 (475)
T ss_pred             cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence            998899999999999999999988754   458899999999999999999998877766 8999999988764    35


Q ss_pred             CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       372 ~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                      ++.++++||++||..||++|+++     .|+|+||||+.....
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~-----~eaL~hpW~~~~~~~  446 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSA-----DEALNHPWFKDAPCL  446 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCH-----HHHhcChhhhccccc
Confidence            89999999999999999999999     999999999987643

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-59  Score=482.22  Aligned_cols=255  Identities=33%  Similarity=0.593  Sum_probs=248.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      .+|+..+.||+|||++||.+++..+|+.||+|++.+..+......+.+.+|++|.++|+|||||+++.+|++..++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            56999999999999999999999999999999999998888889999999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~  308 (482)
                      |+|..++|..++.+.+.++|.+++.|++||+.||.|||+++|||||||..|+||+++.+|||+|||+|..+.. +++..+
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T  177 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT  177 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999874 478889


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCc
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP  388 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP  388 (482)
                      .||||.|.|||++...+++..+||||+||+||-||+|++||...+..+++.+|....+.+|..+|.++++||.+||++||
T Consensus       178 lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P  257 (592)
T KOG0575|consen  178 LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNP  257 (592)
T ss_pred             ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCCCCCCChHHHHhCcCCC
Q 047009          389 GKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       389 ~~R~s~~~~~~~eil~hp~f~  409 (482)
                      .+||++     ++|+.|+||+
T Consensus       258 ~~Rpsl-----~~vL~h~Ff~  273 (592)
T KOG0575|consen  258 SERPSL-----DEVLDHPFFK  273 (592)
T ss_pred             ccCCCH-----HHHhcCHhhh
Confidence            999999     9999999994

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-60  Score=468.88  Aligned_cols=291  Identities=41%  Similarity=0.732  Sum_probs=274.3

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ..+..+.|..-++||+||||.||-++.+.||+.||+|.+.|+.+..+.......+|..||++++.++||.+-+.|++.+.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            45677899999999999999999999999999999999999988887777888899999999999999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          225 LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      +|+||..|+||+|..+|.+.+  .|++..+++|+++|+.||++||+.+||+|||||+|||||+.|+++|+|+|+|..+.+
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999999999877  799999999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC----chHHHHHHHHhcccCCCccCChHHHH
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG----NRAKIQQKIVKDKLRLPAFLSSEAHS  378 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~  378 (482)
                      +......+||.+|||||++.+..|+.+.|||||||++|||+.|+.||...    ..+++.+.++.....+|..+|+++++
T Consensus       340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaks  419 (591)
T KOG0986|consen  340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKS  419 (591)
T ss_pred             CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHH
Confidence            88888889999999999999999999999999999999999999999653    34577788888889999999999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccc
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCI  435 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~  435 (482)
                      |.+.+|.+||.+|+++...+++++++||||+++||+.+++..+.|||+|......|.
T Consensus       420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyak  476 (591)
T KOG0986|consen  420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAK  476 (591)
T ss_pred             HHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchh
Confidence            999999999999999977899999999999999999999999999999987665543

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-59  Score=502.50  Aligned_cols=318  Identities=39%  Similarity=0.732  Sum_probs=282.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ...+||+++++||+|+||.|.+++++.|++.||+|+++|-..........|..|.+||.--+.+-|++|+++|+++.++|
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            45689999999999999999999999999999999999977776777888999999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--  304 (482)
                      +|||||+||+|..++.+.+.++++.+++|+++|+.||.-||+.|+|||||||+|||||..||+||+|||.|-.+..+.  
T Consensus       152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998876333  


Q ss_pred             CCcccccCCCCCchhhhcC-----CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc--ccCCC--ccCChH
Q 047009          305 RSNSMIGTVEYMAPEIVLG-----KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--KLRLP--AFLSSE  375 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~-----~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p--~~~s~~  375 (482)
                      .+...+|||.|.+||++..     +.|+..+||||+||++|||+.|..||+..+..+++-+|...  .+.||  ..+|.+
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee  311 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE  311 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence            3466799999999999963     56899999999999999999999999999999999999876  77888  458999


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCC-CCCCCC
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLS-DSPAAT  454 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~-~s~~~~  454 (482)
                      +++||+++|. +|..|++-  +|.+||++||||.+++|+.+  |...|||+|.+.+..+++||+-........ ..|...
T Consensus       312 akdLI~~ll~-~~e~RLgr--ngiedik~HpFF~g~~W~~i--R~~~pP~vPevssd~DTsnFd~~~dd~~~~e~~p~~~  386 (1317)
T KOG0612|consen  312 AKDLIEALLC-DREVRLGR--NGIEDIKNHPFFEGIDWDNI--RESVPPVVPEVSSDDDTSNFDVDEDDLRDAETFPPRI  386 (1317)
T ss_pred             HHHHHHHHhc-Chhhhccc--ccHHHHHhCccccCCChhhh--hhcCCCCCCcCCCCCccccccccccccchhhccCCCC
Confidence            9999999995 89999974  67799999999999999776  778999999999999999995433322211 122111


Q ss_pred             C---CCCCCCccCeeeec
Q 047009          455 P---KNNTNPFADFSYVR  469 (482)
Q Consensus       455 ~---~~~~~~f~~f~~~~  469 (482)
                      +   .++.-||-||+|..
T Consensus       387 ~~~f~Gn~LPFIGfTy~~  404 (1317)
T KOG0612|consen  387 PKAFSGNHLPFIGFTYTH  404 (1317)
T ss_pred             CCCCcCCcCCeeeeeecc
Confidence            1   35679999999996

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.9e-57  Score=455.78  Aligned_cols=314  Identities=40%  Similarity=0.771  Sum_probs=279.0

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGG  235 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (482)
                      +.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.++++++||||++++++|...+.+|+||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999999999999999998766545555666788999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc-cCCCCCcccccCCC
Q 047009          236 HLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVE  314 (482)
Q Consensus       236 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~~~~~~~gt~~  314 (482)
                      +|..++..++.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.. .........+||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~  160 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence            99999988889999999999999999999999999999999999999999999999999999863 23334456789999


Q ss_pred             CCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCCC
Q 047009          315 YMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       315 y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                      |+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+......+|..++.++++||++||++||++|++.
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  240 (323)
T cd05571         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG  240 (323)
T ss_pred             ccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCC
Confidence            99999999999999999999999999999999999999888888999888899999999999999999999999999976


Q ss_pred             CCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC-------CCCCCCccCeee
Q 047009          395 GPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP-------KNNTNPFADFSY  467 (482)
Q Consensus       395 ~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~-------~~~~~~f~~f~~  467 (482)
                      ....+.++++||||.+++|..+..+.+.|++.|.+....+...|+..++.......|....       ......|.+|+|
T Consensus       241 ~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  320 (323)
T cd05571         241 GPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQSITITPPDRYDSLGLLQLEERPHFPQFSY  320 (323)
T ss_pred             CCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCcccCCCCcccccccccccccccCCCCee
Confidence            5556799999999999999999999999999999988888888887777665544433222       123567999999


Q ss_pred             ec
Q 047009          468 VR  469 (482)
Q Consensus       468 ~~  469 (482)
                      ..
T Consensus       321 ~~  322 (323)
T cd05571         321 SA  322 (323)
T ss_pred             eC
Confidence            74

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-56  Score=452.96  Aligned_cols=315  Identities=40%  Similarity=0.744  Sum_probs=278.1

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ..+++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   94 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY   94 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence            34689999999999999999999999999999999998776555556677889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      +||||+.||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....  .
T Consensus        95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~  172 (329)
T PTZ00263         95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--T  172 (329)
T ss_pred             EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--c
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999876433  3


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhcc
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~  386 (482)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....+.+..+.+.+|..++..+++||++||++
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~  252 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQT  252 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhc
Confidence            45689999999999999999999999999999999999999999988888999999999999999999999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCCCCCCCCccCe
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADF  465 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~~~~~~~f~~f  465 (482)
                      ||.+|+++....+++|++||||++++|..+..+.+.+|+.+......+..+|... ...+....+ ......+..|.||
T Consensus       253 dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~~-~~~~~~~~~~~~~  329 (329)
T PTZ00263        253 DHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEKY-PDSPVDRLP-PLTAAQQAEFAGF  329 (329)
T ss_pred             CHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcccchhccCC-cccccccCC-CCchhhhhhcCCC
Confidence            9999999766778999999999999999999888888887777777777777642 222221111 1223346778876

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.2e-56  Score=448.14  Aligned_cols=318  Identities=40%  Similarity=0.782  Sum_probs=278.1

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      +|++++.||+|+||.||+|+++.+++.||+|++.+.........+....|..++..+ +|++|+++++++.+.+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            689999999999999999999999999999999876544444555667788888877 5899999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCCCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~  308 (482)
                      ||+++|+|...+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~  160 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT  160 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999998643 2333456


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCc
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP  388 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP  388 (482)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.+......+|..++.++.+||.+||++||
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p  240 (323)
T cd05616         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP  240 (323)
T ss_pred             CCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCH
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCCCccCe
Q 047009          389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP---KNNTNPFADF  465 (482)
Q Consensus       389 ~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~---~~~~~~f~~f  465 (482)
                      .+|+++.+....++++|+||+.++|..+..+.++||+.|.... .+..+|+..+...+....|....   ..++..|+||
T Consensus       241 ~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (323)
T cd05616         241 GKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACG-RDAENFDKFFTRHPPVLTPPDQEVIMNLDQSEFEGF  319 (323)
T ss_pred             HhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCC-chhhhcCchhccCCccCCCCCccccccccccccCCC
Confidence            9999987677899999999999999999999999999998754 55667766555433222222222   2345899999


Q ss_pred             eeec
Q 047009          466 SYVR  469 (482)
Q Consensus       466 ~~~~  469 (482)
                      +|+.
T Consensus       320 ~~~~  323 (323)
T cd05616         320 SYVN  323 (323)
T ss_pred             cccC
Confidence            9974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-57  Score=442.90  Aligned_cols=258  Identities=30%  Similarity=0.536  Sum_probs=238.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe-E
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR-L  225 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~  225 (482)
                      ...++.+.++.||+|..|+||+|+++.|++.+|+|++...  .+....+++.+|+++++..+||+||++|++|..++. +
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence            4557888899999999999999999999999999999543  345667788999999999999999999999999995 9


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      +|+||||+||+|...+...+.++|..+..++.++++||.|||+ ++||||||||+|||++..|.|||||||.++.+... 
T Consensus       154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            9999999999999999988999999999999999999999996 89999999999999999999999999999998765 


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC-----chHHHHHHHHhc-ccCCCcc-CChHHH
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG-----NRAKIQQKIVKD-KLRLPAF-LSSEAH  377 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~~~  377 (482)
                      ..++++||..|||||.+.+..|+.++||||||++++||++|+.||...     +..++...|..+ .+.+|.. +|++++
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~  312 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFR  312 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHH
Confidence            778999999999999999999999999999999999999999999774     678889999985 5678886 999999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      +||..||++||.+|+++     +|+++|||++...
T Consensus       313 ~FV~~CL~Kdp~~R~s~-----~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  313 SFVSCCLRKDPSERPSA-----KQLLQHPFIKKFE  342 (364)
T ss_pred             HHHHHHhcCCcccCCCH-----HHHhcCHHHhhcc
Confidence            99999999999999999     9999999998643

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=9.3e-56  Score=446.49  Aligned_cols=319  Identities=42%  Similarity=0.789  Sum_probs=282.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCC-ceeeeeeeeecCCeEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP-FVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~lV~  229 (482)
                      +|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+..|+.++..++|+ +|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999999886554455566778899999999765 6888999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCCCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~  308 (482)
                      ||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++... .......
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT  160 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence            999999999999888889999999999999999999999999999999999999999999999999987532 2333445


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCc
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP  388 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP  388 (482)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..+.+......+|..++.++.+||++||.+||
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P  240 (324)
T cd05587         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHP  240 (324)
T ss_pred             ecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence            68999999999999999999999999999999999999999999999999999998889999999999999999999999


Q ss_pred             CCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCCCccCe
Q 047009          389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP---KNNTNPFADF  465 (482)
Q Consensus       389 ~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~---~~~~~~f~~f  465 (482)
                      .+|++.+....+++++||||+.++|..+..+.+.+++.|.........+|+..+.......+|....   ..++..|++|
T Consensus       241 ~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (324)
T cd05587         241 AKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFFTREPPVLTPPDKLVIANIDQSEFQGF  320 (324)
T ss_pred             HHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcchhhhcCcccccCccccCCCCccccccccccccCCC
Confidence            9999986667789999999999999999999999999999988888889987766554433333222   3456789999


Q ss_pred             eeec
Q 047009          466 SYVR  469 (482)
Q Consensus       466 ~~~~  469 (482)
                      +|+.
T Consensus       321 ~~~~  324 (324)
T cd05587         321 SFVN  324 (324)
T ss_pred             cccC
Confidence            9873

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1e-55  Score=446.10  Aligned_cols=316  Identities=37%  Similarity=0.727  Sum_probs=279.2

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHH---HhCCCCceeeeeeeeecCCeEEEE
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL---TKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il---~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      |++++.||+|+||.||+|+++.+++.||||++++.........+.+.+|++++   +.++||||+++++++.+.+.+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78899999999999999999999999999999876554455566677777765   456899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCCCc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~  307 (482)
                      |||++||+|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++... ......
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS  159 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence            999999999887754 579999999999999999999999999999999999999999999999999987632 233345


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccC
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE  387 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~d  387 (482)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|..++..+.+||++||++|
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d  239 (324)
T cd05589         160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRN  239 (324)
T ss_pred             ccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            67899999999999999999999999999999999999999999998889999999888899999999999999999999


Q ss_pred             cCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC----CCCCCCCcc
Q 047009          388 PGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT----PKNNTNPFA  463 (482)
Q Consensus       388 P~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~----~~~~~~~f~  463 (482)
                      |.+||+.....+.++++||||++++|..+..+.+.|++.|.+....+.++|+..+...+...+|..+    ....+..|.
T Consensus       240 P~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (324)
T cd05589         240 PERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAPVLTPPREPRLLTEEEQELFR  319 (324)
T ss_pred             HhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcchhhhcCccccccccccCCCccccccchhhhcccC
Confidence            9999987667789999999999999999999999999999999888999998777665444443332    245689999


Q ss_pred             Ceeee
Q 047009          464 DFSYV  468 (482)
Q Consensus       464 ~f~~~  468 (482)
                      +|+|+
T Consensus       320 ~~~~~  324 (324)
T cd05589         320 GFDYV  324 (324)
T ss_pred             CcccC
Confidence            99985

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-55  Score=448.26  Aligned_cols=314  Identities=40%  Similarity=0.694  Sum_probs=277.0

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCC-eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTS-EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ....++|++.+.||+|+||.||+|.++.++ ..||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY  105 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence            356789999999999999999999977655 7899999987665555566778899999999999999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      +|+||||+.||+|..++..++.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....  
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~--  183 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--  183 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence            999999999999999999888999999999999999999999999999999999999999999999999999987643  


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhh
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L  384 (482)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.+..+...+|..++..+++||++||
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l  263 (340)
T PTZ00426        184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLL  263 (340)
T ss_pred             CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence            23457899999999999999999999999999999999999999999998889999999988999999999999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCCCCCCCCccC
Q 047009          385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFAD  464 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~~~~~~~f~~  464 (482)
                      +.||.+|++....+++++++||||++++|..+..+.+.+|+.|........++|++.-.+    ..+.....+..++|.|
T Consensus       264 ~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  339 (340)
T PTZ00426        264 SHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFERVQED----LTIADKITNENDPFFD  339 (340)
T ss_pred             ccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCCcchhhcCCCccc----ccccCCCccccCcccC
Confidence            999999986555567999999999999999999999999999998777777777542222    2222333345578877


Q ss_pred             e
Q 047009          465 F  465 (482)
Q Consensus       465 f  465 (482)
                      |
T Consensus       340 ~  340 (340)
T PTZ00426        340 W  340 (340)
T ss_pred             C
Confidence            6

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-58  Score=458.22  Aligned_cols=297  Identities=37%  Similarity=0.699  Sum_probs=287.1

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ..+.+.+++++..||-||||.|-+++.+.....+|+|+++|..+.+..+.+.+..|.+||...+.|+||+||..|.+..+
T Consensus       415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky  494 (732)
T KOG0614|consen  415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY  494 (732)
T ss_pred             cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence            34667889999999999999999999887766799999999999999999999999999999999999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      +|++||-|-||.|...|..++.|.+..+++|+..++.|++|||++|||+|||||+|++|+.+|.+||.|||+|+.+..+.
T Consensus       495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc--ccCCCccCChHHHHHHHH
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--KLRLPAFLSSEAHSLLKG  382 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~LI~~  382 (482)
                      .+.++||||.|.|||++..++++.++|+||||+++||||+|.+||.+.++..+++.|+++  .+.+|..++..+.+||++
T Consensus       575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~  654 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK  654 (732)
T ss_pred             ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence            999999999999999999999999999999999999999999999999999999999997  678999999999999999


Q ss_pred             hhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCcccc
Q 047009          383 LLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKK  441 (482)
Q Consensus       383 ~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~  441 (482)
                      +...+|.+|++....|..||++|.||.++||+-+..+.+.||++|.+.++.+.+||+..
T Consensus       655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~  713 (732)
T KOG0614|consen  655 LCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNF  713 (732)
T ss_pred             HHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCC
Confidence            99999999999888999999999999999999999999999999999999999999864

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.8e-55  Score=443.92  Aligned_cols=314  Identities=39%  Similarity=0.729  Sum_probs=276.6

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +.||+|+||+||+|+++.+++.||+|++.+.........+.+..|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999999999999999999876554445566677888888876 799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCCCcccccCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~~~gt~  313 (482)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++... ........+||+
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP  160 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence            9999999888899999999999999999999999999999999999999999999999999988642 233445678999


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCC
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s  393 (482)
                      .|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+......+|..++.++++||++||++||.+|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~  240 (320)
T cd05590         161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLG  240 (320)
T ss_pred             cccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCC
Confidence            99999999999999999999999999999999999999999999999999888899999999999999999999999999


Q ss_pred             CCC-CChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCC---CCCCCCCCCccCeeeec
Q 047009          394 AGP-KGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPA---ATPKNNTNPFADFSYVR  469 (482)
Q Consensus       394 ~~~-~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~---~~~~~~~~~f~~f~~~~  469 (482)
                      +.. .+.+++++||||..++|..+..+.+.|+|.|.+....+..+|+..........++.   ..+..+++.|.+|+|.+
T Consensus       241 ~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (320)
T cd05590         241 SLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKEDPVLTPIEESLLPMINQDEFRNFSYTA  320 (320)
T ss_pred             CCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCccCCCCcccccccccccCcCCCcccC
Confidence            732 34589999999999999999999999999999999889999987665543333322   12344678999999863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.2e-55  Score=444.98  Aligned_cols=315  Identities=39%  Similarity=0.759  Sum_probs=277.6

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGG  235 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (482)
                      +.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999999999999999998776555556667888999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCCCcccccCCC
Q 047009          236 HLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVE  314 (482)
Q Consensus       236 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~~~gt~~  314 (482)
                      +|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++... ........+||+.
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~  160 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE  160 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence            999999888889999999999999999999999999999999999999999999999999998642 2233445689999


Q ss_pred             CCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCCC
Q 047009          315 YMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       315 y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                      |+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..+.+......+|..++.++.+||++||++||++|++.
T Consensus       161 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  240 (328)
T cd05593         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGG  240 (328)
T ss_pred             ccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence            99999999999999999999999999999999999988888888888888889999999999999999999999999976


Q ss_pred             CCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---------CCCCCCccCe
Q 047009          395 GPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP---------KNNTNPFADF  465 (482)
Q Consensus       395 ~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~---------~~~~~~f~~f  465 (482)
                      .+..+.+|++|+||.+++|..+..+.+.|++.|..........|+..++.......+....         ...+..|.+|
T Consensus       241 ~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (328)
T cd05593         241 GPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQTITITPPEKYDEDGMDCMDNERRPHFPQF  320 (328)
T ss_pred             CCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCcccccCCcccCCccccccccccccccccccccCCc
Confidence            6667799999999999999999999999999999888888888887776654433332221         1234678999


Q ss_pred             eeecC
Q 047009          466 SYVRP  470 (482)
Q Consensus       466 ~~~~~  470 (482)
                      +|...
T Consensus       321 ~~~~~  325 (328)
T cd05593         321 SYSAS  325 (328)
T ss_pred             eeeCC
Confidence            98754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.7e-55  Score=442.14  Aligned_cols=313  Identities=42%  Similarity=0.798  Sum_probs=279.7

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +.||+|+||+||+|+++.+++.||+|++++...........+..|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999999999999999999987655555566777899999888 799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc-cCCCCCcccccCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~~~~~~~gt~  313 (482)
                      |+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. .........+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~  160 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP  160 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence            999999988888999999999999999999999999999999999999999999999999999763 2233345568999


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCC
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s  393 (482)
                      .|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+......+|..++.++.+||++||++||++||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s  240 (318)
T cd05570         161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLG  240 (318)
T ss_pred             cccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCC
Confidence            99999999999999999999999999999999999999888888888988888899999999999999999999999999


Q ss_pred             CCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCCCccCeeee
Q 047009          394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP---KNNTNPFADFSYV  468 (482)
Q Consensus       394 ~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~---~~~~~~f~~f~~~  468 (482)
                      +......++++||||+.++|.....+.+.|++.|.........+|+..+...+...++....   ..+|++|.||+|.
T Consensus       241 ~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (318)
T cd05570         241 CLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNIDQEEFRGFSYI  318 (318)
T ss_pred             CCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCchhccCcccCCCCcccccccccccccCCCCCC
Confidence            86667799999999999999999999999999999988888899987776555444444433   3568999999985

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-55  Score=441.83  Aligned_cols=308  Identities=45%  Similarity=0.821  Sum_probs=273.9

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCCch
Q 047009          158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL  237 (482)
Q Consensus       158 LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (482)
                      ||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++.+++||||++++++|...+.+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999999999999999876555555667788899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCCCcccccCCCCC
Q 047009          238 FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYM  316 (482)
Q Consensus       238 ~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~~~gt~~y~  316 (482)
                      ..++..++.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... ........+||+.|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~  160 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL  160 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence            9999888899999999999999999999999999999999999999999999999999998642 233345678999999


Q ss_pred             chhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCCCCC
Q 047009          317 APEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGP  396 (482)
Q Consensus       317 APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~  396 (482)
                      |||++.+..++.++|||||||++|+|++|+.||.+.+..+..+.+......+|..++.++++||.+||++||.+|+++  
T Consensus       161 aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~--  238 (312)
T cd05585         161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGY--  238 (312)
T ss_pred             CHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCC--
Confidence            999999999999999999999999999999999999888999999999999999999999999999999999999986  


Q ss_pred             CChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC---CCCCCCCccCeee
Q 047009          397 KGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT---PKNNTNPFADFSY  467 (482)
Q Consensus       397 ~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~---~~~~~~~f~~f~~  467 (482)
                      .++.++++||||...+|..+..+.+++++.|.+....+.++|+..++.....++....   ....+..|.+|+|
T Consensus       239 ~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (312)
T cd05585         239 NGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSVVDDSHLSETVQQQFGGWSY  312 (312)
T ss_pred             CCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhhcCccccccccccCCCccccccchhccccCCCCC
Confidence            4569999999999999999999999999999988888888888776654333332222   2334778888886

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-55  Score=437.34  Aligned_cols=289  Identities=40%  Similarity=0.787  Sum_probs=266.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++...........+.+.+|+.++++++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999998765444455667889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCccc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM  309 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  309 (482)
                      ||+++|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....  ....
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~  158 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTL  158 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccc
Confidence            99999999999998889999999999999999999999999999999999999999999999999999876432  3456


Q ss_pred             ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcC
Q 047009          310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPG  389 (482)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~  389 (482)
                      +||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....+.+..+...+|..++..+++||++||+.||.
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (291)
T cd05612         159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRT  238 (291)
T ss_pred             cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHH
Confidence            89999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccc
Q 047009          390 KRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEK  440 (482)
Q Consensus       390 ~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~  440 (482)
                      +|++.....++++++||||..++|..+..+...|+..|.+....+..+|+.
T Consensus       239 ~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  289 (291)
T cd05612         239 RRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDD  289 (291)
T ss_pred             HccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCccccccccC
Confidence            999865556799999999999999999999999999999888888777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.4e-55  Score=440.34  Aligned_cols=311  Identities=39%  Similarity=0.781  Sum_probs=276.3

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHh-CCCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK-IDHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +.||+|+||.||+|+++.+++.||+|++++.........+....|..++.. .+||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            369999999999999999999999999987654444445556667777765 4899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCCcccccCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~~gt~  313 (482)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+||+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~  160 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999986432 23345678999


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCC
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s  393 (482)
                      .|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+......+|..++.++.+||.+||+.||++|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~  240 (316)
T cd05592         161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLG  240 (316)
T ss_pred             cccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            99999999999999999999999999999999999999998888888888888889999999999999999999999998


Q ss_pred             CCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCCCccCeeeecC
Q 047009          394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP---KNNTNPFADFSYVRP  470 (482)
Q Consensus       394 ~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~---~~~~~~f~~f~~~~~  470 (482)
                      +    ..++++||||..++|..+..+.+.|+|.|......+..+|+..++......++....   ..++..|.+|+|.+|
T Consensus       241 ~----~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (316)
T cd05592         241 V----DGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRLSPVDKKLLASMDQEQFRGFSFTNP  316 (316)
T ss_pred             C----hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccccccCCCccccccccccccccCCCcccCc
Confidence            7    258999999999999999999999999999888888899998888776655544432   457899999999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.5e-55  Score=440.58  Aligned_cols=320  Identities=46%  Similarity=0.883  Sum_probs=277.0

Q ss_pred             CeEEEEEecccCceEEEEEEEc---CCCeEEEEEEeechhhch-hhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKK---NTSEIYAMKVMRKDKIVE-KNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~~~~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  225 (482)
                      +|++++.||+|+||+||+|++.   .+++.||+|++.+..... ....+.+.+|+.+++.+ +||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999998864   478999999998754322 23445678899999999 599999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC--
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--  303 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~--  303 (482)
                      ++||||++||+|..++..++.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....  
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence            999999999999999988888999999999999999999999999999999999999999999999999999865332  


Q ss_pred             CCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCC----chHHHHHHHHhcccCCCccCChHHHH
Q 047009          304 TRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGG----NRAKIQQKIVKDKLRLPAFLSSEAHS  378 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~  378 (482)
                      ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...    ....+...+......+|..++..+++
T Consensus       161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (332)
T cd05614         161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD  240 (332)
T ss_pred             CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            233456899999999999875 4789999999999999999999999643    33455566677777888889999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCCCCC
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNN  458 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~~~~  458 (482)
                      ||.+||+.||++|++++...++++++||||++.+|..+..+.+.++|.|......+..+|...+.......++...+...
T Consensus       241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (332)
T cd05614         241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGTPPSG  320 (332)
T ss_pred             HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCcccCCCCCCccc
Confidence            99999999999999886667899999999999999999999999999999888878888877666655556666666666


Q ss_pred             CCCccCeeeecC
Q 047009          459 TNPFADFSYVRP  470 (482)
Q Consensus       459 ~~~f~~f~~~~~  470 (482)
                      ...|.+|+|++|
T Consensus       321 ~~~~~~~~~~~~  332 (332)
T cd05614         321 ARVFQGYSFVAP  332 (332)
T ss_pred             ccccCCceecCC
Confidence            789999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.2e-55  Score=440.59  Aligned_cols=314  Identities=39%  Similarity=0.762  Sum_probs=276.7

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGG  235 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (482)
                      +.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||++++++|...+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36999999999999999999999999998875545555667778999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc-cCCCCCcccccCCC
Q 047009          236 HLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVE  314 (482)
Q Consensus       236 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~~~~~~~gt~~  314 (482)
                      +|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.. .........+||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~  160 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence            99999988888999999999999999999999999999999999999999999999999998763 22233345689999


Q ss_pred             CCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCCC
Q 047009          315 YMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       315 y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                      |+|||++.+..++.++|||||||++|||++|+.||...+.......+......+|..+++++++||++||++||++|++.
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  240 (323)
T cd05595         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG  240 (323)
T ss_pred             cCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCC
Confidence            99999999999999999999999999999999999998888888888888889999999999999999999999999977


Q ss_pred             CCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC-------CCCCCCccCeee
Q 047009          395 GPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP-------KNNTNPFADFSY  467 (482)
Q Consensus       395 ~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~-------~~~~~~f~~f~~  467 (482)
                      ++..+.++++|+||.+++|..+..+.+.|++.|..........|+..++.......|....       ...-..|..|||
T Consensus       241 ~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (323)
T cd05595         241 GPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQRTHFPQFSY  320 (323)
T ss_pred             CCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCcccccCCccCCCCcccccccccccccccccCCCcc
Confidence            6677899999999999999999999999999999988888888888777654433322111       122367888888


Q ss_pred             ec
Q 047009          468 VR  469 (482)
Q Consensus       468 ~~  469 (482)
                      +.
T Consensus       321 ~~  322 (323)
T cd05595         321 SA  322 (323)
T ss_pred             cC
Confidence            63

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.5e-55  Score=442.10  Aligned_cols=313  Identities=37%  Similarity=0.756  Sum_probs=274.4

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +.||+|+||.||+|+++.+++.||+|++++...........+.+|+.++..+ +||||++++++|.+...+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3699999999999999999999999999987655555667788999999998 799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc-cCCCCCcccccCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~~~~~~~gt~  313 (482)
                      |+|..++.+++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. .........+||+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence            999999988889999999999999999999999999999999999999999999999999999753 3334445678999


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC---------chHHHHHHHHhcccCCCccCChHHHHHHHHhh
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG---------NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L  384 (482)
                      .|+|||++.+..++.++|||||||++|+|++|+.||...         ......+.+......+|..++.++.+||++||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  240 (329)
T cd05588         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFL  240 (329)
T ss_pred             cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            999999999999999999999999999999999999531         22345667777888899999999999999999


Q ss_pred             ccCcCCcCCCCC-CChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC---CCCCCC
Q 047009          385 QKEPGKRLGAGP-KGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT---PKNNTN  460 (482)
Q Consensus       385 ~~dP~~R~s~~~-~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~---~~~~~~  460 (482)
                      ++||.+|+++.. .+++++++||||..++|..+..+.+.|++.|.........+|+..+...+...+|...   ...++.
T Consensus       241 ~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  320 (329)
T cd05588         241 NKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTPDDPDVIARIDQS  320 (329)
T ss_pred             ccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCCcchhhhcCCccccCccccCCCCcccccccccc
Confidence            999999998632 2469999999999999999999999999999998888888998888776655555433   345678


Q ss_pred             CccCeeee
Q 047009          461 PFADFSYV  468 (482)
Q Consensus       461 ~f~~f~~~  468 (482)
                      .|.+|.|.
T Consensus       321 ~~~~~~~~  328 (329)
T cd05588         321 EFEGFEYI  328 (329)
T ss_pred             ccCCCccc
Confidence            99999886

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.4e-54  Score=437.98  Aligned_cols=318  Identities=42%  Similarity=0.785  Sum_probs=276.6

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCCeEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      +|+..+.||+|+||+||+|+++.+|+.||+|++.+.........+.+..|..++..+. |++|+++++++.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            5888999999999999999999999999999998765544455566778999998886 577888999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~  308 (482)
                      ||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~  160 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT  160 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence            9999999999998888999999999999999999999999999999999999999999999999999986432 223445


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCc
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP  388 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP  388 (482)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+.+.+......+|..++.++.+|+.+||++||
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p  240 (323)
T cd05615         161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP  240 (323)
T ss_pred             ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCH
Confidence            67999999999999999999999999999999999999999999988899999999889999999999999999999999


Q ss_pred             CCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC---CCCCCCCccCe
Q 047009          389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT---PKNNTNPFADF  465 (482)
Q Consensus       389 ~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~---~~~~~~~f~~f  465 (482)
                      .+|+++.....+++++||||+.++|..+..+.+++||.|..... ...+|++.........++..+   ...+...|.+|
T Consensus       241 ~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (323)
T cd05615         241 SKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKFFTRGQPVLTPPDQLVIANIDQADFEGF  319 (323)
T ss_pred             hhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCCC-chhhcCccccccCCCCCCCcccccccccccccCCC
Confidence            99999866678999999999999999999999999999987664 367787766544332222221   12334689999


Q ss_pred             eeec
Q 047009          466 SYVR  469 (482)
Q Consensus       466 ~~~~  469 (482)
                      +|+.
T Consensus       320 ~~~~  323 (323)
T cd05615         320 SYVN  323 (323)
T ss_pred             cccC
Confidence            9863

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.3e-54  Score=436.99  Aligned_cols=311  Identities=38%  Similarity=0.737  Sum_probs=273.4

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHh-CCCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK-IDHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +.||+|+||+||+|+++.+++.||+|++++..............|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            369999999999999999999999999987654333444556678888876 4999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCCCcccccCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~~~gt~  313 (482)
                      |+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence            9999999888889999999999999999999999999999999999999999999999999997632 223345568999


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCC
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s  393 (482)
                      .|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.+.+......+|..++.++++||.+||++||++|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~  240 (316)
T cd05619         161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLG  240 (316)
T ss_pred             cccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCC
Confidence            99999999999999999999999999999999999999888888888888878888889999999999999999999999


Q ss_pred             CCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCC---CCCCCCCCccCeeeecC
Q 047009          394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAA---TPKNNTNPFADFSYVRP  470 (482)
Q Consensus       394 ~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~---~~~~~~~~f~~f~~~~~  470 (482)
                      +.    .++++||||+.++|..+..+.+.|++.|......+.++|++.+.+.....+...   ....+++.|++|++..|
T Consensus       241 ~~----~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (316)
T cd05619         241 VK----GDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLSVTDRMLINSMDQNMFENFSFINP  316 (316)
T ss_pred             Ch----HHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcChhhhcCCcccCCCcccccccccccccCCCcccCc
Confidence            82    489999999999999999999999999999888889999988776544333221   22467899999999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-55  Score=433.70  Aligned_cols=258  Identities=34%  Similarity=0.596  Sum_probs=240.7

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ..++|.+.+.||.|+||+||+|+++.++..||||.+.+..+ .++..+.+..|+.||+.++|||||+|++++.+.+.+||
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            46899999999999999999999999999999999998865 45677888999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC------CceeEcccCcccccc
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD------GHVMLTDFGLAKQFD  301 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~------g~vKL~DFGla~~~~  301 (482)
                      |||||+||+|..++++++.+++..++.++.||+.||++||+++||||||||.||||+..      -.+||+|||+|+.+.
T Consensus        87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999999999999999999999999999999999999999999999999999875      458999999999999


Q ss_pred             CCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC---CCccCChHHHH
Q 047009          302 ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR---LPAFLSSEAHS  378 (482)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~  378 (482)
                      .+....+.||++.|||||++....|+.|+|+||+|+|+|+|++|+.||...+..++...+.++.-.   ++..++....+
T Consensus       167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~  246 (429)
T KOG0595|consen  167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRE  246 (429)
T ss_pred             chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhh
Confidence            998999999999999999999999999999999999999999999999999999999988887543   44568899999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      |+..+|+++|..|.+.     .+-..|++...-
T Consensus       247 Ll~~ll~~~~~~~~~~-----~~~~~~~~l~~~  274 (429)
T KOG0595|consen  247 LLISLLQRNPKDRISF-----EDFFDHPFLAAN  274 (429)
T ss_pred             hhhHHHhcCccccCch-----HHhhhhhhcccC
Confidence            9999999999999988     888888887653

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-54  Score=438.80  Aligned_cols=315  Identities=49%  Similarity=0.896  Sum_probs=276.7

Q ss_pred             EEecccCceEEEEEEEc---CCCeEEEEEEeechhhc-hhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEe
Q 047009          156 KVVGQGAFGRVYQVRKK---NTSEIYAMKVMRKDKIV-EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~---~~~~~vAiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  231 (482)
                      +.||+|+||.||+|++.   .+++.||+|++.+.... .......+.+|+.+|+.++||||++++++|..++.+|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999864   46889999999875432 223445677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCCCcccc
Q 047009          232 INGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMI  310 (482)
Q Consensus       232 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~~~  310 (482)
                      ++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... ........+
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  161 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC  161 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccC
Confidence            9999999999888889999999999999999999999999999999999999999999999999997542 333345568


Q ss_pred             cCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCC
Q 047009          311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGK  390 (482)
Q Consensus       311 gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~  390 (482)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..+...+|..+++++.+||++||++||++
T Consensus       162 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  241 (323)
T cd05584         162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSS  241 (323)
T ss_pred             CCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhH
Confidence            99999999999999999999999999999999999999999988888899999988999999999999999999999999


Q ss_pred             cCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC--CCCCCCccCeeee
Q 047009          391 RLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP--KNNTNPFADFSYV  468 (482)
Q Consensus       391 R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~--~~~~~~f~~f~~~  468 (482)
                      |++..+..++++++||||...+|..+..+.+.|++.+......+.+.|+..++.....+++....  ....+.|.||+|+
T Consensus       242 R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (323)
T cd05584         242 RLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQIFLGFTYV  321 (323)
T ss_pred             cCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCchhcccccccCccccccccccccCcCCCeec
Confidence            99776667799999999999999999999999999998888888888887776655444443322  2235899999998


Q ss_pred             cC
Q 047009          469 RP  470 (482)
Q Consensus       469 ~~  470 (482)
                      .|
T Consensus       322 ~~  323 (323)
T cd05584         322 AP  323 (323)
T ss_pred             CC
Confidence            76

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-54  Score=437.53  Aligned_cols=311  Identities=37%  Similarity=0.720  Sum_probs=272.8

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHh-CCCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK-IDHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +.||+|+||.||+|+++.+|+.||+|++++..............|..++.. ++||||+++++++.+.+.+|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999999999999999999987654333445566778888876 4899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCCCcccccCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~~~gt~  313 (482)
                      |+|..++..++.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++... ........+||+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence            9999999888889999999999999999999999999999999999999999999999999987532 223345678999


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCC
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s  393 (482)
                      .|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.+......+|..++.++++||++||+.||++|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~  240 (316)
T cd05620         161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLG  240 (316)
T ss_pred             CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            99999999999999999999999999999999999999888888888888888889999999999999999999999999


Q ss_pred             CCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC---CCCCCCCccCeeeecC
Q 047009          394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT---PKNNTNPFADFSYVRP  470 (482)
Q Consensus       394 ~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~---~~~~~~~f~~f~~~~~  470 (482)
                      +    .+++++||||+.++|..+..+++.+++.|......+.++|++.........+....   ...++.+|++|+|.+|
T Consensus       241 ~----~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (316)
T cd05620         241 V----VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLSYSDKNLIDSMDQSAFAGFSFINP  316 (316)
T ss_pred             C----hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccccccCcccCCCcccccccccccCcCCCcccCC
Confidence            7    25899999999999999999999999999998888888998766654333332221   2456789999999887

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=9e-55  Score=439.48  Aligned_cols=314  Identities=42%  Similarity=0.744  Sum_probs=273.6

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHH-HHHhCCCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD-ILTKIDHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +.||+|+||+||+|+++.+|+.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36999999999999999999999999998765444444445555654 56779999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc-cCCCCCcccccCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~~~~~~~gt~  313 (482)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.. .........+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP  160 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence            999999988889999999999999999999999999999999999999999999999999999763 2233445678999


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCC
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s  393 (482)
                      .|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++.+.+......++..++..+.++|++||++||.+|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~  240 (325)
T cd05604         161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLG  240 (325)
T ss_pred             hhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCC
Confidence            99999999999999999999999999999999999999998889999888888888889999999999999999999999


Q ss_pred             CCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC---------CCCCCCCccC
Q 047009          394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT---------PKNNTNPFAD  464 (482)
Q Consensus       394 ~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~---------~~~~~~~f~~  464 (482)
                      + .....++++||||..++|..+..+.+.+++.|......+.++|+..+.+.....+...+         ......+|.|
T Consensus       241 ~-~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (325)
T cd05604         241 A-KEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDAFVG  319 (325)
T ss_pred             C-CCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCCccccCCcccCcccccccccccccccccccccCC
Confidence            8 34568999999999999999999999999999988888888998777665544443211         1223578999


Q ss_pred             eeeecC
Q 047009          465 FSYVRP  470 (482)
Q Consensus       465 f~~~~~  470 (482)
                      |+|.+|
T Consensus       320 ~~~~~~  325 (325)
T cd05604         320 FSYAPP  325 (325)
T ss_pred             CEecCC
Confidence            999976

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2e-54  Score=437.66  Aligned_cols=313  Identities=37%  Similarity=0.771  Sum_probs=274.3

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.++.++ +||||+++++++.+...+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3699999999999999999999999999987655556667788999999888 699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc-cCCCCCcccccCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~~~~~~~gt~  313 (482)
                      |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.. .........+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP  160 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence            999999988888999999999999999999999999999999999999999999999999999863 2334445678999


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCC-------CchHHHHHHHHhcccCCCccCChHHHHHHHHhhcc
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIG-------GNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~-------~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~  386 (482)
                      .|+|||++.+..++.++|||||||++|+|++|+.||..       .......+.+......+|..++..+.++|++||++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~  240 (327)
T cd05617         161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNK  240 (327)
T ss_pred             ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcc
Confidence            99999999999999999999999999999999999953       22345566777777889999999999999999999


Q ss_pred             CcCCcCCCCC-CChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC---CCCCCCCc
Q 047009          387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT---PKNNTNPF  462 (482)
Q Consensus       387 dP~~R~s~~~-~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~---~~~~~~~f  462 (482)
                      ||++|+++.+ .+.+++++||||+.++|+.+..+.+.|+|.|......+..+|+..+...+...++...   ...++..|
T Consensus       241 dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (327)
T cd05617         241 DPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFDTQFTSEPVQLTPDDEDVIKRIDQSEF  320 (327)
T ss_pred             CHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCCcchhhcCCccccCcccCCCCCcccccccccccc
Confidence            9999998732 3568999999999999999999999999999998888889998877666554444333   24577889


Q ss_pred             cCeeee
Q 047009          463 ADFSYV  468 (482)
Q Consensus       463 ~~f~~~  468 (482)
                      .||+|.
T Consensus       321 ~~~~~~  326 (327)
T cd05617         321 EGFEYI  326 (327)
T ss_pred             CCCcCC
Confidence            999886

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-54  Score=438.46  Aligned_cols=312  Identities=45%  Similarity=0.796  Sum_probs=272.5

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHH-HHHhCCCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD-ILTKIDHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +.||+|+||+||+|+++.+|+.||+|++.+...........+..|.. +++.++||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999999999999999998765544444445555555 56789999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCCCcccccCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~~~gt~  313 (482)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++... ........+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP  160 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence            9999999888899999999999999999999999999999999999999999999999999997642 233345568999


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCC
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s  393 (482)
                      .|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++.+.+......++..++.++.+||++||++||.+|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  240 (323)
T cd05575         161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLG  240 (323)
T ss_pred             hhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCC
Confidence            99999999999999999999999999999999999999998899999998888888889999999999999999999999


Q ss_pred             CCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---------CCCCCCccC
Q 047009          394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP---------KNNTNPFAD  464 (482)
Q Consensus       394 ~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~---------~~~~~~f~~  464 (482)
                      +. ....++++||||..++|..+..+.+.+|+.|.+.......+|+..+...+...+...++         ......|.|
T Consensus       241 ~~-~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (323)
T cd05575         241 AK-DDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEADDAFLG  319 (323)
T ss_pred             CC-CCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcchhhhcCccccccccccccCCCcccccccccccccccccCC
Confidence            83 56689999999999999999999999999999988888888887776655544332221         234588999


Q ss_pred             eeee
Q 047009          465 FSYV  468 (482)
Q Consensus       465 f~~~  468 (482)
                      |+|.
T Consensus       320 ~~~~  323 (323)
T cd05575         320 FSYA  323 (323)
T ss_pred             CccC
Confidence            9984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9.6e-55  Score=438.54  Aligned_cols=313  Identities=40%  Similarity=0.745  Sum_probs=272.9

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +.||+|+||.||+|+++.+++.||+|++.+.........+.+..|..++..+ +||||++++++|.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            3699999999999999999999999999886554455566677899998876 899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCCCcccccCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~~~gt~  313 (482)
                      |+|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... ........+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP  160 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence            9999999888889999999999999999999999999999999999999999999999999997642 233345568999


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCC
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s  393 (482)
                      .|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....+.+......+|..++.++.+||++||++||++|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~  240 (321)
T cd05591         161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLG  240 (321)
T ss_pred             cccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence            99999999999999999999999999999999999999999999999999988899999999999999999999999996


Q ss_pred             CCCC--ChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC---CCCCCCCccCeeee
Q 047009          394 AGPK--GSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT---PKNNTNPFADFSYV  468 (482)
Q Consensus       394 ~~~~--~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~---~~~~~~~f~~f~~~  468 (482)
                      +...  .++++++||||..++|..+..+.+.++|.|......+..+|+..++.......+...   ..-++..|.||+++
T Consensus       241 ~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (321)
T cd05591         241 CVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTKEEPVLTPVDPAVIKQINQEEFRGFSFF  320 (321)
T ss_pred             CCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchhhhcCCccccCccccCCCCccccccccccccCCCccc
Confidence            5332  569999999999999999999999999999988777777887655543222222211   23456789999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-55  Score=446.23  Aligned_cols=260  Identities=38%  Similarity=0.703  Sum_probs=243.6

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh--hHHHHHHHHHHHHHhCC-CCceeeeeeeeecCC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK--NHAEYMKAERDILTKID-HPFVVQLKYSFQTKY  223 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~--~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  223 (482)
                      ...+.|++.+.||+|+||+|++|++..++..||+|++.++.....  ...+.+.+|+.++++++ ||||++++.++.+..
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            456889999999999999999999999999999998877633211  34566779999999999 999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC-CceeEcccCccccc-c
Q 047009          224 RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQF-D  301 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~-g~vKL~DFGla~~~-~  301 (482)
                      .+|+||||+.||+|++++...+++.|..++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++... .
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999 99999999999988 5


Q ss_pred             CCCCCcccccCCCCCchhhhcCCC-CC-chhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccC-ChHHHH
Q 047009          302 ENTRSNSMIGTVEYMAPEIVLGKG-HN-KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFL-SSEAHS  378 (482)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~-~~-~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~-s~~~~~  378 (482)
                      ......+.|||+.|+|||++.++. |+ .++||||+||+||.|++|+.||...+...++.+|.++.+.+|..+ |.++++
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~  253 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARS  253 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHH
Confidence            677888999999999999999988 85 799999999999999999999999999999999999999999999 999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      ||++||..||.+|+++     .+|++||||+..
T Consensus       254 Li~~mL~~~P~~R~t~-----~~i~~h~w~~~~  281 (370)
T KOG0583|consen  254 LIEKMLVPDPSTRITL-----LEILEHPWFQKE  281 (370)
T ss_pred             HHHHHcCCCcccCCCH-----HHHhhChhhccC
Confidence            9999999999999999     999999999963

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.8e-54  Score=440.97  Aligned_cols=315  Identities=39%  Similarity=0.701  Sum_probs=261.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++.+++|+||+++++.+++...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998866555556677889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-----
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-----  304 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-----  304 (482)
                      ||++||+|..++.+++.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+....     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999997643211     


Q ss_pred             -------------------------------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc
Q 047009          305 -------------------------------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN  353 (482)
Q Consensus       305 -------------------------------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~  353 (482)
                                                     .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence                                           1134689999999999999999999999999999999999999999988


Q ss_pred             hHHHHHHHHhc--ccCCCc--cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCcccc
Q 047009          354 RAKIQQKIVKD--KLRLPA--FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEV  429 (482)
Q Consensus       354 ~~~~~~~i~~~--~~~~p~--~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~  429 (482)
                      ..+...++...  .+.+|.  .+++++++||.+|+. +|.+|++.  .+++||++||||++++|+.+..+...+|+  .+
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r--~~~~ei~~hp~f~~~~~~~~~~~~~~~~~--~~  315 (363)
T cd05628         241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGA--PGVEEIKTNPFFEGVDWEHIRERPAAIPI--EI  315 (363)
T ss_pred             HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCC--CCHHHHhCCCCCCCCCHHHHHhCCCCCCc--cC
Confidence            88888888763  445564  378999999999885 67766542  34599999999999999999877655553  44


Q ss_pred             CCcccccCccccccCCCCC----CC--CCCCCCCCCCCccCeeeec
Q 047009          430 AGKHCIANFEKKWTDMPLS----DS--PAATPKNNTNPFADFSYVR  469 (482)
Q Consensus       430 ~~~~~~~~f~~~~~~~~~~----~s--~~~~~~~~~~~f~~f~~~~  469 (482)
                      ....+.++|+.........    .+  +..........|.||+|..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (363)
T cd05628         316 KSIDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVFINYTYKR  361 (363)
T ss_pred             CCcchhhccCCCCccccccccccccCCcccccCcCCcccCCceeec
Confidence            5566677777543322111    11  1111123346799999973

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4e-54  Score=426.47  Aligned_cols=278  Identities=38%  Similarity=0.700  Sum_probs=247.2

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      .|++.+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.++++++|+||+++++++.+.+.+++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            38899999999999999999999999999999987665444445567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcc
Q 047009          231 FINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS  308 (482)
Q Consensus       231 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  308 (482)
                      |+++|+|..++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG  160 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence            99999998777543  3689999999999999999999999999999999999999999999999999988655444556


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch----HHHHHHHHhcccCCCccCChHHHHHHHHhh
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR----AKIQQKIVKDKLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L  384 (482)
                      .+||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.    ......+......++..++.++.+||++||
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  240 (285)
T cd05631         161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL  240 (285)
T ss_pred             CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHh
Confidence            7899999999999999999999999999999999999999987554    233444445556677889999999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccc
Q 047009          385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE  428 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~  428 (482)
                      +.||.+|+++...+++++++||||.+++|+.++++.+.|||+|.
T Consensus       241 ~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05631         241 TKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD  284 (285)
T ss_pred             hcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence            99999999975566799999999999999999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-55  Score=452.24  Aligned_cols=260  Identities=33%  Similarity=0.546  Sum_probs=247.4

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      ++-|++.+.||.|+-|.|.+|++..||+.+|||++.+...........+.+|+-||+.+.|||+++||++|+++.++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            46799999999999999999999999999999999987544455566788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS  308 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  308 (482)
                      .||++||.|++++.++|++++.++..+++||+.|+.|+|..+|+||||||+|+|||..+++||+|||+|..-.++....+
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998888888889


Q ss_pred             cccCCCCCchhhhcCCCC-CchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccC
Q 047009          309 MIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE  387 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~-~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~d  387 (482)
                      -||+|.|.|||++.|..| +.++||||.|||||.||||++||.+.|...++.++.++.+.+|.+++.++++||++||..|
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VD  250 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVD  250 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccC
Confidence            999999999999999988 5799999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          388 PGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       388 P~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      |.+|++.     +||++|||+.+..-
T Consensus       251 p~~RiT~-----~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  251 PSTRITT-----EEILKHPFLSGYTS  271 (786)
T ss_pred             ccccccH-----HHHhhCchhhcCCC
Confidence            9999999     99999999987653

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.3e-54  Score=434.43  Aligned_cols=313  Identities=36%  Similarity=0.757  Sum_probs=269.7

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +.||+|+||+||+|+++.+++.||+|++++...........+.+|+.++.++ +||||+++++++.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999987655555666788899988876 899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc-cCCCCCcccccCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~~~~~~~gt~  313 (482)
                      |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.. .........+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence            999999988889999999999999999999999999999999999999999999999999999763 2333445678999


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCC---------CchHHHHHHHHhcccCCCccCChHHHHHHHHhh
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIG---------GNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L  384 (482)
                      .|+|||++.+..++.++|||||||++|+|++|+.||..         .....+.+.+......+|..++.++.+||++||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L  240 (329)
T cd05618         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL  240 (329)
T ss_pred             cccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHh
Confidence            99999999999999999999999999999999999952         122345666777788899999999999999999


Q ss_pred             ccCcCCcCCCCC-CChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC---CCCCCC
Q 047009          385 QKEPGKRLGAGP-KGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT---PKNNTN  460 (482)
Q Consensus       385 ~~dP~~R~s~~~-~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~---~~~~~~  460 (482)
                      ++||++|+++.+ .+..++++||||++++|..+..+++.|++.|...+.....+|+...+.++....|...   ...++.
T Consensus       241 ~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (329)
T cd05618         241 NKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFDAQFTNEPVQLTPDDDDIVRKIDQS  320 (329)
T ss_pred             cCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCcccchhcCcccccCCccCCCCccccccccccc
Confidence            999999999632 3468999999999999999999999999999998887788887766655444333322   124567


Q ss_pred             CccCeeee
Q 047009          461 PFADFSYV  468 (482)
Q Consensus       461 ~f~~f~~~  468 (482)
                      .|.||.|.
T Consensus       321 ~~~~~~~~  328 (329)
T cd05618         321 EFEGFEYI  328 (329)
T ss_pred             ccCCCccc
Confidence            78898875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.9e-54  Score=433.54  Aligned_cols=290  Identities=42%  Similarity=0.784  Sum_probs=262.4

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGG  235 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (482)
                      +.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.++..++||||+++++++...+.+|+||||++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999999999999999998876545555666778999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCCCcccccCC
Q 047009          236 HLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTV  313 (482)
Q Consensus       236 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~~~gt~  313 (482)
                      +|..++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++... ........+||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            999999888889999999999999999999997 799999999999999999999999999997632 233344568999


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCC
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s  393 (482)
                      .|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||++||++||++|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  240 (325)
T cd05594         161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLG  240 (325)
T ss_pred             ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCC
Confidence            99999999999999999999999999999999999999988888888888888999999999999999999999999997


Q ss_pred             CCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCC
Q 047009          394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDM  445 (482)
Q Consensus       394 ~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~  445 (482)
                      ..+..+.++++|+||.++.|.....+.+.|++.|..........|+..++..
T Consensus       241 ~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (325)
T cd05594         241 GGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQ  292 (325)
T ss_pred             CCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCchhhcC
Confidence            6666779999999999999999999999999999888777777787666543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-53  Score=440.93  Aligned_cols=313  Identities=40%  Similarity=0.714  Sum_probs=262.7

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      .|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            68999999999999999999999999999999988766556667788999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-------
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-------  303 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-------  303 (482)
                      |++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+...       
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~  161 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ  161 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence            9999999999988888999999999999999999999999999999999999999999999999998643110       


Q ss_pred             -----------------------------------------CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHH
Q 047009          304 -----------------------------------------TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEM  342 (482)
Q Consensus       304 -----------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyel  342 (482)
                                                               ....+.+||+.|+|||++.+..++.++|||||||++|||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el  241 (381)
T cd05626         162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM  241 (381)
T ss_pred             ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence                                                     011346899999999999999999999999999999999


Q ss_pred             hhCCCCCCCCchHHHHHHHHh--cccCCCc--cCChHHHHHHHHhhcc--CcCCcCCCCCCChHHHHhCcCCCCCChhhh
Q 047009          343 LTGKPPFIGGNRAKIQQKIVK--DKLRLPA--FLSSEAHSLLKGLLQK--EPGKRLGAGPKGSEEIKSHKWFKPINWKKL  416 (482)
Q Consensus       343 ltG~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~LI~~~L~~--dP~~R~s~~~~~~~eil~hp~f~~~~~~~~  416 (482)
                      ++|+.||...+..+....+..  ..+.+|.  .+++++++||.+||..  ++..|+++     +++++||||.+++|...
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~-----~~~l~hp~f~~~~~~~~  316 (381)
T cd05626         242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA-----DDIKAHPFFSEVDFSSD  316 (381)
T ss_pred             HhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH-----HHHhcCcccCCCChhHH
Confidence            999999988887766666654  3344554  5799999999996654  45558888     99999999999999876


Q ss_pred             hhccCCCCCccccCCcccccCccccccCCCCC----CCCCC-----CC--CCCCCCccCeeeec
Q 047009          417 EAREIQPGFCPEVAGKHCIANFEKKWTDMPLS----DSPAA-----TP--KNNTNPFADFSYVR  469 (482)
Q Consensus       417 ~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~----~s~~~-----~~--~~~~~~f~~f~~~~  469 (482)
                      . +...+|+.|.+....+.++|+......+..    ++...     ++  ....+.|-+|+|.+
T Consensus       317 ~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (381)
T cd05626         317 I-RTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFRR  379 (381)
T ss_pred             h-hcCCCCccCcCCCcchhhhcCCCCcccccccCCccchhhhccccCcccccccccccccEeec
Confidence            5 355678999998888888887654433321    11111     11  12258899999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-55  Score=445.04  Aligned_cols=319  Identities=40%  Similarity=0.729  Sum_probs=277.4

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ....-|..++.||-|+||+|.+++..+|...||+|.++|..+..++....++.|.+||..-+.+-||+||+.|++++.+|
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            44456999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-----
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-----  301 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-----  301 (482)
                      +||||++||++..+|.+.+.|.|+.+++|++++.+|+++.|..|+|||||||+|||||.+|+|||+|||||.-+.     
T Consensus       706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999996431     


Q ss_pred             ----CC----------------------------------CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHh
Q 047009          302 ----EN----------------------------------TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEML  343 (482)
Q Consensus       302 ----~~----------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyell  343 (482)
                          ++                                  ......+||+.|+|||++...+|+..+||||.|||||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                00                                  0123568999999999999999999999999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHHhc--ccCCC--ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhc
Q 047009          344 TGKPPFIGGNRAKIQQKIVKD--KLRLP--AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR  419 (482)
Q Consensus       344 tG~~PF~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~  419 (482)
                      .|+.||...+..+...++.+-  .+.+|  ..+|.++.+||.++. .+++.|++-  .+.++++.||||++|||..+  |
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGk--ng~d~vKaHpfFkgIDfssl--R  940 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGK--NGADQVKAHPFFKGIDFSSL--R  940 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcc--cchhhhhcCccccccchHhh--h
Confidence            999999998888877777653  33444  569999999999877 589999975  78889999999999999984  5


Q ss_pred             cCCCCCccccCCcccccCccccccCCCCCCCCCCCC------CCCCCCccCeeeecC
Q 047009          420 EIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP------KNNTNPFADFSYVRP  470 (482)
Q Consensus       420 ~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~------~~~~~~f~~f~~~~~  470 (482)
                      +.+.+|+|++..+.+++|||....+..+.|....+.      .....+|-.|+|.+.
T Consensus       941 kq~ApYIP~ItHptDTSNFdpvdpeklwnddses~~~~~~~nkhpehaFyEFTfRrF  997 (1034)
T KOG0608|consen  941 KQRAPYIPRITHPTDTSNFDPVDPEKLWNDDSESPNVRDTLNKHPEHAFYEFTFRRF  997 (1034)
T ss_pred             hccCCcCccccCCCccccCCcCCccccccccccCCCcccccccCCccceeEeeeehh
Confidence            667789999999999999987555444443322221      122467888888763

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-54  Score=436.83  Aligned_cols=311  Identities=45%  Similarity=0.817  Sum_probs=272.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||+||+|+++.+++.||||++.+...........+.+|+.++..++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999998876555566677889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-----
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-----  304 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-----  304 (482)
                      ||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......     
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999998764432     


Q ss_pred             -------------------------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHH
Q 047009          305 -------------------------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ  359 (482)
Q Consensus       305 -------------------------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~  359 (482)
                                               ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~  240 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN  240 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence                                     2345679999999999999999999999999999999999999999988888888


Q ss_pred             HHHh--cccCCCcc--CChHHHHHHHHhhccCcCCcCC-CCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCccc
Q 047009          360 KIVK--DKLRLPAF--LSSEAHSLLKGLLQKEPGKRLG-AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHC  434 (482)
Q Consensus       360 ~i~~--~~~~~p~~--~s~~~~~LI~~~L~~dP~~R~s-~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~  434 (482)
                      ++..  ....+|..  +++++.+||.+||. ||.+|++ +     +++++||||++++|....  ...|++.|.+....+
T Consensus       241 ~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~-----~~ll~hp~~~~~~~~~~~--~~~~~~~~~~~~~~~  312 (350)
T cd05573         241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSF-----EEIKSHPFFKGIDWENLR--ETKPPFVPELSSPLD  312 (350)
T ss_pred             HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCH-----HHHhcCCCcCCCCHHHHh--hCCCCcCCCCCCchh
Confidence            8877  45555544  59999999999997 9999999 7     999999999999999876  666889999888888


Q ss_pred             ccCccccccCCCCCCCCC----CCCCCCCCCccCeeee
Q 047009          435 IANFEKKWTDMPLSDSPA----ATPKNNTNPFADFSYV  468 (482)
Q Consensus       435 ~~~f~~~~~~~~~~~s~~----~~~~~~~~~f~~f~~~  468 (482)
                      ..+|+..-...+..+.+.    ......+.+|.+|+|.
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (350)
T cd05573         313 TSNFDDFEDDKDLSDYLSQNSKKLNKGKQLAFVGFTYK  350 (350)
T ss_pred             hhhcCCCCcccccccccccccccccccccCccCCCccC
Confidence            888887655554433211    2223467899999984

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-53  Score=431.09  Aligned_cols=314  Identities=44%  Similarity=0.801  Sum_probs=270.1

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHH-HHHHhCCCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAER-DILTKIDHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +.||+|+||+||+|+++.+++.||+|++.+...........+..|. .+++.++||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            3699999999999999999999999999876543333333444444 456789999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCCCcccccCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~~~gt~  313 (482)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... ........+||+
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  160 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP  160 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence            9999999888889999999999999999999999999999999999999999999999999998642 333445678999


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCC
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s  393 (482)
                      .|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..+.+......++..++..+.+||.+||++||.+|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  240 (325)
T cd05602         161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLG  240 (325)
T ss_pred             cccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCC
Confidence            99999999999999999999999999999999999999888888889888888888889999999999999999999999


Q ss_pred             CCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---------CCCCCCccC
Q 047009          394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP---------KNNTNPFAD  464 (482)
Q Consensus       394 ~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~---------~~~~~~f~~  464 (482)
                      + .....++++|+||..++|..+..+.+.|++.|..........|+..+...+...+....+         ......|.|
T Consensus       241 ~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  319 (325)
T cd05602         241 A-KDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPDSILVTASVKEAAEAFLG  319 (325)
T ss_pred             C-CCCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcchhhhcCCccccCCcccccCCCchhhhhcccccccccccCC
Confidence            8 345679999999999999999999999999999888888888877666555443322111         223466899


Q ss_pred             eeeecC
Q 047009          465 FSYVRP  470 (482)
Q Consensus       465 f~~~~~  470 (482)
                      |+|..|
T Consensus       320 ~~~~~~  325 (325)
T cd05602         320 FSYAPP  325 (325)
T ss_pred             CccCCC
Confidence            998765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-53  Score=435.95  Aligned_cols=315  Identities=41%  Similarity=0.743  Sum_probs=265.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|..++||||++++++|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998765555556677889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-----
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-----  304 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-----  304 (482)
                      ||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+....     
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999987643211     


Q ss_pred             ----------------------------------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCC
Q 047009          305 ----------------------------------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFI  350 (482)
Q Consensus       305 ----------------------------------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~  350 (482)
                                                        ...+.+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~  240 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence                                              1123579999999999999999999999999999999999999999


Q ss_pred             CCchHHHHHHHHhcc--cCCCc--cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCc
Q 047009          351 GGNRAKIQQKIVKDK--LRLPA--FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFC  426 (482)
Q Consensus       351 ~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~  426 (482)
                      +.+..+....+....  +.+|.  .+++++++||++||. +|.+|++.  .+++++++||||++++|+.+.  ...+++.
T Consensus       241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~--~~~~~ll~h~~~~~~~~~~~~--~~~~~~~  315 (364)
T cd05599         241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN--NGVNEIKSHPFFKGVDWEHIR--ERPAPII  315 (364)
T ss_pred             CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC--CCHHHHhcCCCcCCCCHHHHh--hcCCCCC
Confidence            888887777776543  33443  478999999999996 99999983  345999999999999998764  4467788


Q ss_pred             cccCCcccccCccccccCCCCCCC----CCCCCCCCCCCccCeeeec
Q 047009          427 PEVAGKHCIANFEKKWTDMPLSDS----PAATPKNNTNPFADFSYVR  469 (482)
Q Consensus       427 p~~~~~~~~~~f~~~~~~~~~~~s----~~~~~~~~~~~f~~f~~~~  469 (482)
                      |......+.++|+..-........    +.......+..|.+|+|.+
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (364)
T cd05599         316 PELKSITDTSNFDDFEEIDLDVPTSPGPPRGKIKSKDLAFIGYTYKR  362 (364)
T ss_pred             CCCCCchhhhhccccccccccccCCCccccccccccCCCCCCCeeeC
Confidence            888777777788653222211111    1111235568899999975

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.6e-54  Score=430.87  Aligned_cols=312  Identities=48%  Similarity=0.866  Sum_probs=268.7

Q ss_pred             EEecccCceEEEEEEE---cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEec
Q 047009          156 KVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFI  232 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~---~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  232 (482)
                      +.||+|+||.||++++   +.+|+.||+|++.+.... ......+.+|+.+|++++||||+++++++.+.+.+|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            5799999999999886   457899999999876432 223445678999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCccccc
Q 047009          233 NGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSNSMIG  311 (482)
Q Consensus       233 ~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~~g  311 (482)
                      ++|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ......+|
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  160 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG  160 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence            99999999988888999999999999999999999999999999999999999999999999999875433 33456789


Q ss_pred             CCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCc
Q 047009          312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR  391 (482)
Q Consensus       312 t~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R  391 (482)
                      |+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+......+|..++..+++||++||++||.+|
T Consensus       161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R  240 (318)
T cd05582         161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANR  240 (318)
T ss_pred             ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHc
Confidence            99999999999999999999999999999999999999998888888889888889999999999999999999999999


Q ss_pred             CCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC-CCCCCCCccCeeee
Q 047009          392 LGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT-PKNNTNPFADFSYV  468 (482)
Q Consensus       392 ~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~-~~~~~~~f~~f~~~  468 (482)
                      +++.....+++++|+||..++|..+..+++.|++.|......+...++..+...+...++... .......|.+|+|+
T Consensus       241 ~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~  318 (318)
T cd05582         241 LGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDSPGIPPSANAHQLFRGFSFV  318 (318)
T ss_pred             CCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCCCCcchhhhcCcccccCccccCCCCccccccccccCCCEeC
Confidence            998555578999999999999999999999999998876666655565544433222222222 22345789999985

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.8e-53  Score=427.64  Aligned_cols=312  Identities=43%  Similarity=0.786  Sum_probs=269.0

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHH-HHHhCCCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD-ILTKIDHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +.||+|+||.||+|+++.+++.||+|++.+...........+..|.. +++.++||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999999999999999998765544444444555554 67889999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc-cCCCCCcccccCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~~~~~~~gt~  313 (482)
                      |+|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.. .........+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP  160 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence            999999988888999999999999999999999999999999999999999999999999999863 2233345578999


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCC
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s  393 (482)
                      .|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+......+|...+.++.++|.+||++||.+|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  240 (321)
T cd05603         161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLG  240 (321)
T ss_pred             ccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCC
Confidence            99999999999999999999999999999999999999988888999998888899899999999999999999999998


Q ss_pred             CCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC------CCCCCCccCeee
Q 047009          394 AGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP------KNNTNPFADFSY  467 (482)
Q Consensus       394 ~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~------~~~~~~f~~f~~  467 (482)
                      + ...+.++++|+||..++|..+..+.+.|++.|...+......|+..++......+...++      ...-+.|.||+|
T Consensus       241 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (321)
T cd05603         241 A-KADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSASSAFLGFSY  319 (321)
T ss_pred             C-CCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCCcccccccccccCCCCcccccccccccccCCCcc
Confidence            7 245679999999999999999989999999998888777778876666544443333222      223466889987


Q ss_pred             e
Q 047009          468 V  468 (482)
Q Consensus       468 ~  468 (482)
                      .
T Consensus       320 ~  320 (321)
T cd05603         320 A  320 (321)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.5e-53  Score=433.97  Aligned_cols=315  Identities=38%  Similarity=0.709  Sum_probs=263.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..++||||+++++.|++.+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998766555566777889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-----
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-----  304 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-----  304 (482)
                      ||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+....     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999987542211     


Q ss_pred             -------------------------------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc
Q 047009          305 -------------------------------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN  353 (482)
Q Consensus       305 -------------------------------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~  353 (482)
                                                     .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence                                           1124589999999999999999999999999999999999999999988


Q ss_pred             hHHHHHHHHhc--ccCCCcc--CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCcccc
Q 047009          354 RAKIQQKIVKD--KLRLPAF--LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEV  429 (482)
Q Consensus       354 ~~~~~~~i~~~--~~~~p~~--~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~  429 (482)
                      .......+...  .+.+|..  ++.++++||.+|+ .||.+|++.  .+++++++||||++++|..+..+...+|+  .+
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~--~~~~ei~~hp~f~~~~~~~~~~~~~~~~~--~~  315 (360)
T cd05627         241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGS--NGVEEIKSHPFFEGVDWGHIRERPAAIPI--EI  315 (360)
T ss_pred             HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCC--CCHHHHhcCCCCCCCCHHHHhcCCCCCCc--cC
Confidence            88888887753  3445543  7899999999987 499999975  46799999999999999999877665554  34


Q ss_pred             CCcccccCccccccCC---CCCCCCCCCCCCCCCCccCeeeec
Q 047009          430 AGKHCIANFEKKWTDM---PLSDSPAATPKNNTNPFADFSYVR  469 (482)
Q Consensus       430 ~~~~~~~~f~~~~~~~---~~~~s~~~~~~~~~~~f~~f~~~~  469 (482)
                      ....+.++|+..-...   +...............|-+|+|.+
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (360)
T cd05627         316 KSIDDTSNFDEFPESDILQPAENTIEPDYKSKDWVFLNYTYKR  358 (360)
T ss_pred             CCcchhhhcCCCCcccccCCCccccccccCcCCcccCCceeec
Confidence            5566677776422211   111111111234567899999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-53  Score=436.12  Aligned_cols=316  Identities=40%  Similarity=0.721  Sum_probs=262.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++++.||+|+||+||+|+++.+++.||||++.+.........+.+.+|+.+++.++||||++++++|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999998765545556677889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-----
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-----  304 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-----  304 (482)
                      ||++||+|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.+....     
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999996431100     


Q ss_pred             -------------------------------------------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHH
Q 047009          305 -------------------------------------------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYE  341 (482)
Q Consensus       305 -------------------------------------------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilye  341 (482)
                                                                 .....+||+.|+|||++.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE  240 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence                                                       0013579999999999999999999999999999999


Q ss_pred             HhhCCCCCCCCchHHHHHHHHhc--ccCCCc--cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhh
Q 047009          342 MLTGKPPFIGGNRAKIQQKIVKD--KLRLPA--FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLE  417 (482)
Q Consensus       342 lltG~~PF~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~  417 (482)
                      |++|+.||.+.+..+....+...  .+.+|.  .++.++++||++||. +|.+|++.  .++.+++.||||++++|+.+ 
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r--~~~~~~l~hp~~~~~~~~~~-  316 (377)
T cd05629         241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGR--GGAHEIKSHPFFRGVDWDTI-  316 (377)
T ss_pred             hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCC--CCHHHHhcCCCcCCCCHHHH-
Confidence            99999999988887777777653  445554  478999999999997 88887632  34599999999999999888 


Q ss_pred             hccCCCCCccccCCcccccCccccccCCC----CC--CCCC--CCCCCCCCCccCeeeecC
Q 047009          418 AREIQPGFCPEVAGKHCIANFEKKWTDMP----LS--DSPA--ATPKNNTNPFADFSYVRP  470 (482)
Q Consensus       418 ~~~~~p~~~p~~~~~~~~~~f~~~~~~~~----~~--~s~~--~~~~~~~~~f~~f~~~~~  470 (482)
                       +.+.+|+.|......+...|........    ..  .++.  ..+...+.+|.||+|.+.
T Consensus       317 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (377)
T cd05629         317 -RQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGYTYKRF  376 (377)
T ss_pred             -ccCCCCcccCCCCccccccCCccccccCccccccccccccccccccccCcccccceecCC
Confidence             5678889998777666665643322111    00  0111  112345688999998763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.9e-53  Score=435.71  Aligned_cols=287  Identities=44%  Similarity=0.779  Sum_probs=252.0

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++++++||||+++++.|.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            69999999999999999999999999999999987765555667788999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC--------
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE--------  302 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~--------  302 (482)
                      |++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+..        
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~  161 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  161 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence            999999999998888899999999999999999999999999999999999999999999999999753210        


Q ss_pred             ----------------------------------------CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHH
Q 047009          303 ----------------------------------------NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEM  342 (482)
Q Consensus       303 ----------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyel  342 (482)
                                                              .....+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el  241 (382)
T cd05625         162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  241 (382)
T ss_pred             cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence                                                    0011245799999999999999999999999999999999


Q ss_pred             hhCCCCCCCCchHHHHHHHHhc--ccCCC--ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhh
Q 047009          343 LTGKPPFIGGNRAKIQQKIVKD--KLRLP--AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEA  418 (482)
Q Consensus       343 ltG~~PF~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~  418 (482)
                      ++|+.||.+.+..+....+...  ...+|  ..+++++.+||.+|+ .+|.+|++.  .+++++++||||+.++|.... 
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~--~~~~ei~~hp~f~~~~~~~~~-  317 (382)
T cd05625         242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK--NGADEIKAHPFFKTIDFSSDL-  317 (382)
T ss_pred             HhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC--CCHHHHhcCCCcCCcChHHHH-
Confidence            9999999988877777776653  33444  358999999999987 599999983  456999999999999998755 


Q ss_pred             ccCCCCCccccCCcccccCcccc
Q 047009          419 REIQPGFCPEVAGKHCIANFEKK  441 (482)
Q Consensus       419 ~~~~p~~~p~~~~~~~~~~f~~~  441 (482)
                      ++..+|+.|.+..+.+.++|+..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
T cd05625         318 RQQSAPYIPKITHPTDTSNFDPV  340 (382)
T ss_pred             hcCCCCccCcCCCcchhhhcCCC
Confidence            45678999999888888888754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-54  Score=400.48  Aligned_cols=260  Identities=34%  Similarity=0.645  Sum_probs=248.5

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ....+++|++.+.||+|.||.||+|+.+.++..||+|++.|.++........+.+|++|.+.|+||||+++|++|.+...
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r   96 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR   96 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence            34678999999999999999999999999999999999999998888888889999999999999999999999999999


Q ss_pred             EEEEEEecCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          225 LYLVLDFINGGHLFFQLY--HHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      +||++||...|+|+..|.  ....+++..+..|+.|++.||.|+|.++||||||||+|+|++.+|.+||+|||-+.... 
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999999998  66789999999999999999999999999999999999999999999999999987755 


Q ss_pred             CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHH
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKG  382 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~  382 (482)
                      .....++|||..|.+||...+..++..+|+|++|++.||++.|.+||...+..+++++|.+..+.+|..++.+++|||.+
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~  255 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISR  255 (281)
T ss_pred             CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHH
Confidence            55667899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          383 LLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       383 ~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      ||.++|.+|...     .|++.|||+..
T Consensus       256 ll~~~p~~r~~l-----~~v~~hpwI~a  278 (281)
T KOG0580|consen  256 LLVKNPIERLAL-----TEVMDHPWIVA  278 (281)
T ss_pred             HhccCccccccH-----HHHhhhHHHHh
Confidence            999999999998     99999999864

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.3e-53  Score=433.64  Aligned_cols=316  Identities=36%  Similarity=0.671  Sum_probs=264.6

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ..++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            34789999999999999999999999999999999987655444556668899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--C
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--R  305 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--~  305 (482)
                      ||||++||+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......  .
T Consensus       121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence            99999999999988654 68999999999999999999999999999999999999999999999999998764332  2


Q ss_pred             CcccccCCCCCchhhhcCCC----CCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc--cCCCc--cCChHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKG----HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPA--FLSSEAH  377 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~----~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~  377 (482)
                      ....+||+.|+|||++.+..    ++.++|||||||++|+|++|+.||.+.+.......+....  +.+|.  .++..++
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~  279 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK  279 (370)
T ss_pred             cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHH
Confidence            34678999999999997653    7889999999999999999999999988888888887643  45555  4699999


Q ss_pred             HHHHHhhccCcCC--cCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCC-CCCC
Q 047009          378 SLLKGLLQKEPGK--RLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDS-PAAT  454 (482)
Q Consensus       378 ~LI~~~L~~dP~~--R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s-~~~~  454 (482)
                      +||.+||..++.+  |+++     .|+++||||+...|.....+...+|+.|......+.++|+..........+ +...
T Consensus       280 ~li~~~L~~~~~r~~R~~~-----~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (370)
T cd05621         280 NLICAFLTDREVRLGRNGV-----EEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPK  354 (370)
T ss_pred             HHHHHHccCchhccCCCCH-----HHHhcCcccCCCCcChHhcCCCCCCcCCCCCCcchhhhcCCccccccccccCCCCc
Confidence            9999999855443  6666     999999999998887776678888999999888888888753332221111 1111


Q ss_pred             -CCCCCCCccCeeeec
Q 047009          455 -PKNNTNPFADFSYVR  469 (482)
Q Consensus       455 -~~~~~~~f~~f~~~~  469 (482)
                       ....+..|.||+|++
T Consensus       355 ~~~~~~~~~~~~~~~~  370 (370)
T cd05621         355 AFVGNQLPFIGFTYYR  370 (370)
T ss_pred             cccccccccCCCEecC
Confidence             123468999999975

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.4e-53  Score=432.79  Aligned_cols=316  Identities=36%  Similarity=0.664  Sum_probs=267.9

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ...++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34578999999999999999999999999999999998765544455566788999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--  304 (482)
                      +||||++||+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......  
T Consensus       120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence            99999999999988765 468999999999999999999999999999999999999999999999999998764332  


Q ss_pred             CCcccccCCCCCchhhhcCC----CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc--cCCCc--cCChHH
Q 047009          305 RSNSMIGTVEYMAPEIVLGK----GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPA--FLSSEA  376 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~----~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~--~~s~~~  376 (482)
                      .....+||+.|+|||++.+.    .++.++|||||||++|||++|+.||.+.+....+..+....  +.+|.  .++.++
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA  278 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence            23456899999999999764    37899999999999999999999999988888888887643  45565  479999


Q ss_pred             HHHHHHhhccCcCC--cCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCC--CCC
Q 047009          377 HSLLKGLLQKEPGK--RLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSD--SPA  452 (482)
Q Consensus       377 ~~LI~~~L~~dP~~--R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~--s~~  452 (482)
                      ++||++||+.+|.+  |+++     +++++||||++.+|.....+...+++.|......+..+|++.........  ...
T Consensus       279 ~~li~~~L~~~p~r~~R~s~-----~ell~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (370)
T cd05596         279 KDLICAFLTDREVRLGRNGV-----DEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDIEDDDKNEETFPLP  353 (370)
T ss_pred             HHHHHHHccChhhccCCCCH-----HHHhcCcccCCCChhhHHhcCCCcCccCcCCCcchhhhcCCccccccccccCCCc
Confidence            99999999999988  8888     99999999999999888888888999999888877888876444331111  111


Q ss_pred             CCCCCCCCCccCeeee
Q 047009          453 ATPKNNTNPFADFSYV  468 (482)
Q Consensus       453 ~~~~~~~~~f~~f~~~  468 (482)
                      .....+...|.||+|.
T Consensus       354 ~~~~~~~~~~~~~~~~  369 (370)
T cd05596         354 KAFAGNQLPFIGFTYS  369 (370)
T ss_pred             cccccccCccCCCeec
Confidence            1112334569999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.3e-52  Score=430.29  Aligned_cols=290  Identities=44%  Similarity=0.772  Sum_probs=250.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+|++++||||+++++.|.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998765544555677889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC------
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------  303 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~------  303 (482)
                      ||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..+...      
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999998532100      


Q ss_pred             --------------------------------------CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhC
Q 047009          304 --------------------------------------TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTG  345 (482)
Q Consensus       304 --------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG  345 (482)
                                                            ......+||+.|||||++.+..++.++|||||||++|||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G  240 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG  240 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence                                                  011245799999999999999999999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHhcc--cCCC--ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccC
Q 047009          346 KPPFIGGNRAKIQQKIVKDK--LRLP--AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREI  421 (482)
Q Consensus       346 ~~PF~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~  421 (482)
                      +.||.+.+..+....+....  ..+|  ..++.++.+||.+|+ .+|.+|++.  .++.++++||||+.++|..+. +..
T Consensus       241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~--~t~~ell~h~~~~~~~~~~~~-~~~  316 (376)
T cd05598         241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK--NGADEIKAHPFFKGIDFASLI-RRQ  316 (376)
T ss_pred             CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC--CCHHHHhCCCCcCCCCHHHHh-hcC
Confidence            99999888777766665432  2333  358999999999977 599999932  234999999999999998887 556


Q ss_pred             CCCCccccCCcccccCcccccc
Q 047009          422 QPGFCPEVAGKHCIANFEKKWT  443 (482)
Q Consensus       422 ~p~~~p~~~~~~~~~~f~~~~~  443 (482)
                      .+++.|.+....+.++|+....
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~  338 (376)
T cd05598         317 KAPYIPKITHPTDTSNFDPVDP  338 (376)
T ss_pred             CCCCCCcCCCcchhhhcCCCCc
Confidence            7788898888888888775433

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-52  Score=424.54  Aligned_cols=286  Identities=46%  Similarity=0.829  Sum_probs=253.3

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC---CCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI---DHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       158 LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      ||+|+||+||+|+++.+++.||+|++.+..............|..++..+   +||||+++++++.+...+|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999999876554444444556677777765   799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCCCcccccCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~~~~~gt~  313 (482)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  160 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT  160 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence            9999999888899999999999999999999999999999999999999999999999999997642 233345678999


Q ss_pred             CCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCc-cCChHHHHHHHHhhccCcCCc
Q 047009          314 EYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA-FLSSEAHSLLKGLLQKEPGKR  391 (482)
Q Consensus       314 ~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~-~~s~~~~~LI~~~L~~dP~~R  391 (482)
                      .|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..++.+.+..+...+|. .++.++++||++||++||.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R  240 (330)
T cd05586         161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR  240 (330)
T ss_pred             cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence            99999999764 5899999999999999999999999999888888888888888775 479999999999999999999


Q ss_pred             CCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccC
Q 047009          392 LGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD  444 (482)
Q Consensus       392 ~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~  444 (482)
                      +++ ...++++++||||..++|..+..+.++|++.|........++|+..+..
T Consensus       241 ~~~-~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (330)
T cd05586         241 LGA-HRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFTN  292 (330)
T ss_pred             CCC-CCCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcchhhcCccccc
Confidence            976 3456999999999999999999999999999998877777788765544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6e-52  Score=419.40  Aligned_cols=311  Identities=37%  Similarity=0.699  Sum_probs=263.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999999876545556677889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC--C
Q 047009          230 DFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR--S  306 (482)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~--~  306 (482)
                      ||++||+|..++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.....  .
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            999999999999876 6799999999999999999999999999999999999999999999999999987644332  2


Q ss_pred             cccccCCCCCchhhhc------CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc--cCCCc--cCChHH
Q 047009          307 NSMIGTVEYMAPEIVL------GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPA--FLSSEA  376 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~------~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~--~~s~~~  376 (482)
                      ...+||+.|+|||++.      +..++.++|||||||++|+|++|+.||...+.......+....  ..+|.  .++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF  240 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence            3457999999999997      4567899999999999999999999999888877777776542  33443  579999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCC---C
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPA---A  453 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~---~  453 (482)
                      .+||.+||. ||.+|+++     +++++||||..++|..+..  ..|++.|......+..+|+......+......   .
T Consensus       241 ~~li~~ll~-~p~~R~t~-----~~l~~h~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (330)
T cd05601         241 LDLIQSLLC-GQKERLGY-----EGLCCHPFFSKIDWNNIRN--SLPPFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQL  312 (330)
T ss_pred             HHHHHHHcc-ChhhCCCH-----HHHhCCCCcCCCCHHHHhh--CCCCccCcCCCcchhhhcCCCccccccccccccccC
Confidence            999999997 99999999     9999999999999998763  55778888887777888876544433322111   1


Q ss_pred             CC---CCCCCCccCeeee
Q 047009          454 TP---KNNTNPFADFSYV  468 (482)
Q Consensus       454 ~~---~~~~~~f~~f~~~  468 (482)
                      .+   .....+|-+|+|.
T Consensus       313 ~~~~~~~~~~~~~~~~~~  330 (330)
T cd05601         313 KPNGFSGKDLPFVGFSFI  330 (330)
T ss_pred             CCcCCCCCCCCccCceeC
Confidence            11   2345889999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-51  Score=418.21  Aligned_cols=281  Identities=41%  Similarity=0.727  Sum_probs=250.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998876544556667889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCccc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM  309 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  309 (482)
                      ||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....  .....
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~  158 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSV  158 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999987543  34567


Q ss_pred             ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc--cCCCc------cCChHHHHHHH
Q 047009          310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPA------FLSSEAHSLLK  381 (482)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~------~~s~~~~~LI~  381 (482)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+....  +..|.      .++.++.+||.
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~  238 (333)
T cd05600         159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT  238 (333)
T ss_pred             ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHH
Confidence            89999999999999999999999999999999999999999888887777766532  22222      45899999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCcc
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE  439 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~  439 (482)
                      +||..+|.+|+++     +++++||||..++|..+.  ...|++.|..........|+
T Consensus       239 ~~l~~~~~rr~s~-----~~ll~h~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  289 (333)
T cd05600         239 KLINDPSRRFGSL-----EDIKNHPFFKEVDWNELR--ELKPPFVPELESEIDTGYFD  289 (333)
T ss_pred             HHhhChhhhcCCH-----HHHHhCcccCCCCHHHHh--hCCCCCCCCCCCcchhhhcc
Confidence            9999999999998     999999999999998876  77888988876655554554

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3e-53  Score=429.34  Aligned_cols=255  Identities=37%  Similarity=0.660  Sum_probs=240.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|-+.+.||+|+||.||+|+.+.+.+.||||.+.|... .....+.+.+|++|++.++|||||.++++|++..++|+|
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            4688899999999999999999999999999999988764 345667789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC-Cc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-SN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~~  307 (482)
                      .||+.| +|+.+|...+.++|+.++.++.+++.||.|||+++|+|||+||.|||++..|++|+||||+|+.+..+.. ..
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence            999988 9999999999999999999999999999999999999999999999999999999999999999866543 45


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccC
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE  387 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~d  387 (482)
                      +.-|||.|||||++.+..|+..+|+||||||+|||++|++||.......+...|.++....|...+..+.+||..+|.+|
T Consensus       159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kd  238 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKD  238 (808)
T ss_pred             eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcC
Confidence            67899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCcCCCCCCChHHHHhCcCCCC
Q 047009          388 PGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       388 P~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      |.+|++-     .+++.|||.++
T Consensus       239 P~~RltW-----~~Ll~HpF~k~  256 (808)
T KOG0597|consen  239 PAQRLTW-----TDLLGHPFWKG  256 (808)
T ss_pred             hhhcccH-----HHHhcChHHhh
Confidence            9999986     99999999875

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.7e-51  Score=423.57  Aligned_cols=320  Identities=37%  Similarity=0.677  Sum_probs=263.8

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      ....++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            34568999999999999999999999999999999999876554445556678899999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  304 (482)
                      |+||||++||+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...... 
T Consensus       119 ~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence            999999999999988865 458999999999999999999999999999999999999999999999999998764322 


Q ss_pred             -CCcccccCCCCCchhhhcCCC----CCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc--cCCCc--cCChH
Q 047009          305 -RSNSMIGTVEYMAPEIVLGKG----HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPA--FLSSE  375 (482)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~~----~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~--~~s~~  375 (482)
                       .....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||.+.+.......+....  +.+|.  .++.+
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  277 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence             234678999999999997643    7899999999999999999999999988888888887643  44554  58999


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCC-CCCC
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDS-PAAT  454 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s-~~~~  454 (482)
                      +++||.+||. +|.+|++-  .++++|++|+||++.+|.....+...+|+.|........++|++...+...... +...
T Consensus       278 ~~~li~~~L~-~~~~r~~r--~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (371)
T cd05622         278 AKNLICAFLT-DREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDIEEDKGEEETFPIPK  354 (371)
T ss_pred             HHHHHHHHcC-ChhhhcCC--CCHHHHhcCcccCCCChhHHhcCCCCCCCCCCCCCcchhhhcCCCcccccccccCCCCc
Confidence            9999999998 66665432  344999999999998887766778888999988777777777654332221111 1111


Q ss_pred             -CCCCCCCccCeeeec
Q 047009          455 -PKNNTNPFADFSYVR  469 (482)
Q Consensus       455 -~~~~~~~f~~f~~~~  469 (482)
                       .......|.||+|+.
T Consensus       355 ~~~~~~~~~~~~~~~~  370 (371)
T cd05622         355 AFVGNQLPFVGFTYYS  370 (371)
T ss_pred             cccccccccCCCeecC
Confidence             122348999999973

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-51  Score=405.89  Aligned_cols=278  Identities=40%  Similarity=0.725  Sum_probs=245.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      .|++.+.||+|+||+||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48899999999999999999999999999999987654444445567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcc
Q 047009          231 FINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS  308 (482)
Q Consensus       231 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  308 (482)
                      |+.+|+|..++...  ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||+++..........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG  160 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence            99999998887654  4589999999999999999999999999999999999999999999999999987655444456


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHH----HHHHHHhcccCCCccCChHHHHHHHHhh
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAK----IQQKIVKDKLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~LI~~~L  384 (482)
                      .+|++.|+|||++.+..++.++||||+||++|||++|+.||.+.+...    +...+......++..++..+++||.+||
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05605         161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL  240 (285)
T ss_pred             ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHc
Confidence            689999999999999999999999999999999999999998765533    3344445556677789999999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccc
Q 047009          385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE  428 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~  428 (482)
                      ..||.+|++....+++++++|+||...+|+.+..++++|||+|.
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05605         241 TKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD  284 (285)
T ss_pred             cCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCC
Confidence            99999999664445699999999999999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-54  Score=397.43  Aligned_cols=258  Identities=32%  Similarity=0.586  Sum_probs=240.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .+.|++.+.||+|.|+.|+++.++.+|+.+|+|+++...+... ..+.+.+|++|-+.|+|||||+|.+.+...+..|||
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4678899999999999999999999999999999988776554 667799999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC---CceeEcccCccccccCCCC
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD---GHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~---g~vKL~DFGla~~~~~~~~  305 (482)
                      +|+|.|++|..-+..+-.++|..+-.+++||+.||.|+|.+||||||+||+|+||-+.   .-+||+|||+|..+..+..
T Consensus        89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~  168 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA  168 (355)
T ss_pred             EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence            9999999999888887788999999999999999999999999999999999999643   3599999999999987777


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCc----cCChHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLK  381 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~LI~  381 (482)
                      ....+|||.|||||+++..+|+..+|||+.|||||-|+.|++||.+.+...+++.|.++.+.+|.    .+++++++||+
T Consensus       169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvr  248 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIR  248 (355)
T ss_pred             cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHH
Confidence            88899999999999999999999999999999999999999999999999999999999888775    58999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      +||..||.+|+++     .|+|+|||+++-+
T Consensus       249 rML~~dP~kRIta-----~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  249 RMLTVNPKKRITA-----DEALKHPWICNRE  274 (355)
T ss_pred             HHhccChhhhccH-----HHHhCCchhcchH
Confidence            9999999999999     9999999998743

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8e-53  Score=399.61  Aligned_cols=256  Identities=30%  Similarity=0.513  Sum_probs=224.6

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      ++.|+.+.++|+|+||.||++++++||+.||||++.... .+....+-..+|+++|++++|+|+|.|+.+|....+++||
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            467899999999999999999999999999999987543 2344556678999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCCC
Q 047009          229 LDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~~  306 (482)
                      +|||+..- .+.|.+. ..++.+.++.|+.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+. .+...
T Consensus        80 FE~~dhTv-L~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   80 FEYCDHTV-LHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             eeecchHH-HHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            99998854 4455443 568999999999999999999999999999999999999999999999999999987 67777


Q ss_pred             cccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-------------------c
Q 047009          307 NSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-------------------L  366 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-------------------~  366 (482)
                      +..+.|..|+|||.+.| ..|+..+||||+||++.||++|.+.|.+.+..+....|.+.-                   +
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            88899999999999998 789999999999999999999999999988777666665411                   1


Q ss_pred             CCCc------------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          367 RLPA------------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       367 ~~p~------------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      .+|.            .++.-+.||+++||+.||.+|+++     ++++.|+||.++
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc-----~qll~H~yFd~~  290 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSC-----EQLLHHPYFDGF  290 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccH-----HHHhcChHHHHH
Confidence            2221            367789999999999999999999     999999999653

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-53  Score=400.22  Aligned_cols=248  Identities=32%  Similarity=0.544  Sum_probs=224.6

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeee-eeecCCe
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY-SFQTKYR  224 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~~~  224 (482)
                      .....+|+++++||+|+||+||++++..+|+.||.|.++-..+ +....+.+..|+.+|++|+|||||++++ .|..+..
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            3456789999999999999999999999999999999986544 4556677889999999999999999988 5655555


Q ss_pred             -EEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--CcccCCCCCcEEEccCCceeEcccC
Q 047009          225 -LYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHA--NG--IMHRDLKPENILLGADGHVMLTDFG  295 (482)
Q Consensus       225 -~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~--~~--IiHrDLKp~NILl~~~g~vKL~DFG  295 (482)
                       ++||||||.+|+|...+++    +..++|..+|.|+.|++.||.++|+  .+  |+||||||.||+|+.+|.+||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence             8999999999999888764    4569999999999999999999999  45  9999999999999999999999999


Q ss_pred             ccccccCCC-CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC-CC-ccC
Q 047009          296 LAKQFDENT-RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-LP-AFL  372 (482)
Q Consensus       296 la~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~-~p-~~~  372 (482)
                      +++.+.... ...+.+|||.||+||++.+.+|+.++||||+||++|||+.-++||.+.+...+.++|.++.+. +| ..+
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~Y  253 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHY  253 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHh
Confidence            999986543 457889999999999999999999999999999999999999999999999999999999775 77 678


Q ss_pred             ChHHHHHHHHhhccCcCCcCCC
Q 047009          373 SSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       373 s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                      |.++..||..|+..||..||+.
T Consensus       254 S~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  254 STDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             hhHHHHHHHHHccCCcccCCCc
Confidence            9999999999999999999984

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-52  Score=413.99  Aligned_cols=258  Identities=33%  Similarity=0.623  Sum_probs=227.8

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh-----------hHHHHHHHHHHHHHhCCCCceee
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK-----------NHAEYMKAERDILTKIDHPFVVQ  214 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~hpnIv~  214 (482)
                      +..+++|++++.||+|.||+|.+|++..+++.||||++.+......           ...+.+++|+.||+++.|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            3567899999999999999999999999999999999988664321           23467899999999999999999


Q ss_pred             eeeeeec--CCeEEEEEEecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeE
Q 047009          215 LKYSFQT--KYRLYLVLDFINGGHLFFQLYHHGL-FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVML  291 (482)
Q Consensus       215 l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL  291 (482)
                      |+.+..+  .+++|||+|||..|.+... -..+. +++.+++.|+++++.||+|||.+|||||||||+|+||+++|++||
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence            9999865  4689999999999987532 22344 899999999999999999999999999999999999999999999


Q ss_pred             cccCccccccCC------CCCcccccCCCCCchhhhcCCC----CCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHH
Q 047009          292 TDFGLAKQFDEN------TRSNSMIGTVEYMAPEIVLGKG----HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI  361 (482)
Q Consensus       292 ~DFGla~~~~~~------~~~~~~~gt~~y~APE~l~~~~----~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i  361 (482)
                      +|||.+.....+      ......+|||.|||||.+.+..    .+.+.||||+||+||.|+.|+.||.+....+++.+|
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI  331 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI  331 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence            999999876322      1223478999999999998732    357899999999999999999999999999999999


Q ss_pred             HhcccCCCcc--CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          362 VKDKLRLPAF--LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       362 ~~~~~~~p~~--~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      .+..+.+|..  +..++++||.+||++||.+|+++     .+|+.|||..
T Consensus       332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l-----~~ik~Hpwvt  376 (576)
T KOG0585|consen  332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITL-----PDIKLHPWVT  376 (576)
T ss_pred             hcCcccCCCcccccHHHHHHHHHHhhcChhheeeh-----hhheecceec
Confidence            9999999976  79999999999999999999999     9999999974

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.9e-50  Score=398.46  Aligned_cols=289  Identities=46%  Similarity=0.834  Sum_probs=265.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|++++++++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998766555556677889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCccc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM  309 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  309 (482)
                      ||+++++|..++.+.+.+++..+..++.||+.||.|||++||+||||+|+|||++.+|.+||+|||+++.....  ....
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~  158 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTL  158 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCC
Confidence            99999999999988889999999999999999999999999999999999999999999999999999886544  3456


Q ss_pred             ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcC
Q 047009          310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPG  389 (482)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~  389 (482)
                      +|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.....+.+..+...+|..++..++++|.+||..||.
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  238 (290)
T cd05580         159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLT  238 (290)
T ss_pred             CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHH
Confidence            79999999999998889999999999999999999999998888878888888888889999999999999999999999


Q ss_pred             CcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccc
Q 047009          390 KRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEK  440 (482)
Q Consensus       390 ~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~  440 (482)
                      +|++.....++|+++||||+.++|..+....+.+|+.|....+.+.++|++
T Consensus       239 ~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (290)
T cd05580         239 KRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDD  289 (290)
T ss_pred             HccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCCCccccccccC
Confidence            999665567799999999999999999999999999998887777777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.6e-50  Score=399.69  Aligned_cols=270  Identities=36%  Similarity=0.693  Sum_probs=237.5

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCCch
Q 047009          158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL  237 (482)
Q Consensus       158 LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (482)
                      ||+|+||+||+|.++.+++.||+|.+.+.........+.+..|+.+++.++|+||+++++++.....+|+||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999999999999999999876554444556678899999999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCcccccC
Q 047009          238 FFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSMIGT  312 (482)
Q Consensus       238 ~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~~~gt  312 (482)
                      ..++..    +..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..+.... ......||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            877643    3568999999999999999999999999999999999999999999999999998764432 23446799


Q ss_pred             CCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch----HHHHHHHHhcccCCCccCChHHHHHHHHhhccCc
Q 047009          313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR----AKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP  388 (482)
Q Consensus       313 ~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP  388 (482)
                      +.|+|||++.+..++.++|+|||||++|+|++|+.||.....    ......+......+|..++.++.+|+.+||+.||
T Consensus       161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  240 (280)
T cd05608         161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP  240 (280)
T ss_pred             cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCH
Confidence            999999999999999999999999999999999999976432    3344555556667778899999999999999999


Q ss_pred             CCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCcc
Q 047009          389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP  427 (482)
Q Consensus       389 ~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p  427 (482)
                      .+|+++....++++++||||++++|..+....+.+||.|
T Consensus       241 ~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~  279 (280)
T cd05608         241 EKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP  279 (280)
T ss_pred             HHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCC
Confidence            999987555679999999999999999999999888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3e-50  Score=407.82  Aligned_cols=314  Identities=35%  Similarity=0.692  Sum_probs=255.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++++.||+|+||.||+++++.+++.||+|++.+...........+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999998755444455666888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC--C
Q 047009          230 DFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR--S  306 (482)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~--~  306 (482)
                      ||+.||+|..++.+ .+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.......  .
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            99999999999987 46789999999999999999999999999999999999999999999999999987643322  2


Q ss_pred             cccccCCCCCchhhhcC-----CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc--cCCCc---cCChHH
Q 047009          307 NSMIGTVEYMAPEIVLG-----KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPA---FLSSEA  376 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~-----~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~---~~s~~~  376 (482)
                      ...+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||...+..+....+....  +.+|.   .++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~  240 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA  240 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence            34579999999999976     467889999999999999999999999888888887776643  34444   368999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCcccccc--CCCCCCCCCCC
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWT--DMPLSDSPAAT  454 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~--~~~~~~s~~~~  454 (482)
                      ++||.+||..++ +|+..  .+++++++|+||++++|..+  +...+++.|.........+|+....  ..+...++...
T Consensus       241 ~~li~~ll~~~~-~~~~~--~~~~~~~~h~~f~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (331)
T cd05624         241 KDLIQRLICSRE-RRLGQ--NGIEDFKKHAFFEGIDWENI--RNLEAPYIPDVSSPSDTSNFDVDDDVLRNPEIAPPSSH  315 (331)
T ss_pred             HHHHHHHccCch-hhcCC--CCHHHHhcCCCcCCCCHHHH--hhCCCCccCCCCCcchhhhcCCccccccccccCCCccc
Confidence            999999998655 44432  34599999999999999987  4567888888777776667653322  12222222211


Q ss_pred             C--CCCCCCccCeeee
Q 047009          455 P--KNNTNPFADFSYV  468 (482)
Q Consensus       455 ~--~~~~~~f~~f~~~  468 (482)
                      .  ..--.++.+|+|.
T Consensus       316 ~~~~~~~~~~~~~~~~  331 (331)
T cd05624         316 TGFSGLHLPFVGFTYT  331 (331)
T ss_pred             cccCCCCcCCCCceeC
Confidence            1  1112568888873

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-50  Score=405.99  Aligned_cols=311  Identities=36%  Similarity=0.698  Sum_probs=252.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++++.||+|+||.||+++++.+++.||+|++.+.........+.+.+|+.++..++|+||++++++|.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765545555667889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC--C
Q 047009          230 DFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR--S  306 (482)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~--~  306 (482)
                      ||++||+|..++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.....  .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99999999999876 45799999999999999999999999999999999999999999999999999977543322  2


Q ss_pred             cccccCCCCCchhhhcC-----CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc--cCCCc---cCChHH
Q 047009          307 NSMIGTVEYMAPEIVLG-----KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPA---FLSSEA  376 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~-----~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~---~~s~~~  376 (482)
                      ...+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.+..+....+....  ..+|.   .++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA  240 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence            33579999999999973     457889999999999999999999999888877777776543  33333   479999


Q ss_pred             HHHHHHhhccCcCC--cCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCC--CCC
Q 047009          377 HSLLKGLLQKEPGK--RLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSD--SPA  452 (482)
Q Consensus       377 ~~LI~~~L~~dP~~--R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~--s~~  452 (482)
                      ++||++||..++++  |+++     +++++||||.+++|..+..  ..+++.|......+..+|+..-.......  +|.
T Consensus       241 ~~li~~ll~~~~~r~~r~~~-----~~~l~hp~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (331)
T cd05597         241 KDLIRRLICSPETRLGRNGL-----QDFKDHPFFEGIDWDNIRN--STAPYVPEVSSPTDTSNFDVDDDDLRNTESLPPS  313 (331)
T ss_pred             HHHHHHHccCcccccCCCCH-----HHHhcCCCCCCCCHHHHhh--CCCCccCcCCCcchhhhcCCcccccccccccCCC
Confidence            99999999753333  5555     9999999999999988864  35678888777776667764332221111  111


Q ss_pred             C--CCCCCCCCccCeee
Q 047009          453 A--TPKNNTNPFADFSY  467 (482)
Q Consensus       453 ~--~~~~~~~~f~~f~~  467 (482)
                      .  .....-.++.+|.|
T Consensus       314 ~~~~~~~~~~~~~~~~~  330 (331)
T cd05597         314 SHGAFSGNHLPFVGFTY  330 (331)
T ss_pred             CcCcCCcCCCCCCceee
Confidence            1  11233467777777

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.7e-50  Score=405.26  Aligned_cols=312  Identities=35%  Similarity=0.669  Sum_probs=253.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+++++.+++.||+|++.+...........+.+|+.++..++|+||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999998765544555566888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--CC
Q 047009          230 DFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--RS  306 (482)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--~~  306 (482)
                      ||+++|+|..++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....  ..
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999999999977 4678999999999999999999999999999999999999999999999999997653322  22


Q ss_pred             cccccCCCCCchhhhc-----CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc--cCCCc---cCChHH
Q 047009          307 NSMIGTVEYMAPEIVL-----GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPA---FLSSEA  376 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~-----~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~---~~s~~~  376 (482)
                      ...+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+...++....  ..+|.   .++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~  240 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA  240 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence            3468999999999986     3468899999999999999999999999988888888887653  33443   579999


Q ss_pred             HHHHHHhhccCcCC--cCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCC--CCCCCCC
Q 047009          377 HSLLKGLLQKEPGK--RLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDM--PLSDSPA  452 (482)
Q Consensus       377 ~~LI~~~L~~dP~~--R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~--~~~~s~~  452 (482)
                      ++||++||..++++  |+++     +++++||||.+++|+.+..  ..+++.|........++++..-...  .....|.
T Consensus       241 ~~li~~ll~~~~~r~~r~~~-----~~~~~h~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (332)
T cd05623         241 KDLIRRLICSREHRLGQNGI-----EDFKQHPFFTGIDWDNIRN--CEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPP  313 (332)
T ss_pred             HHHHHHHccChhhhcCCCCH-----HHHhCCCCcCCCCHHHHhh--CCCCccCCCCCCcccccCCCCcccccccCCCCCC
Confidence            99999999765444  3444     9999999999999998853  5667788777666666554211111  1111111


Q ss_pred             C--CCCCCCCCccCeeee
Q 047009          453 A--TPKNNTNPFADFSYV  468 (482)
Q Consensus       453 ~--~~~~~~~~f~~f~~~  468 (482)
                      .  .......+|.+|+|.
T Consensus       314 ~~~~~~~~~~~~~~~~~~  331 (332)
T cd05623         314 SHTAFSGHHLPFVGFTYT  331 (332)
T ss_pred             CccccccCCCCcCCeeec
Confidence            1  112335778888875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-52  Score=406.09  Aligned_cols=253  Identities=32%  Similarity=0.602  Sum_probs=243.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      .+|++.+.||+|.||+|-+|.....|+.||||.++++.+.++...-.+.+|++||+.|+||||+++|.+|++.+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            57999999999999999999999999999999999999998888899999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCccc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM  309 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  309 (482)
                      ||..+|.|++++...+.+++.+++.+++||++|+.|+|+++++|||||.+|||||.++++||+|||++..+.......++
T Consensus       133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTF  212 (668)
T KOG0611|consen  133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTF  212 (668)
T ss_pred             EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999888889999


Q ss_pred             ccCCCCCchhhhcCCCC-CchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCc
Q 047009          310 IGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP  388 (482)
Q Consensus       310 ~gt~~y~APE~l~~~~~-~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP  388 (482)
                      ||+|.|.+||++.|.+| ++.+|-|||||+||.|+.|..||.|.+...+..+|..+.+.-|.. +..+.-||+.||..||
T Consensus       213 CGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwmLmVNP  291 (668)
T KOG0611|consen  213 CGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIRWMLMVNP  291 (668)
T ss_pred             cCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHHHHHhcCc
Confidence            99999999999999998 579999999999999999999999999999999999998887764 6778999999999999


Q ss_pred             CCcCCCCCCChHHHHhCcCC
Q 047009          389 GKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       389 ~~R~s~~~~~~~eil~hp~f  408 (482)
                      .+|.++     +||-.|=|.
T Consensus       292 ~RRATi-----eDiAsHWWv  306 (668)
T KOG0611|consen  292 ERRATI-----EDIASHWWV  306 (668)
T ss_pred             ccchhH-----HHHhhhhee
Confidence            999998     999999874

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-51  Score=404.02  Aligned_cols=255  Identities=35%  Similarity=0.578  Sum_probs=222.4

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC--eEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY--RLY  226 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~  226 (482)
                      ..++...+.||+|+||.||++.++.+|...|+|.+.....   ...+.+.+|+.+|++++|||||+.++......  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            3568888999999999999999999999999999876521   12667899999999999999999999855444  699


Q ss_pred             EEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc-CCceeEcccCccccccC--
Q 047009          227 LVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA-DGHVMLTDFGLAKQFDE--  302 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~-~g~vKL~DFGla~~~~~--  302 (482)
                      +.|||++||+|.+++.+.+ .+++..++.|++||++||+|||++|||||||||+|||++. +|.+||+|||+++....  
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999999999887 7999999999999999999999999999999999999999 79999999999988653  


Q ss_pred             --CCCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCC-CchHHHHHHHHhcc--cCCCccCChHH
Q 047009          303 --NTRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDK--LRLPAFLSSEA  376 (482)
Q Consensus       303 --~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~-~~~~~~~~~i~~~~--~~~p~~~s~~~  376 (482)
                        ........||+.|||||++... ....++|||||||++.||+||+.||.. .......-.+....  +.+|..+|.++
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence              2234568999999999999963 334599999999999999999999987 44444445555443  57889999999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      ++||.+||.+||++||++     +++|+|||.+..
T Consensus       253 ~~Fl~~C~~~~p~~Rpta-----~eLL~hpf~~~~  282 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTA-----EELLEHPFLKQN  282 (313)
T ss_pred             HHHHHHHhhcCcccCcCH-----HHHhhChhhhcc
Confidence            999999999999999999     999999998763

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-49  Score=394.59  Aligned_cols=278  Identities=40%  Similarity=0.702  Sum_probs=240.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      .|++.+.||+|+||.||+|.++.+++.||+|.+.+...........+.+|+.++++++|+||+++++.+.+.+.+|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            47888999999999999999999999999999987654444445567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcc
Q 047009          231 FINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS  308 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  308 (482)
                      |++|++|..++...+  .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG  160 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence            999999988886543  589999999999999999999999999999999999999999999999999987654444455


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchH---HHHHHH-HhcccCCCccCChHHHHHHHHhh
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA---KIQQKI-VKDKLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~---~~~~~i-~~~~~~~p~~~s~~~~~LI~~~L  384 (482)
                      ..||..|+|||++.+..++.++||||||+++|+|++|+.||......   .....+ ......++..+++++++||++||
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05630         161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL  240 (285)
T ss_pred             CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHh
Confidence            68999999999999999999999999999999999999999764321   112222 22233466778999999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccc
Q 047009          385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE  428 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~  428 (482)
                      +.||.+|+++...+++|+++||||+.++|..+...+..|+|.|.
T Consensus       241 ~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05630         241 CKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD  284 (285)
T ss_pred             hcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCC
Confidence            99999999964445699999999999999999999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.7e-49  Score=391.79  Aligned_cols=270  Identities=34%  Similarity=0.676  Sum_probs=232.3

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCCch
Q 047009          158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL  237 (482)
Q Consensus       158 LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (482)
                      ||+|+||.||+++.+.+|+.||+|.+.+...........+..|++++++++||||+++++++.+...+|+||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999999999999999999876544433444566799999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccccCCCC
Q 047009          238 FFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEY  315 (482)
Q Consensus       238 ~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y  315 (482)
                      ..++...+  .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.............||..|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY  160 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence            88876543  4788889999999999999999999999999999999999999999999999877654444556799999


Q ss_pred             CchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch----HHHHHHHHhcccCCC-ccCChHHHHHHHHhhccCcCC
Q 047009          316 MAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR----AKIQQKIVKDKLRLP-AFLSSEAHSLLKGLLQKEPGK  390 (482)
Q Consensus       316 ~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~----~~~~~~i~~~~~~~p-~~~s~~~~~LI~~~L~~dP~~  390 (482)
                      +|||++.+..++.++|+|||||++|||++|+.||.....    ..+...+......++ ..++.++++||++||++||.+
T Consensus       161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~  240 (277)
T cd05607         161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPED  240 (277)
T ss_pred             cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhh
Confidence            999999999999999999999999999999999976432    334444444444333 458999999999999999999


Q ss_pred             cCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccc
Q 047009          391 RLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE  428 (482)
Q Consensus       391 R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~  428 (482)
                      ||++. ...+++++|+||+.++|..++.+.+.|||.|.
T Consensus       241 R~~~~-~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~  277 (277)
T cd05607         241 RLGSR-EKNDDPRKHEFFKTINFPRLEAGLIPPPFVPD  277 (277)
T ss_pred             CCCCc-cchhhhhcChhhcCCCHHHHhcCcCCCCCCCC
Confidence            99982 33477899999999999999999999998763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-51  Score=414.83  Aligned_cols=255  Identities=34%  Similarity=0.535  Sum_probs=232.8

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      -...|....+||+|+.|.||.|+...+++.||||.+.....   ...+.+.+|+.+|+..+|+|||++++.|-..+.+|+
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV  347 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV  347 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence            34678899999999999999999999999999999987653   345668899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CC
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RS  306 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~  306 (482)
                      |||||+||+|.+.+.. ..++|.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||+|..+.... ..
T Consensus       348 VMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             EEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence            9999999998876654 558999999999999999999999999999999999999999999999999999876544 67


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc---ccCCCccCChHHHHHHHHh
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~LI~~~  383 (482)
                      .+++|||.|||||++..+.|+.++||||||+++.||+-|++||...++......|...   .+..|..+|+++++||.+|
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c  506 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC  506 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence            8899999999999999999999999999999999999999999988888777777664   4566788999999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      |+.|+.+|+++     .|+|+||||+..
T Consensus       507 L~~dv~~RasA-----~eLL~HpFl~~a  529 (550)
T KOG0578|consen  507 LVVDVEQRASA-----KELLEHPFLKMA  529 (550)
T ss_pred             hhcchhcCCCH-----HHHhcChhhhhc
Confidence            99999999999     999999999643

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.9e-49  Score=390.03  Aligned_cols=278  Identities=38%  Similarity=0.690  Sum_probs=244.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.++++++|+||+++++++..++..|+|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            37888999999999999999999999999999987655444445567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcc
Q 047009          231 FINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS  308 (482)
Q Consensus       231 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  308 (482)
                      |+.+++|..++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG  160 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence            99999998887654  3689999999999999999999999999999999999999999999999999977654444455


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHH----HHHHHhcccCCCccCChHHHHHHHHhh
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKI----QQKIVKDKLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~LI~~~L  384 (482)
                      ..|+..|+|||++.+..++.++|+||||+++|+|++|+.||.+......    ...+......++..++.++.+|+.+||
T Consensus       161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05632         161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL  240 (285)
T ss_pred             CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHc
Confidence            6899999999999999999999999999999999999999987655433    333344445566778999999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccc
Q 047009          385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE  428 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~  428 (482)
                      +.||.+|+++...++.++++|+||+.++|+.++.++..|+|.|.
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05632         241 TKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD  284 (285)
T ss_pred             cCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence            99999999976566799999999999999999999999999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-49  Score=406.86  Aligned_cols=257  Identities=38%  Similarity=0.657  Sum_probs=241.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCCeEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~l  227 (482)
                      ...|++.+.||+|.||.||+++.+.+|+.||+|++.+.........+.+.+|+.||+++. |||||.+++.|++...+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            467999999999999999999999999999999999988766666778999999999998 9999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC----CceeEcccCccccccCC
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD----GHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~----g~vKL~DFGla~~~~~~  303 (482)
                      |||++.||.|++.+.+. .+++..+..++.||+.|+.|||+.||+||||||+|+|+...    +.+|++|||++......
T Consensus       114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~  192 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG  192 (382)
T ss_pred             EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence            99999999999999877 49999999999999999999999999999999999999643    57999999999998877


Q ss_pred             CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCc----cCChHHHHH
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSL  379 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~L  379 (482)
                      ......|||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+......+|..+.+.++.    .++..+++|
T Consensus       193 ~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~  272 (382)
T KOG0032|consen  193 ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDF  272 (382)
T ss_pred             ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHH
Confidence            7888999999999999999999999999999999999999999999999999999999999887753    479999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      |++||..||.+|+++     .++|+|||+++.
T Consensus       273 i~~ll~~dp~~R~ta-----~~~L~HpWi~~~  299 (382)
T KOG0032|consen  273 IRKLLEFDPRKRLTA-----AQALQHPWIKSI  299 (382)
T ss_pred             HHHhcccCcccCCCH-----HHHhcCccccCC
Confidence            999999999999999     999999999875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-51  Score=406.67  Aligned_cols=257  Identities=32%  Similarity=0.534  Sum_probs=227.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCC-e
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKY-R  224 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~-~  224 (482)
                      ..+++|.++++||.|+||.||+|+.+.+|+.||||.++++... -++.-. .+|+.-|++|+ |||||+|..++.+.+ .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            3467899999999999999999999999999999999876533 222222 47999999999 999999999998887 9


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          225 LYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      +|+|||||+. +|++++..+ ..|++..++.|+.||++||+|+|++|+.|||+||||||+..+..+||+|||+|+.+...
T Consensus        85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence            9999999986 888888765 56999999999999999999999999999999999999998999999999999999888


Q ss_pred             CCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc------------------
Q 047009          304 TRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD------------------  364 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~------------------  364 (482)
                      ...+..+.|..|+|||++.. ..|+.+.|+||+|||++|+.+-++.|.|.+..+...+|..-                  
T Consensus       164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~  243 (538)
T KOG0661|consen  164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA  243 (538)
T ss_pred             CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence            88888999999999999876 56899999999999999999999999999988877777651                  


Q ss_pred             -ccCCCc-----------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          365 -KLRLPA-----------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       365 -~~~~p~-----------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                       .+.+|.           .++.++.+||.+||..||++||+|     .++++||||+..
T Consensus       244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA-----~~al~~pffq~~  297 (538)
T KOG0661|consen  244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTA-----SQALQHPFFQVG  297 (538)
T ss_pred             hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccH-----HHHhcCcccccc
Confidence             233332           368999999999999999999999     999999999854

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-49  Score=390.72  Aligned_cols=263  Identities=31%  Similarity=0.486  Sum_probs=232.4

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      ....++|++...||.|.-++||+|+...+++.||||++..++..  +..+.+.+|+..|+.++||||++++.+|..+..+
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            35668999999999999999999999999999999999988754  3478899999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-
Q 047009          226 YLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-  302 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-  302 (482)
                      |+||.||.+|++++.+...  ..++|..+..+++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+-. 
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999999998764  3489999999999999999999999999999999999999999999999998876532 


Q ss_pred             CCC----CcccccCCCCCchhhhcC--CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCc------
Q 047009          303 NTR----SNSMIGTVEYMAPEIVLG--KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA------  370 (482)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~--~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~------  370 (482)
                      +.+    .++++||++|||||++..  .+|+.|+||||||++..||.+|..||....+.++.-.-+++.+..+.      
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~  259 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK  259 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence            222    166799999999999644  68999999999999999999999999988887776666666554221      


Q ss_pred             ----cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhh
Q 047009          371 ----FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK  415 (482)
Q Consensus       371 ----~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~  415 (482)
                          .++..++.+|..||++||.+||++     +++|+|+||+...-.+
T Consensus       260 d~~k~~~ksf~e~i~~CL~kDP~kRptA-----skLlkh~FFk~~k~~~  303 (516)
T KOG0582|consen  260 DEDKKFSKSFREMIALCLVKDPSKRPTA-----SKLLKHAFFKKAKSKE  303 (516)
T ss_pred             HHhhhhcHHHHHHHHHHhhcCcccCCCH-----HHHhccHHHhhccchh
Confidence                367899999999999999999999     9999999998765443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-50  Score=401.21  Aligned_cols=256  Identities=31%  Similarity=0.519  Sum_probs=225.5

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC--Ce
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK--YR  224 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~  224 (482)
                      ...+.|+.+++||+|+||.||+|++..+|+.||+|.++.+.. .......+.+|+.||++|+||||++|.+...+.  +.
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            456789999999999999999999999999999999988753 334556677999999999999999999988766  78


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          225 LYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      +|||+|||+. +|.-++... -.|++.+++.|+.||+.||+|||++||+|||||.+|||||.+|.+||+|||||+.+...
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999999987 777666553 36999999999999999999999999999999999999999999999999999976543


Q ss_pred             C--CCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc----------ccCCCc
Q 047009          304 T--RSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD----------KLRLPA  370 (482)
Q Consensus       304 ~--~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~----------~~~~p~  370 (482)
                      .  ..++.+-|..|+|||++.|. .|+.++|+||.||||.||++|++.|.+.+..+...+|.+-          ...+|.
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence            3  45677889999999999984 7999999999999999999999999999998888888762          112221


Q ss_pred             -------------------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          371 -------------------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       371 -------------------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                                         .++..+.+|+..||..||.+|.++     .++|+|+||.
T Consensus       352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA-----~~aL~seyF~  404 (560)
T KOG0600|consen  352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTA-----SSALQSEYFT  404 (560)
T ss_pred             ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccH-----HHHhcCcccc
Confidence                               268999999999999999999999     9999999994

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6e-50  Score=375.03  Aligned_cols=258  Identities=30%  Similarity=0.538  Sum_probs=235.4

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc-----hhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecC
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-----EKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTK  222 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~-----~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  222 (482)
                      .+.|+-.+.||+|..+.|.++.++.+|+.+|+|++......     ..+..+.-..|+.||+++ .||+|+++.++|+++
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            35677778899999999999999999999999998653221     233445566899999997 799999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..+++|+|.|+.|.|+++|...-.++|+.++.+++|++.|++|||.++||||||||+|||++++.++||+|||+|..+..
T Consensus        96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            99999999999999999999988999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCcccccCCCCCchhhhcC------CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccC
Q 047009          303 NTRSNSMIGTVEYMAPEIVLG------KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFL  372 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~------~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~  372 (482)
                      +......||||+|+|||.+..      .+|+..+|+||+|||||-|+.|.+||......-+...|..+++.|-    ..+
T Consensus       176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadi  255 (411)
T KOG0599|consen  176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADI  255 (411)
T ss_pred             chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhc
Confidence            999999999999999999864      4789999999999999999999999998888889999999988764    358


Q ss_pred             ChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       373 s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      |...++||++||+.||.+|+++     +|+|.||||..+
T Consensus       256 s~~~KdLIsrlLqVdp~~Rita-----ke~LaHpff~q~  289 (411)
T KOG0599|consen  256 SATVKDLISRLLQVDPTKRITA-----KEALAHPFFIQI  289 (411)
T ss_pred             cccHHHHHHHHHeeCchhcccH-----HHHhcChHHHHH
Confidence            9999999999999999999999     999999999653

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.8e-48  Score=383.77  Aligned_cols=253  Identities=33%  Similarity=0.520  Sum_probs=216.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++..... .....+.+.+|+.++++++||||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            479999999999999999999999999999999976532 2234556788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--CCc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--RSN  307 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--~~~  307 (482)
                      ||++++.+.........+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......  ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            999998776655555679999999999999999999999999999999999999999999999999998764322  223


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-------------------cCC
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-------------------LRL  368 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-------------------~~~  368 (482)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+....                   ..+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            4679999999999999999999999999999999999999998766544333322210                   011


Q ss_pred             -------------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          369 -------------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       369 -------------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                                   ...++.++++||++||++||++||++     +++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~-----~~~l~hp~f  287 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT-----EQCLNHPAF  287 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH-----HHHhcCCCC
Confidence                         12368889999999999999999999     999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-48  Score=395.05  Aligned_cols=250  Identities=28%  Similarity=0.475  Sum_probs=220.5

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC-eEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY-RLY  226 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~  226 (482)
                      ...+..+.+.||.|+||+||+|.++++. .||+|++......... .+.+.+|+.+|.+++|||||+++|++.... .++
T Consensus        39 ~~~~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   39 DPDELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             ChHHhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence            3455666677999999999999998642 3999999876654444 778999999999999999999999999887 799


Q ss_pred             EEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCCCCcEEEccCC-ceeEcccCccccccC
Q 047009          227 LVLDFINGGHLFFQLYH--HGLFREDLARIYAAEIVSAVSHLHANG-IMHRDLKPENILLGADG-HVMLTDFGLAKQFDE  302 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~-IiHrDLKp~NILl~~~g-~vKL~DFGla~~~~~  302 (482)
                      |||||+++|+|..++..  ++.++...+..++.||++||+|||+++ ||||||||+|||++.++ ++||+|||+++....
T Consensus       117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            99999999999999988  578999999999999999999999999 99999999999999998 999999999998765


Q ss_pred             C-CCCcccccCCCCCchhhhc--CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc--ccCCCccCChHHH
Q 047009          303 N-TRSNSMIGTVEYMAPEIVL--GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--KLRLPAFLSSEAH  377 (482)
Q Consensus       303 ~-~~~~~~~gt~~y~APE~l~--~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~  377 (482)
                      . .......||+.|||||++.  ...|+.++|||||||++|||+||+.||.+.........+...  ++.+|..+++.+.
T Consensus       197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~  276 (362)
T KOG0192|consen  197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLS  276 (362)
T ss_pred             ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence            4 3444578999999999999  669999999999999999999999999998886666666543  5567788999999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .||..||..||.+||++     .+|..
T Consensus       277 ~l~~~CW~~dp~~RP~f-----~ei~~  298 (362)
T KOG0192|consen  277 SLMERCWLVDPSRRPSF-----LEIVS  298 (362)
T ss_pred             HHHHHhCCCCCCcCCCH-----HHHHH
Confidence            99999999999999998     67653

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.8e-49  Score=377.17  Aligned_cols=262  Identities=34%  Similarity=0.555  Sum_probs=226.7

Q ss_pred             ccccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeee--c
Q 047009          144 VCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQ--T  221 (482)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~  221 (482)
                      .++..+++|+.+..|++|+||.||+|+++.|++.||+|.++.+.-.. ..--.-.+|+.+|.+++|||||.+..+..  +
T Consensus        70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~  148 (419)
T KOG0663|consen   70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSN  148 (419)
T ss_pred             cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence            35677899999999999999999999999999999999998775221 11223458999999999999999977764  4


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF  300 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~  300 (482)
                      -+.+|||||||+. +|...+...+ +|...+++.++.|+++||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+
T Consensus       149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence            4679999999987 8888887765 8999999999999999999999999999999999999999999999999999997


Q ss_pred             cCC-CCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc--------------
Q 047009          301 DEN-TRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--------------  364 (482)
Q Consensus       301 ~~~-~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~--------------  364 (482)
                      +.. ...+..+-|..|+|||++.| +.|++++|+||+|||+.||+++++.|.|....+..++|.+.              
T Consensus       228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            654 34567788999999999988 57999999999999999999999999999888888877651              


Q ss_pred             -----ccCCC------------cc-CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          365 -----KLRLP------------AF-LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       365 -----~~~~p------------~~-~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                           ...++            .. ++....+|+..+|.+||.+|.|+     .|.|+|.||....
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA-----~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITA-----EDGLKHEYFRETP  368 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccH-----HHhhcccccccCC
Confidence                 11222            11 56899999999999999999999     9999999999853

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8e-48  Score=384.47  Aligned_cols=257  Identities=27%  Similarity=0.465  Sum_probs=212.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++.....  ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            4789999999999999999999999999999999975432  12233467899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCC
Q 047009          229 LDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~  306 (482)
                      |||+.+ +|..++..+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... ....
T Consensus        82 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  160 (303)
T cd07869          82 FEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY  160 (303)
T ss_pred             EECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence            999964 676666554 5689999999999999999999999999999999999999999999999999976432 2233


Q ss_pred             cccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCch-HHHHHHHHhc--c-----------------
Q 047009          307 NSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNR-AKIQQKIVKD--K-----------------  365 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~-~~~~~~i~~~--~-----------------  365 (482)
                      ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... ....+.+...  .                 
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence            45678999999999876 4589999999999999999999999977533 2222222110  0                 


Q ss_pred             --cC--CC---------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          366 --LR--LP---------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       366 --~~--~p---------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                        ..  .+         ..+++.+++||++||++||++|+++     +|+++||||+.+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~-----~~~l~h~~f~~~~~  296 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA-----QAALSHEYFSDLPP  296 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH-----HHHhcCcccccCCh
Confidence              00  00         0145788999999999999999999     99999999998875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.6e-48  Score=364.76  Aligned_cols=255  Identities=29%  Similarity=0.491  Sum_probs=221.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      .+|..+++||+|.||.||+|++..||+.||||.++..+..+. ......+|++.|+.++|+||+.|+++|...+.+.||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            568889999999999999999999999999999987754332 2334568999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCc
Q 047009          230 DFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSN  307 (482)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  307 (482)
                      |||+. +|...++.+ ..++...++.|+.++++||+|||++.|+||||||.|+|++++|.+||+|||+|+.+.... ...
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            99985 888888765 468999999999999999999999999999999999999999999999999999975433 333


Q ss_pred             ccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc--c---------C--------
Q 047009          308 SMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--L---------R--------  367 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~--~---------~--------  367 (482)
                      ..+-|..|+|||.+.| +.|+..+|+||.|||+.||+-|.+-|.|.+..+....|...-  +         .        
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence            4478999999999987 579999999999999999999999999988877777776520  0         0        


Q ss_pred             -CC--------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          368 -LP--------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       368 -~p--------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                       +|        ...+.++.||+.+||.+||.+|+++     .|+++|+||+..
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita-----~qaL~~~yf~~~  287 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITA-----SQALKHPYFKSL  287 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccH-----HHHhcchhhhcC
Confidence             11        1257888999999999999999999     999999999863

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-49  Score=393.52  Aligned_cols=259  Identities=35%  Similarity=0.584  Sum_probs=242.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .+=|.+.+.||+|-|+.|.+|++.-||+.||||++.|.++..- ....+..|++.|+.++|||||+||.+..+..++|||
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            3559999999999999999999999999999999999876443 344567899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc-cCCceeEcccCccccccCCCCC
Q 047009          229 LDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG-ADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~-~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      +|+-.+|+|++++.++ ..+.|+.++.|++||+.|+.|+|+..+|||||||+|+++- .-|.+||+|||++..+..+...
T Consensus        96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL  175 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL  175 (864)
T ss_pred             EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence            9999999999999876 4699999999999999999999999999999999999775 5689999999999999999999


Q ss_pred             cccccCCCCCchhhhcCCCCC-chhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhc
Q 047009          307 NSMIGTVEYMAPEIVLGKGHN-KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~-~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ++.||+..|-|||++.|..|+ +++||||||||||-|++|++||...+..+....|+.-++.+|..++.++++||..||.
T Consensus       176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLv  255 (864)
T KOG4717|consen  176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLV  255 (864)
T ss_pred             hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHh
Confidence            999999999999999999986 5899999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      .||++|.+.     ++|..|+|++.++-
T Consensus       256 RdPkkRAsl-----EeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  256 RDPKKRASL-----EEIVSTSWLQAGDR  278 (864)
T ss_pred             cCchhhccH-----HHHhccccccCCCC
Confidence            999999988     99999999998874

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.5e-47  Score=379.99  Aligned_cols=252  Identities=29%  Similarity=0.493  Sum_probs=215.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++.+.||.|+||.||+|+++.+++.||+|+++....  ......+.+|+.++++++||||+++++++.+....++|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            5789999999999999999999999999999999875432  22234567899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCC
Q 047009          229 LDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~  306 (482)
                      |||+.+ +|..++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... ...
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence            999986 8888876654 5789999999999999999999999999999999999999999999999999865332 223


Q ss_pred             cccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-------------------c
Q 047009          307 NSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-------------------L  366 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-------------------~  366 (482)
                      ....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+....                   .
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            45678999999999876 568999999999999999999999998877666555443210                   0


Q ss_pred             CCC-----------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          367 RLP-----------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       367 ~~p-----------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      .+|           ..++.++++||++||+.||.+|+++     +|+++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~-----~~~l~hp~f  288 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA-----EAALRHSYF  288 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCH-----HHHhcCCCC
Confidence            111           2468899999999999999999999     999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.7e-47  Score=376.77  Aligned_cols=270  Identities=37%  Similarity=0.708  Sum_probs=237.8

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCCch
Q 047009          158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL  237 (482)
Q Consensus       158 LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (482)
                      ||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999999999999999999876544444555667899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccccCCCC
Q 047009          238 FFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEY  315 (482)
Q Consensus       238 ~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y  315 (482)
                      ..++.+.+  .+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.............++..|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY  160 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence            99987765  7899999999999999999999999999999999999999999999999999876544444556788999


Q ss_pred             CchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch----HHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCc
Q 047009          316 MAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR----AKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR  391 (482)
Q Consensus       316 ~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R  391 (482)
                      +|||++.+..++.++|+||||+++|+|++|+.||.....    ..+...+......++..+++.+.++|++||+.||.+|
T Consensus       161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  240 (277)
T cd05577         161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR  240 (277)
T ss_pred             CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHc
Confidence            999999988899999999999999999999999976544    3344444444556777789999999999999999999


Q ss_pred             CCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCcc
Q 047009          392 LGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP  427 (482)
Q Consensus       392 ~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p  427 (482)
                      |++....+.++++||||..++|..+.+...+|||.|
T Consensus       241 ~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~  276 (277)
T cd05577         241 LGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP  276 (277)
T ss_pred             cCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCC
Confidence            987555679999999999999999988888888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-49  Score=395.15  Aligned_cols=256  Identities=28%  Similarity=0.504  Sum_probs=232.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ..|..++.||+|+||.||+|.+..+++.||+|++..+..  ....+.+++|+.+|..++++||.++|++|..+..++++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            457788999999999999999999999999999987753  456778899999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~  308 (482)
                      |||.||++.+.+...+.+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+.... ...+
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            999999999999888878999999999999999999999999999999999999999999999999998875443 3488


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CCCccCChHHHHHHHHhhccC
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLLKGLLQKE  387 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~LI~~~L~~d  387 (482)
                      ++||+.|||||++.+.+|+.++||||||++.|||++|.+|+....+......|-+..+ .+...+++.+++||..||++|
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~  250 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKN  250 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcC
Confidence            9999999999999999999999999999999999999999998888666666665533 344578999999999999999


Q ss_pred             cCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          388 PGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       388 P~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      |+.||+|     .++++|+|++...
T Consensus       251 P~~RpsA-----~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  251 PEFRPSA-----KELLKHKFIKRAK  270 (467)
T ss_pred             cccCcCH-----HHHhhhHHHHhcC
Confidence            9999999     9999999998744

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7e-47  Score=383.01  Aligned_cols=258  Identities=25%  Similarity=0.441  Sum_probs=222.9

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ..++|++++.||+|+||.||+|+++.++..||+|++....  .....+.+.+|+++|++++||||+++++++...+.+++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            3478999999999999999999999999999999997642  23345668899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      ||||+++|+|..++...+.+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||+++..... ..
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  159 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA  159 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-cc
Confidence            999999999999998888899999999999999999999986 6999999999999999999999999999876432 33


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHh-----------------------
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----------------------  363 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~-----------------------  363 (482)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+..                       
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence            456799999999999999999999999999999999999999976655443322211                       


Q ss_pred             -----------------------c-ccCCC-ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          364 -----------------------D-KLRLP-AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       364 -----------------------~-~~~~p-~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                                             . ....+ ..++.++++||++||++||++||++     .||++||||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~-----~ell~h~~~~~~~~  309 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADL-----KMLMNHTFIKRSEV  309 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCH-----HHHhcChHHhhccc
Confidence                                   1 11111 2368899999999999999999999     99999999986543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.7e-46  Score=373.84  Aligned_cols=281  Identities=40%  Similarity=0.727  Sum_probs=243.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++++.||+|+||.||++.++.+++.||+|.+.+...........+.+|+++++.++||||+++++.+..++.+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999998765444455667889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC------
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------  303 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~------  303 (482)
                      ||++|++|..++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.....      
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998742100      


Q ss_pred             ----------CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCc---
Q 047009          304 ----------TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA---  370 (482)
Q Consensus       304 ----------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~---  370 (482)
                                .......|+..|+|||.+.+..++.++|+||||+++|||++|+.||.+.+..++.+.+..+....|.   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE  240 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence                      0112346788999999999999999999999999999999999999988888888887776554443   


Q ss_pred             cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCccc
Q 047009          371 FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHC  434 (482)
Q Consensus       371 ~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~  434 (482)
                      .++.+++++|.+||++||.+||+.  ..+.++++||||...+|.......  ..+.|+.....+
T Consensus       241 ~~~~~~~~li~~~l~~~P~~R~~~--~~~~~ll~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  300 (305)
T cd05609         241 ALPADAQDLISRLLRQNPLERLGT--GGAFEVKQHRFFLGLDWNGLLRQK--AEFIPQLESEDD  300 (305)
T ss_pred             cCCHHHHHHHHHHhccChhhccCc--cCHHHHHhCccccCCCHHHHhhcC--CCCCCCCCCccc
Confidence            578999999999999999999996  456999999999999999876443  356666544433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.3e-47  Score=382.37  Aligned_cols=256  Identities=28%  Similarity=0.417  Sum_probs=212.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC-----CeE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK-----YRL  225 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~  225 (482)
                      +|++.+.||+|+||.||+|+++.+++.||||++..... .......+.+|+.++++++||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            58999999999999999999999999999999875321 223345678899999999999999999887543     358


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  304 (482)
                      |+||||+. ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... 
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            99999995 6898888888889999999999999999999999999999999999999999999999999998643221 


Q ss_pred             ---CCcccccCCCCCchhhhcC--CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHh---------------c
Q 047009          305 ---RSNSMIGTVEYMAPEIVLG--KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK---------------D  364 (482)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~--~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~---------------~  364 (482)
                         .....+||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+.......+..               .
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence               1234679999999999876  6789999999999999999999999977654332221111               0


Q ss_pred             -----------cc--CC---CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          365 -----------KL--RL---PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       365 -----------~~--~~---p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                                 ..  .+   -..+++++.+||.+||+.||++||++     +|+++||||+++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~e~l~hp~f~~~~~  298 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA-----EEALADPYFKGLAK  298 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCH-----HHHhcCchhhhcCc
Confidence                       00  00   02367889999999999999999998     99999999987654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-46  Score=375.67  Aligned_cols=268  Identities=46%  Similarity=0.837  Sum_probs=236.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.+.........+.+.+|+.+++.++|+||+++++.+......|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999998776554456677889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC---
Q 047009          230 DFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT---  304 (482)
Q Consensus       230 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~---  304 (482)
                      ||+.|++|..++.+.  ..+++..++.++.||+.||+|||+.|++||||||+||+++.+|.++|+|||++.......   
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999988754  568999999999999999999999999999999999999999999999999987643211   


Q ss_pred             ---------------------------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHH
Q 047009          305 ---------------------------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKI  357 (482)
Q Consensus       305 ---------------------------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~  357 (482)
                                                 ......||..|+|||++.+..++.++||||||+++|+|++|+.||.+.+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                       11235789999999999999999999999999999999999999998888887


Q ss_pred             HHHHHhcccCCCcc--CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhh
Q 047009          358 QQKIVKDKLRLPAF--LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEA  418 (482)
Q Consensus       358 ~~~i~~~~~~~p~~--~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~  418 (482)
                      ...+......++..  ++.+++++|.+||.+||++||+. ..+++++++||||++++|..+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~-~~~~~~ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGS-KRGAAEIKQHPFFRGVNWALIRH  302 (316)
T ss_pred             HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCc-hhhHHHHHcCchhhcCChhhccc
Confidence            77777766666654  69999999999999999999993 12239999999999999988765

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.4e-46  Score=368.74  Aligned_cols=270  Identities=39%  Similarity=0.752  Sum_probs=223.8

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHH---hCCCCceeeeeeeeecCCeEEEEEEecC
Q 047009          157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT---KIDHPFVVQLKYSFQTKYRLYLVLDFIN  233 (482)
Q Consensus       157 ~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~---~l~hpnIv~l~~~~~~~~~~~lV~E~~~  233 (482)
                      .||+|+||.||+|.+..+++.||+|.+.+.............+|..+++   ..+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999998765433332333344544433   4479999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccccCC
Q 047009          234 GGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTV  313 (482)
Q Consensus       234 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~  313 (482)
                      ||+|..++..++.+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++....... .....||.
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~  159 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  159 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCc
Confidence            99999999888889999999999999999999999999999999999999999999999999997654332 23457999


Q ss_pred             CCCchhhhc-CCCCCchhHHHHHhHHHHHHhhCCCCCCCCc---hHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcC
Q 047009          314 EYMAPEIVL-GKGHNKAADWWSVGILLYEMLTGKPPFIGGN---RAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPG  389 (482)
Q Consensus       314 ~y~APE~l~-~~~~~~~sDvwSlGvilyelltG~~PF~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~  389 (482)
                      .|+|||.+. +..++.++|+||+||++|+|++|+.||....   ..............+|..++.+++++|++||+.||.
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  239 (279)
T cd05633         160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS  239 (279)
T ss_pred             CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHH
Confidence            999999986 4668999999999999999999999996533   233333333445567788999999999999999999


Q ss_pred             CcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCcc
Q 047009          390 KRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP  427 (482)
Q Consensus       390 ~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p  427 (482)
                      +|++....+++++++||||++++|.........+|..|
T Consensus       240 ~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~  277 (279)
T cd05633         240 KRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP  277 (279)
T ss_pred             HhcCCCCCCHHHHHhCccccCCCHhHHhcCCCCCCCCC
Confidence            99975445569999999999999988765555555444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.9e-48  Score=389.90  Aligned_cols=256  Identities=37%  Similarity=0.578  Sum_probs=239.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe-EEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR-LYL  227 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~l  227 (482)
                      +++|+.++.||+|+||.+++++++..++.|++|.+.......+. .+...+|+.+++++.|||||.+++.|..++. ++|
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            57899999999999999999999999999999999987765544 3467789999999999999999999988888 999


Q ss_pred             EEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-
Q 047009          228 VLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  304 (482)
                      ||+||+||+|.+.+.+.+  .|+++.+..|+.||+.|+.|||+++|+|||||+.||+++.++.|||+|||+|+.+.... 
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            999999999999887654  58999999999999999999999999999999999999999999999999999987766 


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-cCCCccCChHHHHHHHHh
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~LI~~~  383 (482)
                      ...+.+||+.||+||++.+.+|+.++|||||||++|||++-+++|.+.+...+..+|.... ..+|..++.+++.||+.|
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~  241 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSM  241 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHH
Confidence            7788999999999999999999999999999999999999999999999999999999987 578899999999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      |.++|..||++     .++|.+|....
T Consensus       242 l~~~P~~RPsa-----~~LL~~P~l~~  263 (426)
T KOG0589|consen  242 LRKNPEHRPSA-----LELLRRPHLLR  263 (426)
T ss_pred             hhcCCccCCCH-----HHHhhChhhhh
Confidence            99999999999     99999988764

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.1e-47  Score=397.27  Aligned_cols=252  Identities=29%  Similarity=0.472  Sum_probs=211.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC------
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK------  222 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  222 (482)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++....       ....+|+.+|+.++||||++++++|...      
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            468999999999999999999999999999999886532       1234799999999999999998876432      


Q ss_pred             --CeEEEEEEecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC-ceeEcccC
Q 047009          223 --YRLYLVLDFINGGHLFFQLY----HHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG-HVMLTDFG  295 (482)
Q Consensus       223 --~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g-~vKL~DFG  295 (482)
                        ..+++||||+++ +|..++.    ....+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence              257799999986 5655543    346789999999999999999999999999999999999999765 69999999


Q ss_pred             ccccccCCCCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc----------
Q 047009          296 LAKQFDENTRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD----------  364 (482)
Q Consensus       296 la~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~----------  364 (482)
                      +|+.+.........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+....+.+.          
T Consensus       217 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~  296 (440)
T PTZ00036        217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK  296 (440)
T ss_pred             cchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            99987665555667899999999998764 6899999999999999999999999987765555444321          


Q ss_pred             -------ccC------------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          365 -------KLR------------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       365 -------~~~------------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                             .+.            +|...+.++++||++||++||.+|+++     .|+++||||..+..
T Consensus       297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta-----~e~l~hp~f~~~~~  359 (440)
T PTZ00036        297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP-----IEALADPFFDDLRD  359 (440)
T ss_pred             HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCH-----HHHhCChhHHhhhc
Confidence                   111            334568899999999999999999999     99999999987654

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-47  Score=392.49  Aligned_cols=262  Identities=32%  Similarity=0.578  Sum_probs=247.6

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ..+..|.+.++||+|.|++|.+|++..++..||||++.+........ ..+.+|+++|+.|+|||||+++.+..+...+|
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~-~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR-QKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH-HHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            45678999999999999999999999999999999999987655443 44889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      +||||+.+|.+++++.+++...+..++.++.|+++|++|||+++|||||||++||||+.+.++||+|||++..+..+...
T Consensus       132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l  211 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML  211 (596)
T ss_pred             EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999988999


Q ss_pred             cccccCCCCCchhhhcCCCC-CchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhc
Q 047009          307 NSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~-~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      .+.||++.|.|||++.+..| ++.+|+||+|+++|-|+.|.+||.+.+..++..+.+.+++++|-.++.++.+||+++|.
T Consensus       212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lv  291 (596)
T KOG0586|consen  212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLV  291 (596)
T ss_pred             cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHhhc
Confidence            99999999999999999887 57999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                      .+|.+|+++     ++|+.|.|.....-.
T Consensus       292 l~Pskr~~~-----dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  292 LNPSKRGPC-----DQIMKDRWRNDLLEA  315 (596)
T ss_pred             cCccccCCH-----HHhhhhcccchhhhh
Confidence            999999999     999999998754433

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.1e-46  Score=370.89  Aligned_cols=252  Identities=28%  Similarity=0.440  Sum_probs=211.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcC-CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC---CCCceeeeeeeee-----
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKN-TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI---DHPFVVQLKYSFQ-----  220 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~-----  220 (482)
                      ++|++++.||+|+||+||+|++.. +++.||+|+++...... .......+|+.+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999854 57889999987643222 2223345677777665   6999999999875     


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccc
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK  298 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~  298 (482)
                      ....+++||||+. ++|..++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            3456899999997 5888887653  458999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-----C------
Q 047009          299 QFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-----R------  367 (482)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-----~------  367 (482)
                      ............||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+.....     .      
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence            77655555667899999999999999999999999999999999999999998877766666653210     0      


Q ss_pred             ----------------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          368 ----------------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       368 ----------------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                                      +...++..+++||.+||+.||++||++     .++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-----~~~l~hp~f  290 (290)
T cd07862         239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----YSALSHPYF  290 (290)
T ss_pred             ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCH-----HHHhcCCCC
Confidence                            112467889999999999999999999     999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2e-47  Score=372.54  Aligned_cols=249  Identities=34%  Similarity=0.599  Sum_probs=217.7

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC--C---eE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK--Y---RL  225 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~---~~  225 (482)
                      .|+-.+++|.|+||.||+|....+++.||||.+..+.-       .-.+|+.+|+.++|||||+|..+|...  .   .+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            47888999999999999999999999999999876532       224799999999999999999888532  2   45


Q ss_pred             EEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC-CceeEcccCccccc
Q 047009          226 YLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQF  300 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~-g~vKL~DFGla~~~  300 (482)
                      .+|||||+. +|...++.    +..++.-.++.|+.||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus        98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen   98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            689999986 88887764    5678889999999999999999999999999999999999977 89999999999999


Q ss_pred             cCCCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc---------------
Q 047009          301 DENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---------------  364 (482)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~---------------  364 (482)
                      ..++...+...|..|+|||.+.| ..|+.+.||||.||++.||+.|++-|.|.+..+....|.+-               
T Consensus       177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence            88888889999999999999988 57999999999999999999999999998877776666551               


Q ss_pred             --ccCCC------------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          365 --KLRLP------------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       365 --~~~~p------------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                        ...+|            ...++++.+|+.++|+++|++|.++     .|++.||||..+.
T Consensus       257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~-----~~~l~h~fFdelr  313 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSA-----LEALAHPFFDELR  313 (364)
T ss_pred             cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCH-----HHHhcchhhHHhh
Confidence              11122            2468999999999999999999999     9999999998654

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-47  Score=369.12  Aligned_cols=256  Identities=31%  Similarity=0.492  Sum_probs=221.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec-----CCe
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT-----KYR  224 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~~  224 (482)
                      ..|..++.||+|+||.|..|.++.+|+.||||.+... +...-..++..+|+++|+.++|+||+.+.+.+..     -..
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            4566689999999999999999999999999998743 3345567778899999999999999999999865     356


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC--
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE--  302 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~--  302 (482)
                      +|+|+|+|+ .+|...+..+..++++.++.++.||++||.|+|+.+|+||||||.|+|++.+..+||+|||+|+....  
T Consensus       101 vYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             eEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            999999994 58888888877799999999999999999999999999999999999999999999999999999863  


Q ss_pred             -CCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc----------------
Q 047009          303 -NTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD----------------  364 (482)
Q Consensus       303 -~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~----------------  364 (482)
                       ....+..+.|..|+|||++.. ..|+.+.||||+|||+.||++|++.|.|.+.....+.|..-                
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence             344566788999999999865 68999999999999999999999999988766555555431                


Q ss_pred             -------ccCCC--------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          365 -------KLRLP--------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       365 -------~~~~p--------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                             ....|        +..++.+.+|+.+||..||.+|+|+     +|+|+|||+....
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita-----~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITA-----EEALAHPYLAPYH  317 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCH-----HHHhcChhhhhhc
Confidence                   11111        2478999999999999999999999     9999999998743

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.3e-46  Score=361.91  Aligned_cols=257  Identities=42%  Similarity=0.793  Sum_probs=231.9

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCCch
Q 047009          158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL  237 (482)
Q Consensus       158 LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (482)
                      ||.|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.+...+|+||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            69999999999999999999999999876655455667789999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccccCCCCCc
Q 047009          238 FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA  317 (482)
Q Consensus       238 ~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~A  317 (482)
                      ..++.+...+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++............|+..|+|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  160 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA  160 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence            99998888899999999999999999999999999999999999999999999999999988765544455688999999


Q ss_pred             hhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc--hHHHHHHHH--hcccCCCccCChHHHHHHHHhhccCcCCcCC
Q 047009          318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN--RAKIQQKIV--KDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       318 PE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s  393 (482)
                      ||.+.+..++.++|+||||+++|+|++|..||...+  ..+....+.  .....+|...+.+++++|.+||+.||.+|++
T Consensus       161 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~  240 (262)
T cd05572         161 PEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLG  240 (262)
T ss_pred             hhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcC
Confidence            999998889999999999999999999999998776  666677766  4566778888999999999999999999999


Q ss_pred             CCCCChHHHHhCcCCCCCChh
Q 047009          394 AGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       394 ~~~~~~~eil~hp~f~~~~~~  414 (482)
                      .....++|+++||||++.+|+
T Consensus       241 ~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         241 NLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             CcccCHHHHhcChhhhCCCCC
Confidence            544556999999999999985

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-46  Score=386.05  Aligned_cols=250  Identities=27%  Similarity=0.358  Sum_probs=210.0

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++++.||+|+||.||+|.++.+++.||+|....         ..+.+|+.+|++++||||++++++|......+
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            345789999999999999999999999999999997532         23568999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC--CC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE--NT  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~--~~  304 (482)
                      +|||++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....  ..
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            9999996 68888888878899999999999999999999999999999999999999999999999999975422  12


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc-------hHHHHHHHHh--------------
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN-------RAKIQQKIVK--------------  363 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~-------~~~~~~~i~~--------------  363 (482)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+       .......+..              
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            3345689999999999999999999999999999999999998875422       1111111111              


Q ss_pred             ------------cccCCC---------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          364 ------------DKLRLP---------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       364 ------------~~~~~p---------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                                  .....|         ..++.++.+||.+||+.||.+||++     +|+++||||+.+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta-----~elL~hp~f~~~  382 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA-----EALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH-----HHHhcChhhccC
Confidence                        000111         1246789999999999999999999     999999999874

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.9e-46  Score=379.76  Aligned_cols=254  Identities=27%  Similarity=0.447  Sum_probs=212.5

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC----
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY----  223 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----  223 (482)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++.++||||++++++|....    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            35899999999999999999999999999999999976432 2334556778999999999999999999986543    


Q ss_pred             --eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          224 --RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       224 --~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                        .+|+||||+.+ +|...+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence              57999999986 4555543  358889999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHh------------------
Q 047009          302 ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK------------------  363 (482)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~------------------  363 (482)
                      .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.+                  
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR  254 (359)
T ss_pred             cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence            55455567899999999999999999999999999999999999999987765433322211                  


Q ss_pred             ----cccCC--------------------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          364 ----DKLRL--------------------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       364 ----~~~~~--------------------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                          .....                    ....+.++++||.+||..||++||++     .|+++||||..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-----~e~l~hp~~~~  320 (359)
T cd07876         255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV-----DEALRHPYITV  320 (359)
T ss_pred             HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCH-----HHHhcCchhhh
Confidence                11111                    11246789999999999999999999     99999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.3e-46  Score=379.84  Aligned_cols=254  Identities=26%  Similarity=0.435  Sum_probs=214.4

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC-----
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK-----  222 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----  222 (482)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            35789999999999999999999999999999999876432 233445677899999999999999999887543     


Q ss_pred             -CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          223 -YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       223 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                       ..+|+||||+.+ +|...+.  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence             357999999976 5666654  347889999999999999999999999999999999999999999999999998766


Q ss_pred             CCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc----------------
Q 047009          302 ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK----------------  365 (482)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~----------------  365 (482)
                      .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....                
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (364)
T cd07875         178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  257 (364)
T ss_pred             CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence            5555556789999999999999999999999999999999999999998877666555544310                


Q ss_pred             ------cCC--------------------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          366 ------LRL--------------------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       366 ------~~~--------------------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                            ..+                    ....+.++++||.+||+.||.+||++     .|+++||||..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~-----~e~L~hp~~~~  323 (364)
T cd07875         258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV-----DEALQHPYINV  323 (364)
T ss_pred             HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH-----HHHhcCccccc
Confidence                  000                    01134678999999999999999999     99999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.7e-46  Score=380.25  Aligned_cols=253  Identities=30%  Similarity=0.510  Sum_probs=213.1

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ..++|++++.||+|+||.||+|+++.+++.||||++....  .......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  149 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV  149 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence            4577889999999999999999999999999999986543  23345668899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCC
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRS  306 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~  306 (482)
                      ||||+.+|+|..    .....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+... ...
T Consensus       150 v~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        150 LLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             EEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence            999999999854    234577888899999999999999999999999999999999999999999999876432 223


Q ss_pred             cccccCCCCCchhhhcC-----CCCCchhHHHHHhHHHHHHhhCCCCCCCCchH---HHHHHHH-hcccCCCccCChHHH
Q 047009          307 NSMIGTVEYMAPEIVLG-----KGHNKAADWWSVGILLYEMLTGKPPFIGGNRA---KIQQKIV-KDKLRLPAFLSSEAH  377 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~-----~~~~~~sDvwSlGvilyelltG~~PF~~~~~~---~~~~~i~-~~~~~~p~~~s~~~~  377 (482)
                      ...+||..|+|||++..     ...+.++|||||||++|||++|+.||......   .....+. ......+..++.+++
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  305 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR  305 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence            45689999999999853     33456899999999999999999999743322   2222222 233455677899999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      +||.+||+.||++||++     .|+++||||...
T Consensus       306 ~li~~~l~~~P~~Rpt~-----~ell~hp~~~~~  334 (353)
T PLN00034        306 HFISCCLQREPAKRWSA-----MQLLQHPFILRA  334 (353)
T ss_pred             HHHHHHccCChhhCcCH-----HHHhcCcccccC
Confidence            99999999999999999     999999999874

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.6e-46  Score=365.60  Aligned_cols=251  Identities=30%  Similarity=0.465  Sum_probs=209.8

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC---CCCceeeeeeeeec-----C
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI---DHPFVVQLKYSFQT-----K  222 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~-----~  222 (482)
                      +|++.+.||+|+||+||+|+++.+++.||+|.++...... .......+|+.+++.+   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            5899999999999999999999999999999987643211 1222345677776655   79999999998864     3


Q ss_pred             CeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF  300 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~  300 (482)
                      ..+++||||+.+ +|..++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            468999999985 787777654  34899999999999999999999999999999999999999999999999999877


Q ss_pred             cCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-----------c---
Q 047009          301 DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-----------L---  366 (482)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-----------~---  366 (482)
                      ..........||..|+|||++.+..++.++|||||||++|+|++|++||.+.+......++....           .   
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP  238 (288)
T ss_pred             cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence            65545556788999999999999999999999999999999999999998877665555544310           0   


Q ss_pred             -------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          367 -------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       367 -------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                                   .+...++.++++||.+||++||++||++     .|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~~l~hp~f  288 (288)
T cd07863         239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA-----FRALQHPFF  288 (288)
T ss_pred             ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH-----HHHhcCCCC
Confidence                         0112467889999999999999999999     999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.7e-45  Score=363.34  Aligned_cols=270  Identities=38%  Similarity=0.742  Sum_probs=226.0

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHH---HHHHhCCCCceeeeeeeeecCCeEEEEEEecC
Q 047009          157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAER---DILTKIDHPFVVQLKYSFQTKYRLYLVLDFIN  233 (482)
Q Consensus       157 ~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~---~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~  233 (482)
                      .||+|+||.||+|++..+++.||+|.+.+..............|.   .+++..+||+|+++++++...+.+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999999876543222222233343   34455689999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccccCC
Q 047009          234 GGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTV  313 (482)
Q Consensus       234 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~  313 (482)
                      ||+|..++...+.+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||++..+... .....+|+.
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~  159 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTH  159 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCCc
Confidence            9999999988888999999999999999999999999999999999999999999999999999865432 234568999


Q ss_pred             CCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCC---chHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcC
Q 047009          314 EYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGG---NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPG  389 (482)
Q Consensus       314 ~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~  389 (482)
                      .|+|||++.+. .++.++|+||+|+++|+|++|+.||...   ........+......+|..++.++.++|++||..||.
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~  239 (278)
T cd05606         160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN  239 (278)
T ss_pred             CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHH
Confidence            99999999754 6899999999999999999999999766   3344444455556677888899999999999999999


Q ss_pred             CcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCcc
Q 047009          390 KRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP  427 (482)
Q Consensus       390 ~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p  427 (482)
                      +|+......+.++++||||+.++|..+..+...++-.|
T Consensus       240 ~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~  277 (278)
T cd05606         240 RRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIP  277 (278)
T ss_pred             hccCCCCCCHHHHHhCccccCCCchHhhhcccCCCCCC
Confidence            99954333459999999999999998877665555443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-45  Score=357.60  Aligned_cols=254  Identities=33%  Similarity=0.511  Sum_probs=223.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc--hhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV--EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+......  .......+.+|+.++++++||||+++++++.....+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5799999999999999999999999999999998754322  22344568899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC-
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-  306 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~-  306 (482)
                      |+||++|++|...+...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++........ 
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999999865432211 


Q ss_pred             ---cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc--ccCCCccCChHHHHHHH
Q 047009          307 ---NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--KLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       307 ---~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~LI~  381 (482)
                         ....|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+...  ...+|..++..+.+||+
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  241 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR  241 (263)
T ss_pred             ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHH
Confidence               3456889999999999999999999999999999999999999876665555444433  44567789999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +||.++|.+||++     .++++|+||
T Consensus       242 ~~l~~~p~~Rpt~-----~~ll~~~~~  263 (263)
T cd06625         242 RTFVENAKKRPSA-----EELLRHFFV  263 (263)
T ss_pred             HHhhcCcccCCCH-----HHHhhCCCC
Confidence            9999999999998     999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.1e-45  Score=391.73  Aligned_cols=251  Identities=27%  Similarity=0.435  Sum_probs=206.5

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCC------Cceeeeeeeeec
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH------PFVVQLKYSFQT  221 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~l~~~~~~  221 (482)
                      ..++|++++.||+|+||+||+|.+..+++.||||+++...    ........|+.+++.++|      .++++++++|..
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            4578999999999999999999999999999999996532    122334567777776654      458899988876


Q ss_pred             C-CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCC------------
Q 047009          222 K-YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADG------------  287 (482)
Q Consensus       222 ~-~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g------------  287 (482)
                      . .++|+|||++ |++|..++.+++.+++..++.|+.||+.||.|||+ .|||||||||+|||++.++            
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence            4 5789999988 67898888888899999999999999999999998 5999999999999998776            


Q ss_pred             ----ceeEcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHh
Q 047009          288 ----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK  363 (482)
Q Consensus       288 ----~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~  363 (482)
                          .+||+|||.+....  ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+.+
T Consensus       282 ~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~  359 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK  359 (467)
T ss_pred             CCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence                49999999886532  234567899999999999999999999999999999999999999988776554443332


Q ss_pred             cccCCCc------------------------------------------cCChHHHHHHHHhhccCcCCcCCCCCCChHH
Q 047009          364 DKLRLPA------------------------------------------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEE  401 (482)
Q Consensus       364 ~~~~~p~------------------------------------------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~e  401 (482)
                      ....+|.                                          ..++.+.+||++||++||.+|+++     +|
T Consensus       360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta-----~e  434 (467)
T PTZ00284        360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA-----RQ  434 (467)
T ss_pred             HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH-----HH
Confidence            1111110                                          013567899999999999999999     99


Q ss_pred             HHhCcCCCC
Q 047009          402 IKSHKWFKP  410 (482)
Q Consensus       402 il~hp~f~~  410 (482)
                      +++||||..
T Consensus       435 ~L~Hp~~~~  443 (467)
T PTZ00284        435 MTTHPYVLK  443 (467)
T ss_pred             HhcCccccc
Confidence            999999975

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=9.2e-46  Score=380.75  Aligned_cols=256  Identities=26%  Similarity=0.384  Sum_probs=217.2

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC-----eE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY-----RL  225 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~  225 (482)
                      +|++++.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++.++||||+++++++....     .+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            5888999999999999999999999999999986532 12234456788999999999999999999998776     78


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC--
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--  303 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~--  303 (482)
                      |+||||+. ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            99999997 578888877788999999999999999999999999999999999999999999999999999865332  


Q ss_pred             CCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHh-------------------
Q 047009          304 TRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-------------------  363 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~-------------------  363 (482)
                      .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+..                   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence            223345789999999999874 579999999999999999999999988776555444432                   


Q ss_pred             ----ccc---------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          364 ----DKL---------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       364 ----~~~---------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                          ...         .+....+.++.+||.+||+.||.+||++     .|+++||||++..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-----~e~l~hp~~~~~~~  296 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA-----ADALAHPYLDEGRL  296 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH-----HHHhcCHhhCCCcc
Confidence                111         1233468899999999999999999999     99999999998654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-46  Score=364.08  Aligned_cols=257  Identities=30%  Similarity=0.536  Sum_probs=221.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCc-eeeeeeeeecCC----
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF-VVQLKYSFQTKY----  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~----  223 (482)
                      +..|+.+++||+|+||+||+|+.+.+|+.||+|.++.+... +..-....+|+.+|+.|+|+| |++|++++.+..    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            45678888899999999999999999999999999876432 122334578999999999999 999999998877    


Q ss_pred             --eEEEEEEecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          224 --RLYLVLDFINGGHLFFQLYHHG----LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       224 --~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                        .+++|+||+.. +|..++...+    .++...++.+++||+.||+|||+++|+||||||.||||+++|.+||+|||+|
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              89999999975 8888887755    4777899999999999999999999999999999999999999999999999


Q ss_pred             ccccC-CCCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-----------
Q 047009          298 KQFDE-NTRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-----------  364 (482)
Q Consensus       298 ~~~~~-~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-----------  364 (482)
                      +...- .......++|..|+|||++.|. .|+..+||||+|||++||++++..|.+.+..+....|..-           
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            98763 3346678899999999999986 7999999999999999999999999998887777776651           


Q ss_pred             -------ccCCCc------------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          365 -------KLRLPA------------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       365 -------~~~~p~------------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                             +..++.            ..+....+++.+||+.+|.+|.++     +.++.||||....
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa-----~~al~h~yf~~~~  309 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISA-----KGALTHPYFSELP  309 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCH-----HHHhcChhhcccc
Confidence                   111111            124589999999999999999999     9999999999874

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.2e-45  Score=362.74  Aligned_cols=277  Identities=49%  Similarity=0.905  Sum_probs=239.1

Q ss_pred             CeEEEEEecccCceEEEEEEEc---CCCeEEEEEEeechhhc-hhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKK---NTSEIYAMKVMRKDKIV-EKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  225 (482)
                      +|++.+.||+|+||.||+|++.   .+|+.||+|++...... .....+.+.+|+.++.++ +|+||++++++|+....+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999875   47899999999765432 223456678899999999 599999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  304 (482)
                      |+||||+++++|..++.....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999998764322 


Q ss_pred             -CCcccccCCCCCchhhhcCC--CCCchhHHHHHhHHHHHHhhCCCCCCCC----chHHHHHHHHhcccCCCccCChHHH
Q 047009          305 -RSNSMIGTVEYMAPEIVLGK--GHNKAADWWSVGILLYEMLTGKPPFIGG----NRAKIQQKIVKDKLRLPAFLSSEAH  377 (482)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~--~~~~~sDvwSlGvilyelltG~~PF~~~----~~~~~~~~i~~~~~~~p~~~s~~~~  377 (482)
                       ......|+..|+|||.+.+.  .++.++||||||+++|+|++|+.||...    ...++.+.+......+|..++..+.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T cd05613         161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK  240 (290)
T ss_pred             cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence             22356789999999998763  4788999999999999999999999643    2344555555556667788999999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCcc
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP  427 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p  427 (482)
                      +|+++||+.||++|+++++..+++++.||||..++|+.+..+..+++|.|
T Consensus       241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  290 (290)
T cd05613         241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP  290 (290)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhhccCCCCCCC
Confidence            99999999999999988777889999999999999999988887777754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.4e-45  Score=374.09  Aligned_cols=256  Identities=27%  Similarity=0.474  Sum_probs=219.4

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ..++|++.+.||+|+||.||+|.++.++..+|+|++....  .....+.+.+|++++++++||||++++++|.+.+.+++
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            3478999999999999999999999999999999987642  22345568899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      ||||+.+|+|..++...+.+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||++...... ..
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~  159 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA  159 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-cc
Confidence            999999999999998888899999999999999999999985 7999999999999999999999999999765332 23


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHH-------------------------
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI-------------------------  361 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i-------------------------  361 (482)
                      ...+||..|+|||++.+..++.++|||||||++|+|++|+.||...+...+...+                         
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (333)
T cd06650         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS  239 (333)
T ss_pred             ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence            4567999999999999999999999999999999999999999765443332111                         


Q ss_pred             -------------------Hhc-ccCCC-ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          362 -------------------VKD-KLRLP-AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       362 -------------------~~~-~~~~p-~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                                         ... ...++ ..++.++++||.+||++||++||++     .|++.|+||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~-----~ell~h~~~~~~  305 (333)
T cd06650         240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADL-----KQLMVHAFIKRS  305 (333)
T ss_pred             hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCH-----HHHhhCHHHhcC
Confidence                               111 11111 1357899999999999999999999     999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-45  Score=391.18  Aligned_cols=254  Identities=30%  Similarity=0.488  Sum_probs=225.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCC-CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNT-SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      ..|.+.+.||+|+||.||+|....+ ++.||+|.+....   ......+.+|+.+|+.++||||++++++|...+.+|||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            4599999999999999999998877 7889999875432   33445678899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          229 LDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      |||++||+|..++..    ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999999887753    3568999999999999999999999999999999999999999999999999998764332


Q ss_pred             ---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CCCccCChHHHHHH
Q 047009          305 ---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLL  380 (482)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~LI  380 (482)
                         .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++.+.+..+.. .+|..++.++++||
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  303 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL  303 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHH
Confidence               24456899999999999999999999999999999999999999998888888888776654 46677899999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      .+||.+||++||++     .+++.|+|++.+
T Consensus       304 ~~~L~~dP~~Rps~-----~~~l~~~~~~~~  329 (478)
T PTZ00267        304 DPLLSKNPALRPTT-----QQLLHTEFLKYV  329 (478)
T ss_pred             HHHhccChhhCcCH-----HHHHhCHHHHHH
Confidence            99999999999999     999999998643

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.1e-45  Score=368.09  Aligned_cols=255  Identities=28%  Similarity=0.490  Sum_probs=215.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|.+.+.||+|+||.||+|+++.+++.||+|+++....  ......+.+|+.++++++||||+++++++..++..++|
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            5789999999999999999999999999999999876432  22233466899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CC
Q 047009          229 LDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~  306 (482)
                      |||+.+ +|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            999986 777777654 458899999999999999999999999999999999999999999999999997653322 23


Q ss_pred             cccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-------------------cc
Q 047009          307 NSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-------------------KL  366 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-------------------~~  366 (482)
                      ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.+.                   ..
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            34578999999999876 46899999999999999999999999887665544433321                   01


Q ss_pred             CCC-----------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          367 RLP-----------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       367 ~~p-----------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      .++           ..++.++++||.+||+.||.+|+++     +|+++||||+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~h~~~~~~  292 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA-----EEAMKHAYFRSL  292 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCH-----HHHhcChhhhhc
Confidence            111           2468899999999999999999999     999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2e-45  Score=391.76  Aligned_cols=257  Identities=32%  Similarity=0.490  Sum_probs=226.6

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC-----
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY-----  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  223 (482)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...... ......+.+|+.++..++|+||++++..+...+     
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            47899999999999999999999999999999999876542 344556788999999999999999988775432     


Q ss_pred             ---eEEEEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCc
Q 047009          224 ---RLYLVLDFINGGHLFFQLYHH----GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGL  296 (482)
Q Consensus       224 ---~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGl  296 (482)
                         .+++||||+++|+|..++..+    ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl  189 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF  189 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence               378999999999999888643    4689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC---CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CCCccC
Q 047009          297 AKQFDEN---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFL  372 (482)
Q Consensus       297 a~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~  372 (482)
                      ++.+...   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.+.+..+.. .+|..+
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSI  269 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence            9875422   233467899999999999999999999999999999999999999999888888887776644 467889


Q ss_pred             ChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       373 s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      ++++.+||.+||+.||.+||++     .++++|||++..
T Consensus       270 ~~~l~~li~~~L~~dP~~RPs~-----~ell~~p~~~~~  303 (496)
T PTZ00283        270 SPEMQEIVTALLSSDPKRRPSS-----SKLLNMPICKLF  303 (496)
T ss_pred             CHHHHHHHHHHcccChhhCcCH-----HHHHhCHHHHHh
Confidence            9999999999999999999999     999999998764

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-45  Score=358.15  Aligned_cols=251  Identities=39%  Similarity=0.667  Sum_probs=217.4

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEe
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  231 (482)
                      |++++.||+|+||+||+|++..+++.||+|++......... .....+|+.++++++||||+++++++.....+++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            78999999999999999999999999999999887543322 23345599999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc-cCCCCCcccc
Q 047009          232 INGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMI  310 (482)
Q Consensus       232 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~~~~~~~  310 (482)
                      +.+++|..++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+... ..........
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999988889999999999999999999999999999999999999999999999999999863 3334455678


Q ss_pred             cCCCCCchhhhc-CCCCCchhHHHHHhHHHHHHhhCCCCCCCC---chHHHHHHHHhcccCCC----ccCChHHHHHHHH
Q 047009          311 GTVEYMAPEIVL-GKGHNKAADWWSVGILLYEMLTGKPPFIGG---NRAKIQQKIVKDKLRLP----AFLSSEAHSLLKG  382 (482)
Q Consensus       311 gt~~y~APE~l~-~~~~~~~sDvwSlGvilyelltG~~PF~~~---~~~~~~~~i~~~~~~~p----~~~s~~~~~LI~~  382 (482)
                      +|..|+|||++. +..++.++||||||+++|+|++|..||...   +...............+    ...+.++.++|.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  239 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK  239 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence            899999999998 888999999999999999999999999887   33333433333222111    1124899999999


Q ss_pred             hhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          383 LLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       383 ~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      ||+.||++||++     .++++||||
T Consensus       240 ~l~~~p~~R~~~-----~~l~~~~~~  260 (260)
T PF00069_consen  240 MLSKDPEQRPSA-----EELLKHPWF  260 (260)
T ss_dssp             HSSSSGGGSTTH-----HHHHTSGGG
T ss_pred             HccCChhHCcCH-----HHHhcCCCC
Confidence            999999999999     999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.2e-45  Score=375.26  Aligned_cols=254  Identities=27%  Similarity=0.447  Sum_probs=212.8

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC-----
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK-----  222 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----  222 (482)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||++++++|...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            35789999999999999999999999999999999876432 233455677899999999999999999988643     


Q ss_pred             -CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          223 -YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       223 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                       ...|+||||+++ +|...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence             357999999976 5655554  358889999999999999999999999999999999999999999999999998766


Q ss_pred             CCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-----------------
Q 047009          302 ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-----------------  364 (482)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-----------------  364 (482)
                      .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...                 
T Consensus       171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (355)
T cd07874         171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_pred             CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence            555556678999999999999999999999999999999999999999877654433322211                 


Q ss_pred             -----c-----cC---------------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          365 -----K-----LR---------------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       365 -----~-----~~---------------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                           .     ..               .+...+.++++||.+||+.||++||++     .|+++||||..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~-----~ell~hp~~~~  316 (355)
T cd07874         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-----DEALQHPYINV  316 (355)
T ss_pred             HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH-----HHHhcCcchhc
Confidence                 0     00               011235678999999999999999999     99999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-46  Score=379.15  Aligned_cols=240  Identities=26%  Similarity=0.443  Sum_probs=215.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      +.+.+++.||+|.||.||+|.++++ ..||+|.++....    ..+.+.+|+.+|++|+|+|||++++++..++.+||||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            4566788999999999999999874 4699999986532    3345669999999999999999999999988999999


Q ss_pred             EecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCc
Q 047009          230 DFINGGHLFFQLYH--HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN  307 (482)
Q Consensus       230 E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  307 (482)
                      |||+.|+|.++|+.  .+.+...+...++.|||+||+||+++++|||||..+||||++++.+||+|||+|+...++....
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            99999999999987  4568999999999999999999999999999999999999999999999999999765544433


Q ss_pred             ccc--cCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHh
Q 047009          308 SMI--GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       308 ~~~--gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~  383 (482)
                      ..-  -...|.|||.+....++.+||||||||+||||+| |+.||.+.+..+..+.+.++ ++.-|..+|+++.+++..|
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C  440 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC  440 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence            222  2568999999999999999999999999999999 99999999999999999887 6788899999999999999


Q ss_pred             hccCcCCcCCC
Q 047009          384 LQKEPGKRLGA  394 (482)
Q Consensus       384 L~~dP~~R~s~  394 (482)
                      |+.+|++|||+
T Consensus       441 W~~~P~~RPtF  451 (468)
T KOG0197|consen  441 WHEDPEDRPTF  451 (468)
T ss_pred             hhCCcccCCCH
Confidence            99999999998

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-45  Score=354.51  Aligned_cols=254  Identities=44%  Similarity=0.818  Sum_probs=221.6

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHH-HhCCCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL-TKIDHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +.||+|+||.||+|.++.+++.||+|++.+...........+..|..++ ...+|+||+++++++...+.+|+||||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5699999999999999999999999999765443333333445555544 456899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccccCCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE  314 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~  314 (482)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||+++....   .....|+..
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~  158 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPD  158 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcC
Confidence            99999998888899999999999999999999999999999999999999999999999999886433   334578999


Q ss_pred             CCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHHHHHHhhccCcCC
Q 047009          315 YMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLKGLLQKEPGK  390 (482)
Q Consensus       315 y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~LI~~~L~~dP~~  390 (482)
                      |+|||.+.+..++.++||||||+++|+|++|..||...+.......+.......+    ..++.++.++|.+||+.||++
T Consensus       159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~  238 (260)
T cd05611         159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK  238 (260)
T ss_pred             ccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHH
Confidence            9999999998899999999999999999999999998888887777766654433    357899999999999999999


Q ss_pred             cCCCCCCChHHHHhCcCCCCCChh
Q 047009          391 RLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       391 R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                      ||++  .+.+|++.||||+.++|+
T Consensus       239 R~~~--~~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         239 RLGA--NGYQEIKSHPFFKSINWD  260 (260)
T ss_pred             ccCC--CcHHHHHcChHhhcCCCC
Confidence            9987  566899999999999995

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.5e-45  Score=355.07  Aligned_cols=255  Identities=43%  Similarity=0.773  Sum_probs=230.0

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++.+.||.|+||.||+|+++.+++.||+|++.+.........+.+.+|+.++++++||||+++++++......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58999999999999999999999999999999987765555567788999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccc
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI  310 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  310 (482)
                      |+.|++|..++.....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.............
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~  160 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS  160 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence            99999999999887789999999999999999999999999999999999999999999999999998765554455677


Q ss_pred             cCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc---hHHHHHHHHhcccCCCccCChHHHHHHHHhhccC
Q 047009          311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN---RAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE  387 (482)
Q Consensus       311 gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~d  387 (482)
                      |+..|+|||++.+..++.++|+||||+++|+|++|+.||...+   ...+.+........+|..++.++.++|.+||+.|
T Consensus       161 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  240 (258)
T cd05578         161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERD  240 (258)
T ss_pred             CChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCC
Confidence            8999999999999889999999999999999999999998776   3444444444566778889999999999999999


Q ss_pred             cCCcCCCCCCChHHHHhCcCC
Q 047009          388 PGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       388 P~~R~s~~~~~~~eil~hp~f  408 (482)
                      |.+|+++.   .+|+++||||
T Consensus       241 p~~R~~~~---~~~l~~~~~~  258 (258)
T cd05578         241 PQKRLGDN---LKDLKNHPYF  258 (258)
T ss_pred             hhHcCCcc---HHHHhcCCCC
Confidence            99999872   6899999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.2e-44  Score=358.21  Aligned_cols=275  Identities=48%  Similarity=0.897  Sum_probs=237.4

Q ss_pred             CeEEEEEecccCceEEEEEEEc---CCCeEEEEEEeechhhch-hhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKK---NTSEIYAMKVMRKDKIVE-KNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~~~~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  225 (482)
                      +|++.+.||+|+||.||+|++.   .+++.||+|++++..... ....+.+.+|+.++.++ +||||+++++.+.....+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999999864   467889999998654322 23445678899999999 699999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  304 (482)
                      |+||||+.+|+|..++...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++...... 
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            9999999999999999887889999999999999999999999999999999999999999999999999988754332 


Q ss_pred             -CCcccccCCCCCchhhhcCCC--CCchhHHHHHhHHHHHHhhCCCCCCCCc----hHHHHHHHHhcccCCCccCChHHH
Q 047009          305 -RSNSMIGTVEYMAPEIVLGKG--HNKAADWWSVGILLYEMLTGKPPFIGGN----RAKIQQKIVKDKLRLPAFLSSEAH  377 (482)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~~--~~~~sDvwSlGvilyelltG~~PF~~~~----~~~~~~~i~~~~~~~p~~~s~~~~  377 (482)
                       .....+|+..|+|||.+.+..  ++.++|+||||+++|+|++|..||....    ..++.+.+.......|..++..++
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  240 (288)
T cd05583         161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR  240 (288)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence             223457899999999987765  7889999999999999999999996432    234455555666677788999999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCcc
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP  427 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p  427 (482)
                      ++|.+||+.||++||++  .++.++++||||+.++|..+.++.+.|+|.|
T Consensus       241 ~li~~~l~~~p~~R~t~--~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  288 (288)
T cd05583         241 DFIQKLLEKDPKKRLGA--NGADEIKNHPFFQGIDWDDLAAKRIPAPFKP  288 (288)
T ss_pred             HHHHHHhcCCHhhccCc--chHHHHhcCcccccCCHHHHhhhccCCCCCC
Confidence            99999999999999997  5678999999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.7e-45  Score=352.82  Aligned_cols=254  Identities=49%  Similarity=0.880  Sum_probs=230.6

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCCch
Q 047009          158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL  237 (482)
Q Consensus       158 LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (482)
                      ||.|+||.||+|++..+|+.||+|++.+.........+.+.+|++++++++||||+++++.+......|+||||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999999999999999876655556677788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC---------CCcc
Q 047009          238 FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT---------RSNS  308 (482)
Q Consensus       238 ~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~---------~~~~  308 (482)
                      ..++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++.......         ....
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            9999887889999999999999999999999999999999999999999999999999987643321         2234


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccC--ChHHHHHHHHhhcc
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFL--SSEAHSLLKGLLQK  386 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~LI~~~L~~  386 (482)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..+....|...  +..+.+||++||+.
T Consensus       161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  240 (265)
T cd05579         161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP  240 (265)
T ss_pred             cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcC
Confidence            5788999999999998899999999999999999999999998888888888887777777665  99999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      +|.+||++  ....++++||||++++|
T Consensus       241 ~p~~Rpt~--~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         241 DPEKRLGA--KSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             CHhhcCCC--ccHHHHhcCccccCCCC
Confidence            99999998  67789999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=355.51  Aligned_cols=250  Identities=33%  Similarity=0.559  Sum_probs=221.3

Q ss_pred             CCCeEEE-EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeec----C
Q 047009          149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQT----K  222 (482)
Q Consensus       149 ~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----~  222 (482)
                      ++||.+- ++||-|-.|+|..+.++.||+.+|+|++....        ..++|+++--.. .|||||+++++|++    .
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r  131 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQGR  131 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence            3566663 57999999999999999999999999986432        345777765544 69999999998854    4


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC---CceeEcccCcc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD---GHVMLTDFGLA  297 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~---g~vKL~DFGla  297 (482)
                      ..+.+|||.|+||.|+..++.++.  |+|.++..|++||+.|+.|||+.+|.||||||+|+|....   ..+||+|||+|
T Consensus       132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence            568899999999999999998865  9999999999999999999999999999999999999754   47999999999


Q ss_pred             ccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc----hHHHHHHHHhcccCCCc---
Q 047009          298 KQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN----RAKIQQKIVKDKLRLPA---  370 (482)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~----~~~~~~~i~~~~~~~p~---  370 (482)
                      +.-.......+.|-||.|.|||++....|+..+|+||+||++|.||+|.+||+...    ...+..+|..+.+.||.   
T Consensus       212 K~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW  291 (400)
T KOG0604|consen  212 KETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW  291 (400)
T ss_pred             cccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH
Confidence            99776777788999999999999999999999999999999999999999998754    35678899999999985   


Q ss_pred             -cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          371 -FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       371 -~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                       .+|++++++|+++|+.+|.+|+++     +++++|||+..-
T Consensus       292 s~VSe~aKdlIR~LLkt~PteRlTI-----~~~m~hpwi~~~  328 (400)
T KOG0604|consen  292 SCVSEAAKDLIRKLLKTEPTERLTI-----EEVMDHPWINQY  328 (400)
T ss_pred             hHHHHHHHHHHHHHhcCCchhheeH-----HHhhcCchhccc
Confidence             489999999999999999999999     999999999763

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-44  Score=373.40  Aligned_cols=256  Identities=24%  Similarity=0.356  Sum_probs=214.8

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcC--CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKN--TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      ...+|++++.||+|+||.||+|...+  +++.||+|.+....        ...+|+.+|++++||||++++++|.....+
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            34679999999999999999997654  56889999886532        245799999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      |+|||++. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus       162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            99999996 57888887778899999999999999999999999999999999999999999999999999987643322


Q ss_pred             ---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchH---HHHHHHHh----cc----------
Q 047009          306 ---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA---KIQQKIVK----DK----------  365 (482)
Q Consensus       306 ---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~---~~~~~i~~----~~----------  365 (482)
                         .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....   .....+.+    ..          
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence               23567999999999999999999999999999999999999999764321   11111111    00          


Q ss_pred             ---------------cCCC-----ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhh
Q 047009          366 ---------------LRLP-----AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLE  417 (482)
Q Consensus       366 ---------------~~~p-----~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~  417 (482)
                                     ...|     ..++.++++||++||..||.+||++     .|+++||||....|+.+.
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa-----~e~l~~p~f~~~~~~~~~  387 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA-----QDILSLPLFTKEPINLLN  387 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCH-----HHHhhCchhhccchhhhc
Confidence                           1111     1246788999999999999999999     999999999998887764

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.8e-45  Score=380.38  Aligned_cols=250  Identities=30%  Similarity=0.480  Sum_probs=217.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-C-----CceeeeeeeeecCC
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-H-----PFVVQLKYSFQTKY  223 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h-----pnIv~l~~~~~~~~  223 (482)
                      -+|++++.||+|+||.|.+|.+..|++.||||+++.+.    ....+...|+.||..|+ |     -|+|+++++|...+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            37999999999999999999999999999999998653    45556678999999997 3     58999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC--ceeEcccCcccc
Q 047009          224 RLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG--HVMLTDFGLAKQ  299 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g--~vKL~DFGla~~  299 (482)
                      ++|||+|.+.. +|+++++.+.  .|+...++.++.||+.||.+||+.||||+|||||||||..-+  .|||+|||.|..
T Consensus       262 HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  262 HLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             ceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            99999999965 9999998874  488999999999999999999999999999999999997544  699999999987


Q ss_pred             ccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc---------------
Q 047009          300 FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---------------  364 (482)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~---------------  364 (482)
                      ....  ..+.+.+..|+|||+|.|.+|+.+.||||||||++||++|.+.|.|.+..+....|..-               
T Consensus       341 ~~q~--vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~  418 (586)
T KOG0667|consen  341 ESQR--VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA  418 (586)
T ss_pred             cCCc--ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence            5433  33788899999999999999999999999999999999999999998887777766640               


Q ss_pred             -------------------------------------ccCCCc-----------cCChHHHHHHHHhhccCcCCcCCCCC
Q 047009          365 -------------------------------------KLRLPA-----------FLSSEAHSLLKGLLQKEPGKRLGAGP  396 (482)
Q Consensus       365 -------------------------------------~~~~p~-----------~~s~~~~~LI~~~L~~dP~~R~s~~~  396 (482)
                                                           ....|.           .-...+.+||++||..||.+|+++  
T Consensus       419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp--  496 (586)
T KOG0667|consen  419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP--  496 (586)
T ss_pred             ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH--
Confidence                                                 001120           013567899999999999999999  


Q ss_pred             CChHHHHhCcCCCCC
Q 047009          397 KGSEEIKSHKWFKPI  411 (482)
Q Consensus       397 ~~~~eil~hp~f~~~  411 (482)
                         .++++||||.+.
T Consensus       497 ---~qal~Hpfl~~~  508 (586)
T KOG0667|consen  497 ---AQALNHPFLTGT  508 (586)
T ss_pred             ---HHHhcCcccccc
Confidence               999999999864

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.7e-44  Score=347.08  Aligned_cols=252  Identities=29%  Similarity=0.525  Sum_probs=221.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec-CCeEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT-KYRLYLVL  229 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV~  229 (482)
                      +|++++.||+|++|.||++.++.+++.||+|.+..... .....+.+.+|+.++++++|+|++++++.+.. ...+|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            58999999999999999999999999999999976543 23345567889999999999999999988864 45689999


Q ss_pred             EecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCC
Q 047009          230 DFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRS  306 (482)
Q Consensus       230 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~  306 (482)
                      ||+++++|..++...  ..+++.+++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            999999999888763  45899999999999999999999999999999999999999999999999999876432 233


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CCCccCChHHHHHHHHhhc
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~LI~~~L~  385 (482)
                      ....|++.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+..+.. ..+..+++++.+||.+||+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  239 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS  239 (257)
T ss_pred             ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhc
Confidence            456789999999999999999999999999999999999999988877777666666544 4566789999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      .||.+||++     .++++||||
T Consensus       240 ~~p~~Rp~~-----~~~l~~~~~  257 (257)
T cd08223         240 KRPEKRPSV-----KSILRQPYI  257 (257)
T ss_pred             cCcccCCCH-----HHHhcCCCC
Confidence            999999998     999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.6e-44  Score=358.53  Aligned_cols=256  Identities=29%  Similarity=0.479  Sum_probs=215.6

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      .+++|++++.||.|+||.||+|+++.+++.||+|.+.....  ......+.+|+.++++++||||+++++++.....+++
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            35789999999999999999999999999999999875432  2223446689999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-C
Q 047009          228 VLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-R  305 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  305 (482)
                      ||||+.+ +|...+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus        82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence            9999975 788777654 568999999999999999999999999999999999999999999999999997653322 2


Q ss_pred             CcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-------------------c
Q 047009          306 SNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-------------------K  365 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-------------------~  365 (482)
                      .....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+...                   .
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence            2345678999999998764 5788999999999999999999999887765544433321                   0


Q ss_pred             cCCC-----------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          366 LRLP-----------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       366 ~~~p-----------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      ..+|           ..+++.+++||.+||+.||.+||++     +|+++||||+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~-----~eil~h~~f~~~  292 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA-----EEAMKHPYFHCL  292 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCH-----HHHhcCcccccc
Confidence            1111           2468899999999999999999999     999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.5e-45  Score=368.18  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=207.4

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEc-----CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKK-----NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQ  220 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  220 (482)
                      +..++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+|..+ +||||+++++++.
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            34578999999999999999999752     345789999987542  223445688999999999 8999999999886


Q ss_pred             cC-CeEEEEEEecCCCchHHHHHhc-------------------------------------------------------
Q 047009          221 TK-YRLYLVLDFINGGHLFFQLYHH-------------------------------------------------------  244 (482)
Q Consensus       221 ~~-~~~~lV~E~~~gg~L~~~l~~~-------------------------------------------------------  244 (482)
                      .. +.+++||||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            54 4689999999999999888653                                                       


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC---CCcccccCCC
Q 047009          245 -------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT---RSNSMIGTVE  314 (482)
Q Consensus       245 -------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~~gt~~  314 (482)
                             ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......   ......+++.
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                   236778888999999999999999999999999999999999999999999998653221   1223456788


Q ss_pred             CCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHH-HHHHHHhc-ccCCCccCChHHHHHHHHhhccCcCCc
Q 047009          315 YMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAK-IQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKR  391 (482)
Q Consensus       315 y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R  391 (482)
                      |+|||++.+..++.++|||||||++|||++ |..||.+....+ ..+.+..+ ....|..+++++.+||.+||+.||.+|
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  321 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER  321 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence            999999999999999999999999999997 999998765433 33334333 345577789999999999999999999


Q ss_pred             CCCCCCChHHHHh
Q 047009          392 LGAGPKGSEEIKS  404 (482)
Q Consensus       392 ~s~~~~~~~eil~  404 (482)
                      |++     .+|++
T Consensus       322 Ps~-----~el~~  329 (338)
T cd05102         322 PTF-----SALVE  329 (338)
T ss_pred             cCH-----HHHHH
Confidence            998     77764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.8e-44  Score=357.54  Aligned_cols=240  Identities=18%  Similarity=0.198  Sum_probs=211.3

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec----CCeEEEEEEe
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT----KYRLYLVLDF  231 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~  231 (482)
                      ..||+|++|.||+|.+  +|+.||||++++.........+.+.+|+.+|++++||||+++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5799999999999988  578999999987654344445778899999999999999999999876    4578999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccc
Q 047009          232 INGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI  310 (482)
Q Consensus       232 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  310 (482)
                      ++||+|..++...+.+++.....++.|++.||.|||+. +++||||||+|||++.+|.+||+|||+++.+...  .....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--~~~~~  181 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNV  181 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--ccccc
Confidence            99999999998888899999999999999999999984 9999999999999999999999999999875432  23457


Q ss_pred             cCCCCCchhhhcC--CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc--ccCCCccCChHHHHHHHHhhcc
Q 047009          311 GTVEYMAPEIVLG--KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--KLRLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       311 gt~~y~APE~l~~--~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~LI~~~L~~  386 (482)
                      ||..|+|||++.+  ..++.++|||||||++|||++|+.||.+.+..++...+...  .+.+|..++.++++||.+||+.
T Consensus       182 ~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~  261 (283)
T PHA02988        182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSH  261 (283)
T ss_pred             CcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcC
Confidence            8999999999976  68999999999999999999999999988888888877554  4456667899999999999999


Q ss_pred             CcCCcCCCCCCChHHHHh
Q 047009          387 EPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~  404 (482)
                      ||++||++     +++++
T Consensus       262 dp~~Rps~-----~ell~  274 (283)
T PHA02988        262 DSIKRPNI-----KEILY  274 (283)
T ss_pred             CcccCcCH-----HHHHH
Confidence            99999998     78764

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=352.96  Aligned_cols=251  Identities=33%  Similarity=0.555  Sum_probs=223.8

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +.||+|+|+.|--+....+|..||||++.|..   .....++.+|++++.+. .|+||++|+.+|+++.+.|||||.|.|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G  160 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG  160 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence            56999999999999999999999999998863   45667788999999998 599999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC---ceeEcccCccccccCCC-------
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG---HVMLTDFGLAKQFDENT-------  304 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g---~vKL~DFGla~~~~~~~-------  304 (482)
                      |.|..++.++..|+|.++..+.++|+.||.|||.+||.||||||+|||...-.   -+||+||.+...+..+.       
T Consensus       161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast  240 (463)
T KOG0607|consen  161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST  240 (463)
T ss_pred             chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence            99999999999999999999999999999999999999999999999997655   48999999886543221       


Q ss_pred             -CCcccccCCCCCchhhhc-----CCCCCchhHHHHHhHHHHHHhhCCCCCCCC---------------chHHHHHHHHh
Q 047009          305 -RSNSMIGTVEYMAPEIVL-----GKGHNKAADWWSVGILLYEMLTGKPPFIGG---------------NRAKIQQKIVK  363 (482)
Q Consensus       305 -~~~~~~gt~~y~APE~l~-----~~~~~~~sDvwSlGvilyelltG~~PF~~~---------------~~~~~~~~i~~  363 (482)
                       ...+.+|+..|||||+..     ...|+.++|.||||||+|.||.|++||.|.               -...++..|..
T Consensus       241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE  320 (463)
T KOG0607|consen  241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE  320 (463)
T ss_pred             ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence             234678999999999873     346899999999999999999999999763               13578889999


Q ss_pred             cccCCCcc----CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          364 DKLRLPAF----LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       364 ~~~~~p~~----~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                      +.+.||+.    +|.++++||+.+|.+|+.+|+++     .++++|||++.+.-+
T Consensus       321 GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa-----~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  321 GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSA-----AQVLNHPWVQRCAPE  370 (463)
T ss_pred             cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhh-----hhccCCccccccchh
Confidence            99999963    89999999999999999999999     999999999987544

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.6e-44  Score=360.34  Aligned_cols=253  Identities=27%  Similarity=0.474  Sum_probs=218.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+|++..++..||+|.+....  .......+.+|++++++++||||++++++|.+.+.+|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            47999999999999999999999999999999987542  2234456788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  308 (482)
                      ||++|++|..++.+.+.+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++...... ....
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~  157 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS  157 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cccc
Confidence            999999999999888889999999999999999999997 59999999999999999999999999998765332 2345


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc------------------------
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD------------------------  364 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~------------------------  364 (482)
                      .+|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+...                        
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM  237 (308)
T ss_pred             CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence            68899999999999888999999999999999999999999765543333222111                        


Q ss_pred             -------------ccCCCc-cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          365 -------------KLRLPA-FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       365 -------------~~~~p~-~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                                   ....|. .++.++++||.+||..||++||++     .++++||||..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~ll~~~~~~~  292 (308)
T cd06615         238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL-----KELTKHPFIKR  292 (308)
T ss_pred             hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH-----HHHhcChhhhh
Confidence                         111121 367889999999999999999998     99999999976

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.4e-45  Score=371.86  Aligned_cols=249  Identities=27%  Similarity=0.376  Sum_probs=205.0

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ...+|++++.||+|+||.||+|+++.+++.||+|+..+..         ...|+.++++++||||+++++++......++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            3467999999999999999999999999999999854432         2468999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          228 VLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      |||++.+ +|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus       135 v~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        135 VLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             EEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            9999965 77777754 467899999999999999999999999999999999999999999999999999865444444


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCC-CCCch----------HHHHHHHHh---cccCCC---
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPF-IGGNR----------AKIQQKIVK---DKLRLP---  369 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF-~~~~~----------~~~~~~i~~---~~~~~p---  369 (482)
                      ....||+.|+|||++.+..++.++|||||||++|||+++..|+ .....          ..+...+..   ....++   
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  293 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP  293 (357)
T ss_pred             ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence            5678999999999999999999999999999999999855444 32111          111111110   001111   


Q ss_pred             ---------------------------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          370 ---------------------------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       370 ---------------------------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                                                 ..++.++.+||++||+.||++||++     .|+++||||+.+
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta-----~e~l~hp~f~~~  357 (357)
T PHA03209        294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA-----EEILNYPMFAQL  357 (357)
T ss_pred             ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCH-----HHHhcCchhccC
Confidence                                       1356778889999999999999999     999999999864

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.7e-44  Score=350.12  Aligned_cols=253  Identities=31%  Similarity=0.516  Sum_probs=221.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhch------hhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE------KNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+.......      ....+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999999899999999987543221      2234568899999999999999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      .++||||+++++|..++...+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999998764211


Q ss_pred             -------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-ccCCCccCChHH
Q 047009          305 -------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEA  376 (482)
Q Consensus       305 -------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (482)
                             ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+... ...+|..++..+
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEA  240 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHH
Confidence                   112356889999999999999999999999999999999999999876665555444443 345677789999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      .++|++||+.||.+||++     .+|++|+||
T Consensus       241 ~~li~~~l~~~p~~Rp~~-----~~il~~~~~  267 (267)
T cd06628         241 IDFLEKTFEIDHNKRPTA-----AELLKHPFL  267 (267)
T ss_pred             HHHHHHHccCCchhCcCH-----HHHhhCCCC
Confidence            999999999999999998     999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.1e-44  Score=357.53  Aligned_cols=260  Identities=32%  Similarity=0.515  Sum_probs=224.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      +.|++++.||+|+||.||+|+++.+++.||+|++....   ....+.+.+|+.+++.++||||+++++.+.....+|+||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            56999999999999999999999999999999987542   344566788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCc
Q 047009          230 DFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSN  307 (482)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~  307 (482)
                      ||++|++|..++.+ ...+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++...... ....
T Consensus        89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence            99999999877654 456899999999999999999999999999999999999999999999999998764322 2234


Q ss_pred             ccccCCCCCchhhhc-----CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc---CCCccCChHHHHH
Q 047009          308 SMIGTVEYMAPEIVL-----GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL---RLPAFLSSEAHSL  379 (482)
Q Consensus       308 ~~~gt~~y~APE~l~-----~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~L  379 (482)
                      ...+++.|+|||++.     ...++.++|||||||++|+|++|+.||...+......++.....   ..+..++.++.++
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF  248 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence            567899999999985     34568899999999999999999999987776555555544322   2345678999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhh
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLE  417 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~  417 (482)
                      |++||..||++||++     +++++||||..++|....
T Consensus       249 i~~~l~~~p~~Rp~~-----~~il~~~~~~~~~~~~~~  281 (292)
T cd06644         249 LKTALDKHPETRPSA-----AQLLEHPFVSSVTSNRPL  281 (292)
T ss_pred             HHHHhcCCcccCcCH-----HHHhcCccccccccchhH
Confidence            999999999999998     999999999999987743

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=9.1e-44  Score=344.57  Aligned_cols=252  Identities=31%  Similarity=0.538  Sum_probs=224.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|.+.+.||+|++|.||+|.++.+++.|++|.+...... ......+.+|+.++++++||||+++++++...+..|+|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            588999999999999999999999999999998765433 3445667889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCc
Q 047009          231 FINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSN  307 (482)
Q Consensus       231 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  307 (482)
                      |++|++|..++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.... ...
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            99999999988764  568899999999999999999999999999999999999999999999999998764432 233


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CCCccCChHHHHHHHHhhcc
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~LI~~~L~~  386 (482)
                      ...|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+..+.. .++..++.++.++|.+||+.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK  239 (256)
T ss_pred             ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccC
Confidence            45789999999999999999999999999999999999999988887777777766543 45557899999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCC
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +|++||++     .++++|||+
T Consensus       240 ~p~~Rp~~-----~~ll~~~~~  256 (256)
T cd08529         240 DYRQRPDT-----FQLLRNPSL  256 (256)
T ss_pred             CcccCcCH-----HHHhhCCCC
Confidence            99999999     999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-44  Score=368.15  Aligned_cols=253  Identities=28%  Similarity=0.448  Sum_probs=211.6

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC------
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK------  222 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  222 (482)
                      .++|++++.||+|+||+||+|.+..+++.||+|++.+... .......+.+|+.+|++++||||++++++|...      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4789999999999999999999999999999999876432 223445577899999999999999999888543      


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..+|++++++ +++|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            3578999998 678876654 46799999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc----------------
Q 047009          303 NTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK----------------  365 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~----------------  365 (482)
                        .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....                
T Consensus       171 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07878         171 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA  248 (343)
T ss_pred             --CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence              2345679999999999987 568999999999999999999999998766554444433210                


Q ss_pred             -------cCCC--------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          366 -------LRLP--------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       366 -------~~~p--------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                             ...+        ...++.+.+||.+||+.||.+||++     .|+++||||...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~-----~ell~hp~~~~~  304 (343)
T cd07878         249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISA-----SEALAHPYFSQY  304 (343)
T ss_pred             HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCcchhcc
Confidence                   0011        1356778999999999999999999     999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6e-44  Score=392.99  Aligned_cols=150  Identities=45%  Similarity=0.807  Sum_probs=141.0

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|.+++.||+|+||+||+|.+..+++.||||++++...........+..|+.++..++||||+++++++.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            57899999999999999999999999999999999876655555667788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK  298 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~  298 (482)
                      |||+.|++|..++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.5e-44  Score=351.13  Aligned_cols=253  Identities=31%  Similarity=0.500  Sum_probs=215.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|+.++++++|+||+++++++.....+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            479999999999999999999999999999999875432 2223345678999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~  308 (482)
                      ||++++.|...+.....+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++....... ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            999999888877766779999999999999999999999999999999999999999999999999998765433 2334


Q ss_pred             cccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-------------------cCC
Q 047009          309 MIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-------------------LRL  368 (482)
Q Consensus       309 ~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-------------------~~~  368 (482)
                      ..++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+....                   ...
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            568899999999876 457899999999999999999999998766544433332110                   001


Q ss_pred             C------------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          369 P------------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       369 p------------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      |            ..++..+.+||.+||+.||++||++     .+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~eil~~~~f  286 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSC-----EELLEHPYF  286 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCH-----HHHhcCCCC
Confidence            1            2367889999999999999999999     999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7e-44  Score=348.07  Aligned_cols=252  Identities=29%  Similarity=0.475  Sum_probs=218.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhh---chhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI---VEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      +|++.+.||+|+||.||+|... +++.+|+|.+.....   ........+.+|+.++++++|+||+++++++.+....++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            5788899999999999999864 688999999875421   123344668899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-----
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-----  302 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-----  302 (482)
                      ||||++|++|..++.+.+.+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.+||+|||++.....     
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            999999999999998888899999999999999999999999999999999999999999999999999876421     


Q ss_pred             --CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc---ccCCCccCChHHH
Q 047009          303 --NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAH  377 (482)
Q Consensus       303 --~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~s~~~~  377 (482)
                        ........|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+...   ...++..++.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI  239 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence              11223457899999999999999999999999999999999999999876655444444333   2346677899999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +||++||+++|.+||++     .++++||||
T Consensus       240 ~~i~~~l~~~p~~Rp~~-----~~~l~~~~~  265 (265)
T cd06631         240 DFVTSCLTRDQHERPSA-----LQLLRHDFL  265 (265)
T ss_pred             HHHHHHhcCCcccCCCH-----HHHhcCCCC
Confidence            99999999999999999     999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.5e-44  Score=362.34  Aligned_cols=253  Identities=22%  Similarity=0.376  Sum_probs=209.2

Q ss_pred             EEEEeccc--CceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEe
Q 047009          154 VLKVVGQG--AFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       154 i~~~LG~G--~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  231 (482)
                      ++++||+|  +|++||+++++.+|+.||+|++..+.. .....+.+.+|+.+++.++||||++++++|..++..|+||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            46789999  789999999999999999999976543 233456788899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-C----
Q 047009          232 INGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-T----  304 (482)
Q Consensus       232 ~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~----  304 (482)
                      +++|+|.+++..+  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+...... .    
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            9999999988653  45899999999999999999999999999999999999999999999999875443211 0    


Q ss_pred             ---CCcccccCCCCCchhhhcC--CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC------------
Q 047009          305 ---RSNSMIGTVEYMAPEIVLG--KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR------------  367 (482)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~--~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~------------  367 (482)
                         ......++..|+|||++.+  ..++.++|||||||++|||++|+.||..............+...            
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence               1123457788999999976  46899999999999999999999999765544333322221110            


Q ss_pred             ----------------------------------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          368 ----------------------------------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       368 ----------------------------------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                                                        ....+++++++||++||+.||++||++     +++++||||+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~ell~~p~f~~~~  314 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA-----STLLNHSFFKQIK  314 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCH-----HHHhcChhhhhcc
Confidence                                              112356789999999999999999999     9999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=370.35  Aligned_cols=255  Identities=34%  Similarity=0.605  Sum_probs=230.8

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      .++||.|.||+||-|+++.+|+.||||++.|.++..+ ....+++|+.||+.+.||.||.|...|++.+++++|||.+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            4689999999999999999999999999999876544 457899999999999999999999999999999999999987


Q ss_pred             CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC---ceeEcccCccccccCCCCCcccc
Q 047009          235 GHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG---HVMLTDFGLAKQFDENTRSNSMI  310 (482)
Q Consensus       235 g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g---~vKL~DFGla~~~~~~~~~~~~~  310 (482)
                      .-|.-.|.. .+++++...+++..||+.||.|||-++|+|+||||+||||.+..   .+||||||+|+.+.+.....+.+
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV  727 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV  727 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence            545444433 57899999999999999999999999999999999999997653   69999999999999998889999


Q ss_pred             cCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCc----cCChHHHHHHHHhhcc
Q 047009          311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKGLLQK  386 (482)
Q Consensus       311 gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~LI~~~L~~  386 (482)
                      |||.|+|||+++.++|+.+-|+||+|||+|--|.|..||  ...+++.++|.+..+.+|.    .++.++.|||..+|+.
T Consensus       728 GTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPF--NEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqV  805 (888)
T KOG4236|consen  728 GTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPF--NEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQV  805 (888)
T ss_pred             CCccccCHHHHhhccccccccceeeeEEEEEEecccccC--CCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHH
Confidence            999999999999999999999999999999999999999  4556788888888888875    4899999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCCCCCC-hhhhh
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWFKPIN-WKKLE  417 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f~~~~-~~~~~  417 (482)
                      .-++|.+.     +..+.|||+++.. |.++.
T Consensus       806 km~kRysv-----dk~lsh~Wlq~yq~w~DLR  832 (888)
T KOG4236|consen  806 KMRKRYSV-----DKSLSHPWLQDYQTWLDLR  832 (888)
T ss_pred             HHHHhcch-----HhhccchhhhcchHHHHHH
Confidence            99999999     9999999999754 66653

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-44  Score=352.80  Aligned_cols=257  Identities=32%  Similarity=0.512  Sum_probs=224.0

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||.|+||.||+|.++.+++.||+|++....   ....+.+.+|+.++++++||||+++++.+......|+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            367999999999999999999999899999999987542   33455677899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCC
Q 047009          229 LDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~  306 (482)
                      |||+++++|..++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR  160 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence            9999999999988764 5689999999999999999999999999999999999999999999999999876532 2233


Q ss_pred             cccccCCCCCchhhhc-----CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc---cCCCccCChHHHH
Q 047009          307 NSMIGTVEYMAPEIVL-----GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHS  378 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~-----~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~  378 (482)
                      ....||+.|+|||++.     +..++.++|+||||+++|+|++|+.||...+.......+....   +..|..++.++.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND  240 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence            4567899999999985     3457789999999999999999999998877766666666543   2345678999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      +|.+||+.||.+||++     .++++|+||.....
T Consensus       241 li~~~l~~~p~~Rps~-----~~il~~~~~~~~~~  270 (280)
T cd06611         241 FLKSCLVKDPDDRPTA-----AELLKHPFVSDQSD  270 (280)
T ss_pred             HHHHHhccChhhCcCH-----HHHhcChhhcccch
Confidence            9999999999999999     99999999998654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.6e-44  Score=349.11  Aligned_cols=251  Identities=29%  Similarity=0.480  Sum_probs=215.3

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++....   ......+.+|+.++++++||||+++++++.....+++|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            468999999999999999999999999999999987542   23345577899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  307 (482)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.... ...
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            9999999999999888889999999999999999999999999999999999999999999999999998764322 234


Q ss_pred             ccccCCCCCchhhhc---CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCC-----CccCChHHHHH
Q 047009          308 SMIGTVEYMAPEIVL---GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL-----PAFLSSEAHSL  379 (482)
Q Consensus       308 ~~~gt~~y~APE~l~---~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~-----p~~~s~~~~~L  379 (482)
                      ...|+..|+|||.+.   ...++.++|+|||||++|||++|+.||...+.......+....+..     +..++..+++|
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF  244 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence            567899999999985   3457889999999999999999999997655443333333322221     23468899999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcC
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKW  407 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~  407 (482)
                      |++||..||.+||++     ++|++|+|
T Consensus       245 i~~~l~~~P~~Rp~~-----~~il~~l~  267 (267)
T cd06646         245 VKISLTKNPKKRPTA-----ERLLTHLF  267 (267)
T ss_pred             HHHHhhCChhhCcCH-----HHHhcCCC
Confidence            999999999999999     99999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-44  Score=349.64  Aligned_cols=255  Identities=29%  Similarity=0.537  Sum_probs=224.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||.|+||.||+|++..+++.||+|++....  .......+.+|+.+++.++|+||+++++++.+...+|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            46889999999999999999999999999999987653  2334456788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~  308 (482)
                      ||+++++|..++... .+++..++.++.|++.||.|||+++++||||+|+||+++.++.++|+|||+++..... .....
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            999999999988765 7899999999999999999999999999999999999999999999999999887543 33445


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-cCCCcc-CChHHHHHHHHhhcc
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-LRLPAF-LSSEAHSLLKGLLQK  386 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p~~-~s~~~~~LI~~~L~~  386 (482)
                      ..|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+.... ..++.. ++.++.++|.+||..
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  237 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK  237 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhC
Confidence            678999999999999889999999999999999999999998777666666555543 233444 789999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      ||++||++     +++++|+||....
T Consensus       238 ~p~~Rpt~-----~~il~~~~~~~~~  258 (274)
T cd06609         238 DPKERPSA-----KELLKHKFIKKAK  258 (274)
T ss_pred             ChhhCcCH-----HHHhhChhhcCCC
Confidence            99999998     9999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.3e-43  Score=349.66  Aligned_cols=251  Identities=31%  Similarity=0.527  Sum_probs=209.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++.+.||+|++|.||+|+++.+++.||+|++..... .......+.+|+.++++++||||+++++++.++..+|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            58999999999999999999999999999999875432 22334567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CC
Q 047009          231 FINGGHLFFQLYHH---GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RS  306 (482)
Q Consensus       231 ~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~  306 (482)
                      |+. ++|..++...   +.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++....... ..
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            998 5787777543   468999999999999999999999999999999999999999999999999998653222 22


Q ss_pred             cccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc------------------cc-
Q 047009          307 NSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD------------------KL-  366 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~------------------~~-  366 (482)
                      ....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...                  .. 
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            344678999999998764 5789999999999999999999999876543322222110                  00 


Q ss_pred             ----------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          367 ----------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       367 ----------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                                .....++.++++||++||+.||.+||++     .+|++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~~ll~~~~~  285 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISA-----KKALNHPYF  285 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCH-----HHHhcCCCC
Confidence                      0123478999999999999999999999     999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8.1e-44  Score=351.21  Aligned_cols=252  Identities=28%  Similarity=0.471  Sum_probs=214.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.+..  .......+.+|+.++++++||||+++++++......++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            46889999999999999999999999999999987642  2334456888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCccc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM  309 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  309 (482)
                      ||+++++|..+    ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++...... .....
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~  153 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTY  153 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCC
Confidence            99999988643    35788899999999999999999999999999999999999999999999999876433 23456


Q ss_pred             ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch-------HHHHHHHHhcc-cCCC-ccCChHHHHHH
Q 047009          310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR-------AKIQQKIVKDK-LRLP-AFLSSEAHSLL  380 (482)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~-------~~~~~~i~~~~-~~~p-~~~s~~~~~LI  380 (482)
                      +||..|+|||++.+..++.++|+||||+++|+|++|+.||.....       ....+.+.... ...+ ...+.++++||
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI  233 (279)
T ss_pred             CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence            899999999999999999999999999999999999999965321       12223332221 2222 34788999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      .+||+.||.+||++     +|+++||||...+-
T Consensus       234 ~~~l~~~P~~Rp~~-----~eil~~~~~~~~~~  261 (279)
T cd06619         234 TQCMRKQPKERPAP-----ENLMDHPFIVQYND  261 (279)
T ss_pred             HHHhhCChhhCCCH-----HHHhcCcccccccC
Confidence            99999999999998     99999999987653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.7e-44  Score=350.43  Aligned_cols=251  Identities=31%  Similarity=0.514  Sum_probs=215.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++...   ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            367899999999999999999999999999999987543   23344577899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~  307 (482)
                      |||+++++|..++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999998765432 2234


Q ss_pred             ccccCCCCCchhhhc---CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC-----ccCChHHHHH
Q 047009          308 SMIGTVEYMAPEIVL---GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP-----AFLSSEAHSL  379 (482)
Q Consensus       308 ~~~gt~~y~APE~l~---~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~L  379 (482)
                      ...|+..|+|||++.   ...++.++|+|||||++|+|++|+.||...........+.......+     ..++..+++|
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF  244 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHH
Confidence            567999999999985   45688999999999999999999999976554443333333322221     2467889999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcC
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKW  407 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~  407 (482)
                      |.+||+.||++||++     ++|++|||
T Consensus       245 i~~~l~~~P~~R~~~-----~~ll~~~~  267 (267)
T cd06645         245 VKMALTKNPKKRPTA-----EKLLQHPF  267 (267)
T ss_pred             HHHHccCCchhCcCH-----HHHhcCCC
Confidence            999999999999998     99999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.2e-43  Score=344.79  Aligned_cols=254  Identities=33%  Similarity=0.501  Sum_probs=218.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhh--chhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC--CeE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI--VEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK--YRL  225 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~  225 (482)
                      ++|++.+.||+|+||.||+|.++.+++.||||.+.....  ......+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            579999999999999999999999999999999864321  1223456788999999999999999999998763  568


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC--
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--  303 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~--  303 (482)
                      ++||||++|++|..++...+.+++..+..++.|++.||+|||+++|+|+||||+||+++.++.+||+|||+++.....  
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            899999999999999988788999999999999999999999999999999999999999999999999999865321  


Q ss_pred             --CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc--ccCCCccCChHHHHH
Q 047009          304 --TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--KLRLPAFLSSEAHSL  379 (482)
Q Consensus       304 --~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~L  379 (482)
                        .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...  ....|..++..+.++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF  241 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence              1223456899999999999988999999999999999999999999876555444444432  234566788999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      |++||. +|++||++     +||++|||+.
T Consensus       242 i~~~l~-~p~~Rp~~-----~~il~~~~~~  265 (265)
T cd06652         242 LKRIFV-EAKLRPSA-----DELLRHTFVH  265 (265)
T ss_pred             HHHHhc-ChhhCCCH-----HHHhcCcccC
Confidence            999995 99999998     9999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-43  Score=346.55  Aligned_cols=254  Identities=33%  Similarity=0.504  Sum_probs=217.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhh--chhhHHHHHHHHHHHHHhCCCCceeeeeeeeec--CCeE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI--VEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT--KYRL  225 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~  225 (482)
                      .+|++.+.||+|+||.||+|.+..++..||+|++.....  ........+.+|+.++++++||||+++++++..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            478999999999999999999999999999999875432  122345668899999999999999999998865  4678


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC--
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--  303 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~--  303 (482)
                      +++|||+++++|..++...+.+++...+.++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++.+...  
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            999999999999999988888999999999999999999999999999999999999999999999999999865321  


Q ss_pred             --CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc--ccCCCccCChHHHHH
Q 047009          304 --TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--KLRLPAFLSSEAHSL  379 (482)
Q Consensus       304 --~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~L  379 (482)
                        .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+...  ...+|..+++.+++|
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF  241 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence              1123356899999999999999999999999999999999999999876655444443332  345567789999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      | +||..+|++||++     +||++||||+
T Consensus       242 i-~~~~~~p~~Rp~~-----~eil~hp~~~  265 (266)
T cd06651         242 L-GCIFVEARHRPSA-----EELLRHPFAQ  265 (266)
T ss_pred             H-HHhcCChhhCcCH-----HHHhcCcccc
Confidence            9 5777899999998     9999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.4e-44  Score=351.87  Aligned_cols=251  Identities=26%  Similarity=0.485  Sum_probs=208.5

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++.+.||+|+||.||+|+++.+|+.||+|++..... .......+.+|+.++++++||||+++++++.+...+++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            48899999999999999999999999999999976432 22233456789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCcc
Q 047009          231 FINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNS  308 (482)
Q Consensus       231 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~  308 (482)
                      |+.+ +|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ....
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            9975 67776654 5679999999999999999999999999999999999999999999999999998754322 2234


Q ss_pred             cccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCC-CCCchHHHHHHHHhcc-----------------c---
Q 047009          309 MIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPF-IGGNRAKIQQKIVKDK-----------------L---  366 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF-~~~~~~~~~~~i~~~~-----------------~---  366 (482)
                      ..++..|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+..+.+.+..                 .   
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP  238 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence            5678999999998774 4789999999999999999998885 4444444433332210                 0   


Q ss_pred             ---------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          367 ---------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       367 ---------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                               .....++.++++||++||+.||.+||++     +++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-----~~il~h~~f  284 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA-----EEALQHPYF  284 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH-----HHHhcCCCC
Confidence                     0112468899999999999999999999     999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-43  Score=343.48  Aligned_cols=250  Identities=30%  Similarity=0.506  Sum_probs=220.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|++....   ....+.+.+|+.++++++||||+++++++.+...+|++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            68999999999999999999999999999999997653   234567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCc
Q 047009          230 DFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSN  307 (482)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  307 (482)
                      ||+++++|..++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++....... ...
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            999999999988776 789999999999999999999999999999999999999999999999999998764332 334


Q ss_pred             ccccCCCCCchhhhcCC---CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC-----CCccCChHHHHH
Q 047009          308 SMIGTVEYMAPEIVLGK---GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-----LPAFLSSEAHSL  379 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~---~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~L  379 (482)
                      ...|+..|+|||.+.+.   .++.++|+||||+++|+|++|+.||...+.......+....+.     .+..++.++++|
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF  239 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence            56789999999999877   8899999999999999999999999887765555555444222     233467889999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcC
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKW  407 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~  407 (482)
                      |++||..||.+||++     .+|+.|+|
T Consensus       240 i~~~l~~~p~~Rpt~-----~~il~~~~  262 (262)
T cd06613         240 IKKCLTKDPKKRPTA-----TKLLQHPF  262 (262)
T ss_pred             HHHHcCCChhhCCCH-----HHHhcCCC
Confidence            999999999999999     99999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-43  Score=350.07  Aligned_cols=252  Identities=34%  Similarity=0.536  Sum_probs=218.3

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEe
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  231 (482)
                      |++.+.||+|+||.||+|++..++..+|+|.+....   ....+.+.+|+.+++.++||||++++++|......|+||||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            678899999999999999999999999999986543   23455678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCccc
Q 047009          232 INGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSNSM  309 (482)
Q Consensus       232 ~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~  309 (482)
                      +++++|...+.+ .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... ......
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence            999999887755 467899999999999999999999999999999999999999999999999999765322 233456


Q ss_pred             ccCCCCCchhhhc-----CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc---cCCCccCChHHHHHHH
Q 047009          310 IGTVEYMAPEIVL-----GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK  381 (482)
Q Consensus       310 ~gt~~y~APE~l~-----~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~LI~  381 (482)
                      .||..|+|||++.     +..++.++|||||||++|+|++|+.||...+..+....+....   ...|..++.++++||.
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK  243 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence            7899999999984     4557889999999999999999999998877666655555432   2345668899999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      +||++||.+||++     .++++||||+..
T Consensus       244 ~~l~~~p~~Rp~~-----~~il~~~~~~~~  268 (282)
T cd06643         244 KCLEKNVDARWTT-----TQLLQHPFVTVN  268 (282)
T ss_pred             HHccCChhhCcCH-----HHHhcCCCEecc
Confidence            9999999999999     999999999853

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-43  Score=392.97  Aligned_cols=263  Identities=27%  Similarity=0.458  Sum_probs=221.7

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec--C
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT--K  222 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~  222 (482)
                      +...+++|++++.||+|+||+||+|+++.++..||+|++...... ......+..|+.+|++++|||||+++++|..  .
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            345568999999999999999999999999999999999865432 3345667889999999999999999998854  4


Q ss_pred             CeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-------CCcccCCCCCcEEEcc------
Q 047009          223 YRLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHAN-------GIMHRDLKPENILLGA------  285 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~-------~IiHrDLKp~NILl~~------  285 (482)
                      ..+||||||+.+|+|..+|..    .+.+++..++.|+.||+.||.|||+.       +||||||||+||||+.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            679999999999999988865    35799999999999999999999984       4999999999999964      


Q ss_pred             -----------CCceeEcccCccccccCCCCCcccccCCCCCchhhhcC--CCCCchhHHHHHhHHHHHHhhCCCCCCCC
Q 047009          286 -----------DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG--KGHNKAADWWSVGILLYEMLTGKPPFIGG  352 (482)
Q Consensus       286 -----------~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwSlGvilyelltG~~PF~~~  352 (482)
                                 .+.+||+|||+++.+.........+||+.|+|||++.+  ..++.++||||||||||+|++|+.||...
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                       23599999999988765555566789999999999965  45889999999999999999999999766


Q ss_pred             chHHHHHHHHhcccCCC-ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          353 NRAKIQQKIVKDKLRLP-AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       353 ~~~~~~~~i~~~~~~~p-~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      +.......+......+| ...+.++.+||..||..+|.+||++     .++|.|+||+.+..
T Consensus       247 ~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa-----~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        247 NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSA-----LQCLGYQIIKNVGP  303 (1021)
T ss_pred             CcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCH-----HHHhccHHHhhcCC
Confidence            54443333333333443 4578999999999999999999999     99999999987653

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.8e-43  Score=349.00  Aligned_cols=260  Identities=23%  Similarity=0.335  Sum_probs=219.9

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  221 (482)
                      +..++|++.+.||+|+||.||+|..++     .+..||+|.+.....  ......+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            445789999999999999999997653     356899999865431  2233456789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeE
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHHG----------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVML  291 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL  291 (482)
                      ....|+||||+++|+|..++...+          .++...+..++.|++.||.|||+++|+||||||+|||++.++.+||
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999999987532          2456678889999999999999999999999999999999999999


Q ss_pred             cccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-cc
Q 047009          292 TDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KL  366 (482)
Q Consensus       292 ~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~  366 (482)
                      +|||+++.......   .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..+..+.+..+ ..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL  240 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999986532211   122345778999999999999999999999999999998 89999888887777776654 34


Q ss_pred             CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh------CcCCCCCCh
Q 047009          367 RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS------HKWFKPINW  413 (482)
Q Consensus       367 ~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~------hp~f~~~~~  413 (482)
                      ..+..++..++++|.+||+.||++||++     .++++      ||||++++|
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         241 DQPDNCPERVTDLMRMCWQFNPKMRPTF-----LEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCH-----HHHHHHHHhhcCCCCCCCCC
Confidence            5667788999999999999999999998     67765      999999998

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=376.03  Aligned_cols=258  Identities=32%  Similarity=0.535  Sum_probs=230.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      +-|+|+..||.|+||+||+|..+.++-..|-|++.-.   ..+..+.+.-|+.||..++||+||+|++.|...+.++|+.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            4478889999999999999999999999999998654   3456677788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc-cCCCCCc
Q 047009          230 DFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSN  307 (482)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~~~~  307 (482)
                      |||.||-....+.. ...+.+.+++.+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+... .......
T Consensus       109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD  188 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD  188 (1187)
T ss_pred             eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence            99999988776654 456999999999999999999999999999999999999999999999999987653 3345567


Q ss_pred             ccccCCCCCchhhhc-----CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC---CCccCChHHHHH
Q 047009          308 SMIGTVEYMAPEIVL-----GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR---LPAFLSSEAHSL  379 (482)
Q Consensus       308 ~~~gt~~y~APE~l~-----~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~L  379 (482)
                      +++|||.|||||+..     ..+|+.++||||||++|.||..+.+|-...++....-+|.+..++   -|..++..+.||
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~Df  268 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDF  268 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHH
Confidence            899999999999974     568999999999999999999999999999998888888876443   367789999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhh
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK  415 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~  415 (482)
                      +++||.+||..||++     .+|++||||.+++-.+
T Consensus       269 Lk~cL~Knp~~Rp~a-----aqll~Hpfv~~~~SnK  299 (1187)
T KOG0579|consen  269 LKRCLVKNPRNRPPA-----AQLLKHPFVQNAPSNK  299 (1187)
T ss_pred             HHHHHhcCCccCCCH-----HHHhhCcccccCCcch
Confidence            999999999999999     9999999999877543

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.8e-43  Score=342.53  Aligned_cols=249  Identities=30%  Similarity=0.509  Sum_probs=219.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.+.....     .+.+.+|+.++++++|+||+++++++.....+|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            679999999999999999999999899999999876431     567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCc
Q 047009          230 DFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSN  307 (482)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  307 (482)
                      ||+++++|.+++.. ...+++..++.++.|++.||.|||+.+|+||||+|+||+++.++.+||+|||++....... ...
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence            99999999998875 4568999999999999999999999999999999999999999999999999998765433 334


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc---ccCCCccCChHHHHHHHHhh
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~LI~~~L  384 (482)
                      ...|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+...   ....+..++.++.++|.+||
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL  237 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence            456899999999999999999999999999999999999999876654444333322   22344567889999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHhCcCC
Q 047009          385 QKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +.||++||++     .|++.||||
T Consensus       238 ~~~P~~Rps~-----~~il~~~~~  256 (256)
T cd06612         238 VKDPEERPSA-----IQLLQHPFI  256 (256)
T ss_pred             hcChhhCcCH-----HHHhcCCCC
Confidence            9999999999     999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.4e-43  Score=346.89  Aligned_cols=250  Identities=30%  Similarity=0.502  Sum_probs=212.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecC------
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTK------  222 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~------  222 (482)
                      +.|++.+.||+|+||.||+|.++.+++.||+|++....    .....+.+|+.++.++ +|+||++++++|...      
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            56888999999999999999999999999999987543    2234577899999998 799999999998653      


Q ss_pred             CeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF  300 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~  300 (482)
                      ..+|+||||+.+|+|..++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            4689999999999999988764  46899999999999999999999999999999999999999999999999999875


Q ss_pred             cCC-CCCcccccCCCCCchhhhc-----CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc--CCCccC
Q 047009          301 DEN-TRSNSMIGTVEYMAPEIVL-----GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL--RLPAFL  372 (482)
Q Consensus       301 ~~~-~~~~~~~gt~~y~APE~l~-----~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~--~~p~~~  372 (482)
                      ... .......|+..|+|||++.     +..++.++|||||||++|||++|+.||...........+.....  ..+..+
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW  241 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCc
Confidence            432 2334568999999999986     34688899999999999999999999976655544444433321  123457


Q ss_pred             ChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       373 s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +.++.+||.+||..||.+||++     .++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rpt~-----~~il~~~~~  272 (272)
T cd06637         242 SKKFQSFIESCLVKNHSQRPTT-----EQLMKHPFI  272 (272)
T ss_pred             CHHHHHHHHHHcCCChhhCCCH-----HHHhhCCCC
Confidence            8999999999999999999998     999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.3e-43  Score=343.52  Aligned_cols=252  Identities=31%  Similarity=0.513  Sum_probs=220.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||.|+||+||+|....++..+|+|++.......  ....+.+|+.+++.++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47999999999999999999999899999999987654322  5567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC-
Q 047009          230 DFINGGHLFFQLYHH---GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-  305 (482)
Q Consensus       230 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-  305 (482)
                      |++++++|..++...   +.+++..++.++.|++.||.|||++||+||||||+||++++++.+||+|||++..+..... 
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999998764   4589999999999999999999999999999999999999999999999999987643322 


Q ss_pred             ----CcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CCC-----ccCCh
Q 047009          306 ----SNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLP-----AFLSS  374 (482)
Q Consensus       306 ----~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p-----~~~s~  374 (482)
                          ....+|+..|+|||++... .++.++|+||||+++|+|++|+.||...+..+....+..... .++     ..++.
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK  238 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence                2345789999999999877 789999999999999999999999988776666655554422 122     25678


Q ss_pred             HHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          375 EAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       375 ~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      ++.+||.+||++||.+||++     .+|++||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~-----~~ll~~p~~  267 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTA-----EELLKHKFF  267 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCH-----HHHhhCCCC
Confidence            99999999999999999998     999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-43  Score=349.53  Aligned_cols=251  Identities=22%  Similarity=0.401  Sum_probs=218.8

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCC-----eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTS-----EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      ..++|++.+.||+|+||.||+|.+...+     ..||+|.+....  .......+.+|+.++.+++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            3568999999999999999999987655     789999987543  233455688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHH----------------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD  286 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~  286 (482)
                      ...|++|||+++|+|..++...                ..+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            9999999999999999998765                457888899999999999999999999999999999999999


Q ss_pred             CceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHH
Q 047009          287 GHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIV  362 (482)
Q Consensus       287 g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~  362 (482)
                      +.+||+|||+++......   ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++...+.
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR  240 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999998653222   2334567889999999999899999999999999999998 999999988888888877


Q ss_pred             hccc-CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          363 KDKL-RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       363 ~~~~-~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      .... ..|..++.++.+|+++||+.||.+||++     .+|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~-----~~i~~~  279 (283)
T cd05048         241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRF-----KDIHTR  279 (283)
T ss_pred             cCCcCCCcccCCHHHHHHHHHHccCChhhCcCH-----HHHHHH
Confidence            6543 4567899999999999999999999999     888763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.4e-43  Score=345.80  Aligned_cols=258  Identities=41%  Similarity=0.769  Sum_probs=232.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCCeEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV  228 (482)
                      ++|.+.+.||+|+||.||+|..+.+++.||+|++.+...........+.+|..++.+++ |+||+++++++......++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999998765555555567889999999998 99999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC----
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT----  304 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~----  304 (482)
                      |||+.+++|..++.+.+.+++..++.++.|++.||.|||++|++|+||||+||+++.+|.++|+|||++.......    
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            9999999999999988899999999999999999999999999999999999999999999999999998754322    


Q ss_pred             -----------------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC
Q 047009          305 -----------------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR  367 (482)
Q Consensus       305 -----------------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~  367 (482)
                                       ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+.....+.+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS  240 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC
Confidence                             123456789999999999888999999999999999999999999988877777888777888


Q ss_pred             CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          368 LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       368 ~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +|..+++.+.+||.+||+.||.+||++. .+.+++++||||
T Consensus       241 ~~~~~~~~~~~li~~~l~~~p~~R~~~~-~~~~~ll~~~~~  280 (280)
T cd05581         241 FPPNFPPDAKDLIEKLLVLDPQDRLGVN-EGYDELKAHPFF  280 (280)
T ss_pred             CCCccCHHHHHHHHHHhcCCHhhCCCcc-cCHHHHhcCCCC
Confidence            8899999999999999999999999972 244799999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=373.11  Aligned_cols=242  Identities=29%  Similarity=0.455  Sum_probs=218.6

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      -++...-++.||.|+.|.||+|+.++  +.||||.++.-          -+.+++-|++|+||||+.+.++|.....+||
T Consensus       122 PFe~IsELeWlGSGaQGAVF~Grl~n--etVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCI  189 (904)
T KOG4721|consen  122 PFEEISELEWLGSGAQGAVFLGRLHN--ETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCI  189 (904)
T ss_pred             CHHHhhhhhhhccCcccceeeeeccC--ceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence            33445557889999999999999874  78999986532          1357888999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCc
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN  307 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  307 (482)
                      |||||..|-|...|+....+.......|..+|+.||.|||.+.|||||||.-||||+.+..|||+|||.++.+.+.....
T Consensus       190 iMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM  269 (904)
T KOG4721|consen  190 IMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKM  269 (904)
T ss_pred             eeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999988777778


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc--cCCCccCChHHHHHHHHhhc
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~LI~~~L~  385 (482)
                      +++||..|||||+|+..+.+.|+|||||||+|||||||..||.+.+...++--+..+.  +..|..+++.++=||++||+
T Consensus       270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~  349 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN  349 (904)
T ss_pred             hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence            8999999999999999999999999999999999999999999888776666665554  45678899999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCc
Q 047009          386 KEPGKRLGAGPKGSEEIKSHK  406 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp  406 (482)
                      -.|.+||++     .+|+.|=
T Consensus       350 sKpRNRPSF-----rqil~Hl  365 (904)
T KOG4721|consen  350 SKPRNRPSF-----RQILLHL  365 (904)
T ss_pred             cCCCCCccH-----HHHHHHH
Confidence            999999999     8988874

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.3e-43  Score=350.37  Aligned_cols=254  Identities=30%  Similarity=0.500  Sum_probs=220.0

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      ..+|++.+.||+|+||.||+|.++.+++.||+|.+.....   ...+.+.+|+.+++.++|+||+++++.|......|+|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            3689999999999999999999999999999999876542   2345678899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  307 (482)
                      |||++|++|..++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus        96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence            999999999988754 568999999999999999999999999999999999999999999999999988654322 223


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc---ccCCCccCChHHHHHHHHhh
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~LI~~~L  384 (482)
                      ...|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...   ....+..++..+.+||.+||
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence            457899999999999988999999999999999999999999876654433333222   22345668899999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          385 QKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      .+||.+||++     .+|++|+||...
T Consensus       255 ~~~p~~Rpt~-----~eil~~~~~~~~  276 (296)
T cd06654         255 DMDVEKRGSA-----KELLQHQFLKIA  276 (296)
T ss_pred             cCCcccCcCH-----HHHhhChhhhcc
Confidence            9999999998     999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.7e-43  Score=350.19  Aligned_cols=254  Identities=31%  Similarity=0.508  Sum_probs=222.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++.....+|+|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            569999999999999999999999999999999875432   33456788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~  308 (482)
                      ||+++++|..++.. ..+++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... ....
T Consensus        96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence            99999999988764 468999999999999999999999999999999999999999999999999988754332 2334


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc---ccCCCccCChHHHHHHHHhhc
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ..|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+.......+...   .+..+..++..+.+||++||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE  254 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhh
Confidence            67899999999999999999999999999999999999999887765544444433   223456689999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      .||.+||++     .+|+.||||+...
T Consensus       255 ~dp~~Rpt~-----~~il~~~~~~~~~  276 (296)
T cd06655         255 MDVEKRGSA-----KELLQHPFLKLAK  276 (296)
T ss_pred             cChhhCCCH-----HHHhhChHhhhcc
Confidence            999999998     9999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-43  Score=345.69  Aligned_cols=254  Identities=26%  Similarity=0.494  Sum_probs=218.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc---hhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      +|+..+.||+|+||.||+|.+..+++.||+|++......   .....+.+.+|+.++++++|+||+++++++.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999999999999999999754321   12245678899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC-ceeEcccCccccccCCC--
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG-HVMLTDFGLAKQFDENT--  304 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~--  304 (482)
                      ||||++|++|..++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.......  
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998888899999999999999999999999999999999999998876 59999999998754321  


Q ss_pred             ---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHH-----hcccCCCccCChHH
Q 047009          305 ---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV-----KDKLRLPAFLSSEA  376 (482)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~-----~~~~~~p~~~s~~~  376 (482)
                         ......|+..|+|||++.+..++.++|+||+|+++|+|++|+.||...+.......+.     .....+|..++.++
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL  240 (268)
T ss_pred             CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHH
Confidence               1234578999999999999899999999999999999999999997544332222221     12345666789999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      .++|.+||..||.+||++     .++++||||+
T Consensus       241 ~~~i~~~l~~~p~~R~~~-----~~ll~~~~~~  268 (268)
T cd06630         241 RDVTLRCLELQPEDRPPS-----RELLKHPVFR  268 (268)
T ss_pred             HHHHHHHcCCCcccCcCH-----HHHhcCcccC
Confidence            999999999999999999     9999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.4e-43  Score=340.54  Aligned_cols=252  Identities=28%  Similarity=0.497  Sum_probs=224.5

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++.+.||+|+||.||+|.++.+++.||+|.+...... ......+.+|+.++++++||||+++++.+...+.+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            589999999999999999999999999999999865433 3345678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC-ceeEcccCccccccCCCCCc
Q 047009          231 FINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG-HVMLTDFGLAKQFDENTRSN  307 (482)
Q Consensus       231 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~~~~  307 (482)
                      |+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence            99999999998764  3489999999999999999999999999999999999998654 58999999999876555555


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-cCCCccCChHHHHHHHHhhcc
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~LI~~~L~~  386 (482)
                      ...|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.......+.... ..++..++.+++++|.+||..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  239 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL  239 (256)
T ss_pred             ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccC
Confidence            6788999999999999889999999999999999999999998887777766666543 356777899999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCC
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      ||.+||++     .|+++||||
T Consensus       240 ~p~~Rpt~-----~~ll~~p~~  256 (256)
T cd08220         240 DPSKRPQL-----SQIMAQPIC  256 (256)
T ss_pred             ChhhCCCH-----HHHhhCCCC
Confidence            99999999     999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.8e-43  Score=340.25  Aligned_cols=253  Identities=32%  Similarity=0.519  Sum_probs=221.8

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhh--chhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI--VEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +|+..+.||+|+||+||+|..+.+++.||+|.+.....  ..+...+.+.+|+.+++.++|+||+++++++.....+++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            46778899999999999999998899999999876432  1234556788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS  308 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  308 (482)
                      +||+++++|..++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++...........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999987654444456


Q ss_pred             cccCCCCCchhhhcCCC-CCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHh--cccCCCccCChHHHHHHHHhhc
Q 047009          309 MIGTVEYMAPEIVLGKG-HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK--DKLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~-~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ..|+..|+|||.+.... ++.++|+||||+++|+|++|+.||...........+..  ....++..++..+++||++||.
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  240 (258)
T cd06632         161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ  240 (258)
T ss_pred             cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence            67899999999998776 89999999999999999999999977665444444443  2335667789999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      .+|.+||++     .+++.|||+
T Consensus       241 ~~p~~Rp~~-----~~~l~~~~~  258 (258)
T cd06632         241 RDPSLRPTA-----AELLEHPFV  258 (258)
T ss_pred             cCcccCcCH-----HHHhcCCCC
Confidence            999999998     999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.9e-43  Score=340.73  Aligned_cols=252  Identities=31%  Similarity=0.574  Sum_probs=223.2

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++.+.||+|+||.||+++...+|+.||+|.+....... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            5899999999999999999999999999999997654322 334567889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC-Cc
Q 047009          231 FINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-SN  307 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~~  307 (482)
                      |+.+++|..++....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            999999998887643  578999999999999999999999999999999999999999999999999987643322 23


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CCCccCChHHHHHHHHhhcc
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~LI~~~L~~  386 (482)
                      ...|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+..+.. ..+..++.++.++|.+||+.
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (256)
T cd08218         160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR  239 (256)
T ss_pred             hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhC
Confidence            45688999999999999999999999999999999999999988877777777666543 46677899999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCC
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +|.+||++     .++++||||
T Consensus       240 ~p~~Rp~~-----~~vl~~~~~  256 (256)
T cd08218         240 NPRDRPSV-----NSILEKNFI  256 (256)
T ss_pred             ChhhCcCH-----HHHhhCcCC
Confidence            99999999     999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.3e-43  Score=355.82  Aligned_cols=243  Identities=29%  Similarity=0.511  Sum_probs=193.3

Q ss_pred             EEEecccCceEEEEEEEcC--CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec--CCeEEEEEE
Q 047009          155 LKVVGQGAFGRVYQVRKKN--TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT--KYRLYLVLD  230 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV~E  230 (482)
                      .++||+|+||+||+|+++.  +++.||+|.+.....     ...+.+|+.+|++++||||++++++|..  ...+|+|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            3579999999999999764  678999999875432     2335689999999999999999998854  567899999


Q ss_pred             ecCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE----ccCCceeEcccCcc
Q 047009          231 FINGGHLFFQLYHH---------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL----GADGHVMLTDFGLA  297 (482)
Q Consensus       231 ~~~gg~L~~~l~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl----~~~g~vKL~DFGla  297 (482)
                      |+.+ +|..++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            9965 777666432         248999999999999999999999999999999999999    45679999999999


Q ss_pred             ccccCC----CCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchH---------HHHHHHHh
Q 047009          298 KQFDEN----TRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRA---------KIQQKIVK  363 (482)
Q Consensus       298 ~~~~~~----~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~---------~~~~~i~~  363 (482)
                      +.....    ......+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+....         .....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            876432    12345688999999999987 45899999999999999999999999653321         11111111


Q ss_pred             c----------------------------ccCC----------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          364 D----------------------------KLRL----------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       364 ~----------------------------~~~~----------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      .                            ....          ....+.++.+||++||+.||.+|+|+     +|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~-----~e~l~h  314 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS-----EQAMQD  314 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCH-----HHHhcC
Confidence            0                            0000          01135678999999999999999999     999999


Q ss_pred             cCC
Q 047009          406 KWF  408 (482)
Q Consensus       406 p~f  408 (482)
                      |||
T Consensus       315 p~f  317 (317)
T cd07868         315 PYF  317 (317)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-43  Score=371.92  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=206.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      ...|.+.+.||+|+||.||+|.+..+++.||||.....         .+.+|+++|++++|+|||++++++...+..++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~---------~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA---------SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc---------CHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            45799999999999999999999999999999964321         245799999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC---
Q 047009          229 LDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT---  304 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~---  304 (482)
                      ||++. ++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....   
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            99996 5888777654 569999999999999999999999999999999999999999999999999998754322   


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc--------hHHHHHHHHhcccC---CCc---
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN--------RAKIQQKIVKDKLR---LPA---  370 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~--------~~~~~~~i~~~~~~---~p~---  370 (482)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|..|+....        ...+.+.+......   ++.   
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            1234679999999999999999999999999999999999876653321        12233333222111   110   


Q ss_pred             ----------------------------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          371 ----------------------------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       371 ----------------------------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                                                  .++.++.+||.+||+.||.+||++     .|+|+||||+.
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa-----~elL~hp~f~~  460 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSA-----AELLRLPLFQS  460 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCH-----HHHhhCcccCC
Confidence                                        245689999999999999999999     99999999975

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.6e-43  Score=338.71  Aligned_cols=252  Identities=32%  Similarity=0.535  Sum_probs=224.6

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++++.||.|+||.||.++...+++.+++|.+....... .....+.+|+.++++++|+||+++++++.+.+.++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            5899999999999999999999999999999987654332 345567889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCc
Q 047009          231 FINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSN  307 (482)
Q Consensus       231 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  307 (482)
                      |+++|+|..++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            99999999998765  468999999999999999999999999999999999999999999999999998764333 334


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC-CCccCChHHHHHHHHhhcc
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-LPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~LI~~~L~~  386 (482)
                      ...|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..+... .+..++.++.++|.+||++
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ  239 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccc
Confidence            567899999999999888999999999999999999999999988888877777766443 3456789999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCC
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +|.+||++     .++++|+|+
T Consensus       240 ~p~~R~s~-----~~ll~~~~l  256 (256)
T cd08221         240 DPEKRPTA-----DEVLDQPLL  256 (256)
T ss_pred             CcccCCCH-----HHHhhCcCC
Confidence            99999998     999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.5e-43  Score=344.25  Aligned_cols=250  Identities=21%  Similarity=0.313  Sum_probs=214.4

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEc---CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKK---NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ..++|++.+.||+|+||.||+|.++   ..+..||+|+++...  .......+.+|+.++.+++||||+++++++.....
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            3467999999999999999999875   456789999987643  22334567889999999999999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          225 LYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      .++||||+++|+|..++... +.+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999988764 57899999999999999999999999999999999999999999999999987664322


Q ss_pred             CCC--cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHH
Q 047009          304 TRS--NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSL  379 (482)
Q Consensus       304 ~~~--~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L  379 (482)
                      ...  ....++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+..+.+..+ ....|..++..+.++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL  240 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence            211  12345678999999999999999999999999999775 99999888877777776654 345667789999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHh
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +.+||+.+|.+||++     ++|++
T Consensus       241 i~~c~~~~p~~RP~~-----~~i~~  260 (266)
T cd05064         241 MLDCWQKERGERPRF-----SQIHS  260 (266)
T ss_pred             HHHHcCCCchhCCCH-----HHHHH
Confidence            999999999999998     77764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.1e-43  Score=340.54  Aligned_cols=256  Identities=35%  Similarity=0.572  Sum_probs=226.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|++|.||+|+++.+++.||+|++.....  ......+.+|+.++.+++|+||+++++++.....+++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            479999999999999999999999999999999876532  144566889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC-c
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-N  307 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~-~  307 (482)
                      ||+++++|..++.....+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++......... .
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            999999999999888889999999999999999999999 99999999999999999999999999999876543332 2


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC---chHHHHHHHHhc-ccCCCcc-CChHHHHHHHH
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG---NRAKIQQKIVKD-KLRLPAF-LSSEAHSLLKG  382 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~---~~~~~~~~i~~~-~~~~p~~-~s~~~~~LI~~  382 (482)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...   ...+....+... ...++.. ++..+.++|.+
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  238 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA  238 (264)
T ss_pred             ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHH
Confidence            567899999999999999999999999999999999999999776   344555555543 3345555 88999999999


Q ss_pred             hhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          383 LLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       383 ~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      ||..+|++||++     .++++||||+.++
T Consensus       239 ~l~~~p~~R~~~-----~~ll~~~~~~~~~  263 (264)
T cd06623         239 CLQKDPKKRPSA-----AELLQHPFIKKAD  263 (264)
T ss_pred             HccCChhhCCCH-----HHHHhCHHHHhcc
Confidence            999999999999     9999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.1e-43  Score=340.05  Aligned_cols=252  Identities=32%  Similarity=0.579  Sum_probs=223.2

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeee--cCCeEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQ--TKYRLYLV  228 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~lV  228 (482)
                      +|++++.||.|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.  ....++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            58999999999999999999999999999999876543 2344566788999999999999999998775  34568999


Q ss_pred             EEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          229 LDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLH-----ANGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH-----~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      |||+++++|..++..    ...+++..++.++.||+.||.|||     +.+|+|+||||+||+++.++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999988865    357899999999999999999999     89999999999999999999999999999988


Q ss_pred             ccCCCC-CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CCCccCChHHH
Q 047009          300 FDENTR-SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAH  377 (482)
Q Consensus       300 ~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~  377 (482)
                      ...... .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+...+.+.+..+.. .++..++..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN  239 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHH
Confidence            754443 3456789999999999998899999999999999999999999998887777777776654 45677899999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +++.+||+.+|++||++     .+|++|||+
T Consensus       240 ~l~~~~l~~~p~~Rp~~-----~~il~~~~~  265 (265)
T cd08217         240 EVIKSMLNVDPDKRPST-----EELLQLPLI  265 (265)
T ss_pred             HHHHHHccCCcccCCCH-----HHHhhCCCC
Confidence            99999999999999999     999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7.1e-43  Score=339.00  Aligned_cols=248  Identities=34%  Similarity=0.586  Sum_probs=219.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++.+.||+|+||.||+++++.+++.||+|.++....  ....+.+.+|+.+++.++|+||+++++.+.+.+.+|+|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            58999999999999999999999999999999875432  2345667889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCc
Q 047009          231 FINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSN  307 (482)
Q Consensus       231 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~  307 (482)
                      |+++|+|..++...  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...... ....
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence            99999999887653  45899999999999999999999999999999999999999999999999999876432 2234


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CCCccCChHHHHHHHHhhcc
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~LI~~~L~~  386 (482)
                      ...|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+..+.. .+|..++..+++||++||+.
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  238 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR  238 (255)
T ss_pred             cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhC
Confidence            56789999999999999999999999999999999999999998887777777766644 36677899999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhC
Q 047009          387 EPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~h  405 (482)
                      ||.+||++     .+|+.-
T Consensus       239 ~P~~Rp~~-----~~il~~  252 (255)
T cd08219         239 NPRSRPSA-----TTILSR  252 (255)
T ss_pred             CcccCCCH-----HHHhhc
Confidence            99999998     888763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-43  Score=349.82  Aligned_cols=254  Identities=29%  Similarity=0.493  Sum_probs=217.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++++.||+|+||.||+|+++.+++.||+|.+....  .......+.+|+.++++++||||+++++++...+.+|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            47899999999999999999999999999999987542  2233456788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          230 DFINGGHLFFQLYHH---GLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       230 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      ||++|++|..++...   ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++..+... .
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~  157 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-L  157 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-c
Confidence            999999998887653   378999999999999999999997 59999999999999999999999999999876432 2


Q ss_pred             CcccccCCCCCchhhhcCC------CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHH---HHhc-ccCCCccCChH
Q 047009          306 SNSMIGTVEYMAPEIVLGK------GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQK---IVKD-KLRLPAFLSSE  375 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~------~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~---i~~~-~~~~p~~~s~~  375 (482)
                      .....|++.|+|||.+.+.      .++.++|+|||||++|+|++|+.||...+.......   +... ...+|..++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD  237 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence            3445788999999998654      358899999999999999999999976555443333   2222 34567778999


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      +.+||.+||+.+|.+||++     +++++||||...
T Consensus       238 ~~~li~~~l~~~p~~Rp~~-----~~l~~~~~~~~~  268 (286)
T cd06622         238 AQDFVAKCLNKIPNRRPTY-----AQLLEHPWLVKY  268 (286)
T ss_pred             HHHHHHHHcccCcccCCCH-----HHHhcChhhhhc
Confidence            9999999999999999999     999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.7e-43  Score=345.98  Aligned_cols=259  Identities=27%  Similarity=0.437  Sum_probs=212.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHH-HHhCCCCceeeeeeeeecCCeEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI-LTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++++... .... ..+..|..+ ++.++||||+++++++......|+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            479999999999999999999999999999999876532 1222 234445554 6677999999999999999999999


Q ss_pred             EEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          229 LDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      |||++ |+|...+..    ...+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99997 467666543    34689999999999999999999997 9999999999999999999999999999876544


Q ss_pred             CCCcccccCCCCCchhhhcC----CCCCchhHHHHHhHHHHHHhhCCCCCCCC-chHHHHHHHHh-cccCCC-ccCChHH
Q 047009          304 TRSNSMIGTVEYMAPEIVLG----KGHNKAADWWSVGILLYEMLTGKPPFIGG-NRAKIQQKIVK-DKLRLP-AFLSSEA  376 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~----~~~~~~sDvwSlGvilyelltG~~PF~~~-~~~~~~~~i~~-~~~~~p-~~~s~~~  376 (482)
                      .......|+..|+|||++.+    ..++.++|+|||||++|+|++|+.||... +..+....+.. ....+| ..++.++
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF  237 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence            43444678999999999865    45688999999999999999999999643 22222333333 233444 3578999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhh
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKL  416 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~  416 (482)
                      .+||.+||..+|.+||++     +++++||||....+...
T Consensus       238 ~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~~~~~~  272 (283)
T cd06617         238 QDFVNKCLKKNYKERPNY-----PELLQHPFFELHLSKNT  272 (283)
T ss_pred             HHHHHHHccCChhhCcCH-----HHHhcCchhhhcccccH
Confidence            999999999999999999     99999999998765533

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.7e-43  Score=345.48  Aligned_cols=253  Identities=30%  Similarity=0.494  Sum_probs=214.7

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecC----
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTK----  222 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~----  222 (482)
                      ..++|++.+.||+|+||.||+|..+.+++.||+|++....    .....+.+|+.++.++ +|||++++++++...    
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~   95 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV   95 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence            4588999999999999999999999999999999986542    2234567899999998 899999999998643    


Q ss_pred             -CeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          223 -YRLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       223 -~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                       +..|+||||++||+|..++..    ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~  175 (291)
T cd06639          96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS  175 (291)
T ss_pred             CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence             468999999999999887753    356899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC-CCcccccCCCCCchhhhcCC-----CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc---cCC
Q 047009          298 KQFDENT-RSNSMIGTVEYMAPEIVLGK-----GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRL  368 (482)
Q Consensus       298 ~~~~~~~-~~~~~~gt~~y~APE~l~~~-----~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~---~~~  368 (482)
                      ....... ......|+..|+|||++...     .++.++|||||||++|+|++|+.||...+.......+.+..   ...
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  255 (291)
T cd06639         176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH  255 (291)
T ss_pred             hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc
Confidence            8754322 23445789999999998653     36889999999999999999999998776655555554442   223


Q ss_pred             CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          369 PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       369 p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      +..++..+.+||.+||+.||.+||++     .+|++||||+
T Consensus       256 ~~~~~~~l~~li~~~l~~~p~~Rps~-----~~il~~~~~~  291 (291)
T cd06639         256 PEKWCRSFNHFISQCLIKDFEARPSV-----THLLEHPFIK  291 (291)
T ss_pred             ccccCHHHHHHHHHHhhcChhhCcCH-----HHHhcCcccC
Confidence            55677899999999999999999998     9999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.8e-43  Score=347.37  Aligned_cols=253  Identities=32%  Similarity=0.490  Sum_probs=214.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++.+.... ....+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            4799999999999999999999999999999998764322 234456778999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~  308 (482)
                      ||++++.|..+......+++..+..++.||+.||.|||+.||+||||+|+||++++++.+||+|||++....... ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            999999888877666679999999999999999999999999999999999999999999999999998754332 2334


Q ss_pred             cccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-------------------ccC-
Q 047009          309 MIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-------------------KLR-  367 (482)
Q Consensus       309 ~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-------------------~~~-  367 (482)
                      ..++..|+|||++.+ ..++.++||||||+++|||++|++||...+..+....+...                   ... 
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            568999999999876 45788999999999999999999999766544433333210                   000 


Q ss_pred             -----------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          368 -----------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       368 -----------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                                 ..+.++..+.+||.+||+.||.+||++     .++++|+||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~-----~~il~~~~~  286 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS-----SQLLHHEFF  286 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhH-----HHHhcCCCC
Confidence                       123468899999999999999999999     999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.8e-43  Score=349.38  Aligned_cols=254  Identities=30%  Similarity=0.498  Sum_probs=220.0

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      ..+|++++.||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++|+||++++++|......|+|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            3789999999999999999999999999999999876432   2345578899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  307 (482)
                      |||+++++|..++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++....... ...
T Consensus        95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence            999999999988854 568899999999999999999999999999999999999999999999999998754332 233


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc---ccCCCccCChHHHHHHHHhh
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~LI~~~L  384 (482)
                      ...|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+.......+...   ....|..++..+++||.+||
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  253 (297)
T cd06656         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL  253 (297)
T ss_pred             cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHc
Confidence            457899999999999999999999999999999999999999776654333222222   22345668899999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          385 QKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      ..||++||++     +++++||||+..
T Consensus       254 ~~~p~~Rps~-----~~il~~~~~~~~  275 (297)
T cd06656         254 EMDVDRRGSA-----KELLQHPFLKLA  275 (297)
T ss_pred             cCChhhCcCH-----HHHhcCchhccc
Confidence            9999999999     999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.4e-43  Score=348.59  Aligned_cols=248  Identities=21%  Similarity=0.312  Sum_probs=206.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcC----------------CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCce
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKN----------------TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV  212 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI  212 (482)
                      .++|++.+.||+|+||.||+|.++.                ++..||+|++....  .......+.+|+.++.+++||||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence            3689999999999999999998643                34579999987643  23345668899999999999999


Q ss_pred             eeeeeeeecCCeEEEEEEecCCCchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 047009          213 VQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-------------------LFREDLARIYAAEIVSAVSHLHANGIMH  273 (482)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-------------------~l~~~~~~~i~~qi~~aL~yLH~~~IiH  273 (482)
                      +++++++.+.+..++||||+.+|+|..++....                   .+++..+..++.||+.||.|||++||+|
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            999999999999999999999999998886532                   3567788899999999999999999999


Q ss_pred             cCCCCCcEEEccCCceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh--CCCC
Q 047009          274 RDLKPENILLGADGHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT--GKPP  348 (482)
Q Consensus       274 rDLKp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt--G~~P  348 (482)
                      |||||+|||++.++.+||+|||+++.+....   ......++..|+|||++.+..++.++||||||+++|||++  |..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            9999999999999999999999998754332   1233456789999999999899999999999999999986  6788


Q ss_pred             CCCCchHHHHHHHHhc--------ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHH
Q 047009          349 FIGGNRAKIQQKIVKD--------KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIK  403 (482)
Q Consensus       349 F~~~~~~~~~~~i~~~--------~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil  403 (482)
                      |.+.+..+....+...        ....|..++..+.+||.+||+.||++||++     .+|.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~-----~~i~  299 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF-----SDIH  299 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH-----HHHH
Confidence            8876665554443221        123355688999999999999999999998     7774

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-43  Score=346.35  Aligned_cols=253  Identities=34%  Similarity=0.565  Sum_probs=217.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+|.++.+++.||+|+++.... .....+.+.+|+.++++++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            479999999999999999999999999999999876432 2334567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--CCc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--RSN  307 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--~~~  307 (482)
                      ||++++.+.....+...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.......  ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            999998777666666779999999999999999999999999999999999999999999999999998765433  334


Q ss_pred             ccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc----------------------
Q 047009          308 SMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD----------------------  364 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~----------------------  364 (482)
                      ...++..|+|||++.+. .++.++|+||||+++|+|++|+.||.+.+..+....+...                      
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            56789999999999888 8899999999999999999999999876554333322210                      


Q ss_pred             ----------ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          365 ----------KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       365 ----------~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                                ...++..++.++++||++||..+|++||++     +++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~f  288 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC-----DELLQHPYF  288 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccH-----HHHhcCCCC
Confidence                      001233458999999999999999999999     999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.2e-43  Score=350.73  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=213.3

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeE--EEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEI--YAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKY  223 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  223 (482)
                      +..++|++.+.||+|+||.||+|.++.++..  +|+|.+...  ........+.+|+.++.++ +|+||+++++++...+
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            4568999999999999999999999877754  577665432  2334456678899999999 8999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC
Q 047009          224 RLYLVLDFINGGHLFFQLYHHG----------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG  287 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g  287 (482)
                      .+|+||||+++|+|..++...+                .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            9999999999999999887543                478889999999999999999999999999999999999999


Q ss_pred             ceeEcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-c
Q 047009          288 HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-K  365 (482)
Q Consensus       288 ~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~  365 (482)
                      .+||+|||+++............++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+..+.+... .
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  241 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  241 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCc
Confidence            999999999875332222222334678999999998889999999999999999998 99999888777777666544 3


Q ss_pred             cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          366 LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       366 ~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ...+..++.++.+||.+||+.+|++||++     ++++.+
T Consensus       242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~~il~~  276 (303)
T cd05088         242 LEKPLNCDDEVYDLMRQCWREKPYERPSF-----AQILVS  276 (303)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            34566688999999999999999999999     888765

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.4e-43  Score=344.23  Aligned_cols=253  Identities=30%  Similarity=0.498  Sum_probs=212.2

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeee-----
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQ-----  220 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----  220 (482)
                      ...++|++.+.||+|+||.||+|.++.+++.||+|++....    .....+.+|+.+++.+ +||||+++++++.     
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            45689999999999999999999999999999999976532    2234567899999999 7999999999873     


Q ss_pred             cCCeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCc
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGL  296 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGl  296 (482)
                      .....++||||++|++|...+..    ...+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~  170 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV  170 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence            45678999999999999887643    35688999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC-CCCcccccCCCCCchhhhcC-----CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc---ccC
Q 047009          297 AKQFDEN-TRSNSMIGTVEYMAPEIVLG-----KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLR  367 (482)
Q Consensus       297 a~~~~~~-~~~~~~~gt~~y~APE~l~~-----~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~---~~~  367 (482)
                      ++..... .......|++.|+|||++..     ..++.++|||||||++|+|++|+.||...+.......+...   ...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (286)
T cd06638         171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH  250 (286)
T ss_pred             eeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCccc
Confidence            9875432 23345579999999999853     45788999999999999999999999876654443333322   122


Q ss_pred             CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          368 LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       368 ~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      .|..++..+.+||.+||+.||.+||++     .||++|+||
T Consensus       251 ~~~~~~~~~~~li~~~l~~~p~~Rps~-----~ell~~~~~  286 (286)
T cd06638         251 QPELWSNEFNDFIRKCLTKDYEKRPTV-----SDLLQHVFI  286 (286)
T ss_pred             CCCCcCHHHHHHHHHHccCCcccCCCH-----HHHhhcccC
Confidence            345578899999999999999999999     999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-44  Score=365.95  Aligned_cols=255  Identities=25%  Similarity=0.358  Sum_probs=221.8

Q ss_pred             CcccccccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeee
Q 047009          140 DSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSF  219 (482)
Q Consensus       140 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  219 (482)
                      .+...+.+..+++.+...||+|.||+||+|+|-++   ||||+++.+.... +..+.|++|+..|++-+|.||+=+.|+|
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~  457 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGAC  457 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhh
Confidence            34456667778899999999999999999999874   9999999887654 4889999999999999999999999999


Q ss_pred             ecCCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccc
Q 047009          220 QTKYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK  298 (482)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~  298 (482)
                      ..... .||+.+|+|.+|+.++.-. .+|.....+.|++||++||.|||.++|||||||..||+|.+++.|||+|||++.
T Consensus       458 ~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  458 MNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             cCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccccee
Confidence            88877 8999999999999988653 568899999999999999999999999999999999999999999999999997


Q ss_pred             c---ccCCCCCcccccCCCCCchhhhcC---CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC-----
Q 047009          299 Q---FDENTRSNSMIGTVEYMAPEIVLG---KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-----  367 (482)
Q Consensus       299 ~---~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~-----  367 (482)
                      .   +..........|...|||||+++.   .+|+..+||||||+++|||++|.+||...+.+.++-.+..+...     
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~  616 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK  616 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh
Confidence            5   333344455678899999999975   47899999999999999999999999987877777777666332     


Q ss_pred             CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          368 LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       368 ~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .-..+++++++|+..||.+++++||.+     .+|+.
T Consensus       617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F-----~~il~  648 (678)
T KOG0193|consen  617 IRSNCPKAMKRLLSDCWKFDREERPLF-----PQLLS  648 (678)
T ss_pred             hhccCHHHHHHHHHHHHhcCcccCccH-----HHHHH
Confidence            223577899999999999999999999     77774

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.3e-43  Score=357.62  Aligned_cols=252  Identities=27%  Similarity=0.477  Sum_probs=212.7

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC------
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK------  222 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  222 (482)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.++++++||||++++++|...      
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4789999999999999999999999999999999865432 233445567899999999999999999988644      


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ...|+||||+.+ +|...+...  +++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++....
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            357999999975 777776543  89999999999999999999999999999999999999999999999999988665


Q ss_pred             CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc------------------
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD------------------  364 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~------------------  364 (482)
                      ........||..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...                  
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN  250 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence            54445567899999999999999999999999999999999999999877654444433221                  


Q ss_pred             ----ccC--------------C-------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          365 ----KLR--------------L-------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       365 ----~~~--------------~-------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                          ...              +       +...+..+++||.+||+.||++||++     .|++.||||+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~eiL~~~~~~  315 (353)
T cd07850         251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV-----DDALQHPYIN  315 (353)
T ss_pred             HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCH-----HHHhcChhHh
Confidence                000              0       11245678999999999999999999     9999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.1e-43  Score=349.53  Aligned_cols=258  Identities=32%  Similarity=0.498  Sum_probs=215.4

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC--Ce
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK--YR  224 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~  224 (482)
                      ..+++|++.+.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.++++++|+||+++++++...  +.
T Consensus         4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (309)
T cd07845           4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS   82 (309)
T ss_pred             ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence            35689999999999999999999999999999999987543221 2223356799999999999999999998754  56


Q ss_pred             EEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          225 LYLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      +++||||+.+ +|..++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        83 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            8999999975 77777765 367899999999999999999999999999999999999999999999999999876533


Q ss_pred             C-CCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-----------------
Q 047009          304 T-RSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-----------------  364 (482)
Q Consensus       304 ~-~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-----------------  364 (482)
                      . ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...                 
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence            2 2233456888999999876 56899999999999999999999999988877666655541                 


Q ss_pred             --ccCCC-----------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          365 --KLRLP-----------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       365 --~~~~p-----------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                        ...++           ..+++++.+||++||+.||++||++     +++++||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~-----~~il~h~~f~~~  296 (309)
T cd07845         242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA-----EEALESSYFKEK  296 (309)
T ss_pred             cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCH-----HHHhcChhhccC
Confidence              11111           1258899999999999999999999     999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=9.7e-43  Score=343.22  Aligned_cols=252  Identities=33%  Similarity=0.539  Sum_probs=215.1

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++.+.||+|+||.||+|.++.+|+.||+|++...... ......+.+|+.++++++||||+++++++.....+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            589999999999999999999999999999999865432 2345568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--CCc
Q 047009          231 FINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--RSN  307 (482)
Q Consensus       231 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--~~~  307 (482)
                      |+ +++|..++.. ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......  ...
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            99 9999988865 3568999999999999999999999999999999999999999999999999998765432  234


Q ss_pred             ccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-------------------cC
Q 047009          308 SMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-------------------LR  367 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-------------------~~  367 (482)
                      ...|+..|+|||++.+. .++.++||||+|+++|+|++|.+||.+.+.......+....                   ..
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT  238 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence            46789999999998764 46899999999999999999999997776655544443310                   00


Q ss_pred             C-----------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          368 L-----------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       368 ~-----------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      +           ....+.++.+||.+||+.||++||++     +++++||||.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~-----~~~l~h~~~~  286 (286)
T cd07832         239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA-----AEALRHPYFT  286 (286)
T ss_pred             CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH-----HHHhhCcCcC
Confidence            1           12357899999999999999999999     9999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.2e-43  Score=343.99  Aligned_cols=253  Identities=30%  Similarity=0.501  Sum_probs=219.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||.|+||.||+|.++.+++.||+|++.....  ......+.+|+.++++++||||+++++.+.....+++|+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            468888999999999999999999999999999876532  244566788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCc
Q 047009          230 DFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN  307 (482)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  307 (482)
                      ||+++++|..++... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||.+........ .
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  157 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-K  157 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-h
Confidence            999999999998876 789999999999999999999999 9999999999999999999999999999877543222 2


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC-----chHHHHHHHHhc-ccCCCcc-CChHHHHHH
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG-----NRAKIQQKIVKD-KLRLPAF-LSSEAHSLL  380 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~~~~LI  380 (482)
                      ...|+..|+|||.+.+..++.++||||||+++|+|++|+.||...     ......+.+... ...++.. ++.+++++|
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV  237 (265)
T ss_pred             cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence            277899999999999999999999999999999999999999654     223334444433 3344444 889999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      .+||..||.+||++     .+++.||||+.
T Consensus       238 ~~~l~~~p~~Rpt~-----~~ll~~~~~~~  262 (265)
T cd06605         238 NLCLIKDPRERPSY-----KELLEHPFIKK  262 (265)
T ss_pred             HHHcCCCchhCcCH-----HHHhhCchhhc
Confidence            99999999999999     99999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.2e-43  Score=347.00  Aligned_cols=255  Identities=29%  Similarity=0.446  Sum_probs=216.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc--hhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV--EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +|++.+.||+|+||.||+|.++.+++.||+|.+......  .......+..|+.++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            488999999999999999999999999999999865432  122344567899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCC
Q 047009          229 LDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~  306 (482)
                      |||+ +|+|..++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++..... ...
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 889999988766 7999999999999999999999999999999999999999999999999999876443 223


Q ss_pred             cccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-------------------
Q 047009          307 NSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-------------------  366 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-------------------  366 (482)
                      ....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+..+...++.....                   
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            34467889999999865 4678999999999999999999988987776555554432100                   


Q ss_pred             ----C-----CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          367 ----R-----LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       367 ----~-----~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                          .     .....+.++.+||.+||++||++||++     .|++.|+||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-----~e~l~~~~~~~~  288 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITA-----RQALEHPYFSND  288 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCH-----HHHhhCccccCC
Confidence                0     012357889999999999999999998     999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.8e-43  Score=347.05  Aligned_cols=255  Identities=27%  Similarity=0.452  Sum_probs=219.9

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ..++|++++.||+|+||+||+|.+..+|+.||+|++....  .....+.+.+|+.+++.++||||+++++++.....+++
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            3468999999999999999999999999999999987542  23345678899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      ||||+++++|..++...+.+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...... ..
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~  159 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IA  159 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-cc
Confidence            99999999999998888889999999999999999999997 59999999999999999999999999998765332 23


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchH-----------HHHHHHHhc-ccCCCcc-CC
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA-----------KIQQKIVKD-KLRLPAF-LS  373 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~-----------~~~~~i~~~-~~~~p~~-~s  373 (482)
                      ...+|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+..           +..+.+... ...++.. ++
T Consensus       160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd06620         160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP  239 (284)
T ss_pred             CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence            3568999999999999889999999999999999999999999765431           233333332 2233333 78


Q ss_pred             hHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       374 ~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      .++.+||.+||++||.+||++     .|+++|+||..
T Consensus       240 ~~~~~li~~~l~~dp~~Rpt~-----~e~~~~~~~~~  271 (284)
T cd06620         240 EDLRDFVDACLLKDPTERPTP-----QQLCAMPPFIQ  271 (284)
T ss_pred             HHHHHHHHHHhcCCcccCcCH-----HHHhcCccccc
Confidence            899999999999999999999     99999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.8e-43  Score=363.00  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=209.6

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCC-----eEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTS-----EIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQ  220 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  220 (482)
                      ...++|++.+.||+|+||.||+|++..+|     ..||+|++.....  ....+.+.+|+.+++.+ +|+||++++++|.
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            34578999999999999999999865433     5799999976432  23456688999999999 8999999999999


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhc--------------------------------------------------------
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHH--------------------------------------------------------  244 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~--------------------------------------------------------  244 (482)
                      ..+.+++||||+++|+|.+++..+                                                        
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            999999999999999999888542                                                        


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC---Cc
Q 047009          245 --------------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR---SN  307 (482)
Q Consensus       245 --------------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~---~~  307 (482)
                                    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......   ..
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                          2367888999999999999999999999999999999999999999999999987543321   12


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc--ccCCCccCChHHHHHHHHhh
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD--KLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~LI~~~L  384 (482)
                      ...++..|||||++.+..++.++|||||||++|||++ |+.||...........+...  ....|..++.+++++|.+||
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  352 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW  352 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence            2335678999999999999999999999999999997 99999876554444444333  33456678999999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHh
Q 047009          385 QKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~  404 (482)
                      +.||.+||++     .++.+
T Consensus       353 ~~dp~~RPs~-----~~l~~  367 (374)
T cd05106         353 NLEPTERPTF-----SQISQ  367 (374)
T ss_pred             CCChhhCcCH-----HHHHH
Confidence            9999999999     77764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.8e-43  Score=343.60  Aligned_cols=256  Identities=29%  Similarity=0.501  Sum_probs=223.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ..|+.++.||.|+||.||+|.++.++..||+|++.....  ......+.+|+.++++++|+||+++++++.+....|+||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            457888999999999999999999999999999875432  234567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~  308 (482)
                      ||++||+|.+++.. +.+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            99999999988864 568999999999999999999999999999999999999999999999999997764332 2334


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHhhccC
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKE  387 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~L~~d  387 (482)
                      ..++..|+|||++.+..++.++|+|||||++|||++|+.||...+.......+... ...++..++..+.++|.+||+.+
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  240 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKD  240 (277)
T ss_pred             ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccC
Confidence            56889999999999989999999999999999999999999887766655555433 33445567899999999999999


Q ss_pred             cCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          388 PGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       388 P~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      |++||++     .+++.|+||.....
T Consensus       241 p~~Rp~~-----~~il~~~~~~~~~~  261 (277)
T cd06640         241 PSFRPTA-----KELLKHKFIVKNAK  261 (277)
T ss_pred             cccCcCH-----HHHHhChHhhhcch
Confidence            9999999     99999999986554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.1e-42  Score=336.55  Aligned_cols=252  Identities=32%  Similarity=0.557  Sum_probs=218.6

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.++++++|+||+++++.+.+...+++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            588999999999999999999989999999999876432 3467778999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC-----
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-----  305 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-----  305 (482)
                      |+++++|.+++...+.+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++........     
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            999999999998877889999999999999999999999999999999999999999999999999987643322     


Q ss_pred             CcccccCCCCCchhhhcCCC---CCchhHHHHHhHHHHHHhhCCCCCCCCc-hHHHHHHHHh-cccCCCccC--ChHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKG---HNKAADWWSVGILLYEMLTGKPPFIGGN-RAKIQQKIVK-DKLRLPAFL--SSEAHS  378 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~---~~~~sDvwSlGvilyelltG~~PF~~~~-~~~~~~~i~~-~~~~~p~~~--s~~~~~  378 (482)
                      .....++..|+|||++.+..   ++.++||||||+++|+|++|+.||...+ .......+.. ....+|...  +..+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence            12356889999999998776   8899999999999999999999997653 2222323332 233455544  899999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      ||.+||+.||.+||++     .+++.|||+
T Consensus       240 li~~~l~~~p~~R~~~-----~~i~~~~~~  264 (264)
T cd06626         240 FLDRCLESDPKKRPTA-----SELLQHPFV  264 (264)
T ss_pred             HHHHHccCCcccCCCH-----HHHhcCCCC
Confidence            9999999999999999     999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-42  Score=340.07  Aligned_cols=253  Identities=29%  Similarity=0.509  Sum_probs=214.8

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc-------hhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-------EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      +|.+.+.||.|+||.||+|....+|+.||+|.++.....       .....+.+.+|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            478889999999999999999999999999998643211       1123456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          224 RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      ..++||||+.+++|..++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999865322


Q ss_pred             ---CCCcccccCCCCCchhhhcCCC--CCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc--ccCCCc----cC
Q 047009          304 ---TRSNSMIGTVEYMAPEIVLGKG--HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--KLRLPA----FL  372 (482)
Q Consensus       304 ---~~~~~~~gt~~y~APE~l~~~~--~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~----~~  372 (482)
                         .......|+..|+|||++....  ++.++|+||||+++|+|++|..||...+.......+...  ...++.    .+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence               1223457899999999998754  889999999999999999999999765544333333222  223332    46


Q ss_pred             ChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       373 s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +.++++||.+||.+||.+||++     +++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTA-----RELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCH-----HHHhhCCCC
Confidence            8999999999999999999998     999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=334.70  Aligned_cols=249  Identities=58%  Similarity=1.019  Sum_probs=227.7

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCCch
Q 047009          158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL  237 (482)
Q Consensus       158 LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (482)
                      ||+|+||.||++.+..+++.||+|++.+...........+.+|+.++++++|+||+++++.+..+..+|+||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999999989999999999887655555667788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCcccccCCCCC
Q 047009          238 FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSNSMIGTVEYM  316 (482)
Q Consensus       238 ~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~~gt~~y~  316 (482)
                      ..++...+.+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++...... .......|+..|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL  160 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence            999988888999999999999999999999999999999999999999999999999999876443 2345567899999


Q ss_pred             chhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCCCCC
Q 047009          317 APEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGP  396 (482)
Q Consensus       317 APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~  396 (482)
                      |||.+.+...+.++|+||||+++|+|++|+.||...+.....+.+......+|..++..+.++|++||..||.+||++..
T Consensus       161 ~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             ChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            99999998899999999999999999999999988887788888888888899999999999999999999999999822


Q ss_pred             CChHHHHhCcCC
Q 047009          397 KGSEEIKSHKWF  408 (482)
Q Consensus       397 ~~~~eil~hp~f  408 (482)
                        .+++++||||
T Consensus       241 --~~~l~~~~~f  250 (250)
T cd05123         241 --AEEIKAHPFF  250 (250)
T ss_pred             --HHHHHhCCCC
Confidence              5799999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.3e-42  Score=341.53  Aligned_cols=248  Identities=29%  Similarity=0.490  Sum_probs=207.5

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecC--CeEEEE
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTK--YRLYLV  228 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~~~~lV  228 (482)
                      |++++.||+|+||.||+|.++.+++.||+|++++... ..... ...+|+.++.++. |+||+++++++.+.  +.+++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            6789999999999999999999999999999876432 22222 2346888888885 99999999999887  889999


Q ss_pred             EEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCc
Q 047009          229 LDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  307 (482)
                      |||+.+ +|...+.. .+.+++..++.++.||+.||+|||++||+||||||+||+++. +.+||+|||+++.........
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence            999975 77777765 357899999999999999999999999999999999999999 999999999998775544444


Q ss_pred             ccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc------------------ccCC
Q 047009          308 SMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD------------------KLRL  368 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~------------------~~~~  368 (482)
                      ...++..|+|||++.. ..++.++|||||||++|||++|..||.+.+..+....+...                  ...+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            5678999999998754 55788999999999999999999999887765554444321                  1111


Q ss_pred             C-----------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          369 P-----------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       369 p-----------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      |           ..++.++.+||.+||++||++||++     +++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~-----~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA-----KQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCH-----HHHhhCCCC
Confidence            1           2468999999999999999999999     999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.2e-42  Score=342.63  Aligned_cols=251  Identities=30%  Similarity=0.499  Sum_probs=211.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeee------c
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQ------T  221 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~------~  221 (482)
                      .+.|++.+.||+|+||.||+|+++.+++.||+|++....    .....+..|+.+++++ +|+||+++++++.      .
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            367999999999999999999999999999999986542    2334577899999998 7999999999985      3


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      ...+|++|||+++|+|..++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            46789999999999999888653  4588888999999999999999999999999999999999999999999999886


Q ss_pred             ccCC-CCCcccccCCCCCchhhhc-----CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-C-CCcc
Q 047009          300 FDEN-TRSNSMIGTVEYMAPEIVL-----GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-R-LPAF  371 (482)
Q Consensus       300 ~~~~-~~~~~~~gt~~y~APE~l~-----~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~-~p~~  371 (482)
                      .... .......|++.|+|||.+.     +..++.++|+|||||++|+|++|+.||...........+..... . .+..
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  250 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKK  250 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccc
Confidence            5422 2334567999999999986     35688899999999999999999999977655444433333221 1 1235


Q ss_pred             CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       372 ~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      ++.++.+||++||..||.+||++     .||++||||
T Consensus       251 ~~~~~~~li~~cl~~~p~~Rp~~-----~ell~~~~~  282 (282)
T cd06636         251 WSKKFIDFIEGCLVKNYLSRPST-----EQLLKHPFI  282 (282)
T ss_pred             cCHHHHHHHHHHhCCChhhCcCH-----HHHhcCCCC
Confidence            78999999999999999999999     999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.4e-42  Score=340.67  Aligned_cols=246  Identities=30%  Similarity=0.530  Sum_probs=206.6

Q ss_pred             CCeEEEEEe--cccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEE
Q 047009          150 EDFEVLKVV--GQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       150 ~~y~i~~~L--G~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~  226 (482)
                      ++|++.+.+  |.|+||.||+++.+.++..+|+|++.+.....        .|+.+...+ +||||++++++|...+.+|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            456666665  99999999999999999999999987653211        122222222 7999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC-ceeEcccCccccccCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG-HVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~~  305 (482)
                      +||||+++|+|..++..++.+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||+++.....  
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--  163 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--  163 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence            9999999999999998888899999999999999999999999999999999999999998 9999999999875432  


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHH----HHHHHhcccCCCccCChHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKI----QQKIVKDKLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~LI~  381 (482)
                       ....|+..|+|||++.+..++.++||||||+++|+|++|+.||.......+    ...........+..++..+++||.
T Consensus       164 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  242 (267)
T PHA03390        164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQ  242 (267)
T ss_pred             -ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHH
Confidence             235689999999999999999999999999999999999999975543322    111123344556678999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      +||+.||.+|++.    .+++++||||++
T Consensus       243 ~~l~~~p~~R~~~----~~~~l~h~~~~~  267 (267)
T PHA03390        243 SMLKYNINYRLTN----YNEIIKHPFLKI  267 (267)
T ss_pred             HHhccChhhCCch----HHHHhcCCcccC
Confidence            9999999999953    289999999974

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-42  Score=342.91  Aligned_cols=251  Identities=30%  Similarity=0.528  Sum_probs=210.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++++.||.|++|.||+|+++.+++.||||.+..+.. .......+.+|++++++++||||+++++++.+....++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            58999999999999999999999999999999875432 22333567889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCc
Q 047009          231 FINGGHLFFQLYH--HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSN  307 (482)
Q Consensus       231 ~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  307 (482)
                      |+. ++|..++..  .+.+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||++....... ...
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            996 578877755  3568999999999999999999999999999999999999999999999999998654322 223


Q ss_pred             ccccCCCCCchhhhcCCC-CCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc------------------c--
Q 047009          308 SMIGTVEYMAPEIVLGKG-HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK------------------L--  366 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~-~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~------------------~--  366 (482)
                      ...++..|+|||++.+.. ++.++||||||+++|+|+||+.||.+.+......++....                  .  
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF  238 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence            446788999999987654 6889999999999999999999998766544333322210                  0  


Q ss_pred             ---------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          367 ---------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       367 ---------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                               .....++.+++++|.+||+.||.+||++     +++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~~l~~~~f  284 (284)
T cd07860         239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA-----KAALAHPFF  284 (284)
T ss_pred             ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH-----HHHhcCCCC
Confidence                     0123468899999999999999999999     999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1e-42  Score=345.37  Aligned_cols=253  Identities=34%  Similarity=0.572  Sum_probs=214.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC--CeEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK--YRLY  226 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~  226 (482)
                      +++|++.+.||+|+||.||+|.++.+++.||+|.++..... ......+.+|+.++++++||||+++++++...  ...|
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            46899999999999999999999999999999999765432 22333466899999999999999999998877  8999


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-C
Q 047009          227 LVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-T  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~  304 (482)
                      +||||+.+ +|...+... ..+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++...... .
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            99999985 888887664 45899999999999999999999999999999999999999999999999999876543 3


Q ss_pred             CCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-------------------
Q 047009          305 RSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-------------------  364 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-------------------  364 (482)
                      ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+......++...                   
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence            33445688999999998765 4689999999999999999999999877665555444321                   


Q ss_pred             ------------ccCCCcc-CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          365 ------------KLRLPAF-LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       365 ------------~~~~p~~-~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                                  ...++.. +++.+.+||++||+.||++||++     .|++.|+||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~-----~ell~~~~f  293 (293)
T cd07843         242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA-----EDALKHPYF  293 (293)
T ss_pred             ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH-----HHHhcCCCC
Confidence                        0112333 58889999999999999999999     999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-42  Score=338.33  Aligned_cols=251  Identities=31%  Similarity=0.512  Sum_probs=213.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCC----
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKY----  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~----  223 (482)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++.....    ..+.+.+|+.+++++ +|+||+++++++....    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            4789999999999999999999999999999999876532    335678999999999 7999999999996544    


Q ss_pred             --eEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          224 --RLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       224 --~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                        .+|+||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence              58999999999999888765    357899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC-CCCcccccCCCCCchhhhcC-----CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc---CC
Q 047009          298 KQFDEN-TRSNSMIGTVEYMAPEIVLG-----KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL---RL  368 (482)
Q Consensus       298 ~~~~~~-~~~~~~~gt~~y~APE~l~~-----~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~---~~  368 (482)
                      ...... .......|+..|+|||++..     ..++.++|||||||++|+|++|+.||...+.......+.....   ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  240 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS  240 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence            765332 22345678999999999864     3467899999999999999999999987665555555554422   22


Q ss_pred             CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          369 PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       369 p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +..++.++++||.+||..||++||++     .++++|||+
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rpt~-----~~ll~~~~~  275 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRPFM-----EELLEHPFI  275 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCcCH-----HHHhcCCCC
Confidence            34478899999999999999999999     999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.6e-42  Score=337.06  Aligned_cols=248  Identities=25%  Similarity=0.397  Sum_probs=216.4

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ...+|.+.+.||+|+||.||+|.++.+++.||+|++..+.    .....+.+|+.++++++|+||+++++++.....+++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            3467999999999999999999999999999999987542    234557789999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          228 VLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      ||||+++++|..++...  ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999999988654  3588999999999999999999999999999999999999999999999999987654322


Q ss_pred             C--cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHH
Q 047009          306 S--NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       306 ~--~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~  381 (482)
                      .  ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+..+.+... ....|..++.++.++|.
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  239 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMR  239 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence            1  12234668999999999999999999999999999998 99999988887777777654 45667788999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +||+.||++||++     .++++
T Consensus       240 ~cl~~~p~~Rp~~-----~~l~~  257 (263)
T cd05052         240 ACWQWNPSDRPSF-----AEIHQ  257 (263)
T ss_pred             HHccCCcccCCCH-----HHHHH
Confidence            9999999999998     77754

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.6e-42  Score=341.08  Aligned_cols=252  Identities=26%  Similarity=0.424  Sum_probs=205.3

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|.+++.||+|+||.||+|.++.+|+.||+|++.....  ......+.+|+.+++.++|+||+++++++.+....|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            4789999999999999999999999999999999875432  22233456899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCC
Q 047009          229 LDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~  306 (482)
                      |||+. ++|...+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ....
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            99996 566665544 35678889999999999999999999999999999999999999999999999976432 2223


Q ss_pred             cccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchH-HHHHHHHhc--------------cc----
Q 047009          307 NSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRA-KIQQKIVKD--------------KL----  366 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~-~~~~~i~~~--------------~~----  366 (482)
                      ....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+.. +....+...              ..    
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            445679999999998764 5789999999999999999999999765432 111111100              00    


Q ss_pred             -----CCCc---------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          367 -----RLPA---------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       367 -----~~p~---------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                           ..+.         ..+.++.++|.+||+.||++||++     .|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~-----~~~l~h~~~  291 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA-----QDALLHPYF  291 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH-----HHHhcCCCC
Confidence                 0000         125688999999999999999999     999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.8e-43  Score=359.73  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=207.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEE-----cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecC
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRK-----KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTK  222 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  222 (482)
                      .++|++.+.||+|+||+||+|++     ..++..||+|+++....  ....+.+.+|+.+|..+ +||||++++++|...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            46899999999999999999974     34677899999875432  23445678899999999 899999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC---------------------------------------------------------
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHG---------------------------------------------------------  245 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~---------------------------------------------------------  245 (482)
                      +..++||||++||+|..++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999998886432                                                         


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC--
Q 047009          246 ------------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR--  305 (482)
Q Consensus       246 ------------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~--  305 (482)
                                        .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                              367788899999999999999999999999999999999999999999999987543221  


Q ss_pred             -CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchH-HHHHHHHhc-ccCCCccCChHHHHHHH
Q 047009          306 -SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRA-KIQQKIVKD-KLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       306 -~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~LI~  381 (482)
                       .....++..|+|||++.+..++.++|||||||++|||++ |..||...... ...+.+..+ ....|...+.++++||.
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  351 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMK  351 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHH
Confidence             122345678999999999999999999999999999998 99999776543 333334333 23345667899999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +||+.||++||++     .+|++
T Consensus       352 ~cl~~dP~~RPs~-----~eil~  369 (375)
T cd05104         352 SCWDADPLKRPTF-----KQIVQ  369 (375)
T ss_pred             HHccCChhHCcCH-----HHHHH
Confidence            9999999999998     88875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.4e-42  Score=336.23  Aligned_cols=250  Identities=30%  Similarity=0.501  Sum_probs=213.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+|+++.+++.||||.+.............+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            68999999999999999999999999999999987644444455666788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-
Q 047009          230 DFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       230 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  304 (482)
                      ||+++|+|..++..    ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... 
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            99999999887753    3458999999999999999999999999999999999999999999999999998764322 


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc--hHHHHHHHHhccc-CCC-ccCChHHHHHH
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN--RAKIQQKIVKDKL-RLP-AFLSSEAHSLL  380 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~--~~~~~~~i~~~~~-~~p-~~~s~~~~~LI  380 (482)
                      ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||....  .....+.+..... ..+ ..++..+.++|
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELV  241 (267)
T ss_pred             HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence            2234578899999999999889999999999999999999999996543  2344454443221 222 35778999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHh
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||+.+|.+||++     .++++
T Consensus       242 ~~cl~~~p~~Rp~~-----~~vl~  260 (267)
T cd08228         242 SMCIYPDPDQRPDI-----GYVHQ  260 (267)
T ss_pred             HHHCCCCcccCcCH-----HHHHH
Confidence            99999999999999     88875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-46  Score=350.53  Aligned_cols=252  Identities=27%  Similarity=0.449  Sum_probs=224.6

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      -|.++.+||+|+||.||+|.++.+|..+|||.+..+     ...+.+.+|+.|+++++.|++|++|+.|.....+|||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            377889999999999999999999999999988754     345667889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCcc
Q 047009          231 FINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSNS  308 (482)
Q Consensus       231 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~  308 (482)
                      ||..|+..+.++. ++.++++++..+++..++||+|||...-||||||..||||+.+|+.||+|||.|..+.+. ...++
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            9999999988864 567999999999999999999999999999999999999999999999999999886543 34578


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc---cCCCccCChHHHHHHHHhhc
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ..|||.|||||++..-+|+.++||||||++..||..|++||.+..+......|-...   ++-|..+|.++.|||++||.
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi  268 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI  268 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence            899999999999999999999999999999999999999998776655544444432   23456789999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      ++|++|-++     -++++|+|.++..
T Consensus       269 K~PE~R~TA-----~~L~~H~FiknA~  290 (502)
T KOG0574|consen  269 KKPEERKTA-----LRLCEHTFIKNAP  290 (502)
T ss_pred             CCHHHHHHH-----HHHhhhhhhcCCC
Confidence            999999998     8999999998644

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-42  Score=340.73  Aligned_cols=252  Identities=29%  Similarity=0.499  Sum_probs=207.4

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++.+.||+|++|.||+|.++.+++.||+|.+.....  ......+.+|+.++++++|+||+++++++.+....|+|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            5789999999999999999999999999999999876432  11223456799999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CC
Q 047009          229 LDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~  306 (482)
                      |||+.+ +|..++.+. +.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++...... ..
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence            999985 898887664 468999999999999999999999999999999999999999999999999987643221 12


Q ss_pred             cccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCc-hHHHHHHHHhc-------------------c
Q 047009          307 NSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN-RAKIQQKIVKD-------------------K  365 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~-~~~~~~~i~~~-------------------~  365 (482)
                      ....++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+ ..+....+.+.                   .
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            23457889999999876 458999999999999999999999997655 22222222110                   0


Q ss_pred             --cCC---------CccCC--hHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          366 --LRL---------PAFLS--SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       366 --~~~---------p~~~s--~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                        ...         ...++  .++.++|.+||+.||.+||++     .+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~-----~e~l~~~~f  291 (291)
T cd07844         241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA-----AEAMKHPYF  291 (291)
T ss_pred             ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCH-----HHHhcCCCC
Confidence              000         01234  788999999999999999999     999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.1e-42  Score=329.93  Aligned_cols=252  Identities=35%  Similarity=0.567  Sum_probs=223.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC--CeEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK--YRLYLV  228 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV  228 (482)
                      +|.+.+.||+|++|.||+|.++.+++.|++|++...... ....+.+.+|+.++++++||||+++++.+...  ..+++|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            488899999999999999999999999999999765432 34567788999999999999999999999888  899999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC---
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR---  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~---  305 (482)
                      +||+++++|.+++.....+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999988765543   


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc-hHHHHHHHH--hcccCCCccCChHHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN-RAKIQQKIV--KDKLRLPAFLSSEAHSLLKG  382 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~-~~~~~~~i~--~~~~~~p~~~s~~~~~LI~~  382 (482)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+ .......+.  .....+|..++..+++||.+
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  239 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK  239 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence            455678999999999999889999999999999999999999997765 333333333  23446677889999999999


Q ss_pred             hhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          383 LLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       383 ~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      ||+.||++||++     .+++.||||
T Consensus       240 ~l~~~p~~Rp~~-----~~ll~~~~~  260 (260)
T cd06606         240 CLRRDPKKRPTA-----DELLQHPFL  260 (260)
T ss_pred             hCcCChhhCCCH-----HHHhhCCCC
Confidence            999999999999     999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.3e-42  Score=334.80  Aligned_cols=246  Identities=24%  Similarity=0.401  Sum_probs=212.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++.+.||+|+||.||+|+++. +..+|+|.+.....    ..+.+.+|+.++++++||||+++++++......++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            4679999999999999999998875 45799998875432    234567899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC-
Q 047009          229 LDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~-  306 (482)
                      |||+++|+|..++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++........ 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            9999999999988653 56899999999999999999999999999999999999999999999999999875432221 


Q ss_pred             -cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc-cCCCccCChHHHHHHHHh
Q 047009          307 -NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       307 -~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~LI~~~  383 (482)
                       ....++..|+|||++.+..++.++|+||||+++|+|++ |+.||...+..+....+..+. ...|...+.++.+||.+|
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSC  237 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence             22345668999999999999999999999999999999 999999888888888777653 345666889999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHh
Q 047009          384 LQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~  404 (482)
                      |+.||++||++     +++++
T Consensus       238 ~~~~p~~Rps~-----~~l~~  253 (256)
T cd05114         238 WHEKPEGRPTF-----AELLR  253 (256)
T ss_pred             ccCCcccCcCH-----HHHHH
Confidence            99999999998     78764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.3e-42  Score=341.48  Aligned_cols=249  Identities=24%  Similarity=0.429  Sum_probs=215.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      .++|.+.+.||+|+||.||+|.+..     +++.||+|++....  .....+.+.+|+++|++++|+||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            4679999999999999999998753     36789999987543  2234567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCce
Q 047009          224 RLYLVLDFINGGHLFFQLYHHG--------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHV  289 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~--------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~v  289 (482)
                      ..++||||+++++|..++..++              .+++..+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence            9999999999999999987643              37888999999999999999999999999999999999999999


Q ss_pred             eEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc
Q 047009          290 MLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK  365 (482)
Q Consensus       290 KL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~  365 (482)
                      ||+|||+++......   ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+..+.
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR  241 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence            999999998643222   1233456788999999999999999999999999999998 999998888888888877665


Q ss_pred             cC-CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          366 LR-LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       366 ~~-~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .. .+..++..+++||.+||+.||.+||++     .|+++
T Consensus       242 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~eil~  276 (280)
T cd05049         242 LLQRPRTCPSEVYDIMLGCWKRDPQQRINI-----KDIHE  276 (280)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCCCH-----HHHHH
Confidence            43 456789999999999999999999998     78764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=364.96  Aligned_cols=248  Identities=28%  Similarity=0.499  Sum_probs=218.3

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGG  235 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (482)
                      -+||+|.||+||.|+++.|....|||.+....   ....+-+..|+.+-++|+|.|||+++|++..++++-|.||-++||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            36999999999999999999999999986542   345566889999999999999999999999999999999999999


Q ss_pred             chHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc-cCCceeEcccCccccccC-CCCCcccc
Q 047009          236 HLFFQLYHH-GLF--REDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG-ADGHVMLTDFGLAKQFDE-NTRSNSMI  310 (482)
Q Consensus       236 ~L~~~l~~~-~~l--~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~-~~g~vKL~DFGla~~~~~-~~~~~~~~  310 (482)
                      +|..+|... |++  .|...-+|.+||++||.|||++.|||||||-+|+|++ -.|.+||+|||-++.+.. +.-+.++.
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence            999998764 777  7888999999999999999999999999999999996 579999999999998643 44566889


Q ss_pred             cCCCCCchhhhcC--CCCCchhHHHHHhHHHHHHhhCCCCCCCCc--hHHHHH-HHHhcccCCCccCChHHHHHHHHhhc
Q 047009          311 GTVEYMAPEIVLG--KGHNKAADWWSVGILLYEMLTGKPPFIGGN--RAKIQQ-KIVKDKLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       311 gt~~y~APE~l~~--~~~~~~sDvwSlGvilyelltG~~PF~~~~--~~~~~~-~i~~~~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ||..|||||++..  ++|+.++|||||||++.||.||++||....  ...+++ -+.+..+++|..++.+++.||.+|+.
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe  817 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE  817 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence            9999999999975  579999999999999999999999996532  222322 23455678999999999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      .||..||++     .++|..||++.-
T Consensus       818 pd~~~R~sA-----~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  818 PDPCDRPSA-----KDLLQDPFLQHN  838 (1226)
T ss_pred             CCcccCccH-----HHhccCcccccC
Confidence            999999999     999999999864

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-42  Score=348.19  Aligned_cols=242  Identities=29%  Similarity=0.525  Sum_probs=191.8

Q ss_pred             EEecccCceEEEEEEEcC--CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeee--cCCeEEEEEEe
Q 047009          156 KVVGQGAFGRVYQVRKKN--TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQ--TKYRLYLVLDF  231 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~lV~E~  231 (482)
                      .+||+|+||+||+|+++.  ++..||+|.+.....     ...+.+|+.++++++||||+++++++.  ....+++||||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            579999999999999764  568899999875432     234678999999999999999999884  45678999999


Q ss_pred             cCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE----ccCCceeEcccCccc
Q 047009          232 INGGHLFFQLYHH---------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL----GADGHVMLTDFGLAK  298 (482)
Q Consensus       232 ~~gg~L~~~l~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl----~~~g~vKL~DFGla~  298 (482)
                      +.+ +|...+...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            976 666665421         247889999999999999999999999999999999999    566799999999998


Q ss_pred             cccCCC----CCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchH---------HHHHHHHh-
Q 047009          299 QFDENT----RSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRA---------KIQQKIVK-  363 (482)
Q Consensus       299 ~~~~~~----~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~---------~~~~~i~~-  363 (482)
                      ......    ......||+.|+|||++.+ ..++.++|||||||++|||+||++||......         .....+.. 
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            764322    2344678999999999977 45899999999999999999999999653321         00000000 


Q ss_pred             ---------------------------ccc----------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCc
Q 047009          364 ---------------------------DKL----------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHK  406 (482)
Q Consensus       364 ---------------------------~~~----------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp  406 (482)
                                                 ...          ......+..+.+||.+||+.||.+||++     +|+++||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~-----~e~l~hp  315 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITS-----EQALQDP  315 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCH-----HHHhcCC
Confidence                                       000          0011235678899999999999999999     9999999


Q ss_pred             CC
Q 047009          407 WF  408 (482)
Q Consensus       407 ~f  408 (482)
                      ||
T Consensus       316 ~f  317 (317)
T cd07867         316 YF  317 (317)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.3e-42  Score=336.23  Aligned_cols=251  Identities=28%  Similarity=0.471  Sum_probs=211.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      +.+.....||+|+||.||+|.+..++..||+|.+....   ....+.+.+|+.++++++|+||+++++++...+..++|+
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            34444568999999999999999999999999987543   234556889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc-CCceeEcccCccccccCCC-
Q 047009          230 DFINGGHLFFQLYHH-GLF--REDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA-DGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l--~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~~-  304 (482)
                      ||+++++|..++... +.+  ++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||++....... 
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            999999999988764 455  78888999999999999999999999999999999986 6799999999997654322 


Q ss_pred             CCcccccCCCCCchhhhcCC--CCCchhHHHHHhHHHHHHhhCCCCCCCCchHH--HHH-HHHhcccCCCccCChHHHHH
Q 047009          305 RSNSMIGTVEYMAPEIVLGK--GHNKAADWWSVGILLYEMLTGKPPFIGGNRAK--IQQ-KIVKDKLRLPAFLSSEAHSL  379 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~--~~~~~sDvwSlGvilyelltG~~PF~~~~~~~--~~~-~i~~~~~~~p~~~s~~~~~L  379 (482)
                      ......|+..|+|||++.+.  .++.++|+||||+++|+|++|+.||.......  ... ........+|..++.++++|
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF  244 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence            23345689999999998764  37899999999999999999999997543221  111 12233455677889999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +++||+.+|.+||++     .+++.||||
T Consensus       245 i~~~l~~~p~~Rpt~-----~~ll~~~~~  268 (268)
T cd06624         245 ILRCFEPDPDKRASA-----HDLLQDPFL  268 (268)
T ss_pred             HHHHcCCCchhCCCH-----HHHHhCCCC
Confidence            999999999999999     999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.6e-42  Score=339.74  Aligned_cols=251  Identities=20%  Similarity=0.389  Sum_probs=214.0

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEc----CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKK----NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~----~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      .+++|++.+.||+|+||+||+|.+.    .++..||+|.+....  .......+.+|+.++++++||||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            3578999999999999999999853    456789999987532  2334466788999999999999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC
Q 047009          224 RLYLVLDFINGGHLFFQLYHH-----------------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD  286 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-----------------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~  286 (482)
                      ..|+||||+++|+|..++...                 ..+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            999999999999999888532                 237788889999999999999999999999999999999999


Q ss_pred             CceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHH
Q 047009          287 GHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIV  362 (482)
Q Consensus       287 g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~  362 (482)
                      +.+||+|||+++......   ......++..|+|||++.+..++.++||||||+++|||++ |..||.+.+...+.+.+.
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~  240 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR  240 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999998753322   2234456778999999998889999999999999999998 999998877766666665


Q ss_pred             hcc-cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          363 KDK-LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       363 ~~~-~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ... +..+..++..+.++|.+||+.||.+||++     .+|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-----~~i~~~  279 (283)
T cd05090         241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRF-----KDIHTR  279 (283)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCH-----HHHHHH
Confidence            543 45567789999999999999999999998     787753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4e-42  Score=338.34  Aligned_cols=251  Identities=23%  Similarity=0.317  Sum_probs=212.6

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      ..++|++.+.||+|+||.||+|.++.     ++..||+|++....  .......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            45789999999999999999998653     35789999986532  122344577899999999999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHG----------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLT  292 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~  292 (482)
                      ...++||||+++|+|..++....          .++...+..++.|++.||.|||++|++||||||+||+++.++.+||+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence            99999999999999999886532          24677888899999999999999999999999999999999999999


Q ss_pred             ccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc-cC
Q 047009          293 DFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LR  367 (482)
Q Consensus       293 DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~-~~  367 (482)
                      |||+++.......   .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+.... ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD  241 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999986533221   122355788999999999999999999999999999999 799998888777777666554 35


Q ss_pred             CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          368 LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       368 ~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      .+..++..++++|.+||+.||++||++     .|++++
T Consensus       242 ~~~~~~~~~~~li~~~l~~~p~~Rps~-----~e~l~~  274 (277)
T cd05062         242 KPDNCPDMLFELMRMCWQYNPKMRPSF-----LEIISS  274 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            667789999999999999999999998     788753

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.1e-43  Score=346.26  Aligned_cols=256  Identities=29%  Similarity=0.503  Sum_probs=220.8

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+.....  ....+.+.+|+.++++++||||+++++++......|+|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            46667889999999999999999999999999875432  2345678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCccc
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSM  309 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~~  309 (482)
                      |+++++|..++.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++..+.... .....
T Consensus        83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06642          83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence            9999999988754 568999999999999999999999999999999999999999999999999998764332 22345


Q ss_pred             ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-cCCCccCChHHHHHHHHhhccCc
Q 047009          310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLKGLLQKEP  388 (482)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~LI~~~L~~dP  388 (482)
                      .|+..|+|||.+.+..++.++|+|||||++|||++|+.||...........+.... ..++..++.++.++|.+||+.+|
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  241 (277)
T cd06642         162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDP  241 (277)
T ss_pred             cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCc
Confidence            68899999999999999999999999999999999999997766655555544332 23445678899999999999999


Q ss_pred             CCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          389 GKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       389 ~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                      .+||++     .++++|+||....+.
T Consensus       242 ~~Rp~~-----~~il~~~~~~~~~~~  262 (277)
T cd06642         242 RFRPTA-----KELLKHKFITRYTKK  262 (277)
T ss_pred             ccCcCH-----HHHHHhHHHHHHhhh
Confidence            999999     999999999875543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.3e-42  Score=347.25  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=211.1

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeE----EEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEI----YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      ...+|++.+.||+|+||.||+|++..+++.    ||+|+++...  .....+.+.+|+.+++.++||||+++++++... 
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            457899999999999999999998766654    8999986432  233455678899999999999999999998765 


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 RLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..++|+||+++|+|.+++..+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            567999999999999998775 4588889999999999999999999999999999999999999999999999987654


Q ss_pred             CCCC---cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHH
Q 047009          303 NTRS---NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAH  377 (482)
Q Consensus       303 ~~~~---~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (482)
                      ....   ....++..|+|||++.+..++.++|||||||++|||++ |+.||.+....++.+.+..+ ....+..++.++.
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  241 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence            3322   22234678999999999999999999999999999997 99999887766655544433 3344567889999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ++|.+||..||.+||++     .+++.+
T Consensus       242 ~li~~cl~~~p~~Rps~-----~~l~~~  264 (316)
T cd05108         242 MIMVKCWMIDADSRPKF-----RELIIE  264 (316)
T ss_pred             HHHHHHccCChhhCcCH-----HHHHHH
Confidence            99999999999999999     888875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.2e-42  Score=343.46  Aligned_cols=254  Identities=30%  Similarity=0.465  Sum_probs=206.7

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC----
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY----  223 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----  223 (482)
                      .+++|++.+.||+|+||.||+|.++.+++.||||++..... .......+.+|+.++++++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            35789999999999999999999999999999999875432 1222334567999999999999999999886543    


Q ss_pred             ----eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccc
Q 047009          224 ----RLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK  298 (482)
Q Consensus       224 ----~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~  298 (482)
                          ..++||||+.+ +|...+... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence                45999999975 777766554 368999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC-----CcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-------
Q 047009          299 QFDENTR-----SNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-------  365 (482)
Q Consensus       299 ~~~~~~~-----~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-------  365 (482)
                      .......     .....++..|+|||++.+. .++.++|+||||+++|+|++|+.||.+.+.......+..-.       
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV  247 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            7543221     2345678899999998765 47889999999999999999999998776544333322210       


Q ss_pred             ------------cCCCc-------------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          366 ------------LRLPA-------------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       366 ------------~~~p~-------------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                                  ..++.             ..+..+++||.+||..||.+||++     +++++||||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~-----~e~l~h~~f  310 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA-----DTALNHDFF  310 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH-----HHHhcCCCC
Confidence                        01111             135678899999999999999999     999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.7e-42  Score=332.77  Aligned_cols=252  Identities=32%  Similarity=0.578  Sum_probs=219.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++.+.||+|+||.||+|.++.+|..||+|.+...... ....+.+.+|+.+++.++|+||+++++.+......++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            588999999999999999999999999999999775432 2344567889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc-eeEcccCccccccCCCC-C
Q 047009          231 FINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH-VMLTDFGLAKQFDENTR-S  306 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~-vKL~DFGla~~~~~~~~-~  306 (482)
                      |+++++|..++....  .+++..+..++.|++.||.|||+++|+|+||||+||+++.++. +||+|||.+........ .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            999999999887643  4789999999999999999999999999999999999998864 69999999987644322 2


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CCCccCChHHHHHHHHhhc
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~LI~~~L~  385 (482)
                      ....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+..... ..+..++.+++++|.+||.
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  239 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK  239 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhc
Confidence            334689999999999988899999999999999999999999988777666665555433 3455678999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      .+|++||++     .++++||||
T Consensus       240 ~~p~~Rpt~-----~~ll~~~~~  257 (257)
T cd08225         240 VSPRDRPSI-----TSILKRPFL  257 (257)
T ss_pred             cChhhCcCH-----HHHhhCCCC
Confidence            999999999     999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.4e-43  Score=346.57  Aligned_cols=253  Identities=29%  Similarity=0.509  Sum_probs=217.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      +.|.....||+|+||.||++.+..+++.||||.+....   ....+.+.+|+.+++.++|+||+++++.+...+..|+||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            34555677999999999999999999999999986543   234556789999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~  308 (482)
                      ||+++++|..++. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .....
T Consensus        99 e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658          99 EFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             eCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence            9999999988774 456899999999999999999999999999999999999999999999999998765322 22344


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc---ccCCCccCChHHHHHHHHhhc
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ..|+..|+|||.+.+..++.++|+||||+++|||++|+.||...+.......+...   .......++..++++|.+||.
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  257 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV  257 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHcc
Confidence            67899999999999989999999999999999999999999887766655554432   122233578899999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      .||.+||++     +++++|+||+..
T Consensus       258 ~~P~~Rpt~-----~~il~~~~~~~~  278 (292)
T cd06658         258 REPSQRATA-----QELLQHPFLKLA  278 (292)
T ss_pred             CChhHCcCH-----HHHhhChhhhcc
Confidence            999999998     999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.1e-42  Score=340.60  Aligned_cols=247  Identities=25%  Similarity=0.448  Sum_probs=213.9

Q ss_pred             CCeEEEEEecccCceEEEEEEE-----cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRK-----KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ++|.+.+.||+|+||+||++..     ..++..||+|.+....   ......+.+|+.++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            6799999999999999999985     3345779999987542   2345568899999999999999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeE
Q 047009          225 LYLVLDFINGGHLFFQLYHHG-------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVML  291 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~-------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL  291 (482)
                      +++||||+++++|..++..++             .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence            999999999999999887544             3899999999999999999999999999999999999999999999


Q ss_pred             cccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhccc-
Q 047009          292 TDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKL-  366 (482)
Q Consensus       292 ~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~~-  366 (482)
                      +|||+++......   ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+..+.. 
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~  241 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL  241 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            9999998653222   1223445778999999999999999999999999999998 9999988888778888877653 


Q ss_pred             CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          367 RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       367 ~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ..+..++.++.+|+.+||+.||.+||++     .++++
T Consensus       242 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~v~~  274 (288)
T cd05093         242 QRPRTCPKEVYDLMLGCWQREPHMRLNI-----KEIHS  274 (288)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCH-----HHHHH
Confidence            4566789999999999999999999998     67643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.5e-42  Score=341.69  Aligned_cols=257  Identities=29%  Similarity=0.504  Sum_probs=212.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++.+.||+|++|+||+|.++.+|+.||+|.+..... .....+.+.+|+.++++++||||+++++++.+....|+|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            3689999999999999999999999999999999866432 223345577899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc-CCceeEcccCccccccCCC-
Q 047009          229 LDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA-DGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~~-  304 (482)
                      |||+++ +|..++.....  +++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||++....... 
T Consensus        80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            999965 77777755433  578888999999999999999999999999999999985 4579999999997653322 


Q ss_pred             CCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc------------------
Q 047009          305 RSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK------------------  365 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~------------------  365 (482)
                      ......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+...++....                  
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence            2234567899999999876 457899999999999999999999998766554444332210                  


Q ss_pred             ---cC--------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          366 ---LR--------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       366 ---~~--------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                         ..        ....++.++.++|.+||+.||++||++     .++++||||.+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~-----~~~l~~~~~~~~~  291 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA-----RAALEHEYFKDLG  291 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH-----HHHhcCchHhHHh
Confidence               00        113468899999999999999999998     9999999998754

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-42  Score=333.65  Aligned_cols=252  Identities=32%  Similarity=0.487  Sum_probs=218.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechh--hchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC--CeE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDK--IVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK--YRL  225 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~  225 (482)
                      .+|++.+.||+|+||.||+|.++.+++.||+|++....  .........+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57999999999999999999999999999999986432  11234456788999999999999999999998664  568


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC--
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--  303 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~--  303 (482)
                      ++|+||+++++|..++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.....  
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            899999999999999988788999999999999999999999999999999999999999999999999999875321  


Q ss_pred             --CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc--ccCCCccCChHHHHH
Q 047009          304 --TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--KLRLPAFLSSEAHSL  379 (482)
Q Consensus       304 --~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~L  379 (482)
                        .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||..........++...  ...+|..++.++.++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  241 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF  241 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHH
Confidence              1223456899999999999988999999999999999999999999876655544444433  345688899999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcC
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKW  407 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~  407 (482)
                      |.+||. +|.+||++     .+++.|||
T Consensus       242 i~~~l~-~~~~r~~~-----~~~~~~~~  263 (264)
T cd06653         242 LKQIFV-EEKRRPTA-----EFLLRHPF  263 (264)
T ss_pred             HHHHhc-CcccCccH-----HHHhcCCC
Confidence            999999 57999999     89999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-41  Score=329.13  Aligned_cols=252  Identities=33%  Similarity=0.596  Sum_probs=224.1

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++.+.||+|++|.||+|.++.+++.||+|.+...... ....+.+.+|++++++++|+|++++++++.+....++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            588999999999999999999999999999999876532 2455678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC-Cccc
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-SNSM  309 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~  309 (482)
                      |+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ ....
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            999999999998888899999999999999999999999999999999999999999999999999987654332 2446


Q ss_pred             ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHH-hcccCCCccCChHHHHHHHHhhccCc
Q 047009          310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV-KDKLRLPAFLSSEAHSLLKGLLQKEP  388 (482)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~LI~~~L~~dP  388 (482)
                      .|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...+.......+. .....++..++..++++|.+||..+|
T Consensus       160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  239 (254)
T cd06627         160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDP  239 (254)
T ss_pred             ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCCh
Confidence            78999999999988889999999999999999999999997766544444433 34455677889999999999999999


Q ss_pred             CCcCCCCCCChHHHHhCcCC
Q 047009          389 GKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       389 ~~R~s~~~~~~~eil~hp~f  408 (482)
                      ++||++     .+++.||||
T Consensus       240 ~~R~~~-----~~~l~~~~~  254 (254)
T cd06627         240 NLRPTA-----KQLLKHPWI  254 (254)
T ss_pred             hhCcCH-----HHHhcCCCC
Confidence            999998     999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.6e-42  Score=338.14  Aligned_cols=251  Identities=22%  Similarity=0.373  Sum_probs=214.4

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      ..++|.+.+.||+|+||.||+|.++.     ++..||+|.+....  .......+.+|+.+++.++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            34779999999999999999999987     77899999886432  122344577899999999999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC---ceeEc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHG-------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG---HVMLT  292 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g---~vKL~  292 (482)
                      ...++||||+.|++|..++...+       .+++..+..++.||+.||+|||+++++||||||+|||++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999999887653       488899999999999999999999999999999999998765   59999


Q ss_pred             ccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccC
Q 047009          293 DFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLR  367 (482)
Q Consensus       293 DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~  367 (482)
                      |||+++.+.....   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+... ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD  241 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999987632221   112234568999999999999999999999999999997 99999988777776666543 455


Q ss_pred             CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          368 LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       368 ~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      .|..++..+.+++.+||+.||++||++     .++++|
T Consensus       242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~-----~~vl~~  274 (277)
T cd05036         242 PPKGCPGPVYRIMTDCWQHTPEDRPNF-----ATILER  274 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCH-----HHHHHH
Confidence            677889999999999999999999999     888875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.2e-42  Score=339.56  Aligned_cols=253  Identities=29%  Similarity=0.505  Sum_probs=208.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCCe----
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKYR----  224 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~----  224 (482)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++++. ||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            479999999999999999999999999999999876432 2223355778999999995 6999999999877665    


Q ss_pred             -EEEEEEecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc-CCceeEcccCcc
Q 047009          225 -LYLVLDFINGGHLFFQLYHH-----GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA-DGHVMLTDFGLA  297 (482)
Q Consensus       225 -~~lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~-~g~vKL~DFGla  297 (482)
                       .|+||||+++ +|..++...     ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999986 787776542     35799999999999999999999999999999999999998 899999999999


Q ss_pred             ccccCC-CCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc----------
Q 047009          298 KQFDEN-TRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK----------  365 (482)
Q Consensus       298 ~~~~~~-~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~----------  365 (482)
                      +.+... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.......+....          
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            865322 22233467889999999865 457999999999999999999999998776555444433210          


Q ss_pred             -------cCC-----------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          366 -------LRL-----------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       366 -------~~~-----------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                             ..+           ...++.++.+||.+||.+||.+||++     .|++.||||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~-----~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA-----KAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH-----HHHhcCCCcC
Confidence                   000           12478899999999999999999998     9999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.9e-42  Score=338.42  Aligned_cols=253  Identities=29%  Similarity=0.505  Sum_probs=219.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      .|...+.||+|++|.||++.++.+++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            3555679999999999999999999999999986432   2334557889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCccc
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSM  309 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~~  309 (482)
                      |+.|++|..++.. +.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++....... .....
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            9999999998876 678999999999999999999999999999999999999999999999999987654322 22345


Q ss_pred             ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC---CCccCChHHHHHHHHhhcc
Q 047009          310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR---LPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~LI~~~L~~  386 (482)
                      .|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+......   .+..++..+.+||.+||..
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR  255 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence            7899999999999988999999999999999999999999888777777666655322   2334789999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      +|++||++     .++++|+||+...
T Consensus       256 ~p~~Rpt~-----~~il~~~~~~~~~  276 (285)
T cd06648         256 DPAQRATA-----AELLNHPFLAKAG  276 (285)
T ss_pred             ChhhCcCH-----HHHccCcccccCC
Confidence            99999999     9999999998743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.7e-42  Score=329.71  Aligned_cols=252  Identities=33%  Similarity=0.605  Sum_probs=225.1

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++.+.||.|+||.||++.+..+++.||+|++..... .......+.+|+++++.++|+|++++++.+......++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            58999999999999999999999999999999976543 23455667889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-C
Q 047009          231 FINGGHLFFQLYHH----GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-R  305 (482)
Q Consensus       231 ~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~  305 (482)
                      |+++++|..++...    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            99999999988764    679999999999999999999999999999999999999999999999999998764433 3


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-cCCCccCChHHHHHHHHhh
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~LI~~~L  384 (482)
                      .....|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+...+...+.... ..+|..++..+.++|.+||
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  239 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL  239 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence            345678999999999999999999999999999999999999998887777777766553 3456678999999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHhCcCC
Q 047009          385 QKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      ..+|.+||++     .++++||||
T Consensus       240 ~~~p~~Rp~~-----~~ll~~~~~  258 (258)
T cd08215         240 QKDPEERPSI-----AQILQSPFI  258 (258)
T ss_pred             CCChhhCcCH-----HHHhcCCCC
Confidence            9999999999     999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-42  Score=343.78  Aligned_cols=260  Identities=27%  Similarity=0.426  Sum_probs=213.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCCeEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV  228 (482)
                      ++|+..+.||+|+||.||++.++.+++.||+|.+.+....  .....+.+|+.++.++. |+||+++++++......+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            5677788999999999999999999999999998765322  34556788999999996 99999999999999999999


Q ss_pred             EEecCCCchH---HHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          229 LDFINGGHLF---FQLY--HHGLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       229 ~E~~~gg~L~---~~l~--~~~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      |||+.+ ++.   ..+.  ..+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            999875 433   2222  246799999999999999999999975 999999999999999999999999999987654


Q ss_pred             CCCCcccccCCCCCchhhhcCC---CCCchhHHHHHhHHHHHHhhCCCCCCCCch-HHHHHHHHhc-ccCCC----ccCC
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGK---GHNKAADWWSVGILLYEMLTGKPPFIGGNR-AKIQQKIVKD-KLRLP----AFLS  373 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~---~~~~~sDvwSlGvilyelltG~~PF~~~~~-~~~~~~i~~~-~~~~p----~~~s  373 (482)
                      ........|+..|+|||++.+.   .++.++|||||||++|+|++|+.||...+. .+....+... ...++    ..++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS  240 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccC
Confidence            4444556789999999999876   689999999999999999999999975442 1222222222 12222    2478


Q ss_pred             hHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhh
Q 047009          374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLE  417 (482)
Q Consensus       374 ~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~  417 (482)
                      .++.+||.+||++||++||++     ++|++||||+...|.+..
T Consensus       241 ~~l~~li~~~l~~~p~~Rpt~-----~~i~~~~~~~~~~~~~~~  279 (288)
T cd06616         241 PSFVNFINLCLIKDESKRPKY-----KELLEHPFIKDYEERNVD  279 (288)
T ss_pred             HHHHHHHHHHccCChhhCcCH-----HHHhcChhhhchhhcchh
Confidence            999999999999999999999     999999999987766543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.9e-42  Score=341.14  Aligned_cols=248  Identities=23%  Similarity=0.398  Sum_probs=211.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCe--EEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSE--IYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~--~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~  226 (482)
                      ++|++.+.||+|+||.||+|..+.++.  .+++|.++..  ......+.+.+|+.++.++ +||||+++++++...+.+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            689999999999999999999887764  4688887632  2233455678899999999 7999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcee
Q 047009          227 LVLDFINGGHLFFQLYHHG----------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVM  290 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vK  290 (482)
                      +||||+++|+|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999986542                478889999999999999999999999999999999999999999


Q ss_pred             EcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCC
Q 047009          291 LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRL  368 (482)
Q Consensus       291 L~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~  368 (482)
                      |+|||++..............+..|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+..+ ....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK  239 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            999999875332212222233567999999999999999999999999999997 99999988887777777654 3345


Q ss_pred             CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          369 PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       369 p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      |..++.++.+||.+||+.||.+||++     +++++
T Consensus       240 ~~~~~~~~~~li~~~l~~~p~~Rp~~-----~~i~~  270 (297)
T cd05089         240 PRNCDDEVYELMRQCWRDRPYERPPF-----AQISV  270 (297)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            66789999999999999999999999     78764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.6e-42  Score=337.21  Aligned_cols=250  Identities=30%  Similarity=0.540  Sum_probs=211.7

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++.+.||.|++|.||+|+++.+|+.||+|++.....  ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            58999999999999999999999999999999976532  2233456789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CC
Q 047009          231 FINGGHLFFQLYHH---GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RS  306 (482)
Q Consensus       231 ~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~  306 (482)
                      |+++ +|..++...   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence            9986 787777654   358999999999999999999999999999999999999999999999999998654322 22


Q ss_pred             cccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc------------------cC
Q 047009          307 NSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK------------------LR  367 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~------------------~~  367 (482)
                      ....++..|++||++.+. .++.++||||||+++|+|++|+.||.+.+..+....+....                  ..
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            345678999999998764 57899999999999999999999998877665555443210                  00


Q ss_pred             -----------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          368 -----------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       368 -----------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                                 +.+.++..++++|.+||+.||.+||++     .++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~-----~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA-----HDALQHPWF  284 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCH-----HHHhcCCCC
Confidence                       112457889999999999999999998     999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.1e-42  Score=343.19  Aligned_cols=253  Identities=28%  Similarity=0.414  Sum_probs=216.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ..|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||++++++|.+....|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56899999999999999999999999999999987654334445566889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcc
Q 047009          230 DFINGGHLFFQLY-HHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  308 (482)
                      ||+.| ++...+. ..+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++......   ..
T Consensus        95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~  170 (307)
T cd06607          95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NS  170 (307)
T ss_pred             HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CC
Confidence            99985 5655554 3457899999999999999999999999999999999999999999999999998765332   34


Q ss_pred             cccCCCCCchhhhc---CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-ccCC-CccCChHHHHHHHHh
Q 047009          309 MIGTVEYMAPEIVL---GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-KLRL-PAFLSSEAHSLLKGL  383 (482)
Q Consensus       309 ~~gt~~y~APE~l~---~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-~~~~-p~~~s~~~~~LI~~~  383 (482)
                      ..|+..|+|||++.   ...++.++||||||+++|||++|+.||.+.+.......+... ...+ +..++..++++|.+|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  250 (307)
T cd06607         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC  250 (307)
T ss_pred             ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHH
Confidence            57889999999984   356888999999999999999999999887766655554433 2222 234788999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      |..||++||++     .+|+.|+||...
T Consensus       251 l~~~p~~Rp~~-----~~il~~~~~~~~  273 (307)
T cd06607         251 LQKIPQDRPSS-----EELLKHRFVLRE  273 (307)
T ss_pred             hcCChhhCcCH-----HHHhcChhhccc
Confidence            99999999998     999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.8e-42  Score=332.16  Aligned_cols=248  Identities=22%  Similarity=0.389  Sum_probs=212.4

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|+++++||+|+||.||+|.... +..||+|.+.....    ..+.+.+|+.++++++|+||+++++.+...+..+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            345789999999999999999999764 56799998865432    3456788999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          227 LVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      +||||+++|+|..++...  ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999999988653  457888999999999999999999999999999999999999999999999998764332


Q ss_pred             C--CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHH
Q 047009          305 R--SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLL  380 (482)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI  380 (482)
                      .  .....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+... ....+..++.++.++|
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM  237 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            2  122345678999999999889999999999999999998 99999887777777766654 2333456889999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHh
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||..+|++||++     +++.+
T Consensus       238 ~~~l~~~p~~Rp~~-----~~i~~  256 (261)
T cd05072         238 KTCWKEKAEERPTF-----DYLQS  256 (261)
T ss_pred             HHHccCCcccCcCH-----HHHHH
Confidence            99999999999998     67653

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.2e-42  Score=336.72  Aligned_cols=253  Identities=29%  Similarity=0.513  Sum_probs=221.0

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      -|++++.||.|+||.||+|.++.+++.||+|++.....  ......+.+|+.++++++||||+++++++......|+|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            37788999999999999999999999999999865432  2345668899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCccc
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSM  309 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~~  309 (482)
                      |+++++|..++.. +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+.... .....
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence            9999999988754 568999999999999999999999999999999999999999999999999987754322 22345


Q ss_pred             ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-cCCCccCChHHHHHHHHhhccCc
Q 047009          310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLKGLLQKEP  388 (482)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~LI~~~L~~dP  388 (482)
                      .|+..|+|||.+.+...+.++|+|||||++|+|++|..||...+.......+.... ..++..++.++.++|.+||+.+|
T Consensus       162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  241 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP  241 (277)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            78999999999998889999999999999999999999998777666666655443 34556788999999999999999


Q ss_pred             CCcCCCCCCChHHHHhCcCCCCC
Q 047009          389 GKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       389 ~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      .+||++     .++++||||...
T Consensus       242 ~~Rp~~-----~~~l~~~~~~~~  259 (277)
T cd06641         242 SFRPTA-----KELLKHKFIVRF  259 (277)
T ss_pred             hhCcCH-----HHHHhCHHHhhh
Confidence            999998     999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.2e-42  Score=331.35  Aligned_cols=241  Identities=22%  Similarity=0.402  Sum_probs=206.2

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCCc
Q 047009          157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGH  236 (482)
Q Consensus       157 ~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~  236 (482)
                      .||+|+||.||+|+++.+++.||+|.+....  ..+....+.+|+.++++++||||+++++++.....+++||||+++++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            5999999999999999999999999886432  23445668899999999999999999999999999999999999999


Q ss_pred             hHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCc---ccccC
Q 047009          237 LFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN---SMIGT  312 (482)
Q Consensus       237 L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~---~~~gt  312 (482)
                      |..++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........   ...++
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence            999987654 58999999999999999999999999999999999999999999999999998654322111   11234


Q ss_pred             CCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHhhccCcCC
Q 047009          313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGK  390 (482)
Q Consensus       313 ~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~  390 (482)
                      ..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+... ....+..++..+.+|+.+||+.||++
T Consensus       160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  239 (252)
T cd05084         160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQ  239 (252)
T ss_pred             eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhh
Confidence            57999999999999999999999999999997 99999877666655555443 44566778999999999999999999


Q ss_pred             cCCCCCCChHHHHh
Q 047009          391 RLGAGPKGSEEIKS  404 (482)
Q Consensus       391 R~s~~~~~~~eil~  404 (482)
                      ||++     .++++
T Consensus       240 Rps~-----~~~~~  248 (252)
T cd05084         240 RPSF-----STVHQ  248 (252)
T ss_pred             CcCH-----HHHHH
Confidence            9998     77763

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.1e-42  Score=332.13  Aligned_cols=240  Identities=22%  Similarity=0.364  Sum_probs=206.9

Q ss_pred             EecccCceEEEEEEE--cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          157 VVGQGAFGRVYQVRK--KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       157 ~LG~G~fg~Vy~a~~--~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      .||+|+||.||+|.+  +.+++.||+|+++... ......+.+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            589999999999965  4567899999987543 233455668889999999999999999998864 467899999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC----Ccccc
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR----SNSMI  310 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~----~~~~~  310 (482)
                      |+|..++...+.+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||+++.+.....    .....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            99999998888899999999999999999999999999999999999999999999999999987643322    12233


Q ss_pred             cCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHhhccCc
Q 047009          311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP  388 (482)
Q Consensus       311 gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP  388 (482)
                      ++..|+|||.+....++.++|+|||||++|||++ |+.||.+.+..++.+.+.++ ....|..++.++.+||.+||+.||
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p  239 (257)
T cd05116         160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV  239 (257)
T ss_pred             CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCc
Confidence            4679999999988889999999999999999998 99999888777777777765 346777899999999999999999


Q ss_pred             CCcCCCCCCChHHHH
Q 047009          389 GKRLGAGPKGSEEIK  403 (482)
Q Consensus       389 ~~R~s~~~~~~~eil  403 (482)
                      .+||++     ++|.
T Consensus       240 ~~Rp~~-----~~i~  249 (257)
T cd05116         240 DERPGF-----AVVE  249 (257)
T ss_pred             hhCcCH-----HHHH
Confidence            999998     6664

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=334.39  Aligned_cols=250  Identities=25%  Similarity=0.349  Sum_probs=215.5

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCC-----eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTS-----EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      ..++|++.+.||+|+||.||+|.++..+     ..||+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            4578999999999999999999987544     889999986543  123345577899999999999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHG----------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLT  292 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~  292 (482)
                      ...++||||+++|+|..++....          .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999999886532          36778899999999999999999999999999999999999999999


Q ss_pred             ccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccC
Q 047009          293 DFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLR  367 (482)
Q Consensus       293 DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~  367 (482)
                      |||+++.+....   ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+.....+.+..+ ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD  241 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence            999998754322   2234567889999999998889999999999999999998 99999888887777777654 346


Q ss_pred             CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          368 LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       368 ~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +|..++.++.+||.+||+.+|++||++     .++++
T Consensus       242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~l~~  273 (277)
T cd05032         242 LPENCPDKLLELMRMCWQYNPKMRPTF-----LEIVS  273 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCCCH-----HHHHH
Confidence            677889999999999999999999998     78775

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-42  Score=330.27  Aligned_cols=243  Identities=28%  Similarity=0.468  Sum_probs=216.4

Q ss_pred             EEecccCceEEEEEEEcCC---CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEec
Q 047009          156 KVVGQGAFGRVYQVRKKNT---SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFI  232 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  232 (482)
                      +.||+|+||.||+|.+...   +..||+|++.......  ..+.+.+|+.++..++|+||+++++++.....+++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            3699999999999999866   8899999998654322  4667889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          233 NGGHLFFQLYHH---------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       233 ~gg~L~~~l~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      ++++|..++...         ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999875         77999999999999999999999999999999999999999999999999999886543


Q ss_pred             ---CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHH
Q 047009          304 ---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHS  378 (482)
Q Consensus       304 ---~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (482)
                         .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..++.+.+..+ ....|..++.++.+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYE  238 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHH
Confidence               22345567899999999998899999999999999999999 69999988888888777754 44667788999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      +|.+||+.||.+||++     .+++++
T Consensus       239 li~~~l~~~p~~Rps~-----~~l~~~  260 (262)
T cd00192         239 LMLSCWQLDPEDRPTF-----SELVER  260 (262)
T ss_pred             HHHHHccCCcccCcCH-----HHHHHh
Confidence            9999999999999998     888864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.9e-42  Score=349.34  Aligned_cols=256  Identities=25%  Similarity=0.406  Sum_probs=213.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec----CCeE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT----KYRL  225 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~  225 (482)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.+|++++||||++++++|..    ...+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            689999999999999999999999999999999876432 22345567789999999999999999988753    4578


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  304 (482)
                      |+||||+. |+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++...... 
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            99999996 5898888877889999999999999999999999999999999999999999999999999998753222 


Q ss_pred             ----CCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc---------------
Q 047009          305 ----RSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---------------  364 (482)
Q Consensus       305 ----~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~---------------  364 (482)
                          .....+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...               
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence                1234578999999999866 46899999999999999999999999876544332222110               


Q ss_pred             -----------ccCC-----CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          365 -----------KLRL-----PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       365 -----------~~~~-----p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                                 ....     ...++.+++++|++||+.||.+||++     .+++.||||+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~~l~~~~~~~~~  301 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV-----EQALQHPFLAQYH  301 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCH-----HHHHhChhhhhcc
Confidence                       0011     13468999999999999999999998     9999999998643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-42  Score=336.59  Aligned_cols=254  Identities=30%  Similarity=0.558  Sum_probs=217.0

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC---CCceeeeeeeeecCCeEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID---HPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~l  227 (482)
                      .|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.++++++   |||++++++++......|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            4788899999999999999999999999999987542  2334556788999999996   9999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CC
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RS  306 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~  306 (482)
                      ||||++|++|..++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... ..
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            9999999999988765 578999999999999999999999999999999999999999999999999998764432 23


Q ss_pred             cccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-cCCCc-cCChHHHHHHHHh
Q 047009          307 NSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-LRLPA-FLSSEAHSLLKGL  383 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p~-~~s~~~~~LI~~~  383 (482)
                      ....|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......+.... ..++. .++.++.++|.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC  238 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHH
Confidence            44578999999999875 457899999999999999999999998776655444433322 22333 2788999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      |+.||++||++     .++++|+||+...
T Consensus       239 l~~~p~~R~~~-----~~il~~~~~~~~~  262 (277)
T cd06917         239 LDEEPKERLSA-----EELLKSKWIKAHS  262 (277)
T ss_pred             cCCCcccCcCH-----HHHhhChHhhccc
Confidence            99999999998     9999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-41  Score=334.55  Aligned_cols=256  Identities=29%  Similarity=0.449  Sum_probs=214.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec--CCeEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT--KYRLYL  227 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l  227 (482)
                      ++|+..+.||.|++|.||+|.+..+++.||+|++.....  ......+.+|++++++++||||++++++|..  .+.+|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            479999999999999999999999999999999876432  2345667889999999999999999998865  447899


Q ss_pred             EEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          228 VLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      ||||++|++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999999877643    345889999999999999999999999999999999999999999999999998765432


Q ss_pred             CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC-----chHHHHHHHHhc-ccCCCc------c
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG-----NRAKIQQKIVKD-KLRLPA------F  371 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~-----~~~~~~~~i~~~-~~~~p~------~  371 (482)
                      . .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...     ...+....+... ...++.      .
T Consensus       159 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd06621         159 L-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK  237 (287)
T ss_pred             c-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence            2 22456788999999999999999999999999999999999999765     223344444332 112221      2


Q ss_pred             CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       372 ~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      +++.+.+||.+||..||.+||++     .|++.|+||+...-
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rpt~-----~eil~~~~~~~~~~  274 (287)
T cd06621         238 WSEEFKDFIKQCLEKDPTRRPTP-----WDMLEHPWIKAQMK  274 (287)
T ss_pred             hHHHHHHHHHHHcCCCcccCCCH-----HHHHhCcccccccc
Confidence            46789999999999999999999     99999999976543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=332.67  Aligned_cols=250  Identities=23%  Similarity=0.361  Sum_probs=214.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCC---CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNT---SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      .++|++.+.||+|+||.||+|+++.+   ...||+|+++...  .......+.+|+.++++++||||+++++.+...+..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            46899999999999999999998654   4589999987543  233445677899999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          226 YLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      ++||||+++++|..++..+ +.+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999998764 478999999999999999999999999999999999999999999999999998864211


Q ss_pred             C---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHH
Q 047009          305 R---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSL  379 (482)
Q Consensus       305 ~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L  379 (482)
                      .   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+... ....+..++..+.+|
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  240 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL  240 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            1   112344678999999999999999999999999999998 99999887777777777654 334566789999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      +.+||+.+|++||++     .+|+++
T Consensus       241 i~~cl~~~p~~Rp~~-----~ei~~~  261 (266)
T cd05033         241 MLDCWQKDRNERPTF-----SQIVST  261 (266)
T ss_pred             HHHHcCCCcccCcCH-----HHHHHH
Confidence            999999999999998     787753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5e-42  Score=348.21  Aligned_cols=255  Identities=27%  Similarity=0.444  Sum_probs=213.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC-----Ce
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK-----YR  224 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~  224 (482)
                      ++|.+.+.||+|+||+||+|++..+++.||||.+..... .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            579999999999999999999999999999999875422 223344567899999999999999999988654     35


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-  303 (482)
                      +|+||||+. ++|..++...+.+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||+++..... 
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            899999996 588888888888999999999999999999999999999999999999999999999999999876433 


Q ss_pred             CCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc------------------
Q 047009          304 TRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD------------------  364 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~------------------  364 (482)
                      .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+...                  
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07858         163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR  242 (337)
T ss_pred             ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence            23345578999999999875 56899999999999999999999999876543322222110                  


Q ss_pred             ----------cc---CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          365 ----------KL---RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       365 ----------~~---~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                                ..   .....++.++.+||++||+.||++||++     +++++||||..+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~-----~ell~h~~~~~~  297 (337)
T cd07858         243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV-----EEALAHPYLASL  297 (337)
T ss_pred             HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCH-----HHHHcCcchhhh
Confidence                      00   0123578999999999999999999998     999999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-42  Score=341.77  Aligned_cols=252  Identities=32%  Similarity=0.534  Sum_probs=205.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcC--CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC--CeEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKN--TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK--YRLY  226 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~  226 (482)
                      .|++.+.||+|+||.||+|.++.  +++.||+|.+...........+.+.+|+.++++++||||+++++++.+.  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            48899999999999999999988  8999999999874422333445677899999999999999999999988  8899


Q ss_pred             EEEEecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc----CCceeEcccCcc
Q 047009          227 LVLDFINGGHLFFQLYHH-----GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA----DGHVMLTDFGLA  297 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~----~g~vKL~DFGla  297 (482)
                      +||||+++ +|...+...     ..+++..++.++.||+.||.|||+++|+||||||+||+++.    +|.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999976 565555322     36899999999999999999999999999999999999999    999999999999


Q ss_pred             ccccCCC----CCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHH---------HHHHHHh
Q 047009          298 KQFDENT----RSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAK---------IQQKIVK  363 (482)
Q Consensus       298 ~~~~~~~----~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~---------~~~~i~~  363 (482)
                      +......    .....++|..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+...         ....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            8754322    2234578999999998876 458999999999999999999999997654321         0001000


Q ss_pred             --------------------------cccCCC-----------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCc
Q 047009          364 --------------------------DKLRLP-----------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHK  406 (482)
Q Consensus       364 --------------------------~~~~~p-----------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp  406 (482)
                                                ....++           ...+.++.++|.+||+.||++||++     .|+++||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~-----~eil~~~  314 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA-----EEALEHP  314 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH-----HHHhcCC
Confidence                                      001111           1467789999999999999999999     9999999


Q ss_pred             CC
Q 047009          407 WF  408 (482)
Q Consensus       407 ~f  408 (482)
                      ||
T Consensus       315 ~f  316 (316)
T cd07842         315 YF  316 (316)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.9e-42  Score=334.08  Aligned_cols=250  Identities=30%  Similarity=0.498  Sum_probs=213.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+|+++.+++.||||.+.+...........+.+|+.+++.++||||++++++|...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            67899999999999999999999999999999987655444555667889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-
Q 047009          230 DFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       230 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  304 (482)
                      ||+++++|..++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... 
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            99999999988763    3568999999999999999999999999999999999999999999999999988764332 


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch--HHHHHHHHhccc-CC-CccCChHHHHHH
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR--AKIQQKIVKDKL-RL-PAFLSSEAHSLL  380 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~--~~~~~~i~~~~~-~~-p~~~s~~~~~LI  380 (482)
                      ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+...  ....+.+..... .. +..++.++++||
T Consensus       162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV  241 (267)
T ss_pred             ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHH
Confidence            22345789999999999999999999999999999999999999976543  333344433222 12 235788999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHh
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||+.||.+||++     .+|++
T Consensus       242 ~~~l~~~p~~Rpt~-----~~i~~  260 (267)
T cd08229         242 NMCINPDPEKRPDI-----TYVYD  260 (267)
T ss_pred             HHhcCCCcccCCCH-----HHHHH
Confidence            99999999999998     76653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-42  Score=346.42  Aligned_cols=253  Identities=28%  Similarity=0.448  Sum_probs=207.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC-----Ce
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK-----YR  224 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~  224 (482)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++....  .......+.+|+.++++++|+||+++++++...     ..
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            68999999999999999999999999999999986432  223445577899999999999999999876543     35


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      .|+|+||+.+ +|...+. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        83 ~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          83 VYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             EEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            8999999975 7776664 4578999999999999999999999999999999999999999999999999998753322


Q ss_pred             ----CCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHh---------------c
Q 047009          305 ----RSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK---------------D  364 (482)
Q Consensus       305 ----~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~---------------~  364 (482)
                          .....+||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..               .
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence                1233578999999998765 5689999999999999999999999977654332222211               0


Q ss_pred             -----------ccC-----CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          365 -----------KLR-----LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       365 -----------~~~-----~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                                 ...     ....++.++.+||.+||+.||++||++     .++++||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~e~l~hp~~~~~  298 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV-----EEALAHPYLEQY  298 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCH-----HHHhcCcccccc
Confidence                       000     012457889999999999999999999     999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.5e-42  Score=342.47  Aligned_cols=252  Identities=28%  Similarity=0.510  Sum_probs=216.9

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEe
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  231 (482)
                      |+....||+|+||.||+|.+..+++.||+|++.....   ...+.+.+|+.++..++||||+++++.+......|+||||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            3344579999999999999998999999999875432   2345578899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCcccc
Q 047009          232 INGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSNSMI  310 (482)
Q Consensus       232 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~~  310 (482)
                      +++++|..++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ......+
T Consensus       100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~  178 (297)
T cd06659         100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  178 (297)
T ss_pred             CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence            999999886644 56899999999999999999999999999999999999999999999999999765432 2234567


Q ss_pred             cCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc---cCCCccCChHHHHHHHHhhccC
Q 047009          311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLKGLLQKE  387 (482)
Q Consensus       311 gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~LI~~~L~~d  387 (482)
                      |+..|+|||++.+..++.++|+|||||++|||++|+.||...+.......+....   ...+..++..+.++|++||+.+
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~  258 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTRE  258 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCC
Confidence            9999999999999899999999999999999999999998777666655554432   2233457889999999999999


Q ss_pred             cCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          388 PGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       388 P~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      |.+||++     .++++|+||....
T Consensus       259 P~~Rps~-----~~ll~~~~~~~~~  278 (297)
T cd06659         259 PQERATA-----QELLDHPFLLQTG  278 (297)
T ss_pred             cccCcCH-----HHHhhChhhccCC
Confidence            9999998     9999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.8e-43  Score=360.93  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=221.3

Q ss_pred             EEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc-hhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe--EEEEE
Q 047009          153 EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR--LYLVL  229 (482)
Q Consensus       153 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--~~lV~  229 (482)
                      +...+||+|+|-+||+|.+..+|..||--.++...+. .....+++..|+.+|+.|+|||||+++++|.+..+  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4567899999999999999999999987666544433 34556889999999999999999999999987665  88999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEcc-CCceeEcccCccccccCCCCC
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG--IMHRDLKPENILLGA-DGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--IiHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~~~~  306 (482)
                      |.+..|+|+.++.+++.+....++.|++||++||.|||++.  |||||||.+||+|+. .|.|||+|+|+|+........
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak  202 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK  202 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccc
Confidence            99999999999999999999999999999999999999984  999999999999985 489999999999987655544


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCC-CCchHHHHHHHHhcccC--CCccCChHHHHHHHHh
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFI-GGNRAKIQQKIVKDKLR--LPAFLSSEAHSLLKGL  383 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~-~~~~~~~~~~i~~~~~~--~p~~~s~~~~~LI~~~  383 (482)
                       ..+|||.|||||+.. ..|+..+||||||++|+||+|+..||. ..+...+++++..+..+  +...-.+++++||.+|
T Consensus       203 -svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekC  280 (632)
T KOG0584|consen  203 -SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKC  280 (632)
T ss_pred             -eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHH
Confidence             489999999999988 679999999999999999999999995 47888999999887532  2233478999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      |.. .++|+++     .|+|.|+||..-
T Consensus       281 l~~-~~~R~sa-----~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  281 LAT-KSERLSA-----KELLKDPFFDED  302 (632)
T ss_pred             hcC-chhccCH-----HHHhhChhhccc
Confidence            999 9999999     999999999863

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.6e-41  Score=324.67  Aligned_cols=249  Identities=38%  Similarity=0.579  Sum_probs=218.5

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++.+.||+|++|.||++.+..+++.|++|++.....   .....+.+|+.++++++|+||+++++.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            58899999999999999999998999999999976542   345678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCccc
Q 047009          231 FINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM  309 (482)
Q Consensus       231 ~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~  309 (482)
                      |+++++|...+... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+............
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  157 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM  157 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence            99999999988776 57899999999999999999999999999999999999999999999999999887554434567


Q ss_pred             ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-ccCCCc--cCChHHHHHHHHhhcc
Q 047009          310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-KLRLPA--FLSSEAHSLLKGLLQK  386 (482)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-~~~~p~--~~s~~~~~LI~~~L~~  386 (482)
                      .|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+... ...++.  .++..+.++|.+||+.
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  237 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK  237 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence            8899999999999888999999999999999999999999877554444433332 223333  2489999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcC
Q 047009          387 EPGKRLGAGPKGSEEIKSHKW  407 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~  407 (482)
                      ||++||++     .++++|||
T Consensus       238 ~p~~R~t~-----~~~l~~~~  253 (253)
T cd05122         238 NPEKRPTA-----EQLLKHPF  253 (253)
T ss_pred             ChhhCCCH-----HHHhcCCC
Confidence            99999999     99999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=392.47  Aligned_cols=254  Identities=32%  Similarity=0.560  Sum_probs=225.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      ++.-...||.|.||.||-|.+.++|+..|+|.++-.... ......+.+|..+|..|+|||+|+++++=...+.++|.||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            466678899999999999999999999999998766543 4556678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-----C
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-----R  305 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-----~  305 (482)
                      ||.||+|.+.+...+-.+|...+.|..|++.|++|||+.|||||||||+||+|+.+|.+|++|||.|..+..+.     .
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            99999999999888888999999999999999999999999999999999999999999999999999876543     2


Q ss_pred             CcccccCCCCCchhhhcC---CCCCchhHHHHHhHHHHHHhhCCCCCCCCc-hHHHHHHHHhc-ccCCCccCChHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLG---KGHNKAADWWSVGILLYEMLTGKPPFIGGN-RAKIQQKIVKD-KLRLPAFLSSEAHSLL  380 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~---~~~~~~sDvwSlGvilyelltG~~PF~~~~-~~~~~~~i~~~-~~~~p~~~s~~~~~LI  380 (482)
                      ...+.||+.|||||++.+   +++..+.|||||||++.||+||+.||...+ ...+...+..+ .+.+|..+|.+.++||
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence            346789999999999976   567889999999999999999999997643 34444455444 6789999999999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      .+||+.||++|+++     .||++|.|-+.
T Consensus      1475 e~Cl~~dP~~Rw~~-----~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTA-----SQLLEHAFGKS 1499 (1509)
T ss_pred             HHHHhcCchhhhHH-----HHHHHhhcccc
Confidence            99999999999998     89999998654

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.9e-41  Score=333.83  Aligned_cols=249  Identities=24%  Similarity=0.372  Sum_probs=211.5

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCe----EEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSE----IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      ..++|++++.||+|+||+||+|++..+++    .||+|+++...  .......+.+|+.+++.++||||+++++++... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   81 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-   81 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence            45789999999999999999999877765    48999987543  233455678899999999999999999998754 


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 RLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..++++||+++|+|.+++..+ +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            567999999999999998764 5689999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCC---cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHH
Q 047009          303 NTRS---NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAH  377 (482)
Q Consensus       303 ~~~~---~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (482)
                      ....   ....++..|+|||.+.+..++.++|||||||++|||++ |..||.......+...+... ....+..++.++.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY  241 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence            3221   12234678999999999999999999999999999998 99999877766666655554 3445667899999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ++|.+||+.||++||++     .+++.
T Consensus       242 ~li~~~l~~dp~~Rp~~-----~~l~~  263 (279)
T cd05109         242 MIMVKCWMIDSECRPRF-----RELVD  263 (279)
T ss_pred             HHHHHHcCCChhhCcCH-----HHHHH
Confidence            99999999999999999     78874

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.8e-41  Score=329.22  Aligned_cols=250  Identities=32%  Similarity=0.526  Sum_probs=215.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++..........+.+.+|+.++++++|+||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999999999999997654444555677889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-
Q 047009          230 DFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       230 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  304 (482)
                      ||+++|+|..++..    ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... 
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            99999999988864    2458999999999999999999999999999999999999999999999999998764332 


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc--hHHHHHHHHhccc-CCCc-cCChHHHHHH
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN--RAKIQQKIVKDKL-RLPA-FLSSEAHSLL  380 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~--~~~~~~~i~~~~~-~~p~-~~s~~~~~LI  380 (482)
                      ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||....  .....+.+..+.. ..|. .++..+.++|
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  241 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV  241 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence            2334578999999999999999999999999999999999999996543  2344444444322 3444 6788999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHh
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||..+|++||++     .+|++
T Consensus       242 ~~cl~~~p~~Rp~~-----~~il~  260 (267)
T cd08224         242 SRCINPDPEKRPDI-----SYVLQ  260 (267)
T ss_pred             HHHcCCCcccCCCH-----HHHHH
Confidence            99999999999998     77664

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.5e-42  Score=338.77  Aligned_cols=250  Identities=20%  Similarity=0.338  Sum_probs=215.2

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCC-----CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNT-----SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      .+.+|++.+.||+|+||.||+|.+..+     ++.||+|+++...  .....+.+.+|+.++..++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            346788899999999999999987643     5789999987543  223456688899999999999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHH----------------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD  286 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~  286 (482)
                      ...++++||+.+++|..++...                ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999887532                347888889999999999999999999999999999999999


Q ss_pred             CceeEcccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHH
Q 047009          287 GHVMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIV  362 (482)
Q Consensus       287 g~vKL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~  362 (482)
                      +.+||+|||+++.......   .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999987543221   233456789999999998889999999999999999998 999999888888888877


Q ss_pred             hccc-CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          363 KDKL-RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       363 ~~~~-~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .... ..+..++..+.+|+.+||+++|.+||++     .+|+.
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~-----~~i~~  278 (283)
T cd05091         241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRF-----KDIHS  278 (283)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCH-----HHHHH
Confidence            7654 4577899999999999999999999998     88875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.7e-41  Score=330.46  Aligned_cols=247  Identities=22%  Similarity=0.390  Sum_probs=212.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||.||+|++++ +..||+|.+.....    ..+.+.+|+.++++++||||+++++++......++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            4689999999999999999998765 44699999875432    134577899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC-
Q 047009          229 LDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~-  306 (482)
                      |||+.+|+|..++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++........ 
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999999998764 46899999999999999999999999999999999999999999999999999865433211 


Q ss_pred             -cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc-cCCCccCChHHHHHHHHh
Q 047009          307 -NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       307 -~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~LI~~~  383 (482)
                       ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+....+..+. ...+...+..+++++.+|
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSC  237 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence             12335678999999998889999999999999999998 999998877777777776653 334566789999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      |+.||.+||++     .+|+++
T Consensus       238 l~~~p~~Rp~~-----~~ll~~  254 (256)
T cd05113         238 WHEKAEERPTF-----QQLLSS  254 (256)
T ss_pred             cCCCcccCCCH-----HHHHHh
Confidence            99999999998     888753

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-43  Score=328.38  Aligned_cols=258  Identities=29%  Similarity=0.483  Sum_probs=222.3

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  225 (482)
                      ..+++.+.+..||.|+.|+|++++.+.+|...|||.+.+..  .+++.+++.+.++++... ++|.||+.+++|..+..+
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV  166 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV  166 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence            45678888999999999999999999999999999998764  455667777888877665 599999999999999999


Q ss_pred             EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          226 YLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      ++.||.|.- .+..++.+ .++++|..+-.+...+++||.||.++ ||||||+||+|||+|..|++||||||++..+-++
T Consensus       167 ~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  167 FICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence            999999963 33333332 57799999999999999999999975 8999999999999999999999999999998777


Q ss_pred             CCCcccccCCCCCchhhhcCC---CCCchhHHHHHhHHHHHHhhCCCCCCCC-chHHHHHHHHhccc-CCCc--cCChHH
Q 047009          304 TRSNSMIGTVEYMAPEIVLGK---GHNKAADWWSVGILLYEMLTGKPPFIGG-NRAKIQQKIVKDKL-RLPA--FLSSEA  376 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~---~~~~~sDvwSlGvilyelltG~~PF~~~-~~~~~~~~i~~~~~-~~p~--~~s~~~  376 (482)
                      ...+...|.+.|||||.+.-.   .|+..+||||||++++||.||+.||.+. ...++..++++..+ .+|.  .+|+.+
T Consensus       246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F  325 (391)
T KOG0983|consen  246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDF  325 (391)
T ss_pred             cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHH
Confidence            777778999999999999653   6899999999999999999999999874 45677777777544 3332  489999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      ++|+..||.+|+.+||..     .++++|||+...+
T Consensus       326 ~~fv~~CL~kd~r~RP~Y-----~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  326 QSFVKDCLTKDHRKRPKY-----NKLLEHPFIKRYE  356 (391)
T ss_pred             HHHHHHHhhcCcccCcch-----HHHhcCcceeecc
Confidence            999999999999999999     9999999997643

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=335.79  Aligned_cols=250  Identities=29%  Similarity=0.527  Sum_probs=210.5

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEe
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  231 (482)
                      |++.+.||.|++|.||+|.++.+|+.||+|++..+.. .......+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            6788999999999999999999999999999976532 223334567899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCcc
Q 047009          232 INGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNS  308 (482)
Q Consensus       232 ~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~  308 (482)
                      ++ ++|..++....  .+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++....... ....
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            95 58988887765  68999999999999999999999999999999999999999999999999997654322 2233


Q ss_pred             cccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc----------------------
Q 047009          309 MIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK----------------------  365 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~----------------------  365 (482)
                      ..++..|+|||++.+. .++.++||||||+++|+|++|+.||...+.......+....                      
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP  238 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence            4678899999988764 57899999999999999999999998766544333332210                      


Q ss_pred             -------cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          366 -------LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       366 -------~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                             ......++.++.++|.+||+.||.+||++     +|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~il~~~~~  283 (283)
T cd07835         239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA-----KAALQHPYF  283 (283)
T ss_pred             cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH-----HHHhcCCCC
Confidence                   01123467899999999999999999998     999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.3e-41  Score=327.44  Aligned_cols=251  Identities=31%  Similarity=0.534  Sum_probs=223.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +|++.+.||+|+||.||+++++.+++.||+|.+....... .....+.+|+.+++.++|+||+++++++......|+|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            5899999999999999999999999999999998754332 344566789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          231 FINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       231 ~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      |+++++|..++.+    ...+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||+++..... ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~  158 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MA  158 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cc
Confidence            9999999988866    356899999999999999999999999999999999999999999999999999876544 33


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CCCccCChHHHHHHHHhhc
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~LI~~~L~  385 (482)
                      ....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+..... .++..++.+++++|.+||.
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  238 (256)
T cd08530         159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ  238 (256)
T ss_pred             ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcC
Confidence            446789999999999999999999999999999999999999998888777777666543 4556789999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      .+|++||++     .++++||+.
T Consensus       239 ~~p~~Rp~~-----~~~l~~p~~  256 (256)
T cd08530         239 VKPKLRPNC-----DKILASPAV  256 (256)
T ss_pred             CCcccCCCH-----HHHhcCCCC
Confidence            999999999     999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-42  Score=368.42  Aligned_cols=264  Identities=24%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCC-eEEEEE--------------EeechhhchhhHHHHHHHHHHHHHhCCCCc
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTS-EIYAMK--------------VMRKDKIVEKNHAEYMKAERDILTKIDHPF  211 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAiK--------------~~~~~~~~~~~~~~~~~~E~~il~~l~hpn  211 (482)
                      ...++|++++.||+|+||+||+|..+... ..++.|              ++.+...........+.+|+.+|++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            34578999999999999999998765432 222222              111111112234456789999999999999


Q ss_pred             eeeeeeeeecCCeEEEEEEecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC
Q 047009          212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH-----GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD  286 (482)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~  286 (482)
                      |+++++++...+..|+|++++.+ +|..++...     .......++.++.||+.||.|||++|||||||||+|||++.+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            99999999999999999999965 666665432     223456778899999999999999999999999999999999


Q ss_pred             CceeEcccCccccccCCC--CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCC-CCCC--chHHHHHHH
Q 047009          287 GHVMLTDFGLAKQFDENT--RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPP-FIGG--NRAKIQQKI  361 (482)
Q Consensus       287 g~vKL~DFGla~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~P-F~~~--~~~~~~~~i  361 (482)
                      |.+||+|||+++.+....  .....+||+.|+|||++.+..++.++|||||||++|||++|..+ |...  +.......+
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            999999999998765432  23356899999999999999999999999999999999998764 4322  111111111


Q ss_pred             Hhc----ccCCC----------------------------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          362 VKD----KLRLP----------------------------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       362 ~~~----~~~~p----------------------------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      ...    ...+|                            ..++.++.++|.+||+.||++||++     .|++.||||.
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa-----~elL~hp~f~  458 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA-----AELLALPLFS  458 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCH-----HHHhhChhhh
Confidence            110    00011                            1256778889999999999999999     9999999999


Q ss_pred             CCChhhh
Q 047009          410 PINWKKL  416 (482)
Q Consensus       410 ~~~~~~~  416 (482)
                      ....+.+
T Consensus       459 ~~~~~~~  465 (501)
T PHA03210        459 AEEEEEI  465 (501)
T ss_pred             cCCchHH
Confidence            8776554

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.3e-41  Score=375.25  Aligned_cols=246  Identities=26%  Similarity=0.396  Sum_probs=205.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++.++||+|+||.||+|++..+|+.||+|++..+........+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            47899999999999999999999999999999999765433344456788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          229 LDFINGGHLFFQLYHH-----------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-----------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                      |||++||+|..++...           ..++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999888641           23455667889999999999999999999999999999999999999999999


Q ss_pred             ccccCC-------------------CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHH
Q 047009          298 KQFDEN-------------------TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ  358 (482)
Q Consensus       298 ~~~~~~-------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~  358 (482)
                      +.....                   ......+||+.|||||++.+..++.++|||||||++|||++|+.||...+.....
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            865211                   1112357999999999999999999999999999999999999999875544333


Q ss_pred             HHHH-hcccCC--CccCChHHHHHHHHhhccCcCCcCCC
Q 047009          359 QKIV-KDKLRL--PAFLSSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       359 ~~i~-~~~~~~--p~~~s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                      .... ......  ...+++.+.+++.+||+.||++|++.
T Consensus       241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss  279 (932)
T PRK13184        241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS  279 (932)
T ss_pred             hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCH
Confidence            2211 111111  13578999999999999999999876

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=330.95  Aligned_cols=245  Identities=24%  Similarity=0.434  Sum_probs=210.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      .+|++.+.||+|+||.||+|+++. +..+|+|++.+...    ....+.+|+.+++.++||||+++++++...+..|+||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            578999999999999999998874 56799999875432    1234677999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC--
Q 047009          230 DFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS--  306 (482)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~--  306 (482)
                      ||++|++|.+++..+ +.+++..+..++.||+.||+|||++||+||||||+||+++.+|.+||+|||+++........  
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            999999999998764 46899999999999999999999999999999999999999999999999999875432211  


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHhh
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~L  384 (482)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+... ....|..++.++.+++.+||
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  238 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCW  238 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence            11223457999999999999999999999999999999 89999887777777766654 34566778999999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHh
Q 047009          385 QKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~  404 (482)
                      +.+|++||++     .++++
T Consensus       239 ~~~p~~Rpt~-----~~~l~  253 (256)
T cd05059         239 HEKPEDRPAF-----KKLLS  253 (256)
T ss_pred             cCChhhCcCH-----HHHHH
Confidence            9999999998     88875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.5e-42  Score=339.71  Aligned_cols=255  Identities=31%  Similarity=0.497  Sum_probs=218.4

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++.+.||+|+||.||++....+++.||+|.+....   ....+.+.+|+.+++.++||||+++++++......|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            478999999999999999999998889999999986542   23345678899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  307 (482)
                      +||+++++|..++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus        95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             EecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence            999999999988865 457899999999999999999999999999999999999999999999999987654332 233


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-cc--CCCccCChHHHHHHHHhh
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-KL--RLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-~~--~~p~~~s~~~~~LI~~~L  384 (482)
                      ...|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+... ..  ..+..++..++++|++||
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  253 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHc
Confidence            457899999999999888999999999999999999999999876654433333222 22  233457889999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          385 QKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      ..+|.+||++     .+++.|+||+..+
T Consensus       254 ~~~p~~Rp~~-----~~il~h~~~~~~~  276 (293)
T cd06647         254 EMDVEKRGSA-----KELLQHPFLKIAK  276 (293)
T ss_pred             cCChhhCcCH-----HHHhcCHHHhcCc
Confidence            9999999998     9999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=332.16  Aligned_cols=247  Identities=22%  Similarity=0.339  Sum_probs=209.5

Q ss_pred             eEEEEEecccCceEEEEEEEcCC---CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe----
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNT---SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR----  224 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----  224 (482)
                      |.+.+.||+|+||.||+|....+   +..||+|+++.+.. .......+.+|+.+++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            56789999999999999987653   47899999876432 23345668899999999999999999998765443    


Q ss_pred             --EEEEEEecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCc
Q 047009          225 --LYLVLDFINGGHLFFQLYHH------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGL  296 (482)
Q Consensus       225 --~~lV~E~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGl  296 (482)
                        .++||||+++|+|..++...      ..+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              79999999999998887442      3588999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCcc
Q 047009          297 AKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAF  371 (482)
Q Consensus       297 a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~  371 (482)
                      ++.......   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++.+.+..+ ....|..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED  239 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcC
Confidence            987543221   122345678999999999999999999999999999999 99999888877777777654 4556778


Q ss_pred             CChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       372 ~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ++.++.++|.+||+.||++||++     .++++
T Consensus       240 ~~~~~~~li~~~l~~~p~~Rp~~-----~e~~~  267 (273)
T cd05035         240 CLDELYDLMYSCWRADPKDRPTF-----TKLRE  267 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            99999999999999999999998     78775

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=367.98  Aligned_cols=247  Identities=28%  Similarity=0.428  Sum_probs=211.2

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeee-ec--
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSF-QT--  221 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~-~~--  221 (482)
                      .++-.++++.+.|.+|||+.||+|++...|..||+|++-..   ++...+.+.+|+.+|++|. |+|||.+++.. ..  
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~  109 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS  109 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence            35557889999999999999999999998899999998653   4677888999999999996 99999999932 11  


Q ss_pred             ----CCeEEEEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEccCCceeEcc
Q 047009          222 ----KYRLYLVLDFINGGHLFFQLYH--HGLFREDLARIYAAEIVSAVSHLHANG--IMHRDLKPENILLGADGHVMLTD  293 (482)
Q Consensus       222 ----~~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~--IiHrDLKp~NILl~~~g~vKL~D  293 (482)
                          ...++|.||||.||.|.+++.+  +..|+|.++..|+.|+++|+++||..+  |||||||-|||||+.+|+.||||
T Consensus       110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence                2357899999999999999874  356999999999999999999999997  99999999999999999999999


Q ss_pred             cCccccccCCCCC----------cccccCCCCCchhhh---cCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHH
Q 047009          294 FGLAKQFDENTRS----------NSMIGTVEYMAPEIV---LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQK  360 (482)
Q Consensus       294 FGla~~~~~~~~~----------~~~~gt~~y~APE~l---~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~  360 (482)
                      ||.|...-.....          ....-|+.|+|||++   .+.+.+.|+|||||||+||-|+....||.....    -.
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----la  265 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LA  265 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----ee
Confidence            9998753221111          123459999999997   577899999999999999999999999976532    36


Q ss_pred             HHhcccCCCc--cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          361 IVKDKLRLPA--FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       361 i~~~~~~~p~--~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      |+++++.+|.  .++..+++||+.||+.||++||++     -+++.
T Consensus       266 Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI-----~Qv~~  306 (738)
T KOG1989|consen  266 ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNI-----YQVLE  306 (738)
T ss_pred             EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCH-----HHHHH
Confidence            7888999986  589999999999999999999998     66654

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.5e-41  Score=335.83  Aligned_cols=257  Identities=32%  Similarity=0.518  Sum_probs=223.7

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .+.|++.+.||+|+||.||+|.+..++..||+|++.....    ..+.+.+|+.++++++|+||+++++++......|+|
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            4668889999999999999999998899999999976532    345677899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCC
Q 047009          229 LDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~  306 (482)
                      +||++|++|.+++...+ .+++..+..++.|++.||+|||+.||+|+||||+||+++.+|.++|+|||++...... ...
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  173 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR  173 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence            99999999999998876 8999999999999999999999999999999999999999999999999998765432 122


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CC--CccCChHHHHHHHHh
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RL--PAFLSSEAHSLLKGL  383 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~--p~~~s~~~~~LI~~~  383 (482)
                      ....++..|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+..... ..  +..++.++++||.+|
T Consensus       174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  253 (286)
T cd06614         174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKC  253 (286)
T ss_pred             ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHH
Confidence            345688999999999998899999999999999999999999987766555555443322 22  234789999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                      |+.+|.+||++     .++++|+||+...|.
T Consensus       254 l~~~p~~Rpt~-----~~il~~~~~~~~~~~  279 (286)
T cd06614         254 LVKDPEKRPSA-----EELLQHPFLKKACPK  279 (286)
T ss_pred             hccChhhCcCH-----HHHhhChHhhccCch
Confidence            99999999999     999999999986654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.1e-41  Score=335.87  Aligned_cols=250  Identities=22%  Similarity=0.326  Sum_probs=212.8

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCC----------------eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCc
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTS----------------EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF  211 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----------------~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn  211 (482)
                      ..++|++++.||+|+||.||+|.+..++                ..||+|.+.....  ....+.+.+|++++++++|||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence            3478999999999999999999876644                5689999876532  245567889999999999999


Q ss_pred             eeeeeeeeecCCeEEEEEEecCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 047009          212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-----------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPEN  280 (482)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~N  280 (482)
                      |+++++++...+..++||||+.+++|..++....           .+++..++.++.|++.||.|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999987765           68999999999999999999999999999999999


Q ss_pred             EEEccCCceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh--CCCCCCCCchH
Q 047009          281 ILLGADGHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT--GKPPFIGGNRA  355 (482)
Q Consensus       281 ILl~~~g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt--G~~PF~~~~~~  355 (482)
                      |+++.++.++|+|||+++......   ......++..|+|||++.+..++.++|||||||++|||++  |..||...+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            999999999999999998653322   2234456789999999998889999999999999999998  78899877766


Q ss_pred             HHHHHHHhc--------ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          356 KIQQKIVKD--------KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       356 ~~~~~i~~~--------~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .....+...        ....+..++.++.+||.+||+.||.+||++     .+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~-----~el~~  292 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF-----REIHL  292 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCH-----HHHHH
Confidence            665555432        123345578999999999999999999998     88854

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-41  Score=329.09  Aligned_cols=247  Identities=26%  Similarity=0.418  Sum_probs=211.9

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ..++|++.+.||+|++|.||+|.+.. ++.||+|.++....    ..+.+.+|+.++++++||||+++++++...+..|+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            34679999999999999999999765 56799999876432    23457789999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          228 VLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      ||||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999999987654  689999999999999999999999999999999999999999999999999987653221


Q ss_pred             C--cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHH
Q 047009          306 S--NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       306 ~--~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~  381 (482)
                      .  ....++..|+|||++.+..++.++|+||||+++|||++ |+.||.+.+.......+... ....+..++..+.+++.
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIML  238 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence            1  11122457999999999999999999999999999999 99999888877777766554 33456678999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +||+.+|.+||++     .+|++
T Consensus       239 ~~l~~~P~~Rp~~-----~~l~~  256 (261)
T cd05068         239 DCWKEDPDDRPTF-----ETLQW  256 (261)
T ss_pred             HHhhcCcccCCCH-----HHHHH
Confidence            9999999999998     67653

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2e-41  Score=331.67  Aligned_cols=247  Identities=23%  Similarity=0.355  Sum_probs=207.4

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCe--EEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec------CC
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSE--IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT------KY  223 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~--~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~  223 (482)
                      |.+.+.||+|+||.||+|++..++.  .||+|.++... ......+.+.+|+.+++.++|+||+++++.+..      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            3467889999999999999887765  69999987643 233446677889999999999999999987632      22


Q ss_pred             eEEEEEEecCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          224 RLYLVLDFINGGHLFFQLYH------HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                      ..++||||+.+|+|..++..      ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            56899999999999887642      234789999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc-cCCCccC
Q 047009          298 KQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAFL  372 (482)
Q Consensus       298 ~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~~  372 (482)
                      +.......   .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+.....+...+..+. ...+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  239 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC  239 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            87643321   122346778999999999999999999999999999999 899998887777777776653 3556778


Q ss_pred             ChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       373 s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +..+.++|.+||+.||.+||++     .+|++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~-----~~l~~  266 (272)
T cd05075         240 LDGLYSLMSSCWLLNPKDRPSF-----ETLRC  266 (272)
T ss_pred             CHHHHHHHHHHcCCCcccCcCH-----HHHHH
Confidence            9999999999999999999998     78765

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.4e-41  Score=335.54  Aligned_cols=248  Identities=25%  Similarity=0.439  Sum_probs=213.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      ..+|.+.+.||+|+||.||+|++..     ++..+++|.+....   ....+.+.+|+.++++++|+||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            4679999999999999999998643     45679999986543   233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC
Q 047009          224 RLYLVLDFINGGHLFFQLYHHG----------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG  287 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g  287 (482)
                      ..++||||+++++|.+++..++                .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence            9999999999999999987643                378899999999999999999999999999999999999999


Q ss_pred             ceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHh
Q 047009          288 HVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK  363 (482)
Q Consensus       288 ~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~  363 (482)
                      .+||+|||+++......   ......|+..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+..+.+..
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  240 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ  240 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence            99999999997653322   1233456889999999999999999999999999999998 9999988887777777766


Q ss_pred             ccc-CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          364 DKL-RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       364 ~~~-~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +.. ..+..++..+.+||.+||++||++||++     .++++
T Consensus       241 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~v~~  277 (291)
T cd05094         241 GRVLERPRVCPKEVYDIMLGCWQREPQQRLNI-----KEIYK  277 (291)
T ss_pred             CCCCCCCccCCHHHHHHHHHHcccChhhCcCH-----HHHHH
Confidence            544 3456678999999999999999999998     77754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=358.16  Aligned_cols=250  Identities=28%  Similarity=0.421  Sum_probs=221.3

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEe
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  231 (482)
                      |.-++.||.|+||.||.|++..+.+.||||.+.-......+.-..+..|+..|.+++|||+|.+.++|-.+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            55567899999999999999999999999999876555555667788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccc
Q 047009          232 INGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI  310 (482)
Q Consensus       232 ~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  310 (482)
                      |-| +-.+.+.- .+++.+..+..|+.+.+.||+|||+.+.||||||..||||++.|.|||+|||.|....   ..++++
T Consensus       108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---PAnsFv  183 (948)
T KOG0577|consen  108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---PANSFV  183 (948)
T ss_pred             Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC---chhccc
Confidence            976 55555543 4679999999999999999999999999999999999999999999999999998753   467899


Q ss_pred             cCCCCCchhhhcC---CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-cCCC-ccCChHHHHHHHHhhc
Q 047009          311 GTVEYMAPEIVLG---KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-LRLP-AFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       311 gt~~y~APE~l~~---~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~~LI~~~L~  385 (482)
                      |||.|||||+|..   +.|+-++||||||++..||.-.++|+...|-.....-|..+. +.++ +.+|..+++||..||+
T Consensus       184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLq  263 (948)
T KOG0577|consen  184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ  263 (948)
T ss_pred             CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHh
Confidence            9999999999964   579999999999999999999999998888877777776654 3444 4589999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      +-|.+||+.     ++++.|+|...
T Consensus       264 KipqeRpts-----e~ll~H~fv~R  283 (948)
T KOG0577|consen  264 KIPQERPTS-----EELLKHRFVLR  283 (948)
T ss_pred             hCcccCCcH-----HHHhhcchhcc
Confidence            999999999     99999999853

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-41  Score=335.92  Aligned_cols=252  Identities=22%  Similarity=0.378  Sum_probs=215.2

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCC-----eEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTS-----EIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQ  220 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  220 (482)
                      +..++|++.+.||+|+||.||++.++..+     ..+|+|++.....  ......+.+|+.+++++ +|+||+++++++.
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            34478999999999999999999986543     7899999876432  23345578899999999 8999999999999


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHH----------------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG  284 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~  284 (482)
                      ..+.++++|||+++|+|..++...                +.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence            999999999999999999988642                3578889999999999999999999999999999999999


Q ss_pred             cCCceeEcccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHH
Q 047009          285 ADGHVMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQK  360 (482)
Q Consensus       285 ~~g~vKL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~  360 (482)
                      .++.+||+|||+++.+.....   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+..+.
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  246 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  246 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            999999999999987643221   122335678999999999999999999999999999997 9999998887777777


Q ss_pred             HHhcc-cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          361 IVKDK-LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       361 i~~~~-~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      +.... ...+..++.++.+|+.+||..||++||++     .+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~eil~~  287 (293)
T cd05053         247 LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTF-----KQLVED  287 (293)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCH-----HHHHHH
Confidence            66553 35667788999999999999999999999     888763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.4e-41  Score=344.01  Aligned_cols=253  Identities=27%  Similarity=0.433  Sum_probs=208.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC-------
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK-------  222 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-------  222 (482)
                      .+|++.+.||.|+||.||+|.++.+|+.||+|.+.....   ...+.+.+|+.++++++||||+++++++...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            689999999999999999999999999999999876532   3455678899999999999999998776543       


Q ss_pred             -------CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc-CCceeEccc
Q 047009          223 -------YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA-DGHVMLTDF  294 (482)
Q Consensus       223 -------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~-~g~vKL~DF  294 (482)
                             ..+|+||||+++ +|...+. .+.+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          82 VGSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             cccccccceEEEEeecccc-cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence                   358999999974 8877765 456899999999999999999999999999999999999984 557899999


Q ss_pred             CccccccCCC----CCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc----
Q 047009          295 GLAKQFDENT----RSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK----  365 (482)
Q Consensus       295 Gla~~~~~~~----~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~----  365 (482)
                      |+++.+....    ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....    
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9997653221    1223467889999998754 568899999999999999999999998776555444433210    


Q ss_pred             ---------------------cC-----CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          366 ---------------------LR-----LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       366 ---------------------~~-----~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                                           ..     +...++.++++||.+||+.||.+||++     .++++||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~ell~h~~~~~~~  307 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA-----EEALMHPYMSCYS  307 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH-----HHHhCCCcccccc
Confidence                                 00     113478899999999999999999998     9999999998643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-41  Score=343.77  Aligned_cols=253  Identities=30%  Similarity=0.458  Sum_probs=213.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC-----
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY-----  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  223 (482)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++....     
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            478999999999999999999999999999999986542 22334456778999999999999999999987654     


Q ss_pred             -eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 -RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                       .+++||||+ |++|..++. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence             458999999 678877665 46789999999999999999999999999999999999999999999999999987543


Q ss_pred             CCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc---------------
Q 047009          303 NTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL---------------  366 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~---------------  366 (482)
                        ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......+.+...               
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07880         171 --EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA  248 (343)
T ss_pred             --CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence              2334577999999999876 4588999999999999999999999987765544444332111               


Q ss_pred             ----------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          367 ----------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       367 ----------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                                      .+...++.++.++|.+||+.||++||++     .+++.||||+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~-----~~~l~~~~~~~~  304 (343)
T cd07880         249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITA-----AEALAHPYFEEF  304 (343)
T ss_pred             HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCH-----HHHhcCccHhhh
Confidence                            1123568889999999999999999999     999999999865

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=333.18  Aligned_cols=250  Identities=31%  Similarity=0.479  Sum_probs=211.3

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC---CCCceeeeeeeeecCCe----
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI---DHPFVVQLKYSFQTKYR----  224 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~----  224 (482)
                      |++.+.||+|+||.||+|+++.+++.||+|++..... .......+.+|+.+++++   +|+||+++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            6789999999999999999998899999999975432 222234456777777666   69999999999988776    


Q ss_pred             -EEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          225 -LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       225 -~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                       ++++|||+.+ +|..++....  .+++..++.++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++....
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             9999999985 7888776643  58999999999999999999999999999999999999999999999999998875


Q ss_pred             CCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-----cC---------
Q 047009          302 ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-----LR---------  367 (482)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-----~~---------  367 (482)
                      .........++..|+|||++.+..++.++|+|||||++|+|++|++||.+.+..+...++....     ..         
T Consensus       159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07838         159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR  238 (287)
T ss_pred             CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence            5544455668999999999999999999999999999999999999998887776666554311     00         


Q ss_pred             --C-----------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          368 --L-----------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       368 --~-----------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                        +           ...++..+.+||.+||+.||.+||++     ++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~-----~~il~~~~~  287 (287)
T cd07838         239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA-----FEALQHPYF  287 (287)
T ss_pred             hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH-----HHHhcCcCC
Confidence              0           01346788999999999999999998     999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-41  Score=326.21  Aligned_cols=244  Identities=25%  Similarity=0.418  Sum_probs=214.5

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ..++|++.+.||.|+||.||+|...  |+.||+|.+.....    ..+.+.+|+.++++++|+||+++++++.+....++
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            4578999999999999999999875  68899999876532    45668889999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          228 VLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      ||||+++++|..++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            999999999999987765  689999999999999999999999999999999999999999999999999987643222


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHh
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~  383 (482)
                        ...++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+...+...+..+ ....+..+++++.++|.+|
T Consensus       158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (256)
T cd05039         158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC  235 (256)
T ss_pred             --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence              3345678999999998889999999999999999997 99999888777777666554 4456677899999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHh
Q 047009          384 LQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~  404 (482)
                      |..+|.+||++     .++++
T Consensus       236 l~~~p~~Rp~~-----~~l~~  251 (256)
T cd05039         236 WELDPAKRPTF-----KQLRE  251 (256)
T ss_pred             hccChhhCcCH-----HHHHH
Confidence            99999999998     77764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.2e-42  Score=344.76  Aligned_cols=255  Identities=29%  Similarity=0.430  Sum_probs=219.5

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC-----eE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY-----RL  225 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~  225 (482)
                      +|++.+.||.|+||.||+|++..+++.||+|.+.+.. ......+.+.+|+.+++.++|+||+++++++....     .+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            5899999999999999999999999999999987643 22344566888999999999999999999988775     78


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  304 (482)
                      |+||||+.+ +|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... 
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            999999985 788888877789999999999999999999999999999999999999999999999999998865432 


Q ss_pred             ---CCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC-------------
Q 047009          305 ---RSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-------------  367 (482)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~-------------  367 (482)
                         ......+|..|+|||++.+. .++.++|+||||+++|+|++|+.||.+.+..+....+....-.             
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence               23455789999999999888 8899999999999999999999999887766655554431100             


Q ss_pred             ------------------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          368 ------------------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       368 ------------------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                                        ....++.++.+||.+||++||.+||++     ++++.||||+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~ll~~~~~~~~~  296 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA-----DEALAHPYLAQLH  296 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCH-----HHHHhCccHHhhc
Confidence                              112367889999999999999999999     9999999998753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2e-41  Score=337.79  Aligned_cols=255  Identities=30%  Similarity=0.481  Sum_probs=207.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec-----
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT-----  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----  221 (482)
                      ..+++|++.+.||+|+||.||+|.++.+++.||+|++....... .......+|+.+++.++||||+++++.+..     
T Consensus         5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            44789999999999999999999999999999999987653222 122345689999999999999999987743     


Q ss_pred             ---CCeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          222 ---KYRLYLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       222 ---~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                         ...+++||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence               3357999999976 56665554 457999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC------------CcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc
Q 047009          298 KQFDENTR------------SNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD  364 (482)
Q Consensus       298 ~~~~~~~~------------~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~  364 (482)
                      +.......            .....|++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+.......+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            86533211            1234678899999988764 5889999999999999999999999887766555444321


Q ss_pred             cc-----------------------CCC-------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          365 KL-----------------------RLP-------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       365 ~~-----------------------~~p-------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      ..                       ..+       ..++..+.+||.+||+.||.+||++     .+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~-----~ell~~~~f  311 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA-----SDALEHPYF  311 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH-----HHHhcCCCC
Confidence            00                       000       1245788999999999999999998     999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.3e-41  Score=337.31  Aligned_cols=249  Identities=21%  Similarity=0.359  Sum_probs=212.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcC-------CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeee
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKN-------TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQ  220 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  220 (482)
                      .++|.+.+.||+|+||.||+|++..       +...||+|.+....  .......+.+|+.+++.+ +||||+++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            4789999999999999999998653       23579999987642  223345677899999999 7999999999999


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHHG----------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG  284 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~  284 (482)
                      ..+..|+||||+++|+|..++..++                .+++..+..++.||+.||+|||++|++||||||+|||++
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  174 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  174 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence            9999999999999999999997642                478888999999999999999999999999999999999


Q ss_pred             cCCceeEcccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHH
Q 047009          285 ADGHVMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQK  360 (482)
Q Consensus       285 ~~g~vKL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~  360 (482)
                      .++.+||+|||+++.......   .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~  254 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  254 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence            999999999999986543221   112234568999999999999999999999999999998 9999988887777777


Q ss_pred             HHhcc-cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          361 IVKDK-LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       361 i~~~~-~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +.... ...|..++.++.+||.+||..+|.+||++     .++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~evl~  294 (307)
T cd05098         255 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-----KQLVE  294 (307)
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCH-----HHHHH
Confidence            66553 35677789999999999999999999998     77765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-41  Score=332.83  Aligned_cols=245  Identities=33%  Similarity=0.531  Sum_probs=206.9

Q ss_pred             EEEEEecccCceEEEEEEEc----CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          153 EVLKVVGQGAFGRVYQVRKK----NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       153 ~i~~~LG~G~fg~Vy~a~~~----~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .+.+.||.|.||.||+|.+.    ..+..|+||+++..  ......+.+.+|++++++++||||+++++++...+.+++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence            56789999999999999998    45678999999543  2334467788999999999999999999999988889999


Q ss_pred             EEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--
Q 047009          229 LDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--  304 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--  304 (482)
                      |||+++|+|.+++...  ..+++..+..++.||+.||.|||+++|+|+||+++|||++.++.+||+|||++.......  
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999887  679999999999999999999999999999999999999999999999999998763221  


Q ss_pred             -CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHH
Q 047009          305 -RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~  381 (482)
                       ......+...|+|||.+.+..++.++||||||+++|||++ |+.||...+..++...+.++ ....+..++..+.++|.
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  239 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQ  239 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHH
Confidence             1233456788999999999989999999999999999999 78999988888888887655 34556778999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .||..||.+||++     ++|++
T Consensus       240 ~C~~~~p~~RPs~-----~~i~~  257 (259)
T PF07714_consen  240 QCWSHDPEKRPSF-----QEILQ  257 (259)
T ss_dssp             HHT-SSGGGS--H-----HHHHH
T ss_pred             HHcCCChhhCcCH-----HHHHh
Confidence            9999999999998     88764

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.5e-41  Score=327.58  Aligned_cols=244  Identities=25%  Similarity=0.440  Sum_probs=210.0

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeee-ecCCeE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSF-QTKYRL  225 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~  225 (482)
                      +...+|++.+.||+|+||.||++...  |..||+|.++.+.     ..+.+.+|+.++++++|+|++++++++ ......
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            44578999999999999999999765  6789999986542     245678899999999999999999875 456678


Q ss_pred             EEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          226 YLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      ++||||+++++|..++...+  .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999999987654  4788999999999999999999999999999999999999999999999999865432


Q ss_pred             CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHH
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~  381 (482)
                      .  ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+...+...+.++ ....+..++..+.++|.
T Consensus       156 ~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMK  233 (256)
T ss_pred             C--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            2  33455678999999999999999999999999999997 99999888777777766554 34556778999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +||+.||++||++     .++++
T Consensus       234 ~~l~~~p~~Rpt~-----~~l~~  251 (256)
T cd05082         234 QCWHLDAATRPSF-----LQLRE  251 (256)
T ss_pred             HHhcCChhhCcCH-----HHHHH
Confidence            9999999999998     77764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.5e-41  Score=336.32  Aligned_cols=255  Identities=30%  Similarity=0.503  Sum_probs=210.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC---
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY---  223 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---  223 (482)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|+++.... .......+.+|+.++++++||||+++++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            456889999999999999999999999999999999976532 2223345678999999999999999999887654   


Q ss_pred             -------eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccC
Q 047009          224 -------RLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFG  295 (482)
Q Consensus       224 -------~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFG  295 (482)
                             .+++|+||+++ ++...+... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence                   79999999987 566655543 468999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCC--CCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc------
Q 047009          296 LAKQFDENT--RSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL------  366 (482)
Q Consensus       296 la~~~~~~~--~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~------  366 (482)
                      ++.......  ......++..|+|||.+.+. .++.++|||||||++|+|++|++||...+.......+.+...      
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (302)
T cd07864         162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV  241 (302)
T ss_pred             ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            998764332  12234568899999988754 578999999999999999999999987665544444333100      


Q ss_pred             ------------------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          367 ------------------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       367 ------------------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                                              .....++..+.+||.+||+.||.+||++     .+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~-----~~il~~~~~  302 (302)
T cd07864         242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA-----EEALNSPWL  302 (302)
T ss_pred             cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCH-----HHHhcCCCC
Confidence                                    0012368899999999999999999998     999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.2e-41  Score=328.78  Aligned_cols=245  Identities=27%  Similarity=0.410  Sum_probs=208.4

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++.+.||+|+||.||+|++..++ .||+|++.+...    ..+.+.+|+.++++++||||+++++.+.. ...++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv   78 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   78 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence            467999999999999999999987764 599999876432    22457889999999999999999988754 557899


Q ss_pred             EEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          229 LDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      |||+++|+|..++...  ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||.++.+......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999999998763  35788999999999999999999999999999999999999999999999999876433321


Q ss_pred             --cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHH
Q 047009          307 --NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKG  382 (482)
Q Consensus       307 --~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~  382 (482)
                        ....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.........+... ....+..++..+.+||.+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  238 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ  238 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence              23446678999999999999999999999999999999 89999887777777666554 234456789999999999


Q ss_pred             hhccCcCCcCCCCCCChHHHHh
Q 047009          383 LLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       383 ~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ||++||.+||++     .++++
T Consensus       239 ~l~~~p~~Rp~~-----~~~~~  255 (262)
T cd05071         239 CWRKEPEERPTF-----EYLQA  255 (262)
T ss_pred             HccCCcccCCCH-----HHHHH
Confidence            999999999998     66653

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.3e-41  Score=351.40  Aligned_cols=245  Identities=23%  Similarity=0.370  Sum_probs=204.9

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCC-----CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeec
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNT-----SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQT  221 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  221 (482)
                      ..++|++++.||+|+||.||+|.+...     +..||||++....  .....+.+.+|+.+|+++. ||||+++++++..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            347899999999999999999987543     3579999997542  2334567889999999996 9999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc---------------------------------------------------------
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHH---------------------------------------------------------  244 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~---------------------------------------------------------  244 (482)
                      .+.+||||||+++|+|.+++.++                                                         
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            99999999999999999887542                                                         


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc
Q 047009          245 ---------------------------------------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA  285 (482)
Q Consensus       245 ---------------------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~  285 (482)
                                                             ..+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~  272 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence                                                   13677788899999999999999999999999999999999


Q ss_pred             CCceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHH-HHHH
Q 047009          286 DGHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAK-IQQK  360 (482)
Q Consensus       286 ~g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~-~~~~  360 (482)
                      ++.+||+|||+++......   ......++..|+|||++.+..++.++|||||||++|||++ |..||....... ....
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~  352 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK  352 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence            9999999999998753322   2233457788999999999999999999999999999997 999997754433 3333


Q ss_pred             HHhc-ccCCCccCChHHHHHHHHhhccCcCCcCCC
Q 047009          361 IVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       361 i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                      +..+ ....+..++.++.++|.+||+.||++||++
T Consensus       353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  387 (400)
T cd05105         353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSF  387 (400)
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCH
Confidence            3333 344567789999999999999999999998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=359.41  Aligned_cols=244  Identities=38%  Similarity=0.635  Sum_probs=216.4

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~  226 (482)
                      ..++|++...+|.|+|+.|..+.+..+++.+++|++.+..-       ...+|+.++... +||||+++.+.+.+..+.|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence            46789999999999999999999999999999999987621       123566555554 8999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE-ccCCceeEcccCccccccCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL-GADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl-~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      +|||.+.|+.+.+.+.....+. ..+..|++||+.|+.|||++|||||||||+|||+ +..|+++|+|||.++.....  
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999999999999888777666 7778899999999999999999999999999999 69999999999999987654  


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchH-HHHHHHHhcccCCCccCChHHHHHHHHhh
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA-KIQQKIVKDKLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~LI~~~L  384 (482)
                      ..+.|-|..|.|||++...+|+.++||||||++||+||+|+.||...... ++..+|..+.+.  ..+|.++++||++||
T Consensus       470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~LL  547 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQLL  547 (612)
T ss_pred             hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHHHhc
Confidence            45567799999999999999999999999999999999999999776555 666666655443  889999999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHhCcCC
Q 047009          385 QKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +.||.+|+++     .+++.||||
T Consensus       548 ~~dP~~Rl~~-----~~i~~h~w~  566 (612)
T KOG0603|consen  548 QVDPALRLGA-----DEIGAHPWF  566 (612)
T ss_pred             cCChhhCcCh-----hhhccCcch
Confidence            9999999999     999999999

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.3e-41  Score=327.95  Aligned_cols=234  Identities=35%  Similarity=0.541  Sum_probs=202.2

Q ss_pred             cCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCCchHHH
Q 047009          161 GAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQ  240 (482)
Q Consensus       161 G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~  240 (482)
                      |.+|+||+|+++.+++.||+|.+.+...        ..+|...+....||||+++++++......++||||++||+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            8999999999999999999999976531        22345555566799999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccccCCCCCchhh
Q 047009          241 LYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI  320 (482)
Q Consensus       241 l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~  320 (482)
                      +.+...+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||.+......  .....++..|+|||.
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~  153 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV  153 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence            988888999999999999999999999999999999999999999999999999988765432  234556788999999


Q ss_pred             hcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChH
Q 047009          321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSE  400 (482)
Q Consensus       321 l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~  400 (482)
                      +.+..++.++|+||+|+++|||++|+.||...... .   .....+.+|..++..+++||.+||++||++|++++..+.+
T Consensus       154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~  229 (237)
T cd05576         154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I---NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVE  229 (237)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c---ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchH
Confidence            98888999999999999999999999988543211 1   0112345778899999999999999999999998777889


Q ss_pred             HHHhCcCC
Q 047009          401 EIKSHKWF  408 (482)
Q Consensus       401 eil~hp~f  408 (482)
                      ++++||||
T Consensus       230 ~~~~h~~~  237 (237)
T cd05576         230 DIKSHPFF  237 (237)
T ss_pred             HHHcCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.1e-41  Score=332.08  Aligned_cols=248  Identities=25%  Similarity=0.430  Sum_probs=212.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEc-----CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKK-----NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      ..+|++.++||+|+||.||+|...     .++..+|+|.+....   ....+.+.+|+++++.++|+||+++++++...+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            367889999999999999999753     356789999876532   334557889999999999999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc
Q 047009          224 RLYLVLDFINGGHLFFQLYHHG---------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH  288 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~---------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~  288 (482)
                      ..++||||+++|+|..++...+               .+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence            9999999999999999887653               4788999999999999999999999999999999999999999


Q ss_pred             eeEcccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc
Q 047009          289 VMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD  364 (482)
Q Consensus       289 vKL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~  364 (482)
                      +||+|||++........   .....+++.|+|||.+.+..++.++|||||||++|||++ |.+||......+..+.+..+
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG  240 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence            99999999976532221   223345788999999999999999999999999999998 99999887777777666654


Q ss_pred             -ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          365 -KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       365 -~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                       ....+..+++.+.+||.+||+.||.+||++     ++|++
T Consensus       241 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~-----~~l~~  276 (280)
T cd05092         241 RELERPRTCPPEVYAIMQGCWQREPQQRMVI-----KDIHS  276 (280)
T ss_pred             ccCCCCCCCCHHHHHHHHHHccCChhhCCCH-----HHHHH
Confidence             345567789999999999999999999998     77764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-41  Score=330.55  Aligned_cols=247  Identities=26%  Similarity=0.415  Sum_probs=215.3

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      ..+|++.+.||.|+||.||+|.++. ++.+|+|++.....   .....+.+|+.+++.++|+||+++++++......++|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            4679999999999999999999988 88999999876532   2345678899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC-
Q 047009          229 LDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-  305 (482)
                      |||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            9999999999998753  4589999999999999999999999999999999999999999999999999987643221 


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHh
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~  383 (482)
                      .....++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+..+ ....+..+++.+.++|.+|
T Consensus       161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  240 (261)
T cd05148         161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC  240 (261)
T ss_pred             ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHH
Confidence            223345678999999999999999999999999999998 89999888877777777654 3455677899999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHh
Q 047009          384 LQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~  404 (482)
                      |+.||.+||++     .+|++
T Consensus       241 l~~~p~~Rpt~-----~~l~~  256 (261)
T cd05148         241 WAAEPEDRPSF-----KALRE  256 (261)
T ss_pred             cCCCchhCcCH-----HHHHH
Confidence            99999999998     67654

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.3e-41  Score=345.72  Aligned_cols=250  Identities=24%  Similarity=0.404  Sum_probs=206.4

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeec-
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQT-  221 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-  221 (482)
                      -++|++.+.||+|+||.||+|.+.+     +++.||+|+++...  .....+.+.+|+.++.++ +|+||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            3589999999999999999997543     45789999987532  223445677899999999 89999999998764 


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc---------------------------------------------------------
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHH---------------------------------------------------------  244 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~---------------------------------------------------------  244 (482)
                      ...++++|||+++|+|..++...                                                         
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            46789999999999999887542                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC---CCcccccCCCCCc
Q 047009          245 ----GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT---RSNSMIGTVEYMA  317 (482)
Q Consensus       245 ----~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~A  317 (482)
                          ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....   ......++..|+|
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence                257888899999999999999999999999999999999999999999999998764322   1233456778999


Q ss_pred             hhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHH-HHHHhc-ccCCCccCChHHHHHHHHhhccCcCCcCCC
Q 047009          318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQ-QKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       318 PE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~-~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                      ||++.+..++.++|||||||++|||++ |..||.+....+.. ..+..+ ....|...+.++.+++.+||+.+|.+||++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~  323 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF  323 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence            999999999999999999999999998 99999775543333 333322 334566788999999999999999999999


Q ss_pred             CCCChHHHHhC
Q 047009          395 GPKGSEEIKSH  405 (482)
Q Consensus       395 ~~~~~~eil~h  405 (482)
                           .++++|
T Consensus       324 -----~ell~~  329 (337)
T cd05054         324 -----SELVEI  329 (337)
T ss_pred             -----HHHHHH
Confidence                 888764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=9.3e-42  Score=344.83  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=204.5

Q ss_pred             EEeccc--CceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecC
Q 047009          156 KVVGQG--AFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFIN  233 (482)
Q Consensus       156 ~~LG~G--~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~  233 (482)
                      ..||+|  +||+||+|+++.+|+.||+|++...... ....+.+.+|+.+++.++||||++++++|...+..++||||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            356666  9999999999999999999998765432 2445778899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-C-----
Q 047009          234 GGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-R-----  305 (482)
Q Consensus       234 gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~-----  305 (482)
                      +++|..++.+.  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++||+.+....... .     
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            99999888764  348999999999999999999999999999999999999999999999998654322111 0     


Q ss_pred             --CcccccCCCCCchhhhcCC--CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC--------------
Q 047009          306 --SNSMIGTVEYMAPEIVLGK--GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR--------------  367 (482)
Q Consensus       306 --~~~~~gt~~y~APE~l~~~--~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~--------------  367 (482)
                        .....++..|+|||++.+.  .++.++|||||||++|+|++|+.||.+.........+......              
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR  242 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence              1112356679999999774  4789999999999999999999999876554443333221110              


Q ss_pred             ---------------------------------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          368 ---------------------------------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       368 ---------------------------------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                                                       .+..++..+.+||++||+.||++||++     .++++|+||+.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta-----~e~l~~~~~~~~  314 (328)
T cd08226         243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA-----SSLLSHAFFKQV  314 (328)
T ss_pred             hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCH-----HHHhhCHHHHHH
Confidence                                             112356789999999999999999999     999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-41  Score=330.43  Aligned_cols=250  Identities=32%  Similarity=0.561  Sum_probs=211.8

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC--CeEEEEE
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK--YRLYLVL  229 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV~  229 (482)
                      |++.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.++++++|+|++++++++...  +..++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            678999999999999999999999999999998764 2233445577899999999999999999999888  8999999


Q ss_pred             EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--CC
Q 047009          230 DFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--RS  306 (482)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--~~  306 (482)
                      ||+++ +|..++... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++.......  ..
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            99985 788777665 578999999999999999999999999999999999999999999999999998765432  23


Q ss_pred             cccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-------------------
Q 047009          307 NSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-------------------  366 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-------------------  366 (482)
                      ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.....                   
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            34567889999998775 4578999999999999999999999988776655554443100                   


Q ss_pred             ------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          367 ------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       367 ------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                                  .+...++.++.++|++||..||.+||++     ++++.|+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-----~~~l~~~~~  287 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA-----DQALQHEYF  287 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH-----HHHhhCcCC
Confidence                        0011138899999999999999999999     999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.6e-41  Score=335.73  Aligned_cols=256  Identities=27%  Similarity=0.402  Sum_probs=216.4

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEe
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  231 (482)
                      |...+.||+|+||+||+|++..+++.||+|++.............+.+|+.+++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66678899999999999999999999999999765444444556678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccc
Q 047009          232 INGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI  310 (482)
Q Consensus       232 ~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  310 (482)
                      +.+ ++...+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....   ......
T Consensus       103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~~~  178 (313)
T cd06633         103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFV  178 (313)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCCcc
Confidence            975 66666654 4568999999999999999999999999999999999999999999999999986532   233567


Q ss_pred             cCCCCCchhhhc---CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CC-CccCChHHHHHHHHhhc
Q 047009          311 GTVEYMAPEIVL---GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RL-PAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       311 gt~~y~APE~l~---~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~LI~~~L~  385 (482)
                      |+..|+|||++.   +..++.++|||||||++|+|++|..||...+.......+..... .. ...++..+++||.+||+
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  258 (313)
T cd06633         179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ  258 (313)
T ss_pred             ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHcc
Confidence            899999999984   35688899999999999999999999987776555555544322 22 23467889999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCCChhhh
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKL  416 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~  416 (482)
                      ++|.+||++     .++++||||+..+-.++
T Consensus       259 ~~P~~Rp~~-----~~~l~~~~~~~~~~~~~  284 (313)
T cd06633         259 KIPQERPAS-----AELLRHDFVRRDRPARV  284 (313)
T ss_pred             CChhhCcCH-----HHHhcCcccCCCchhHH
Confidence            999999999     99999999997664433

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.3e-41  Score=335.01  Aligned_cols=251  Identities=23%  Similarity=0.375  Sum_probs=211.5

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEE-----cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRK-----KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQ  220 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  220 (482)
                      ...++|.+.+.||+|+||.||+|.+     ..++..||+|+++...  .....+.+.+|+.+++++ +||||+++++++.
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            3447899999999999999999975     3355689999987543  233456788999999999 8999999999999


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccc
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK  298 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~  298 (482)
                      ..+.+|+||||+.+|+|..++....  .+++..+..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||+++
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999999987643  38999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc--cCCCccC
Q 047009          299 QFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK--LRLPAFL  372 (482)
Q Consensus       299 ~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~--~~~p~~~  372 (482)
                      .......   .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+............  ...+...
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA  269 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCC
Confidence            7543221   223346788999999999999999999999999999998 999998776655444444332  2345567


Q ss_pred             ChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       373 s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +.++.+|+.+||.++|++||++     .++++
T Consensus       270 ~~~~~~li~~cl~~~p~~Rpt~-----~ell~  296 (302)
T cd05055         270 PAEIYDIMKTCWDADPLKRPTF-----KQIVQ  296 (302)
T ss_pred             CHHHHHHHHHHcCCCchhCcCH-----HHHHH
Confidence            8999999999999999999999     78764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-41  Score=325.68  Aligned_cols=241  Identities=22%  Similarity=0.336  Sum_probs=206.2

Q ss_pred             EEecccCceEEEEEEEcCCC---eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEec
Q 047009          156 KVVGQGAFGRVYQVRKKNTS---EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFI  232 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  232 (482)
                      ++||+|+||.||+|.+..++   ..||+|.+......  ...+.+.+|+.++++++|+||+++++++.. ...++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence            46999999999999876554   78999999866432  345567889999999999999999998764 4679999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC----cc
Q 047009          233 NGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS----NS  308 (482)
Q Consensus       233 ~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~----~~  308 (482)
                      .+|+|..++...+.+++..+..++.|++.||+|||.++++||||||+|||++.++.+||+|||+++........    ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            99999999988888999999999999999999999999999999999999999999999999999876433221    11


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHhhcc
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~L~~  386 (482)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+... ....|..++..++++|.+||..
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  237 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKY  237 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcC
Confidence            223467999999999999999999999999999998 99999887777776666554 3356677899999999999999


Q ss_pred             CcCCcCCCCCCChHHHHh
Q 047009          387 EPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~  404 (482)
                      ||++||++     .++++
T Consensus       238 ~p~~Rp~~-----~~l~~  250 (257)
T cd05060         238 RPEDRPTF-----SELES  250 (257)
T ss_pred             ChhhCcCH-----HHHHH
Confidence            99999998     67654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.4e-41  Score=326.99  Aligned_cols=245  Identities=25%  Similarity=0.413  Sum_probs=209.3

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ..++|++.+.||+|+||.||+|.+.. +..||+|.+.....    ..+.+.+|+.++++++|+||+++++++.. ...++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYI   77 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEE
Confidence            34789999999999999999998764 56699999876442    23457889999999999999999988754 56789


Q ss_pred             EEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          228 VLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      +|||+++++|..++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999999988753  3589999999999999999999999999999999999999999999999999987643322


Q ss_pred             --CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHH
Q 047009          306 --SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       306 --~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~  381 (482)
                        .....++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+....+... ....+...+..+++||.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML  237 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence              122345668999999998899999999999999999999 99999888877777777654 44566778999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHH
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIK  403 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil  403 (482)
                      +||.+||++||++     .++.
T Consensus       238 ~~l~~~p~~Rpt~-----~~l~  254 (260)
T cd05070         238 QCWKKDPEERPTF-----EYLQ  254 (260)
T ss_pred             HHcccCcccCcCH-----HHHH
Confidence            9999999999998     6665

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.3e-41  Score=336.08  Aligned_cols=249  Identities=21%  Similarity=0.354  Sum_probs=211.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcC-------CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeee
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKN-------TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQ  220 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  220 (482)
                      .++|.+.+.||+|+||.||+|++..       ....||+|.++...  .......+.+|+.+++++ +||||+++++++.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            3689999999999999999998642       34579999987542  233455678899999999 6999999999999


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHH----------------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG  284 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~  284 (482)
                      ..+.+|+||||+++|+|..++...                ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  168 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence            999999999999999999998653                2478888999999999999999999999999999999999


Q ss_pred             cCCceeEcccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHH
Q 047009          285 ADGHVMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQK  360 (482)
Q Consensus       285 ~~g~vKL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~  360 (482)
                      .++.+||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..++...
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~  248 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL  248 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999987543211   122234568999999999999999999999999999999 9999988888777777


Q ss_pred             HHhcc-cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          361 IVKDK-LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       361 i~~~~-~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +.... ...+..++.++++||.+||+.||++||++     .++++
T Consensus       249 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~ll~  288 (314)
T cd05099         249 LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTF-----KQLVE  288 (314)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCH-----HHHHH
Confidence            76653 35567788999999999999999999998     77774

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.1e-41  Score=328.16  Aligned_cols=249  Identities=25%  Similarity=0.396  Sum_probs=211.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCC---eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTS---EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      .++|++.+.||+|+||.||+|+++.++   ..||+|.++...  .....+.+.+|+.++++++||||+++++++...+..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            468999999999999999999986444   479999986543  223456788899999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          226 YLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      |+||||+++++|..++... +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.+....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999998765 468999999999999999999999999999999999999999999999999998764322


Q ss_pred             C----CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHH
Q 047009          305 R----SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHS  378 (482)
Q Consensus       305 ~----~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (482)
                      .    .....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+.+. ....+..++..+.+
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ  240 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHH
Confidence            1    112233568999999999999999999999999999886 99999887777777766654 23444567899999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ++.+||+++|.+||++     .++++
T Consensus       241 li~~~l~~~p~~Rp~~-----~~i~~  261 (267)
T cd05066         241 LMLDCWQKDRNERPKF-----EQIVS  261 (267)
T ss_pred             HHHHHcccCchhCCCH-----HHHHH
Confidence            9999999999999998     67754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-42  Score=347.07  Aligned_cols=256  Identities=29%  Similarity=0.474  Sum_probs=208.6

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  225 (482)
                      +.-..|++++.||+||.++||++...+. ..||+|.+.... .+.....-+.+|+.+|.+| .|.+||+|++|-..++.+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            4456799999999999999999987664 556777665433 2445667789999999999 489999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          226 YLVLDFINGGHLFFQLYHHGL-FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      |+||||=+ .+|..+|.+.+. .+.-.+++|..||+.|+.++|..||||.||||.|+|+ -.|.+||+|||+|..+...+
T Consensus       436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence            99999864 489888887654 3335889999999999999999999999999999999 67899999999999876544


Q ss_pred             C---CcccccCCCCCchhhhcCCC-----------CCchhHHHHHhHHHHHHhhCCCCCCCCc-hHHHHHHHHhc--ccC
Q 047009          305 R---SNSMIGTVEYMAPEIVLGKG-----------HNKAADWWSVGILLYEMLTGKPPFIGGN-RAKIQQKIVKD--KLR  367 (482)
Q Consensus       305 ~---~~~~~gt~~y~APE~l~~~~-----------~~~~sDvwSlGvilyelltG~~PF~~~~-~~~~~~~i~~~--~~~  367 (482)
                      .   ..+.+||+.||+||.+....           .+.++||||||||||+|+.|++||..-. ...-+..|..-  .++
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie  593 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE  593 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence            3   35679999999999996533           3578999999999999999999994322 22223333333  346


Q ss_pred             CCccCChH-HHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          368 LPAFLSSE-AHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       368 ~p~~~s~~-~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      ||..-+.. +.++++.||..||++||++     .++|+|||...+
T Consensus       594 fp~~~~~~~li~~mK~CL~rdPkkR~si-----~eLLqhpFl~~~  633 (677)
T KOG0596|consen  594 FPDIPENDELIDVMKCCLARDPKKRWSI-----PELLQHPFLQIQ  633 (677)
T ss_pred             ccCCCCchHHHHHHHHHHhcCcccCCCc-----HHHhcCcccccc
Confidence            66544443 9999999999999999999     999999999874

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7e-41  Score=331.88  Aligned_cols=247  Identities=23%  Similarity=0.376  Sum_probs=209.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+.....  ......+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            57889999999999999998753     236799998875432  23346688899999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 047009          226 YLVLDFINGGHLFFQLYHH------------------------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENI  281 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NI  281 (482)
                      ++||||+.+|+|..++...                        ..+++..+..++.|++.||.|||+++|+||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999887642                        2477888999999999999999999999999999999


Q ss_pred             EEccCCceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHH
Q 047009          282 LLGADGHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKI  357 (482)
Q Consensus       282 Ll~~~g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~  357 (482)
                      |+++++.+||+|||+++......   ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....++
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999998653221   1233456778999999999999999999999999999998 9999988887777


Q ss_pred             HHHHHhc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          358 QQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       358 ~~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+.+... ....|..++.++.+||.+||+.||++||++     .++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~-----~~i~~  281 (290)
T cd05045         239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF-----ADISK  281 (290)
T ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCH-----HHHHH
Confidence            7766543 344567789999999999999999999998     77764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7e-41  Score=327.82  Aligned_cols=249  Identities=24%  Similarity=0.403  Sum_probs=212.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCe---EEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSE---IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      .++|++.+.||+|+||.||+|.++.+++   .||+|++.+..  .......+..|+.++++++||||+++++++.+....
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            4679999999999999999999887664   69999987542  233456788999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          226 YLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      ++||||+++|+|..++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999888764 568999999999999999999999999999999999999999999999999987654322


Q ss_pred             CCcc---cc---cCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHH
Q 047009          305 RSNS---MI---GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEA  376 (482)
Q Consensus       305 ~~~~---~~---gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (482)
                      ....   ..   ++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+..+.+... ....+..++..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTAL  240 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHH
Confidence            2111   11   2357999999999999999999999999999886 99999888777777776543 334456788999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+++.+||+.+|.+||++     ++|+.
T Consensus       241 ~~li~~~l~~~p~~Rp~~-----~~i~~  263 (269)
T cd05065         241 HQLMLDCWQKDRNARPKF-----GQIVS  263 (269)
T ss_pred             HHHHHHHcCCChhhCcCH-----HHHHH
Confidence            999999999999999998     77764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-41  Score=328.90  Aligned_cols=241  Identities=26%  Similarity=0.414  Sum_probs=204.0

Q ss_pred             EecccCceEEEEEEEcCCCe--EEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEEEEEEecC
Q 047009          157 VVGQGAFGRVYQVRKKNTSE--IYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLVLDFIN  233 (482)
Q Consensus       157 ~LG~G~fg~Vy~a~~~~~~~--~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~  233 (482)
                      .||+|+||.||+|+++.++.  .+|+|.++...  .....+.+.+|+.++.++ +||||+++++++...+.+|+||||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            58999999999999988775  46888876432  234455678899999999 89999999999999999999999999


Q ss_pred             CCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          234 GGHLFFQLYHHG----------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       234 gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                      +|+|..++..+.                .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence            999999987543                4788899999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChH
Q 047009          298 KQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSE  375 (482)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~  375 (482)
                      ..............+..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+..+.+..+ ....+..++.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (270)
T cd05047         160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDE  239 (270)
T ss_pred             cccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHH
Confidence            64332212222234667999999999999999999999999999997 99999888777777766554 34456678899


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +.+|+.+||..||.+||++     .+++.
T Consensus       240 ~~~li~~~l~~~p~~Rps~-----~~il~  263 (270)
T cd05047         240 VYDLMRQCWREKPYERPSF-----AQILV  263 (270)
T ss_pred             HHHHHHHHcccChhhCCCH-----HHHHH
Confidence            9999999999999999999     77764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.1e-41  Score=340.73  Aligned_cols=256  Identities=29%  Similarity=0.400  Sum_probs=213.0

Q ss_pred             CCeE-EEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhh-----------HHHHHHHHHHHHHhCCCCceeeeee
Q 047009          150 EDFE-VLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKN-----------HAEYMKAERDILTKIDHPFVVQLKY  217 (482)
Q Consensus       150 ~~y~-i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~-----------~~~~~~~E~~il~~l~hpnIv~l~~  217 (482)
                      ++|. +.+.||.|+||+||+|.++.+++.||+|++.........           ....+.+|+.++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 457799999999999999999999999998764322100           0124678999999999999999999


Q ss_pred             eeecCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                      ++...+..++||||+. |+|..++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence            9999999999999997 589988888888999999999999999999999999999999999999999999999999999


Q ss_pred             ccccC---------------CCCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHH
Q 047009          298 KQFDE---------------NTRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI  361 (482)
Q Consensus       298 ~~~~~---------------~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i  361 (482)
                      +....               ........++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+....+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            76541               1112234578899999999764 4789999999999999999999999887776655544


Q ss_pred             Hhccc----------------------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          362 VKDKL----------------------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       362 ~~~~~----------------------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      ....-                            ......+.++.+||.+||+.||.+||++     +|++.|+||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-----~~~l~~~~~~~~  319 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA-----KEALKHEYFKSD  319 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH-----HHHhcCcccCCC
Confidence            33100                            0012357889999999999999999998     999999999864

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.1e-41  Score=330.01  Aligned_cols=249  Identities=21%  Similarity=0.321  Sum_probs=208.0

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeE----EEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEI----YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      ..++|++++.||+|+||+||+|.+..++..    |++|.+....  .......+..|+.++++++||||+++++++.. .
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~   81 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A   81 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence            347899999999999999999999877764    6777764321  22334567788889999999999999998754 4


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 RLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..++++||+++|+|.+++... +.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            578999999999999999764 5689999999999999999999999999999999999999999999999999987543


Q ss_pred             CC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc-cCCCccCChHHH
Q 047009          303 NT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAH  377 (482)
Q Consensus       303 ~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~  377 (482)
                      ..   ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.....+.+.+.++. ...+..++.++.
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY  241 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHH
Confidence            22   1233456788999999999899999999999999999998 999998877766655555443 344556788999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +++.+||..||++||++     .|+++
T Consensus       242 ~li~~c~~~~p~~Rps~-----~el~~  263 (279)
T cd05111         242 MVMVKCWMIDENVRPTF-----KELAN  263 (279)
T ss_pred             HHHHHHcCCCcccCcCH-----HHHHH
Confidence            99999999999999999     78764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.2e-40  Score=325.81  Aligned_cols=250  Identities=21%  Similarity=0.352  Sum_probs=212.5

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCe---EEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSE---IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ..++|+..+.||+|+||.||+|+.+.++.   .+|+|.+....  .....+.+.+|+.++++++|+||+++.+++...+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            34689999999999999999999876554   79999986542  22335567889999999999999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          225 LYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      .|+||||+++++|..++..+ +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999988764 57899999999999999999999999999999999999999999999999999876432


Q ss_pred             CCC----cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHH
Q 047009          304 TRS----NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAH  377 (482)
Q Consensus       304 ~~~----~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (482)
                      ...    .....+..|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+... ....+..++.++.
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  240 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY  240 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            211    11223457999999999899999999999999999997 99999888877777777654 2233455789999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +|+.+||+.+|++||++     .+|++
T Consensus       241 ~li~~c~~~~p~~Rp~~-----~~i~~  262 (268)
T cd05063         241 QLMLQCWQQDRARRPRF-----VDIVN  262 (268)
T ss_pred             HHHHHHcCCCcccCcCH-----HHHHH
Confidence            99999999999999998     77764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.2e-41  Score=335.97  Aligned_cols=252  Identities=29%  Similarity=0.416  Sum_probs=216.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ..|+..+.||+|+||.||+|++..++..||+|++........+....+.+|+.++++++|||++++++++......++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34778899999999999999999999999999997654434445567888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcc
Q 047009          230 DFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  308 (482)
                      ||+.| +|.+.+.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....   ...
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~  180 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANS  180 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---ccc
Confidence            99976 66666544 46689999999999999999999999999999999999999999999999999876433   234


Q ss_pred             cccCCCCCchhhhc---CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CC-CccCChHHHHHHHHh
Q 047009          309 MIGTVEYMAPEIVL---GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RL-PAFLSSEAHSLLKGL  383 (482)
Q Consensus       309 ~~gt~~y~APE~l~---~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~LI~~~  383 (482)
                      ..|++.|+|||++.   ...++.++|||||||++|+|++|+.||...+.......+..... .. +..++..+++||.+|
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  260 (317)
T cd06635         181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC  260 (317)
T ss_pred             ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence            57899999999984   45688999999999999999999999988776666666655432 22 345788999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      |+.+|.+||++     .++++|+|+..
T Consensus       261 l~~~p~~Rpt~-----~~il~~~~~~~  282 (317)
T cd06635         261 LQKIPQDRPTS-----EELLKHMFVLR  282 (317)
T ss_pred             ccCCcccCcCH-----HHHHhChhhhc
Confidence            99999999998     99999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-42  Score=351.80  Aligned_cols=254  Identities=25%  Similarity=0.398  Sum_probs=221.7

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCe---E-EEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSE---I-YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT  221 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~-vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  221 (482)
                      .+.-++..+.++||+|+||.||+|+.+..+.   . ||+|..+.+..........+.+|+++|+.++|||||++||+...
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            3455677788999999999999999876422   3 89999886554566778889999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF  300 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~  300 (482)
                      ...+++|||+|.||+|.++|++++ .++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+||+|||+++..
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            999999999999999999999987 4999999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCCCc-ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc--cCCCccCChHH
Q 047009          301 DENTRSN-SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK--LRLPAFLSSEA  376 (482)
Q Consensus       301 ~~~~~~~-~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~  376 (482)
                      ....... ..--...|+|||.+....|+.++|||||||++||+++ |..||.+....++..+|....  ...|...+.++
T Consensus       313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~  392 (474)
T KOG0194|consen  313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKEL  392 (474)
T ss_pred             cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHH
Confidence            4222222 1124578999999999999999999999999999999 899999999999999996654  45567788999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ..++.+|+..||++|++.     .++.+
T Consensus       393 ~~~~~~c~~~~p~~R~tm-----~~i~~  415 (474)
T KOG0194|consen  393 AKVMKQCWKKDPEDRPTM-----STIKK  415 (474)
T ss_pred             HHHHHHhccCChhhccCH-----HHHHH
Confidence            999999999999999998     66653

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=323.93  Aligned_cols=248  Identities=25%  Similarity=0.397  Sum_probs=213.9

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++.+.||+|+||.||+|.+++ ++.||+|.+.....    ..+.+.+|+.++++++|+||+++++++......+
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            345789999999999999999999765 57799999876432    2345788999999999999999999999989999


Q ss_pred             EEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          227 LVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      +||||+++++|..++....  .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++.+....
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999999987653  68999999999999999999999999999999999999999999999999998764322


Q ss_pred             C--CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHH
Q 047009          305 R--SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLL  380 (482)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI  380 (482)
                      .  .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+.....+.+... ....+...+.++.+++
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLM  237 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            1  112234578999999999999999999999999999998 99999888877777777654 3455667789999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHh
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||+.+|.+||++     +++++
T Consensus       238 ~~~l~~~p~~Rp~~-----~~l~~  256 (261)
T cd05034         238 LQCWDKDPEERPTF-----EYLQS  256 (261)
T ss_pred             HHHcccCcccCCCH-----HHHHH
Confidence            99999999999998     67653

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-41  Score=341.37  Aligned_cols=253  Identities=28%  Similarity=0.425  Sum_probs=209.8

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC-----
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK-----  222 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----  222 (482)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+.+.+|+.++++++||||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            34789999999999999999999999999999999876422 223345677899999999999999999988543     


Q ss_pred             -CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          223 -YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       223 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                       ...|++++++ |++|...+.. ..+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||+++...
T Consensus        94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~  171 (345)
T cd07877          94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  171 (345)
T ss_pred             cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence             3478888887 6788776654 468999999999999999999999999999999999999999999999999998753


Q ss_pred             CCCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc--------------
Q 047009          302 ENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL--------------  366 (482)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~--------------  366 (482)
                      .  ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.....              
T Consensus       172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (345)
T cd07877         172 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  249 (345)
T ss_pred             c--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence            3  2344578999999999876 5688999999999999999999999987665444433322110              


Q ss_pred             ---------CCC--------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          367 ---------RLP--------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       367 ---------~~p--------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                               ..|        ...++++++||.+||+.||.+|+++     .++++||||+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~h~~f~~  305 (345)
T cd07877         250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-----AQALAHAYFAQ  305 (345)
T ss_pred             HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCH-----HHHhcChhhhh
Confidence                     111        1357889999999999999999998     99999999986

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=7.2e-41  Score=332.99  Aligned_cols=257  Identities=30%  Similarity=0.491  Sum_probs=211.6

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  225 (482)
                      ...++|++.+.||+|+||.||+|.++.+++.||+|.+++...  ......+..|+.++.++ .||||+++++++.+....
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   89 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV   89 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence            456889999999999999999999999999999999976432  12234455577666666 599999999999999999


Q ss_pred             EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          226 YLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      |+||||+.+ .|...+.. .+.+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||++..+...
T Consensus        90 ~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          90 FICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             EEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            999999865 66655544 4578999999999999999999997 59999999999999999999999999999876544


Q ss_pred             CCCcccccCCCCCchhhhcCCC----CCchhHHHHHhHHHHHHhhCCCCCCCCch-HHHHHHHHhcc-cCCC--ccCChH
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKG----HNKAADWWSVGILLYEMLTGKPPFIGGNR-AKIQQKIVKDK-LRLP--AFLSSE  375 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~----~~~~sDvwSlGvilyelltG~~PF~~~~~-~~~~~~i~~~~-~~~p--~~~s~~  375 (482)
                      .......++..|+|||.+.+..    ++.++||||||+++|+|++|+.||..... .+....+.... ..++  ..++.+
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (296)
T cd06618         169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD  248 (296)
T ss_pred             CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence            4444556889999999997654    78899999999999999999999976332 33444444332 2333  236889


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      +.+||.+||.+||.+||++     +++++|+||...
T Consensus       249 l~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~  279 (296)
T cd06618         249 FCSFVDLCLTKDHRKRPKY-----RELLQHPFIRRY  279 (296)
T ss_pred             HHHHHHHHccCChhhCCCH-----HHHhcChhhhcc
Confidence            9999999999999999999     999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-41  Score=341.93  Aligned_cols=253  Identities=30%  Similarity=0.450  Sum_probs=213.6

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe----
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR----  224 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----  224 (482)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+.+|+.++++++||||+++++++.....    
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            478999999999999999999999999999999987542 223344567789999999999999999988866554    


Q ss_pred             --EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          225 --LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       225 --~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                        .++|+||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence              89999999 5688887764 5689999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc---------------
Q 047009          303 NTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL---------------  366 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~---------------  366 (482)
                      .  .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....               
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07851         171 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA  248 (343)
T ss_pred             c--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence            3  344578899999999876 4678999999999999999999999987776555554433210               


Q ss_pred             ----------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          367 ----------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       367 ----------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                                      .....++.++.+||.+||+.||.+||++     .+|++||||+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~-----~ell~h~~~~~~  304 (343)
T cd07851         249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITA-----AEALAHPYLAEY  304 (343)
T ss_pred             HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCH-----HHHhcCCCcccc
Confidence                            0112358899999999999999999999     999999999853

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.5e-41  Score=333.37  Aligned_cols=251  Identities=20%  Similarity=0.364  Sum_probs=213.9

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEc-------CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKK-------NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYS  218 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  218 (482)
                      +..++|.+.+.||+|+||.||+|++.       ..+..||+|.+....  .......+.+|+.+++.+ +||||++++++
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            44578999999999999999999753       234579999987542  233456688999999999 89999999999


Q ss_pred             eecCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 047009          219 FQTKYRLYLVLDFINGGHLFFQLYHHG----------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENIL  282 (482)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NIL  282 (482)
                      +......|+||||+++|+|..++....                .++...+..++.||+.||.|||++||+||||||+|||
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  169 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL  169 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence            999999999999999999999987642                3677788899999999999999999999999999999


Q ss_pred             EccCCceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHH
Q 047009          283 LGADGHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQ  358 (482)
Q Consensus       283 l~~~g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~  358 (482)
                      ++.++.+||+|||+++......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..++.
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  249 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  249 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence            9999999999999998764322   1223446778999999999999999999999999999998 89999888888888


Q ss_pred             HHHHhcc-cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          359 QKIVKDK-LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       359 ~~i~~~~-~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +.+.... ...+..++.++++||.+||..+|.+||++     .++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-----~e~l~  291 (304)
T cd05101         250 KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTF-----KQLVE  291 (304)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCH-----HHHHH
Confidence            7776543 34566789999999999999999999998     78775

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.1e-40  Score=325.18  Aligned_cols=240  Identities=23%  Similarity=0.355  Sum_probs=203.0

Q ss_pred             EecccCceEEEEEEEc--CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          157 VVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       157 ~LG~G~fg~Vy~a~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      .||+|+||.||+|.++  .++..||+|++....  .....+.+.+|+.++++++||||++++++++. ...++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            3899999999999775  456679999987542  23445668899999999999999999998864 468999999999


Q ss_pred             CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC----Cccc
Q 047009          235 GHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR----SNSM  309 (482)
Q Consensus       235 g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~----~~~~  309 (482)
                      |+|..++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.......    ....
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999998875 45789999999999999999999999999999999999999999999999999986543221    1112


Q ss_pred             ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHhhccC
Q 047009          310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKE  387 (482)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~L~~d  387 (482)
                      .++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+.++ ...+|...+.++.++|.+||..|
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~  238 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYK  238 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence            23578999999998889999999999999999996 99999888777777666654 34567788999999999999999


Q ss_pred             cCCcCCCCCCChHHHHh
Q 047009          388 PGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       388 P~~R~s~~~~~~~eil~  404 (482)
                      |++||++     .+|.+
T Consensus       239 ~~~Rp~~-----~~i~~  250 (257)
T cd05115         239 WEDRPNF-----AKVEE  250 (257)
T ss_pred             hhhCcCH-----HHHHH
Confidence            9999998     66643

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.3e-40  Score=324.46  Aligned_cols=245  Identities=27%  Similarity=0.411  Sum_probs=208.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++.+.||+|+||.||+|.+..++ .+|+|++.....    ..+.+.+|+.++++++|+|++++++++.. ...++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIV   78 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEE
Confidence            367999999999999999999987654 599998865432    23457789999999999999999988754 567899


Q ss_pred             EEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC-
Q 047009          229 LDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-  305 (482)
                      |||+.+|+|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||+++....... 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999999988764  3478899999999999999999999999999999999999999999999999987643321 


Q ss_pred             -CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHH
Q 047009          306 -SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKG  382 (482)
Q Consensus       306 -~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~  382 (482)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+....+....+... ....+..++..++++|++
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKL  238 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence             123346778999999999999999999999999999999 99999888777777666554 334566789999999999


Q ss_pred             hhccCcCCcCCCCCCChHHHHh
Q 047009          383 LLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       383 ~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ||++||++||++     +++++
T Consensus       239 ~l~~~p~~Rp~~-----~~i~~  255 (260)
T cd05069         239 CWKKDPDERPTF-----EYIQS  255 (260)
T ss_pred             HccCCcccCcCH-----HHHHH
Confidence            999999999998     77764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.9e-41  Score=330.59  Aligned_cols=250  Identities=23%  Similarity=0.399  Sum_probs=213.3

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      ..++|++.+.||+|+||.||+|.++.     ++..||+|++....  .......+.+|+.++++++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            34789999999999999999998753     67899999987543  223345688899999999999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHG----------------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPEN  280 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~----------------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~N  280 (482)
                      ...++||||+++|+|..++....                      .+++..+..++.||+.||.|||+++++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999886432                      36778889999999999999999999999999999


Q ss_pred             EEEccCCceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHH
Q 047009          281 ILLGADGHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAK  356 (482)
Q Consensus       281 ILl~~~g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~  356 (482)
                      |+++.++.+||+|||++.......   ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999987653221   1222345678999999999999999999999999999997 889998888888


Q ss_pred             HHHHHHhccc-CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          357 IQQKIVKDKL-RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       357 ~~~~i~~~~~-~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ....+..+.. ..+..++.++.+||.+||+.||.+||++     .|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~el~~  284 (288)
T cd05050         241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSF-----ASINR  284 (288)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCH-----HHHHH
Confidence            7777766543 3466789999999999999999999998     77653

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.8e-41  Score=340.70  Aligned_cols=255  Identities=31%  Similarity=0.459  Sum_probs=210.6

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC------
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK------  222 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  222 (482)
                      .++|.+.+.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||++++++|...      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            3689999999999999999999999999999999876432 222344577899999999999999999988654      


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..+|+|+||+.+ +|...+  ...+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++....
T Consensus        93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence            346999999974 665544  34689999999999999999999999999999999999999999999999999986533


Q ss_pred             CCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-----------------
Q 047009          303 NTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-----------------  364 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-----------------  364 (482)
                        ......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+...                 
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (342)
T cd07879         170 --EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA  247 (342)
T ss_pred             --CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence              2234578899999999876 46899999999999999999999999887654444333321                 


Q ss_pred             ------ccCCC--------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          365 ------KLRLP--------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       365 ------~~~~p--------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                            ....+        ...+.++.+||.+||+.||.+||++     .+++.||||+.+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~-----~e~l~h~~f~~~~~~  306 (342)
T cd07879         248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTA-----TEALEHPYFDSFRDA  306 (342)
T ss_pred             HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCH-----HHHhcCcchhhcccc
Confidence                  00011        2367889999999999999999998     999999999987653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2e-40  Score=321.73  Aligned_cols=246  Identities=23%  Similarity=0.402  Sum_probs=212.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      ..+|++.+.||+|+||.||+|.+.. +..+|+|++......    ...+.+|++++++++||||+++++++......++|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            4689999999999999999998864 668999998754321    23477899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC--
Q 047009          229 LDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR--  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~--  305 (482)
                      |||+.+++|..++... +.++++.++.++.|++.||+|||+++++||||||+||+++.++.+||+|||+++.......  
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999999888764 5689999999999999999999999999999999999999999999999999986543221  


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHh
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~  383 (482)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+...+.+.+.++ ....|...+..+.+|+.+|
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  237 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC  237 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence            122345678999999999999999999999999999998 99999888877777777654 3344666799999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHh
Q 047009          384 LQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~  404 (482)
                      |+.+|++||++     .++++
T Consensus       238 l~~~p~~Rp~~-----~~~l~  253 (256)
T cd05112         238 WKERPEDRPSF-----SLLLH  253 (256)
T ss_pred             cccChhhCCCH-----HHHHH
Confidence            99999999998     88875

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-40  Score=324.46  Aligned_cols=246  Identities=24%  Similarity=0.404  Sum_probs=209.9

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      .-++|+++++||+|+||.||+|..+. ++.||+|.+.....    ..+.+.+|+.++++++|+||+++++++. .+..++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI   77 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence            34789999999999999999998764 67899999876542    2345778999999999999999998874 456899


Q ss_pred             EEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          228 VLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      +|||+.+++|..++...  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999999988653  3588899999999999999999999999999999999999999999999999987653221


Q ss_pred             --CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHH
Q 047009          306 --SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       306 --~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~  381 (482)
                        .....++..|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+..+.+... ....+...+.++.++|.
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMR  237 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence              223456778999999999999999999999999999999 99999888877777666544 33556678899999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +||+.+|++||++     +++++
T Consensus       238 ~~l~~~p~~Rp~~-----~~l~~  255 (260)
T cd05067         238 LCWKEKPEERPTF-----EYLRS  255 (260)
T ss_pred             HHccCChhhCCCH-----HHHHH
Confidence            9999999999998     77664

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=326.84  Aligned_cols=249  Identities=26%  Similarity=0.399  Sum_probs=213.8

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCe----EEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSE----IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      ..++|++.+.||+|+||+||+|.++.+|+    .||+|.+.+...  ......+.+|+.++++++||||+++++++.. .
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            34789999999999999999999877664    689998876532  3445667889999999999999999999987 7


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 RLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..++||||+++|+|.+++..+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            889999999999999998774 4689999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCCc---ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHH
Q 047009          303 NTRSN---SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAH  377 (482)
Q Consensus       303 ~~~~~---~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (482)
                      .....   ...++..|+|||.+....++.++|+||||+++|||++ |+.||.+....++.+.+..+ ....|...+..+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY  241 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence            32221   1223568999999998899999999999999999998 99999988888877777665 3455667889999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +++.+||..||++||++     .++++
T Consensus       242 ~~~~~~l~~~p~~Rp~~-----~~l~~  263 (279)
T cd05057         242 MVLVKCWMIDAESRPTF-----KELIN  263 (279)
T ss_pred             HHHHHHcCCChhhCCCH-----HHHHH
Confidence            99999999999999998     66653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.8e-41  Score=333.34  Aligned_cols=248  Identities=30%  Similarity=0.509  Sum_probs=214.2

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      ..+||+|+||.||++..+.+++.||+|.+....   ......+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            467999999999999999999999999885432   23455688899999999999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCcccccCC
Q 047009          235 GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~~~gt~  313 (482)
                      ++|..++. .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++....... ......|++
T Consensus       102 ~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  180 (292)
T cd06657         102 GALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP  180 (292)
T ss_pred             CcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCc
Confidence            99988764 4568999999999999999999999999999999999999999999999999987654322 233467899


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc---cCCCccCChHHHHHHHHhhccCcCC
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLKGLLQKEPGK  390 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~LI~~~L~~dP~~  390 (482)
                      .|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......+....   ......++..+.++|.+||..||.+
T Consensus       181 ~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~  260 (292)
T cd06657         181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQ  260 (292)
T ss_pred             cccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCccc
Confidence            9999999988889999999999999999999999998877665555554332   2223457899999999999999999


Q ss_pred             cCCCCCCChHHHHhCcCCCCC
Q 047009          391 RLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       391 R~s~~~~~~~eil~hp~f~~~  411 (482)
                      ||++     .++++||||...
T Consensus       261 R~~~-----~~ll~~~~~~~~  276 (292)
T cd06657         261 RATA-----AELLKHPFLAKA  276 (292)
T ss_pred             CcCH-----HHHhcChHHhcc
Confidence            9999     999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.4e-40  Score=326.53  Aligned_cols=249  Identities=23%  Similarity=0.401  Sum_probs=214.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ++|++++.||+|+||.||+|+.+.     +.+.||+|.+....  .....+.+.+|++++++++|+||+++++++.+...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            689999999999999999999764     34679999886542  22345668899999999999999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccC
Q 047009          225 LYLVLDFINGGHLFFQLYHHG---------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFG  295 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFG  295 (482)
                      .|+||||+++|+|..++....         .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~  162 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS  162 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence            999999999999999997765         68999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCC--CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcccC--CCc
Q 047009          296 LAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLR--LPA  370 (482)
Q Consensus       296 la~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~~~--~p~  370 (482)
                      +++.....  .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+..+...  .+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  242 (275)
T cd05046         163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPE  242 (275)
T ss_pred             cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCC
Confidence            98754321  12234466788999999998889999999999999999998 89999887777777777655543  356


Q ss_pred             cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          371 FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       371 ~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      .++..+.++|.+||+.||.+||++     .+++++
T Consensus       243 ~~~~~l~~~i~~~l~~~p~~Rp~~-----~~~l~~  272 (275)
T cd05046         243 GCPSRLYKLMTRCWAVNPKDRPSF-----SELVSA  272 (275)
T ss_pred             CCCHHHHHHHHHHcCCCcccCCCH-----HHHHHH
Confidence            688999999999999999999998     788753

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7e-41  Score=329.15  Aligned_cols=250  Identities=33%  Similarity=0.571  Sum_probs=212.8

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEe
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  231 (482)
                      |++.+.||+|++|.||+|.+..+++.+|+|.+..... .......+.+|+.++++++|+||+++++++.+....++||||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            5678899999999999999999999999999876543 223455677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCccc
Q 047009          232 INGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSM  309 (482)
Q Consensus       232 ~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~~  309 (482)
                      +++ +|...+.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+....... .....
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            986 77777765 3678999999999999999999999999999999999999999999999999998765443 22345


Q ss_pred             ccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-------------------cC--
Q 047009          310 IGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-------------------LR--  367 (482)
Q Consensus       310 ~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-------------------~~--  367 (482)
                      .++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+....+....                   ..  
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP  238 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence            688899999999876 78999999999999999999999998877655544443210                   00  


Q ss_pred             ---------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          368 ---------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       368 ---------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                               ....++.++++||.+||+.||.+||++     .+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-----~~ll~~~~~  283 (283)
T cd05118         239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA-----EQALAHPYF  283 (283)
T ss_pred             cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH-----HHHhhCCCC
Confidence                     112367899999999999999999999     999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.3e-41  Score=361.59  Aligned_cols=253  Identities=24%  Similarity=0.428  Sum_probs=222.0

Q ss_pred             cccccCCCCeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeee
Q 047009          143 TVCCVGIEDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY  217 (482)
Q Consensus       143 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  217 (482)
                      ....+...+.+..+.||+|+||+||+|+..+     ....||||.++...  +......|++|+++|..++|||||+|+|
T Consensus       479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlG  556 (774)
T KOG1026|consen  479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLG  556 (774)
T ss_pred             ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence            3344566788999999999999999998654     34689999998754  3346677999999999999999999999


Q ss_pred             eeecCCeEEEEEEecCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 047009          218 SFQTKYRLYLVLDFINGGHLFFQLYHHG--------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL  283 (482)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl  283 (482)
                      .|..++.+|+|+|||..|+|..+|..++              .++..+...|+.||+.||+||-++.+|||||-.+|+||
T Consensus       557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV  636 (774)
T ss_pred             EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence            9999999999999999999999996532              27778889999999999999999999999999999999


Q ss_pred             ccCCceeEcccCccccccCCCCC---cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHH
Q 047009          284 GADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQ  359 (482)
Q Consensus       284 ~~~g~vKL~DFGla~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~  359 (482)
                      .++-.|||+|||+++.+-..+..   ....-...||+||.|..+.++++|||||+||+|||+++ |+.||.+....+..+
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe  716 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE  716 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence            99999999999999975332221   12233679999999999999999999999999999998 999999999999999


Q ss_pred             HHHhccc-CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHH
Q 047009          360 KIVKDKL-RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEI  402 (482)
Q Consensus       360 ~i~~~~~-~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~ei  402 (482)
                      .|.+++. ..|..++.++.+|+..||+.+|++||++     .||
T Consensus       717 ~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF-----~eI  755 (774)
T KOG1026|consen  717 CIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSF-----KEI  755 (774)
T ss_pred             HHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCH-----HHH
Confidence            9999865 6688999999999999999999999999     666

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1e-40  Score=324.79  Aligned_cols=252  Identities=27%  Similarity=0.480  Sum_probs=215.2

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc--hhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV--EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +|.+.+.||+|+||.||++.+..++..+++|+++.....  .......+..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            588999999999999999999888777888877643321  122334566789999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-
Q 047009          229 LDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-  303 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-  303 (482)
                      |||+++++|...+..    ...+++..++.++.|++.||.|||++|++|+||||+||+++. +.+||+|||+++..... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999887753    356899999999999999999999999999999999999975 67999999999875432 


Q ss_pred             CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-cCCCccCChHHHHHHHH
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLKG  382 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~LI~~  382 (482)
                      .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..+. ..++..++.++.++|.+
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQS  239 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHH
Confidence            23345678999999999998889999999999999999999999998777766666665543 34566789999999999


Q ss_pred             hhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          383 LLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       383 ~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      ||..||.+||++     .++++||||
T Consensus       240 ~l~~~p~~Rp~~-----~~il~~~~~  260 (260)
T cd08222         240 MLNKDPSLRPSA-----AEILRNPFI  260 (260)
T ss_pred             HhcCChhhCcCH-----HHHhhCCCC
Confidence            999999999999     999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-43  Score=362.49  Aligned_cols=309  Identities=43%  Similarity=0.753  Sum_probs=280.8

Q ss_pred             EecccCceEEEEEEE---cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCCeEEEEEEec
Q 047009          157 VVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKYRLYLVLDFI  232 (482)
Q Consensus       157 ~LG~G~fg~Vy~a~~---~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~  232 (482)
                      .+|+|+||.|++++.   .+.|..||+|+.++.....+... .-..|..++..++ ||++|+++..|+++..++++++|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            379999999998653   44678899999988765444333 5567889999987 999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccccC
Q 047009          233 NGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT  312 (482)
Q Consensus       233 ~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt  312 (482)
                      .||+|+..+.+...+.+...+.+..+++.|++++|+.+|+|||+|++||+++.+|++|+.|||+++..-.....   |||
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt  156 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGT  156 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccc
Confidence            99999999998889999999999999999999999999999999999999999999999999999986544333   999


Q ss_pred             CCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcC
Q 047009          313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRL  392 (482)
Q Consensus       313 ~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~  392 (482)
                      ..|||||++.  ++..++||||+|++++||++|..||.+    ++...|.+.++.+|..++..+++++..++.++|.+|+
T Consensus       157 ~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrL  230 (612)
T KOG0603|consen  157 YEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRL  230 (612)
T ss_pred             hhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHh
Confidence            9999999998  788999999999999999999999977    8888999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCCC-CCCCCccCeeeecCC
Q 047009          393 GAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPK-NNTNPFADFSYVRPA  471 (482)
Q Consensus       393 s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~~-~~~~~f~~f~~~~~~  471 (482)
                      +.++.+..+|++|+||..++|..+..++++|+|+|......+..+|+..++.....++|...+. ++...|.||+|+.|.
T Consensus       231 g~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P~dsp~~~~~~s~~~if~g~sfva~~  310 (612)
T KOG0603|consen  231 GAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQVPADSPLLSASGSDHTIFSGPSFVAPG  310 (612)
T ss_pred             ccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccCCcccCCCCCCCccccchhcCCCccChH
Confidence            9998999999999999999999999999999999999999999999999999988888887664 556899999999998


Q ss_pred             cccc
Q 047009          472 ASFL  475 (482)
Q Consensus       472 ~~~~  475 (482)
                      ..+.
T Consensus       311 il~~  314 (612)
T KOG0603|consen  311 VLED  314 (612)
T ss_pred             Hhhc
Confidence            7443

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.7e-40  Score=322.41  Aligned_cols=241  Identities=26%  Similarity=0.413  Sum_probs=207.8

Q ss_pred             EEecccCceEEEEEEEcC-CC--eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEec
Q 047009          156 KVVGQGAFGRVYQVRKKN-TS--EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFI  232 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~-~~--~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  232 (482)
                      +.||+|++|.||+|.+.. .+  ..||+|.+......  ...+.+.+|+.++++++||||+++++.+.. ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            368999999999999865 33  36999999876543  556678899999999999999999999988 8899999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC----CC
Q 047009          233 NGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT----RS  306 (482)
Q Consensus       233 ~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~----~~  306 (482)
                      ++|+|...+....  .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.+....    ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999999987764  68999999999999999999999999999999999999999999999999998764321    11


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc--ccCCCccCChHHHHHHHHh
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD--KLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~LI~~~  383 (482)
                      ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+....+...  ....+..++..+.+++.+|
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  237 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC  237 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence            23457789999999999999999999999999999998 99999887777776666643  3344566889999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHh
Q 047009          384 LQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~  404 (482)
                      |+.+|++||++     .++++
T Consensus       238 l~~~p~~Rps~-----~~~~~  253 (257)
T cd05040         238 WAHNPADRPTF-----AALRE  253 (257)
T ss_pred             CCCCcccCCCH-----HHHHH
Confidence            99999999998     77764

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.5e-40  Score=333.03  Aligned_cols=254  Identities=28%  Similarity=0.406  Sum_probs=214.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ..|+..+.||+|+||.||+|+++.+++.||+|.+.............+.+|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777889999999999999999999999999987543333344556778999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcc
Q 047009          230 DFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  308 (482)
                      ||+.| ++...+.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++......   ..
T Consensus        95 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~  170 (308)
T cd06634          95 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NX  170 (308)
T ss_pred             EccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---cc
Confidence            99974 67666643 456899999999999999999999999999999999999999999999999998765432   34


Q ss_pred             cccCCCCCchhhhc---CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CC-CccCChHHHHHHHHh
Q 047009          309 MIGTVEYMAPEIVL---GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RL-PAFLSSEAHSLLKGL  383 (482)
Q Consensus       309 ~~gt~~y~APE~l~---~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~LI~~~  383 (482)
                      ..|++.|+|||.+.   ...++.++|||||||++|+|++|+.||...+.......+..... .. +..++..+++||++|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  250 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence            57899999999985   34678899999999999999999999977665555544444332 22 345889999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      |.++|.+||++     +++++|+|+....
T Consensus       251 l~~~P~~Rp~~-----~~ll~~~~~~~~~  274 (308)
T cd06634         251 LQKIPQDRPTS-----EVLLKHRFVLRER  274 (308)
T ss_pred             hhCCcccCCCH-----HHHhhCccccccC
Confidence            99999999998     9999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.4e-40  Score=335.04  Aligned_cols=254  Identities=30%  Similarity=0.427  Sum_probs=208.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCC--CeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeec----CC
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNT--SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQT----KY  223 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----~~  223 (482)
                      +|++.+.||+|+||.||+|++..+  +..||+|++.... ......+.+.+|+.+++++ +||||+++++.+..    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            488999999999999999999988  8999999987532 2223345567899999999 59999999886532    24


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          224 RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      .+|+++||+. ++|...+.....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.+...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            5789999986 589888888888999999999999999999999999999999999999999999999999999875432


Q ss_pred             C-----CCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-------------
Q 047009          304 T-----RSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-------------  364 (482)
Q Consensus       304 ~-----~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-------------  364 (482)
                      .     ......||..|+|||++.+ ..++.++||||||+++|+|++|++||.+.+.......+...             
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            1     1234578999999998876 56899999999999999999999999876644433322211             


Q ss_pred             ---------------ccC---CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          365 ---------------KLR---LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       365 ---------------~~~---~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                                     ...   ....++..+++||.+||+.||.+||++     .+++.||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-----~~ll~~~~~~~~  298 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV-----EEALEHPYLAIW  298 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCH-----HHHhcChhhhhh
Confidence                           001   112357899999999999999999998     999999999643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-41  Score=327.90  Aligned_cols=250  Identities=36%  Similarity=0.580  Sum_probs=212.8

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEe
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  231 (482)
                      |++.+.||+|+||.||+|+...+++.||+|++.... ......+.+..|+.++++++|+||+++++++.+...+++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            677889999999999999999999999999998754 2233345567899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCccc
Q 047009          232 INGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSM  309 (482)
Q Consensus       232 ~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~~  309 (482)
                      +++ +|..++.+. ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.+||+|||+++...... .....
T Consensus        80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            985 899888776 579999999999999999999999999999999999999999999999999998764432 23344


Q ss_pred             ccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc------------------ccCCC-
Q 047009          310 IGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD------------------KLRLP-  369 (482)
Q Consensus       310 ~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~------------------~~~~p-  369 (482)
                      .++..|+|||.+.+. .++.++|+|||||++|||++|+.||.+.+..+...++...                  ...++ 
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            567889999999876 7899999999999999999999999887765554444321                  00011 


Q ss_pred             ----------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          370 ----------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       370 ----------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                                +.++..+.++|++||..||++||++     +++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-----~~~l~~p~~  282 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA-----KEALKHPYF  282 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCCCH-----HHHhhCcCC
Confidence                      1247889999999999999999999     999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7e-41  Score=335.43  Aligned_cols=250  Identities=23%  Similarity=0.371  Sum_probs=203.2

Q ss_pred             Eeccc--CceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          157 VVGQG--AFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       157 ~LG~G--~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      +||+|  ++|.||.++.+.+++.||+|++..... .....+.+.+|+.+++.++|+||++++++|......+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            34444  556677777777899999999987532 334567789999999999999999999999999999999999999


Q ss_pred             CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--------
Q 047009          235 GHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--------  304 (482)
Q Consensus       235 g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--------  304 (482)
                      |+|..++...  ..+++..+..++.|++.||+|||+++|+||||||+||+++.+|.+||+|||.+.......        
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            9999988764  458999999999999999999999999999999999999999999999999987643211        


Q ss_pred             CCcccccCCCCCchhhhcC--CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-----------------
Q 047009          305 RSNSMIGTVEYMAPEIVLG--KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-----------------  365 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~--~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-----------------  365 (482)
                      ......++..|+|||++.+  ..++.++|+|||||++|||++|+.||..............+.                 
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM  243 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence            1234467889999999976  458899999999999999999999998655433221111110                 


Q ss_pred             -----------------cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          366 -----------------LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       366 -----------------~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                                       ...+..++.++.+||.+||+.||++||++     +++++||||+.+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~ll~~p~~~~~~  302 (314)
T cd08216         244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA-----SQLLNHSFFKQCK  302 (314)
T ss_pred             CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCH-----HHHhcCchHhhhc
Confidence                             00112245788999999999999999999     9999999998664

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=331.15  Aligned_cols=248  Identities=20%  Similarity=0.326  Sum_probs=206.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCC--------------CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeee
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNT--------------SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL  215 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~--------------~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l  215 (482)
                      ++|++.+.||+|+||.||+|++..+              ...||+|.++...  .......+.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            6899999999999999999987543              2359999987542  23345568899999999999999999


Q ss_pred             eeeeecCCeEEEEEEecCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 047009          216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHG------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL  283 (482)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl  283 (482)
                      ++++......++||||+.+++|..++....            .+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill  162 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV  162 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence            999999999999999999999999886532            36788889999999999999999999999999999999


Q ss_pred             ccCCceeEcccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh--CCCCCCCCchHHHH
Q 047009          284 GADGHVMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT--GKPPFIGGNRAKIQ  358 (482)
Q Consensus       284 ~~~g~vKL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt--G~~PF~~~~~~~~~  358 (482)
                      +.++.+||+|||++..+.....   .....++..|+|||++.+..++.++|||||||++|+|++  |..||...+..+..
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~  242 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI  242 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence            9999999999999986533221   223345778999999999999999999999999999988  77899877666655


Q ss_pred             HHHHh-----c---ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          359 QKIVK-----D---KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       359 ~~i~~-----~---~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ..+.+     .   ....+..++..+.+||.+||+.||++||++     .+|++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~-----~~i~~  291 (295)
T cd05097         243 ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF-----NKIHH  291 (295)
T ss_pred             HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCH-----HHHHH
Confidence            54432     1   122355678999999999999999999998     77754

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.1e-40  Score=320.73  Aligned_cols=246  Identities=27%  Similarity=0.431  Sum_probs=214.4

Q ss_pred             eEEEEEecccCceEEEEEEEcCCC----eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      |++.+.||.|+||.||+|++...+    ..||+|++.....  ....+.+.+|+.++..++|+||+++++.+.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            456789999999999999998866    8999999965532  2256678899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          228 VLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      +|||+++++|..++.....  +++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++.......
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999999876544  89999999999999999999999999999999999999999999999999987654322


Q ss_pred             Cc--ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc-cCCCccCChHHHHHHH
Q 047009          306 SN--SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLK  381 (482)
Q Consensus       306 ~~--~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~LI~  381 (482)
                      ..  ...++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+...+.+.+.... ...+..++.++.+++.
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  238 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLML  238 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence            21  1336789999999988889999999999999999998 899998888877777776653 3456678999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +||..||++||++     .++++
T Consensus       239 ~~l~~~p~~Rpt~-----~~ll~  256 (258)
T smart00219      239 QCWAEDPEDRPTF-----SELVE  256 (258)
T ss_pred             HHCcCChhhCcCH-----HHHHh
Confidence            9999999999998     88875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=327.34  Aligned_cols=249  Identities=33%  Similarity=0.554  Sum_probs=209.7

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCCeEEEEEE
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      |++.+.||+|+||+||+|....+++.||||.+......  .......+|+..+.+++ |+||+++++++...+..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            67889999999999999999999999999998764321  12223456889999999 9999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcc
Q 047009          231 FINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS  308 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  308 (482)
                      |+ +|+|...+....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++..........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence            99 778988887764  789999999999999999999999999999999999999999999999999987765444455


Q ss_pred             cccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-------------------ccCC
Q 047009          309 MIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-------------------KLRL  368 (482)
Q Consensus       309 ~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-------------------~~~~  368 (482)
                      ..|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||...+..+....+...                   ...+
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            678999999998854 55789999999999999999999999877655444433221                   0000


Q ss_pred             -----------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          369 -----------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       369 -----------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                                 ....+..+.+||++||+.||++||++     +|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-----~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA-----SQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH-----HHHhhCCCC
Confidence                       11236889999999999999999999     999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.4e-40  Score=329.25  Aligned_cols=248  Identities=22%  Similarity=0.368  Sum_probs=205.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcC----------------CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCcee
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKN----------------TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV  213 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~----------------~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv  213 (482)
                      ++|++.+.||+|+||.||+|++..                ++..||+|++....  .......+.+|+.+++.++|+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            579999999999999999986543                34579999987542  234456788999999999999999


Q ss_pred             eeeeeeecCCeEEEEEEecCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 047009          214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-----------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENIL  282 (482)
Q Consensus       214 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NIL  282 (482)
                      ++++++...+..++||||+.+|+|..++....           .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            99999999999999999999999999887643           3567789999999999999999999999999999999


Q ss_pred             EccCCceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh--CCCCCCCCchHHH
Q 047009          283 LGADGHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT--GKPPFIGGNRAKI  357 (482)
Q Consensus       283 l~~~g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt--G~~PF~~~~~~~~  357 (482)
                      ++.++.++|+|||+++.+....   ......++..|+|||+..+..++.++|+|||||++|||++  |..||...+..+.
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            9999999999999998753322   1223345678999999988889999999999999999998  7899977666554


Q ss_pred             HHHHHh--------cccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          358 QQKIVK--------DKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       358 ~~~i~~--------~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ......        .....+..++..+.+|+.+||+.||++||++     .+|.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-----~~i~~  292 (296)
T cd05095         243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF-----QEIHA  292 (296)
T ss_pred             HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCH-----HHHHH
Confidence            443321        1223355678999999999999999999998     77653

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2e-40  Score=335.93  Aligned_cols=250  Identities=21%  Similarity=0.357  Sum_probs=212.3

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCC-------CeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeee
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNT-------SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQ  220 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  220 (482)
                      ..+|++.+.||+|+||.||+|++...       +..||+|++....  .....+.+.+|+.+++++ +||||+++++++.
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            35799999999999999999986432       2369999887532  233456688899999999 8999999999999


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHHG----------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG  284 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~  284 (482)
                      ..+.++++|||+++|+|..++.+..                .++...+..++.||+.||.|||++||+||||||+|||++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~  168 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT  168 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence            9999999999999999999987532                367788888999999999999999999999999999999


Q ss_pred             cCCceeEcccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHH
Q 047009          285 ADGHVMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQK  360 (482)
Q Consensus       285 ~~g~vKL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~  360 (482)
                      .++.+||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  248 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  248 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            999999999999987543221   122334567999999999999999999999999999998 8999998888888777


Q ss_pred             HHhc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          361 IVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       361 i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      +... ....+..++.++.+||.+||+.+|.+||++     .+++++
T Consensus       249 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~ell~~  289 (334)
T cd05100         249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTF-----KQLVED  289 (334)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCH-----HHHHHH
Confidence            7654 335566788999999999999999999998     888864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.9e-41  Score=340.04  Aligned_cols=256  Identities=34%  Similarity=0.525  Sum_probs=211.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecC--CeE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTK--YRL  225 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--~~~  225 (482)
                      .++|++.+.||+|+||.||+|.++.+++.||+|.+.+... .......+.+|+.+++++ +||||++++++|...  ..+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4789999999999999999999999999999999865322 223344567899999999 999999999988643  468


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  304 (482)
                      |+||||+.+ +|..++... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++...... 
T Consensus        85 ~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          85 YLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             EEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            999999975 888887665 78899999999999999999999999999999999999999999999999998754322 


Q ss_pred             -----CCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc------------
Q 047009          305 -----RSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL------------  366 (482)
Q Consensus       305 -----~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~------------  366 (482)
                           ......||..|+|||++.+ ..++.++|+||||+++|+|++|+.||.+.........+.....            
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence                 2234578999999998865 5678999999999999999999999977654443333221100            


Q ss_pred             -------------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          367 -------------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       367 -------------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                                         .....++.++.+||.+||+.||.+||++     .++++||||+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~-----~~il~~~~~~~~~  302 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA-----EEALEHPYVAQFH  302 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCH-----HHHhhChhhhhhc
Confidence                               0112368899999999999999999999     9999999998753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-41  Score=341.56  Aligned_cols=250  Identities=26%  Similarity=0.343  Sum_probs=201.9

Q ss_pred             cccccccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeee
Q 047009          141 SVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQ  220 (482)
Q Consensus       141 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  220 (482)
                      +......++++|.-...||+|+||.||+|...++ ..||||++.......   ...+.+|+.+|.+++|||+|+|+|||.
T Consensus        66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~  141 (361)
T KOG1187|consen   66 SYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCL  141 (361)
T ss_pred             eHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence            3334445668899999999999999999998874 889999876643211   334899999999999999999999999


Q ss_pred             cCC-eEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCCCcEEEccCCceeEccc
Q 047009          221 TKY-RLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANG---IMHRDLKPENILLGADGHVMLTDF  294 (482)
Q Consensus       221 ~~~-~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---IiHrDLKp~NILl~~~g~vKL~DF  294 (482)
                      +.+ ..+||+|||++|+|.++|....  .++|.....|+.++++||+|||...   |||||||++|||||++.++||+||
T Consensus       142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF  221 (361)
T KOG1187|consen  142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF  221 (361)
T ss_pred             cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence            888 5999999999999999998765  8899999999999999999999853   999999999999999999999999


Q ss_pred             CccccccC-CCCCccc-ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc---h---HHHHH-HHHhcc
Q 047009          295 GLAKQFDE-NTRSNSM-IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN---R---AKIQQ-KIVKDK  365 (482)
Q Consensus       295 Gla~~~~~-~~~~~~~-~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~---~---~~~~~-~i~~~~  365 (482)
                      |+|+.... .....+. .||.+|+|||++..+..+.++|||||||+|+||+||+.+.....   .   .+... .+.++.
T Consensus       222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~  301 (361)
T KOG1187|consen  222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK  301 (361)
T ss_pred             cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence            99977654 3333333 89999999999999889999999999999999999998876422   1   11111 111111


Q ss_pred             ------cCCC-ccCC-----hHHHHHHHHhhccCcCCcCCC
Q 047009          366 ------LRLP-AFLS-----SEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       366 ------~~~p-~~~s-----~~~~~LI~~~L~~dP~~R~s~  394 (482)
                            ..+. ...+     ..+..+...|++.+|++||+.
T Consensus       302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m  342 (361)
T KOG1187|consen  302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTM  342 (361)
T ss_pred             hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCH
Confidence                  1111 2222     224567889999999999998

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.5e-40  Score=318.14  Aligned_cols=241  Identities=23%  Similarity=0.423  Sum_probs=205.8

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGG  235 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (482)
                      ++||+|+||.||+|... ++..||+|++....  .......+.+|+.++++++||||+++++.+......++||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            36899999999999865 57889999987542  2233446788999999999999999999999999999999999999


Q ss_pred             chHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC--cccccC
Q 047009          236 HLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS--NSMIGT  312 (482)
Q Consensus       236 ~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~--~~~~gt  312 (482)
                      +|..++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........  ....++
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            999988654 46789999999999999999999999999999999999999999999999999764332211  122446


Q ss_pred             CCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHhhccCcCC
Q 047009          313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGK  390 (482)
Q Consensus       313 ~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~  390 (482)
                      ..|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+... ....+..++..+.+|+.+||+.+|++
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  237 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPEN  237 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCccc
Confidence            78999999998889999999999999999998 99999888777766666554 34556778999999999999999999


Q ss_pred             cCCCCCCChHHHHh
Q 047009          391 RLGAGPKGSEEIKS  404 (482)
Q Consensus       391 R~s~~~~~~~eil~  404 (482)
                      ||++     .++++
T Consensus       238 Rp~~-----~~l~~  246 (250)
T cd05085         238 RPKF-----SELQK  246 (250)
T ss_pred             CCCH-----HHHHH
Confidence            9998     77764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.9e-40  Score=344.61  Aligned_cols=251  Identities=21%  Similarity=0.352  Sum_probs=209.5

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQ  220 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~  220 (482)
                      +..++|.+.+.||+|+||.||+|++.+     +++.||+|+++...  .....+.+.+|+.+|.++. ||||+++++++.
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            444678999999999999999999643     45789999997643  2233456788999999997 999999999999


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhcC-------------------------------------------------------
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHHG-------------------------------------------------------  245 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~-------------------------------------------------------  245 (482)
                      ..+.+++||||+.+|+|.+++.+++                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999886532                                                       


Q ss_pred             -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 047009          246 -------------------------------------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENIL  282 (482)
Q Consensus       246 -------------------------------------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NIL  282 (482)
                                                                 .+++..+..|+.||+.||+|||+++|+||||||+|||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL  271 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL  271 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence                                                       2566677889999999999999999999999999999


Q ss_pred             EccCCceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHH
Q 047009          283 LGADGHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQ  358 (482)
Q Consensus       283 l~~~g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~  358 (482)
                      ++.++.+||+|||+++......   ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+..
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            9999999999999998653221   1233467889999999999999999999999999999998 89999775554444


Q ss_pred             HH-HHhc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          359 QK-IVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       359 ~~-i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .. +..+ .+..|..++.++.+||.+||..+|.+||++     ++|++
T Consensus       352 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~-----~ell~  394 (401)
T cd05107         352 YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDF-----SQLVH  394 (401)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            33 3333 345567789999999999999999999999     88875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.5e-40  Score=325.52  Aligned_cols=247  Identities=26%  Similarity=0.361  Sum_probs=200.2

Q ss_pred             CCe-EEEEEecccCceEEEEEEE----cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec--C
Q 047009          150 EDF-EVLKVVGQGAFGRVYQVRK----KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT--K  222 (482)
Q Consensus       150 ~~y-~i~~~LG~G~fg~Vy~a~~----~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~  222 (482)
                      ++| ++++.||+|+||+||++..    ..++..||+|++....  .......+.+|+.+|++++||||+++++++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            345 8999999999999988653    4567899999987542  12344567789999999999999999998765  3


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..+++||||+++|+|..++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            4689999999999999888654 589999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC----CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchH---------------HHHHHHHh
Q 047009          303 NTR----SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA---------------KIQQKIVK  363 (482)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~---------------~~~~~i~~  363 (482)
                      ...    .....++..|+|||.+.+..++.++||||||+++|+|++|..||......               ...+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence            222    12234567799999999888999999999999999999999998543211               01111111


Q ss_pred             -cccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          364 -DKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       364 -~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                       .....+..++.++.+++.+||+.||++||++     +++++
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-----~~i~~  276 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTF-----RSLIP  276 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCCH-----HHHHH
Confidence             1223456678999999999999999999999     77764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-40  Score=319.20  Aligned_cols=241  Identities=24%  Similarity=0.404  Sum_probs=208.0

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGG  235 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (482)
                      ++||+|+||.||+|.+.. ++.||+|.+......  .....+.+|++++++++|+||+++++++......++||||+.++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            369999999999999988 899999998765432  34566889999999999999999999999999999999999999


Q ss_pred             chHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC---ccccc
Q 047009          236 HLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIG  311 (482)
Q Consensus       236 ~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~---~~~~g  311 (482)
                      +|..++... ..+++..+..++.+++.||.|||+++++||||||+|||++.++.+||+|||+++........   ....+
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999988664 56889999999999999999999999999999999999999999999999999865422211   12234


Q ss_pred             CCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHhhccCcC
Q 047009          312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPG  389 (482)
Q Consensus       312 t~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~  389 (482)
                      +..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+... ....|..++.++.++|.+||+.+|.
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  237 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPE  237 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChh
Confidence            667999999998899999999999999999999 89999887777766666554 3455677899999999999999999


Q ss_pred             CcCCCCCCChHHHHh
Q 047009          390 KRLGAGPKGSEEIKS  404 (482)
Q Consensus       390 ~R~s~~~~~~~eil~  404 (482)
                      +||++     .|+++
T Consensus       238 ~Rp~~-----~ell~  247 (251)
T cd05041         238 NRPSF-----SEIYN  247 (251)
T ss_pred             hCcCH-----HHHHH
Confidence            99998     88875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.5e-40  Score=324.01  Aligned_cols=250  Identities=19%  Similarity=0.323  Sum_probs=212.0

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcC----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec-C
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKN----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT-K  222 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~  222 (482)
                      ..++|++.+.||+|+||.||+|.+..    ++..||+|++....  .....+.+.+|+.++++++|+||+++++++.. .
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            45789999999999999999999876    35889999886432  34456678899999999999999999998655 5


Q ss_pred             CeEEEEEEecCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEccc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHH--------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDF  294 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DF  294 (482)
                      ...++++||+++|+|..++...        ..+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence            7789999999999999988653        35889999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCC
Q 047009          295 GLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLP  369 (482)
Q Consensus       295 Gla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p  369 (482)
                      |+++.+.....   .....++..|+|||++.+..++.++||||||+++||+++ |+.||...+..++...+..+ .+..+
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  241 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP  241 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC
Confidence            99987543221   123456778999999999999999999999999999999 99999888777766666554 23445


Q ss_pred             ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          370 AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       370 ~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ..+++++.+++.+||..||++||++     .++++
T Consensus       242 ~~~~~~~~~li~~~l~~~p~~Rps~-----~~~~~  271 (280)
T cd05043         242 INCPDELFAVMACCWALDPEERPSF-----SQLVQ  271 (280)
T ss_pred             CcCCHHHHHHHHHHcCCChhhCCCH-----HHHHH
Confidence            5678999999999999999999998     77764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.1e-40  Score=332.03  Aligned_cols=253  Identities=29%  Similarity=0.460  Sum_probs=209.3

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec-CCeEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT-KYRLY  226 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~  226 (482)
                      ..++|++++.||+|+||.||+|.++.+++.||+|++.+... .....+.+.+|+.+++.++||||++++++|.. ....|
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            45789999999999999999999999999999999875432 22344567789999999999999999999865 56789


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      +||||+ +++|...+. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....  ..
T Consensus        87 lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~  162 (328)
T cd07856          87 FVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QM  162 (328)
T ss_pred             EEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--Cc
Confidence            999999 457877665 45688899999999999999999999999999999999999999999999999986533  22


Q ss_pred             cccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHh----------------------
Q 047009          307 NSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK----------------------  363 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~----------------------  363 (482)
                      ....++..|+|||++.+ ..++.++||||||+++|+|++|+.||...+.......+.+                      
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd07856         163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV  242 (328)
T ss_pred             CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence            34577899999999866 6789999999999999999999999977654322211111                      


Q ss_pred             ----cccCCC-----ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          364 ----DKLRLP-----AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       364 ----~~~~~p-----~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                          .....|     ..++.+++++|++||+.+|++||++     ++++.|+||..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-----~ell~~~~~~~  293 (328)
T cd07856         243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISA-----AEALAHPYLAP  293 (328)
T ss_pred             hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCCcccc
Confidence                000111     2467899999999999999999998     99999999974

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=9e-40  Score=318.63  Aligned_cols=242  Identities=23%  Similarity=0.391  Sum_probs=206.6

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++.+.||+|+||.||+|.+.. +..+|+|.+....    ...+.+.+|+.++++++|+||+++++.+.. ...+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            345789999999999999999998664 5569999887542    234567889999999999999999999887 7789


Q ss_pred             EEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          227 LVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      ++|||+++|+|.+++.+.  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999998764  357888889999999999999999999999999999999999999999999998764322


Q ss_pred             C--CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHH
Q 047009          305 R--SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLL  380 (482)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI  380 (482)
                      .  .....++..|+|||++.+..++.++|+||||+++|+|++ |+.||.+.+...+...+..+ ....+...+.++.+++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  236 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM  236 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence            1  122345678999999999889999999999999999998 99999888777777766654 2344567889999999


Q ss_pred             HHhhccCcCCcCCC
Q 047009          381 KGLLQKEPGKRLGA  394 (482)
Q Consensus       381 ~~~L~~dP~~R~s~  394 (482)
                      .+||+++|++||++
T Consensus       237 ~~~l~~~p~~Rp~~  250 (260)
T cd05073         237 MRCWKNRPEERPTF  250 (260)
T ss_pred             HHHcccCcccCcCH
Confidence            99999999999998

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.4e-40  Score=321.18  Aligned_cols=249  Identities=24%  Similarity=0.402  Sum_probs=210.9

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCC---CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNT---SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ..++|.+.+.||+|+||.||+|.+...   ...||+|......  .....+.+.+|+.++++++||||+++++++.+. .
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~   80 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-P   80 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-C
Confidence            346799999999999999999987654   3579999886543  233456788999999999999999999988764 5


Q ss_pred             EEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          225 LYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      .|+||||+++|+|..++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            689999999999999997644 5899999999999999999999999999999999999999999999999999876433


Q ss_pred             CC--CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHH
Q 047009          304 TR--SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSL  379 (482)
Q Consensus       304 ~~--~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L  379 (482)
                      ..  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+.++ ....|..++.++.++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL  240 (270)
T ss_pred             cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence            22  122234568999999998999999999999999999986 99999888777666666554 456677889999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHh
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      |.+||..+|.+||++     .+++.
T Consensus       241 i~~~l~~~P~~Rpt~-----~~~~~  260 (270)
T cd05056         241 MTKCWAYDPSKRPRF-----TELKA  260 (270)
T ss_pred             HHHHcCCChhhCcCH-----HHHHH
Confidence            999999999999998     77764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-40  Score=337.43  Aligned_cols=250  Identities=25%  Similarity=0.423  Sum_probs=205.0

Q ss_pred             CCCeEEEEEecccCceEEEEEEEc-----CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeec-
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKK-----NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQT-  221 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-  221 (482)
                      .++|++.+.||+|+||.||+|++.     .+++.||||+++...  .......+.+|+.+|.++ +||||+++++++.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            468999999999999999999853     457899999997543  223455678899999999 68999999998765 


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc---------------------------------------------------------
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHH---------------------------------------------------------  244 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~---------------------------------------------------------  244 (482)
                      ...+++||||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            45688999999999999888643                                                         


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC---CCccccc
Q 047009          245 ----------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT---RSNSMIG  311 (482)
Q Consensus       245 ----------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~~g  311 (482)
                                ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......   ......+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                      135677788899999999999999999999999999999999999999999998753221   1222345


Q ss_pred             CCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchH-HHHHHHHhc-ccCCCccCChHHHHHHHHhhccCc
Q 047009          312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRA-KIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP  388 (482)
Q Consensus       312 t~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP  388 (482)
                      +..|+|||++.+..++.++||||||+++|+|++ |..||.+.... .....+..+ ....|..+++++.+++..||+.||
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p  323 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP  323 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCCh
Confidence            678999999999999999999999999999997 99999765433 333333332 345566788999999999999999


Q ss_pred             CCcCCCCCCChHHHHhC
Q 047009          389 GKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       389 ~~R~s~~~~~~~eil~h  405 (482)
                      .+||++     .+|++|
T Consensus       324 ~~Rps~-----~eil~~  335 (343)
T cd05103         324 SQRPTF-----SELVEH  335 (343)
T ss_pred             hhCcCH-----HHHHHH
Confidence            999999     888875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-40  Score=324.13  Aligned_cols=236  Identities=21%  Similarity=0.335  Sum_probs=199.0

Q ss_pred             EecccCceEEEEEEEcCCCe-------EEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          157 VVGQGAFGRVYQVRKKNTSE-------IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       157 ~LG~G~fg~Vy~a~~~~~~~-------~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      .||+|+||.||+|.++.++.       .||+|.+....   ....+.+.+|..+++.++||||+++++++......++||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            58999999999999876544       38888876432   334556778999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc--------eeEcccCccccc
Q 047009          230 DFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH--------VMLTDFGLAKQF  300 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~--------vKL~DFGla~~~  300 (482)
                      ||+++|+|..++..++ .+++..+..++.||+.||+|||++||+||||||+||+++.++.        ++++|||++...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9999999999987654 5899999999999999999999999999999999999988765        699999998764


Q ss_pred             cCCCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhC-CCCCCCCchHHHHHHHHhcccCCCccCChHHHH
Q 047009          301 DENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTG-KPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHS  378 (482)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG-~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  378 (482)
                      ..   .....++..|+|||++.+ ..++.++||||||+++|+|++| ..||...+..... .+......+|...+.++.+
T Consensus       159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  234 (258)
T cd05078         159 LP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWTELAN  234 (258)
T ss_pred             CC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcHHHHH
Confidence            32   234578899999999987 4589999999999999999998 5677655554433 3444566778778899999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ||.+||++||++||++     ++|++
T Consensus       235 li~~~l~~~p~~Rps~-----~~il~  255 (258)
T cd05078         235 LINQCMDYEPDFRPSF-----RAIIR  255 (258)
T ss_pred             HHHHHhccChhhCCCH-----HHHHH
Confidence            9999999999999998     88875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.2e-40  Score=320.48  Aligned_cols=237  Identities=20%  Similarity=0.286  Sum_probs=195.8

Q ss_pred             EecccCceEEEEEEEcCC------------CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          157 VVGQGAFGRVYQVRKKNT------------SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       157 ~LG~G~fg~Vy~a~~~~~------------~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      .||+|+||.||+|.....            ...||+|++....   ......+.+|+.++..++||||+++++++.....
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            589999999999985432            2358899876542   2334567788999999999999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc-------eeEcccCc
Q 047009          225 LYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH-------VMLTDFGL  296 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~-------vKL~DFGl  296 (482)
                      .++||||+++|+|..++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.       +|++|||+
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            99999999999998887654 56899999999999999999999999999999999999987764       89999999


Q ss_pred             cccccCCCCCcccccCCCCCchhhhc-CCCCCchhHHHHHhHHHHHHh-hCCCCCCCCchHHHHHHHHhcccCCCccCCh
Q 047009          297 AKQFDENTRSNSMIGTVEYMAPEIVL-GKGHNKAADWWSVGILLYEML-TGKPPFIGGNRAKIQQKIVKDKLRLPAFLSS  374 (482)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDvwSlGvilyell-tG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~  374 (482)
                      +.....   .....|+..|+|||++. +..++.++|||||||++|||+ +|+.||......+.. .+...........+.
T Consensus       159 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~  234 (262)
T cd05077         159 PITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVTPSCK  234 (262)
T ss_pred             CccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCCCChH
Confidence            876532   23456788999999987 567899999999999999998 589999766554432 333344444444678


Q ss_pred             HHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          375 EAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       375 ~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ++.+||.+||+.||.+||++     .+|+++
T Consensus       235 ~~~~li~~cl~~dp~~Rp~~-----~~il~~  260 (262)
T cd05077         235 ELADLMTHCMNYDPNQRPFF-----RAIMRD  260 (262)
T ss_pred             HHHHHHHHHcCCChhhCcCH-----HHHHHh
Confidence            89999999999999999999     888864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.5e-40  Score=317.84  Aligned_cols=242  Identities=25%  Similarity=0.439  Sum_probs=207.0

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ..++|++.+.||+|+||.||++..  +++.||+|.+....     ..+.+.+|+.++++++||||+++++++... ..++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            457899999999999999999864  57789999986532     234578899999999999999999998765 4789


Q ss_pred             EEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          228 VLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      ||||+.+++|..++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....  
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence            999999999999987653  4788999999999999999999999999999999999999999999999999764322  


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHh
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~  383 (482)
                      ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.++ .+..+..++..+.+||++|
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  233 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSC  233 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHH
Confidence            223344678999999998899999999999999999997 99999888877777766654 2344566889999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHh
Q 047009          384 LQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~  404 (482)
                      |+.+|.+||++     ++++.
T Consensus       234 l~~~p~~Rp~~-----~~l~~  249 (254)
T cd05083         234 WETEPKKRPSF-----HKLRE  249 (254)
T ss_pred             cCCChhhCcCH-----HHHHH
Confidence            99999999998     77764

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-41  Score=312.78  Aligned_cols=251  Identities=27%  Similarity=0.397  Sum_probs=208.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC---
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY---  223 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---  223 (482)
                      ++-++|++.+.||+|||+.||+++.-.+++.||+|.+.-..   .+..+...+|++..++++|||+++++++...+.   
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            45588999999999999999999999999999999997654   456677889999999999999999988874433   


Q ss_pred             --eEEEEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEccCCceeEcccC
Q 047009          224 --RLYLVLDFINGGHLFFQLYHH----GLFREDLARIYAAEIVSAVSHLHANG--IMHRDLKPENILLGADGHVMLTDFG  295 (482)
Q Consensus       224 --~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~--IiHrDLKp~NILl~~~g~vKL~DFG  295 (482)
                        ..||++.|...|+|.+.+...    ..++|.++..|+.+|++||++||+..  .+||||||.|||+.+++.++|.|||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence              499999999999998887653    36899999999999999999999998  9999999999999999999999999


Q ss_pred             ccccccCCC----------CCcccccCCCCCchhhhcCC---CCCchhHHHHHhHHHHHHhhCCCCCCCCch--HHHHHH
Q 047009          296 LAKQFDENT----------RSNSMIGTVEYMAPEIVLGK---GHNKAADWWSVGILLYEMLTGKPPFIGGNR--AKIQQK  360 (482)
Q Consensus       296 la~~~~~~~----------~~~~~~gt~~y~APE~l~~~---~~~~~sDvwSlGvilyelltG~~PF~~~~~--~~~~~~  360 (482)
                      .+....-.-          .......|..|+|||.+.-+   ..+.++|||||||+||+|+.|..||...-.  ..+.-.
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA  254 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA  254 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence            997642110          01223468899999999654   457899999999999999999999942111  112223


Q ss_pred             HHhcccCCCc--cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          361 IVKDKLRLPA--FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       361 i~~~~~~~p~--~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      +..+++.+|.  .+|..+.+||+.||+.||.+||++     .+++.+
T Consensus       255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i-----~~ll~~  296 (302)
T KOG2345|consen  255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTI-----PELLSK  296 (302)
T ss_pred             eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCH-----HHHHHH
Confidence            4455667764  489999999999999999999999     788753

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.9e-40  Score=322.44  Aligned_cols=237  Identities=23%  Similarity=0.320  Sum_probs=196.3

Q ss_pred             EecccCceEEEEEEEcCC------------------------CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCce
Q 047009          157 VVGQGAFGRVYQVRKKNT------------------------SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV  212 (482)
Q Consensus       157 ~LG~G~fg~Vy~a~~~~~------------------------~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI  212 (482)
                      +||+|+||.||+|....+                        ...||+|++....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            599999999999975322                        2458999886543   2334557788999999999999


Q ss_pred             eeeeeeeecCCeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC----
Q 047009          213 VQLKYSFQTKYRLYLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG----  287 (482)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g----  287 (482)
                      +++++++......++||||+++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999988865 46789999999999999999999999999999999999998654    


Q ss_pred             ---ceeEcccCccccccCCCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHh-hCCCCCCCCchHHHHHHHH
Q 047009          288 ---HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEML-TGKPPFIGGNRAKIQQKIV  362 (482)
Q Consensus       288 ---~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyell-tG~~PF~~~~~~~~~~~i~  362 (482)
                         .+||+|||++......   ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+... ..
T Consensus       159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~  234 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FY  234 (274)
T ss_pred             ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HH
Confidence               4899999998654221   23457889999999876 56899999999999999995 7999998776555433 33


Q ss_pred             hcccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          363 KDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       363 ~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      .....+|...+..+.++|.+||+.+|.+||++     .+|+++
T Consensus       235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-----~~il~~  272 (274)
T cd05076         235 EKKHRLPEPSCKELATLISQCLTYEPTQRPSF-----RTILRD  272 (274)
T ss_pred             HhccCCCCCCChHHHHHHHHHcccChhhCcCH-----HHHHHh
Confidence            34455666677899999999999999999998     888864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.4e-40  Score=323.17  Aligned_cols=247  Identities=25%  Similarity=0.383  Sum_probs=202.6

Q ss_pred             CeEEEEEecccCceEEEEEEE----cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC--Ce
Q 047009          151 DFEVLKVVGQGAFGRVYQVRK----KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK--YR  224 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~----~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~  224 (482)
                      -|++++.||+|+||.||+|+.    +.++..||+|.++...  .......+.+|+.++++++||||+++++++...  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            478999999999999999984    4568899999987542  233456688999999999999999999998775  56


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          225 LYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      .++||||++|++|..++.+. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.+...
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence            89999999999999988665 35899999999999999999999999999999999999999999999999999876432


Q ss_pred             CC----CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc---------------hHHHHHHHHhc
Q 047009          304 TR----SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN---------------RAKIQQKIVKD  364 (482)
Q Consensus       304 ~~----~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~---------------~~~~~~~i~~~  364 (482)
                      ..    .....|+..|+|||++.+..++.++||||||+++|+|++++.|+....               .......+..+
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG  242 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence            21    223556778999999999899999999999999999999877653211               01111111111


Q ss_pred             -ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          365 -KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       365 -~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                       ....+..++..+.+||.+||+.||.+||++     .++++
T Consensus       243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~il~  278 (284)
T cd05079         243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTF-----QNLIE  278 (284)
T ss_pred             ccCCCCCCCCHHHHHHHHHHccCCcccCcCH-----HHHHH
Confidence             233456689999999999999999999998     88875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-41  Score=296.59  Aligned_cols=255  Identities=28%  Similarity=0.537  Sum_probs=217.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ..|.-.++||+|.||+||+|+++++++.||+|.++.+... ...-....+|+-+|+.++|.|||++++....+..+-+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            3566678899999999999999999999999999876532 233345678999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC-c
Q 047009          230 DFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-N  307 (482)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~-~  307 (482)
                      |||.. +|..+... ++.+..+.++.++.|+++||.|+|++++.||||||.|+|++.+|.+||+|||+++.++-.-.. .
T Consensus        81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys  159 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS  159 (292)
T ss_pred             HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence            99975 67665544 678999999999999999999999999999999999999999999999999999987644332 3


Q ss_pred             ccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc-------c----CCCc----
Q 047009          308 SMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-------L----RLPA----  370 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~-------~----~~p~----  370 (482)
                      ..+-|..|++|.++.| +-|+++.|+||-|||+.|+.. |++.|.+.+..+...+|....       .    .+|+    
T Consensus       160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence            4567899999999988 468999999999999999986 899999999888888876521       0    1111    


Q ss_pred             --------------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          371 --------------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       371 --------------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                                    .++..-++|+.++|..+|.+|+++     +++++||||.+.
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisa-----eaalqhpyf~d~  289 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISA-----EAALQHPYFSDF  289 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCH-----HHHhcCcccccc
Confidence                          245677999999999999999999     999999999864

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=362.66  Aligned_cols=251  Identities=23%  Similarity=0.398  Sum_probs=219.3

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCe-----EEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSE-----IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  221 (482)
                      +.-...++.+.||+|.||.||.|...+...     .||||.+++.  .+......+.+|..+|+.++|||||+++|++.+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            445678899999999999999998765432     4888888764  355667788999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEccc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHH-------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDF  294 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DF  294 (482)
                      ....+|++|||+||+|..+|++.       ..++...+..++.||++|++||+++++|||||..+|+||+....+||+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999875       34788999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCC-cc--cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHH-HHHhcccCCC
Q 047009          295 GLAKQFDENTRS-NS--MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQ-KIVKDKLRLP  369 (482)
Q Consensus       295 Gla~~~~~~~~~-~~--~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~-~i~~~~~~~p  369 (482)
                      |+|+.+...... ..  ..-...|||||.+....++.++|||||||+|||++| |..||.+.+..++.. ....+++..|
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P  926 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP  926 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence            999954332221 11  122468999999999999999999999999999999 999999988888877 5555688889


Q ss_pred             ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          370 AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       370 ~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ..++..+.+++..||+.+|.+||++     ..|++
T Consensus       927 ~~CP~~ly~lM~~CW~~~pe~RP~F-----~~i~~  956 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQCWKHDPEDRPSF-----RTIVE  956 (1025)
T ss_pred             CCCChHHHHHHHHHccCChhhCccH-----HHHHh
Confidence            9999999999999999999999999     78776

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.2e-39  Score=325.55  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=208.0

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCe----EEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSE----IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      ..++|+..+.||+|+||.||+|.+..+|.    .||+|.+....  .......+.+|+.+++.++||||+++++++... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            45789999999999999999999887775    46888876543  223334577899999999999999999998764 


Q ss_pred             eEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 RLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..++++||+++|+|.+++..+. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            4679999999999999887654 589999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHH
Q 047009          303 NTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAH  377 (482)
Q Consensus       303 ~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (482)
                      ...   .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+.......+.+..+ .+..+..++..+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY  241 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence            222   223345778999999999999999999999999999997 99999877665555544433 2344556789999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +++.+||..+|++||++     .++++
T Consensus       242 ~li~~c~~~~p~~Rp~~-----~~l~~  263 (303)
T cd05110         242 MVMVKCWMIDADSRPKF-----KELAA  263 (303)
T ss_pred             HHHHHHcCCChhhCcCH-----HHHHH
Confidence            99999999999999998     78765

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2e-39  Score=320.03  Aligned_cols=247  Identities=25%  Similarity=0.399  Sum_probs=200.7

Q ss_pred             CCeEEEEEecccCceEEEEEEE----cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec--CC
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRK----KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT--KY  223 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~----~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~  223 (482)
                      .+|++++.||+|+||.||+|..    ..+++.||+|.+....   ....+.+.+|+.++++++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            5799999999999999999984    4568899999987542   3445668899999999999999999987643  45


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 RLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      .+++||||+++|+|..++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            689999999999999998764 4689999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCC----cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHH---------------HHHHHHh
Q 047009          303 NTRS----NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAK---------------IQQKIVK  363 (482)
Q Consensus       303 ~~~~----~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~---------------~~~~i~~  363 (482)
                      ....    ....++..|+|||++.+..++.++|||||||++|||++|..++.......               ....+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            2221    11223456999999999999999999999999999999887764322110               0111222


Q ss_pred             c--ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          364 D--KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       364 ~--~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .  .+..+..++.++.+||.+||..+|++||++     .+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-----~ei~~  278 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSF-----SELAL  278 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCH-----HHHHH
Confidence            2  223445688999999999999999999999     78765

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.7e-40  Score=319.93  Aligned_cols=241  Identities=25%  Similarity=0.435  Sum_probs=204.4

Q ss_pred             EecccCceEEEEEEEcCCC------eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          157 VVGQGAFGRVYQVRKKNTS------EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       157 ~LG~G~fg~Vy~a~~~~~~------~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      .||+|+||.||+|+++...      +.||+|.+.+..  .......+.+|+.+++.++||||+++++++......++|||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            5899999999999986544      789999886542  12334567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC-----ceeEcccCccc
Q 047009          231 FINGGHLFFQLYHH-------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG-----HVMLTDFGLAK  298 (482)
Q Consensus       231 ~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g-----~vKL~DFGla~  298 (482)
                      |+++++|..++...       ..+++..+..++.|++.||.|||+++++|+||||+||+++.++     .+||+|||+++
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            99999999988643       3478888999999999999999999999999999999999888     89999999998


Q ss_pred             cccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCC
Q 047009          299 QFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLS  373 (482)
Q Consensus       299 ~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s  373 (482)
                      .......   .....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+..+ .+..+..++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCP  239 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccch
Confidence            6533221   223355788999999999999999999999999999998 99999877776666665543 445677789


Q ss_pred             hHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       374 ~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ..+.+||.+||+++|.+||++     +++++
T Consensus       240 ~~~~~li~~~l~~~p~~Rp~~-----~~i~~  265 (269)
T cd05044         240 DKIYQLMTNCWAQDPSERPTF-----DRIQE  265 (269)
T ss_pred             HHHHHHHHHHcCCCcccCCCH-----HHHHH
Confidence            999999999999999999998     77764

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2e-39  Score=315.85  Aligned_cols=242  Identities=23%  Similarity=0.341  Sum_probs=199.4

Q ss_pred             EEecccCceEEEEEEEcC---CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeee-cCCeEEEEEEe
Q 047009          156 KVVGQGAFGRVYQVRKKN---TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQ-TKYRLYLVLDF  231 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~  231 (482)
                      +.||+|+||.||+|.+..   .+..||+|.+....  .....+.+.+|+.+++.++||||+++++++. .++..++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            368999999999998653   34679999875422  2334566778999999999999999999765 45668999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-----C
Q 047009          232 INGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-----R  305 (482)
Q Consensus       232 ~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-----~  305 (482)
                      +.+|+|..++.+. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++......     .
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            9999999998764 346777788899999999999999999999999999999999999999999998653221     1


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHh
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~  383 (482)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..++...+..+ ....+..++..+.+++.+|
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  238 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSC  238 (262)
T ss_pred             cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHH
Confidence            123456778999999999999999999999999999999 57778777766666666554 3344566789999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHh
Q 047009          384 LQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~  404 (482)
                      |+.+|++||++     .++++
T Consensus       239 l~~~p~~Rp~~-----~~il~  254 (262)
T cd05058         239 WHPKPEMRPTF-----SELVS  254 (262)
T ss_pred             cCCChhhCCCH-----HHHHH
Confidence            99999999998     78765

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.8e-39  Score=317.58  Aligned_cols=249  Identities=34%  Similarity=0.560  Sum_probs=211.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcC-CCeEEEEEEeechhh-------chhhHHHHHHHHHHHHHh-CCCCceeeeeeeeec
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKN-TSEIYAMKVMRKDKI-------VEKNHAEYMKAERDILTK-IDHPFVVQLKYSFQT  221 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~~~~~~~-------~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~  221 (482)
                      +|++.+.||+|+||.||+|.++. +++.+|+|.+.....       ........+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999988 688999998864321       122334556678888765 799999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCceeEcccCc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVMLTDFGL  296 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~vKL~DFGl  296 (482)
                      .+..++||||++|++|...+..    ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999887643    3468999999999999999999996 6899999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC-CC-ccCCh
Q 047009          297 AKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-LP-AFLSS  374 (482)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~-~p-~~~s~  374 (482)
                      +.............|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+...... .+ ..++.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE  240 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence            98765544445667899999999999988999999999999999999999999887776666666655433 22 25789


Q ss_pred             HHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          375 EAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       375 ~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ++.++|.+||+.||++||++     .|+..
T Consensus       241 ~l~~li~~cl~~~p~~Rp~~-----~e~~~  265 (269)
T cd08528         241 DVTDVITSCLTPDAEARPDI-----IQVSA  265 (269)
T ss_pred             HHHHHHHHHCCCCCccCCCH-----HHHHH
Confidence            99999999999999999998     67654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-39  Score=316.03  Aligned_cols=235  Identities=22%  Similarity=0.286  Sum_probs=196.3

Q ss_pred             EEecccCceEEEEEEEcCCC----------eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          156 KVVGQGAFGRVYQVRKKNTS----------EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~----------~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      +.||+|+||.||+|.++.++          ..+++|++.....    ....+.+|+.++++++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            36999999999999998776          3578887764431    14567889999999999999999999988 778


Q ss_pred             EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC-------ceeEcccCcc
Q 047009          226 YLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG-------HVMLTDFGLA  297 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g-------~vKL~DFGla  297 (482)
                      ++||||+++|+|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++       .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998766 789999999999999999999999999999999999999888       8999999999


Q ss_pred             ccccCCCCCcccccCCCCCchhhhcCC--CCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcccCCCccCCh
Q 047009          298 KQFDENTRSNSMIGTVEYMAPEIVLGK--GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLSS  374 (482)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~  374 (482)
                      .....   .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||...+......... .....+.....
T Consensus       156 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  231 (259)
T cd05037         156 ITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCA  231 (259)
T ss_pred             ccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCch
Confidence            87543   2344577889999999887  78999999999999999999 688887765443333222 22233333458


Q ss_pred             HHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          375 EAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       375 ~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+.++|.+||..+|.+||++     .++++
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~-----~~il~  256 (259)
T cd05037         232 ELANLINQCWTYDPTKRPSF-----RAILR  256 (259)
T ss_pred             HHHHHHHHHhccChhhCCCH-----HHHHH
Confidence            99999999999999999998     78764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.4e-39  Score=316.98  Aligned_cols=240  Identities=24%  Similarity=0.358  Sum_probs=193.0

Q ss_pred             EecccCceEEEEEEEcC--CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          157 VVGQGAFGRVYQVRKKN--TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       157 ~LG~G~fg~Vy~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      .||+|+||.||+|....  ....+|+|.+....  .......+.+|+.+++.++|+||+++++.+.....+|+||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            59999999999997543  34578888876432  223345577899999999999999999999999999999999999


Q ss_pred             CchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC---CC
Q 047009          235 GHLFFQLYHHG-----LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT---RS  306 (482)
Q Consensus       235 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~---~~  306 (482)
                      |+|..++....     .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......   ..
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence            99999987643     24677888999999999999999999999999999999999999999999987542221   12


Q ss_pred             cccccCCCCCchhhhcC-------CCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHh-cccC-----CCccC
Q 047009          307 NSMIGTVEYMAPEIVLG-------KGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLR-----LPAFL  372 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~-------~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~-~~~~-----~p~~~  372 (482)
                      ....++..|+|||++..       ..++.++|||||||++|||++ |..||......+....+.. ....     ++..+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY  239 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence            33456778999999753       356889999999999999999 8899987766555444433 3222     23457


Q ss_pred             ChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       373 s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +..+.+++..|+ .||.+||++     ++|++
T Consensus       240 ~~~~~~~~~~~~-~dp~~Rpt~-----~~v~~  265 (269)
T cd05042         240 SDRWYEVMQFCW-LDPETRPTA-----EEVHE  265 (269)
T ss_pred             CHHHHHHHHHHh-cCcccccCH-----HHHHH
Confidence            889999999999 599999998     77764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-41  Score=328.47  Aligned_cols=253  Identities=28%  Similarity=0.511  Sum_probs=212.3

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCC--C----ceeeeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH--P----FVVQLKYSFQ  220 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~h--p----nIv~l~~~~~  220 (482)
                      ...++|++++++|+|.||+|..+.+..++..||||+++.-    ....+..+-|+++|.++++  |    -+|++.++|.
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            4468999999999999999999999999999999998743    2455666779999999942  2    3788899999


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc-------------
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA-------------  285 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~-------------  285 (482)
                      ..++.|||+|.+ |-++++++..++  +++...++.++.|++.+++|||+.+++|-||||+|||+.+             
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence            999999999998 558999998765  5899999999999999999999999999999999999942             


Q ss_pred             -------CCceeEcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHH--
Q 047009          286 -------DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAK--  356 (482)
Q Consensus       286 -------~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~--  356 (482)
                             +-.|||+|||.|+.-.+..  .+.+.|..|+|||++.+-+++..+||||+||||+||.+|...|...+..+  
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                   2368999999998754433  67889999999999999999999999999999999999999998765443  


Q ss_pred             -HHHHHHhc------------------ccCCCcc-------------------------CChHHHHHHHHhhccCcCCcC
Q 047009          357 -IQQKIVKD------------------KLRLPAF-------------------------LSSEAHSLLKGLLQKEPGKRL  392 (482)
Q Consensus       357 -~~~~i~~~------------------~~~~p~~-------------------------~s~~~~~LI~~~L~~dP~~R~  392 (482)
                       ++++|+..                  ++..|..                         --.++.|||++||.+||.+|+
T Consensus       319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri  398 (415)
T KOG0671|consen  319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI  398 (415)
T ss_pred             HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence             55555531                  1111111                         124678999999999999999


Q ss_pred             CCCCCChHHHHhCcCCCCC
Q 047009          393 GAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       393 s~~~~~~~eil~hp~f~~~  411 (482)
                      |+     .|++.||||+..
T Consensus       399 Tl-----~EAL~HpFF~~~  412 (415)
T KOG0671|consen  399 TL-----REALSHPFFARL  412 (415)
T ss_pred             cH-----HHHhcCHHhhcC
Confidence            99     999999999864

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.7e-39  Score=315.86  Aligned_cols=241  Identities=24%  Similarity=0.335  Sum_probs=193.9

Q ss_pred             EEecccCceEEEEEEEcC--CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecC
Q 047009          156 KVVGQGAFGRVYQVRKKN--TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFIN  233 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~  233 (482)
                      +.||+|+||.||+|....  ++..+|+|.++....  ......+.+|+.++++++||||+++++++.+...+++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            358999999999998653  457899998875432  2233457789999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC---C
Q 047009          234 GGHLFFQLYHHG-----LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT---R  305 (482)
Q Consensus       234 gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~---~  305 (482)
                      +|+|..++....     .+++..++.++.|++.||+|||++|++||||||+||+++.++++||+|||+++......   .
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999999886532     35667788899999999999999999999999999999999999999999997643221   1


Q ss_pred             CcccccCCCCCchhhhcCC-------CCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHh-cccCCC-----cc
Q 047009          306 SNSMIGTVEYMAPEIVLGK-------GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLP-----AF  371 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~-------~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~-~~~~~p-----~~  371 (482)
                      .....|+..|+|||++.+.       .++.++||||||+++|||++ |+.||...+..+....... ....++     ..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            2335678899999998643       35789999999999999996 9999977665554433322 222222     24


Q ss_pred             CChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       372 ~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+..+.+++..|+ .+|.+||++     ++|..
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rpt~-----~~l~~  265 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRPSA-----EEVHL  265 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCCCH-----HHHHH
Confidence            6788999999999 689999999     77763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.5e-39  Score=316.01  Aligned_cols=247  Identities=23%  Similarity=0.378  Sum_probs=205.4

Q ss_pred             eEEEEEecccCceEEEEEEEc---CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC-----
Q 047009          152 FEVLKVVGQGAFGRVYQVRKK---NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY-----  223 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  223 (482)
                      |.+.+.||+|+||.||+|.++   .+++.||||++..+.. .....+.+.+|+.++++++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            567889999999999999864   3578999999976532 2334566788999999999999999999875432     


Q ss_pred             -eEEEEEEecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCc
Q 047009          224 -RLYLVLDFINGGHLFFQLYHH------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGL  296 (482)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGl  296 (482)
                       ..++++||+.+|+|..++...      ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             247899999999998776432      2478889999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCcc
Q 047009          297 AKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAF  371 (482)
Q Consensus       297 a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~  371 (482)
                      ++......   ......+++.|++||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+... ....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPD  239 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence            98754322   1223345678999999999999999999999999999999 99999888777776666554 3455567


Q ss_pred             CChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       372 ~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+..+.+++.+||+.+|++||++     .+++.
T Consensus       240 ~~~~~~~l~~~~l~~~p~~Rps~-----~~~~~  267 (273)
T cd05074         240 CLEDVYELMCQCWSPEPKCRPSF-----QHLRD  267 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            88999999999999999999998     77765

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1e-38  Score=317.90  Aligned_cols=251  Identities=16%  Similarity=0.215  Sum_probs=193.0

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCC---CeEEEEEEeechhhchhhH--------HHHHHHHHHHHHhCCCCceeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNT---SEIYAMKVMRKDKIVEKNH--------AEYMKAERDILTKIDHPFVVQL  215 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~~~~~~~~~~~~--------~~~~~~E~~il~~l~hpnIv~l  215 (482)
                      +.-++|++.+.||+|+||+||+|++..+   +..+|+|+...........        ......+...+..++|++|+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            3346899999999999999999999887   6778888654322110000        0111223344566789999999


Q ss_pred             eeeeecCC----eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeE
Q 047009          216 KYSFQTKY----RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVML  291 (482)
Q Consensus       216 ~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL  291 (482)
                      ++++....    ..++++|++.. ++...+.....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            98765443    34778887754 56556655556788889999999999999999999999999999999999999999


Q ss_pred             cccCccccccCCC--------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch-H-------
Q 047009          292 TDFGLAKQFDENT--------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR-A-------  355 (482)
Q Consensus       292 ~DFGla~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~-~-------  355 (482)
                      +|||+|+.+....        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+. .       
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            9999998753221        12335799999999999999999999999999999999999999987632 2       


Q ss_pred             -HHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          356 -KIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       356 -~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                       +....+..+...+ ...++++.++++.|++.+|.+||+.     ++|++
T Consensus       248 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~-----~~l~~  291 (294)
T PHA02882        248 CDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDY-----DALIK  291 (294)
T ss_pred             HHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCH-----HHHHH
Confidence             2233444444433 3468999999999999999999998     77764

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.8e-39  Score=315.66  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=205.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcC----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec--CC
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKN----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT--KY  223 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~  223 (482)
                      .+|++.+.||+|+||.||+|++..    +++.||+|++......  ...+.+.+|+.+++.++|+||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            578889999999999999998653    4789999999865432  345678899999999999999999998877  56


Q ss_pred             eEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 RLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..++||||+++++|..++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            7899999999999999987654 589999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCC----cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHH---------------HHHHHHh
Q 047009          303 NTRS----NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAK---------------IQQKIVK  363 (482)
Q Consensus       303 ~~~~----~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~---------------~~~~i~~  363 (482)
                      ....    ....++..|+|||.+.+..++.++||||||+++|||++|..||.......               +...+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            2211    12344567999999998899999999999999999999999986532211               1122221


Q ss_pred             c-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          364 D-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       364 ~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      . ....+..++.++.+|+.+||+.+|.+||++     .||++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-----~ei~~  278 (284)
T cd05038         242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSF-----ADLIL  278 (284)
T ss_pred             CCcCCCCccCCHHHHHHHHHHhccChhhCCCH-----HHHHH
Confidence            1 223345678899999999999999999998     77764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.5e-40  Score=358.91  Aligned_cols=251  Identities=32%  Similarity=0.514  Sum_probs=209.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec-------
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT-------  221 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-------  221 (482)
                      ..+|+.++.||+||||.||+|+++-+|+.||||.+....  .......+.+|+.+|.+|+|||||+++..|..       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            578999999999999999999999999999999998764  44556678899999999999999997542100       


Q ss_pred             --------------------------------------------------------------------------------
Q 047009          222 --------------------------------------------------------------------------------  221 (482)
Q Consensus       222 --------------------------------------------------------------------------------  221 (482)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CeEEEEEEecCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHH
Q 047009          222 ------------------------K--------YRLYLVLDFINGGHLFFQLYHHGLF-REDLARIYAAEIVSAVSHLHA  268 (482)
Q Consensus       222 ------------------------~--------~~~~lV~E~~~gg~L~~~l~~~~~l-~~~~~~~i~~qi~~aL~yLH~  268 (482)
                                              +        ..+||-||||+...+.+.+.++... ..+.++.+++||+.||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                    0        1368999999987777777666554 578899999999999999999


Q ss_pred             CCCcccCCCCCcEEEccCCceeEcccCcccccc-------------------CCCCCcccccCCCCCchhhhcCCC---C
Q 047009          269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-------------------ENTRSNSMIGTVEYMAPEIVLGKG---H  326 (482)
Q Consensus       269 ~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-------------------~~~~~~~~~gt~~y~APE~l~~~~---~  326 (482)
                      +|||||||||.||+|++++.|||+|||+|+...                   .....+..+||.-|+|||++.+..   |
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            999999999999999999999999999998721                   111345679999999999998755   9


Q ss_pred             CchhHHHHHhHHHHHHhhCCCCCC-CCchHHHHHHHHhcccCCCccC----ChHHHHHHHHhhccCcCCcCCCCCCChHH
Q 047009          327 NKAADWWSVGILLYEMLTGKPPFI-GGNRAKIQQKIVKDKLRLPAFL----SSEAHSLLKGLLQKEPGKRLGAGPKGSEE  401 (482)
Q Consensus       327 ~~~sDvwSlGvilyelltG~~PF~-~~~~~~~~~~i~~~~~~~p~~~----s~~~~~LI~~~L~~dP~~R~s~~~~~~~e  401 (482)
                      +.|+|+||||||++||+.   ||. ...+..+..++.++.++.|..+    -+.-..+|++||++||++||||     .|
T Consensus       796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA-----~e  867 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA-----TE  867 (1351)
T ss_pred             cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH-----HH
Confidence            999999999999999986   463 3566677788887777766322    3456889999999999999999     99


Q ss_pred             HHhCcCCC
Q 047009          402 IKSHKWFK  409 (482)
Q Consensus       402 il~hp~f~  409 (482)
                      +|++.||-
T Consensus       868 LL~s~llp  875 (1351)
T KOG1035|consen  868 LLNSELLP  875 (1351)
T ss_pred             HhhccCCC
Confidence            99999998

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.5e-40  Score=316.86  Aligned_cols=256  Identities=30%  Similarity=0.534  Sum_probs=207.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCC----eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec-CC
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT-KY  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~  223 (482)
                      ...|+++..||+|+||.||+|..++++    +.||||.++.++.. .......-+|+.+++.++|||++.|..+|.+ +.
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            356999999999999999999666553    37999998765321 1223345689999999999999999999977 78


Q ss_pred             eEEEEEEecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC----CceeEccc
Q 047009          224 RLYLVLDFINGGHLFFQLYHH-----GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD----GHVMLTDF  294 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~----g~vKL~DF  294 (482)
                      .+++++||++. +|...+..+     ..++...++.++.||+.|+.|||++-|+||||||.|||+..+    |.|||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            89999999987 787777543     358999999999999999999999999999999999999988    89999999


Q ss_pred             CccccccCC----CCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCch---------HHHHHH
Q 047009          295 GLAKQFDEN----TRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNR---------AKIQQK  360 (482)
Q Consensus       295 Gla~~~~~~----~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~---------~~~~~~  360 (482)
                      |+++.+...    ......+-|..|+|||.+.| +.|+.+.||||+|||+.||+|-++.|.+...         .+..++
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            999987532    22345678999999999998 4689999999999999999999999976421         123333


Q ss_pred             HHhc-----------ccCCCc--------------------------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHH
Q 047009          361 IVKD-----------KLRLPA--------------------------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIK  403 (482)
Q Consensus       361 i~~~-----------~~~~p~--------------------------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil  403 (482)
                      |.+-           -..+|.                          .-++.+.+|+.+||.+||.+|+++     ++++
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta-----~qAl  335 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA-----EQAL  335 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH-----HHHh
Confidence            4331           001111                          125568999999999999999999     9999


Q ss_pred             hCcCCCCC
Q 047009          404 SHKWFKPI  411 (482)
Q Consensus       404 ~hp~f~~~  411 (482)
                      +|+||..-
T Consensus       336 eh~yF~~d  343 (438)
T KOG0666|consen  336 EHPYFTED  343 (438)
T ss_pred             cccccccC
Confidence            99999864

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-40  Score=334.10  Aligned_cols=239  Identities=25%  Similarity=0.440  Sum_probs=210.8

Q ss_pred             EEEEEecccCceEEEEEEEcCC----CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          153 EVLKVVGQGAFGRVYQVRKKNT----SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       153 ~i~~~LG~G~fg~Vy~a~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .+.++||.|.||.||+|....-    .-.||||..+.+.  ..+..+.+..|..+|+.++|||||+|+|+|... ..|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence            3456799999999999986442    3469999988764  344577889999999999999999999999765 57899


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCc
Q 047009          229 LDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  307 (482)
                      ||.++-|.|..+|+.++ .++......|+.||+.||+|||++++|||||..+|||+.+...+||+|||+++.+.+.....
T Consensus       469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk  548 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK  548 (974)
T ss_pred             EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence            99999999999998764 68888899999999999999999999999999999999999999999999999987765544


Q ss_pred             cccc--CCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHh
Q 047009          308 SMIG--TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       308 ~~~g--t~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~  383 (482)
                      ...|  ...|||||.+.-+.++.++|||.|||.+||++. |..||.+....+..-.|-++ +++.|+.+++.+..|+.+|
T Consensus       549 aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskc  628 (974)
T KOG4257|consen  549 ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKC  628 (974)
T ss_pred             ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHH
Confidence            4444  568999999999999999999999999999886 99999998877777666665 7889999999999999999


Q ss_pred             hccCcCCcCCC
Q 047009          384 LQKEPGKRLGA  394 (482)
Q Consensus       384 L~~dP~~R~s~  394 (482)
                      |.+||.+||.+
T Consensus       629 WayeP~kRPrf  639 (974)
T KOG4257|consen  629 WAYEPSKRPRF  639 (974)
T ss_pred             hccCcccCCcH
Confidence            99999999998

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.6e-38  Score=310.07  Aligned_cols=240  Identities=22%  Similarity=0.332  Sum_probs=192.8

Q ss_pred             EecccCceEEEEEEEcCCC--eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCC
Q 047009          157 VVGQGAFGRVYQVRKKNTS--EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFING  234 (482)
Q Consensus       157 ~LG~G~fg~Vy~a~~~~~~--~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g  234 (482)
                      .||+|+||+||+|+...++  ..+++|.+....  .....+.+.+|+.+++.++||||+++++.+.+....|+||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            5999999999999764432  356677665432  223456788899999999999999999999999999999999999


Q ss_pred             CchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC---CCCc
Q 047009          235 GHLFFQLYHH----GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSN  307 (482)
Q Consensus       235 g~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~---~~~~  307 (482)
                      |+|..++.+.    ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++......   ....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence            9999988764    23566778889999999999999999999999999999999999999999998653211   1223


Q ss_pred             ccccCCCCCchhhhcC-------CCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-c-----cCCCccCC
Q 047009          308 SMIGTVEYMAPEIVLG-------KGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-K-----LRLPAFLS  373 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~-------~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~-----~~~p~~~s  373 (482)
                      ..+|+..|+|||++..       ..++.++||||||+++|||++ |..||...+..+....+.++ .     ..++..++
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS  239 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence            4678899999999853       235779999999999999997 67899777766665554443 2     22334578


Q ss_pred             hHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       374 ~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +.+.+++..|| .+|.+||++     ++|++
T Consensus       240 ~~~~~l~~~c~-~~P~~Rp~~-----~~i~~  264 (268)
T cd05086         240 ERWYEVLQFCW-LSPEKRATA-----EEVHR  264 (268)
T ss_pred             HHHHHHHHHHh-hCcccCCCH-----HHHHH
Confidence            99999999999 689999998     77754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=311.90  Aligned_cols=254  Identities=25%  Similarity=0.406  Sum_probs=210.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHh-CCCCceeeeeeeeecCCeEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK-IDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      ++.+-+..||.|+||+|++..++.+|+..|||.++....  .....++..|.+...+ -+.||||+++|..-.++.+|+.
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC  141 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC  141 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence            455566789999999999999999999999999987653  3445566777776544 5799999999999999999999


Q ss_pred             EEecCCCchHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          229 LDFINGGHLFFQL-----YHHGLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       229 ~E~~~gg~L~~~l-----~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ||+|.- +|..+.     .++..++|..+-.|+...+.||.||.+. +|||||+||+||||+..|.+||||||++..+.+
T Consensus       142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            999964 443221     2346799999999999999999999975 899999999999999999999999999998877


Q ss_pred             CCCCcccccCCCCCchhhhcC--CCCCchhHHHHHhHHHHHHhhCCCCCCCCc-hHHHHHHHHhcccCC---Cc---cCC
Q 047009          303 NTRSNSMIGTVEYMAPEIVLG--KGHNKAADWWSVGILLYEMLTGKPPFIGGN-RAKIQQKIVKDKLRL---PA---FLS  373 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwSlGvilyelltG~~PF~~~~-~~~~~~~i~~~~~~~---p~---~~s  373 (482)
                      +-..+...|...|||||.+..  .+|+.++|+||||++|||+.||+.||.+-+ ..+....+..+.++.   +.   .++
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s  300 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS  300 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence            766777889999999999964  569999999999999999999999996533 334444444444332   22   278


Q ss_pred             hHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       374 ~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      ..+..+|..||.+|-+.||..     .+++++||++..
T Consensus       301 ~~~~~fintCl~Kd~~~Rpky-----~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  301 FSMVRFINTCLIKDRSDRPKY-----DDLKKFPFYRMY  333 (361)
T ss_pred             HHHHHHHHHHhhcccccCcch-----hhhhcCchhhhh
Confidence            999999999999999999999     999999999753

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=338.38  Aligned_cols=242  Identities=37%  Similarity=0.532  Sum_probs=200.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC------
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY------  223 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------  223 (482)
                      ..+..-+.||+|+||.||+++++.+|+.||||.+++..  .....+...+|+++|++++|+|||++.++=++..      
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            34666788999999999999999999999999998754  3455677889999999999999999988765543      


Q ss_pred             eEEEEEEecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc--CC--ceeEcccCc
Q 047009          224 RLYLVLDFINGGHLFFQLYHH---GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA--DG--HVMLTDFGL  296 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~--~g--~vKL~DFGl  296 (482)
                      .-.+|||||.||+|+..|.+-   ..+++.+...+...++.||.|||++||+||||||.||++-.  +|  ..||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            457999999999999999752   45999999999999999999999999999999999999953  34  479999999


Q ss_pred             cccccCCCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCc----hHHHHHHHHhc-------
Q 047009          297 AKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN----RAKIQQKIVKD-------  364 (482)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~----~~~~~~~i~~~-------  364 (482)
                      |+.++++....+.+||..|++||++.. +.|+..+|.|||||++|+++||..||....    ..++...+...       
T Consensus       171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i  250 (732)
T KOG4250|consen  171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI  250 (732)
T ss_pred             cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence            999999999999999999999999994 889999999999999999999999995421    22233333221       


Q ss_pred             --------------ccCCCccCChHH----HHHHHHhhccCcCCcCC
Q 047009          365 --------------KLRLPAFLSSEA----HSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       365 --------------~~~~p~~~s~~~----~~LI~~~L~~dP~~R~s  393 (482)
                                    .+++|..++..+    -..+..+|..+|.+|..
T Consensus       251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~  297 (732)
T KOG4250|consen  251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH  297 (732)
T ss_pred             eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence                          123344444443    45677788999999984

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.5e-37  Score=296.07  Aligned_cols=240  Identities=50%  Similarity=0.830  Sum_probs=213.4

Q ss_pred             CceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCCchHHHH
Q 047009          162 AFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL  241 (482)
Q Consensus       162 ~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l  241 (482)
                      +||.||+|.+..+++.+|+|++........  .+.+.+|+..+++++|+||+++++.+......++++||+.+++|..++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999999999999999999976543221  567889999999999999999999999999999999999999999998


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccccCCCCCchhhh
Q 047009          242 YHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV  321 (482)
Q Consensus       242 ~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l  321 (482)
                      .....+++..+..++.+++.+|.|||+.+|+|+||+|.||+++.++.++|+|||.+.............++..|++||.+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            87766899999999999999999999999999999999999999999999999999987665455667889999999999


Q ss_pred             cCCCCCchhHHHHHhHHHHHHhhCCCCCCC-CchHHHHHHHHhcccCCCcc---CChHHHHHHHHhhccCcCCcCCCCCC
Q 047009          322 LGKGHNKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDKLRLPAF---LSSEAHSLLKGLLQKEPGKRLGAGPK  397 (482)
Q Consensus       322 ~~~~~~~~sDvwSlGvilyelltG~~PF~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~LI~~~L~~dP~~R~s~~~~  397 (482)
                      .+..++.++|+||||+++|+|++|..||.. .+.....+.+..........   ++.++.+++.+||..+|++||++   
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~---  235 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA---  235 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCH---
Confidence            988899999999999999999999999987 55666666666555544433   88999999999999999999999   


Q ss_pred             ChHHHHhCcCC
Q 047009          398 GSEEIKSHKWF  408 (482)
Q Consensus       398 ~~~eil~hp~f  408 (482)
                        .++++||||
T Consensus       236 --~~~~~~~~~  244 (244)
T smart00220      236 --EEALQHPFF  244 (244)
T ss_pred             --HHHhhCCCC
Confidence              999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=9.9e-38  Score=336.48  Aligned_cols=257  Identities=20%  Similarity=0.306  Sum_probs=184.1

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCC----CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeee---
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNT----SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYS---  218 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~---  218 (482)
                      ....++|++.+.||+|+||.||+|++..+    +..||+|.+.....     .+....|  .+....+.++..+...   
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            34678999999999999999999999998    89999998764321     1111111  1122222233222222   


Q ss_pred             ---eecCCeEEEEEEecCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 047009          219 ---FQTKYRLYLVLDFINGGHLFFQLYHHGL--------------------FREDLARIYAAEIVSAVSHLHANGIMHRD  275 (482)
Q Consensus       219 ---~~~~~~~~lV~E~~~gg~L~~~l~~~~~--------------------l~~~~~~~i~~qi~~aL~yLH~~~IiHrD  275 (482)
                         ......+++||||+.+++|.+++.....                    ..+..++.++.||+.||+|||++||+|||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence               2456679999999999999988865421                    12344667999999999999999999999


Q ss_pred             CCCCcEEEcc-CCceeEcccCccccccCC--CCCcccccCCCCCchhhhcCCC----------------------CCchh
Q 047009          276 LKPENILLGA-DGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG----------------------HNKAA  330 (482)
Q Consensus       276 LKp~NILl~~-~g~vKL~DFGla~~~~~~--~~~~~~~gt~~y~APE~l~~~~----------------------~~~~s  330 (482)
                      |||+|||++. ++.+||+|||+|+.+...  ......+||+.|||||.+....                      ++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999986 589999999999865432  2345678999999999764332                      34466


Q ss_pred             HHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc---------------------CCCccCChHHHHHHHHhhccCcC
Q 047009          331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL---------------------RLPAFLSSEAHSLLKGLLQKEPG  389 (482)
Q Consensus       331 DvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~---------------------~~p~~~s~~~~~LI~~~L~~dP~  389 (482)
                      |||||||+||||+++..++... .......+.....                     .+....+....+||++||++||+
T Consensus       361 DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            9999999999999987765321 1111111111110                     00111233456899999999999


Q ss_pred             CcCCCCCCChHHHHhCcCCCCCChhh
Q 047009          390 KRLGAGPKGSEEIKSHKWFKPINWKK  415 (482)
Q Consensus       390 ~R~s~~~~~~~eil~hp~f~~~~~~~  415 (482)
                      +||++     .++++||||.+..+..
T Consensus       440 kR~ta-----~e~L~Hpff~~~~~~~  460 (566)
T PLN03225        440 QRISA-----KAALAHPYFDREGLLG  460 (566)
T ss_pred             cCCCH-----HHHhCCcCcCCCCccc
Confidence            99999     9999999999887753

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=320.72  Aligned_cols=257  Identities=30%  Similarity=0.499  Sum_probs=216.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhch----hhHHHHHHHHHHHHHhCCCCceeeeeeeee-cCC
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE----KNHAEYMKAERDILTKIDHPFVVQLKYSFQ-TKY  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~  223 (482)
                      -++|-++.+||+|||+.||+|-+....++||+|+-...+.+.    .+..+...+|.+|-+.|+||.||++|++|. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            467999999999999999999999999999999976544332    345566778999999999999999999995 667


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCCCCcEEEcc---CCceeEcccCccc
Q 047009          224 RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN--GIMHRDLKPENILLGA---DGHVMLTDFGLAK  298 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~IiHrDLKp~NILl~~---~g~vKL~DFGla~  298 (482)
                      ..|-|+|||+|.+|..+|..+..+++.+++.|+.||+.||.||.+.  .|||-||||.||||-.   .|.+||+|||+++
T Consensus       542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence            7899999999999999999999999999999999999999999987  5999999999999953   4789999999999


Q ss_pred             cccCCCC--------CcccccCCCCCchhhhcCC----CCCchhHHHHHhHHHHHHhhCCCCCCCCch-HHHHH--HHHh
Q 047009          299 QFDENTR--------SNSMIGTVEYMAPEIVLGK----GHNKAADWWSVGILLYEMLTGKPPFIGGNR-AKIQQ--KIVK  363 (482)
Q Consensus       299 ~~~~~~~--------~~~~~gt~~y~APE~l~~~----~~~~~sDvwSlGvilyelltG~~PF~~~~~-~~~~~--~i~~  363 (482)
                      .++....        +....||..|++||.+.-.    ..+.++||||+|||+|.++.|+.||...-. .++.+  .|++
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk  701 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK  701 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence            9864322        3456899999999998532    468899999999999999999999954322 22222  2333


Q ss_pred             c-ccCCC--ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          364 D-KLRLP--AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       364 ~-~~~~p--~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      . ...||  +.++.++++||++||++.-+.|...     .++-.||||..
T Consensus       702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV-----~qLA~dpyllP  746 (775)
T KOG1151|consen  702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDV-----QQLACDPYLLP  746 (775)
T ss_pred             ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhH-----HHHccCccccc
Confidence            2 34555  5699999999999999999999887     89999999976

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=329.15  Aligned_cols=245  Identities=25%  Similarity=0.415  Sum_probs=218.3

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCC---eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTS---EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      +..++..+.++||+|.||.|++|.|+..+   ..||||.++.+....  ....|.+|+.+|.+|+|+|+|+||+...+ .
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-q  183 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q  183 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence            34567788899999999999999987632   579999998776432  56678999999999999999999999987 6


Q ss_pred             eEEEEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          224 RLYLVLDFINGGHLFFQLYH--HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      .+.+|||++++|+|.+.|.+  +..|....+..|+.||+.||.||.++++|||||..+|+||-....|||+|||+.+.+.
T Consensus       184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence            77899999999999999987  3568888999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCccccc----CCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChH
Q 047009          302 ENTRSNSMIG----TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSE  375 (482)
Q Consensus       302 ~~~~~~~~~g----t~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~  375 (482)
                      .++....+.+    ...|+|||.++...++.++|||++||++|||++ |+.||.|.....+.++|-++ ++.-|..++..
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csed  343 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSED  343 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHH
Confidence            7766554433    457999999999999999999999999999998 99999999999999988754 56778899999


Q ss_pred             HHHHHHHhhccCcCCcCCC
Q 047009          376 AHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~  394 (482)
                      +.++++.||..+|.+||++
T Consensus       344 IY~imk~cWah~paDRptF  362 (1039)
T KOG0199|consen  344 IYQIMKNCWAHNPADRPTF  362 (1039)
T ss_pred             HHHHHHHhccCCccccccH
Confidence            9999999999999999998

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-40  Score=303.82  Aligned_cols=255  Identities=31%  Similarity=0.488  Sum_probs=210.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec-------
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT-------  221 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-------  221 (482)
                      .+.|+-+.+||+|.||.||+|+.+++|+.||+|++-.+.. ....-....+|+++|..|+|+|++.++..|.+       
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            4568888999999999999999999999999997654321 11222345689999999999999999887743       


Q ss_pred             -CCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          222 -KYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       222 -~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                       ...+|+||++|+. +|.-.|... .+++...++.++.+++.||.|+|+..|+|||+|++|+||+.+|.+||+|||+++.
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence             2358999999986 788777655 5799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCC-----CCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHh--cc------
Q 047009          300 FDENT-----RSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK--DK------  365 (482)
Q Consensus       300 ~~~~~-----~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~--~~------  365 (482)
                      +....     ..+..+-|..|++||.+.| +.|+++.|||+-|||+.||++|.+-|.+.+.......|..  +.      
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            64322     2344566999999999988 5799999999999999999999999988877666655543  10      


Q ss_pred             -----------cC---CCc-------------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          366 -----------LR---LPA-------------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       366 -----------~~---~p~-------------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                                 +.   +|.             .-++++.+|+.+||..||.+|+.+     .++++|.||..
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~a-----d~alnh~~F~k  320 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDA-----DQALNHDFFWK  320 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcch-----Hhhhchhhhhc
Confidence                       10   111             125689999999999999999998     99999999964

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-38  Score=331.91  Aligned_cols=254  Identities=30%  Similarity=0.520  Sum_probs=222.6

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeee-----cC
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQ-----TK  222 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----~~  222 (482)
                      .+-|++..+||+|.+|+||+++.+.+++..|+|++....    ...+.++.|.+||+.+ +|||++.++++|.     ..
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            467999999999999999999999999999999987654    3445577899999987 6999999999984     35


Q ss_pred             CeEEEEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc
Q 047009          223 YRLYLVLDFINGGHLFFQLYH--HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF  300 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~  300 (482)
                      +.+|||||||.||+.-+++..  ...+.|..+..|+++++.||.+||.+.+||||||=.|||++.+|.|||+|||.+..+
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            689999999999999887765  356899999999999999999999999999999999999999999999999999887


Q ss_pred             cC-CCCCcccccCCCCCchhhhcC-----CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc---CCCcc
Q 047009          301 DE-NTRSNSMIGTVEYMAPEIVLG-----KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL---RLPAF  371 (482)
Q Consensus       301 ~~-~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~---~~p~~  371 (482)
                      +. -.+.++.+|||.|||||++..     ..|+..+|+||||++..||.-|.+|+.+..+....-.|-.+.+   .-|..
T Consensus       174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k  253 (953)
T KOG0587|consen  174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK  253 (953)
T ss_pred             ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence            53 345678899999999999964     3578899999999999999999999998888777766665532   33567


Q ss_pred             CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       372 ~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      +++++.+||..||.+|-.+||+.     .++++|||+..-
T Consensus       254 Ws~~FndFIs~cL~Kd~e~RP~~-----~~ll~hpFi~e~  288 (953)
T KOG0587|consen  254 WSKKFNDFISTCLVKDYEQRPST-----EELLKHPFITEQ  288 (953)
T ss_pred             HHHHHHHHHHHHHhhccccCcch-----hhhccCCccccc
Confidence            89999999999999999999998     899999999843

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-38  Score=318.75  Aligned_cols=241  Identities=25%  Similarity=0.386  Sum_probs=216.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      .+.....+||-|.||.||.|.|+...-.||||.++.+.    ...+.+..|+.+|+.++|||+|+|+++|..+...|||+
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence            46677889999999999999999988999999987653    56777889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCc
Q 047009          230 DFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN  307 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  307 (482)
                      |||..|+|.++|+...  .++.-.+..++.||..||+||..+++|||||..+|+|+.++..+|++|||+++.+.....+.
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence            9999999999998754  36667778889999999999999999999999999999999999999999999986554432


Q ss_pred             c--cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHh
Q 047009          308 S--MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       308 ~--~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~  383 (482)
                      .  .--...|.|||-+....++.++|||+|||+|||+.| |..||.+.+....+.-+-++ ++.-|..+++....|++.|
T Consensus       423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraC  502 (1157)
T KOG4278|consen  423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRAC  502 (1157)
T ss_pred             ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHH
Confidence            1  122568999999999999999999999999999998 99999999999988887776 5677899999999999999


Q ss_pred             hccCcCCcCCC
Q 047009          384 LQKEPGKRLGA  394 (482)
Q Consensus       384 L~~dP~~R~s~  394 (482)
                      |+..|..||++
T Consensus       503 W~WsPsDRPsF  513 (1157)
T KOG4278|consen  503 WNWSPSDRPSF  513 (1157)
T ss_pred             hcCCcccCccH
Confidence            99999999998

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=328.85  Aligned_cols=251  Identities=23%  Similarity=0.386  Sum_probs=222.6

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCC---eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTS---EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      +......|.++||.|.||.|++|+.+..|   ..||||.++...  .......|..|+.||-+.+||||++|.++.....
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK  703 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence            34567889999999999999999998766   579999997653  3445666889999999999999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 RLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      .+.||.|||++|+|..+|+.+ +.|...++.-+++.|+.||.||-+.|.|||||..+|||++.+-.+|++|||+++.+.+
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence            999999999999999999876 6799999999999999999999999999999999999999999999999999998755


Q ss_pred             CC-CCcc-ccc--CCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHH
Q 047009          303 NT-RSNS-MIG--TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEA  376 (482)
Q Consensus       303 ~~-~~~~-~~g--t~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (482)
                      +. ...+ .-|  ...|.|||.|..+.++.++||||+||+|||.++ |..||-+.+..+.++.|.++ +++-|..++..+
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL  863 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAAL  863 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHH
Confidence            43 2222 222  468999999999999999999999999999886 99999999999999988876 556667899999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ..|+..||++|-.+||.+     .+|..
T Consensus       864 ~qLMldCWqkdR~~RP~F-----~qiV~  886 (996)
T KOG0196|consen  864 YQLMLDCWQKDRNRRPKF-----AQIVS  886 (996)
T ss_pred             HHHHHHHHHHHhhcCCCH-----HHHHH
Confidence            999999999999999999     88875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.2e-38  Score=289.76  Aligned_cols=265  Identities=26%  Similarity=0.453  Sum_probs=219.2

Q ss_pred             ccccCCCcccccccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCce
Q 047009          134 DENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFV  212 (482)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnI  212 (482)
                      .+.+...+..+..-..++|++.+++|+|.|+.||.|....+.+.++||+++.-+      .+.+.+|+.||+.|. ||||
T Consensus        22 ~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NI   95 (338)
T KOG0668|consen   22 REYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNI   95 (338)
T ss_pred             hhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCe
Confidence            344444555555667899999999999999999999999999999999987532      345889999999997 9999


Q ss_pred             eeeeeeeecCC--eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC-Cce
Q 047009          213 VQLKYSFQTKY--RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD-GHV  289 (482)
Q Consensus       213 v~l~~~~~~~~--~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~-g~v  289 (482)
                      ++|++...+..  ...||+||+++.+...+.   ..++...++.|+.|+++||.|+|+.||+|||+||.|+++|.. ..+
T Consensus        96 i~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkL  172 (338)
T KOG0668|consen   96 IKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKL  172 (338)
T ss_pred             eehhhhhcCccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhcee
Confidence            99999987653  467999999987765433   457888899999999999999999999999999999999965 469


Q ss_pred             eEcccCccccccCCCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCC-CCchHHHHHHHHh----
Q 047009          290 MLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFI-GGNRAKIQQKIVK----  363 (482)
Q Consensus       290 KL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~-~~~~~~~~~~i~~----  363 (482)
                      +|+|+|+|.....+...+-.+.+..|--||.+.. ..|+.+-|+|||||++..|+..+.||. |.+..+..-+|.+    
T Consensus       173 rlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt  252 (338)
T KOG0668|consen  173 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGT  252 (338)
T ss_pred             eeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhCh
Confidence            9999999999888877788888999999999876 678999999999999999999998874 4443333333332    


Q ss_pred             ---------cccCCCc------------------------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          364 ---------DKLRLPA------------------------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       364 ---------~~~~~p~------------------------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                               -.+.+++                        -+++++.|||.++|.+|-.+|+|+     .|++.||||..
T Consensus       253 ~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTa-----kEam~HpyF~~  327 (338)
T KOG0668|consen  253 DELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTA-----KEAMAHPYFAP  327 (338)
T ss_pred             HHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccch-----HHHhcCchHHH
Confidence                     1222221                        157999999999999999999999     99999999987


Q ss_pred             CC
Q 047009          411 IN  412 (482)
Q Consensus       411 ~~  412 (482)
                      +.
T Consensus       328 ~~  329 (338)
T KOG0668|consen  328 VR  329 (338)
T ss_pred             HH
Confidence            53

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=315.70  Aligned_cols=246  Identities=22%  Similarity=0.346  Sum_probs=211.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      +...+.++||+|.||.|.++.... +..||+|+++.+.  ..+....+.+|+++|.+|+|||||+|+++|..++.+++|+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            456788999999999999998765 7899999998764  3455678999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC--
Q 047009          230 DFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR--  305 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~--  305 (482)
                      |||++|+|..++..+.  .+.......++.||+.||+||.+.++|||||.++|+|++.++++||+|||+++.+-.+..  
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            9999999999998873  334556677999999999999999999999999999999999999999999997643332  


Q ss_pred             -CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh--CCCCCCCCchHHHHHHHHh---c-----ccCCCccCCh
Q 047009          306 -SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT--GKPPFIGGNRAKIQQKIVK---D-----KLRLPAFLSS  374 (482)
Q Consensus       306 -~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt--G~~PF~~~~~~~~~~~i~~---~-----~~~~p~~~s~  374 (482)
                       ....+-...|||+|.+..+.++.++|+|+||+++||+++  ...||...+.++..++...   .     -+..|..++.
T Consensus       695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~  774 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ  774 (807)
T ss_pred             eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence             223455789999999999999999999999999999865  8899988777766655443   1     2345677999


Q ss_pred             HHHHHHHHhhccCcCCcCCCCCCChHHHH
Q 047009          375 EAHSLLKGLLQKEPGKRLGAGPKGSEEIK  403 (482)
Q Consensus       375 ~~~~LI~~~L~~dP~~R~s~~~~~~~eil  403 (482)
                      .+.+||..||.+|-++||++     +++-
T Consensus       775 ~lyelml~Cw~~es~~RPsF-----e~lh  798 (807)
T KOG1094|consen  775 GLYELMLRCWRRESEQRPSF-----EQLH  798 (807)
T ss_pred             HHHHHHHHHhchhhhcCCCH-----HHHH
Confidence            99999999999999999999     7763

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=3.8e-38  Score=316.95  Aligned_cols=260  Identities=29%  Similarity=0.424  Sum_probs=220.4

Q ss_pred             CcccccccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC------CCcee
Q 047009          140 DSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID------HPFVV  213 (482)
Q Consensus       140 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv  213 (482)
                      ..+.++.+.-++|.+....|+|-|++|..|++..-|..||||+|....+..+    .=+.|+.||++|+      --|++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K----tGl~EleiLkKL~~AD~Edk~Hcl  497 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK----TGLKELEILKKLNDADPEDKFHCL  497 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh----hhhHHHHHHHHhhccCchhhhHHH
Confidence            3566667777899999999999999999999999999999999987654322    2357999999995      36899


Q ss_pred             eeeeeeecCCeEEEEEEecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC-ce
Q 047009          214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL---FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG-HV  289 (482)
Q Consensus       214 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g-~v  289 (482)
                      +|+-.|...+++|||+|-+. .+|...|.+.|.   |....++.|+.|++.||..|...||+|.||||+|||+++.. .+
T Consensus       498 rl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  498 RLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCccee
Confidence            99999999999999999885 488888887653   78899999999999999999999999999999999998764 58


Q ss_pred             eEcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC
Q 047009          290 MLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP  369 (482)
Q Consensus       290 KL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p  369 (482)
                      ||||||.|....++..+ ...-+..|.|||++.|..|+...|+||+||+||||.||+..|.|.+...+..-.+.-+-.+|
T Consensus       577 KLCDfGSA~~~~eneit-PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p  655 (752)
T KOG0670|consen  577 KLCDFGSASFASENEIT-PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP  655 (752)
T ss_pred             eeccCcccccccccccc-HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence            99999999887766654 34557789999999999999999999999999999999999999887776655443222222


Q ss_pred             cc-----------------------------------------------------C-------ChHHHHHHHHhhccCcC
Q 047009          370 AF-----------------------------------------------------L-------SSEAHSLLKGLLQKEPG  389 (482)
Q Consensus       370 ~~-----------------------------------------------------~-------s~~~~~LI~~~L~~dP~  389 (482)
                      ..                                                     +       -..+++||.+||..||.
T Consensus       656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~  735 (752)
T KOG0670|consen  656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE  735 (752)
T ss_pred             HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence            10                                                     1       24688999999999999


Q ss_pred             CcCCCCCCChHHHHhCcCCCC
Q 047009          390 KRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       390 ~R~s~~~~~~~eil~hp~f~~  410 (482)
                      +|+++     .++|.||||..
T Consensus       736 KRit~-----nqAL~HpFi~~  751 (752)
T KOG0670|consen  736 KRITV-----NQALKHPFITE  751 (752)
T ss_pred             hcCCH-----HHHhcCCcccC
Confidence            99999     99999999974

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-36  Score=320.36  Aligned_cols=259  Identities=23%  Similarity=0.293  Sum_probs=191.3

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEc----------------CCCeEEEEEEeechhhchh-----------hHHHHHHH
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKK----------------NTSEIYAMKVMRKDKIVEK-----------NHAEYMKA  199 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~----------------~~~~~vAiK~~~~~~~~~~-----------~~~~~~~~  199 (482)
                      ...++|++.++||+|+||.||+|.+.                ..++.||||.+........           ...+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            45789999999999999999999752                2346799999865321110           01122334


Q ss_pred             HHHHHHhCCCCce-----eeeeeeeec--------CCeEEEEEEecCCCchHHHHHhc----------------------
Q 047009          200 ERDILTKIDHPFV-----VQLKYSFQT--------KYRLYLVLDFINGGHLFFQLYHH----------------------  244 (482)
Q Consensus       200 E~~il~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~l~~~----------------------  244 (482)
                      |+.++.+++|.++     ++++++|..        .+..+|||||+++|+|.+++...                      
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777778876654     566666642        35689999999999998887542                      


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCccc--ccCCCCCchhh
Q 047009          245 --GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM--IGTVEYMAPEI  320 (482)
Q Consensus       245 --~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~--~gt~~y~APE~  320 (482)
                        ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++...........  .+|+.|+|||.
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence              12355678889999999999999999999999999999999999999999999765443333333  34889999999


Q ss_pred             hcCCC--------------------C--CchhHHHHHhHHHHHHhhCCC-CCCCCchH-----------HHHHHHHhccc
Q 047009          321 VLGKG--------------------H--NKAADWWSVGILLYEMLTGKP-PFIGGNRA-----------KIQQKIVKDKL  366 (482)
Q Consensus       321 l~~~~--------------------~--~~~sDvwSlGvilyelltG~~-PF~~~~~~-----------~~~~~i~~~~~  366 (482)
                      +....                    |  ..+.||||+||++|+|++|.. ||.+....           .....+....+
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~  461 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY  461 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence            86432                    1  124799999999999999986 77542211           11112222333


Q ss_pred             CCC--ccCChHHHHHHHHhhccCc---CCcCCCCCCChHHHHhCcCCCC
Q 047009          367 RLP--AFLSSEAHSLLKGLLQKEP---GKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       367 ~~p--~~~s~~~~~LI~~~L~~dP---~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      .++  ...+..+++||.+||.++|   .+|+|+     +|+|+||||..
T Consensus       462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa-----~eaL~Hp~f~~  505 (507)
T PLN03224        462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSV-----GQALSHRFFLP  505 (507)
T ss_pred             CcccccccChHHHHHHHHHhccCCCCcccCCCH-----HHHhCCCCcCC
Confidence            333  4578999999999999876   689999     99999999964

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=298.68  Aligned_cols=263  Identities=27%  Similarity=0.463  Sum_probs=218.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC------
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK------  222 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  222 (482)
                      ..+|.-++.+|.|.- .|..|-+.-+++.||+|.+... .......++..+|..++..++|+||++++.+|.-.      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            367888999999998 7778888888999999998776 34456677788999999999999999999999544      


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ...|+|||+|.. +|...+.  -.+.-+.+..+..|+++|+.|||+.||+||||||+||++..++.+||.|||+|+....
T Consensus        94 ~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   94 QEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             HhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence            357999999976 6766654  3467788999999999999999999999999999999999999999999999998766


Q ss_pred             CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-----------------
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-----------------  365 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-----------------  365 (482)
                      .-..+..+.|..|.|||++.+.+|...+||||+||++.||++|+..|.|.+..+.+.++....                 
T Consensus       171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~  250 (369)
T KOG0665|consen  171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN  250 (369)
T ss_pred             ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence            556677899999999999999999999999999999999999999999887666555554310                 


Q ss_pred             ----------cC----CCcc-----------CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhcc
Q 047009          366 ----------LR----LPAF-----------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEARE  420 (482)
Q Consensus       366 ----------~~----~p~~-----------~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~  420 (482)
                                ..    +|+.           -+..+++|+.+||..||++|.++     +++|+||||+  -|  ....+
T Consensus       251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv-----~daL~HPY~~--vw--~~~~e  321 (369)
T KOG0665|consen  251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISV-----DDALRHPYIK--VW--YDPDE  321 (369)
T ss_pred             HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccH-----HHHhcCCeee--ee--ccccc
Confidence                      00    1211           14578999999999999999999     9999999999  35  33344


Q ss_pred             CCCCC
Q 047009          421 IQPGF  425 (482)
Q Consensus       421 ~~p~~  425 (482)
                      ++.|.
T Consensus       322 v~ap~  326 (369)
T KOG0665|consen  322 VEAPP  326 (369)
T ss_pred             ccCCC
Confidence            44443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-36  Score=299.36  Aligned_cols=261  Identities=26%  Similarity=0.408  Sum_probs=200.5

Q ss_pred             CcccccccCC-CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-----C---C
Q 047009          140 DSVTVCCVGI-EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-----H---P  210 (482)
Q Consensus       140 ~~~~~~~~~~-~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-----h---p  210 (482)
                      ..+.++.... ++|.+.++||.|-|++||+|.+..+.+.||+|+.+...    ...+....|+++|++++     |   .
T Consensus        67 HpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~  142 (590)
T KOG1290|consen   67 HPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKK  142 (590)
T ss_pred             ceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence            3455555555 89999999999999999999999999999999987643    56667788999999983     2   5


Q ss_pred             ceeeeeeeee----cCCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEE
Q 047009          211 FVVQLKYSFQ----TKYRLYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILL  283 (482)
Q Consensus       211 nIv~l~~~~~----~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl  283 (482)
                      +||+|++.|.    .+.++|+|+|++ |-+|+.++.+.  +.++...++.|++||+.||.|||++ ||||.||||+|||+
T Consensus       143 ~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  143 CVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             eeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            7999999995    456899999999 55777777654  4589999999999999999999975 99999999999999


Q ss_pred             ccC-----------C-----------------------------------------------------------------
Q 047009          284 GAD-----------G-----------------------------------------------------------------  287 (482)
Q Consensus       284 ~~~-----------g-----------------------------------------------------------------  287 (482)
                      ..+           +                                                                 
T Consensus       222 ~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~  301 (590)
T KOG1290|consen  222 CSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQE  301 (590)
T ss_pred             eccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccc
Confidence            311           0                                                                 


Q ss_pred             --------------------------------------------------------------------------------
Q 047009          288 --------------------------------------------------------------------------------  287 (482)
Q Consensus       288 --------------------------------------------------------------------------------  287 (482)
                                                                                                      
T Consensus       302 s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~  381 (590)
T KOG1290|consen  302 SYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVN  381 (590)
T ss_pred             ccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccC
Confidence                                                                                            


Q ss_pred             ----------ceeEcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc----
Q 047009          288 ----------HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN----  353 (482)
Q Consensus       288 ----------~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~----  353 (482)
                                .+||+|||-|....  ...+..+.|..|+|||++.|.+|+..+||||++|++|||+||...|...+    
T Consensus       382 p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y  459 (590)
T KOG1290|consen  382 PDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENY  459 (590)
T ss_pred             CCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence                      02222232222211  01122345788999999999999999999999999999999999995321    


Q ss_pred             --hHHHHHHHHh------------------------------------------cccCCCccCChHHHHHHHHhhccCcC
Q 047009          354 --RAKIQQKIVK------------------------------------------DKLRLPAFLSSEAHSLLKGLLQKEPG  389 (482)
Q Consensus       354 --~~~~~~~i~~------------------------------------------~~~~~p~~~s~~~~~LI~~~L~~dP~  389 (482)
                        .++.+..|..                                          .++.++..-..++.+||.-||+.+|.
T Consensus       460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe  539 (590)
T KOG1290|consen  460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE  539 (590)
T ss_pred             CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc
Confidence              1112222221                                          22233333457788999999999999


Q ss_pred             CcCCCCCCChHHHHhCcCCCCCC
Q 047009          390 KRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       390 ~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      +|++|     .+.++|||+.++-
T Consensus       540 KR~tA-----~~cl~hPwLn~~~  557 (590)
T KOG1290|consen  540 KRPTA-----AQCLKHPWLNPVA  557 (590)
T ss_pred             ccccH-----HHHhcCccccCCC
Confidence            99999     8999999999763

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-36  Score=315.31  Aligned_cols=240  Identities=29%  Similarity=0.466  Sum_probs=199.0

Q ss_pred             EEEecccCceE-EEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEEEEEEec
Q 047009          155 LKVVGQGAFGR-VYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLVLDFI  232 (482)
Q Consensus       155 ~~~LG~G~fg~-Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~  232 (482)
                      .+.+|.|+.|+ ||+|...  |+.||||.+-.+      ......+|+..|+.- +|||||++++.-++.+..||..|.|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC--CceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            45689999887 7888875  579999987543      345678999999987 6999999999999999999999999


Q ss_pred             CCCchHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc---CC--ceeEcccCccccccCC
Q 047009          233 NGGHLFFQLYHHGL----FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA---DG--HVMLTDFGLAKQFDEN  303 (482)
Q Consensus       233 ~gg~L~~~l~~~~~----l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~---~g--~vKL~DFGla~~~~~~  303 (482)
                      .. +|.+++...+.    ......+....|+++||++||+.+||||||||.||||+.   ++  .++|+|||+++.+..+
T Consensus       586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            76 89888876411    111335778999999999999999999999999999986   34  6899999999998654


Q ss_pred             C----CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhC-CCCCCCCchHHHHHHHHhcccCCCc---cCChH
Q 047009          304 T----RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTG-KPPFIGGNRAKIQQKIVKDKLRLPA---FLSSE  375 (482)
Q Consensus       304 ~----~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG-~~PF~~~~~~~~~~~i~~~~~~~p~---~~s~~  375 (482)
                      .    +.....||-+|+|||++....-+.++||||+||++|+.++| ..||  .+..+-..+|+++...+-.   .-..+
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpF--Gd~~~R~~NIl~~~~~L~~L~~~~d~e  742 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPF--GDSLERQANILTGNYTLVHLEPLPDCE  742 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCC--CchHHhhhhhhcCccceeeeccCchHH
Confidence            3    24566899999999999998888999999999999999985 9999  4555566678877655432   22238


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      +++||.+||++||..||++     .++|.||+|..
T Consensus       743 A~dLI~~ml~~dP~~RPsa-----~~VL~HPlFW~  772 (903)
T KOG1027|consen  743 AKDLISRMLNPDPQLRPSA-----TDVLNHPLFWD  772 (903)
T ss_pred             HHHHHHHhcCCCcccCCCH-----HHHhCCCccCC
Confidence            9999999999999999999     99999999975

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.8e-35  Score=336.89  Aligned_cols=236  Identities=20%  Similarity=0.279  Sum_probs=188.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ..|...+.||+|+||.||+|+++.++..||+|.+.....       ....|+.++++++|||||+++++|.+....|+||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            456777899999999999999999999999999864321       1134688899999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH---ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      ||+++|+|.+++..   +++..+..++.||+.||+|||   +.+|+||||||+||+++.++..++. ||.......   .
T Consensus       763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~  835 (968)
T PLN00113        763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---D  835 (968)
T ss_pred             eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---C
Confidence            99999999998853   788999999999999999999   6699999999999999999888875 665544321   2


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch-----HHHHHHHHh---------cc----cCC
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR-----AKIQQKIVK---------DK----LRL  368 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~-----~~~~~~i~~---------~~----~~~  368 (482)
                      ....||+.|||||++.+..++.++|||||||++|||++|+.||.....     .+.......         ..    ...
T Consensus       836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (968)
T PLN00113        836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV  915 (968)
T ss_pred             CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence            234789999999999999999999999999999999999999853211     111111000         00    011


Q ss_pred             CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          369 PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       369 p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +.....++.+++.+||+.||++||++     .|+++
T Consensus       916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~-----~evl~  946 (968)
T PLN00113        916 NQNEIVEVMNLALHCTATDPTARPCA-----NDVLK  946 (968)
T ss_pred             cHHHHHHHHHHHHhhCcCCchhCcCH-----HHHHH
Confidence            11122357789999999999999998     78875

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=312.59  Aligned_cols=250  Identities=25%  Similarity=0.418  Sum_probs=212.9

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcC-------CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeee
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKN-------TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSF  219 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  219 (482)
                      .-++..+.+.||.|.||+|++|..+.       ....||+|.++....  ....+.+..|+++|+.+ .|+||+.+++++
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            33455677799999999999997542       145799999876543  35677789999999998 699999999999


Q ss_pred             ecCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 047009          220 QTKYRLYLVLDFINGGHLFFQLYHHG----------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL  283 (482)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl  283 (482)
                      ...+.+++|+||+..|+|..+|.+++                .++......++.||+.|++||+++++|||||-.+|||+
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI  451 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe
Confidence            99999999999999999999998766                37888899999999999999999999999999999999


Q ss_pred             ccCCceeEcccCccccccCCCCCc--cccc--CCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCc-hHHH
Q 047009          284 GADGHVMLTDFGLAKQFDENTRSN--SMIG--TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGN-RAKI  357 (482)
Q Consensus       284 ~~~g~vKL~DFGla~~~~~~~~~~--~~~g--t~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~-~~~~  357 (482)
                      ..+..+||+|||+|+.........  ...|  ...|||||.+....|+.++||||+||+|||+++ |..||.+.. ..++
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l  531 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL  531 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence            999999999999999654333221  1222  345999999999999999999999999999998 999998855 6667


Q ss_pred             HHHHHhc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          358 QQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       358 ~~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+.+..+ ++..|..++.++.++++.||+.+|++||++     .++.+
T Consensus       532 ~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F-----~~~~~  574 (609)
T KOG0200|consen  532 LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTF-----SECVE  574 (609)
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCH-----HHHHH
Confidence            7767666 557899999999999999999999999999     66653

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=265.95  Aligned_cols=213  Identities=28%  Similarity=0.488  Sum_probs=180.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHh-CCCCceeeeeeeeecCCeEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK-IDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      ++..-+..||+|++|.|-+.++..+|...|+|.+...- . ....+++.+|+++..+ ..+|++|.+++.+.+...+++.
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-N-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-C-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            55566778999999999999999999999999997642 2 3344556778887665 5899999999999999999999


Q ss_pred             EEecCCCchHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          229 LDFINGGHLFF----QLYHHGLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       229 ~E~~~gg~L~~----~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      ||.|.- +|..    .+.+.+.++|..+-.|+..++.||.|||++ .|||||+||+|||++.+|++|+||||.+..+.++
T Consensus       124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            999964 5532    234457799999999999999999999987 8999999999999999999999999999988766


Q ss_pred             CCCcccccCCCCCchhhhcC----CCCCchhHHHHHhHHHHHHhhCCCCCCC-CchHHHHHHHHhcc
Q 047009          304 TRSNSMIGTVEYMAPEIVLG----KGHNKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDK  365 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~----~~~~~~sDvwSlGvilyelltG~~PF~~-~~~~~~~~~i~~~~  365 (482)
                      -..+-..|.-.|||||.+..    ++|+-++||||||+++.||.+++.||.. .++.+...++.+..
T Consensus       203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence            55555788899999999854    4799999999999999999999999954 56667777776653

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=283.48  Aligned_cols=250  Identities=28%  Similarity=0.453  Sum_probs=206.6

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC-----eEEEEEE
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY-----RLYLVLD  230 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~lV~E  230 (482)
                      +.||.|+||.||.+.+..+|+.||+|.+..-. ..-...+.+.+|+++|...+|.|++..++..+...     .+|+++|
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            56999999999999999999999999886432 22234456778999999999999999887776543     4688899


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC--CCCcc
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNS  308 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~  308 (482)
                      .|.. +|...+..-..++.+.++.+..||++||.|||+.||+||||||.|+|+++|..+||||||+|+..+..  ...+.
T Consensus       138 LmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTq  216 (449)
T KOG0664|consen  138 LMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTH  216 (449)
T ss_pred             HHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHH
Confidence            8864 78777777788999999999999999999999999999999999999999999999999999986543  33445


Q ss_pred             cccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHh-----------------------c
Q 047009          309 MIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----------------------D  364 (482)
Q Consensus       309 ~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~-----------------------~  364 (482)
                      .+-|-.|+|||++.| +.|+.++||||+|||+.||+..+..|...++.+..+.|..                       +
T Consensus       217 EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~  296 (449)
T KOG0664|consen  217 EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRA  296 (449)
T ss_pred             HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhcc
Confidence            567889999999988 5689999999999999999999999987776655555443                       1


Q ss_pred             ccCCCc-----------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          365 KLRLPA-----------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       365 ~~~~p~-----------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      ..+-|.           .-..+..+++.++|..||++|.+.     ++.+.|++....+
T Consensus       297 ~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~-----~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  297 GLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISV-----EEALQHRYLEEGR  350 (449)
T ss_pred             CCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccH-----hhhcccccccccc
Confidence            222221           234577899999999999999998     8999999987644

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-36  Score=308.31  Aligned_cols=255  Identities=30%  Similarity=0.485  Sum_probs=224.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      -++|+++..+|.|+||.||+|+++.+++..|+|+++.+.   .....-++.|+-+++..+|||||.+++.|...+.+++.
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            378999999999999999999999999999999998754   35566678999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCCc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~  307 (482)
                      ||||.||+|.+.-.-.+.+++.++...+++.++||+|||+.|-+|||||-.|||+++.|.+|++|||.+..+.. -....
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence            99999999988777779999999999999999999999999999999999999999999999999999877643 23456


Q ss_pred             ccccCCCCCchhhh---cCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCC-----CccCChHHHHH
Q 047009          308 SMIGTVEYMAPEIV---LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL-----PAFLSSEAHSL  379 (482)
Q Consensus       308 ~~~gt~~y~APE~l---~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~-----p~~~s~~~~~L  379 (482)
                      ++.||+.|||||+.   +..+|...+|+|++|++..|+---++|.....+........+..+.-     +..+++.+++|
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f  250 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF  250 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence            78999999999986   45679999999999999999999898876666655555555544332     34589999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      ++.+|.++|++||++     +.+|.|||...-
T Consensus       251 vK~altknpKkRpta-----eklL~h~fvs~~  277 (829)
T KOG0576|consen  251 VKGALTKNPKKRPTA-----EKLLQHPFVSQT  277 (829)
T ss_pred             HHHHhcCCCccCCCh-----hhheeceeeccc
Confidence            999999999999999     788889998653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-35  Score=298.90  Aligned_cols=204  Identities=29%  Similarity=0.522  Sum_probs=183.5

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhH-----HHHHHHHHHHHHhCC---CCceeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNH-----AEYMKAERDILTKID---HPFVVQLKYS  218 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~-----~~~~~~E~~il~~l~---hpnIv~l~~~  218 (482)
                      -...+|..++.+|.|+||.|++|.++.+...|+||.+.|+++.....     .-.+-.|+.||.+|+   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            34578999999999999999999999999999999999987653322     223457999999998   9999999999


Q ss_pred             eecCCeEEEEEEec-CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          219 FQTKYRLYLVLDFI-NGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       219 ~~~~~~~~lV~E~~-~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                      |++++++||+||-- +|.+|++++..+..++|.+++.|++|++.|+++||++||||||||-+|+.++.+|.+||+|||.|
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence            99999999999976 45699999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCcccccCCCCCchhhhcCCCC-CchhHHHHHhHHHHHHhhCCCCCCC
Q 047009          298 KQFDENTRSNSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIG  351 (482)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwSlGvilyelltG~~PF~~  351 (482)
                      ..... .....++||..|.|||++.|..| +..-|||+||++||.++...-||+.
T Consensus       718 a~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  718 AYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            87654 34567899999999999999887 6789999999999999999999864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=304.15  Aligned_cols=241  Identities=24%  Similarity=0.342  Sum_probs=210.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCe----EEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSE----IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ..+..++||.|+||+||+|.+-..|+    +||||++....  ..+....+..|+-+|.+|+|||+++|++++.... +-
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            34557899999999999999866554    68999887654  3344566888999999999999999999998776 78


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          227 LVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      ||++||++|.|.++++.+ +.+-......|..||++||.|||.++++||||-.+|||+.+-.++||+|||+++.+.....
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999999775 5688888999999999999999999999999999999999999999999999998754433


Q ss_pred             Cccc---ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHH
Q 047009          306 SNSM---IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLL  380 (482)
Q Consensus       306 ~~~~---~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI  380 (482)
                      ....   .-.+.|||-|.+....|+.++|||||||++||++| |..|+.+....++-+.+.++ ++.-|+.++.++.-++
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m  933 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM  933 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence            2222   22568999999999999999999999999999998 99999999988888877665 6777899999999999


Q ss_pred             HHhhccCcCCcCCC
Q 047009          381 KGLLQKEPGKRLGA  394 (482)
Q Consensus       381 ~~~L~~dP~~R~s~  394 (482)
                      .+||..|+..||++
T Consensus       934 vkCwmid~~~rp~f  947 (1177)
T KOG1025|consen  934 VKCWMIDADSRPTF  947 (1177)
T ss_pred             HHHhccCcccCccH
Confidence            99999999999998

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=281.74  Aligned_cols=241  Identities=24%  Similarity=0.422  Sum_probs=196.2

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHh--CCCCceeeeeeeeecC
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK--IDHPFVVQLKYSFQTK  222 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~  222 (482)
                      ........+++++||+|.||.||+|+..+  +.||||++...      +.+.+++|.+|.+.  ++|+||++++++-...
T Consensus       205 pl~~l~pl~l~eli~~Grfg~V~KaqL~~--~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~  276 (534)
T KOG3653|consen  205 PLLELDPLQLLELIGRGRFGCVWKAQLDN--RLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRG  276 (534)
T ss_pred             ccccCCchhhHHHhhcCccceeehhhccC--ceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence            33557788899999999999999998865  89999998754      35567889888875  5899999998876555


Q ss_pred             C----eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCcccCCCCCcEEEccCCce
Q 047009          223 Y----RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN---------GIMHRDLKPENILLGADGHV  289 (482)
Q Consensus       223 ~----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------~IiHrDLKp~NILl~~~g~v  289 (482)
                      .    .++||++|.+.|+|.++|..+ .+++.....++.-+++||+|||+.         .|+|||||..||||..|++.
T Consensus       277 t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  277 TADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             CccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence            4    799999999999999999765 579999999999999999999963         59999999999999999999


Q ss_pred             eEcccCccccccCCC---CCcccccCCCCCchhhhcCCCC------CchhHHHHHhHHHHHHhhCCC------------C
Q 047009          290 MLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGH------NKAADWWSVGILLYEMLTGKP------------P  348 (482)
Q Consensus       290 KL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~------~~~sDvwSlGvilyelltG~~------------P  348 (482)
                      .|+|||+|..+..+.   .....+||..|||||++.|.-.      -.+.||||+|.+||||++.-.            |
T Consensus       356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp  435 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP  435 (534)
T ss_pred             EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence            999999999875432   3345799999999999987532      136899999999999988433            3


Q ss_pred             CC-----CCchHHHHHHHHh--cccCCCcc-----CChHHHHHHHHhhccCcCCcCCC
Q 047009          349 FI-----GGNRAKIQQKIVK--DKLRLPAF-----LSSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       349 F~-----~~~~~~~~~~i~~--~~~~~p~~-----~s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                      |.     ..+.+++...++.  .++.+|..     .-..+++.|..||..||+.|+|+
T Consensus       436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA  493 (534)
T KOG3653|consen  436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA  493 (534)
T ss_pred             hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence            32     1233455555444  35666654     24678999999999999999998

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-33  Score=276.99  Aligned_cols=247  Identities=26%  Similarity=0.409  Sum_probs=195.1

Q ss_pred             CCcccccccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHh--CCCCceeeee
Q 047009          139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK--IDHPFVVQLK  216 (482)
Q Consensus       139 ~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~  216 (482)
                      +..+-+......+..+.+.||+|.||.||+|+++  |+.||||++...      ......+|.+|.++  |+|+||+.++
T Consensus       200 GlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFI  271 (513)
T KOG2052|consen  200 GLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFI  271 (513)
T ss_pred             CchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhh
Confidence            3444555556678999999999999999999997  578999998643      23446789999886  5999999998


Q ss_pred             eeeecC----CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccCCCCCcEEEc
Q 047009          217 YSFQTK----YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN--------GIMHRDLKPENILLG  284 (482)
Q Consensus       217 ~~~~~~----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~IiHrDLKp~NILl~  284 (482)
                      +.-...    ..+|||++|-+.|+|+++|.+ ..++.+....++..++.||+|||..        .|.|||||..|||+.
T Consensus       272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK  350 (513)
T KOG2052|consen  272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  350 (513)
T ss_pred             hccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence            776433    258999999999999999988 5678888889999999999999953        499999999999999


Q ss_pred             cCCceeEcccCccccccCCC-----CCcccccCCCCCchhhhcCCCC------CchhHHHHHhHHHHHHhh---------
Q 047009          285 ADGHVMLTDFGLAKQFDENT-----RSNSMIGTVEYMAPEIVLGKGH------NKAADWWSVGILLYEMLT---------  344 (482)
Q Consensus       285 ~~g~vKL~DFGla~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~------~~~sDvwSlGvilyellt---------  344 (482)
                      ++|.+-|+|+|+|.......     ..+..+||-.|||||++...-.      -..+||||||.++||++.         
T Consensus       351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e  430 (513)
T KOG2052|consen  351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE  430 (513)
T ss_pred             cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence            99999999999998765432     3467899999999999976422      246899999999999875         


Q ss_pred             -CCCCCCCC-----chHHHHHHHHhc--ccCCCccCC-----hHHHHHHHHhhccCcCCcCCC
Q 047009          345 -GKPPFIGG-----NRAKIQQKIVKD--KLRLPAFLS-----SEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       345 -G~~PF~~~-----~~~~~~~~i~~~--~~~~p~~~s-----~~~~~LI~~~L~~dP~~R~s~  394 (482)
                       -++||.+.     +.+++.+-+.-.  ++.+|..+.     ..+-.+++.||..||.-|+++
T Consensus       431 ey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA  493 (513)
T KOG2052|consen  431 EYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA  493 (513)
T ss_pred             hhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence             24688652     334454444333  445555432     234568999999999999998

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=9.3e-32  Score=254.22  Aligned_cols=214  Identities=43%  Similarity=0.681  Sum_probs=189.1

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEe
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  231 (482)
                      |.+.+.||.|++|.||+|....+++.+|+|.+......  ...+.+.+|+..+.+++|+|++++++++......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            56789999999999999999998999999999875432  2456788999999999999999999999998999999999


Q ss_pred             cCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--CCcc
Q 047009          232 INGGHLFFQLYHHGL-FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--RSNS  308 (482)
Q Consensus       232 ~~gg~L~~~l~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--~~~~  308 (482)
                      +.+++|..++..... +++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||.+.......  ....
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence            999999999987766 8999999999999999999999999999999999999999999999999998875543  3455


Q ss_pred             cccCCCCCchhhh-cCCCCCchhHHHHHhHHHHHHhhCCCCCCC--CchHHHHHHHHhcccC
Q 047009          309 MIGTVEYMAPEIV-LGKGHNKAADWWSVGILLYEMLTGKPPFIG--GNRAKIQQKIVKDKLR  367 (482)
Q Consensus       309 ~~gt~~y~APE~l-~~~~~~~~sDvwSlGvilyelltG~~PF~~--~~~~~~~~~i~~~~~~  367 (482)
                      ..++..|++||.+ ....++.++|+|+||+++|+|++|+.||..  .+...+.+.+..+...
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL  220 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence            6788999999999 677788899999999999999999999977  4555777888777643

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=3.1e-31  Score=245.79  Aligned_cols=211  Identities=41%  Similarity=0.706  Sum_probs=188.5

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCCch
Q 047009          158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL  237 (482)
Q Consensus       158 LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (482)
                      ||+|++|.||++....+++.+++|++.......  ..+.+.+|+.+++.+.|++|+++++++......++++||+.|++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999999889999999988654211  346688999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc-CCceeEcccCccccccCCC-CCcccccCCC
Q 047009          238 FFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA-DGHVMLTDFGLAKQFDENT-RSNSMIGTVE  314 (482)
Q Consensus       238 ~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~~-~~~~~~gt~~  314 (482)
                      ..++... ..++...++.++.+++.+|.+||++|++|+||+|.||+++. ++.++|+|||.+....... ......+...
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence            9998765 56899999999999999999999999999999999999999 8999999999998764432 2334567889


Q ss_pred             CCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCC
Q 047009          315 YMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       315 y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s  393 (482)
                      |++||.+... .++.+.|+|++|+++|+|                               ..+.+++.+||+.||++||+
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R~~  207 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPS  207 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccCcC
Confidence            9999999887 889999999999999999                               67899999999999999999


Q ss_pred             CCCCChHHHHhCc
Q 047009          394 AGPKGSEEIKSHK  406 (482)
Q Consensus       394 ~~~~~~~eil~hp  406 (482)
                      +     .++++|+
T Consensus       208 ~-----~~l~~~~  215 (215)
T cd00180         208 A-----KEILEHL  215 (215)
T ss_pred             H-----HHHhhCC
Confidence            8     8998874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.98  E-value=2.3e-32  Score=295.18  Aligned_cols=285  Identities=36%  Similarity=0.651  Sum_probs=227.4

Q ss_pred             ccccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          144 VCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      .....-++|+.+++|..|+||.||+++++.+.+.+|+| ++++.+.-++          ||.....|++|          
T Consensus        77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn----------ilt~a~npfvv----------  135 (1205)
T KOG0606|consen   77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN----------ILTFAGNPFVV----------  135 (1205)
T ss_pred             ccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc----------cccccCCccee----------
Confidence            33445689999999999999999999999999999995 4444332111          55666677766          


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          224 RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                                 |+-...+..-+.++.+.        +.+++|||+.||+|||+||+|.+|+.-|++|++|||+++.....
T Consensus       136 -----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                       55555565556666544        78999999999999999999999999999999999999864211


Q ss_pred             C----------------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC
Q 047009          304 T----------------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR  367 (482)
Q Consensus       304 ~----------------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~  367 (482)
                      .                .....|||+.|.|||++...+|+..+|||++|+|+||.+.|..||.+.++++++..++...+.
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence            1                123469999999999999999999999999999999999999999999999999999999888


Q ss_pred             CCcc---CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccC
Q 047009          368 LPAF---LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD  444 (482)
Q Consensus       368 ~p~~---~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~  444 (482)
                      +|..   ++++++++|.++|+.+|..|.+.  .++-++++|+||+.+||..|.+++  .+|+|......+++.|+..-..
T Consensus       277 wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt--~ga~evk~h~ff~~LDw~~llRqk--aefvpql~~eddtsyfdTRs~R  352 (1205)
T KOG0606|consen  277 WPEEDEALPPEAQDLIEQLLRQNPLCRLGT--GGALEVKQHGFFQLLDWKSLLRQK--AEFVPQLESEDDTSYFDTRSDR  352 (1205)
T ss_pred             ccccCcCCCHHHHHHHHHHHHhChHhhccc--chhhhhhhccceeecccchhhhhh--ccccccccccccchhhcccchh
Confidence            8854   78999999999999999999987  488999999999999999887765  4799999999999999864433


Q ss_pred             CCCCCCCCCCCCCCCCCccCeeeecCCc
Q 047009          445 MPLSDSPAATPKNNTNPFADFSYVRPAA  472 (482)
Q Consensus       445 ~~~~~s~~~~~~~~~~~f~~f~~~~~~~  472 (482)
                      .-...+........--.|..|+-..|..
T Consensus       353 yh~~~se~~~~ees~~~~~qFsscs~r~  380 (1205)
T KOG0606|consen  353 YHHFESEDTGDEESSLEFRQFSSCSPRF  380 (1205)
T ss_pred             eeeccccCCccccccccccccccccccc
Confidence            3212222211122223567776665554

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=1.9e-32  Score=271.38  Aligned_cols=250  Identities=26%  Similarity=0.486  Sum_probs=199.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcC---CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKN---TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  225 (482)
                      +.|.++++||.|.|+.||+|.+..   ..+.||+|.+...     ..-.++.+|+++|..+ .+.||+++.+++..++..
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            678999999999999999998877   7889999988654     3345688999999998 589999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc-CCceeEcccCcccccc---
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA-DGHVMLTDFGLAKQFD---  301 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~-~g~vKL~DFGla~~~~---  301 (482)
                      .+|+||++.....+++..   ++...++.|++.++.||.++|.+|||||||||.|+|.+. .+.-.|.|||+|...+   
T Consensus       111 ~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             EEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            999999998877766543   567889999999999999999999999999999999985 4678999999997211   


Q ss_pred             --------------C--C--------------------------CCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHH
Q 047009          302 --------------E--N--------------------------TRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGIL  338 (482)
Q Consensus       302 --------------~--~--------------------------~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvi  338 (482)
                                    .  +                          .......||++|.|||++.. ...++++||||.|||
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence                          0  0                          00012469999999999976 456889999999999


Q ss_pred             HHHHhhCCCCCCCCch-HHHHHHHH--------------hcc---------------------c------C---------
Q 047009          339 LYEMLTGKPPFIGGNR-AKIQQKIV--------------KDK---------------------L------R---------  367 (482)
Q Consensus       339 lyelltG~~PF~~~~~-~~~~~~i~--------------~~~---------------------~------~---------  367 (482)
                      ++-+++++.||..... ......|.              .++                     +      +         
T Consensus       268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~  347 (418)
T KOG1167|consen  268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE  347 (418)
T ss_pred             eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence            9999999999943210 00000000              000                     0      0         


Q ss_pred             -CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          368 -LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       368 -~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                       .-+..+..+.+|+.+||..||.+|.++     +++|+||||...+
T Consensus       348 ~~~d~~~~~~~dlLdk~le~np~kRitA-----EeALkHpFF~~~~  388 (418)
T KOG1167|consen  348 IGSDVFPALLLDLLDKCLELNPQKRITA-----EDALKHPFFDEAD  388 (418)
T ss_pred             cccccccHHHHHHHHHHccCChhhcccH-----HHHhcCcCCcchh
Confidence             011246689999999999999999999     9999999999654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-31  Score=248.07  Aligned_cols=235  Identities=25%  Similarity=0.347  Sum_probs=188.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeee-eeecCCeEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKY-SFQTKYRLYL  227 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~-~~~~~~~~~l  227 (482)
                      +.|.+.+.||+|.||++.+|+++.++..+++|.+.+...    ....+.+|...--.| .|.||+.-|+ .|++.+.+.+
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            679999999999999999999999999999999987653    344567787765555 5899998764 5899999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc--CCceeEcccCccccccCCCC
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA--DGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~--~g~vKL~DFGla~~~~~~~~  305 (482)
                      ++||++.|+|..-+... .+-|...+.++.|+++||.|+|++++||||||.+||||-.  ..++||||||+.+..+.  .
T Consensus       100 ~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--t  176 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--T  176 (378)
T ss_pred             eeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc--e
Confidence            99999999998877654 4678888999999999999999999999999999999943  34799999999876432  2


Q ss_pred             CcccccCCCCCchhhhcCC-----CCCchhHHHHHhHHHHHHhhCCCCCCCCch-----HHHHHHHHhcccCCCc---cC
Q 047009          306 SNSMIGTVEYMAPEIVLGK-----GHNKAADWWSVGILLYEMLTGKPPFIGGNR-----AKIQQKIVKDKLRLPA---FL  372 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~-----~~~~~sDvwSlGvilyelltG~~PF~~~~~-----~~~~~~i~~~~~~~p~---~~  372 (482)
                      ....--+..|.+||+....     ...+.+|+|.||+++|.+|||.+||.....     .+..+-........|.   .+
T Consensus       177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f  256 (378)
T KOG1345|consen  177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF  256 (378)
T ss_pred             ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence            2223346679999987543     236789999999999999999999964322     2223333333445554   47


Q ss_pred             ChHHHHHHHHhhccCcCCc
Q 047009          373 SSEAHSLLKGLLQKEPGKR  391 (482)
Q Consensus       373 s~~~~~LI~~~L~~dP~~R  391 (482)
                      ++.+..+.++-|..++++|
T Consensus       257 s~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  257 SEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             CHHHHHHHHHhcCCccccc
Confidence            8999999999999999999

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-30  Score=252.27  Aligned_cols=248  Identities=19%  Similarity=0.288  Sum_probs=208.0

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCC-----eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeee-cC
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTS-----EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQ-TK  222 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~  222 (482)
                      -.++++..++-+|.||.||.|.+++..     +.|-+|.++..  ..+-+...+..|.-+|..+.|||+.++.++.. +.
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY  360 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence            356888889999999999999776532     34556665433  23456677888999999999999999988774 45


Q ss_pred             CeEEEEEEecCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEccc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHH--------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDF  294 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DF  294 (482)
                      ...+.++.++.-|+|..+|...        ..++..+...++.|++.|++|||+.||||.||..+|.+||+.-++||+|=
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs  440 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS  440 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence            5678889999999999988721        24677788889999999999999999999999999999999999999999


Q ss_pred             CccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCC
Q 047009          295 GLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLP  369 (482)
Q Consensus       295 Gla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p  369 (482)
                      .+++.+-..+.   -...-....||+||.+....|+.++|+|||||+||||+| |+.|+...++.++...+.++ ++.-|
T Consensus       441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP  520 (563)
T KOG1024|consen  441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP  520 (563)
T ss_pred             hhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC
Confidence            99987533221   122234678999999999999999999999999999998 99999999999999998887 56778


Q ss_pred             ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHH
Q 047009          370 AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIK  403 (482)
Q Consensus       370 ~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil  403 (482)
                      -++++++..++.-||..+|++||++     +++.
T Consensus       521 ~NCPDeLf~vMacCWallpeeRPsf-----~Qlv  549 (563)
T KOG1024|consen  521 FNCPDELFTVMACCWALLPEERPSF-----SQLV  549 (563)
T ss_pred             CCCcHHHHHHHHHHHhcCcccCCCH-----HHHH
Confidence            8999999999999999999999998     6664

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=7.7e-31  Score=294.99  Aligned_cols=197  Identities=18%  Similarity=0.187  Sum_probs=148.6

Q ss_pred             CCC-Cceeeeeeee-------ecCCeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 047009          207 IDH-PFVVQLKYSF-------QTKYRLYLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK  277 (482)
Q Consensus       207 l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLK  277 (482)
                      ++| +||++++++|       .....++++|||+ +++|..++.. ...+++..++.|+.||+.||+|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            345 5777777777       2234577889988 5599999965 3569999999999999999999999999999999


Q ss_pred             CCcEEEcc-------------------CCceeEcccCccccccCC-----------------CCCcccccCCCCCchhhh
Q 047009          278 PENILLGA-------------------DGHVMLTDFGLAKQFDEN-----------------TRSNSMIGTVEYMAPEIV  321 (482)
Q Consensus       278 p~NILl~~-------------------~g~vKL~DFGla~~~~~~-----------------~~~~~~~gt~~y~APE~l  321 (482)
                      |+||||+.                   ++.+||+|||+++.....                 ......+||+.|||||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            99999954                   445667777776542110                 001124689999999999


Q ss_pred             cCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC-CCccCChHHHHHHHHhhccCcCCcCCCCCCChH
Q 047009          322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSE  400 (482)
Q Consensus       322 ~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~  400 (482)
                      .+..|+.++|||||||+||||++|..|+....  .....+...... ..........+++.+||++||.+||++     .
T Consensus       188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~-----~  260 (793)
T PLN00181        188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSM-----S  260 (793)
T ss_pred             ccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcCh-----H
Confidence            99999999999999999999999999875322  222222221111 011124567899999999999999999     9


Q ss_pred             HHHhCcCCCCC
Q 047009          401 EIKSHKWFKPI  411 (482)
Q Consensus       401 eil~hp~f~~~  411 (482)
                      |+++||||...
T Consensus       261 eil~h~~~~~~  271 (793)
T PLN00181        261 ELLQSEFINEP  271 (793)
T ss_pred             HHhhchhhhhh
Confidence            99999999763

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=2.4e-27  Score=232.28  Aligned_cols=251  Identities=40%  Similarity=0.647  Sum_probs=210.2

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCC-ceeeeeeeeecCCeEEEEEE
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP-FVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~lV~E  230 (482)
                      |.+.+.||.|+||.||++.+.   ..+|+|.+.............+.+|+.++..+.|+ +|+++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999988   67999999877644433567788999999999988 79999999988888899999


Q ss_pred             ecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC-ceeEcccCccccccCCC--
Q 047009          231 FINGGHLFFQLYHHG---LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG-HVMLTDFGLAKQFDENT--  304 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~--  304 (482)
                      ++.++++...+....   .+.+.....++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++......  
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999997766654   789999999999999999999999999999999999999998 79999999998654432  


Q ss_pred             -----CCcccccCCCCCchhhhcC---CCCCchhHHHHHhHHHHHHhhCCCCCCCCch----HHHHHHHHhcccC-CCcc
Q 047009          305 -----RSNSMIGTVEYMAPEIVLG---KGHNKAADWWSVGILLYEMLTGKPPFIGGNR----AKIQQKIVKDKLR-LPAF  371 (482)
Q Consensus       305 -----~~~~~~gt~~y~APE~l~~---~~~~~~sDvwSlGvilyelltG~~PF~~~~~----~~~~~~i~~~~~~-~p~~  371 (482)
                           .....+||..|+|||.+.+   ..++...|+||+|++++++++|..||.....    ......+...... ....
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 3467789999999999998   5789999999999999999999999877663    4555555554433 2222


Q ss_pred             CC--------hHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          372 LS--------SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       372 ~s--------~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      ..        ..+.+++.+++..+|..|.+.     .+...++|...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~-----~~~~~~~~~~~  280 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSS-----SSDLSHDLLAH  280 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCH-----HHHhhchHhhC
Confidence            22        478999999999999999988     66666655443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=8.9e-29  Score=226.98  Aligned_cols=158  Identities=23%  Similarity=0.228  Sum_probs=130.9

Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccccCC
Q 047009          235 GHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTV  313 (482)
Q Consensus       235 g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~  313 (482)
                      |+|.+++..+ +.+++..++.++.||+.||.|||+++      ||+|||++.++.+|+  ||+++......    ..||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            6888888764 45999999999999999999999998      999999999999999  99998764322    36899


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch-HHHHHHHHhcccCC-------CccCCh--HHHHHHHHh
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR-AKIQQKIVKDKLRL-------PAFLSS--EAHSLLKGL  383 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~-~~~~~~i~~~~~~~-------p~~~s~--~~~~LI~~~  383 (482)
                      .|||||++.+..|+.++|||||||++|||++|+.||..... ......+.......       +..++.  +++++|.+|
T Consensus        69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c  148 (176)
T smart00750       69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC  148 (176)
T ss_pred             cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence            99999999999999999999999999999999999976443 23333333322211       122344  699999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      |..||.+||++     .++++|+|+.
T Consensus       149 l~~~p~~Rp~~-----~~ll~~~~~~  169 (176)
T smart00750      149 ASRLPQRREAA-----NHYLAHCRAL  169 (176)
T ss_pred             HhcccccccCH-----HHHHHHHHHH
Confidence            99999999999     9999999875

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=3.1e-29  Score=270.47  Aligned_cols=256  Identities=26%  Similarity=0.444  Sum_probs=207.3

Q ss_pred             EEEEEecccCceEEEEEEEcCCCeEEEEEEeech---hhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          153 EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKD---KIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       153 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~---~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      .....+|.|++|.|+.+......+.++.|.....   ..........+..|..+-.++.|||++..+..++.....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4568899999999998888777777777765421   1112222233667777778899999988877777766666669


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-----C
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----T  304 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-----~  304 (482)
                      |||++ +|+..+...+.+....+..++.|++.||.|||+.||.|||||++|+++..+|.+||+|||.+..+...     .
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            99999 99999988888999999999999999999999999999999999999999999999999999875432     3


Q ss_pred             CCcccccCCCCCchhhhcCCCCCc-hhHHHHHhHHHHHHhhCCCCCCCCchHHHH--HH-------HHhcccCCCccCCh
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNK-AADWWSVGILLYEMLTGKPPFIGGNRAKIQ--QK-------IVKDKLRLPAFLSS  374 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~-~sDvwSlGvilyelltG~~PF~~~~~~~~~--~~-------i~~~~~~~p~~~s~  374 (482)
                      .....+|+..|+|||++.+..|+. ..||||.|+++..|.+|+.||.-....+..  +.       +..+...+...++.
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~  559 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR  559 (601)
T ss_pred             hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence            345678999999999999999975 789999999999999999999765544332  11       11112222344788


Q ss_pred             HHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          375 EAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       375 ~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                      ..+.+|.+||+.||.+|.++     ++|++.+||+.++-.
T Consensus       560 ~~~~~~~~~l~~~P~~R~ti-----~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  560 ETRIIIYRMLQLDPTKRITI-----EQILNDEWIRSIECC  594 (601)
T ss_pred             hHHHHHHHHccCChhheecH-----HHHhhChHhhhcceE
Confidence            99999999999999999999     999999999987643

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.1e-26  Score=236.39  Aligned_cols=167  Identities=22%  Similarity=0.223  Sum_probs=132.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcC-CCeEEEEEEeechhh--chhhHHHHHHHHHHHHHhCCCCceee-eeeeeecC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKN-TSEIYAMKVMRKDKI--VEKNHAEYMKAERDILTKIDHPFVVQ-LKYSFQTK  222 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~-l~~~~~~~  222 (482)
                      ...++|++.+.||+|+||+||+|+++. +++.||||++.....  ......+.+.+|+++|++++|+||+. +++.    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            445789999999999999999999876 678889998753311  12334566899999999999999985 4432    


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC-CCCcEEEccCCceeEcccCcccccc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDL-KPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDL-Kp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      +..|+||||++|++|.. +..   ..   ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence            45799999999999963 211   11   1467899999999999999999999 9999999999999999999999764


Q ss_pred             CCC---------CCcccccCCCCCchhhhcCC
Q 047009          302 ENT---------RSNSMIGTVEYMAPEIVLGK  324 (482)
Q Consensus       302 ~~~---------~~~~~~gt~~y~APE~l~~~  324 (482)
                      ...         .....++++.|+|||.+...
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            322         11356789999999998654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.7e-25  Score=224.67  Aligned_cols=240  Identities=25%  Similarity=0.390  Sum_probs=190.1

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCC-eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCC----Cceeeeeeee-ecCCe
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTS-EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH----PFVVQLKYSF-QTKYR  224 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~h----pnIv~l~~~~-~~~~~  224 (482)
                      +|.+.+.||+|+||.||+|.+..++ +.+|+|+........  . ..+..|..++..+..    .++.++++.+ .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--C-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999988775 689999877643211  1 157789999998873    6888999988 57888


Q ss_pred             EEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC-----CceeEcccCcc
Q 047009          225 LYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD-----GHVMLTDFGLA  297 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~-----g~vKL~DFGla  297 (482)
                      -|+||+.+ |.+|.++....  +.|+...+..++.|++.+|++||+.|++||||||.|+++...     ..+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            89999988 66888877544  579999999999999999999999999999999999999865     35999999999


Q ss_pred             c--ccc-CCC-------C-CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc--
Q 047009          298 K--QFD-ENT-------R-SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--  364 (482)
Q Consensus       298 ~--~~~-~~~-------~-~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~--  364 (482)
                      +  ... ...       . .....||..|+++....+...+.+.|+||++.++.+|+.|.+||.+.........+.+.  
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8  321 110       0 22356999999999999999999999999999999999999999775543223322222  


Q ss_pred             -cc-C-CCccCChHHHHHHHHhhccCcCCcCCC
Q 047009          365 -KL-R-LPAFLSSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       365 -~~-~-~p~~~s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                       .. . +....+.++..+...+-..+...+|..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy  287 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDY  287 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCH
Confidence             11 1 223356777888777777888888876

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=3.9e-25  Score=205.08  Aligned_cols=269  Identities=21%  Similarity=0.316  Sum_probs=208.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCC-CceeeeeeeeecCCeE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH-PFVVQLKYSFQTKYRL  225 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~  225 (482)
                      +..+.|.++++||.|+||.+|+|....+|+.||||+-....     ....+.-|..+...|++ ..|..+..++....+-
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            34578999999999999999999999999999999865432     12346679999999975 5677777788888888


Q ss_pred             EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC---CceeEcccCcccccc
Q 047009          226 YLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD---GHVMLTDFGLAKQFD  301 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~---g~vKL~DFGla~~~~  301 (482)
                      .+|||.+ |-+|.+++.- ...|+...+..++-|++.-++|+|.+++|||||||+|+|+.-+   ..+-|+|||+|+.+.
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999998 5577766643 3568999999999999999999999999999999999999754   358899999999864


Q ss_pred             CCC--------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC---chHHHHHHHHhcccCCC-
Q 047009          302 ENT--------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG---NRAKIQQKIVKDKLRLP-  369 (482)
Q Consensus       302 ~~~--------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~---~~~~~~~~i~~~~~~~p-  369 (482)
                      +..        ......||..|.+--...+...+...|+-|+|.+|.++.-|.+||.+.   +...-+++|.+.+...| 
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            321        224568999999999988888899999999999999999999999874   44556677877776655 


Q ss_pred             ----ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHH-------hCcCCCCCChhhhhhccCCC
Q 047009          370 ----AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIK-------SHKWFKPINWKKLEAREIQP  423 (482)
Q Consensus       370 ----~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil-------~hp~f~~~~~~~~~~~~~~p  423 (482)
                          ..++.++.-.|.-|-..--.+-|..  .-..++.       +|.+=--.||..++++.-+.
T Consensus       246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy--~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~~q~  308 (341)
T KOG1163|consen  246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDY--MYLRQLFRILFRTLNHQYDYIYDWTMLKQKSQQS  308 (341)
T ss_pred             HHHhCCCcHHHHHHHHHHhhcCCCCCCcH--HHHHHHHHHHHhhccccCCeEeeHHHHHHHhhcc
Confidence                4578888888888865544554443  1123332       23322236798887655443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.3e-24  Score=206.95  Aligned_cols=210  Identities=24%  Similarity=0.405  Sum_probs=178.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCCeEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV  228 (482)
                      -.|++.++||+|+||..+.|.+.-++++||||.-..+     ..+..+..|.+..+.|. .+.|...+++.+.+-+-.||
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            3699999999999999999999999999999985443     34556788999888885 68999998888888888999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC-----ceeEcccCccccccC
Q 047009          229 LDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG-----HVMLTDFGLAKQFDE  302 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g-----~vKL~DFGla~~~~~  302 (482)
                      +|++ |-+|.++..-. ..|+.+.+..++.|++.-++|+|++.+|+|||||+|+||..-|     .|-|+|||+|+.+.+
T Consensus       103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9998 45776665443 4699999999999999999999999999999999999997543     588999999998643


Q ss_pred             CCC--------CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCC---CchHHHHHHHHhcc
Q 047009          303 NTR--------SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIG---GNRAKIQQKIVKDK  365 (482)
Q Consensus       303 ~~~--------~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~---~~~~~~~~~i~~~~  365 (482)
                      ...        ..+..||..||+--...|+..+...|+-|||-++++.|-|.+||.+   .+..+-+++|...+
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K  255 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK  255 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence            321        2467899999999999999999999999999999999999999977   45566677776543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=7e-24  Score=207.66  Aligned_cols=234  Identities=26%  Similarity=0.376  Sum_probs=154.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCC-----------Cceeee----
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH-----------PFVVQL----  215 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-----------pnIv~l----  215 (482)
                      .+...+.||.|+++.||.+++..||+.+|+|+.........+..+.+++|.-....+.+           ..++.+    
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            35678899999999999999999999999999987665555667777777655444322           122221    


Q ss_pred             -e---eeeecC---C-----eEEEEEEecCCCchHHHH---HhcCCC----CHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 047009          216 -K---YSFQTK---Y-----RLYLVLDFINGGHLFFQL---YHHGLF----REDLARIYAAEIVSAVSHLHANGIMHRDL  276 (482)
Q Consensus       216 -~---~~~~~~---~-----~~~lV~E~~~gg~L~~~l---~~~~~l----~~~~~~~i~~qi~~aL~yLH~~~IiHrDL  276 (482)
                       -   .++...   .     +.+++|+-+. ++|...+   ......    .......+..|+++.+++||+.||+|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence             1   011111   1     3467888875 4776554   333222    12223445689999999999999999999


Q ss_pred             CCCcEEEccCCceeEcccCccccccCCCCCcccccCCCCCchhhhcCC--------CCCchhHHHHHhHHHHHHhhCCCC
Q 047009          277 KPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGK--------GHNKAADWWSVGILLYEMLTGKPP  348 (482)
Q Consensus       277 Kp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~--------~~~~~sDvwSlGvilyelltG~~P  348 (482)
                      ||+|++++.+|.++|+||+.....+....  ....+..|.+||.....        .++.+.|.|+||+++|.|++|+.|
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            99999999999999999988776443222  13456789999987542        478899999999999999999999


Q ss_pred             CCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCc
Q 047009          349 FIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR  391 (482)
Q Consensus       349 F~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R  391 (482)
                      |...........    .+.....++..++.||+++|++||.+|
T Consensus       250 f~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            976544322211    233333789999999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=4.8e-24  Score=199.23  Aligned_cols=142  Identities=19%  Similarity=0.238  Sum_probs=112.0

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhh-----------------------HHHHHHHHHHHHHhCCCCc
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKN-----------------------HAEYMKAERDILTKIDHPF  211 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~-----------------------~~~~~~~E~~il~~l~hpn  211 (482)
                      ...||+|+||.||+|.+. +|+.||||+++........                       .......|+.++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            357999999999999987 8999999999865321111                       0123456999999998777


Q ss_pred             eeeeeeeeecCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccCCCCCcEEEccCCcee
Q 047009          212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL-HANGIMHRDLKPENILLGADGHVM  290 (482)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~IiHrDLKp~NILl~~~g~vK  290 (482)
                      +........ .. .+|||||++|+++.......+.+++..+..++.|++.+|.|| |+.||+||||||+|||++ ++.++
T Consensus        81 v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILL-KS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEe-cC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            643322222 22 379999999987765544567899999999999999999999 799999999999999998 58899


Q ss_pred             EcccCccccc
Q 047009          291 LTDFGLAKQF  300 (482)
Q Consensus       291 L~DFGla~~~  300 (482)
                      |+|||+|...
T Consensus       158 LiDFG~a~~~  167 (190)
T cd05147         158 IIDVSQSVEH  167 (190)
T ss_pred             EEEccccccC
Confidence            9999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=4.9e-24  Score=202.91  Aligned_cols=174  Identities=14%  Similarity=0.150  Sum_probs=136.5

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHH------HHHHHHHHHhCCCCceeeeeeeeec
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEY------MKAERDILTKIDHPFVVQLKYSFQT  221 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~  221 (482)
                      .-++|+++++||.|+||.||++..  ++..+|+|+++.+..........      +.+|++.+.++.|++|..+..++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            347899999999999999999765  35679999997654333333233      6789999999999999998887653


Q ss_pred             C--------CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcc
Q 047009          222 K--------YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTD  293 (482)
Q Consensus       222 ~--------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~D  293 (482)
                      .        +..+|||||++|.+|.+..    .+++.    ...+++.+|..||+.|++|||+||.||+++.+| ++|+|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence            3        3578999999999997653    23332    456999999999999999999999999999999 99999


Q ss_pred             cCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHh
Q 047009          294 FGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEML  343 (482)
Q Consensus       294 FGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyell  343 (482)
                      ||..+...+....           ..++..+.|+.++|+|+||+++..+.
T Consensus       178 fg~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence            9998765322211           11455666888999999999887654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=8.8e-24  Score=208.07  Aligned_cols=264  Identities=27%  Similarity=0.397  Sum_probs=188.6

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCe-----------------------------------EEEEEEeechhhch-
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSE-----------------------------------IYAMKVMRKDKIVE-  190 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----------------------------------~vAiK~~~~~~~~~-  190 (482)
                      ..+++|++...||+|..+.||.|+...+|.                                   +.|||.+-.-...+ 
T Consensus       154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~  233 (598)
T KOG4158|consen  154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG  233 (598)
T ss_pred             cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence            567999999999999999999987665322                                   35677654322111 


Q ss_pred             -hhHHHHHHHHHH------H--------HHh--------CCCCceeeeeeeeecC-------------------------
Q 047009          191 -KNHAEYMKAERD------I--------LTK--------IDHPFVVQLKYSFQTK-------------------------  222 (482)
Q Consensus       191 -~~~~~~~~~E~~------i--------l~~--------l~hpnIv~l~~~~~~~-------------------------  222 (482)
                       ....+.+.+|.-      .        .+.        -+|||||++..+|.+.                         
T Consensus       234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g  313 (598)
T KOG4158|consen  234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG  313 (598)
T ss_pred             hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence             111222233320      0        111        2599999998777432                         


Q ss_pred             --CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc--cCC--ceeEcccCc
Q 047009          223 --YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG--ADG--HVMLTDFGL  296 (482)
Q Consensus       223 --~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~--~~g--~vKL~DFGl  296 (482)
                        ..+|+||..... +|..++-.+. .+....+.++.|+++|+.|||++||.|||+|.+|||+.  +|+  .+.|+|||+
T Consensus       314 ~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC  391 (598)
T KOG4158|consen  314 EPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC  391 (598)
T ss_pred             CCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence              247999998865 7888886554 45666777899999999999999999999999999994  444  478999999


Q ss_pred             cccccC-------CCCCcccccCCCCCchhhhcCCC------CCchhHHHHHhHHHHHHhhCCCCCCCCchHHHH--HHH
Q 047009          297 AKQFDE-------NTRSNSMIGTVEYMAPEIVLGKG------HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ--QKI  361 (482)
Q Consensus       297 a~~~~~-------~~~~~~~~gt~~y~APE~l~~~~------~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~--~~i  361 (482)
                      |-.-+.       ....-..-|...-||||+....+      .-.++|.|+.|.+.||+++..-||++.....+.  .-.
T Consensus       392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq  471 (598)
T KOG4158|consen  392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ  471 (598)
T ss_pred             eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh
Confidence            854221       12223446788899999987542      124899999999999999999999874332211  111


Q ss_pred             HhcccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          362 VKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       362 ~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                      ....+.+|..+++.+++|+..+|+.||++|++.  .-+..+++-..+..-+|-
T Consensus       472 e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp--~iAANvl~LsLw~~~~~v  522 (598)
T KOG4158|consen  472 ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP--NIAANVLNLSLWRMGEDV  522 (598)
T ss_pred             hhhCCCCcccCChHHHHHHHHHhcCCccccCCc--cHHHhHHHHHHhcCchHH
Confidence            123456788899999999999999999999987  456778876666666663

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=3.7e-23  Score=193.28  Aligned_cols=144  Identities=22%  Similarity=0.244  Sum_probs=114.3

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh-----------------------hHHHHHHHHHHHHHhCCCCc
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK-----------------------NHAEYMKAERDILTKIDHPF  211 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~-----------------------~~~~~~~~E~~il~~l~hpn  211 (482)
                      .+.||+|+||.||+|.+. +|+.||||+++.......                       .....+..|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999987 899999999987531100                       01233568999999999998


Q ss_pred             eeeeeeeeecCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCcee
Q 047009          212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVM  290 (482)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~vK  290 (482)
                      +.....+...  ..||||||++|+++.........++...+..++.|++.+|.+||+ +||+||||||+|||++ ++.++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            7443333222  237999999998665443345668888999999999999999999 9999999999999998 89999


Q ss_pred             EcccCccccccC
Q 047009          291 LTDFGLAKQFDE  302 (482)
Q Consensus       291 L~DFGla~~~~~  302 (482)
                      |+|||+++....
T Consensus       158 liDFG~a~~~~~  169 (190)
T cd05145         158 IIDVSQAVELDH  169 (190)
T ss_pred             EEEcccceecCC
Confidence            999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=8.7e-23  Score=190.79  Aligned_cols=187  Identities=19%  Similarity=0.212  Sum_probs=142.5

Q ss_pred             EEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhh-HHHHHHHHHHHHHhCC-CCceeeeeeeeecCCeEEEEEE
Q 047009          153 EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKN-HAEYMKAERDILTKID-HPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       153 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~-~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      .+...|++|+||+||++..  .+..++.+.+......... ....+.+|+++|++|. |++|.+++++    +..|++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4567899999999998765  4667877776654432221 1224789999999995 4788888875    34689999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC-CCCcEEEccCCceeEcccCccccccCCCCC---
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDL-KPENILLGADGHVMLTDFGLAKQFDENTRS---  306 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDL-Kp~NILl~~~g~vKL~DFGla~~~~~~~~~---  306 (482)
                      |+.|.+|...+..      . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.........   
T Consensus        79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~  151 (218)
T PRK12274         79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL  151 (218)
T ss_pred             eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence            9999988654321      1 1357889999999999999999999 799999999999999999999865443310   


Q ss_pred             -----------cccccCCCCCchhhhcCC-CCC-chhHHHHHhHHHHHHhhCCCCCCCC
Q 047009          307 -----------NSMIGTVEYMAPEIVLGK-GHN-KAADWWSVGILLYEMLTGKPPFIGG  352 (482)
Q Consensus       307 -----------~~~~gt~~y~APE~l~~~-~~~-~~sDvwSlGvilyelltG~~PF~~~  352 (482)
                                 .....++.|++|+...-- ..+ ...+|++.|.-+|.++|+..++.+.
T Consensus       152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                       112368899999976543 333 5789999999999999999987543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-23  Score=227.91  Aligned_cols=241  Identities=22%  Similarity=0.331  Sum_probs=182.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechh--hchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDK--IVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +|...+.||.+.|=+|.+|++.. |. |+||++-++.  +.-....+++ .|++ ...++|||.+.+...-.+....|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            57788899999999999999876 44 8999987654  1122333333 3444 6677999999998887888888999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc--cCCCC-
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTR-  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~--~~~~~-  305 (482)
                      -+|+.. +|++.+..+..+..-+.+.|+.||+.||..+|+.||+|+|||.+||||++=+-+.|+||..-+..  .++.. 
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            999976 89999998888999999999999999999999999999999999999999888999999876642  22111 


Q ss_pred             -Cc----ccccCCCCCchhhhcCCC-----------CCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcccCC
Q 047009          306 -SN----SMIGTVEYMAPEIVLGKG-----------HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL  368 (482)
Q Consensus       306 -~~----~~~gt~~y~APE~l~~~~-----------~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~~~~  368 (482)
                       ..    +-..-.+|+|||.+....           .+++-||||+||++.||++ |++||.-   ..+..--. +.-..
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQL~aYr~-~~~~~  254 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQLLAYRS-GNADD  254 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HHHHhHhc-cCccC
Confidence             11    112234799999986522           5678999999999999988 8999932   11111000 00000


Q ss_pred             C-----ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          369 P-----AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       369 p-----~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      +     .--+..+++||..|++.||.+|+++     ++.|+-
T Consensus       255 ~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSA-----edyL~~  291 (1431)
T KOG1240|consen  255 PEQLLEKIEDVSLRNLILSMIQRDPSKRLSA-----EDYLQK  291 (1431)
T ss_pred             HHHHHHhCcCccHHHHHHHHHccCchhccCH-----HHHHHh
Confidence            0     1124578999999999999999999     888874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.88  E-value=1.2e-23  Score=227.95  Aligned_cols=296  Identities=33%  Similarity=0.562  Sum_probs=254.4

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      ....+++.+.+-+-.|.++.++.+.-..+|...++|+..+......+..+....+..++-...+|.+++....+.-....
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            45788999999999999999999999889988888887765555555555666777777777889999887777777889


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc----
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD----  301 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~----  301 (482)
                      +|+++|+.|++|...|..-+..+++.++.+...+..+++|||...++|||++|.|+|...+|+.+++|||......    
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence            9999999999999999888889999999999999999999999999999999999999999999999998443211    


Q ss_pred             ---C-------------------------CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc
Q 047009          302 ---E-------------------------NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN  353 (482)
Q Consensus       302 ---~-------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~  353 (482)
                         .                         ........||+.|.+||...+..+...+|||++|++++|.++|.+||....
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence               0                         011234679999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHHHhcccCCCc---cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccC
Q 047009          354 RAKIQQKIVKDKLRLPA---FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVA  430 (482)
Q Consensus       354 ~~~~~~~i~~~~~~~p~---~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~  430 (482)
                      .....++|.+.....|.   ..+.++++++..+|..+|.+|.++  .++.++..|+||++++|+.+....  -.|+|...
T Consensus      1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a--~~~~e~k~~~~~~~~~~~~l~~q~--~~~~p~~~ 1115 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGA--KGAAEVKGHPFFQDVDWENLALQK--AEFVPQPE 1115 (1205)
T ss_pred             hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCc--ccccccccCCccCCCCcccccccc--CccCCCCC
Confidence            99999999999888775   479999999999999999999998  566799999999999999886543  35788887


Q ss_pred             CcccccCccccccCC
Q 047009          431 GKHCIANFEKKWTDM  445 (482)
Q Consensus       431 ~~~~~~~f~~~~~~~  445 (482)
                      ...+.++|...|...
T Consensus      1116 s~~dtS~~~~r~~~~ 1130 (1205)
T KOG0606|consen 1116 STQDTSYFESRFSEE 1130 (1205)
T ss_pred             CCCccchhhcccccc
Confidence            788888888777643

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=7e-23  Score=192.94  Aligned_cols=242  Identities=19%  Similarity=0.315  Sum_probs=196.7

Q ss_pred             ccccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          144 VCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      ..++.+.+..++.+|.+...|..|+|++.++  -++.|+++...... .....+..|.-.|+-..||||+.+++.|....
T Consensus       184 ~~gid~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnspp  260 (448)
T KOG0195|consen  184 YTGIDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPP  260 (448)
T ss_pred             ccCcchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence            3446677788889999999999999999764  46678887665433 33345778888888999999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC-Cc-ccCCCCCcEEEccCCceeEc--ccCcc
Q 047009          224 RLYLVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHANG-IM-HRDLKPENILLGADGHVMLT--DFGLA  297 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~-Ii-HrDLKp~NILl~~~g~vKL~--DFGla  297 (482)
                      ++.++..||+.|+|+..|.....  ....++..++.+|++|++|||+.. ++ ---|....+++|++-+.+|+  |--++
T Consensus       261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs  340 (448)
T KOG0195|consen  261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS  340 (448)
T ss_pred             CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee
Confidence            99999999999999999977653  567888999999999999999974 44 44688999999999877764  22222


Q ss_pred             ccccCCCCCcccccCCCCCchhhhcCCCCC---chhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc--ccCCCccC
Q 047009          298 KQFDENTRSNSMIGTVEYMAPEIVLGKGHN---KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--KLRLPAFL  372 (482)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~---~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~  372 (482)
                      -  .+    ....-.|.||+||.+..++-+   .++|+|||++++|||.|...||..-.+.+.-.+|.-+  +..+|+.+
T Consensus       341 f--qe----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgi  414 (448)
T KOG0195|consen  341 F--QE----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGI  414 (448)
T ss_pred             e--ec----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCc
Confidence            1  11    112336899999999887654   5899999999999999999999988887776666544  56789999


Q ss_pred             ChHHHHHHHHhhccCcCCcCCC
Q 047009          373 SSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       373 s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                      +..+..|++-|++.||.+||.+
T Consensus       415 s~hm~klm~icmnedpgkrpkf  436 (448)
T KOG0195|consen  415 SRHMNKLMNICMNEDPGKRPKF  436 (448)
T ss_pred             cHHHHHHHHHHhcCCCCcCCCc
Confidence            9999999999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=2e-21  Score=214.51  Aligned_cols=197  Identities=25%  Similarity=0.385  Sum_probs=164.6

Q ss_pred             ccccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC---CCceeeeeeeee
Q 047009          144 VCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID---HPFVVQLKYSFQ  220 (482)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~  220 (482)
                      ...+.-..|.|.+.||+|+||+||+|...+ |+.||+|+=+....++--.      =.+++.+|+   -+.|+.+..++.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI------~~q~~~RLk~~~~~~~~~~~~a~~  764 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI------CLQVMERLKPQMLPSIMHISSAHV  764 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee------hHHHHHhhchhhhcchHHHHHHHc
Confidence            344566889999999999999999999988 9999999977654332111      123344444   345556666666


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc-------CCceeEcc
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA-------DGHVMLTD  293 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~-------~g~vKL~D  293 (482)
                      ..+..+||+||.+.|+|.+++...+.+++..+.+++.|++..+++||..+|||+||||+|+||..       +--++|+|
T Consensus       765 ~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  765 FQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             cCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence            77778899999999999999998889999999999999999999999999999999999999953       23599999


Q ss_pred             cCccccc---cCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCC
Q 047009          294 FGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKP  347 (482)
Q Consensus       294 FGla~~~---~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~  347 (482)
                      ||.+-.+   .++......++|-.+-.+|+..|+.++..+|.|.|+.+++-||.|+.
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9998653   45566677899999999999999999999999999999999999964

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=7.6e-21  Score=179.89  Aligned_cols=135  Identities=17%  Similarity=0.181  Sum_probs=107.7

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-----CCCceeeeeeeeecCC---eEE
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-----DHPFVVQLKYSFQTKY---RLY  226 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~---~~~  226 (482)
                      .+.||+|+||.||.  +..++.. +||++.....   ...+.+.+|+.+++.+     +||||++++++++++.   .++
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            46799999999995  6666665 6999876432   2345688999999999     6799999999998874   434


Q ss_pred             -EEEEe--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCCcccCCCCCcEEEccC----CceeEcccCccc
Q 047009          227 -LVLDF--INGGHLFFQLYHHGLFREDLARIYAAEIVSAV-SHLHANGIMHRDLKPENILLGAD----GHVMLTDFGLAK  298 (482)
Q Consensus       227 -lV~E~--~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL-~yLH~~~IiHrDLKp~NILl~~~----g~vKL~DFGla~  298 (482)
                       +|+||  +.+|+|.+++.+ +.+++.  ..++.|++.++ +|||+++|+||||||+|||++..    +.++|+||+-++
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence             78999  558999999965 456666  35678888888 99999999999999999999743    379999954443

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=9.3e-21  Score=183.07  Aligned_cols=146  Identities=22%  Similarity=0.220  Sum_probs=115.1

Q ss_pred             CeEEEEEecccCceEEEEEE-EcCCCeEEEEEEeechhhch---------------------hhHHHHHHHHHHHHHhCC
Q 047009          151 DFEVLKVVGQGAFGRVYQVR-KKNTSEIYAMKVMRKDKIVE---------------------KNHAEYMKAERDILTKID  208 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~-~~~~~~~vAiK~~~~~~~~~---------------------~~~~~~~~~E~~il~~l~  208 (482)
                      .|.+.+.||+|+||.||+|. +..+|+.||+|+++......                     ......+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47888999999999999998 66789999999998643110                     001234678999999997


Q ss_pred             CCc--eeeeeeeeecCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCCCCcEEEcc
Q 047009          209 HPF--VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG-IMHRDLKPENILLGA  285 (482)
Q Consensus       209 hpn--Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-IiHrDLKp~NILl~~  285 (482)
                      +..  +.+++..    ...++||||++|++|.........+....+..++.||+.+|.+||++| |+||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            633  3333332    234799999999888665544555667777889999999999999999 99999999999999 


Q ss_pred             CCceeEcccCcccccc
Q 047009          286 DGHVMLTDFGLAKQFD  301 (482)
Q Consensus       286 ~g~vKL~DFGla~~~~  301 (482)
                      ++.++|+|||.+....
T Consensus       184 ~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCCEEEEEChhhhccC
Confidence            8899999999987643

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.83  E-value=4.6e-21  Score=195.94  Aligned_cols=244  Identities=25%  Similarity=0.324  Sum_probs=168.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCC---CeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeee------eee
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNT---SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLK------YSF  219 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~------~~~  219 (482)
                      ....+.+-.+..+++.+...+...+   .+.++-|....+.   ........+++-.+... .|+..+..-      ..+
T Consensus       244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~  320 (516)
T KOG1033|consen  244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESS  320 (516)
T ss_pred             ccccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccccCCcccccCCCCchhhhc
Confidence            3455566677777777776554443   2334433332221   12223333444444443 344433221      011


Q ss_pred             -----ecCCeEEEEEEecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeE
Q 047009          220 -----QTKYRLYLVLDFINGGHLFFQLYHHG---LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVML  291 (482)
Q Consensus       220 -----~~~~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL  291 (482)
                           ....++||.|++|.-.+|.+++.+..   ..+......++.|++.|++|   +|.+|||+||.||+...+..+||
T Consensus       321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kI  397 (516)
T KOG1033|consen  321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKI  397 (516)
T ss_pred             cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhh
Confidence                 11335899999999999999997553   35667788899999999999   99999999999999999999999


Q ss_pred             cccCccccccCCC-------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHh
Q 047009          292 TDFGLAKQFDENT-------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK  363 (482)
Q Consensus       292 ~DFGla~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~  363 (482)
                      +|||+........       ..+..+||..||+||.+.+..|+.++||||||+||+||+. =...|   ........+..
T Consensus       398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~  474 (516)
T KOG1033|consen  398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRD  474 (516)
T ss_pred             hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhc
Confidence            9999998765544       4456789999999999999999999999999999999998 33333   23334444444


Q ss_pred             cccC--CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          364 DKLR--LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       364 ~~~~--~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +.+.  +-.. .++-..|+.+||...|.+||++     .+.--|.|.
T Consensus       475 g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~-----~~~~~~~~~  515 (516)
T KOG1033|consen  475 GIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSA-----IEVALHEFL  515 (516)
T ss_pred             CCCChHHhhc-CcHHHHHHHHhcCCCcccCchH-----HHHhhhhhc
Confidence            4433  1112 2445799999999999999976     555555553

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.9e-19  Score=170.21  Aligned_cols=137  Identities=26%  Similarity=0.347  Sum_probs=113.6

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhc-----hhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-----EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      +.||+|++|.||+|.+  .|..+++|+.......     .......+.+|+.++..+.|++|.....++.+....++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999987  4667999986543211     11223457789999999999998777667767778899999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      |++|++|...+.....    ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||+++.
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988865432    6778899999999999999999999999999999 88999999999875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=1.2e-21  Score=211.79  Aligned_cols=256  Identities=29%  Similarity=0.456  Sum_probs=209.4

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcC-CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCCeEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKN-TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~  226 (482)
                      ...|.+.+.||+|+|+.|-++.... ....+|+|.+.... ......+.+..|..+-+.+. |.|++++++.....+..+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            3568888999999999999887643 44567777776543 23445556667888888887 999999999999999999


Q ss_pred             EEEEecCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCcEEEccCC-ceeEcccCccccccC
Q 047009          227 LVLDFINGGHLFFQL-YHHG-LFREDLARIYAAEIVSAVSHLH-ANGIMHRDLKPENILLGADG-HVMLTDFGLAKQFDE  302 (482)
Q Consensus       227 lV~E~~~gg~L~~~l-~~~~-~l~~~~~~~i~~qi~~aL~yLH-~~~IiHrDLKp~NILl~~~g-~vKL~DFGla~~~~~  302 (482)
                      ++++|..|++++..+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .++++|||+|..+..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999999888 4444 5677888999999999999999 99999999999999999999 999999999988654


Q ss_pred             -C---CCCccccc-CCCCCchhhhcCCC-CCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHH-HHHhc----ccCCCcc
Q 047009          303 -N---TRSNSMIG-TVEYMAPEIVLGKG-HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ-KIVKD----KLRLPAF  371 (482)
Q Consensus       303 -~---~~~~~~~g-t~~y~APE~l~~~~-~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~-~i~~~----~~~~p~~  371 (482)
                       +   ......+| ++.|+|||...+.. .....|+||.|+++.-|++|..|+.......... .....    .......
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS  257 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence             2   22345688 99999999999854 4678999999999999999999997654433211 11111    1334456


Q ss_pred             CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       372 ~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      ++....+++.++|..+|..|.+.     +++..++|+..
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~-----~~~~~d~~~~~  291 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSI-----EELKLDNWLSS  291 (601)
T ss_pred             CChhhhhcccccccCCchhcccc-----ccccccccccc
Confidence            89999999999999999999999     99999999987

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=4.6e-19  Score=166.13  Aligned_cols=134  Identities=24%  Similarity=0.242  Sum_probs=107.0

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeechhhc-----hhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEe
Q 047009          157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-----EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       157 ~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  231 (482)
                      .||+|+||.||+|.+  +|..|++|+.......     .......+.+|++++..+.|+++.....++......++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            389999999999985  4578999986543211     112235677899999999988765544455556667899999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc
Q 047009          232 INGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF  300 (482)
Q Consensus       232 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~  300 (482)
                      ++|++|...+.....       .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||+++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999887754321       7789999999999999999999999999999 899999999998763

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=6.7e-19  Score=165.38  Aligned_cols=140  Identities=20%  Similarity=0.177  Sum_probs=108.9

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhch-------------------hhHHHHHHHHHHHHHhCCCCc-
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE-------------------KNHAEYMKAERDILTKIDHPF-  211 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~-------------------~~~~~~~~~E~~il~~l~hpn-  211 (482)
                      |.+.+.||+|+||.||++... +|+.||||++.......                   .........|..++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            777889999999999999875 68999999977542100                   001123567888999998774 


Q ss_pred             -eeeeeeeeecCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcee
Q 047009          212 -VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVM  290 (482)
Q Consensus       212 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vK  290 (482)
                       +...++    ....++||||++|++|.....      ......++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             344433    234589999999998865432      134567889999999999999999999999999999999999


Q ss_pred             EcccCccccccC
Q 047009          291 LTDFGLAKQFDE  302 (482)
Q Consensus       291 L~DFGla~~~~~  302 (482)
                      |+|||++.....
T Consensus       166 liDfg~~~~~~~  177 (198)
T cd05144         166 IIDWPQMVSTDH  177 (198)
T ss_pred             EEECCccccCCC
Confidence            999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=2.5e-18  Score=185.39  Aligned_cols=140  Identities=22%  Similarity=0.222  Sum_probs=112.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhh-----chhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-----VEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ..|...+.||+|+||+||++.+....  +++|+......     ......+.+.+|+++++.++|++++....++.+...
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            34567899999999999999876543  44443322111     112234567899999999999999887777777777


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF  300 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~  300 (482)
                      .++||||++|++|..++.        ....++.|++.+|.|||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus       411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            889999999999988775        356789999999999999999999999999999 6789999999999763

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=2.6e-18  Score=159.36  Aligned_cols=140  Identities=24%  Similarity=0.280  Sum_probs=100.0

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHH---------------------HHHHHHHHHHhCCCCc--
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAE---------------------YMKAERDILTKIDHPF--  211 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~---------------------~~~~E~~il~~l~hpn--  211 (482)
                      .+.||+|+||+||+|.+. +++.||||+++...........                     ....|...+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999987 7889999998764322111111                     1135666666664433  


Q ss_pred             eeeeeeeeecCCeEEEEEEecCCCchHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCce
Q 047009          212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQ-LYHHGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHV  289 (482)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~-l~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~v  289 (482)
                      +.+.+++    ...++||||++|+.+... +... ... ..++.++.+++.++.++|. .||+||||||+||+++ ++.+
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            3333332    235899999999644211 1111 111 6678899999999999999 9999999999999999 9999


Q ss_pred             eEcccCccccccC
Q 047009          290 MLTDFGLAKQFDE  302 (482)
Q Consensus       290 KL~DFGla~~~~~  302 (482)
                      +|+|||.+.....
T Consensus       154 ~liDfg~a~~~~~  166 (187)
T cd05119         154 YIIDVPQAVEIDH  166 (187)
T ss_pred             EEEECcccccccC
Confidence            9999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.74  E-value=8.9e-18  Score=174.65  Aligned_cols=191  Identities=23%  Similarity=0.320  Sum_probs=153.1

Q ss_pred             HHhCCCCceeeeeeeeecCCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCC-cccCCCCCcE
Q 047009          204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGI-MHRDLKPENI  281 (482)
Q Consensus       204 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~I-iHrDLKp~NI  281 (482)
                      |+.+.|.|+.++++.+.+....++|.+||..|+|.+.+... -.++..-...++++|+.||+|||.-.| .|+.++..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            45689999999999999999999999999999999999773 456777777889999999999998866 9999999999


Q ss_pred             EEccCCceeEcccCccccccC---CCCCcccccCCCCCchhhhcCCC-------CCchhHHHHHhHHHHHHhhCCCCCCC
Q 047009          282 LLGADGHVMLTDFGLAKQFDE---NTRSNSMIGTVEYMAPEIVLGKG-------HNKAADWWSVGILLYEMLTGKPPFIG  351 (482)
Q Consensus       282 Ll~~~g~vKL~DFGla~~~~~---~~~~~~~~gt~~y~APE~l~~~~-------~~~~sDvwSlGvilyelltG~~PF~~  351 (482)
                      ++|....+||+|||+......   ........-...|.|||.+.+..       -+.+.|+||+|+++||+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999877532   01111222345799999998742       35679999999999999999999976


Q ss_pred             C----chHHHHHHHHh-cccCC-Cc-----cCChHHHHHHHHhhccCcCCcCCC
Q 047009          352 G----NRAKIQQKIVK-DKLRL-PA-----FLSSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       352 ~----~~~~~~~~i~~-~~~~~-p~-----~~s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                      .    +..++...+.+ +...+ |.     .+.+++..+++.||..+|.+||++
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~  214 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI  214 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence            3    22456666665 22111 21     345679999999999999999998

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=4.6e-17  Score=143.56  Aligned_cols=132  Identities=24%  Similarity=0.298  Sum_probs=111.7

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCC--CceeeeeeeeecCCeEEEEEEe
Q 047009          154 VLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH--PFVVQLKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       154 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~  231 (482)
                      +++.||+|.++.||++...+  ..+++|.......     ...+.+|..+++.+.|  .++.+++.++...+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            35789999999999999865  6799999865431     3457789999999976  5889998888888889999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          232 INGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN---GIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       232 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~---~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      +.|+.+...       +......++.+++.+|++||..   +++|+|++|+||+++..+.++++|||.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            999877543       4556677889999999999985   799999999999999989999999999865

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=2.6e-16  Score=152.28  Aligned_cols=137  Identities=22%  Similarity=0.308  Sum_probs=104.0

Q ss_pred             EEec-ccCceEEEEEEEcCCCeEEEEEEeechhhc----------hhhHHHHHHHHHHHHHhCCCCce--eeeeeeeecC
Q 047009          156 KVVG-QGAFGRVYQVRKKNTSEIYAMKVMRKDKIV----------EKNHAEYMKAERDILTKIDHPFV--VQLKYSFQTK  222 (482)
Q Consensus       156 ~~LG-~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~----------~~~~~~~~~~E~~il~~l~hpnI--v~l~~~~~~~  222 (482)
                      ..|| .||.|+||.+...  +..++||.+....+.          .......+.+|+.++.+|.|++|  ++.+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 7888888888764  567999988653321          11233557889999999998775  5666554332


Q ss_pred             -C---eEEEEEEecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          223 -Y---RLYLVLDFING-GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       223 -~---~~~lV~E~~~g-g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                       .   ..++|||+++| .+|..++.. ..+++..    +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence             2   23599999998 588777654 4555543    568999999999999999999999999999999999999998


Q ss_pred             cc
Q 047009          298 KQ  299 (482)
Q Consensus       298 ~~  299 (482)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            65

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=2.1e-16  Score=164.68  Aligned_cols=253  Identities=24%  Similarity=0.263  Sum_probs=196.8

Q ss_pred             CCeEEEEEecc--cCceEEEEEEE--cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCe
Q 047009          150 EDFEVLKVVGQ--GAFGRVYQVRK--KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       150 ~~y~i~~~LG~--G~fg~Vy~a~~--~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  224 (482)
                      ..|.+.+.+|.  |.+|.||.++.  ..++..+|+|.-+... ........=.+|....+++ .|+|.++.+..+...+.
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCCc
Confidence            44667788999  99999999998  8889999999743221 1111122223566655666 49999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHH----HHHHHHHCCCcccCCCCCcEEEccC-CceeEcccCccc
Q 047009          225 LYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVS----AVSHLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAK  298 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~----aL~yLH~~~IiHrDLKp~NILl~~~-g~vKL~DFGla~  298 (482)
                      +++-+|++. .+|..+..... .+++..++.+..+...    ||.++|+.+|+|-|+||+||++..+ ...+++|||+..
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~  271 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS  271 (524)
T ss_pred             ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence            999999996 57766665544 4889999999999999    9999999999999999999999999 889999999999


Q ss_pred             cccCCCCC------cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC--chHHHHHHHHhcccCCCc
Q 047009          299 QFDENTRS------NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG--NRAKIQQKIVKDKLRLPA  370 (482)
Q Consensus       299 ~~~~~~~~------~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~--~~~~~~~~i~~~~~~~p~  370 (482)
                      .+..+...      ....|...|++||...+. ++.+.|+|++|.++.+..+|..++..+  +......... ...++-.
T Consensus       272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e~~~  349 (524)
T KOG0601|consen  272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLEFCE  349 (524)
T ss_pred             EccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cchhhhc
Confidence            88665422      222578889999998765 889999999999999999987776544  2211111111 2233445


Q ss_pred             cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          371 FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       371 ~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      ..+.++...+..|++.+|..|+++     +.+++|++....
T Consensus       350 ~~s~~l~~~~~~~~d~~~~~~~~~-----q~~~~l~~i~s~  385 (524)
T KOG0601|consen  350 GGSSSLRSVTSQMLDEDPRLRLTA-----QILTALNVIHSK  385 (524)
T ss_pred             CcchhhhhHHHHhcCcchhhhhHH-----HHHhccccccch
Confidence            567888889999999999999998     999999998853

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.57  E-value=4.3e-15  Score=158.15  Aligned_cols=146  Identities=19%  Similarity=0.365  Sum_probs=98.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhch-------------------------------hhHHHHH
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE-------------------------------KNHAEYM  197 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~-------------------------------~~~~~~~  197 (482)
                      ..+|+. +.||.|++|.||+|+.+++|+.||||+.++.....                               .+..+.+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            355776 78999999999999999889999999998642100                               0122233


Q ss_pred             HHHHHHHH------hC----CCCceeeeeeeeec-CCeEEEEEEecCCCchHHH--HHhcC----CCCHHHHHHHHHHHH
Q 047009          198 KAERDILT------KI----DHPFVVQLKYSFQT-KYRLYLVLDFINGGHLFFQ--LYHHG----LFREDLARIYAAEIV  260 (482)
Q Consensus       198 ~~E~~il~------~l----~hpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~--l~~~~----~l~~~~~~~i~~qi~  260 (482)
                      .+|+++..      ++    .+.+.+.+-..|.+ ....+|||||+.|+.+.+.  +...+    .+.+..+..++.|++
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence            34444333      32    13322332222221 2345699999999999753  33333    244444555555554


Q ss_pred             HHHHHHHHCCCcccCCCCCcEEEccCC----ceeEcccCccccccC
Q 047009          261 SAVSHLHANGIMHRDLKPENILLGADG----HVMLTDFGLAKQFDE  302 (482)
Q Consensus       261 ~aL~yLH~~~IiHrDLKp~NILl~~~g----~vKL~DFGla~~~~~  302 (482)
                             ..|++|+|+||.||+++.+|    .++++|||++..++.
T Consensus       278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   58999999999999999988    999999999987754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=7.2e-14  Score=146.70  Aligned_cols=143  Identities=20%  Similarity=0.293  Sum_probs=96.9

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhch-------------------------------hhHHH------HHH
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE-------------------------------KNHAE------YMK  198 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~-------------------------------~~~~~------~~~  198 (482)
                      +.||.|++|.||+|+.+ +|+.||||+.+......                               .+...      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999986 58899999986542100                               00000      133


Q ss_pred             HHHHHHHhC----CCCceeeeeeee-ecCCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHCCC
Q 047009          199 AERDILTKI----DHPFVVQLKYSF-QTKYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVS-AVSHLHANGI  271 (482)
Q Consensus       199 ~E~~il~~l----~hpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~-aL~yLH~~~I  271 (482)
                      +|+..+.++    .|.+-+.+-..+ ......+|||||++|++|.+..... ....   ...++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            455555544    232223322222 2233468999999999997765432 1121   2345556655 4788999999


Q ss_pred             cccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          272 MHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       272 iHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      +|+|+||.||+++.+|.++|+|||++..+..
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999987753

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=9e-15  Score=152.52  Aligned_cols=251  Identities=24%  Similarity=0.279  Sum_probs=190.9

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEc-CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCe
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKK-NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  224 (482)
                      .-..+|.++..||.|.|+.|+.+..+ .++..|++|...+.......... -..|+.+...+ .|.++++....|.....
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccccc
Confidence            34578999999999999999998766 67789999988765543333333 23466666655 58999998888888888


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC-CceeEcccCccccccCC
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~-g~vKL~DFGla~~~~~~  303 (482)
                      .|+=.|||+++++...+.-...+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..+++|||+.+.+.-.
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence            88999999999887666555668888999999999999999999999999999999999886 78899999998753211


Q ss_pred             CCCcccccCCCCC--chhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHH
Q 047009          304 TRSNSMIGTVEYM--APEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       304 ~~~~~~~gt~~y~--APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~  381 (482)
                        .....+.-.++  +++......+..+.|++|||..+++.++|...-..   ......|..+..........+++.+.+
T Consensus       421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~~~~~~i~~~~~p~~~~~~~~~q~~~k  495 (524)
T KOG0601|consen  421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES---GVQSLTIRSGDTPNLPGLKLQLQVLLK  495 (524)
T ss_pred             --cccccccccccccchhhccccccccccccccccccccccccCcccCcc---cccceeeecccccCCCchHHhhhhhhh
Confidence              11122233444  55555667788999999999999999998753211   122344555555444455589999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      .++..++..|+.+     .++..|.=|
T Consensus       496 v~~~~~~~~~~l~-----~~l~~~~~~  517 (524)
T KOG0601|consen  496 VMINPDRKRRPSA-----VELSLHSEF  517 (524)
T ss_pred             hhcCCccccchhh-----hhhcccchh
Confidence            9999999999988     666666544

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.51  E-value=2.5e-13  Score=143.19  Aligned_cols=219  Identities=17%  Similarity=0.195  Sum_probs=151.6

Q ss_pred             EEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCCchHHHHHhcCCC
Q 047009          168 QVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLF  247 (482)
Q Consensus       168 ~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l  247 (482)
                      .|..+.++.+|.+.+++...-   ...+...+-++-|+.++||||++++..++..+.+|||+|-+.  -|-.++.+.+  
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~--  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG--  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--
Confidence            466777888999998875532   445667788889999999999999999999999999999986  4555555544  


Q ss_pred             CHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC-CcccccCCCCCchhhhcCCC
Q 047009          248 REDLARIYAAEIVSAVSHLH-ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-SNSMIGTVEYMAPEIVLGKG  325 (482)
Q Consensus       248 ~~~~~~~i~~qi~~aL~yLH-~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~~gt~~y~APE~l~~~~  325 (482)
                       ...+..-+.||+.||.||| +.+++|++|.-..|+++..|..||++|.++........ .....---.|..|+.+....
T Consensus       103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence             5556667899999999998 56899999999999999999999999998865432221 11111122466777654443


Q ss_pred             CCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh-
Q 047009          326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS-  404 (482)
Q Consensus       326 ~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~-  404 (482)
                        ...|.|.|||++++++.|..+-  ..           ....+..+++....+-.+.+--.+..|+.. ..-..+++. 
T Consensus       182 --~s~D~~~Lg~li~el~ng~~~~--~~-----------~~~~~~~ipk~~~~~~~k~~~~~~~~r~n~-~~~~~~~~~~  245 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGSLLT--KT-----------DLSNTGKIPKALIELYCKKLGATELKRPNK-LRFILECRLL  245 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcccCc--ch-----------hhhccCccchhHHHHHHHHhccccccccch-hhHHHHHHhc
Confidence              4579999999999999993321  11           112233344444555545555555556552 111233333 


Q ss_pred             CcCCCC
Q 047009          405 HKWFKP  410 (482)
Q Consensus       405 hp~f~~  410 (482)
                      |.||++
T Consensus       246 ~gff~n  251 (690)
T KOG1243|consen  246 GGFFRN  251 (690)
T ss_pred             cccccc
Confidence            666665

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=2.4e-14  Score=139.03  Aligned_cols=244  Identities=18%  Similarity=0.219  Sum_probs=167.5

Q ss_pred             EEEEEEEcCCCeEEEEEEeechhhc-hhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC-----CeEEEEEEecCCCchH
Q 047009          165 RVYQVRKKNTSEIYAMKVMRKDKIV-EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK-----YRLYLVLDFINGGHLF  238 (482)
Q Consensus       165 ~Vy~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~  238 (482)
                      .||++.++..|..|.--.+...... -+...+....-..-|-.+.|.|||+++.++.+.     .+..++.|||..|+|.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            3667766666655433222111100 011222233334556677899999999888553     4588999999999999


Q ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEccCCceeEcccCcccccc-----CCCCCc
Q 047009          239 FQLYHH----GLFREDLARIYAAEIVSAVSHLHANG--IMHRDLKPENILLGADGHVMLTDFGLAKQFD-----ENTRSN  307 (482)
Q Consensus       239 ~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~--IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-----~~~~~~  307 (482)
                      .+|++.    ..+.....++|+-||+.||.|||+..  |+|+++..+.|++..+|-+|++--.-...-.     ......
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~  240 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS  240 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence            888763    35778888899999999999999984  9999999999999999999986322111100     000111


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCC-CCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhcc
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPP-FIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~P-F~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~  386 (482)
                      ...+-++|.|||.=.....+.++|||+||+...||..|..- -.+.........|...-+.+..   ..-+++|.+||+-
T Consensus       241 ~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len---~lqr~~i~kcl~~  317 (458)
T KOG1266|consen  241 VNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLEN---GLQRGSITKCLEG  317 (458)
T ss_pred             ccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccC---ccccCcCcccccC
Confidence            23456889999976666677899999999999999988764 2333333333334333222222   2347899999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCCCCCChhhh
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWFKPINWKKL  416 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f~~~~~~~~  416 (482)
                      .|+.||++     .+++.||..-++.-.++
T Consensus       318 eP~~rp~a-----r~llfHpllfeVhslkl  342 (458)
T KOG1266|consen  318 EPNGRPDA-----RLLLFHPLLFEVHSLKL  342 (458)
T ss_pred             CCCCCcch-----hhhhcCceeeecchHHH
Confidence            99999999     99999999877765544

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=2e-13  Score=124.18  Aligned_cols=128  Identities=21%  Similarity=0.276  Sum_probs=95.8

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCcee-eeeeeeecCCeEEEEEEecC
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV-QLKYSFQTKYRLYLVLDFIN  233 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~lV~E~~~  233 (482)
                      ++.|+.|.++.||+++..  ++.|++|+......    ......+|..+++.+.+.+++ +++....  ...++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            467899999999998865  67899999765421    112356788888888655544 4444433  23479999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-----cccCCCCCcEEEccCCceeEcccCcccc
Q 047009          234 GGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI-----MHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       234 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~I-----iHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      |.++...        ......++.+++.+|..||+.++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            9887532        11123457899999999999985     9999999999998 67899999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.46  E-value=5.3e-13  Score=124.61  Aligned_cols=141  Identities=16%  Similarity=0.193  Sum_probs=101.7

Q ss_pred             EEecccCceEEEEEEEcC------CCeEEEEEEeechhhc-------------------hhhHHHH----HHHHHHHHHh
Q 047009          156 KVVGQGAFGRVYQVRKKN------TSEIYAMKVMRKDKIV-------------------EKNHAEY----MKAERDILTK  206 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~------~~~~vAiK~~~~~~~~-------------------~~~~~~~----~~~E~~il~~  206 (482)
                      ..||.|.-+.||.|...+      .+..+|||+.+.....                   ..+....    .++|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998654      3578999997542210                   0111222    3389999998


Q ss_pred             CCC--CceeeeeeeeecCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccCCCCCcEEE
Q 047009          207 IDH--PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL-HANGIMHRDLKPENILL  283 (482)
Q Consensus       207 l~h--pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~IiHrDLKp~NILl  283 (482)
                      +..  -++.+.+++    ..-+|||||+.++.+.....+...++++.+..+..+++.+|..| |+.||||+||++.|||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~  158 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW  158 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            853  344444443    34579999998765533222334466667777889999999999 89999999999999999


Q ss_pred             ccCCceeEcccCcccccc
Q 047009          284 GADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       284 ~~~g~vKL~DFGla~~~~  301 (482)
                      + +|.+.|+|||.+...+
T Consensus       159 ~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         159 H-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             E-CCcEEEEECCCceeCC
Confidence            6 5789999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=4.5e-11  Score=113.16  Aligned_cols=140  Identities=16%  Similarity=0.227  Sum_probs=104.7

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCC--ceeeeeeeeecC---CeEEEEEE
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP--FVVQLKYSFQTK---YRLYLVLD  230 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~~~---~~~~lV~E  230 (482)
                      +.||.|..+.||++...+ |+.|++|+.......  .....+..|..+++.+.+.  ++.+++.+....   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            568999999999998754 678999997654321  1234578899999998753  356666666553   36689999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA------------------------------------------  268 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~------------------------------------------  268 (482)
                      |++|.++...+.. ..+++.....++.+++++|.+||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999887654421 346666777777888888888873                                          


Q ss_pred             --------------CCCcccCCCCCcEEEcc--CCceeEcccCcccc
Q 047009          269 --------------NGIMHRDLKPENILLGA--DGHVMLTDFGLAKQ  299 (482)
Q Consensus       269 --------------~~IiHrDLKp~NILl~~--~g~vKL~DFGla~~  299 (482)
                                    ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          23589999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=7.9e-11  Score=107.14  Aligned_cols=134  Identities=25%  Similarity=0.249  Sum_probs=98.1

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeech-----hhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKD-----KIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~-----~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      ..+++|+-+.+|.+.+.+  ..+.+|.=.++     .+..+-..++..+|+.++.++.--.|..-+-++.+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~g--~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG--LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeeccC--cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            357899999999997753  34666653332     22223344566789999998865444333334455566679999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      |++|..|.+.+...       ...++..+-.-+.-||..||||+||.++||++..++ +.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999888888665       144566777778889999999999999999996654 99999999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.17  E-value=2.6e-10  Score=103.43  Aligned_cols=144  Identities=27%  Similarity=0.320  Sum_probs=104.8

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEe-----echhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          154 VLKVVGQGAFGRVYQVRKKNTSEIYAMKVM-----RKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       154 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~-----~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .+..|-+|+-+.|+++.+.  |+.+.||.-     +...+..+-...+.++|+++|.++.--.|.--.-+|.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            5678999999999998875  566667643     333333444566788999999988644443333345555666799


Q ss_pred             EEecCC-CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc---eeEcccCcccc
Q 047009          229 LDFING-GHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH---VMLTDFGLAKQ  299 (482)
Q Consensus       229 ~E~~~g-g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~---vKL~DFGla~~  299 (482)
                      |||++| .++.+++....  .........++.+|-..+.-||.++|||+||..+||+|..+|.   +-|+|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999988 35666665432  2233333678899999999999999999999999999987763   57999999865

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.13  E-value=1.4e-09  Score=111.90  Aligned_cols=214  Identities=18%  Similarity=0.272  Sum_probs=154.6

Q ss_pred             CceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec----CCeEEEEEEecCCC-c
Q 047009          162 AFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT----KYRLYLVLDFINGG-H  236 (482)
Q Consensus       162 ~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~gg-~  236 (482)
                      --.+.|++..+-+|..|++|+++-.+....+   ....-.+.++++.|.|+|++..+|.+    +..+++|++|.++. +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            3467899999999999999999554433222   12345678899999999999998873    45689999999864 5


Q ss_pred             hHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          237 LFFQLYH---------------HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       237 L~~~l~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      |.++...               +...+|..+|.|+.|+..||.++|+.|+..+-|.|.+||++.+.+++|+-.|....+.
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            5544321               2346789999999999999999999999999999999999998899999888776654


Q ss_pred             CCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHH
Q 047009          302 ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~  381 (482)
                      .+..             |-+.   --.+-|.=.||.+++.|.||..-   .+..+..+.....  .+-..++.+++++|.
T Consensus       445 ~d~~-------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n---s~~~d~~~~s~~~--~I~~~yS~D~rn~v~  503 (655)
T KOG3741|consen  445 EDPT-------------EPLE---SQQQNDLRDLGLLLLALATGTEN---SNRTDSTQSSHLT--RITTTYSTDLRNVVE  503 (655)
T ss_pred             CCCC-------------cchh---HHhhhhHHHHHHHHHHHhhcccc---cccccchHHHHHH--HhhhhhhHHHHHHHH
Confidence            4330             1111   12467888999999999999542   1111111111110  223457889999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      -+...++++ .++     .+++.|
T Consensus       504 yl~s~~~~~-ksI-----~~llp~  521 (655)
T KOG3741|consen  504 YLESLNFRE-KSI-----QDLLPM  521 (655)
T ss_pred             HHHhcCccc-ccH-----HHHHHH
Confidence            999888885 344     666653

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.06  E-value=1.1e-10  Score=123.84  Aligned_cols=154  Identities=23%  Similarity=0.398  Sum_probs=119.5

Q ss_pred             HHHHHHHHHHHHC-CCcccCCCCCcEEEccCCceeEcccCccccccCCCC----------CcccccCCCCCchhhhcCCC
Q 047009          257 AEIVSAVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR----------SNSMIGTVEYMAPEIVLGKG  325 (482)
Q Consensus       257 ~qi~~aL~yLH~~-~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~----------~~~~~gt~~y~APE~l~~~~  325 (482)
                      .+.+.||.|+|+. ++||++|.|++|.++.+|..||+.|+++........          .....-...|.|||++.+..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            3455999999976 899999999999999999999999999876433111          01123456899999999988


Q ss_pred             CCchhHHHHHhHHHHHHh-hCCCCCCCCchHHHHHHHHh-----cccCCCccCChHHHHHHHHhhccCcCCcCCCCCCCh
Q 047009          326 HNKAADWWSVGILLYEML-TGKPPFIGGNRAKIQQKIVK-----DKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGS  399 (482)
Q Consensus       326 ~~~~sDvwSlGvilyell-tG~~PF~~~~~~~~~~~i~~-----~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~  399 (482)
                      .+.++|+||+|+++|.+. .|+.-+...+....+ .+..     +.......++.++++=|.++|..++.-||++     
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~-----  259 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL-----  259 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch-----
Confidence            899999999999999999 566656544332222 2111     2334557799999999999999999999987     


Q ss_pred             HHHHhCcCCCCCChhhh
Q 047009          400 EEIKSHKWFKPINWKKL  416 (482)
Q Consensus       400 ~eil~hp~f~~~~~~~~  416 (482)
                      ..++..+||.+..-..+
T Consensus       260 ~~l~~~~ff~D~~~~aL  276 (700)
T KOG2137|consen  260 DLLLSIPFFSDPGLKAL  276 (700)
T ss_pred             hhhhcccccCCchhhhh
Confidence            89999999988665554

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.99  E-value=1.3e-08  Score=100.08  Aligned_cols=133  Identities=18%  Similarity=0.113  Sum_probs=91.1

Q ss_pred             EEEEEEEcCCCeEEEEEEeechhhch--h------hHHHHHHHHHHHHHhCCCCce--eeeeeeeec-----CCeEEEEE
Q 047009          165 RVYQVRKKNTSEIYAMKVMRKDKIVE--K------NHAEYMKAERDILTKIDHPFV--VQLKYSFQT-----KYRLYLVL  229 (482)
Q Consensus       165 ~Vy~a~~~~~~~~vAiK~~~~~~~~~--~------~~~~~~~~E~~il~~l~hpnI--v~l~~~~~~-----~~~~~lV~  229 (482)
                      .|+++..  .|+.|.||.........  +      .-.....+|...+.+|..-+|  ...++++..     ....+|||
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            3555544  35678888764322110  0      011135678888877743222  223333332     23578999


Q ss_pred             EecCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc-------CCceeEcccCcccc
Q 047009          230 DFINGG-HLFFQLYH--HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA-------DGHVMLTDFGLAKQ  299 (482)
Q Consensus       230 E~~~gg-~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~-------~g~vKL~DFGla~~  299 (482)
                      |++++. +|.+++..  ....+......++.+++..+.-||..||+|+|+++.|||++.       ++.+.|+||+.++.
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            999986 78777753  244566777889999999999999999999999999999985       46799999998854

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=5.9e-09  Score=96.96  Aligned_cols=129  Identities=26%  Similarity=0.305  Sum_probs=83.2

Q ss_pred             EEEEEEEcCCCeEEEEEEeechhh-----------------------chhhHHHHHHHHHHHHHhCCCC--ceeeeeeee
Q 047009          165 RVYQVRKKNTSEIYAMKVMRKDKI-----------------------VEKNHAEYMKAERDILTKIDHP--FVVQLKYSF  219 (482)
Q Consensus       165 ~Vy~a~~~~~~~~vAiK~~~~~~~-----------------------~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~  219 (482)
                      .||.|...+ |..+|+|+.+....                       ...-...+.++|.+.|.++..-  ++.+.+++.
T Consensus         1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            489888754 77999999764321                       0111335677899999999765  344554332


Q ss_pred             ecCCeEEEEEEecC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCCcccCCCCCcEEEccCCceeEcccCc
Q 047009          220 QTKYRLYLVLDFIN--GGHLFFQLYHHGLFREDLARIYAAEIVSAVSH-LHANGIMHRDLKPENILLGADGHVMLTDFGL  296 (482)
Q Consensus       220 ~~~~~~~lV~E~~~--gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~y-LH~~~IiHrDLKp~NILl~~~g~vKL~DFGl  296 (482)
                          .-+|||||++  |..+.. +... .++.+....++.+++..+.. +|+.||+|+||.+.|||++.+ .+.|+|||.
T Consensus        80 ----~~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ----CCEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence                2359999999  655543 3221 12244566778888886655 579999999999999999877 899999999


Q ss_pred             ccccc
Q 047009          297 AKQFD  301 (482)
Q Consensus       297 a~~~~  301 (482)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            87643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.93  E-value=2.3e-08  Score=100.93  Aligned_cols=231  Identities=18%  Similarity=0.295  Sum_probs=154.9

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceee--------eeeeeecCCeEE
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ--------LKYSFQTKYRLY  226 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~--------l~~~~~~~~~~~  226 (482)
                      .+.||+|+-+.+|-.-.-  +.. +-|++.+.....   ..  +.-..+.+.-.||-+-.        |++. .....+-
T Consensus        16 gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~---~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iG   86 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAA---QA--QKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIG   86 (637)
T ss_pred             CccccCCccceeeecchh--hch-hheeecCCCchH---HH--HHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeE
Confidence            467999999999964322  222 358877653211   11  11111223335665432        1111 1222377


Q ss_pred             EEEEecCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          227 LVLDFINGGHLFFQLYH-------HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      +.|..+.|..-...+.+       .....++.+...++.++.+.+-||..|.+-+|+.++|+|+++++.+.|.|=..-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence            88998887643322321       12367788899999999999999999999999999999999999999998765555


Q ss_pred             ccCCCCCcccccCCCCCchhhhc-----CCCCCchhHHHHHhHHHHHHhhC-CCCCCCCc-----hHHHHHHHHhcccC-
Q 047009          300 FDENTRSNSMIGTVEYMAPEIVL-----GKGHNKAADWWSVGILLYEMLTG-KPPFIGGN-----RAKIQQKIVKDKLR-  367 (482)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDvwSlGvilyelltG-~~PF~~~~-----~~~~~~~i~~~~~~-  367 (482)
                      ..++......+|...|.+||.-.     +..-+...|-|.||+++++|+.| +.||.+..     .......|..+.+. 
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence            45555566778999999999865     34456789999999999999886 99997632     11112233332211 


Q ss_pred             ----------CC-----ccCChHHHHHHHHhhcc--CcCCcCCC
Q 047009          368 ----------LP-----AFLSSEAHSLLKGLLQK--EPGKRLGA  394 (482)
Q Consensus       368 ----------~p-----~~~s~~~~~LI~~~L~~--dP~~R~s~  394 (482)
                                -|     .-+++.++.|..+|+..  ++.-||++
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a  290 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA  290 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence                      11     13688999999999864  46689987

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.85  E-value=2.9e-10  Score=119.52  Aligned_cols=241  Identities=19%  Similarity=0.192  Sum_probs=171.1

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCc-eeeeeeeeecCCeEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF-VVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lV~  229 (482)
                      .+......++|+++++++.+...+...+ .+.+...        ....-++++|.+++||| .+..++.++.+...++++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence            3455566899999999998876654444 5655432        23456889999999999 777788888889999999


Q ss_pred             EecCCC-chHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCc
Q 047009          230 DFINGG-HLFFQL-YHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN  307 (482)
Q Consensus       230 E~~~gg-~L~~~l-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  307 (482)
                      +++.++ +-.... ...-.+.+-+...+.+.-.++|+|||+.--+|||    ||+..+ +..|.+||+....+.......
T Consensus       314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~  388 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPR  388 (829)
T ss_pred             hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccc
Confidence            999887 221110 0011123333445566778899999998779999    887754 789999999999887776778


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc--cCCC--ccCChHHH-HHHHH
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLP--AFLSSEAH-SLLKG  382 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~-~LI~~  382 (482)
                      +..+|+.++|||+.....+....|.|++|+-..+|.-|.+|-..  +......+..+.  +.+-  ...+...+ ++...
T Consensus       389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~  466 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAP  466 (829)
T ss_pred             cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCccc
Confidence            88999999999999999999999999999987888888777543  111111111110  0000  01122222 47888


Q ss_pred             hhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          383 LLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       383 ~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      |+..-|..|+..     ..++.|++|.++.
T Consensus       467 ~~~g~P~~pkv~-----mgacfsKvfngCp  491 (829)
T KOG0576|consen  467 CLNGLPPTPKVH-----MGACFSKVFNGCP  491 (829)
T ss_pred             ccCCCCCCCcch-----hhHHHHHHhccCc
Confidence            999999999888     7888899988754

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=6.5e-08  Score=91.52  Aligned_cols=105  Identities=24%  Similarity=0.314  Sum_probs=81.0

Q ss_pred             HHHHHHHHHHHhCCCCc--eeeeeeeeecC----CeEEEEEEecCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 047009          195 EYMKAERDILTKIDHPF--VVQLKYSFQTK----YRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH  267 (482)
Q Consensus       195 ~~~~~E~~il~~l~hpn--Iv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH  267 (482)
                      ....+|...+..|..-.  +.+.+++....    ...+||+|++++. +|.+++......+......++.+++..+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            34667777777764322  22333333321    3468999999985 78888876555777788899999999999999


Q ss_pred             HCCCcccCCCCCcEEEccCC---ceeEcccCcccc
Q 047009          268 ANGIMHRDLKPENILLGADG---HVMLTDFGLAKQ  299 (482)
Q Consensus       268 ~~~IiHrDLKp~NILl~~~g---~vKL~DFGla~~  299 (482)
                      .+||+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999999999999887   899999998875

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.72  E-value=1.1e-07  Score=91.57  Aligned_cols=139  Identities=21%  Similarity=0.227  Sum_probs=99.1

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc------------h-------hhHHHHHHHHHHHHHhCCCC--
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV------------E-------KNHAEYMKAERDILTKIDHP--  210 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~------------~-------~~~~~~~~~E~~il~~l~hp--  210 (482)
                      ..+...||.|.-+.||.|.+. .|..+|||.-+.....            .       .-.....++|..+|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            345688999999999999887 4788999975432110            0       11233456888899888544  


Q ss_pred             ceeeeeeeeecCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcee
Q 047009          211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVM  290 (482)
Q Consensus       211 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vK  290 (482)
                      .+.+-++    .++-.+||||++|-.|...     ++..+....++..|+.-+.-+-..||||+|+.+-||++++||.+.
T Consensus       172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIA----WNRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCccc----cccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            4444332    2445699999999776532     123444555666677666666689999999999999999999999


Q ss_pred             EcccCccccc
Q 047009          291 LTDFGLAKQF  300 (482)
Q Consensus       291 L~DFGla~~~  300 (482)
                      ++||--+...
T Consensus       243 vIDwPQ~v~~  252 (304)
T COG0478         243 VIDWPQAVPI  252 (304)
T ss_pred             EEeCcccccC
Confidence            9999776554

>PRK09902 hypothetical protein; Provisional

Probab=98.67  E-value=3.1e-07  Score=86.35  Aligned_cols=140  Identities=12%  Similarity=0.169  Sum_probs=100.1

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeechhhch---hhHHHHHHHHHHHHHhCCCCc--eeeeeeeeec----CCeEEEE
Q 047009          158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE---KNHAEYMKAERDILTKIDHPF--VVQLKYSFQT----KYRLYLV  228 (482)
Q Consensus       158 LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~---~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~----~~~~~lV  228 (482)
                      -|+||-+.|+.....+  +.|-+|.-.......   ......+.+|...|.+|..-+  +.+...+-..    ...-+||
T Consensus        26 ~~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            3578999999877654  357788754211111   334567889999999885322  3343322111    2346799


Q ss_pred             EEecCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc--eeEcccCcccc
Q 047009          229 LDFING-GHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH--VMLTDFGLAKQ  299 (482)
Q Consensus       229 ~E~~~g-g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~--vKL~DFGla~~  299 (482)
                      +|-+.| .+|.+++...  ...++.....+..+++.++.-||+.|+.|+|+-+.|||++.+|.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998865 4777777553  34567777889999999999999999999999999999987777  99999987765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.58  E-value=2.5e-07  Score=103.60  Aligned_cols=205  Identities=20%  Similarity=0.254  Sum_probs=155.7

Q ss_pred             hHHHHHHHHHHHHHhCCCCceeeeeeeeecCC----eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 047009          192 NHAEYMKAERDILTKIDHPFVVQLKYSFQTKY----RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH  267 (482)
Q Consensus       192 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH  267 (482)
                      .......-|+..+.++.|+|++.++.+-....    ...+..+++.+-++...++.-+..+.+.++.+..++++||.|+|
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence            34445556777888899999999877653322    23355688888899999999999999999999999999999999


Q ss_pred             HCCCcccCCCCC---cEEEccCCceeEc--ccCccccccCCCCCcccccCCCCCchhhhcCCCCCch--hHHHHHhHHHH
Q 047009          268 ANGIMHRDLKPE---NILLGADGHVMLT--DFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKA--ADWWSVGILLY  340 (482)
Q Consensus       268 ~~~IiHrDLKp~---NILl~~~g~vKL~--DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~--sDvwSlGvily  340 (482)
                      +....|.-+...   +-..+.++.+.++  ||+..+.+..........-+..+.++|....+.++.+  .|+|.+|..+.
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            996666655544   4455667777777  9999998877776666677788999999888877665  69999999999


Q ss_pred             HHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          341 EMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       341 elltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      .+..|..+-   ........+.      +.....+..+++.+|+..++++|+++     .+++.|+|.+.
T Consensus       384 ~~~~~~~i~---~~~~~~~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~-----~~ll~~~f~~~  439 (1351)
T KOG1035|consen  384 QLSQGEDIS---EKSAVPVSLL------DVLSTSELLDALPKCLDEDSEERLSA-----LELLTHPFLRF  439 (1351)
T ss_pred             hhhhcCccc---ccccchhhhh------ccccchhhhhhhhhhcchhhhhccch-----hhhhhchhccc
Confidence            998876542   1111111111      11122278899999999999999999     99999999875

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.54  E-value=2e-06  Score=81.36  Aligned_cols=141  Identities=20%  Similarity=0.237  Sum_probs=91.1

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHH------HHHHHHHHHHhCCC---Cceeeeee-
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAE------YMKAERDILTKIDH---PFVVQLKY-  217 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~------~~~~E~~il~~l~h---pnIv~l~~-  217 (482)
                      .-++|.+.+++-......|.+..-.  |+.+.+|..+...........      ...+++..+.++..   -.+..++. 
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            3467999999998888888876554  578999987654322111111      12233333333322   22222221 


Q ss_pred             ----eeecCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcc
Q 047009          218 ----SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTD  293 (482)
Q Consensus       218 ----~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~D  293 (482)
                          .+.-....+++|||++|..|.+...    +++    .+...|..++.-||+.|+.|+|..|.|++++.++ ++++|
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID  177 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID  177 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence                2222334568999999988754321    233    2445677889999999999999999999998554 99999


Q ss_pred             cCcccc
Q 047009          294 FGLAKQ  299 (482)
Q Consensus       294 FGla~~  299 (482)
                      |+..+.
T Consensus       178 ~~~k~~  183 (229)
T PF06176_consen  178 TQGKRM  183 (229)
T ss_pred             Cccccc
Confidence            987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.52  E-value=1.4e-06  Score=83.23  Aligned_cols=139  Identities=22%  Similarity=0.226  Sum_probs=94.5

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhh---------------------HHHHHHHHHHHHHhCCCC--ce
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKN---------------------HAEYMKAERDILTKIDHP--FV  212 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~---------------------~~~~~~~E~~il~~l~hp--nI  212 (482)
                      ..|+.|.-++||+|.. .++..||+|+++.....-+.                     ...+..+|..-|+++..-  .+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            4677888899999986 34789999998764322111                     223445677777776322  22


Q ss_pred             eeeeeeeecCCeEEEEEEecCCCch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCcee
Q 047009          213 VQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVM  290 (482)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L-~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~vK  290 (482)
                      .+-+.+.    +-.|||||+..... .-.|.. -.+..+.+..+..++++.+.-|-. .++||+||..-|||+. +|.+.
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence            2333332    23599999975421 111111 123333677788899999888877 8999999999999998 88999


Q ss_pred             EcccCcccccc
Q 047009          291 LTDFGLAKQFD  301 (482)
Q Consensus       291 L~DFGla~~~~  301 (482)
                      |+|||-|....
T Consensus       207 iID~~QaV~~~  217 (268)
T COG1718         207 IIDVSQAVTID  217 (268)
T ss_pred             EEECccccccC
Confidence            99999987654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.51  E-value=4.2e-07  Score=96.76  Aligned_cols=143  Identities=24%  Similarity=0.331  Sum_probs=90.9

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhch-------------------------------hhHHHH------HH
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE-------------------------------KNHAEY------MK  198 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~-------------------------------~~~~~~------~~  198 (482)
                      ..|+.++-|.||+|+.+. |+.||||+.+..-...                               .+..+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            568999999999999987 8999999976532100                               011112      22


Q ss_pred             HHHHHHHhC-----CCCceeeeeeeeecCCeEEEEEEecCCCchHHH--HHhcCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 047009          199 AERDILTKI-----DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQ--LYHHGLFREDLARIYAAEIVS-AVSHLHANG  270 (482)
Q Consensus       199 ~E~~il~~l-----~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~--l~~~~~l~~~~~~~i~~qi~~-aL~yLH~~~  270 (482)
                      +|..-+.++     +.+++.=-.-+++-...-.|+|||+.|-.+.+.  +.. ..++.+.   ++..++. -+..+=..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence            344444443     234432222223333445699999999888766  333 2344222   2222222 133344589


Q ss_pred             CcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          271 IMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       271 IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      ++|.|..|.||+++.+|++.+.|||+...+++.
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            999999999999999999999999999876543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.38  E-value=1.1e-05  Score=76.35  Aligned_cols=138  Identities=26%  Similarity=0.353  Sum_probs=81.8

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCC--ceeeeeeee---ecCCeEEEEE
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP--FVVQLKYSF---QTKYRLYLVL  229 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~---~~~~~~~lV~  229 (482)
                      ++.|+.|..+.||++...+ + .+++|+....     .....+.+|..+++.+...  .+.+++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-S-EEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            4779999999999998876 3 7899997654     2345567888888877433  234555433   3344579999


Q ss_pred             EecCCCchHH----------------HHH---hc----CCCCHHH---H---HHH---------------HHHHHH-HHH
Q 047009          230 DFINGGHLFF----------------QLY---HH----GLFREDL---A---RIY---------------AAEIVS-AVS  264 (482)
Q Consensus       230 E~~~gg~L~~----------------~l~---~~----~~l~~~~---~---~~i---------------~~qi~~-aL~  264 (482)
                      ++++|..+..                .+.   ..    ..+....   .   ...               ...+.. .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999987766                111   11    0001000   0   000               111222 333


Q ss_pred             HHHH-------CCCcccCCCCCcEEEc-cCCceeEcccCcccc
Q 047009          265 HLHA-------NGIMHRDLKPENILLG-ADGHVMLTDFGLAKQ  299 (482)
Q Consensus       265 yLH~-------~~IiHrDLKp~NILl~-~~g~vKL~DFGla~~  299 (482)
                      .+++       ..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            4442       3599999999999999 667778999988754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.37  E-value=3.7e-06  Score=80.77  Aligned_cols=134  Identities=17%  Similarity=0.150  Sum_probs=82.2

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCc--eeeeeeeeecCCeEEEEEEecC
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF--VVQLKYSFQTKYRLYLVLDFIN  233 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~  233 (482)
                      ..||+|..+.||+.    .+..+++|......     ....+.+|.++++.+..-.  +.+.+.+....+...+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            56899999999973    24457889876432     2234678999998886433  3555666677777889999999


Q ss_pred             CCc-hH--------------HHHHh-----cC----CCCH-HHHHHHHHH----------HHH-HHHHHHH----CCCcc
Q 047009          234 GGH-LF--------------FQLYH-----HG----LFRE-DLARIYAAE----------IVS-AVSHLHA----NGIMH  273 (482)
Q Consensus       234 gg~-L~--------------~~l~~-----~~----~l~~-~~~~~i~~q----------i~~-aL~yLH~----~~IiH  273 (482)
                      |.. +.              ..+..     +.    .... .....+..+          +.. ...+|..    ..++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            963 11              11100     10    0010 000111111          111 1222321    24789


Q ss_pred             cCCCCCcEEEccCCceeEcccCcccc
Q 047009          274 RDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       274 rDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      +|+.|.||+++.++ +.|+||+.+..
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcCc
Confidence            99999999999888 99999998754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.17  E-value=6.7e-06  Score=74.75  Aligned_cols=129  Identities=23%  Similarity=0.255  Sum_probs=93.4

Q ss_pred             EEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceee-eeeeeecCCeEEEEEEe
Q 047009          153 EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ-LKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       153 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~-l~~~~~~~~~~~lV~E~  231 (482)
                      +..+.||+|.+|.||++.+.+  ..+|+|+-+.+.     ....+..|+++|..+.-.++-. ++.+-.    .++.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~--~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRG--GEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeeccC--ceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence            446789999999999999874  589999876543     3556889999999998777654 433332    2366999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC-CCcEEEccCCceeEcccCcccc
Q 047009          232 INGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK-PENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       232 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLK-p~NILl~~~g~vKL~DFGla~~  299 (482)
                      +.|-.|...-...   .    +.-...++.+---|-..||-|..|. |..++|-.++.+.|+||..|+.
T Consensus        94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9998876543211   1    2223445666555778899999987 7666666777999999999875

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.17  E-value=1.4e-05  Score=77.30  Aligned_cols=134  Identities=16%  Similarity=0.096  Sum_probs=80.5

Q ss_pred             ecccCc-eEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCCeEEEEEEecCCC
Q 047009          158 VGQGAF-GRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKYRLYLVLDFINGG  235 (482)
Q Consensus       158 LG~G~f-g~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (482)
                      |-.|.. +.||++...  +..+.+|+.....      ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            445555 889988654  3568888875432      223567888888773 333456677776666788999999997


Q ss_pred             chHHHH----------------Hh-cC------CCCHH---HHHHH---HH----------------HHHHHHHHHH---
Q 047009          236 HLFFQL----------------YH-HG------LFRED---LARIY---AA----------------EIVSAVSHLH---  267 (482)
Q Consensus       236 ~L~~~l----------------~~-~~------~l~~~---~~~~i---~~----------------qi~~aL~yLH---  267 (482)
                      .+....                .+ +.      .+...   .....   +.                .+...+..|-   
T Consensus        78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  157 (244)
T cd05150          78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR  157 (244)
T ss_pred             cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence            664321                00 00      01100   00000   00                0111122221   


Q ss_pred             ----HCCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          268 ----ANGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       268 ----~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                          ...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence                12489999999999999987788999998754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.16  E-value=3.3e-05  Score=72.22  Aligned_cols=128  Identities=25%  Similarity=0.355  Sum_probs=91.2

Q ss_pred             CCeEEEEEecccCc-eEEEEEEEcCCCeEEEEEEeechhhch------------------hhHHHHHHHHHHHHHhC---
Q 047009          150 EDFEVLKVVGQGAF-GRVYQVRKKNTSEIYAMKVMRKDKIVE------------------KNHAEYMKAERDILTKI---  207 (482)
Q Consensus       150 ~~y~i~~~LG~G~f-g~Vy~a~~~~~~~~vAiK~~~~~~~~~------------------~~~~~~~~~E~~il~~l---  207 (482)
                      .+++.++.||.|.- |.||+++..  |+.||+|++..-....                  .....-+..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78999999999999 999999875  5799999933211000                  02233466777776666   


Q ss_pred             CCCce--eeeeeeeecC------------------CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 047009          208 DHPFV--VQLKYSFQTK------------------YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH  267 (482)
Q Consensus       208 ~hpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH  267 (482)
                      .+.++  |+.+++..-.                  ....||.||++...         .+....    +.+|.+-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence            45566  8888887211                  12468899887653         122222    567888889999


Q ss_pred             HCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          268 ANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       268 ~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                      ..||+-+|+|+.|..     .-||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999986     3489999864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.12  E-value=1.8e-05  Score=84.27  Aligned_cols=141  Identities=20%  Similarity=0.290  Sum_probs=87.5

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhch----------------------------hhHHHHHH------HHH
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE----------------------------KNHAEYMK------AER  201 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~----------------------------~~~~~~~~------~E~  201 (482)
                      +.||.-+.|.||+|+.++ |+.||||+-+..-...                            .+..+.+.      +|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            569999999999999998 9999999976532000                            01111122      222


Q ss_pred             HH----HHhCCCCc------eeeeeeeeecCCeEEEEEEecCCCchH--HHHHhcCCCCHHHHHHHHHHHHHH-HHHHHH
Q 047009          202 DI----LTKIDHPF------VVQLKYSFQTKYRLYLVLDFINGGHLF--FQLYHHGLFREDLARIYAAEIVSA-VSHLHA  268 (482)
Q Consensus       202 ~i----l~~l~hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~--~~l~~~~~l~~~~~~~i~~qi~~a-L~yLH~  268 (482)
                      +-    .+.+.|-+      |.+++..+.  ..-.|+||||+|..+.  +.+.+++ ++...+.   ..+.++ ++-+=.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~---~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRG-ISPHDIL---NKLVEAYLEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcC-CCHHHHH---HHHHHHHHHHHHh
Confidence            22    22223444      333433332  3456999999998664  3454444 3333322   222222 122335


Q ss_pred             CCCcccCCCCCcEEEcc----CCceeEcccCccccccCC
Q 047009          269 NGIMHRDLKPENILLGA----DGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       269 ~~IiHrDLKp~NILl~~----~g~vKL~DFGla~~~~~~  303 (482)
                      .|++|+|-.|.||+++.    ++.+.+.|||+...+...
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            78999999999999984    568999999999876543

>smart00133 S_TK_X Extension to Ser/Thr-type protein kinases

Probab=98.12  E-value=3e-06  Score=64.23  Aligned_cols=61  Identities=34%  Similarity=0.721  Sum_probs=49.1

Q ss_pred             CCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCCC---CCCCCccCeeeec
Q 047009          409 KPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPK---NNTNPFADFSYVR  469 (482)
Q Consensus       409 ~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~~---~~~~~f~~f~~~~  469 (482)
                      ++++|+.+..++++|||+|.+.+..+.++|+..++.....+++.....   ..+..|.||+|+.
T Consensus         1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~~~~~s~~~~~~~~~~~~~~F~gfsy~~   64 (64)
T smart00133        1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEETPVLTPVDSPASGGSQQEPFRGFSYVF   64 (64)
T ss_pred             CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCCCCCCCCCCccccccccccccCCCcccC
Confidence            479999999999999999999999999999988887766666554322   1147899999963

>PLN02876 acyl-CoA dehydrogenase

Probab=98.04  E-value=4.4e-05  Score=86.83  Aligned_cols=80  Identities=14%  Similarity=0.291  Sum_probs=56.8

Q ss_pred             EEEecccCceEEEEEEEcCCC--eEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCce--eeeeeeeecC---CeEE
Q 047009          155 LKVVGQGAFGRVYQVRKKNTS--EIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFV--VQLKYSFQTK---YRLY  226 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~--~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnI--v~l~~~~~~~---~~~~  226 (482)
                      ++.++.|.++.+|+......+  ..+++|+.......  .....+.+|..+|+.+. |.++  .+++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            477899999999998776533  46778876543211  12345778999999995 6654  6777777654   4678


Q ss_pred             EEEEecCCCc
Q 047009          227 LVLDFINGGH  236 (482)
Q Consensus       227 lV~E~~~gg~  236 (482)
                      +||||++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            9999999864

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.99  E-value=1e-06  Score=100.62  Aligned_cols=250  Identities=16%  Similarity=0.068  Sum_probs=163.3

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc--hhhHHHHHHHHHHHHHhCCCCceeeeeeeeec--CC
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV--EKNHAEYMKAERDILTKIDHPFVVQLKYSFQT--KY  223 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~  223 (482)
                      ++.++++.--+|-|.+++--.-+.+.++  +.+|+.+.-...  .+-..+.+..|.+.++...|+++.....-...  ..
T Consensus      1227 ~~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred             HhhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence            3566777666666665543322223222  445555432221  11223344456666777899999876554432  33


Q ss_pred             eEEEEEEecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CcccCCCCCcEEEccCCceeEccc
Q 047009          224 RLYLVLDFINGGHLFFQLYHHG----LFREDLARIYAAEIVSAVSHLHANG-----IMHRDLKPENILLGADGHVMLTDF  294 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~-----IiHrDLKp~NILl~~~g~vKL~DF  294 (482)
                      ..|.+++|+.+|.++..+.+..    .+.+..+.....+.+.+..-+|+..     .+|++||+-|.+|..+.++|++++
T Consensus      1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred             HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence            4689999999999999886542    2333334444444477777777541     789999999999999999999999


Q ss_pred             Cccccc-cCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc------cC
Q 047009          295 GLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK------LR  367 (482)
Q Consensus       295 Gla~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~------~~  367 (482)
                      |+.+.. .........++++.|++|++...-.++.++|+|..|+-+|++..|..+|..     ..+.+.++.      .+
T Consensus      1385 gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~-----flq~~Lkgiidn~tf~s 1459 (2724)
T KOG1826|consen 1385 GLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF-----FLQPALKGIIDNHTFFS 1459 (2724)
T ss_pred             ccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH-----HHHHHHcCccccccccc
Confidence            999942 223344567889999999999988899999999999999999999888742     333333332      22


Q ss_pred             CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          368 LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       368 ~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      ++.-.|.++......+|-..-.+||+-     ..++.-+.|.
T Consensus      1460 Ie~l~pgdaNve~~~~Ll~K~~~rp~q-----~isls~d~~a 1496 (2724)
T KOG1826|consen 1460 IEKLKPGDANVEALHRLLWKYMERPGQ-----YISLSRDHFA 1496 (2724)
T ss_pred             ccccCCCcccHHHHHHHHHHhhhcchh-----hhhccccccc
Confidence            333344555555555555566677765     5666655553

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.99  E-value=0.00011  Score=68.89  Aligned_cols=130  Identities=23%  Similarity=0.269  Sum_probs=91.2

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhc-------------hhhHHHHHHHHHHHHHhCC------CCceeeee
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-------------EKNHAEYMKAERDILTKID------HPFVVQLK  216 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~-------------~~~~~~~~~~E~~il~~l~------hpnIv~l~  216 (482)
                      ..||+|+.-.||.  +..+ ....||++......             .........+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~--HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE--CCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            4699999999995  4443 34679998876500             0112344556666655555      78899999


Q ss_pred             eeeecCCeEEEEEEecCCC------chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC---
Q 047009          217 YSFQTKYRLYLVLDFINGG------HLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG---  287 (482)
Q Consensus       217 ~~~~~~~~~~lV~E~~~gg------~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g---  287 (482)
                      |..+++.-..+|+|.+...      +|.+++. ++.+++ ..   ...+-.-..||-+++|+.+|++|.||++...+   
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK-EGGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHH-cCCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            9999999999999997532      5677774 344555 32   33444556788999999999999999997543   


Q ss_pred             -ceeEcc
Q 047009          288 -HVMLTD  293 (482)
Q Consensus       288 -~vKL~D  293 (482)
                       .+.|+|
T Consensus       159 ~~lvlID  165 (199)
T PF10707_consen  159 FRLVLID  165 (199)
T ss_pred             eEEEEEe
Confidence             466766

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.89  E-value=5.9e-05  Score=72.62  Aligned_cols=72  Identities=11%  Similarity=0.116  Sum_probs=43.6

Q ss_pred             EEecccCce-EEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCC---ceeeeeeeeecC---CeEEEE
Q 047009          156 KVVGQGAFG-RVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP---FVVQLKYSFQTK---YRLYLV  228 (482)
Q Consensus       156 ~~LG~G~fg-~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~~~---~~~~lV  228 (482)
                      +.|+.|+.. .||+..     ..+.+|+.....     ....+.+|..+|..+...   .+.+.+......   ...+++
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            457777776 499752     246778755421     234578899998877532   223333333221   245889


Q ss_pred             EEecCCCch
Q 047009          229 LDFINGGHL  237 (482)
Q Consensus       229 ~E~~~gg~L  237 (482)
                      |++++|.++
T Consensus        73 ~~~i~G~~l   81 (235)
T cd05155          73 YRWLEGETA   81 (235)
T ss_pred             EEeecCCCC
Confidence            999999665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.78  E-value=0.00017  Score=69.18  Aligned_cols=75  Identities=20%  Similarity=0.254  Sum_probs=47.8

Q ss_pred             EEEecccCceEEEEEEEcC-CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCC-ceeeeeeeeecCCeEEEEEEec
Q 047009          155 LKVVGQGAFGRVYQVRKKN-TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP-FVVQLKYSFQTKYRLYLVLDFI  232 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~lV~E~~  232 (482)
                      ++.|..|-...+|++.... .++.|++|+......    ..-...+|..+++.+... ...++++.+..    .+||||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence            4668888889999987553 356788998754321    111234688888888433 33444444332    3899999


Q ss_pred             CCCch
Q 047009          233 NGGHL  237 (482)
Q Consensus       233 ~gg~L  237 (482)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            98765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.76  E-value=6.3e-05  Score=70.12  Aligned_cols=99  Identities=17%  Similarity=0.176  Sum_probs=79.6

Q ss_pred             HHHHHHHHhCCC-CceeeeeeeeecCCeEEEEEEecCCCchHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 047009          198 KAERDILTKIDH-PFVVQLKYSFQTKYRLYLVLDFINGGHLFF---QLYHHGLFREDLARIYAAEIVSAVSHLHA---NG  270 (482)
Q Consensus       198 ~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~---~l~~~~~l~~~~~~~i~~qi~~aL~yLH~---~~  270 (482)
                      ..|.-+|+.+.+ +++.+++|+|-.    ++|.||...+++..   .+.+....++..+..++.+++..+++|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357888888876 699999999943    47999998776642   12222345888999999999999999998   35


Q ss_pred             CcccCCCCCcEEEccCCceeEcccCccccc
Q 047009          271 IMHRDLKPENILLGADGHVMLTDFGLAKQF  300 (482)
Q Consensus       271 IiHrDLKp~NILl~~~g~vKL~DFGla~~~  300 (482)
                      +.-.|++++|+-++++|++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            777999999999999999999999887654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.61  E-value=0.0014  Score=68.16  Aligned_cols=79  Identities=14%  Similarity=0.121  Sum_probs=52.6

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhc--h--hhHHHHHHHHHHHHHhCC---CCceeeeeeeeecCCeEEE
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV--E--KNHAEYMKAERDILTKID---HPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~--~--~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~l  227 (482)
                      .+.||.|.+..||++...+.++.|.||.-......  .  .-..++...|.+.|..+.   -.++.+++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            36799999999999998765468999985421100  0  123445667888887763   2455666555  3455679


Q ss_pred             EEEecCCC
Q 047009          228 VLDFINGG  235 (482)
Q Consensus       228 V~E~~~gg  235 (482)
                      ||||+++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999864

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.58  E-value=0.00046  Score=69.62  Aligned_cols=144  Identities=18%  Similarity=0.266  Sum_probs=97.4

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc-----------------------hhhHHHHHHHHHHHHHhCCCC
Q 047009          154 VLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-----------------------EKNHAEYMKAERDILTKIDHP  210 (482)
Q Consensus       154 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~-----------------------~~~~~~~~~~E~~il~~l~hp  210 (482)
                      +-..|..|.-+.||.|...+ |..+|||+++-.-+.                       .+...-+...|++-|++|+.-
T Consensus       148 inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            44568889999999988654 777999998643221                       112234566788888888654


Q ss_pred             ceeeeeeeeecCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCcEEEccCCce
Q 047009          211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH-ANGIMHRDLKPENILLGADGHV  289 (482)
Q Consensus       211 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~IiHrDLKp~NILl~~~g~v  289 (482)
                      .|.-- .-..-. .-.|||+|+.+...-.-..+.-.++...++.+-.|++.-|.-|- ..++||.||.--|+|+ .+|.+
T Consensus       227 GIP~P-ePIlLk-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l  303 (520)
T KOG2270|consen  227 GIPCP-EPILLK-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL  303 (520)
T ss_pred             CCCCC-Cceeee-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence            43211 001111 22599999974332222223445777788888888888877765 5699999999999999 67899


Q ss_pred             eEcccCcccccc
Q 047009          290 MLTDFGLAKQFD  301 (482)
Q Consensus       290 KL~DFGla~~~~  301 (482)
                      .|+|.+-+...+
T Consensus       304 yiIDVSQSVE~D  315 (520)
T KOG2270|consen  304 YIIDVSQSVEHD  315 (520)
T ss_pred             EEEEccccccCC
Confidence            999998876544

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.51  E-value=0.00028  Score=68.77  Aligned_cols=132  Identities=13%  Similarity=0.191  Sum_probs=75.2

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCce-eeeeeeeecCCeEEEEEEecCCCc
Q 047009          158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV-VQLKYSFQTKYRLYLVLDFINGGH  236 (482)
Q Consensus       158 LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~gg~  236 (482)
                      +..|-.+.+|+..  .+++.+++|+......   ...-...+|..+++.+..-.+ .+++....    -++||||++|..
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~   74 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV   74 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence            5567788899876  3456788897654311   100123578888888854323 23333332    258999999865


Q ss_pred             hHH--------------HHH---hcC----CCC-HHHHHHHHHHH---------HHHHHHHHH--------CCCcccCCC
Q 047009          237 LFF--------------QLY---HHG----LFR-EDLARIYAAEI---------VSAVSHLHA--------NGIMHRDLK  277 (482)
Q Consensus       237 L~~--------------~l~---~~~----~l~-~~~~~~i~~qi---------~~aL~yLH~--------~~IiHrDLK  277 (482)
                      +..              .+.   ...    .++ ...+..+..++         ...+..+-.        ..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            421              111   111    111 11122222122         111222222        248999999


Q ss_pred             CCcEEEccCCceeEcccCcccc
Q 047009          278 PENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       278 p~NILl~~~g~vKL~DFGla~~  299 (482)
                      |.||+++.++ +.|+||..|..
T Consensus       155 ~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       155 AYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cCcEEEeCCC-CEEEeccccCc
Confidence            9999999887 78999998865

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=97.47  E-value=0.0016  Score=65.22  Aligned_cols=76  Identities=8%  Similarity=0.046  Sum_probs=52.5

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCC---Cceeeeeeeeec---CCeEEEE
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH---PFVVQLKYSFQT---KYRLYLV  228 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~~~~~~---~~~~~lV  228 (482)
                      .+.||.|..+.||.....+ + .+.+|..+..     .....+..|...|+.|..   -.+.++++.+..   .+..+||
T Consensus        19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         19 VECISEQPYAALWALYDSQ-G-NPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             eeecCCccceeEEEEEcCC-C-CEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            4679999999999876433 3 4667774321     122457789998888743   346667766643   4668999


Q ss_pred             EEecCCCch
Q 047009          229 LDFINGGHL  237 (482)
Q Consensus       229 ~E~~~gg~L  237 (482)
                      ||+++|+++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998754

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.43  E-value=0.00071  Score=67.59  Aligned_cols=75  Identities=15%  Similarity=0.171  Sum_probs=47.6

Q ss_pred             EEEecccCceEEEEEEEcC------CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCce-eeeeeeeecCCeEEE
Q 047009          155 LKVVGQGAFGRVYQVRKKN------TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV-VQLKYSFQTKYRLYL  227 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~l  227 (482)
                      ++.|..|-...||++....      .++.|++|+.....    .......+|..++..+....+ .++++++..    .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence            3556677778899887643      25789999976532    112234678888888753333 345555542    26


Q ss_pred             EEEecCCCch
Q 047009          228 VLDFINGGHL  237 (482)
Q Consensus       228 V~E~~~gg~L  237 (482)
                      |+||++|..+
T Consensus        75 v~e~i~G~~l   84 (302)
T cd05156          75 IEEFIPSRTL   84 (302)
T ss_pred             hhheeCCCcC
Confidence            8999988755

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.42  E-value=0.002  Score=64.65  Aligned_cols=140  Identities=20%  Similarity=0.217  Sum_probs=80.7

Q ss_pred             EEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCc--eeeeeee------eecCCe
Q 047009          153 EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF--VVQLKYS------FQTKYR  224 (482)
Q Consensus       153 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~------~~~~~~  224 (482)
                      ..++.++.|....+|++... +| .+.+|+.....     ..+.+..|..++..|....  +.+++..      ....+.
T Consensus        25 ~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~   97 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK   97 (307)
T ss_pred             eeccccCCccccceEEEEeC-CC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence            34566788888899988643 34 57789875421     1223445666666663211  3333221      123456


Q ss_pred             EEEEEEecCCCchH-------HH-------HHhc-CCCC--------HHH-----HH----------HHHHHHHHHHHHH
Q 047009          225 LYLVLDFINGGHLF-------FQ-------LYHH-GLFR--------EDL-----AR----------IYAAEIVSAVSHL  266 (482)
Q Consensus       225 ~~lV~E~~~gg~L~-------~~-------l~~~-~~l~--------~~~-----~~----------~i~~qi~~aL~yL  266 (482)
                      .+++++|++|..+.       ..       +... ..++        ...     ..          .....+...++++
T Consensus        98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l  177 (307)
T TIGR00938        98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL  177 (307)
T ss_pred             EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence            78999999985431       00       1110 0010        000     00          0111233455555


Q ss_pred             HH-------CCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          267 HA-------NGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       267 H~-------~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      ..       .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            43       5899999999999999988778999998743

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.31  E-value=0.00024  Score=70.53  Aligned_cols=139  Identities=17%  Similarity=0.235  Sum_probs=93.1

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh---h----------------HHHHHHHHHHHHHhCC-CCc
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK---N----------------HAEYMKAERDILTKID-HPF  211 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~---~----------------~~~~~~~E~~il~~l~-hpn  211 (482)
                      +.+.+.||-|.-+.||.+-+.. |++.++|+-+.....-.   +                ..-...+|...|+.|. |-+
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            5677899999999999988764 78899997543221100   0                1112346777777773 333


Q ss_pred             eeeeeeeeecCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeE
Q 047009          212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVML  291 (482)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL  291 (482)
                      =|+-  . .+.++-++|||++.|-.|...-.      ...+..+...+..-+--|-.+|+||+|..--||++++++.+++
T Consensus       173 pVPk--p-iD~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~v  243 (465)
T KOG2268|consen  173 PVPK--P-IDHNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVV  243 (465)
T ss_pred             CCCC--c-ccccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEE
Confidence            2221  1 23345679999999877753221      1123334555666667788999999999999999999999999


Q ss_pred             cccCccccc
Q 047009          292 TDFGLAKQF  300 (482)
Q Consensus       292 ~DFGla~~~  300 (482)
                      +||--+...
T Consensus       244 IDFPQmvS~  252 (465)
T KOG2268|consen  244 IDFPQMVST  252 (465)
T ss_pred             eechHhhcc
Confidence            999765443

>PRK05231 homoserine kinase; Provisional

Probab=97.27  E-value=0.0061  Score=61.32  Aligned_cols=31  Identities=32%  Similarity=0.500  Sum_probs=26.4

Q ss_pred             CCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       269 ~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      .++||+|+.|.|||++.+...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            3899999999999998665568999998754

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.23  E-value=0.0039  Score=61.99  Aligned_cols=137  Identities=21%  Similarity=0.231  Sum_probs=81.9

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCc--eeeeeee------eecCCeEE
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF--VVQLKYS------FQTKYRLY  226 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~------~~~~~~~~  226 (482)
                      ++.|..|....+|++...  +..+++|+....      ....+..|+.++..+.+..  +.+++..      ....+..+
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            466888888899988653  346889987641      1234566777777774322  3343321      13345678


Q ss_pred             EEEEecCCCchHH-------HH-------Hhc-CCCCH--------HHHH------------HHHHHHHHHHHHHHH---
Q 047009          227 LVLDFINGGHLFF-------QL-------YHH-GLFRE--------DLAR------------IYAAEIVSAVSHLHA---  268 (482)
Q Consensus       227 lV~E~~~gg~L~~-------~l-------~~~-~~l~~--------~~~~------------~i~~qi~~aL~yLH~---  268 (482)
                      +|++|++|..+..       .+       ... ..+..        ....            .....+..++.++.+   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999999865411       01       000 00000        0000            011123344555553   


Q ss_pred             ----CCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          269 ----NGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       269 ----~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                          .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence                3799999999999999887788999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.90  E-value=0.0078  Score=59.59  Aligned_cols=30  Identities=37%  Similarity=0.540  Sum_probs=25.5

Q ss_pred             CCcccCCCCCcEEEccCCc-eeEcccCcccc
Q 047009          270 GIMHRDLKPENILLGADGH-VMLTDFGLAKQ  299 (482)
Q Consensus       270 ~IiHrDLKp~NILl~~~g~-vKL~DFGla~~  299 (482)
                      .++|+|++|.|||++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997565 46999998865

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.89  E-value=0.008  Score=61.39  Aligned_cols=78  Identities=15%  Similarity=0.122  Sum_probs=48.0

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeechhhc----hhhHHHHHHHHHHHHHhCC--CCceeeeeeeeecCCeEEEEEE
Q 047009          157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV----EKNHAEYMKAERDILTKID--HPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       157 ~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~----~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      .||.|.-..||++....+++.|+||--...-..    -.-..++..-|...|+...  -|..+.-+.. .+.....+|||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-FDTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-EccccceehHh
Confidence            479999999999998654467999965432111    0223344556777777653  3433333233 34445569999


Q ss_pred             ecCCC
Q 047009          231 FINGG  235 (482)
Q Consensus       231 ~~~gg  235 (482)
                      +++..
T Consensus        81 dL~~~   85 (370)
T TIGR01767        81 DLSHH   85 (370)
T ss_pred             hCccc
Confidence            98653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=96.69  E-value=0.0093  Score=60.97  Aligned_cols=136  Identities=16%  Similarity=0.172  Sum_probs=79.1

Q ss_pred             EEecccCceEEEEEEEcC----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCce-eeeeeeeecCCeEEEEEE
Q 047009          156 KVVGQGAFGRVYQVRKKN----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV-VQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E  230 (482)
                      +.|-.|-...+|++....    .++.|.+|+.....   ..... -.+|..+++.+..-++ .++++.+...    .|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e  113 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE  113 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence            445558888999987533    24679999876532   11222 2568888888854333 3455666433    5899


Q ss_pred             ecCCCchHHH--------------HH---hcC------CCCHHHHHHHHHHH-----------------HHHHHHHH---
Q 047009          231 FINGGHLFFQ--------------LY---HHG------LFREDLARIYAAEI-----------------VSAVSHLH---  267 (482)
Q Consensus       231 ~~~gg~L~~~--------------l~---~~~------~l~~~~~~~i~~qi-----------------~~aL~yLH---  267 (482)
                      |++|.+|...              +.   +..      ....+.+..+..++                 ...+..|.   
T Consensus       114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~  193 (344)
T PLN02236        114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL  193 (344)
T ss_pred             eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence            9987665211              10   000      01112222332211                 11122221   


Q ss_pred             -----HCCCcccCCCCCcEEEcc-CCceeEcccCcccc
Q 047009          268 -----ANGIMHRDLKPENILLGA-DGHVMLTDFGLAKQ  299 (482)
Q Consensus       268 -----~~~IiHrDLKp~NILl~~-~g~vKL~DFGla~~  299 (482)
                           ...++|+|+++.|||++. ++.+.|+||..|..
T Consensus       194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence                 125899999999999986 47899999988754

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.61  E-value=0.026  Score=56.41  Aligned_cols=30  Identities=33%  Similarity=0.514  Sum_probs=26.0

Q ss_pred             CCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       269 ~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      .+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            47899999999999987 6789999997643

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.53  E-value=0.027  Score=58.59  Aligned_cols=76  Identities=18%  Similarity=0.119  Sum_probs=49.2

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh----hHHHHHHHHHHHHHhCC---CCceeeeeeeeecCCeEEE
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK----NHAEYMKAERDILTKID---HPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~----~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~l  227 (482)
                      .+.||.|.-..||++...  +..|+||.-........    ....+...|...|+.+.   ..++.+++.++.+  ..++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence            577999999999998864  34588997652211000    12333445666666553   2467777777763  4568


Q ss_pred             EEEecCC
Q 047009          228 VLDFING  234 (482)
Q Consensus       228 V~E~~~g  234 (482)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            9999987

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.49  E-value=0.012  Score=59.73  Aligned_cols=140  Identities=17%  Similarity=0.204  Sum_probs=78.5

Q ss_pred             CeEEEEEecccCceEEEEEEEcCC---CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCce-eeeeeeeecCCeEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNT---SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV-VQLKYSFQTKYRLY  226 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~  226 (482)
                      +.++. .|..|=...+|++...+.   +..|.+|+.....   ..... -.+|..+++.+..-++ .++++++.. +   
T Consensus        16 ~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~~-G---   86 (330)
T PLN02421         16 DFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVID-RERELQAIKYLSAAGFGAKLLGVFGN-G---   86 (330)
T ss_pred             ceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEec-hHHHHHHHHHHHhcCCCCceeEEeCC-c---
Confidence            44443 444477788998875442   2378899876432   11111 2468888888854444 345555532 2   


Q ss_pred             EEEEecCCCchHH--------------HHHh-c-CC------C-CHHHHHHHHHHH----------------------HH
Q 047009          227 LVLDFINGGHLFF--------------QLYH-H-GL------F-REDLARIYAAEI----------------------VS  261 (482)
Q Consensus       227 lV~E~~~gg~L~~--------------~l~~-~-~~------l-~~~~~~~i~~qi----------------------~~  261 (482)
                      +|.+|++|..|..              .+.+ + ..      . ....+..+..++                      ..
T Consensus        87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~  166 (330)
T PLN02421         87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD  166 (330)
T ss_pred             EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence            5899998765421              0110 1 01      1 112222222221                      11


Q ss_pred             HHHHHH----HCC----CcccCCCCCcEEEcc-CCceeEcccCcccc
Q 047009          262 AVSHLH----ANG----IMHRDLKPENILLGA-DGHVMLTDFGLAKQ  299 (482)
Q Consensus       262 aL~yLH----~~~----IiHrDLKp~NILl~~-~g~vKL~DFGla~~  299 (482)
                      -+..+.    ..+    ++|.|+.+.|||+++ ++.++++||..|..
T Consensus       167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            122222    112    799999999999975 57899999998854

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.42  E-value=0.027  Score=56.06  Aligned_cols=75  Identities=17%  Similarity=0.259  Sum_probs=46.0

Q ss_pred             EEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC---CCceeeeeeeeecCCeEEEEE
Q 047009          153 EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID---HPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       153 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      +-.+.|+.|....+|+..  .+++.|-+|+-...      ....+..|..-|+.|.   --.+.+.+.+....+.-+|||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            345778999999999876  56778999987632      2234667777777773   345667777777777779999


Q ss_pred             EecCCC
Q 047009          230 DFINGG  235 (482)
Q Consensus       230 E~~~gg  235 (482)
                      ||++.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.40  E-value=0.036  Score=55.82  Aligned_cols=145  Identities=16%  Similarity=0.233  Sum_probs=82.0

Q ss_pred             EEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCC--ceeeeeeeeecCC--eEEEE
Q 047009          153 EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP--FVVQLKYSFQTKY--RLYLV  228 (482)
Q Consensus       153 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~~~~--~~~lV  228 (482)
                      .+++.+..|.--.+|.....  ++.++++ ... ............+|..+++.+.--  -+-..++.|.++.  ..|.|
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v  103 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV  103 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence            34444544444445544443  6678887 321 112234455567888888877431  2233455665554  67999


Q ss_pred             EEecCCCchHH----------HHH--------h-c-------------CCCCHHHHHHHHHH--------------HHHH
Q 047009          229 LDFINGGHLFF----------QLY--------H-H-------------GLFREDLARIYAAE--------------IVSA  262 (482)
Q Consensus       229 ~E~~~gg~L~~----------~l~--------~-~-------------~~l~~~~~~~i~~q--------------i~~a  262 (482)
                      |+|++|..+..          +..        . +             +.....++..+..+              ...-
T Consensus       104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            99999842211          111        0 0             00011111111111              2233


Q ss_pred             HHHHHHC--------CCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          263 VSHLHAN--------GIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       263 L~yLH~~--------~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      ..+|+.+        .++|+|+.+.||+++.++-+-+.||+++..-+
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            5555543        37999999999999999999999999987644

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.26  E-value=0.012  Score=62.00  Aligned_cols=159  Identities=21%  Similarity=0.238  Sum_probs=101.6

Q ss_pred             HHHHHHHHHHhCCCCceeeeeeeeecC-CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 047009          196 YMKAERDILTKIDHPFVVQLKYSFQTK-YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR  274 (482)
Q Consensus       196 ~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHr  274 (482)
                      .+.-...+++.+.|+|..+.+++-... .+..+|||++. .+|.+.+..+. +-...       +.       .+|+.|-
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s-------~~-------~~~~~~~   91 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDES-------LL-------AHGVLHL   91 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhh-------hc-------cccccee
Confidence            345567889999999999988876543 45789999985 47877776543 21111       11       1222221


Q ss_pred             CCCCCcEEEccCCceeEcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch
Q 047009          275 DLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR  354 (482)
Q Consensus       275 DLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~  354 (482)
                           |       .++++| -++.   ..   .+..|                +++|||++|.++.++.-|...+.....
T Consensus        92 -----~-------~~~~td-~~~t---~~---~~~~~----------------pKsdVwsl~~i~~el~L~~~l~~~~~~  136 (725)
T KOG1093|consen   92 -----N-------IIYITD-HFLT---KY---PSPIG----------------PKSDVWSLGFIILELYLGISLEAELTE  136 (725)
T ss_pred             -----h-------hhhccc-cccc---cC---CCCCC----------------cchhhhhHHHHHHHHHHhhHHHHHHHH
Confidence                 1       233444 1111   00   11111                399999999999999999887765555


Q ss_pred             HHHHHHHHhcccCCC-------------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          355 AKIQQKIVKDKLRLP-------------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       355 ~~~~~~i~~~~~~~p-------------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      .+....|.+-. ..+             -.++....+++.+|+-..|..||..     .++.+++-|..+
T Consensus       137 s~~l~~i~k~~-~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~-----~~~~k~~i~~ev  200 (725)
T KOG1093|consen  137 SEYLEILLKYY-TDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP-----MELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHhc-cCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch-----hHHhcCccHHHH
Confidence            54444444321 111             1257778899999999999999976     788888888765

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.24  E-value=0.0099  Score=56.10  Aligned_cols=30  Identities=47%  Similarity=0.685  Sum_probs=21.6

Q ss_pred             CCcccCCCCCcEEE-ccCCceeEcccCcccc
Q 047009          270 GIMHRDLKPENILL-GADGHVMLTDFGLAKQ  299 (482)
Q Consensus       270 ~IiHrDLKp~NILl-~~~g~vKL~DFGla~~  299 (482)
                      .+.|+|+.+.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8899999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=95.93  E-value=0.0024  Score=45.48  Aligned_cols=43  Identities=28%  Similarity=0.586  Sum_probs=28.8

Q ss_pred             cCCcccccCccccccCCCCCCCCC-CC---CCCCCCCccCeeeecCC
Q 047009          429 VAGKHCIANFEKKWTDMPLSDSPA-AT---PKNNTNPFADFSYVRPA  471 (482)
Q Consensus       429 ~~~~~~~~~f~~~~~~~~~~~s~~-~~---~~~~~~~f~~f~~~~~~  471 (482)
                      +.+..+++|||.+++.++...++. ..   ....+..|.||+|++|.
T Consensus         2 v~~~~DtsnFD~eFt~~~~~~t~~~~~~~~~~~~~~~F~GFTy~~~s   48 (48)
T PF00433_consen    2 VKSETDTSNFDPEFTEEPPVDTPPSDPSPLSSSMQENFQGFTYVNPS   48 (48)
T ss_dssp             -SSTT-GTTSCHHHHTSSSSS--S--HHHHCTSSGGGGTT-CEETCT
T ss_pred             CCchhhhhhcCcccccCCCCCCCcccCCcccccccCcCCCCeecCCC
Confidence            456789999999999999888875 21   13345569999999874

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A ....

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.86  E-value=0.056  Score=56.00  Aligned_cols=79  Identities=18%  Similarity=0.222  Sum_probs=49.5

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhch---hhHHHHHHHHHHHHHhCC--CCceeeeeeeeecCCeEEEEE
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE---KNHAEYMKAERDILTKID--HPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~---~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      .+.||.|.-.-||++.+...++.|+||--...--..   .-..++..-|...|+...  .|..|+=+.+ .+.....+||
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~D~e~~~~vM  112 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-FDSVMNCCVM  112 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-ECcHHhhHHH
Confidence            577999999999999985445678898643221111   223455666778887763  3443433233 3444556899


Q ss_pred             EecCC
Q 047009          230 DFING  234 (482)
Q Consensus       230 E~~~g  234 (482)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            99864

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.76  E-value=0.14  Score=51.40  Aligned_cols=30  Identities=17%  Similarity=0.186  Sum_probs=27.6

Q ss_pred             CCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          270 GIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       270 ~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      +++|+|+.+.|||++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999988754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=95.61  E-value=0.069  Score=55.39  Aligned_cols=78  Identities=13%  Similarity=0.188  Sum_probs=45.8

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCC-e-----EEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCce-eeeeeeeecCC
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTS-E-----IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV-VQLKYSFQTKY  223 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~-~-----~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~  223 (482)
                      ++++ +.|..|-...+|++...... .     .|.+++....   ..... .-.+|..+++.+...++ .++++.+..  
T Consensus        52 ~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~--  124 (383)
T PTZ00384         52 FIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD--  124 (383)
T ss_pred             cEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC--
Confidence            3444 45555888899998754331 2     2444432111   01111 12468889999865444 556676653  


Q ss_pred             eEEEEEEecCCCch
Q 047009          224 RLYLVLDFINGGHL  237 (482)
Q Consensus       224 ~~~lV~E~~~gg~L  237 (482)
                        ++|.||++|..|
T Consensus       125 --g~l~efIeGr~l  136 (383)
T PTZ00384        125 --FTIQEWVEGNTM  136 (383)
T ss_pred             --EEEEEEeccccC
Confidence              599999998765

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.42  E-value=0.067  Score=54.37  Aligned_cols=103  Identities=21%  Similarity=0.305  Sum_probs=66.8

Q ss_pred             CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEccCCceeEcccCccccc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQF  300 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl~~~g~vKL~DFGla~~~  300 (482)
                      ..+.|++|++- |+.+.. +   ..-..+++..++.+.+..+.-|..+ ..-|||+.-.||||+ +|+|.|+||-+++.-
T Consensus       298 ~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         298 TLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            34567788765 444421 1   2234566777888888877777765 789999999999999 999999999999842


Q ss_pred             cCCCCCcccccCCCCCchhhhcCCCCCchhHHHHH
Q 047009          301 DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSV  335 (482)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSl  335 (482)
                      ..+.    .+-....--|-.+.|.. +..-+||-+
T Consensus       372 ~~q~----~isy~rldhp~lF~G~d-d~QFeIYrl  401 (488)
T COG5072         372 YSQG----IISYNRLDHPDLFNGVD-DYQFEIYRL  401 (488)
T ss_pred             cCCc----eeeccccCchhhhcCcc-ceeeeHHHH
Confidence            1111    11112233455555443 555666654

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.25  E-value=0.074  Score=50.59  Aligned_cols=150  Identities=13%  Similarity=0.155  Sum_probs=88.0

Q ss_pred             cCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCCchHHH
Q 047009          161 GAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQ  240 (482)
Q Consensus       161 G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~  240 (482)
                      |+.++.-.++.+- |. ..+|.+..-.+.  -....+.++.+++.++.  .|++|..-  +...+-++.|+|-.-..   
T Consensus        73 ~gNsTl~~~kt~i-G~-L~lKKi~slp~~--~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GP-LFLKKIRSLPCC--INDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---  141 (308)
T ss_pred             CCceEEEEecccc-ch-hhhhhccCCCcc--cchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---
Confidence            4445544444333 33 445555433221  12234567888888775  57777643  55667899999854221   


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccccCCCCCch
Q 047009          241 LYHHGLFREDLARIYAAEIVSAVSHLHAN--GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP  318 (482)
Q Consensus       241 l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~AP  318 (482)
                               ...-++. .=+.+|.-.|+.  +.+|+|-.|+||+-|..|.+||.|=+..-.   .        +..|.- 
T Consensus       142 ---------~~~N~i~-agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~---~--------~V~~vN-  199 (308)
T PF07387_consen  142 ---------NFSNFIT-AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE---N--------QVNMVN-  199 (308)
T ss_pred             ---------chhHHHH-HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhhh---h--------eeeEEe-
Confidence                     1111222 225678888953  799999999999999999999999875421   0        111221 


Q ss_pred             hhhcCCCCCchhHHHHHhHHHHHHhhC
Q 047009          319 EIVLGKGHNKAADWWSVGILLYEMLTG  345 (482)
Q Consensus       319 E~l~~~~~~~~sDvwSlGvilyelltG  345 (482)
                        ......+.++.+-+|=.-++++...
T Consensus       200 --~~Y~~lT~~aE~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  200 --IEYESLTQEAEVKVFVKSCLKLVEK  224 (308)
T ss_pred             --eeccccChHHHHHHHHHHHHHHHHH
Confidence              0123346666666666666666553

The function of this family is unknown.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.96  E-value=0.56  Score=47.47  Aligned_cols=29  Identities=31%  Similarity=0.321  Sum_probs=24.4

Q ss_pred             CCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       269 ~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      .++||+|+.+.|||++ + .+.|+||+.+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            3689999999999995 4 578999998753

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.75  E-value=0.46  Score=48.23  Aligned_cols=134  Identities=23%  Similarity=0.317  Sum_probs=78.4

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCc------eeee----eeeeecCCeEEE
Q 047009          158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF------VVQL----KYSFQTKYRLYL  227 (482)
Q Consensus       158 LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn------Iv~l----~~~~~~~~~~~l  227 (482)
                      |.. .-..||+....+ |+ +++|+.+.. .    ....+..|...|..|.-..      +..+    +.......+.+-
T Consensus        34 l~s-~eN~~f~~~~~~-g~-~iLki~~~~-~----~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~  105 (331)
T COG2334          34 LNS-EENSNFRVQTED-GR-YILKIYRPG-W----TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA  105 (331)
T ss_pred             ccc-ccCceEEEEecC-CC-eEEEEecCC-C----CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence            444 556788877665 33 489998775 1    2233556777777663211      2222    122222247788


Q ss_pred             EEEecCCCchHH-----HH----------Hh--cC----------CCCHH----HH---------HHHHHHHHHHHHHHH
Q 047009          228 VLDFINGGHLFF-----QL----------YH--HG----------LFRED----LA---------RIYAAEIVSAVSHLH  267 (482)
Q Consensus       228 V~E~~~gg~L~~-----~l----------~~--~~----------~l~~~----~~---------~~i~~qi~~aL~yLH  267 (482)
                      +++|++|..+..     .+          ..  .+          ...+.    ..         .....++...+..+.
T Consensus       106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~  185 (331)
T COG2334         106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL  185 (331)
T ss_pred             EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence            999999976651     11          00  00          01111    00         012344555555555


Q ss_pred             HC--------C--CcccCCCCCcEEEccCCc-eeEcccCcccc
Q 047009          268 AN--------G--IMHRDLKPENILLGADGH-VMLTDFGLAKQ  299 (482)
Q Consensus       268 ~~--------~--IiHrDLKp~NILl~~~g~-vKL~DFGla~~  299 (482)
                      +.        +  +||+|+.|.|||++.+.. +.++||+.|..
T Consensus       186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            42        3  999999999999998885 88999998753

>PTZ00296 choline kinase; Provisional

Probab=94.74  E-value=0.2  Score=52.93  Aligned_cols=79  Identities=15%  Similarity=0.229  Sum_probs=47.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCC--------CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCcee-eeeeeee
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNT--------SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV-QLKYSFQ  220 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~--------~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~  220 (482)
                      ++. -++.|..|-.-.+|++.....        ++.|.+|+.-...   .... .-.+|..+++.+..-+|- ++++.+.
T Consensus       106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~  180 (442)
T PTZ00296        106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS  180 (442)
T ss_pred             ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC
Confidence            344 456777788888998875522        4679999875432   1111 224577777777543432 4555553


Q ss_pred             cCCeEEEEEEecCCCch
Q 047009          221 TKYRLYLVLDFINGGHL  237 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L  237 (482)
                       +   +.|.||++|..|
T Consensus       181 -g---g~I~efi~g~~l  193 (442)
T PTZ00296        181 -G---GRIEEWLYGDPL  193 (442)
T ss_pred             -C---CEEEEeeCCccC
Confidence             2   367999988643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	482
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-86
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-85
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-80
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-80
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-80
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-80
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-75
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-74
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-71
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-71
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-71
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-71
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-71
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-71
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-71
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-71
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-68
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-68
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-68
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-67
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-67
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-67
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-67
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-67
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-67
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-67
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-67
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-67
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-67
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-67
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-67
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-67
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-67
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-67
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-67
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-67
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-67
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-66
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-66
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-66
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-66
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-66
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-66
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-66
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-66
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-66
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-66
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-66
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-66
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-66
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-66
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-66
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-66
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-66
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-66
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-66
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-66
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-66
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-66
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-66
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-66
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-66
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-66
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-66
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-66
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-66
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-66
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-66
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-66
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-66
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-66
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-65
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-65
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-65
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-65
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-65
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-65
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-65
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-65
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-65
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-64
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-62
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-61
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-57
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-57
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-57
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-56
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-56
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-56
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-56
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-56
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-56
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-56
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-56
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-56
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-56
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-56
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-56
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-56
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-56
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-56
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-56
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-56
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-55
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-53
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-53
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-53
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-53
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-53
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-52
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-52
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-51
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-50
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-50
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-50
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-49
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-49
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-49
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-49
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-46
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-46
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-46
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-46
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-43
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-43
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-43
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-42
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-42
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-41
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-41
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-41
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-41
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-41
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-41
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-41
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-41
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-41
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-41
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-41
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-41
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-41
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-41
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-41
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-41
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-41
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-41
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-41
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-41
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-41
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-41
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-41
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-41
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-41
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-41
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-40
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-40
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-40
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-40
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-40
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-39
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-39
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-39
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-39
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-38
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-38
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-38
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-38
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-38
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-38
2jam_B	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-38
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-38
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-38
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-38
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-38
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-37
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-37
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-37
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-37
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-37
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-37
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-37
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-36
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-36
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-36
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-36
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-35
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-35
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-35
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-34
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-34
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-34
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-34
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-34
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-34
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-34
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-33
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-33
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-33
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-33
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-33
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-33
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-33
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-33
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-33
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-32
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-32
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-32
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-32
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-32
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-32
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-32
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-32
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-32
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-32
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-32
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-32
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-31
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-31
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-31
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-31
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-31
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-31
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-31
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-31
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-31
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-31
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-31
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-31
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-31
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-31
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-30
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-30
3soa_A	444	Full-Length Human Camkii Length = 444		5e-30
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-30
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-30
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-29
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-29
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-29
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-29
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-29
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-29
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-29
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-29
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-29
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-29
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-29
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-29
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-28
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-28
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-28
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-28
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-28
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-28
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-28
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-28
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-28
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-28
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-28
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-28
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-28
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-28
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-28
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-28
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-28
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-28
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-28
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-28
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-28
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-28
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-28
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-28
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-28
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-28
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-27
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-27
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-27
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-27
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-27
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-27
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-27
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-27
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-27
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-27
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-27
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-27
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-27
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-27
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-26
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-26
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-26
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-26
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-26
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-26
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-26
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-26
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-26
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-26
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-26
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-26
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-26
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-26
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-26
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-26
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-26
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-26
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-26
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-26
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-26
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-26
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-26
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-26
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-26
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-26
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-26
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-26
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-26
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-26
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-26
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-26
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-26
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-26
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-26
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-26
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-26
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-26
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-26
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-26
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-26
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-26
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-26
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-25
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-25
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-25
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-25
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-25
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-25
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-25
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-25
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-25
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-25
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-25
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-25
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-25
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-25
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-25
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-25
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-25
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-25
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-25
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-25
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-25
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-25
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-25
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-25
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-25
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-25
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-25
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-25
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-25
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-25
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-25
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-25
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-25
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-25
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-25
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-25
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-25
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-25
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-25
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-25
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-25
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-25
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-25
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-25
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-25
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-25
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-25
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-25
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-25
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-25
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		8e-25
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-25
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-25
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-25
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-25
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-25
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		9e-25
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-24
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-24
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-24
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-24
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-24
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-24
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-24
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-24
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-24
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-24
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-24
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-24
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-24
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-24
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-24
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-24
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-24
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-24
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-24
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-24
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-23
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-23
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-23
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-23
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-23
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-22
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-22
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-22
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-22
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-22
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-22
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-22
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-22
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-22
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-22
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-22
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-22
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-22
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-22
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-22
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-22
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-22
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-22
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-22
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-22
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-21
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-21
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-21
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-21
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-21
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-21
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-21
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-21
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-21
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-21
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-21
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-21
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-21
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-21
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-21
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-21
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-21
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-21
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-21
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-21
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-21
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-21
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-21
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-21
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-21
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-21
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-21
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-21
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-21
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-21
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-21
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-21
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-20
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-20
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-20
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-20
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-20
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-20
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-20
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-20
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-20
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		4e-20
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-20
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-20
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-20
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-19
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-19
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-19
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-19
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-19
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-19
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-19
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-19
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-19
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-19
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-19
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-19
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-19
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		5e-19
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-19
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-19
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-19
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-18
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-18
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-18
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-18
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-18
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-18
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-18
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-18
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-18
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-18
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-18
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-18
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-18
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-18
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-18
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-18
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-18
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-18
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-18
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-18
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-18
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-18
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-18
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-18
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-18
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-18
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-18
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-18
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-18
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-18
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-18
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-18
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-18
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-18
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-18
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-18
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-18
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-18
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-18
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-18
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-18
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-18
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-18
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-18
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-18
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-18
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-18
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-18
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-18
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-17
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-17
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-17
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-17
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-17
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-17
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-17
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-17
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-17
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-17
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-17
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-17
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-17
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-17
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-17
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-17
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-17
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-17
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-17
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-17
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-17
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-17
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-17
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-17
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-17
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-17
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-17
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-17
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-17
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-17
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-17
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-17
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-17
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-17
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-17
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-17
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-17
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-17
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-17
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-17
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-17
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-16
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-16
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-16
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-16
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-16
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-16
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-16
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-16
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-16
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-16
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-16
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-16
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-16
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-15
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-15
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-15
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-15
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-15
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-15
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-15
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-15
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-15
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-15
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-15
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-15
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-15
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-15
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-15
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-15
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-15
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-15
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-15
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-15
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-15
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-15
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-15
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-15
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-15
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-15
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-15
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-15
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-15
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-15
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-15
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-15
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-15
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-15
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-15
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-15
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-15
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-15
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-15
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-15
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-15
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-15
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-15
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-15
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-15
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-15
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-15
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-15
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-15
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-15
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-15
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-15
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-15
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-15
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-15
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-14
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-14
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-14
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-14
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-14
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-14
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		4e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-14
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-14
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-14
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-14
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-14
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-13
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-13
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-13
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-12
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-12
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-12
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		6e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		7e-12
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		8e-12
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		8e-12
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		9e-12
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		9e-12
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		9e-12
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		9e-12
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-12
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		9e-12
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-11
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-11
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-11
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-11
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-11
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-11
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-11
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-11
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		5e-11
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-11
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-11
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		5e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-11
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-11
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		5e-11
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		5e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-11
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-11
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-11
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		6e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-11
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		8e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		9e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		9e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-10
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-10

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  314 bits (805), Expect = 6e-86,   Method: Compositional matrix adjust.
 Identities = 153/307 (49%), Positives = 215/307 (70%), Gaps = 5/307 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEK-NHAEYMKAERDILT 205
           E FE+L+V+G+G +G+V+QVRK    NT +I+AMKV++K  IV       + KAER+IL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
           ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL   G+F ED A  Y AEI  A+ H
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
           LH  GI++RDLKPENI+L   GHV LTDFGL K+   + T +++  GT+EYMAPEI++  
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 196
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
           GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI+K KL LP +L+ EA  LLK LL
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 256
Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
           ++    RLGAGP  + E+++H +F+ INW++L AR+++P F P +  +  ++ F+ K+T 
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 316
Query: 445 MPLSDSP 451
               DSP
Sbjct: 317 QTPVDSP 323

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  313 bits (802), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 153/307 (49%), Positives = 214/307 (69%), Gaps = 5/307 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEK-NHAEYMKAERDILT 205
           E FE+L+V+G+G +G+V+QVRK    NT +I+AMKV++K  IV       + KAER+IL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
           ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL   G+F ED A  Y AEI  A+ H
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
           LH  GI++RDLKPENI+L   GHV LTDFGL K+   + T ++   GT+EYMAPEI++  
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRS 196
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
           GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI+K KL LP +L+ EA  LLK LL
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 256
Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
           ++    RLGAGP  + E+++H +F+ INW++L AR+++P F P +  +  ++ F+ K+T 
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 316
Query: 445 MPLSDSP 451
               DSP
Sbjct: 317 QTPVDSP 323

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  296 bits (759), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 150/307 (48%), Positives = 209/307 (68%), Gaps = 8/307 (2%)
Query: 128 IDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMR 184
           + E SI  +VK  S          FE+LKV+GQG+FG+V+ VRK    ++  +YAMKV++
Sbjct: 9   LKEISITHHVKAGSEKADP---SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLK 65
Query: 185 KDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH 244
           K  +  ++     K ERDIL  ++HPFVV+L Y+FQT+ +LYL+LDF+ GG LF +L   
Sbjct: 66  KATLKVRDRVR-TKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE 124
Query: 245 GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDEN 303
            +F E+  + Y AE+   + HLH+ GI++RDLKPENILL  +GH+ LTDFGL+K+  D  
Sbjct: 125 VMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHE 184
Query: 304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
            ++ S  GTVEYMAPE+V  +GH+ +ADWWS G+L++EMLTG  PF G +R +    I+K
Sbjct: 185 KKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILK 244
Query: 364 DKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQP 423
            KL +P FLS+EA SLL+ L ++ P  RLG+GP G+EEIK H ++  I+W KL  REI+P
Sbjct: 245 AKLGMPQFLSTEAQSLLRALFKRNPANRLGSGPDGAEEIKRHVFYSTIDWNKLYRREIKP 304
Query: 424 GFCPEVA 430
            F P VA
Sbjct: 305 PFKPAVA 311

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  296 bits (759), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 149/309 (48%), Positives = 207/309 (66%), Gaps = 13/309 (4%)
Query: 152 FEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           FE+LKV+GQG+FG+V+ V+K    +  ++YAMKV++K  +  ++     K ERDIL +++
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN 84
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HPF+V+L Y+FQT+ +LYL+LDF+ GG LF +L    +F E+  + Y AE+  A+ HLH+
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHN 327
            GI++RDLKPENILL  +GH+ LTDFGL+K+  D   ++ S  GTVEYMAPE+V  +GH 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           ++ADWWS G+L++EMLTG  PF G +R +    I+K KL +P FLS EA SLL+ L ++ 
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRN 264
Query: 388 PGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPL 447
           P  RLGAGP G EEIK H +F  I+W KL  REI P F P          F+ ++T    
Sbjct: 265 PANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDPEFT---- 320
Query: 448 SDSPAATPK 456
               A TPK
Sbjct: 321 ----AKTPK 325

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  295 bits (755), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 143/280 (51%), Positives = 198/280 (70%), Gaps = 5/280 (1%)
Query: 152 FEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           FE+LKV+GQG+FG+V+ V+K    +  ++YAMKV++K  +  ++     K ERDIL +++
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN 85
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HPF+V+L Y+FQT+ +LYL+LDF+ GG LF +L    +F E+  + Y AE+  A+ HLH+
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 145
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHN 327
            GI++RDLKPENILL  +GH+ LTDFGL+K+  D   ++ S  GTVEYMAPE+V  +GH 
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 205
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           ++ADWWS G+L++EMLTG  PF G +R +    I+K KL +P FLS EA SLL+ L ++ 
Sbjct: 206 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRN 265
Query: 388 PGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP 427
           P  RLGAGP G EEIK H +F  I+W KL  REI P F P
Sbjct: 266 PANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 305

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  295 bits (755), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 143/280 (51%), Positives = 198/280 (70%), Gaps = 5/280 (1%)
Query: 152 FEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           FE+LKV+GQG+FG+V+ V+K    +  ++YAMKV++K  +  ++     K ERDIL +++
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN 84
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HPF+V+L Y+FQT+ +LYL+LDF+ GG LF +L    +F E+  + Y AE+  A+ HLH+
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHN 327
            GI++RDLKPENILL  +GH+ LTDFGL+K+  D   ++ S  GTVEYMAPE+V  +GH 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           ++ADWWS G+L++EMLTG  PF G +R +    I+K KL +P FLS EA SLL+ L ++ 
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRN 264
Query: 388 PGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP 427
           P  RLGAGP G EEIK H +F  I+W KL  REI P F P
Sbjct: 265 PANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  278 bits (712), Expect = 4e-75,   Method: Compositional matrix adjust.
 Identities = 145/305 (47%), Positives = 209/305 (68%), Gaps = 13/305 (4%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEK-NHAEYMKAERD 202
           VGIE+FE+LKV+G GA+G+V+ VRK    +T ++YAMKV++K  IV+K    E+ + ER 
Sbjct: 51  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 203 ILTKIDH-PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           +L  I   PF+V L Y+FQT+ +L+L+LD+INGG LF  L     F E   +IY  EIV 
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPE 319
           A+ HLH  GI++RD+K ENILL ++GHV+LTDFGL+K+F  DE  R+    GT+EYMAP+
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 320 IVLG--KGHNKAADWWSVGILLYEMLTGKPPFI----GGNRAKIQQKIVKDKLRLPAFLS 373
           IV G   GH+KA DWWS+G+L+YE+LTG  PF       ++A+I ++I+K +   P  +S
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 290
Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKH 433
           + A  L++ LL K+P KRLG GP+ ++EIK H +F+ INW  L A+++   F P +  + 
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDEL 350
Query: 434 CIANF 438
            ++NF
Sbjct: 351 DVSNF 355

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  276 bits (706), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 145/336 (43%), Positives = 212/336 (63%), Gaps = 12/336 (3%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK-IDH 209
           DF  LKV+G+G+FG+V   R K     YA+KV++K  I++K   +++ +ER++L K + H
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF+V L +SFQT  +LY VLD+INGG LF+ L     F E  AR YAAEI SA+ +LH+ 
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
            I++RDLKPENILL + GH++LTDFGL K+  + N+ +++  GT EY+APE++  + +++
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDR 218
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
             DWW +G +LYEML G PPF   N A++   I+   L+L   +++ A  LL+GLLQK+ 
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDR 278
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLS 448
            KRLGA      EIKSH +F  INW  L  ++I P F P V+G + + +F+ ++T+ P+ 
Sbjct: 279 TKRLGAK-DDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVP 337
Query: 449 DSPAATP---------KNNTNPFADFSYVRPAASFL 475
           ++    P         K     F  FSY  P  SFL
Sbjct: 338 NAIGKAPDSVLVTASVKEAAEAFLGFSYAPPTDSFL 373

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  266 bits (680), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 122/306 (39%), Positives = 197/306 (64%), Gaps = 1/306 (0%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V + DF+ LK++G+G FG+V  VR+K T   YAMK++RK+ I+ K+   +   E  +L  
Sbjct: 5   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HPF+  LKY+FQT  RL  V+++ NGG LFF L    +F E+ AR Y AEIVSA+ +L
Sbjct: 65  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 124
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKG 325
           H+  +++RD+K EN++L  DGH+ +TDFGL K+   +     +  GT EY+APE++    
Sbjct: 125 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 184
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G+++YEM+ G+ PF   +  ++ + I+ +++R P  LS EA SLL GLL+
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 244
Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDM 445
           K+P +RLG GP  ++E+  H++F  INW+ +  +++ P F P+V  +     F+ ++T  
Sbjct: 245 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 304
Query: 446 PLSDSP 451
            ++ +P
Sbjct: 305 SITITP 310

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  266 bits (679), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 122/306 (39%), Positives = 197/306 (64%), Gaps = 1/306 (0%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V + DF+ LK++G+G FG+V  VR+K T   YAMK++RK+ I+ K+   +   E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HPF+  LKY+FQT  RL  V+++ NGG LFF L    +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKG 325
           H+  +++RD+K EN++L  DGH+ +TDFGL K+   +     +  GT EY+APE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G+++YEM+ G+ PF   +  ++ + I+ +++R P  LS EA SLL GLL+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDM 445
           K+P +RLG GP  ++E+  H++F  INW+ +  +++ P F P+V  +     F+ ++T  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 301
Query: 446 PLSDSP 451
            ++ +P
Sbjct: 302 SITITP 307

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  266 bits (679), Expect = 3e-71,   Method: Compositional matrix adjust.
 Identities = 122/306 (39%), Positives = 197/306 (64%), Gaps = 1/306 (0%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V + DF+ LK++G+G FG+V  VR+K T   YAMK++RK+ I+ K+   +   E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HPF+  LKY+FQT  RL  V+++ NGG LFF L    +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKG 325
           H+  +++RD+K EN++L  DGH+ +TDFGL K+   +     +  GT EY+APE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G+++YEM+ G+ PF   +  ++ + I+ +++R P  LS EA SLL GLL+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDM 445
           K+P +RLG GP  ++E+  H++F  INW+ +  +++ P F P+V  +     F+ ++T  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 301
Query: 446 PLSDSP 451
            ++ +P
Sbjct: 302 SITITP 307

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  266 bits (679), Expect = 3e-71,   Method: Compositional matrix adjust.
 Identities = 126/333 (37%), Positives = 202/333 (60%), Gaps = 11/333 (3%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V + DF+ LK++G+G FG+V  VR+K T   YAMK++RK+ I+ K+   +   E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HPF+  LKY+FQT  RL  V+++ NGG LFF L    +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKG 325
           H+  +++RD+K EN++L  DGH+ +TDFGL K+   +        GT EY+APE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G+++YEM+ G+ PF   +  ++ + I+ +++R P  LS EA SLL GLL+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDM 445
           K+P +RLG GP  ++E+  H++F  INW+ +  +++ P F P+V  +     F+ ++T  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 301
Query: 446 PLSDSP----------AATPKNNTNPFADFSYV 468
            ++ +P              +     F DF Y+
Sbjct: 302 SITITPPDRYDSLGLLELDQREEQEMFEDFDYI 334

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  265 bits (677), Expect = 4e-71,   Method: Compositional matrix adjust.
 Identities = 126/333 (37%), Positives = 202/333 (60%), Gaps = 11/333 (3%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V + DF+ LK++G+G FG+V  VR+K T   YAMK++RK+ I+ K+   +   E  +L  
Sbjct: 7   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HPF+  LKY+FQT  RL  V+++ NGG LFF L    +F E+ AR Y AEIVSA+ +L
Sbjct: 67  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 126
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKG 325
           H+  +++RD+K EN++L  DGH+ +TDFGL K+   +        GT EY+APE++    
Sbjct: 127 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 186
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G+++YEM+ G+ PF   +  ++ + I+ +++R P  LS EA SLL GLL+
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 246
Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDM 445
           K+P +RLG GP  ++E+  H++F  INW+ +  +++ P F P+V  +     F+ ++T  
Sbjct: 247 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 306
Query: 446 PLSDSP----------AATPKNNTNPFADFSYV 468
            ++ +P              +     F DF Y+
Sbjct: 307 SITITPPDRYDSLGLLELDQREEQEMFEDFDYI 339

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  265 bits (677), Expect = 4e-71,   Method: Compositional matrix adjust.
 Identities = 137/341 (40%), Positives = 209/341 (61%), Gaps = 6/341 (1%)
Query: 135 ENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA 194
           E+ K  S  +  V + DF  L V+G+G+FG+V    +K T E+YA+K+++KD +++ +  
Sbjct: 4   EDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDV 63
Query: 195 EYMKAERDILTKIDHP-FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLAR 253
           E    E+ +L  +D P F+ QL   FQT  RLY V++++NGG L + +   G F+E  A 
Sbjct: 64  ECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAV 123
Query: 254 IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGT 312
            YAAEI   +  LH  GI++RDLK +N++L ++GH+ + DFG+ K+   +   +    GT
Sbjct: 124 FYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGT 183
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFL 372
            +Y+APEI+  + + K+ DWW+ G+LLYEML G+PPF G +  ++ Q I++  +  P  L
Sbjct: 184 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL 243
Query: 373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGK 432
           S EA S+ KGL+ K P KRLG GP+G  +++ H +F+ I+W+KLE REIQP F P+V GK
Sbjct: 244 SKEAVSICKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGK 303
Query: 433 HCIANFEKKWT-DMPLSDSPAATPKNNTNP--FADFSYVRP 470
               NF+K +T   P+   P      N +   F  F YV P
Sbjct: 304 GA-ENFDKFFTRGQPVLXPPDQLVIANIDQSDFEGFXYVNP 343

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  265 bits (676), Expect = 5e-71,   Method: Compositional matrix adjust.
 Identities = 122/306 (39%), Positives = 196/306 (64%), Gaps = 1/306 (0%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V + DF+ LK++G+G FG+V  VR+K T   YAMK++RK+ I+ K+   +   E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HPF+  LKY+FQT  RL  V+++ NGG LFF L    +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKG 325
           H+  +++RD+K EN++L  DGH+ +TDFGL K+   +        GT EY+APE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G+++YEM+ G+ PF   +  ++ + I+ +++R P  LS EA SLL GLL+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDM 445
           K+P +RLG GP  ++E+  H++F  INW+ +  +++ P F P+V  +     F+ ++T  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 301
Query: 446 PLSDSP 451
            ++ +P
Sbjct: 302 SITITP 307

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  264 bits (674), Expect = 9e-71,   Method: Compositional matrix adjust.
 Identities = 122/306 (39%), Positives = 195/306 (63%), Gaps = 1/306 (0%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V + DF+ LK++G+G FG+V  VR+K T   YAMK++RK+ I+ K+   +   E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HPF+  LKY+FQT  RL  V+++ NGG LFF L    +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKG 325
           H+  +++RD+K EN++L  DGH+ +TDFGL K+   +        GT EY+APE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G+++YEM+ G+ PF   +  ++ + I+ +++R P  LS EA SLL GLL+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDM 445
           K+P +RLG GP  ++E+  H++F  INW+ +  +++ P F P+V  +     F+ ++T  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 301
Query: 446 PLSDSP 451
            ++  P
Sbjct: 302 SITIXP 307

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  256 bits (653), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 123/307 (40%), Positives = 195/307 (63%), Gaps = 2/307 (0%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V + +FE LK++G+G FG+V  V++K T   YAMK+++K+ IV K+   +   E  +L  
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HPF+  LKYSFQT  RL  V+++ NGG LFF L    +F ED AR Y AEIVSA+ +L
Sbjct: 65  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 124
Query: 267 HA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
           H+   +++RDLK EN++L  DGH+ +TDFGL K+   +        GT EY+APE++   
Sbjct: 125 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 184
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
            + +A DWW +G+++YEM+ G+ PF   +  K+ + I+ +++R P  L  EA SLL GLL
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 244
Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
           +K+P +RLG G + ++EI  H++F  I W+ +  +++ P F P+V  +     F++++T 
Sbjct: 245 KKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTA 304
Query: 445 MPLSDSP 451
             ++ +P
Sbjct: 305 QMITITP 311

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  256 bits (653), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 123/307 (40%), Positives = 195/307 (63%), Gaps = 2/307 (0%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V + +FE LK++G+G FG+V  V++K T   YAMK+++K+ IV K+   +   E  +L  
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HPF+  LKYSFQT  RL  V+++ NGG LFF L    +F ED AR Y AEIVSA+ +L
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 125
Query: 267 HA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
           H+   +++RDLK EN++L  DGH+ +TDFGL K+   +        GT EY+APE++   
Sbjct: 126 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 185
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
            + +A DWW +G+++YEM+ G+ PF   +  K+ + I+ +++R P  L  EA SLL GLL
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 245
Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
           +K+P +RLG G + ++EI  H++F  I W+ +  +++ P F P+V  +     F++++T 
Sbjct: 246 KKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTA 305
Query: 445 MPLSDSP 451
             ++ +P
Sbjct: 306 QMITITP 312

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  255 bits (652), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 123/307 (40%), Positives = 195/307 (63%), Gaps = 2/307 (0%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V + +FE LK++G+G FG+V  V++K T   YAMK+++K+ IV K+   +   E  +L  
Sbjct: 7   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HPF+  LKYSFQT  RL  V+++ NGG LFF L    +F ED AR Y AEIVSA+ +L
Sbjct: 67  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 126
Query: 267 HA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
           H+   +++RDLK EN++L  DGH+ +TDFGL K+   +        GT EY+APE++   
Sbjct: 127 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 186
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
            + +A DWW +G+++YEM+ G+ PF   +  K+ + I+ +++R P  L  EA SLL GLL
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 246
Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
           +K+P +RLG G + ++EI  H++F  I W+ +  +++ P F P+V  +     F++++T 
Sbjct: 247 KKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTA 306
Query: 445 MPLSDSP 451
             ++ +P
Sbjct: 307 QMITITP 313

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  253 bits (647), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 122/299 (40%), Positives = 192/299 (64%), Gaps = 2/299 (0%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V + +FE LK++G+G FG+V  V++K T   YAMK+++K+ IV K+   +   E  +L  
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HPF+  LKYSFQT  RL  V+++ NGG LFF L    +F ED AR Y AEIVSA+ +L
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 267 HA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
           H+   +++RDLK EN++L  DGH+ +TDFGL K+   +     +  GT EY+APE++   
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
            + +A DWW +G+++YEM+ G+ PF   +  K+ + I+ +++R P  L  EA SLL GLL
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 384
Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWT 443
           +K+P +RLG G + ++EI  H++F  I W+ +  +++ P F P+V  +     F++++T
Sbjct: 385 KKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFT 443

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  253 bits (647), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 122/299 (40%), Positives = 192/299 (64%), Gaps = 2/299 (0%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V + +FE LK++G+G FG+V  V++K T   YAMK+++K+ IV K+   +   E  +L  
Sbjct: 148 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 207
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HPF+  LKYSFQT  RL  V+++ NGG LFF L    +F ED AR Y AEIVSA+ +L
Sbjct: 208 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 267
Query: 267 HA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
           H+   +++RDLK EN++L  DGH+ +TDFGL K+   +     +  GT EY+APE++   
Sbjct: 268 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 327
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
            + +A DWW +G+++YEM+ G+ PF   +  K+ + I+ +++R P  L  EA SLL GLL
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 387
Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWT 443
           +K+P +RLG G + ++EI  H++F  I W+ +  +++ P F P+V  +     F++++T
Sbjct: 388 KKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFT 446

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  253 bits (647), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 123/302 (40%), Positives = 187/302 (61%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K +S       ++ FE +K +G G+FGRV  V+ K T   YAMK++ K K+V+    E+ 
Sbjct: 22  KWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT 81
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 82  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 141
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 142 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 199
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 259
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 260 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 319
Query: 438 FE 439
           F+
Sbjct: 320 FD 321

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  253 bits (647), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 123/302 (40%), Positives = 187/302 (61%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K +S       ++ FE +K +G G+FGRV  V+ K T   YAMK++ K K+V+    E+ 
Sbjct: 22  KWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT 81
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 82  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA 141
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 142 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 199
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 259
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 260 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 319
Query: 438 FE 439
           F+
Sbjct: 320 FD 321

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  253 bits (646), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 123/302 (40%), Positives = 187/302 (61%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K +S       ++ FE +K +G G+FGRV  V+ K T   YAMK++ K K+V+    E+ 
Sbjct: 30  KWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT 89
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 207
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 327
Query: 438 FE 439
           F+
Sbjct: 328 FD 329

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  253 bits (646), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 123/302 (40%), Positives = 187/302 (61%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K +S       ++ FE +K +G G+FGRV  V+ K T   YAMK++ K K+V+    E+ 
Sbjct: 30  KWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT 89
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 207
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 327
Query: 438 FE 439
           F+
Sbjct: 328 FD 329

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  253 bits (645), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 121/291 (41%), Positives = 184/291 (63%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+ K T   +AMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L+YSF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  252 bits (644), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 121/291 (41%), Positives = 184/291 (63%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+ K T   +AMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L+YSF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  252 bits (644), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 121/291 (41%), Positives = 184/291 (63%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+ K T   +AMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L+YSF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  252 bits (644), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 123/302 (40%), Positives = 187/302 (61%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K +S       ++ FE +K +G G+FGRV  V+ K T   YAMK++ K K+V+    E+ 
Sbjct: 50  KWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT 109
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 169
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 227
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 287
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 288 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 347
Query: 438 FE 439
           F+
Sbjct: 348 FD 349

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  251 bits (641), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 120/300 (40%), Positives = 187/300 (62%), Gaps = 2/300 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K ++ +     ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 206
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G  P G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 267 DLLRNLLQVDLTKRFGNLPNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 326

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  251 bits (641), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 120/291 (41%), Positives = 184/291 (63%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+ ++ GT EY+APEI+L KG+NK
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEYLAPEIILSKGYNK 218
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 278
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  251 bits (641), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 120/291 (41%), Positives = 184/291 (63%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 85
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+ ++ GT EY+APEI+L KG+NK
Sbjct: 146 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEYLAPEIILSKGYNK 203
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 204 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 263
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 264 TKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 314

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  251 bits (641), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 122/302 (40%), Positives = 186/302 (61%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K +S       ++ FE +K +G G+FGRV  V+ K T   YAMK++ K K+V+    E+ 
Sbjct: 30  KWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT 89
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 207
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +I +HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIXNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 327
Query: 438 FE 439
           F+
Sbjct: 328 FD 329

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  251 bits (641), Expect = 7e-67,   Method: Compositional matrix adjust.
 Identities = 120/302 (39%), Positives = 188/302 (62%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K ++ +     ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLAGTPEYLA 206
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 326
Query: 438 FE 439
           F+
Sbjct: 327 FD 328

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  251 bits (640), Expect = 8e-67,   Method: Compositional matrix adjust.
 Identities = 120/302 (39%), Positives = 188/302 (62%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K ++ +     ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLXGTPEYLA 206
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 326
Query: 438 FE 439
           F+
Sbjct: 327 FD 328

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  251 bits (640), Expect = 8e-67,   Method: Compositional matrix adjust.
 Identities = 119/291 (40%), Positives = 184/291 (63%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  251 bits (640), Expect = 9e-67,   Method: Compositional matrix adjust.
 Identities = 120/291 (41%), Positives = 183/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 120/302 (39%), Positives = 188/302 (62%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K ++ +     ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 206
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 326
Query: 438 FE 439
           F+
Sbjct: 327 FD 328

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 120/302 (39%), Positives = 188/302 (62%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K ++ +     ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+ 
Sbjct: 30  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 89
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 207
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 327
Query: 438 FE 439
           F+
Sbjct: 328 FD 329

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 120/302 (39%), Positives = 188/302 (62%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K ++ +     ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+ 
Sbjct: 16  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 75
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 76  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 135
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 136 QIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 193
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 253
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 254 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 313
Query: 438 FE 439
           F+
Sbjct: 314 FD 315

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 120/291 (41%), Positives = 183/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 120/302 (39%), Positives = 188/302 (62%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K ++ +     ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 206
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 326
Query: 438 FE 439
           F+
Sbjct: 327 FD 328

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 120/302 (39%), Positives = 188/302 (62%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K ++ +     ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 206
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 326
Query: 438 FE 439
           F+
Sbjct: 327 FD 328

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 120/302 (39%), Positives = 188/302 (62%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K ++ +     ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+ 
Sbjct: 24  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 83
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 84  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 143
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 144 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 201
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 261
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 262 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 321
Query: 438 FE 439
           F+
Sbjct: 322 FD 323

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 120/302 (39%), Positives = 188/302 (62%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K ++ +     ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 206
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 326
Query: 438 FE 439
           F+
Sbjct: 327 FD 328

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 119/291 (40%), Positives = 184/291 (63%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 180
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 238
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 239 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 298
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 299 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 349

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 120/302 (39%), Positives = 188/302 (62%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K ++ +     ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 206
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 326
Query: 438 FE 439
           F+
Sbjct: 327 FD 328

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  250 bits (638), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 120/291 (41%), Positives = 183/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  250 bits (638), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 120/291 (41%), Positives = 183/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  250 bits (638), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 120/291 (41%), Positives = 183/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 278
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  250 bits (638), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 120/291 (41%), Positives = 183/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 278
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  250 bits (638), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 120/291 (41%), Positives = 183/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  250 bits (638), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 120/291 (41%), Positives = 183/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  250 bits (638), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 122/302 (40%), Positives = 186/302 (61%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K +S       ++ FE +K +G G+FGRV  V+ K T   YAMK++ K K+V+    E+ 
Sbjct: 30  KWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT 89
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V+++  GG +F  L   G F E  AR YAA
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+++   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLA 207
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 327
Query: 438 FE 439
           F+
Sbjct: 328 FD 329

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  250 bits (638), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 119/291 (40%), Positives = 184/291 (63%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  249 bits (636), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 119/302 (39%), Positives = 188/302 (62%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K ++ +     ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLA 206
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+Y+M  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 326
Query: 438 FE 439
           F+
Sbjct: 327 FD 328

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  249 bits (636), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 119/291 (40%), Positives = 184/291 (63%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+    T   ++ GT EY+APEI+L KG+NK
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATW--TLCGTPEYLAPEIILSKGYNK 238
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 239 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 298
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 299 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 349

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  249 bits (635), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 117/291 (40%), Positives = 184/291 (63%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+++   G++ +TDFG AK+     R+  + GT EY+APEI++ KG+NK
Sbjct: 160 LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIIISKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  249 bits (635), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 120/291 (41%), Positives = 183/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V+++  GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+++   G++ +TDFGLAK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  249 bits (635), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 123/318 (38%), Positives = 198/318 (62%), Gaps = 8/318 (2%)
Query: 131 SSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE 190
           S  D N   D +      + DF  L V+G+G+FG+V    +K T E+YA+K+++KD +++
Sbjct: 327 SKFDNNGNRDRMK-----LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 381
Query: 191 KNHAEYMKAERDILTKIDHP-FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE 249
            +  E    E+ +L     P F+ QL   FQT  RLY V++++NGG L + +   G F+E
Sbjct: 382 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE 441
Query: 250 DLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNS 308
             A  YAAEI   +  L + GI++RDLK +N++L ++GH+ + DFG+ K+   +   +  
Sbjct: 442 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKX 501
Query: 309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL 368
             GT +Y+APEI+  + + K+ DWW+ G+LLYEML G+ PF G +  ++ Q I++  +  
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 561
Query: 369 PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE 428
           P  +S EA ++ KGL+ K PGKRLG GP+G  +IK H +F+ I+W+KLE +EIQP + P+
Sbjct: 562 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPK 621
Query: 429 VAGKHCIANFEKKWTDMP 446
            +G++   NF++ +T  P
Sbjct: 622 ASGRNA-ENFDRFFTRHP 638

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  248 bits (634), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 119/291 (40%), Positives = 182/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ + DFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  248 bits (634), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 120/291 (41%), Positives = 183/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V+++  GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+++   G++ +TDFGLAK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  248 bits (633), Expect = 5e-66,   Method: Compositional matrix adjust.
 Identities = 118/291 (40%), Positives = 183/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+AP I+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPAIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  248 bits (633), Expect = 5e-66,   Method: Compositional matrix adjust.
 Identities = 123/318 (38%), Positives = 197/318 (61%), Gaps = 8/318 (2%)
Query: 131 SSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE 190
           S  D N   D +      + DF  L V+G+G+FG+V    +K T E+YA+K+++KD +++
Sbjct: 6   SKFDNNGNRDRMK-----LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 60
Query: 191 KNHAEYMKAERDILTKIDHP-FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE 249
            +  E    E+ +L     P F+ QL   FQT  RLY V++++NGG L + +   G F+E
Sbjct: 61  DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE 120
Query: 250 DLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNS 308
             A  YAAEI   +  L + GI++RDLK +N++L ++GH+ + DFG+ K+   +   +  
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKX 180
Query: 309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL 368
             GT +Y+APEI+  + + K+ DWW+ G+LLYEML G+ PF G +  ++ Q I++  +  
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 240
Query: 369 PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE 428
           P  +S EA ++ KGL+ K PGKRLG GP+G  +IK H +F+ I+W+KLE +EIQP + P+
Sbjct: 241 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPK 300
Query: 429 VAGKHCIANFEKKWTDMP 446
             G++   NF++ +T  P
Sbjct: 301 ACGRNA-ENFDRFFTRHP 317

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  248 bits (632), Expect = 6e-66,   Method: Compositional matrix adjust.
 Identities = 119/291 (40%), Positives = 182/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V+++  GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+++   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  248 bits (632), Expect = 6e-66,   Method: Compositional matrix adjust.
 Identities = 118/291 (40%), Positives = 183/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            K  G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKAFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  248 bits (632), Expect = 6e-66,   Method: Compositional matrix adjust.
 Identities = 116/293 (39%), Positives = 188/293 (64%), Gaps = 3/293 (1%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++DF++L+ +G G+FGRV+ +R ++    YAMKV++K+ +V     E+   ER +L+ + 
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HPF++++  +FQ   ++++++D+I GG LF  L     F   +A+ YAAE+  A+ +LH+
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             I++RDLKPENILL  +GH+ +TDFG AK   + T    + GT +Y+APE+V  K +NK
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--XLCGTPDYIAPEVVSTKPYNK 182
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           + DWWS GIL+YEML G  PF   N  K  +KI+  +LR P F + +   LL  L+ ++ 
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL 242
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEV-AGKHCIANFEK 440
            +RLG    G+E++K+H WFK + W+KL +R I+  + P +  G+   + F+K
Sbjct: 243 SQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDK 295

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  248 bits (632), Expect = 7e-66,   Method: Compositional matrix adjust.
 Identities = 119/291 (40%), Positives = 182/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ + DFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  248 bits (632), Expect = 7e-66,   Method: Compositional matrix adjust.
 Identities = 119/291 (40%), Positives = 182/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+L+   G++ + DFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  247 bits (631), Expect = 8e-66,   Method: Compositional matrix adjust.
 Identities = 119/291 (40%), Positives = 182/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V+++  GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+++   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  247 bits (631), Expect = 9e-66,   Method: Compositional matrix adjust.
 Identities = 119/291 (40%), Positives = 182/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+V+L++SF+    LY+V+++  GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+++   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  247 bits (630), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 119/302 (39%), Positives = 187/302 (61%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K ++ +     ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K+V+    E+ 
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F E  AR YAA
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+     R+  + GT E +A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEALA 206
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 326
Query: 438 FE 439
           F+
Sbjct: 327 FD 328

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  246 bits (629), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 121/358 (33%), Positives = 220/358 (61%), Gaps = 15/358 (4%)
Query: 128 IDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDK 187
           I+E     N +        +G++DF++L+V+G+G++ +V  VR K T  IYAM+V++K+ 
Sbjct: 30  IEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKEL 89
Query: 188 IVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL 246
           + +    ++++ E+ +  +  +HPF+V L   FQT+ RL+ V++++NGG L F +     
Sbjct: 90  VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK 149
Query: 247 FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTR 305
             E+ AR Y+AEI  A+++LH  GI++RDLK +N+LL ++GH+ LTD+G+ K+       
Sbjct: 150 LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 209
Query: 306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPF--IGGNRAKIQ----- 358
           +++  GT  Y+APEI+ G+ +  + DWW++G+L++EM+ G+ PF  +G +    Q     
Sbjct: 210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 269
Query: 359 --QKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPK-GSEEIKSHKWFKPINWKK 415
             Q I++ ++R+P  LS +A S+LK  L K+P +RLG  P+ G  +I+ H +F+ ++W  
Sbjct: 270 LFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 329
Query: 416 LEAREIQPGFCPEVAGKHCIANFEKKWTDMPLS---DSPAATPKNNTNPFADFSYVRP 470
           +E +++ P F P ++G+  + NF+ ++T+ P+    D      K + + F  F Y+ P
Sbjct: 330 MEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLXPDDDDIVRKIDQSEFEGFEYINP 387

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  246 bits (628), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 129/334 (38%), Positives = 200/334 (59%), Gaps = 14/334 (4%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT- 205
           +GI++FE ++V+G+G+FG+V   R K T ++YA+KV++KD I++ +  E    E+ IL+ 
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             +HPF+ QL   FQT  RL+ V++F+NGG L F +     F E  AR YAAEI+SA+  
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSNSMIGTVEYMAPEIVLGK 324
           LH  GI++RDLK +N+LL  +GH  L DFG+ K+   N   + +  GT +Y+APEI+   
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
            +  A DWW++G+LLYEML G  PF   N   + + I+ D++  P +L  +A  +LK  +
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFM 259
Query: 385 QKEPGKRLGAGPKGSEE-IKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWT 443
            K P  RLG+  +G E  I  H +FK I+W +L  R+I+P F P +  +  ++NF+  + 
Sbjct: 260 TKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDF- 318
Query: 444 DMPLSDSPAATPKN-------NTNPFADFSYVRP 470
              + + P   P +       N + F +F YV P
Sbjct: 319 ---IKEEPVLXPIDEGHLPMINQDEFRNFEYVSP 349

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  246 bits (628), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 121/302 (40%), Positives = 184/302 (60%), Gaps = 2/302 (0%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           K +S       ++ FE ++ +G G+FGRV  V+ K T   YAMK++ K K+V+    E+ 
Sbjct: 30  KWESPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT 89
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             E+ I   ++ PF+V+L++SF+    LY+VL++  GG +F  L   G F E  AR YAA
Sbjct: 90  LNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +IV    +LH+  +++RDLKPEN+L+   G++ + DFG AK+     R+  + GT EY+A
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLA 207
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+  
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
            LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +N
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 327
Query: 438 FE 439
           F+
Sbjct: 328 FD 329

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  246 bits (627), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 118/291 (40%), Positives = 181/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+ +L++SF+    LY+V+++  GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+++   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 278
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  246 bits (627), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 118/291 (40%), Positives = 181/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+ +L++SF+    LY+V+++  GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+++   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 278
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  246 bits (627), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 118/291 (40%), Positives = 181/291 (62%), Gaps = 2/291 (0%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ FE +K +G G+FGRV  V+   T   YAMK++ K K+V+    E+   E+ IL  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            PF+ +L++SF+    LY+V+++  GG +F  L   G F E  AR YAA+IV    +LH+
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +++RDLKPEN+++   G++ +TDFG AK+     R+  + GT EY+APEI+L KG+NK
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           A DWW++G+L+YEM  G PPF      +I +KIV  K+R P+  SS+   LL+ LLQ + 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 278
Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
            KR G    G  +IK+HKWF   +W  +  R+++  F P+  G    +NF+
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  245 bits (625), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 119/339 (35%), Positives = 214/339 (63%), Gaps = 15/339 (4%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +G++DF++L+V+G+G++ +V  VR K T  IYAMKV++K+ + +    ++++ E+ +  +
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 61
Query: 207 I-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V++++NGG L F +       E+ AR Y+AEI  A+++
Sbjct: 62  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
           LH  GI++RDLK +N+LL ++GH+ LTD+G+ K+       ++   GT  Y+APEI+ G+
Sbjct: 122 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 325 GHNKAADWWSVGILLYEMLTGKPPF--IGGNRAKIQ-------QKIVKDKLRLPAFLSSE 375
            +  + DWW++G+L++EM+ G+ PF  +G +    Q       Q I++ ++R+P  LS +
Sbjct: 182 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 241
Query: 376 AHSLLKGLLQKEPGKRLGAGPK-GSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHC 434
           A S+LK  L K+P +RLG  P+ G  +I+ H +F+ ++W  +E +++ P F P ++G+  
Sbjct: 242 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFG 301
Query: 435 IANFEKKWTDMPLS---DSPAATPKNNTNPFADFSYVRP 470
           + NF+ ++T+ P+    D      K + + F  F Y+ P
Sbjct: 302 LDNFDSQFTNEPVQLXPDDDDIVRKIDQSEFEGFEYINP 340

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  244 bits (624), Expect = 6e-65,   Method: Compositional matrix adjust.
 Identities = 119/339 (35%), Positives = 214/339 (63%), Gaps = 15/339 (4%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +G++DF++L+V+G+G++ +V  VR K T  IYAMKV++K+ + +    ++++ E+ +  +
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 207 I-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V++++NGG L F +       E+ AR Y+AEI  A+++
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
           LH  GI++RDLK +N+LL ++GH+ LTD+G+ K+       ++   GT  Y+APEI+ G+
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 185
Query: 325 GHNKAADWWSVGILLYEMLTGKPPF--IGGNRAKIQ-------QKIVKDKLRLPAFLSSE 375
            +  + DWW++G+L++EM+ G+ PF  +G +    Q       Q I++ ++R+P  LS +
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 245
Query: 376 AHSLLKGLLQKEPGKRLGAGPK-GSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHC 434
           A S+LK  L K+P +RLG  P+ G  +I+ H +F+ ++W  +E +++ P F P ++G+  
Sbjct: 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFG 305
Query: 435 IANFEKKWTDMPLS---DSPAATPKNNTNPFADFSYVRP 470
           + NF+ ++T+ P+    D      K + + F  F Y+ P
Sbjct: 306 LDNFDSQFTNEPVQLXPDDDDIVRKIDQSEFEGFEYINP 344

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  241 bits (615), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 118/350 (33%), Positives = 215/350 (61%), Gaps = 15/350 (4%)
Query: 136 NVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAE 195
           N +        +G++DF++L+V+G+G++ +V  VR K T  IYAMKV++K+ + +    +
Sbjct: 6   NTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID 65
Query: 196 YMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI 254
           +++ E+ +  +  +HPF+V L   FQT+ RL+ V++++NGG L F +       E+ AR 
Sbjct: 66  WVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF 125
Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTV 313
           Y+AEI  A+++LH  GI++RDLK +N+LL ++GH+ LTD+G+ K+       ++   GT 
Sbjct: 126 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTP 185
Query: 314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPF--IGGNRAKIQ-------QKIVKD 364
            Y+APEI+ G+ +  + DWW++G+L++EM+ G+ PF  +G +    Q       Q I++ 
Sbjct: 186 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 245
Query: 365 KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPK-GSEEIKSHKWFKPINWKKLEAREIQP 423
           ++R+P  +S +A S+LK  L K+P +RLG  P+ G  +I+ H +F+ ++W  +E +++ P
Sbjct: 246 QIRIPRSMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQKQVVP 305
Query: 424 GFCPEVAGKHCIANFEKKWTDMPLS---DSPAATPKNNTNPFADFSYVRP 470
            F P ++G+  + NF+ ++T+  +    D      K + + F  F Y+ P
Sbjct: 306 PFKPNISGEFGLDNFDSQFTNERVQLXPDDDDIVRKIDQSEFEGFEYINP 355

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  236 bits (601), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 126/337 (37%), Positives = 202/337 (59%), Gaps = 11/337 (3%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT- 205
           + IEDFE+ K++G+G+FG+V+    K T++ +A+K ++KD ++  +  E    E+ +L+ 
Sbjct: 15  LKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 74
Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             +HPF+  +  +FQTK  L+ V++++NGG L + +     F    A  YAAEI+  +  
Sbjct: 75  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 134
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
           LH+ GI++RDLK +NILL  DGH+ + DFG+ K+    + ++N   GT +Y+APEI+LG+
Sbjct: 135 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQ 194
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
            +N + DWWS G+LLYEML G+ PF G +  ++   I  D    P +L  EA  LL  L 
Sbjct: 195 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 254
Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
            +EP KRLG   +G  +I+ H  F+ INW++LE +EI P F P+V      +NF+K++ +
Sbjct: 255 VREPEKRLGV--RG--DIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLN 310
Query: 445 ----MPLSDSPAATPKNNTNPFADFSYVRPAASFLQS 477
               +  +D  A     + N F +F ++ P    L S
Sbjct: 311 EKPRLXFADR-ALINSMDQNMFRNFXFMNPGMERLIS 346

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  232 bits (592), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 125/337 (37%), Positives = 201/337 (59%), Gaps = 11/337 (3%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT- 205
           + IEDF + K++G+G+FG+V+    K T++ +A+K ++KD ++  +  E    E+ +L+ 
Sbjct: 14  LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             +HPF+  +  +FQTK  L+ V++++NGG L + +     F    A  YAAEI+  +  
Sbjct: 74  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 133
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
           LH+ GI++RDLK +NILL  DGH+ + DFG+ K+    + ++N   GT +Y+APEI+LG+
Sbjct: 134 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQ 193
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
            +N + DWWS G+LLYEML G+ PF G +  ++   I  D    P +L  EA  LL  L 
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 253
Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
            +EP KRLG   +G  +I+ H  F+ INW++LE +EI P F P+V      +NF+K++ +
Sbjct: 254 VREPEKRLGV--RG--DIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLN 309
Query: 445 ----MPLSDSPAATPKNNTNPFADFSYVRPAASFLQS 477
               +  +D  A     + N F +F ++ P    L S
Sbjct: 310 EKPRLSFADR-ALINSMDQNMFRNFXFMNPGMERLIS 345

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  218 bits (555), Expect = 5e-57,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 167/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 214
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   PA    +A  L++ LL  
Sbjct: 215 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEKLLVL 274
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 275 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 305

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  218 bits (554), Expect = 7e-57,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 168/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+NS +GT +Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 211
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
           +K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 212 SKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  218 bits (554), Expect = 7e-57,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 167/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+NS +GT +Y++PE++  K  
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 212
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 272
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 273 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 303

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  217 bits (553), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 167/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+NS +GT +Y++PE++  K  
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 208
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 268
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 269 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 299

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  216 bits (551), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 167/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N+ +GT +Y++PE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSA 209
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 269
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  216 bits (550), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 166/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  216 bits (549), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 166/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 269
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  216 bits (549), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 166/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 188
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 189 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 248
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 249 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 279

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  216 bits (549), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 166/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 189
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 190 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 249
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 250 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 280

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  216 bits (549), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 166/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 186
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 187 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 246
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 247 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 277

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  216 bits (549), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 166/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 269
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  216 bits (549), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 166/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 212
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 272
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 273 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 303

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  216 bits (549), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 166/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  216 bits (549), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 166/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  216 bits (549), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 166/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 193
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 194 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 253
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 254 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 284

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  216 bits (549), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 166/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 187
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 248 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 278

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  215 bits (548), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 166/271 (61%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 208
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 268
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 269 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 299

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  215 bits (547), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 165/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L + FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 216
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 217 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 276
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 277 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 307

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  214 bits (545), Expect = 9e-56,   Method: Compositional matrix adjust.
 Identities = 106/271 (39%), Positives = 165/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I  KI+K +   P     +A  L++ LL  
Sbjct: 212 XKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  214 bits (545), Expect = 9e-56,   Method: Compositional matrix adjust.
 Identities = 106/271 (39%), Positives = 165/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F      R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 269
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  214 bits (544), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 106/271 (39%), Positives = 165/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+N  +GT +Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I  KI+K +   P     +A  L++ LL  
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 387 EPGKRLGAGP-KGSEEIKSHKWFKPINWKKL 416
           +  KRLG    +G   +K+H +F+ + W+ L
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  205 bits (522), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 106/299 (35%), Positives = 169/299 (56%), Gaps = 10/299 (3%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V  + FE+L+ +G+G+FG+V  V+K +T ++YAMK M K K VE+N    +  E  I+  
Sbjct: 12  VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           ++HPF+V L YSFQ +  +++V+D + GG L + L  +  F+E+  +++  E+V A+ +L
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV---LG 323
               I+HRD+KP+NILL   GHV +TDF +A      T+  +M GT  YMAPE+     G
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPF---IGGNRAKIQQKIVKDKLRLPAFLSSEAHSLL 380
            G++ A DWWS+G+  YE+L G+ P+      +  +I        +  P+  S E  SLL
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLL 251
Query: 381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
           K LL+  P +R         ++++  +   INW  +  + + PGF P     +C   FE
Sbjct: 252 KKLLEPNPDQRFSQ----LSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFE 306

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  204 bits (519), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 106/288 (36%), Positives = 174/288 (60%), Gaps = 8/288 (2%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + + DF V +++G+G FG VY  RK +T ++YAMK + K +I  K        ER +L+ 
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 207 I---DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV 263
           +   D PF+V + Y+F T  +L  +LD +NGG L + L  HG+F E   R YAAEI+  +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL- 322
            H+H   +++RDLKP NILL   GHV ++D GLA  F +  + ++ +GT  YMAPE++  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQK 364
Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFI---GGNRAKIQQKIVKDKLRLPAFLSSEAHSL 379
           G  ++ +ADW+S+G +L+++L G  PF      ++ +I +  +   + LP   S E  SL
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP 427
           L+GLLQ++  +RLG   +G++E+K   +F+ ++W+ +  ++  P   P
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 472

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  204 bits (519), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 106/288 (36%), Positives = 174/288 (60%), Gaps = 8/288 (2%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + + DF V +++G+G FG VY  RK +T ++YAMK + K +I  K        ER +L+ 
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 207 I---DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV 263
           +   D PF+V + Y+F T  +L  +LD +NGG L + L  HG+F E   R YAAEI+  +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL- 322
            H+H   +++RDLKP NILL   GHV ++D GLA  F +  + ++ +GT  YMAPE++  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQK 364
Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFI---GGNRAKIQQKIVKDKLRLPAFLSSEAHSL 379
           G  ++ +ADW+S+G +L+++L G  PF      ++ +I +  +   + LP   S E  SL
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP 427
           L+GLLQ++  +RLG   +G++E+K   +F+ ++W+ +  ++  P   P
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 472

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  204 bits (519), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 106/288 (36%), Positives = 174/288 (60%), Gaps = 8/288 (2%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + + DF V +++G+G FG VY  RK +T ++YAMK + K +I  K        ER +L+ 
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 207 I---DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV 263
           +   D PF+V + Y+F T  +L  +LD +NGG L + L  HG+F E   R YAAEI+  +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL- 322
            H+H   +++RDLKP NILL   GHV ++D GLA  F +  + ++ +GT  YMAPE++  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQK 364
Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFI---GGNRAKIQQKIVKDKLRLPAFLSSEAHSL 379
           G  ++ +ADW+S+G +L+++L G  PF      ++ +I +  +   + LP   S E  SL
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP 427
           L+GLLQ++  +RLG   +G++E+K   +F+ ++W+ +  ++  P   P
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 472

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  204 bits (519), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 106/288 (36%), Positives = 174/288 (60%), Gaps = 8/288 (2%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + + DF V +++G+G FG VY  RK +T ++YAMK + K +I  K        ER +L+ 
Sbjct: 185 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 244
Query: 207 I---DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV 263
           +   D PF+V + Y+F T  +L  +LD +NGG L + L  HG+F E   R YAAEI+  +
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL- 322
            H+H   +++RDLKP NILL   GHV ++D GLA  F +  + ++ +GT  YMAPE++  
Sbjct: 305 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQK 363
Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFI---GGNRAKIQQKIVKDKLRLPAFLSSEAHSL 379
           G  ++ +ADW+S+G +L+++L G  PF      ++ +I +  +   + LP   S E  SL
Sbjct: 364 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 423
Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP 427
           L+GLLQ++  +RLG   +G++E+K   +F+ ++W+ +  ++  P   P
Sbjct: 424 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 471

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  201 bits (511), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 119/344 (34%), Positives = 193/344 (56%), Gaps = 19/344 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ED+EV+KV+G+GAFG V  VR K+T ++YAMK++ K ++++++ + +   ERDI+   + 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P+VVQL Y+FQ    LY+V++++ GG L   + ++ +  E  AR Y AE+V A+  +H+ 
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDAIHSM 187
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG-- 325
           G +HRD+KP+N+LL   GH+ L DFG   + ++    R ++ +GT +Y++PE++  +G  
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 326 --HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLP--AFLSSEAHSL 379
             + +  DWWSVG+ LYEML G  PF   +      KI+  K+ L  P    +S EA +L
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
           +   L     + +  G  G EEIK H +FK   W     R+      P+++     +NF+
Sbjct: 308 ICAFLTD---REVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFD 364
Query: 440 KKWTDMPLSDS---PAATPKNNTNPFADFSYVRPAASFLQSNSP 480
               D    ++   P A   N   PF  F+Y      +L S +P
Sbjct: 365 DLEEDKGEEETFPIPKAFVGNQL-PFVGFTYY-SNRRYLSSANP 406

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  201 bits (510), Expect = 9e-52,   Method: Compositional matrix adjust.
 Identities = 119/344 (34%), Positives = 193/344 (56%), Gaps = 19/344 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ED+EV+KV+G+GAFG V  VR K+T ++YAMK++ K ++++++ + +   ERDI+   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P+VVQL Y+FQ    LY+V++++ GG L   + ++ +  E  AR Y AE+V A+  +H+ 
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDAIHSM 192
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG-- 325
           G +HRD+KP+N+LL   GH+ L DFG   + ++    R ++ +GT +Y++PE++  +G  
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 326 --HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLP--AFLSSEAHSL 379
             + +  DWWSVG+ LYEML G  PF   +      KI+  K+ L  P    +S EA +L
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 312
Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
           +   L     + +  G  G EEIK H +FK   W     R+      P+++     +NF+
Sbjct: 313 ICAFLTD---REVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFD 369
Query: 440 KKWTDMPLSDS---PAATPKNNTNPFADFSYVRPAASFLQSNSP 480
               D    ++   P A   N   PF  F+Y      +L S +P
Sbjct: 370 DLEEDKGEEETFPIPKAFVGNQL-PFVGFTYY-SNRRYLSSANP 411

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 116/331 (35%), Positives = 188/331 (56%), Gaps = 18/331 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ED+EV+KV+G+GAFG V  VR K+T ++YAMK++ K ++++++ + +   ERDI+   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P+VVQL Y+FQ    LY+V++++ GG L   + ++ +  E  AR Y AE+V A+  +H+ 
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDAIHSM 192
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG-- 325
           G +HRD+KP+N+LL   GH+ L DFG   + ++    R ++ +GT +Y++PE++  +G  
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 326 --HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLP--AFLSSEAHSL 379
             + +  DWWSVG+ LYEML G  PF   +      KI+  K+ L  P    +S EA +L
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 312
Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE 439
           +   L     + +  G  G EEIK H +FK   W     R+      P+++     +NF+
Sbjct: 313 ICAFLTD---REVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFD 369
Query: 440 KKWTDMPLSDS---PAATPKNNTNPFADFSY 467
               D    ++   P A   N   PF  F+Y
Sbjct: 370 DLEEDKGEEETFPIPKAFVGNQL-PFVGFTY 399

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  196 bits (498), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 131/405 (32%), Positives = 214/405 (52%), Gaps = 32/405 (7%)
Query: 91  GPSSCVSESSKLTKLIL--RESEDAEELLECVDGLTVKEIDESSIDENVKGDS------- 141
           G  +  S   KL  LI   R   + E LL+ ++ L V ++D  ++ +N   D+       
Sbjct: 4   GDGAGASRQRKLEALIRDPRSPINVESLLDGLNSL-VLDLDFPALRKNKNIDNFLNRYEK 62
Query: 142 ----VTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
               +    +  ED++V+KV+G+GAFG V  VR K + ++YAMK++ K ++++++ + + 
Sbjct: 63  IVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFF 122
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
             ERDI+   + P+VVQL  +FQ    LY+V++++ GG L   + ++ +  E  A+ Y A
Sbjct: 123 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFYTA 181
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEY 315
           E+V A+  +H+ G++HRD+KP+N+LL   GH+ L DFG   + DE      ++ +GT +Y
Sbjct: 182 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDY 241
Query: 316 MAPEIVLGKG----HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLP 369
           ++PE++  +G    + +  DWWSVG+ L+EML G  PF   +      KI+  K+ L  P
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFP 301
Query: 370 --AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP 427
             A +S  A +L+   L     + +  G  G EEIK H +FK   W     RE      P
Sbjct: 302 EDAEISKHAKNLICAFLTD---REVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVP 358
Query: 428 EVAGKHCIANF---EKKWTDMPLSDSPAATPKNNTNPFADFSYVR 469
           E++     +NF   E    D+     P A   N   PF  F+Y R
Sbjct: 359 ELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQL-PFIGFTYYR 402

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  195 bits (495), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 116/339 (34%), Positives = 191/339 (56%), Gaps = 28/339 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDFE++KV+G+GAFG V  V+ KNT  IYAMK++ K +++++      + ERD+L   D 
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHA 268
            ++  L Y+FQ +  LYLV+D+  GG L   L        ED+AR Y  E+V A+  +H 
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFG--LAKQFDENTRSNSMIGTVEYMAPEIV----- 321
              +HRD+KP+N+LL  +GH+ L DFG  L    D   +S+  +GT +Y++PEI+     
Sbjct: 194 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 322 -LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLPAF---LSSE 375
            +GK +    DWWS+G+ +YEML G+ PF   +  +   KI+  +++ + P+    +S E
Sbjct: 254 GMGK-YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEE 312
Query: 376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCI 435
           A  L++ L+     +RLG    G E+ K H +F+ +NW+ +  R ++  + P+V+     
Sbjct: 313 AKDLIQRLICSRE-RRLGQ--NGIEDFKKHAFFEGLNWENI--RNLEAPYIPDVSSPSDT 367
Query: 436 ANFEKKWTDMPLSDSPAATPKNNTN------PFADFSYV 468
           +NF+    D  L ++    P ++T       PF  F++ 
Sbjct: 368 SNFDVD--DDVLRNTEILPPGSHTGFSGLHLPFIGFTFT 404

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  195 bits (495), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 116/339 (34%), Positives = 191/339 (56%), Gaps = 28/339 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDFE++KV+G+GAFG V  V+ KNT  IYAMK++ K +++++      + ERD+L   D 
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHA 268
            ++  L Y+FQ +  LYLV+D+  GG L   L        ED+AR Y  E+V A+  +H 
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFG--LAKQFDENTRSNSMIGTVEYMAPEIV----- 321
              +HRD+KP+N+LL  +GH+ L DFG  L    D   +S+  +GT +Y++PEI+     
Sbjct: 210 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 322 -LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLPAF---LSSE 375
            +GK +    DWWS+G+ +YEML G+ PF   +  +   KI+  +++ + P+    +S E
Sbjct: 270 GMGK-YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEE 328
Query: 376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCI 435
           A  L++ L+     +RLG    G E+ K H +F+ +NW+ +  R ++  + P+V+     
Sbjct: 329 AKDLIQRLICSRE-RRLGQ--NGIEDFKKHAFFEGLNWENI--RNLEAPYIPDVSSPSDT 383
Query: 436 ANFEKKWTDMPLSDSPAATPKNNTN------PFADFSYV 468
           +NF+    D  L ++    P ++T       PF  F++ 
Sbjct: 384 SNFDVD--DDVLRNTEILPPGSHTGFSGLHLPFIGFTFT 420

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  193 bits (490), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 123/342 (35%), Positives = 180/342 (52%), Gaps = 29/342 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE+LKV+G+GAF  V  V+ K T ++YAMK+M K  ++++      + ERD+L   D 
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHA 268
            ++ QL ++FQ +  LYLV+++  GG L   L   G     ++AR Y AEIV A+  +H 
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFG--LAKQFDENTRSNSMIGTVEYMAPEIVLG--- 323
            G +HRD+KP+NILL   GH+ L DFG  L  + D   RS   +GT +Y++PEI+     
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 324 ----KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLPAF---LSS 374
                 +    DWW++G+  YEM  G+ PF   + A+   KIV  K+ L LP     +  
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPE 300
Query: 375 EAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHC 434
           EA   ++ LL   P  RLG G  G+ + ++H +F  ++W  L  R+  P F P+  G   
Sbjct: 301 EARDFIQRLLCP-PETRLGRG--GAGDFRTHPFFFGLDWDGL--RDSVPPFTPDFEGATD 355
Query: 435 IANF---EKKWTDM------PLSDSPAATPKNNTNPFADFSY 467
             NF   E   T M       LSD     P     PF  +SY
Sbjct: 356 TCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSY 397

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  191 bits (486), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 110/289 (38%), Positives = 163/289 (56%), Gaps = 6/289 (2%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F   +V+G+G FG V   + + T ++YA K + K +I ++        E+ IL K++  F
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHAN 269
           VV L Y+++TK  L LVL  +NGG L F +YH G   F E  A  YAAEI   +  LH  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKA 329
            I++RDLKPENILL   GH+ ++D GLA    E       +GTV YMAPE+V  + +  +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 330 ADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLKGLLQ 385
            DWW++G LLYEM+ G+ PF    +   ++++ +    +P       S +A SL   LL 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHC 434
           K+P +RLG     + E+K H  FK +N+K+L A  ++P F P+    +C
Sbjct: 426 KDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYC 474

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  191 bits (486), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 116/338 (34%), Positives = 183/338 (54%), Gaps = 26/338 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDFE+LKV+G+GAFG V  V+ KN  +++AMK++ K +++++      + ERD+L   D 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHA 268
            ++  L Y+FQ    LYLV+D+  GG L   L        E++AR Y AE+V A+  +H 
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFG--LAKQFDENTRSNSMIGTVEYMAPEIVL---- 322
              +HRD+KP+NIL+  +GH+ L DFG  L    D   +S+  +GT +Y++PEI+     
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 323 GKG-HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV--KDKLRLPAF---LSSEA 376
           GKG +    DWWS+G+ +YEML G+ PF   +  +   KI+  K++ + P     +S  A
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313
Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIA 436
             L++ L+     +    G  G E+ K H +F  I+W  +  R  +  + PEV+     +
Sbjct: 314 KDLIRRLICSREHR---LGQNGIEDFKKHPFFSGIDWDNI--RNCEAPYIPEVSSPTDTS 368
Query: 437 NFEKKWTDMPLSDSPAATPKNNTN------PFADFSYV 468
           NF+    D  L +S    P  +T       PF  F+Y 
Sbjct: 369 NFDVD--DDCLKNSETMPPPTHTAFSGHHLPFVGFTYT 404

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  191 bits (485), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 110/289 (38%), Positives = 163/289 (56%), Gaps = 6/289 (2%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F   +V+G+G FG V   + + T ++YA K + K +I ++        E+ IL K++  F
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHAN 269
           VV L Y+++TK  L LVL  +NGG L F +YH G   F E  A  YAAEI   +  LH  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKA 329
            I++RDLKPENILL   GH+ ++D GLA    E       +GTV YMAPE+V  + +  +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 330 ADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLKGLLQ 385
            DWW++G LLYEM+ G+ PF    +   ++++ +    +P       S +A SL   LL 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHC 434
           K+P +RLG     + E+K H  FK +N+K+L A  ++P F P+    +C
Sbjct: 426 KDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYC 474

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 100/291 (34%), Positives = 175/291 (60%), Gaps = 9/291 (3%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +G + F   +V+G+G FG V+  + K T ++YA K + K ++ ++   +    E+ IL K
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSA 262
           +   F+V L Y+F+TK  L LV+  +NGG + + +Y+    +  F+E  A  Y A+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSNSMIGTVEYMAPEIV 321
           + HLH   I++RDLKPEN+LL  DG+V ++D GLA +     T++    GT  +MAPE++
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIG-GNRA---KIQQKIVKDKLRLPAFLSSEAH 377
           LG+ ++ + D++++G+ LYEM+  + PF   G +    +++Q++++  +  P   S  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE 428
              + LLQK+P KRLG      + +++H  F+ I+W++LEA  + P F P+
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 100/291 (34%), Positives = 175/291 (60%), Gaps = 9/291 (3%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +G + F   +V+G+G FG V+  + K T ++YA K + K ++ ++   +    E+ IL K
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSA 262
           +   F+V L Y+F+TK  L LV+  +NGG + + +Y+    +  F+E  A  Y A+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSNSMIGTVEYMAPEIV 321
           + HLH   I++RDLKPEN+LL  DG+V ++D GLA +     T++    GT  +MAPE++
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIG-GNRA---KIQQKIVKDKLRLPAFLSSEAH 377
           LG+ ++ + D++++G+ LYEM+  + PF   G +    +++Q++++  +  P   S  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE 428
              + LLQK+P KRLG      + +++H  F+ I+W++LEA  + P F P+
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 100/291 (34%), Positives = 175/291 (60%), Gaps = 9/291 (3%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +G + F   +V+G+G FG V+  + K T ++YA K + K ++ ++   +    E+ IL K
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSA 262
           +   F+V L Y+F+TK  L LV+  +NGG + + +Y+    +  F+E  A  Y A+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSNSMIGTVEYMAPEIV 321
           + HLH   I++RDLKPEN+LL  DG+V ++D GLA +     T++    GT  +MAPE++
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIG-GNRA---KIQQKIVKDKLRLPAFLSSEAH 377
           LG+ ++ + D++++G+ LYEM+  + PF   G +    +++Q++++  +  P   S  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE 428
              + LLQK+P KRLG      + +++H  F+ I+W++LEA  + P F P+
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 100/291 (34%), Positives = 175/291 (60%), Gaps = 9/291 (3%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +G + F   +V+G+G FG V+  + K T ++YA K + K ++ ++   +    E+ IL K
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSA 262
           +   F+V L Y+F+TK  L LV+  +NGG + + +Y+    +  F+E  A  Y A+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSNSMIGTVEYMAPEIV 321
           + HLH   I++RDLKPEN+LL  DG+V ++D GLA +     T++    GT  +MAPE++
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIG-GNRA---KIQQKIVKDKLRLPAFLSSEAH 377
           LG+ ++ + D++++G+ LYEM+  + PF   G +    +++Q++++  +  P   S  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE 428
              + LLQK+P KRLG      + +++H  F+ I+W++LEA  + P F P+
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 149/261 (57%), Gaps = 6/261 (2%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I+DF++++ +G+G FG VY  R+K    I A+KV+ K ++ ++     ++ E +I + + 
Sbjct: 13  IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP ++++   F  + R+YL+L+F   G L+ +L  HG F E  +  +  E+  A+ + H 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             ++HRD+KPEN+L+G  G + + DFG +     + R   M GT++Y+ PE++ GK H++
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRXMCGTLDYLPPEMIEGKTHDE 191
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
             D W  G+L YE L G PPF   +  +  ++IV   L+ P FLS  +  L+  LL+  P
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHP 251
Query: 389 GKRLGAGPKGSEEIKSHKWFK 409
            +RL    KG   +  H W K
Sbjct: 252 PQRLPL--KG---VMEHPWVK 267

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  172 bits (436), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 148/261 (56%), Gaps = 6/261 (2%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I+DF++ + +G+G FG VY  R+K    I A+KV+ K ++ ++     ++ E +I + + 
Sbjct: 14  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP ++++   F  + R+YL+L+F   G L+ +L  HG F E  +  +  E+  A+ + H 
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 133
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             ++HRD+KPEN+L+G  G + + DFG +     + R   M GT++Y+ PE++ GK H++
Sbjct: 134 RKVIHRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRXMCGTLDYLPPEMIEGKTHDE 192
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
             D W  G+L YE L G PPF   +  +  ++IV   L+ P FLS  +  L+  LL+  P
Sbjct: 193 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHP 252
Query: 389 GKRLGAGPKGSEEIKSHKWFK 409
            +RL    KG   +  H W K
Sbjct: 253 PQRLPL--KG---VMEHPWVK 268

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  168 bits (425), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 151
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 152 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 210
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 270
Query: 388 PGKR 391
           P +R
Sbjct: 271 PSQR 274

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  167 bits (424), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 151
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R + + GT++Y+ PE++ G+ H+
Sbjct: 152 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRDDLCGTLDYLPPEMIEGRMHD 210
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 270
Query: 388 PGKR 391
           P +R
Sbjct: 271 PSQR 274

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  167 bits (424), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCH 130
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 189
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 249
Query: 388 PGKR 391
           P +R
Sbjct: 250 PSQR 253

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 142
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 143 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 201
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 202 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 261
Query: 388 PGKR 391
           P +R
Sbjct: 262 PSQR 265

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 145/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R +++ GT++Y+ PE++ G+ H+
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRDTLCGTLDYLPPEMIEGRMHD 185
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245
Query: 388 PGKR 391
           P +R
Sbjct: 246 PSQR 249

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 81/244 (33%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+KN+  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 126 SKKVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF         ++I + +   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 PGKR 391
           P +R
Sbjct: 245 PSQR 248

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 88/280 (31%), Positives = 155/280 (55%), Gaps = 11/280 (3%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 PGKRLGAGPKGSEEIKSHKWF-----KPINWKKLEAREIQ 422
           P +R         E+  H W      KP N +  E+   Q
Sbjct: 245 PSQR-----PMLREVLEHPWITANSSKPSNCQNKESASKQ 279

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 187
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 388 PGKR 391
           P +R
Sbjct: 248 PSQR 251

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 189
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 249
Query: 388 PGKR 391
           P +R
Sbjct: 250 PSQR 253

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 153/276 (55%), Gaps = 11/276 (3%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE + G+ H+
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEXIEGRXHD 189
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 249
Query: 388 PGKRLGAGPKGSEEIKSHKWF-----KPINWKKLEA 418
           P +R         E+  H W      KP N +  E+
Sbjct: 250 PSQR-----PXLREVLEHPWITANSSKPSNCQNKES 280

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 143/244 (58%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R   + GT++Y+ PE++ G+ H+
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTELCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 PGKR 391
           P +R
Sbjct: 245 PSQR 248

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     + R++ + GT++Y+ PE++ G+ H+
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMIEGRMHD 185
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245
Query: 388 PGKR 391
           P +R
Sbjct: 246 PSQR 249

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     + R++ + GT++Y+ PE++ G+ H+
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 PGKR 391
           P +R
Sbjct: 245 PSQR 248

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     + R++ + GT++Y+ PE++ G+ H+
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMIEGRMHD 189
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 249
Query: 388 PGKR 391
           P +R
Sbjct: 250 PSQR 253

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 129
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 130 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 188
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 248
Query: 388 PGKR 391
           P +R
Sbjct: 249 PSQR 252

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 124
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 125 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 183
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 243
Query: 388 PGKR 391
           P +R
Sbjct: 244 PSQR 247

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     + R++ + GT++Y+ PE++ G+ H+
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 PGKR 391
           P +R
Sbjct: 245 PSQR 248

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 143/244 (58%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCH 130
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R   + GT++Y+ PE++ G+ H+
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLXGTLDYLPPEMIEGRMHD 189
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 249
Query: 388 PGKR 391
           P +R
Sbjct: 250 PSQR 253

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R + + GT++Y+ PE++ G+ H+
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRDDLCGTLDYLPPEMIEGRMHD 187
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 388 PGKR 391
           P +R
Sbjct: 248 PSQR 251

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSCH-APSSRRTTLSGTLDYLPPEMIEGRMHD 185
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245
Query: 388 PGKR 391
           P +R
Sbjct: 246 PSQR 249

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIEGRMHD 187
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 388 PGKR 391
           P +R
Sbjct: 248 PSQR 251

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 187
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 388 PGKR 391
           P +R
Sbjct: 248 PSQR 251

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  166 bits (419), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 143/244 (58%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 127
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R   + GT++Y+ PE++ G+ H+
Sbjct: 128 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMIEGRMHD 186
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 246
Query: 388 PGKR 391
           P +R
Sbjct: 247 PSQR 250

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  165 bits (418), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 79/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 127
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + +FG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 128 SKRVIHRDIKPENLLLGSAGELKIANFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 186
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 246
Query: 388 PGKR 391
           P +R
Sbjct: 247 PSQR 250

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  165 bits (417), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 PGKR 391
           P +R
Sbjct: 245 PSQR 248

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  165 bits (417), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 143/244 (58%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R   + GT++Y+ PE++ G+ H+
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTXLCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 PGKR 391
           P +R
Sbjct: 245 PSQR 248

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  165 bits (417), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 143/244 (58%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K    I A+KV+ K ++ +      ++ E +I + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 122
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 123 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 181
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 241
Query: 388 PGKR 391
           P +R
Sbjct: 242 PSQR 245

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  164 bits (416), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 143/244 (58%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R   + GT++Y+ PE++ G+ H+
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 PGKR 391
           P +R
Sbjct: 245 PSQR 248

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 79/244 (32%), Positives = 144/244 (59%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + +FG +     ++R  ++ GT++Y+ PE++ G+ H+
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIANFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 187
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 388 PGKR 391
           P +R
Sbjct: 248 PSQR 251

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 150/261 (57%), Gaps = 6/261 (2%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +EDF++ + +G+G FG VY  R++ +  I A+KV+ K ++ +      ++ E +I + + 
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H+
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             ++HRD+KPEN+LLG++G + + DFG +     ++R +++ GT++Y+ PE++ G+ H++
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVH-APSSRRDTLCGTLDYLPPEMIEGRMHDE 189
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
             D WS+G+L YE L G PPF      +  ++I + +   P F++  A  L+  LL+   
Sbjct: 190 KVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLLKHNA 249
Query: 389 GKRLGAGPKGSEEIKSHKWFK 409
            +RL        E+  H W K
Sbjct: 250 SQRLTLA-----EVLEHPWIK 265

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 143/244 (58%), Gaps = 1/244 (0%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +  ++HRD+KPEN+LLG+ G + + DFG +     ++R   + GT++Y+ PE++ G+ H+
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMIEGRMHD 187
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 388 PGKR 391
           P +R
Sbjct: 248 PSQR 251

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 149/261 (57%), Gaps = 6/261 (2%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +EDF++ + +G+G FG VY  R++ +  I A+KV+ K ++ +      ++ E +I + + 
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H+
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             ++HRD+KPEN+LLG++G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H++
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHDE 189
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
             D WS+G+L YE L G PPF      +  ++I + +   P F++  A  L+  LL+   
Sbjct: 190 KVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLLKHNA 249
Query: 389 GKRLGAGPKGSEEIKSHKWFK 409
            +RL        E+  H W K
Sbjct: 250 SQRLTLA-----EVLEHPWIK 265

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  161 bits (407), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 148/261 (56%), Gaps = 6/261 (2%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I+DFE+ + +G+G FG VY  R+K +  I A+KV+ K +I ++     ++ E +I   + 
Sbjct: 22  IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +++L   F  + R+YL+L++   G L+ +L     F E        E+  A+ + H 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             ++HRD+KPEN+LLG  G + + DFG +     + R  +M GT++Y+ PE++ G+ HN+
Sbjct: 142 KKVIHRDIKPENLLLGLKGELKIADFGWSVH-APSLRRKTMCGTLDYLPPEMIEGRMHNE 200
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
             D W +G+L YE+L G PPF   +  +  ++IVK  L+ PA + + A  L+  LL+  P
Sbjct: 201 KVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRHNP 260
Query: 389 GKRLGAGPKGSEEIKSHKWFK 409
            +RL        ++ +H W +
Sbjct: 261 SERLPLA-----QVSAHPWVR 276

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  158 bits (400), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 154/261 (59%), Gaps = 9/261 (3%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I ++ +LK +G+G F +V   R   T +  A+K++ K ++   +  +  +  R I+  ++
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLN 71
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +V+L    +T+  LYLV+++ +GG +F  L  HG  +E  AR    +IVSAV + H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             I+HRDLK EN+LL AD ++ + DFG + +F    + ++  G+  Y APE+  GK ++ 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 329 -AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS+G++LY +++G  PF G N  ++++++++ K R+P ++S++  +LLK  L   
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILN 251
Query: 388 PGKRLGAGPKGS-EEIKSHKW 407
           P KR      G+ E+I   +W
Sbjct: 252 PSKR------GTLEQIMKDRW 266

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  158 bits (399), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 154/261 (59%), Gaps = 9/261 (3%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I ++ +LK +G+G F +V   R   T +  A+K++ K ++   +  +  +  R I+  ++
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLN 71
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +V+L    +T+  LYLV+++ +GG +F  L  HG  +E  AR    +IVSAV + H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             I+HRDLK EN+LL AD ++ + DFG + +F    + ++  G+  Y APE+  GK ++ 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 329 -AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS+G++LY +++G  PF G N  ++++++++ K R+P ++S++  +LLK  L   
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILN 251
Query: 388 PGKRLGAGPKGS-EEIKSHKW 407
           P KR      G+ E+I   +W
Sbjct: 252 PSKR------GTLEQIMKDRW 266

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  157 bits (398), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 154/261 (59%), Gaps = 9/261 (3%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I ++ +LK +G+G F +V   R   T +  A+K++ K ++   +  +  +  R I+  ++
Sbjct: 6   IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLN 64
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +V+L    +T+  LYLV+++ +GG +F  L  HG  +E  AR    +IVSAV + H 
Sbjct: 65  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             I+HRDLK EN+LL AD ++ + DFG + +F    + ++  G+  Y APE+  GK ++ 
Sbjct: 125 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 184
Query: 329 -AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS+G++LY +++G  PF G N  ++++++++ K R+P ++S++  +LLK  L   
Sbjct: 185 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILN 244
Query: 388 PGKRLGAGPKGS-EEIKSHKW 407
           P KR      G+ E+I   +W
Sbjct: 245 PSKR------GTLEQIMKDRW 259

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  157 bits (398), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 94/296 (31%), Positives = 166/296 (56%), Gaps = 16/296 (5%)
Query: 139 GDSVTVCC---VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAE 195
           G+S+  C      I ++ +LK +G+G F +V   R   T    A+K++ K ++   +  +
Sbjct: 1   GNSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK 60
Query: 196 YMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY 255
             +  R I+  ++HP +V+L    +T+  LYL++++ +GG +F  L  HG  +E  AR  
Sbjct: 61  LFREVR-IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK 119
Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEY 315
             +IVSAV + H   I+HRDLK EN+LL AD ++ + DFG + +F    + ++  G   Y
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPY 179
Query: 316 MAPEIVLGKGHNK-AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSS 374
            APE+  GK ++    D WS+G++LY +++G  PF G N  ++++++++ K R+P ++S+
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239
Query: 375 EAHSLLKGLLQKEPGKRLGAGPKGS-EEIKSHKWFKPINWKKLEAREIQPGFCPEV 429
           +  +LLK  L   P KR      G+ E+I   +W    +    E  E++P   PE+
Sbjct: 240 DCENLLKRFLVLNPIKR------GTLEQIMKDRWINAGH----EEDELKPFVEPEL 285

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 154/261 (59%), Gaps = 9/261 (3%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I ++ +LK +G+G F +V   R   T +  A++++ K ++   +  +  +  R I+  ++
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVR-IMKVLN 71
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +V+L    +T+  LYLV+++ +GG +F  L  HG  +E  AR    +IVSAV + H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             I+HRDLK EN+LL AD ++ + DFG + +F    + ++  G+  Y APE+  GK ++ 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 329 -AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS+G++LY +++G  PF G N  ++++++++ K R+P ++S++  +LLK  L   
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILN 251
Query: 388 PGKRLGAGPKGS-EEIKSHKW 407
           P KR      G+ E+I   +W
Sbjct: 252 PSKR------GTLEQIMKDRW 266

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 153/261 (58%), Gaps = 9/261 (3%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I ++ +LK +G+G F +V   R   T +  A+K++ K ++   +  +  +  R I+  ++
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLN 71
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +V+L    +T+  LYLV+++ +GG +F  L  HG  +E  AR    +IVSAV + H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             I+HRDLK EN+LL AD ++ + DFG + +F    + ++  G   Y APE+  GK ++ 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 329 -AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS+G++LY +++G  PF G N  ++++++++ K R+P ++S++  +LLK  L   
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILN 251
Query: 388 PGKRLGAGPKGS-EEIKSHKW 407
           P KR      G+ E+I   +W
Sbjct: 252 PSKR------GTLEQIMKDRW 266

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 162/283 (57%), Gaps = 13/283 (4%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I ++ +LK +G+G F +V   R   T    A+K++ K ++   +  +  +  R I+  ++
Sbjct: 11  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVR-IMKILN 69
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +V+L    +T+  LYL++++ +GG +F  L  HG  +E  AR    +IVSAV + H 
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             I+HRDLK EN+LL AD ++ + DFG + +F    + ++  G+  Y APE+  GK ++ 
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDG 189
Query: 329 -AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS+G++LY +++G  PF G N  ++++++++ K R+P ++S++  +LLK  L   
Sbjct: 190 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLN 249
Query: 388 PGKRLGAGPKGS-EEIKSHKWFKPINWKKLEAREIQPGFCPEV 429
           P KR      G+ E+I   +W    +    E  E++P   PE+
Sbjct: 250 PIKR------GTLEQIMKDRWINAGH----EEDELKPFVEPEL 282

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 153/261 (58%), Gaps = 9/261 (3%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I ++ +LK +G+G F +V   R   T +  A++++ K ++   +  +  +  R I+  ++
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVR-IMKVLN 71
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +V+L    +T+  LYLV+++ +GG +F  L  HG  +E  AR    +IVSAV + H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             I+HRDLK EN+LL AD ++ + DFG + +F    + +   G+  Y APE+  GK ++ 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDG 191
Query: 329 -AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS+G++LY +++G  PF G N  ++++++++ K R+P ++S++  +LLK  L   
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILN 251
Query: 388 PGKRLGAGPKGS-EEIKSHKW 407
           P KR      G+ E+I   +W
Sbjct: 252 PSKR------GTLEQIMKDRW 266

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  155 bits (393), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 148/264 (56%), Gaps = 14/264 (5%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           ++   V+G GAF  V     K T ++ A+K + K+ +  K  +  M+ E  +L KI HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS--MENEIAVLHKIKHPN 77
Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           +V L   +++   LYL++  ++GG LF ++   G + E  A     +++ AV +LH  GI
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 272 MHRDLKPENIL---LGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           +HRDLKPEN+L   L  D  +M++DFGL+K  D  +  ++  GT  Y+APE++  K ++K
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSLLKGLL 384
           A D WS+G++ Y +L G PPF   N AK+ ++I+K +     P +  +S  A   ++ L+
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 257
Query: 385 QKEPGKRLGAGPKGSEEIKSHKWF 408
           +K+P KR        E+   H W 
Sbjct: 258 EKDPEKRFTC-----EQALQHPWI 276

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 91/262 (34%), Positives = 151/262 (57%), Gaps = 15/262 (5%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           +V+G+G+FG V   + K T +  A+KV+ K ++ +K   E +  E  +L ++DHP +++L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE-DLARIYAAEIVSAVSHLHANGIMHR 274
              F+ K   YLV +   GG LF ++     F E D ARI   +++S ++++H N I+HR
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSGITYMHKNKIVHR 150
Query: 275 DLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           DLKPEN+LL +   D ++ + DFGL+  F+ + +    IGT  Y+APE++ G  +++  D
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCD 209
Query: 332 WWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPAF--LSSEAHSLLKGLLQKE 387
            WS G++LY +L+G PPF G N   I +K+ K K    LP +  +S  A  L++ +L   
Sbjct: 210 VWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV 269
Query: 388 PGKRLGAGPKGSEEIKSHKWFK 409
           P  R+ A      +   H+W +
Sbjct: 270 PSMRISA-----RDALDHEWIQ 286

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  155 bits (391), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 148/263 (56%), Gaps = 14/263 (5%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           ++   V+G GAF  V     K T ++ A+K + K+ +  K  +  M+ E  +L KI HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS--MENEIAVLHKIKHPN 77
Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           +V L   +++   LYL++  ++GG LF ++   G + E  A     +++ AV +LH  GI
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 272 MHRDLKPENIL---LGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           +HRDLKPEN+L   L  D  +M++DFGL+K  D  +  ++  GT  Y+APE++  K ++K
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSLLKGLL 384
           A D WS+G++ Y +L G PPF   N AK+ ++I+K +     P +  +S  A   ++ L+
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 257
Query: 385 QKEPGKRLGAGPKGSEEIKSHKW 407
           +K+P KR        E+   H W
Sbjct: 258 EKDPEKRFTC-----EQALQHPW 275

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  155 bits (391), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 91/262 (34%), Positives = 151/262 (57%), Gaps = 15/262 (5%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           +V+G+G+FG V   + K T +  A+KV+ K ++ +K   E +  E  +L ++DHP +++L
Sbjct: 55  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE-DLARIYAAEIVSAVSHLHANGIMHR 274
              F+ K   YLV +   GG LF ++     F E D ARI   +++S ++++H N I+HR
Sbjct: 115 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSGITYMHKNKIVHR 173
Query: 275 DLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           DLKPEN+LL +   D ++ + DFGL+  F+ + +    IGT  Y+APE++ G  +++  D
Sbjct: 174 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCD 232
Query: 332 WWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPAF--LSSEAHSLLKGLLQKE 387
            WS G++LY +L+G PPF G N   I +K+ K K    LP +  +S  A  L++ +L   
Sbjct: 233 VWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV 292
Query: 388 PGKRLGAGPKGSEEIKSHKWFK 409
           P  R+ A      +   H+W +
Sbjct: 293 PSMRISA-----RDALDHEWIQ 309

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 91/262 (34%), Positives = 151/262 (57%), Gaps = 15/262 (5%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           +V+G+G+FG V   + K T +  A+KV+ K ++ +K   E +  E  +L ++DHP +++L
Sbjct: 56  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE-DLARIYAAEIVSAVSHLHANGIMHR 274
              F+ K   YLV +   GG LF ++     F E D ARI   +++S ++++H N I+HR
Sbjct: 116 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSGITYMHKNKIVHR 174
Query: 275 DLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           DLKPEN+LL +   D ++ + DFGL+  F+ + +    IGT  Y+APE++ G  +++  D
Sbjct: 175 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCD 233
Query: 332 WWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPAF--LSSEAHSLLKGLLQKE 387
            WS G++LY +L+G PPF G N   I +K+ K K    LP +  +S  A  L++ +L   
Sbjct: 234 VWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV 293
Query: 388 PGKRLGAGPKGSEEIKSHKWFK 409
           P  R+ A      +   H+W +
Sbjct: 294 PSMRISA-----RDALDHEWIQ 310

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  154 bits (390), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 148/263 (56%), Gaps = 14/263 (5%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           ++   V+G GAF  V     K T ++ A+K + K+ +  K  +  M+ E  +L KI HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS--MENEIAVLHKIKHPN 77
Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           +V L   +++   LYL++  ++GG LF ++   G + E  A     +++ AV +LH  GI
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 272 MHRDLKPENIL---LGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           +HRDLKPEN+L   L  D  +M++DFGL+K  D  +  ++  GT  Y+APE++  K ++K
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSLLKGLL 384
           A D WS+G++ Y +L G PPF   N AK+ ++I+K +     P +  +S  A   ++ L+
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 257
Query: 385 QKEPGKRLGAGPKGSEEIKSHKW 407
           +K+P KR        E+   H W
Sbjct: 258 EKDPEKRFTC-----EQALQHPW 275

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 150/261 (57%), Gaps = 9/261 (3%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I ++ +LK +G+G F +V   R   T +  A+K++ K ++   +  +  +  R I   ++
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IXKVLN 71
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +V+L    +T+  LYLV ++ +GG +F  L  HG  +E  AR    +IVSAV + H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQ 131
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             I+HRDLK EN+LL AD ++ + DFG + +F    + ++  G   Y APE+  GK ++ 
Sbjct: 132 KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 329 -AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS+G++LY +++G  PF G N  ++++++++ K R+P + S++  +LLK  L   
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLKKFLILN 251
Query: 388 PGKRLGAGPKGS-EEIKSHKW 407
           P KR      G+ E+I   +W
Sbjct: 252 PSKR------GTLEQIXKDRW 266

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 91/262 (34%), Positives = 150/262 (57%), Gaps = 15/262 (5%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           +V+G+G+FG V   + K T +  A+KV+ K ++ +K   E +  E  +L ++DHP +++L
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE-DLARIYAAEIVSAVSHLHANGIMHR 274
              F+ K   YLV +   GG LF ++     F E D ARI   +++S ++++H N I+HR
Sbjct: 98  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSGITYMHKNKIVHR 156
Query: 275 DLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           DLKPEN+LL     D ++ + DFGL+  F+ + +    IGT  Y+APE++ G  +++  D
Sbjct: 157 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCD 215
Query: 332 WWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPAF--LSSEAHSLLKGLLQKE 387
            WS G++LY +L+G PPF G N   I +K+ K K    LP +  +S  A  L++ +L   
Sbjct: 216 VWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV 275
Query: 388 PGKRLGAGPKGSEEIKSHKWFK 409
           P  R+ A      +   H+W +
Sbjct: 276 PSMRISA-----RDALDHEWIQ 292

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           ++   V+G GAF  V     K T ++ A+K + K  +  K  +  M+ E  +L KI HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS--MENEIAVLHKIKHPN 77
Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           +V L   +++   LYL++  ++GG LF ++   G + E  A     +++ AV +LH  GI
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 272 MHRDLKPENIL---LGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           +HRDLKPEN+L   L  D  +M++DFGL+K  D  +  ++  GT  Y+APE++  K ++K
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSLLKGLL 384
           A D WS+G++ Y +L G PPF   N AK+ ++I+K +     P +  +S  A   ++ L+
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 257
Query: 385 QKEPGKRLGAGPKGSEEIKSHKWF 408
           +K+P KR        E+   H W 
Sbjct: 258 EKDPEKRFTC-----EQALQHPWI 276

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 91/262 (34%), Positives = 148/262 (56%), Gaps = 15/262 (5%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           +V+G+G+FG V   + K T +  A+KV+ K ++ +K   E +  E  +L ++DHP + +L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE-DLARIYAAEIVSAVSHLHANGIMHR 274
              F+ K   YLV +   GG LF ++     F E D ARI   +++S +++ H N I+HR
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSGITYXHKNKIVHR 150
Query: 275 DLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           DLKPEN+LL +   D ++ + DFGL+  F+ + +    IGT  Y+APE++ G  +++  D
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT-YDEKCD 209
Query: 332 WWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPAF--LSSEAHSLLKGLLQKE 387
            WS G++LY +L+G PPF G N   I +K+ K K    LP +  +S  A  L++  L   
Sbjct: 210 VWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKXLTYV 269
Query: 388 PGKRLGAGPKGSEEIKSHKWFK 409
           P  R+ A      +   H+W +
Sbjct: 270 PSXRISA-----RDALDHEWIQ 286

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 151/268 (56%), Gaps = 14/268 (5%)
Query: 148 GIED-FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           G+ D ++ +K +G GA+G V   + K T    A+K+++K  +   +++  +  E  +L +
Sbjct: 18  GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 77
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           +DHP +++L   F+ K   YLV++   GG LF ++     F E  A +   +++S  ++L
Sbjct: 78  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 137
Query: 267 HANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG 323
           H + I+HRDLKPEN+LL +   D  + + DFGL+  F+   +    +GT  Y+APE VL 
Sbjct: 138 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE-VLR 196
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSL 379
           K +++  D WS G++LY +L G PPF G    +I +++ K K     P +  +S EA  L
Sbjct: 197 KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQL 256
Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKW 407
           +K +L  EP KR+ A     EE  +H W
Sbjct: 257 VKLMLTYEPSKRISA-----EEALNHPW 279

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 99/322 (30%), Positives = 167/322 (51%), Gaps = 15/322 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E ++ +K +G GA+G V   R K T    A+K++RK  +   ++++ ++ E  +L  +DH
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-EVAVLKLLDH 95
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +++L   F+ K   YLV++   GG LF ++ H   F E  A +   +++S V++LH +
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 270 GIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
            I+HRDLKPEN+LL +   D  + + DFGL+  F+   +    +GT  Y+APE VL K +
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE-VLRKKY 214
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKG 382
           ++  D WS+G++L+ +L G PPF G    +I +K+ K K    +     +S  A  L+K 
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274
Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKW 442
           +LQ +  +R+ A     ++   H W K +  KK    E+ P     +       N +K  
Sbjct: 275 MLQFDSQRRISA-----QQALEHPWIKEMCSKKESGIEL-PSLANAIENMRKFQNSQKLA 328
Query: 443 TDMPLSDSPAATPKNNTNPFAD 464
               L  +   T +  T    D
Sbjct: 329 QAALLYMASKLTSQEETKELTD 350

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 151/268 (56%), Gaps = 14/268 (5%)
Query: 148 GIED-FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           G+ D ++ +K +G GA+G V   + K T    A+K+++K  +   +++  +  E  +L +
Sbjct: 1   GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 60
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           +DHP +++L   F+ K   YLV++   GG LF ++     F E  A +   +++S  ++L
Sbjct: 61  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 120
Query: 267 HANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG 323
           H + I+HRDLKPEN+LL +   D  + + DFGL+  F+   +    +GT  Y+APE VL 
Sbjct: 121 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE-VLR 179
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSL 379
           K +++  D WS G++LY +L G PPF G    +I +++ K K     P +  +S EA  L
Sbjct: 180 KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQL 239
Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKW 407
           +K +L  EP KR+ A     EE  +H W
Sbjct: 240 VKLMLTYEPSKRISA-----EEALNHPW 262

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/253 (33%), Positives = 148/253 (58%), Gaps = 11/253 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E + ++ ++G+G+FG V + + + T + YA+KV+ K     K+ +  ++ E ++L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE-DLARIYAAEIVSAVSHLHA 268
           P +++L    +     Y+V +   GG LF ++     F E D ARI   ++ S ++++H 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSGITYMHK 139
Query: 269 NGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
           + I+HRDLKPENILL +   D  + + DFGL+  F +NT+    IGT  Y+APE++ G  
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT- 198
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPAF--LSSEAHSLLK 381
           +++  D WS G++LY +L+G PPF G N   I +++   K    LP +  +S +A  L++
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 382 GLLQKEPGKRLGA 394
            +L   P  R+ A
Sbjct: 259 KMLTFHPSLRITA 271

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/253 (33%), Positives = 148/253 (58%), Gaps = 11/253 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E + ++ ++G+G+FG V + + + T + YA+KV+ K     K+ +  ++ E ++L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE-DLARIYAAEIVSAVSHLHA 268
           P +++L    +     Y+V +   GG LF ++     F E D ARI   ++ S ++++H 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSGITYMHK 139
Query: 269 NGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
           + I+HRDLKPENILL +   D  + + DFGL+  F +NT+    IGT  Y+APE++ G  
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT- 198
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPAF--LSSEAHSLLK 381
           +++  D WS G++LY +L+G PPF G N   I +++   K    LP +  +S +A  L++
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 382 GLLQKEPGKRLGA 394
            +L   P  R+ A
Sbjct: 259 KMLTFHPSLRITA 271

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/253 (33%), Positives = 148/253 (58%), Gaps = 11/253 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E + ++ ++G+G+FG V + + + T + YA+KV+ K     K+ +  ++ E ++L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE-DLARIYAAEIVSAVSHLHA 268
           P +++L    +     Y+V +   GG LF ++     F E D ARI   ++ S ++++H 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSGITYMHK 139
Query: 269 NGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
           + I+HRDLKPENILL +   D  + + DFGL+  F +NT+    IGT  Y+APE++ G  
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT- 198
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPAF--LSSEAHSLLK 381
           +++  D WS G++LY +L+G PPF G N   I +++   K    LP +  +S +A  L++
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 382 GLLQKEPGKRLGA 394
            +L   P  R+ A
Sbjct: 259 KMLTFHPSLRITA 271

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 147/263 (55%), Gaps = 14/263 (5%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           FE  + +G GAF  V    +K T +++A+K + K  +  K     ++ E  +L KI H  
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL--KGKESSIENEIAVLRKIKHEN 81
Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           +V L+  +++   LYLV+  ++GG LF ++   G + E  A     +++ AV +LH  GI
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 272 MHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           +HRDLKPEN+L  +   +  +M++DFGL+K   +    ++  GT  Y+APE++  K ++K
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSK 201
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSLLKGLL 384
           A D WS+G++ Y +L G PPF   N +K+ ++I+K +     P +  +S  A   ++ L+
Sbjct: 202 AVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLM 261
Query: 385 QKEPGKRLGAGPKGSEEIKSHKW 407
           +K+P KR        E+   H W
Sbjct: 262 EKDPNKRYTC-----EQAARHPW 279

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 87/262 (33%), Positives = 152/262 (58%), Gaps = 9/262 (3%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I ++ + K +G+G F +V   R   T    A+K++ K ++   +  +  +  R I+  ++
Sbjct: 14  IGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVR-IMKILN 72
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +V+L    +T+  LYLV+++ +GG +F  L  HG  +E  AR    +IVSAV + H 
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             I+HRDLK EN+LL  D ++ + DFG + +F    + ++  G+  Y APE+  GK ++ 
Sbjct: 133 KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDG 192
Query: 329 -AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS+G++LY +++G  PF G N  ++++++++ K R+P ++S++  +LLK LL   
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKLLVLN 252
Query: 388 PGKRLGAGPKGS-EEIKSHKWF 408
           P KR      GS E+I   +W 
Sbjct: 253 PIKR------GSLEQIMKDRWM 268

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 140/251 (55%), Gaps = 4/251 (1%)
Query: 146 CVG--IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI 203
           C+G  IEDF+V  ++G+G+F  VY+    +T    A+K++ K  + +    + ++ E  I
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSA 262
             ++ HP +++L   F+    +YLVL+  + G +   L +    F E+ AR +  +I++ 
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIV 321
           + +LH++GI+HRDL   N+LL  + ++ + DFGLA Q    + +  ++ GT  Y++PEI 
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184
Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLK 381
               H   +D WS+G + Y +L G+PPF          K+V     +P+FLS EA  L+ 
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH 244
Query: 382 GLLQKEPGKRL 392
            LL++ P  RL
Sbjct: 245 QLLRRNPADRL 255

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 99/282 (35%), Positives = 150/282 (53%), Gaps = 26/282 (9%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK-----------DKIVEKNHAE 195
           +G   F+V K+ G GA+G V   ++KN     A+KV++K           +K +EK H E
Sbjct: 34  IGESYFKVRKL-GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 196 YMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY 255
            +  E  +L  +DHP +++L   F+ K   YLV +F  GG LF Q+ +   F E  A   
Sbjct: 93  -IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151
Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADG---HVMLTDFGLAKQFDENTRSNSMIGT 312
             +I+S + +LH + I+HRD+KPENILL       ++ + DFGL+  F ++ +    +GT
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP--- 369
             Y+APE VL K +N+  D WS G+++Y +L G PPF G N   I +K+ K K       
Sbjct: 212 AYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270
Query: 370 -AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP 410
              +S EA  L+K +L  +  KR  A     EE  + +W K 
Sbjct: 271 WKNISDEAKELIKLMLTYDYNKRCTA-----EEALNSRWIKK 307

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 90/282 (31%), Positives = 158/282 (56%), Gaps = 22/282 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-----EKNHAEYMKAERDIL 204
           +++ + K +G GA G V    ++ T +  A+K++ K K       E + A  ++ E +IL
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            K++HP ++++K  F  +   Y+VL+ + GG LF ++  +   +E   ++Y  +++ AV 
Sbjct: 69  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 265 HLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           +LH NGI+HRDLKPEN+LL +   D  + +TDFG +K   E +   ++ GT  Y+APE++
Sbjct: 128 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 187
Query: 322 LG---KGHNKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDKLR-LP---AFLS 373
           +     G+N+A D WS+G++L+  L+G PPF     +  ++ +I   K   +P   A +S
Sbjct: 188 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 247
Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK 415
            +A  L+K LL  +P  R       +EE   H W +  + K+
Sbjct: 248 EKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKR 284

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 90/282 (31%), Positives = 158/282 (56%), Gaps = 22/282 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-----EKNHAEYMKAERDIL 204
           +++ + K +G GA G V    ++ T +  A+K++ K K       E + A  ++ E +IL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            K++HP ++++K  F  +   Y+VL+ + GG LF ++  +   +E   ++Y  +++ AV 
Sbjct: 70  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 265 HLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           +LH NGI+HRDLKPEN+LL +   D  + +TDFG +K   E +   ++ GT  Y+APE++
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 322 LG---KGHNKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDKLR-LP---AFLS 373
           +     G+N+A D WS+G++L+  L+G PPF     +  ++ +I   K   +P   A +S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK 415
            +A  L+K LL  +P  R       +EE   H W +  + K+
Sbjct: 249 EKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKR 285

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 90/282 (31%), Positives = 158/282 (56%), Gaps = 22/282 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-----EKNHAEYMKAERDIL 204
           +++ + K +G GA G V    ++ T +  A+K++ K K       E + A  ++ E +IL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            K++HP ++++K  F  +   Y+VL+ + GG LF ++  +   +E   ++Y  +++ AV 
Sbjct: 70  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 265 HLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           +LH NGI+HRDLKPEN+LL +   D  + +TDFG +K   E +   ++ GT  Y+APE++
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 322 LG---KGHNKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDKLR-LP---AFLS 373
           +     G+N+A D WS+G++L+  L+G PPF     +  ++ +I   K   +P   A +S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK 415
            +A  L+K LL  +P  R       +EE   H W +  + K+
Sbjct: 249 EKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKR 285

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 90/282 (31%), Positives = 158/282 (56%), Gaps = 22/282 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-----EKNHAEYMKAERDIL 204
           +++ + K +G GA G V    ++ T +  A+K++ K K       E + A  ++ E +IL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            K++HP ++++K  F  +   Y+VL+ + GG LF ++  +   +E   ++Y  +++ AV 
Sbjct: 70  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 265 HLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           +LH NGI+HRDLKPEN+LL +   D  + +TDFG +K   E +   ++ GT  Y+APE++
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 322 LG---KGHNKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDKLR-LP---AFLS 373
           +     G+N+A D WS+G++L+  L+G PPF     +  ++ +I   K   +P   A +S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK 415
            +A  L+K LL  +P  R       +EE   H W +  + K+
Sbjct: 249 EKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKR 285

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 90/282 (31%), Positives = 158/282 (56%), Gaps = 22/282 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-----EKNHAEYMKAERDIL 204
           +++ + K +G GA G V    ++ T +  A+K++ K K       E + A  ++ E +IL
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            K++HP ++++K  F  +   Y+VL+ + GG LF ++  +   +E   ++Y  +++ AV 
Sbjct: 76  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 265 HLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           +LH NGI+HRDLKPEN+LL +   D  + +TDFG +K   E +   ++ GT  Y+APE++
Sbjct: 135 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 194
Query: 322 LG---KGHNKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDKLR-LP---AFLS 373
           +     G+N+A D WS+G++L+  L+G PPF     +  ++ +I   K   +P   A +S
Sbjct: 195 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 254
Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK 415
            +A  L+K LL  +P  R       +EE   H W +  + K+
Sbjct: 255 EKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKR 291

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 158/282 (56%), Gaps = 22/282 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-----EKNHAEYMKAERDIL 204
           +++ + K +G GA G V    ++ T +  A++++ K K       E + A  ++ E +IL
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            K++HP ++++K  F  +   Y+VL+ + GG LF ++  +   +E   ++Y  +++ AV 
Sbjct: 209 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 265 HLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           +LH NGI+HRDLKPEN+LL +   D  + +TDFG +K   E +   ++ GT  Y+APE++
Sbjct: 268 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 327
Query: 322 LG---KGHNKAADWWSVGILLYEMLTGKPPFI-GGNRAKIQQKIVKDKLR-LP---AFLS 373
           +     G+N+A D WS+G++L+  L+G PPF     +  ++ +I   K   +P   A +S
Sbjct: 328 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 387
Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK 415
            +A  L+K LL  +P  R       +EE   H W +  + K+
Sbjct: 388 EKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKR 424

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  141 bits (356), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 158/282 (56%), Gaps = 22/282 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-----EKNHAEYMKAERDIL 204
           +++ + K +G GA G V    ++ T +  A++++ K K       E + A  ++ E +IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            K++HP ++++K  F  +   Y+VL+ + GG LF ++  +   +E   ++Y  +++ AV 
Sbjct: 195 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 265 HLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           +LH NGI+HRDLKPEN+LL +   D  + +TDFG +K   E +   ++ GT  Y+APE++
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313
Query: 322 LG---KGHNKAADWWSVGILLYEMLTGKPPFI-GGNRAKIQQKIVKDKLR-LP---AFLS 373
           +     G+N+A D WS+G++L+  L+G PPF     +  ++ +I   K   +P   A +S
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373
Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK 415
            +A  L+K LL  +P  R       +EE   H W +  + K+
Sbjct: 374 EKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKR 410

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/249 (34%), Positives = 141/249 (56%), Gaps = 13/249 (5%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           FEV   +G+GA   VY+ ++K T + YA+KV++K   V+K   + ++ E  +L ++ HP 
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDK---KIVRTEIGVLLRLSHPN 109
Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           +++LK  F+T   + LVL+ + GG LF ++   G + E  A     +I+ AV++LH NGI
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 272 MHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           +HRDLKPEN+L      D  + + DFGL+K  +      ++ GT  Y APEI+ G  +  
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGP 229
Query: 329 AADWWSVGILLYEMLTGKPPFIG--GNRAKIQQKIVKDKLRLPAF---LSSEAHSLLKGL 383
             D WSVGI+ Y +L G  PF    G++   ++ +  +   +  +   +S  A  L++ L
Sbjct: 230 EVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKL 289
Query: 384 LQKEPGKRL 392
           +  +P KRL
Sbjct: 290 IVLDPKKRL 298

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 88/270 (32%), Positives = 149/270 (55%), Gaps = 26/270 (9%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT--KIDH 209
           +E++K +G G FG    +R K ++E+ A+K + + + +++N       +R+I+    + H
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN------VKREIINHRSLRH 73
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +V+ K    T   L +V+++ +GG LF ++ + G F ED AR +  +++S VS+ HA 
Sbjct: 74  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 133
Query: 270 GIMHRDLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
            + HRDLK EN LL  DG     + + DFG +K    +++  S +GT  Y+APE++L K 
Sbjct: 134 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 191
Query: 326 HN-KAADWWSVGILLYEMLTGKPPFIG----GNRAKIQQKIVKDKLRLPAF--LSSEAHS 378
           ++ K AD WS G+ LY ML G  PF       N  K   +I+  +  +P +  +S E   
Sbjct: 192 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 251
Query: 379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
           L+  +   +P KR+        EI++H+WF
Sbjct: 252 LISRIFVADPAKRISI-----PEIRNHEWF 276

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 145/281 (51%), Gaps = 14/281 (4%)
Query: 135 ENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA 194
           EN+    +  C    +D+++ + +G+GAF  V +  KK  ++ YA K++   K+  ++H 
Sbjct: 16  ENLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ 75
Query: 195 EYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI 254
           + ++ E  I   + HP +V+L  S   +   YLV D + GG LF  +     + E  A  
Sbjct: 76  K-LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH 134
Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGAD---GHVMLTDFGLAKQFD-ENTRSNSMI 310
              +I+ +V+H+H + I+HRDLKPEN+LL +      V L DFGLA +   E        
Sbjct: 135 CIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA 194
Query: 311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA 370
           GT  Y++PE++    + K  D W+ G++LY +L G PPF   ++ K+ Q+I       P+
Sbjct: 195 GTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPS 254
Query: 371 ----FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKW 407
                ++ EA +L+  +L   P KR+ A     ++   H W
Sbjct: 255 PEWDTVTPEAKNLINQMLTINPAKRITA-----DQALKHPW 290

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 88/270 (32%), Positives = 147/270 (54%), Gaps = 26/270 (9%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT--KIDH 209
           +E++K +G G FG    +R K ++E+ A+K + + + +  N       +R+I+    + H
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAAN------VKREIINHRSLRH 74
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +V+ K    T   L +V+++ +GG LF ++ + G F ED AR +  +++S VS+ HA 
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 270 GIMHRDLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
            + HRDLK EN LL  DG     + + DFG +K    +++  S +GT  Y+APE++L K 
Sbjct: 135 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 326 HN-KAADWWSVGILLYEMLTGKPPFIG----GNRAKIQQKIVKDKLRLPAF--LSSEAHS 378
           ++ K AD WS G+ LY ML G  PF       N  K   +I+  +  +P +  +S E   
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
           L+  +   +P KR+        EI++H+WF
Sbjct: 253 LISRIFVADPAKRISI-----PEIRNHEWF 277

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 88/270 (32%), Positives = 148/270 (54%), Gaps = 26/270 (9%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT--KIDH 209
           +E++K +G G FG    +R K  +E+ A+K + + + +++N       +R+I+    + H
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDEN------VKREIINHRSLRH 74
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +V+ K    T   L +V+++ +GG LF ++ + G F ED AR +  +++S VS+ HA 
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAM 134
Query: 270 GIMHRDLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
            + HRDLK EN LL  DG     + + DFG +K    +++  S +GT  Y+APE++L K 
Sbjct: 135 QVAHRDLKLENTLL--DGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKE 192
Query: 326 HN-KAADWWSVGILLYEMLTGKPPFIG----GNRAKIQQKIVKDKLRLPAF--LSSEAHS 378
           ++ K AD WS G+ LY ML G  PF       N  K   +I+  +  +P +  +S E   
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
           L+  +   +P KR+        EI++H+WF
Sbjct: 253 LISRIFVADPAKRISI-----PEIRNHEWF 277

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 140/254 (55%), Gaps = 12/254 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD--ILTKI 207
           ++++V + +G+GAF  V +   K T   +A K++   K+  ++   + K ER+  I  K+
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKL 62
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +V+L  S Q +   YLV D + GG LF  +     + E  A     +I+ ++++ H
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 268 ANGIMHRDLKPENILLGADGH---VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGK 324
           +NGI+HR+LKPEN+LL +      V L DFGLA + +++   +   GT  Y++PE++   
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLL 380
            ++K  D W+ G++LY +L G PPF   ++ ++  +I       P+     ++ EA SL+
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242
Query: 381 KGLLQKEPGKRLGA 394
             +L   P KR+ A
Sbjct: 243 DSMLTVNPKKRITA 256

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 140/254 (55%), Gaps = 12/254 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD--ILTKI 207
           ++++V + +G+GAF  V +   K T   +A K++   K+  ++   + K ER+  I  K+
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKL 61
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +V+L  S Q +   YLV D + GG LF  +     + E  A     +I+ ++++ H
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 121
Query: 268 ANGIMHRDLKPENILLGADGH---VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGK 324
           +NGI+HR+LKPEN+LL +      V L DFGLA + +++   +   GT  Y++PE++   
Sbjct: 122 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 181
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLL 380
            ++K  D W+ G++LY +L G PPF   ++ ++  +I       P+     ++ EA SL+
Sbjct: 182 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 241
Query: 381 KGLLQKEPGKRLGA 394
             +L   P KR+ A
Sbjct: 242 DSMLTVNPKKRITA 255

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 93/331 (28%), Positives = 159/331 (48%), Gaps = 21/331 (6%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E +  L+ +G+G+FG+   V+       Y +K +   ++  K   E  + E  +L  + 
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE-SRREVAVLANMK 81
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHL 266
           HP +VQ + SF+    LY+V+D+  GG LF ++      LF+ED    +  +I  A+ H+
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-SNSMIGTVEYMAPEIVLGKG 325
           H   I+HRD+K +NI L  DG V L DFG+A+  +     + + IGT  Y++PEI   K 
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLLKGLL 384
           +N  +D W++G +LYE+ T K  F  G+   +  KI+      +    S +  SL+  L 
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261
Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPE-VAGKHCIANFEKKWT 443
           ++ P  R                   I  K   A+ I+    P+ +A + C+  F  K+ 
Sbjct: 262 KRNPRDRPSVN--------------SILEKGFIAKRIEKFLSPQLIAEEFCLKTFS-KFG 306
Query: 444 DMPLSDSPAATPKNNTNPFADFSYVRPAASF 474
             P+     A+ +N+ +        +PAA +
Sbjct: 307 SQPIPAKRPASGQNSISVMPAQKITKPAAKY 337

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 140/254 (55%), Gaps = 12/254 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD--ILTKI 207
           ++++V + +G+GAF  V +   K T   +A K++   K+  ++   + K ER+  I  K+
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKL 62
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +V+L  S Q +   YLV D + GG LF  +     + E  A     +I+ ++++ H
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 268 ANGIMHRDLKPENILLGADGH---VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGK 324
           +NGI+HR+LKPEN+LL +      V L DFGLA + +++   +   GT  Y++PE++   
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLL 380
            ++K  D W+ G++LY +L G PPF   ++ ++  +I       P+     ++ EA SL+
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242
Query: 381 KGLLQKEPGKRLGA 394
             +L   P KR+ A
Sbjct: 243 DSMLTVNPKKRITA 256

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 148/270 (54%), Gaps = 26/270 (9%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT--KIDH 209
           +E++K +G G FG    +R K ++E+ A+K + + + +++N       +R+I+    + H
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN------VKREIINHRSLRH 74
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +V+ K    T   L +V+++ +GG LF ++ + G F ED AR +  +++S VS+ HA 
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 270 GIMHRDLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
            + HRDLK EN LL  DG     + +  FG +K    +++  S +GT  Y+APE++L K 
Sbjct: 135 QVCHRDLKLENTLL--DGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 326 HN-KAADWWSVGILLYEMLTGKPPFIG----GNRAKIQQKIVKDKLRLPAF--LSSEAHS 378
           ++ K AD WS G+ LY ML G  PF       N  K   +I+  +  +P +  +S E   
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
           L+  +   +P KR+        EI++H+WF
Sbjct: 253 LISRIFVADPAKRISI-----PEIRNHEWF 277

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 140/254 (55%), Gaps = 12/254 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD--ILTKI 207
           ++++V + +G+GAF  V +   K T   +A K++   K+  +   ++ K ER+  I  K+
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREARICRKL 85
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +V+L  S Q +   YLV D + GG LF  +     + E  A     +I+ ++++ H
Sbjct: 86  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 145
Query: 268 ANGIMHRDLKPENILLGADGH---VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGK 324
           +NGI+HR+LKPEN+LL +      V L DFGLA + +++   +   GT  Y++PE++   
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLL 380
            ++K  D W+ G++LY +L G PPF   ++ ++  +I       P+     ++ EA SL+
Sbjct: 206 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 265
Query: 381 KGLLQKEPGKRLGA 394
             +L   P KR+ A
Sbjct: 266 DSMLTVNPKKRITA 279

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 142/267 (53%), Gaps = 14/267 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +++++ + +G+GAF  V +  K  T + YA K++   K+  ++H + ++ E  I   + H
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDH-QKLEREARICRLLKH 62
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +V+L  S   +   YLV D + GG LF  +     + E  A     +I+ +V+H H N
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 270 GIMHRDLKPENILLGADGH---VMLTDFGLAKQFDENTRS-NSMIGTVEYMAPEIVLGKG 325
           GI+HRDLKPEN+LL +      V L DFGLA +   + ++     GT  Y++PE++    
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLK 381
           + K  D W+ G++LY +L G PPF   ++ ++ Q+I       P+     ++ EA  L+ 
Sbjct: 183 YGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF 408
            +L   P KR+ A    SE +K H W 
Sbjct: 243 KMLTINPAKRITA----SEALK-HPWI 264

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 142/267 (53%), Gaps = 14/267 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +++++ + +G+GAF  V +  K  T + YA K++   K+  ++H + ++ E  I   + H
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK-LEREARICRLLKH 62
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +V+L  S   +   YLV D + GG LF  +     + E  A     +I+ +V+H H N
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 270 GIMHRDLKPENILLGADGH---VMLTDFGLAKQFDENTRS-NSMIGTVEYMAPEIVLGKG 325
           GI+HRDLKPEN+LL +      V L DFGLA +   + ++     GT  Y++PE++    
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLK 381
           + K  D W+ G++LY +L G PPF   ++ ++ Q+I       P+     ++ EA  L+ 
Sbjct: 183 YGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF 408
            +L   P KR+ A    SE +K H W 
Sbjct: 243 KMLTINPAKRITA----SEALK-HPWI 264

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 126/237 (53%), Gaps = 1/237 (0%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           + +G+G F + Y++   +T E++A KV+ K  +++ +  E M  E  I   +D+P VV  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
              F+    +Y+VL+      L           E  AR +  + +  V +LH N ++HRD
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRD 167
Query: 276 LKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWS 334
           LK  N+ L  D  V + DFGLA + + +  R  ++ GT  Y+APE++  KGH+   D WS
Sbjct: 168 LKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWS 227
Query: 335 VGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           +G +LY +L GKPPF      +   +I K++  +P  ++  A +L++ +L  +P  R
Sbjct: 228 LGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLR 284

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 86/270 (31%), Positives = 147/270 (54%), Gaps = 26/270 (9%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT--KIDH 209
           +E++K +G G FG    +R K ++E+ A+K + + + +++N       +R+I+    + H
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN------VKREIINHRSLRH 74
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +V+ K    T   L +V+++ +GG LF ++ + G F ED AR +  +++S VS+ HA 
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 270 GIMHRDLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
            + HRDLK EN LL  DG     + +  FG +K    +++    +GT  Y+APE++L K 
Sbjct: 135 QVCHRDLKLENTLL--DGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKE 192
Query: 326 HN-KAADWWSVGILLYEMLTGKPPFIG----GNRAKIQQKIVKDKLRLPAF--LSSEAHS 378
           ++ K AD WS G+ LY ML G  PF       N  K   +I+  +  +P +  +S E   
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
           L+  +   +P KR+        EI++H+WF
Sbjct: 253 LISRIFVADPAKRISI-----PEIRNHEWF 277

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 139/264 (52%), Gaps = 24/264 (9%)
Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAE---YMKAERDILTKIDHPFVV 213
            +G+G++G V    +K T      ++ R  K + K   E     K E +I+  +DHP ++
Sbjct: 16  TIGRGSWGEVKIAVQKGT------RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE-DLARIYAAEIVSAVSHLHANGIM 272
           +L  +F+    +YLV++   GG LF ++ H  +FRE D ARI   +++SAV++ H   + 
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDVLSAVAYCHKLNVA 128
Query: 273 HRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKA 329
           HRDLKPEN L      D  + L DFGLA +F       + +GT  Y++P+++ G  +   
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPE 187
Query: 330 ADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKGLLQ 385
            D WS G+++Y +L G PPF      ++  KI +     P      +S +A SL++ LL 
Sbjct: 188 CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLT 247
Query: 386 KEPGKRLGAGPKGSEEIKSHKWFK 409
           K P +R+      S +   H+WF+
Sbjct: 248 KSPKQRI-----TSLQALEHEWFE 266

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 125/237 (52%), Gaps = 1/237 (0%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           + +G+G F + Y++   +T E++A KV+ K  +++ +  E M  E  I   +D+P VV  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
              F+    +Y+VL+      L           E  AR +  + +  V +LH N ++HRD
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRD 167
Query: 276 LKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWS 334
           LK  N+ L  D  V + DFGLA + + +  R   + GT  Y+APE++  KGH+   D WS
Sbjct: 168 LKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWS 227
Query: 335 VGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           +G +LY +L GKPPF      +   +I K++  +P  ++  A +L++ +L  +P  R
Sbjct: 228 LGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLR 284

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 139/264 (52%), Gaps = 24/264 (9%)
Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAE---YMKAERDILTKIDHPFVV 213
            +G+G++G V    +K T      ++ R  K + K   E     K E +I+  +DHP ++
Sbjct: 33  TIGRGSWGEVKIAVQKGT------RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE-DLARIYAAEIVSAVSHLHANGIM 272
           +L  +F+    +YLV++   GG LF ++ H  +FRE D ARI   +++SAV++ H   + 
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDVLSAVAYCHKLNVA 145
Query: 273 HRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKA 329
           HRDLKPEN L      D  + L DFGLA +F       + +GT  Y++P+++ G  +   
Sbjct: 146 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPE 204
Query: 330 ADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKGLLQ 385
            D WS G+++Y +L G PPF      ++  KI +     P      +S +A SL++ LL 
Sbjct: 205 CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLT 264
Query: 386 KEPGKRLGAGPKGSEEIKSHKWFK 409
           K P +R+      S +   H+WF+
Sbjct: 265 KSPKQRI-----TSLQALEHEWFE 283

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 125/237 (52%), Gaps = 1/237 (0%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           + +G+G F + Y++   +T E++A KV+ K  +++ +  E M  E  I   +D+P VV  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
              F+    +Y+VL+      L           E  AR +  + +  V +LH N ++HRD
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRD 167
Query: 276 LKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWS 334
           LK  N+ L  D  V + DFGLA + + +  R   + GT  Y+APE++  KGH+   D WS
Sbjct: 168 LKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWS 227
Query: 335 VGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           +G +LY +L GKPPF      +   +I K++  +P  ++  A +L++ +L  +P  R
Sbjct: 228 LGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLR 284

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 125/237 (52%), Gaps = 1/237 (0%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           + +G+G F + Y++   +T E++A KV+ K  +++ +  E M  E  I   +D+P VV  
Sbjct: 32  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 91
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
              F+    +Y+VL+      L           E  AR +  + +  V +LH N ++HRD
Sbjct: 92  HGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRD 151
Query: 276 LKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWS 334
           LK  N+ L  D  V + DFGLA + + +  R   + GT  Y+APE++  KGH+   D WS
Sbjct: 152 LKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWS 211
Query: 335 VGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           +G +LY +L GKPPF      +   +I K++  +P  ++  A +L++ +L  +P  R
Sbjct: 212 LGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLR 268

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 124/235 (52%), Gaps = 1/235 (0%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G F + +++   +T E++A K++ K  +++ +  E M  E  I   + H  VV    
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L           E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
             N+ L  D  V + DFGLA + + +  R  ++ GT  Y+APE++  KGH+   D WS+G
Sbjct: 149 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 208
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++Y +L GKPPF      +   +I K++  +P  ++  A SL++ +LQ +P  R
Sbjct: 209 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 263

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 124/235 (52%), Gaps = 1/235 (0%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G F + +++   +T E++A K++ K  +++ +  E M  E  I   + H  VV    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L           E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
             N+ L  D  V + DFGLA + + +  R  ++ GT  Y+APE++  KGH+   D WS+G
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++Y +L GKPPF      +   +I K++  +P  ++  A SL++ +LQ +P  R
Sbjct: 205 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 259

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 124/235 (52%), Gaps = 1/235 (0%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G F + +++   +T E++A K++ K  +++ +  E M  E  I   + H  VV    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L           E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
             N+ L  D  V + DFGLA + + +  R  ++ GT  Y+APE++  KGH+   D WS+G
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++Y +L GKPPF      +   +I K++  +P  ++  A SL++ +LQ +P  R
Sbjct: 205 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 259

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 86/270 (31%), Positives = 144/270 (53%), Gaps = 26/270 (9%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT--KIDH 209
           ++ +K +G G FG    +R K T E+ A+K + +   +++N       +R+I+    + H
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN------VQREIINHRSLRH 75
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +V+ K    T   L +++++ +GG L+ ++ + G F ED AR +  +++S VS+ H+ 
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135
Query: 270 GIMHRDLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
            I HRDLK EN LL  DG     + + DFG +K    +++  S +GT  Y+APE++L + 
Sbjct: 136 QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQE 193
Query: 326 HN-KAADWWSVGILLYEMLTGKPPFIG----GNRAKIQQKIVKDKLRLP--AFLSSEAHS 378
           ++ K AD WS G+ LY ML G  PF       +  K  Q+I+  K  +P    +S E   
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253
Query: 379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
           L+  +   +P  R+        EIK+H WF
Sbjct: 254 LISRIFVADPATRISI-----PEIKTHSWF 278

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 136/264 (51%), Gaps = 6/264 (2%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V I  + +   +G G FG+V     + T    A+K++ + KI   +    +K E   L  
Sbjct: 8   VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL 67
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HP +++L     T    ++V+++++GG LF  +  HG   E  AR    +I+SAV + 
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           H + ++HRDLKPEN+LL A  +  + DFGL+    +     +  G+  Y APE++ G+ +
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 327 -NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
                D WS G++LY +L G  PF   +   + +KI      +P +L+    +LL  +LQ
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQ 247
Query: 386 KEPGKRLGAGPKGSEEIKSHKWFK 409
            +P KR        ++I+ H+WFK
Sbjct: 248 VDPLKRATI-----KDIREHEWFK 266

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 132/254 (51%), Gaps = 6/254 (2%)
Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLK 216
            +G G FG+V   + + T    A+K++ + KI   +    ++ E   L    HP +++L 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDL 276
               T   +++V+++++GG LF  +  +G   E  +R    +I+S V + H + ++HRDL
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142
Query: 277 KPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH-NKAADWWSV 335
           KPEN+LL A  +  + DFGL+    +        G+  Y APE++ G+ +     D WS 
Sbjct: 143 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSS 202
Query: 336 GILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAG 395
           G++LY +L G  PF   +   + +KI       P +L+    SLLK +LQ +P KR    
Sbjct: 203 GVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATI- 261
Query: 396 PKGSEEIKSHKWFK 409
               ++I+ H+WFK
Sbjct: 262 ----KDIREHEWFK 271

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 135/264 (51%), Gaps = 6/264 (2%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V I  + +   +G G FG+V     + T    A+K++ + KI   +    +K E   L  
Sbjct: 8   VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL 67
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HP +++L     T    ++V+++++GG LF  +  HG   E  AR    +I+SAV + 
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           H + ++HRDLKPEN+LL A  +  + DFGL+    +        G+  Y APE++ G+ +
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLY 187
Query: 327 -NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
                D WS G++LY +L G  PF   +   + +KI      +P +L+    +LL  +LQ
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQ 247
Query: 386 KEPGKRLGAGPKGSEEIKSHKWFK 409
            +P KR        ++I+ H+WFK
Sbjct: 248 VDPLKRATI-----KDIREHEWFK 266

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 136/253 (53%), Gaps = 14/253 (5%)
Query: 150 EDF-EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           EDF E++  +G GAFG+VY+ + K TS + A KV+  D   E+   +YM  E DIL   D
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 92
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L  +F  +  L+++++F  GG +    L       E   ++   + + A+++LH
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGL-AKQFDENTRSNSMIGTVEYMAPEIVL---- 322
            N I+HRDLK  NIL   DG + L DFG+ AK      R +S IGT  +MAPE+V+    
Sbjct: 153 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 323 -GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHS 378
             + ++  AD WS+GI L EM   +PP    N  ++  KI K +   L  P+  SS    
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 272
Query: 379 LLKGLLQKEPGKR 391
            LK  L+K    R
Sbjct: 273 FLKKCLEKNVDAR 285

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 123/235 (52%), Gaps = 1/235 (0%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G F + +++   +T E++A K++ K  +++ +  E M  E  I   + H  VV    
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L           E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
             N+ L  D  V + DFGLA + + +  R   + GT  Y+APE++  KGH+   D WS+G
Sbjct: 167 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 226
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++Y +L GKPPF      +   +I K++  +P  ++  A SL++ +LQ +P  R
Sbjct: 227 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 281

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 136/253 (53%), Gaps = 14/253 (5%)
Query: 150 EDF-EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           EDF E++  +G GAFG+VY+ + K TS + A KV+  D   E+   +YM  E DIL   D
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 92
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L  +F  +  L+++++F  GG +    L       E   ++   + + A+++LH
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGL-AKQFDENTRSNSMIGTVEYMAPEIVL---- 322
            N I+HRDLK  NIL   DG + L DFG+ AK      R +S IGT  +MAPE+V+    
Sbjct: 153 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 323 -GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHS 378
             + ++  AD WS+GI L EM   +PP    N  ++  KI K +   L  P+  SS    
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 272
Query: 379 LLKGLLQKEPGKR 391
            LK  L+K    R
Sbjct: 273 FLKKCLEKNVDAR 285

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 123/235 (52%), Gaps = 1/235 (0%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G F + +++   +T E++A K++ K  +++ +  E M  E  I   + H  VV    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L           E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
             N+ L  D  V + DFGLA + + +  R   + GT  Y+APE++  KGH+   D WS+G
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 228
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++Y +L GKPPF      +   +I K++  +P  ++  A SL++ +LQ +P  R
Sbjct: 229 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 283

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 123/235 (52%), Gaps = 1/235 (0%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G F + +++   +T E++A K++ K  +++ +  E M  E  I   + H  VV    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L           E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
             N+ L  D  V + DFGLA + + +  R   + GT  Y+APE++  KGH+   D WS+G
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 202
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++Y +L GKPPF      +   +I K++  +P  ++  A SL++ +LQ +P  R
Sbjct: 203 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 257

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 147/272 (54%), Gaps = 20/272 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKN--HAEYMKAERDILTKIDH 209
           +E+ +V+G+GAF  V +   + T + +A+K++   K         E +K E  I   + H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG----LFREDLARIYAAEIVSAVSH 265
           P +V+L  ++ +   LY+V +F++G  L F++        ++ E +A  Y  +I+ A+ +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 266 LHANGIMHRDLKPENILLGADGH---VMLTDFGLAKQFDENTR-SNSMIGTVEYMAPEIV 321
            H N I+HRD+KPEN+LL +  +   V L DFG+A Q  E+   +   +GT  +MAPE+V
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAH 377
             + + K  D W  G++L+ +L+G  PF  G + ++ + I+K K ++     + +S  A 
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFY-GTKERLFEGIIKGKYKMNPRQWSHISESAK 264
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
            L++ +L  +P +R+        E  +H W K
Sbjct: 265 DLVRRMLMLDPAERITV-----YEALNHPWLK 291

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  132 bits (331), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 149/275 (54%), Gaps = 25/275 (9%)
Query: 149 IEDFEVLKV-VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D  + K  +G GAFG V+ V ++++     +K + KD+   +   E ++AE ++L  +
Sbjct: 20  IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSL 77
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEI----VSAV 263
           DHP ++++   F+  + +Y+V++   GG L  ++       + L+  Y AE+    ++A+
Sbjct: 78  DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 264 SHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
           ++ H+  ++H+DLKPENIL         + + DFGLA+ F  +  S +  GT  YMAPE 
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE- 196
Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF------LSS 374
           V  +      D WS G+++Y +LTG  PF G +  ++QQK      + P +      L+ 
Sbjct: 197 VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT---YKEPNYAVECRPLTP 253
Query: 375 EAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           +A  LLK +L K+P +R  A      ++  H+WFK
Sbjct: 254 QAVDLLKQMLTKDPERRPSAA-----QVLHHEWFK 283

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 91/253 (35%), Positives = 135/253 (53%), Gaps = 14/253 (5%)
Query: 150 EDF-EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           EDF E++  +G GAFG+VY+ + K TS + A KV+  D   E+   +YM  E DIL   D
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 92
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L  +F  +  L+++++F  GG +    L       E   ++   + + A+++LH
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGL-AKQFDENTRSNSMIGTVEYMAPEIVL---- 322
            N I+HRDLK  NIL   DG + L DFG+ AK      R +  IGT  +MAPE+V+    
Sbjct: 153 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETS 212
Query: 323 -GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHS 378
             + ++  AD WS+GI L EM   +PP    N  ++  KI K +   L  P+  SS    
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 272
Query: 379 LLKGLLQKEPGKR 391
            LK  L+K    R
Sbjct: 273 FLKKCLEKNVDAR 285

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 82/266 (30%), Positives = 137/266 (51%), Gaps = 14/266 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +++++ + +G+GAF  V +  K  T   YA K++   K+  ++H + ++ E  I   + H
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQK-LEREARICRLLKH 62
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
             +V+L  S   +   YLV D + GG LF  +     + E  A     +I+ AV H H  
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 122
Query: 270 GIMHRDLKPENILLGAD---GHVMLTDFGLAKQFDENTRS-NSMIGTVEYMAPEIVLGKG 325
           G++HRDLKPEN+LL +      V L DFGLA +   + ++     GT  Y++PE++  + 
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEA 182
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLK 381
           + K  D W+ G++LY +L G PPF   ++ K+ Q+I       P+     ++ EA +L+ 
Sbjct: 183 YGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 242
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKW 407
            +L   P KR+ A      E   H W
Sbjct: 243 QMLTINPAKRITA-----HEALKHPW 263

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 136/276 (49%), Gaps = 14/276 (5%)
Query: 141 SVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAE 200
           +   C    E++++ + +G+GAF  V +  K    + YA  ++   K+  ++H + ++ E
Sbjct: 2   ATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LERE 60
Query: 201 RDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIV 260
             I   + HP +V+L  S   +   YL+ D + GG LF  +     + E  A     +I+
Sbjct: 61  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL 120
Query: 261 SAVSHLHANGIMHRDLKPENILLGAD---GHVMLTDFGLAKQFD-ENTRSNSMIGTVEYM 316
            AV H H  G++HR+LKPEN+LL +      V L DFGLA + + E        GT  Y+
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FL 372
           +PE++    + K  D W+ G++LY +L G PPF   ++ ++ Q+I       P+     +
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240
Query: 373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
           + EA  L+  +L   P KR+ A      E   H W 
Sbjct: 241 TPEAKDLINKMLTINPSKRITAA-----EALKHPWI 271

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 142/283 (50%), Gaps = 17/283 (6%)
Query: 149 IEDF-EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDIL 204
           +EDF ++ + +G G F  V + R+K+T   YA K ++K +          E ++ E  IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            ++ HP ++ L   ++ +  + L+L+ ++GG LF  L       E+ A  +  +I+  V+
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
           +LH   I H DLKPENI+L        H+ L DFGLA + ++     ++ GT E++APEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSE----A 376
           V  +     AD WS+G++ Y +L+G  PF+G  + +    I            S+    A
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR 419
              ++ LL KE  KRL       +E   H W  P++ ++   R
Sbjct: 250 KDFIRKLLVKETRKRLTI-----QEALRHPWITPVDTQQAMVR 287

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 133/265 (50%), Gaps = 14/265 (5%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +++ + +G+GAF  V +  K    + YA K++   K+  ++H + ++ E  I   + HP 
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQK-LEREARICRLLKHPN 82
Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           +V+L  S   +   YL+ D + GG LF  +     + E  A     +I+ AV H H  G+
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 272 MHRDLKPENILLGAD---GHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHN 327
           +HRDLKPEN+LL +      V L DFGLA + + E        GT  Y++PE++    + 
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYG 202
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKGL 383
           K  D W+ G++LY +L G PPF   ++ ++ Q+I       P+     ++ EA  L+  +
Sbjct: 203 KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKM 262
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWF 408
           L   P KR+ A      E   H W 
Sbjct: 263 LTINPSKRITAA-----EALKHPWI 282

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 82/252 (32%), Positives = 140/252 (55%), Gaps = 20/252 (7%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           K +G+G+F    +   K +++ +A+K++ K   +E N  + + A +  L +  HP +V+L
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALK--LCE-GHPNIVKL 71
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
              F  +   +LV++ +NGG LF ++     F E  A     ++VSAVSH+H  G++HRD
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 276 LKPENILLGADG---HVMLTDFGLAK-QFDENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           LKPEN+L   +     + + DFG A+ +  +N    +   T+ Y APE++   G++++ D
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCD 191
Query: 332 WWSVGILLYEMLTGKPPFIGGNRA-------KIQQKIVKDKLRLPA----FLSSEAHSLL 380
            WS+G++LY ML+G+ PF   +R+       +I +KI K            +S EA  L+
Sbjct: 192 LWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLI 251
Query: 381 KGLLQKEPGKRL 392
           +GLL  +P KRL
Sbjct: 252 QGLLTVDPNKRL 263

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 134/262 (51%), Gaps = 7/262 (2%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I +++++K +G+G+FG+V       T +  A+K++ K  + + +    ++ E   L  + 
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +++L    ++K  + +V+++  G  LF  +       E  AR +  +I+SAV + H 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 121
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH-N 327
           + I+HRDLKPEN+LL    +V + DFGL+    +     +  G+  Y APE++ GK +  
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS G++LY ML  + PF   +   + + I      LP FLS  A  L+K +L   
Sbjct: 182 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 241
Query: 388 PGKRLGAGPKGSEEIKSHKWFK 409
           P  R+        EI    WFK
Sbjct: 242 PLNRISI-----HEIMQDDWFK 258

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 134/262 (51%), Gaps = 7/262 (2%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I +++++K +G+G+FG+V       T +  A+K++ K  + + +    ++ E   L  + 
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +++L    ++K  + +V+++  G  LF  +       E  AR +  +I+SAV + H 
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 125
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH-N 327
           + I+HRDLKPEN+LL    +V + DFGL+    +     +  G+  Y APE++ GK +  
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS G++LY ML  + PF   +   + + I      LP FLS  A  L+K +L   
Sbjct: 186 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 245
Query: 388 PGKRLGAGPKGSEEIKSHKWFK 409
           P  R+        EI    WFK
Sbjct: 246 PLNRISI-----HEIMQDDWFK 262

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 134/262 (51%), Gaps = 7/262 (2%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I +++++K +G+G+FG+V       T +  A+K++ K  + + +    ++ E   L  + 
Sbjct: 12  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +++L    ++K  + +V+++  G  LF  +       E  AR +  +I+SAV + H 
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 130
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH-N 327
           + I+HRDLKPEN+LL    +V + DFGL+    +     +  G+  Y APE++ GK +  
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS G++LY ML  + PF   +   + + I      LP FLS  A  L+K +L   
Sbjct: 191 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 250
Query: 388 PGKRLGAGPKGSEEIKSHKWFK 409
           P  R+        EI    WFK
Sbjct: 251 PLNRISI-----HEIMQDDWFK 267

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 134/262 (51%), Gaps = 7/262 (2%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I +++++K +G+G+FG+V       T +  A+K++ K  + + +    ++ E   L  + 
Sbjct: 13  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +++L    ++K  + +V+++  G  LF  +       E  AR +  +I+SAV + H 
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 131
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH-N 327
           + I+HRDLKPEN+LL    +V + DFGL+    +     +  G+  Y APE++ GK +  
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS G++LY ML  + PF   +   + + I      LP FLS  A  L+K +L   
Sbjct: 192 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 251
Query: 388 PGKRLGAGPKGSEEIKSHKWFK 409
           P  R+        EI    WFK
Sbjct: 252 PLNRISI-----HEIMQDDWFK 268

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 143/284 (50%), Gaps = 17/284 (5%)
Query: 149 IED-FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDIL 204
           +ED +E+ + +G G F  V + R+K T + YA K ++K ++         E ++ E +IL
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            +I HP ++ L   F+ K  + L+L+ ++GG LF  L       ED A  +  +I+  V 
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122
Query: 265 HLHANGIMHRDLKPENILL----GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
           +LH+  I H DLKPENI+L      +  + L DFG+A + +      ++ GT E++APEI
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEA 376
           V  +     AD WS+G++ Y +L+G  PF+G  + +    I  V        F   S  A
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 242
Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEARE 420
              ++ LL K+P +R+        +   H W K I  + +   +
Sbjct: 243 KDFIRRLLVKDPKRRMTIA-----QSLEHSWIKAIRRRNVRGED 281

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 142/284 (50%), Gaps = 17/284 (5%)
Query: 149 IED-FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDIL 204
           +ED +E+ + +G G F  V + R+K T + YA K ++K ++         E ++ E +IL
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            +I HP ++ L   F+ K  + L+L+ ++GG LF  L       ED A  +  +I+  V 
Sbjct: 84  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 143
Query: 265 HLHANGIMHRDLKPENILL----GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
           +LH+  I H DLKPENI+L      +  + L DFG+A + +      ++ GT E++APEI
Sbjct: 144 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 203
Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEA 376
           V  +     AD WS+G++ Y +L+G  PF+G  + +    I  V        F   S  A
Sbjct: 204 VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 263
Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEARE 420
              ++ LL K+P +R+            H W K I  + +   +
Sbjct: 264 KDFIRRLLVKDPKRRMXIAQS-----LEHSWIKAIRRRNVRGED 302

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 140/260 (53%), Gaps = 15/260 (5%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           +++G G FG+V++  +  T    A K+++   + +K   E +K E  ++ ++DH  ++QL
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHANLIQL 151
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI-YAAEIVSAVSHLHANGIMHR 274
             +F++K  + LV+++++GG LF ++        +L  I +  +I   + H+H   I+H 
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 275 DLKPENIL-LGADG-HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADW 332
           DLKPENIL +  D   + + DFGLA+++    +     GT E++APE+V     +   D 
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271
Query: 333 WSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLKGLLQKEP 388
           WSVG++ Y +L+G  PF+G N A+    I+  +  L       +S EA   +  LL KE 
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 389 GKRLGAGPKGSEEIKSHKWF 408
             R+ A    SE +K H W 
Sbjct: 332 SWRISA----SEALK-HPWL 346

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  125 bits (313), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 136/279 (48%), Gaps = 26/279 (9%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVM--------RKDKIVEKNHAEYMKAER 201
           E++E  +++G+G    V +   K T + YA+K++          +++ E   A     E 
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL--KEV 74
Query: 202 DILTKID-HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIV 260
           DIL K+  HP ++QLK +++T    +LV D +  G LF  L       E   R     ++
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
             +  LH   I+HRDLKPENILL  D ++ LTDFG + Q D   +  S+ GT  Y+APEI
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEI 194
Query: 321 VLGK------GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF- 371
           +         G+ K  D WS G+++Y +L G PPF    +  + + I+    +   P + 
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 254
Query: 372 -LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
             S     L+   L  +P KR  A     EE  +H +F+
Sbjct: 255 DYSDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQ 288

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  125 bits (313), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 135/265 (50%), Gaps = 15/265 (5%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +++L+ +G GAFG V++  +K T  ++  K +     ++K     +K E  I+ ++ HP 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPK 109
Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI-YAAEIVSAVSHLHANG 270
           ++ L  +F+ KY + L+L+F++GG LF ++        +   I Y  +    + H+H + 
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 271 IMHRDLKPENILLGAD--GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           I+H D+KPENI+        V + DFGLA + + +        T E+ APEIV  +    
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 229
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSLLKGLL 384
             D W++G+L Y +L+G  PF G +  +  Q + +        AF  +S EA   +K LL
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 289
Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFK 409
           QKEP KRL        +   H W K
Sbjct: 290 QKEPRKRLTV-----HDALEHPWLK 309

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 139/273 (50%), Gaps = 17/273 (6%)
Query: 149 IED-FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDIL 204
           +ED +E+ + +G G F  V + R+K T + YA K ++K ++         E ++ E +IL
Sbjct: 10  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 69
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            +I HP ++ L   F+ K  + L+L+ ++GG LF  L       ED A  +  +I+  V 
Sbjct: 70  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 129
Query: 265 HLHANGIMHRDLKPENILL----GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
           +LH+  I H DLKPENI+L      +  + L DFG+A + +      ++ GT E++APEI
Sbjct: 130 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEA 376
           V  +     AD WS+G++ Y +L+G  PF+G  + +    I  V        F   S  A
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 249
Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
              ++ LL K+P +R+        +   H W K
Sbjct: 250 KDFIRRLLVKDPKRRMXIA-----QSLEHSWIK 277

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 141/283 (49%), Gaps = 17/283 (6%)
Query: 149 IEDF-EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDIL 204
           +EDF ++ + +G G F  V + R+K+T   YA K ++K +          E ++ E  IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            ++ H  V+ L   ++ +  + L+L+ ++GG LF  L       E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
           +LH   I H DLKPENI+L        H+ L DFGLA + ++     ++ GT E++APEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEA 376
           V  +     AD WS+G++ Y +L+G  PF+G  + +    I            +  S  A
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR 419
              ++ LL KE  KRL       +E   H W  P++ ++   R
Sbjct: 250 KDFIRKLLVKETRKRLTI-----QEALRHPWITPVDNQQAMVR 287

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 141/283 (49%), Gaps = 17/283 (6%)
Query: 149 IEDF-EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDIL 204
           +EDF ++ + +G G F  V + R+K+T   YA K ++K +          E ++ E  IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            ++ H  V+ L   ++ +  + L+L+ ++GG LF  L       E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
           +LH   I H DLKPENI+L        H+ L DFGLA + ++     ++ GT E++APEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSE----A 376
           V  +     AD WS+G++ Y +L+G  PF+G  + +    I            S+    A
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR 419
              ++ LL KE  KRL       +E   H W  P++ ++   R
Sbjct: 250 KDFIRKLLVKETRKRLTI-----QEALRHPWITPVDNQQAMVR 287

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 141/283 (49%), Gaps = 17/283 (6%)
Query: 149 IEDF-EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDIL 204
           +EDF ++ + +G G F  V + R+K+T   YA K ++K +          E ++ E  IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            ++ H  V+ L   ++ +  + L+L+ ++GG LF  L       E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
           +LH   I H DLKPENI+L        H+ L DFGLA + ++     ++ GT E++APEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEA 376
           V  +     AD WS+G++ Y +L+G  PF+G  + +    I            +  S  A
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR 419
              ++ LL KE  KRL       +E   H W  P++ ++   R
Sbjct: 250 KDFIRKLLVKETRKRLTI-----QEALRHPWITPVDNQQAMVR 287

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 135/258 (52%), Gaps = 11/258 (4%)
Query: 154 VLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKIDHPF 211
           + + +G+G+FG+V       T +  A+K + +  +  K    +M+ ER+I  L  + HP 
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--KKSDMHMRVEREISYLKLLRHPH 70
Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           +++L     T   + +V+++  GG LF  +       ED  R +  +I+ A+ + H + I
Sbjct: 71  IIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH-NKAA 330
           +HRDLKPEN+LL  + +V + DFGL+    +     +  G+  Y APE++ GK +     
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEV 189
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGK 390
           D WS GI+LY ML G+ PF       + +K+      +P FLS  A SL++ ++  +P +
Sbjct: 190 DVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQ 249
Query: 391 RLGAGPKGSEEIKSHKWF 408
           R+       +EI+   WF
Sbjct: 250 RITI-----QEIRRDPWF 262

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 141/283 (49%), Gaps = 17/283 (6%)
Query: 149 IEDF-EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDIL 204
           +EDF ++ + +G G F  V + R+K+T   YA K ++K +          E ++ E  IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            ++ H  V+ L   ++ +  + L+L+ ++GG LF  L       E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
           +LH   I H DLKPENI+L        H+ L DFGLA + ++     ++ GT E++APEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSE----A 376
           V  +     AD WS+G++ Y +L+G  PF+G  + +    I            S+    A
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR 419
              ++ LL KE  KRL       +E   H W  P++ ++   R
Sbjct: 250 KDFIRKLLVKETRKRLTI-----QEALRHPWITPVDNQQAMVR 287

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 141/283 (49%), Gaps = 17/283 (6%)
Query: 149 IEDF-EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDIL 204
           +EDF ++ + +G G F  V + R+K+T   YA K ++K +          E ++ E  IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            ++ H  V+ L   ++ +  + L+L+ ++GG LF  L       E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
           +LH   I H DLKPENI+L        H+ L DFGLA + ++     ++ GT E++APEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEA 376
           V  +     AD WS+G++ Y +L+G  PF+G  + +    I            +  S  A
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR 419
              ++ LL KE  KRL       +E   H W  P++ ++   R
Sbjct: 250 KDFIRKLLVKETRKRLTI-----QEALRHPWITPVDNQQAMVR 287

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 135/279 (48%), Gaps = 26/279 (9%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVM--------RKDKIVEKNHAEYMKAER 201
           E++E  +++G+G    V +   K T + YA+K++          +++ E   A     E 
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL--KEV 61
Query: 202 DILTKID-HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIV 260
           DIL K+  HP ++QLK +++T    +LV D +  G LF  L       E   R     ++
Sbjct: 62  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 121
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
             +  LH   I+HRDLKPENILL  D ++ LTDFG + Q D   +   + GT  Y+APEI
Sbjct: 122 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 181
Query: 321 VLGK------GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF- 371
           +         G+ K  D WS G+++Y +L G PPF    +  + + I+    +   P + 
Sbjct: 182 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 241
Query: 372 -LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
             S     L+   L  +P KR  A     EE  +H +F+
Sbjct: 242 DYSDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQ 275

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 135/279 (48%), Gaps = 26/279 (9%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVM--------RKDKIVEKNHAEYMKAER 201
           E++E  +++G+G    V +   K T + YA+K++          +++ E   A     E 
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL--KEV 74
Query: 202 DILTKID-HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIV 260
           DIL K+  HP ++QLK +++T    +LV D +  G LF  L       E   R     ++
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
             +  LH   I+HRDLKPENILL  D ++ LTDFG + Q D   +   + GT  Y+APEI
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 321 VLGK------GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF- 371
           +         G+ K  D WS G+++Y +L G PPF    +  + + I+    +   P + 
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 254
Query: 372 -LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
             S     L+   L  +P KR  A     EE  +H +F+
Sbjct: 255 DYSDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQ 288

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 139/274 (50%), Gaps = 16/274 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTKIDHPFVVQ 214
           +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +I HP V+ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ + GG LF  L       E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           DLKPENI+L         + + DFGLA + D      ++ GT E++APEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEAHSLLKGLLQK 386
           D WS+G++ Y +L+G  PF+G  + +    +  V  +     F   S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EPGKRLGAGPKGSEEIKSHKWFKPINWKKLEARE 420
           +P KR+       ++   H W KP + ++  +R+
Sbjct: 259 DPKKRMTI-----QDSLQHPWIKPKDTQQALSRK 287

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 142/272 (52%), Gaps = 20/272 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKN--HAEYMKAERDILTKIDH 209
           +E+ +V+G+G F  V +   + T + +A+K++   K         E +K E  I   + H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG----LFREDLARIYAAEIVSAVSH 265
           P +V+L  ++ +   LY+V +F++G  L F++        ++ E +A  Y  +I+ A+ +
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 266 LHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTR-SNSMIGTVEYMAPEIV 321
            H N I+HRD+KP  +LL +      V L  FG+A Q  E+   +   +GT  +MAPE+V
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 207
Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAH 377
             + + K  D W  G++L+ +L+G  PF  G + ++ + I+K K ++     + +S  A 
Sbjct: 208 KREPYGKPVDVWGCGVILFILLSGCLPFY-GTKERLFEGIIKGKYKMNPRQWSHISESAK 266
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
            L++ +L  +P +R+        E  +H W K
Sbjct: 267 DLVRRMLMLDPAERITV-----YEALNHPWLK 293

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 133/264 (50%), Gaps = 16/264 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTKIDHPFVVQ 214
           +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +I HP V+ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ + GG LF  L       E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           DLKPENI+L         + + DFGLA + D      ++ GT E++APEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEAHSLLKGLLQK 386
           D WS+G++ Y +L+G  PF+G  + +    +  V  +     F   S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EPGKRLGAGPKGSEEIKSHKWFKP 410
           +P KR+       ++   H W KP
Sbjct: 259 DPKKRMTI-----QDSLQHPWIKP 277

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 133/264 (50%), Gaps = 16/264 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTKIDHPFVVQ 214
           +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +I HP V+ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ + GG LF  L       E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           DLKPENI+L         + + DFGLA + D      ++ GT E++APEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEAHSLLKGLLQK 386
           D WS+G++ Y +L+G  PF+G  + +    +  V  +     F   S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EPGKRLGAGPKGSEEIKSHKWFKP 410
           +P KR+       ++   H W KP
Sbjct: 259 DPKKRMTI-----QDSLQHPWIKP 277

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 139/293 (47%), Gaps = 37/293 (12%)
Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE--------------- 190
           CV +  + +   +G+G++G V     +N +  YAMKV+ K K++                
Sbjct: 9   CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRP 68
Query: 191 --------KNHAEYMKAERDILTKIDHPFVVQLKYSFQ--TKYRLYLVLDFINGGHLFFQ 240
                   +   E +  E  IL K+DHP VV+L        +  LY+V + +N G +  +
Sbjct: 69  APGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM-E 127
Query: 241 LYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF 300
           +       ED AR Y  +++  + +LH   I+HRD+KP N+L+G DGH+ + DFG++ +F
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 301 D-ENTRSNSMIGTVEYMAPEIVLGKGH---NKAADWWSVGILLYEMLTGKPPFIGGNRAK 356
              +   ++ +GT  +MAPE +         KA D W++G+ LY  + G+ PF+      
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 357 IQQKIVKDKLRLP--AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKW 407
           +  KI    L  P    ++ +   L+  +L K P  R+        EIK H W
Sbjct: 248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV-----PEIKLHPW 295

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 133/264 (50%), Gaps = 16/264 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTKIDHPFVVQ 214
           +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +I HP V+ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ + GG LF  L       E+ A  +  +I++ V +LH+  I H 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 275 DLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           DLKPENI+L         + + DFGLA + D      ++ GT E++APEIV  +     A
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 197
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEAHSLLKGLLQK 386
           D WS+G++ Y +L+G  PF+G  + +    +  V  +     F   S+ A   ++ LL K
Sbjct: 198 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 257
Query: 387 EPGKRLGAGPKGSEEIKSHKWFKP 410
           +P KR+       ++   H W KP
Sbjct: 258 DPKKRMTI-----QDSLQHPWIKP 276

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 143/272 (52%), Gaps = 20/272 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKN--HAEYMKAERDILTKIDH 209
           +E+ +V+G+G F  V +   + T + +A+K++   K         E +K E  I   + H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG----LFREDLARIYAAEIVSAVSH 265
           P +V+L  ++ +   LY+V +F++G  L F++        ++ E +A  Y  +I+ A+ +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 266 LHANGIMHRDLKPENILLGADGH---VMLTDFGLAKQFDENTR-SNSMIGTVEYMAPEIV 321
            H N I+HRD+KP  +LL +  +   V L  FG+A Q  E+   +   +GT  +MAPE+V
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAH 377
             + + K  D W  G++L+ +L+G  PF  G + ++ + I+K K ++     + +S  A 
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFY-GTKERLFEGIIKGKYKMNPRQWSHISESAK 264
Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
            L++ +L  +P +R+        E  +H W K
Sbjct: 265 DLVRRMLMLDPAERITV-----YEALNHPWLK 291

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/256 (32%), Positives = 135/256 (52%), Gaps = 13/256 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E +E++  +G GAFG+VY+ + K T  + A KV+      E+   +Y+  E +IL   DH
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYI-VEIEILATCDH 67
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           P++V+L  ++    +L+++++F  GG +    L       E   ++   +++ A++ LH+
Sbjct: 68  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGL-AKQFDENTRSNSMIGTVEYMAPEIVLGKG-- 325
             I+HRDLK  N+L+  +G + L DFG+ AK      + +S IGT  +MAPE+V+ +   
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 187
Query: 326 ---HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSL 379
              ++  AD WS+GI L EM   +PP    N  ++  KI K     L  P+  S E    
Sbjct: 188 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 247
Query: 380 LKGLLQKEPGKRLGAG 395
           LK  L K P  R  A 
Sbjct: 248 LKIALDKNPETRPSAA 263

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 133/264 (50%), Gaps = 16/264 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTKIDHPFVVQ 214
           +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +I HP V+ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ + GG LF  L       E+ A  +  +I++ V +LH+  I H 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 275 DLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           DLKPENI+L         + + DFGLA + D      ++ GT E++APEIV  +     A
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 197
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEAHSLLKGLLQK 386
           D WS+G++ Y +L+G  PF+G  + +    +  V  +     F   S+ A   ++ LL K
Sbjct: 198 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 257
Query: 387 EPGKRLGAGPKGSEEIKSHKWFKP 410
           +P KR+       ++   H W KP
Sbjct: 258 DPKKRMTI-----QDSLQHPWIKP 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 139/274 (50%), Gaps = 16/274 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTKIDHPFVVQ 214
           +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +I HP V+ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ + GG LF  L       E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           DLKPENI+L         + + DFGLA + D      ++ GT E++APEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEAHSLLKGLLQK 386
           D WS+G++ Y +L+G  PF+G  + +    +  V  +     F   S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EPGKRLGAGPKGSEEIKSHKWFKPINWKKLEARE 420
           +P KR+       ++   H W KP + ++  +R+
Sbjct: 259 DPKKRMTI-----QDSLQHPWIKPKDTQQALSRK 287

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 133/264 (50%), Gaps = 16/264 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTKIDHPFVVQ 214
           +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +I HP V+ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ + GG LF  L       E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           DLKPENI+L         + + DFGLA + D      ++ GT E++APEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEAHSLLKGLLQK 386
           D WS+G++ Y +L+G  PF+G  + +    +  V  +     F   S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EPGKRLGAGPKGSEEIKSHKWFKP 410
           +P KR+       ++   H W KP
Sbjct: 259 DPKKRMTI-----QDSLQHPWIKP 277

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 133/264 (50%), Gaps = 16/264 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTKIDHPFVVQ 214
           +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +I HP V+ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ + GG LF  L       E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           DLKPENI+L         + + DFGLA + D      ++ GT E++APEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEAHSLLKGLLQK 386
           D WS+G++ Y +L+G  PF+G  + +    +  V  +     F   S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EPGKRLGAGPKGSEEIKSHKWFKP 410
           +P KR+       ++   H W KP
Sbjct: 259 DPKKRMTI-----QDSLQHPWIKP 277

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 139/274 (50%), Gaps = 16/274 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTKIDHPFVVQ 214
           +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +I HP V+ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ + GG LF  L       E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           DLKPENI+L         + + DFGLA + D      ++ GT E++APEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEAHSLLKGLLQK 386
           D WS+G++ Y +L+G  PF+G  + +    +  V  +     F   S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EPGKRLGAGPKGSEEIKSHKWFKPINWKKLEARE 420
           +P KR+       ++   H W KP + ++  +R+
Sbjct: 259 DPKKRMTI-----QDSLQHPWIKPKDTQQALSRK 287

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 133/264 (50%), Gaps = 16/264 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTKIDHPFVVQ 214
           +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +I HP V+ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ + GG LF  L       E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           DLKPENI+L         + + DFGLA + D      ++ GT E++APEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEAHSLLKGLLQK 386
           D WS+G++ Y +L+G  PF+G  + +    +  V  +     F   S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EPGKRLGAGPKGSEEIKSHKWFKP 410
           +P KR+       ++   H W KP
Sbjct: 259 DPKKRMTI-----QDSLQHPWIKP 277

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 138/258 (53%), Gaps = 17/258 (6%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E +E++  +G GAFG+VY+ + K T  + A KV+      E+   +Y+  E +IL   DH
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYI-VEIEILATCDH 75
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGH---LFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           P++V+L  ++    +L+++++F  GG    +  +L   GL  E   ++   +++ A++ L
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL-DRGL-TEPQIQVVCRQMLEALNFL 133
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGL-AKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
           H+  I+HRDLK  N+L+  +G + L DFG+ AK      + +S IGT  +MAPE+V+ + 
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 326 -----HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAH 377
                ++  AD WS+GI L EM   +PP    N  ++  KI K     L  P+  S E  
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253
Query: 378 SLLKGLLQKEPGKRLGAG 395
             LK  L K P  R  A 
Sbjct: 254 DFLKIALDKNPETRPSAA 271

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 139/274 (50%), Gaps = 16/274 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTKIDHPFVVQ 214
           +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +I HP V+ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ + GG LF  L       E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           DLKPENI+L         + + DFGLA + D      ++ GT E++APEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEAHSLLKGLLQK 386
           D WS+G++ Y +L+G  PF+G  + +    +  V  +     F   S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EPGKRLGAGPKGSEEIKSHKWFKPINWKKLEARE 420
           +P KR+       ++   H W KP + ++  +R+
Sbjct: 259 DPKKRMTI-----QDSLQHPWIKPKDTQQALSRK 287

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 133/264 (50%), Gaps = 16/264 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTKIDHPFVVQ 214
           +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +I HP V+ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ + GG LF  L       E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           DLKPENI+L         + + DFGLA + D      ++ GT E++APEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEAHSLLKGLLQK 386
           D WS+G++ Y +L+G  PF+G  + +    +  V  +     F   S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EPGKRLGAGPKGSEEIKSHKWFKP 410
           +P KR+       ++   H W KP
Sbjct: 259 DPKKRMTI-----QDSLQHPWIKP 277

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 131/251 (52%), Gaps = 12/251 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E F+VL+ +G+G++G VY+   K T +I A+K +     VE +  E +K E  I+ + D 
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIK-EISIMQQCDS 83
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           P VV+   S+     L++V+++   G +    +L +  L  +++A I  + +   + +LH
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL-KGLEYLH 142
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGH 326
               +HRD+K  NILL  +GH  L DFG+A Q  D   + N +IGT  +MAPE++   G+
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGL 383
           N  AD WS+GI   EM  GKPP+   +  +    I  +     R P   S      +K  
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQC 262
Query: 384 LQKEPGKRLGA 394
           L K P +R  A
Sbjct: 263 LVKSPEQRATA 273

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 130/271 (47%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ +++ + +G GAFG V++V ++ T   +A K +      +K   E ++ E   ++ + 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLR 212
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V L  +F+    + ++ +F++GG LF ++   H    ED A  Y  ++   + H+H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 268 ANGIMHRDLKPENILLGA--DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
            N  +H DLKPENI+        + L DFGL    D         GT E+ APE+  GK 
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSLLK 381
                D WSVG+L Y +L+G  PF G N  +  + +      +   AF  +S +    ++
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN 412
            LL  +P  R+        +   H W  P N
Sbjct: 393 KLLLADPNTRMTI-----HQALEHPWLTPGN 418

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 138/274 (50%), Gaps = 16/274 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTKIDHPFVVQ 214
           +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +I HP V+ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ + GG LF  L       E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           DLKPENI+L         + + DFGLA + D      ++ GT  ++APEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEAHSLLKGLLQK 386
           D WS+G++ Y +L+G  PF+G  + +    +  V  +     F   S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EPGKRLGAGPKGSEEIKSHKWFKPINWKKLEARE 420
           +P KR+       ++   H W KP + ++  +R+
Sbjct: 259 DPKKRMTI-----QDSLQHPWIKPKDTQQALSRK 287

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 135/269 (50%), Gaps = 21/269 (7%)
Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMR--KDKIVEKNHAEYMKAER---DILTKI-DHP 210
           V+G+G    V +   + T   +A+K+M    +++  +   E  +A R    IL ++  HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG 270
            ++ L  S+++   ++LV D +  G LF  L       E   R     ++ AVS LHAN 
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN 220
Query: 271 IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV------LGK 324
           I+HRDLKPENILL  +  + L+DFG +   +   +   + GT  Y+APEI+         
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHP 280
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSLL 380
           G+ K  D W+ G++L+ +L G PPF    +  + + I++ + +   P +   SS    L+
Sbjct: 281 GYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLI 340
Query: 381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
             LLQ +P  RL A     E+   H +F+
Sbjct: 341 SRLLQVDPEARLTA-----EQALQHPFFE 364

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 130/271 (47%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ +++ + +G GAFG V++V ++ T   +A K +      +K   E ++ E   ++ + 
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLR 106
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V L  +F+    + ++ +F++GG LF ++   H    ED A  Y  ++   + H+H
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 268 ANGIMHRDLKPENILLGA--DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
            N  +H DLKPENI+        + L DFGL    D         GT E+ APE+  GK 
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 226
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSLLK 381
                D WSVG+L Y +L+G  PF G N  +  + +      +   AF  +S +    ++
Sbjct: 227 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 286
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN 412
            LL  +P  R+        +   H W  P N
Sbjct: 287 KLLLADPNTRMTI-----HQALEHPWLTPGN 312

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 133/256 (51%), Gaps = 13/256 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQGA G VY      T +  A++ M    + ++   E +  E  ++ +  +P +V    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            +NILLG DG V LTDFG   Q   E ++ ++M+GT  +MAPE+V  K +    D WS+G
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           I+  EM+ G+PP++  N  +    I  +   +L+ P  LS+     L   L  +  KR  
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS 263
Query: 394 AGPKGSEEIKSHKWFK 409
           A     +E+  H++ K
Sbjct: 264 A-----KELLQHQFLK 274

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 133/256 (51%), Gaps = 13/256 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQGA G VY      T +  A++ M    + ++   E +  E  ++ +  +P +V    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            +NILLG DG V LTDFG   Q   E ++ + M+GT  +MAPE+V  K +    D WS+G
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           I+  EM+ G+PP++  N  +    I  +   +L+ P  LS+     L   L+ +  KR  
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS 263
Query: 394 AGPKGSEEIKSHKWFK 409
           A     +E+  H++ K
Sbjct: 264 A-----KELLQHQFLK 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 133/256 (51%), Gaps = 13/256 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQGA G VY      T +  A++ M    + ++   E +  E  ++ +  +P +V    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 144
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            +NILLG DG V LTDFG   Q   E ++ + M+GT  +MAPE+V  K +    D WS+G
Sbjct: 145 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLG 204
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           I+  EM+ G+PP++  N  +    I  +   +L+ P  LS+     L   L+ +  KR  
Sbjct: 205 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS 264
Query: 394 AGPKGSEEIKSHKWFK 409
           A     +E+  H++ K
Sbjct: 265 A-----KELIQHQFLK 275

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 143/279 (51%), Gaps = 33/279 (11%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           G+E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L ++
Sbjct: 1   GMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           +HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-K 324
           H++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+ +  + T+ Y APEI+LG K
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF-------- 371
            ++ A D WS+G +  EM+T +  F G +      +I +     D++  P          
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 372 ----------------LSSEAHSLLKGLLQKEPGKRLGA 394
                           L  +  SLL  +L  +P KR+ A
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTKIDHPFVVQ 214
           +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +I HP V+ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+ + + GG LF  L       E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           DLKPENI+L         + + DFGLA + D      ++ GT E++APEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAF--LSSEAHSLLKGLLQK 386
           D WS+G++ Y +L+G  PF+G  + +    +  V  +     F   S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EPGKRLGAGPKGSEEIKSHKWFKP 410
           +P KR+       ++   H W KP
Sbjct: 259 DPKKRMTI-----QDSLQHPWIKP 277

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 132/256 (51%), Gaps = 13/256 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQGA G VY      T +  A++ M    + ++   E +  E  ++ +  +P +V    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            +NILLG DG V LTDFG   Q   E ++ + M+GT  +MAPE+V  K +    D WS+G
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           I+  EM+ G+PP++  N  +    I  +   +L+ P  LS+     L   L  +  KR  
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS 263
Query: 394 AGPKGSEEIKSHKWFK 409
           A     +E+  H++ K
Sbjct: 264 A-----KELLQHQFLK 274

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 132/253 (52%), Gaps = 11/253 (4%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVR-KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           + +F + K +G+G F  VY+     +   +   KV   D +  K  A+ +K E D+L ++
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQL 89
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG----LFREDLARIYAAEIVSAV 263
           +HP V++   SF     L +VL+  + G L   + H      L  E     Y  ++ SA+
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVL 322
            H+H+  +MHRD+KP N+ + A G V L D GL + F  + T ++S++GT  YM+PE + 
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGG--NRAKIQQKIVK-DKLRLPA-FLSSEAHS 378
             G+N  +D WS+G LLYEM   + PF G   N   + +KI + D   LP+   S E   
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269
Query: 379 LLKGLLQKEPGKR 391
           L+   +  +P KR
Sbjct: 270 LVNMCINPDPEKR 282

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 134/256 (52%), Gaps = 13/256 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQGA G VY      T +  A++ M    + ++   E +  E  ++ +  +P +V    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HR++K
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRNIK 144
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            +NILLG DG V LTDFG   Q   E ++ ++M+GT  +MAPE+V  K +    D WS+G
Sbjct: 145 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 204
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           I+  EM+ G+PP++  N  +    I  +   +L+ P  LS+     L   L+ +  KR  
Sbjct: 205 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS 264
Query: 394 AGPKGSEEIKSHKWFK 409
           A     +E+  H++ K
Sbjct: 265 A-----KELIQHQFLK 275

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 142/278 (51%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  +S  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+ +  + T+ Y APEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 143/280 (51%), Gaps = 33/280 (11%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKE 62
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
           ++HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++ 
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG- 323
            H++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+ +  + T+ Y APEI+LG 
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 182
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF------- 371
           K ++ A D WS+G +  EM+T +  F G +      +I +     D++  P         
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 242
Query: 372 -----------------LSSEAHSLLKGLLQKEPGKRLGA 394
                            L  +  SLL  +L  +P KR+ A
Sbjct: 243 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 282

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKPEN+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 123 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 280

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKPEN+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 124 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKPEN+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKPEN+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 141/279 (50%), Gaps = 33/279 (11%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           +HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-K 324
           H++ ++HRDLKPEN+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K
Sbjct: 120 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF-------- 371
            ++ A D WS+G +  EM+T +  F G +      +I +     D++  P          
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 372 ----------------LSSEAHSLLKGLLQKEPGKRLGA 394
                           L  +  SLL  +L  +P KR+ A
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 142/278 (51%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 67
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+ +  + T+ Y APEI+LG K 
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 187
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 247
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 285

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 142/278 (51%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+ +  + T+ Y APEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 142/278 (51%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+ +  + T+ Y APEI+LG K 
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 181
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 142/278 (51%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+ +  + T+ Y APEI+LG K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 143/302 (47%), Gaps = 27/302 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-D 208
           + +EV + +G G++    +   K T+  +A+K++ K K   ++  E    E +IL +   
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPTE----EIEILLRYGQ 74
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP ++ LK  +     +Y+V + + GG L  ++     F E  A      I   V +LHA
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 269 NGIMHRDLKPENILL----GADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLG 323
            G++HRDLKP NIL     G    + + DFG AKQ   EN    +   T  ++APE++  
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGG---NRAKIQQKIVKDKLRLPA----FLSSEA 376
           +G++ A D WS+G+LLY MLTG  PF  G      +I  +I   K  L       +S  A
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254
Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIA 436
             L+  +L  +P +RL A       +  H W   ++W +L   ++     P +      A
Sbjct: 255 KDLVSKMLHVDPHQRLTAAL-----VLRHPWI--VHWDQLPQYQLNRQDAPHLVKGAMAA 307
Query: 437 NF 438
            +
Sbjct: 308 TY 309

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 141/277 (50%), Gaps = 33/277 (11%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           P +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H+
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KGH 326
           + ++HRDLKP+N+L+  +G + L DFGLA+ F    R+ +  + T+ Y APEI+LG K +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF---------- 371
           + A D WS+G +  EM+T +  F G +      +I +     D++  P            
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 372 --------------LSSEAHSLLKGLLQKEPGKRLGA 394
                         L  +  SLL  +L  +P KR+ A
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 135/249 (54%), Gaps = 14/249 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ED+EVL  +G G++GR  ++R+K+  +I   K +    + E    + + +E ++L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 210 PFVVQL--KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS--- 264
           P +V+   +   +T   LY+V+++  GG L   +      R+ L   +   +++ ++   
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 265 ---HLHANG---IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-SNSMIGTVEYMA 317
              H  ++G   ++HRDLKP N+ L    +V L DFGLA+  + +T  + + +GT  YM+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEA 376
           PE +    +N+ +D WS+G LLYE+    PPF   ++ ++  KI + K  R+P   S E 
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244
Query: 377 HSLLKGLLQ 385
           + ++  +L 
Sbjct: 245 NEIITRMLN 253

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 142/278 (51%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 67
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+ +  + T+ Y APEI+LG K 
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKY 187
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 247
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 285

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 142/278 (51%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+ +  + T+ Y APEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKY 180
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 280

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 280

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 135/249 (54%), Gaps = 14/249 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ED+EVL  +G G++GR  ++R+K+  +I   K +    + E    + + +E ++L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 210 PFVVQL--KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS--- 264
           P +V+   +   +T   LY+V+++  GG L   +      R+ L   +   +++ ++   
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 265 ---HLHANG---IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-SNSMIGTVEYMA 317
              H  ++G   ++HRDLKP N+ L    +V L DFGLA+  + +T  + + +GT  YM+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 184
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEA 376
           PE +    +N+ +D WS+G LLYE+    PPF   ++ ++  KI + K  R+P   S E 
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244
Query: 377 HSLLKGLLQ 385
           + ++  +L 
Sbjct: 245 NEIITRMLN 253

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 141/279 (50%), Gaps = 33/279 (11%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           +HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-K 324
           H++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF-------- 371
            ++ A D WS+G +  EM+T +  F G +      +I +     D++  P          
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 372 ----------------LSSEAHSLLKGLLQKEPGKRLGA 394
                           L  +  SLL  +L  +P KR+ A
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 141/279 (50%), Gaps = 33/279 (11%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           +HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-K 324
           H++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF-------- 371
            ++ A D WS+G +  EM+T +  F G +      +I +     D++  P          
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 372 ----------------LSSEAHSLLKGLLQKEPGKRLGA 394
                           L  +  SLL  +L  +P KR+ A
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 64
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 125 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 184
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 244
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 245 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 282

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 141/279 (50%), Gaps = 33/279 (11%)
Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           +HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-K 324
           H++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF-------- 371
            ++ A D WS+G +  EM+T +  F G +      +I +     D++  P          
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 372 ----------------LSSEAHSLLKGLLQKEPGKRLGA 394
                           L  +  SLL  +L  +P KR+ A
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 280

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 133/271 (49%), Gaps = 25/271 (9%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-D 208
           + + V + +G G++    +   K T+  YA+KV+ K K   ++ +E    E +IL +   
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK---RDPSE----EIEILLRYGQ 79
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP ++ LK  +     +YLV + + GG L  ++     F E  A      I   V +LH+
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 269 NGIMHRDLKPENILL----GADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLG 323
            G++HRDLKP NIL     G    + + DFG AKQ   EN    +   T  ++APE++  
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKR 199
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGG---NRAKIQQKIVKDKLRLPA----FLSSEA 376
           +G+++  D WS+GILLY ML G  PF  G      +I  +I   K  L       +S  A
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETA 259
Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKW 407
             L+  +L  +P +RL A     +++  H W
Sbjct: 260 KDLVSKMLHVDPHQRLTA-----KQVLQHPW 285

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 130/243 (53%), Gaps = 10/243 (4%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+ G V     +++ ++ A+K M    + ++   E +  E  I+    H  VV++  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 215
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   + H  +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 274
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   ++GT  +MAPE++    +    D WS+G
Sbjct: 275 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 334
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKDKL--RLPAF--LSSEAHSLLKGLLQKEPGKRL 392
           I++ EM+ G+PP+      K   K+++D L  RL     +S      L  LL ++P +R 
Sbjct: 335 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 393
Query: 393 GAG 395
            A 
Sbjct: 394 TAA 396

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 133/271 (49%), Gaps = 25/271 (9%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-D 208
           + + V + +G G++    +   K T+  YA+KV+ K K   ++ +E    E +IL +   
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK---RDPSE----EIEILLRYGQ 79
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP ++ LK  +     +YLV + + GG L  ++     F E  A      I   V +LH+
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 269 NGIMHRDLKPENILL----GADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLG 323
            G++HRDLKP NIL     G    + + DFG AKQ   EN    +   T  ++APE++  
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKR 199
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGG---NRAKIQQKIVKDKLRLPA----FLSSEA 376
           +G+++  D WS+GILLY ML G  PF  G      +I  +I   K  L       +S  A
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETA 259
Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKW 407
             L+  +L  +P +RL A     +++  H W
Sbjct: 260 KDLVSKMLHVDPHQRLTA-----KQVLQHPW 285

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 152/301 (50%), Gaps = 17/301 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPINWKKLEAREIQPGFCPEVAG--KHCIANF 438
            +L + P  R+        +IK  +W+ KP+       R    G     +G  KH  +N 
Sbjct: 243 KILVENPSARITI-----PDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNL 297
Query: 439 E 439
           +
Sbjct: 298 D 298

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+  +R D   E   +  ++ E  +L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+ +  + T+ Y APEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+  +R D   E   +  ++ E  +L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+ +  + T+ Y APEI+LG K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 130/243 (53%), Gaps = 10/243 (4%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+ G V     +++ ++ A+K M    + ++   E +  E  I+    H  VV++  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   + H  +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 152
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   ++GT  +MAPE++    +    D WS+G
Sbjct: 153 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 212
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKDKL--RLPAF--LSSEAHSLLKGLLQKEPGKRL 392
           I++ EM+ G+PP+      K   K+++D L  RL     +S      L  LL ++P +R 
Sbjct: 213 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 271
Query: 393 GAG 395
            A 
Sbjct: 272 TAA 274

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 130/243 (53%), Gaps = 10/243 (4%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+ G V     +++ ++ A+K M    + ++   E +  E  I+    H  VV++  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   + H  +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 143
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   ++GT  +MAPE++    +    D WS+G
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 203
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKDKL--RLPAF--LSSEAHSLLKGLLQKEPGKRL 392
           I++ EM+ G+PP+      K   K+++D L  RL     +S      L  LL ++P +R 
Sbjct: 204 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 262
Query: 393 GAG 395
            A 
Sbjct: 263 TAA 265

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV + ++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+ +  + T+ Y APEI+LG K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 130/243 (53%), Gaps = 10/243 (4%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+ G V     +++ ++ A+K M    + ++   E +  E  I+    H  VV++  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 95
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   + H  +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 154
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   ++GT  +MAPE++    +    D WS+G
Sbjct: 155 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 214
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKDKL--RLPAF--LSSEAHSLLKGLLQKEPGKRL 392
           I++ EM+ G+PP+      K   K+++D L  RL     +S      L  LL ++P +R 
Sbjct: 215 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 273
Query: 393 GAG 395
            A 
Sbjct: 274 TAA 276

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 152/301 (50%), Gaps = 17/301 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPINWKKLEAREIQPGFCPEVAG--KHCIANF 438
            +L + P  R+        +IK  +W+ KP+       R    G     +G  KH  +N 
Sbjct: 244 KILVENPSARITI-----PDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNL 298
Query: 439 E 439
           +
Sbjct: 299 D 299

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  114 bits (286), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 130/243 (53%), Gaps = 10/243 (4%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+ G V     +++ ++ A+K M    + ++   E +  E  I+    H  VV++  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   + H  +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 147
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   ++GT  +MAPE++    +    D WS+G
Sbjct: 148 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 207
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKDKL--RLPAF--LSSEAHSLLKGLLQKEPGKRL 392
           I++ EM+ G+PP+      K   K+++D L  RL     +S      L  LL ++P +R 
Sbjct: 208 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 266
Query: 393 GAG 395
            A 
Sbjct: 267 TAA 269

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEIXINKMLN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 243 KILVENPSARITI-----PDIKKDRWYNKPL 268

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 140/278 (50%), Gaps = 33/278 (11%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV + ++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KG 325
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R+    + T+ Y APEI+LG K 
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----DKLRLPAF--------- 371
           ++ A D WS+G +  EM+T +  F G +      +I +     D++  P           
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGA 394
                          L  +  SLL  +L  +P KR+ A
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 244 KILVENPSARITI-----PDIKKDRWYNKPL 269

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 244 KILVENPSARITI-----PDIKKDRWYNKPL 269

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 244 KILVENPSARITI-----PDIKKDRWYNKPL 269

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 243 KILVENPSARITI-----PDIKKDRWYNKPL 268

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 243 KILVENPSARITI-----PDIKKDRWYNKPL 268

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINAMLN 63
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 244 KILVENPSARITI-----PDIKKDRWYNKPL 269

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 243 KILVENPSARITI-----PDIKKDRWYNKPL 268

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 61
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 242 KILVENPSARITI-----PDIKKDRWYNKPL 267

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 130/243 (53%), Gaps = 10/243 (4%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+ G V     +++ ++ A+K M    + ++   E +  E  I+    H  VV++  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 138
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   + H  +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 197
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   ++GT  +MAPE++    +    D WS+G
Sbjct: 198 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 257
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKDKL--RLPAF--LSSEAHSLLKGLLQKEPGKRL 392
           I++ EM+ G+PP+      K   K+++D L  RL     +S      L  LL ++P +R 
Sbjct: 258 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 316
Query: 393 GAG 395
            A 
Sbjct: 317 TAA 319

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 244 KILVENPSARITI-----PDIKKDRWYNKPL 269

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 131/241 (54%), Gaps = 8/241 (3%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+ G V   R+K++    A+K+M   K   +   E +  E  I+    H  VV++  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L+++++F+ GG L   +    L  E +A +  A ++ A+++LHA G++HRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEA-VLQALAYLHAQGVIHRDIK 168
Query: 278 PENILLGADGHVMLTDFGLAKQFDENT-RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            ++ILL  DG V L+DFG   Q  ++  +   ++GT  +MAPE++    +    D WS+G
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLG 228
Query: 337 ILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           I++ EM+ G+PP+   +  +  +++      KL+    +S      L+ +L ++P +R  
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT 288
Query: 394 A 394
           A
Sbjct: 289 A 289

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 243 KILVENPSARITI-----PDIKKDRWYNKPL 268

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 244 KILVENPSARITI-----PDIKKDRWYNKPL 269

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 243 KILVENPSARITI-----PDIKKDRWYNKPL 268

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 243 KILVENPSARITI-----PDIKKDRWYNKPL 268

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEIXINKMLN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 243 KILVENPSARITI-----PDIKKDRWYNKPL 268

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEIXINKMLN 63
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 244 KILVENPSARITI-----PDIKKDRWYNKPL 269

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 243 KILVENPSARITI-----PDIKKDRWYNKPL 268

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 243 KILVENPSARITI-----PDIKKDRWYNKPL 268

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 133/248 (53%), Gaps = 14/248 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ED+EVL  +G G++GR  ++R+K+  +I   K +    + E    + + +E ++L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 210 PFVVQL--KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS--- 264
           P +V+   +   +T   LY+V+++  GG L   +      R+ L   +   +++ ++   
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 265 ---HLHANG---IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-SNSMIGTVEYMA 317
              H  ++G   ++HRDLKP N+ L    +V L DFGLA+  + +   +   +GT  YM+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMS 184
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEA 376
           PE +    +N+ +D WS+G LLYE+    PPF   ++ ++  KI + K  R+P   S E 
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244
Query: 377 HSLLKGLL 384
           + ++  +L
Sbjct: 245 NEIITRML 252

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 140/302 (46%), Gaps = 27/302 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-D 208
           + +EV + +G G++    +   K T+  +A+K++ K K   ++  E    E +IL +   
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSK---RDPTE----EIEILLRYGQ 74
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP ++ LK  +     +Y+V +   GG L  ++     F E  A      I   V +LHA
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 269 NGIMHRDLKPENILL----GADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLG 323
            G++HRDLKP NIL     G    + + DFG AKQ   EN    +   T  ++APE++  
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLER 194
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGG---NRAKIQQKIVKDKLRLPA----FLSSEA 376
           +G++ A D WS+G+LLY  LTG  PF  G      +I  +I   K  L       +S  A
Sbjct: 195 QGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254
Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIA 436
             L+   L  +P +RL A       +  H W   ++W +L   ++     P +      A
Sbjct: 255 KDLVSKXLHVDPHQRLTAAL-----VLRHPWI--VHWDQLPQYQLNRQDAPHLVKGAXAA 307
Query: 437 NF 438
            +
Sbjct: 308 TY 309

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 106
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 166 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 225
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 226 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 265

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 112
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 231
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 116
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 176 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 235
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 236 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 275

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 90
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 150 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 209
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 249

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 79
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 139 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 198
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 199 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 238

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 114
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 174 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 233
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 234 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 273

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 112
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 231
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 39  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 91
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 150
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 151 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 210
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 211 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 250

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 90
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 150 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 209
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 249

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 45  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 97
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 157 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 216
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 217 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 256

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 83
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 84  RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 143 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 202
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 203 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 242

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 86
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 145
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 146 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 205
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 206 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 245

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 131/271 (48%), Gaps = 16/271 (5%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           K +G+G F  V Q   K+T + YA K ++K +  +   AE +     +      P V+ L
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 216 KYSFQTKYRLYLVLDFINGGHLF---FQLYHHGLFREDLARIYAAEIVSAVSHLHANGIM 272
              ++    + L+L++  GG +F          +   D+ R+   +I+  V +LH N I+
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-IKQILEGVYYLHQNNIV 153
Query: 273 HRDLKPENILLGAD---GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKA 329
           H DLKP+NILL +    G + + DFG++++         ++GT EY+APEI+       A
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTA 213
Query: 330 ADWWSVGILLYEMLTGKPPFIGGNRAK----IQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
            D W++GI+ Y +LT   PF+G +  +    I Q  V       + +S  A   ++ LL 
Sbjct: 214 TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLV 273
Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKL 416
           K P KR  A     E   SH W +  +++ L
Sbjct: 274 KNPEKRPTA-----EICLSHSWLQQWDFENL 299

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 82
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 142 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 201
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 202 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 241

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 110/200 (55%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E F  L+ +G+G+FG V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 64
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P+V +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+ +GT  +MAPE++    ++ 
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 183
Query: 329 AADWWSVGILLYEMLTGKPP 348
            AD WS+GI   E+  G+PP
Sbjct: 184 KADIWSLGITAIELARGEPP 203

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 118/205 (57%), Gaps = 4/205 (1%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E ++ L+ VG+G +G VY+  K +   I A+K +R D   E   +  ++ E  +L ++ 
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELH 77
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +V L     ++  L LV +F+          +    ++   +IY  +++  V+H H 
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KGH 326
           + I+HRDLKP+N+L+ +DG + L DFGLA+ F    RS +  + T+ Y AP++++G K +
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 327 NKAADWWSVGILLYEMLTGKPPFIG 351
           + + D WS+G +  EM+TGKP F G
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPG 222

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 109/200 (54%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E F  L  +G+G+FG VY+    +T E+ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 76
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 77  PYITRYFGSYLKSTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSE 135
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N  +GT  +MAPE++    ++ 
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDF 195
Query: 329 AADWWSVGILLYEMLTGKPP 348
            AD WS+GI   E+  G+PP
Sbjct: 196 KADIWSLGITAIELAKGEPP 215

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 157
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 217 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 276
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 277 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 316

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 110/200 (55%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E F  L+ +G+G+FG V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 84
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P+V +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 85  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 143
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+ +GT  +MAPE++    ++ 
Sbjct: 144 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 203
Query: 329 AADWWSVGILLYEMLTGKPP 348
            AD WS+GI   E+  G+PP
Sbjct: 204 KADIWSLGITAIELARGEPP 223

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 120/220 (54%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH  +V+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 KYSFQTK------YRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +         L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 118/205 (57%), Gaps = 4/205 (1%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E ++ L+ VG+G +G VY+  K +   I A+K +R D   E   +  ++ E  +L ++ 
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELH 77
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +V L     ++  L LV +F+          +    ++   +IY  +++  V+H H 
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KGH 326
           + I+HRDLKP+N+L+ +DG + L DFGLA+ F    RS +  + T+ Y AP++++G K +
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 327 NKAADWWSVGILLYEMLTGKPPFIG 351
           + + D WS+G +  EM+TGKP F G
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPG 222

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 137/258 (53%), Gaps = 17/258 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+ G V    +K+T +  A+K M    + ++   E +  E  I+    H  VV +  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKM---DLRKQQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   + H  +  E +A +    ++ A+S+LH  G++HRD+K
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV-CLSVLRALSYLHNQGVIHRDIK 168
Query: 278 PENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVG 336
            ++ILL +DG + L+DFG   Q   E  +   ++GT  +MAPE++    +    D WS+G
Sbjct: 169 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLG 228
Query: 337 ILLYEMLTGKPPFIGGNRAKIQ-QKIVKDKL--RLPAF--LSSEAHSLLKGLLQKEPGKR 391
           I++ EM+ G+PP+   N   +Q  + ++D L  R+     +SS     L  +L +EP +R
Sbjct: 229 IMVIEMIDGEPPYF--NEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQR 286
Query: 392 LGAGPKGSEEIKSHKWFK 409
             A     +E+  H + K
Sbjct: 287 ATA-----QELLGHPFLK 299

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 142/271 (52%), Gaps = 15/271 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPI 411
            +L + P  R+        +IK  +W+ KP+
Sbjct: 243 KILVENPSARITI-----PDIKKDRWYNKPL 268

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 110/200 (55%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E F  L+ +G+G+FG V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 23  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 80
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
            +V +   S+    +L+++++++ GG     L   G F E        EI+  + +LH+ 
Sbjct: 81  SYVTKYYGSYLKGSKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSE 139
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+ +GT  +MAPE++    ++ 
Sbjct: 140 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 199
Query: 329 AADWWSVGILLYEMLTGKPP 348
            AD WS+GI   E+  G+PP
Sbjct: 200 KADIWSLGITAIELAKGEPP 219

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 142/279 (50%), Gaps = 32/279 (11%)
Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K+++      +    + +A +      
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ------ 68
Query: 208 DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVS 261
             P +V++   ++  Y     L +V++ ++GG LF ++   G   F E  A      I  
Sbjct: 69  -CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 127
Query: 262 AVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    +   T  Y+AP
Sbjct: 128 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 187
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF------- 371
           E++  + ++K+ D WS+G+++Y +L G PPF   +   I   + K ++R+  +       
Sbjct: 188 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPNPEW 246
Query: 372 --LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
             +S E   L++ LL+ EP +R+        E  +H W 
Sbjct: 247 SEVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 280

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 109/200 (54%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E F  L+ +G+G+FG V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 79
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P+V +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N  +GT  +MAPE++    ++ 
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS 198
Query: 329 AADWWSVGILLYEMLTGKPP 348
            AD WS+GI   E+  G+PP
Sbjct: 199 KADIWSLGITAIELARGEPP 218

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 142/279 (50%), Gaps = 32/279 (11%)
Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K+++      +    + +A +      
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ------ 67
Query: 208 DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVS 261
             P +V++   ++  Y     L +V++ ++GG LF ++   G   F E  A      I  
Sbjct: 68  -CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 262 AVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    +   T  Y+AP
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 186
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF------- 371
           E++  + ++K+ D WS+G+++Y +L G PPF   +   I   + K ++R+  +       
Sbjct: 187 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPNPEW 245
Query: 372 --LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
             +S E   L++ LL+ EP +R+        E  +H W 
Sbjct: 246 SEVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 279

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 142/279 (50%), Gaps = 32/279 (11%)
Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K+++      +    + +A +      
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ------ 74
Query: 208 DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVS 261
             P +V++   ++  Y     L +V++ ++GG LF ++   G   F E  A      I  
Sbjct: 75  -CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 133
Query: 262 AVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    +   T  Y+AP
Sbjct: 134 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 193
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF------- 371
           E++  + ++K+ D WS+G+++Y +L G PPF   +   I   + K ++R+  +       
Sbjct: 194 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPNPEW 252
Query: 372 --LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
             +S E   L++ LL+ EP +R+        E  +H W 
Sbjct: 253 SEVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 286

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 142/279 (50%), Gaps = 32/279 (11%)
Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K+++      +    + +A +      
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ------ 73
Query: 208 DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVS 261
             P +V++   ++  Y     L +V++ ++GG LF ++   G   F E  A      I  
Sbjct: 74  -CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 132
Query: 262 AVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    +   T  Y+AP
Sbjct: 133 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 192
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF------- 371
           E++  + ++K+ D WS+G+++Y +L G PPF   +   I   + K ++R+  +       
Sbjct: 193 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPNPEW 251
Query: 372 --LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
             +S E   L++ LL+ EP +R+        E  +H W 
Sbjct: 252 SEVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 285

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 142/279 (50%), Gaps = 32/279 (11%)
Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K+++      +    + +A +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ------ 69
Query: 208 DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVS 261
             P +V++   ++  Y     L +V++ ++GG LF ++   G   F E  A      I  
Sbjct: 70  -CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 262 AVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    +   T  Y+AP
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 188
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF------- 371
           E++  + ++K+ D WS+G+++Y +L G PPF   +   I   + K ++R+  +       
Sbjct: 189 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPNPEW 247
Query: 372 --LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
             +S E   L++ LL+ EP +R+        E  +H W 
Sbjct: 248 SEVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 281

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 142/279 (50%), Gaps = 32/279 (11%)
Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K+++      +    + +A +      
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ------ 75
Query: 208 DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVS 261
             P +V++   ++  Y     L +V++ ++GG LF ++   G   F E  A      I  
Sbjct: 76  -CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 134
Query: 262 AVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    +   T  Y+AP
Sbjct: 135 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 194
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF------- 371
           E++  + ++K+ D WS+G+++Y +L G PPF   +   I   + K ++R+  +       
Sbjct: 195 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPNPEW 253
Query: 372 --LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
             +S E   L++ LL+ EP +R+        E  +H W 
Sbjct: 254 SEVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 287

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 109/200 (54%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E F  L+ +G+G+FG V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 64
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P+V +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N  +GT  +MAPE++    ++ 
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS 183
Query: 329 AADWWSVGILLYEMLTGKPP 348
            AD WS+GI   E+  G+PP
Sbjct: 184 KADIWSLGITAIELARGEPP 203

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 142/279 (50%), Gaps = 32/279 (11%)
Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K+++      +    + +A +      
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ------ 113
Query: 208 DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVS 261
             P +V++   ++  Y     L +V++ ++GG LF ++   G   F E  A      I  
Sbjct: 114 -CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 262 AVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    +   T  Y+AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF------- 371
           E++  + ++K+ D WS+G+++Y +L G PPF   +   I   + K ++R+  +       
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPNPEW 291
Query: 372 --LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
             +S E   L++ LL+ EP +R+        E  +H W 
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 325

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 54/143 (37%), Positives = 87/143 (60%), Gaps = 2/143 (1%)
Query: 226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA 285
           YLV+++I G  L   +  HG    D A  +  +I+  + H H   I+HRD+KP+NIL+ +
Sbjct: 87  YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS 146
Query: 286 DGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEML 343
           +  + + DFG+AK   E   T++N ++GTV+Y +PE   G+  ++  D +S+GI+LYEML
Sbjct: 147 NKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206
Query: 344 TGKPPFIGGNRAKIQQKIVKDKL 366
            G+PPF G     I  K ++D +
Sbjct: 207 VGEPPFNGETAVSIAIKHIQDSV 229

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 144/282 (51%), Gaps = 38/282 (13%)
Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K+++      +    + +A +      
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ------ 67
Query: 208 DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVS 261
             P +V++   ++  Y     L +V++ ++GG LF ++   G   F E  A      I  
Sbjct: 68  -CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 262 AVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIG---TVEY 315
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK   E T  NS+     T  Y
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTEPCYTPYY 183
Query: 316 MAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF---- 371
           +APE++  + ++K+ D WS+G+++Y +L G PPF   +   I   + K ++R+  +    
Sbjct: 184 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPN 242
Query: 372 -----LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
                +S E   L++ LL+ EP +R+        E  +H W 
Sbjct: 243 PEWSEVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 279

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 142/279 (50%), Gaps = 32/279 (11%)
Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K+++      +    + +A +      
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ------ 83
Query: 208 DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVS 261
             P +V++   ++  Y     L +V++ ++GG LF ++   G   F E  A      I  
Sbjct: 84  -CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 142
Query: 262 AVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    +   T  Y+AP
Sbjct: 143 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 202
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF------- 371
           E++  + ++K+ D WS+G+++Y +L G PPF   +   I   + K ++R+  +       
Sbjct: 203 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPNPEW 261
Query: 372 --LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
             +S E   L++ LL+ EP +R+        E  +H W 
Sbjct: 262 SEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWI 295

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 110/213 (51%), Gaps = 19/213 (8%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           FE++++VG G +G+VY+ R   T ++ A+KVM     V  +  E +K E ++L K  H  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 81
Query: 212 VVQLKYSFQTKY-------RLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSA 262
            +   Y    K        +L+LV++F   G +    +       +E+       EI+  
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSMIGTVEYMAPEIV 321
           +SHLH + ++HRD+K +N+LL  +  V L DFG++ Q D    R N+ IGT  +MAPE++
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 322 LGKGHNKA-----ADWWSVGILLYEMLTGKPPF 349
               +  A     +D WS+GI   EM  G PP 
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 142/279 (50%), Gaps = 32/279 (11%)
Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K+++      +    + +A +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ------ 69
Query: 208 DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVS 261
             P +V++   ++  Y     L +V++ ++GG LF ++   G   F E  A      I  
Sbjct: 70  -CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 262 AVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    +   T  Y+AP
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 188
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF------- 371
           E++  + ++K+ D WS+G+++Y +L G PPF   +   I   + K ++R+  +       
Sbjct: 189 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPNPEW 247
Query: 372 --LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
             +S E   L++ LL+ EP +R+        E  +H W 
Sbjct: 248 SEVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 281

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 142/279 (50%), Gaps = 32/279 (11%)
Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K+++      +    + +A +      
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ------ 119
Query: 208 DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVS 261
             P +V++   ++  Y     L +V++ ++GG LF ++   G   F E  A      I  
Sbjct: 120 -CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 178
Query: 262 AVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    +   T  Y+AP
Sbjct: 179 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 238
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF------- 371
           E++  + ++K+ D WS+G+++Y +L G PPF   +   I   + K ++R+  +       
Sbjct: 239 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPNPEW 297
Query: 372 --LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
             +S E   L++ LL+ EP +R+        E  +H W 
Sbjct: 298 SEVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 331

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 136/271 (50%), Gaps = 19/271 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA-----ERDIL 204
           + +  +  +G GAFG V+    K  ++   +K ++K+K++E    E  K      E  IL
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAV 263
           ++++H  ++++   F+ +    LV++    G  LF  +  H    E LA     ++VSAV
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG 323
            +L    I+HRD+K ENI++  D  + L DFG A   +      +  GT+EY APE+++G
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG 203
Query: 324 KGHN-KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKG 382
             +     + WS+G+ LY ++  + PF         ++ V+  +  P  +S E  SL+ G
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELMSLVSG 257
Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWF-KPIN 412
           LLQ  P +R        E++ +  W  +P+N
Sbjct: 258 LLQPVPERRTTL-----EKLVTDPWVTQPVN 283

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 120/220 (54%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + + K        +   E  I+ K+DH  +V+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK-------AFKNRELQIMRKLDHCNIVRL 78
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPAT-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 136/254 (53%), Gaps = 16/254 (6%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKIDH 209
           +E+ +++G G    V+  R        A+KV+R D  + ++ + Y++  R+      ++H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAALNH 71
Query: 210 PFVVQLKYSFQTKYRL----YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
           P +V +  + + +       Y+V+++++G  L   ++  G      A    A+   A++ 
Sbjct: 72  PAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEYMAPEIV 321
            H NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++IGT +Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF----LSSEAH 377
            G   +  +D +S+G +LYE+LTG+PPF G +   +  + V++    P+     LS++  
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 251
Query: 378 SLLKGLLQKEPGKR 391
           +++   L K P  R
Sbjct: 252 AVVLKALAKNPENR 265

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 136/254 (53%), Gaps = 16/254 (6%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKIDH 209
           +E+ +++G G    V+  R        A+KV+R D  + ++ + Y++  R+      ++H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAALNH 71
Query: 210 PFVVQLKYSFQTKYRL----YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
           P +V +  + + +       Y+V+++++G  L   ++  G      A    A+   A++ 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEYMAPEIV 321
            H NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++IGT +Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF----LSSEAH 377
            G   +  +D +S+G +LYE+LTG+PPF G +   +  + V++    P+     LS++  
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 251
Query: 378 SLLKGLLQKEPGKR 391
           +++   L K P  R
Sbjct: 252 AVVLKALAKNPENR 265

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 136/254 (53%), Gaps = 16/254 (6%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKIDH 209
           +E+ +++G G    V+  R        A+KV+R D  + ++ + Y++  R+      ++H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAALNH 71
Query: 210 PFVVQLKYSFQTKYRL----YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
           P +V +  + + +       Y+V+++++G  L   ++  G      A    A+   A++ 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEYMAPEIV 321
            H NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++IGT +Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF----LSSEAH 377
            G   +  +D +S+G +LYE+LTG+PPF G +   +  + V++    P+     LS++  
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 251
Query: 378 SLLKGLLQKEPGKR 391
           +++   L K P  R
Sbjct: 252 AVVLKALAKNPENR 265

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 136/254 (53%), Gaps = 16/254 (6%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKIDH 209
           +E+ +++G G    V+  R        A+KV+R D  + ++ + Y++  R+      ++H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAALNH 71
Query: 210 PFVVQLKYSFQTKYRL----YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
           P +V +  + + +       Y+V+++++G  L   ++  G      A    A+   A++ 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEYMAPEIV 321
            H NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++IGT +Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF----LSSEAH 377
            G   +  +D +S+G +LYE+LTG+PPF G +   +  + V++    P+     LS++  
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHEGLSADLD 251
Query: 378 SLLKGLLQKEPGKR 391
           +++   L K P  R
Sbjct: 252 AVVLKALAKNPENR 265

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 120/220 (54%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + + K        +   E  I+ K+DH  +V+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK-------AFKNRELQIMRKLDHCNIVRL 78
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 120/220 (54%), Gaps = 20/220 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG VYQ +  ++ E+ A+K + + K        +   E  I+ K+DH  +V+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK-------AFKNRELQIMRKLDHCNIVRL 78
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFREDL----ARIYAAEIVSAVSH 265
           +Y F +      +  L LVLD++    ++    H+   ++ L     ++Y  ++  ++++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE++ G 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             +  + D WS G +L E+L G+P F G +      +I+K
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 134/254 (52%), Gaps = 16/254 (6%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKIDH 209
           +E+ +++G G    V+  R        A+KV+R D  + ++ + Y++  R+      ++H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAALNH 71
Query: 210 PFVVQLKYSFQTKYRL----YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
           P +V +  + + +       Y+V+++++G  L   ++  G      A    A+   A++ 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS----NSMIGTVEYMAPEIV 321
            H NGI+HRD+KP NIL+ A   V + DFG+A+   ++  S     ++IGT +Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF----LSSEAH 377
            G   +  +D +S+G +LYE+LTG+PPF G +   +  + V++    P+     LS++  
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 251
Query: 378 SLLKGLLQKEPGKR 391
           +++   L K P  R
Sbjct: 252 AVVLKALAKNPENR 265

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 118/209 (56%), Gaps = 11/209 (5%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK---DKIVEKNHAEYMKAERDILT 205
           +E +E L +VG+G++G V + R K+T  I A+K   +   DK+V+K     +K    +L 
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIK----LLK 79
Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSAVS 264
           ++ H  +V L    + K R YLV +F++   L   +L+ +GL  + + + Y  +I++ + 
Sbjct: 80  QLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQ-VVQKYLFQIINGIG 138
Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSNSMIGTVEYMAPEIVLG 323
             H++ I+HRD+KPENIL+   G V L DFG A+         +  + T  Y APE+++G
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG 198
Query: 324 K-GHNKAADWWSVGILLYEMLTGKPPFIG 351
              + KA D W++G L+ EM  G+P F G
Sbjct: 199 DVKYGKAVDVWAIGCLVTEMFMGEPLFPG 227

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 141/268 (52%), Gaps = 16/268 (5%)
Query: 138 KGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM 197
           +G  +T      + +E+ +++G G    V+  R        A+KV+R D  + ++ + Y+
Sbjct: 17  RGSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD--LARDPSFYL 74
Query: 198 KAERDI--LTKIDHPFVVQLKYSFQTKYRL----YLVLDFINGGHLFFQLYHHGLFREDL 251
           +  R+      ++HP +V +  + + +       Y+V+++++G  L   ++  G      
Sbjct: 75  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 134
Query: 252 ARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSN 307
           A    A+   A++  H NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ 
Sbjct: 135 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 194
Query: 308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR 367
           ++IGT +Y++PE   G   +  +D +S+G +LYE+LTG+PPF G +   +  + V++   
Sbjct: 195 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 254
Query: 368 LPAF----LSSEAHSLLKGLLQKEPGKR 391
            P+     LS++  +++   L K P  R
Sbjct: 255 PPSARHEGLSADLDAVVLKALAKNPENR 282

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 86/292 (29%), Positives = 132/292 (45%), Gaps = 55/292 (18%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKN--HAEYMKAERDILTKIDHPFVVQL 215
           +GQG++G V    +  T  I A+K+M K+KI + N    E +K E  ++ K+ HP + +L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYH-------------------------------- 243
              ++ +  + LV++  +GGHL  +L                                  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 244 -HGLF-------REDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG--HVMLTD 293
            HG         RE L      +I SA+ +LH  GI HRD+KPEN L   +    + L D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 294 FGLAKQF-----DENTRSNSMIGTVEYMAPEIV--LGKGHNKAADWWSVGILLYEMLTGK 346
           FGL+K+F      E     +  GT  ++APE++    + +    D WS G+LL+ +L G 
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 347 PPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSLLKGLLQKEPGKRLGA 394
            PF G N A    +++  KL    P +  LS  A  LL  LL +   +R  A
Sbjct: 274 VPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 42/289 (14%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           +++G+GA+ +V         + YA+K++ K      + +   +    +     +  +++L
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQ--AGHSRSRVFREVETLYQCQGNKNILEL 76
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
              F+   R YLV + + GG +   +     F E  A     ++ +A+  LH  GI HRD
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRD 136
Query: 276 LKPENILLGAD---GHVMLTDFGLAKQFDENTRSNSMI--------GTVEYMAPEIV--- 321
           LKPENIL  +      V + DF L      N     +         G+ EYMAPE+V   
Sbjct: 137 LKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVF 196
Query: 322 --LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA---------------KIQQKIVKD 364
                 ++K  D WS+G++LY ML+G PPF+G   A               K+ + I + 
Sbjct: 197 TDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG 256
Query: 365 KLRLP----AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           K   P    A +SSEA  L+  LL ++  +RL A      ++  H W +
Sbjct: 257 KYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAA-----QVLQHPWVQ 300

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 137/278 (49%), Gaps = 30/278 (10%)
Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K ++      +    + +A +      
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVELHWRASQ------ 113
Query: 208 DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVS 261
             P +V++   ++  Y     L +V + ++GG LF ++   G   F E  A      I  
Sbjct: 114 -CPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGE 172
Query: 262 AVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    +   T  Y+AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKI----QQKIVKDKLRLP----A 370
           E++  + ++K+ D WS+G++ Y +L G PPF   +   I    + +I   +   P    +
Sbjct: 233 EVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWS 292
Query: 371 FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
            +S E   L++ LL+ EP +R         E  +H W 
Sbjct: 293 EVSEEVKXLIRNLLKTEPTQRXTIT-----EFXNHPWI 325

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 14/211 (6%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +E+ + +G G FG V +   ++T E  A+K  R++ +  KN   +   E  I+ K++HP 
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWC-LEIQIMKKLNHPN 73
Query: 212 VVQLKYSFQTKYRL------YLVLDFINGGHL---FFQLYHHGLFREDLARIYAAEIVSA 262
           VV  +       +L       L +++  GG L     Q  +    +E   R   ++I SA
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVML---TDFGLAKQFDENTRSNSMIGTVEYMAPE 319
           + +LH N I+HRDLKPENI+L      ++    D G AK+ D+       +GT++Y+APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 320 IVLGKGHNKAADWWSVGILLYEMLTGKPPFI 350
           ++  K +    D+WS G L +E +TG  PF+
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 14/211 (6%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +E+ + +G G FG V +   ++T E  A+K  R++ +  KN   +   E  I+ K++HP 
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWC-LEIQIMKKLNHPN 74
Query: 212 VVQLKYSFQTKYRL------YLVLDFINGGHL---FFQLYHHGLFREDLARIYAAEIVSA 262
           VV  +       +L       L +++  GG L     Q  +    +E   R   ++I SA
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVML---TDFGLAKQFDENTRSNSMIGTVEYMAPE 319
           + +LH N I+HRDLKPENI+L      ++    D G AK+ D+       +GT++Y+APE
Sbjct: 135 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 194
Query: 320 IVLGKGHNKAADWWSVGILLYEMLTGKPPFI 350
           ++  K +    D+WS G L +E +TG  PF+
Sbjct: 195 LLEQKKYTVTVDYWSFGTLAFECITGFRPFL 225

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 138/279 (49%), Gaps = 42/279 (15%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           DFE + V+GQGAFG+V + R    S  YA+K +R  +  EK     + +E  +L  ++H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EK--LSTILSEVMLLASLNHQ 62
Query: 211 FVVQLKYSF-------------QTKYRLYLVLDFINGGHLFFQLYHHGLF--REDLARIY 255
           +VV+   ++             + K  L++ +++   G L+  ++   L   R++  R++
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT----------- 304
             +I+ A+S++H+ GI+HRDLKP NI +    +V + DFGLAK    +            
Sbjct: 123 R-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 305 ----RSNSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ 359
                  S IGT  Y+A E++ G GH N+  D +S+GI+ +EM+   P   G  R  I +
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILK 239
Query: 360 KIVKDKLRLPAFLSSEA----HSLLKGLLQKEPGKRLGA 394
           K+    +  P             +++ L+  +P KR GA
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA 278

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 107/206 (51%), Gaps = 5/206 (2%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKIDH 209
           +E L  +G+G F  VY+ R KNT++I A+K ++     E        A R+I  L ++ H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P ++ L  +F  K  + LV DF+          +  +      + Y    +  + +LH +
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-NSMIGTVEYMAPEIVLG-KGHN 327
            I+HRDLKP N+LL  +G + L DFGLAK F    R+    + T  Y APE++ G + + 
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGN 353
              D W+VG +L E+L  + PF+ G+
Sbjct: 192 VGVDMWAVGCILAELLL-RVPFLPGD 216

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 134/290 (46%), Gaps = 46/290 (15%)
Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAE-YMKAERDILTKID-HPFVVQ 214
           V+G+GA  RV       TS+ YA+K++ K    +  H    +  E ++L +   H  V++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEK----QPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   F+ + R YLV + + GG +   ++    F E  A +   ++ SA+  LH  GI HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 275 DLKPENILLGADGH---VMLTDFGLAKQFDENTRSNSM--------IGTVEYMAPEIVLG 323
           DLKPENIL         V + DFGL      N   + +         G+ EYMAPE+V  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195
Query: 324 KG-----HNKAADWWSVGILLYEMLTGKPPFIG---------------GNRAKIQQKIVK 363
                  ++K  D WS+G++LY +L+G PPF+G                 +  + + I +
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE 255
Query: 364 DKLRLP----AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
            K   P    A +S  A  L+  LL ++  +RL A      ++  H W +
Sbjct: 256 GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA-----QVLQHPWVQ 300

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 136/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+ +     LF  +   G  +E+LAR +  +++ AV H
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 188
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +SSE   L++  
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 242
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 243 LALRPSDR-----PTFEEIQNHPWMQDV 265

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 118/217 (54%), Gaps = 4/217 (1%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E +  L+ +G+G +G VY+  + N  E +A+K +R +K  E   +  ++ E  IL ++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  +V+L     TK RL LV + ++           G      A+ +  ++++ +++ H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KGH 326
             ++HRDLKP+N+L+  +G + + DFGLA+ F    R  +  I T+ Y AP++++G K +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           +   D WSVG +  EM+ G P F G + A    +I +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 137/292 (46%), Gaps = 38/292 (13%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ +E L+ +G+G +G V++ + + T EI A+K +R D   E   +  ++ E  +L ++ 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELK 59
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  +V+L     +  +L LV +F +     +    +G    ++ + +  +++  +   H+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KGH 326
             ++HRDLKP+N+L+  +G + L DFGLA+ F    R  S  + T+ Y  P+++ G K +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL------------RLPAF--- 371
           + + D WS G +  E+     P   GN    Q K +   L            +LP +   
Sbjct: 180 STSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
                          L++    LL+ LL+  P +R+ A     EE   H +F
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-----EEALQHPYF 286

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 118/217 (54%), Gaps = 4/217 (1%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E +  L+ +G+G +G VY+  + N  E +A+K +R +K  E   +  ++ E  IL ++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  +V+L     TK RL LV + ++           G      A+ +  ++++ +++ H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KGH 326
             ++HRDLKP+N+L+  +G + + DFGLA+ F    R  +  + T+ Y AP++++G K +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           +   D WSVG +  EM+ G P F G + A    +I +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 134/286 (46%), Gaps = 34/286 (11%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D+E+ +V+G GA   V         E  A+K +  +K  + +  E +K E   +++  H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLK-EIQAMSQCHH 72
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH--------HGLFREDLARIYAAEIVS 261
           P +V    SF  K  L+LV+  ++GG +   + H         G+  E        E++ 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK------QFDENTRSNSMIGTVEY 315
            + +LH NG +HRD+K  NILLG DG V + DFG++           N    + +GT  +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 316 MAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKI-----------QQKIVK 363
           MAPE++   +G++  AD WS GI   E+ TG  P+      K+            +  V+
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252
Query: 364 DKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           DK  L  +  S    ++   LQK+P KR  A      E+  HK+F+
Sbjct: 253 DKEMLKKYGKS-FRKMISLCLQKDPEKRPTAA-----ELLRHKFFQ 292

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 118/217 (54%), Gaps = 4/217 (1%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E +  L+ +G+G +G VY+  + N  E +A+K +R +K  E   +  ++ E  IL ++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  +V+L     TK RL LV + ++           G      A+ +  ++++ +++ H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KGH 326
             ++HRDLKP+N+L+  +G + + DFGLA+ F    R  +  + T+ Y AP++++G K +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           +   D WSVG +  EM+ G P F G + A    +I +
Sbjct: 179 STTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFR 215

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 203
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +SSE   L++  
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 257
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 258 LALRPSDR-----PTFEEIQNHPWMQDV 280

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 204
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +SSE   L++  
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 258
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 259 LALRPSDR-----PTFEEIQNHPWMQDV 281

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 136/286 (47%), Gaps = 34/286 (11%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D+E+ +V+G GA   V         E  A+K +  +K  + +  E +K E   +++  H
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLK-EIQAMSQCHH 67
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH--------HGLFREDLARIYAAEIVS 261
           P +V    SF  K  L+LV+  ++GG +   + H         G+  E        E++ 
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK------QFDENTRSNSMIGTVEY 315
            + +LH NG +HRD+K  NILLG DG V + DFG++           N    + +GT  +
Sbjct: 128 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 187
Query: 316 MAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKI-----------QQKIVK 363
           MAPE++   +G++  AD WS GI   E+ TG  P+      K+            +  V+
Sbjct: 188 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 247
Query: 364 DKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           DK  L  +  S    ++   LQK+P KR    P  +E ++ HK+F+
Sbjct: 248 DKEMLKKYGKS-FRKMISLCLQKDPEKR----PTAAELLR-HKFFQ 287

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 216
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +SSE   L++  
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 270
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 271 LALRPSDR-----PTFEEIQNHPWMQDV 293

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 164
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 223
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +SSE   L++  
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 277
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 278 LALRPSDR-----PTFEEIQNHPWMQDV 300

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 189
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +SSE   L++  
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 243
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 244 LALRPSDR-----PTFEEIQNHPWMQDV 266

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 231
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +SSE   L++  
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 285
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 286 LALRPSDR-----PTFEEIQNHPWMQDV 308

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 137/279 (49%), Gaps = 42/279 (15%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           DFE + V+GQGAFG+V + R    S  YA+K +R  +  EK     + +E  +L  ++H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EK--LSTILSEVMLLASLNHQ 62
Query: 211 FVVQLKYSF-------------QTKYRLYLVLDFINGGHLFFQLYHHGLF--REDLARIY 255
           +VV+   ++             + K  L++ +++     L+  ++   L   R++  R++
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT----------- 304
             +I+ A+S++H+ GI+HRDLKP NI +    +V + DFGLAK    +            
Sbjct: 123 R-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 305 ----RSNSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ 359
                  S IGT  Y+A E++ G GH N+  D +S+GI+ +EM+   P   G  R  I +
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILK 239
Query: 360 KIVKDKLRLPAFLSSEA----HSLLKGLLQKEPGKRLGA 394
           K+    +  P             +++ L+  +P KR GA
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA 278

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 188
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +SSE   L++  
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 242
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 243 LALRPSDR-----PTFEEIQNHPWMQDV 265

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 189
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +SSE   L++  
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 243
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 244 LALRPSDR-----PTFEEIQNHPWMQDV 266

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 189
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +SSE   L++  
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 243
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 244 LALRPSDR-----PTFEEIQNHPWMQDV 266

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 131/249 (52%), Gaps = 15/249 (6%)
Query: 157 VVGQGAFGRVYQVRK-KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           V+G+G +G VY  R   N   I   ++  +D      +++ +  E  +   + H  +VQ 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS----RYSQPLHEEIALHKHLKHKNIVQY 84
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHH-GLFREDLARI--YAAEIVSAVSHLHANGIM 272
             SF     + + ++ + GG L   L    G  +++   I  Y  +I+  + +LH N I+
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 273 HRDLKPENILLGA-DGHVMLTDFGLAKQFDE-NTRSNSMIGTVEYMAPEIVLG--KGHNK 328
           HRD+K +N+L+    G + ++DFG +K+    N  + +  GT++YMAPEI+    +G+ K
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 329 AADWWSVGILLYEMLTGKPPF--IGGNRAKI-QQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
           AAD WS+G  + EM TGKPPF  +G  +A + +  + K    +P  +S+EA + +    +
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFE 264
Query: 386 KEPGKRLGA 394
            +P KR  A
Sbjct: 265 PDPDKRACA 273

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +SSE   L++  
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 238
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 239 LALRPSDR-----PTFEEIQNHPWMQDV 261

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 133/290 (45%), Gaps = 46/290 (15%)
Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAE-YMKAERDILTKID-HPFVVQ 214
           V+G+GA  RV       TS+ YA+K++ K    +  H    +  E ++L +   H  V++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEK----QPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   F+ + R YLV + + GG +   ++    F E  A +   ++ SA+  LH  GI HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 275 DLKPENILLGADGH---VMLTDFGLAKQFDENTRSNSM--------IGTVEYMAPEIVLG 323
           DLKPENIL         V + DF L      N   + +         G+ EYMAPE+V  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195
Query: 324 KG-----HNKAADWWSVGILLYEMLTGKPPFIG---------------GNRAKIQQKIVK 363
                  ++K  D WS+G++LY +L+G PPF+G                 +  + + I +
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE 255
Query: 364 DKLRLP----AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
            K   P    A +S  A  L+  LL ++  +RL A      ++  H W +
Sbjct: 256 GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA-----QVLQHPWVQ 300

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 187
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +SSE   L++  
Sbjct: 188 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSECQHLIRWC 241
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 242 LALRPSDR-----PTFEEIQNHPWMQDV 264

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 131/264 (49%), Gaps = 18/264 (6%)
Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEY-MKAERDILTKIDHPFVVQL 215
           ++G+G++G+V +V    T    A+K+++K K+    + E  +K E  +L ++ H  V+QL
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 216 KYSF--QTKYRLYLVLDF-INGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIM 272
                 + K ++Y+V+++ + G            F    A  Y  +++  + +LH+ GI+
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF-----DENTRSNSMIGTVEYMAPEIVLGKGHN 327
           H+D+KP N+LL   G + ++  G+A+       D+  R++   G+  +  PEI  G    
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAFQPPEIANGLDTF 189
Query: 328 KA--ADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
                D WS G+ LY + TG  PF G N  K+ + I K    +P         LLKG+L+
Sbjct: 190 SGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLE 249
Query: 386 KEPGKRLGAGPKGSEEIKSHKWFK 409
            EP KR         +I+ H WF+
Sbjct: 250 YEPAKRFSI-----RQIRQHSWFR 268

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 217
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I+  ++     +SSE   L++  
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSSECQHLIRWC 271
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 272 LALRPSDR-----PTFEEIQNHPWMQDV 294

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 216
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I+  ++     +SSE   L++  
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSSECQHLIRWC 270
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 271 LALRPSDR-----PTFEEIQNHPWMQDV 293

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 216
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I+  ++     +SSE   L++  
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSSECQHLIRWC 270
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 271 LALRPSDR-----PTFEEIQNHPWMQDV 293

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 117/226 (51%), Gaps = 16/226 (7%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA-EYMKAERDILTKIDHPFVVQ 214
           +++G G FG+VY  R     +  A+K  R D   + +   E ++ E  +   + HP ++ 
Sbjct: 13  EIIGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI--- 271
           L+     +  L LV++F  GG L  ++        D+   +A +I   +++LH   I   
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLN-RVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 272 MHRDLKPENILLG--------ADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG 323
           +HRDLK  NIL+         ++  + +TDFGLA+++   T+  S  G   +MAPE++  
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGAYAWMAPEVIRA 188
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP 369
              +K +D WS G+LL+E+LTG+ PF G +   +   +  +KL LP
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP 234

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 217
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I+  ++     +SSE   L++  
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSSECQHLIRWC 271
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 272 LALRPSDR-----PTFEEIQNHPWMQDV 294

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 204
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +S E   L++  
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXECQHLIRWC 258
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 259 LALRPSDR-----PTFEEIQNHPWMQDV 281

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 203
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +S E   L++  
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXECQHLIRWC 257
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 258 LALRPSDR-----PTFEEIQNHPWMQDV 280

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 137/292 (46%), Gaps = 38/292 (13%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ +E L+ +G+G +G V++ + + T EI A+K +R D   E   +  ++ E  +L ++ 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELK 59
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  +V+L     +  +L LV +F +     +    +G    ++ + +  +++  +   H+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KGH 326
             ++HRDLKP+N+L+  +G + L +FGLA+ F    R  S  + T+ Y  P+++ G K +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL------------RLPAF--- 371
           + + D WS G +  E+     P   GN    Q K +   L            +LP +   
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 372 ---------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
                          L++    LL+ LL+  P +R+ A     EE   H +F
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-----EEALQHPYF 286

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 231
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +S E   L++  
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXECQHLIRWC 285
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 286 LALRPSDR-----PTFEEIQNHPWMQDV 308

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 131/249 (52%), Gaps = 15/249 (6%)
Query: 157 VVGQGAFGRVYQVRK-KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           V+G+G +G VY  R   N   I   ++  +D      +++ +  E  +   + H  +VQ 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS----RYSQPLHEEIALHKHLKHKNIVQY 70
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHH-GLFREDLARI--YAAEIVSAVSHLHANGIM 272
             SF     + + ++ + GG L   L    G  +++   I  Y  +I+  + +LH N I+
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 130
Query: 273 HRDLKPENILLGA-DGHVMLTDFGLAKQFDE-NTRSNSMIGTVEYMAPEIVLG--KGHNK 328
           HRD+K +N+L+    G + ++DFG +K+    N  + +  GT++YMAPEI+    +G+ K
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 190
Query: 329 AADWWSVGILLYEMLTGKPPF--IGGNRAKI-QQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
           AAD WS+G  + EM TGKPPF  +G  +A + +  + K    +P  +S+EA + +    +
Sbjct: 191 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFE 250
Query: 386 KEPGKRLGA 394
            +P KR  A
Sbjct: 251 PDPDKRACA 259

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 121/245 (49%), Gaps = 39/245 (15%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +  +E++K +G+GA+G V++   + T E+ A+K +  D       A+    E  ILT++ 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNSTDAQRTFREIMILTELS 66
Query: 209 -HPFVVQLKYSFQ--TKYRLYLVLDFINGGHLFFQLYHHGLFREDL-----ARIYAAEIV 260
            H  +V L    +      +YLV D++           H + R ++      +    +++
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMETDL-------HAVIRANILEPVHKQYVVYQLI 119
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--------------DENTRS 306
             + +LH+ G++HRD+KP NILL A+ HV + DFGL++ F              +ENT +
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 307 --------NSMIGTVEYMAPEIVLGKG-HNKAADWWSVGILLYEMLTGKPPFIGGNRAKI 357
                      + T  Y APEI+LG   + K  D WS+G +L E+L GKP F G +    
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239
Query: 358 QQKIV 362
            ++I+
Sbjct: 240 LERII 244

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 140/301 (46%), Gaps = 54/301 (17%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F+ L+ +G G +  VY+   K T    A+K ++ D   E+        E  ++ ++ H  
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHEN 64
Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH------HGLFREDLARIYAAEIVSAVSH 265
           +V+L     T+ +L LV +F++     +           GL   +L + +  +++  ++ 
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL-ELNLVKYFQWQLLQGLAF 123
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD--ENTRSNSMIGTVEYMAPEIVLG 323
            H N I+HRDLKP+N+L+   G + L DFGLA+ F    NT S+ ++ T+ Y AP++++G
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMG 182
Query: 324 -KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL------------RLPA 370
            + ++ + D WS G +L EM+TGKP F G N  + Q K++ D +            +LP 
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPSVTKLPK 241
Query: 371 F-----------------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKW 407
           +                       L       L GLLQ  P  RL A     ++   H W
Sbjct: 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA-----KQALHHPW 296
Query: 408 F 408
           F
Sbjct: 297 F 297

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 204
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +S E   L++  
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXECQHLIRWC 258
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 259 LALRPXDR-----PTFEEIQNHPWMQDV 281

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I+  ++     +SSE   L++  
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSSECQHLIRWC 238
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 239 LALRPSDR-----PTFEEIQNHPWMQDV 261

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 124/256 (48%), Gaps = 17/256 (6%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I D E L  +G G  G+V+++R + T  + A+K MR+    E+N    M  +  +L   D
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV-VLKSHD 82
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL-H 267
            P++VQ   +F T   +++ ++ +       +    G   E +       IV A+ +L  
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV-----L 322
            +G++HRD+KP NILL   G + L DFG++ +  ++   +   G   YMAPE +      
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-----LPAFL--SSE 375
              ++  AD WS+GI L E+ TG+ P+      K   +++   L+     LP  +  S +
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPY---KNCKTDFEVLTKVLQEEPPLLPGHMGFSGD 259
Query: 376 AHSLLKGLLQKEPGKR 391
             S +K  L K+  KR
Sbjct: 260 FQSFVKDCLTKDHRKR 275

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 58  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 117
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 118 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 177
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 178 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 236
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +S E   L++  
Sbjct: 237 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXECQHLIRWC 290
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 291 LALRPSDR-----PTFEEIQNHPWMQDV 313

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +S E   L++  
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXECQHLIRWC 238
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 239 LALRPSDR-----PTFEEIQNHPWMQDV 261

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 116/212 (54%), Gaps = 23/212 (10%)
Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL- 215
           ++GQGA   V++ R K T +++A+KV      +     +    E ++L K++H  +V+L 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLF 73
Query: 216 --KYSFQTKYRLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHAN 269
             +    T++++ L+++F   G L+  L      +GL   +   I   ++V  ++HL  N
Sbjct: 74  AIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLREN 131
Query: 270 GIMHRDLKPENIL--LGADGHVM--LTDFGLAKQFDENTRSNSMIGTVEYMAPEI----V 321
           GI+HR++KP NI+  +G DG  +  LTDFG A++ +++ +  S+ GT EY+ P++    V
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191
Query: 322 LGKGHNK----AADWWSVGILLYEMLTGKPPF 349
           L K H K      D WS+G+  Y   TG  PF
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 112/214 (52%), Gaps = 12/214 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ED + L  +G+GA+G V ++  K + +I A+K +R   + EK   + +     ++   D 
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS-TVDEKEQKQLLMDLDVVMRSSDC 80
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLF-----REDLARIYAAEIVSAVS 264
           P++VQ   +   +   ++ ++ ++     F  Y + +       E L +I  A  V A++
Sbjct: 81  PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA-TVKALN 139
Query: 265 HLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV-- 321
           HL  N  I+HRD+KP NILL   G++ L DFG++ Q  ++       G   YMAPE +  
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 199
Query: 322 --LGKGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
               +G++  +D WS+GI LYE+ TG+ P+   N
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 211
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I++ ++     +S E   L++  
Sbjct: 212 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXECQHLIRWC 265
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 266 LALRPSDR-----PTFEEIQNHPWMQDV 288

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 133/268 (49%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 217
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I+  ++     +S E   L++  
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSXECQHLIRWC 271
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 272 LALRPSDR-----PTFEEIQNHPWMQDV 294

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 133/268 (49%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 217
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I+  ++     +S E   L++  
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSXECQHLIRWC 271
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 272 LALRPSDR-----PTFEEIQNHPWMQDV 294

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 133/262 (50%), Gaps = 28/262 (10%)
Query: 150 EDFEVLK-VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +D+++ K V+G G  G+V +   + T +  A+K++       +    + +A         
Sbjct: 9   DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGG------ 62
Query: 209 HPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSA 262
            P +V +   ++  +     L ++++ + GG LF ++   G   F E  A     +I +A
Sbjct: 63  -PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 121
Query: 263 VSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE 319
           +  LH++ I HRD+KPEN+L  +   D  + LTDFG AK+  +N        T  Y+APE
Sbjct: 122 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY-TPYYVAPE 180
Query: 320 IVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF-------- 371
           ++  + ++K+ D WS+G+++Y +L G PPF       I   + K ++RL  +        
Sbjct: 181 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-KRRIRLGQYGFPNPEWS 239
Query: 372 -LSSEAHSLLKGLLQKEPGKRL 392
            +S +A  L++ LL+ +P +RL
Sbjct: 240 EVSEDAKQLIRLLLKTDPTERL 261

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 133/262 (50%), Gaps = 28/262 (10%)
Query: 150 EDFEVLK-VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +D+++ K V+G G  G+V +   + T +  A+K++       +    + +A         
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGG------ 81
Query: 209 HPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSA 262
            P +V +   ++  +     L ++++ + GG LF ++   G   F E  A     +I +A
Sbjct: 82  -PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 263 VSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE 319
           +  LH++ I HRD+KPEN+L  +   D  + LTDFG AK+  +N        T  Y+APE
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY-TPYYVAPE 199
Query: 320 IVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF-------- 371
           ++  + ++K+ D WS+G+++Y +L G PPF       I   + K ++RL  +        
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-KRRIRLGQYGFPNPEWS 258
Query: 372 -LSSEAHSLLKGLLQKEPGKRL 392
            +S +A  L++ LL+ +P +RL
Sbjct: 259 EVSEDAKQLIRLLLKTDPTERL 280

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 133/268 (49%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKID 208
           ++V  ++G G FG VY   + + +   A+K + KD+I    E  +   +  E  +L K+ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 209 HPF--VVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             F  V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ AV H
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 266 LHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLG 323
            H  G++HRD+K ENIL+  + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 216
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILLY+M+ G  PF      +  ++I+  ++     +S E   L++  
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIGGQVFFRQRVSXECQHLIRWC 270
Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           L   P  R        EEI++H W + +
Sbjct: 271 LALRPSDR-----PTFEEIQNHPWMQDV 293

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 132/269 (49%), Gaps = 22/269 (8%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---EKNHAEYMKAERDILTKI 207
           ++ +  ++G+G FG V+   +       A+KV+ +++++     + +     E  +L K+
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 208 D----HPFVVQLKYSFQTKYRLYLVLDF-INGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
                HP V++L   F+T+    LVL+  +    LF  +   G   E  +R +  ++V+A
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 263 VSHLHANGIMHRDLKPENILLG-ADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE-I 320
           + H H+ G++HRD+K ENIL+    G   L DFG      +   ++   GT  Y  PE I
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWI 210
Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLL 380
              + H   A  WS+GILLY+M+ G  PF      +  Q+I++ +L  PA +S +  +L+
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPF------ERDQEILEAELHFPAHVSPDCCALI 264
Query: 381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           +  L  +P  R        EEI    W +
Sbjct: 265 RRCLAPKPSSR-----PSLEEILLDPWMQ 288

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 135/279 (48%), Gaps = 42/279 (15%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           DFE + V+GQGAFG+V + R    S  YA+K +R  +  EK     + +E  +L  ++H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EK--LSTILSEVXLLASLNHQ 62
Query: 211 FVVQLKYSF-------------QTKYRLYLVLDFINGGHLFFQLYHHGLF--REDLARIY 255
           +VV+   ++             + K  L++  ++     L+  ++   L   R++  R++
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE------------- 302
             +I+ A+S++H+ GI+HR+LKP NI +    +V + DFGLAK                 
Sbjct: 123 R-QILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 303 --NTRSNSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ 359
             +    S IGT  Y+A E++ G GH N+  D +S+GI+ +E +   P   G  R  I +
Sbjct: 182 GSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY--PFSTGXERVNILK 239
Query: 360 KIVKDKLRLPAFLSSEA----HSLLKGLLQKEPGKRLGA 394
           K+    +  P             +++ L+  +P KR GA
Sbjct: 240 KLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGA 278

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 109/201 (54%), Gaps = 4/201 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE +  +G G  G V++V  K +  + A K++  +  ++      +  E  +L + + 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 125
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH-A 268
           P++V    +F +   + + ++ ++GG L   L   G   E +    +  ++  +++L   
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 185
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           + IMHRD+KP NIL+ + G + L DFG++ Q   ++ +NS +GT  YM+PE + G  ++ 
Sbjct: 186 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 244
Query: 329 AADWWSVGILLYEMLTGKPPF 349
            +D WS+G+ L EM  G+ P 
Sbjct: 245 QSDIWSMGLSLVEMAVGRYPI 265

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 120/229 (52%), Gaps = 18/229 (7%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ F+V ++ GQG FG V   ++K+T    A+K + +D        + M+     L  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD----LAVLH 77
Query: 209 HPFVVQLKYSFQT-----KYRLYL--VLDFI-NGGHLFFQLYHHGLFRED--LARIYAAE 258
           HP +VQL+  F T     +  +YL  V++++ +  H   + Y+         L +++  +
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 259 IVSAVS--HLHANGIMHRDLKPENILLG-ADGHVMLTDFGLAKQFDENTRSNSMIGTVEY 315
           ++ ++   HL +  + HRD+KP N+L+  ADG + L DFG AK+   +  + + I +  Y
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 316 MAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
            APE++ G  H   A D WSVG +  EM+ G+P F G N A    +IV+
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 112/233 (48%), Gaps = 20/233 (8%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI-----LTK 206
           +E +  +G GA+G VY+ R  ++    A+K +R            +   R++     L  
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 207 IDHPFVVQLKYSFQT-----KYRLYLVLDFINGGHLFF--QLYHHGLFRE---DLARIYA 256
            +HP VV+L     T     + ++ LV + ++     +  +    GL  E   DL R   
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR--- 127
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYM 316
            + +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +        ++ T+ Y 
Sbjct: 128 -QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP 369
           APE++L   +    D WSVG +  EM   KP F G + A    KI  D + LP
Sbjct: 187 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF-DLIGLP 238

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 115/212 (54%), Gaps = 23/212 (10%)
Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL- 215
           ++GQGA   V++ R K T +++A+KV      +     +    E ++L K++H  +V+L 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLF 73
Query: 216 --KYSFQTKYRLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHAN 269
             +    T++++ L+++F   G L+  L      +GL   +   I   ++V  ++HL  N
Sbjct: 74  AIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLREN 131
Query: 270 GIMHRDLKPENIL--LGADGHVM--LTDFGLAKQFDENTRSNSMIGTVEYMAPEI----V 321
           GI+HR++KP NI+  +G DG  +  LTDFG A++ +++ +   + GT EY+ P++    V
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAV 191
Query: 322 LGKGHNK----AADWWSVGILLYEMLTGKPPF 349
           L K H K      D WS+G+  Y   TG  PF
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 109/201 (54%), Gaps = 4/201 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE +  +G G  G V++V  K +  + A K++  +  ++      +  E  +L + + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH-A 268
           P++V    +F +   + + ++ ++GG L   L   G   E +    +  ++  +++L   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           + IMHRD+KP NIL+ + G + L DFG++ Q   ++ +NS +GT  YM+PE + G  ++ 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 329 AADWWSVGILLYEMLTGKPPF 349
            +D WS+G+ L EM  G+ P 
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 109/201 (54%), Gaps = 4/201 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE +  +G G  G V++V  K +  + A K++  +  ++      +  E  +L + + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH-A 268
           P++V    +F +   + + ++ ++GG L   L   G   E +    +  ++  +++L   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           + IMHRD+KP NIL+ + G + L DFG++ Q   ++ +NS +GT  YM+PE + G  ++ 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 329 AADWWSVGILLYEMLTGKPPF 349
            +D WS+G+ L EM  G+ P 
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 109/201 (54%), Gaps = 4/201 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE +  +G G  G V++V  K +  + A K++  +  ++      +  E  +L + + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH-A 268
           P++V    +F +   + + ++ ++GG L   L   G   E +    +  ++  +++L   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           + IMHRD+KP NIL+ + G + L DFG++ Q   ++ +NS +GT  YM+PE + G  ++ 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 329 AADWWSVGILLYEMLTGKPPF 349
            +D WS+G+ L EM  G+ P 
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPI 203

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 109/201 (54%), Gaps = 4/201 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE +  +G G  G V++V  K +  + A K++  +  ++      +  E  +L + + 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 90
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH-A 268
           P++V    +F +   + + ++ ++GG L   L   G   E +    +  ++  +++L   
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           + IMHRD+KP NIL+ + G + L DFG++ Q   ++ +NS +GT  YM+PE + G  ++ 
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 209
Query: 329 AADWWSVGILLYEMLTGKPPF 349
            +D WS+G+ L EM  G+ P 
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPI 230

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 109/201 (54%), Gaps = 4/201 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE +  +G G  G V++V  K +  + A K++  +  ++      +  E  +L + + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH-A 268
           P++V    +F +   + + ++ ++GG L   L   G   E +    +  ++  +++L   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           + IMHRD+KP NIL+ + G + L DFG++ Q   ++ +NS +GT  YM+PE + G  ++ 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 329 AADWWSVGILLYEMLTGKPPF 349
            +D WS+G+ L EM  G+ P 
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 109/201 (54%), Gaps = 4/201 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE +  +G G  G V++V  K +  + A K++  +  ++      +  E  +L + + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH-A 268
           P++V    +F +   + + ++ ++GG L   L   G   E +    +  ++  +++L   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           + IMHRD+KP NIL+ + G + L DFG++ Q   ++ +NS +GT  YM+PE + G  ++ 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 329 AADWWSVGILLYEMLTGKPPF 349
            +D WS+G+ L EM  G+ P 
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPI 203

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 111/205 (54%), Gaps = 4/205 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE +  +G G  G V++V  K +  + A K++  +  ++      +  E  +L + + 
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 82
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH-A 268
           P++V    +F +   + + ++ ++GG L   L   G   E +    +  ++  +++L   
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 142
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           + IMHRD+KP NIL+ + G + L DFG++ Q  ++  +NS +GT  YM+PE + G  ++ 
Sbjct: 143 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSV 201
Query: 329 AADWWSVGILLYEMLTGKPPFIGGN 353
            +D WS+G+ L EM  G+ P   G+
Sbjct: 202 QSDIWSMGLSLVEMAVGRYPIGSGS 226

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 133/279 (47%), Gaps = 53/279 (18%)
Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K+++      +    + +A +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ------ 69
Query: 208 DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVS 261
             P +V++   ++  Y     L +V++ ++GG LF ++   G   F E  A      I  
Sbjct: 70  -CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 262 AVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+                   
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------------- 169
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF------- 371
               G+ ++K+ D WS+G+++Y +L G PPF   +   I   + K ++R+  +       
Sbjct: 170 --TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPNPEW 226
Query: 372 --LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
             +S E   L++ LL+ EP +R+        E  +H W 
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 260

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 114/233 (48%), Gaps = 23/233 (9%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI-----LTK 206
           +E +  +G GA+G VY+ R  ++    A+K +R   +        +   R++     L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGEEGLPISTVREVALLRRLEA 62
Query: 207 IDHPFVVQLKYSFQT-----KYRLYLVLDFINGGHLFF--QLYHHGLFRE---DLARIYA 256
            +HP VV+L     T     + ++ LV + ++     +  +    GL  E   DL R   
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR--- 119
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYM 316
            + +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +      + ++ T+ Y 
Sbjct: 120 -QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYR 178
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP 369
           APE++L   +    D WSVG +  EM   KP F G + A    KI  D + LP
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF-DLIGLP 230

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 142/303 (46%), Gaps = 51/303 (16%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK--AERDI--L 204
           +E +E +  +G+G++G V++ R ++T +I A+K     K +E      +K  A R+I  L
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRML 56
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSAV 263
            ++ HP +V L   F+ K RL+LV ++ +   L     Y  G+  E L +    + + AV
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGV-PEHLVKSITWQTLQAV 115
Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVL 322
           +  H +  +HRD+KPENIL+     + L DFG A+     +   +  + T  Y +PE+++
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175
Query: 323 GKG-HNKAADWWSVGILLYEMLTGKPPFIG--------------GNRAKIQQKIVKD--- 364
           G   +    D W++G +  E+L+G P + G              G+     Q++      
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235
Query: 365 ---------------KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
                          +L+ P  +S  A  LLKG L  +P +RL       E++  H +F+
Sbjct: 236 FSGVKIPDPEDMEPLELKFPN-ISYPALGLLKGCLHMDPTERLTC-----EQLLHHPYFE 289
Query: 410 PIN 412
            I 
Sbjct: 290 NIR 292

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 124/245 (50%), Gaps = 6/245 (2%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE +  +G G  G V++V  K +  + A K++  +  ++      +  E  +L + + 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 66
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH-A 268
           P++V    +F +   + + ++ ++GG L   L   G   E +    +  ++  +++L   
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 126
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           + IMHRD+KP NIL+ + G + L DFG++ Q  +   +N  +GT  YM+PE + G  ++ 
Sbjct: 127 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEM-ANEFVGTRSYMSPERLQGTHYSV 185
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-KLRLP-AFLSSEAHSLLKGLLQK 386
            +D WS+G+ L EM  G+ P       ++   IV +   +LP A  S E    +   L K
Sbjct: 186 QSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIK 245
Query: 387 EPGKR 391
            P +R
Sbjct: 246 NPAER 250

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 113/233 (48%), Gaps = 23/233 (9%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI-----LTK 206
           +E +  +G GA+G VY+ R  ++    A+K +R   +        +   R++     L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGEEGLPISTVREVALLRRLEA 62
Query: 207 IDHPFVVQLKYSFQT-----KYRLYLVLDFINGGHLFF--QLYHHGLFRE---DLARIYA 256
            +HP VV+L     T     + ++ LV + ++     +  +    GL  E   DL R   
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR--- 119
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYM 316
            + +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +        ++ T+ Y 
Sbjct: 120 -QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYR 178
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP 369
           APE++L   +    D WSVG +  EM   KP F G + A    KI  D + LP
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF-DLIGLP 230

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 122/254 (48%), Gaps = 20/254 (7%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+FG V+++  K T    A+K +R    +E   AE + A       +  P +V L  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVR----LEVFRAEELMA----CAGLTSPRIVPLYG 152
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   +   G   ED A  Y  + +  + +LH+  I+H D+K
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 278 PENILLGADG-HVMLTDFGLAKQFDENTRSNSMI------GTVEYMAPEIVLGKGHNKAA 330
            +N+LL +DG H  L DFG A     +    S++      GT  +MAPE+VLG+  +   
Sbjct: 213 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKV 272
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL----PAFLSSEAHSLLKGLLQK 386
           D WS   ++  ML G  P+    R  +  KI  +   +    P+     A ++ +G L+K
Sbjct: 273 DVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEG-LRK 331
Query: 387 EPGKRLGAGPKGSE 400
           EP  R+ A   G +
Sbjct: 332 EPIHRVSAAELGGK 345

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 120/240 (50%), Gaps = 22/240 (9%)
Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRK-KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI- 203
           C   + +E +  +G+GA+G+V++ R  KN     A+K +R   +        +   R++ 
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVA 63
Query: 204 ----LTKIDHPFVVQL-------KYSFQTKYRLYLVLDFINGGHLFF--QLYHHGLFRED 250
               L   +HP VV+L       +   +TK  L LV + ++     +  ++   G+  E 
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTET 121
Query: 251 LARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI 310
           +  +   +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +       S++
Sbjct: 122 IKDM-MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180
Query: 311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA 370
            T+ Y APE++L   +    D WSVG +  EM   KP F G +      KI+ D + LP 
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL-DVIGLPG 239

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 113/233 (48%), Gaps = 23/233 (9%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI-----LTK 206
           +E +  +G GA+G VY+ R  ++    A+K +R   +        +   R++     L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGEEGLPISTVREVALLRRLEA 62
Query: 207 IDHPFVVQLKYSFQT-----KYRLYLVLDFINGGHLFF--QLYHHGLFRE---DLARIYA 256
            +HP VV+L     T     + ++ LV + ++     +  +    GL  E   DL R   
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR--- 119
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYM 316
            + +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +        ++ T+ Y 
Sbjct: 120 -QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYR 178
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP 369
           APE++L   +    D WSVG +  EM   KP F G + A    KI  D + LP
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF-DLIGLP 230

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 120/240 (50%), Gaps = 22/240 (9%)
Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRK-KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI- 203
           C   + +E +  +G+GA+G+V++ R  KN     A+K +R   +        +   R++ 
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVA 63
Query: 204 ----LTKIDHPFVVQL-------KYSFQTKYRLYLVLDFINGGHLFF--QLYHHGLFRED 250
               L   +HP VV+L       +   +TK  L LV + ++     +  ++   G+  E 
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTET 121
Query: 251 LARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI 310
           +  +   +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +       S++
Sbjct: 122 IKDM-MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180
Query: 311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA 370
            T+ Y APE++L   +    D WSVG +  EM   KP F G +      KI+ D + LP 
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL-DVIGLPG 239

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 111/221 (50%), Gaps = 10/221 (4%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ ++ LK +G GA G V            A+K + +     + HA+    E  +L  ++
Sbjct: 21  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 79
Query: 209 HPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
           H  ++ L   F  +  L      YLV++ ++      Q+ H  L  E ++ +   +++  
Sbjct: 80  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYL-LYQMLCG 136
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    N      + T  Y APE++L
Sbjct: 137 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVIL 196
Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           G G+ +  D WSVG ++ E++ G   F G +      K+++
Sbjct: 197 GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 237

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 120/240 (50%), Gaps = 22/240 (9%)
Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRK-KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI- 203
           C   + +E +  +G+GA+G+V++ R  KN     A+K +R   +        +   R++ 
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVA 63
Query: 204 ----LTKIDHPFVVQL-------KYSFQTKYRLYLVLDFINGGHLFF--QLYHHGLFRED 250
               L   +HP VV+L       +   +TK  L LV + ++     +  ++   G+  E 
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTET 121
Query: 251 LARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI 310
           +  +   +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +       S++
Sbjct: 122 IKDM-MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180
Query: 311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA 370
            T+ Y APE++L   +    D WSVG +  EM   KP F G +      KI+ D + LP 
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL-DVIGLPG 239

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 130/258 (50%), Gaps = 27/258 (10%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +  ++ EV +VVG+GAFG V + +       +  K +   +I  ++  +    E   L++
Sbjct: 6   IDYKEIEVEEVVGRGAFGVVCKAK-------WRAKDVAIKQIESESERKAFIVELRQLSR 58
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-----LFREDLARIYAAEIVS 261
           ++HP +V+L  +      + LV+++  GG L+  L  HG      +    A  +  +   
Sbjct: 59  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCLQCSQ 114
Query: 262 AVSHLHA---NGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMA 317
            V++LH+     ++HRDLKP N+LL A G V+ + DFG A     +  +N   G+  +MA
Sbjct: 115 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMA 172
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPF--IGGNRAKIQQKIVKDKLRLPAF--LS 373
           PE+  G  +++  D +S GI+L+E++T + PF  IGG   +I    V +  R P    L 
Sbjct: 173 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA-VHNGTRPPLIKNLP 231
Query: 374 SEAHSLLKGLLQKEPGKR 391
               SL+     K+P +R
Sbjct: 232 KPIESLMTRCWSKDPSQR 249

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 109/247 (44%), Gaps = 12/247 (4%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F  L+ +G G+FG VY  R    SE+ A+K M           + +  E   L K+ HP 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
            +Q +  +  ++  +LV+++  G        H    +E          +  +++LH++ +
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175
Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG---HNK 328
           +HRD+K  NILL   G V L DFG A        +N  +GT  +MAPE++L      ++ 
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYDG 232
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL----L 384
             D WS+GI   E+   KPP    N       I +++   PA  S       +      L
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--SPALQSGHWSEYFRNFVDSCL 290
Query: 385 QKEPGKR 391
           QK P  R
Sbjct: 291 QKIPQDR 297

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 130/258 (50%), Gaps = 27/258 (10%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +  ++ EV +VVG+GAFG V + +       +  K +   +I  ++  +    E   L++
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAK-------WRAKDVAIKQIESESERKAFIVELRQLSR 57
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-----LFREDLARIYAAEIVS 261
           ++HP +V+L  +      + LV+++  GG L+  L  HG      +    A  +  +   
Sbjct: 58  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 262 AVSHLHA---NGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMA 317
            V++LH+     ++HRDLKP N+LL A G V+ + DFG A     +  +N   G+  +MA
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMA 171
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPF--IGGNRAKIQQKIVKDKLRLPAF--LS 373
           PE+  G  +++  D +S GI+L+E++T + PF  IGG   +I    V +  R P    L 
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA-VHNGTRPPLIKNLP 230
Query: 374 SEAHSLLKGLLQKEPGKR 391
               SL+     K+P +R
Sbjct: 231 KPIESLMTRCWSKDPSQR 248

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
           KV+G G+FG V+Q +   + E+   KV++  +        +   E  I+  + HP VV L
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR--------FKNRELQIMRIVKHPNVVDL 97
Query: 216 KYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFRED----LARIYAAEIVSAVSH 265
           K  F +      +  L LVL+++    ++    H+   ++     L ++Y  +++ ++++
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
           +H+ GI HRD+KP+N+LL     V+ L DFG AK       + S I +  Y APE++ G 
Sbjct: 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGA 216
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIG 351
             +    D WS G ++ E++ G+P F G
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQPLFPG 244

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +EVLKV+G+G+FG+V +       +  A+K++R +K   +  AE ++   + L K D   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRI-LEHLRKQDKDN 157
Query: 212 VVQLKYSFQT-KYRLYLVLDFINGGHLFFQLYHHGLFRE---DLARIYAAEIVSAVSHLH 267
            + + +  +   +R ++ + F       ++L     F+     L R +A  I+  +  LH
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 268 ANGIMHRDLKPENILLGADGH--VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
            N I+H DLKPENILL   G   + + DFG      E+ R  + I +  Y APE++LG  
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILGAR 275
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIG 351
           +    D WS+G +L E+LTG P   G
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPG 301

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 109/247 (44%), Gaps = 12/247 (4%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F  L+ +G G+FG VY  R    SE+ A+K M           + +  E   L K+ HP 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
            +Q +  +  ++  +LV+++  G        H    +E          +  +++LH++ +
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG---HNK 328
           +HRD+K  NILL   G V L DFG A        +N  +GT  +MAPE++L      ++ 
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL----L 384
             D WS+GI   E+   KPP    N       I +++   PA  S       +      L
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--SPALQSGHWSEYFRNFVDSCL 251
Query: 385 QKEPGKR 391
           QK P  R
Sbjct: 252 QKIPQDR 258

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 114/237 (48%), Gaps = 28/237 (11%)
Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK----AER 201
           C  +  +E L  +GQG FG V++ R + T +  A+K     K++ +N  E        E 
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 68
Query: 202 DILTKIDHPFVVQLKYSFQTKYR--------LYLVLDFINGGHLFFQLYHHGLFREDLAR 253
            IL  + H  VV L    +TK          +YLV DF    H    L  + L +  L+ 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--HDLAGLLSNVLVKFTLSE 126
Query: 254 I--YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-----DENTRS 306
           I      +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F      +  R 
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 307 NSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV 362
            + + T+ Y  PE++LG + +    D W  G ++ EM T + P + GN  + Q  ++
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 242

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 109/201 (54%), Gaps = 4/201 (1%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE +  +G G  G V +V+ + +  I A K++  +  ++      +  E  +L + + 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNS 73
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH-A 268
           P++V    +F +   + + ++ ++GG L   L       E++    +  ++  +++L   
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 133
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           + IMHRD+KP NIL+ + G + L DFG++ Q   ++ +NS +GT  YMAPE + G  ++ 
Sbjct: 134 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMAPERLQGTHYSV 192
Query: 329 AADWWSVGILLYEMLTGKPPF 349
            +D WS+G+ L E+  G+ P 
Sbjct: 193 QSDIWSMGLSLVELAVGRYPI 213

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 114/237 (48%), Gaps = 28/237 (11%)
Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA----ER 201
           C  +  +E L  +GQG FG V++ R + T +  A+K     K++ +N  E        E 
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 68
Query: 202 DILTKIDHPFVVQLKYSFQTKYR--------LYLVLDFINGGHLFFQLYHHGLFREDLAR 253
            IL  + H  VV L    +TK          +YLV DF    H    L  + L +  L+ 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--HDLAGLLSNVLVKFTLSE 126
Query: 254 I--YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-----DENTRS 306
           I      +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F      +  R 
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 307 NSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV 362
            + + T+ Y  PE++LG + +    D W  G ++ EM T + P + GN  + Q  ++
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 242

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 121/254 (47%), Gaps = 20/254 (7%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+FG V+++  K T    A+K +R    +E   AE + A       +  P +V L  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVR----LEVFRAEELMA----CAGLTSPRIVPLYG 133
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   +   G   ED A  Y  + +  + +LH+  I+H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 278 PENILLGADG-HVMLTDFGLAKQFDENTRSNSMI------GTVEYMAPEIVLGKGHNKAA 330
            +N+LL +DG H  L DFG A     +     ++      GT  +MAPE+VLG+  +   
Sbjct: 194 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKV 253
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL----PAFLSSEAHSLLKGLLQK 386
           D WS   ++  ML G  P+    R  +  KI  +   +    P+     A ++ +G L+K
Sbjct: 254 DVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEG-LRK 312
Query: 387 EPGKRLGAGPKGSE 400
           EP  R+ A   G +
Sbjct: 313 EPIHRVSAAELGGK 326

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM-------KAERDIL 204
           +EVLKV+G+G+FG+V +       +  A+K++R +K   +  AE +       K ++D  
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
             + H       ++F+    +   L  +N   L  +    G F   L R +A  I+  + 
Sbjct: 159 MNVIHMLE---NFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLD 214
Query: 265 HLHANGIMHRDLKPENILLGADGH--VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
            LH N I+H DLKPENILL   G   + + DFG      E+ R  + I +  Y APE++L
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVIL 272
Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIG 351
           G  +    D WS+G +L E+LTG P   G
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGYPLLPG 301

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 114/237 (48%), Gaps = 28/237 (11%)
Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK----AER 201
           C  +  +E L  +GQG FG V++ R + T +  A+K     K++ +N  E        E 
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 68
Query: 202 DILTKIDHPFVVQLKYSFQTKYR--------LYLVLDFINGGHLFFQLYHHGLFREDLAR 253
            IL  + H  VV L    +TK          +YLV DF    H    L  + L +  L+ 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCE--HDLAGLLSNVLVKFTLSE 126
Query: 254 I--YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-----DENTRS 306
           I      +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F      +  R 
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 307 NSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV 362
            + + T+ Y  PE++LG + +    D W  G ++ EM T + P + GN  + Q  ++
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 242

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 114/237 (48%), Gaps = 28/237 (11%)
Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK----AER 201
           C  +  +E L  +GQG FG V++ R + T +  A+K     K++ +N  E        E 
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 67
Query: 202 DILTKIDHPFVVQLKYSFQTKYR--------LYLVLDFINGGHLFFQLYHHGLFREDLAR 253
            IL  + H  VV L    +TK          +YLV DF    H    L  + L +  L+ 
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--HDLAGLLSNVLVKFTLSE 125
Query: 254 I--YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-----DENTRS 306
           I      +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F      +  R 
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 307 NSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV 362
            + + T+ Y  PE++LG + +    D W  G ++ EM T + P + GN  + Q  ++
Sbjct: 186 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 241

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 110/221 (49%), Gaps = 10/221 (4%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ ++ LK +G GA G V            A+K + +     + HA+    E  +L  ++
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 81
Query: 209 HPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
           H  ++ L   F  +  L      YLV++ ++      Q+ H  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    N      + T  Y APE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           G G+    D WSVG ++ E++ G   F G +      K+++
Sbjct: 199 GMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIE 239

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 124/267 (46%), Gaps = 16/267 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E + + + +G+G FG V++  + ++ + Y  K ++    V+      +K E  IL    H
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILNIARH 60
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL-FREDLARIYAAEIVSAVSHLHA 268
             ++ L  SF++   L ++ +FI+G  +F ++        E     Y  ++  A+  LH+
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 269 NGIMHRDLKPENILLGA--DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           + I H D++PENI+        + + +FG A+Q         +    EY APE+      
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSLLKG 382
           + A D WS+G L+Y +L+G  PF+     +I + I+  +      AF  +S EA   +  
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           LL KE   R+ A      E   H W K
Sbjct: 241 LLVKERKSRMTAS-----EALQHPWLK 262

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 118/248 (47%), Gaps = 17/248 (6%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +  L+ VG GA+G V       T    A+K + +     +  A+    E  +L  + H  
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRHEN 85
Query: 212 VVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
           V+ L   F     L      YLV+ F+  G    +L  H    ED  +    +++  + +
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-K 324
           +HA GI+HRDLKP N+ +  D  + + DFGLA+Q D  +     + T  Y APE++L   
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMXGXVVTRWYRAPEVILNWM 201
Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA-----FLSSEAHSL 379
            + +  D WSVG ++ EM+TGK  F G +     ++I+K     PA       S EA + 
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261
Query: 380 LKGLLQKE 387
           +KGL + E
Sbjct: 262 MKGLPELE 269

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +EVLKV+G+G FG+V +       +  A+K++R +K   +  AE ++   + L K D   
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRI-LEHLRKQDKDN 157
Query: 212 VVQLKYSFQT-KYRLYLVLDFINGGHLFFQLYHHGLFRE---DLARIYAAEIVSAVSHLH 267
            + + +  +   +R ++ + F       ++L     F+     L R +A  I+  +  LH
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 268 ANGIMHRDLKPENILLGADGH--VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
            N I+H DLKPENILL   G   + + DFG      E+ R    I +  Y APE++LG  
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYXXIQSRFYRAPEVILGAR 275
Query: 326 HNKAADWWSVGILLYEMLTGKPPFIG 351
           +    D WS+G +L E+LTG P   G
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPG 301

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 135/250 (54%), Gaps = 13/250 (5%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           D  + + +G G+FG V++  + + S++    +M +D   E+ + E+++ E  I+ ++ HP
Sbjct: 38  DLNIKEKIGAGSFGTVHRA-EWHGSDVAVKILMEQDFHAERVN-EFLR-EVAIMKRLRHP 94
Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDL---ARI-YAAEIVSAVSHL 266
            +V    +      L +V ++++ G L+ +L H    RE L    R+  A ++   +++L
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 267 HANG--IMHRDLKPENILLGADGHVMLTDFGLAK-QFDENTRSNSMIGTVEYMAPEIVLG 323
           H     I+HR+LK  N+L+     V + DFGL++ +      S S  GT E+MAPE++  
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAFLSSEAHSLLK 381
           +  N+ +D +S G++L+E+ T + P+   N A++   +     +L +P  L+ +  ++++
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 382 GLLQKEPGKR 391
           G    EP KR
Sbjct: 274 GCWTNEPWKR 283

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 134/250 (53%), Gaps = 13/250 (5%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           D  + + +G G+FG V++  + + S++    +M +D   E+ + E+++ E  I+ ++ HP
Sbjct: 38  DLNIKEKIGAGSFGTVHRA-EWHGSDVAVKILMEQDFHAERVN-EFLR-EVAIMKRLRHP 94
Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDL---ARI-YAAEIVSAVSHL 266
            +V    +      L +V ++++ G L+ +L H    RE L    R+  A ++   +++L
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 267 HANG--IMHRDLKPENILLGADGHVMLTDFGLAK-QFDENTRSNSMIGTVEYMAPEIVLG 323
           H     I+HRDLK  N+L+     V + DFGL++ +      S    GT E+MAPE++  
Sbjct: 154 HNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRD 213
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI--VKDKLRLPAFLSSEAHSLLK 381
           +  N+ +D +S G++L+E+ T + P+   N A++   +     +L +P  L+ +  ++++
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 382 GLLQKEPGKR 391
           G    EP KR
Sbjct: 274 GCWTNEPWKR 283

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 121/241 (50%), Gaps = 20/241 (8%)
Query: 179 AMKVMRKDKIV---EKNHAEYMKAERDILTKIDHPF--VVQLKYSFQTKYRLYLVLDFIN 233
           A+K + KD+I    E  +   +  E  +L K+   F  V++L   F+      L+L+   
Sbjct: 80  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 139
Query: 234 GGH-LFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD-GHVML 291
               LF  +   G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+  + G + L
Sbjct: 140 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 199
Query: 292 TDFGLAKQFDENTRSNSMIGTVEYMAPE-IVLGKGHNKAADWWSVGILLYEMLTGKPPFI 350
            DFG +    ++T      GT  Y  PE I   + H ++A  WS+GILLY+M+ G  PF 
Sbjct: 200 IDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF- 257
Query: 351 GGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP 410
                +  ++I++ ++     +SSE   L++  L   P  R        EEI++H W + 
Sbjct: 258 -----EHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQD 307
Query: 411 I 411
           +
Sbjct: 308 V 308

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 118/225 (52%), Gaps = 15/225 (6%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ +E+  ++G+G+FG+V +   +   E  A+K++ K+K    N A+      +++ K D
Sbjct: 34  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 92
Query: 209 HP---FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE---DLARIYAAEIVSA 262
                ++V LK  F  +  L LV + ++  +  + L  +  FR    +L R +A ++ +A
Sbjct: 93  TEMKYYIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 150
Query: 263 VSHLHAN--GIMHRDLKPENILLG--ADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           +  L      I+H DLKPENILL       + + DFG + Q  +  R    I +  Y +P
Sbjct: 151 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSP 208
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           E++LG  ++ A D WS+G +L EM TG+P F G N      KIV+
Sbjct: 209 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 253

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      Y+V++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +    +V  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YLLYQMLV-GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG+++ EM+ G   F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 118/225 (52%), Gaps = 15/225 (6%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ +E+  ++G+G+FG+V +   +   E  A+K++ K+K    N A+      +++ K D
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 111
Query: 209 HP---FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE---DLARIYAAEIVSA 262
                ++V LK  F  +  L LV + ++  +  + L  +  FR    +L R +A ++ +A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 263 VSHLHAN--GIMHRDLKPENILLG--ADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           +  L      I+H DLKPENILL       + + DFG + Q  +  R    I +  Y +P
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSP 227
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           E++LG  ++ A D WS+G +L EM TG+P F G N      KIV+
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 110/221 (49%), Gaps = 10/221 (4%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ ++ LK +G GA G V            A+K + +     + HA+    E  ++  ++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 119
Query: 209 HPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
           H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++ +   +++  
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 176
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T  Y APE++L
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           G G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      Y+V++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +    +V  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YLLYQMLV-GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG+++ EM+ G   F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 118/225 (52%), Gaps = 15/225 (6%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ +E+  ++G+G+FG+V +   +   E  A+K++ K+K    N A+      +++ K D
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 111
Query: 209 HP---FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE---DLARIYAAEIVSA 262
                ++V LK  F  +  L LV + ++  +  + L  +  FR    +L R +A ++ +A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 263 VSHLHAN--GIMHRDLKPENILLGADGH--VMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           +  L      I+H DLKPENILL       + + DFG + Q  +  R    I +  Y +P
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSP 227
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           E++LG  ++ A D WS+G +L EM TG+P F G N      KIV+
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 131/256 (51%), Gaps = 23/256 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRK---DKIVEKNHAEYMKAERDI 203
           E  E+ + +G+G FG V+Q   +  +N +   A+K  +    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT----- 64
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARI--YAAEI 259
           + + DHP +V+L     T+  ++++++    G L  F Q+  + L   DLA +  YA ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMA 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G   +++MA
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSE 375
           PE +  +    A+D W  G+ ++E+L  G  PF G     +  +I   ++L +P      
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 240
Query: 376 AHSLLKGLLQKEPGKR 391
            +SL+      +P +R
Sbjct: 241 LYSLMTKCWAYDPSRR 256

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 130/256 (50%), Gaps = 23/256 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRK---DKIVEKNHAEYMKAERDI 203
           E  E+ + +G+G FG V+Q   +  +N +   A+K  +    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT----- 64
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARI--YAAEI 259
           + + DHP +V+L     T+  ++++++    G L  F Q+    L   DLA +  YA ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSL---DLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMA 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G   +++MA
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMA 180
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSE 375
           PE +  +    A+D W  G+ ++E+L  G  PF G     +  +I   ++L +P      
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 240
Query: 376 AHSLLKGLLQKEPGKR 391
            +SL+      +P +R
Sbjct: 241 LYSLMTKCWAYDPSRR 256

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 111/228 (48%), Gaps = 37/228 (16%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEI-------------YAMKVMRKDKIVEKNHAEYM 197
           DF++  ++G+GA+G V     K T EI             +A++ +R+ KI++     + 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK-----HF 66
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
           K E  I       F +Q   SF+    +Y++ + +       ++    +  +D  + +  
Sbjct: 67  KHENIITI-----FNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIY 119
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS--------- 308
           + + AV  LH + ++HRDLKP N+L+ ++  + + DFGLA+  DE+   NS         
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 309 --MIGTVEYMAPEIVLGKG-HNKAADWWSVGILLYEMLTGKPPFIGGN 353
              + T  Y APE++L    +++A D WS G +L E+   +P F G +
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 131/256 (51%), Gaps = 23/256 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRK---DKIVEKNHAEYMKAERDI 203
           E  E+ + +G+G FG V+Q   +  +N +   A+K  +    D + EK   E +      
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 67
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARI--YAAEI 259
           + + DHP +V+L     T+  ++++++    G L  F Q+  + L   DLA +  YA ++
Sbjct: 68  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 123
Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMA 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G   +++MA
Sbjct: 124 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 183
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSE 375
           PE +  +    A+D W  G+ ++E+L  G  PF G     +  +I   ++L +P      
Sbjct: 184 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 243
Query: 376 AHSLLKGLLQKEPGKR 391
            +SL+      +P +R
Sbjct: 244 LYSLMTKCWAYDPSRR 259

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 131/256 (51%), Gaps = 23/256 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRK---DKIVEKNHAEYMKAERDI 203
           E  E+ + +G+G FG V+Q   +  +N +   A+K  +    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT----- 64
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARI--YAAEI 259
           + + DHP +V+L     T+  ++++++    G L  F Q+  + L   DLA +  YA ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMA 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G   +++MA
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSE 375
           PE +  +    A+D W  G+ ++E+L  G  PF G     +  +I   ++L +P      
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 240
Query: 376 AHSLLKGLLQKEPGKR 391
            +SL+      +P +R
Sbjct: 241 LYSLMTKCWAYDPSRR 256

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 131/256 (51%), Gaps = 23/256 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRK---DKIVEKNHAEYMKAERDI 203
           E  E+ + +G+G FG V+Q   +  +N +   A+K  +    D + EK   E +      
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 66
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARI--YAAEI 259
           + + DHP +V+L     T+  ++++++    G L  F Q+  + L   DLA +  YA ++
Sbjct: 67  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 122
Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMA 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G   +++MA
Sbjct: 123 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 182
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSE 375
           PE +  +    A+D W  G+ ++E+L  G  PF G     +  +I   ++L +P      
Sbjct: 183 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 242
Query: 376 AHSLLKGLLQKEPGKR 391
            +SL+      +P +R
Sbjct: 243 LYSLMTKCWAYDPSRR 258

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 131/256 (51%), Gaps = 23/256 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRK---DKIVEKNHAEYMKAERDI 203
           E  E+ + +G+G FG V+Q   +  +N +   A+K  +    D + EK   E +      
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT----- 92
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARI--YAAEI 259
           + + DHP +V+L     T+  ++++++    G L  F Q+  + L   DLA +  YA ++
Sbjct: 93  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 148
Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMA 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G   +++MA
Sbjct: 149 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 208
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSE 375
           PE +  +    A+D W  G+ ++E+L  G  PF G     +  +I   ++L +P      
Sbjct: 209 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 268
Query: 376 AHSLLKGLLQKEPGKR 391
            +SL+      +P +R
Sbjct: 269 LYSLMTKCWAYDPSRR 284

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 131/256 (51%), Gaps = 23/256 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRK---DKIVEKNHAEYMKAERDI 203
           E  E+ + +G+G FG V+Q   +  +N +   A+K  +    D + EK   E +      
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 69
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARI--YAAEI 259
           + + DHP +V+L     T+  ++++++    G L  F Q+  + L   DLA +  YA ++
Sbjct: 70  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 125
Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMA 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G   +++MA
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 185
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSE 375
           PE +  +    A+D W  G+ ++E+L  G  PF G     +  +I   ++L +P      
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 245
Query: 376 AHSLLKGLLQKEPGKR 391
            +SL+      +P +R
Sbjct: 246 LYSLMTKCWAYDPSRR 261

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 131/256 (51%), Gaps = 23/256 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRK---DKIVEKNHAEYMKAERDI 203
           E  E+ + +G+G FG V+Q   +  +N +   A+K  +    D + EK   E +      
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 61
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARI--YAAEI 259
           + + DHP +V+L     T+  ++++++    G L  F Q+  + L   DLA +  YA ++
Sbjct: 62  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 117
Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMA 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G   +++MA
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSE 375
           PE +  +    A+D W  G+ ++E+L  G  PF G     +  +I   ++L +P      
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 237
Query: 376 AHSLLKGLLQKEPGKR 391
            +SL+      +P +R
Sbjct: 238 LYSLMTKCWAYDPSRR 253

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 111/228 (48%), Gaps = 37/228 (16%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEI-------------YAMKVMRKDKIVEKNHAEYM 197
           DF++  ++G+GA+G V     K T EI             +A++ +R+ KI++     + 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK-----HF 66
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
           K E  I       F +Q   SF+    +Y++ + +       ++    +  +D  + +  
Sbjct: 67  KHENIITI-----FNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIY 119
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS--------- 308
           + + AV  LH + ++HRDLKP N+L+ ++  + + DFGLA+  DE+   NS         
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 309 --MIGTVEYMAPEIVLGKG-HNKAADWWSVGILLYEMLTGKPPFIGGN 353
              + T  Y APE++L    +++A D WS G +L E+   +P F G +
Sbjct: 180 TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 119/252 (47%), Gaps = 16/252 (6%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-D 208
           + F+ L  +G G++G V++VR K    +YA+K         K+ A  + AE     K+  
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL-AEVGSHEKVGQ 115
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH-----GLFREDLARIYAAEIVSAV 263
           HP  V+L+ +++    LYL  +          L  H         E     Y  + + A+
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGP-----SLQQHCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG 323
           +HLH+ G++H D+KP NI LG  G   L DFGL  +           G   YMAPE++ G
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230
Query: 324 KGHNKAADWWSVGILLYEMLTG-KPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKG 382
             +  AAD +S+G+ + E+    + P  G    +++Q  +  +    A LSSE  S+L  
Sbjct: 231 S-YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFT--AGLSSELRSVLVM 287
Query: 383 LLQKEPGKRLGA 394
           +L+ +P  R  A
Sbjct: 288 MLEPDPKLRATA 299

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 119/235 (50%), Gaps = 13/235 (5%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI-LT 205
           V  +D E +  +G+GA+G V ++R   + +I A+K +R    V     + +  + DI + 
Sbjct: 48  VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMR 105
Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGG--HLFFQLYHHG-LFREDLARIYAAEIVSA 262
            +D PF V    +   +  +++ ++ ++      + Q+   G    ED+    A  IV A
Sbjct: 106 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 165
Query: 263 VSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           + HLH+   ++HRD+KP N+L+ A G V + DFG++    ++       G   YMAPE +
Sbjct: 166 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERI 225
Query: 322 ----LGKGHNKAADWWSVGILLYEMLTGKPPF--IGGNRAKIQQKIVKDKLRLPA 370
                 KG++  +D WS+GI + E+   + P+   G    +++Q + +   +LPA
Sbjct: 226 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 280

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YL-LYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 110/221 (49%), Gaps = 10/221 (4%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ ++ LK +G GA G V            A+K + +     + HA+    E  ++  ++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 119
Query: 209 HPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
           H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++ +   +++  
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 176
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T  Y APE++L
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           G G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 10/210 (4%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTK 206
           +E +  L  +G+G +  VY+ + K T  + A+K +R    +E        A R++  L  
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKD 56
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           + H  +V L     T+  L LV ++++     +      +      +++  +++  +++ 
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGL--AKQFDENTRSNSMIGTVEYMAPEIVLGK 324
           H   ++HRDLKP+N+L+   G + L DFGL  AK     T  N ++ T+ Y  P+I+LG 
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGS 175
Query: 325 -GHNKAADWWSVGILLYEMLTGKPPFIGGN 353
             ++   D W VG + YEM TG+P F G  
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGST 205

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 111/228 (48%), Gaps = 37/228 (16%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEI-------------YAMKVMRKDKIVEKNHAEYM 197
           DF++  ++G+GA+G V     K T EI             +A++ +R+ KI++     + 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK-----HF 66
Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
           K E  I       F +Q   SF+    +Y++ + +       ++    +  +D  + +  
Sbjct: 67  KHENIITI-----FNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIY 119
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS--------- 308
           + + AV  LH + ++HRDLKP N+L+ ++  + + DFGLA+  DE+   NS         
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 309 --MIGTVEYMAPEIVLGKG-HNKAADWWSVGILLYEMLTGKPPFIGGN 353
              + T  Y APE++L    +++A D WS G +L E+   +P F G +
Sbjct: 180 TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      Y+V++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+ G   F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 17  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY 72
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++
Sbjct: 73  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMS 130
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 131 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 189
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 240

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 17  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY 72
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++
Sbjct: 73  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMS 130
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 131 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 189
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 240

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      Y+V++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+ G   F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      Y+V++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+ G   F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 15  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY 70
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++
Sbjct: 71  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMS 128
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 129 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 187
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 188 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 238

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 129/256 (50%), Gaps = 23/256 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRK---DKIVEKNHAEYMKAERDI 203
           E  E+ + +G+G FG V+Q   +  +N +   A+K  +    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT----- 64
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARI--YAAEI 259
           + + DHP +V+L     T+  ++++++    G L  F Q+    L   DLA +  YA ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSL---DLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMA 317
            +A+++L +   +HRD+   N+L+ A   V L DFGL++  +++T   +  G   +++MA
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSE 375
           PE +  +    A+D W  G+ ++E+L  G  PF G     +  +I   ++L +P      
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 240
Query: 376 AHSLLKGLLQKEPGKR 391
            +SL+      +P +R
Sbjct: 241 LYSLMTKCWAYDPSRR 256

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 17  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY 72
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      Y+V++ ++      Q+    L  E ++
Sbjct: 73  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMS 130
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 131 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 189
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+ G   F G +      K+++
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 240

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      Y+V++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+ G   F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 10  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY 65
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++
Sbjct: 66  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMS 123
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 124 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 182
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 183 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 233

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 10  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY 65
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++
Sbjct: 66  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMS 123
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 124 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 182
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 183 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 233

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 9   GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY 64
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMS 122
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 123 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 181
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 120/235 (51%), Gaps = 13/235 (5%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI-LT 205
           V  +D E +  +G+GA+G V ++R   + +I A+K +R    V     + +  + DI + 
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMR 61
Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGG--HLFFQLYHHG-LFREDLARIYAAEIVSA 262
            +D PF V    +   +  +++ ++ ++      + Q+   G    ED+    A  IV A
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 263 VSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           + HLH+   ++HRD+KP N+L+ A G V + DFG++    ++   +   G   YMAPE +
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181
Query: 322 ----LGKGHNKAADWWSVGILLYEMLTGKPPF--IGGNRAKIQQKIVKDKLRLPA 370
                 KG++  +D WS+GI + E+   + P+   G    +++Q + +   +LPA
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 134/281 (47%), Gaps = 25/281 (8%)
Query: 134 DENVKGDSVTVCCVGIED--FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK 191
           D++ K  S    C+ ++   + +LK +G G   +V+QV  +   +IYA+K +  ++   +
Sbjct: 38  DDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQ 96
Query: 192 NHAEYMKAERDILTKID-HPFVVQLKYSFQ-TKYRLYLVLDFINGGHLFFQLYHHGLFRE 249
               Y + E   L K+  H   +   Y ++ T   +Y+V++  N   L   L        
Sbjct: 97  TLDSY-RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDP 154
Query: 250 DLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS--- 306
              + Y   ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   
Sbjct: 155 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVK 213
Query: 307 NSMIGTVEYMAPEIVLGKGHNK-----------AADWWSVGILLYEMLTGKPPF--IGGN 353
           +S +GTV YM PE +     ++            +D WS+G +LY M  GK PF  I   
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
Query: 354 RAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
            +K+   I  + ++  P     +   +LK  L+++P +R+ 
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 314

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      Y+V++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+ G   F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YL-LYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      Y+V++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +    +V  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YLLYQMLV-GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+ G   F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 9   GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY 64
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      YLV++ ++      Q+    L  E ++
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMS 122
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 123 YL-LYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVT 181
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      Y+V++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+ G   F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 18  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY 73
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      Y+V++ ++      Q+    L  E ++
Sbjct: 74  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMS 131
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 132 YLLY-QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVT 190
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+ G   F G +      K+++
Sbjct: 191 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 241

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 112/241 (46%), Gaps = 12/241 (4%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHA 194
           G     C +G +D  +L+ +G G+FG V    +      T  + A+K ++ D + +    
Sbjct: 1   GSQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAM 59
Query: 195 EYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLAR 253
           +    E + +  +DH  +++L Y       + +V +    G L  +L  H G F      
Sbjct: 60  DDFIREVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS 118
Query: 254 IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG-- 311
            YA ++   + +L +   +HRDL   N+LL     V + DFGL +   +N     M    
Sbjct: 119 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 178
Query: 312 --TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
                + APE +  +  + A+D W  G+ L+EM T G+ P+IG N ++I  KI K+  RL
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 238
Query: 369 P 369
           P
Sbjct: 239 P 239

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 21  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY 76
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      Y+V++ ++      Q+    L  E ++
Sbjct: 77  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMS 134
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 135 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 193
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 194 RYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIE 244

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 134/280 (47%), Gaps = 25/280 (8%)
Query: 134 DENVKGDSVTVCCVGIED--FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK 191
           D++ K  S    C+ ++   + +LK +G G   +V+QV  +   +IYA+K +  ++   +
Sbjct: 38  DDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQ 96
Query: 192 NHAEYMKAERDILTKID-HPFVVQLKYSFQ-TKYRLYLVLDFINGGHLFFQLYHHGLFRE 249
               Y + E   L K+  H   +   Y ++ T   +Y+V++  N   L   L        
Sbjct: 97  TLDSY-RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDP 154
Query: 250 DLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS--- 306
              + Y   ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   
Sbjct: 155 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVK 213
Query: 307 NSMIGTVEYMAPEIVLGKGHNK-----------AADWWSVGILLYEMLTGKPPF--IGGN 353
           +S +GTV YM PE +     ++            +D WS+G +LY M  GK PF  I   
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
Query: 354 RAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRL 392
            +K+   I  + ++  P     +   +LK  L+++P +R+
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 313

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 10  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY 65
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      Y+V++ ++      Q+    L  E ++
Sbjct: 66  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMS 123
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 124 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 182
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 183 RYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIE 233

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 129/256 (50%), Gaps = 23/256 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRK---DKIVEKNHAEYMKAERDI 203
           E  E+ + +G+G FG V+Q   +  +N +   A+K  +    D + EK   E +      
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL-----T 444
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARI--YAAEI 259
           + + DHP +V+L     T+  ++++++    G L  F Q+    L   DLA +  YA ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSL---DLASLILYAYQL 500
Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMA 317
            +A+++L +   +HRD+   N+L+ A   V L DFGL++  +++T   +  G   +++MA
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSE 375
           PE +  +    A+D W  G+ ++E+L  G  PF G     +  +I   ++L +P      
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620
Query: 376 AHSLLKGLLQKEPGKR 391
            +SL+      +P +R
Sbjct: 621 LYSLMTKCWAYDPSRR 636

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 132/304 (43%), Gaps = 49/304 (16%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL-- 215
           VG GA+G V     K + E  A+K + +     +  A+    E  +L  + H  V+ L  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQHENVIGLLD 90
Query: 216 ----KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
                 S +  Y  YLV+ F+       Q      F E+  +    +++  + ++H+ G+
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTD---LQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGV 147
Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH-NKAA 330
           +HRDLKP N+ +  D  + + DFGLA+  D        + T  Y APE++L   H N+  
Sbjct: 148 VHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSWMHYNQTV 205
Query: 331 DWWSVGILLYEMLTGKPPFIGGN----------------------------RAKIQ---Q 359
           D WSVG ++ EMLTGK  F G +                            ++ IQ   Q
Sbjct: 206 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQ 265
Query: 360 KIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR 419
              KD  +L    S +A  LL+ +L+ +  KRL A      +  +H +F+P    + E  
Sbjct: 266 TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA-----QALTHPFFEPFRDPEEETE 320
Query: 420 EIQP 423
             QP
Sbjct: 321 AQQP 324

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 112/241 (46%), Gaps = 12/241 (4%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHA 194
           G     C +G +D  +L+ +G G+FG V    +      T  + A+K ++ D + +    
Sbjct: 1   GSQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAM 59
Query: 195 EYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLAR 253
           +    E + +  +DH  +++L Y       + +V +    G L  +L  H G F      
Sbjct: 60  DDFIREVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS 118
Query: 254 IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG-- 311
            YA ++   + +L +   +HRDL   N+LL     V + DFGL +   +N     M    
Sbjct: 119 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 178
Query: 312 --TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
                + APE +  +  + A+D W  G+ L+EM T G+ P+IG N ++I  KI K+  RL
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 238
Query: 369 P 369
           P
Sbjct: 239 P 239

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 132/304 (43%), Gaps = 49/304 (16%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL-- 215
           VG GA+G V     K + E  A+K + +     +  A+    E  +L  + H  V+ L  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQHENVIGLLD 108
Query: 216 ----KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
                 S +  Y  YLV+ F+       Q      F E+  +    +++  + ++H+ G+
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTD---LQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGV 165
Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH-NKAA 330
           +HRDLKP N+ +  D  + + DFGLA+  D        + T  Y APE++L   H N+  
Sbjct: 166 VHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSWMHYNQTV 223
Query: 331 DWWSVGILLYEMLTGKPPFIGGN----------------------------RAKIQ---Q 359
           D WSVG ++ EMLTGK  F G +                            ++ IQ   Q
Sbjct: 224 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQ 283
Query: 360 KIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR 419
              KD  +L    S +A  LL+ +L+ +  KRL A      +  +H +F+P    + E  
Sbjct: 284 TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA-----QALTHPFFEPFRDPEEETE 338
Query: 420 EIQP 423
             QP
Sbjct: 339 AQQP 342

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 152 FEVLKVVGQGAFGRVY----QVRKKNTS---------EIYAMKVMRKDKIVEKNHAEYMK 198
           +  L+ +G+GA+G V      VRK   +         + Y  + +R+ +I+ +   E + 
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAE 258
             RDIL             + +    +Y+V D +      ++L        D    +  +
Sbjct: 105 GIRDILRA----------STLEAMRDVYIVQDLMETD--LYKLLKSQQLSNDHICYFLYQ 152
Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK----QFDENTRSNSMIGTVE 314
           I+  + ++H+  ++HRDLKP N+L+     + + DFGLA+    + D        + T  
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRW 212
Query: 315 YMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           Y APEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G FG VY+   K  S   A+K +++D +      E++K E  ++ +I HP +VQL  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 74
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y     R++++ +     A +I SA+ +L     +H
Sbjct: 75  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 274 RDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           RDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 332 WWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPG 389
            W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P 
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 252
Query: 390 KR 391
            R
Sbjct: 253 DR 254

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 111/236 (47%), Gaps = 12/236 (5%)
Query: 144 VCCVGIEDFEVLKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA 199
            C +G +D  +L+ +G G+FG V    +      T  + A+K ++ D + +    +    
Sbjct: 12  TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIR 70
Query: 200 ERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLARIYAAE 258
           E + +  +DH  +++L Y       + +V +    G L  +L  H G F       YA +
Sbjct: 71  EVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG----TVE 314
           +   + +L +   +HRDL   N+LL     V + DFGL +   +N     M         
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA 189
Query: 315 YMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
           + APE +  +  + A+D W  G+ L+EM T G+ P+IG N ++I  KI K+  RLP
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 122/242 (50%), Gaps = 14/242 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G +G VY+   K  S   A+K +++D +      E++K E  ++ +I HP +VQL  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 74
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L   L      R++++ +     A +I SA+ +L     +H
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 274 RDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           RDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 332 WWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPG 389
            W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P 
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 252
Query: 390 KR 391
            R
Sbjct: 253 DR 254

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 133/313 (42%), Gaps = 53/313 (16%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--------------DKIVEKNHA 194
           I D+ +++ + QG F ++    K N  + YA+K   K              DKI  K+  
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEKDN--KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 195 EYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFI-NGGHLFFQLYHHGLFRE---- 249
           +  K E  I+T I + + +  +        +Y++ +++ N   L F  Y   L +     
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 250 ---DLARIYAAEIVSAVSHLH-ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR 305
               + +     ++++ S++H    I HRD+KP NIL+  +G V L+DFG ++   +   
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 306 SNSMIGTVEYMAPEIVLGKGHNKAA--DWWSVGILLYEMLTGKPPF---------IGGNR 354
             S  GT E+M PE    +     A  D WS+GI LY M     PF             R
Sbjct: 208 KGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
Query: 355 AK-IQQKIVKDKLRLP----------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIK 403
            K I+  + ++    P           FLS+E    LK  L+K P +R+      SE+  
Sbjct: 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI-----TSEDAL 321
Query: 404 SHKWFKPINWKKL 416
            H+W    N + L
Sbjct: 322 KHEWLADTNIEDL 334

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 130/256 (50%), Gaps = 23/256 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRK---DKIVEKNHAEYMKAERDI 203
           E  E+ + +G+G FG V+Q   +  +N +   A+K  +    D + EK   E +      
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL-----T 444
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARI--YAAEI 259
           + + DHP +V+L     T+  ++++++    G L  F Q+    L   DLA +  YA ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSL---DLASLILYAYQL 500
Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMA 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G   +++MA
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSE 375
           PE +  +    A+D W  G+ ++E+L  G  PF G     +  +I   ++L +P      
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620
Query: 376 AHSLLKGLLQKEPGKR 391
            +SL+      +P +R
Sbjct: 621 LYSLMTKCWAYDPSRR 636

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 111/236 (47%), Gaps = 12/236 (5%)
Query: 144 VCCVGIEDFEVLKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA 199
            C +G +D  +L+ +G G+FG V    +      T  + A+K ++ D + +    +    
Sbjct: 12  TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIR 70
Query: 200 ERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLARIYAAE 258
           E + +  +DH  +++L Y       + +V +    G L  +L  H G F       YA +
Sbjct: 71  EVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG----TVE 314
           +   + +L +   +HRDL   N+LL     V + DFGL +   +N     M         
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189
Query: 315 YMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
           + APE +  +  + A+D W  G+ L+EM T G+ P+IG N ++I  KI K+  RLP
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      Y+V++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++
Sbjct: 189 RYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIE 239

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 117/241 (48%), Gaps = 14/241 (5%)
Query: 139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK 198
           GDS       ++ ++ LK +G GA G V            A+K + +     + HA+   
Sbjct: 16  GDSTFTV---LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY 71
Query: 199 AERDILTKIDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLA 252
            E  ++  ++H  ++ L   F  +  L      Y+V++ ++      Q+    L  E ++
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMS 129
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
            +   +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T
Sbjct: 130 YL-LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVT 188
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-KLRLPAF 371
             Y APE++LG G+ +  D WSVG ++ EM+  K  F G +      K+++      PAF
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAF 248
Query: 372 L 372
           +
Sbjct: 249 M 249

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 111/236 (47%), Gaps = 12/236 (5%)
Query: 144 VCCVGIEDFEVLKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA 199
            C +G +D  +L+ +G G+FG V    +      T  + A+K ++ D + +    +    
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIR 60
Query: 200 ERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLARIYAAE 258
           E + +  +DH  +++L Y       + +V +    G L  +L  H G F       YA +
Sbjct: 61  EVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG----TVE 314
           +   + +L +   +HRDL   N+LL     V + DFGL +   +N     M         
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA 179
Query: 315 YMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
           + APE +  +  + A+D W  G+ L+EM T G+ P+IG N ++I  KI K+  RLP
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 122/242 (50%), Gaps = 14/242 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G +G VY+   K  S   A+K +++D +      E++K E  ++ +I HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L   L      R++++ +     A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           RDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPG 389
            W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P 
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 254
Query: 390 KR 391
            R
Sbjct: 255 DR 256

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 111/236 (47%), Gaps = 12/236 (5%)
Query: 144 VCCVGIEDFEVLKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA 199
            C +G +D  +L+ +G G+FG V    +      T  + A+K ++ D + +    +    
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIR 60
Query: 200 ERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLARIYAAE 258
           E + +  +DH  +++L Y       + +V +    G L  +L  H G F       YA +
Sbjct: 61  EVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG----TVE 314
           +   + +L +   +HRDL   N+LL     V + DFGL +   +N     M         
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 315 YMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
           + APE +  +  + A+D W  G+ L+EM T G+ P+IG N ++I  KI K+  RLP
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 122/242 (50%), Gaps = 14/242 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G +G VY+   K  S   A+K +++D +      E++K E  ++ +I HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L   L      R++++ +     A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           RDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPG 389
            W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P 
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 254
Query: 390 KR 391
            R
Sbjct: 255 DR 256

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 116/248 (46%), Gaps = 20/248 (8%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           VG+G+FG V++++ K T    A+K +R    +E    E + A       +  P +V L  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVA----CAGLSSPRIVPLYG 117
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   +   G   ED A  Y  + +  + +LH   I+H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 278 PENILLGADG-HVMLTDFGLAKQFDENTRSNSMI------GTVEYMAPEIVLGKGHNKAA 330
            +N+LL +DG    L DFG A     +    S++      GT  +MAPE+V+GK  +   
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 237
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSS----EAHSLLKGLLQK 386
           D WS   ++  ML G  P+    R  +  KI  +   +     S     A ++ +G L+K
Sbjct: 238 DIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG-LRK 296
Query: 387 EPGKRLGA 394
           EP  R  A
Sbjct: 297 EPVHRASA 304

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 116/248 (46%), Gaps = 20/248 (8%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           VG+G+FG V++++ K T    A+K +R    +E    E + A       +  P +V L  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVA----CAGLSSPRIVPLYG 133
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   +   G   ED A  Y  + +  + +LH   I+H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 278 PENILLGADG-HVMLTDFGLAKQFDENTRSNSMI------GTVEYMAPEIVLGKGHNKAA 330
            +N+LL +DG    L DFG A     +    S++      GT  +MAPE+V+GK  +   
Sbjct: 194 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 253
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSS----EAHSLLKGLLQK 386
           D WS   ++  ML G  P+    R  +  KI  +   +     S     A ++ +G L+K
Sbjct: 254 DIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG-LRK 312
Query: 387 EPGKRLGA 394
           EP  R  A
Sbjct: 313 EPVHRASA 320

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G +G VY+   K  S   A+K +++D +      E++K E  ++ +I HP +VQL  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 77
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y     R+++  +     A +I SA+ +L     +H
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 274 RDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           RDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +D
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 332 WWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPG 389
            W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P 
Sbjct: 196 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 255
Query: 390 KR 391
            R
Sbjct: 256 DR 257

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 76
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V +++N G L  F +       R       +A+I S ++++     +HRD
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +KEP +R
Sbjct: 197 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 256

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 111/236 (47%), Gaps = 12/236 (5%)
Query: 144 VCCVGIEDFEVLKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA 199
            C +G +D  +L+ +G G+FG V    +      T  + A+K ++ D + +    +    
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIR 60
Query: 200 ERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLARIYAAE 258
           E + +  +DH  +++L Y       + +V +    G L  +L  H G F       YA +
Sbjct: 61  EVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG----TVE 314
           +   + +L +   +HRDL   N+LL     V + DFGL +   +N     M         
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 315 YMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
           + APE +  +  + A+D W  G+ L+EM T G+ P+IG N ++I  KI K+  RLP
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 127/249 (51%), Gaps = 14/249 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  +++K +G G FG V+       +++ A+K ++   +  ++  E    E  I+ K+ H
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTKV-AIKTLKPGTMSPESFLE----EAQIMKKLKH 63
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH---HGLFREDLARIYAAEIVSAVSHL 266
             +VQL Y+  ++  +Y+V +++N G L   L       L   +L  + AA++ + ++++
Sbjct: 64  DKLVQL-YAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDM-AAQVAAGMAYI 121
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGK 324
                +HRDL+  NIL+G      + DFGLA+  ++N  T        +++ APE  L  
Sbjct: 122 ERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYG 181
Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKG 382
                +D WS GILL E++T G+ P+ G N  ++ +++ +  ++  P       H L+  
Sbjct: 182 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIH 241
Query: 383 LLQKEPGKR 391
             +K+P +R
Sbjct: 242 CWKKDPEER 250

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 123/243 (50%), Gaps = 16/243 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDHPFVVQLK 216
           +G G +G VY+   K  S   A+K +++D + VE    E++K E  ++ +I HP +VQL 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLK-EAAVMKEIKHPNLVQLL 80
Query: 217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIM 272
                +   Y++++F+  G+L   L      R+++  +     A +I SA+ +L     +
Sbjct: 81  GVCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           HRDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 258
Query: 389 GKR 391
             R
Sbjct: 259 SDR 261

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 76
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V +++N G L  F +       R       +A+I S ++++     +HRD
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +KEP +R
Sbjct: 197 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 256

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 123/243 (50%), Gaps = 16/243 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDHPFVVQLK 216
           +G G +G VY+   K  S   A+K +++D + VE    E++K E  ++ +I HP +VQL 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLK-EAAVMKEIKHPNLVQLL 80
Query: 217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIM 272
                +   Y++ +F+  G+L    Y     R++++ +     A +I SA+ +L     +
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 138
Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           HRDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 258
Query: 389 GKR 391
             R
Sbjct: 259 SDR 261

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 133/280 (47%), Gaps = 25/280 (8%)
Query: 134 DENVKGDSVTVCCVGIED--FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK 191
           D++ K  S    C+ ++   + +LK +G G   +V+QV  +   +IYA+K +  ++   +
Sbjct: 38  DDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQ 96
Query: 192 NHAEYMKAERDILTKID-HPFVVQLKYSFQ-TKYRLYLVLDFINGGHLFFQLYHHGLFRE 249
               Y + E   L K+  H   +   Y ++ T   +Y+V++  N   L   L        
Sbjct: 97  TLDSY-RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDP 154
Query: 250 DLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS--- 306
              + Y   ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   
Sbjct: 155 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVK 213
Query: 307 NSMIGTVEYMAPEIVLGKGHNK-----------AADWWSVGILLYEMLTGKPPF--IGGN 353
           +S +G V YM PE +     ++            +D WS+G +LY M  GK PF  I   
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
Query: 354 RAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRL 392
            +K+   I  + ++  P     +   +LK  L+++P +R+
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 313

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G +G VY+   K  S   A+K +++D +      E++K E  ++ +I HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L   L      R++++ +     A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           RDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPG 389
            W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P 
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 254
Query: 390 KR 391
            R
Sbjct: 255 DR 256

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 25/269 (9%)
Query: 146 CVGIED--FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI 203
           C+ ++   + +LK +G G   +V+QV  +   +IYA+K +  ++   +    Y + E   
Sbjct: 6   CISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSY-RNEIAY 63
Query: 204 LTKID-HPFVVQLKYSFQ-TKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           L K+  H   +   Y ++ T   +Y+V++  N   L   L           + Y   ++ 
Sbjct: 64  LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLE 122
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAP 318
           AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S +GTV YM P
Sbjct: 123 AVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 181
Query: 319 EIVLGKGHNK-----------AADWWSVGILLYEMLTGKPPF--IGGNRAKIQQKIVKD- 364
           E +     ++            +D WS+G +LY M  GK PF  I    +K+   I  + 
Sbjct: 182 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 241
Query: 365 KLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           ++  P     +   +LK  L+++P +R+ 
Sbjct: 242 EIEFPDIPEKDLQDVLKCCLKRDPKQRIS 270

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G +G VY+   K  S   A+K +++D +      E++K E  ++ +I HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y     R++++ +     A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           RDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPG 389
            W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P 
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 254
Query: 390 KR 391
            R
Sbjct: 255 DR 256

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV-----------YQVRKKNTSE--IYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V             +RK +  E   Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 92  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 19  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 72
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 73  AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 132
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +KEP +R
Sbjct: 193 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 252

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 122/243 (50%), Gaps = 16/243 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDHPFVVQLK 216
           +G G +G VY+   K  S   A+K +++D + VE    E++K E  ++ +I HP +VQL 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLK-EAAVMKEIKHPNLVQLL 80
Query: 217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIM 272
                +   Y++ +F+  G+L   L      R+++  +     A +I SA+ +L     +
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           HRDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 258
Query: 389 GKR 391
             R
Sbjct: 259 SDR 261

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 88  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 36  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 95
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 96  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 143
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 144 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 204 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 238

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 88  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 30  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 89
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 90  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 137
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 111/211 (52%), Gaps = 33/211 (15%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMK-VMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           +V+G+G FG+  +V  + T E+  MK ++R D   E+    ++K E  ++  ++HP V++
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLK-EVKVMRCLEHPNVLK 71
Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI-------YAAEIVSAVSHLH 267
                    RL  + ++I GG L       G+ +   ++        +A +I S +++LH
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTL------RGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAK-QFDENT--------------RSNSMIGT 312
           +  I+HRDL   N L+  + +V++ DFGLA+   DE T              +  +++G 
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEML 343
             +MAPE++ G+ +++  D +S GI+L E++
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G +G VY+   K  S   A+K +++D +      E++K E  ++ +I HP +VQL  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 74
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L   L      R++++ +     A +I SA+ +L     +H
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 274 RDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           RDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 332 WWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPG 389
            W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P 
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 252
Query: 390 KR 391
            R
Sbjct: 253 DR 254

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 88  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 33  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 93  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 140
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 235

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 34  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 93
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 94  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 141
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 142 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 202 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 236

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 25  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 84
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 85  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 132
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 133 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 193 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 227

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 92  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 120/242 (49%), Gaps = 14/242 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G +G VY+   K  S   A+K +++D +      E++K E  ++ +I HP +VQL  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 77
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y     R+++  +     A +I SA+ +L     +H
Sbjct: 78  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 274 RDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
           RDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +D
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 332 WWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPG 389
            W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P 
Sbjct: 196 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 255
Query: 390 KR 391
            R
Sbjct: 256 DR 257

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 26  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 86  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 133
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 228

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 122/243 (50%), Gaps = 16/243 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDHPFVVQLK 216
           +G G +G VY+   K  S   A+K +++D + VE    E++K E  ++ +I HP +VQL 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLK-EAAVMKEIKHPNLVQLL 80
Query: 217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIM 272
                +   Y++ +F+  G+L   L      R+++  +     A +I SA+ +L     +
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           HRDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 258
Query: 389 GKR 391
             R
Sbjct: 259 SDR 261

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 122/243 (50%), Gaps = 16/243 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDHPFVVQLK 216
           +G G +G VY+   K  S   A+K +++D + VE    E++K E  ++ +I HP +VQL 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLK-EAAVMKEIKHPNLVQLL 80
Query: 217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIM 272
                +   Y++ +F+  G+L    Y     R+++  +     A +I SA+ +L     +
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           HRDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 258
Query: 389 GKR 391
             R
Sbjct: 259 SDR 261

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 116/248 (46%), Gaps = 20/248 (8%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G+FG V++++ K T    A+K +R    +E    E + A       +  P +V L  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVA----CAGLSSPRIVPLYG 131
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   +   G   ED A  Y  + +  + +LH   I+H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 278 PENILLGADG-HVMLTDFGLAKQFDENTRSNSMI------GTVEYMAPEIVLGKGHNKAA 330
            +N+LL +DG    L DFG A     +    S++      GT  +MAPE+V+GK  +   
Sbjct: 192 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 251
Query: 331 DWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSS----EAHSLLKGLLQK 386
           D WS   ++  ML G  P+    R  +  KI  +   +     S     A ++ +G L+K
Sbjct: 252 DIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG-LRK 310
Query: 387 EPGKRLGA 394
           EP  R  A
Sbjct: 311 EPVHRASA 318

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 92  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 33  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 93  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 140
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 235

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 25/269 (9%)
Query: 146 CVGIED--FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI 203
           C+ ++   + +LK +G G   +V+QV  +   +IYA+K +  ++   +    Y + E   
Sbjct: 3   CISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSY-RNEIAY 60
Query: 204 LTKID-HPFVVQLKYSFQ-TKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           L K+  H   +   Y ++ T   +Y+V++  N   L   L           + Y   ++ 
Sbjct: 61  LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLE 119
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAP 318
           AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S +GTV YM P
Sbjct: 120 AVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 319 EIVLGKGHNK-----------AADWWSVGILLYEMLTGKPPF--IGGNRAKIQQKIVKD- 364
           E +     ++            +D WS+G +LY M  GK PF  I    +K+   I  + 
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238
Query: 365 KLRLPAFLSSEAHSLLKGLLQKEPGKRLG 393
           ++  P     +   +LK  L+++P +R+ 
Sbjct: 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRIS 267

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 129/268 (48%), Gaps = 25/268 (9%)
Query: 146 CVGIED--FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI 203
           C+ ++   + +LK +G G   +V+QV  +   +IYA+K +  ++   +    Y + E   
Sbjct: 2   CISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSY-RNEIAY 59
Query: 204 LTKID-HPFVVQLKYSFQ-TKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           L K+  H   +   Y ++ T   +Y+V++  N   L   L           + Y   ++ 
Sbjct: 60  LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLE 118
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAP 318
           AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S +GTV YM P
Sbjct: 119 AVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 177
Query: 319 EIVLGKGHNK-----------AADWWSVGILLYEMLTGKPPF--IGGNRAKIQQKIVKD- 364
           E +     ++            +D WS+G +LY M  GK PF  I    +K+   I  + 
Sbjct: 178 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 237
Query: 365 KLRLPAFLSSEAHSLLKGLLQKEPGKRL 392
           ++  P     +   +LK  L+++P +R+
Sbjct: 238 EIEFPDIPEKDLQDVLKCCLKRDPKQRI 265

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 48  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 108 DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 155
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 26  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 86  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 133
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 228

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 92  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 275 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 328
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 329 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +KEP +R
Sbjct: 449 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 508

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 122/243 (50%), Gaps = 16/243 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDHPFVVQLK 216
           +G G +G VY+   K  S   A+K +++D + VE    E++K E  ++ +I HP +VQL 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLK-EAAVMKEIKHPNLVQLL 79
Query: 217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIM 272
                +   Y++ +F+  G+L   L      R+++  +     A +I SA+ +L     +
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKNFI 137
Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           HRDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P
Sbjct: 198 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 257
Query: 389 GKR 391
             R
Sbjct: 258 SDR 260

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 92  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKCQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 122/243 (50%), Gaps = 16/243 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDHPFVVQLK 216
           +G G +G VY+   K  S   A+K +++D + VE    E++K E  ++ +I HP +VQL 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLK-EAAVMKEIKHPNLVQLL 77
Query: 217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIM 272
                +   Y++ +F+  G+L   L      R+++  +     A +I SA+ +L     +
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           HRDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P
Sbjct: 196 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 255
Query: 389 GKR 391
             R
Sbjct: 256 SDR 258

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 88  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 122/243 (50%), Gaps = 16/243 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDHPFVVQLK 216
           +G G +G VY+   K  S   A+K +++D + VE    E++K E  ++ +I HP +VQL 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLK-EAAVMKEIKHPNLVQLL 75
Query: 217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIM 272
                +   Y++ +F+  G+L   L      R+++  +     A +I SA+ +L     +
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKNFI 133
Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           HRDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 253
Query: 389 GKR 391
             R
Sbjct: 254 SDR 256

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 122/243 (50%), Gaps = 16/243 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDHPFVVQLK 216
           +G G +G VY+   K  S   A+K +++D + VE    E++K E  ++ +I HP +VQL 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLK-EAAVMKEIKHPNLVQLL 75
Query: 217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIM 272
                +   Y++ +F+  G+L   L      R+++  +     A +I SA+ +L     +
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKNFI 133
Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           HRDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 253
Query: 389 GKR 391
             R
Sbjct: 254 SDR 256

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 125/261 (47%), Gaps = 23/261 (8%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HP 210
           + +LK +G G   +V+QV  +   +IYA+K +  ++   +    Y + E   L K+  H 
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQHS 87
Query: 211 FVVQLKYSFQ-TKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
             +   Y ++ T   +Y+V++  N   L   L           + Y   ++ AV  +H +
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKGH 326
           GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S +GTV YM PE +     
Sbjct: 147 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 327 NK-----------AADWWSVGILLYEMLTGKPPF--IGGNRAKIQQKIVKD-KLRLPAFL 372
           ++            +D WS+G +LY M  GK PF  I    +K+   I  + ++  P   
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 373 SSEAHSLLKGLLQKEPGKRLG 393
             +   +LK  L+++P +R+ 
Sbjct: 266 EKDLQDVLKCCLKRDPKQRIS 286

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 12/216 (5%)
Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           L+ VG GA+G V         +  A+K + +       HA     E  +L  + H  V+ 
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 215 L------KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           L        S +    +YLV   + G  L   +    L  E + +    +++  + ++H+
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKSQALSDEHV-QFLVYQLLRGLKYIHS 149
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH-N 327
            GI+HRDLKP N+ +  D  + + DFGLA+Q DE       + T  Y APEI+L   H N
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM--TGYVATRWYRAPEIMLNWMHYN 207
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           +  D WSVG ++ E+L GK  F G +     ++I++
Sbjct: 208 QTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 243

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 122/243 (50%), Gaps = 16/243 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDHPFVVQLK 216
           +G G +G VY+   K  S   A+K +++D + VE    E++K E  ++ +I HP +VQL 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLK-EAAVMKEIKHPNLVQLL 77
Query: 217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIM 272
                +   Y++ +F+  G+L   L      R+++  +     A +I SA+ +L     +
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           HRDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P
Sbjct: 196 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 255
Query: 389 GKR 391
             R
Sbjct: 256 SDR 258

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 117/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V+++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +K+P +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGIN 91
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 92  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 245
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +KEP +R
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 425

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 88  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 245
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +KEP +R
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 425

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 122/243 (50%), Gaps = 16/243 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDHPFVVQLK 216
           +G G +G VY+   K  S   A+K +++D + VE    E++K E  ++ +I HP +VQL 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLK-EAAVMKEIKHPNLVQLL 88
Query: 217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIM 272
                +   Y++ +F+  G+L    Y     R+++  +     A +I SA+ +L     +
Sbjct: 89  GVCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 146
Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           HRDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 206
Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P
Sbjct: 207 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 266
Query: 389 GKR 391
             R
Sbjct: 267 SDR 269

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 122/243 (50%), Gaps = 16/243 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDHPFVVQLK 216
           +G G +G VY+   K  S   A+K +++D + VE    E++K E  ++ +I HP +VQL 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLK-EAAVMKEIKHPNLVQLL 77
Query: 217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIM 272
                +   Y++ +F+  G+L    Y     R+++  +     A +I SA+ +L     +
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           HRDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++   Q  P
Sbjct: 196 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 255
Query: 389 GKR 391
             R
Sbjct: 256 SDR 258

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+     E +    
Sbjct: 30  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 90  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 137
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ KI H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKIRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +K+P +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 117/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V+++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +K+P +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 117/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V+++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +K+P +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 110/230 (47%), Gaps = 39/230 (16%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           F V++ +G G FGRV   +  +  + YA+KV+R  K     +    K E DIL KI +  
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDD 92
Query: 212 VVQ---LKYSFQTKYRLYLVLDFINGGHLFFQLY----HHGLFREDLARIYAAEIVSAVS 264
           +     +KY  +  Y  ++ L F   G   +++     ++G   ED+ ++Y  EI+ A++
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDI-KLYCIEILKALN 151
Query: 265 HLHANGIMHRDLKPENILLG--------------ADGH-----------VMLTDFGLAKQ 299
           +L    + H DLKPENILL                DG            + L DFG A  
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 300 FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPF 349
             ++    S+I T +Y APE++L  G + ++D WS G +L E+ TG   F
Sbjct: 212 --KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+ +   E +    
Sbjct: 48  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +YLV   +  G   ++L        D    +  +I+ 
Sbjct: 108 DI---IRAPTIEQMK-------DVYLVTHLM--GADLYKLLKTQHLSNDHICYFLYQILR 155
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 66/241 (27%)
Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           + DFE ++ +G+G FG V++ + K     YA+K +R      +   E +  E   L K++
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE 61
Query: 209 HPFVVQLKYSFQTKY----------RLYLVL-----------DFINGG------------ 235
           HP +V+   ++  K           ++YL +           D++NG             
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 236 HLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFG 295
           H+F Q                  I  AV  LH+ G+MHRDLKP NI    D  V + DFG
Sbjct: 122 HIFLQ------------------IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163
Query: 296 LAKQFDEN-------------TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEM 342
           L    D++              R    +GT  YM+PE + G  ++   D +S+G++L+E+
Sbjct: 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
Query: 343 L 343
           L
Sbjct: 224 L 224

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 119/239 (49%), Gaps = 10/239 (4%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G FG V+     N  ++ A+K +R+  + E++  E    E +++ K+ HP +VQL  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 67
Query: 218 SFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L  +     GLF  +       ++   +++L    ++HRDL
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 277 KPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWS 334
              N L+G +  + ++DFG+ +    D+ T S      V++ +PE+     ++  +D WS
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 335 VGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            G+L++E+ + GK P+   + +++ + I    +L  P   S+  + ++    ++ P  R
Sbjct: 188 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 246

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 12/216 (5%)
Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           L+ VG GA+G V         +  A+K + +       HA     E  +L  + H  V+ 
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 215 L------KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           L        S +    +YLV   + G  L   +    L  E + +    +++  + ++H+
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHV-QFLVYQLLRGLKYIHS 149
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH-N 327
            GI+HRDLKP N+ +  D  + + DFGLA+Q DE       + T  Y APEI+L   H N
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM--TGYVATRWYRAPEIMLNWMHYN 207
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           +  D WSVG ++ E+L GK  F G +     ++I++
Sbjct: 208 QTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 243

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFGRV---------YQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAER 201
           L  +G+GA+G V          +V  K  S    + Y  + +R+ KI+     E +    
Sbjct: 30  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           DI   I  P + Q+K        +Y+V D +      ++L        D    +  +I+ 
Sbjct: 90  DI---IRAPTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 137
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM----IGTVEYMA 317
            + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y A
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 119/239 (49%), Gaps = 10/239 (4%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G FG V+     N  ++ A+K +R+  + E++  E    E +++ K+ HP +VQL  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 69
Query: 218 SFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L  +     GLF  +       ++   +++L    ++HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDL 129
Query: 277 KPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWS 334
              N L+G +  + ++DFG+ +    D+ T S      V++ +PE+     ++  +D WS
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 335 VGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            G+L++E+ + GK P+   + +++ + I    +L  P   S+  + ++    ++ P  R
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 248

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 119/239 (49%), Gaps = 10/239 (4%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G FG V+     N  ++ A+K +R+  + E++  E    E +++ K+ HP +VQL  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 69
Query: 218 SFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L  +     GLF  +       ++   +++L    ++HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 129
Query: 277 KPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWS 334
              N L+G +  + ++DFG+ +    D+ T S      V++ +PE+     ++  +D WS
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 335 VGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            G+L++E+ + GK P+   + +++ + I    +L  P   S+  + ++    ++ P  R
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 248

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 12/216 (5%)
Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           L+ VG GA+G V         +  A+K + +       HA     E  +L  + H  V+ 
Sbjct: 25  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIG 83
Query: 215 L------KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           L        S +    +YLV   + G  L   +    L  E + +    +++  + ++H+
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHV-QFLVYQLLRGLKYIHS 141
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH-N 327
            GI+HRDLKP N+ +  D  + + DFGLA+Q DE       + T  Y APEI+L   H N
Sbjct: 142 AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEM--TGYVATRWYRAPEIMLNWMHYN 199
Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
           +  D WSVG ++ E+L GK  F G +     ++I++
Sbjct: 200 QTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 235

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 116/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +K+P +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 116/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 15  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 68
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 69  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 128
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +K+P +R
Sbjct: 189 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 248

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 116/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 17  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 70
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 71  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 130
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +K+P +R
Sbjct: 191 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 250

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 125/250 (50%), Gaps = 16/250 (6%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDH 209
           D  +   +G G +G VY+   K  S   A+K +++D + VE    E++K E  ++ +I H
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLK-EAAVMKEIKH 275
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSH 265
           P +VQL      +   Y++ +F+  G+L    Y     R++++ +     A +I SA+ +
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLG 323
           L     +HR+L   N L+G +  V + DFGL++    D  T        +++ APE +  
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 324 KGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLK 381
              +  +D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 453
Query: 382 GLLQKEPGKR 391
              Q  P  R
Sbjct: 454 ACWQWNPSDR 463

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 119/239 (49%), Gaps = 10/239 (4%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G FG V+     N  ++ A+K +R+  + E++  E    E +++ K+ HP +VQL  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 72
Query: 218 SFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L  +     GLF  +       ++   +++L    ++HRDL
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132
Query: 277 KPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWS 334
              N L+G +  + ++DFG+ +    D+ T S      V++ +PE+     ++  +D WS
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 335 VGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            G+L++E+ + GK P+   + +++ + I    +L  P   S+  + ++    ++ P  R
Sbjct: 193 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDR 251

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 116/251 (46%), Gaps = 23/251 (9%)
Query: 150 EDFEVLKVVGQGAFGRV---YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           E ++ L  VG GA+G V   Y V  K+  +I   K+ R  + +   HA+    E  +L  
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDV--KSGLKIAVKKLSRPFQSI--IHAKRTYRELRLLKH 106
Query: 207 IDHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIV 260
           + H  V+ L   F     L      YLV   +  G     +       +D  +    +I+
Sbjct: 107 MKHENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 164
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
             + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI
Sbjct: 165 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEI 222
Query: 321 VLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFL-----SS 374
           +L   H N   D WSVG ++ E+LTG+  F G +     Q+I++     PA +     S 
Sbjct: 223 MLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSH 282
Query: 375 EAHSLLKGLLQ 385
           EA + +  L Q
Sbjct: 283 EARNYINSLPQ 293

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 245
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 246 AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +KEP +R
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 425

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 108/215 (50%), Gaps = 33/215 (15%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKID 208
           DF+ ++++G G FG+V++ + +   + Y +K ++ +           KAER++  L K+D
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLD 62
Query: 209 HPFVVQL---------------KYSFQTKYR-LYLVLDFINGGHLFFQLYHHGLFREDLA 252
           H  +V                 K S ++K + L++ ++F + G L  + +      E L 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTL--EQWIEKRRGEKLD 120
Query: 253 RIYAAE----IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS 308
           ++ A E    I   V ++H+  +++RDLKP NI L     V + DFGL      + +   
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXR 180
Query: 309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEML 343
             GT+ YM+PE +  + + K  D +++G++L E+L
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 116/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +K+P +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 116/240 (48%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +K+P +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 119/239 (49%), Gaps = 10/239 (4%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G FG V+     N  ++ A+K +R+  + E++  E    E +++ K+ HP +VQL  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 70
Query: 218 SFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L  +     GLF  +       ++   +++L    ++HRDL
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 277 KPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWS 334
              N L+G +  + ++DFG+ +    D+ T S      V++ +PE+     ++  +D WS
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 335 VGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            G+L++E+ + GK P+   + +++ + I    +L  P   S+  + ++    ++ P  R
Sbjct: 191 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDR 249

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 115/240 (47%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 16  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 69
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  + +V ++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 70  AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 129
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +KEP +R
Sbjct: 190 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 249

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 124/250 (49%), Gaps = 16/250 (6%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDH 209
           D  +   +G G +G VY+   K  S   A+K +++D + VE    E++K E  ++ +I H
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLK-EAAVMKEIKH 314
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSH 265
           P +VQL      +   Y++ +F+  G+L    Y     R+++  +     A +I SA+ +
Sbjct: 315 PNLVQLLGVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEY 372
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLG 323
           L     +HR+L   N L+G +  V + DFGL++    D  T        +++ APE +  
Sbjct: 373 LEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 432
Query: 324 KGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLK 381
              +  +D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++
Sbjct: 433 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 492
Query: 382 GLLQKEPGKR 391
              Q  P  R
Sbjct: 493 ACWQWNPSDR 502

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 124/257 (48%), Gaps = 19/257 (7%)
Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI--VEKNHAEYMKAERDI 203
           C+ IE     +V+G G FG V   R K   +      ++  K+   EK   +++  E  I
Sbjct: 44  CIKIE-----RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFL-CEASI 97
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSA 262
           + + DHP VV L+        + +V++F+  G L  F   H G F           I + 
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAG 157
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYMA 317
           + +L   G +HRDL   NIL+ ++    ++DFGL++  +++     T +   I  V + A
Sbjct: 158 MRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKI-PVRWTA 216
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEA 376
           PE +  +    A+D WS GI+++E+++ G+ P+   +   +  K +++  RLPA +   A
Sbjct: 217 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-IKAIEEGYRLPAPMDCPA 275
Query: 377 --HSLLKGLLQKEPGKR 391
             H L+    QKE  +R
Sbjct: 276 GLHQLMLDCWQKERAER 292

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 115/240 (47%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L   NIL+G +    + DFGLA+  ++N  T        +++ APE  L       +D W
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +K+P +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 74
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQILR 132
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 190
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 115/240 (47%), Gaps = 12/240 (5%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 193 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGNM----SPEAFLQEAQVMKKLRHEKLVQL-Y 246
Query: 218 SFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R       AA+I S ++++     +HRD
Sbjct: 247 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 306
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
           L+  NIL+G +    + DFGL +  ++N  T        +++ APE  L       +D W
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 366
Query: 334 SVGILLYEMLT-GKPPFIGG-NRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           S GILL E+ T G+ P+ G  NR  + Q     ++  P       H L+    +K+P +R
Sbjct: 367 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 426

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 135/291 (46%), Gaps = 58/291 (19%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKID 208
           DF+ ++++G G FG+V++ + +   + Y   V+R+   V+ N+    KAER++  L K+D
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTY---VIRR---VKYNNE---KAEREVKALAKLD 63
Query: 209 HPFVVQL----------------------------KYSFQTKYR-LYLVLDFINGGHLFF 239
           H  +V                              K S ++K + L++ ++F + G L  
Sbjct: 64  HVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTL-- 121
Query: 240 QLYHHGLFREDLARIYAAE----IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFG 295
           + +      E L ++ A E    I   V ++H+  ++HRDLKP NI L     V + DFG
Sbjct: 122 EQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 296 LAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR- 354
           L      + +     GT+ YM+PE +  + + K  D +++G++L E+L         ++ 
Sbjct: 182 LVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF 241
Query: 355 -AKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS 404
              ++  I+ D          +  +LL+ LL K+P  R    P  SE +++
Sbjct: 242 FTDLRDGIISD------IFDKKEKTLLQKLLSKKPEDR----PNTSEILRT 282

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 30/215 (13%)
Query: 158 VGQGAFGRVYQVRKKNTSEI--YAMKVMRKDKIVEKNHAEYMKAERDI--LTKIDHPFVV 213
           VG+G +G VY+ ++K+  +   YA+K +    I        M A R+I  L ++ HP V+
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-------MSACREIALLRELKHPNVI 81
Query: 214 QLKYSF--QTKYRLYLVLDFINGGHLFFQLYHHG--------LFREDLARIYAAEIVSAV 263
            L+  F      +++L+ D+          +H               + +    +I+  +
Sbjct: 82  SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 264 SHLHANGIMHRDLKPENILLGAD----GHVMLTDFGLAKQFDENTRS----NSMIGTVEY 315
            +LHAN ++HRDLKP NIL+  +    G V + D G A+ F+   +     + ++ T  Y
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 316 MAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPF 349
            APE++LG  H  KA D W++G +  E+LT +P F
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + K    I+   HA+    E  +L  +
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSII---HAKRTYRELRLLKHM 90
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 206
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 118/239 (49%), Gaps = 10/239 (4%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G FG V+     N  ++ A+K +++  + E +  E    E +++ K+ HP +VQL  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKV-AIKTIKEGSMSEDDFIE----EAEVMMKLSHPKLVQLYG 89
Query: 218 SFQTKYRLYLVLDFINGGHLFFQL-YHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L    GLF  +       ++   +++L    ++HRDL
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 149
Query: 277 KPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWS 334
              N L+G +  + ++DFG+ +    D+ T S      V++ +PE+     ++  +D WS
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 335 VGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            G+L++E+ + GK P+   + +++ + I    +L  P   S+  + ++    ++ P  R
Sbjct: 210 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 268

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 98
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 214
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 97
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 155
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 213
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 80
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 196
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 124/261 (47%), Gaps = 23/261 (8%)
Query: 103 TKLILRESEDAEELLECV-------DGLTVKEIDESSIDENVKGDS---VTVCCVGIEDF 152
           +KL + E    E L++ V       DGL  + I    ++  V        +   + +++ 
Sbjct: 136 SKLSIDEEVYFENLMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKEL 195
Query: 153 EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           ++L+ +G+G FG V     +      A+K ++ D       A+   AE  ++T++ H  +
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAFLAEASVMTQLRHSNL 248
Query: 213 VQL-KYSFQTKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHAN 269
           VQL     + K  LY+V +++  G L   L   G  +   D    ++ ++  A+ +L  N
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKA 329
             +HRDL   N+L+  D    ++DFGL K+      +  +   V++ APE +  K  +  
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTK 366
Query: 330 ADWWSVGILLYEMLT-GKPPF 349
           +D WS GILL+E+ + G+ P+
Sbjct: 367 SDVWSFGILLWEIYSFGRVPY 387

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 74
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 190
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 114/235 (48%), Gaps = 13/235 (5%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V  +D E +  +G+GA+G V + R   + +I A+K +R    V     + +  + DI  +
Sbjct: 31  VKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRA--TVNSQEQKRLLXDLDISXR 88
Query: 207 -IDHPFVVQLKYSFQTKYRLYLVLDFINGG--HLFFQLYHHG-LFREDLARIYAAEIVSA 262
            +D PF V    +   +  +++  +  +      + Q+   G    ED+    A  IV A
Sbjct: 89  TVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 148
Query: 263 VSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           + HLH+   ++HRD+KP N+L+ A G V   DFG++    ++   +   G   Y APE +
Sbjct: 149 LEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERI 208
Query: 322 ----LGKGHNKAADWWSVGILLYEMLTGKPPF--IGGNRAKIQQKIVKDKLRLPA 370
                 KG++  +D WS+GI   E+   + P+   G    +++Q + +   +LPA
Sbjct: 209 NPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 263

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 15/218 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G+FG VY+ +      +  + V            +  K E  +L K  H  ++ L  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 86
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY--AAEIVSAVSHLHANGIMHRD 275
            + TK +L +V  +  G  L+  L H    + ++ ++   A +    + +LHA  I+HRD
Sbjct: 87  GYSTKPQLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDENTRSN---SMIGTVEYMAPEIVLGKGHNK---A 329
           LK  NI L  D  V + DFGLA +    + S+    + G++ +MAPE++  +  N     
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 330 ADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDKL 366
           +D ++ GI+LYE++TG+ P+    NR +I + + +  L
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + +++ ++L+ +G+G FG V     +      A+K ++ D       A+   AE  ++T+
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAFLAEASVMTQ 55
Query: 207 IDHPFVVQL-KYSFQTKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAV 263
           + H  +VQL     + K  LY+V +++  G L   L   G  +   D    ++ ++  A+
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG 323
            +L  N  +HRDL   N+L+  D    ++DFGL K+      +  +   V++ APE +  
Sbjct: 116 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALRE 173
Query: 324 KGHNKAADWWSVGILLYEMLT-GKPPF 349
           K  +  +D WS GILL+E+ + G+ P+
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 155 LKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           ++ +G+G FG+V    Y      T E+ A+K ++ D      H    K E DIL  + H 
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHE 93
Query: 211 FVVQLKYSFQTK--YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            +++ K   +      L LV++++  G L   L  H +    L  ++A +I   +++LHA
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLL-LFAQQICEGMAYLHA 152
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI----GTVEYMAPEIVLGK 324
              +HRDL   N+LL  D  V + DFGLAK   E      +       V + APE +   
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEY 212
Query: 325 GHNKAADWWSVGILLYEMLT 344
               A+D WS G+ LYE+LT
Sbjct: 213 KFYYASDVWSFGVTLYELLT 232

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 98
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--XGXVATRWYRAPEIM 214
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 88
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 89  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 146
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 147 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 204
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 205 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 237

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--AGFVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--AGFVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 155 LKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           ++ +G+G FG+V    Y      T E+ A+K ++ D      H    K E DIL  + H 
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLYHE 76
Query: 211 FVVQLKYSF--QTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            +++ K     Q +  L LV++++  G L   L  H +    L  ++A +I   +++LHA
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL-LFAQQICEGMAYLHA 135
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI----GTVEYMAPEIVLGK 324
              +HR+L   N+LL  D  V + DFGLAK   E      +       V + APE +   
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 325 GHNKAADWWSVGILLYEMLT 344
               A+D WS G+ LYE+LT
Sbjct: 196 KFYYASDVWSFGVTLYELLT 215

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 9/218 (4%)
Query: 141 SVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAE 200
           S       I+ +  +  +G+G +G VY+     T+E  A+K +R +   E      ++ E
Sbjct: 25  SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-E 83
Query: 201 RDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIV 260
             +L ++ H  +++LK      +RL+L+ ++     L   +  +      + + +  +++
Sbjct: 84  VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYMDKNPDVSMRVIKSFLYQLI 142
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGH-----VMLTDFGLAKQFDENTRSNSM-IGTVE 314
           + V+  H+   +HRDLKP+N+LL          + + DFGLA+ F    R  +  I T+ 
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW 202
Query: 315 YMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIG 351
           Y  PEI+LG  H + + D WS+  +  EML   P F G
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 74
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--AGFVATRWYRAPEIM 190
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 108/218 (49%), Gaps = 15/218 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G+FG VY+ +      +  + V            +  K E  +L K  H  ++ L  
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 74
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY--AAEIVSAVSHLHANGIMHRD 275
            + TK +L +V  +  G  L+  L H    + ++ ++   A +    + +LHA  I+HRD
Sbjct: 75  GYSTKPQLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 133
Query: 276 LKPENILLGADGHVMLTDFGLA---KQFDENTRSNSMIGTVEYMAPEIVLGKGHNK---A 329
           LK  NI L  D  V + DFGLA    ++  + +   + G++ +MAPE++  +  N     
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 193
Query: 330 ADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDKL 366
           +D ++ GI+LYE++TG+ P+    NR +I + + +  L
Sbjct: 194 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 231

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + +++ ++L+ +G+G FG V     +      A+K ++ D       A+   AE  ++T+
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAFLAEASVMTQ 70
Query: 207 IDHPFVVQL-KYSFQTKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAV 263
           + H  +VQL     + K  LY+V +++  G L   L   G  +   D    ++ ++  A+
Sbjct: 71  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG 323
            +L  N  +HRDL   N+L+  D    ++DFGL K+      +  +   V++ APE +  
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALRE 188
Query: 324 KGHNKAADWWSVGILLYEMLT-GKPPF 349
           K  +  +D WS GILL+E+ + G+ P+
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 84
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 200
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 84
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 200
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 16/217 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +++E+++ +G GA+G V   R++ T +  A+K +     V  N    ++ E  IL    H
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKH 113
Query: 210 PFVVQLKYSFQTKY------RLYLVLDFINGGHLFFQLYHHGL-FREDLARIYAAEIVSA 262
             ++ +K   +          +Y+VLD +       Q+ H       +  R +  +++  
Sbjct: 114 DNIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQLLRG 171
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-----DENTRSNSMIGTVEYMA 317
           + ++H+  ++HRDLKP N+L+  +  + + DFG+A+       +        + T  Y A
Sbjct: 172 LKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 231
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
           PE++L    + +A D WSVG +  EML  +  F G N
Sbjct: 232 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 268

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 83
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 199
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 77
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 78  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 136 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 193
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 194 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 226

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 80
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 196
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 119/260 (45%), Gaps = 19/260 (7%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH- 209
           D +   V+G+G FG+V + R K         + R  +   K+       E ++L K+ H 
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 75
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--------------- 254
           P ++ L  + + +  LYL +++   G+L   L    +   D A                 
Sbjct: 76  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 255 -YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTV 313
            +AA++   + +L     +HRDL   NIL+G +    + DFGL++  +   +       V
Sbjct: 136 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 195
Query: 314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAF 371
            +MA E +    +   +D WS G+LL+E+++ G  P+ G   A++ +K+ +  +L  P  
Sbjct: 196 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 255
Query: 372 LSSEAHSLLKGLLQKEPGKR 391
              E + L++   +++P +R
Sbjct: 256 CDDEVYDLMRQCWREKPYER 275

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 90
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 206
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 90
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 206
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGXVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 85
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 201
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 80
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 196
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 89
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 147
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 205
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 80
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 196
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 123/261 (47%), Gaps = 23/261 (8%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HP 210
           + +LK +G G   +V+QV  +   +IYA+K +  ++   +    Y + E   L K+  H 
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQHS 87
Query: 211 FVVQLKYSFQ-TKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
             +   Y ++ T   +Y+V++  N   L   L           + Y   ++ AV  +H +
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGH 326
           GI+H DLKP N L+  DG + L DFG+A Q   +      +S +GTV YM PE +     
Sbjct: 147 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 327 NK-----------AADWWSVGILLYEMLTGKPPF--IGGNRAKIQQKIVKD-KLRLPAFL 372
           ++            +D WS+G +LY M  GK PF  I    +K+   I  + ++  P   
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 373 SSEAHSLLKGLLQKEPGKRLG 393
             +   +LK  L+++P +R+ 
Sbjct: 266 EKDLQDVLKCCLKRDPKQRIS 286

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 89
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 147
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 205
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 83
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 199
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 98
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 214
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 97
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 155
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 213
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 119/260 (45%), Gaps = 19/260 (7%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH- 209
           D +   V+G+G FG+V + R K         + R  +   K+       E ++L K+ H 
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--------------- 254
           P ++ L  + + +  LYL +++   G+L   L    +   D A                 
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 255 -YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTV 313
            +AA++   + +L     +HRDL   NIL+G +    + DFGL++  +   +       V
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 205
Query: 314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAF 371
            +MA E +    +   +D WS G+LL+E+++ G  P+ G   A++ +K+ +  +L  P  
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 265
Query: 372 LSSEAHSLLKGLLQKEPGKR 391
              E + L++   +++P +R
Sbjct: 266 CDDEVYDLMRQCWREKPYER 285

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 126/258 (48%), Gaps = 16/258 (6%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKK---NTSEIYAMKVMRKDKIVEKNHAEYMKAERDI 203
           + +   ++ +V+G G FG V + R K         A+K + K    E+   E++ +E  I
Sbjct: 13  IDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFL-SEASI 70
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVS 261
           + + +HP +++L+        + ++ +F+  G L  F +L + G F           I S
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIAS 129
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGT--VEY 315
            + +L     +HRDL   NIL+ ++    ++DFGL++  +EN    T ++S+ G   + +
Sbjct: 130 GMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRW 189
Query: 316 MAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLS 373
            APE +  +    A+D WS GI+++E+++ G+ P+   +   +   I +D +L  P    
Sbjct: 190 TAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCP 249
Query: 374 SEAHSLLKGLLQKEPGKR 391
           +  H L+    QK+   R
Sbjct: 250 TSLHQLMLDCWQKDRNAR 267

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 83
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 199
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 76
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 77  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 134
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 135 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 192
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 225

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 75
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 133
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 191
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 74
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 190
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGL +  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 101
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 159
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 217
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 75
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 133
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 191
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 84
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 200
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 120/261 (45%), Gaps = 17/261 (6%)
Query: 142 VTVCCVGIEDFEVLKVVGQGAFGRVY--QVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA 199
           + + CV IE     +V+G G FG V    ++     EI+      K    EK   +++ +
Sbjct: 30  IDISCVKIE-----QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-S 83
Query: 200 ERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAE 258
           E  I+ + DHP V+ L+        + ++ +F+  G L  F   + G F           
Sbjct: 84  EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 143
Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIG---T 312
           I + + +L     +HRDL   NIL+ ++    ++DFGL++  +++T      S +G    
Sbjct: 144 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 203
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPA 370
           + + APE +  +    A+D WS GI+++E+++ G+ P+       +   I +D +L  P 
Sbjct: 204 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 263
Query: 371 FLSSEAHSLLKGLLQKEPGKR 391
              S  H L+    QK+   R
Sbjct: 264 DCPSALHQLMLDCWQKDRNHR 284

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + +++ ++L+ +G+G FG V     +      A+K ++ D       A+   AE  ++T+
Sbjct: 9   LNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAFLAEASVMTQ 61
Query: 207 IDHPFVVQL-KYSFQTKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAV 263
           + H  +VQL     + K  LY+V +++  G L   L   G  +   D    ++ ++  A+
Sbjct: 62  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 121
Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG 323
            +L  N  +HRDL   N+L+  D    ++DFGL K+      +  +   V++ APE +  
Sbjct: 122 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALRE 179
Query: 324 KGHNKAADWWSVGILLYEMLT-GKPPF 349
              +  +D WS GILL+E+ + G+ P+
Sbjct: 180 AAFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 101
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 159
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--XGYVATRWYRAPEIM 217
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  +G GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 83
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 199
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 126/258 (48%), Gaps = 16/258 (6%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKK---NTSEIYAMKVMRKDKIVEKNHAEYMKAERDI 203
           + +   ++ +V+G G FG V + R K         A+K + K    E+   E++ +E  I
Sbjct: 11  IDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFL-SEASI 68
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVS 261
           + + +HP +++L+        + ++ +F+  G L  F +L + G F           I S
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIAS 127
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGT--VEY 315
            + +L     +HRDL   NIL+ ++    ++DFGL++  +EN    T ++S+ G   + +
Sbjct: 128 GMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRW 187
Query: 316 MAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLS 373
            APE +  +    A+D WS GI+++E+++ G+ P+   +   +   I +D +L  P    
Sbjct: 188 TAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCP 247
Query: 374 SEAHSLLKGLLQKEPGKR 391
           +  H L+    QK+   R
Sbjct: 248 TSLHQLMLDCWQKDRNAR 265

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 155 LKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           ++ +G+G FG+V    Y      T E+ A+K ++ D      H    K E DIL  + H 
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLYHE 76
Query: 211 FVVQLKYSF--QTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            +++ K     Q +  L LV++++  G L   L  H +    L  ++A +I   +++LH+
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL-LFAQQICEGMAYLHS 135
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI----GTVEYMAPEIVLGK 324
              +HR+L   N+LL  D  V + DFGLAK   E      +       V + APE +   
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 325 GHNKAADWWSVGILLYEMLT 344
               A+D WS G+ LYE+LT
Sbjct: 196 KFYYASDVWSFGVTLYELLT 215

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 16/217 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +++E+++ +G GA+G V   R++ T +  A+K +     V  N    ++ E  IL    H
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKH 112
Query: 210 PFVVQLKYSFQTKY------RLYLVLDFINGGHLFFQLYHHGL-FREDLARIYAAEIVSA 262
             ++ +K   +          +Y+VLD +       Q+ H       +  R +  +++  
Sbjct: 113 DNIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQLLRG 170
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-----DENTRSNSMIGTVEYMA 317
           + ++H+  ++HRDLKP N+L+  +  + + DFG+A+       +        + T  Y A
Sbjct: 171 LKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 318 PEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
           PE++L    + +A D WSVG +  EML  +  F G N
Sbjct: 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 84
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 200
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + D+GLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 15/218 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G+FG VY+ +      +  + V            +  K E  +L K  H  ++ L  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 86
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY--AAEIVSAVSHLHANGIMHRD 275
            + T  +L +V  +  G  L+  L H    + ++ ++   A +    + +LHA  I+HRD
Sbjct: 87  GYSTAPQLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDENTRSN---SMIGTVEYMAPEIVLGKGHNK---A 329
           LK  NI L  D  V + DFGLA +    + S+    + G++ +MAPE++  +  N     
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 330 ADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDKL 366
           +D ++ GI+LYE++TG+ P+    NR +I + + +  L
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 123/248 (49%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++ K +G G FG V+       +++ A+K M+   +      E   AE +++  + H
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 69
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 70  DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+ A     + DFGLA+  ++N  T        +++ APE +    
Sbjct: 129 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 188
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G +  ++ + + +  ++  P     E ++++   
Sbjct: 189 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRC 248
Query: 384 LQKEPGKR 391
            +  P +R
Sbjct: 249 WKNRPEER 256

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 124/248 (50%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E+  +LK +G G FG V   + K   ++ A+K++++  + E    +    E   + K+ H
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEFFQ----EAQTMMKLSH 62
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI-YAAEIVSAVSHLHA 268
           P +V+       +Y +Y+V ++I+ G L   L  HG   E    +    ++   ++ L +
Sbjct: 63  PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT---VEYMAPEIVLGKG 325
           +  +HRDL   N L+  D  V ++DFG+ +   ++   +S +GT   V++ APE+     
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS-VGTKFPVKWSAPEVFHYFK 181
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHSLLKGL 383
           ++  +D W+ GIL++E+ + GK P+     +++  K+ +  +L  P   S   + ++   
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSC 241
Query: 384 LQKEPGKR 391
             + P KR
Sbjct: 242 WHELPEKR 249

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 119/260 (45%), Gaps = 19/260 (7%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH- 209
           D +   V+G+G FG+V + R K         + R  +   K+       E ++L K+ H 
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 82
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--------------- 254
           P ++ L  + + +  LYL +++   G+L   L    +   D A                 
Sbjct: 83  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 142
Query: 255 -YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTV 313
            +AA++   + +L     +HR+L   NIL+G +    + DFGL++  +   +       V
Sbjct: 143 HFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 202
Query: 314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAF 371
            +MA E +    +   +D WS G+LL+E+++ G  P+ G   A++ +K+ +  +L  P  
Sbjct: 203 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 262
Query: 372 LSSEAHSLLKGLLQKEPGKR 391
              E + L++   +++P +R
Sbjct: 263 CDDEVYDLMRQCWREKPYER 282

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 85
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEI 320
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+   DE T     + T  Y APEI
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT---GYVATRWYRAPEI 200
Query: 321 VLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           +L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 85
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEI 320
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+   DE T     + T  Y APEI
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT---GYVATRWYRAPEI 200
Query: 321 VLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           +L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 85
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEI 320
            + ++H+  I+HRDLKP N+ +  D  + + DFGLA+   DE T     + T  Y APEI
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT---GYVATRWYRAPEI 200
Query: 321 VLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           +L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G+FG VY+ +      +  + V            +  K E  +L K  H  ++ L  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 70
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE---------DLARIYAAEIVSAVSHLHA 268
            + TK +L +V  +  G      LYHH    E         D+AR    +    + +LHA
Sbjct: 71  GYSTKPQLAIVTQWCEGS----SLYHHLHIIETKFEMIKLIDIAR----QTAQGMDYLHA 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN---SMIGTVEYMAPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA +    + S+    + G++ +MAPE++  + 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 326 HNK---AADWWSVGILLYEMLTGKPPFIG-GNRAKI 357
            N     +D ++ GI+LYE++TG+ P+    NR +I
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G+FG VY+ +      +  + V            +  K E  +L K  H  ++ L  
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 75
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE---------DLARIYAAEIVSAVSHLHA 268
            + TK +L +V  +  G      LYHH    E         D+AR    +    + +LHA
Sbjct: 76  GYSTKPQLAIVTQWCEGS----SLYHHLHIIETKFEMIKLIDIAR----QTAQGMDYLHA 127
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLA---KQFDENTRSNSMIGTVEYMAPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA    ++  + +   + G++ +MAPE++  + 
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 326 HNK---AADWWSVGILLYEMLTGKPPFIG-GNRAKI 357
            N     +D ++ GI+LYE++TG+ P+    NR +I
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 223

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 123/270 (45%), Gaps = 31/270 (11%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSE-----IYAMKVMRKDKIVEKNHAEYMKAERDIL 204
            D  + + +G+GAFG+V+     N S      + A+K ++   +  +      + E ++L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD---FQREAELL 71
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-----------------LF 247
           T + H  +V+          L +V +++  G L   L  HG                 L 
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 248 REDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENT 304
              +  I A++I S + +L +   +HRDL   N L+GA+  V + DFG+++     D   
Sbjct: 132 LSQMLHI-ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 190
Query: 305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK 363
                +  + +M PE ++ +     +D WS G++L+E+ T GK P+   +  ++ + I +
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250
Query: 364 DK-LRLPAFLSSEAHSLLKGLLQKEPGKRL 392
            + L  P     E + ++ G  Q+EP +RL
Sbjct: 251 GRVLERPRVCPKEVYDVMLGCWQREPQQRL 280

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G+FG VY+ +      +  + V            +  K E  +L K  H  ++ L  
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 72
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE---------DLARIYAAEIVSAVSHLHA 268
            + TK +L +V  +  G      LYHH    E         D+AR    +    + +LHA
Sbjct: 73  GYSTKPQLAIVTQWCEGS----SLYHHLHIIETKFEMIKLIDIAR----QTAQGMDYLHA 124
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLA---KQFDENTRSNSMIGTVEYMAPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA    ++  + +   + G++ +MAPE++  + 
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 326 HNK---AADWWSVGILLYEMLTGKPPFIG-GNRAKI 357
            N     +D ++ GI+LYE++TG+ P+    NR +I
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 220

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G+FG VY+ +      +  + V            +  K E  +L K  H  ++ L  
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 75
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE---------DLARIYAAEIVSAVSHLHA 268
            + TK +L +V  +  G      LYHH    E         D+AR    +    + +LHA
Sbjct: 76  GYSTKPQLAIVTQWCEGS----SLYHHLHIIETKFEMIKLIDIAR----QTAQGMDYLHA 127
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLA---KQFDENTRSNSMIGTVEYMAPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA    ++  + +   + G++ +MAPE++  + 
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 326 HNK---AADWWSVGILLYEMLTGKPPFIG-GNRAKI 357
            N     +D ++ GI+LYE++TG+ P+    NR +I
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 223

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 117/248 (47%), Gaps = 8/248 (3%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ED  + + +G+G FG V+  R +  + + A+K  R + +     A++++  R IL +  H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEAR-ILKQYSH 171
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL-FREDLARIYAAEIVSAVSHLHA 268
           P +V+L      K  +Y+V++ + GG     L   G   R         +  + + +L +
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS---MIGTVEYMAPEIVLGKG 325
              +HRDL   N L+     + ++DFG++++  +   + S       V++ APE +    
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHSLLKGL 383
           ++  +D WS GILL+E  + G  P+   +  + ++ + K  +L  P         L++  
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQC 351
Query: 384 LQKEPGKR 391
              EPG+R
Sbjct: 352 WAYEPGQR 359

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G+FG VY+ +      +  + V            +  K E  +L K  H  ++ L  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 70
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE---------DLARIYAAEIVSAVSHLHA 268
            + TK +L +V  +  G      LYHH    E         D+AR    +    + +LHA
Sbjct: 71  GYSTKPQLAIVTQWCEGS----SLYHHLHIIETKFEMIKLIDIAR----QTAQGMDYLHA 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLA---KQFDENTRSNSMIGTVEYMAPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA    ++  + +   + G++ +MAPE++  + 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 326 HNK---AADWWSVGILLYEMLTGKPPFIG-GNRAKI 357
            N     +D ++ GI+LYE++TG+ P+    NR +I
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + DF LA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G+FG VY+ +      +  + V            +  K E  +L K  H  ++ L  
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 90
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE---------DLARIYAAEIVSAVSHLHA 268
            + TK +L +V  +  G      LYHH    E         D+AR    +    + +LHA
Sbjct: 91  GYSTKPQLAIVTQWCEGS----SLYHHLHIIETKFEMIKLIDIAR----QTAQGMDYLHA 142
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN---SMIGTVEYMAPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA +    + S+    + G++ +MAPE++  + 
Sbjct: 143 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 326 HNK---AADWWSVGILLYEMLTGKPPFIG-GNRAKI 357
            N     +D ++ GI+LYE++TG+ P+    NR +I
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 238

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 123/248 (49%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++ K +G G FG V+       +++ A+K M+   +      E   AE +++  + H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 242
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 243 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+ A     + DFGLA+  ++N  T        +++ APE +    
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G +  ++ + + +  ++  P     E ++++   
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRC 421
Query: 384 LQKEPGKR 391
            +  P +R
Sbjct: 422 WKNRPEER 429

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G+FG VY+ +      +  + V            +  K E  +L K  H  ++ L  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 98
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE---------DLARIYAAEIVSAVSHLHA 268
            + TK +L +V  +  G      LYHH    E         D+AR    +    + +LHA
Sbjct: 99  GYSTKPQLAIVTQWCEGS----SLYHHLHIIETKFEMIKLIDIAR----QTAQGMDYLHA 150
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN---SMIGTVEYMAPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA +    + S+    + G++ +MAPE++  + 
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 326 HNK---AADWWSVGILLYEMLTGKPPFIG-GNRAKI 357
            N     +D ++ GI+LYE++TG+ P+    NR +I
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 246

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 119/243 (48%), Gaps = 16/243 (6%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDHPFVVQLK 216
           +G G +G VY    K  S   A+K +++D + VE    E++K E  ++ +I HP +VQL 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE----EFLK-EAAVMKEIKHPNLVQLL 94
Query: 217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIVSAVSHLHANGIM 272
                +   Y+V +++  G+L   L      RE++  +     A +I SA+ +L     +
Sbjct: 95  GVCTLEPPFYIVTEYMPYGNLLDYLRECN--REEVTAVVLLYMATQISSAMEYLEKKNFI 152
Query: 273 HRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGHNKAA 330
           HRDL   N L+G +  V + DFGL++    D  T        +++ APE +     +  +
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKS 212
Query: 331 DWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEP 388
           D W+ G+LL+E+ T G  P+ G + +++   + K  ++  P     + + L++   +  P
Sbjct: 213 DVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVYELMRACWKWSP 272
Query: 389 GKR 391
             R
Sbjct: 273 ADR 275

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + +  FGLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 117/248 (47%), Gaps = 8/248 (3%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ED  + + +G+G FG V+  R +  + + A+K  R + +     A++++  R IL +  H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEAR-ILKQYSH 171
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL-FREDLARIYAAEIVSAVSHLHA 268
           P +V+L      K  +Y+V++ + GG     L   G   R         +  + + +L +
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS---MIGTVEYMAPEIVLGKG 325
              +HRDL   N L+     + ++DFG++++  +   + S       V++ APE +    
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHSLLKGL 383
           ++  +D WS GILL+E  + G  P+   +  + ++ + K  +L  P         L++  
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQC 351
Query: 384 LQKEPGKR 391
              EPG+R
Sbjct: 352 WAYEPGQR 359

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G+FG VY+ +      +  + V            +  K E  +L K  H  ++ L  
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 97
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE---------DLARIYAAEIVSAVSHLHA 268
            + TK +L +V  +  G      LYHH    E         D+AR    +    + +LHA
Sbjct: 98  GYSTKPQLAIVTQWCEGS----SLYHHLHIIETKFEMIKLIDIAR----QTAQGMDYLHA 149
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLA---KQFDENTRSNSMIGTVEYMAPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA    ++  + +   + G++ +MAPE++  + 
Sbjct: 150 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 326 HNK---AADWWSVGILLYEMLTGKPPFIG-GNRAKI 357
            N     +D ++ GI+LYE++TG+ P+    NR +I
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 245

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 123/249 (49%), Gaps = 14/249 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D   LK +G G FG V   + +   ++ A+K++++  + E    E    E  ++  + H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 78
Query: 210 PFVVQLKYSFQTKYR-LYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +   H    + L  +   ++  A+ +L
Sbjct: 79  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 136
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGK 324
            +   +HRDL   N L+   G V ++DFGL++    DE T S      V +  PE+++  
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYS 196
Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKG 382
             +  +D W+ G+L++E+ + GK P+     ++  + I +  +L  P   S + ++++  
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 256
Query: 383 LLQKEPGKR 391
              ++  +R
Sbjct: 257 CWHEKADER 265

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G+FG VY+ +      +  + V            +  K E  +L K  H  ++ L  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 98
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE---------DLARIYAAEIVSAVSHLHA 268
            + TK +L +V  +  G      LYHH    E         D+AR    +    + +LHA
Sbjct: 99  GYSTKPQLAIVTQWCEGS----SLYHHLHIIETKFEMIKLIDIAR----QTAQGMDYLHA 150
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLA---KQFDENTRSNSMIGTVEYMAPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA    ++  + +   + G++ +MAPE++  + 
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 326 HNK---AADWWSVGILLYEMLTGKPPFIG-GNRAKI 357
            N     +D ++ GI+LYE++TG+ P+    NR +I
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 246

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 22/214 (10%)
Query: 149 IEDFEVL--KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           IE  EV+    +G G+FG VY+ +      +  +KV+  D   E+  A   + E  +L K
Sbjct: 33  IEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVV--DPTPEQFQA--FRNEVAVLRK 88
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGG----HLFFQLYHHGLFRE-DLARIYAAEIVS 261
             H  ++ L   + TK  L +V  +  G     HL  Q     +F+  D+AR    +   
Sbjct: 89  TRHVNIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIAR----QTAQ 143
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA---KQFDENTRSNSMIGTVEYMAP 318
            + +LHA  I+HRD+K  NI L     V + DFGLA    ++  + +     G+V +MAP
Sbjct: 144 GMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAP 203
Query: 319 EIVLGKGHNK---AADWWSVGILLYEMLTGKPPF 349
           E++  + +N     +D +S GI+LYE++TG+ P+
Sbjct: 204 EVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + D GLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 130/266 (48%), Gaps = 15/266 (5%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI 203
           +  ED  + +++G+G FG VY+      K      A+K  +KD  ++ N  ++M +E  I
Sbjct: 5   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-NKEKFM-SEAVI 62
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI-YAAEIVSA 262
           +  +DHP +V+L    + +   +++++    G L   L  +    + L  + Y+ +I  A
Sbjct: 63  MKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 121
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMAPEI 320
           +++L +   +HRD+   NIL+ +   V L DFGL++  ++     + +    +++M+PE 
Sbjct: 122 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 181
Query: 321 VLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHS 378
           +  +    A+D W   + ++E+L+ GK PF       +   + K D+L  P       ++
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT 241
Query: 379 LLKGLLQKEPGKRLGAGPKGSEEIKS 404
           L+      +P  R    P+ +E + S
Sbjct: 242 LMTRCWDYDPSDR----PRFTELVCS 263

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + D GLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 123/249 (49%), Gaps = 14/249 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D   LK +G G FG V   + +   ++ A+K++++  + E    E    E  ++  + H
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 63
Query: 210 PFVVQLKYSFQTKYR-LYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +   H    + L  +   ++  A+ +L
Sbjct: 64  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 121
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGK 324
            +   +HRDL   N L+   G V ++DFGL++    DE T S      V +  PE+++  
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYS 181
Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKG 382
             +  +D W+ G+L++E+ + GK P+     ++  + I +  +L  P   S + ++++  
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 241
Query: 383 LLQKEPGKR 391
              ++  +R
Sbjct: 242 CWHEKADER 250

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 119/261 (45%), Gaps = 17/261 (6%)
Query: 142 VTVCCVGIEDFEVLKVVGQGAFGRVY--QVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA 199
           + + CV IE     +V+G G FG V    ++     EI+      K    EK   +++ +
Sbjct: 4   IDISCVKIE-----QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-S 57
Query: 200 ERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAE 258
           E  I+ + DHP V+ L+        + ++ +F+  G L  F   + G F           
Sbjct: 58  EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 117
Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIG---T 312
           I + + +L     +HR L   NIL+ ++    ++DFGL++  +++T      S +G    
Sbjct: 118 IAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 177
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPA 370
           + + APE +  +    A+D WS GI+++E+++ G+ P+       +   I +D +L  P 
Sbjct: 178 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 237
Query: 371 FLSSEAHSLLKGLLQKEPGKR 391
              S  H L+    QK+   R
Sbjct: 238 DCPSALHQLMLDCWQKDRNHR 258

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 115/228 (50%), Gaps = 13/228 (5%)
Query: 151 DFEVLKVVGQGAFGRVYQ---VRKKNTSEI-YAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + + +KV+G GAFG VY+   V +  T +I  A+K++  +    K + E+M  E  I+  
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL-NETTGPKANVEFMD-EALIMAS 96
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSH 265
           +DHP +V+L         + LV   +  G L   ++ H       L   +  +I   + +
Sbjct: 97  MDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 155
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMAPEIVL 322
           L    ++HRDL   N+L+ +  HV +TDFGLA+  + + +  +  G    +++MA E + 
Sbjct: 156 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 323 GKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            +     +D WS G+ ++E++T G  P+ G    +I   + K + RLP
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLP 262

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 124/253 (49%), Gaps = 11/253 (4%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI 203
           +  ED  + +++G+G FG VY+      K      A+K  +KD  ++ N  ++M +E  I
Sbjct: 21  IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-NKEKFM-SEAVI 78
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI-YAAEIVSA 262
           +  +DHP +V+L    + +   +++++    G L   L  +    + L  + Y+ +I  A
Sbjct: 79  MKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 137
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMAPEI 320
           +++L +   +HRD+   NIL+ +   V L DFGL++  ++     + +    +++M+PE 
Sbjct: 138 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 197
Query: 321 VLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHS 378
           +  +    A+D W   + ++E+L+ GK PF       +   + K D+L  P       ++
Sbjct: 198 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT 257
Query: 379 LLKGLLQKEPGKR 391
           L+      +P  R
Sbjct: 258 LMTRCWDYDPSDR 270

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 124/253 (49%), Gaps = 11/253 (4%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI 203
           +  ED  + +++G+G FG VY+      K      A+K  +KD  ++ N  ++M +E  I
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-NKEKFM-SEAVI 66
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI-YAAEIVSA 262
           +  +DHP +V+L    + +   +++++    G L   L  +    + L  + Y+ +I  A
Sbjct: 67  MKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMAPEI 320
           +++L +   +HRD+   NIL+ +   V L DFGL++  ++     + +    +++M+PE 
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 185
Query: 321 VLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHS 378
           +  +    A+D W   + ++E+L+ GK PF       +   + K D+L  P       ++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT 245
Query: 379 LLKGLLQKEPGKR 391
           L+      +P  R
Sbjct: 246 LMTRCWDYDPSDR 258

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 117/253 (46%), Gaps = 16/253 (6%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +  + KVVG G FG V   R K  +  EI       K    EK   +++  E  I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +++L+        + +V +++  G L  F   H   F           I S + +L 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPEIV 321
             G +HRDL   NIL+ ++    ++DFGLA+  +++      TR   +   + + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI--PIRWTSPEAI 222
Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEA--HS 378
             +    A+D WS GI+L+E+++ G+ P+   +   +  K V +  RLP  +   A  + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDEGYRLPPPMDCPAALYQ 281
Query: 379 LLKGLLQKEPGKR 391
           L+    QK+   R
Sbjct: 282 LMLDCWQKDRNNR 294

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 123/249 (49%), Gaps = 14/249 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D   LK +G G FG V   + +   ++ A+K++++  + E    E    E  ++  + H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 78
Query: 210 PFVVQLKYSFQTKYR-LYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +   H    + L  +   ++  A+ +L
Sbjct: 79  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 136
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGK 324
            +   +HRDL   N L+   G V ++DFGL++    DE T S      V +  PE+++  
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 196
Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKG 382
             +  +D W+ G+L++E+ + GK P+     ++  + I +  +L  P   S + ++++  
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 256
Query: 383 LLQKEPGKR 391
              ++  +R
Sbjct: 257 CWHEKADER 265

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
           E ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHM 78
Query: 208 DHPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            H  V+ L   F     L      YLV   +  G     +       +D  +    +I+ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
            + ++H+  I+HRDLKP N+ +  D  + + D GLA+  D+       + T  Y APEI+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEM--TGYVATRWYRAPEIM 194
Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGN 353
           L   H N+  D WSVG ++ E+LTG+  F G +
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 123/249 (49%), Gaps = 14/249 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D   LK +G G FG V   + +   ++ A+K++++  + E    E    E  ++  + H
Sbjct: 8   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 62
Query: 210 PFVVQLKYSFQTKYR-LYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +   H    + L  +   ++  A+ +L
Sbjct: 63  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 120
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGK 324
            +   +HRDL   N L+   G V ++DFGL++    DE T S      V +  PE+++  
Sbjct: 121 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 180
Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKG 382
             +  +D W+ G+L++E+ + GK P+     ++  + I +  +L  P   S + ++++  
Sbjct: 181 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 240
Query: 383 LLQKEPGKR 391
              ++  +R
Sbjct: 241 CWHEKADER 249

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIY---AMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + F + +++G+G FG V + + K     +   A+K+++ D I   +  E+++ E   + +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-EAACMKE 81
Query: 207 IDHPFVVQL---KYSFQTKYRL---YLVLDFINGG--HLFFQLYHHG-----LFREDLAR 253
            DHP V +L       + K RL    ++L F+  G  H F      G     L  + L R
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 254 IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMI 310
            +  +I   + +L +   +HRDL   N +L  D  V + DFGL+++    D   +  +  
Sbjct: 142 -FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIV-KDKLRL 368
             V+++A E +    +   +D W+ G+ ++E++T G+ P+ G   A+I   ++  ++L+ 
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ 260
Query: 369 PAFLSSEAHSLLKGLLQKEPGKR 391
           P     E + L+      +P +R
Sbjct: 261 PPECMEEVYDLMYQCWSADPKQR 283

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 117/253 (46%), Gaps = 16/253 (6%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +  + KVVG G FG V   R K  +  EI       K    EK   +++  E  I+ + D
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 75
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +++L+        + +V +++  G L  F   H   F           I S + +L 
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 135
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPEIV 321
             G +HRDL   NIL+ ++    ++DFGL++  +++      TR   +   + + +PE +
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAI 193
Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEA--HS 378
             +    A+D WS GI+L+E+++ G+ P+   +   +  K V +  RLP  +   A  + 
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDEGYRLPPPMDCPAALYQ 252
Query: 379 LLKGLLQKEPGKR 391
           L+    QK+   R
Sbjct: 253 LMLDCWQKDRNNR 265

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 117/253 (46%), Gaps = 16/253 (6%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +  + KVVG G FG V   R K  +  EI       K    EK   +++  E  I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +++L+        + +V +++  G L  F   H   F           I S + +L 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPEIV 321
             G +HRDL   NIL+ ++    ++DFGL++  +++      TR   +   + + +PE +
Sbjct: 165 DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAI 222
Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEA--HS 378
             +    A+D WS GI+L+E+++ G+ P+   +   +  K V +  RLP  +   A  + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDEGYRLPPPMDCPAALYQ 281
Query: 379 LLKGLLQKEPGKR 391
           L+    QK+   R
Sbjct: 282 LMLDCWQKDRNNR 294

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 123/249 (49%), Gaps = 14/249 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D   LK +G G FG V   + +   ++ A+K++++  + E    E    E  ++  + H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 58
Query: 210 PFVVQLKYSFQTKYR-LYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +   H    + L  +   ++  A+ +L
Sbjct: 59  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 116
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGK 324
            +   +HRDL   N L+   G V ++DFGL++    DE T S      V +  PE+++  
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKG 382
             +  +D W+ G+L++E+ + GK P+     ++  + I +  +L  P   S + ++++  
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236
Query: 383 LLQKEPGKR 391
              ++  +R
Sbjct: 237 CWHEKADER 245

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 117/253 (46%), Gaps = 16/253 (6%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +  + KVVG G FG V   R K  +  EI       K    EK   +++  E  I+ + D
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 92
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +++L+        + +V +++  G L  F   H   F           I S + +L 
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 152
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPEIV 321
             G +HRDL   NIL+ ++    ++DFGL++  +++      TR   +   + + +PE +
Sbjct: 153 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAI 210
Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEA--HS 378
             +    A+D WS GI+L+E+++ G+ P+   +   +  K V +  RLP  +   A  + 
Sbjct: 211 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDEGYRLPPPMDCPAALYQ 269
Query: 379 LLKGLLQKEPGKR 391
           L+    QK+   R
Sbjct: 270 LMLDCWQKDRNNR 282

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 27/222 (12%)
Query: 152 FEVLKVVGQGAFGRVYQ-VRKKNTSEIYAMKVMRK-DKIVEKNHAEYMKAERDILTKIDH 209
           +E++  +G+GAFG+V + +  K      A+K+++  D+  E   +E    E    T  + 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 210 PF-VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHL 266
            F  VQ+   F+    + +V + + G   +  +  +G   FR D  R  A +I  +V+ L
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 267 HANGIMHRDLKPENILLGADGH-------------------VMLTDFGLAKQFDENTRSN 307
           H+N + H DLKPENIL     +                   + + DFG A   DE+   +
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HS 192
Query: 308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPF 349
           +++ T  Y APE++L  G ++  D WS+G +L E   G   F
Sbjct: 193 TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 115/228 (50%), Gaps = 13/228 (5%)
Query: 151 DFEVLKVVGQGAFGRVYQ---VRKKNTSEI-YAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + + +KV+G GAFG VY+   V +  T +I  A+K++  +    K + E+M  E  I+  
Sbjct: 16  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL-NETTGPKANVEFMD-EALIMAS 73
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSH 265
           +DHP +V+L         + LV   +  G L   ++ H       L   +  +I   + +
Sbjct: 74  MDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 132
Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMAPEIVL 322
           L    ++HRDL   N+L+ +  HV +TDFGLA+  + + +  +  G    +++MA E + 
Sbjct: 133 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 323 GKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            +     +D WS G+ ++E++T G  P+ G    +I   + K + RLP
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLP 239

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 123/249 (49%), Gaps = 14/249 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D   LK +G G FG V   + +   ++ A+K++++  + E    E    E  ++  + H
Sbjct: 15  KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 69
Query: 210 PFVVQLKYSFQTKYR-LYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +   H    + L  +   ++  A+ +L
Sbjct: 70  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 127
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGK 324
            +   +HRDL   N L+   G V ++DFGL++    DE T S      V +  PE+++  
Sbjct: 128 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 187
Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKG 382
             +  +D W+ G+L++E+ + GK P+     ++  + I +  +L  P   S + ++++  
Sbjct: 188 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 247
Query: 383 LLQKEPGKR 391
              ++  +R
Sbjct: 248 CWHEKADER 256

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 101/250 (40%), Gaps = 44/250 (17%)
Query: 132 SIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKN--TSEIYAMKVMRKDKIV 189
           ++   +   S    C G+ D E + V  +  F  V   R  N  +      +V+R+ +++
Sbjct: 25  TVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 190 EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE 249
              H   +   RDI    + P            ++LYLV +               L R 
Sbjct: 84  NHFHHPNILGLRDIFVHFEEP----------AMHKLYLVTE---------------LMRT 118
Query: 250 DLAR-IYAAEIVSAVSH--------------LHANGIMHRDLKPENILLGADGHVMLTDF 294
           DLA+ I+   IV +  H              LH  G++HRDL P NILL  +  + + DF
Sbjct: 119 DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178
Query: 295 GLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
            LA++   +      +    Y APE+V+  KG  K  D WS G ++ EM   K  F G  
Sbjct: 179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238
Query: 354 RAKIQQKIVK 363
                 KIV+
Sbjct: 239 FYNQLNKIVE 248

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 101/250 (40%), Gaps = 44/250 (17%)
Query: 132 SIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKN--TSEIYAMKVMRKDKIV 189
           ++   +   S    C G+ D E + V  +  F  V   R  N  +      +V+R+ +++
Sbjct: 25  TVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 190 EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE 249
              H   +   RDI    + P            ++LYLV +               L R 
Sbjct: 84  NHFHHPNILGLRDIFVHFEEP----------AMHKLYLVTE---------------LMRT 118
Query: 250 DLAR-IYAAEIVSAVSH--------------LHANGIMHRDLKPENILLGADGHVMLTDF 294
           DLA+ I+   IV +  H              LH  G++HRDL P NILL  +  + + DF
Sbjct: 119 DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178
Query: 295 GLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
            LA++   +      +    Y APE+V+  KG  K  D WS G ++ EM   K  F G  
Sbjct: 179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238
Query: 354 RAKIQQKIVK 363
                 KIV+
Sbjct: 239 FYNQLNKIVE 248

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 123/249 (49%), Gaps = 14/249 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D   LK +G G FG V   + +   ++ A+K++++  + E    E    E  ++  + H
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 63
Query: 210 PFVVQLKYSFQTKYR-LYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +   H    + L  +   ++  A+ +L
Sbjct: 64  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 121
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGK 324
            +   +HRDL   N L+   G V ++DFGL++    DE T S      V +  PE+++  
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 181
Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKG 382
             +  +D W+ G+L++E+ + GK P+     ++  + I +  +L  P   S + ++++  
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 241
Query: 383 LLQKEPGKR 391
              ++  +R
Sbjct: 242 CWHEKADER 250

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G G+FG VY+ +      +  + V            +  K E  +L K  H  ++ L  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 70
Query: 218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE---------DLARIYAAEIVSAVSHLHA 268
            + T  +L +V  +  G      LYHH    E         D+AR    +    + +LHA
Sbjct: 71  GYSTAPQLAIVTQWCEGS----SLYHHLHIIETKFEMIKLIDIAR----QTAQGMDYLHA 122
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLA---KQFDENTRSNSMIGTVEYMAPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA    ++  + +   + G++ +MAPE++  + 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 326 HNK---AADWWSVGILLYEMLTGKPPFIG-GNRAKI 357
            N     +D ++ GI+LYE++TG+ P+    NR +I
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 117/253 (46%), Gaps = 16/253 (6%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +  + KVVG G FG V   R K  +  EI       K    EK   +++  E  I+ + D
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 102
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +++L+        + +V +++  G L  F   H   F           I S + +L 
Sbjct: 103 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 162
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPEIV 321
             G +HRDL   NIL+ ++    ++DFGL++  +++      TR   +   + + +PE +
Sbjct: 163 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAI 220
Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEA--HS 378
             +    A+D WS GI+L+E+++ G+ P+   +   +  K V +  RLP  +   A  + 
Sbjct: 221 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDEGYRLPPPMDCPAALYQ 279
Query: 379 LLKGLLQKEPGKR 391
           L+    QK+   R
Sbjct: 280 LMLDCWQKDRNNR 292

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 117/253 (46%), Gaps = 16/253 (6%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +  + KVVG G FG V   R K  +  EI       K    EK   +++  E  I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +++L+        + +V +++  G L  F   H   F           I S + +L 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPEIV 321
             G +HRDL   NIL+ ++    ++DFGL++  +++      TR   +   + + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAI 222
Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEA--HS 378
             +    A+D WS GI+L+E+++ G+ P+   +   +  K V +  RLP  +   A  + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDEGYRLPPPMDCPAALYQ 281
Query: 379 LLKGLLQKEPGKR 391
           L+    QK+   R
Sbjct: 282 LMLDCWQKDRNNR 294

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 117/253 (46%), Gaps = 16/253 (6%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +  + KVVG G FG V   R K  +  EI       K    EK   +++  E  I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +++L+        + +V +++  G L  F   H   F           I S + +L 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPEIV 321
             G +HRDL   NIL+ ++    ++DFGL++  +++      TR   +   + + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAI 222
Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEA--HS 378
             +    A+D WS GI+L+E+++ G+ P+   +   +  K V +  RLP  +   A  + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDEGYRLPPPMDCPAALYQ 281
Query: 379 LLKGLLQKEPGKR 391
           L+    QK+   R
Sbjct: 282 LMLDCWQKDRNNR 294

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 119/267 (44%), Gaps = 33/267 (12%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +  ++ +G+G F  V  V   +    YA+K   +    E+   E  + E D+    +HP 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALK---RILCHEQQDREEAQREADMHRLFNHPN 87
Query: 212 VVQL-KYSFQ---TKYRLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAV 263
           +++L  Y  +    K+  +L+L F   G L+ ++           ED        I   +
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ---FDENTRSNSMIG-------TV 313
             +HA G  HRDLKP NILLG +G  +L D G   Q     E +R    +        T+
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 314 EYMAPEIVLGKGH---NKAADWWSVGILLYEMLTGKPP----FIGGNRAKIQQKIVKDKL 366
            Y APE+   + H   ++  D WS+G +LY M+ G+ P    F  G+   +    V+++L
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL---AVQNQL 264
Query: 367 RLPA--FLSSEAHSLLKGLLQKEPGKR 391
            +P     SS    LL  ++  +P +R
Sbjct: 265 SIPQSPRHSSALWQLLNSMMTVDPHQR 291

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 117/253 (46%), Gaps = 16/253 (6%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +  + KVVG G FG V   R K  +  EI       K    EK   +++  E  I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +++L+        + +V +++  G L  F   H   F           I S + +L 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPEIV 321
             G +HRDL   NIL+ ++    ++DFGL++  +++      TR   +   + + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAI 222
Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEA--HS 378
             +    A+D WS GI+L+E+++ G+ P+   +   +  K V +  RLP  +   A  + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDEGYRLPPPMDCPAALYQ 281
Query: 379 LLKGLLQKEPGKR 391
           L+    QK+   R
Sbjct: 282 LMLDCWQKDRNNR 294

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 117/253 (46%), Gaps = 16/253 (6%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +  + KVVG G FG V   R K  +  EI       K    EK   +++  E  I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +++L+        + +V +++  G L  F   H   F           I S + +L 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPEIV 321
             G +HRDL   NIL+ ++    ++DFGL++  +++      TR   +   + + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAI 222
Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEA--HS 378
             +    A+D WS GI+L+E+++ G+ P+   +   +  K V +  RLP  +   A  + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDEGYRLPPPMDCPAALYQ 281
Query: 379 LLKGLLQKEPGKR 391
           L+    QK+   R
Sbjct: 282 LMLDCWQKDRNNR 294

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 85/188 (45%), Gaps = 2/188 (1%)
Query: 166 VYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL 225
           VY+        I A+K+  +    +       + E     ++  P VV +    +   +L
Sbjct: 50  VYEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQL 109
Query: 226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA 285
           Y+    ING  L   L   G      A     +I SA+   HA G  HRD+KPENIL+ A
Sbjct: 110 YVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA 169
Query: 286 DGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEML 343
           D    L DFG+A    +   T+  + +GT+ Y APE          AD +++  +LYE L
Sbjct: 170 DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECL 229
Query: 344 TGKPPFIG 351
           TG PP+ G
Sbjct: 230 TGSPPYQG 237

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 116/253 (45%), Gaps = 16/253 (6%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +  + KVVG G FG V   R K  +  EI       K    EK   +++  E  I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +++L+        + +V +++  G L  F   H   F           I S + +L 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPEIV 321
             G +HRDL   NIL+ ++    ++DFGL +  +++      TR   +   + + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI--PIRWTSPEAI 222
Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEA--HS 378
             +    A+D WS GI+L+E+++ G+ P+   +   +  K V +  RLP  +   A  + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDEGYRLPPPMDCPAALYQ 281
Query: 379 LLKGLLQKEPGKR 391
           L+    QK+   R
Sbjct: 282 LMLDCWQKDRNNR 294

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 120/265 (45%), Gaps = 35/265 (13%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+GAFG+V     + + K  T    A+K++++     ++ A  + +E  IL  I H 
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 90
Query: 211 FVVQLKYSFQTK--YRLYLVLDFINGGHL-------------FFQLYHHGLFREDLARIY 255
             V       TK    L ++++F   G+L             +  LY   L  E L   Y
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI-CY 149
Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIGT 312
           + ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R       
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-----DKL 366
           +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +      ++
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEGTRM 266
Query: 367 RLPAFLSSEAHSLLKGLLQKEPGKR 391
           R P + + E +  +      EP +R
Sbjct: 267 RAPDYTTPEMYQTMLDCWHGEPSQR 291

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 112/233 (48%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L++  +  G L   +  H   ++++   Y      +I 
Sbjct: 76  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 131
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 132 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 243

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 112/233 (48%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L++  +  G L   +  H   ++++   Y      +I 
Sbjct: 73  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGXLLDYVREH---KDNIGSQYLLNWCVQIA 128
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 129 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 240

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 40/104 (38%), Positives = 63/104 (60%), Gaps = 2/104 (1%)
Query: 250 DLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA-DGHVMLTDFGLAKQFDENTRSNS 308
           +L  IY  ++  AV  +H+ GI HRD+KP+N+L+ + D  + L DFG AK+   +  S +
Sbjct: 141 NLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA 200
Query: 309 MIGTVEYMAPEIVLGKG-HNKAADWWSVGILLYEMLTGKPPFIG 351
            I +  Y APE++LG   +  + D WS+G +  E++ GKP F G
Sbjct: 201 XICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 25/207 (12%)
Query: 158 VGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV 213
           +G G FG V    Y++RKK      A+KV+++    EK   E M  E  I+ ++D+P++V
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQID--VAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIV 73
Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLF--REDLARIYAAEIVSAVS----HLH 267
           +L    Q +  L LV++   GG L     H  L   RE++     AE++  VS    +L 
Sbjct: 74  RLIGVCQAE-ALMLVMEMAGGGPL-----HKFLVGKREEIPVSNVAELLHQVSMGMKYLE 127
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGT--VEYMAPEIVLG 323
               +HRDL   N+LL    +  ++DFGL+K    D++  +    G   +++ APE +  
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 324 KGHNKAADWWSVGILLYEMLT-GKPPF 349
           +  +  +D WS G+ ++E L+ G+ P+
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPY 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 112/233 (48%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L++  +  G L   +  H   ++++   Y      +I 
Sbjct: 74  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 129
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 241

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 37/268 (13%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+GAFG+V     + + K  T    A+K++++     ++ A  + +E  IL  I H 
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 90
Query: 211 FVVQLKYSFQTK--YRLYLVLDFINGGHLFFQLYH-------HGLFREDLAR-------- 253
             V       TK    L ++++F   G+L   L         + +  EDL +        
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 254 -IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSM 309
             Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R    
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK----- 363
              +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +     
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEG 267
Query: 364 DKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++R P + + E +  +      EP +R
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQR 295

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 112/233 (48%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L++  +  G L   +  H   ++++   Y      +I 
Sbjct: 73  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 128
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 129 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 240

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 115/226 (50%), Gaps = 13/226 (5%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  +++K +G G FG V+     N++++ A+K ++   +  +   E    E +++  + H
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAFLE----EANLMKTLQH 66
Query: 210 PFVVQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHL 266
             +V+L Y+  TK   +Y++ +F+  G L   L      +  L ++  ++A+I   ++++
Sbjct: 67  DKLVRL-YAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 125
Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGK 324
                +HRDL+  N+L+       + DFGLA+  ++N  T        +++ APE +   
Sbjct: 126 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 185
Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
                ++ WS GILLYE++T GK P+ G   A +   + +   R+P
Sbjct: 186 CFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQG-YRMP 230

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 112/233 (48%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L++  +  G L   +  H   ++++   Y      +I 
Sbjct: 75  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 130
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 242

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 116/253 (45%), Gaps = 16/253 (6%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +  + KVVG G FG V   R K  +  EI       K    EK   +++  E  I+ + D
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 75
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +++L+        + +V + +  G L  F   H   F           I S + +L 
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 135
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPEIV 321
             G +HRDL   NIL+ ++    ++DFGL++  +++      TR   +   + + +PE +
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAI 193
Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEA--HS 378
             +    A+D WS GI+L+E+++ G+ P+   +   +  K V +  RLP  +   A  + 
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDEGYRLPPPMDCPAALYQ 252
Query: 379 LLKGLLQKEPGKR 391
           L+    QK+   R
Sbjct: 253 LMLDCWQKDRNNR 265

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 112/233 (48%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L++  +  G L   +  H   ++++   Y      +I 
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 127
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 239

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 112/225 (49%), Gaps = 11/225 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  +++K +G G FG V+     N++++ A+K ++   +  +   E    E +++  + H
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAFLE----EANLMKTLQH 67
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L      +  +Y++ +++  G L   L      +  L ++  ++A+I   ++++ 
Sbjct: 68  DKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 127
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  N+L+       + DFGLA+  ++N  T        +++ APE +    
Sbjct: 128 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGC 187
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
               +D WS GILLYE++T GK P+ G   A +   + +   R+P
Sbjct: 188 FTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQG-YRMP 231

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 116/253 (45%), Gaps = 16/253 (6%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +  + KVVG G FG V   R K  +  EI       K    EK   +++  E  I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +++L+        + +V + +  G L  F   H   F           I S + +L 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPEIV 321
             G +HRDL   NIL+ ++    ++DFGL++  +++      TR   +   + + +PE +
Sbjct: 165 DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAI 222
Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEA--HS 378
             +    A+D WS GI+L+E+++ G+ P+   +   +  K V +  RLP  +   A  + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDEGYRLPPPMDCPAALYQ 281
Query: 379 LLKGLLQKEPGKR 391
           L+    QK+   R
Sbjct: 282 LMLDCWQKDRNNR 294

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 119/268 (44%), Gaps = 38/268 (14%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+GAFG+V     + + K  T    A+K++++     ++ A  + +E  IL  I H 
Sbjct: 34  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 91
Query: 211 FVVQLKYSFQTK--YRLYLVLDFINGGHLFF----------------QLYHHGLFREDLA 252
             V       TK    L ++++F   G+L                   LY   L  E L 
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSM 309
             Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R    
Sbjct: 152 -CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK----- 363
              +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +     
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEG 267
Query: 364 DKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++R P + + E +  +      EP +R
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQR 295

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I+E   A   KA ++IL      
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIMELREATSPKANKEILDEAYVM 105
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L         + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 106 ASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 161
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 162 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 222 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 273

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 116/253 (45%), Gaps = 16/253 (6%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +  + KVVG G FG V   R K  +  EI       K    EK   +++  E  I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +++L+        + +V + +  G L  F   H   F           I S + +L 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPEIV 321
             G +HRDL   NIL+ ++    ++DFGL++  +++      TR   +   + + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAI 222
Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEA--HS 378
             +    A+D WS GI+L+E+++ G+ P+   +   +  K V +  RLP  +   A  + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDEGYRLPPPMDCPAALYQ 281
Query: 379 LLKGLLQKEPGKR 391
           L+    QK+   R
Sbjct: 282 LMLDCWQKDRNNR 294

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 32/216 (14%)
Query: 155 LKVVGQGAFGRVYQ----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           +KV+G GAFG VY+       +N     A+KV+R++   + N    +  E  ++  +  P
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE--ILDEAYVMAGVGSP 79
Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLF----REDLARI-------YAAEI 259
           +V +L           L +   +   L  QL  +G      RE+  R+       +  +I
Sbjct: 80  YVSRL-----------LGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI 128
Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTV--EYM 316
              +S+L    ++HRDL   N+L+ +  HV +TDFGLA+  D + T  ++  G V  ++M
Sbjct: 129 AKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 188
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG 351
           A E +L +     +D WS G+ ++E++T G  P+ G
Sbjct: 189 ALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDG 224

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 120/262 (45%), Gaps = 21/262 (8%)
Query: 142 VTVCCVGIEDFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKA 199
           +   C+ IE     +V+G G FG V   R K     E+       K    EK   +++  
Sbjct: 19  IEASCITIE-----RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFL-G 72
Query: 200 ERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAE 258
           E  I+ + DHP ++ L+        + +V +++  G L  F   + G F           
Sbjct: 73  EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRG 132
Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGT 312
           I + + +L   G +HRDL   NIL+ ++    ++DFGL++  +++      TR   +   
Sbjct: 133 ISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--P 190
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAF 371
           + + APE +  +    A+D WS GI+++E+++ G+ P+       +  K V++  RLP+ 
Sbjct: 191 IRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDV-IKAVEEGYRLPSP 249
Query: 372 LSSEA--HSLLKGLLQKEPGKR 391
           +   A  + L+    QKE   R
Sbjct: 250 MDCPAALYQLMLDCWQKERNSR 271

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 37/268 (13%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+GAFG+V     + + K  T    A+K++++     ++ A  + +E  IL  I H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 81
Query: 211 FVVQLKYSFQTK--YRLYLVLDFINGGHLFFQLYH-------HGLFREDLAR-------- 253
             V       TK    L ++++F   G+L   L         + +  EDL +        
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 254 -IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSM 309
             Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R    
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK----- 363
              +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +     
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEG 258
Query: 364 DKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++R P + + E +  +      EP +R
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCWHGEPSQR 286

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 37/268 (13%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+GAFG+V     + + K  T    A+K++++     ++ A  + +E  IL  I H 
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 90
Query: 211 FVVQLKYSFQTK--YRLYLVLDFINGGHLFFQLYH-------HGLFREDLAR-------- 253
             V       TK    L ++++F   G+L   L         + +  EDL +        
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 254 -IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSM 309
             Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R    
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK----- 363
              +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +     
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEG 267
Query: 364 DKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++R P + + E +  +      EP +R
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQR 295

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 37/268 (13%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+GAFG+V     + + K  T    A+K++++     ++ A  + +E  IL  I H 
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 90
Query: 211 FVVQLKYSFQTK--YRLYLVLDFINGGHLFFQLYH-------HGLFREDLAR-------- 253
             V       TK    L ++++F   G+L   L         + +  EDL +        
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 254 -IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSM 309
             Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R    
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK----- 363
              +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +     
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEG 267
Query: 364 DKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++R P + + E +  +      EP +R
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQR 295

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 152 FEVLKVVGQGAFGRVYQ-VRKKNTSEIYAMKVMRK-DKIVEKNHAEYMKAERDILTKIDH 209
           +E++  +G+GAFG+V + +  K      A+K+++  D+  E   +E    E    T  + 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 210 PF-VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHL 266
            F  VQ+   F+    + +V + + G   +  +  +G   FR D  R  A +I  +V+ L
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 267 HANGIMHRDLKPENILLGADGH-------------------VMLTDFGLAKQFDENTRSN 307
           H+N + H DLKPENIL     +                   + + DFG A   DE+   +
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HS 192
Query: 308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPF 349
           +++    Y APE++L  G ++  D WS+G +L E   G   F
Sbjct: 193 TLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGXLLDYVREH---KDNIGSQYLLNWCVQIA 127
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 239

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 120/265 (45%), Gaps = 35/265 (13%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+GAFG+V     + + K  T    A+K++++     ++ A  + +E  IL  I H 
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 90
Query: 211 FVVQLKYSFQTK--YRLYLVLDFINGGHL-------------FFQLYHHGLFREDLARIY 255
             V       TK    L ++++F   G+L             +  LY   L  E L   Y
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI-XY 149
Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIGT 312
           + ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R       
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-----DKL 366
           +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +      ++
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFXRRLKEGTRM 266
Query: 367 RLPAFLSSEAHSLLKGLLQKEPGKR 391
           R P + + E +  +      EP +R
Sbjct: 267 RAPDYTTPEMYQTMLDCWHGEPSQR 291

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 25/207 (12%)
Query: 158 VGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV 213
           +G G FG V    Y++RKK      A+KV+++    EK   E M  E  I+ ++D+P++V
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID--VAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIV 399
Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLF--REDLARIYAAEIVSAVS----HLH 267
           +L    Q +  L LV++   GG L     H  L   RE++     AE++  VS    +L 
Sbjct: 400 RLIGVCQAE-ALMLVMEMAGGGPL-----HKFLVGKREEIPVSNVAELLHQVSMGMKYLE 453
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGT--VEYMAPEIVLG 323
               +HR+L   N+LL    +  ++DFGL+K    D++  +    G   +++ APE +  
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 324 KGHNKAADWWSVGILLYEMLT-GKPPF 349
           +  +  +D WS G+ ++E L+ G+ P+
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPY 540

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 35/266 (13%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+GAFG+V     + + K  T    A+K++++     ++ A  + +E  IL  I H 
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 92
Query: 211 FVVQLKYSFQTK--YRLYLVLDFINGGHL----------FFQLYHHGLFREDLAR----I 254
             V       TK    L ++++F   G+L          F       L+++ L       
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIG 311
           Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R      
Sbjct: 153 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-----DK 365
            +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +      +
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEGTR 269
Query: 366 LRLPAFLSSEAHSLLKGLLQKEPGKR 391
           +R P + + E +  +      EP +R
Sbjct: 270 MRAPDYTTPEMYQTMLDCWHGEPSQR 295

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 110/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L         + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 75  ASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 130
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 242

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 74  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 129
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 241

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 127
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 239

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 75  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 130
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 242

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 75  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 130
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 242

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 79  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 134
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 246

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 111/210 (52%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMR---KDKI-VEKNHAEYMKAERDILT 205
           +D+++++ +G+G +  V++      +E   +K+++   K+KI  E    E ++   +I+T
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIIT 96
Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             D   +V+   S        LV + +N    F QLY   L   D+ R Y  EI+ A+ +
Sbjct: 97  LAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLYQ-TLTDYDI-RFYMYEILKALDY 146
Query: 266 LHANGIMHRDLKPENILLGADGH-VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
            H+ GIMHRD+KP N+++  +   + L D+GLA+ +      N  + +  +  PE+++  
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
           + ++ + D WS+G +L  M+  K PF  G+
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 110/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 77
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L         + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 78  ASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 133
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 134 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 194 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 245

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 155 LKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           ++ +G+G FG+V    Y     NT E  A+K ++ +     NH   +K E +IL  + H 
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE 83
Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLAR-----------IYAAEI 259
            +V        KY+     D  NG  L  +    G  +E L +            YA +I
Sbjct: 84  NIV--------KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEY 315
              + +L +   +HRDL   N+L+ ++  V + DFGL K  + +    T  +     V +
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 195
Query: 316 MAPEIVLGKGHNKAADWWSVGILLYEMLT 344
            APE ++      A+D WS G+ L+E+LT
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 110/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L         + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 72  ASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 127
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 239

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 110/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 81
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L         + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 82  ASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 137
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 138 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 198 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 249

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 121/268 (45%), Gaps = 33/268 (12%)
Query: 142 VTVCCVGIEDFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKA 199
           +   C+ IE     KV+G G FG V   R K     EI       K    +K   +++ +
Sbjct: 26  IDASCIKIE-----KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-S 79
Query: 200 ERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEI 259
           E  I+ + DHP ++ L+        + ++ +++  G L          R++  R    ++
Sbjct: 80  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQL 133
Query: 260 V-------SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRS 306
           V       S + +L     +HRDL   NIL+ ++    ++DFG+++  +++      TR 
Sbjct: 134 VGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 193
Query: 307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK 365
             +   + + APE +  +    A+D WS GI+++E+++ G+ P+   +   +  K +++ 
Sbjct: 194 GKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-IKAIEEG 250
Query: 366 LRLPAFLSS--EAHSLLKGLLQKEPGKR 391
            RLP  +      H L+    QKE   R
Sbjct: 251 YRLPPPMDCPIALHQLMLDCWQKERSDR 278

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 120/268 (44%), Gaps = 37/268 (13%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+GAFG+V     + + K  T    A+K++++     ++ A  + +E  IL  I H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 81
Query: 211 FVVQLKYSFQTK--YRLYLVLDFINGGHLFFQLYH-------HGLFREDLAR-------- 253
             V       TK    L ++ +F   G+L   L         + +  EDL +        
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 254 -IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSM 309
             Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R    
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK----- 363
              +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +     
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEG 258
Query: 364 DKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++R P + + E +  +      EP +R
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCWHGEPSQR 286

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 96
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 97  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 152
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 153 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 213 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 264

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 37/268 (13%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+GAFG+V     + + K  T    A+K++++     ++ A  + +E  IL  I H 
Sbjct: 70  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 127
Query: 211 FVVQLKYSFQTK--YRLYLVLDFINGGHLFFQLYH-------HGLFREDLAR-------- 253
             V       TK    L ++++F   G+L   L         + +  EDL +        
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 254 -IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSM 309
             Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R    
Sbjct: 188 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK----- 363
              +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +     
Sbjct: 248 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEG 304
Query: 364 DKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++R P + + E +  +      EP +R
Sbjct: 305 TRMRAPDYTTPEMYQTMLDCWHGEPSQR 332

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 68
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 69  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 124
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 125 EGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 185 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 236

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 119/269 (44%), Gaps = 39/269 (14%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+GAFG+V     + + K  T    A+K++++     ++ A  + +E  IL  I H 
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 92
Query: 211 FVVQLKYSFQTK--YRLYLVLDFINGGHLFF-----------------QLYHHGLFREDL 251
             V       TK    L ++++F   G+L                    LY   L  E L
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 252 ARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNS 308
              Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R   
Sbjct: 153 I-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK---- 363
               +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +    
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKE 268
Query: 364 -DKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
             ++R P + + E +  +      EP +R
Sbjct: 269 GTRMRAPDYTTPEMYQTMLDCWHGEPSQR 297

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 66  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 121
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 233

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 118/258 (45%), Gaps = 28/258 (10%)
Query: 158 VGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           +G+GAFG+V     Y +  +    + A+K +   K    N  +    E ++LT + H  +
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDFHREAELLTNLQHEHI 77
Query: 213 VQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG--------------LFREDLARIYAAE 258
           V+          L +V +++  G L   L  HG              L +  +  I A +
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI-AQQ 136
Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEY 315
           I + + +L +   +HRDL   N L+G +  V + DFG+++     D        +  + +
Sbjct: 137 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 316 MAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAFLS 373
           M PE ++ +     +D WS+G++L+E+ T GK P+   +  ++ + I + + L+ P    
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCP 256
Query: 374 SEAHSLLKGLLQKEPGKR 391
            E + L+ G  Q+EP  R
Sbjct: 257 QEVYELMLGCWQREPHMR 274

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 121/268 (45%), Gaps = 33/268 (12%)
Query: 142 VTVCCVGIEDFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKA 199
           +   C+ IE     KV+G G FG V   R K     EI       K    +K   +++ +
Sbjct: 5   IDASCIKIE-----KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-S 58
Query: 200 ERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEI 259
           E  I+ + DHP ++ L+        + ++ +++  G L          R++  R    ++
Sbjct: 59  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQL 112
Query: 260 V-------SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRS 306
           V       S + +L     +HRDL   NIL+ ++    ++DFG+++  +++      TR 
Sbjct: 113 VGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 172
Query: 307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK 365
             +   + + APE +  +    A+D WS GI+++E+++ G+ P+   +   +  K +++ 
Sbjct: 173 GKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-IKAIEEG 229
Query: 366 LRLPAFLSS--EAHSLLKGLLQKEPGKR 391
            RLP  +      H L+    QKE   R
Sbjct: 230 YRLPPPMDCPIALHQLMLDCWQKERSDR 257

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 121/268 (45%), Gaps = 33/268 (12%)
Query: 142 VTVCCVGIEDFEVLKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKA 199
           +   C+ IE     KV+G G FG V   R K     EI       K    +K   +++ +
Sbjct: 11  IDASCIKIE-----KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-S 64
Query: 200 ERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEI 259
           E  I+ + DHP ++ L+        + ++ +++  G L          R++  R    ++
Sbjct: 65  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQL 118
Query: 260 V-------SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRS 306
           V       S + +L     +HRDL   NIL+ ++    ++DFG+++  +++      TR 
Sbjct: 119 VGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 178
Query: 307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK 365
             +   + + APE +  +    A+D WS GI+++E+++ G+ P+   +   +  K +++ 
Sbjct: 179 GKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-IKAIEEG 235
Query: 366 LRLPAFLSS--EAHSLLKGLLQKEPGKR 391
            RLP  +      H L+    QKE   R
Sbjct: 236 YRLPPPMDCPIALHQLMLDCWQKERSDR 263

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 120/268 (44%), Gaps = 37/268 (13%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+GAFG+V     + + K  T    A+K++++     ++ A  + +E  IL  I H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 81
Query: 211 FVVQLKYSFQTK--YRLYLVLDFINGGHLFFQLYH-------HGLFREDLAR-------- 253
             V       TK    L ++ +F   G+L   L         + +  EDL +        
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 254 -IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSM 309
             Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R    
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK----- 363
              +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +     
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEG 258
Query: 364 DKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++R P + + E +  +      EP +R
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCWHGEPSQR 286

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 155 LKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           ++ +G+G FG+V    Y     NT E  A+K ++ +     NH   +K E +IL  + H 
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE 71
Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLAR-----------IYAAEI 259
            +V        KY+     D  NG  L  +    G  +E L +            YA +I
Sbjct: 72  NIV--------KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 123
Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEY 315
              + +L +   +HRDL   N+L+ ++  V + DFGL K  + +    T  +     V +
Sbjct: 124 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 183
Query: 316 MAPEIVLGKGHNKAADWWSVGILLYEMLT 344
            APE ++      A+D WS G+ L+E+LT
Sbjct: 184 YAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 24/152 (15%)
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-------- 309
           +I  AV  LH+ G+MHRDLKP NI    D  V + DFGL    D++    ++        
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 310 -----IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD 364
                +GT  YM+PE + G  ++   D +S+G++L+E+L            ++  +I+ D
Sbjct: 232 THXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS----FSTQMERV--RIITD 285
Query: 365 --KLRLPAFLSS---EAHSLLKGLLQKEPGKR 391
              L+ P   +    + H +++ +L   P +R
Sbjct: 286 VRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 121/249 (48%), Gaps = 24/249 (9%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++ K +G G FG V+       +++ A+K M+   +      E   AE +++  + H
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 236
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 237 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT---VEYMAPEIVLGK 324
               +HRDL+  NIL+ A     + DFGLA+           +G    +++ APE +   
Sbjct: 296 QRNYIHRDLRAANILVSASLVCKIADFGLAR-----------VGAKFPIKWTAPEAINFG 344
Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKG 382
                +D WS GILL E++T G+ P+ G +  ++ + + +  ++  P     E ++++  
Sbjct: 345 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR 404
Query: 383 LLQKEPGKR 391
             +  P +R
Sbjct: 405 CWKNRPEER 413

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 122/248 (49%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G FG V+       +++ A+K +++  +      +   AE +++ ++ H
Sbjct: 21  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 75
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 76  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 134
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ APE +    
Sbjct: 135 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 194
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 195 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 254
Query: 384 LQKEPGKR 391
            ++ P  R
Sbjct: 255 WKERPEDR 262

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 122/248 (49%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G FG V+       +++ A+K +++  +      +   AE +++ ++ H
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 73
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 74  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 132
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ APE +    
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 192
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 252
Query: 384 LQKEPGKR 391
            ++ P  R
Sbjct: 253 WKERPEDR 260

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 122/248 (49%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G FG V+       +++ A+K +++  +      +   AE +++ ++ H
Sbjct: 22  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 76
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 77  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 135
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ APE +    
Sbjct: 136 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 195
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 196 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 255
Query: 384 LQKEPGKR 391
            ++ P  R
Sbjct: 256 WKERPEDR 263

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 122/248 (49%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G FG V+       +++ A+K +++  +      +   AE +++ ++ H
Sbjct: 15  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 69
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 70  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 128
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ APE +    
Sbjct: 129 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 188
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 189 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 248
Query: 384 LQKEPGKR 391
            ++ P  R
Sbjct: 249 WKERPEDR 256

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 123/265 (46%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQVR-------KKNTSEIYAMKVMRKDK--------IVEKNHAEYMKAE 200
           K +G+GAFG+V           K N     A+K+++ D         I E    + +   
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 201 RDILTKI-----DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH---GLFREDLA 252
           ++I+  +     D P  V ++Y+ +   R YL      G    F   H+    L  +DL 
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
              A ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ + 
Sbjct: 154 SC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+LL+E+ T G  P+ G    ++  K++K+  R+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKLLKEGHRM 271
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             P+  ++E + +++      P +R
Sbjct: 272 DKPSNCTNELYMMMRDCWHAVPSQR 296

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 122/248 (49%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G FG V+       +++ A+K +++  +      +   AE +++ ++ H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 68  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ APE +    
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246
Query: 384 LQKEPGKR 391
            ++ P  R
Sbjct: 247 WKERPEDR 254

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 122/248 (49%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G FG V+       +++ A+K +++  +      +   AE +++ ++ H
Sbjct: 18  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 72
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 73  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 131
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ APE +    
Sbjct: 132 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 191
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 192 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 251
Query: 384 LQKEPGKR 391
            ++ P  R
Sbjct: 252 WKERPEDR 259

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 106/229 (46%), Gaps = 25/229 (10%)
Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           LK +G G  G V+     +  +  A+K   K  + +    ++   E  I+ ++DH  +V+
Sbjct: 16  LKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 215 L--------------KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIV 260
           +                S      +Y+V +++        +   G   E+ AR++  +++
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLLEEHARLFMYQLL 130
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIG----TVEY 315
             + ++H+  ++HRDLKP N+ +  +  V+ + DFGLA+  D +      +     T  Y
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 316 MAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
            +P ++L    + KA D W+ G +  EMLTGK  F G +  +  Q I++
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 120/268 (44%), Gaps = 37/268 (13%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+GAFG+V     + + K  T    A+K++++     ++ A  + +E  IL  I H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 81
Query: 211 FVVQLKYSFQTK--YRLYLVLDFINGGHLFFQLYH-------HGLFREDLAR-------- 253
             V       TK    L ++ +F   G+L   L         + +  EDL +        
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 254 -IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSM 309
             Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R    
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK----- 363
              +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +     
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEG 258
Query: 364 DKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++R P + + E +  +      EP +R
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCWHGEPSQR 286

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 122/248 (49%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G FG V+       +++ A+K +++  +      +   AE +++ ++ H
Sbjct: 23  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 77
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 78  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 136
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ APE +    
Sbjct: 137 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 196
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 197 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 256
Query: 384 LQKEPGKR 391
            ++ P  R
Sbjct: 257 WKERPEDR 264

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 117/246 (47%), Gaps = 23/246 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L++  +  G L   +  H   ++++   Y      +I 
Sbjct: 74  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 129
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++MA
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSE 375
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   + K ++L  P   + +
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 249
Query: 376 AHSLLK 381
            + +++
Sbjct: 250 VYMIMR 255

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 122/248 (49%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G FG V+       +++ A+K +++  +      +   AE +++ ++ H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 68  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ APE +    
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246
Query: 384 LQKEPGKR 391
            ++ P  R
Sbjct: 247 WKERPEDR 254

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 122/248 (49%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G FG V+       +++ A+K +++  +      +   AE +++ ++ H
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 73
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 74  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 132
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ APE +    
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 192
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 252
Query: 384 LQKEPGKR 391
            ++ P  R
Sbjct: 253 WKERPEDR 260

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 123/250 (49%), Gaps = 25/250 (10%)
Query: 158 VGQGAFGRVYQ-VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLK 216
           +G+G+F  VY+ +  + T E+   ++  +D+ + K+  +  K E + L  + HP +V+  
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCEL--QDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 217 YSFQTKYR----LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG-- 270
            S+++  +    + LV +    G L   L    + +  + R +  +I+  +  LH     
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 271 IMHRDLKPENILL-GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKA 329
           I+HRDLK +NI + G  G V + D GLA      + + ++IGT E+ APE    K ++++
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYEEK-YDES 209
Query: 330 ADWWSVGILLYEMLTGKPPFI-GGNRAKIQQKIVK-------DKLRLPAFLSSEAHSLLK 381
            D ++ G    E  T + P+    N A+I +++         DK+ +P     E   +++
Sbjct: 210 VDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP-----EVKEIIE 264
Query: 382 GLLQKEPGKR 391
           G +++   +R
Sbjct: 265 GCIRQNKDER 274

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 15  LKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 71
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIV 260
            H  +V+ K   YS   +  L L+++F+  G L   L  H   +E +  I    Y ++I 
Sbjct: 72  QHDNIVKYKGVCYS-AGRRNLKLIMEFLPYGSLREYLQKH---KERIDHIKLLQYTSQIC 127
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YM 316
             + +L     +HRDL   NIL+  +  V + DFGL K   ++     +    E    + 
Sbjct: 128 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT 344
           APE +     + A+D WS G++LYE+ T
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L++  +  G L   +  H   ++++   Y      +I 
Sbjct: 74  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 129
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++MA
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 241

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 122/248 (49%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G FG V+       +++ A+K +++  +      +   AE +++ ++ H
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 68
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 69  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 127
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ APE +    
Sbjct: 128 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 187
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 188 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 247
Query: 384 LQKEPGKR 391
            ++ P  R
Sbjct: 248 WKERPEDR 255

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+  GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L++  +  G L   +  H   ++++   Y      +I 
Sbjct: 79  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 134
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 246

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 122/260 (46%), Gaps = 30/260 (11%)
Query: 158 VGQGAFGRVYQVRKKNT-----SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           +G+GAFG+V+     N        + A+K +++     ++  +  + E ++LT + H  +
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTMLQHQHI 82
Query: 213 VQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHHG------LFREDLA---------RIYA 256
           V+  +   T+ R L +V +++  G L   L  HG         ED+A            A
Sbjct: 83  VRF-FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTV 313
           +++ + + +L     +HRDL   N L+G    V + DFG+++     D        +  +
Sbjct: 142 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAF 371
            +M PE +L +     +D WS G++L+E+ T GK P+   +  +    I + + L  P  
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 261
Query: 372 LSSEAHSLLKGLLQKEPGKR 391
              E +++++G  Q+EP +R
Sbjct: 262 CPPEVYAIMRGCWQREPQQR 281

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 122/248 (49%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G FG V+       +++ A+K +++  +      +   AE +++ ++ H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 68  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ APE +    
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246
Query: 384 LQKEPGKR 391
            ++ P  R
Sbjct: 247 WKERPEDR 254

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L++  +  G L   +  H   ++++   Y      +I 
Sbjct: 76  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 131
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++MA
Sbjct: 132 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 243

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 122/260 (46%), Gaps = 30/260 (11%)
Query: 158 VGQGAFGRVYQVRKKNT-----SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           +G+GAFG+V+     N        + A+K +++     ++  +  + E ++LT + H  +
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTMLQHQHI 76
Query: 213 VQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHHG------LFREDLA---------RIYA 256
           V+  +   T+ R L +V +++  G L   L  HG         ED+A            A
Sbjct: 77  VRF-FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTV 313
           +++ + + +L     +HRDL   N L+G    V + DFG+++     D        +  +
Sbjct: 136 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAF 371
            +M PE +L +     +D WS G++L+E+ T GK P+   +  +    I + + L  P  
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 255
Query: 372 LSSEAHSLLKGLLQKEPGKR 391
              E +++++G  Q+EP +R
Sbjct: 256 CPPEVYAIMRGCWQREPQQR 275

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 122/260 (46%), Gaps = 30/260 (11%)
Query: 158 VGQGAFGRVYQVRKKNT-----SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           +G+GAFG+V+     N        + A+K +++     ++  +  + E ++LT + H  +
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTMLQHQHI 105
Query: 213 VQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHHG------LFREDLA---------RIYA 256
           V+  +   T+ R L +V +++  G L   L  HG         ED+A            A
Sbjct: 106 VRF-FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTV 313
           +++ + + +L     +HRDL   N L+G    V + DFG+++     D        +  +
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAF 371
            +M PE +L +     +D WS G++L+E+ T GK P+   +  +    I + + L  P  
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 284
Query: 372 LSSEAHSLLKGLLQKEPGKR 391
              E +++++G  Q+EP +R
Sbjct: 285 CPPEVYAIMRGCWQREPQQR 304

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 122/248 (49%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G FG V+       +++ A+K +++  +      +   AE +++ ++ H
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 62
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 63  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 121
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ APE +    
Sbjct: 122 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 181
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 182 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 241
Query: 384 LQKEPGKR 391
            ++ P  R
Sbjct: 242 WKERPEDR 249

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 118/257 (45%), Gaps = 33/257 (12%)
Query: 156 KVVGQGAFGRVYQVRKKNTS---EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           KV+G G FG VY+   K +S   E+       K    EK   +++  E  I+ +  H  +
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQFSHHNI 108
Query: 213 VQLKYSFQTKYRLYLVLDFINGGHL----------FFQLYHHGLFREDLARIYAAEIVSA 262
           ++L+        + ++ +++  G L          F  L   G+ R          I + 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG---------IAAG 159
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYMA 317
           + +L     +HRDL   NIL+ ++    ++DFGL++  +++     T S   I  + + A
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI-PIRWTA 218
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPAFLS--S 374
           PE +  +    A+D WS GI+++E++T G+ P+   +  ++  K + D  RLP  +   S
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-MKAINDGFRLPTPMDCPS 277
Query: 375 EAHSLLKGLLQKEPGKR 391
             + L+    Q+E  +R
Sbjct: 278 AIYQLMMQCWQQERARR 294

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/331 (24%), Positives = 138/331 (41%), Gaps = 85/331 (25%)
Query: 147 VGIEDFEVLK-VVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDI 203
           V + D  ++K ++G+G++G VY    KNT +  A+K + +  + +++    + +  E  I
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID---CKRILREITI 78
Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV 263
           L ++   ++++L       Y L +  D +    L+  L    +   DL +++   I    
Sbjct: 79  LNRLKSDYIIRL-------YDLIIPDDLLKFDELYIVL---EIADSDLKKLFKTPIFLTE 128
Query: 264 SHL--------------HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN-- 307
            H+              H +GI+HRDLKP N LL  D  V + DFGLA+  +    +N  
Sbjct: 129 EHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 308 ---------------------SMIGTVEYMAPE-IVLGKGHNKAADWWSVGILLYEML-- 343
                                S + T  Y APE I+L + + K+ D WS G +  E+L  
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 344 --------TGKPPFIGG----------NRAKIQQKIVKDKLRLP-AFLSSEAHSLLKGLL 384
                   T + P   G          N  K+ +K  +D+L +    + +     LK + 
Sbjct: 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNIN 308
Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKK 415
           + E  K +   P        H+  KPIN K+
Sbjct: 309 KPEVIKYIKLFP--------HR--KPINLKQ 329

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 158 VGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV 213
           +G+G FG V    Y     NT  + A+K ++       +     + E  IL  +   F+V
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIV 71
Query: 214 QLKYSFQTKYR--LYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLHAN 269
           + +       R  L LV++++  G L   L  H   R D +R+  Y+++I   + +L + 
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSR 130
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF----DENTRSNSMIGTVEYMAPEIVLGKG 325
             +HRDL   NIL+ ++ HV + DFGLAK      D           + + APE +    
Sbjct: 131 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNI 190
Query: 326 HNKAADWWSVGILLYEMLT 344
            ++ +D WS G++LYE+ T
Sbjct: 191 FSRQSDVWSFGVVLYELFT 209

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 110/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+  GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 127
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 239

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L         + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 74  ASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 129
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++MA
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 241

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L         + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 72  ASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 127
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++MA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 239

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 110/233 (47%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+  GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L     T   + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 79  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 134
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++MA
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 246

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 23/233 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL------ 204
           +F+ +KV+G GAFG VY+       E    KV     I E   A   KA ++IL      
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY----AAEIV 260
             +D+P V +L         + L+   +  G L   +  H   ++++   Y      +I 
Sbjct: 79  ASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIA 134
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG---TVEYMA 317
             +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++MA
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            E +L + +   +D WS G+ ++E++T G  P+ G   ++I   I++   RLP
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 246

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G FG VY+    NT+ +   K+     I  +   +    E  ++ K  H  +V+L  
Sbjct: 39  MGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 218 SFQTKYRLYLVLDFINGGHLFFQL----------YHHGLFREDLARIYAAEIVSAVSHLH 267
                  L LV  ++  G L  +L          +H    R  +A+  A    + ++ LH
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH---MRCKIAQGAA----NGINFLH 150
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSMIGTVEYMAPEIVLGK 324
            N  +HRD+K  NILL       ++DFGLA+   +F +    + ++GT  YMAPE + G+
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGE 210
Query: 325 GHNKAADWWSVGILLYEMLTGKP 347
              K +D +S G++L E++TG P
Sbjct: 211 ITPK-SDIYSFGVVLLEIITGLP 232

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 19  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 75
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIV 260
            H  +V+ K   YS   +  L L+++++  G L   L  H   +E +  I    Y ++I 
Sbjct: 76  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQIC 131
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YM 316
             + +L     +HRDL   NIL+  +  V + DFGL K   ++     +    E    + 
Sbjct: 132 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 191
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT 344
           APE +     + A+D WS G++LYE+ T
Sbjct: 192 APESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 68
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIV 260
            H  +V+ K   YS   +  L L+++++  G L   L  H   +E +  I    Y ++I 
Sbjct: 69  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQIC 124
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YM 316
             + +L     +HRDL   NIL+  +  V + DFGL K   ++     +    E    + 
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 184
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT 344
           APE +     + A+D WS G++LYE+ T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 71
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIV 260
            H  +V+ K   YS   +  L L+++++  G L   L  H   +E +  I    Y ++I 
Sbjct: 72  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQIC 127
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YM 316
             + +L     +HRDL   NIL+  +  V + DFGL K   ++     +    E    + 
Sbjct: 128 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT 344
           APE +     + A+D WS G++LYE+ T
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 123/265 (46%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQVR-------KKNTSEIYAMKVMRKDK--------IVEKNHAEYMKAE 200
           K +G+GAFG+V           K N     A+K+++ D         I E    + +   
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 201 RDILTKI-----DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH---GLFREDLA 252
           ++I+  +     D P  V ++Y+ +   R YL      G    +   H+    L  +DL 
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
              A ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ + 
Sbjct: 139 SC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+LL+E+ T G  P+ G    ++  K++K+  R+
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKLLKEGHRM 256
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             P+  ++E + +++      P +R
Sbjct: 257 DKPSNCTNELYMMMRDCWHAVPSQR 281

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 17  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 73
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIV 260
            H  +V+ K   YS   +  L L+++++  G L   L  H   +E +  I    Y ++I 
Sbjct: 74  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQIC 129
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YM 316
             + +L     +HRDL   NIL+  +  V + DFGL K   ++     +    E    + 
Sbjct: 130 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 189
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT 344
           APE +     + A+D WS G++LYE+ T
Sbjct: 190 APESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 106/230 (46%), Gaps = 42/230 (18%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKIDH 209
           +E+  ++G G++G V +   K    + A+K + +  + +++    + +  E  IL +++H
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID---CKRILREIAILNRLNH 111
Query: 210 PFVVQ-----LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDL-ARIYAAEIVSAV 263
             VV+     +    +    LY+VL+  +    F +L+   ++  +L  +     ++  V
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGV 169
Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-------------- 309
            ++H+ GI+HRDLKP N L+  D  V + DFGLA+  D     NS               
Sbjct: 170 KYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 310 --------------IGTVEYMAPE-IVLGKGHNKAADWWSVGILLYEMLT 344
                         + T  Y APE I+L + + +A D WS+G +  E+L 
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 11  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 67
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIV 260
            H  +V+ K   YS   +  L L+++++  G L   L  H   +E +  I    Y ++I 
Sbjct: 68  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQIC 123
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YM 316
             + +L     +HRDL   NIL+  +  V + DFGL K   ++     +    E    + 
Sbjct: 124 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 183
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT 344
           APE +     + A+D WS G++LYE+ T
Sbjct: 184 APESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 10  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 66
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIV 260
            H  +V+ K   YS   +  L L+++++  G L   L  H   +E +  I    Y ++I 
Sbjct: 67  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQIC 122
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YM 316
             + +L     +HRDL   NIL+  +  V + DFGL K   ++     +    E    + 
Sbjct: 123 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 182
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT 344
           APE +     + A+D WS G++LYE+ T
Sbjct: 183 APESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 130/265 (49%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQ-----VRKKNTSEIYAMKV-MRKDKIVEKNHAEYMKAERDILTKI-D 208
           K +G+GAFG+V       + K    E   + V M KD   EK+ ++ + +E +++  I  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIGK 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL---------YHHGLFREDLARIYAAEI 259
           H  ++ L  +      LY+++++ + G+L   L         Y + + R    ++   ++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 260 VS-------AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
           VS        + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ + 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+L++E+ T G  P+ G    ++  K++K+  R+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHRM 278
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             PA  ++E + +++      P +R
Sbjct: 279 DKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 18  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 74
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIV 260
            H  +V+ K   YS   +  L L+++++  G L   L  H   +E +  I    Y ++I 
Sbjct: 75  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQIC 130
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YM 316
             + +L     +HRDL   NIL+  +  V + DFGL K   ++     +    E    + 
Sbjct: 131 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 190
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT 344
           APE +     + A+D WS G++LYE+ T
Sbjct: 191 APESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 122/248 (49%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G FG V+       +++ A+K +++  +      +   AE +++ ++ H
Sbjct: 9   ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 63
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 64  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 122
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HR+L+  NIL+       + DFGLA+  ++N  T        +++ APE +    
Sbjct: 123 ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 182
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 183 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 242
Query: 384 LQKEPGKR 391
            ++ P  R
Sbjct: 243 WKERPEDR 250

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 43  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 99
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIV 260
            H  +V+ K   YS   +  L L+++++  G L   L  H   +E +  I    Y ++I 
Sbjct: 100 QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQIC 155
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YM 316
             + +L     +HRDL   NIL+  +  V + DFGL K   ++     +    E    + 
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 215
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT 344
           APE +     + A+D WS G++LYE+ T
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 68
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIV 260
            H  +V+ K   YS   +  L L+++++  G L   L  H   +E +  I    Y ++I 
Sbjct: 69  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQIC 124
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YM 316
             + +L     +HRDL   NIL+  +  V + DFGL K   ++     +    E    + 
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 184
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT 344
           APE +     + A+D WS G++LYE+ T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 123/265 (46%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQVR-------KKNTSEIYAMKVMRKDK--------IVEKNHAEYMKAE 200
           K +G+GAFG+V           K N     A+K+++ D         I E    + +   
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 201 RDILTKI-----DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH---GLFREDLA 252
           ++I+  +     D P  V ++Y+ +   R YL      G    +   H+    L  +DL 
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
              A ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ + 
Sbjct: 154 SC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+LL+E+ T G  P+ G    ++  K++K+  R+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKLLKEGHRM 271
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             P+  ++E + +++      P +R
Sbjct: 272 DKPSNCTNELYMMMRDCWHAVPSQR 296

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 16  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 72
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIV 260
            H  +V+ K   YS   +  L L+++++  G L   L  H   +E +  I    Y ++I 
Sbjct: 73  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQIC 128
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YM 316
             + +L     +HRDL   NIL+  +  V + DFGL K   ++     +    E    + 
Sbjct: 129 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 188
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT 344
           APE +     + A+D WS G++LYE+ T
Sbjct: 189 APESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G FG VY+    NT+ +   K+     I  +   +    E  ++ K  H  +V+L  
Sbjct: 39  MGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 218 SFQTKYRLYLVLDFINGGHLFFQL----------YHHGLFREDLARIYAAEIVSAVSHLH 267
                  L LV  ++  G L  +L          +H    R  +A+  A    + ++ LH
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH---MRCKIAQGAA----NGINFLH 150
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSMIGTVEYMAPEIVLGK 324
            N  +HRD+K  NILL       ++DFGLA+   +F +      ++GT  YMAPE + G+
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGE 210
Query: 325 GHNKAADWWSVGILLYEMLTGKP 347
              K +D +S G++L E++TG P
Sbjct: 211 ITPK-SDIYSFGVVLLEIITGLP 232

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 71
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSA 262
            H  +V+ K   YS   +  L L+++++  G L   L  H   R D  ++  Y ++I   
Sbjct: 72  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQAHAE-RIDHIKLLQYTSQICKG 129
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YMAP 318
           + +L     +HRDL   NIL+  +  V + DFGL K   ++     +    E    + AP
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 319 EIVLGKGHNKAADWWSVGILLYEMLT 344
           E +     + A+D WS G++LYE+ T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 132/267 (49%), Gaps = 35/267 (13%)
Query: 156 KVVGQGAFGRVYQ-----VRKKNTSEIYAMKV-MRKDKIVEKNHAEYMKAERDILTKI-D 208
           K +G+GAFG+V       + K    E   + V M KD   EK+ ++ + +E +++  I  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL---------YHHGLFREDLARIYAAEI 259
           H  ++ L  +      LY+++++ + G+L   L         Y + + R    ++   ++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 260 VS-------AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-----ENTRSN 307
           VS        + +L +   +HRDL   N+L+  +  + + DFGLA+  +     +NT + 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKL 366
            +   V++MAPE +  + +   +D WS G+L++E+ T G  P+ G    ++  K++K+  
Sbjct: 220 RL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGH 276
Query: 367 RL--PAFLSSEAHSLLKGLLQKEPGKR 391
           R+  PA  ++E + +++      P +R
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 124/267 (46%), Gaps = 35/267 (13%)
Query: 156 KVVGQGAFGRVYQVR-------KKNTSEIYAMKVMRKDK--------IVEKNHAEYMKAE 200
           K +G+GAFG+V           K N     A+K+++ D         I E    + +   
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 201 RDILTKI-----DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH---GLFREDLA 252
           ++I+  +     D P  V ++Y+ +   R YL      G    +   H+    L  +DL 
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
              A ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ + 
Sbjct: 143 SC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQ--KIVKDKL 366
              V++MAPE +  + +   +D WS G+LL+E+ T G  P+ G     +++  K++K+  
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG---VPVEELFKLLKEGH 258
Query: 367 RL--PAFLSSEAHSLLKGLLQKEPGKR 391
           R+  P+  ++E + +++      P +R
Sbjct: 259 RMDKPSNCTNELYMMMRDCWHAVPSQR 285

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 124/267 (46%), Gaps = 35/267 (13%)
Query: 156 KVVGQGAFGRVYQVR-------KKNTSEIYAMKVMRKDK--------IVEKNHAEYMKAE 200
           K +G+GAFG+V           K N     A+K+++ D         I E    + +   
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 201 RDILTKI-----DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH---GLFREDLA 252
           ++I+  +     D P  V ++Y+ +   R YL      G    +   H+    L  +DL 
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
              A ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ + 
Sbjct: 146 SC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQ--KIVKDKL 366
              V++MAPE +  + +   +D WS G+LL+E+ T G  P+ G     +++  K++K+  
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG---VPVEELFKLLKEGH 261
Query: 367 RL--PAFLSSEAHSLLKGLLQKEPGKR 391
           R+  P+  ++E + +++      P +R
Sbjct: 262 RMDKPSNCTNELYMMMRDCWHAVPSQR 288

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 86
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIV 260
            H  +V+ K   YS   +  L L+++++  G L   L  H   +E +  I    Y ++I 
Sbjct: 87  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQIC 142
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YM 316
             + +L     +HRDL   NIL+  +  V + DFGL K   ++     +    E    + 
Sbjct: 143 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 202
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT 344
           APE +     + A+D WS G++LYE+ T
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 86
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIV 260
            H  +V+ K   YS   +  L L+++++  G L   L  H   +E +  I    Y ++I 
Sbjct: 87  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQIC 142
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YM 316
             + +L     +HRDL   NIL+  +  V + DFGL K   ++     +    E    + 
Sbjct: 143 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 202
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT 344
           APE +     + A+D WS G++LYE+ T
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 123/265 (46%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQVR-------KKNTSEIYAMKVMRKDK--------IVEKNHAEYMKAE 200
           K +G+GAFG+V           K N     A+K+++ D         I E    + +   
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 201 RDILTKI-----DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH---GLFREDLA 252
           ++I+  +     D P  V ++Y+ +   R YL      G    +   H+    L  +DL 
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
              A ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ + 
Sbjct: 147 SC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+LL+E+ T G  P+ G    ++  K++K+  R+
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKLLKEGHRM 264
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             P+  ++E + +++      P +R
Sbjct: 265 DKPSNCTNELYMMMRDCWHAVPSQR 289

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 158 VGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV 213
           +G+G FG V    Y     NT  + A+K ++     ++      + E  IL  +   F+V
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD---FQREIQILKALHSDFIV 75
Query: 214 QLK-YSFQT-KYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLHAN 269
           + +  S+   +  L LV++++  G L   L  H   R D +R+  Y+++I   + +L + 
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSR 134
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF----DENTRSNSMIGTVEYMAPEIVLGKG 325
             +HRDL   NIL+ ++ HV + DFGLAK      D           + + APE +    
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 194
Query: 326 HNKAADWWSVGILLYEMLT 344
            ++ +D WS G++LYE+ T
Sbjct: 195 FSRQSDVWSFGVVLYELFT 213

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 124/267 (46%), Gaps = 35/267 (13%)
Query: 156 KVVGQGAFGRVYQVR-------KKNTSEIYAMKVMRKDK--------IVEKNHAEYMKAE 200
           K +G+GAFG+V           K N     A+K+++ D         I E    + +   
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 201 RDILTKI-----DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH---GLFREDLA 252
           ++I+  +     D P  V ++Y+ +   R YL      G    +   H+    L  +DL 
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
              A ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ + 
Sbjct: 154 SC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQ--KIVKDKL 366
              V++MAPE +  + +   +D WS G+LL+E+ T G  P+ G     +++  K++K+  
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG---VPVEELFKLLKEGH 269
Query: 367 RL--PAFLSSEAHSLLKGLLQKEPGKR 391
           R+  P+  ++E + +++      P +R
Sbjct: 270 RMDKPSNCTNELYMMMRDCWHAVPSQR 296

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 158 VGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV 213
           +G+G FG V    Y     NT  + A+K ++     ++      + E  IL  +   F+V
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD---FQREIQILKALHSDFIV 74
Query: 214 QLK-YSFQT-KYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLHAN 269
           + +  S+   +  L LV++++  G L   L  H   R D +R+  Y+++I   + +L + 
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSR 133
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF----DENTRSNSMIGTVEYMAPEIVLGKG 325
             +HRDL   NIL+ ++ HV + DFGLAK      D           + + APE +    
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 193
Query: 326 HNKAADWWSVGILLYEMLT 344
            ++ +D WS G++LYE+ T
Sbjct: 194 FSRQSDVWSFGVVLYELFT 212

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 124/267 (46%), Gaps = 35/267 (13%)
Query: 156 KVVGQGAFGRVYQVR-------KKNTSEIYAMKVMRKDK--------IVEKNHAEYMKAE 200
           K +G+GAFG+V           K N     A+K+++ D         I E    + +   
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 201 RDILTKI-----DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH---GLFREDLA 252
           ++I+  +     D P  V ++Y+ +   R YL      G    +   H+    L  +DL 
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
              A ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ + 
Sbjct: 195 SC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQ--KIVKDKL 366
              V++MAPE +  + +   +D WS G+LL+E+ T G  P+ G     +++  K++K+  
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG---VPVEELFKLLKEGH 310
Query: 367 RL--PAFLSSEAHSLLKGLLQKEPGKR 391
           R+  P+  ++E + +++      P +R
Sbjct: 311 RMDKPSNCTNELYMMMRDCWHAVPSQR 337

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKY 217
           +G+G FG VY+    NT+ +   K+     I  +   +    E  ++ K  H  +V+L  
Sbjct: 33  MGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 218 SFQTKYRLYLVLDFINGGHLFFQL----------YHHGLFREDLARIYAAEIVSAVSHLH 267
                  L LV  ++  G L  +L          +H    R  +A+  A    + ++ LH
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH---MRCKIAQGAA----NGINFLH 144
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSMIGTVEYMAPEIVLGK 324
            N  +HRD+K  NILL       ++DFGLA+   +F +      ++GT  YMAPE + G+
Sbjct: 145 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGE 204
Query: 325 GHNKAADWWSVGILLYEMLTGKP 347
              K +D +S G++L E++TG P
Sbjct: 205 ITPK-SDIYSFGVVLLEIITGLP 226

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 152 FEVLKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + +  +G+G FG V    Y     NT  + A+K ++     ++      + E  IL  +
Sbjct: 25  LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD---FQREIQILKAL 81
Query: 208 DHPFVVQLK-YSFQT-KYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAV 263
              F+V+ +  S+   +  L LV++++  G L   L  H   R D +R+  Y+++I   +
Sbjct: 82  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGM 140
Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF----DENTRSNSMIGTVEYMAPE 319
            +L +   +HRDL   NIL+ ++ HV + DFGLAK      D           + + APE
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200
Query: 320 IVLGKGHNKAADWWSVGILLYEMLT 344
            +     ++ +D WS G++LYE+ T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 120/276 (43%), Gaps = 46/276 (16%)
Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HP 210
             V +V+ +G F  VY+ +   +   YA+K +  ++  EKN A  +  E   + K+  HP
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRA--IIQEVCFMKKLSGHP 86
Query: 211 FVVQL-------KYSFQTKYRLYLVLDFINGGHL---FFQLYHHGLFREDLARIYAAEIV 260
            +VQ        K    T    +L+L  +  G L     ++   G    D       +  
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 261 SAVSHLHANG--IMHRDLKPENILLGADGHVMLTDFGLAKQF-----------------D 301
            AV H+H     I+HRDLK EN+LL   G + L DFG A                    +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 302 ENTRSNSMIGTVEYMAPEIVLGKGH---NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ 358
           E TR+ + +    Y  PEI+    +    +  D W++G +LY +   + PF  G  AK+ 
Sbjct: 207 EITRNTTPM----YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG--AKL- 259
Query: 359 QKIVKDKLRLPAFLSSEA--HSLLKGLLQKEPGKRL 392
            +IV  K  +P   +     HSL++ +LQ  P +RL
Sbjct: 260 -RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL 294

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 123/265 (46%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQVR-------KKNTSEIYAMKVMRKDK--------IVEKNHAEYMKAE 200
           K +G+GAFG+V           K N     A+K+++ D         I E    + +   
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 201 RDILTKI-----DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH---GLFREDLA 252
           ++I+  +     D P  V ++Y+ +   R YL      G    +   H+    L  +DL 
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
              A ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ + 
Sbjct: 154 SC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+LL+E+ T G  P+ G    ++  K++K+  R+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKLLKEGHRM 271
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             P+  ++E + +++      P +R
Sbjct: 272 DKPSNCTNELYMMMRDCWHAVPSQR 296

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 155 LKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           ++ +G+G FG+V    Y      T E+ A+K +++    +       + E +IL  + H 
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG--WQREIEILRTLYHE 71
Query: 211 FVVQLKYSF--QTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            +V+ K     Q +  + LV++++  G L   L  H +    L  ++A +I   +++LHA
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL-LFAQQICEGMAYLHA 130
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI----GTVEYMAPEIVLGK 324
              +HR L   N+LL  D  V + DFGLAK   E      +       V + APE +   
Sbjct: 131 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 190
Query: 325 GHNKAADWWSVGILLYEMLT 344
               A+D WS G+ LYE+LT
Sbjct: 191 KFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 155 LKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           ++ +G+G FG+V    Y      T E+ A+K +++    +       + E +IL  + H 
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG--WQREIEILRTLYHE 70
Query: 211 FVVQLKYSF--QTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            +V+ K     Q +  + LV++++  G L   L  H +    L  ++A +I   +++LHA
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL-LFAQQICEGMAYLHA 129
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI----GTVEYMAPEIVLGK 324
              +HR L   N+LL  D  V + DFGLAK   E      +       V + APE +   
Sbjct: 130 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 189
Query: 325 GHNKAADWWSVGILLYEMLT 344
               A+D WS G+ LYE+LT
Sbjct: 190 KFYYASDVWSFGVTLYELLT 209

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 130/265 (49%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQ-----VRKKNTSEIYAMKV-MRKDKIVEKNHAEYMKAERDILTKI-D 208
           K +G+GAFG+V       + K    E   + V M KD   EK+ ++ + +E +++  I  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL---------YHHGLFREDLARIYAAEI 259
           H  ++ L  +      LY+++++ + G+L   L         Y + + R    ++   ++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 260 VS-------AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
           VS        + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ + 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+L++E+ T G  P+ G    ++  K++K+  R+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHRM 278
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             PA  ++E + +++      P +R
Sbjct: 279 DKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           LV + +N    F QLY   L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+L+  +
Sbjct: 111 LVFEHVNNTD-FKQLYQ-TLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHE 167
Query: 287 GH-VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +L  M+ 
Sbjct: 168 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 227
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 228 RKEPFFHGH 236

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 130/265 (49%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQ-----VRKKNTSEIYAMKV-MRKDKIVEKNHAEYMKAERDILTKI-D 208
           K +G+GAFG+V       + K    E   + V M KD   EK+ ++ + +E +++  I  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL---------YHHGLFREDLARIYAAEI 259
           H  ++ L  +      LY+++++ + G+L   L         Y + + R    ++   ++
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 260 VS-------AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
           VS        + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ + 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+L++E+ T G  P+ G    ++  K++K+  R+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHRM 278
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             PA  ++E + +++      P +R
Sbjct: 279 DKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 68
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIV 260
            H  +V+ K   YS   +  L L+++++  G L   L  H   +E +  I    Y ++I 
Sbjct: 69  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQIC 124
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YM 316
             + +L     +HRDL   NIL+  +  V + DFGL K   ++     +    E    + 
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT 344
           APE +     + A+D WS G++LYE+ T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 130/265 (49%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQ-----VRKKNTSEIYAMKV-MRKDKIVEKNHAEYMKAERDILTKI-D 208
           K +G+GAFG+V       + K    E   + V M KD   EK+ ++ + +E +++  I  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL---------YHHGLFREDLARIYAAEI 259
           H  ++ L  +      LY+++++ + G+L   L         Y + + R    ++   ++
Sbjct: 100 HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 260 VS-------AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
           VS        + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ + 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+L++E+ T G  P+ G    ++  K++K+  R+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHRM 278
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             PA  ++E + +++      P +R
Sbjct: 279 DKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           LV + +N    F QLY   L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 111 LVFEHVNNTD-FKQLYQ-TLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 167
Query: 287 GH-VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +L  M+ 
Sbjct: 168 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 227
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 228 RKEPFFHGH 236

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 70/128 (54%), Gaps = 5/128 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG-A 285
           LV ++IN    F QLY   +  +   R Y  E++ A+ + H+ GIMHRD+KP N+++   
Sbjct: 112 LVFEYINNTD-FKQLYQ--ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 168
Query: 286 DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +L  M+ 
Sbjct: 169 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 228
Query: 345 GKPPFIGG 352
            + PF  G
Sbjct: 229 RREPFFHG 236

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 80/317 (25%), Positives = 130/317 (41%), Gaps = 77/317 (24%)
Query: 150 EDFEVLKVVGQGAFGRVYQ-VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           E +E++  +G+G FGRV Q V  +      A+K++   K VEK + E  + E ++L KI+
Sbjct: 33  ERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKII---KNVEK-YKEAARLEINVLEKIN 88
Query: 209 HP------FVVQLKYSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVS 261
                     VQ+   F     + +  + +      F +  ++  +     R  A ++  
Sbjct: 89  EKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQ 148
Query: 262 AVSHLHANGIMHRDLKPENILLGADGH-------------------VMLTDFGLAKQFDE 302
           AV  LH N + H DLKPENIL     +                   V + DFG A  FD 
Sbjct: 149 AVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT-FDH 207
Query: 303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPF------------- 349
              S +++ T  Y APE++L  G ++  D WS+G +++E   G   F             
Sbjct: 208 EHHS-TIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMME 266
Query: 350 --IGGNRAKIQQKIVKDKLR-----------------------LPAFLSSEAH------S 378
             +G   +++ +K  K K                         L  +L+SEA        
Sbjct: 267 RILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFD 326
Query: 379 LLKGLLQKEPGKRLGAG 395
           L++ +L+ EP KRL  G
Sbjct: 327 LIESMLEYEPAKRLTLG 343

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           LV + +N    F QLY   L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 111 LVFEHVNNTD-FKQLYQ-TLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 167
Query: 287 GH-VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +L  M+ 
Sbjct: 168 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 227
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 228 RKEPFFHGH 236

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           LV + +N    F QLY   L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 111 LVFEHVNNTD-FKQLYQ-TLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 167
Query: 287 GH-VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +L  M+ 
Sbjct: 168 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 227
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 228 RKEPFFHGH 236

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           LV + +N    F QLY   L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 111 LVFEHVNNTD-FKQLYQ-TLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 167
Query: 287 GH-VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +L  M+ 
Sbjct: 168 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 227
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 228 RKEPFFHGH 236

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           LV + +N    F QLY   L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 111 LVFEHVNNTD-FKQLYQ-TLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 167
Query: 287 GH-VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +L  M+ 
Sbjct: 168 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 227
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 228 RKEPFFHGH 236

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 70/128 (54%), Gaps = 5/128 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG-A 285
           LV ++IN    F QLY   +  +   R Y  E++ A+ + H+ GIMHRD+KP N+++   
Sbjct: 117 LVFEYINNTD-FKQLYQ--ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 173
Query: 286 DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +L  M+ 
Sbjct: 174 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 233
Query: 345 GKPPFIGG 352
            + PF  G
Sbjct: 234 RREPFFHG 241

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           LV + +N    F QLY   L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 110 LVFEHVNNTD-FKQLYQ-TLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 166
Query: 287 GH-VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +L  M+ 
Sbjct: 167 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 227 RKEPFFHGH 235

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           LV + +N    F QLY   L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 111 LVFEHVNNTD-FKQLYQ-TLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 167
Query: 287 GH-VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +L  M+ 
Sbjct: 168 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 227
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 228 RKEPFFHGH 236

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           LV + +N    F QLY   L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 109 LVFEHVNNTD-FKQLYQ-TLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 165
Query: 287 GH-VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +L  M+ 
Sbjct: 166 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 226 RKEPFFHGH 234

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           LV + +N    F QLY   L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 110 LVFEHVNNTD-FKQLYQ-TLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 166
Query: 287 GH-VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +L  M+ 
Sbjct: 167 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 227 RKEPFFHGH 235

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           LV + +N    F QLY   L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 111 LVFEHVNNTD-FKQLYQ-TLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 167
Query: 287 GH-VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +L  M+ 
Sbjct: 168 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 227
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 228 RKEPFFHGH 236

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           LV + +N    F QLY   L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 111 LVFEHVNNTD-FKQLYQ-TLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 167
Query: 287 GH-VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +L  M+ 
Sbjct: 168 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 227
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 228 RKEPFFHGH 236

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 129/265 (48%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQ-----VRKKNTSEIYAMKV-MRKDKIVEKNHAEYMKAERDILTKI-D 208
           K +G+G FG+V       + K    E   + V M KD   EK+ ++ + +E +++  I  
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 91
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL---------YHHGLFREDLARIYAAEI 259
           H  ++ L  +      LY+++++ + G+L   L         Y + + R    ++   ++
Sbjct: 92  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 260 VS-------AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
           VS        + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ + 
Sbjct: 152 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+L++E+ T G  P+ G    ++  K++K+  R+
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHRM 270
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             PA  ++E + +++      P +R
Sbjct: 271 DKPANCTNELYMMMRDCWHAVPSQR 295

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 13/160 (8%)
Query: 241 LYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF 300
            Y   +  EDL   Y+ ++   +  L +   +HRDL   NILL  +  V + DFGLA+  
Sbjct: 191 FYKEPITMEDLIS-YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDI 249
Query: 301 DEN---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNR-- 354
            +N    R       +++MAPE +  K ++  +D WS G+LL+E+ + G  P+ G     
Sbjct: 250 YKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDE 309
Query: 355 ---AKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
              +++++ +   ++R P + + E + ++     ++P +R
Sbjct: 310 DFCSRLREGM---RMRAPEYSTPEIYQIMLDCWHRDPKER 346

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 129/265 (48%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQ-----VRKKNTSEIYAMKV-MRKDKIVEKNHAEYMKAERDILTKI-D 208
           K +G+G FG+V       + K    E   + V M KD   EK+ ++ + +E +++  I  
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 88
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL---------YHHGLFREDLARIYAAEI 259
           H  ++ L  +      LY+++++ + G+L   L         Y + + R    ++   ++
Sbjct: 89  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 260 VS-------AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
           VS        + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ + 
Sbjct: 149 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+L++E+ T G  P+ G    ++  K++K+  R+
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHRM 267
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             PA  ++E + +++      P +R
Sbjct: 268 DKPANCTNELYMMMRDCWHAVPSQR 292

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 120/248 (48%), Gaps = 12/248 (4%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G  G V+       +++ A+K +++  +      +   AE +++ ++ H
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 68  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD--ENTRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  +  E T        +++ APE +    
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGT 186
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246
Query: 384 LQKEPGKR 391
            ++ P  R
Sbjct: 247 WKERPEDR 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 129/265 (48%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQ-----VRKKNTSEIYAMKV-MRKDKIVEKNHAEYMKAERDILTKI-D 208
           K +G+G FG+V       + K    E   + V M KD   EK+ ++ + +E +++  I  
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 86
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL---------YHHGLFREDLARIYAAEI 259
           H  ++ L  +      LY+++++ + G+L   L         Y + + R    ++   ++
Sbjct: 87  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 260 VS-------AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
           VS        + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ + 
Sbjct: 147 VSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+L++E+ T G  P+ G    ++  K++K+  R+
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHRM 265
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             PA  ++E + +++      P +R
Sbjct: 266 DKPANCTNELYMMMRDCWHAVPSQR 290

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 129/265 (48%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQ-----VRKKNTSEIYAMKV-MRKDKIVEKNHAEYMKAERDILTKI-D 208
           K +G+G FG+V       + K    E   + V M KD   EK+ ++ + +E +++  I  
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIGK 145
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL---------YHHGLFREDLARIYAAEI 259
           H  ++ L  +      LY+++++ + G+L   L         Y + + R    ++   ++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 260 VS-------AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
           VS        + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ + 
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+L++E+ T G  P+ G    ++  K++K+  R+
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHRM 324
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             PA  ++E + +++      P +R
Sbjct: 325 DKPANCTNELYMMMRDCWHAVPSQR 349

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           LV + +N    F QLY   L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 116 LVFEHVNNTD-FKQLYQ-TLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 172
Query: 287 GH-VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +L  M+ 
Sbjct: 173 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 232
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 233 RKEPFFHGH 241

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 129/265 (48%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQ-----VRKKNTSEIYAMKV-MRKDKIVEKNHAEYMKAERDILTKI-D 208
           K +G+GAFG+V       + K    E   + V M KD   EK+ ++ + +E +++  I  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL---------YHHGLFREDLARIYAAEI 259
           H  ++ L  +      LY+++ + + G+L   L         Y + + R    ++   ++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 260 VS-------AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
           VS        + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ + 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+L++E+ T G  P+ G    ++  K++K+  R+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHRM 278
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             PA  ++E + +++      P +R
Sbjct: 279 DKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 129/265 (48%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQ-----VRKKNTSEIYAMKV-MRKDKIVEKNHAEYMKAERDILTKI-D 208
           K +G+GAFG+V       + K    E   + V M KD   EK+ ++ + +E +++  I  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL---------YHHGLFREDLARIYAAEI 259
           H  ++ L  +      LY+++ + + G+L   L         Y + + R    ++   ++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 260 VS-------AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
           VS        + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ + 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+L++E+ T G  P+ G    ++  K++K+  R+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHRM 278
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             PA  ++E + +++      P +R
Sbjct: 279 DKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/267 (23%), Positives = 128/267 (47%), Gaps = 35/267 (13%)
Query: 156 KVVGQGAFGRVYQ-----VRKKNTSEIYAMKV-MRKDKIVEKNHAEYMKAERDILTKI-D 208
           K +G+GAFG+V       + K    E   + V M KD   EK+ ++ + +E +++  I  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIGK 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY------------------HHGLFRED 250
           H  ++ L  +      LY+++++ + G+L   L                       F++ 
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 251 LARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSN 307
           ++  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ 
Sbjct: 160 VSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKL 366
           +    V++MAPE +  + +   +D WS G+L++E+ T G  P+ G    ++  K++K+  
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGH 276
Query: 367 RL--PAFLSSEAHSLLKGLLQKEPGKR 391
           R+  PA  ++E + +++      P +R
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 130/265 (49%), Gaps = 31/265 (11%)
Query: 156 KVVGQGAFGRVYQ-----VRKKNTSEIYAMKV-MRKDKIVEKNHAEYMKAERDILTKI-D 208
           K +G+GAFG+V       + K    E   + V M KD   E++ ++ + +E +++  I  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSD-LVSEMEMMKMIGK 99
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL---------YHHGLFREDLARIYAAEI 259
           H  ++ L  +      LY+++++ + G+L   L         Y + + R    ++   ++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 260 VS-------AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM 309
           VS        + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ + 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
              V++MAPE +  + +   +D WS G+L++E+ T G  P+ G    ++  K++K+  R+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHRM 278
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             PA  ++E + +++      P +R
Sbjct: 279 DKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 60/103 (58%), Gaps = 2/103 (1%)
Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH-VMLTDFGLAKQFDENTRSNSMIG 311
           R Y  EI+ A+ + H+ GIMHRD+KP N+++  +   + L D+GLA+ +      N  + 
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 312 TVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
           +  +  PE+++  + ++ + D WS+G +L  M+  K PF  G+
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 141/306 (46%), Gaps = 40/306 (13%)
Query: 115 ELLECVDGLTVKEIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRV-----YQV 169
           +++E  +G +   ID + +  N K +          + +  K +G GAFG+V     + +
Sbjct: 17  KIIESYEGNSYTFIDPTQLPYNEKWE------FPRNNLQFGKTLGAGAFGKVVEATAFGL 70
Query: 170 RKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLV 228
            K++     A+K+++       +  E + +E  I++ +  H  +V L  +      + ++
Sbjct: 71  GKEDAVLKVAVKMLKS--TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 128
Query: 229 LDFINGGHLF---------------FQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMH 273
            ++   G L                F + +  L   DL   +++++   ++ L +   +H
Sbjct: 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH-FSSQVAQGMAFLASKNCIH 187
Query: 274 RDLKPENILLGADGHVM-LTDFGLAKQF--DEN--TRSNSMIGTVEYMAPEIVLGKGHNK 328
           RD+   N+LL  +GHV  + DFGLA+    D N   + N+ +  V++MAPE +    +  
Sbjct: 188 RDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARL-PVKWMAPESIFDCVYTV 245
Query: 329 AADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL--PAFLSSEAHSLLKGLLQ 385
            +D WS GILL+E+ + G  P+ G        K+VKD  ++  PAF     +S+++    
Sbjct: 246 QSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWA 305
Query: 386 KEPGKR 391
            EP  R
Sbjct: 306 LEPTHR 311

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 152 FEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            + L+ +G+G FG V   R    + NT E+ A+K ++      + H    + E +IL  +
Sbjct: 13  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 69
Query: 208 DHPFVVQLK---YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI----YAAEIV 260
            H  +V+ K   YS   +  L L+++++  G L   L  H   +E +  I    Y ++I 
Sbjct: 70  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQIC 125
Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----YM 316
             + +L     +HR+L   NIL+  +  V + DFGL K   ++     +    E    + 
Sbjct: 126 KGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 185
Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT 344
           APE +     + A+D WS G++LYE+ T
Sbjct: 186 APESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 125/301 (41%), Gaps = 75/301 (24%)
Query: 131 SSIDENVKGDSVTVCCVGIED-FEVLKVVGQGAFGRVYQVRKKNTSEIYAMK-------- 181
           SS  EN+      +  V + D +E+  ++G+G++G VY    KN ++  A+K        
Sbjct: 8   SSGRENLYFQGAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFED 67
Query: 182 ------VMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGG 235
                 ++R+  I+ +  ++Y+    D++   D      LK+       LY+VL+  +  
Sbjct: 68  LIDCKRILREITILNRLKSDYIIRLHDLIIPED-----LLKFD-----ELYIVLEIADSD 117
Query: 236 HLFFQLYHHGLF-REDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDF 294
               +L+   +F  E   +     ++     +H +GI+HRDLKP N LL  D  V + DF
Sbjct: 118 --LKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDF 175
Query: 295 GLAKQFDENT--------------------------RSNSMIGTVEYMAPE-IVLGKGHN 327
           GLA+  + +                           +  S + T  Y APE I+L + + 
Sbjct: 176 GLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT 235
Query: 328 KAADWWSVGILLYEML----------TGKPPFIGG----------NRAKIQQKIVKDKLR 367
            + D WS G +  E+L          T + P   G          N  K+ +K  +D+L 
Sbjct: 236 NSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLN 295
Query: 368 L 368
           +
Sbjct: 296 I 296

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 127/279 (45%), Gaps = 41/279 (14%)
Query: 150 EDFEVLKVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
           E+ E  KV+G GAFG+V     Y + K   S   A+K++++    + +  E + +E  ++
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMM 102
Query: 205 TKI-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL-------------YHHG----- 245
           T++  H  +V L  +      +YL+ ++   G L   L             Y +      
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 246 ------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ 299
                 L  EDL   +A ++   +  L     +HRDL   N+L+     V + DFGLA+ 
Sbjct: 163 EEDLNVLTFEDLL-CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 300 F--DEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNR 354
              D N   R N+ +  V++MAPE +    +   +D WS GILL+E+ + G  P+ G   
Sbjct: 222 IMSDSNYVVRGNARL-PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280
Query: 355 AKIQQKIVKDKLRL--PAFLSSEAHSLLKGLLQKEPGKR 391
                K++++  ++  P + + E + +++     +  KR
Sbjct: 281 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 319

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 72/138 (52%), Gaps = 20/138 (14%)
Query: 224 RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN--------GIMHRD 275
           +LYL+ D+   G L+  L    L  + + ++ A   VS + HLH           I HRD
Sbjct: 109 QLYLITDYHENGSLYDYLKSTTLDAKSMLKL-AYSSVSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 276 LKPENILLGADGHVMLTDFGLAKQFDENTRS-----NSMIGTVEYMAPEIV---LGKGHN 327
           LK +NIL+  +G   + D GLA +F  +T       N+ +GT  YM PE++   L + H 
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 328 KA---ADWWSVGILLYEM 342
           ++   AD +S G++L+E+
Sbjct: 228 QSYIMADMYSFGLILWEV 245

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 119/258 (46%), Gaps = 13/258 (5%)
Query: 133 IDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE-K 191
           +D + K + V        +   LKV+G G FG V+  +     E  ++K+    K++E K
Sbjct: 14  LDPSEKANKVLARIFKETELRKLKVLGSGVFGTVH--KGVWIPEGESIKIPVCIKVIEDK 71
Query: 192 NHAEYMKAERDILTKI---DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH-GLF 247
           +  +  +A  D +  I   DH  +V+L         L LV  ++  G L   +  H G  
Sbjct: 72  SGRQSFQAVTDHMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGAL 130
Query: 248 REDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENT 304
              L   +  +I   + +L  +G++HR+L   N+LL +   V + DFG+A      D+  
Sbjct: 131 GPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 190
Query: 305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK 363
             +     +++MA E +    +   +D WS G+ ++E++T G  P+ G   A++   + K
Sbjct: 191 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 250
Query: 364 -DKLRLPAFLSSEAHSLL 380
            ++L  P   + + + ++
Sbjct: 251 GERLAQPQICTIDVYMVM 268

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/276 (22%), Positives = 118/276 (42%), Gaps = 38/276 (13%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKN--TSEIYAMKV--MRKDKIVEKNHAEYMKAERDILTK 206
           + E ++ +G+GAFGRV+Q R       E + M    M K++      A++ + E  ++ +
Sbjct: 48  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR-EAALMAE 106
Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGG-----------HLFFQLYHHGLFREDLARI- 254
            D+P +V+L         + L+ +++  G           H    L H  L     AR+ 
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL--STRARVS 164
Query: 255 --------------YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF 300
                          A ++ + +++L     +HRDL   N L+G +  V + DFGL++  
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 301 ---DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAK 356
              D      +    + +M PE +    +   +D W+ G++L+E+ + G  P+ G    +
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284
Query: 357 IQQKIVK-DKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           +   +   + L  P     E ++L++    K P  R
Sbjct: 285 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 320

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 141/301 (46%), Gaps = 34/301 (11%)
Query: 115 ELLECVDGLTVKEIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRV-----YQV 169
           +++E  +G +   ID + +  N K +          + +  K +G GAFG+V     + +
Sbjct: 9   KIIESYEGNSYTFIDPTQLPYNEKWEFPR------NNLQFGKTLGAGAFGKVVEATAFGL 62
Query: 170 RKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLV 228
            K++     A+K+++       +  E + +E  I++ +  H  +V L  +      + ++
Sbjct: 63  GKEDAVLKVAVKMLKS--TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 120
Query: 229 LDFINGGHLFFQLYHHG---LFREDLARI-------YAAEIVSAVSHLHANGIMHRDLKP 278
            ++   G L   L       L +ED   +       +++++   ++ L +   +HRD+  
Sbjct: 121 TEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAA 180
Query: 279 ENILLGADGHVM-LTDFGLAKQF--DEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
            N+LL  +GHV  + DFGLA+    D N   + N+ +  V++MAPE +    +   +D W
Sbjct: 181 RNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARL-PVKWMAPESIFDCVYTVQSDVW 238
Query: 334 SVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL--PAFLSSEAHSLLKGLLQKEPGK 390
           S GILL+E+ + G  P+ G        K+VKD  ++  PAF     +S+++     EP  
Sbjct: 239 SYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTH 298
Query: 391 R 391
           R
Sbjct: 299 R 299

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 127/278 (45%), Gaps = 52/278 (18%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+G FG+V     + ++ +      A+K+++++     +    + +E ++L +++HP
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHP 86
Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE--------------------- 249
            V++L  +      L L++++   G L       G  RE                     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 250 ----------DLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ 299
                     DL   +A +I   + +L    ++HRDL   NIL+     + ++DFGL++ 
Sbjct: 141 HPDERALTMGDLIS-FAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 300 -FDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNR 354
            ++E++   RS   I  V++MA E +    +   +D WS G+LL+E++T G  P+ G   
Sbjct: 200 VYEEDSXVKRSQGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
Query: 355 AKIQQKI-VKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++   +    ++  P   S E + L+    ++EP KR
Sbjct: 259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP----FVV 213
           +G+G FG V+  R K   E  A+K+        +  + + +AE      + H     F+ 
Sbjct: 50  IGKGRFGEVW--RGKWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN---- 269
                  T  +L+LV D+   G LF  L  + +  E + ++ A    S ++HLH      
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEIVGT 162
Query: 270 ----GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-----NSMIGTVEYMAPEI 320
                I HRDLK +NIL+  +G   + D GLA + D  T +     N  +GT  YMAPE+
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 321 V---LGKGH---NKAADWWSVGILLYEMLTGKPPFIGG 352
           +   +   H    K AD +++G++ +E+   +   IGG
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG 258

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP----FVV 213
           +G+G FG V+  R K   E  A+K+        +  + + +AE      + H     F+ 
Sbjct: 37  IGKGRFGEVW--RGKWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIA 90
Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN---- 269
                  T  +L+LV D+   G LF  L  + +  E + ++ A    S ++HLH      
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEIVGT 149
Query: 270 ----GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-----NSMIGTVEYMAPEI 320
                I HRDLK +NIL+  +G   + D GLA + D  T +     N  +GT  YMAPE+
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 209
Query: 321 V---LGKGH---NKAADWWSVGILLYEMLTGKPPFIGG 352
           +   +   H    K AD +++G++ +E+   +   IGG
Sbjct: 210 LDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG 245

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 71/146 (48%), Gaps = 12/146 (8%)
Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIG 311
           Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R      
Sbjct: 203 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 262
Query: 312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-----DK 365
            +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +      +
Sbjct: 263 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEGTR 319
Query: 366 LRLPAFLSSEAHSLLKGLLQKEPGKR 391
           +R P + + E +  +      EP +R
Sbjct: 320 MRAPDYTTPEMYQTMLDCWHGEPSQR 345

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 71/146 (48%), Gaps = 12/146 (8%)
Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIG 311
           Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R      
Sbjct: 205 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 264
Query: 312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-----DK 365
            +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +      +
Sbjct: 265 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEGTR 321
Query: 366 LRLPAFLSSEAHSLLKGLLQKEPGKR 391
           +R P + + E +  +      EP +R
Sbjct: 322 MRAPDYTTPEMYQTMLDCWHGEPSQR 347

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP----FVV 213
           +G+G FG V+  R K   E  A+K+        +  + + +AE      + H     F+ 
Sbjct: 12  IGKGRFGEVW--RGKWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIA 65
Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN---- 269
                  T  +L+LV D+   G LF  L  + +  E + ++ A    S ++HLH      
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEIVGT 124
Query: 270 ----GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-----NSMIGTVEYMAPEI 320
                I HRDLK +NIL+  +G   + D GLA + D  T +     N  +GT  YMAPE+
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 184
Query: 321 V---LGKGH---NKAADWWSVGILLYEMLTGKPPFIGG 352
           +   +   H    K AD +++G++ +E+   +   IGG
Sbjct: 185 LDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG 220

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 71/146 (48%), Gaps = 12/146 (8%)
Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIG 311
           Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R      
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-----DK 365
            +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +      +
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEGTR 314
Query: 366 LRLPAFLSSEAHSLLKGLLQKEPGKR 391
           +R P + + E +  +      EP +R
Sbjct: 315 MRAPDYTTPEMYQTMLDCWHGEPSQR 340

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP----FVV 213
           +G+G FG V+  R K   E  A+K+        +  + + +AE      + H     F+ 
Sbjct: 11  IGKGRFGEVW--RGKWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIA 64
Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN---- 269
                  T  +L+LV D+   G LF  L  + +  E + ++ A    S ++HLH      
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEIVGT 123
Query: 270 ----GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-----NSMIGTVEYMAPEI 320
                I HRDLK +NIL+  +G   + D GLA + D  T +     N  +GT  YMAPE+
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 321 V---LGKGH---NKAADWWSVGILLYEMLTGKPPFIGG 352
           +   +   H    K AD +++G++ +E+   +   IGG
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG 219

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 71/146 (48%), Gaps = 12/146 (8%)
Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIG 311
           Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R      
Sbjct: 196 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 255
Query: 312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-----DK 365
            +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G    KI ++  +      +
Sbjct: 256 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEGTR 312
Query: 366 LRLPAFLSSEAHSLLKGLLQKEPGKR 391
           +R P + + E +  +      EP +R
Sbjct: 313 MRAPDYTTPEMYQTMLDCWHGEPSQR 338

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 112/220 (50%), Gaps = 16/220 (7%)
Query: 140 DSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSE----IYAMKVMRKDKIVEKNHAE 195
           +++TV     +D+EV++ VG+G +  V++    N +E         V +K    E    +
Sbjct: 21  EALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQ 80
Query: 196 YMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY 255
            +    +I+  +D   +V+ ++S        L+ +++N     F++ +  L   D+ R Y
Sbjct: 81  NLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVLYPTLTDYDI-RYY 130
Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVE 314
             E++ A+ + H+ GIMHRD+KP N+++  +   + L D+GLA+ +      N  + +  
Sbjct: 131 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 315 YMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
           +  PE+++  + ++ + D WS+G +   M+  K PF  G+
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 112/220 (50%), Gaps = 16/220 (7%)
Query: 140 DSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSE----IYAMKVMRKDKIVEKNHAE 195
           +++TV     +D+EV++ VG+G +  V++    N +E         V +K    E    +
Sbjct: 42  EALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQ 101
Query: 196 YMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY 255
            +    +I+  +D   +V+ ++S        L+ +++N     F++ +  L   D+ R Y
Sbjct: 102 NLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVLYPTLTDYDI-RYY 151
Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVE 314
             E++ A+ + H+ GIMHRD+KP N+++  +   + L D+GLA+ +      N  + +  
Sbjct: 152 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 211
Query: 315 YMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
           +  PE+++  + ++ + D WS+G +   M+  K PF  G+
Sbjct: 212 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 251

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 95/193 (49%), Gaps = 41/193 (21%)
Query: 258 EIVSAVSHLHANGIMHRDLKPENILL------------GADG-HVMLTDFGLAKQFDE-- 302
           +I S V+HLH+  I+HRDLKP+NIL+            GA+   ++++DFGL K+ D   
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 303 ---NTRSNSMIGTVEYMAPEIV-------LGKGHNKAADWWSVGILLYEMLT-GKPPFIG 351
               T  N+  GT  + APE++         +   ++ D +S+G + Y +L+ GK PF  
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF-- 240
Query: 352 GNRAKIQQKIVKDKLRLPAF-------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS 404
           G++   +  I++    L          L +EA  L+  ++  +P KR  A      ++  
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA-----MKVLR 295
Query: 405 HKWFKPINWKKLE 417
           H  F P + KKLE
Sbjct: 296 HPLFWPKS-KKLE 307

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP----FVV 213
           +G+G FG V+  R K   E  A+K+        +  + + +AE      + H     F+ 
Sbjct: 14  IGKGRFGEVW--RGKWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIA 67
Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN---- 269
                  T  +L+LV D+   G LF  L  + +  E + ++ A    S ++HLH      
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEIVGT 126
Query: 270 ----GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-----NSMIGTVEYMAPEI 320
                I HRDLK +NIL+  +G   + D GLA + D  T +     N  +GT  YMAPE+
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 186
Query: 321 V---LGKGH---NKAADWWSVGILLYEMLTGKPPFIGG 352
           +   +   H    K AD +++G++ +E+   +   IGG
Sbjct: 187 LDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG 222

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 158 VGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP----FVV 213
           +G+G FG V+  R K   E  A+K+        +  + + +AE      + H     F+ 
Sbjct: 17  IGKGRFGEVW--RGKWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIA 70
Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN---- 269
                  T  +L+LV D+   G LF  L  + +  E + ++ A    S ++HLH      
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEIVGT 129
Query: 270 ----GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-----NSMIGTVEYMAPEI 320
                I HRDLK +NIL+  +G   + D GLA + D  T +     N  +GT  YMAPE+
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 189
Query: 321 V---LGKGH---NKAADWWSVGILLYEMLTGKPPFIGG 352
           +   +   H    K AD +++G++ +E+   +   IGG
Sbjct: 190 LDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG 225

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 112/220 (50%), Gaps = 16/220 (7%)
Query: 140 DSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSE----IYAMKVMRKDKIVEKNHAE 195
           +++TV     +D+EV++ VG+G +  V++    N +E         V +K    E    +
Sbjct: 21  EALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQ 80
Query: 196 YMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY 255
            +    +I+  +D   +V+ ++S        L+ +++N     F++ +  L   D+ R Y
Sbjct: 81  NLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVLYPTLTDYDI-RYY 130
Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVE 314
             E++ A+ + H+ GIMHRD+KP N+++  +   + L D+GLA+ +      N  + +  
Sbjct: 131 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 315 YMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
           +  PE+++  + ++ + D WS+G +   M+  K PF  G+
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 102/234 (43%), Gaps = 42/234 (17%)
Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVM--RKDKIVEKNHAEY---MKAERDIL 204
            D  +L+ VG+G +G V+  R     E  A+K+   R +K   +    Y   M    +IL
Sbjct: 8   RDITLLECVGKGRYGEVW--RGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENIL 65
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
                 F+     S  +  +L+L+  +   G L+  L    L      RI  + I S ++
Sbjct: 66  G-----FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLA 119
Query: 265 HLHAN--------GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-----SNSMIG 311
           HLH           I HRDLK +NIL+  +G   + D GLA    ++T      +N  +G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 312 TVEYMAPEI------VLGKGHNKAADWWSVGILLYE----MLTG------KPPF 349
           T  YMAPE+      V      K  D W+ G++L+E    M++       KPPF
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 112/220 (50%), Gaps = 16/220 (7%)
Query: 140 DSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSE----IYAMKVMRKDKIVEKNHAE 195
           +++TV     +D+EV++ VG+G +  V++    N +E         V +K    E    +
Sbjct: 21  EALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQ 80
Query: 196 YMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY 255
            +    +I+  +D   +V+ ++S        L+ +++N     F++ +  L   D+ R Y
Sbjct: 81  NLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVLYPTLTDYDI-RYY 130
Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVE 314
             E++ A+ + H+ GIMHRD+KP N+++  +   + L D+GLA+ +      N  + +  
Sbjct: 131 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 315 YMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
           +  PE+++  + ++ + D WS+G +   M+  K PF  G+
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 141/301 (46%), Gaps = 34/301 (11%)
Query: 115 ELLECVDGLTVKEIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRV-----YQV 169
           +++E  +G +   ID + +  N K +          + +  K +G GAFG+V     + +
Sbjct: 17  KIIESYEGNSYTFIDPTQLPYNEKWEFPR------NNLQFGKTLGAGAFGKVVEATAFGL 70
Query: 170 RKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLV 228
            K++     A+K+++       +  E + +E  I++ +  H  +V L  +      + ++
Sbjct: 71  GKEDAVLKVAVKMLKS--TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 128
Query: 229 LDFINGGHLFFQLYHHG---LFREDLARI-------YAAEIVSAVSHLHANGIMHRDLKP 278
            ++   G L   L       L +ED   +       +++++   ++ L +   +HRD+  
Sbjct: 129 TEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAA 188
Query: 279 ENILLGADGHVM-LTDFGLAKQF--DEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWW 333
            N+LL  +GHV  + DFGLA+    D N   + N+ +  V++MAPE +    +   +D W
Sbjct: 189 RNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARL-PVKWMAPESIFDCVYTVQSDVW 246
Query: 334 SVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL--PAFLSSEAHSLLKGLLQKEPGK 390
           S GILL+E+ + G  P+ G        K+VKD  ++  PAF     +S+++     EP  
Sbjct: 247 SYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTH 306
Query: 391 R 391
           R
Sbjct: 307 R 307

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 112/220 (50%), Gaps = 16/220 (7%)
Query: 140 DSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSE----IYAMKVMRKDKIVEKNHAE 195
           +++TV     +D+EV++ VG+G +  V++    N +E         V +K    E    +
Sbjct: 22  EALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQ 81
Query: 196 YMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY 255
            +    +I+  +D   +V+ ++S        L+ +++N     F++ +  L   D+ R Y
Sbjct: 82  NLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVLYPTLTDYDI-RYY 131
Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVE 314
             E++ A+ + H+ GIMHRD+KP N+++  +   + L D+GLA+ +      N  + +  
Sbjct: 132 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 191
Query: 315 YMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
           +  PE+++  + ++ + D WS+G +   M+  K PF  G+
Sbjct: 192 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 231

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           L+ +++N     F++ +  L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 106 LIFEYVNNTD--FKVLYPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 162
Query: 287 -GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +   M+ 
Sbjct: 163 LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF 222
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 223 RKEPFFYGH 231

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 125/250 (50%), Gaps = 20/250 (8%)
Query: 156 KVVGQGAFGRVY--QVRKKNTSEI-YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           K++G G  G V   ++R     ++  A+K + K    E+   +++ +E  I+ + DHP +
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFL-SEASIMGQFDHPNI 112
Query: 213 VQLKYSFQTKYRLYLVL-DFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLHANG 270
           ++L+    T+ RL +++ +++  G L  F   H G F           + + + +L   G
Sbjct: 113 IRLE-GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 271 IMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYMAPEIVLGKG 325
            +HRDL   N+L+ ++    ++DFGL++  +++     T +   I  + + APE +  + 
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI-PIRWTAPEAIAFRT 230
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRLPAFLSS--EAHSLLK 381
            + A+D WS G++++E+L  G+ P+    NR  I    V++  RLPA +      H L+ 
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS--VEEGYRLPAPMGCPHALHQLML 288
Query: 382 GLLQKEPGKR 391
               K+  +R
Sbjct: 289 DCWHKDRAQR 298

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           L+ +++N     F++ +  L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 107 LIFEYVNNTD--FKVLYPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 163
Query: 287 -GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +   M+ 
Sbjct: 164 LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF 223
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 224 RKEPFFYGH 232

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           L+ +++N     F++ +  L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 105 LIFEYVNNTD--FKVLYPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 161
Query: 287 -GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +   M+ 
Sbjct: 162 LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF 221
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 222 RKEPFFYGH 230

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 127/278 (45%), Gaps = 52/278 (18%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+G FG+V     + ++ +      A+K+++++     +    + +E ++L +++HP
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHP 86
Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE--------------------- 249
            V++L  +      L L++++   G L       G  RE                     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 250 ----------DLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ 299
                     DL   +A +I   + +L    ++HRDL   NIL+     + ++DFGL++ 
Sbjct: 141 HPDERALTMGDLIS-FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 300 -FDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNR 354
            ++E++   RS   I  V++MA E +    +   +D WS G+LL+E++T G  P+ G   
Sbjct: 200 VYEEDSXVKRSQGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
Query: 355 AKIQQKI-VKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++   +    ++  P   S E + L+    ++EP KR
Sbjct: 259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 125/250 (50%), Gaps = 20/250 (8%)
Query: 156 KVVGQGAFGRVY--QVRKKNTSEI-YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV 212
           K++G G  G V   ++R     ++  A+K + K    E+   +++ +E  I+ + DHP +
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFL-SEASIMGQFDHPNI 112
Query: 213 VQLKYSFQTKYRLYLVL-DFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVSHLHANG 270
           ++L+    T+ RL +++ +++  G L  F   H G F           + + + +L   G
Sbjct: 113 IRLE-GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 271 IMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYMAPEIVLGKG 325
            +HRDL   N+L+ ++    ++DFGL++  +++     T +   I  + + APE +  + 
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI-PIRWTAPEAIAFRT 230
Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRLPAFLSS--EAHSLLK 381
            + A+D WS G++++E+L  G+ P+    NR  I    V++  RLPA +      H L+ 
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS--VEEGYRLPAPMGCPHALHQLML 288
Query: 382 GLLQKEPGKR 391
               K+  +R
Sbjct: 289 DCWHKDRAQR 298

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 72/129 (55%), Gaps = 5/129 (3%)
Query: 227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD 286
           L+ +++N     F++ +  L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++  +
Sbjct: 105 LIFEYVNNTD--FKVLYPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 161
Query: 287 -GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLT 344
              + L D+GLA+ +      N  + +  +  PE+++  + ++ + D WS+G +   M+ 
Sbjct: 162 LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF 221
Query: 345 GKPPFIGGN 353
            K PF  G+
Sbjct: 222 RKEPFFYGH 230

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 127/278 (45%), Gaps = 52/278 (18%)
Query: 156 KVVGQGAFGRV-----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           K +G+G FG+V     + ++ +      A+K+++++     +    + +E ++L +++HP
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHP 86
Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE--------------------- 249
            V++L  +      L L++++   G L       G  RE                     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 250 ----------DLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ 299
                     DL   +A +I   + +L    ++HRDL   NIL+     + ++DFGL++ 
Sbjct: 141 HPDERALTMGDLIS-FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 300 -FDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNR 354
            ++E++   RS   I  V++MA E +    +   +D WS G+LL+E++T G  P+ G   
Sbjct: 200 VYEEDSYVKRSQGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
Query: 355 AKIQQKI-VKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            ++   +    ++  P   S E + L+    ++EP KR
Sbjct: 259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 112/220 (50%), Gaps = 16/220 (7%)
Query: 140 DSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSE----IYAMKVMRKDKIVEKNHAE 195
           +++TV     +D+EV++ VG+G +  V++    N +E         V +K    E    +
Sbjct: 21  EALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQ 80
Query: 196 YMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIY 255
            +    +I+  +D   +V+ ++S        L+ +++N     F++ +  L   D+ R Y
Sbjct: 81  NLMGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVLYPTLTDYDI-RYY 130
Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVE 314
             E++ A+ + H+ GIMHRD+KP N+++  +   + L D+GLA+ +      N  + +  
Sbjct: 131 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 315 YMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
           +  PE+++  + ++ + D WS+G +   M+  K PF  G+
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 110/224 (49%), Gaps = 22/224 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVM------RKDKIVEKNHAEYMKAERDIL 204
           + E  K +G+G FG V++ R      + A+K +       + +++EK   +  + E  I+
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK--FQEFQREVFIM 77
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAV 263
           + ++HP +V+L        R+  V++F+  G L+ +L       +  +      +I   +
Sbjct: 78  SNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 264 SHLHANG--IMHRDLKPENILL-----GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYM 316
            ++      I+HRDL+  NI L      A     + DFGL++Q   +   + ++G  ++M
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV--SGLLGNFQWM 193
Query: 317 APEIVLGK--GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ 358
           APE +  +   + + AD +S  ++LY +LTG+ PF   +  KI+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 112/236 (47%), Gaps = 13/236 (5%)
Query: 155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE-KNHAEYMKAERDILTKI---DHP 210
           LKV+G G FG V+  +     E  ++K+    K++E K+  +  +A  D +  I   DH 
Sbjct: 18  LKVLGSGVFGTVH--KGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHAN 269
            +V+L         L LV  ++  G L   +  H G     L   +  +I   + +L  +
Sbjct: 76  HIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           G++HR+L   N+LL +   V + DFG+A      D+    +     +++MA E +    +
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 327 NKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHSLL 380
              +D WS G+ ++E++T G  P+ G   A++   + K ++L  P   + + + ++
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVM 250

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 140/306 (45%), Gaps = 40/306 (13%)
Query: 115 ELLECVDGLTVKEIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRV-----YQV 169
           +++E  +G +   ID + +  N K +          + +  K +G GAFG+V     + +
Sbjct: 17  KIIESYEGNSYTFIDPTQLPYNEKWE------FPRNNLQFGKTLGAGAFGKVVEATAFGL 70
Query: 170 RKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLV 228
            K++     A+K+++       +  E + +E  I++ +  H  +V L  +      + ++
Sbjct: 71  GKEDAVLKVAVKMLKS--TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 128
Query: 229 LDFINGGHLF---------------FQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMH 273
            ++   G L                F + +      DL   +++++   ++ L +   +H
Sbjct: 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH-FSSQVAQGMAFLASKNCIH 187
Query: 274 RDLKPENILLGADGHVM-LTDFGLAKQF--DEN--TRSNSMIGTVEYMAPEIVLGKGHNK 328
           RD+   N+LL  +GHV  + DFGLA+    D N   + N+ +  V++MAPE +    +  
Sbjct: 188 RDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARL-PVKWMAPESIFDCVYTV 245
Query: 329 AADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL--PAFLSSEAHSLLKGLLQ 385
            +D WS GILL+E+ + G  P+ G        K+VKD  ++  PAF     +S+++    
Sbjct: 246 QSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWA 305
Query: 386 KEPGKR 391
            EP  R
Sbjct: 306 LEPTHR 311

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI-LTKIDHPFVVQL 215
           ++G G FG+VY+   ++ +     KV  K +  E +            L+   HP +V L
Sbjct: 46  LIGHGVFGKVYKGVLRDGA-----KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSL 100
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEI----VSAVSHLHANGI 271
                 +  + L+  ++  G+L   LY   L    ++     EI       + +LH   I
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 272 MHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           +HRD+K  NILL  +    +TDFG++K   + D+      + GT+ Y+ PE  +     +
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTE 220
Query: 329 AADWWSVGILLYEMLTGKPPFI 350
            +D +S G++L+E+L  +   +
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIV 242

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 37/189 (19%)
Query: 258 EIVSAVSHLHANGIMHRDLKPENILL------------GADG-HVMLTDFGLAKQFDENT 304
           +I S V+HLH+  I+HRDLKP+NIL+            GA+   ++++DFGL K+ D   
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 305 RS-----NSMIGTVEYMAPEIV---LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRA 355
                  N+  GT  + APE++     +   ++ D +S+G + Y +L+ GK PF  G++ 
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKY 258
Query: 356 KIQQKIVKDKLRLPAF-------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
             +  I++    L          L +EA  L+  ++  +P KR  A      ++  H  F
Sbjct: 259 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA-----MKVLRHPLF 313
Query: 409 KPINWKKLE 417
            P + KKLE
Sbjct: 314 WPKS-KKLE 321

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 159 GQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYS 218
           G+G FG VY+    NT+ +   K+     I  +   +    E  +  K  H  +V+L   
Sbjct: 31  GEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 219 FQTKYRLYLVLDFINGGHLFFQL----------YHHGLFREDLARIYAAEIVSAVSHLHA 268
                 L LV  +   G L  +L          +H    R  +A+  A    + ++ LH 
Sbjct: 90  SSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHX---RCKIAQGAA----NGINFLHE 142
Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSMIGTVEYMAPEIVLGKG 325
           N  +HRD+K  NILL       ++DFGLA+   +F +    + ++GT  Y APE + G+ 
Sbjct: 143 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEI 202
Query: 326 HNKAADWWSVGILLYEMLTGKP 347
             K +D +S G++L E++TG P
Sbjct: 203 TPK-SDIYSFGVVLLEIITGLP 223

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 37/189 (19%)
Query: 258 EIVSAVSHLHANGIMHRDLKPENILL------------GADG-HVMLTDFGLAKQFDENT 304
           +I S V+HLH+  I+HRDLKP+NIL+            GA+   ++++DFGL K+ D   
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 305 RS-----NSMIGTVEYMAPEIV---LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRA 355
                  N+  GT  + APE++     +   ++ D +S+G + Y +L+ GK PF  G++ 
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKY 258
Query: 356 KIQQKIVKDKLRLPAF-------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
             +  I++    L          L +EA  L+  ++  +P KR  A      ++  H  F
Sbjct: 259 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA-----MKVLRHPLF 313
Query: 409 KPINWKKLE 417
            P + KKLE
Sbjct: 314 WPKS-KKLE 321

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 142/314 (45%), Gaps = 47/314 (14%)
Query: 115 ELLECVDGLTVKEIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRV-----YQV 169
           +++E  +G +   ID + +  N K +          + +  K +G GAFG+V     + +
Sbjct: 2   KIIESYEGNSYTFIDPTQLPYNEKWEFPR------NNLQFGKTLGAGAFGKVVEATAFGL 55
Query: 170 RKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLV 228
            K++     A+K+++       +  E + +E  I++ +  H  +V L  +      + ++
Sbjct: 56  GKEDAVLKVAVKMLKS--TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 113
Query: 229 LDFINGGHLFFQLYH----------------HGLFREDLARI-------YAAEIVSAVSH 265
            ++   G L   L                   GL +ED   +       +++++   ++ 
Sbjct: 114 TEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAF 173
Query: 266 LHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQF--DEN--TRSNSMIGTVEYMAPEI 320
           L +   +HRD+   N+LL  +GHV  + DFGLA+    D N   + N+ +  V++MAPE 
Sbjct: 174 LASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARL-PVKWMAPES 231
Query: 321 VLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL--PAFLSSEAH 377
           +    +   +D WS GILL+E+ + G  P+ G        K+VKD  ++  PAF     +
Sbjct: 232 IFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIY 291
Query: 378 SLLKGLLQKEPGKR 391
           S+++     EP  R
Sbjct: 292 SIMQACWALEPTHR 305

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 78/145 (53%), Gaps = 10/145 (6%)
Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQF--DEN--TRSNSM 309
           +++++   ++ L +   +HRD+   N+LL  +GHV  + DFGLA+    D N   + N+ 
Sbjct: 171 FSSQVAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNAR 229
Query: 310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
           +  V++MAPE +    +   +D WS GILL+E+ + G  P+ G        K+VKD  ++
Sbjct: 230 L-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 288
Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             PAF     +S+++     EP  R
Sbjct: 289 AQPAFAPKNIYSIMQACWALEPTHR 313

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 11/220 (5%)
Query: 156 KVVGQGAFGRVYQ-VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           +V+G+G FG VY      N  +     V   ++I +         E  I+    HP V+ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 215 L-KYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           L     +++    +VL ++  G L  F +   H    +DL   +  ++   +  L +   
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKF 213
Query: 272 MHRDLKPENILLGADGHVMLTDFGLA-----KQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           +HRDL   N +L     V + DFGLA     K+FD           V++MA E +  +  
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273
Query: 327 NKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK 365
              +D WS G+LL+E++T G PP+   N   I   +++ +
Sbjct: 274 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 313

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 94/193 (48%), Gaps = 41/193 (21%)
Query: 258 EIVSAVSHLHANGIMHRDLKPENILL------------GADG-HVMLTDFGLAKQFDENT 304
           +I S V+HLH+  I+HRDLKP+NIL+            GA+   ++++DFGL K+ D   
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 305 RS-----NSMIGTVEYMAPEIV-------LGKGHNKAADWWSVGILLYEMLT-GKPPFIG 351
                  N+  GT  + APE++         +   ++ D +S+G + Y +L+ GK PF  
Sbjct: 183 XXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF-- 240
Query: 352 GNRAKIQQKIVKDKLRLPAF-------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS 404
           G++   +  I++    L          L +EA  L+  ++  +P KR  A      ++  
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM-----KVLR 295
Query: 405 HKWFKPINWKKLE 417
           H  F P + KKLE
Sbjct: 296 HPLFWPKS-KKLE 307

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 42/230 (18%)
Query: 154 VLKVVGQGAFGRVYQVRKKNTSEIYAMKVM--RKDKIVEKNHAEY---MKAERDILTKID 208
           +L+ VG+G +G V+  R     E  A+K+   R +K   +    Y   M    +IL    
Sbjct: 41  LLECVGKGRYGEVW--RGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENIL---- 94
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
             F+     S  +  +L+L+  +   G L+  L    L      RI  + I S ++HLH 
Sbjct: 95  -GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHI 152
Query: 269 N--------GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-----SNSMIGTVEY 315
                     I HRDLK +NIL+  +G   + D GLA    ++T      +N  +GT  Y
Sbjct: 153 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 212
Query: 316 MAPEI------VLGKGHNKAADWWSVGILLYE----MLTG------KPPF 349
           MAPE+      V      K  D W+ G++L+E    M++       KPPF
Sbjct: 213 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 262

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 11/220 (5%)
Query: 156 KVVGQGAFGRVYQ-VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           +V+G+G FG VY      N  +     V   ++I +         E  I+    HP V+ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 215 L-KYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           L     +++    +VL ++  G L  F +   H    +DL   +  ++   +  L +   
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKF 155
Query: 272 MHRDLKPENILLGADGHVMLTDFGLA-----KQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           +HRDL   N +L     V + DFGLA     K+FD           V++MA E +  +  
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKF 215
Query: 327 NKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK 365
              +D WS G+LL+E++T G PP+   N   I   +++ +
Sbjct: 216 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 255

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVM------RKDKIVEKNHAEYMKAERDIL 204
           + E  K +G+G FG V++ R      + A+K +       + +++EK   +  + E  I+
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK--FQEFQREVFIM 77
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAV 263
           + ++HP +V+L        R+  V++F+  G L+ +L       +  +      +I   +
Sbjct: 78  SNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 264 SHLHANG--IMHRDLKPENILL-----GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYM 316
            ++      I+HRDL+  NI L      A     + DFG ++Q   +   + ++G  ++M
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSV--SGLLGNFQWM 193
Query: 317 APEIVLGK--GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ 358
           APE +  +   + + AD +S  ++LY +LTG+ PF   +  KI+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 11/220 (5%)
Query: 156 KVVGQGAFGRVYQ-VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           +V+G+G FG VY      N  +     V   ++I +         E  I+    HP V+ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 215 L-KYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           L     +++    +VL ++  G L  F +   H    +DL   +  ++   +  L +   
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKF 154
Query: 272 MHRDLKPENILLGADGHVMLTDFGLA-----KQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           +HRDL   N +L     V + DFGLA     K+FD           V++MA E +  +  
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 327 NKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK 365
              +D WS G+LL+E++T G PP+   N   I   +++ +
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 254

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 11/220 (5%)
Query: 156 KVVGQGAFGRVYQ-VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           +V+G+G FG VY      N  +     V   ++I +         E  I+    HP V+ 
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 215 L-KYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           L     +++    +VL ++  G L  F +   H    +DL   +  ++   +  L +   
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKF 159
Query: 272 MHRDLKPENILLGADGHVMLTDFGLA-----KQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           +HRDL   N +L     V + DFGLA     K+FD           V++MA E +  +  
Sbjct: 160 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 219
Query: 327 NKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK 365
              +D WS G+LL+E++T G PP+   N   I   +++ +
Sbjct: 220 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 259

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 11/220 (5%)
Query: 156 KVVGQGAFGRVYQ-VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           +V+G+G FG VY      N  +     V   ++I +         E  I+    HP V+ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 215 L-KYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           L     +++    +VL ++  G L  F +   H    +DL   +  ++   +  L +   
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKF 152
Query: 272 MHRDLKPENILLGADGHVMLTDFGLA-----KQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           +HRDL   N +L     V + DFGLA     K+FD           V++MA E +  +  
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 212
Query: 327 NKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK 365
              +D WS G+LL+E++T G PP+   N   I   +++ +
Sbjct: 213 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 252

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 42/230 (18%)
Query: 154 VLKVVGQGAFGRVYQVRKKNTSEIYAMKVM--RKDKIVEKNHAEY---MKAERDILTKID 208
           +L+ VG+G +G V+  R     E  A+K+   R +K   +    Y   M    +IL    
Sbjct: 12  LLECVGKGRYGEVW--RGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILG--- 66
Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
             F+     S  +  +L+L+  +   G L+  L    L      RI  + I S ++HLH 
Sbjct: 67  --FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHI 123
Query: 269 N--------GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-----SNSMIGTVEY 315
                     I HRDLK +NIL+  +G   + D GLA    ++T      +N  +GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 316 MAPEI------VLGKGHNKAADWWSVGILLYE----MLTG------KPPF 349
           MAPE+      V      K  D W+ G++L+E    M++       KPPF
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 11/220 (5%)
Query: 156 KVVGQGAFGRVYQ-VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           +V+G+G FG VY      N  +     V   ++I +         E  I+    HP V+ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 215 L-KYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           L     +++    +VL ++  G L  F +   H    +DL   +  ++   +  L +   
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKF 155
Query: 272 MHRDLKPENILLGADGHVMLTDFGLA-----KQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           +HRDL   N +L     V + DFGLA     K+FD           V++MA E +  +  
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 215
Query: 327 NKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK 365
              +D WS G+LL+E++T G PP+   N   I   +++ +
Sbjct: 216 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 255

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI-LTKIDHPFVVQL 215
           ++G G FG+VY+   ++ +     KV  K +  E +            L+   HP +V L
Sbjct: 46  LIGHGVFGKVYKGVLRDGA-----KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSL 100
Query: 216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEI----VSAVSHLHANGI 271
                 +  + L+  ++  G+L   LY   L    ++     EI       + +LH   I
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN---SMIGTVEYMAPEIVLGKGHNK 328
           +HRD+K  NILL  +    +TDFG++K+  E  +++    + GT+ Y+ PE  +     +
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTE 220
Query: 329 AADWWSVGILLYEMLTGKPPFI 350
            +D +S G++L+E+L  +   +
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIV 242

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 11/220 (5%)
Query: 156 KVVGQGAFGRVYQ-VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ 214
           +V+G+G FG VY      N  +     V   ++I +         E  I+    HP V+ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 215 L-KYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           L     +++    +VL ++  G L  F +   H    +DL   +  ++   +  L +   
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKF 154
Query: 272 MHRDLKPENILLGADGHVMLTDFGLA-----KQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           +HRDL   N +L     V + DFGLA     K+FD           V++MA E +  +  
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 327 NKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK 365
              +D WS G+LL+E++T G PP+   N   I   +++ +
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 254

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVM------RKDKIVEKNHAEYMKAERDIL 204
           + E  K +G+G FG V++ R      + A+K +       + +++EK   +  + E  I+
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK--FQEFQREVFIM 77
Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAV 263
           + ++HP +V+L        R+  V++F+  G L+ +L       +  +      +I   +
Sbjct: 78  SNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 264 SHLHANG--IMHRDLKPENILL-----GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYM 316
            ++      I+HRDL+  NI L      A     + DF L++Q   +   + ++G  ++M
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSV--SGLLGNFQWM 193
Query: 317 APEIVLGK--GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ 358
           APE +  +   + + AD +S  ++LY +LTG+ PF   +  KI+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 109/224 (48%), Gaps = 31/224 (13%)
Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA-ERDILT 205
           +  E  E+ +++G+G FG+VY  R      I  + +       E+++ + +KA +R+++ 
Sbjct: 30  IPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDI-------ERDNEDQLKAFKREVMA 82
Query: 206 --KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE-DLARIYAAEIVSA 262
             +  H  VV    +  +   L ++     G  L+  +    +  + +  R  A EIV  
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGL--------AKQFDENTRSNSMIGTVE 314
           + +LHA GI+H+DLK +N+    +G V++TDFGL        A + ++  R  +  G + 
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN--GWLC 199
Query: 315 YMAPEIVLGKG---------HNKAADWWSVGILLYEMLTGKPPF 349
           ++APEI+              +K +D +++G + YE+   + PF
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 72/144 (50%), Gaps = 8/144 (5%)
Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT----RSNSMI 310
           ++ ++   ++ L +   +HRDL   NILL       + DFGLA+    ++    + N+ +
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARL 232
Query: 311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL- 368
             V++MAPE +    +   +D WS GI L+E+ + G  P+ G        K++K+  R+ 
Sbjct: 233 -PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML 291
Query: 369 -PAFLSSEAHSLLKGLLQKEPGKR 391
            P    +E + ++K     +P KR
Sbjct: 292 SPEHAPAEMYDIMKTCWDADPLKR 315

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 117/239 (48%), Gaps = 22/239 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA------EYMKAERDILTKIDH 209
           K +G G FG V    KK   ++  +      KI+ KN A      + + AE +++ ++D+
Sbjct: 33  KELGSGNFGTV----KKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDN 87
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           P++V++    + +  + LV++    G L  + Q   H   +  +  ++  ++   + +L 
Sbjct: 88  PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVH--QVSMGMKYLE 144
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGT--VEYMAPEIVLG 323
            +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   V++ APE +  
Sbjct: 145 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 324 KGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHSLL 380
              +  +D WS G+L++E  + G+ P+ G   +++   + K +++  PA    E + L+
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM 263

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 117/239 (48%), Gaps = 22/239 (9%)
Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA------EYMKAERDILTKIDH 209
           K +G G FG V    KK   ++  +      KI+ KN A      + + AE +++ ++D+
Sbjct: 33  KELGSGNFGTV----KKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDN 87
Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           P++V++    + +  + LV++    G L  + Q   H   +  +  ++  ++   + +L 
Sbjct: 88  PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVH--QVSMGMKYLE 144
Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGT--VEYMAPEIVLG 323
            +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   V++ APE +  
Sbjct: 145 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 324 KGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHSLL 380
              +  +D WS G+L++E  + G+ P+ G   +++   + K +++  PA    E + L+
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM 263

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 72/144 (50%), Gaps = 8/144 (5%)
Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT----RSNSMI 310
           ++ ++   ++ L +   +HRDL   NILL       + DFGLA+    ++    + N+ +
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 227
Query: 311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL- 368
             V++MAPE +    +   +D WS GI L+E+ + G  P+ G        K++K+  R+ 
Sbjct: 228 -PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML 286
Query: 369 -PAFLSSEAHSLLKGLLQKEPGKR 391
            P    +E + ++K     +P KR
Sbjct: 287 SPEHAPAEMYDIMKTCWDADPLKR 310

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 72/144 (50%), Gaps = 8/144 (5%)
Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT----RSNSMI 310
           ++ ++   ++ L +   +HRDL   NILL       + DFGLA+    ++    + N+ +
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 232
Query: 311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL- 368
             V++MAPE +    +   +D WS GI L+E+ + G  P+ G        K++K+  R+ 
Sbjct: 233 -PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML 291
Query: 369 -PAFLSSEAHSLLKGLLQKEPGKR 391
            P    +E + ++K     +P KR
Sbjct: 292 SPEHAPAEMYDIMKTCWDADPLKR 315
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	482
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	0.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	0.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-180
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-179
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-178
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-177
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-177
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-174
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-174
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-171
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-170
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-167
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-167
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-166
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-166
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-165
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-165
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-164
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-164
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-162
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-160
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-158
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-118
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-115
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-102
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-95
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-90
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-89
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-87
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-86
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-86
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-84
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-82
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-82
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-82
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-81
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-81
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-81
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-81
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-81
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-80
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-80
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-80
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-80
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-80
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-80
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-80
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-79
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-79
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-79
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-78
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-78
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-77
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-77
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-76
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-76
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-76
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-75
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-75
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-75
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-75
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-75
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-75
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-74
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-74
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-74
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-74
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-74
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-73
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-73
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-72
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-72
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-72
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-72
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-71
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-70
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-70
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-70
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-70
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-70
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-69
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-69
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-69
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-68
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-68
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-68
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-68
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-68
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-67
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-67
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-67
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-66
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-66
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-61
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-61
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-61
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-60
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-59
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-57
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-56
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-56
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-56
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-54
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-54
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-54
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-54
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-53
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-52
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-51
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-51
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-50
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-50
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-49
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-47
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-47
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-47
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-47
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-46
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-46
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-46
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-45
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-44
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-44
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-44
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-44
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-44
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-43
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-43
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-43
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-43
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-43
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-43
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-43
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-42
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-42
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-42
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-42
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-41
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-40
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-40
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-40
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-38
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-38
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-37
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-37
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-36
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-36
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-35
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-34
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-34
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-34
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-32
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-32
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-31
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-31
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-30
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-30
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-30
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-30
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-29
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-29
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-29
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-29
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-28
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-28
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-27
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-27
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-27
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-25
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-25
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-25
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-25
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-25
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-25
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-25
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-25
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-25
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-25
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-25
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-24
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-24
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-24
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-24
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-24
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-24
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-24
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-23
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-23
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-23
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-23
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-23
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-23
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-23
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-22
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-22
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-22
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-22
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-22
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-22
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	9e-22
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-21
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-21
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-21
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-20
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-20
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-19
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-18
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-18
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-17
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-16
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	1e-04

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  518 bits (1337), Expect = 0.0
 Identities = 144/340 (42%), Positives = 212/340 (62%), Gaps = 12/340 (3%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
               DF  LKV+G+G+FG+V   R K     YA+KV++K  I++K   +++ +ER++L K
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94

Query: 207 -IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
            + HPF+V L +SFQT  +LY VLD+INGG LF+ L     F E  AR YAAEI SA+ +
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGY 154

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
           LH+  I++RDLKPENILL + GH++LTDFGL K+  + N+ +++  GT EY+APE++  +
Sbjct: 155 LHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ 214

Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
            +++  DWW +G +LYEML G PPF   N A++   I+   L+L   +++ A  LL+GLL
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL 274

Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
           QK+  KRLGA      EIKSH +F  INW  L  ++I P F P V+G + + +F+ ++T+
Sbjct: 275 QKDRTKRLGA-KDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTE 333

Query: 445 MPLSDSPAATPKNNT---------NPFADFSYVRPAASFL 475
            P+ ++    P +             F  FSY  P  SFL
Sbjct: 334 EPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPPTDSFL 373

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  514 bits (1326), Expect = 0.0
 Identities = 153/313 (48%), Positives = 217/313 (69%), Gaps = 5/313 (1%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEK-NHAEYMKAERD 202
           +  E FE+L+V+G+G +G+V+QVRK    NT +I+AMKV++K  IV       + KAER+
Sbjct: 14  IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73

Query: 203 ILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
           IL ++ HPF+V L Y+FQT  +LYL+L++++GG LF QL   G+F ED A  Y AEI  A
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA 133

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIV 321
           + HLH  GI++RDLKPENI+L   GHV LTDFGL K+   + T +++  GT+EYMAPEI+
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEIL 193

Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLK 381
           +  GHN+A DWWS+G L+Y+MLTG PPF G NR K   KI+K KL LP +L+ EA  LLK
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253

Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKK 441
            LL++    RLGAGP  + E+++H +F+ INW++L AR+++P F P +  +  ++ F+ K
Sbjct: 254 KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSK 313

Query: 442 WTDMPLSDSPAAT 454
           +T     DSP  +
Sbjct: 314 FTRQTPVDSPDDS 326

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  505 bits (1304), Expect = e-180
 Identities = 126/333 (37%), Positives = 203/333 (60%), Gaps = 11/333 (3%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V + DF+ LK++G+G FG+V  VR+K T   YAMK++RK+ I+ K+   +   E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HPF+  LKY+FQT  RL  V+++ NGG LFF L    +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKG 325
           H+  +++RD+K EN++L  DGH+ +TDFGL K+   +     +  GT EY+APE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G+++YEM+ G+ PF   +  ++ + I+ +++R P  LS EA SLL GLL+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241

Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDM 445
           K+P +RLG GP  ++E+  H++F  INW+ +  +++ P F P+V  +     F+ ++T  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 301

Query: 446 PLSDSPAATPKNNT----------NPFADFSYV 468
            ++ +P     +              F DF Y+
Sbjct: 302 SITITPPDRYDSLGLLELDQREEQEMFEDFDYI 334

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  504 bits (1301), Expect = e-179
 Identities = 150/324 (46%), Positives = 210/324 (64%), Gaps = 8/324 (2%)

Query: 127 EIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVM 183
            I E +I  +VK             FE+LKV+GQG+FG+V+ V+K    +  ++YAMKV+
Sbjct: 4   SIKEIAITHHVKEGHEKA---DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60

Query: 184 RKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH 243
           +K  +  ++     K ERDIL +++HPF+V+L Y+FQT+ +LYL+LDF+ GG LF +L  
Sbjct: 61  KKATLKVRDRVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK 119

Query: 244 HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDE 302
             +F E+  + Y AE+  A+ HLH+ GI++RDLKPENILL  +GH+ LTDFGL+K+  D 
Sbjct: 120 EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179

Query: 303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV 362
             ++ S  GTVEYMAPE+V  +GH ++ADWWS G+L++EMLTG  PF G +R +    I+
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239

Query: 363 KDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQ 422
           K KL +P FLS EA SLL+ L ++ P  RLGAGP G EEIK H +F  I+W KL  REI 
Sbjct: 240 KAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIH 299

Query: 423 PGFCPEVAGKHCIANFEKKWTDMP 446
           P F P          F+ ++T   
Sbjct: 300 PPFKPATGRPEDTFYFDPEFTAKT 323

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  503 bits (1298), Expect = e-178
 Identities = 126/336 (37%), Positives = 205/336 (61%), Gaps = 8/336 (2%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + + DF  L V+G+G+FG+V    +K T E+YA+K+++KD +++ +  E    E+ +L  
Sbjct: 17  MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76

Query: 207 ID-HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
               PF+ QL   FQT  RLY V++++NGG L + +   G F+E  A  YAAEI   +  
Sbjct: 77  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 136

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
           L + GI++RDLK +N++L ++GH+ + DFG+ K+   +   + +  GT +Y+APEI+  +
Sbjct: 137 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 196

Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
            + K+ DWW+ G+LLYEML G+ PF G +  ++ Q I++  +  P  +S EA ++ KGL+
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 256

Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
            K PGKRLG GP+G  +IK H +F+ I+W+KLE +EIQP + P+  G+    NF++ +T 
Sbjct: 257 TKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDRFFTR 315

Query: 445 MPLSDSPAATP---KNNTNPFADFSYVRPAASFLQS 477
            P   +P         + + F  FS+V     FL+ 
Sbjct: 316 HPPVLTPPDQEVIRNIDQSEFEGFSFVNS--EFLKP 349

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  499 bits (1287), Expect = e-177
 Identities = 119/320 (37%), Positives = 197/320 (61%), Gaps = 5/320 (1%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
             ++DF++L+ +G G+FGRV+ +R ++    YAMKV++K+ +V     E+   ER +L+ 
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           + HPF++++  +FQ   ++++++D+I GG LF  L     F   +A+ YAAE+  A+ +L
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           H+  I++RDLKPENILL  +GH+ +TDFG AK   + T   ++ GT +Y+APE+V  K +
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVVSTKPY 180

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
           NK+ DWWS GIL+YEML G  PF   N  K  +KI+  +LR P F + +   LL  L+ +
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITR 240

Query: 387 EPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEV-AGKHCIANFEKKWTDM 445
           +  +RLG    G+E++K+H WFK + W+KL +R I+  + P +  G+   + F+ K+ + 
Sbjct: 241 DLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFD-KYPEE 299

Query: 446 PLSDSPAATPKNNTNPFADF 465
            ++           + F DF
Sbjct: 300 DINYGVQGEDPYA-DLFRDF 318

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  500 bits (1289), Expect = e-177
 Identities = 127/330 (38%), Positives = 196/330 (59%), Gaps = 6/330 (1%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +GI++FE ++V+G+G+FG+V   R K T ++YA+KV++KD I++ +  E    E+ IL+ 
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79

Query: 207 I-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             +HPF+ QL   FQT  RL+ V++F+NGG L F +     F E  AR YAAEI+SA+  
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGK 324
           LH  GI++RDLK +N+LL  +GH  L DFG+ K+       + +  GT +Y+APEI+   
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199

Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
            +  A DWW++G+LLYEML G  PF   N   + + I+ D++  P +L  +A  +LK  +
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFM 259

Query: 385 QKEPGKRLGAGPK-GSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWT 443
            K P  RLG+  + G   I  H +FK I+W +L  R+I+P F P +  +  ++NF+  + 
Sbjct: 260 TKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFI 319

Query: 444 DMPLSDSPAAT---PKNNTNPFADFSYVRP 470
                 +P      P  N + F +F YV P
Sbjct: 320 KEEPVLTPIDEGHLPMINQDEFRNFEYVSP 349

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  492 bits (1270), Expect = e-174
 Identities = 117/339 (34%), Positives = 213/339 (62%), Gaps = 15/339 (4%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +G++DF++L+V+G+G++ +V  VR K T  IYAMKV++K+ + +    ++++ E+ +  +
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65

Query: 207 I-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V++++NGG L F +       E+ AR Y+AEI  A+++
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGK 324
           LH  GI++RDLK +N+LL ++GH+ LTD+G+ K+       +++  GT  Y+APEI+ G+
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 185

Query: 325 GHNKAADWWSVGILLYEMLTGKPPFI---------GGNRAKIQQKIVKDKLRLPAFLSSE 375
            +  + DWW++G+L++EM+ G+ PF                + Q I++ ++R+P  LS +
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 245

Query: 376 AHSLLKGLLQKEPGKRLGAGPK-GSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHC 434
           A S+LK  L K+P +RLG  P+ G  +I+ H +F+ ++W  +E +++ P F P ++G+  
Sbjct: 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFG 305

Query: 435 IANFEKKWTDMPLSDSPAATP---KNNTNPFADFSYVRP 470
           + NF+ ++T+ P+  +P       K + + F  F Y+ P
Sbjct: 306 LDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINP 344

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  493 bits (1272), Expect = e-174
 Identities = 119/365 (32%), Positives = 219/365 (60%), Gaps = 15/365 (4%)

Query: 127 EIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKD 186
            I+E     N +        +G++DF++L+V+G+G++ +V  VR K T  IYAM+V++K+
Sbjct: 29  GIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKE 88

Query: 187 KIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG 245
            + +    ++++ E+ +  +  +HPF+V L   FQT+ RL+ V++++NGG L F +    
Sbjct: 89  LVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR 148

Query: 246 LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENT 304
              E+ AR Y+AEI  A+++LH  GI++RDLK +N+LL ++GH+ LTD+G+ K+      
Sbjct: 149 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208

Query: 305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFI---------GGNRA 355
            +++  GT  Y+APEI+ G+ +  + DWW++G+L++EM+ G+ PF               
Sbjct: 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 268

Query: 356 KIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPK-GSEEIKSHKWFKPINWK 414
            + Q I++ ++R+P  LS +A S+LK  L K+P +RLG  P+ G  +I+ H +F+ ++W 
Sbjct: 269 YLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328

Query: 415 KLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP---KNNTNPFADFSYVRPA 471
            +E +++ P F P ++G+  + NF+ ++T+ P+  +P       K + + F  F Y+ P 
Sbjct: 329 MMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPL 388

Query: 472 ASFLQ 476
               +
Sbjct: 389 LMSAE 393

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  484 bits (1249), Expect = e-171
 Identities = 123/338 (36%), Positives = 199/338 (58%), Gaps = 6/338 (1%)

Query: 128 IDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDK 187
           + ++  D   K ++ +     ++ F+ +K +G G+FGRV  V+ K +   YAMK++ K K
Sbjct: 19  LAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78

Query: 188 IVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLF 247
           +V+    E+   E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L   G F
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138

Query: 248 REDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN 307
            E  AR YAA+IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+    T   
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--W 196

Query: 308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR 367
           ++ GT E +APEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV  K+R
Sbjct: 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

Query: 368 LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP 427
            P+  SS+   LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++  F P
Sbjct: 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

Query: 428 EVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADF 465
           +  G    +NF+  + +  +  S     +     F +F
Sbjct: 317 KFKGPGDTSNFD-DYEEEEIRVSI---NEKCGKEFTEF 350

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  483 bits (1245), Expect = e-170
 Identities = 145/305 (47%), Positives = 209/305 (68%), Gaps = 13/305 (4%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEK-NHAEYMKAERD 202
           VGIE+FE+LKV+G GA+G+V+ VRK    +T ++YAMKV++K  IV+K    E+ + ER 
Sbjct: 51  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110

Query: 203 ILTKIDH-PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           +L  I   PF+V L Y+FQT+ +L+L+LD+INGG LF  L     F E   +IY  EIV 
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 170

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPE 319
           A+ HLH  GI++RD+K ENILL ++GHV+LTDFGL+K+F  DE  R+    GT+EYMAP+
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230

Query: 320 IVLG--KGHNKAADWWSVGILLYEMLTGKPPFIGG----NRAKIQQKIVKDKLRLPAFLS 373
           IV G   GH+KA DWWS+G+L+YE+LTG  PF       ++A+I ++I+K +   P  +S
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 290

Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKH 433
           + A  L++ LL K+P KRLG GP+ ++EIK H +F+ INW  L A+++   F P +  + 
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDEL 350

Query: 434 CIANF 438
            ++NF
Sbjct: 351 DVSNF 355

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  486 bits (1252), Expect = e-167
 Identities = 126/337 (37%), Positives = 206/337 (61%), Gaps = 8/337 (2%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + + DF  L V+G+G+FG+V    +K T E+YA+K+++KD +++ +  E    E+ +L  
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397

Query: 207 I-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
               PF+ QL   FQT  RLY V++++NGG L + +   G F+E  A  YAAEI   +  
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGK 324
           L + GI++RDLK +N++L ++GH+ + DFG+ K+   +   + +  GT +Y+APEI+  +
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517

Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
            + K+ DWW+ G+LLYEML G+ PF G +  ++ Q I++  +  P  +S EA ++ KGL+
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 577

Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
            K PGKRLG GP+G  +IK H +F+ I+W+KLE +EIQP + P+ +G+    NF++ +T 
Sbjct: 578 TKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASGR-NAENFDRFFTR 636

Query: 445 MPLSDSPAATP---KNNTNPFADFSYVRPAASFLQSN 478
            P   +P         + + F  FS+V     FL+  
Sbjct: 637 HPPVLTPPDQEVIRNIDQSEFEGFSFVNS--EFLKPE 671

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  476 bits (1226), Expect = e-167
 Identities = 128/412 (31%), Positives = 218/412 (52%), Gaps = 31/412 (7%)

Query: 94  SCVSESSKLTKLIL--RESEDAEELLECVDGLTVKEIDESSI--DENVKG---------D 140
           S  +   K+  L+   +   +++ LL+ +D L V ++D  ++  ++N+           +
Sbjct: 1   SFETRFEKMDNLLRDPKSEVNSDCLLDGLDAL-VYDLDFPALRKNKNIDNFLSRYKDTIN 59

Query: 141 SVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAE 200
            +    +  ED+EV+KV+G+GAFG V  VR K+T ++YAMK++ K ++++++ + +   E
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119

Query: 201 RDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIV 260
           RDI+   + P+VVQL Y+FQ    LY+V++++ GG L   + ++    E  AR Y AE+V
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVV 178

Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAP 318
            A+  +H+ G +HRD+KP+N+LL   GH+ L DFG   + ++    R ++ +GT +Y++P
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238

Query: 319 EIVLGKG----HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----A 370
           E++  +G    + +  DWWSVG+ LYEML G  PF   +      KI+  K  L      
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298

Query: 371 FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVA 430
            +S EA +L+   L  +   RLG    G EEIK H +FK   W     R+      P+++
Sbjct: 299 DISKEAKNLICAFL-TDREVRLGRN--GVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLS 355

Query: 431 GKHCIANFEKKWTDMPLSDSPAATPKNNTN--PFADFSYVRPAASFLQSNSP 480
                +NF+    D    ++         N  PF  F+Y      +L S +P
Sbjct: 356 SDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSN-RRYLSSANP 406

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  473 bits (1219), Expect = e-166
 Identities = 110/317 (34%), Positives = 174/317 (54%), Gaps = 12/317 (3%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V  + FE+L+ +G+G+FG+V  V+K +T ++YAMK M K K VE+N    +  E  I+  
Sbjct: 12  VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           ++HPF+V L YSFQ +  +++V+D + GG L + L  +  F+E+  +++  E+V A+ +L
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL---G 323
               I+HRD+KP+NILL   GHV +TDF +A      T+  +M GT  YMAPE+     G
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191

Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIG---GNRAKIQQKIVKDKLRLPAFLSSEAHSLL 380
            G++ A DWWS+G+  YE+L G+ P+      +  +I        +  P+  S E  SLL
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLL 251

Query: 381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEK 440
           K LL+  P +R         ++++  +   INW  +  + + PGF P     +C   FE 
Sbjct: 252 KKLLEPNPDQRFS----QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFE- 306

Query: 441 KWTDMPLSDSPAATPKN 457
              +M L   P    K 
Sbjct: 307 -LEEMILESKPLHKKKK 322

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  480 bits (1236), Expect = e-166
 Identities = 128/472 (27%), Positives = 207/472 (43%), Gaps = 35/472 (7%)

Query: 35  DSLELDFSDVFGPVPV----------QDSPEVSYGDLVNAVSA---AADASEIIYEDPVI 81
            SLE D+  +    P+                     ++ V+      D         + 
Sbjct: 47  LSLERDYHSLCERNPIGRLLFREFCATRPELSRCVAFLDGVAEYEVTPDDKRKACGRNLT 106

Query: 82  ICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECVDGLTVKEIDESSIDENVKGDS 141
               SH+       V            E    ++L + +  LT + +  +   + +    
Sbjct: 107 QNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIY 166

Query: 142 VTVCC---------VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKN 192
                         V    F   +V+G+G FG V   + + T ++YA K + K +I ++ 
Sbjct: 167 FNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK 226

Query: 193 HAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG--LFRED 250
                  E+ IL K++  FVV L Y+++TK  L LVL  +NGG L F +YH G   F E 
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA 286

Query: 251 LARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI 310
            A  YAAEI   +  LH   I++RDLKPENILL   GH+ ++D GLA    E       +
Sbjct: 287 RAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV 346

Query: 311 GTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA----KIQQKIVKDKL 366
           GTV YMAPE+V  + +  + DWW++G LLYEM+ G+ PF    +     ++++ + +   
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE 406

Query: 367 RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFC 426
                 S +A SL   LL K+P +RLG     + E+K H  FK +N+K+L A  ++P F 
Sbjct: 407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFK 466

Query: 427 PEVAGKHC--IANFEKKWTDMPLSDSPAATPKNNTNPFADFSYVRPAASFLQ 476
           P+    +C  + + E+  T   +   P      + + +  F+       +  
Sbjct: 467 PDPQAIYCKDVLDIEQFSTVKGVELEPT-----DQDFYQKFATGSVPIPWQN 513

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  467 bits (1204), Expect = e-165
 Identities = 108/281 (38%), Positives = 167/281 (59%), Gaps = 4/281 (1%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
              EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD++++
Sbjct: 27  KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           +DHPF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +L
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLG 323
           H  GI+HRDLKPENILL  D H+ +TDFG AK      +  R+NS +GT +Y++PE++  
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206

Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           K   K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ L
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 266

Query: 384 LQKEPGKRLGAGPK-GSEEIKSHKWFKPINWKKLEAREIQP 423
           L  +  KRLG     G   +K+H +F+ + W+ L  +    
Sbjct: 267 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPK 307

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  472 bits (1216), Expect = e-165
 Identities = 126/328 (38%), Positives = 200/328 (60%), Gaps = 2/328 (0%)

Query: 118 ECVDGLTVKEIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEI 177
             +D  +    D S  +E     +     V + +FE LK++G+G FG+V  V++K T   
Sbjct: 116 AEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRY 175

Query: 178 YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL 237
           YAMK+++K+ IV K+   +   E  +L    HPF+  LKYSFQT  RL  V+++ NGG L
Sbjct: 176 YAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL 235

Query: 238 FFQLYHHGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVMLTDFGL 296
           FF L    +F ED AR Y AEIVSA+ +LH+   +++RDLK EN++L  DGH+ +TDFGL
Sbjct: 236 FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL 295

Query: 297 AKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA 355
            K+   +     +  GT EY+APE++    + +A DWW +G+++YEM+ G+ PF   +  
Sbjct: 296 CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 355

Query: 356 KIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK 415
           K+ + I+ +++R P  L  EA SLL GLL+K+P +RLG G + ++EI  H++F  I W+ 
Sbjct: 356 KLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 415

Query: 416 LEAREIQPGFCPEVAGKHCIANFEKKWT 443
           +  +++ P F P+V  +     F++++T
Sbjct: 416 VYEKKLSPPFKPQVTSETDTRYFDEEFT 443

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  480 bits (1236), Expect = e-164
 Identities = 116/416 (27%), Positives = 203/416 (48%), Gaps = 29/416 (6%)

Query: 77  EDPVIICNRSHSLVGPSSCVSESSKLTKLILRESEDAEELLECVDGLTVKEIDESSIDEN 136
            +          L         + +  +  L + +   +L +       + +      + 
Sbjct: 106 REIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKF 165

Query: 137 VKGDSVTVCC----------VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKD 186
           ++ D  T  C          + + DF V +++G+G FG VY  RK +T ++YAMK + K 
Sbjct: 166 IESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225

Query: 187 KIVEKNHAEYMKAERDILTKI---DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH 243
           +I  K        ER +L+ +   D PF+V + Y+F T  +L  +LD +NGG L + L  
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ 285

Query: 244 HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN 303
           HG+F E   R YAAEI+  + H+H   +++RDLKP NILL   GHV ++D GLA  F + 
Sbjct: 286 HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345

Query: 304 TRSNSMIGTVEYMAPEIVL-GKGHNKAADWWSVGILLYEMLTGKPPFIGGN---RAKIQQ 359
            + ++ +GT  YMAPE++  G  ++ +ADW+S+G +L+++L G  PF       + +I +
Sbjct: 346 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404

Query: 360 KIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR 419
             +   + LP   S E  SLL+GLLQ++  +RLG   +G++E+K   +F+ ++W+ +  +
Sbjct: 405 MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQ 464

Query: 420 EIQPGFCPEVAGKHC-----IANFEKKWTDMPLSDSPAATPKNNTNPFADFSYVRP 470
           +  P   P     +      I +F+++ T                  + +F     
Sbjct: 465 KYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQ------ELYRNFPLTIS 514

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  468 bits (1206), Expect = e-164
 Identities = 127/415 (30%), Positives = 200/415 (48%), Gaps = 44/415 (10%)

Query: 102 LTKLILRESEDA-EELLECVDGLTVKEIDESSI--DENVKG---------DSVTVCCVGI 149
           + +L+L       E LL+ + G+  +E+  S +  D+ V             +    +  
Sbjct: 2   MQQLVLDPGFLGLEPLLDLLLGV-HQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQR 60

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE+LKV+G+GAF  V  V+ K T ++YAMK+M K  ++++      + ERD+L   D 
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHA 268
            ++ QL ++FQ +  LYLV+++  GG L   L   G     ++AR Y AEIV A+  +H 
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKG- 325
            G +HRD+KP+NILL   GH+ L DFG   +   D   RS   +GT +Y++PEI+   G 
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240

Query: 326 ------HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP-----AFLSS 374
                 +    DWW++G+  YEM  G+ PF   + A+   KIV  K  L        +  
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPE 300

Query: 375 EAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHC 434
           EA   ++ LL   P  RLG G  G+ + ++H +F  ++W  L  R+  P F P+  G   
Sbjct: 301 EARDFIQRLLCP-PETRLGRG--GAGDFRTHPFFFGLDWDGL--RDSVPPFTPDFEGATD 355

Query: 435 IANFEKKWTDMPLSDSPAATPKNNT---------NPFADFSYVRPAASFLQSNSP 480
             NF+     +    S      ++           PF  +SY     +   S  P
Sbjct: 356 TCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCM--ALRDSEVP 408

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  462 bits (1190), Expect = e-162
 Identities = 124/338 (36%), Positives = 199/338 (58%), Gaps = 11/338 (3%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + IEDF + K++G+G+FG+V+    K T++ +A+K ++KD ++  +  E    E+ +L+ 
Sbjct: 14  LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73

Query: 207 -IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             +HPF+  +  +FQTK  L+ V++++NGG L + +     F    A  YAAEI+  +  
Sbjct: 74  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 133

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGK 324
           LH+ GI++RDLK +NILL  DGH+ + DFG+ K+    + ++N+  GT +Y+APEI+LG+
Sbjct: 134 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 193

Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL 384
            +N + DWWS G+LLYEML G+ PF G +  ++   I  D    P +L  EA  LL  L 
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 253

Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
            +EP KRLG       +I+ H  F+ INW++LE +EI P F P+V      +NF+K++ +
Sbjct: 254 VREPEKRLGVR----GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLN 309

Query: 445 MPLSDSPAATP---KNNTNPFADFSYVRPAASFLQSNS 479
                S A        + N F +FS++ P     +  S
Sbjct: 310 EKPRLSFADRALINSMDQNMFRNFSFMNP--GMERLIS 345

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  464 bits (1196), Expect = e-160
 Identities = 104/333 (31%), Positives = 184/333 (55%), Gaps = 12/333 (3%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +G + F   +V+G+G FG V+  + K T ++YA K + K ++ ++   +    E+ IL K
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSA 262
           +   F+V L Y+F+TK  L LV+  +NGG + + +Y+    +  F+E  A  Y A+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIV 321
           + HLH   I++RDLKPEN+LL  DG+V ++D GLA +     T++    GT  +MAPE++
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGN----RAKIQQKIVKDKLRLPAFLSSEAH 377
           LG+ ++ + D++++G+ LYEM+  + PF          +++Q++++  +  P   S  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421

Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIAN 437
              + LLQK+P KRLG      + +++H  F+ I+W++LEA  + P F P+    +    
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNI 481

Query: 438 FEKKWTDMPLSDSPAATPKNNTNPFADFSYVRP 470
            +        +    A  K +T  F +F+    
Sbjct: 482 QDVGAFS---TVKGVAFEKADTEFFQEFASGTC 511

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  454 bits (1169), Expect = e-158
 Identities = 120/411 (29%), Positives = 195/411 (47%), Gaps = 39/411 (9%)

Query: 94  SCVSESSKLTKLILRESEDAEELLECVDGLT------VKEIDESSI--DENVKG------ 139
           S      +L + IL            V+ L         E + S +  ++N+        
Sbjct: 1   SGEVRLRQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAK 60

Query: 140 ---DSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEY 196
                V    +  EDFE+LKV+G+GAFG V  V+ KN  +++AMK++ K +++++     
Sbjct: 61  PFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC 120

Query: 197 MKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLARIY 255
            + ERD+L   D  ++  L Y+FQ    LYLV+D+  GG L   L        E++AR Y
Sbjct: 121 FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY 180

Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTV 313
            AE+V A+  +H    +HRD+KP+NIL+  +GH+ L DFG   +   D   +S+  +GT 
Sbjct: 181 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240

Query: 314 EYMAPEIVLGK-----GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL 368
           +Y++PEI+         +    DWWS+G+ +YEML G+ PF   +  +   KI+  K R 
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 300

Query: 369 P-----AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQP 423
                   +S  A  L++ L+      RLG    G E+ K H +F  I+W  +  R  + 
Sbjct: 301 QFPTQVTDVSENAKDLIRRLICSRE-HRLGQN--GIEDFKKHPFFSGIDWDNI--RNCEA 355

Query: 424 GFCPEVAGKHCIANFEKKWTDMPLSDSP----AATPKNNTNPFADFSYVRP 470
            + PEV+     +NF+     +  S++           +  PF  F+Y   
Sbjct: 356 PYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTSS 406

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  347 bits (893), Expect = e-118
 Identities = 89/284 (31%), Positives = 152/284 (53%), Gaps = 12/284 (4%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I+DF++ + +G+G FG VY  R+K    I A+KV+ K ++ ++     ++ E +I + + 
Sbjct: 13  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP ++++   F  + R+YL+L+F   G L+ +L  HG F E  +  +  E+  A+ + H 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             ++HRD+KPEN+L+G  G + + DFG +       R  +M GT++Y+ PE++ GK H++
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR-RTMCGTLDYLPPEMIEGKTHDE 191

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
             D W  G+L YE L G PPF   +  +  ++IV   L+ P FLS  +  L+  LL+  P
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHP 251

Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGK 432
            +RL       + +  H W       K  +R + P        K
Sbjct: 252 PQRLPL-----KGVMEHPWV------KANSRRVLPPVYQSTQSK 284

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  339 bits (873), Expect = e-115
 Identities = 84/274 (30%), Positives = 150/274 (54%), Gaps = 6/274 (2%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + + 
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H+
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             ++HRD+KPEN+LLG+ G + + DFG +     + R   + GT++Y+ PE++ G+ H++
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TDLCGTLDYLPPEMIEGRMHDE 186

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
             D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  P
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 246

Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQ 422
            +R         E+  H W    + K    +  +
Sbjct: 247 SQRPML-----REVLEHPWITANSSKPSNCQNKE 275

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  306 bits (786), Expect = e-102
 Identities = 75/266 (28%), Positives = 120/266 (45%), Gaps = 13/266 (4%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
              + F+ L  +G G++G V++VR K    +YA+K         K+ A  +  E     K
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA-EVGSHEK 112

Query: 207 I-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVS 264
           +  HP  V+L+ +++    LYL  +   G  L       G    E     Y  + + A++
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGK 324
           HLH+ G++H D+KP NI LG  G   L DFGL  +           G   YMAPE +L  
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE-LLQG 230

Query: 325 GHNKAADWWSVGILLYEMLTGKP-PFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
            +  AAD +S+G+ + E+      P  G    +++Q  +       A LSSE  S+L  +
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP--EFTAGLSSELRSVLVMM 288

Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFK 409
           L+ +P  R  A     E + +    +
Sbjct: 289 LEPDPKLRATA-----EALLALPVLR 309

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  291 bits (746), Expect = 2e-95
 Identities = 72/319 (22%), Positives = 128/319 (40%), Gaps = 53/319 (16%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--------------DKIVEKNHA 194
           I D+ +++ + QG F ++    K N  + YA+K   K              DKI  K+  
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEKDN--KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 195 EYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG--------L 246
           +  K E  I+T I + + +  +        +Y++ +++    +     +           
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 247 FREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR 305
               + +     ++++ S++H    I HRD+KP NIL+  +G V L+DFG ++   +   
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207

Query: 306 SNSMIGTVEYMAPEIVLGKG--HNKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIV 362
             S  GT E+M PE    +   +    D WS+GI LY M     PF    +  ++   I 
Sbjct: 208 KGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266

Query: 363 KDKLRLPA-------------------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIK 403
              +  P                    FLS+E    LK  L+K P +R+ +     E+  
Sbjct: 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS-----EDAL 321

Query: 404 SHKWFKPINWKKLEAREIQ 422
            H+W    N + L     +
Sbjct: 322 KHEWLADTNIEDLREFSKE 340

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  278 bits (713), Expect = 2e-90
 Identities = 88/317 (27%), Positives = 145/317 (45%), Gaps = 10/317 (3%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E +  L+ +G+G+FG+   V+       Y +K +   ++  K   E  + E  +L  + 
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR-EVAVLANMK 81

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQL--YHHGLFREDLARIYAAEIVSAVSHL 266
           HP +VQ + SF+    LY+V+D+  GG LF ++      LF+ED    +  +I  A+ H+
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSMIGTVEYMAPEIVLGKG 325
           H   I+HRD+K +NI L  DG V L DFG+A+  +     + + IGT  Y++PEI   K 
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201

Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLLKGLL 384
           +N  +D W++G +LYE+ T K  F  G+   +  KI+      +    S +  SL+  L 
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261

Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTD 444
           ++ P  R          I    +      K L  + I   FC +   K        K   
Sbjct: 262 KRNPRDRPSV-----NSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPA 316

Query: 445 MPLSDSPAATPKNNTNP 461
              +       +  T P
Sbjct: 317 SGQNSISVMPAQKITKP 333

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  272 bits (697), Expect = 7e-89
 Identities = 80/263 (30%), Positives = 140/263 (53%), Gaps = 7/263 (2%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           IEDF+V  ++G+G+F  VY+    +T    A+K++ K  + +    + ++ E  I  ++ 
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLH 267
           HP +++L   F+    +YLVL+  + G +   L +    F E+ AR +  +I++ + +LH
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGH 326
           ++GI+HRDL   N+LL  + ++ + DFGLA Q    + +  ++ GT  Y++PEI     H
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
              +D WS+G + Y +L G+PPF          K+V     +P+FLS EA  L+  LL++
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRR 249

Query: 387 EPGKRLGAGPKGSEEIKSHKWFK 409
            P  RL         +  H +  
Sbjct: 250 NPADRLSL-----SSVLDHPFMS 267

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  268 bits (686), Expect = 6e-87
 Identities = 79/307 (25%), Positives = 139/307 (45%), Gaps = 45/307 (14%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
            DFE + V+GQGAFG+V + R    S  YA+K +R  +         + +E  +L  ++H
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST----ILSEVMLLASLNH 61

Query: 210 PFVVQLKYSFQ-------------TKYRLYLVLDFINGGHLFFQLYHHGLF-REDLARIY 255
            +VV+   ++               K  L++ +++   G L+  ++   L  + D     
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS--------- 306
             +I+ A+S++H+ GI+HRDLKP NI +    +V + DFGLAK    +            
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 307 ------NSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ 359
                  S IGT  Y+A E++ G GH N+  D +S+GI+ +EM+   P   G  R  I +
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILK 239

Query: 360 KIVKDKLRLPAFL----SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK 415
           K+    +  P             +++ L+  +P KR GA       + +  W    +  +
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA-----RTLLNSGWLPVKHQDE 294

Query: 416 LEAREIQ 422
           +    ++
Sbjct: 295 VIKEALK 301

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  266 bits (683), Expect = 1e-86
 Identities = 75/262 (28%), Positives = 131/262 (50%), Gaps = 6/262 (2%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
              +   + +G+G F + +++   +T E++A K++ K  +++ +  E M  E  I   + 
Sbjct: 14  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV     F+    +++VL+      L           E  AR Y  +IV    +LH 
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHN 327
           N ++HRDLK  N+ L  D  V + DFGLA + + +  R   + GT  Y+APE++  KGH+
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 193

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS+G ++Y +L GKPPF      +   +I K++  +P  ++  A SL++ +LQ +
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 253

Query: 388 PGKRLGAGPKGSEEIKSHKWFK 409
           P  R         E+ + ++F 
Sbjct: 254 PTARPTI-----NELLNDEFFT 270

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  267 bits (684), Expect = 3e-86
 Identities = 75/262 (28%), Positives = 131/262 (50%), Gaps = 6/262 (2%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
              +   + +G+G F + +++   +T E++A K++ K  +++ +  E M  E  I   + 
Sbjct: 40  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV     F+    +++VL+      L           E  AR Y  +IV    +LH 
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHN 327
           N ++HRDLK  N+ L  D  V + DFGLA + + +  R   + GT  Y+APE++  KGH+
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 219

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS+G ++Y +L GKPPF      +   +I K++  +P  ++  A SL++ +LQ +
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 279

Query: 388 PGKRLGAGPKGSEEIKSHKWFK 409
           P  R         E+ + ++F 
Sbjct: 280 PTARPTI-----NELLNDEFFT 296

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  259 bits (665), Expect = 9e-84
 Identities = 75/283 (26%), Positives = 128/283 (45%), Gaps = 28/283 (9%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V    + +LK +G G   +V+QV  +   +IYA+K +  ++   +    Y   E   L K
Sbjct: 25  VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRN-EIAYLNK 82

Query: 207 IDHP--FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
           +      +++L     T   +Y+V++      L   L           + Y   ++ AV 
Sbjct: 83  LQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 141

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIV 321
            +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S +GTV YM PE +
Sbjct: 142 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

Query: 322 LGKG-----------HNKAADWWSVGILLYEMLTGKPPF--IGGNRAKIQQKIVKD-KLR 367
                           +  +D WS+G +LY M  GK PF  I    +K+   I  + ++ 
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 260

Query: 368 LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP 410
            P     +   +LK  L+++P +R+        E+ +H + + 
Sbjct: 261 FPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQI 298

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  258 bits (660), Expect = 1e-82
 Identities = 75/283 (26%), Positives = 128/283 (45%), Gaps = 28/283 (9%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V    + +LK +G G   +V+QV  +   +IYA+K +  ++   +    Y   E   L K
Sbjct: 6   VKGRIYSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRN-EIAYLNK 63

Query: 207 IDHP--FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
           +      +++L     T   +Y+V++      L   L           + Y   ++ AV 
Sbjct: 64  LQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIV 321
            +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S +GTV YM PE +
Sbjct: 123 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 322 LGKG-----------HNKAADWWSVGILLYEMLTGKPPF--IGGNRAKIQQKIVKD-KLR 367
                           +  +D WS+G +LY M  GK PF  I    +K+   I  + ++ 
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241

Query: 368 LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP 410
            P     +   +LK  L+++P +R+        E+ +H + + 
Sbjct: 242 FPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQI 279

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  261 bits (670), Expect = 3e-82
 Identities = 84/280 (30%), Positives = 146/280 (52%), Gaps = 14/280 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E + ++ ++G+G+FG V + + + T + YA+KV+ K     K+    +  E ++L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDH 80

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +++L    +     Y+V +   GG LF ++     F E  A     ++ S ++++H +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 270 GIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
            I+HRDLKPENILL     D  + + DFGL+  F +NT+    IGT  Y+APE VL   +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTY 199

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKG 382
           ++  D WS G++LY +L+G PPF G N   I +++   K          +S +A  L++ 
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQ 422
           +L   P  R+ A      +   H W +  + +     ++ 
Sbjct: 260 MLTFHPSLRITA-----TQCLEHPWIQKYSSETPTISDLP 294

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  254 bits (650), Expect = 6e-82
 Identities = 75/275 (27%), Positives = 134/275 (48%), Gaps = 19/275 (6%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
            ED+EVL  +G G++GR  ++R+K+  +I   K +    + E    + + +E ++L ++ 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELK 63

Query: 209 HPFVVQLKYSFQ--TKYRLYLVLDFINGGHLFFQLYHHG----LFREDLARIYAAEIVSA 262
           HP +V+        T   LY+V+++  GG L   +           E+       ++  A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 263 VSHLH-----ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSMIGTVEYM 316
           +   H      + ++HRDLKP N+ L    +V L DFGLA+  + +T  + + +GT  YM
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSE 375
           +PE +    +N+ +D WS+G LLYE+    PPF   ++ ++  KI + K  R+P   S E
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243

Query: 376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP 410
            + ++  +L  +   R        EEI  +     
Sbjct: 244 LNEIITRMLNLKDYHRPSV-----EEILENPLILE 273

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  255 bits (652), Expect = 1e-81
 Identities = 68/308 (22%), Positives = 121/308 (39%), Gaps = 53/308 (17%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
                + +  ++GQGA   V++ R K T +++A+KV      +     +    E ++L K
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKK 63

Query: 207 IDHPFVVQLK--YSFQTKYRLYLVLDFINGGHLFFQLYHHG---LFREDLARIYAAEIVS 261
           ++H  +V+L       T     L+++F   G L+  L          E    I   ++V 
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 262 AVSHLHANGIMHRDLKPENILLG----ADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
            ++HL  NGI+HR++KP NI+            LTDFG A++ +++ +  S+ GT EY+ 
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183

Query: 318 PEIV--------LGKGHNKAADWWSVGILLYEMLTGKPPF----IGGNRAKIQQKIVKDK 365
           P++           K +    D WS+G+  Y   TG  PF          ++  KI+  K
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

Query: 366 -------------------------LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSE 400
                                      L   L      +L  +L+ +  K  G      +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-----D 298

Query: 401 EIKSHKWF 408
           +  +    
Sbjct: 299 QFFAETSD 306

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  257 bits (657), Expect = 2e-81
 Identities = 68/294 (23%), Positives = 118/294 (40%), Gaps = 48/294 (16%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
                + +  ++GQGA   V++ R K T +++A+KV      +     +    E ++L K
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKK 63

Query: 207 IDHPFVVQLK--YSFQTKYRLYLVLDFINGGHLFFQLYHHG---LFREDLARIYAAEIVS 261
           ++H  +V+L       T     L+++F   G L+  L          E    I   ++V 
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 262 AVSHLHANGIMHRDLKPENILLG----ADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
            ++HL  NGI+HR++KP NI+            LTDFG A++ +++ +  S+ GT EY+ 
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183

Query: 318 PEIV--------LGKGHNKAADWWSVGILLYEMLTGKPPFI----GGNRAKIQQKIVKDK 365
           P++           K +    D WS+G+  Y   TG  PF          ++  KI+  K
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

Query: 366 -------------------------LRLPAFLSSEAHSLLKGLLQKEPGKRLGA 394
                                      L   L      +L  +L+ +  K  G 
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  259 bits (663), Expect = 3e-81
 Identities = 87/267 (32%), Positives = 146/267 (54%), Gaps = 13/267 (4%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + ++  +V+G+G+FG V   + K T +  A+KV+ K ++ +K   E +  E  +L ++DH
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +++L   F+ K   YLV +   GG LF ++     F E  A     +++S ++++H N
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 270 GIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
            I+HRDLKPEN+LL     D ++ + DFGL+  F+ + +    IGT  Y+APE VL   +
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE-VLHGTY 204

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKG 382
           ++  D WS G++LY +L+G PPF G N   I +K+ K K          +S  A  L++ 
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           +L   P  R+ A      +   H+W +
Sbjct: 265 MLTYVPSMRISA-----RDALDHEWIQ 286

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  252 bits (646), Expect = 4e-81
 Identities = 79/267 (29%), Positives = 141/267 (52%), Gaps = 13/267 (4%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ++++V + +G+GAF  V +   K T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQH 64

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +V+L  S Q +   YLV D + GG LF  +     + E  A     +I+ ++++ H+N
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 270 GIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HR+LKPEN+LL        V L DFGLA + +++   +   GT  Y++PE++    +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKG 382
           +K  D W+ G++LY +L G PPF   ++ ++  +I       P+     ++ EA SL+  
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           +L   P KR+ A     ++     W  
Sbjct: 245 MLTVNPKKRITA-----DQALKVPWIC 266

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  252 bits (646), Expect = 8e-81
 Identities = 78/252 (30%), Positives = 127/252 (50%), Gaps = 9/252 (3%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           + +F + K +G+G F  VY+          A+K ++   +++         E D+L +++
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG----LFREDLARIYAAEIVSAVS 264
           HP V++   SF     L +VL+  + G L   + H      L  E     Y  ++ SA+ 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNSMIGTVEYMAPEIVLG 323
           H+H+  +MHRD+KP N+ + A G V L D GL + F   T  ++S++GT  YM+PE +  
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210

Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIG--GNRAKIQQKIVKDKL-RLPA-FLSSEAHSL 379
            G+N  +D WS+G LLYEM   + PF G   N   + +KI +     LP+   S E   L
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 270

Query: 380 LKGLLQKEPGKR 391
           +   +  +P KR
Sbjct: 271 VNMCINPDPEKR 282

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  255 bits (652), Expect = 1e-80
 Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 28/283 (9%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V    + +LK +G G   +V+QV  +   +IYA+K +  ++   +    Y   E   L K
Sbjct: 53  VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRN-EIAYLNK 110

Query: 207 IDHP--FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
           +      +++L     T   +Y+V++      L   L           + Y   ++ AV 
Sbjct: 111 LQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIV 321
            +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S +G V YM PE +
Sbjct: 170 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

Query: 322 LGKG-----------HNKAADWWSVGILLYEMLTGKPPF--IGGNRAKIQQKIVKD-KLR 367
                           +  +D WS+G +LY M  GK PF  I    +K+   I  + ++ 
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288

Query: 368 LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP 410
            P     +   +LK  L+++P +R+        E+ +H + + 
Sbjct: 289 FPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQI 326

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  256 bits (657), Expect = 3e-80
 Identities = 92/280 (32%), Positives = 152/280 (54%), Gaps = 14/280 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E ++ +K +G GA+G V   R K T    A+K++RK  +   ++   +  E  +L  +DH
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN-SKLLEEVAVLKLLDH 95

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +++L   F+ K   YLV++   GG LF ++ H   F E  A +   +++S V++LH +
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155

Query: 270 GIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
            I+HRDLKPEN+LL     D  + + DFGL+  F+   +    +GT  Y+APE VL K +
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE-VLRKKY 214

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKG 382
           ++  D WS+G++L+ +L G PPF G    +I +K+ K K    +     +S  A  L+K 
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQ 422
           +LQ +  +R+ A     ++   H W K +  KK    E+ 
Sbjct: 275 MLQFDSQRRISA-----QQALEHPWIKEMCSKKESGIELP 309

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  251 bits (643), Expect = 3e-80
 Identities = 82/284 (28%), Positives = 140/284 (49%), Gaps = 16/284 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTK 206
           + ++  + +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           I HP V+ L   ++ K  + L+L+ + GG LF  L       E+ A  +  +I++ V +L
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130

Query: 267 HANGIMHRDLKPENILL----GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           H+  I H DLKPENI+L         + + DFGLA + D      ++ GT E++APEIV 
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHS 378
            +     AD WS+G++ Y +L+G  PF+G  + +    +               S+ A  
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 250

Query: 379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQ 422
            ++ LL K+P KR+       ++   H W KP + ++  +R+  
Sbjct: 251 FIRRLLVKDPKKRMTI-----QDSLQHPWIKPKDTQQALSRKAS 289

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  249 bits (639), Expect = 3e-80
 Identities = 81/267 (30%), Positives = 139/267 (52%), Gaps = 16/267 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + + +   +G+G++G V    +K T    A K + K  + +    +  K E +I+  +DH
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV---DRFKQEIEIMKSLDH 65

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +++L  +F+    +YLV++   GG LF ++ H  +FRE  A     +++SAV++ H  
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 270 GIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
            + HRDLKPEN L      D  + L DFGLA +F       + +GT  Y++P+ VL   +
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ-VLEGLY 184

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKG 382
               D WS G+++Y +L G PPF     +++  KI +     P      +S +A SL++ 
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           LL K P +R+ +      +   H+WF+
Sbjct: 245 LLTKSPKQRITS-----LQALEHEWFE 266

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  249 bits (638), Expect = 5e-80
 Identities = 79/270 (29%), Positives = 139/270 (51%), Gaps = 18/270 (6%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + F   + +G GAFG V+ V ++++     +K + KD+   +   E ++AE ++L  +DH
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDH 79

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLF----FQLYHHGLFREDLARIYAAEIVSAVSH 265
           P ++++   F+  + +Y+V++   GG L               E        ++++A+++
Sbjct: 80  PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139

Query: 266 LHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
            H+  ++H+DLKPENIL         + + DFGLA+ F  +  S +  GT  YMAPE V 
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE-VF 198

Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL---PAFLSSEAHSL 379
            +      D WS G+++Y +LTG  PF G +  ++QQK    +         L+ +A  L
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258

Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           LK +L K+P +R  A      ++  H+WFK
Sbjct: 259 LKQMLTKDPERRPSA-----AQVLHHEWFK 283

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  249 bits (638), Expect = 5e-80
 Identities = 84/267 (31%), Positives = 142/267 (53%), Gaps = 14/267 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E + ++ ++G+G+FG V + + + T + YA+KV+ K     K+    +  E ++L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDH 80

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +++L    +     Y+V +   GG LF ++     F E  A     ++ S ++++H +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 270 GIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
            I+HRDLKPENILL     D  + + DFGL+  F +NT+    IGT  Y+APE VL   +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTY 199

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKG 382
           ++  D WS G++LY +L+G PPF G N   I +++   K          +S +A  L++ 
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           +L   P  R+ A      +   H W +
Sbjct: 260 MLTFHPSLRITA-----TQCLEHPWIQ 281

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  252 bits (645), Expect = 5e-80
 Identities = 79/267 (29%), Positives = 141/267 (52%), Gaps = 13/267 (4%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ++++V + +G+GAF  V +   K T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQH 87

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +V+L  S Q +   YLV D + GG LF  +     + E  A     +I+ ++++ H+N
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147

Query: 270 GIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HR+LKPEN+LL        V L DFGLA + +++   +   GT  Y++PE++    +
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKG 382
           +K  D W+ G++LY +L G PPF   ++ ++  +I       P+     ++ EA SL+  
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           +L   P KR+ A     ++     W  
Sbjct: 268 MLTVNPKKRITA-----DQALKVPWIC 289

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  255 bits (652), Expect = 2e-79
 Identities = 92/277 (33%), Positives = 145/277 (52%), Gaps = 23/277 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV----------EKNHAEYMKA 199
           E +  ++ +G GA+G V   ++KN     A+KV++K +             +   E +  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 200 ERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEI 259
           E  +L  +DHP +++L   F+ K   YLV +F  GG LF Q+ +   F E  A     +I
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155

Query: 260 VSAVSHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYM 316
           +S + +LH + I+HRD+KPENILL    +  ++ + DFGL+  F ++ +    +GT  Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215

Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FL 372
           APE VL K +N+  D WS G+++Y +L G PPF G N   I +K+ K K          +
Sbjct: 216 APE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274

Query: 373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           S EA  L+K +L  +  KR  A     EE  + +W K
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTA-----EEALNSRWIK 306

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  247 bits (634), Expect = 2e-79
 Identities = 82/272 (30%), Positives = 136/272 (50%), Gaps = 16/272 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTK 206
           + +E+ + +G G F  V + R+K T + YA K ++K ++         E ++ E +IL +
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           I HP ++ L   F+ K  + L+L+ ++GG LF  L       ED A  +  +I+  V +L
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124

Query: 267 HANGIMHRDLKPENILL----GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           H+  I H DLKPENI+L      +  + L DFG+A + +      ++ GT E++APEIV 
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184

Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHS 378
            +     AD WS+G++ Y +L+G  PF+G  + +    I           F   S  A  
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD 244

Query: 379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP 410
            ++ LL K+P +R+        +   H W K 
Sbjct: 245 FIRRLLVKDPKRRMTI-----AQSLEHSWIKA 271

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  246 bits (631), Expect = 6e-79
 Identities = 64/294 (21%), Positives = 118/294 (40%), Gaps = 39/294 (13%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
            DF+ ++++G G FG+V++ + +   + Y +K ++ +        E  + E   L K+DH
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDH 63

Query: 210 PFVVQLKYSFQ----------------TKYRLYLVLDFINGGHLFFQL--YHHGLFREDL 251
             +V     +                     L++ ++F + G L   +         + L
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 252 ARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG 311
           A     +I   V ++H+  +++RDLKP NI L     V + DFGL      + +     G
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKG 183

Query: 312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPA 370
           T+ YM+PE +  + + K  D +++G++L E+L      F     +K    +      +  
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF---ETSKFFTDLRDGI--ISD 238

Query: 371 FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPG 424
               +  +LL+ LL K+P  R         EI           K  E  E    
Sbjct: 239 IFDKKEKTLLQKLLSKKPEDRPNT-----SEILRTLTVWK---KSPEKNERHTA 284

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  247 bits (632), Expect = 1e-78
 Identities = 81/272 (29%), Positives = 133/272 (48%), Gaps = 16/272 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTK 206
           + +++ + +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           + H  V+ L   ++ +  + L+L+ ++GG LF  L       E+ A  +  +I+  V++L
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 267 HANGIMHRDLKPENILL----GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           H   I H DLKPENI+L        H+ L DFGLA + ++     ++ GT E++APEIV 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHS 378
            +     AD WS+G++ Y +L+G  PF+G  + +    I               S  A  
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKD 251

Query: 379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP 410
            ++ LL KE  KRL       +E   H W  P
Sbjct: 252 FIRKLLVKETRKRLTI-----QEALRHPWITP 278

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  248 bits (635), Expect = 2e-78
 Identities = 81/272 (29%), Positives = 134/272 (49%), Gaps = 16/272 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA---EYMKAERDILTK 206
           + +++ + +G G F  V + R+K+T   YA K ++K +          E ++ E  IL +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           + HP ++ L   ++ +  + L+L+ ++GG LF  L       E+ A  +  +I+  V++L
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 267 HANGIMHRDLKPENILL----GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           H   I H DLKPENI+L        H+ L DFGLA + ++     ++ GT E++APEIV 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHS 378
            +     AD WS+G++ Y +L+G  PF+G  + +    I               S  A  
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKD 251

Query: 379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP 410
            ++ LL KE  KRL       +E   H W  P
Sbjct: 252 FIRKLLVKETRKRLTI-----QEALRHPWITP 278

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  244 bits (624), Expect = 1e-77
 Identities = 87/267 (32%), Positives = 148/267 (55%), Gaps = 16/267 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + F  ++V+G GAF  V+ V+++ T +++A+K ++K           ++ E  +L KI H
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKH 65

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
             +V L+  +++    YLV+  ++GG LF ++   G++ E  A +   +++SAV +LH N
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 270 GIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPEN+L      +  +M+TDFGL+K       S +  GT  Y+APE++  K +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-TACGTPGYVAPEVLAQKPY 184

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKG 382
           +KA D WS+G++ Y +L G PPF     +K+ +KI +      +     +S  A   +  
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH 244

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           LL+K+P +R        E+  SH W  
Sbjct: 245 LLEKDPNERYTC-----EKALSHPWID 266

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  248 bits (635), Expect = 1e-77
 Identities = 80/277 (28%), Positives = 136/277 (49%), Gaps = 15/277 (5%)

Query: 142 VTVCCVGIED-FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAE 200
            T+ C    + +++ + +G+GAF  V +  K    + YA  ++   K+  ++H + ++ E
Sbjct: 2   ATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLERE 60

Query: 201 RDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIV 260
             I   + HP +V+L  S   +   YL+ D + GG LF  +     + E  A     +I+
Sbjct: 61  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL 120

Query: 261 SAVSHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRS-NSMIGTVEYM 316
            AV H H  G++HR+LKPEN+LL        V L DFGLA + +   ++     GT  Y+
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180

Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FL 372
           +PE++    + K  D W+ G++LY +L G PPF   ++ ++ Q+I       P+     +
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240

Query: 373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           + EA  L+  +L   P KR+ A      E   H W  
Sbjct: 241 TPEAKDLINKMLTINPSKRITA-----AEALKHPWIS 272

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  242 bits (618), Expect = 2e-76
 Identities = 82/315 (26%), Positives = 131/315 (41%), Gaps = 60/315 (19%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAER--DILTKI 207
           + + +   +GQG++G V    +  T  I A+K+M K+KI + N  +  + +    ++ K+
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLF----------------------------- 238
            HP + +L   ++ +  + LV++  +GGHL                              
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 239 -----------FQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG 287
                      F+     + RE L      +I SA+ +LH  GI HRD+KPEN L   + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 288 --HVMLTDFGLAKQFD-----ENTRSNSMIGTVEYMAPEIVLGKGH--NKAADWWSVGIL 338
              + L DFGL+K+F      E     +  GT  ++APE++           D WS G+L
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 339 LYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLKGLLQKEPGKRLGA 394
           L+ +L G  PF G N A    +++  KL         LS  A  LL  LL +   +R  A
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325

Query: 395 GPKGSEEIKSHKWFK 409
                     H W  
Sbjct: 326 -----MRALQHPWIS 335

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  241 bits (616), Expect = 6e-76
 Identities = 80/278 (28%), Positives = 142/278 (51%), Gaps = 21/278 (7%)

Query: 147 VGIED-FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA--EYMKAERDI 203
           V  ED +E+ +V+G+G F  V +   + T + +A+K++   K         E +K E  I
Sbjct: 20  VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASI 79

Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG----LFREDLARIYAAEI 259
              + HP +V+L  ++ +   LY+V +F++G  L F++        ++ E +A  Y  +I
Sbjct: 80  CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139

Query: 260 VSAVSHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFDEN-TRSNSMIGTVEY 315
           + A+ + H N I+HRD+KP  +LL        V L  FG+A Q  E+   +   +GT  +
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

Query: 316 MAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----F 371
           MAPE+V  + + K  D W  G++L+ +L+G  PF G    ++ + I+K K ++       
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSH 258

Query: 372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           +S  A  L++ +L  +P +R+        E  +H W K
Sbjct: 259 ISESAKDLVRRMLMLDPAERITV-----YEALNHPWLK 291

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  243 bits (621), Expect = 7e-76
 Identities = 86/276 (31%), Positives = 149/276 (53%), Gaps = 22/276 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAER-----DIL 204
           +++ + K +G GA G V    ++ T +  A++++ K K    +  E   A       +IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            K++HP ++++K  F  +   Y+VL+ + GG LF ++  +   +E   ++Y  +++ AV 
Sbjct: 195 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 265 HLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           +LH NGI+HRDLKPEN+LL +   D  + +TDFG +K   E +   ++ GT  Y+APE++
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313

Query: 322 LG---KGHNKAADWWSVGILLYEMLTGKPPFIGGN-RAKIQQKIVKDKLRLP----AFLS 373
           +     G+N+A D WS+G++L+  L+G PPF     +  ++ +I   K        A +S
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373

Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
            +A  L+K LL  +P  R        EE   H W +
Sbjct: 374 EKALDLVKKLLVVDPKARFTT-----EEALRHPWLQ 404

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  238 bits (610), Expect = 1e-75
 Identities = 84/285 (29%), Positives = 134/285 (47%), Gaps = 22/285 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA------EYMKAERDI 203
           E++E  +++G+G    V +   K T + YA+K++        +        E    E DI
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 204 LTKID-HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
           L K+  HP ++QLK +++T    +LV D +  G LF  L       E   R     ++  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           +  LH   I+HRDLKPENILL  D ++ LTDFG + Q D   +   + GT  Y+APEI+ 
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 196

Query: 323 G------KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FL 372
                   G+ K  D WS G+++Y +L G PPF    +  + + I+    +  +      
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 256

Query: 373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLE 417
           S     L+   L  +P KR  A     EE  +H +F+    +++ 
Sbjct: 257 SDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQQYVVEEVR 296

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  241 bits (616), Expect = 1e-75
 Identities = 43/305 (14%), Positives = 90/305 (29%), Gaps = 56/305 (18%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAER--------- 201
                 V+GQ       +   + T E + + V    +    N  + MK E          
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 202 ----------------DILTKIDHPFVVQLKYSFQTKYRLYLVL--------DFINGGHL 237
                           D++       +++++   +  + L                G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 238 FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA 297
                 H             +++  ++ LH  G++H  L+P +I+L   G V LT F   
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 298 KQFDENTRSNSMIGTVEYMAPEIVLGKG-----------HNKAADWWSVGILLYEMLTGK 346
            +            +  +  PE+   +               + D W++G+++Y +    
Sbjct: 254 VRDGARV---VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 347 PPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHK 406
            P          + I     R    +     +LL+G L+     RL        +     
Sbjct: 311 LPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLP-----LQAMETP 361

Query: 407 WFKPI 411
            ++ +
Sbjct: 362 EYEQL 366

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  241 bits (616), Expect = 2e-75
 Identities = 81/267 (30%), Positives = 135/267 (50%), Gaps = 15/267 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + +++L+ +G GAFG V++  +K T  ++  K +     ++K     +K E  I+ ++ H
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH 107

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHA 268
           P ++ L  +F+ KY + L+L+F++GG LF ++        E     Y  +    + H+H 
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167

Query: 269 NGIMHRDLKPENILLGA--DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           + I+H D+KPENI+        V + DFGLA + + +        T E+ APEIV  +  
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 227

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSLLKG 382
               D W++G+L Y +L+G  PF G +  +  Q + +        AF  +S EA   +K 
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           LLQKEP KRL        +   H W K
Sbjct: 288 LLQKEPRKRLTV-----HDALEHPWLK 309

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  239 bits (611), Expect = 2e-75
 Identities = 89/282 (31%), Positives = 155/282 (54%), Gaps = 22/282 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-----EKNHAEYMKAERDIL 204
           +++ + K +G GA G V    ++ T +  A+K++ K K       E + A  ++ E +IL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            K++HP ++++K  F  +   Y+VL+ + GG LF ++  +   +E   ++Y  +++ AV 
Sbjct: 70  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128

Query: 265 HLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           +LH NGI+HRDLKPEN+LL +   D  + +TDFG +K   E +   ++ GT  Y+APE++
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

Query: 322 LG---KGHNKAADWWSVGILLYEMLTGKPPFIGGN-RAKIQQKIVKDKLRLP----AFLS 373
           +     G+N+A D WS+G++L+  L+G PPF     +  ++ +I   K        A +S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248

Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK 415
            +A  L+K LL  +P  R        EE   H W +  + K+
Sbjct: 249 EKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMKR 285

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  238 bits (609), Expect = 4e-75
 Identities = 79/275 (28%), Positives = 131/275 (47%), Gaps = 16/275 (5%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH-PFVVQ 214
           K +G+G F  V Q   K+T + YA K ++K +  +   AE +  E  +L      P V+ 
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAVLELAKSCPRVIN 93

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLY--HHGLFREDLARIYAAEIVSAVSHLHANGIM 272
           L   ++    + L+L++  GG +F         +  E+       +I+  V +LH N I+
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153

Query: 273 HRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKA 329
           H DLKP+NILL      G + + DFG++++         ++GT EY+APEI+       A
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTA 213

Query: 330 ADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLKGLLQ 385
            D W++GI+ Y +LT   PF+G +  +    I +  +       + +S  A   ++ LL 
Sbjct: 214 TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLV 273

Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEARE 420
           K P KR  A     E   SH W +  +++ L   E
Sbjct: 274 KNPEKRPTA-----EICLSHSWLQQWDFENLFHPE 303

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  239 bits (611), Expect = 7e-75
 Identities = 80/300 (26%), Positives = 144/300 (48%), Gaps = 24/300 (8%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
                +++G G FG+V++  +  T    A K+++   + +K   E +K E  ++ ++DH 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHAN 269
            ++QL  +F++K  + LV+++++GG LF ++        E    ++  +I   + H+H  
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 270 GIMHRDLKPENILLG--ADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN 327
            I+H DLKPENIL        + + DFGLA+++    +     GT E++APE+V     +
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS 266

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSLLKGL 383
              D WSVG++ Y +L+G  PF+G N A+    I+  +  L    F  +S EA   +  L
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326

Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWT 443
           L KE   R+ A      E   H W          + + +         K+  ++ +   T
Sbjct: 327 LIKEKSWRISA-----SEALKHPWLSDHKLHSRLSAQKK---------KNRGSDAQDFVT 372

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  235 bits (602), Expect = 3e-74
 Identities = 70/267 (26%), Positives = 123/267 (46%), Gaps = 16/267 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E + + + +G+G FG V++  + ++ + Y  K ++     +      +K E  IL    H
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARH 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL-FREDLARIYAAEIVSAVSHLHA 268
             ++ L  SF++   L ++ +FI+G  +F ++        E     Y  ++  A+  LH+
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 269 NGIMHRDLKPENILLGA--DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           + I H D++PENI+        + + +FG A+Q         +    EY APE+      
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSLLKG 382
           + A D WS+G L+Y +L+G  PF+     +I + I+  +      AF  +S EA   +  
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           LL KE   R+ A      E   H W K
Sbjct: 241 LLVKERKSRMTA-----SEALQHPWLK 262

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  236 bits (603), Expect = 4e-74
 Identities = 86/280 (30%), Positives = 155/280 (55%), Gaps = 7/280 (2%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I ++ +LK +G+G F +V   R   T    A+K++ K ++   +  + +  E  I+  ++
Sbjct: 14  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS-LQKLFREVRIMKILN 72

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +V+L    +T+  LYL++++ +GG +F  L  HG  +E  AR    +IVSAV + H 
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN- 327
             I+HRDLK EN+LL AD ++ + DFG + +F    + ++  G   Y APE+  GK ++ 
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS+G++LY +++G  PF G N  ++++++++ K R+P ++S++  +LLK  L   
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLN 252

Query: 388 PGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP 427
           P KR        E+I   +W    + +      ++P    
Sbjct: 253 PIKRGTL-----EQIMKDRWINAGHEEDELKPFVEPELDI 287

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  235 bits (601), Expect = 6e-74
 Identities = 80/270 (29%), Positives = 139/270 (51%), Gaps = 27/270 (10%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQ 214
           K +G+G+F    +   K +++ +A+K++ K            + E   L   + HP +V+
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLCEGHPNIVK 70

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   F  +   +LV++ +NGG LF ++     F E  A     ++VSAVSH+H  G++HR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130

Query: 275 DLKPENILL---GADGHVMLTDFGLAKQFDENTRS-NSMIGTVEYMAPEIVLGKGHNKAA 330
           DLKPEN+L      +  + + DFG A+    + +   +   T+ Y APE++   G++++ 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESC 190

Query: 331 DWWSVGILLYEMLTGKPPFIGGNR-------AKIQQKIVKDKLRLP----AFLSSEAHSL 379
           D WS+G++LY ML+G+ PF   +R        +I +KI K            +S EA  L
Sbjct: 191 DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250

Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           ++GLL  +P KRL         ++ ++W +
Sbjct: 251 IQGLLTVDPNKRLKM-----SGLRYNEWLQ 275

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  236 bits (603), Expect = 6e-74
 Identities = 86/268 (32%), Positives = 140/268 (52%), Gaps = 18/268 (6%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + FEV   +G+GA   VY+ ++K T + YA+KV++K    +      ++ E  +L ++ H
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-----VRTEIGVLLRLSH 107

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +++LK  F+T   + LVL+ + GG LF ++   G + E  A     +I+ AV++LH N
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167

Query: 270 GIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPEN+L      D  + + DFGL+K  +      ++ GT  Y APEI+ G  +
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY 227

Query: 327 NKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDKLRLPA----FLSSEAHSLLK 381
               D WSVGI+ Y +L G  PF        + ++I+  +    +     +S  A  L++
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287

Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
            L+  +P KRL        +   H W  
Sbjct: 288 KLIVLDPKKRLTT-----FQALQHPWVT 310

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  236 bits (603), Expect = 6e-74
 Identities = 50/311 (16%), Positives = 107/311 (34%), Gaps = 45/311 (14%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAER 201
           +G +   V  ++G+GAF +VY+  + +       + + +KV +     E           
Sbjct: 62  LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF---YIGTQLM 118

Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLF-----FQLYHHGLFREDLARIYA 256
           + L        ++   +   +    LV +  + G L      ++     +  + L   +A
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLG-----------ADGHVMLTDFGLA---KQFDE 302
             ++  +  +H   I+H D+KP+N +LG               + L D G +   K F +
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238

Query: 303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ---- 358
            T   +   T  +   E++  K  N   D++ V   +Y ML G    +     + +    
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298

Query: 359 ----------QKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
                      +     L +P      +  LL+  L+K   +      +       ++  
Sbjct: 299 FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIR----ALRNRLI 354

Query: 409 KPINWKKLEAR 419
             +   K   +
Sbjct: 355 VLLLECKRSRK 365

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  241 bits (617), Expect = 1e-73
 Identities = 77/270 (28%), Positives = 127/270 (47%), Gaps = 15/270 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + +++ + +G GAFG V++V ++ T   +A K +      +K   E ++ E   ++ + H
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLRH 213

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           P +V L  +F+    + ++ +F++GG LF      H    ED A  Y  ++   + H+H 
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273

Query: 269 NGIMHRDLKPENILLG--ADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           N  +H DLKPENI+        + L DFGL    D         GT E+ APE+  GK  
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 333

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF--LSSEAHSLLKG 382
               D WSVG+L Y +L+G  PF G N  +  + +      +   AF  +S +    ++ 
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 393

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFKPIN 412
           LL  +P  R+        +   H W  P N
Sbjct: 394 LLLADPNTRMTI-----HQALEHPWLTPGN 418

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  233 bits (597), Expect = 6e-73
 Identities = 80/276 (28%), Positives = 132/276 (47%), Gaps = 21/276 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA-----EYMKAERDIL 204
           + ++   V+G+G    V +   + T   +A+K+M                E  + E  IL
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 205 TKI-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV 263
            ++  HP ++ L  S+++   ++LV D +  G LF  L       E   R     ++ AV
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG 323
           S LHAN I+HRDLKPENILL  +  + L+DFG +   +   +   + GT  Y+APEI+  
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKC 273

Query: 324 ------KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLS 373
                  G+ K  D W+ G++L+ +L G PPF    +  + + I++ + +  +      S
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 333

Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           S    L+  LLQ +P  RL A     E+   H +F+
Sbjct: 334 STVKDLISRLLQVDPEARLTA-----EQALQHPFFE 364

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  230 bits (588), Expect = 1e-72
 Identities = 80/262 (30%), Positives = 134/262 (51%), Gaps = 6/262 (2%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I  + +   +G G FG+V     + T    A+K++ + KI   +    +K E   L    
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +++L     T    ++V+++++GG LF  +  HG   E  AR    +I+SAV + H 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG-HN 327
           + ++HRDLKPEN+LL A  +  + DFGL+    +     +  G+  Y APE++ G+    
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAG 189

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS G++LY +L G  PF   +   + +KI      +P +L+    +LL  +LQ +
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVD 249

Query: 388 PGKRLGAGPKGSEEIKSHKWFK 409
           P KR        ++I+ H+WFK
Sbjct: 250 PLKRATI-----KDIREHEWFK 266

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  240 bits (614), Expect = 3e-72
 Identities = 74/300 (24%), Positives = 128/300 (42%), Gaps = 43/300 (14%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
              +E+ + +G G FG V +   ++T E  A+K  R++   +  + E    E  I+ K++
Sbjct: 13  CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLN 70

Query: 209 HPFVVQLKYSFQTKYRL------YLVLDFINGGHLFFQLYHHG---LFREDLARIYAAEI 259
           HP VV  +       +L       L +++  GG L   L         +E   R   ++I
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130

Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGH---VMLTDFGLAKQFDENTRSNSMIGTVEYM 316
            SA+ +LH N I+HRDLKPENI+L          + D G AK+ D+       +GT++Y+
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 190

Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL---------- 366
           APE++  K +    D+WS G L +E +TG  PF+   +       V++K           
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250

Query: 367 --------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN 412
                          L   L+ +    L+ +L     +R         +  +   F+ ++
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD-----PQNPNVGCFQALD 305

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  230 bits (589), Expect = 7e-72
 Identities = 85/298 (28%), Positives = 139/298 (46%), Gaps = 29/298 (9%)

Query: 125 VKEIDESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMR 184
           ++ +   SI + +  +S+       + +EV + +G G++    +   K T+  +A+K++ 
Sbjct: 1   MQTVGVHSIVQQLHRNSIQFT----DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID 56

Query: 185 KDKIVEKNHAEYMKAERDILTK-IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH 243
           K K            E +IL +   HP ++ LK  +     +Y+V + + GG L  ++  
Sbjct: 57  KSK-------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR 109

Query: 244 HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH----VMLTDFGLAKQ 299
              F E  A      I   V +LHA G++HRDLKP NIL   +      + + DFG AKQ
Sbjct: 110 QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169

Query: 300 F-DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG---NRA 355
              EN    +   T  ++APE++  +G++ A D WS+G+LLY MLTG  PF  G      
Sbjct: 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE 229

Query: 356 KIQQKIVKDKLRLPA----FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           +I  +I   K  L       +S  A  L+  +L  +P +RL A       +  H W  
Sbjct: 230 EILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTA-----ALVLRHPWIV 282

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  229 bits (586), Expect = 8e-72
 Identities = 68/286 (23%), Positives = 117/286 (40%), Gaps = 32/286 (11%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +  + +  ++ +G+G F  V  V   +    YA+K +      E+   E  + E D+   
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRL 82

Query: 207 IDHPFVVQLKYSF----QTKYRLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAE 258
            +HP +++L          K+  +L+L F   G L+ ++           ED        
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI-------- 310
           I   +  +HA G  HRDLKP NILLG +G  +L D G   Q   +   +           
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 311 --GTVEYMAPEIVLGKGH---NKAADWWSVGILLYEMLTGKPPFIGGN-RAKIQQKIVKD 364
              T+ Y APE+   + H   ++  D WS+G +LY M+ G+ P+     +       V++
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262

Query: 365 KLRLPAF--LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
           +L +P     SS    LL  ++  +P +R          + S    
Sbjct: 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHI-----PLLLSQLEA 303

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  229 bits (585), Expect = 2e-71
 Identities = 79/288 (27%), Positives = 141/288 (48%), Gaps = 19/288 (6%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAER-----DI 203
            + +  +  +G GAFG V+    K  ++   +K ++K+K++E    E  K  +      I
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82

Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDF-INGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
           L++++H  ++++   F+ +    LV++   +G  LF  +  H    E LA     ++VSA
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           V +L    I+HRD+K ENI++  D  + L DFG A   +      +  GT+EY APE+++
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202

Query: 323 GKGHN-KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLK 381
           G  +     + WS+G+ LY ++  + PF         ++ V+  +  P  +S E  SL+ 
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELMSLVS 256

Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWF-KPINWKKLEAREIQPGFCPE 428
           GLLQ  P +R        E++ +  W  +P+N       E+     PE
Sbjct: 257 GLLQPVPERRTTL-----EKLVTDPWVTQPVNLADYTWEEVFRVNKPE 299

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  225 bits (576), Expect = 1e-70
 Identities = 82/295 (27%), Positives = 137/295 (46%), Gaps = 37/295 (12%)

Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD--- 202
           CV +  + +   +G+G++G V     +N +  YAMKV+ K K++ +         R    
Sbjct: 9   CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRP 68

Query: 203 --------------------ILTKIDHPFVVQLK--YSFQTKYRLYLVLDFINGGHLFFQ 240
                               IL K+DHP VV+L        +  LY+V + +N G +  +
Sbjct: 69  APGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM-E 127

Query: 241 LYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF 300
           +       ED AR Y  +++  + +LH   I+HRD+KP N+L+G DGH+ + DFG++ +F
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 301 -DENTRSNSMIGTVEYMAPEIVLGKGHN---KAADWWSVGILLYEMLTGKPPFIGGNRAK 356
              +   ++ +GT  +MAPE +         KA D W++G+ LY  + G+ PF+      
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247

Query: 357 IQQKIVKDKLRLPAF--LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           +  KI    L  P    ++ +   L+  +L K P  R+        EIK H W  
Sbjct: 248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV-----PEIKLHPWVT 297

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  224 bits (574), Expect = 2e-70
 Identities = 54/290 (18%), Positives = 110/290 (37%), Gaps = 36/290 (12%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
            +F  L+ +G G FG V++  K+    IYA+K  +K      +    ++          H
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH----GLFREDLARIYAAEIVSAVSH 265
             VV+   ++     + +  ++ NGG L   +  +      F+E   +    ++   + +
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 266 LHANGIMHRDLKPENILLGADGHVM-------------------LTDFGLAKQFDENTRS 306
           +H+  ++H D+KP NI +                          + D G   +    +  
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSP 187

Query: 307 NSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK 365
               G   ++A E++     H   AD +++ + +      +P    G+      +I + +
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGR 244

Query: 366 L-RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK 414
           L R+P  LS E   LLK ++  +P +R  A       +  H      + K
Sbjct: 245 LPRIPQVLSQEFTELLKVMIHPDPERRPSA-----MALVKHSVLLSASRK 289

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  228 bits (582), Expect = 3e-70
 Identities = 48/300 (16%), Positives = 97/300 (32%), Gaps = 49/300 (16%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAER---------- 201
                V+GQ       +   + T E + + V    +    N  + MK E           
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 202 ---------------DILTKIDHPFVVQLKYSFQTKYRLYLVLDF----INGGHLFFQLY 242
                          D++       +++++   +  + L     +     N       L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 243 HHGLFREDL---ARIY-AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK 298
            H    + L   AR+    +++  ++ LH  G++H  L+P +I+L   G V LT F    
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 299 QFDEN--TRSNSMIGTVEYMAPEIVLGKGH-----NKAADWWSVGILLYEMLTGKPPFIG 351
           +   +  +         E  A  ++    H       A D W++G+ +Y +     P   
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319

Query: 352 GNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
                  + I +    +P        +LL+G L+     RL        +      ++ +
Sbjct: 320 DAALGGSEWIFRSCKNIPQ----PVRALLEGFLRYPKEDRLLP-----LQAMETPEYEQL 370

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  222 bits (569), Expect = 7e-70
 Identities = 83/282 (29%), Positives = 143/282 (50%), Gaps = 18/282 (6%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 326 -HNKAADWWSVGILLYEMLTGKPPF-IGGNRAKIQQKIVKDKLRLP--AFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+    +  +      + K  L     + S   +LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQP 423
            +L + P  R+        +IK  +W+     K L+    +P
Sbjct: 244 KILVENPSARITI-----PDIKKDRWYN----KPLKKGAKRP 276

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  222 bits (567), Expect = 2e-69
 Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 42/295 (14%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAER--DILTK 206
           + DFE ++ +G+G FG V++ + K     YA+K +R             K  R    L K
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAK 59

Query: 207 IDHPFVVQLKYSF------------QTKYRLYLVLDFINGGHLFFQLYHHG---LFREDL 251
           ++HP +V+   ++              K  LY+ +      +L   +            +
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119

Query: 252 ARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT------- 304
                 +I  AV  LH+ G+MHRDLKP NI    D  V + DFGL    D++        
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 305 ------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ 358
                 R    +GT  YM+PE + G  ++   D +S+G++L+E+L   P      R +  
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTL 237

Query: 359 QKIVKDKL-RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN 412
             +   K   L        + +++ +L   P +R  A       I  +  F+ ++
Sbjct: 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA-----INIIENAVFEDLD 287

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  224 bits (572), Expect = 3e-69
 Identities = 83/270 (30%), Positives = 139/270 (51%), Gaps = 18/270 (6%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
            + ++ +K +G G FG    +R K T E+ A+K + +   ++    E ++ E      + 
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLR 74

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +V+ K    T   L +++++ +GG L+ ++ + G F ED AR +  +++S VS+ H+
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134

Query: 269 NGIMHRDLKPENILLGAD--GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
             I HRDLK EN LL       + + DFG +K    +++  S +GT  Y+APE++L + +
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEY 194

Query: 327 N-KAADWWSVGILLYEMLTGKPPFIGGNRA----KIQQKIVKDKLRLP--AFLSSEAHSL 379
           + K AD WS G+ LY ML G  PF          K  Q+I+  K  +P    +S E   L
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254

Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           +  +   +P  R+        EIK+H WF 
Sbjct: 255 ISRIFVADPATRISI-----PEIKTHSWFL 279

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  222 bits (569), Expect = 4e-69
 Identities = 75/262 (28%), Positives = 134/262 (51%), Gaps = 7/262 (2%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I  + + + +G+G+FG+V       T +  A+K + +  + + +    ++ E   L  + 
Sbjct: 8   IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +++L     T   + +V+++  GG LF  +       ED  R +  +I+ A+ + H 
Sbjct: 68  HPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR 126

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN- 327
           + I+HRDLKPEN+LL  + +V + DFGL+    +     +  G+  Y APE++ GK +  
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAG 186

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS GI+LY ML G+ PF       + +K+      +P FLS  A SL++ ++  +
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVAD 246

Query: 388 PGKRLGAGPKGSEEIKSHKWFK 409
           P +R+       +EI+   WF 
Sbjct: 247 PMQRITI-----QEIRRDPWFN 263

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  221 bits (565), Expect = 1e-68
 Identities = 85/315 (26%), Positives = 152/315 (48%), Gaps = 18/315 (5%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 326 -HNKAADWWSVGILLYEMLTGKPPF-IGGNRAKIQQKIVKDKLRLP--AFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+    +  +      + K  L     + S   +LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKK 441
            +L + P  R+        +IK  +W+     K L+    +P        +      +  
Sbjct: 244 KILVENPSARITI-----PDIKKDRWYN----KPLKKGAKRPRVTSGGVSESPSGFSKHI 294

Query: 442 WTDMPLSDSPAATPK 456
            +++  S   +A+  
Sbjct: 295 QSNLDFSPVNSASRT 309

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  226 bits (577), Expect = 1e-68
 Identities = 78/262 (29%), Positives = 136/262 (51%), Gaps = 6/262 (2%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           I  + +   +G G FG+V   + + T    A+K++ + KI   +    ++ E   L    
Sbjct: 15  IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +++L     T   +++V+++++GG LF  +  +G   E  +R    +I+S V + H 
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR 134

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHN- 327
           + ++HRDLKPEN+LL A  +  + DFGL+    +     +  G+  Y APE++ G+ +  
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAG 194

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE 387
              D WS G++LY +L G  PF   +   + +KI       P +L+    SLLK +LQ +
Sbjct: 195 PEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVD 254

Query: 388 PGKRLGAGPKGSEEIKSHKWFK 409
           P KR        ++I+ H+WFK
Sbjct: 255 PMKRATI-----KDIREHEWFK 271

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  220 bits (562), Expect = 3e-68
 Identities = 83/290 (28%), Positives = 132/290 (45%), Gaps = 44/290 (15%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQ 214
            V+G+GA  RV       TS+ YA+K++ K     +     +  E ++L +   H  V++
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLE 75

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHR 274
           L   F+ + R YLV + + GG +   ++    F E  A +   ++ SA+  LH  GI HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135

Query: 275 DLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSM--------IGTVEYMAPEIVLG 323
           DLKPENIL         V + DF L      N   + +         G+ EYMAPE+V  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195

Query: 324 -----KGHNKAADWWSVGILLYEMLTGKPPFIGGNRA---------------KIQQKIVK 363
                  ++K  D WS+G++LY +L+G PPF+G   +                + + I +
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE 255

Query: 364 DKLRLP----AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
            K   P    A +S  A  L+  LL ++  +RL A      ++  H W +
Sbjct: 256 GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA-----AQVLQHPWVQ 300

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  220 bits (562), Expect = 5e-68
 Identities = 74/279 (26%), Positives = 134/279 (48%), Gaps = 33/279 (11%)

Query: 150 EDFEVLK-VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI- 207
           +D+++ K V+G G  G+V +   + T +  A+K++       +        E D   +  
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQAS 79

Query: 208 DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLF--FQLYHHGLFREDLARIYAAEIVS 261
             P +V +   ++  +     L ++++ + GG LF   Q      F E  A     +I +
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 262 AVSHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAP 318
           A+  LH++ I HRD+KPEN+L      D  + LTDFG AK+  +N    +   T  Y+AP
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ-TPCYTPYYVAP 198

Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ----QKIVKDKLRLP----A 370
           E++  + ++K+ D WS+G+++Y +L G PPF       I     ++I   +   P    +
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS 258

Query: 371 FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
            +S +A  L++ LL+ +P +RL        +  +H W  
Sbjct: 259 EVSEDAKQLIRLLLKTDPTERLTI-----TQFMNHPWIN 292

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  219 bits (559), Expect = 6e-68
 Identities = 74/270 (27%), Positives = 130/270 (48%), Gaps = 14/270 (5%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEY-MKAERDILTKI 207
           I  + +  ++G+G++G+V +V    T    A+K+++K K+    + E  +K E  +L ++
Sbjct: 4   IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63

Query: 208 DHPFVVQLK--YSFQTKYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYAAEIVSAVS 264
            H  V+QL      + K ++Y+V+++   G            F    A  Y  +++  + 
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI---GTVEYMAPEIV 321
           +LH+ GI+H+D+KP N+LL   G + ++  G+A+        ++     G+  +  PEI 
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183

Query: 322 LGKG--HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSL 379
            G         D WS G+ LY + TG  PF G N  K+ + I K    +P         L
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDL 243

Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           LKG+L+ EP KR         +I+ H WF+
Sbjct: 244 LKGMLEYEPAKRFSI-----RQIRQHSWFR 268

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  221 bits (564), Expect = 1e-67
 Identities = 78/280 (27%), Positives = 136/280 (48%), Gaps = 32/280 (11%)

Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K+++      +        E ++  + 
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA 111

Query: 208 -DHPFVVQLKYSFQTKY----RLYLVLDFINGGHLF--FQLYHHGLFREDLARIYAAEIV 260
              P +V++   ++  Y     L +V++ ++GG LF   Q      F E  A      I 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171

Query: 261 SAVSHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
            A+ +LH+  I HRD+KPEN+L      +  + LTDFG AK+   +    +   T  Y+A
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231

Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ----KIVKDKLRLPA--- 370
           PE++  + ++K+ D WS+G+++Y +L G PPF   +   I      +I   +   P    
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291

Query: 371 -FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
             +S E   L++ LL+ EP +R+        E  +H W  
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIM 326

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  218 bits (557), Expect = 2e-67
 Identities = 67/281 (23%), Positives = 118/281 (41%), Gaps = 23/281 (8%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +        VG+G+FG V++++ K T    A+K +R +    +        E      + 
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLS 108

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            P +V L  + +    + + ++ + GG L   +   G   ED A  Y  + +  + +LH 
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168

Query: 269 NGIMHRDLKPENILLGADG-HVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPEIV 321
             I+H D+K +N+LL +DG    L DFG A     +         + + GT  +MAPE+V
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228

Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHS 378
           +GK  +   D WS   ++  ML G  P+    R  +  KI  +      +P   +     
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ 288

Query: 379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR 419
            ++  L+KEP  R  A      E++            L++ 
Sbjct: 289 AIQEGLRKEPVHRASA-----MELRRKVGKALQEVGGLKSP 324

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  217 bits (555), Expect = 3e-67
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 28/276 (10%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM---KAERDILT 205
              ++V  ++G G FG VY   + + +   A+K + KD+I +            E  +L 
Sbjct: 42  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101

Query: 206 KIDH--PFVVQLKYSFQTKYRLYLVLDFING-GHLFFQLYHHGLFREDLARIYAAEIVSA 262
           K+      V++L   F+      L+L+       LF  +   G  +E+LAR +  +++ A
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 161

Query: 263 VSHLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMI----GTVEYMA 317
           V H H  G++HRD+K ENIL+  + G + L DFG           +++     GT  Y  
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-----ALLKDTVYTDFDGTRVYSP 216

Query: 318 PEIVLGKG-HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEA 376
           PE +     H ++A  WS+GILLY+M+ G  PF         ++I++ ++     +SSE 
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSEC 270

Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN 412
             L++  L   P  R        EEI++H W + + 
Sbjct: 271 QHLIRWCLALRPSDRPTF-----EEIQNHPWMQDVL 301

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  215 bits (550), Expect = 1e-66
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 30/275 (10%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM---KAERDILT 205
             ++ +  ++G+G FG V+   +       A+KV+ +++++  +          E  +L 
Sbjct: 30  EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89

Query: 206 KID----HPFVVQLKYSFQTKYRLYLVLDF-INGGHLFFQLYHHGLFREDLARIYAAEIV 260
           K+     HP V++L   F+T+    LVL+  +    LF  +   G   E  +R +  ++V
Sbjct: 90  KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149

Query: 261 SAVSHLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMI----GTVEY 315
           +A+ H H+ G++HRD+K ENIL+    G   L DFG           +       GT  Y
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-----ALLHDEPYTDFDGTRVY 204

Query: 316 MAPEIVLGKG-HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSS 374
             PE +     H   A  WS+GILLY+M+ G  PF         Q+I++ +L  PA +S 
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFPAHVSP 258

Query: 375 EAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           +  +L++  L  +P  R        EEI    W +
Sbjct: 259 DCCALIRRCLAPKPSSRPSL-----EEILLDPWMQ 288

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  217 bits (553), Expect = 2e-66
 Identities = 49/306 (16%), Positives = 94/306 (30%), Gaps = 52/306 (16%)

Query: 148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           G    ++++ +  G    V+ VR     E +A+KV        ++  E +        ++
Sbjct: 60  GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARL 119

Query: 208 DHPFVVQLK--------------------------YSFQTKYRLYLVLDFING------G 235
                 + +                                    L++   +        
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFS 179

Query: 236 HLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFG 295
            L F     G        I  A+++   ++L + G++H    P+N+ +  DG +ML D  
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVS 239

Query: 296 LAKQFDENTRSNSMIGTVEYMAPEIVLGKG--HNKAADWWSVGILLYEMLTGKPPFIGGN 353
              +    TR  +    V Y   E +         A + W +G+ +Y +     PF G  
Sbjct: 240 ALWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF-GLV 296

Query: 354 RAKIQQKIVKDKLRLPAF----------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIK 403
              I+    +  LR+P            L     +L+   L  +  +RL        E  
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP-----LEAM 351

Query: 404 SHKWFK 409
               F 
Sbjct: 352 ETPEFL 357

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  206 bits (526), Expect = 1e-61
 Identities = 65/305 (21%), Positives = 124/305 (40%), Gaps = 34/305 (11%)

Query: 132 SIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK 191
           S++++   +  +V  VG   F    V+G GA G +   R    +   A+K +  +     
Sbjct: 6   SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--- 61

Query: 192 NHAEYMKAERDILTKID-HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY--HHGLFR 248
               +   E  +L + D HP V++   + + +   Y+ ++         +          
Sbjct: 62  ---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA--TLQEYVEQKDFAHL 116

Query: 249 EDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH-----VMLTDFGLAKQFDEN 303
                    +  S ++HLH+  I+HRDLKP NIL+           M++DFGL K+    
Sbjct: 117 GLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176

Query: 304 TRS----NSMIGTVEYMAPEIVLG---KGHNKAADWWSVGILLYEMLT-GKPPFIGGNRA 355
             S    + + GT  ++APE++     +      D +S G + Y +++ G  PF    + 
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR 236

Query: 356 KIQQKIVK---DKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN 412
           +    +     D L         A  L++ ++  +P KR  A     + +  H +F  + 
Sbjct: 237 QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSA-----KHVLKHPFFWSLE 291

Query: 413 WKKLE 417
            K+L+
Sbjct: 292 -KQLQ 295

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  205 bits (523), Expect = 4e-61
 Identities = 82/311 (26%), Positives = 136/311 (43%), Gaps = 58/311 (18%)

Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           +++  V  K++G G+ G V   +        A+K M  D        +    E  +LT+ 
Sbjct: 13  LKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFC------DIALMEIKLLTES 65

Query: 208 D-HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAE-------I 259
           D HP V++   S  T   LY+ L+  N   L   +    +  E+L              I
Sbjct: 66  DDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQKEYNPISLLRQI 124

Query: 260 VSAVSHLHANGIMHRDLKPENILL-------------GADGHVMLTDFGLAKQFDEN--- 303
            S V+HLH+  I+HRDLKP+NIL+               +  ++++DFGL K+ D     
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184

Query: 304 --TRSNSMIGTVEYMAPEIVLG-------KGHNKAADWWSVGILLYEMLT-GKPPFIGGN 353
             T  N+  GT  + APE++         +   ++ D +S+G + Y +L+ GK PF  G+
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GD 242

Query: 354 RAKIQQKIVKDKLRLPAF-------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHK 406
           +   +  I++    L          L +EA  L+  ++  +P KR  A      ++  H 
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA-----MKVLRHP 297

Query: 407 WFKPINWKKLE 417
            F P + KKLE
Sbjct: 298 LFWPKS-KKLE 307

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  199 bits (509), Expect = 9e-61
 Identities = 73/264 (27%), Positives = 129/264 (48%), Gaps = 18/264 (6%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
            V+G+G +G VY  R  +     A+K + +       +++ +  E  +   + H  +VQ 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQY 84

Query: 216 KYSFQTKYRLYLVLDFINGG---HLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIM 272
             SF     + + ++ + GG    L    +      E     Y  +I+  + +LH N I+
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144

Query: 273 HRDLKPENILLGA-DGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLG--KGHNK 328
           HRD+K +N+L+    G + ++DFG +K+    N  + +  GT++YMAPEI+    +G+ K
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204

Query: 329 AADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDKLR--LPAFLSSEAHSLLKGLLQ 385
           AAD WS+G  + EM TGKPPF   G       K+   K+   +P  +S+EA + +    +
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFE 264

Query: 386 KEPGKRLGAGPKGSEEIKSHKWFK 409
            +P KR  A      ++   ++ K
Sbjct: 265 PDPDKRACA-----NDLLVDEFLK 283

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  197 bits (504), Expect = 7e-60
 Identities = 74/280 (26%), Positives = 127/280 (45%), Gaps = 53/280 (18%)

Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K+++      +        E ++  + 
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA 67

Query: 208 -DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLF--FQLYHHGLFREDLARIYAAEIV 260
              P +V++   ++  Y     L +V++ ++GG LF   Q      F E  A      I 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127

Query: 261 SAVSHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
            A+ +LH+  I HRD+KPEN+L      +  + LTDFG AK+                  
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------------ 169

Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ----KIVKDKLRLPA--- 370
                G+ ++K+ D WS+G+++Y +L G PPF   +   I      +I   +   P    
Sbjct: 170 ---TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226

Query: 371 -FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
             +S E   L++ LL+ EP +R+        E  +H W  
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIM 261

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  197 bits (502), Expect = 1e-59
 Identities = 75/262 (28%), Positives = 133/262 (50%), Gaps = 10/262 (3%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E F  L+ +G+G+FG V++     T ++ A+K++  ++  ++   E ++ E  +L++ D 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDS 79

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P+V +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 138

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+ +GT  +MAPE++    ++ 
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLLKGLLQKE 387
            AD WS+GI   E+  G+PP    +  K+   I K+    L    S      ++  L KE
Sbjct: 199 KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 258

Query: 388 PGKRLGAGPKGSEEIKSHKWFK 409
           P  R  A     +E+  HK+  
Sbjct: 259 PSFRPTA-----KELLKHKFIL 275

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  191 bits (487), Expect = 6e-57
 Identities = 69/277 (24%), Positives = 110/277 (39%), Gaps = 38/277 (13%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           +G     V +V+ +G F  VY+ +   +   YA+K +  ++   +     +  E   + K
Sbjct: 25  LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKK 81

Query: 207 I-DHPFVVQLKYSF-------QTKYRLYLVLDFINGGHLFFQLY---HHGLFREDLARIY 255
           +  HP +VQ   +         T    +L+L  +  G L   L      G    D     
Sbjct: 82  LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141

Query: 256 AAEIVSAVSHLHANG--IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS----- 308
             +   AV H+H     I+HRDLK EN+LL   G + L DFG A         +      
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201

Query: 309 --------MIGTVEYMAPEIV---LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKI 357
                      T  Y  PEI+         +  D W++G +LY +   + PF  G     
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA---- 257

Query: 358 QQKIVKDKLRLPAFL--SSEAHSLLKGLLQKEPGKRL 392
           + +IV  K  +P      +  HSL++ +LQ  P +RL
Sbjct: 258 KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL 294

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  189 bits (483), Expect = 1e-56
 Identities = 66/246 (26%), Positives = 128/246 (52%), Gaps = 8/246 (3%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
              +    +G+G+ G V   R+K++    A+K+M    + ++   E +  E  I+    H
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQH 101

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
             VV++  S+     L+++++F+ GG L   +       E+        ++ A+++LHA 
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQVRLNEEQIATVCEAVLQALAYLHAQ 160

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           G++HRD+K ++ILL  DG V L+DFG   Q   +  +  S++GT  +MAPE++    +  
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYAT 220

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQ 385
             D WS+GI++ EM+ G+PP+   +  +  +++      KL+    +S      L+ +L 
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV 280

Query: 386 KEPGKR 391
           ++P +R
Sbjct: 281 RDPQER 286

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  189 bits (481), Expect = 1e-56
 Identities = 78/264 (29%), Positives = 134/264 (50%), Gaps = 13/264 (4%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + +   + +GQGA G VY      T +  A++ M    + ++   E +  E  ++ +  +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKN 76

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +V    S+     L++V++++ GG L   +       E        E + A+  LH+N
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHNK 328
            ++HRD+K +NILLG DG V LTDFG   Q   E ++ ++M+GT  +MAPE+V  K +  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQ 385
             D WS+GI+  EM+ G+PP++  N  +    I  +   +L+ P  LS+     L   L+
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255

Query: 386 KEPGKRLGAGPKGSEEIKSHKWFK 409
            +  KR  A     +E+  H++ K
Sbjct: 256 MDVEKRGSA-----KELLQHQFLK 274

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  187 bits (477), Expect = 4e-56
 Identities = 62/264 (23%), Positives = 123/264 (46%), Gaps = 18/264 (6%)

Query: 156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQL 215
             +G+G+F  VY+     T+   A   ++  K+  K+  +  K E ++L  + HP +V+ 
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 216 KYSF----QTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG- 270
             S+    + K  + LV + +  G L   L    + +  + R +  +I+  +  LH    
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150

Query: 271 -IMHRDLKPENILL-GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
            I+HRDLK +NI + G  G V + D GLA     +    ++IGT E+MAPE +  + +++
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPE-MYEEKYDE 208

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLKGLLQ 385
           + D ++ G+ + EM T + P+     A    + V               E   +++G ++
Sbjct: 209 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268

Query: 386 KEPGKRLGAGPKGSEEIKSHKWFK 409
           +   +R        +++ +H +F+
Sbjct: 269 QNKDERYSI-----KDLLNHAFFQ 287

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  185 bits (471), Expect = 1e-54
 Identities = 65/334 (19%), Positives = 116/334 (34%), Gaps = 79/334 (23%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKV-------MRKDKIVEK-------NHAE 195
            DFE ++ +G+G FG V++ + K     YA+K        + ++K++ +        H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 196 YMKA-----------------------------------------ERDILTKIDHPFVVQ 214
            ++                                          +   +        V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 215 LKYSFQTKYRLYLVLDFINGGHLFFQL---YHHGLFREDLARIYAAEIVSAVSHLHANGI 271
                  K  LY+ +      +L   +            +      +I  AV  LH+ G+
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQFD-------------ENTRSNSMIGTVEYMAP 318
           MHRDLKP NI    D  V + DFGL    D                     +GT  YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 319 EIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAH 377
           E + G  ++   D +S+G++L+E+L      +   R +I   +   K   L      + H
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--ERVRIITDVRNLKFPLLFTQKYPQEH 303

Query: 378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
            +++ +L   P +R  A      +I  +  F+ +
Sbjct: 304 MMVQDMLSPSPTERPEA-----TDIIENAIFENL 332

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  184 bits (468), Expect = 2e-54
 Identities = 82/265 (30%), Positives = 130/265 (49%), Gaps = 15/265 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E F+VL+ +G+G++G VY+   K T +I A+K +     VE +  E +K E  I+ + D 
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIK-EISIMQQCDS 83

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           P VV+   S+     L++V+++   G +       +    ED         +  + +LH 
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGHN 327
              +HRD+K  NILL  +GH  L DFG+A Q  D   + N++IGT  +MAPE++   G+N
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 203

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLL 384
             AD WS+GI   EM  GKPP+   +  +    I  +     R P   S      +K  L
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCL 263

Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFK 409
            K P +R  A      ++  H + +
Sbjct: 264 VKSPEQRATA-----TQLLQHPFVR 283

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  183 bits (466), Expect = 3e-54
 Identities = 81/270 (30%), Positives = 136/270 (50%), Gaps = 18/270 (6%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E +E++  +G GAFG+VY+ + K T  + A KV+   +   +   E    E +IL   DH
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATCDH 75

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           P++V+L  ++    +L+++++F  GG +    L       E   ++   +++ A++ LH+
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVL----- 322
             I+HRDLK  N+L+  +G + L DFG++ +      + +S IGT  +MAPE+V+     
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195

Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSL 379
              ++  AD WS+GI L EM   +PP    N  ++  KI K     L  P+  S E    
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255

Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           LK  L K P  R  A      ++  H +  
Sbjct: 256 LKIALDKNPETRPSA-----AQLLEHPFVS 280

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  182 bits (465), Expect = 4e-54
 Identities = 73/276 (26%), Positives = 128/276 (46%), Gaps = 22/276 (7%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEY--MKAERDIL 204
             I D E L  +G G  G+V+++R + T  + A+K MR       N  E   +  + D++
Sbjct: 22  AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR----RSGNKEENKRILMDLDVV 77

Query: 205 TK-IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV 263
            K  D P++VQ   +F T   +++ ++ +       +    G   E +       IV A+
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKAL 137

Query: 264 SHLHA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV- 321
            +L   +G++HRD+KP NILL   G + L DFG++ +  ++   +   G   YMAPE + 
Sbjct: 138 YYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERID 197

Query: 322 ----LGKGHNKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKD---KLRLPAFLS 373
                   ++  AD WS+GI L E+ TG+ P+       ++  K++++    L      S
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS 257

Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
            +  S +K  L K+  KR         ++  H + K
Sbjct: 258 GDFQSFVKDCLTKDHRKRPKY-----NKLLEHSFIK 288

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  182 bits (463), Expect = 2e-53
 Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 15/266 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + F  L+ +G G+FG VY  R    SE+ A+K M           + +  E   L K+ H
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P  +Q +  +  ++  +LV+++  G        H    +E          +  +++LH++
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG---KGH 326
            ++HRD+K  NILL   G V L DFG A        +NS +GT  +MAPE++L      +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVILAMDEGQY 230

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGL 383
           +   D WS+GI   E+   KPP    N       I ++    L+   + S    + +   
Sbjct: 231 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-SEYFRNFVDSC 289

Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFK 409
           LQK P  R  +     E +  H++  
Sbjct: 290 LQKIPQDRPTS-----EVLLKHRFVL 310

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  176 bits (449), Expect = 8e-52
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 32/285 (11%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D+E+ +V+G GA   V         E  A+K +  +K       + +  E   +++  H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHH 72

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGG--------HLFFQLYHHGLFREDLARIYAAEIVS 261
           P +V    SF  K  L+LV+  ++GG         +    +  G+  E        E++ 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ------FDENTRSNSMIGTVEY 315
            + +LH NG +HRD+K  NILLG DG V + DFG++           N    + +GT  +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 316 MAPEIVL-GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAF 371
           MAPE++   +G++  AD WS GI   E+ TG  P+      K+    +++    L     
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252

Query: 372 -------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
                         ++   LQK+P KR  A      E+  HK+F+
Sbjct: 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTA-----AELLRHKFFQ 292

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  176 bits (448), Expect = 2e-51
 Identities = 76/278 (27%), Positives = 133/278 (47%), Gaps = 28/278 (10%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-D 208
             FE++++VG G +G+VY+ R   T ++ A+KVM     V  +  E +K E ++L K   
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79

Query: 209 HPFVVQLKYSF------QTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIV 260
           H  +     +F          +L+LV++F   G +    +       +E+       EI+
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139

Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSNSMIGTVEYMAPE 319
             +SHLH + ++HRD+K +N+LL  +  V L DFG++ Q D    R N+ IGT  +MAPE
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199

Query: 320 IVLGK-----GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAF 371
           ++         ++  +D WS+GI   EM  G PP    +  +    I ++   +L+    
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK-SKK 258

Query: 372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
            S +  S ++  L K   +R        E++  H + +
Sbjct: 259 WSKKFQSFIESCLVKNHSQRPAT-----EQLMKHPFIR 291

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  173 bits (441), Expect = 9e-51
 Identities = 70/276 (25%), Positives = 130/276 (47%), Gaps = 27/276 (9%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI---LTK 206
           +D E +  +G+GA+G V ++R   + +I A+K +R       N  E  +   D+   +  
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR----ATVNSQEQKRLLMDLDISMRT 62

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFF---QLYHHGLFRED-LARIYAAEIVSA 262
           +D PF V    +   +  +++ ++ ++     F    +       ED L +I A  IV A
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI-AVSIVKA 121

Query: 263 VSHLHANG-IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           + HLH+   ++HRD+KP N+L+ A G V + DFG++    ++   +   G   YMAPE +
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181

Query: 322 LGKGHNKA----ADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKD---KLRLPAFLS 373
             + + K     +D WS+GI + E+   + P+   G   +  +++V++   +L    F S
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF-S 240

Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           +E        L+K   +R         E+  H +F 
Sbjct: 241 AEFVDFTSQCLKKNSKERPTY-----PELMQHPFFT 271

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  174 bits (443), Expect = 1e-50
 Identities = 72/282 (25%), Positives = 128/282 (45%), Gaps = 29/282 (10%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--- 203
              ED + L  +G+GA+G V ++  K + +I A+K +R       +  E  +   D+   
Sbjct: 19  FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR----STVDEKEQKQLLMDLDVV 74

Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFF----QLYHHGLFRED-LARIYAAE 258
           +   D P++VQ   +   +   ++ ++ ++     F          +  E+ L +I    
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKI-TLA 133

Query: 259 IVSAVSHLHANG-IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
            V A++HL  N  I+HRD+KP NILL   G++ L DFG++ Q  ++       G   YMA
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMA 193

Query: 318 PEIV----LGKGHNKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDKL-RLPAF 371
           PE +      +G++  +D WS+GI LYE+ TG+ P+    +      ++VK    +L   
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS 253

Query: 372 L----SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
                S    + +   L K+  KR        +E+  H +  
Sbjct: 254 EEREFSPSFINFVNLCLTKDESKRPKY-----KELLKHPFIL 290

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  175 bits (445), Expect = 1e-50
 Identities = 67/281 (23%), Positives = 129/281 (45%), Gaps = 15/281 (5%)

Query: 126 KEIDESSIDENVKGDS-------VTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIY 178
           K+++E  +DE  +            V  +  +DFE +  +G G  G V++V  K +  + 
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61

Query: 179 AMKVMRKDKIVEKNHAEY--MKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGH 236
           A K++     +E   A    +  E  +L + + P++V    +F +   + + ++ ++GG 
Sbjct: 62  ARKLIH----LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117

Query: 237 LFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG-IMHRDLKPENILLGADGHVMLTDFG 295
           L   L   G   E +    +  ++  +++L     IMHRD+KP NIL+ + G + L DFG
Sbjct: 118 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 177

Query: 296 LAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA 355
           ++ Q   ++ +NS +GT  YM+PE + G  ++  +D WS+G+ L EM  G+ P    +  
Sbjct: 178 VSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236

Query: 356 KIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGP 396
           +++           A       +  + L +     R     
Sbjct: 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  165 bits (419), Expect = 2e-47
 Identities = 72/247 (29%), Positives = 112/247 (45%), Gaps = 9/247 (3%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           + + ++VG+G  G VY+        I A+K+M +    +      M+ E     ++  P 
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 212 VVQLKYSF-QTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG 270
           VV + + F +   +LY+ +  ING  L   L   G      A     +I SA+   HA G
Sbjct: 96  VVPI-HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154

Query: 271 IMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNK 328
             HRD+KPENIL+ AD    L DFG+A    +   T+  + +GT+ YMAPE         
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATY 214

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSL----LKGLL 384
            AD +++  +LYE LTG PP+ G   + +   I +   R          +      +G +
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARG-M 273

Query: 385 QKEPGKR 391
            K P  R
Sbjct: 274 AKNPEDR 280

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  164 bits (417), Expect = 4e-47
 Identities = 60/252 (23%), Positives = 122/252 (48%), Gaps = 15/252 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
            D  + + +G G+FG V++     +    A+K++ +     +   E+++ E  I+ ++ H
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEWHGS--DVAVKILMEQDFHAERVNEFLR-EVAIMKRLRH 93

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFRE---DLARIYAAEIVSAVSHL 266
           P +V    +      L +V ++++ G L+  L+  G   +         A ++   +++L
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 267 HANG--IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-NSMIGTVEYMAPEIVLG 323
           H     I+HR+LK  N+L+     V + DFGL++       S  S  GT E+MAPE++  
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213

Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL 383
           +  N+ +D +S G++L+E+ T + P+   N A++   +     RL   +    +  +  +
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--IPRNLNPQVAAI 271

Query: 384 LQK----EPGKR 391
           ++     EP KR
Sbjct: 272 IEGCWTNEPWKR 283

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  163 bits (416), Expect = 6e-47
 Identities = 74/306 (24%), Positives = 119/306 (38%), Gaps = 51/306 (16%)

Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI-- 203
            +    +E +  +G GA+G VY+ R  ++    A+K +R            +   R++  
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 204 ---LTKIDHPFVVQLK-----YSFQTKYRLYLVLDFINGGH---LFFQLYHHGLFREDLA 252
              L   +HP VV+L           + ++ LV + ++       +           +  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--QDLRTYLDKAPPPGLPAETI 122

Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT 312
           +    + +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +        ++ T
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 182

Query: 313 VEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK------- 363
           + Y APE++L   +    D WSVG +  EM   KP F G +  +  Q  KI         
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--EADQLGKIFDLIGLPPE 240

Query: 364 ------DKLRLPAF--------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIK 403
                   L   AF              +      LL  +L   P KR+ A         
Sbjct: 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA-----FRAL 295

Query: 404 SHKWFK 409
            H +  
Sbjct: 296 QHSYLH 301

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  163 bits (415), Expect = 7e-47
 Identities = 69/254 (27%), Positives = 126/254 (49%), Gaps = 25/254 (9%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ++ EV +VVG+GAFG V + + +      A+K +  +   +     ++  E   L++++H
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAK--DVAIKQIESESERK----AFIV-ELRQLSRVNH 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG---LFREDLARIYAAEIVSAVSHL 266
           P +V+L  +      + LV+++  GG L+  L+       +    A  +  +    V++L
Sbjct: 61  PNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118

Query: 267 HA---NGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           H+     ++HRDLKP N+LL A G V+ + DFG A   D  T   +  G+  +MAPE+  
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFE 176

Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ-QKIVKDKLRLPAFLSSEAHSLLK 381
           G  +++  D +S GI+L+E++T + PF        +    V +  R P  L       ++
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP--LIKNLPKPIE 234

Query: 382 GLLQ----KEPGKR 391
            L+     K+P +R
Sbjct: 235 SLMTRCWSKDPSQR 248

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  163 bits (414), Expect = 2e-46
 Identities = 88/316 (27%), Positives = 141/316 (44%), Gaps = 51/316 (16%)

Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK--AERDI 203
              +E +E L +VG+G++G V + R K+T  I A+K     K +E +  + +K  A R+I
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREI 75

Query: 204 --LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
             L ++ H  +V L    + K R YLV +F++   L             + + Y  +I++
Sbjct: 76  KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN 135

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS-MIGTVEYMAPEI 320
            +   H++ I+HRD+KPENIL+   G V L DFG A+            + T  Y APE+
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195

Query: 321 VLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK-------------- 363
           ++G     KA D W++G L+ EM  G+P F G +   I Q   I+               
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS--DIDQLYHIMMCLGNLIPRHQELFN 253

Query: 364 -----DKLRLPAF------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHK 406
                  +RLP              LS     L K  L  +P KR         E+  H 
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC-----AELLHHD 308

Query: 407 WFKPINWKKLEAREIQ 422
           +F+   + +  ++E+Q
Sbjct: 309 FFQMDGFAERFSQELQ 324

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  161 bits (409), Expect = 6e-46
 Identities = 78/311 (25%), Positives = 139/311 (44%), Gaps = 47/311 (15%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKI 207
           E +E +  +G+G++G V++ R ++T +I A+K   + +  +    + + A R+I  L ++
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKI-ALREIRMLKQL 59

Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
            HP +V L   F+ K RL+LV ++ +   L     +     E L +    + + AV+  H
Sbjct: 60  KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS-MIGTVEYMAPEIVLGKGH 326
            +  +HRD+KPENIL+     + L DFG A+     +      + T  Y +PE+++G   
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179

Query: 327 -NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK-----------DKLRLPAF- 371
                D W++G +  E+L+G P + G  ++ + Q   I K                  F 
Sbjct: 180 YGPPVDVWAIGCVFAELLSGVPLWPG--KSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237

Query: 372 -------------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN 412
                              +S  A  LLKG L  +P +RL       E++  H +F+ I 
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC-----EQLLHHPYFENIR 292

Query: 413 WKKLEAREIQP 423
             +  A+E   
Sbjct: 293 EIEDLAKEHDK 303

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  163 bits (413), Expect = 9e-46
 Identities = 55/320 (17%), Positives = 105/320 (32%), Gaps = 66/320 (20%)

Query: 150 EDFEVLKVVGQGA--FGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
             +E+L V+G+G      V   R K T E   ++ +  +         +++ E  +    
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLF 83

Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLF--FQLYHHGLFREDLARIYAAEIVSAVSH 265
           +HP +V  + +F     L++V  F+  G        +      E         ++ A+ +
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDENTRSNSM-------IGTVEYMA 317
           +H  G +HR +K  +IL+  DG V L+             R   +       +  + +++
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203

Query: 318 PEIV--LGKGHNKAADWWSVGILLYEMLTGKPPF-------------------------- 349
           PE++    +G++  +D +SVGI   E+  G  PF                          
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263

Query: 350 --------------------IGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPG 389
                                                      S   H  ++  LQ+ P 
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD 323

Query: 390 KRLGAGPKGSEEIKSHKWFK 409
            R  A       + +H +FK
Sbjct: 324 ARPSA-----STLLNHSFFK 338

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  157 bits (398), Expect = 1e-44
 Identities = 58/262 (22%), Positives = 116/262 (44%), Gaps = 26/262 (9%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYM----KAERDILT 205
            + E  K +G+G FG V++ R      + A+K +       +          + E  I++
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL-FREDLARIYAAEIVSAVS 264
            ++HP +V+L Y         +V++F+  G L+ +L       +  +      +I   + 
Sbjct: 79  NLNHPNIVKL-YGLMHN-PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136

Query: 265 HLHANG--IMHRDLKPENILLGADG-----HVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           ++      I+HRDL+  NI L +          + DFGL++        + ++G  ++MA
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMA 194

Query: 318 PEIVLGKG--HNKAADWWSVGILLYEMLTGKPPFIG--GNRAKIQQKIVKDKLRLPAFLS 373
           PE +  +   + + AD +S  ++LY +LTG+ PF      + K    I ++ LR    + 
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT--IP 252

Query: 374 SEAHSLLKGLLQK----EPGKR 391
            +    L+ +++     +P KR
Sbjct: 253 EDCPPRLRNVIELCWSGDPKKR 274

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  156 bits (397), Expect = 2e-44
 Identities = 67/250 (26%), Positives = 123/250 (49%), Gaps = 13/250 (5%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           ++++  +G G    VY       +   A+K +      ++   +  + E    +++ H  
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 212 VVQLKYSF-QTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG 270
           +V +     +     YLV+++I G  L   +  HG    D A  +  +I+  + H H   
Sbjct: 73  IVSM-IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131

Query: 271 IMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNK 328
           I+HRD+KP+NIL+ ++  + + DFG+AK   E   T++N ++GTV+Y +PE   G+  ++
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL----- 383
             D +S+GI+LYEML G+PPF G     I  K ++D   +P   +     + + L     
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS--VPNVTTDVRKDIPQSLSNVIL 249

Query: 384 --LQKEPGKR 391
              +K+   R
Sbjct: 250 RATEKDKANR 259

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  164 bits (416), Expect = 3e-44
 Identities = 62/250 (24%), Positives = 104/250 (41%), Gaps = 29/250 (11%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSE-IYAMKVMRKDKIVEKNHAEYMK---AERDILTKI 207
           +EV   +  G  G +Y    +N +     +K +          AE      AER  L ++
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-----GDAEAQAMAMAERQFLAEV 136

Query: 208 DHPFVVQLKYSF------QTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
            HP +VQ+ ++F            Y+V++++ G  L  +           A  Y  EI+ 
Sbjct: 137 VHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQKLPVAEAIAYLLEILP 193

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           A+S+LH+ G+++ DLKPENI+L  +  + L D G   +         + GT  + APEIV
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI---NSFGYLYGTPGFQAPEIV 249

Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLK 381
              G   A D ++VG  L  +    P   G     + +      L+           LL+
Sbjct: 250 RT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDP--VLKTYDSY----GRLLR 302

Query: 382 GLLQKEPGKR 391
             +  +P +R
Sbjct: 303 RAIDPDPRQR 312

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  154 bits (392), Expect = 7e-44
 Identities = 71/258 (27%), Positives = 123/258 (47%), Gaps = 22/258 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE-KNHAEYMKAERDILTKID 208
            +  + +++G G FG+VY+          A+K  R D   +     E ++ E  +   + 
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP ++ L+     +  L LV++F  GG L  ++        D+   +A +I   +++LH 
Sbjct: 65  HPNIIALRGVCLKEPNLCLVMEFARGGPLN-RVLSGKRIPPDILVNWAVQIARGMNYLHD 123

Query: 269 NG---IMHRDLKPENILLGADGH--------VMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
                I+HRDLK  NIL+             + +TDFGLA+++   T+  S  G   +MA
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGAYAWMA 182

Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAH 377
           PE++     +K +D WS G+LL+E+LTG+ PF G +   +   +  +KL LP  + S   
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP--IPSTCP 240

Query: 378 SLLKGLLQK----EPGKR 391
                L++     +P  R
Sbjct: 241 EPFAKLMEDCWNPDPHSR 258

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  156 bits (396), Expect = 7e-44
 Identities = 75/313 (23%), Positives = 126/313 (40%), Gaps = 67/313 (21%)

Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVR-KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI- 203
           C   + +E +  +G+GA+G+V++ R  KN     A+K +R      +     +   R++ 
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT--GEEGMP-LSTIREVA 63

Query: 204 ----LTKIDHPFVVQLK-----YSFQTKYRLYLVLDFI---------NGGHLFFQLYHHG 245
               L   +HP VV+L           + +L LV + +                      
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVP----- 118

Query: 246 LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR 305
               +  +    +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +     
Sbjct: 119 ---TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175

Query: 306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK 363
             S++ T+ Y APE++L   +    D WSVG +  EM   KP F G +   + Q  KI+ 
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILD 233

Query: 364 -------------DKLRLPAF--------------LSSEAHSLLKGLLQKEPGKRLGAGP 396
                          L   AF              +      LL   L   P KR+ A  
Sbjct: 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-- 291

Query: 397 KGSEEIKSHKWFK 409
                  SH +F+
Sbjct: 292 ---YSALSHPYFQ 301

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  154 bits (391), Expect = 8e-44
 Identities = 50/254 (19%), Positives = 107/254 (42%), Gaps = 18/254 (7%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
            +    L  + +   G +++ R +   +I  +KV++      +   ++ + E   L    
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQGN-DI-VVKVLKVRDWSTRKSRDFNE-ECPRLRIFS 65

Query: 209 HPFVVQLK--YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVS 264
           HP V+ +             L+  ++  G L+  L+    F  D ++   +A ++   ++
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125

Query: 265 HLHA--NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
            LH     I    L   ++++  D    ++   +   F    R    +    ++APE + 
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR----MYAPAWVAPEALQ 181

Query: 323 GKGHN---KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAFLSSEAH 377
            K  +   ++AD WS  +LL+E++T + PF   +  +I  K+  + LR   P  +S    
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVS 241

Query: 378 SLLKGLLQKEPGKR 391
            L+K  + ++P KR
Sbjct: 242 KLMKICMNEDPAKR 255

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  156 bits (396), Expect = 1e-43
 Identities = 80/305 (26%), Positives = 128/305 (41%), Gaps = 61/305 (20%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTK 206
            + +E L  +G+G F  VY+ R KNT++I A+K ++     E        A R+I  L +
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL----------FREDLARIYA 256
           + HP ++ L  +F  K  + LV DF+             L                + Y 
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFM----------ETDLEVIIKDNSLVLTPSHIKAYM 118

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS-MIGTVEY 315
              +  + +LH + I+HRDLKP N+LL  +G + L DFGLAK F    R+ +  + T  Y
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWY 178

Query: 316 MAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK--------- 363
            APE++ G + +    D W+VG +L E+L   P   G   + + Q  +I +         
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG--DSDLDQLTRIFETLGTPTEEQ 236

Query: 364 --DKLRLPAF-----------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS 404
             D   LP +                    +   L++GL    P  R+ A      +   
Sbjct: 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-----TQALK 291

Query: 405 HKWFK 409
            K+F 
Sbjct: 292 MKYFS 296

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  155 bits (394), Expect = 1e-43
 Identities = 73/315 (23%), Positives = 133/315 (42%), Gaps = 72/315 (22%)

Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD--- 202
              I+ +  +  +G+G +G VY+     T+E  A+K +R            ++ E +   
Sbjct: 30  ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------------LEHEEEGVP 77

Query: 203 --------ILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGH-LFFQLYHHGLFREDLAR 253
                   +L ++ H  +++LK      +RL+L+ ++    + L   +  +      + +
Sbjct: 78  GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE--NDLKKYMDKNPDVSMRVIK 135

Query: 254 IYAAEIVSAVSHLHANGIMHRDLKPENILL-----GADGHVMLTDFGLAKQFDENTRSNS 308
            +  ++++ V+  H+   +HRDLKP+N+LL          + + DFGLA+ F    R  +
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195

Query: 309 M-IGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK- 363
             I T+ Y  PEI+LG + ++ + D WS+  +  EML   P F G +  +I Q  KI + 
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS--EIDQLFKIFEV 253

Query: 364 ------------DKL-----------------RLPAFLSSEAHSLLKGLLQKEPGKRLGA 394
                         L                  L A L  E   LL  +L+ +P KR+ A
Sbjct: 254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA 313

Query: 395 GPKGSEEIKSHKWFK 409
                +    H +F 
Sbjct: 314 -----KNALEHPYFS 323

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  154 bits (391), Expect = 3e-43
 Identities = 78/314 (24%), Positives = 133/314 (42%), Gaps = 72/314 (22%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAE-------- 200
              F+ L+ +G G +  VY+   K T    A+K ++            + +E        
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK------------LDSEEGTPSTAI 51

Query: 201 RDI--LTKIDHPFVVQLKYSFQTKYRLYLVLDFIN---GGHL--FFQLYHHGLFREDLAR 253
           R+I  + ++ H  +V+L     T+ +L LV +F++     ++              +L +
Sbjct: 52  REISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111

Query: 254 IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS-MIGT 312
            +  +++  ++  H N I+HRDLKP+N+L+   G + L DFGLA+ F     + S  + T
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT 171

Query: 313 VEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK------ 363
           + Y AP++++G + ++ + D WS G +L EM+TGKP F G N    +Q   I        
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN--DEEQLKLIFDIMGTPN 229

Query: 364 -----DKLRLPAF-----------------------LSSEAHSLLKGLLQKEPGKRLGAG 395
                   +LP +                       L       L GLLQ  P  RL A 
Sbjct: 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA- 288

Query: 396 PKGSEEIKSHKWFK 409
               ++   H WF 
Sbjct: 289 ----KQALHHPWFA 298

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  153 bits (389), Expect = 3e-43
 Identities = 65/255 (25%), Positives = 116/255 (45%), Gaps = 18/255 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
               V + +G G+FG VY+ +        A+K++       +    + K E  +L K  H
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAF-KNEVGVLRKTRH 79

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLARIYAAEIVSAVSHLHA 268
             ++     + T  +L +V  +  G  L+  L+     F        A +    + +LHA
Sbjct: 80  VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM---IGTVEYMAPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA +    + S+      G++ +MAPE++  + 
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 326 HNK---AADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDKLR-----LPAFLSSEA 376
            N     +D ++ GI+LYE++TG+ P+    NR +I + + +  L      + +      
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258

Query: 377 HSLLKGLLQKEPGKR 391
             L+   L+K+  +R
Sbjct: 259 KRLMAECLKKKRDER 273

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  154 bits (391), Expect = 4e-43
 Identities = 73/311 (23%), Positives = 130/311 (41%), Gaps = 69/311 (22%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAE-------- 200
           +E +  L  +G+G +  VY+ + K T  + A+K +R            ++ E        
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR------------LEHEEGAPCTAI 48

Query: 201 RDI--LTKIDHPFVVQLKYSFQTKYRLYLVLDFIN---GGHLFFQLYHHGLFREDLARIY 255
           R++  L  + H  +V L     T+  L LV ++++     +L        +      +++
Sbjct: 49  REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYL---DDCGNIINMHNVKLF 105

Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS-MIGTVE 314
             +++  +++ H   ++HRDLKP+N+L+   G + L DFGLA+     T++    + T+ 
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW 165

Query: 315 YMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK-------- 363
           Y  P+I+LG   ++   D W VG + YEM TG+P F G      +Q   I +        
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST--VEEQLHFIFRILGTPTEE 223

Query: 364 -----------DKLRLPAF-----------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEE 401
                           P +           L S+   LL  LLQ E   R+ A     E+
Sbjct: 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA-----ED 278

Query: 402 IKSHKWFKPIN 412
              H +F  + 
Sbjct: 279 AMKHPFFLSLG 289

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  153 bits (388), Expect = 6e-43
 Identities = 68/252 (26%), Positives = 128/252 (50%), Gaps = 12/252 (4%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +E+ +++G G    V+  R        A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 212 VVQL----KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           +V +    +         Y+V+++++G  L   ++  G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEYMAPEIVLG 323
            NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++IGT +Y++PE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSL 379
              +  +D +S+G +LYE+LTG+PPF G +   +  + V++    P      LS++  ++
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 253

Query: 380 LKGLLQKEPGKR 391
           +   L K P  R
Sbjct: 254 VLKALAKNPENR 265

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  152 bits (387), Expect = 6e-43
 Identities = 76/311 (24%), Positives = 139/311 (44%), Gaps = 70/311 (22%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD------ 202
           +E +  L+ +G+G +G VY+ +     E +A+K +R            ++ E +      
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR------------LEKEDEGIPSTT 47

Query: 203 -----ILTKIDHPFVVQLKYSFQTKYRLYLVLDFIN---GGHLFFQLYHHGLFREDLARI 254
                IL ++ H  +V+L     TK RL LV + ++      L       G      A+ 
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKS 104

Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS-MIGTV 313
           +  ++++ +++ H   ++HRDLKP+N+L+  +G + + DFGLA+ F    R  +  I T+
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL 164

Query: 314 EYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK------- 363
            Y AP++++G K ++   D WSVG +  EM+ G P F G +  +  Q  +I +       
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNS 222

Query: 364 ----DKLRLPAF------------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEE 401
               +   LP +                  L      LL  +L+ +P +R+ A     ++
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-----KQ 277

Query: 402 IKSHKWFKPIN 412
              H +FK  N
Sbjct: 278 ALEHAYFKENN 288

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  152 bits (387), Expect = 1e-42
 Identities = 82/312 (26%), Positives = 140/312 (44%), Gaps = 71/312 (22%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD------ 202
           +E ++ L+ VG+G +G VY+ +      I A+K +R            + AE +      
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR------------LDAEDEGIPSTA 66

Query: 203 -----ILTKIDHPFVVQLKYSFQTKYRLYLVLDFIN---GGHLFFQLYHHGLFREDLARI 254
                +L ++ HP +V L     ++  L LV +F+       L     +    ++   +I
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVL---DENKTGLQDSQIKI 123

Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS-MIGTV 313
           Y  +++  V+H H + I+HRDLKP+N+L+ +DG + L DFGLA+ F    RS +  + T+
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL 183

Query: 314 EYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK------- 363
            Y AP++++G K ++ + D WS+G +  EM+TGKP F G       Q  KI         
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT--DDDQLPKIFSILGTPNP 241

Query: 364 ------------DKLRLPAF-----------LSSEAHSLLKGLLQKEPGKRLGAGPKGSE 400
                        +     F              E   LL  +L  +P KR+ A      
Sbjct: 242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA-----R 296

Query: 401 EIKSHKWFKPIN 412
           +  +H +FK ++
Sbjct: 297 DAMNHPYFKDLD 308

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  150 bits (381), Expect = 4e-42
 Identities = 70/311 (22%), Positives = 137/311 (44%), Gaps = 68/311 (21%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD------ 202
           ++ +E L+ +G+G +G V++ + + T EI A+K +R            +  + +      
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------------LDDDDEGVPSSA 48

Query: 203 -----ILTKIDHPFVVQLKYSFQTKYRLYLVLDFING--GHLFFQLYHHGLFREDLARIY 255
                +L ++ H  +V+L     +  +L LV +F +      F     +G    ++ + +
Sbjct: 49  LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSF 106

Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS-MIGTVE 314
             +++  +   H+  ++HRDLKP+N+L+  +G + L +FGLA+ F    R  S  + T+ 
Sbjct: 107 LFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW 166

Query: 315 YMAPEIVLG-KGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQ--KIVK------- 363
           Y  P+++ G K ++ + D WS G +  E+   G+P F G +     Q  +I +       
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTE 224

Query: 364 ----DKLRLPAF------------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEE 401
                  +LP +                  L++    LL+ LL+  P +R+ A     EE
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-----EE 279

Query: 402 IKSHKWFKPIN 412
              H +F    
Sbjct: 280 ALQHPYFSDFC 290

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  151 bits (384), Expect = 7e-42
 Identities = 83/336 (24%), Positives = 134/336 (39%), Gaps = 68/336 (20%)

Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI-- 203
           C  +  +E L  +GQG FG V++ R + T +  A+K +  +   EK       A R+I  
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPIT-ALREIKI 69

Query: 204 LTKIDHPFVVQLK--------YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI- 254
           L  + H  VV L            + K  +YLV DF    H    L  + L +  L+ I 
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--HDLAGLLSNVLVKFTLSEIK 127

Query: 255 -YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTV 313
                +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F     S     T 
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 314 E-----YMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK-- 363
                 Y  PE++LG + +    D W  G ++ EM T  P   G    +  Q   I +  
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG--NTEQHQLALISQLC 245

Query: 364 -----------------DKLRLP-------------AFLSSEAHSLLKGLLQKEPGKRLG 393
                            +KL L                    A  L+  LL  +P +R+ 
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305

Query: 394 AGPKGSEEIKSHKWFK----PINWKKLEAREIQPGF 425
           +     ++  +H +F     P + K + +  +   F
Sbjct: 306 S-----DDALNHDFFWSDPMPSDLKGMLSTHLTSMF 336

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  152 bits (386), Expect = 1e-41
 Identities = 82/303 (27%), Positives = 138/303 (45%), Gaps = 58/303 (19%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +   KV+G G+FG VYQ +  ++ E+ A+K     K+       +   E  I+ K+DH  
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK-----KV--LQDKRFKNRELQIMRKLDHCN 108

Query: 212 VVQLKYSFQTKYR------LYLVLDFINGGHLFFQLYHHGLFR----EDLARIYAAEIVS 261
           +V+L+Y F +         L LVLD++    ++    H+   +        ++Y  ++  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
           +++++H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE+
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 227

Query: 321 VLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK-------------- 363
           + G   +  + D WS G +L E+L G+P F G   + + Q  +I+K              
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTREQIREMN 285

Query: 364 ---DKLRLPAF------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
               + + P                 EA +L   LL+  P  RL        E  +H +F
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP-----LEACAHSFF 340

Query: 409 KPI 411
             +
Sbjct: 341 DEL 343

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  146 bits (371), Expect = 2e-40
 Identities = 57/263 (21%), Positives = 111/263 (42%), Gaps = 26/263 (9%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
            D    +V+G+G FG+  +V  + T E+  MK + +    ++        E  ++  ++H
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEH 66

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLARIYAAEIVSAVSHLHA 268
           P V++         RL  + ++I GG L   +      +       +A +I S +++LH+
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT---------------RSNSMIGTV 313
             I+HRDL   N L+  + +V++ DFGLA+   +                 +  +++G  
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN-RAKIQQKIVKDKLRLPAFL 372
            +MAPE++ G+ +++  D +S GI+L E++           R       V+  L      
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC-- 244

Query: 373 SSEAHSLLKGLL----QKEPGKR 391
                     +       +P KR
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKR 267

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  146 bits (370), Expect = 3e-40
 Identities = 59/260 (22%), Positives = 109/260 (41%), Gaps = 23/260 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  E+ +++G+G FG+VY  R        A++++  ++  E     + K E     +  H
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAF-KREVMAYRQTRH 88

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL-FREDLARIYAAEIVSAVSHLHA 268
             VV    +  +   L ++     G  L+  +    +    +  R  A EIV  + +LHA
Sbjct: 89  ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAK---QFDENTRSNSM---IGTVEYMAPEIV- 321
            GI+H+DLK +N+    +G V++TDFGL           R + +    G + ++APEI+ 
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207

Query: 322 --------LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAF 371
                        +K +D +++G + YE+   + PF       I  ++            
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIG 267

Query: 372 LSSEAHSLLKGLLQKEPGKR 391
           +  E   +L      E  +R
Sbjct: 268 MGKEISDILLFCWAFEQEER 287

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  147 bits (374), Expect = 4e-40
 Identities = 79/303 (26%), Positives = 136/303 (44%), Gaps = 59/303 (19%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +   KV+G G+FG V+Q +   + E+ A+K + +DK        +   E  I+  + HP 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDK-------RFKNRELQIMRIVKHPN 93

Query: 212 VVQLKYSFQT------KYRLYLVLDFINGGHLFFQLYHHGLFR----EDLARIYAAEIVS 261
           VV LK  F +      +  L LVL+++    ++    H+   +      L ++Y  +++ 
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
           +++++H+ GI HRD+KP+N+LL     V+ L DFG AK       + S I +  Y APE+
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPEL 212

Query: 321 VLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK-------------- 363
           + G   +    D WS G ++ E++ G+P F G +   I Q  +I+K              
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES--GIDQLVEIIKVLGTPSREQIKTMN 270

Query: 364 ---DKLRLPAF------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
               + + P                 +A  L+  LL+  P  RL A      E   H +F
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA-----IEALCHPFF 325

Query: 409 KPI 411
             +
Sbjct: 326 DEL 328

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  141 bits (357), Expect = 1e-38
 Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 56/292 (19%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKI 207
            D  +L+ VG+G +G V++   +   E  A+K+            +    E ++     +
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQG--ENVAVKIFSSR------DEKSWFRETELYNTVML 59

Query: 208 DHPFVVQL----KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV 263
            H  ++        S  +  +L+L+  +   G L+  L    L      RI    I S +
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLSIASGL 118

Query: 264 SHLHA--------NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-----RSNSMI 310
           +HLH           I HRDLK +NIL+  +G   + D GLA    ++T      +N  +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 311 GTVEYMAPEIVLGK------GHNKAADWWSVGILLYEMLTG----------KPPFIGGNR 354
           GT  YMAPE++            K  D W+ G++L+E+             KPPF     
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238

Query: 355 -----AKIQQKIVKDKLRLP---AFLSSEAHSLLKGLLQK----EPGKRLGA 394
                  +++ +  D+ R      + S    + L  L+++     P  RL A
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  137 bits (348), Expect = 6e-37
 Identities = 65/292 (22%), Positives = 115/292 (39%), Gaps = 56/292 (19%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKI 207
           +  +++K +G+G +G V+  + +   E  A+KV                 E +I     +
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKWRG--EKVAVKVFFTT------EEASWFRETEIYQTVLM 88

Query: 208 DHPFVVQL----KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV 263
            H  ++           +  +LYL+ D+   G L+  L    L  + + ++ A   VS +
Sbjct: 89  RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKL-AYSSVSGL 147

Query: 264 SHLHA--------NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-----SNSMI 310
            HLH           I HRDLK +NIL+  +G   + D GLA +F  +T       N+ +
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207

Query: 311 GTVEYMAPEIVLGKGH------NKAADWWSVGILLYEMLTGKPPFIGGNRAK-------- 356
           GT  YM PE++    +         AD +S G++L+E+             +        
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267

Query: 357 -------IQQKIVKDKLRLP---AFLSSEAHSLLKGLLQK----EPGKRLGA 394
                  +++ +   KLR      + S E    +  L+ +     P  RL A
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  137 bits (346), Expect = 8e-37
 Identities = 64/294 (21%), Positives = 115/294 (39%), Gaps = 58/294 (19%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKI 207
              ++L+V  +G FG V++ +  N  E  A+K+            +  + E ++  L  +
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPI------QDKQSWQNEYEVYSLPGM 75

Query: 208 DHPFVVQL----KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV 263
            H  ++Q     K        L+L+  F   G L   L  + +   +L  I A  +   +
Sbjct: 76  KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHI-AETMARGL 134

Query: 264 SHLHAN----------GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM---I 310
           ++LH +           I HRD+K +N+LL  +    + DFGLA +F+    +      +
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194

Query: 311 GTVEYMAPEIVLGKGHN------KAADWWSVGILLYEMLTGKPPFIGGNRA--------- 355
           GT  YMAPE VL    N         D +++G++L+E+ +      G             
Sbjct: 195 GTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253

Query: 356 -------KIQQKIVKDKLRLP---AFLSSEAHSLLKGLL----QKEPGKRLGAG 395
                   +Q+ +V  K R      +      ++L   +      +   RL AG
Sbjct: 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  137 bits (346), Expect = 1e-36
 Identities = 65/292 (22%), Positives = 119/292 (40%), Gaps = 56/292 (19%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKI 207
               + + +G+G FG V++ + +   E  A+K+                 E +I     +
Sbjct: 42  RTIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSR------EERSWFREAEIYQTVML 93

Query: 208 DHPFVVQL----KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV 263
            H  ++           T  +L+LV D+   G LF  L  + +  E + ++ A    S +
Sbjct: 94  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGL 152

Query: 264 SHLHAN--------GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-----SNSMI 310
           +HLH           I HRDLK +NIL+  +G   + D GLA + D  T       N  +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212

Query: 311 GTVEYMAPEIVLGKG------HNKAADWWSVGILLYEMLTG----------KPPFIGGNR 354
           GT  YMAPE++            K AD +++G++ +E+             + P+     
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272

Query: 355 A-----KIQQKIVKDKLRLP---AFLSSEAHSLLKGLLQ----KEPGKRLGA 394
           +     ++++ + + KLR      + S EA  ++  +++         RL A
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  138 bits (349), Expect = 1e-36
 Identities = 81/349 (23%), Positives = 138/349 (39%), Gaps = 79/349 (22%)

Query: 129 DESSIDENVKGDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKN--TSEIYAMKVMRKD 186
           D+   D  VK  S       + ++E  KV G+G +G VY+ ++K+    + YA+K +   
Sbjct: 1   DKMDYDFKVKLSSERERVEDLFEYEGCKV-GRGTYGHVYKAKRKDGKDDKDYALKQIEGT 59

Query: 187 KIVEKNHAEYMKAERDILTKIDHPFVVQLK--YSFQTKYRLYLVLDF--------INGGH 236
            I      E       +L ++ HP V+ L+  +      +++L+ D+        I    
Sbjct: 60  GISMSACREIA-----LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHR 114

Query: 237 LFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD----GHVMLT 292
                         + +    +I+  + +LHAN ++HRDLKP NIL+  +    G V + 
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174

Query: 293 DFGLAKQFDENTRSNSMIG----TVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKP 347
           D G A+ F+   +  + +     T  Y APE++LG  H  KA D W++G +  E+LT +P
Sbjct: 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234

Query: 348 PFIG-------GNRAKIQQ--KIVK-----------DKLRLPAF---------------- 371
            F          N     Q  +I             D  ++P                  
Sbjct: 235 IFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCS 294

Query: 372 -----------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
                        S+A  LL+ LL  +P KR+ +     E+     +F 
Sbjct: 295 LIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS-----EQAMQDPYFL 338

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  135 bits (341), Expect = 1e-35
 Identities = 78/321 (24%), Positives = 130/321 (40%), Gaps = 81/321 (25%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + F+V ++ GQG FG V   ++K+T    A+K + +D        + M+     L  + H
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAVLHH 78

Query: 210 PFVVQLKYSFQTKYR-------LYLVLDFI-------------NGGHL---FFQLYHHGL 246
           P +VQL+  F T          L +V++++                       +++   L
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138

Query: 247 FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL-GADGHVMLTDFGLAKQFDENTR 305
            R  +  +          HL +  + HRD+KP N+L+  ADG + L DFG AK+   +  
Sbjct: 139 IR-SIGCL----------HLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187

Query: 306 SNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIV 362
           + + I +  Y APE++ G + +  A D WSVG +  EM+ G+P F G       Q  +IV
Sbjct: 188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG--DNSAGQLHEIV 245

Query: 363 K-----------------DKLRLPAF---------------LSSEAHSLLKGLLQKEPGK 390
           +                   + L                   + EA+ LL  LLQ  P +
Sbjct: 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE 305

Query: 391 RLGAGPKGSEEIKSHKWFKPI 411
           R+        E   H +F  +
Sbjct: 306 RMKP-----YEALCHPYFDEL 321

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  131 bits (331), Expect = 1e-34
 Identities = 50/236 (21%), Positives = 102/236 (43%), Gaps = 41/236 (17%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTK 206
           +++ ++L+++G+G +G VY+          A+KV          + +    E++I  +  
Sbjct: 12  LDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSF------ANRQNFINEKNIYRVPL 63

Query: 207 IDHPFVVQL-----KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           ++H  + +      + +   +    LV+++   G L   L  H        R+ A  +  
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-AHSVTR 122

Query: 262 AVSHLHA---------NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR------- 305
            +++LH            I HRDL   N+L+  DG  +++DFGL+ +   N         
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182

Query: 306 --SNSMIGTVEYMAPEIVLG-------KGHNKAADWWSVGILLYEMLTGKPPFIGG 352
             + S +GT+ YMAPE++ G       +   K  D +++G++ +E+         G
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  132 bits (335), Expect = 2e-34
 Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 25/216 (11%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA---ERDILTKI- 207
           +EVLKV+G+G+FG+V +       +  A+K++R       N   + +    E  IL  + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILEHLR 151

Query: 208 -----DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFR---EDLARIYAAEI 259
                +   V+ +  +F   +R ++ + F       ++L     F+     L R +A  I
Sbjct: 152 KQDKDNTMNVIHMLENFT--FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209

Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGH--VMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
           +  +  LH N I+H DLKPENILL   G   + + DFG +    E+ R  + I +  Y A
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQSRFYRA 267

Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
           PE++LG  +    D WS+G +L E+LTG P   G +
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  131 bits (332), Expect = 3e-34
 Identities = 76/337 (22%), Positives = 133/337 (39%), Gaps = 90/337 (26%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + + + K +G G+FG V +V    + + +A+K     K+       Y   E DI+  +DH
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KV--LQDPRYKNRELDIMKVLDH 59

Query: 210 PFVVQLKYSFQTKYR--------------------------------------LYLVLDF 231
             +++L   F T                                         L +++++
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 232 INGGHLFFQLYHHGLFREDLA----RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG 287
           +    L   L         +      IY  ++  AV  +H+ GI HRD+KP+N+L+ +  
Sbjct: 120 V-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178

Query: 288 HVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTG 345
           + + L DFG AK+   +  S + I +  Y APE++LG      + D WS+G +  E++ G
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238

Query: 346 KPPFIGGNRAKIQQ--KIVK-----------------DKLRLPAF------------LSS 374
           KP F G     I Q  +I++                  ++R P                S
Sbjct: 239 KPLFSGETS--IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS 296

Query: 375 EAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
            A  LL+ +L+ EP  R+        E  +H +F  +
Sbjct: 297 LAIDLLEQILRYEPDLRINP-----YEAMAHPFFDHL 328

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  124 bits (312), Expect = 2e-32
 Identities = 37/247 (14%), Positives = 74/247 (29%), Gaps = 35/247 (14%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           + +L   G     + +Q          A+  +    ++  +  +   +    L++ID P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 212 VVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           V ++     T+    +V ++I GG L  ++           R     + +A    H  G+
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQ-EVADTSPSPVGAIRA-MQSLAAAADAAHRAGV 150

Query: 272 MHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAAD 331
                 P  + +  DG V+L                        M          N   D
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPDA-------NPQDD 184

Query: 332 WWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP-------AFLSSEAHSLLKGLL 384
              +G  LY +L  + P              +D    P         +  +  ++    +
Sbjct: 185 IRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSV 244

Query: 385 QKEPGKR 391
           Q + G R
Sbjct: 245 QGDGGIR 251

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  123 bits (312), Expect = 6e-32
 Identities = 72/310 (23%), Positives = 129/310 (41%), Gaps = 67/310 (21%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-- 207
           +D+++++ +G+G +  V++      +E   +K+++  K  +K      K +R+I  KI  
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KK------KIKREI--KILE 85

Query: 208 ---DHPFVVQLKYSFQ--TKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
                P ++ L    +        LV + +N    F QLY      +   R Y  EI+ A
Sbjct: 86  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNT-DFKQLYQT--LTDYDIRFYMYEILKA 142

Query: 263 VSHLHANGIMHRDLKPENILL-GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV 321
           + + H+ GIMHRD+KP N+++      + L D+GLA+ +      N  + +  +  PE++
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 202

Query: 322 LG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--KIVK-----------DKLR 367
           +  + ++ + D WS+G +L  M+  K PF  G      Q  +I K           DK  
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG-HDNYDQLVRIAKVLGTEDLYDYIDKYN 261

Query: 368 LP--------------------------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEE 401
           +                             +S EA   L  LL+ +   RL A      E
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA-----RE 316

Query: 402 IKSHKWFKPI 411
              H +F  +
Sbjct: 317 AMEHPYFYTV 326

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  123 bits (310), Expect = 2e-31
 Identities = 51/226 (22%), Positives = 98/226 (43%), Gaps = 35/226 (15%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA---ERDILTKI- 207
           + +++ +G G F  V+  +    +   AMK++R           Y +A   E  +L ++ 
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-------GDKVYTEAAEDEIKLLQRVN 73

Query: 208 ----------DHPFVVQLKYSFQTK--YRLYLVLDF-INGGHLFFQL--YHHGLFREDLA 252
                         +++L   F  K    +++V+ F + G +L   +  Y H        
Sbjct: 74  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133

Query: 253 RIYAAEIVSAVSHLHAN-GIMHRDLKPENILL------GADGHVMLTDFGLAKQFDENTR 305
           +  + +++  + ++H   GI+H D+KPEN+L+           + + D G A     +  
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEH 191

Query: 306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIG 351
             + I T EY +PE++LG      AD WS   L++E++TG   F  
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  123 bits (310), Expect = 2e-31
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 35/222 (15%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA---ERDILTKI- 207
           +E+  ++G+G+FG+V +   +   E  A+K+++       N   ++     E  +L  + 
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQIEVRLLELMN 108

Query: 208 -----DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-------HHGLFREDLARIY 255
                   ++V LK  F  +  L LV +      L + LY         G    +L R +
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRG-VSLNLTRKF 162

Query: 256 AAEIVSAVSHLHAN--GIMHRDLKPENILLGADGH--VMLTDFGLAKQFDENTRSNSMIG 311
           A ++ +A+  L      I+H DLKPENILL       + + DFG +       R    I 
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQ 220

Query: 312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN 353
           +  Y +PE++LG  ++ A D WS+G +L EM TG+P F G N
Sbjct: 221 SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  120 bits (304), Expect = 1e-30
 Identities = 78/350 (22%), Positives = 128/350 (36%), Gaps = 118/350 (33%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA---ERDILTKI- 207
           F V++ +G G FGRV   +  +  + YA+KV+R       N  +Y ++   E DIL KI 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILKKIQ 89

Query: 208 ----DHPFVVQLKYSFQTKYRLYLVLDFINGGHLF--FQLYHHGL-----------FRED 250
               ++  +V+    F   Y            H+   F+     L           F  +
Sbjct: 90  NDDINNNNIVKYHGKFM--YY----------DHMCLIFEPLGPSLYEIITRNNYNGFHIE 137

Query: 251 LARIYAAEIVSAVSHLHANGIMHRDLKPENILL-------------------------GA 285
             ++Y  EI+ A+++L    + H DLKPENILL                           
Sbjct: 138 DIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197

Query: 286 DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTG 345
              + L DFG A    ++    S+I T +Y APE++L  G + ++D WS G +L E+ TG
Sbjct: 198 STGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

Query: 346 KPPFIG------------------------GNRAKIQQKIVKDKLRLPAFLSSEAH---- 377
              F                            +    + + KD+L+L    ++ +     
Sbjct: 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIK 315

Query: 378 ------------------SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
                               L  +LQ +P  R         E+  HK+ +
Sbjct: 316 HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP-----AELLKHKFLE 360

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  122 bits (307), Expect = 2e-30
 Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 24/254 (9%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE--KNHAEYMKAERDI--LT 205
           + ++ LK +G GA G V            A+K     K+    +N     +A R++  + 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-----KLSRPFQNQTHAKRAYRELVLMK 116

Query: 206 KIDHPFVVQLKYSFQTKYR------LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEI 259
            ++H  ++ L   F  +        +YLV++ +       Q+    L   +       ++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL-DHERMSYLLYQM 173

Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPE 319
           +  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T  Y APE
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233

Query: 320 IVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP-----AFLSS 374
           ++LG G+ +  D WSVG ++ EM+  K  F G +    Q   V ++L  P       L  
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKKLQP 292

Query: 375 EAHSLLKGLLQKEP 388
              + ++   +   
Sbjct: 293 TVRNYVENRPKYAG 306

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  120 bits (302), Expect = 2e-30
 Identities = 56/244 (22%), Positives = 91/244 (37%), Gaps = 63/244 (25%)

Query: 152 FEVLKVVGQGAFGRVYQVR-KKNTSEIYAMKVMRKDKIVEKNHAEYMKA---ERDILTKI 207
           +E++  +G+G FG+V +           A+K++R       N  +Y +A   E ++L KI
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVLKKI 73

Query: 208 ------DHPFVVQLKYSFQTKYRLYLVLDFINGGHLF--FQLYHHGL-----------FR 248
                 +    V +   F   +           GH+   F+L                + 
Sbjct: 74  KEKDKENKFLCVLMSDWFN--FH----------GHMCIAFELLGKNTFEFLKENNFQPYP 121

Query: 249 EDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLT---------------- 292
               R  A ++  A+  LH N + H DLKPENIL        L                 
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181

Query: 293 ---DFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPF 349
              DFG A    ++    +++ T  Y  PE++L  G  +  D WS+G +L+E   G   F
Sbjct: 182 RVADFGSA--TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239

Query: 350 IGGN 353
               
Sbjct: 240 QTHE 243

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  118 bits (299), Expect = 4e-30
 Identities = 72/346 (20%), Positives = 123/346 (35%), Gaps = 112/346 (32%)

Query: 152 FEVLKVVGQGAFGRVYQVR-KKNTSEIYAMKVMRKDKIVEKNHAEYMKA---ERDILTKI 207
           +E++  +G+GAFG+V +    K      A+K+++       N   Y +A   E  +L  +
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVLEHL 68

Query: 208 ------DHPFVVQLKYSFQTKYRLYLVLDFINGGHLF--FQLYHHGL-----------FR 248
                      VQ+   F+  +           GH+   F+L                FR
Sbjct: 69  NTTDPNSTFRCVQMLEWFE--HH----------GHICIVFELLGLSTYDFIKENGFLPFR 116

Query: 249 EDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLT---------------- 292
            D  R  A +I  +V+ LH+N + H DLKPENIL     +                    
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176

Query: 293 ---DFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPF 349
              DFG A    ++   ++++ T  Y APE++L  G ++  D WS+G +L E   G   F
Sbjct: 177 KVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234

Query: 350 IG------------------------GNRAK--------------IQQKIVKDKLRLPAF 371
                                       + K                + + +    L  F
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF 294

Query: 372 LSSEAHS------LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
           + S+         L++ +L+ +P KR+        E   H +F  +
Sbjct: 295 MLSQDVEHERLFDLIQKMLEYDPAKRITL-----REALKHPFFDLL 335

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  118 bits (297), Expect = 1e-29
 Identities = 63/260 (24%), Positives = 117/260 (45%), Gaps = 36/260 (13%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE--KNHAEYMKAERDI--LT 205
           + ++ LK +G GA G V            A+K     K+    +N     +A R++  + 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRAYRELVLMK 79

Query: 206 KIDHPFVVQLKYSFQTKYR------LYLVLDFINGGHLFFQLYHHGLFREDLAR------ 253
            ++H  ++ L   F  +        +Y+V++ +   +L        + + +L        
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL------CQVIQMELDHERMSYL 132

Query: 254 IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTV 313
           +Y  +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T 
Sbjct: 133 LY--QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190

Query: 314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP---- 369
            Y APE++LG G+ +  D WSVG ++ EM+ G   F G +    Q   V ++L  P    
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEF 249

Query: 370 -AFLSSEAHSLLKGLLQKEP 388
              L     + ++   +   
Sbjct: 250 MKKLQPTVRTYVENRPKYAG 269

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  116 bits (293), Expect = 2e-29
 Identities = 73/321 (22%), Positives = 124/321 (38%), Gaps = 80/321 (24%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI--LTKI 207
             +  LK +G G  G V+     +  +  A+K     KIV  +      A R+I  + ++
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRRL 65

Query: 208 DHPFVVQLK--------------YSFQTKYRLYLVLDF--------INGGHLFFQLYHHG 245
           DH  +V++                S      +Y+V ++        +  G L  +  H  
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE--HAR 123

Query: 246 LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA-DGHVMLTDFGLAKQFDENT 304
           LF      +Y  +++  + ++H+  ++HRDLKP N+ +   D  + + DFGLA+  D + 
Sbjct: 124 LF------MY--QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175

Query: 305 RSNS-MIGTVE---YMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN------ 353
                +   +    Y +P ++L    + KA D W+ G +  EMLTGK  F G +      
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235

Query: 354 ---------------------RAKIQQKIVKDKLRLPAFL---SSEAHSLLKGLLQKEPG 389
                                   I+  + +    L   L   S EA   L+ +L   P 
Sbjct: 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPM 295

Query: 390 KRLGAGPKGSEEIKSHKWFKP 410
            RL A     EE  SH +   
Sbjct: 296 DRLTA-----EEALSHPYMSI 311

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  116 bits (294), Expect = 3e-29
 Identities = 75/321 (23%), Positives = 128/321 (39%), Gaps = 80/321 (24%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK-AERDI--LTK 206
            DF++  ++G+GA+G V     K T EI A+K     KI   +   +     R+I  L  
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----KIEPFDKPLFALRTLREIKILKH 65

Query: 207 IDHPFVVQLKYSFQTKYR-----LYLVLDF--------INGGHLFFQLYHHGLFREDLAR 253
             H  ++ +    +         +Y++ +         I+   L     H   F      
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML--SDDHIQYF------ 117

Query: 254 IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTV 313
           IY  + + AV  LH + ++HRDLKP N+L+ ++  + + DFGLA+  DE+   NS     
Sbjct: 118 IY--QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175

Query: 314 E-----------YMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPF------------ 349
           +           Y APE++L    +++A D WS G +L E+   +P F            
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

Query: 350 ---------------IGGNRAK--IQQKIVKDKLRLPAFL---SSEAHSLLKGLLQKEPG 389
                          I   RA+  I+   +     L       + +   LL+ +L  +P 
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295

Query: 390 KRLGAGPKGSEEIKSHKWFKP 410
           KR+ A     +E   H + + 
Sbjct: 296 KRITA-----KEALEHPYLQT 311

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  116 bits (294), Expect = 3e-29
 Identities = 77/313 (24%), Positives = 123/313 (39%), Gaps = 72/313 (23%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK-AERDI--LTK 206
             +  L  +G+GA+G V            A+K     KI    H  Y +   R+I  L +
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 81

Query: 207 IDHPFVVQLKYSFQTKYR-----LYLVLDF--------INGGHLFFQLYHHGLFREDLAR 253
             H  ++ +    +         +Y+V D         +   HL     H   F      
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF------ 133

Query: 254 IYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM---- 309
           +Y  +I+  + ++H+  ++HRDLKP N+LL     + + DFGLA+  D +          
Sbjct: 134 LY--QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191

Query: 310 IGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNR-------------- 354
           + T  Y APEI+L  KG+ K+ D WSVG +L EML+ +P F G +               
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251

Query: 355 -----AKIQQKIVKDKLR-LPAF-----------LSSEAHSLLKGLLQKEPGKRLGAGPK 397
                  I     ++ L  LP               S+A  LL  +L   P KR+     
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV--- 308

Query: 398 GSEEIKSHKWFKP 410
             E+  +H + + 
Sbjct: 309 --EQALAHPYLEQ 319

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  115 bits (289), Expect = 1e-28
 Identities = 66/315 (20%), Positives = 107/315 (33%), Gaps = 68/315 (21%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA--------ER 201
             + V + +  G++G V            A+K +       +       +        E 
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 202 DILTKIDHPFVVQLKYSFQTKYR-----LYLVLDF--------INGGHLFFQLYHHGLFR 248
            +L    HP ++ L+  F          LYLV +         I+   +     H   F 
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYF- 139

Query: 249 EDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS 308
                +Y   I+  +  LH  G++HRDL P NILL  +  + + DF LA++   +     
Sbjct: 140 -----MY--HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192

Query: 309 MIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNR------------- 354
            +    Y APE+V+  KG  K  D WS G ++ EM   K  F G                
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252

Query: 355 ------AKIQQKIVKDKLR--LPAF-----------LSSEAHSLLKGLLQKEPGKRLGAG 395
                         +D LR  L                  A  L+  +L+  P +R+   
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST- 311

Query: 396 PKGSEEIKSHKWFKP 410
               E+   H +F+ 
Sbjct: 312 ----EQALRHPYFES 322

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  114 bits (288), Expect = 2e-28
 Identities = 78/318 (24%), Positives = 126/318 (39%), Gaps = 87/318 (27%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE----KNHAEYMKAERDILT 205
           + +     VG GA+G V     K + E  A+K     K+      +  A+    E  +L 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-----KLSRPFQSEIFAKRAYRELLLLK 78

Query: 206 KIDHPFVVQLKYSFQTKYR------LYLVLDF------------INGGHLFFQLYHHGLF 247
            + H  V+ L   F            YLV+ F             +   + + +Y     
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQ---- 134

Query: 248 REDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN 307
                      ++  + ++H+ G++HRDLKP N+ +  D  + + DFGLA+  D      
Sbjct: 135 -----------MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---- 179

Query: 308 SMIGTVE---YMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNR--------- 354
            M G V    Y APE++L    +N+  D WSVG ++ EMLTGK  F G +          
Sbjct: 180 -MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238

Query: 355 ----------AKIQQKIVKDKLR-LPAF-----------LSSEAHSLLKGLLQKEPGKRL 392
                      K+  K  K  ++ LP              S +A  LL+ +L+ +  KRL
Sbjct: 239 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298

Query: 393 GAGPKGSEEIKSHKWFKP 410
            A      +  +H +F+P
Sbjct: 299 TA-----AQALTHPFFEP 311

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  112 bits (282), Expect = 2e-27
 Identities = 79/307 (25%), Positives = 130/307 (42%), Gaps = 64/307 (20%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE--KNHAEYMKAERDI--LT 205
             +  L+ VG GA+G V       T    A+K     K+    ++     +A R++  L 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLK 79

Query: 206 KIDHPFVVQLKYSFQTKYR------LYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAE 258
            + H  V+ L   F            YLV+ F+        +L  H    ED  +    +
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG---KLMKHEKLGEDRIQFLVYQ 136

Query: 259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE---Y 315
           ++  + ++HA GI+HRDLKP N+ +  D  + + DFGLA+Q D     + M G V    Y
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEMTGYVVTRWY 191

Query: 316 MAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNR-------------------A 355
            APE++L    + +  D WSVG ++ EM+TGK  F G +                     
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251

Query: 356 KIQQKIVKDKLR-LPAF-----------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIK 403
           ++Q    K+ ++ LP              S  A +LL+ +L  +  +R+ A      E  
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-----GEAL 306

Query: 404 SHKWFKP 410
           +H +F+ 
Sbjct: 307 AHPYFES 313

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  110 bits (276), Expect = 3e-27
 Identities = 61/235 (25%), Positives = 106/235 (45%), Gaps = 20/235 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQ----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT 205
           +D  +L+ +G G+FG V +         T  + A+K ++ D + +    +    E + + 
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMH 76

Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSAVS 264
            +DH  +++L Y       + +V +    G L      H G F       YA ++   + 
Sbjct: 77  SLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYMAPE 319
           +L +   +HRDL   N+LL     V + DFGL +   +N      + +  +    + APE
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPE 194

Query: 320 IVLGKGHNK---AADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPA 370
            +          A+D W  G+ L+EM T G+ P+IG N ++I  KI K+  RLP 
Sbjct: 195 SLK---TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  112 bits (281), Expect = 6e-27
 Identities = 67/249 (26%), Positives = 120/249 (48%), Gaps = 14/249 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E   +   +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 238

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG---LFREDLARIYAAEIVSAVSHL 266
             +VQL Y+  ++  +Y+V ++++ G L   L       L    L  + AA+I S ++++
Sbjct: 239 EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYV 296

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGK 324
                +HRDL+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L  
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356

Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKG 382
                +D WS GILL E+ T G+ P+ G    ++  ++ +  ++  P       H L+  
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 416

Query: 383 LLQKEPGKR 391
             +KEP +R
Sbjct: 417 CWRKEPEER 425

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  109 bits (275), Expect = 1e-26
 Identities = 75/310 (24%), Positives = 122/310 (39%), Gaps = 74/310 (23%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKIDH 209
           ++ L  VG GA+G V       T    A+K + +    I+   HA+    E  +L  + H
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHMKH 87

Query: 210 PFVVQLKYSFQTKYR------LYLVLDF--------INGGHLFFQLYHHGLFREDLARIY 255
             V+ L   F           +YLV           +    L     H          IY
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFL------IY 139

Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE- 314
             +I+  + ++H+  I+HRDLKP N+ +  D  + + DFGLA+   +      M G V  
Sbjct: 140 --QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVAT 192

Query: 315 --YMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNR----------------- 354
             Y APEI+L    +N+  D WSVG ++ E+LTG+  F G +                  
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252

Query: 355 --AKIQQKIVKDKLR-LPAF-----------LSSEAHSLLKGLLQKEPGKRLGAGPKGSE 400
              KI  +  ++ ++ L               +  A  LL+ +L  +  KR+ A      
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-----A 307

Query: 401 EIKSHKWFKP 410
           +  +H +F  
Sbjct: 308 QALAHAYFAQ 317

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  108 bits (272), Expect = 2e-26
 Identities = 61/235 (25%), Positives = 113/235 (48%), Gaps = 23/235 (9%)

Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIY-AMKVMRKDKIVEKNHAEYMKAERDILT 205
            +F+ +KV+G GAFG VY+   + +    +I  A+K +R+     K + E +  E  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILD-EAYVMA 72

Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAV 263
            +D+P V +L         + L+   +  G L  + + +   +  + L   +  +I   +
Sbjct: 73  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKGM 130

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEYMAPE 319
           ++L    ++HRDL   N+L+    HV +TDFGLAK               +  +++MA E
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 189

Query: 320 IVLGKGHNK---AADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPA 370
            +L   H      +D WS G+ ++E++T G  P+ G   ++I   + K + RLP 
Sbjct: 190 SIL---HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQ 240

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  110 bits (276), Expect = 4e-26
 Identities = 67/249 (26%), Positives = 120/249 (48%), Gaps = 14/249 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E   +   +GQG FG V+      T+ + A+K ++   +      E    E  ++ K+ H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 321

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG---LFREDLARIYAAEIVSAVSHL 266
             +VQL Y+  ++  +Y+V ++++ G L   L       L    L  + AA+I S ++++
Sbjct: 322 EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYV 379

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGK 324
                +HRDL+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L  
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439

Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKG 382
                +D WS GILL E+ T G+ P+ G    ++  ++ +  ++  P       H L+  
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 499

Query: 383 LLQKEPGKR 391
             +KEP +R
Sbjct: 500 CWRKEPEER 508

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  105 bits (264), Expect = 9e-26
 Identities = 59/234 (25%), Positives = 120/234 (51%), Gaps = 23/234 (9%)

Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           E  E+ + +G+G FG V+Q   +  +N +   A+K  +     +    ++++ E   + +
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQ-EALTMRQ 72

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVS 264
            DHP +V+L     T+  ++++++    G L  F Q+  + L    L   YA ++ +A++
Sbjct: 73  FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-YAYQLSTALA 130

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIGTVEYMAPEIV 321
           +L +   +HRD+   N+L+ ++  V L DFGL++  +++     S   +  +++MAPE +
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 189

Query: 322 LGKGHNK---AADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRLPA 370
                 +   A+D W  G+ ++E+L  G  PF G  N   I +  +++  RLP 
Sbjct: 190 N---FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR--IENGERLPM 238

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  104 bits (262), Expect = 2e-25
 Identities = 55/254 (21%), Positives = 126/254 (49%), Gaps = 24/254 (9%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
            +   ++ +G G FG V+     N  ++ A+K +R+  + E+   ++++ E +++ K+ H
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEE---DFIE-EAEVMMKLSH 62

Query: 210 PFVVQLKYSFQTKYR-LYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           P +VQL Y    +   + LV +F+  G L  + +        E L  +   ++   +++L
Sbjct: 63  PKLVQL-YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM-CLDVCEGMAYL 120

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIGTVEYMAPEIVLG 323
               ++HRDL   N L+G +  + ++DFG+ +   ++   + + +    V++ +PE+   
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF-PVKWASPEVFS- 178

Query: 324 KGHNK---AADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL--PAFLSSEAH 377
              ++    +D WS G+L++E+ + GK P+   + +++ + I     RL  P   S+  +
Sbjct: 179 --FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVY 235

Query: 378 SLLKGLLQKEPGKR 391
            ++    ++ P  R
Sbjct: 236 QIMNHCWRERPEDR 249

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  103 bits (260), Expect = 3e-25
 Identities = 63/255 (24%), Positives = 124/255 (48%), Gaps = 26/255 (10%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E+  +LK +G G FG V   + K   ++ A+K++++  + E    E+ + E   + K+ H
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSED---EFFQ-EAQTMMKLSH 62

Query: 210 PFVVQLKYSFQTKYR-LYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           P +V+  Y   +K   +Y+V ++I+ G L  + + +  GL    L  +   ++   ++ L
Sbjct: 63  PKLVKF-YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM-CYDVCEGMAFL 120

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIGTVEYMAPEIVLG 323
            ++  +HRDL   N L+  D  V ++DFG+ +   ++   +   +    V++ APE+   
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF-PVKWSAPEVFH- 178

Query: 324 KGHNK---AADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRL--PAFLSSEA 376
             + K    +D W+ GIL++E+ + GK P+    N   + +  V    RL  P   S   
Sbjct: 179 --YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK--VSQGHRLYRPHLASDTI 234

Query: 377 HSLLKGLLQKEPGKR 391
           + ++     + P KR
Sbjct: 235 YQIMYSCWHELPEKR 249

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  105 bits (265), Expect = 4e-25
 Identities = 61/251 (24%), Positives = 122/251 (48%), Gaps = 14/251 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ED  + + +G+G FG V+  R +  + + A+K  R+        A++++ E  IL +  H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQ-EARILKQYSH 171

Query: 210 PFVVQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHL 266
           P +V+L     T+ + +Y+V++ + GG     L   G  L  + L ++   +  + + +L
Sbjct: 172 PNIVRL-IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQM-VGDAAAGMEYL 229

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT----VEYMAPEIVL 322
            +   +HRDL   N L+     + ++DFG++++  +     +  G     V++ APE + 
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV-YAASGGLRQVPVKWTAPEALN 288

Query: 323 GKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLL 380
              ++  +D WS GILL+E  + G  P+   +  + ++ + K  +L  P         L+
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM 348

Query: 381 KGLLQKEPGKR 391
           +     EPG+R
Sbjct: 349 EQCWAYEPGQR 359

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  107 bits (268), Expect = 4e-25
 Identities = 62/249 (24%), Positives = 117/249 (46%), Gaps = 12/249 (4%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
            D  +   +G G +G VY+   K  S   A+K +++D +      E    E  ++ +I H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 275

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG---LFREDLARIYAAEIVSAVSHL 266
           P +VQL      +   Y++ +F+  G+L   L       +    L  + A +I SA+ +L
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM-ATQISSAMEYL 334

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGK 324
                +HR+L   N L+G +  V + DFGL++    +  T        +++ APE +   
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394

Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKG 382
             +  +D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++ 
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 454

Query: 383 LLQKEPGKR 391
             Q  P  R
Sbjct: 455 CWQWNPSDR 463

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  103 bits (259), Expect = 5e-25
 Identities = 48/226 (21%), Positives = 107/226 (47%), Gaps = 18/226 (7%)

Query: 156 KVVGQGAFGRVYQ--VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV 213
           K +G G FG V +   + K   +  A+K+++ +   +    + + AE +++ ++D+P++V
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNPYIV 81

Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMH 273
           ++           LV++    G L   L  +   ++        ++   + +L  +  +H
Sbjct: 82  RM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140

Query: 274 RDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYMAPEIVLGKGHNK 328
           RDL   N+LL    +  ++DFGL+K    +      +++     V++ APE +    + K
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW-PVKWYAPECIN---YYK 196

Query: 329 ---AADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPA 370
               +D WS G+L++E  + G+ P+ G   +++   + K + R+  
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGC 241

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  105 bits (263), Expect = 6e-25
 Identities = 86/351 (24%), Positives = 134/351 (38%), Gaps = 115/351 (32%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK-NHAEYMK-AERDILTKI 207
             +E++K +G+GA+G V++   + T E+ A+K     KI +   ++   +   R+I   I
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-----KIFDAFQNSTDAQRTFREI--MI 61

Query: 208 -----DHPFVVQLK-----YSFQTKYRLYLVLDF--------INGGHLFFQLYHHGLFRE 249
                 H  +V L       + +    +YLV D+        I    L  +  H      
Sbjct: 62  LTELSGHENIVNLLNVLRADNDRD---VYLVFDYMETDLHAVIRANIL--EPVHKQYV-- 114

Query: 250 DLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM 309
               +Y  +++  + +LH+ G++HRD+KP NILL A+ HV + DFGL++ F    R  + 
Sbjct: 115 ----VY--QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168

Query: 310 IGTVE----------------------YMAPEIVLG-KGHNKAADWWSVGILLYEMLTGK 346
           I                          Y APEI+LG   + K  D WS+G +L E+L GK
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

Query: 347 PPFIGGNR-------------------AKIQQKIVKDKLR-LP----------------- 369
           P F G +                      IQ    K  +  L                  
Sbjct: 229 PIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKW 288

Query: 370 ----------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP 410
                     A  + EA  LL  LLQ  P KR+ A      +   H +   
Sbjct: 289 KNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA-----NDALKHPFVSI 334

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  106 bits (266), Expect = 6e-25
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 16/228 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++ K +G G FG V+       +++ A+K M+   +  +    ++  E +++  + H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVE---AFLA-EANVMKTLQH 242

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG---LFREDLARIYAAEIVSAVSHL 266
             +V+L ++  TK  +Y++ +F+  G L   L            L    +A+I   ++ +
Sbjct: 243 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF-SAQIAEGMAFI 300

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGK 324
                +HRDL+  NIL+ A     + DFGLA+  ++N  T        +++ APE +   
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 360

Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRLPA 370
                +D WS GILL E++T G+ P+ G  N   I+   ++   R+P 
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA--LERGYRMPR 406

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  103 bits (258), Expect = 7e-25
 Identities = 59/255 (23%), Positives = 127/255 (49%), Gaps = 26/255 (10%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D   LK +G G FG V   + +   ++ A+K++++  + E    E+++ E  ++  + H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSED---EFIE-EAKVMMNLSH 78

Query: 210 PFVVQLKYSFQTKYR-LYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +   H    + L  +   ++  A+ +L
Sbjct: 79  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 136

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIGTVEYMAPEIVLG 323
            +   +HRDL   N L+   G V ++DFGL++   ++   +   S    V +  PE+++ 
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPPEVLM- 194

Query: 324 KGHNK---AADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRL--PAFLSSEA 376
             ++K    +D W+ G+L++E+ + GK P+    N    +   +   LRL  P   S + 
Sbjct: 195 --YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IAQGLRLYRPHLASEKV 250

Query: 377 HSLLKGLLQKEPGKR 391
           ++++     ++  +R
Sbjct: 251 YTIMYSCWHEKADER 265

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  103 bits (259), Expect = 8e-25
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 28/209 (13%)

Query: 157 VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKN--HAEYMKAERDILTKIDHPFVVQ 214
            +G+G FG VY+    NT    A+K +     +       ++   E  ++ K  H  +V+
Sbjct: 38  KMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQF-DQEIKVMAKCQHENLVE 94

Query: 215 LK-YSFQTKYRLYLVLDFI-NGGHLFFQLYHHGLFREDLA---------RIYAAEIVSAV 263
           L  +S        LV  ++ NG      L    L   D           +I A    + +
Sbjct: 95  LLGFSSDGDDLC-LVYVYMPNGS-----LLDR-LSCLDGTPPLSWHMRCKI-AQGAANGI 146

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEI 320
           + LH N  +HRD+K  NILL       ++DFGLA+  ++  +   ++ ++GT  YMAPE 
Sbjct: 147 NFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA 206

Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPF 349
           + G+   K +D +S G++L E++TG P  
Sbjct: 207 LRGEITPK-SDIYSFGVVLLEIITGLPAV 234

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  102 bits (257), Expect = 8e-25
 Identities = 60/234 (25%), Positives = 115/234 (49%), Gaps = 23/234 (9%)

Query: 150 EDFEVLKVVGQGAFGRVYQ--VRKKNTSEIY-AMKVMRKDKIVEKNHAEYMKAERDILTK 206
           ED  + +++G+G FG VY+         +I  A+K  +KD     N  ++M  E  I+  
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMS-EAVIMKN 69

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVS 264
           +DHP +V+L      +   +++++    G L  + +   + L    L   Y+ +I  A++
Sbjct: 70  LDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL-YSLQICKAMA 127

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIGTVEYMAPEIV 321
           +L +   +HRD+   NIL+ +   V L DFGL++  ++      S + +  +++M+PE +
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPESI 186

Query: 322 LGKGHNK---AADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRLPA 370
                 +   A+D W   + ++E+L+ GK PF    N+  I    ++   RLP 
Sbjct: 187 N---FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV--LEKGDRLPK 235

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  103 bits (259), Expect = 9e-25
 Identities = 59/234 (25%), Positives = 108/234 (46%), Gaps = 21/234 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKV---MRKDKIVEKNHAEYMKAERDILTK 206
            +F+ +KV+G GAFG VY+       E   + V     ++    K + E +  E  ++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMAS 73

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVS 264
           +D+P V +L         + L+   +  G L  + + +   +  + L   +  +I   ++
Sbjct: 74  VDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKGMN 131

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEYMAPEI 320
           +L    ++HRDL   N+L+    HV +TDFGLAK               +  +++MA E 
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALES 190

Query: 321 VLGKGHNK---AADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPA 370
           +L   H      +D WS G+ ++E++T G  P+ G   ++I   + K + RLP 
Sbjct: 191 IL---HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQ 240

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  102 bits (257), Expect = 1e-24
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 23/211 (10%)

Query: 150 EDFEVLKVVGQGAFGRVYQ----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT 205
              + ++ +G+G FG+V          NT E  A+K ++ +     + A+  K E +IL 
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKK-EIEILR 78

Query: 206 KIDHPFVVQLK--YSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVS 261
            + H  +V+ K   +      + L+++F+  G L  +     + +  +   + YA +I  
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK-YAVQICK 137

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYM 316
            + +L +   +HRDL   N+L+ ++  V + DFGL K  + +      + +     V + 
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS-PVFWY 196

Query: 317 APEIVLGKGHNK---AADWWSVGILLYEMLT 344
           APE ++    +K   A+D WS G+ L+E+LT
Sbjct: 197 APECLM---QSKFYIASDVWSFGVTLHELLT 224

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (258), Expect = 1e-24
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 24/211 (11%)

Query: 150 EDFEVLKVVGQGAFGRVYQ----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT 205
              + L+ +G+G FG V        + NT E+ A+K ++     E++  ++ + E +IL 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFER-EIEILK 97

Query: 206 KIDHPFVVQLK--YSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVS 261
            + H  +V+ K       +  L L+++++  G L  + Q +   +    L + Y ++I  
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICK 156

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-----RSNSMIGTVEYM 316
            + +L     +HRDL   NIL+  +  V + DFGL K   ++      +       + + 
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES-PIFWY 215

Query: 317 APEIVLGKGHNK---AADWWSVGILLYEMLT 344
           APE +     +K   A+D WS G++LYE+ T
Sbjct: 216 APESLT---ESKFSVASDVWSFGVVLYELFT 243

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  102 bits (256), Expect = 1e-24
 Identities = 57/232 (24%), Positives = 113/232 (48%), Gaps = 24/232 (10%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G FG V+       +++ A+K +++  +      +   AE +++ ++ H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSP----DAFLAEANLMKQLQH 67

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG---LFREDLARIYAAEIVSAVSHL 266
             +V+L Y+  T+  +Y++ +++  G L   L       L    L  + AA+I   ++ +
Sbjct: 68  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM-AAQIAEGMAFI 125

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIGTVEYMAPEIVLG 323
                +HRDL+  NIL+       + DFGLA+  ++N    R  +    +++ APE +  
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAIN- 183

Query: 324 KGHNK---AADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRLPA 370
             +      +D WS GILL E++T G+ P+ G  N   IQ   ++   R+  
Sbjct: 184 --YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN--LERGYRMVR 231

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  102 bits (257), Expect = 2e-24
 Identities = 60/265 (22%), Positives = 121/265 (45%), Gaps = 27/265 (10%)

Query: 150 EDFEVLKVVGQGAFGRVYQ--VRKKNTSEIY-AMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + F + +++G+G FG V +  +++++ S +  A+K+++ D I   +  E+++ E   + +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-EAACMKE 81

Query: 207 IDHPFVVQL------KYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARI---- 254
            DHP V +L        +        ++L F+  G L  F      G    +L       
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141

Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMI 310
           +  +I   + +L +   +HRDL   N +L  D  V + DFGL+++            S +
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201

Query: 311 GTVEYMAPE-IVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL 368
             V+++A E +     +   +D W+ G+ ++E++T G+ P+ G   A+I    +    RL
Sbjct: 202 -PVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY-LIGGNRL 258

Query: 369 --PAFLSSEAHSLLKGLLQKEPGKR 391
             P     E + L+      +P +R
Sbjct: 259 KQPPECMEEVYDLMYQCWSADPKQR 283

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  101 bits (255), Expect = 2e-24
 Identities = 54/211 (25%), Positives = 101/211 (47%), Gaps = 24/211 (11%)

Query: 150 EDFEVLKVVGQGAFGRV----YQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT 205
              + L+ +G+G FG V    Y   + NT E+ A+K ++     E++  ++ + E +IL 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFER-EIEILK 66

Query: 206 KIDHPFVVQLK--YSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVS 261
            + H  +V+ K       +  L L+++++  G L  + Q +   +    L + Y ++I  
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICK 125

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYM 316
            + +L     +HRDL   NIL+  +  V + DFGL K   ++      +       + + 
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES-PIFWY 184

Query: 317 APEIVLGKGHNK---AADWWSVGILLYEMLT 344
           APE +     +K   A+D WS G++LYE+ T
Sbjct: 185 APESLT---ESKFSVASDVWSFGVVLYELFT 212

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  102 bits (255), Expect = 4e-24
 Identities = 56/234 (23%), Positives = 107/234 (45%), Gaps = 23/234 (9%)

Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIY-AMKVMRKDKIVEKNHAEYMKAERDILT 205
            +   LKV+G G FG V++   + +  + +I   +KV+ +DK   ++           + 
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTD-HMLAIG 70

Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAV 263
            +DH  +V+L         L LV  ++  G L    + +   L  + L   +  +I   +
Sbjct: 71  SLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN-WGVQIAKGM 128

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEYMAPE 319
            +L  +G++HR+L   N+LL +   V + DFG+A     +      S +    +++MA E
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT-PIKWMALE 187

Query: 320 IVLGKGHNK---AADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLP 369
            +      K    +D WS G+ ++E++T G  P+ G   A++   + K + RL 
Sbjct: 188 SIH---FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-RLA 237

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  104 bits (262), Expect = 4e-24
 Identities = 61/253 (24%), Positives = 125/253 (49%), Gaps = 17/253 (6%)

Query: 150 EDFEVLKVVGQGAFGRVYQ--VRKKNTSEIY-AMKVMRKDKIVEKNHAEYMKAERDILTK 206
           E  E+ + +G+G FG V+Q          +  A+K  +     +    ++++ E   + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQ-EALTMRQ 447

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVS 264
            DHP +V+L     T+  ++++++    G L  F Q+    L    L   YA ++ +A++
Sbjct: 448 FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLIL-YAYQLSTALA 505

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVL 322
           +L +   +HRD+   N+L+ ++  V L DFGL++  +++   +++     +++MAPE + 
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565

Query: 323 GKGHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRL--PAFLSSEAHS 378
            +    A+D W  G+ ++E+L  G  PF G  N   I +  +++  RL  P       +S
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR--IENGERLPMPPNCPPTLYS 623

Query: 379 LLKGLLQKEPGKR 391
           L+      +P +R
Sbjct: 624 LMTKCWAYDPSRR 636

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  101 bits (254), Expect = 4e-24
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 21/209 (10%)

Query: 150 EDFEVLKVVGQGAFGRVYQ----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT 205
              + ++ +G+G FG+V           T E+ A+K ++ D    ++ + + + E DIL 
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQ-EIDILR 88

Query: 206 KIDHPFVVQLK--YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV 263
            + H  +++ K          L LV++++  G L   L  H +    L  ++A +I   +
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-LLFAQQICEGM 147

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYMAP 318
           ++LHA   +HRDL   N+LL  D  V + DFGLAK   E       R +     V + AP
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS-PVFWYAP 206

Query: 319 EIVLGKGHNK---AADWWSVGILLYEMLT 344
           E +      K   A+D WS G+ LYE+LT
Sbjct: 207 ECLK---EYKFYYASDVWSFGVTLYELLT 232

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  100 bits (251), Expect = 7e-24
 Identities = 59/255 (23%), Positives = 114/255 (44%), Gaps = 22/255 (8%)

Query: 153 EVLKVVGQGAFGRVYQ--VRKKNTSEIY-AMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
              +V+G+G FG VY   +   +  +I+ A+K +          ++++  E  I+    H
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT-EGIIMKDFSH 85

Query: 210 PFVVQLK-YSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           P V+ L     +++    +VL ++  G L  F +   H    +DL      ++   + +L
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMKYL 144

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPE- 319
            +   +HRDL   N +L     V + DFGLA+   +        ++ + +  V++MA E 
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-PVKWMALES 203

Query: 320 IVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL--PAFLSSEA 376
           +   K     +D WS G+LL+E++T G PP+   N   I   +++ + RL  P +     
Sbjct: 204 LQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPL 261

Query: 377 HSLLKGLLQKEPGKR 391
           + ++      +   R
Sbjct: 262 YEVMLKCWHPKAEMR 276

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  100 bits (252), Expect = 7e-24
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 25/219 (11%)

Query: 150 EDFEVLKVVGQGAFGRVYQ----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT 205
              + +  +G+G FG V          NT  + A+K ++          ++ + E  IL 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQR-EIQILK 79

Query: 206 KIDHPFVVQLK-YSFQTKYR-LYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVS 261
            +   F+V+ +  S+    + L LV++++  G L  F Q +   L    L   Y+++I  
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL-YSSQICK 138

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYM 316
            + +L +   +HRDL   NIL+ ++ HV + DFGLAK    +      R       + + 
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS-PIFWY 197

Query: 317 APEIVLGKGHNK---AADWWSVGILLYEMLT-GKPPFIG 351
           APE +     N     +D WS G++LYE+ T        
Sbjct: 198 APESLS---DNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  102 bits (257), Expect = 8e-24
 Identities = 76/363 (20%), Positives = 128/363 (35%), Gaps = 113/363 (31%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK---DKIVEKNHAEYMKAERDI--L 204
           + +E+  ++G G++G V +   K    + A+K + +   D I  K      +  R+I  L
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK------RILREIAIL 106

Query: 205 TKIDHPFVVQLK-----YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEI 259
            +++H  VV++         +    LY+VL+                  E   +     +
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNL 165

Query: 260 VSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVE----- 314
           +  V ++H+ GI+HRDLKP N L+  D  V + DFGLA+  D     NS +         
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 315 -----------------------YMAPEIVLG-KGHNKAADWWSVGILLYEMLT------ 344
                                  Y APE++L  + + +A D WS+G +  E+L       
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285

Query: 345 -----GKPPFIGGN------------------RAKIQQ-----------------KIVKD 364
                  P F G +                  R    Q                  + K+
Sbjct: 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE 345

Query: 365 KLR-----LPAF-----------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF 408
             +      P              S++A  LLK +L   P KR+        E  +H +F
Sbjct: 346 DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITI-----NECLAHPFF 400

Query: 409 KPI 411
           K +
Sbjct: 401 KEV 403

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score =  100 bits (252), Expect = 8e-24
 Identities = 66/262 (25%), Positives = 113/262 (43%), Gaps = 33/262 (12%)

Query: 141 SVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAE 200
           S+ V  VG  +F V K +G G FG +   +   T+E  A+K+        K+ A  +  E
Sbjct: 1   SMGVLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP-----MKSRAPQLHLE 54

Query: 201 RDILTKIDH-PFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAA 257
                ++     + Q+ Y         +VL+ + G  L   F L       + +  I A 
Sbjct: 55  YRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMI-AI 112

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGH-----VMLTDFGLAKQF-DENTRS----- 306
           +++S + ++H+  +++RD+KPEN L+G  G+     + + DF LAK++ D  T+      
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172

Query: 307 --NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIG---GNRAKIQQKI 361
              S+ GT  YM+    LGK  ++  D  ++G +    L G  P+ G       +  QKI
Sbjct: 173 EHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI 232

Query: 362 VKDKLRLPAFLSSEAHSLLKGL 383
              K   P         L +  
Sbjct: 233 GDTKRATP------IEVLCENF 248

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  100 bits (250), Expect = 8e-24
 Identities = 62/230 (26%), Positives = 114/230 (49%), Gaps = 18/230 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
            D  +   +G G +G VY+   K  S   A+K +++D +  +   E++K E  ++ +I H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLK-EAAVMKEIKH 68

Query: 210 PFVVQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHL 266
           P +VQL     T+    Y++ +F+  G+L   L            +   A +I SA+ +L
Sbjct: 69  PNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGT--VEYMAPEIVLGK 324
                +HRDL   N L+G +  V + DFGL++    +T +        +++ APE +   
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA-- 185

Query: 325 GHNK---AADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPA 370
            +NK    +D W+ G+LL+E+ T G  P+ G + +++ + + KD  R+  
Sbjct: 186 -YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMER 233

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  100 bits (250), Expect = 2e-23
 Identities = 59/237 (24%), Positives = 109/237 (45%), Gaps = 25/237 (10%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKV---MRKDKIVEKNHAEYMKAERDILTK 206
                 KV+G G FG VY+   K +S    + V     K    EK   +++  E  I+ +
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG-EAGIMGQ 102

Query: 207 IDHPFVVQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAV 263
             H  +++L     +KY+ + ++ +++  G L   L           L  +    I + +
Sbjct: 103 FSHHNIIRL-EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM-LRGIAAGM 160

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYMAP 318
            +L     +HRDL   NIL+ ++    ++DFGL++  +++     T S   I  + + AP
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI-PIRWTAP 219

Query: 319 EIVLGKGHNK---AADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRLPA 370
           E +    + K   A+D WS GI+++E++T G+ P+    N   ++   + D  RLP 
Sbjct: 220 EAIS---YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA--INDGFRLPT 271

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 51/251 (20%), Positives = 104/251 (41%), Gaps = 32/251 (12%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH-P 210
           ++V + +G+G+FG +++      ++  A+K         ++ A  ++ E      +    
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGCT 66

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
            +  + Y  Q      LV+D + G  L     L       + +A   A ++++ V  +H 
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMA-AKQMLARVQSIHE 124

Query: 269 NGIMHRDLKPENILLGADGH-----VMLTDFGLAKQF-DENTRS-------NSMIGTVEY 315
             +++RD+KP+N L+G         + + DFG+ K + D  T+         ++ GT  Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184

Query: 316 MAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIG---GNRAKIQQKIVKDKLRLPAFL 372
           M+    LG+  ++  D  ++G +    L G  P+ G       +  ++I + K   P   
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP--- 241

Query: 373 SSEAHSLLKGL 383
                 L  G 
Sbjct: 242 ---LRELCAGF 249

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  100 bits (251), Expect = 3e-23
 Identities = 52/269 (19%), Positives = 93/269 (34%), Gaps = 85/269 (31%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI---- 207
           + V++ +G G F  V+        +  AMKV++  +    ++ E    E  +L  +    
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSD 94

Query: 208 -DHP---FVVQLKYSFQTKYRLYLVLDFINGGHL-------------FFQLYHHGLFRED 250
            + P    VVQL   F+        +  +NG H+             +    ++      
Sbjct: 95  PNDPNREMVVQLLDDFK--------ISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLP 146

Query: 251 LARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGAD----------------------- 286
             +    +++  + +LH    I+H D+KPENILL  +                       
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206

Query: 287 --------------------------GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
                                       V + D G A     +      I T +Y + E+
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQYRSLEV 264

Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPF 349
           ++G G+N  AD WS   + +E+ TG   F
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLF 293

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 58/270 (21%), Positives = 112/270 (41%), Gaps = 45/270 (16%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIY-------AMKVMRKDKIVEKNHAEYMKAERD 202
           ED    + +GQG F ++++  ++   +          +KV+ K      N++E       
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAAS 64

Query: 203 ILTKIDHPFVVQLKYSFQTKYR-LYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEI 259
           +++K+ H  +V   Y          LV +F+  G L  + +   + +       + A ++
Sbjct: 65  MMSKLSHKHLVLN-YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV-AKQL 122

Query: 260 VSAVSHLHANGIMHRDLKPENILL--------GADGHVMLTDFGLAKQFDENTRSNSMIG 311
            +A+  L  N ++H ++  +NILL        G    + L+D G++              
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-------- 174

Query: 312 TVEY-------MAPE-IVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKI 361
             +        + PE I   K  N A D WS G  L+E+ + G  P     ++ K+Q   
Sbjct: 175 --DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-- 230

Query: 362 VKDKLRLPAFLSSEAHSLLKGLLQKEPGKR 391
            +D+ +LPA  ++E  +L+   +  EP  R
Sbjct: 231 YEDRHQLPAPKAAELANLINNCMDYEPDHR 260

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 57/235 (24%), Positives = 108/235 (45%), Gaps = 23/235 (9%)

Query: 150 EDFEVLKVV-GQGAFGRVYQ-VRKKNTSEIY-AMKVMRKDKIVEKNHAEYMKAERDILTK 206
           ++  +  +  G G FG V Q V +    +I  A+KV+++    + +  E M+ E  I+ +
Sbjct: 9   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMR-EAQIMHQ 66

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVS 264
           +D+P++V+L         L LV++   GG L  F       +   ++A     ++   + 
Sbjct: 67  LDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-LLHQVSMGMK 124

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYMAPE 319
           +L     +HRDL   N+LL    +  ++DFGL+K    +      RS      +++ APE
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW-PLKWYAPE 183

Query: 320 IVLGKGHNK---AADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPA 370
            +      K    +D WS G+ ++E L+ G+ P+      ++   I + K R+  
Sbjct: 184 CIN---FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMEC 234

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 99.1 bits (247), Expect = 6e-23
 Identities = 59/255 (23%), Positives = 113/255 (44%), Gaps = 22/255 (8%)

Query: 153 EVLKVVGQGAFGRVYQ--VRKKNTSEIY-AMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
              +V+G+G FG VY   +   +  +I+ A+K +          ++++  E  I+    H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT-EGIIMKDFSH 149

Query: 210 PFVVQLK-YSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           P V+ L     +++    +VL ++  G L  F +   H    +DL      ++   +  L
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMKFL 208

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYMAPE- 319
            +   +HRDL   N +L     V + DFGLA+   +        ++ + +  V++MA E 
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL-PVKWMALES 267

Query: 320 IVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL--PAFLSSEA 376
           +   K     +D WS G+LL+E++T G PP+   N   I   +++ + RL  P +     
Sbjct: 268 LQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPL 325

Query: 377 HSLLKGLLQKEPGKR 391
           + ++      +   R
Sbjct: 326 YEVMLKCWHPKAEMR 340

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 98.1 bits (245), Expect = 6e-23
 Identities = 54/264 (20%), Positives = 114/264 (43%), Gaps = 26/264 (9%)

Query: 150 EDFEVLKVVGQGAFGRVYQ--VRKKNTSEIY-AMKVMRKDKIVEKNHAEYMKAERDILTK 206
               + K++G+G FG V +  +++++ + +  A+K M+ D   ++   E++  E   +  
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS-EAACMKD 92

Query: 207 IDHPFVVQL-----KYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARI----Y 255
             HP V++L     + S Q   +  ++L F+  G L  +          + +       +
Sbjct: 93  FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152

Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIG 311
             +I   + +L     +HRDL   N +L  D  V + DFGL+K+            + + 
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM- 211

Query: 312 TVEYMAPE-IVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL- 368
            V+++A E +     +   +D W+ G+ ++E+ T G  P+ G    ++    +    RL 
Sbjct: 212 PVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY-LLHGHRLK 269

Query: 369 -PAFLSSEAHSLLKGLLQKEPGKR 391
            P     E + ++    + +P  R
Sbjct: 270 QPEDCLDELYEIMYSCWRTDPLDR 293

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 99.0 bits (247), Expect = 7e-23
 Identities = 62/234 (26%), Positives = 115/234 (49%), Gaps = 20/234 (8%)

Query: 150 EDFEVLKVVGQGAFGRVYQ--VRKKNTSEIY-AMKVMRKDKIVEKNHAEYMKAERDILTK 206
            +  + KVVG G FG V    ++  +  EI  A+K ++     EK   +++  E  I+ +
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLG-EASIMGQ 102

Query: 207 IDHPFVVQLKYSFQTKYR-LYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAV 263
            DHP +++L     TK + + +V +++  G L  F + +        L  +    I S +
Sbjct: 103 FDHPNIIRL-EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM-LRGIASGM 160

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYMAP 318
            +L   G +HRDL   NIL+ ++    ++DFGL +  +++     T     I  + + +P
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI-PIRWTSP 219

Query: 319 EIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRLPA 370
           E +  +    A+D WS GI+L+E+++ G+ P+    N+  I+   V +  RLP 
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA--VDEGYRLPP 271

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 97.7 bits (244), Expect = 9e-23
 Identities = 55/222 (24%), Positives = 108/222 (48%), Gaps = 18/222 (8%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
           +F+   ++G G FG+VY+   ++ +++ A+K    +    +   E+ + E + L+   HP
Sbjct: 40  NFDHKFLIGHGVFGKVYKGVLRDGAKV-ALKRRTPES--SQGIEEF-ETEIETLSFCRHP 95

Query: 211 FVVQL-KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLA-----RIYAAEIVSAVS 264
            +V L  +  +    + L+  ++  G+L   LY   L    ++      I        + 
Sbjct: 96  HLVSLIGFCDERNEMI-LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI-CIGAARGLH 153

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEIV 321
           +LH   I+HRD+K  NILL  +    +TDFG++K+  E  +   S  + GT+ Y+ PE  
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF 213

Query: 322 LGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV 362
           + KG   + +D +S G++L+E+L  +   I  +  +    + 
Sbjct: 214 I-KGRLTEKSDVYSFGVVLFEVLCARSA-IVQSLPREMVNLA 253

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 56/237 (23%), Positives = 112/237 (47%), Gaps = 26/237 (10%)

Query: 150 EDFEVLKVVGQGAFGRVYQ--VRKKNTSEIY-AMKVMRKDKIVEKNHAEYMKAERDILTK 206
               + K++G G  G V    +R     ++  A+K ++     E+   +++  E  I+ +
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLS-EASIMGQ 106

Query: 207 IDHPFVVQLKYSFQTKYR-LYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAV 263
            DHP +++L     T+ R   +V +++  G L  F + +        L  +    + + +
Sbjct: 107 FDHPNIIRL-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM-LRGVGAGM 164

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTVEYMAP 318
            +L   G +HRDL   N+L+ ++    ++DFGL++  +++     T +   I  + + AP
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI-PIRWTAP 223

Query: 319 EIVLGKGHNK---AADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDKLRLPA 370
           E +          A+D WS G++++E+L  G+ P+    NR  I    V++  RLPA
Sbjct: 224 EAIA---FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS--VEEGYRLPA 275

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 99.1 bits (247), Expect = 1e-22
 Identities = 55/254 (21%), Positives = 103/254 (40%), Gaps = 67/254 (26%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE--KNHAEYMKAERDI--LT 205
           +++ +  ++G+G++G VY    KNT +  A+K     K+    ++  +  +  R+I  L 
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK-----KVNRMFEDLIDCKRILREITILN 80

Query: 206 KIDHPFVVQLK-----YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAE-- 258
           ++   ++++L              LY+VL+  +                DL +++     
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD---------------SDLKKLFKTPIF 125

Query: 259 ------------IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS 306
                       ++   + +H +GI+HRDLKP N LL  D  V + DFGLA+  +    +
Sbjct: 126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185

Query: 307 NSMIGTVE-----------------------YMAPEIVLG-KGHNKAADWWSVGILLYEM 342
           N +    E                       Y APE++L  + + K+ D WS G +  E+
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

Query: 343 LTGKPPFIGGNRAK 356
           L      I     +
Sbjct: 246 LNMLQSHINDPTNR 259

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 59/230 (25%), Positives = 111/230 (48%), Gaps = 24/230 (10%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ++ ++L+ +G+G FG V     +      A+K ++ D   +        AE  ++T++ H
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA-----FLAEASVMTQLRH 73

Query: 210 PFVVQLKYS--FQTKYRLYLVLDFINGGHLFFQLYHHG---LFREDLARIYAAEIVSAVS 264
             +VQL      + K  LY+V +++  G L   L   G   L  + L +  + ++  A+ 
Sbjct: 74  SNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAME 131

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGK 324
           +L  N  +HRDL   N+L+  D    ++DFGL K+   +T+    +  V++ APE +   
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE-ASSTQDTGKL-PVKWTAPEALR-- 187

Query: 325 GHNK---AADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPA 370
              K    +D WS GILL+E+ + G+ P+       +  ++ K   ++ A
Sbjct: 188 -EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMDA 235

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 99.6 bits (248), Expect = 2e-22
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 20/227 (8%)

Query: 156 KVVGQGAFGRVYQ-VRKKNTSEIY-AMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV 213
             +G G FG V Q V +    +I  A+KV+++    + +  E M+ E  I+ ++D+P++V
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMR-EAQIMHQLDNPYIV 399

Query: 214 QLKYSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAVSHLHANGI 271
           +L         L LV++   GG L  F       +   ++A     ++   + +L     
Sbjct: 400 RL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-LLHQVSMGMKYLEEKNF 457

Query: 272 MHRDLKPENILLGADGHVMLTDFGLAK--QFDENTRSNSMIGT--VEYMAPEIVLGKGHN 327
           +HR+L   N+LL    +  ++DFGL+K    D++  +    G   +++ APE +      
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN---FR 514

Query: 328 K---AADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPA 370
           K    +D WS G+ ++E L+ G+ P+      ++   I + K R+  
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMEC 560

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 98.6 bits (246), Expect = 2e-22
 Identities = 59/230 (25%), Positives = 112/230 (48%), Gaps = 24/230 (10%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ++ ++L+ +G+G FG V     +      A+K ++ D       A+   AE  ++T++ H
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKND-----ATAQAFLAEASVMTQLRH 245

Query: 210 PFVVQLKY--SFQTKYRLYLVLDFINGGHLFFQLYHHG---LFREDLARIYAAEIVSAVS 264
             +VQL      + K  LY+V +++  G L   L   G   L  + L +  + ++  A+ 
Sbjct: 246 SNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAME 303

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGK 324
           +L  N  +HRDL   N+L+  D    ++DFGL K  + ++  ++    V++ APE +   
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWTAPEALR-- 359

Query: 325 GHNK---AADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRLPA 370
              K    +D WS GILL+E+ + G+ P+       +  ++ K   ++ A
Sbjct: 360 -EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMDA 407

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 94.7 bits (236), Expect = 8e-22
 Identities = 53/251 (21%), Positives = 103/251 (41%), Gaps = 34/251 (13%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEY--MKAERDILTKIDH 209
           + + + +G G+FG +Y        E  A+K+       E    ++  +  E  I   +  
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-------ECVKTKHPQLHIESKIYKMMQG 63

Query: 210 -PFVVQLKYSFQTKYRLYLVLDFI--NGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
              +  +++         +V++ +  +   LF        F      + A +++S + ++
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYI 121

Query: 267 HANGIMHRDLKPENILLGADGH---VMLTDFGLAKQF-DENTRS-------NSMIGTVEY 315
           H+   +HRD+KP+N L+G       V + DFGLAK++ D  T          ++ GT  Y
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

Query: 316 MAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIG---GNRAKIQQKIVKDKLRLPAFL 372
            +    LG   ++  D  S+G +L     G  P+ G     + +  ++I + K+  P   
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238

Query: 373 SSEAHSLLKGL 383
                 L KG 
Sbjct: 239 ---IEVLCKGY 246

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 95.6 bits (238), Expect = 9e-22
 Identities = 43/243 (17%), Positives = 89/243 (36%), Gaps = 31/243 (12%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTS--------EIYAMKVMRKDKIVEKNHAEYMKAERD- 202
           +++     +   G +Y+    +T         + +++K+  KD  +      + +A +  
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 203 ------ILTKIDHPFVVQLKYS--FQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLA 252
                  L       +         Q KYR +LVL  + G  L     +    +  E   
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSL-GRSLQSALDVSPKHVLSERSV 161

Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD--GHVMLTDFGLAKQF-DENT----- 304
              A  ++ A+  LH N  +H ++  ENI +  +    V L  +G A ++          
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221

Query: 305 --RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV 362
               +   G +E+++ ++  G G ++ +D  S+G  + + L G  P+             
Sbjct: 222 EGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQ 281

Query: 363 KDK 365
           K K
Sbjct: 282 KQK 284

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 53/256 (20%), Positives = 104/256 (40%), Gaps = 18/256 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
                 +V+G+G FG VY    + +       A+K +       +    +++ E  ++  
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLR-EGLLMRG 78

Query: 207 IDHPFVVQLK-YSFQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDLARIYAAEIVSAV 263
           ++HP V+ L       +   +++L ++  G L  F +        +DL      ++   +
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF-GLQVARGM 137

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGT---VEYMAP 318
            +L     +HRDL   N +L     V + DFGLA+   +               V++ A 
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 319 EIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL--PAFLSSE 375
           E +        +D WS G+LL+E+LT G PP+   +   +    +    RL  P +    
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF-LAQGRRLPQPEYCPDS 256

Query: 376 AHSLLKGLLQKEPGKR 391
            + +++   + +P  R
Sbjct: 257 LYQVMQQCWEADPAVR 272

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 55/217 (25%), Positives = 107/217 (49%), Gaps = 28/217 (12%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ++F    ++G+G FG+VY+ R  + + + A+K + K++  +    ++ + E ++++   H
Sbjct: 30  DNFSNKNILGRGGFGKVYKGRLADGTLV-AVKRL-KEERTQGGELQF-QTEVEMISMAVH 86

Query: 210 PFVVQLK-YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLA-------RIYAAEIVS 261
             +++L+ +      RL LV  ++  G +   L                  RI A     
Sbjct: 87  RNLLRLRGFCMTPTERL-LVYPYMANGSVASCL--RERPESQPPLDWPKRQRI-ALGSAR 142

Query: 262 AVSHLH--AN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-----TRSNSMIGTV 313
            +++LH   +  I+HRD+K  NILL  +   ++ DFGLAK  D       T    + GT+
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA---VRGTI 199

Query: 314 EYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPF 349
            ++APE +   G  ++  D +  G++L E++TG+  F
Sbjct: 200 GHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAF 235

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 94.7 bits (235), Expect = 5e-21
 Identities = 57/251 (22%), Positives = 106/251 (42%), Gaps = 34/251 (13%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEY--MKAERDILTKI-D 208
           F + + +G G+FG +Y      T+E  A+K+       E    ++  +  E  I   +  
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKTKHPQLLYESKIYRILQG 61

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFI--NGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
              +  +++         LV+D +  +   LF               + A ++++ V  +
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFV 119

Query: 267 HANGIMHRDLKPENILLGADGH---VMLTDFGLAKQF-DENTRS-------NSMIGTVEY 315
           H+   +HRD+KP+N L+G       V + DFGLAK++ D +T          ++ GT  Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

Query: 316 MAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIG---GNRAKIQQKIVKDKLRLPAFL 372
            +    LG   ++  D  S+G +L   L G  P+ G   G + +  +KI + K+      
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS--- 236

Query: 373 SSEAHSLLKGL 383
                +L +G 
Sbjct: 237 ---IEALCRGY 244

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 50/225 (22%), Positives = 98/225 (43%), Gaps = 29/225 (12%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
           E   + + +GQG+FG VY+     V K       A+K    +    +   E++  E  ++
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK-TVNEAASMRERIEFLN-EASVM 82

Query: 205 TKIDHPFVVQLKYSFQTKYR-LYLVLDFINGGHL-----------FFQLYHHGLFREDLA 252
            + +   VV+L     ++ +   ++++ +  G L                        + 
Sbjct: 83  KEFNCHHVVRL-LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141

Query: 253 RIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNS 308
           ++ A EI   +++L+AN  +HRDL   N ++  D  V + DFG+ +   E          
Sbjct: 142 QM-AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 200

Query: 309 MIGTVEYMAPE-IVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG 351
           ++  V +M+PE +  G      +D WS G++L+E+ T  + P+ G
Sbjct: 201 LL-PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQG 243

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 89.3 bits (222), Expect = 7e-20
 Identities = 60/268 (22%), Positives = 115/268 (42%), Gaps = 34/268 (12%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
           ++  +++ +G GAFG VY+     +    +    A+K +  +   E++  +++  E  I+
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLM-EALII 87

Query: 205 TKIDHPFVVQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHHG--------LFREDLARIY 255
           +K +H  +V+       +    +++++ + GG L   L            L   DL  + 
Sbjct: 88  SKFNHQNIVRC-IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV- 145

Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILL--GADGHVM-LTDFGLAKQFDEN----TRSNS 308
           A +I     +L  N  +HRD+   N LL     G V  + DFG+A+             +
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205

Query: 309 MIGTVEYMAPE-IVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDK 365
           M+  V++M PE  + G       D WS G+LL+E+ + G  P+    N+  ++   V   
Sbjct: 206 MLP-VKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF--VTSG 261

Query: 366 LRL--PAFLSSEAHSLLKGLLQKEPGKR 391
            R+  P       + ++    Q +P  R
Sbjct: 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDR 289

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 46/242 (19%), Positives = 94/242 (38%), Gaps = 33/242 (13%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEI-----YAMKVMRKD--------KIVEKNHAEYMK 198
           ++V   +GQG FG +Y     ++  +       +KV   D        K  ++       
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96

Query: 199 AERDILTKIDHPFVVQLKYS-----FQTKYRLYLVLDFINGGHL--FFQLYHHGLFREDL 251
            +     K+ +  V +   S         YR ++++D   G  L   ++       R+ +
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYR-FMIMDRF-GSDLQKIYEANAKRFSRKTV 154

Query: 252 ARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD--GHVMLTDFGLAKQF-DENTRS-- 306
            ++ +  I+  + ++H +  +H D+K  N+LL       V L D+GLA ++  E      
Sbjct: 155 LQL-SLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213

Query: 307 -----NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI 361
                    GT+E+ + +   G   ++  D   +G  + + LTG  P+    +     + 
Sbjct: 214 AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRD 273

Query: 362 VK 363
            K
Sbjct: 274 SK 275

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 46/243 (18%), Positives = 96/243 (39%), Gaps = 32/243 (13%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSE---IYAMKVMRKD--------KIVEKNHAEYMKAE 200
           + + K +G G FG +Y     N  E    + +KV  ++        K  ++   +    +
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 201 RDILTKIDHPFVVQLKYS-----FQTKYRLYLVLDF--INGGHLFFQLYHHGLFREDLAR 253
                ++D+  +     S         YR ++V++   I+   +  Q   +G F++    
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYR-FMVMERLGIDLQKISGQ---NGTFKKSTVL 154

Query: 254 IYAAEIVSAVSHLHANGIMHRDLKPENILLGAD--GHVMLTDFGLAKQF-DENTR----- 305
                ++  + ++H N  +H D+K  N+LLG      V L D+GL+ ++           
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214

Query: 306 --SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK 363
                  GT+E+ + +   G   ++ +D   +G  +   L GK P+    +  +  +  K
Sbjct: 215 NPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274

Query: 364 DKL 366
             L
Sbjct: 275 TNL 277

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 61/268 (22%), Positives = 115/268 (42%), Gaps = 34/268 (12%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
           ++  +++ +G GAFG VY+     +    +    A+K +  +   E++  +++  E  I+
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLM-EALII 128

Query: 205 TKIDHPFVVQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHHG--------LFREDLARIY 255
           +K +H  +V+       +    +++L+ + GG L   L            L   DL  + 
Sbjct: 129 SKFNHQNIVRC-IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV- 186

Query: 256 AAEIVSAVSHLHANGIMHRDLKPENILL--GADGHVM-LTDFGLAKQFDEN----TRSNS 308
           A +I     +L  N  +HRD+   N LL     G V  + DFG+A+             +
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 246

Query: 309 MIGTVEYMAPE-IVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDK 365
           M+  V++M PE  + G       D WS G+LL+E+ + G  P+    N+  ++   V   
Sbjct: 247 MLP-VKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF--VTSG 302

Query: 366 LRL--PAFLSSEAHSLLKGLLQKEPGKR 391
            R+  P       + ++    Q +P  R
Sbjct: 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDR 330

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 68/276 (24%), Positives = 121/276 (43%), Gaps = 41/276 (14%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
           +  ++ K +G+GAFG+V +     + K  T    A+K M K+      H   M  E  IL
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMS-ELKIL 84

Query: 205 TKID-HPFVVQLKY--SFQTKYRLYLVLDFINGGHL-----------------FFQLYHH 244
             I  H  VV L      +    L ++++F   G+L                    LY  
Sbjct: 85  IHIGHHLNVVNL-LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143

Query: 245 GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN- 303
            L  E L    + ++   +  L +   +HRDL   NILL     V + DFGLA+   ++ 
Sbjct: 144 FLTLEHLICY-SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202

Query: 304 ---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG--GNRAKI 357
               + ++ +  +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G   +    
Sbjct: 203 DYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261

Query: 358 QQKIVKDKLRL--PAFLSSEAHSLLKGLLQKEPGKR 391
           ++  +K+  R+  P + + E +  +      EP +R
Sbjct: 262 RR--LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 295

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 85.7 bits (213), Expect = 8e-19
 Identities = 60/274 (21%), Positives = 122/274 (44%), Gaps = 40/274 (14%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
                ++ +G+  FG+VY+           ++  A+K   KDK       E+   E  + 
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK-TLKDKAEGPLREEFRH-EAMLR 66

Query: 205 TKIDHPFVVQLKYSFQTKYR-LYLVLDFINGGHL-----------------FFQLYHHGL 246
            ++ HP VV L     TK + L ++  + + G L                   +     L
Sbjct: 67  ARLQHPNVVCL-LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125

Query: 247 FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--- 303
              D   +  A+I + + +L ++ ++H+DL   N+L+    +V ++D GL ++       
Sbjct: 126 EPPDFVHL-VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY 184

Query: 304 -TRSNSMIGTVEYMAPE-IVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQ 359
               NS++  + +MAPE I+ GK  +  +D WS G++L+E+ + G  P+ G  N+  ++ 
Sbjct: 185 KLLGNSLL-PIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242

Query: 360 KIVKDKLRL--PAFLSSEAHSLLKGLLQKEPGKR 391
             ++++  L  P    +  ++L+     + P +R
Sbjct: 243 --IRNRQVLPCPDDCPAWVYALMIECWNEFPSRR 274

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 64/271 (23%), Positives = 116/271 (42%), Gaps = 34/271 (12%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
            + +  K +G GAFG+V +     + K++     A+K M K           M  E  I+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK-MLKSTAHADEKEALMS-ELKIM 103

Query: 205 TKID-HPFVVQLKYSFQTKYR-LYLVLDFINGGHL---------------FFQLYHHGLF 247
           + +  H  +V L     T    + ++ ++   G L                F + +    
Sbjct: 104 SHLGQHENIVNL-LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 248 REDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---- 303
             DL    ++++   ++ L +   +HRD+   N+LL       + DFGLA+    +    
Sbjct: 163 TRDLLHF-SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221

Query: 304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIV 362
            + N+ +  V++MAPE +    +   +D WS GILL+E+ + G  P+ G        K+V
Sbjct: 222 VKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280

Query: 363 KDKLRL--PAFLSSEAHSLLKGLLQKEPGKR 391
           KD  ++  PAF     +S+++     EP  R
Sbjct: 281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHR 311

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 66/274 (24%), Positives = 121/274 (44%), Gaps = 41/274 (14%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
            D  + + +G+GAFG+V+      +       + A+K ++          ++ + E ++L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQR-EAELL 71

Query: 205 TKIDHPFVVQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHHG-----------------L 246
           T + H  +V+  Y        L +V +++  G L   L  HG                 L
Sbjct: 72  TNLQHEHIVKF-YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 247 FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--- 303
               +  I A++I S + +L +   +HRDL   N L+GA+  V + DFG+++        
Sbjct: 131 GLSQMLHI-ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 189

Query: 304 -TRSNSMIGTVEYMAPE-IVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQ 359
               ++M+  + +M PE I+  K     +D WS G++L+E+ T GK P+    N   I+ 
Sbjct: 190 RVGGHTML-PIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 247

Query: 360 KIVKDKLRL--PAFLSSEAHSLLKGLLQKEPGKR 391
             +     L  P     E + ++ G  Q+EP +R
Sbjct: 248 --ITQGRVLERPRVCPKEVYDVMLGCWQREPQQR 279

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 59/276 (21%), Positives = 111/276 (40%), Gaps = 40/276 (14%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
                 K +G GAFG+V +     + K + +   A+K M K           M  E  +L
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK-MLKPSAHLTEREALMS-ELKVL 80

Query: 205 TKI-DHPFVVQLKYSFQTKYR-LYLVLDFINGGHL-----------FFQLYHHGLFREDL 251
           + + +H  +V L     T      ++ ++   G L                   +  +D 
Sbjct: 81  SYLGNHMNIVNL-LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 252 ARI-------YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN- 303
             +       ++ ++   ++ L +   +HRDL   NILL       + DFGLA+    + 
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 304 ---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT--GKP-PFIGGNRAKI 357
               + N+ +  V++MAPE +    +   +D WS GI L+E+ +    P P +  +    
Sbjct: 200 NYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258

Query: 358 QQKIVKDKLRL--PAFLSSEAHSLLKGLLQKEPGKR 391
           +   +K+  R+  P    +E + ++K     +P KR
Sbjct: 259 KM--IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 64/273 (23%), Positives = 123/273 (45%), Gaps = 40/273 (14%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
            D  +   +G+GAFG+V+      +  +    + A+K +++     +   ++ + E ++L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ--DFQR-EAELL 97

Query: 205 TKIDHPFVVQLKYSFQTKYR-LYLVLDFINGGHLFFQLYHHG----------------LF 247
           T + H  +V+  +   T+ R L +V +++  G L   L  HG                L 
Sbjct: 98  TMLQHQHIVRF-FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 248 REDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---- 303
              L  + A+++ + + +L     +HRDL   N L+G    V + DFG+++         
Sbjct: 157 LGQLLAV-ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 215

Query: 304 TRSNSMIGTVEYMAPE-IVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQK 360
               +M+  + +M PE I+  K     +D WS G++L+E+ T GK P+    N   I   
Sbjct: 216 VGGRTML-PIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC- 272

Query: 361 IVKDKLRL--PAFLSSEAHSLLKGLLQKEPGKR 391
            +     L  P     E +++++G  Q+EP +R
Sbjct: 273 -ITQGRELERPRACPPEVYAIMRGCWQREPQQR 304

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 62/268 (23%), Positives = 119/268 (44%), Gaps = 33/268 (12%)

Query: 150 EDFEVLKVVGQGAFGRVYQ--VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
            D +   V+G+G FG+V +  ++K       A+K   K+   + +H ++   E ++L K+
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDFAG-ELEVLCKL 82

Query: 208 -DHPFVVQLK-YSFQTKYRLYLVLDFINGGHL-----------------FFQLYHHGLFR 248
             HP ++ L        Y LYL +++   G+L                         L  
Sbjct: 83  GHHPNIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141

Query: 249 EDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSN 307
           + L    AA++   + +L     +HRDL   NIL+G +    + DFGL++  +    ++ 
Sbjct: 142 QQLLHF-AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 200

Query: 308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQQKIVKDK 365
             +  V +MA E +    +   +D WS G+LL+E+++ G  P+ G       ++  +   
Sbjct: 201 GRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK--LPQG 257

Query: 366 LRL--PAFLSSEAHSLLKGLLQKEPGKR 391
            RL  P     E + L++   +++P +R
Sbjct: 258 YRLEKPLNCDDEVYDLMRQCWREKPYER 285

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 83.8 bits (208), Expect = 5e-18
 Identities = 57/238 (23%), Positives = 105/238 (44%), Gaps = 41/238 (17%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
           ++  + K +G+G FG+V +     ++ +      A+K M K+        + +  E ++L
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK-MLKENASPSELRDLLS-EFNVL 80

Query: 205 TKIDHPFVVQLKYSFQTKYR-LYLVLDFINGGHL-------------------------F 238
            +++HP V++L Y   ++   L L++++   G L                          
Sbjct: 81  KQVNHPHVIKL-YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139

Query: 239 FQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK 298
                  L   DL    A +I   + +L    ++HRDL   NIL+     + ++DFGL++
Sbjct: 140 DHPDERALTMGDLISF-AWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

Query: 299 QFDEN----TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG 351
              E      RS   I  V++MA E +    +   +D WS G+LL+E++T G  P+ G
Sbjct: 199 DVYEEDSYVKRSQGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 61/275 (22%), Positives = 125/275 (45%), Gaps = 39/275 (14%)

Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKV---MRKDKIVEKNHAEYMKAERDI 203
           +   + K +G+GAFG+V     V         A+ V   M KD   EK+ ++ +  E ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS-EMEM 93

Query: 204 LTKI-DHPFVVQLKYSFQTKYR-LYLVLDFINGGHL-----------------FFQLYHH 244
           +  I  H  ++ L     T+   LY+++++ + G+L                   ++   
Sbjct: 94  MKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 245 GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN- 303
            +  +DL      ++   + +L +   +HRDL   N+L+  +  + + DFGLA+  +   
Sbjct: 153 QMTFKDLVSC-TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 304 ---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG-GNRAKIQ 358
                +N  +  V++MAPE +  + +   +D WS G+L++E+ T G  P+ G       +
Sbjct: 212 YYKKTTNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

Query: 359 QKIVKDKLRL--PAFLSSEAHSLLKGLLQKEPGKR 391
              +K+  R+  PA  ++E + +++      P +R
Sbjct: 271 L--LKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 52/239 (21%), Positives = 103/239 (43%), Gaps = 43/239 (17%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
            + E ++ +G+GAFGRV+Q     +       + A+K M K++      A++ + E  ++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALM 104

Query: 205 TKIDHPFVVQLKYSFQTKYR-LYLVLDFINGGHL-------------------------F 238
            + D+P +V+L        + + L+ +++  G L                          
Sbjct: 105 AEFDNPNIVKL-LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163

Query: 239 FQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK 298
                  L   +   I A ++ + +++L     +HRDL   N L+G +  V + DFGL++
Sbjct: 164 SSPGPPPLSCAEQLCI-ARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

Query: 299 QFDEN----TRSNSMIGTVEYMAPE-IVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG 351
                       N  I  + +M PE I   + +   +D W+ G++L+E+ + G  P+ G
Sbjct: 223 NIYSADYYKADGNDAI-PIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYG 279

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 81.3 bits (201), Expect = 6e-17
 Identities = 60/274 (21%), Positives = 126/274 (45%), Gaps = 37/274 (13%)

Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKV---MRKDKIVEKNHAEYMKAERDI 203
           +   + K +G+G FG+V     V         A+ V   M KD   EK+ ++ +  E ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS-EMEM 139

Query: 204 LTKI-DHPFVVQLKYSFQTKYR-LYLVLDFINGGHL-----------------FFQLYHH 244
           +  I  H  ++ L     T+   LY+++++ + G+L                   ++   
Sbjct: 140 MKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198

Query: 245 GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN- 303
            +  +DL      ++   + +L +   +HRDL   N+L+  +  + + DFGLA+  +   
Sbjct: 199 QMTFKDLVSC-TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257

Query: 304 ---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQ 359
                +N  +  V++MAPE +  + +   +D WS G+L++E+ T G  P+ G    ++ +
Sbjct: 258 YYKKTTNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316

Query: 360 KIVKDKLRL--PAFLSSEAHSLLKGLLQKEPGKR 391
             +K+  R+  PA  ++E + +++      P +R
Sbjct: 317 L-LKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 349

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 34/232 (14%)

Query: 150 EDFEVLKVVGQGAFGRVYQ---VRKKNTSEIYAMKV---MRKDKIVEKNHAEYMKAERDI 203
           +   + K +G+GAFG+V     +           KV   M K    EK+ ++ +  E ++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS-EMEM 127

Query: 204 LTKI-DHPFVVQLKYSFQTKYR-LYLVLDFINGGHL-----------------FFQLYHH 244
           +  I  H  ++ L     T+   LY+++++ + G+L                        
Sbjct: 128 MKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186

Query: 245 GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN- 303
            L  +DL    A ++   + +L +   +HRDL   N+L+  D  + + DFGLA+      
Sbjct: 187 QLSSKDLVSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245

Query: 304 ---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG 351
                +N  +  V++MAPE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 246 YYKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 77.7 bits (192), Expect = 8e-16
 Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 41/238 (17%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
           E+ E  KV+G GAFG+V       + K   S   A+K M K+K         M  E  ++
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK-MLKEKADSSEREALMS-ELKMM 102

Query: 205 TKI-DHPFVVQLKYSFQTKYR-LYLVLDFINGGHL------------------------F 238
           T++  H  +V L     T    +YL+ ++   G L                         
Sbjct: 103 TQLGSHENIVNL-LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161

Query: 239 FQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK 298
            +   + L  EDL    A ++   +  L     +HRDL   N+L+     V + DFGLA+
Sbjct: 162 EEEDLNVLTFEDLLCF-AYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

Query: 299 QFDEN----TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIG 351
               +     R N+ +  V++MAPE +    +   +D WS GILL+E+ + G  P+ G
Sbjct: 221 DIMSDSNYVVRGNARL-PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 73.0 bits (178), Expect = 3e-14
 Identities = 51/317 (16%), Positives = 98/317 (30%), Gaps = 69/317 (21%)

Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT 205
           C+  E  +  + +G+G FG V+Q    +T    A+K++  +     N   + K   +IL 
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVN-GSHQKTFEEILP 72

Query: 206 KI---------------DHP--------FVVQLKY----------------------SFQ 220
           +I                            VQ  Y                       F 
Sbjct: 73  EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132

Query: 221 TKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPE 279
              +L++VL+F  GG    Q     L     A+    ++ ++++   A+    HRDL   
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQ-MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWG 191

Query: 280 NILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILL 339
           N+LL       L      K           I +        V    +  +       ++ 
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSST--------IPSCGL----QVSIIDYTLSRLERDGIVVF 239

Query: 340 YEMLTGKPPFIGGNRA-----KIQQKIVKDKLRLPAFLSSE--AHSLLKGLLQKEPGKRL 392
            ++   +  F G         ++ +K   ++       S+    H L   +L++   K  
Sbjct: 240 CDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK 299

Query: 393 GAGPKGSEEIKSHKWFK 409
              P   +  +  + F 
Sbjct: 300 CNTPAMKQIKRKIQEFH 316

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.7 bits (160), Expect = 6e-12
 Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 9/160 (5%)

Query: 239 FQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK 298
             LY   L  E L   Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+
Sbjct: 183 EDLYKDFLTLEHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

Query: 299 QFDENT----RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGN 353
              ++     + ++ +  +++MAPE +  + +   +D WS G+LL+E+ + G  P+ G  
Sbjct: 242 DIYKDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300

Query: 354 RAKIQQKIVKDKLRL--PAFLSSEAHSLLKGLLQKEPGKR 391
             +   + +K+  R+  P + + E +  +      EP +R
Sbjct: 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 340

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 35/167 (20%), Positives = 59/167 (35%), Gaps = 13/167 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQ-----VRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
           +  ++ K +G+GAFG+V +     + K  T    A+K M K+      H   M  E  IL
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMS-ELKIL 79

Query: 205 TKID-HPFVVQLK-YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
             I  H  VV L     +    L ++++F   G+L   L        +    Y  +    
Sbjct: 80  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK----RNEFVPYKTKGARF 135

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM 309
                  G +  DLK     + +      + F   K   +     + 
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.1 bits (116), Expect = 3e-06
 Identities = 44/305 (14%), Positives = 93/305 (30%), Gaps = 68/305 (22%)

Query: 34  SDSLELDFSDVFGPVPVQDSP-EVSYGDLVNAVSAAADASEIIYEDPVIICNRSHSLVGP 92
            +   L           QD P EV   +    +S  A   E I +      N  H     
Sbjct: 301 DEVKSL-LLKYLD-CRPQDLPREVLTTNPR-RLSIIA---ESIRDGLATWDNWKHV---- 350

Query: 93  SSCVSESSKLTKLILR--ESEDAEELLECVDGLTVKEIDESSIDENVKGDSVTVCCVGIE 150
                   KLT +I       +  E  +  D L+V          +            I 
Sbjct: 351 -----NCDKLTTIIESSLNVLEPAEYRKMFDRLSV-------FPPSAH----------IP 388

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEY----------MKAE 200
              +L ++        +    K+   +   K+ +   +VEK   E           +K +
Sbjct: 389 T-ILLSLI--------WFDVIKSDVMVVVNKLHKY-SLVEKQPKESTISIPSIYLELKVK 438

Query: 201 RDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIV 260
            +    + H  +V   Y+    +    ++      + +  + HH      L  I   E +
Sbjct: 439 LENEYAL-HRSIVD-HYNIPKTFDSDDLIPPYLDQYFYSHIGHH------LKNIEHPERM 490

Query: 261 SAVSHLHAN-GIMHRDLKPENILLGADGHVM--LTDFGLAKQF--DENTRSNSMIGTVEY 315
           +    +  +   + + ++ ++    A G ++  L      K +  D + +   ++  +  
Sbjct: 491 TLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILD 550

Query: 316 MAPEI 320
             P+I
Sbjct: 551 FLPKI 555

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 29/149 (19%), Positives = 54/149 (36%), Gaps = 15/149 (10%)

Query: 158 VGQGAFGRVYQVRKKNTSEIY---AMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV-V 213
           +G+GA   + +    +   I      K  R +++ E         E   L  +    +  
Sbjct: 344 IGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPA 403

Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMH 273
              +         +++ +ING           +  ++L   Y  +I   V  LH N ++H
Sbjct: 404 PYIFDV-DLDNKRIMMSYINGKLA------KDVIEDNLDIAY--KIGEIVGKLHKNDVIH 454

Query: 274 RDLKPENILLGADGHVMLTDFGLAKQFDE 302
            DL   N +   D  + + DFGL K  + 
Sbjct: 455 NDLTTSNFIF--DKDLYIIDFGLGKISNL 481

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	482
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.17
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.12
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.93
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.61
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.55
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.45
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.36
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.27
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.16
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.01
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.84
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.77
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.55
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.48
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.39
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.37
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.3
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.28
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.27
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.18
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.17
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.04
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.88
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.79
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.92
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.79
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.83

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.3e-70  Score=548.46  Aligned_cols=271  Identities=39%  Similarity=0.743  Sum_probs=253.6

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+......+..+.+.+|+++|++++|||||+++++|++.+.+|||
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            47899999999999999999999999999999999988776667778899999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC---CC
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~---~~  305 (482)
                      ||||+||+|.+++.+.+.+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...   ..
T Consensus       111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~  190 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR  190 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999987432   34


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhc
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ..+.|||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++.++|.++.+.+|..+|+++++||++||+
T Consensus       191 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~  270 (311)
T 4aw0_A          191 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLV  270 (311)
T ss_dssp             BCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSC
T ss_pred             ccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHcc
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCCcCCCCC-CChHHHHhCcCCCCCChhhhhhc
Q 047009          386 KEPGKRLGAGP-KGSEEIKSHKWFKPINWKKLEAR  419 (482)
Q Consensus       386 ~dP~~R~s~~~-~~~~eil~hp~f~~~~~~~~~~~  419 (482)
                      +||++|+|+.. .+..+|++||||++++|+.+.++
T Consensus       271 ~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~  305 (311)
T 4aw0_A          271 LDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ  305 (311)
T ss_dssp             SSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred             CCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCC
Confidence            99999999832 13345899999999999999755

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.2e-71  Score=549.98  Aligned_cols=278  Identities=51%  Similarity=0.922  Sum_probs=252.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEc---CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKK---NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      .++|++++.||+|+||+||+|++.   .+++.||||++++...... ....+.+|+.+|++++|||||+++++|++.+.+
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            478999999999999999999984   4688999999987654332 233577899999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~  304 (482)
                      |||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+... ...
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  181 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  181 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999998754 344


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhh
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L  384 (482)
                      ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|.+..+.+|..+|+++++||++||
T Consensus       182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L  261 (304)
T 3ubd_A          182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLF  261 (304)
T ss_dssp             CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHc
Confidence            55678999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCcc
Q 047009          385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP  427 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p  427 (482)
                      ++||++||++...+++|+++||||+++||+.+..++++|||+|
T Consensus       262 ~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P  304 (304)
T 3ubd_A          262 KRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP  304 (304)
T ss_dssp             CSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred             ccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence            9999999998666789999999999999999999999999988

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.6e-69  Score=580.72  Aligned_cols=324  Identities=33%  Similarity=0.647  Sum_probs=279.8

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHH---HHHHHhCCCCceeeeeeeeecC
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAE---RDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E---~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      .+++++|+++++||+|+||+||+|+++.+|+.||||++.+..+........+.+|   +.+++.++|||||+++++|++.
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            4678999999999999999999999999999999999998776555545555555   4556677999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      +.+|||||||+||+|+.++.+.+.+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCCcccccCCCCCchhhhc-CCCCCchhHHHHHhHHHHHHhhCCCCCCCC---chHHHHHHHHhcccCCCccCChHHHH
Q 047009          303 NTRSNSMIGTVEYMAPEIVL-GKGHNKAADWWSVGILLYEMLTGKPPFIGG---NRAKIQQKIVKDKLRLPAFLSSEAHS  378 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~-~~~~~~~sDvwSlGvilyelltG~~PF~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~  378 (482)
                      . ...+.|||+.|||||++. +..|+.++|||||||++|||++|++||.+.   +..++...+....+.+|..+|+++++
T Consensus       345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~d  423 (689)
T 3v5w_A          345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS  423 (689)
T ss_dssp             C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHH
Confidence            3 456789999999999996 468999999999999999999999999764   34567778888899999999999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCC-CCCC
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAA-TPKN  457 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~-~~~~  457 (482)
                      ||++||++||.+|+++...+++||++||||+++||+.+..+++.|||+|.+....+.++||....+.  .++... ....
T Consensus       424 LI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~~~fD~~~fd~--e~~~~~~~~~~  501 (689)
T 3v5w_A          424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDE--EDTKGIKLLDS  501 (689)
T ss_dssp             HHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTTBCCC-----------CCCCCCHH
T ss_pred             HHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCCcCCCCCCccCCc--cccCCCCCCch
Confidence            9999999999999998777899999999999999999999999999999988877777776322211  111111 1123


Q ss_pred             CCCCccCeeeecCCc
Q 047009          458 NTNPFADFSYVRPAA  472 (482)
Q Consensus       458 ~~~~f~~f~~~~~~~  472 (482)
                      ++..|.+|+|..+..
T Consensus       502 d~~~f~~Fs~~~~~~  516 (689)
T 3v5w_A          502 DQELYRNFPLTISER  516 (689)
T ss_dssp             HHTTTTTCCEECHHH
T ss_pred             HHHHHhCCCccCccc
Confidence            568899999987655

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.1e-65  Score=531.65  Aligned_cols=327  Identities=35%  Similarity=0.769  Sum_probs=293.0

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCe
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  224 (482)
                      .+.+++|+++++||+|+||+||+|+++.+++.||+|++++.........+.+.+|+.+|.++ +||||++++++|++...
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            35678999999999999999999999999999999999987766556666788999999887 89999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccc-ccCC
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ-FDEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~-~~~~  303 (482)
                      +|+||||++||+|..++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+. ....
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            999999999999999999989999999999999999999999999999999999999999999999999999987 3445


Q ss_pred             CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC---------chHHHHHHHHhcccCCCccCCh
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG---------NRAKIQQKIVKDKLRLPAFLSS  374 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~---------~~~~~~~~i~~~~~~~p~~~s~  374 (482)
                      ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...         ....+.+.+....+.+|..++.
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~  287 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV  287 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCH
Confidence            5667789999999999999999999999999999999999999999642         3455778888999999999999


Q ss_pred             HHHHHHHHhhccCcCCcCCCCC-CChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCC
Q 047009          375 EAHSLLKGLLQKEPGKRLGAGP-KGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAA  453 (482)
Q Consensus       375 ~~~~LI~~~L~~dP~~R~s~~~-~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~  453 (482)
                      ++++||++||++||.+||++.+ .+++||++||||++++|+.+..+++.|||+|.+.+..++++|+..++.++...++..
T Consensus       288 ~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~~~~~~~~~~~~~  367 (396)
T 4dc2_A          288 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDD  367 (396)
T ss_dssp             HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSCHHHHTSCCCCCCCC
T ss_pred             HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhcChhhccCCCccCCCc
Confidence            9999999999999999999743 357899999999999999999999999999999999999999999998887777654


Q ss_pred             CC---CCCCCCccCeeeecCCc
Q 047009          454 TP---KNNTNPFADFSYVRPAA  472 (482)
Q Consensus       454 ~~---~~~~~~f~~f~~~~~~~  472 (482)
                      ..   ..++..|.||+|+.|..
T Consensus       368 ~~~~~~~~~~~f~~f~~~~~~~  389 (396)
T 4dc2_A          368 DDIVRKIDQSEFEGFEYINPLL  389 (396)
T ss_dssp             HHHHTTSCGGGGTTCCEECC--
T ss_pred             chhhccccccccCCcEeECccc
Confidence            32   34567899999999875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-65  Score=524.05  Aligned_cols=326  Identities=39%  Similarity=0.737  Sum_probs=290.4

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  225 (482)
                      +.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.+ +||||++++++|++.+.+
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            5678999999999999999999999999999999999987666666777788999999998 799999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~  304 (482)
                      |+||||++||+|..++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+... ...
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV  179 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCc
Confidence            9999999999999999998999999999999999999999999999999999999999999999999999998643 344


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhh
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L  384 (482)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++.+.|......+|..++.++++||++||
T Consensus       180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL  259 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFM  259 (353)
T ss_dssp             ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            55678999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcCCcCCC-CCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCC
Q 047009          385 QKEPGKRLGA-GPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP---KNNTN  460 (482)
Q Consensus       385 ~~dP~~R~s~-~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~---~~~~~  460 (482)
                      ++||.+||++ ...+.+||++||||++++|+.+..+++.|||+|.+.+..++++|+..++.+....+|....   ..++.
T Consensus       260 ~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  339 (353)
T 3txo_A          260 TKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQD  339 (353)
T ss_dssp             CSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCHHHHTSCCCCCCCCTTSGGGSCGG
T ss_pred             hhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCcccccccCcccccCCCcCCCccccccCccccc
Confidence            9999999997 3356789999999999999999999999999999999999999999988776655554432   23567


Q ss_pred             CccCeeeecCCc
Q 047009          461 PFADFSYVRPAA  472 (482)
Q Consensus       461 ~f~~f~~~~~~~  472 (482)
                      .|.||+|+.|..
T Consensus       340 ~f~~f~~~~~~~  351 (353)
T 3txo_A          340 EFRNFEYVSPEL  351 (353)
T ss_dssp             GGTTCCEECC--
T ss_pred             ccCCceeeCccc
Confidence            899999998753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.2e-65  Score=515.95  Aligned_cols=324  Identities=39%  Similarity=0.771  Sum_probs=292.9

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++||||++++++|++.+.+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            35689999999999999999999999999999999999876555566777889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc-cCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTR  305 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~~  305 (482)
                      +||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.. .....
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            99999999999999998899999999999999999999999999999999999999999999999999999874 33445


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhc
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...+.+.+....+.+|..+++++++||++||+
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~  241 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK  241 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence            66789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC----------
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP----------  455 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~----------  455 (482)
                      +||.+||+.++.+++||++||||++++|+.+..+++.|||+|.+.+..+.++|+..++..+...++....          
T Consensus       242 ~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (337)
T 1o6l_A          242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQ  321 (337)
T ss_dssp             SSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC-----------------
T ss_pred             cCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhcccchhccCccCcCCCccccccccccccc
Confidence            9999999876677899999999999999999999999999999999999999998888776655443221          


Q ss_pred             CCCCCCccCeeeecC
Q 047009          456 KNNTNPFADFSYVRP  470 (482)
Q Consensus       456 ~~~~~~f~~f~~~~~  470 (482)
                      ..++..|.||+|+.+
T Consensus       322 ~~~~~~f~~f~~~~~  336 (337)
T 1o6l_A          322 REEQEMFEDFDYIAD  336 (337)
T ss_dssp             ---CCTTTTCCEECC
T ss_pred             ccccccCCCceecCC
Confidence            114689999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.2e-66  Score=508.34  Aligned_cols=255  Identities=31%  Similarity=0.553  Sum_probs=221.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|++++|||||+++++|++.+.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            57999999999999999999999999999999999987666666677889999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS  308 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  308 (482)
                      |||| +|+|.+++.+++.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.........+
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~  170 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT  170 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence            9999 679999999999999999999999999999999999999999999999999999999999999998777666778


Q ss_pred             cccCCCCCchhhhcCCCC-CchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccC
Q 047009          309 MIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE  387 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~-~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~d  387 (482)
                      .+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+...+.+.+.++.+.+|..+|+++++||++||++|
T Consensus       171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d  250 (275)
T 3hyh_A          171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN  250 (275)
T ss_dssp             ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSS
T ss_pred             eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCC
Confidence            899999999999999887 5799999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCcCCCCCCChHHHHhCcCCC
Q 047009          388 PGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       388 P~~R~s~~~~~~~eil~hp~f~  409 (482)
                      |++|||+     +|+++||||+
T Consensus       251 P~~R~s~-----~eil~hpw~k  267 (275)
T 3hyh_A          251 PLNRISI-----HEIMQDDWFK  267 (275)
T ss_dssp             GGGSCCH-----HHHHHCHHHH
T ss_pred             hhHCcCH-----HHHHcCcccc
Confidence            9999998     9999999996

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=7.1e-65  Score=518.18  Aligned_cols=325  Identities=38%  Similarity=0.758  Sum_probs=294.0

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  225 (482)
                      ..+++|++++.||+|+||+||+|+++.+++.||||++++.........+.+.+|..+|..+ +||||++++++|++.+.+
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            5578999999999999999999999999999999999987665556677788999999988 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~  304 (482)
                      |+||||++||+|..++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++... ...
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  176 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence            9999999999999999988899999999999999999999999999999999999999999999999999998743 344


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhh
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L  384 (482)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++.+.|....+.+|..++.++++||++||
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL  256 (353)
T 2i0e_A          177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM  256 (353)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence            56678999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCCC
Q 047009          385 QKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP---KNNTNP  461 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~---~~~~~~  461 (482)
                      ++||.+||+++..++++|++||||++++|+.+..++++|||+|.+.+. +.++|+..++..+...++....   ..++..
T Consensus       257 ~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~-~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (353)
T 2i0e_A          257 TKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDRFFTRHPPVLTPPDQEVIRNIDQSE  335 (353)
T ss_dssp             CSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC---CHHHHHHHHSCCCCCCCCHHHHHHSCTTT
T ss_pred             hcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc-chhhccchhccCCcccCCccccccccccccc
Confidence            999999999877788999999999999999999999999999999888 8999998887665544443321   135688


Q ss_pred             ccCeeeecCCc
Q 047009          462 FADFSYVRPAA  472 (482)
Q Consensus       462 f~~f~~~~~~~  472 (482)
                      |.||+|+.|..
T Consensus       336 f~~f~~~~~~~  346 (353)
T 2i0e_A          336 FEGFSFVNSEF  346 (353)
T ss_dssp             TCSCCEECTTC
T ss_pred             cCCCeeeCccc
Confidence            99999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.2e-64  Score=516.22  Aligned_cols=328  Identities=44%  Similarity=0.788  Sum_probs=256.7

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHH-HHhCCCCceeeeeeeeecCCe
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI-LTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ....++|++++.||+|+||+||+|+++.+++.||||++++...........+.+|..+ ++.++||||++++++|++.+.
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            3556899999999999999999999999999999999998776555556667778777 567899999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc-cCC
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~  303 (482)
                      +|+||||++||+|..++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++.. ...
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            9999999999999999998899999999999999999999999999999999999999999999999999999874 344


Q ss_pred             CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHh
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~  383 (482)
                      ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++.+.|......+|..++.++++||++|
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~l  273 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL  273 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHH
T ss_pred             CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Confidence            55667899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC--------
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP--------  455 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~--------  455 (482)
                      |++||.+|+++. .++++|++||||++++|+.+..+++.|||.|.+.+..++++|+..++.++...+....+        
T Consensus       274 L~~dp~~R~~~~-~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  352 (373)
T 2r5t_A          274 LQKDRTKRLGAK-DDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTAS  352 (373)
T ss_dssp             TCSSGGGSTTTT-TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC--------------------------------
T ss_pred             cccCHHhCCCCC-CCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcchhhhcCcccccccccccccCCccccccccc
Confidence            999999999983 56789999999999999999999999999999999999999998888776544322111        


Q ss_pred             -CCCCCCccCeeeecCCccc
Q 047009          456 -KNNTNPFADFSYVRPAASF  474 (482)
Q Consensus       456 -~~~~~~f~~f~~~~~~~~~  474 (482)
                       ...+..|.||+|+.|...+
T Consensus       353 ~~~~~~~f~~f~~~~~~~~~  372 (373)
T 2r5t_A          353 VKEAAEAFLGFSYAPPTDSF  372 (373)
T ss_dssp             --------------------
T ss_pred             cccccccCCCCcccCchhhc
Confidence             1235679999999987644

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.4e-64  Score=510.13  Aligned_cols=322  Identities=38%  Similarity=0.723  Sum_probs=262.6

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCe
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  224 (482)
                      ...+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+..|..++..+ +||||++++++|++...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            35678999999999999999999999999999999999987655555667788899999886 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CC
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-EN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~  303 (482)
                      +|+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++... ..
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999998743 33


Q ss_pred             CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHh
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~  383 (482)
                      ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++.+.|......+|..++.++++||++|
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l  252 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL  252 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHH
Confidence            44567899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCcCCcCCCCCCChH-HHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCC
Q 047009          384 LQKEPGKRLGAGPKGSE-EIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP---KNNT  459 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~-eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~---~~~~  459 (482)
                      |++||.+||++     . +|++||||++++|+.+..+++.|||+|.+.+..+.++|+..++......++....   ..++
T Consensus       253 L~~dp~~R~~~-----~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~  327 (345)
T 1xjd_A          253 FVREPEKRLGV-----RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQ  327 (345)
T ss_dssp             SCSSGGGSBTT-----BSCGGGSGGGTTCCHHHHHTTCSCC--------------------------------------C
T ss_pred             hcCCHhHcCCC-----hHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcchhhhcchhhcccCccCCcccccccccccc
Confidence            99999999998     5 9999999999999999999999999999999999999998887765444433221   2356


Q ss_pred             CCccCeeeecCCc
Q 047009          460 NPFADFSYVRPAA  472 (482)
Q Consensus       460 ~~f~~f~~~~~~~  472 (482)
                      ..|.||+|+.|..
T Consensus       328 ~~f~~f~~~~~~~  340 (345)
T 1xjd_A          328 NMFRNFSFMNPGM  340 (345)
T ss_dssp             CTTTTCCC-----
T ss_pred             cccCCCeeeChhh
Confidence            8999999998764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.5e-65  Score=515.17  Aligned_cols=257  Identities=30%  Similarity=0.555  Sum_probs=230.7

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|++|+|||||+++++|++.+.+||
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            368999999999999999999999999999999999887643 3456778999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-C
Q 047009          228 VLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-T  304 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~  304 (482)
                      |||||+||+|.+++..+  ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+... .
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            99999999999999754  35799999999999999999999999999999999999999999999999999986543 2


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CCCccCChHHHHHHHHh
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~LI~~~  383 (482)
                      ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|..+.+ .++..+|+++++||.+|
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~  260 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL  260 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHH
Confidence            34567899999999999999999999999999999999999999999999999999988765 56778999999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      |++||++||++     +|+++||||+.
T Consensus       261 L~~dP~~R~s~-----~e~l~hp~~~~  282 (350)
T 4b9d_A          261 FKRNPRDRPSV-----NSILEKGFIAK  282 (350)
T ss_dssp             TCSSGGGSCCH-----HHHHTSHHHHT
T ss_pred             ccCChhHCcCH-----HHHhcCHHhhc
Confidence            99999999998     99999999974

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.1e-63  Score=505.60  Aligned_cols=325  Identities=36%  Similarity=0.772  Sum_probs=291.9

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  225 (482)
                      ..+++|++++.||+|+||+||+|+++.+++.||||++.+.........+.+.+|+.+++++ +||||++++++|++...+
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            4568999999999999999999999999999999999987766666777888999999988 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc-cCCC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~~  304 (482)
                      |+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.. ....
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            999999999999999998889999999999999999999999999999999999999999999999999999864 3344


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCC---------CchHHHHHHHHhcccCCCccCChH
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIG---------GNRAKIQQKIVKDKLRLPAFLSSE  375 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~---------~~~~~~~~~i~~~~~~~p~~~s~~  375 (482)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..         .+...+.+.+....+.+|..++.+
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~  245 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK  245 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHH
Confidence            56678999999999999999999999999999999999999999965         344567788888899999999999


Q ss_pred             HHHHHHHhhccCcCCcCCCCC-CChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC
Q 047009          376 AHSLLKGLLQKEPGKRLGAGP-KGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT  454 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~-~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~  454 (482)
                      +++||++||++||.+||++.+ .+.+||++||||++++|+.+..+++.|||+|.+.+..++++|+..++..+...++...
T Consensus       246 ~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (345)
T 3a8x_A          246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDD  325 (345)
T ss_dssp             HHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTTTCGGGSCHHHHTSCSSCCCCCH
T ss_pred             HHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCcccCCCccc
Confidence            999999999999999999742 3568999999999999999999999999999999999999999888777665554432


Q ss_pred             ---CCCCCCCccCeeeecCC
Q 047009          455 ---PKNNTNPFADFSYVRPA  471 (482)
Q Consensus       455 ---~~~~~~~f~~f~~~~~~  471 (482)
                         ...++..|.||+|+.|.
T Consensus       326 ~~~~~~~~~~f~~f~~~~~~  345 (345)
T 3a8x_A          326 DIVRKIDQSEFEGFEYINPL  345 (345)
T ss_dssp             HHHTTSCGGGGTTCCEECCC
T ss_pred             cccccccccccCCCEeeCCC
Confidence               12356789999999874

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.6e-64  Score=508.99  Aligned_cols=253  Identities=29%  Similarity=0.490  Sum_probs=231.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      +.|++++.||+|+||+||+|+++.+|+.||||++.+...   ...+.+.+|+.+|++++|||||+++++|++.+.+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            569999999999999999999999999999999986543   23345789999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~  308 (482)
                      |||+||+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.. .....+
T Consensus       151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence            99999999998865 6799999999999999999999999999999999999999999999999999998754 345677


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc---cCCCccCChHHHHHHHHhhc
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~LI~~~L~  385 (482)
                      .+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++.+.|....   +..+..+|+++++||.+||+
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  309 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  309 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcC
Confidence            899999999999999999999999999999999999999999999999988888763   33445789999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      +||++||++     +|+++||||+..
T Consensus       310 ~dP~~R~ta-----~e~l~Hp~~~~~  330 (346)
T 4fih_A          310 RDPAQRATA-----AELLKHPFLAKA  330 (346)
T ss_dssp             SSTTTSCCH-----HHHTTCGGGGGC
T ss_pred             CChhHCcCH-----HHHhcCHhhcCC
Confidence            999999998     999999999853

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.8e-63  Score=544.64  Aligned_cols=326  Identities=38%  Similarity=0.750  Sum_probs=299.3

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCe
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  224 (482)
                      ...+++|++++.||+|+||+||+|+++.+++.||||++++.........+.+..|..+|..+ +||||++++++|++.+.
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            45678999999999999999999999999999999999987665566667788899999987 79999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc-cCC
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~-~~~  303 (482)
                      +||||||++||+|..++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.. ...
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            9999999999999999999899999999999999999999999999999999999999999999999999999864 344


Q ss_pred             CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHh
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~  383 (482)
                      ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++.+.|....+.+|..+++++++||++|
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l  576 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL  576 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            45667899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATP---KNNTN  460 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~---~~~~~  460 (482)
                      |++||.+|+++++.+++||++||||++++|+.+..++++|||+|.+.+ .+.+||+..++..+...++....   ..++.
T Consensus       577 L~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~-~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  655 (674)
T 3pfq_A          577 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG-RNAENFDRFFTRHPPVLTPPDQEVIRNIDQS  655 (674)
T ss_dssp             SCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG-GGHHHHTTTTTSSCSSCCCCCHHHHTTCCGG
T ss_pred             ccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC-CchhhcCchhccCCCccCCCchhhhhccccc
Confidence            999999999997778899999999999999999999999999999988 88999999999887766665432   34578


Q ss_pred             CccCeeeecCCc
Q 047009          461 PFADFSYVRPAA  472 (482)
Q Consensus       461 ~f~~f~~~~~~~  472 (482)
                      .|.||+|+.|..
T Consensus       656 ~f~~f~~~~~~~  667 (674)
T 3pfq_A          656 EFEGFSFVNSEF  667 (674)
T ss_dssp             GGTTCCEECSSC
T ss_pred             ccCCCcccChhh
Confidence            899999998875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.8e-63  Score=513.20  Aligned_cols=327  Identities=36%  Similarity=0.659  Sum_probs=281.0

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ...++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||++++++|++...+|
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            45689999999999999999999999999999999998866555455556789999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--  304 (482)
                      +||||++||+|..++.. ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......  
T Consensus       146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~  224 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  224 (410)
T ss_dssp             EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence            99999999999998865 568999999999999999999999999999999999999999999999999998765433  


Q ss_pred             CCcccccCCCCCchhhhcCCC----CCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc--cCCCc--cCChHH
Q 047009          305 RSNSMIGTVEYMAPEIVLGKG----HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPA--FLSSEA  376 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~----~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~--~~s~~~  376 (482)
                      ...+.+||+.|+|||++.+..    |+.++|||||||++|||++|+.||.+.+...+..+|....  +.+|.  .++.++
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  304 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  304 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence            245779999999999998776    7899999999999999999999999999999999988753  45554  689999


Q ss_pred             HHHHHHhhccCcCC--cCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC
Q 047009          377 HSLLKGLLQKEPGK--RLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT  454 (482)
Q Consensus       377 ~~LI~~~L~~dP~~--R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~  454 (482)
                      ++||++||+.+|.+  |+++     +||++||||++++|+.+..+++.|||+|.+.+..+.++|+..........+....
T Consensus       305 ~~li~~lL~~~~~rlgR~~~-----~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd~~~~~~~~~~~~~~~  379 (410)
T 3v8s_A          305 KNLICAFLTDREVRLGRNGV-----EEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIP  379 (410)
T ss_dssp             HHHHHHHSSCGGGCTTSSCH-----HHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSCCCCSCCSCCCCCCCC
T ss_pred             HHHHHHHccChhhhCCCCCH-----HHHhcCccccCCCHHHHhhcccCCCCCCcCCCccchhhcCCccccccccccCCCc
Confidence            99999999988888  8887     9999999999999999999999999999999999999999876654332222111


Q ss_pred             --CCCCCCCccCeeeecCCccccccCCC
Q 047009          455 --PKNNTNPFADFSYVRPAASFLQSNSP  480 (482)
Q Consensus       455 --~~~~~~~f~~f~~~~~~~~~~~~~~~  480 (482)
                        ...++.+|.||+|++|.. |+.+.+|
T Consensus       380 ~~~~~~~~~f~~f~~~~~~~-~~~~~~~  406 (410)
T 3v8s_A          380 KAFVGNQLPFVGFTYYSNRR-YLSSANP  406 (410)
T ss_dssp             SSCCCTTGGGTTCCEECC----------
T ss_pred             hhhcccccccccceEeCccc-ccccCCC
Confidence              124578999999999988 8877665

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-62  Score=510.30  Aligned_cols=253  Identities=29%  Similarity=0.490  Sum_probs=232.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      +.|++++.||+|+||+||+|+++.+|+.||||++.+...   ...+.+.+|+.+|++++|||||+++++|.+.+.+||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            579999999999999999999999999999999986543   23445789999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~  308 (482)
                      |||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.. .....+
T Consensus       228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred             eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence            99999999998864 5699999999999999999999999999999999999999999999999999998754 345678


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc---cCCCccCChHHHHHHHHhhc
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~LI~~~L~  385 (482)
                      .|||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...|....   +..+..+|+++++||.+||+
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  386 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  386 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence            899999999999999999999999999999999999999999999999998888763   34456799999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      +||++|+++     +|+|+||||+..
T Consensus       387 ~dP~~R~ta-----~ell~Hp~~~~~  407 (423)
T 4fie_A          387 RDPAQRATA-----AELLKHPFLAKA  407 (423)
T ss_dssp             SSTTTSCCH-----HHHTTCGGGGGC
T ss_pred             CChhHCcCH-----HHHhcCHHhcCC
Confidence            999999998     999999999853

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-61  Score=485.81  Aligned_cols=315  Identities=37%  Similarity=0.735  Sum_probs=271.4

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ..+++|++++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+++.++||||++++++|++...+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            45689999999999999999999999999999999999876555556677889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      +||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....  ..
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~  160 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VT  160 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CB
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--cc
Confidence            9999999999999999988999999999999999999999999999999999999999999999999999987643  34


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhcc
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~  386 (482)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+....+.+|..++.++++||++||++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~  240 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITR  240 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcc
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccC-CcccccCccccccCCCCCCCCCCCCCCCCCCccCe
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVA-GKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADF  465 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~-~~~~~~~f~~~~~~~~~~~s~~~~~~~~~~~f~~f  465 (482)
                      ||.+|++....++++|++||||++++|+.+..+.+.|||.|.+. +..+.++|+.. .+......+.. ....+..|.||
T Consensus       241 dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~d~~~f~~~-~~~~~~~~~~~-~~~~~~~f~~f  318 (318)
T 1fot_A          241 DLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKY-PEEDINYGVQG-EDPYADLFRDF  318 (318)
T ss_dssp             CTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-----------------CCCTTCCS-CCTTGGGSCCC
T ss_pred             CHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCCCccchhhcCCC-CccccccCccC-CchhhhhccCC
Confidence            99999976555679999999999999999999999999999987 57889999863 32222222211 12234678776

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.4e-61  Score=490.42  Aligned_cols=313  Identities=39%  Similarity=0.743  Sum_probs=284.5

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+...+|
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            34689999999999999999999999999999999998876655566777889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      +||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....  ..
T Consensus       118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--~~  195 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RT  195 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--CB
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC--Cc
Confidence            9999999999999999888999999999999999999999999999999999999999999999999999987643  34


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhcc
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~  386 (482)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.+.+..+.+.+|..++.++++||++||++
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~  275 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV  275 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCCCCCCCCCccCe
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADF  465 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~~~~~~~~f~~f  465 (482)
                      ||.+||+....+++||++||||++++|..+..+++.|||+|.+.+..+.++|+ .++......++.   ...+..|.||
T Consensus       276 dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~-~~~~~~~~~~~~---~~~~~~f~~f  350 (350)
T 1rdq_E          276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD-DYEEEEIRVSIN---EKCGKEFTEF  350 (350)
T ss_dssp             CTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC-CCCCCCCCCCSS---CCSTTTTTTC
T ss_pred             CHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccccccc-cccccccccCCC---cchhhhcCCC
Confidence            99999996556679999999999999999999999999999999999999998 455444333221   2234678876

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.6e-62  Score=481.83  Aligned_cols=253  Identities=25%  Similarity=0.441  Sum_probs=223.3

Q ss_pred             CCe-EEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec----CCe
Q 047009          150 EDF-EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT----KYR  224 (482)
Q Consensus       150 ~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~  224 (482)
                      ++| ++.++||+|+||+||+|+++.+++.||+|++.+.... ....+.+.+|+.+|++++|||||+++++|++    ...
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            445 7888999999999999999999999999999876543 3456778999999999999999999999865    456


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEcc-CCceeEcccCcccccc
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG--IMHRDLKPENILLGA-DGHVMLTDFGLAKQFD  301 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--IiHrDLKp~NILl~~-~g~vKL~DFGla~~~~  301 (482)
                      +|||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|  ||||||||+||||+. +|.+||+|||+|+...
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            8999999999999999999999999999999999999999999998  999999999999984 8999999999998643


Q ss_pred             CCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc-hHHHHHHHHhccc--CCCccCChHHHH
Q 047009          302 ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN-RAKIQQKIVKDKL--RLPAFLSSEAHS  378 (482)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~-~~~~~~~i~~~~~--~~p~~~s~~~~~  378 (482)
                       .....+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.+ ...+...+..+..  .++..+++++++
T Consensus       184 -~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (290)
T 3fpq_A          184 -ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE  261 (290)
T ss_dssp             -TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             -CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence             345567899999999999976 59999999999999999999999997654 4556666665532  355678999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      ||.+||++||++|||+     +|+++||||+.
T Consensus       262 li~~~L~~dP~~R~s~-----~e~l~Hp~~~~  288 (290)
T 3fpq_A          262 IIEGCIRQNKDERYSI-----KDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHSCSSGGGSCCH-----HHHHTSGGGC-
T ss_pred             HHHHHccCChhHCcCH-----HHHhcCccccC
Confidence            9999999999999998     99999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2e-62  Score=494.63  Aligned_cols=244  Identities=27%  Similarity=0.404  Sum_probs=221.5

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ..++|++.++||+|+||+||+|+++.+|+.||||+++++..        ..+|+.+|++++|||||+++++|++.+.+||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45789999999999999999999999999999999987643        2369999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC-ceeEcccCccccccCCC--
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG-HVMLTDFGLAKQFDENT--  304 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~--  304 (482)
                      |||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+....  
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999999999999999999999999999999999999999999999999998 69999999999865432  


Q ss_pred             ----CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc---CCCccCChHHH
Q 047009          305 ----RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL---RLPAFLSSEAH  377 (482)
Q Consensus       305 ----~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~---~~p~~~s~~~~  377 (482)
                          .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|..+..   .+|..++++++
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence                22346899999999999999999999999999999999999999999888888888888764   46788999999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +||.+||++||.+||++     .||++
T Consensus       288 ~li~~~L~~dP~~R~sa-----~el~~  309 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASA-----MELRR  309 (336)
T ss_dssp             HHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHccCCHhHCcCH-----HHHHH
Confidence            99999999999999998     88743

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2e-61  Score=506.10  Aligned_cols=324  Identities=33%  Similarity=0.636  Sum_probs=276.6

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ...++|+++++||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..++||||++++++|++...+|
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            45689999999999999999999999999999999998865544445555789999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          227 LVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      +||||++||+|..++.+ .+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.......
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            99999999999999987 57899999999999999999999999999999999999999999999999999987644332


Q ss_pred             --CcccccCCCCCchhhhc-----CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc--ccCCCcc---CC
Q 047009          306 --SNSMIGTVEYMAPEIVL-----GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--KLRLPAF---LS  373 (482)
Q Consensus       306 --~~~~~gt~~y~APE~l~-----~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~~---~s  373 (482)
                        ....+||+.|+|||++.     +..|+.++|||||||++|||++|+.||.+.+..+...+|...  .+.+|..   ++
T Consensus       231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s  310 (437)
T 4aw2_A          231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS  310 (437)
T ss_dssp             EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSC
T ss_pred             cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCC
Confidence              34578999999999997     567899999999999999999999999999999999888764  4566654   89


Q ss_pred             hHHHHHHHHhhccCcCC--cCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCC
Q 047009          374 SEAHSLLKGLLQKEPGK--RLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSP  451 (482)
Q Consensus       374 ~~~~~LI~~~L~~dP~~--R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~  451 (482)
                      +++++||++||..+|++  |+++     +||++||||++++|+.+  ++++|||+|.+.+..+.++|+..+.......++
T Consensus       311 ~~~~dLi~~lL~~~~~r~~r~~~-----~eil~Hpff~~i~w~~l--~~~~~p~~P~~~~~~d~~~fd~~~~~~~~~~~~  383 (437)
T 4aw2_A          311 ENAKDLIRRLICSREHRLGQNGI-----EDFKKHPFFSGIDWDNI--RNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETM  383 (437)
T ss_dssp             HHHHHHHHTTSSCGGGCTTTTTT-----HHHHTSGGGTTCCTTTG--GGSCCSCCCCCSSTTCCTTSCCC----------
T ss_pred             HHHHHHHHHHhcccccccCCCCH-----HHHhCCCccCCCCHHHH--hhCCCCCCCcCCCccchhhcCCcccccccccCC
Confidence            99999999999998888  8887     99999999999999998  578999999999999999999877655443332


Q ss_pred             CCC----CCCCCCCccCeeeecCCccccccC
Q 047009          452 AAT----PKNNTNPFADFSYVRPAASFLQSN  478 (482)
Q Consensus       452 ~~~----~~~~~~~f~~f~~~~~~~~~~~~~  478 (482)
                      ...    ......+|.||+|+++.. +.+.+
T Consensus       384 ~~~~~~~~~~~~~~f~~~~~~~~~~-~~~~~  413 (437)
T 4aw2_A          384 PPPTHTAFSGHHLPFVGFTYTSSCV-LSDRS  413 (437)
T ss_dssp             --------CCTTGGGTTCCEESSCT-TSTTS
T ss_pred             CCCccccccccCccccCCCcCCchh-hccCC
Confidence            221    123457899999999887 44443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.5e-61  Score=497.36  Aligned_cols=321  Identities=36%  Similarity=0.657  Sum_probs=269.1

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ...++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.++..++||||++++++|++...+|
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            45689999999999999999999999999999999998866555555566889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      +||||++||+|..++.+.+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus       138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~  217 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT  217 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence            9999999999999998764 799999999999999999999999999999999999999999999999999988654332


Q ss_pred             --CcccccCCCCCchhhhc-------CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc--ccCCC---cc
Q 047009          306 --SNSMIGTVEYMAPEIVL-------GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--KLRLP---AF  371 (482)
Q Consensus       306 --~~~~~gt~~y~APE~l~-------~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p---~~  371 (482)
                        ....+||+.|+|||++.       +..|+.++|||||||++|||++|+.||.+.+..+++.+|...  .+.+|   ..
T Consensus       218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  297 (412)
T 2vd5_A          218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG  297 (412)
T ss_dssp             EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----C
T ss_pred             cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccC
Confidence              34579999999999997       457899999999999999999999999999999988888764  34455   57


Q ss_pred             CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCC----
Q 047009          372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPL----  447 (482)
Q Consensus       372 ~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~----  447 (482)
                      ++.++++||++||. +|.+|++.  .+++||++||||++++|+.+.  ...|||+|.+.+..++++|+........    
T Consensus       298 ~s~~~~dli~~lL~-~p~~Rlgr--~~~~ei~~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~  372 (412)
T 2vd5_A          298 VPEEARDFIQRLLC-PPETRLGR--GGAGDFRTHPFFFGLDWDGLR--DSVPPFTPDFEGATDTCNFDLVEDGLTAMVSG  372 (412)
T ss_dssp             CCHHHHHHHHTTSS-CGGGCTTT--TTHHHHHTSGGGTTCCSTTST--TSCCSCCCC-----CCSSCC--CCCCCTTSSS
T ss_pred             CCHHHHHHHHHHcC-ChhhcCCC--CCHHHHhcCCCcCCCCHHHHh--hcCCCCCCcCCCcccccccCcccccccccccc
Confidence            99999999999999 99999853  466999999999999999984  5689999999999999999874332111    


Q ss_pred             -----CCCCCCCCCCCCCCccCeeeecCCc
Q 047009          448 -----SDSPAATPKNNTNPFADFSYVRPAA  472 (482)
Q Consensus       448 -----~~s~~~~~~~~~~~f~~f~~~~~~~  472 (482)
                           .+.....+...+.+|.||+|+++..
T Consensus       373 ~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~  402 (412)
T 2vd5_A          373 GGETLSDIREGAPLGVHLPFVGYSYSCMAL  402 (412)
T ss_dssp             SSCCTTTC-----CCTTGGGTTCCBSCCCC
T ss_pred             cCCCcccccCCCccccCCCCCCCcccCccc
Confidence                 1111111223457899999998765

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-59  Score=482.94  Aligned_cols=257  Identities=25%  Similarity=0.389  Sum_probs=226.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec------CC
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT------KY  223 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~  223 (482)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            679999999999999999999999999999999976543 33445678899999999999999999998754      46


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-
Q 047009          224 RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-  302 (482)
                      .+|||||||+ |+|+.++.+++.+++..++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.. 
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            7999999996 67999999889999999999999999999999999999999999999999999999999999987632 


Q ss_pred             ----CCCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC--------
Q 047009          303 ----NTRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP--------  369 (482)
Q Consensus       303 ----~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p--------  369 (482)
                          .....+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+..+.|.......+        
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence                2345678999999999999885 569999999999999999999999999998888888765322111        


Q ss_pred             -----------------------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          370 -----------------------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       370 -----------------------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                                             ..+++++++||++||++||++|+|+     +|+|+||||+....
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-----~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA-----AAALRHPFLAKYHD  353 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCH-----HHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCH-----HHHhcCHhhCcCCC
Confidence                                   2468999999999999999999999     99999999998654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4e-60  Score=472.21  Aligned_cols=254  Identities=28%  Similarity=0.474  Sum_probs=205.4

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC-----
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY-----  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  223 (482)
                      ++||++++.||+|+||+||+|+++.+|+.||||+++...  .....+.+.+|+.+|++++|||||+++++|.+.+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            357999999999999999999999999999999997653  2344567889999999999999999999987544     


Q ss_pred             -------eEEEEEEecCCCchHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcc
Q 047009          224 -------RLYLVLDFINGGHLFFQLYHHGLF---REDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTD  293 (482)
Q Consensus       224 -------~~~lV~E~~~gg~L~~~l~~~~~l---~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~D  293 (482)
                             .+|+|||||+||+|.+++..++.+   .+..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   479999999999999999877654   3456889999999999999999999999999999999999999999


Q ss_pred             cCccccccCCC-------------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch-HHHHH
Q 047009          294 FGLAKQFDENT-------------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR-AKIQQ  359 (482)
Q Consensus       294 FGla~~~~~~~-------------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~-~~~~~  359 (482)
                      ||+|+.+....             ...+.+||+.|||||++.+..|+.++|||||||++|||++   ||.+... .....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            99998865332             1235689999999999999999999999999999999996   8864322 22333


Q ss_pred             HHHhcccCCCc---cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          360 KIVKDKLRLPA---FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       360 ~i~~~~~~~p~---~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                      .+..  ..+|+   ..++.+++||++||++||++||++     .|+++||||++++|.
T Consensus       239 ~~~~--~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~eil~h~~~~~~~~p  289 (299)
T 4g31_A          239 DVRN--LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA-----INIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHT--TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGCCC---
T ss_pred             HHhc--CCCCCCCcccCHHHHHHHHHHcCCChhHCcCH-----HHHhcCHhhCCCCCC
Confidence            3333  33443   356788999999999999999998     999999999999984

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.5e-59  Score=490.12  Aligned_cols=300  Identities=41%  Similarity=0.772  Sum_probs=261.2

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      .+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+++.++||||++++++|.+.+.+
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            35668999999999999999999999999999999999887655555666778899999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCceeEcccCcccccc-CC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-EN  303 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~  303 (482)
                      |+||||++||+|..++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+|+... ..
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            9999999999999999988999999999999999999999998 999999999999999999999999999998743 33


Q ss_pred             CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHh
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~  383 (482)
                      ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...+...+......+|..+++++++||.+|
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  383 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL  383 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            44567899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDM  445 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~  445 (482)
                      |++||.+||+.+..+++|+++||||++++|+.+..+.+.|||+|.+....+..+|+++++.+
T Consensus       384 L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~~~~~~~  445 (446)
T 4ejn_A          384 LKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQ  445 (446)
T ss_dssp             TCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSSTTCCTTC-------
T ss_pred             cccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCccchhhcchhhhcC
Confidence            99999999965555669999999999999999999999999999999999999999988754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.4e-58  Score=466.11  Aligned_cols=305  Identities=50%  Similarity=0.902  Sum_probs=248.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEc---CCCeEEEEEEeechhhch-hhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKK---NTSEIYAMKVMRKDKIVE-KNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      +..++|++++.||+|+||.||+|++.   .+++.||+|++++..... ......+.+|+.+|+.++||||+++++++.+.
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            44578999999999999999999985   688999999998764322 23445677899999999999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-  301 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-  301 (482)
                      +.+|+||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++... 
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            9999999999999999999988899999999999999999999999999999999999999999999999999998643 


Q ss_pred             CCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHH
Q 047009          302 ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~  381 (482)
                      ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....+.+.+....+|..++.++++||.
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  253 (327)
T 3a62_A          174 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK  253 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred             CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            33345567899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSP  451 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~  451 (482)
                      +||++||.+||++.+.++.++++||||++++|+.+..+.+.|||.|......+.++|+..++.....+++
T Consensus       254 ~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~  323 (327)
T 3a62_A          254 KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSP  323 (327)
T ss_dssp             HHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC-----------------------
T ss_pred             HHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcCChhhhhhcchhhhccccCCCC
Confidence            9999999999988666789999999999999999999999999999999888999998877665444443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.9e-58  Score=474.42  Aligned_cols=289  Identities=36%  Similarity=0.701  Sum_probs=265.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+|+.++||||++++++|++...+|
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   91 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF   91 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            55689999999999999999999999999999999999877666666778889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      +||||+.||+|..++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+......
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  171 (384)
T 4fr4_A           92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI  171 (384)
T ss_dssp             EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCce
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999988777777


Q ss_pred             cccccCCCCCchhhhcC---CCCCchhHHHHHhHHHHHHhhCCCCCCC---CchHHHHHHHHhcccCCCccCChHHHHHH
Q 047009          307 NSMIGTVEYMAPEIVLG---KGHNKAADWWSVGILLYEMLTGKPPFIG---GNRAKIQQKIVKDKLRLPAFLSSEAHSLL  380 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~---~~~~~~sDvwSlGvilyelltG~~PF~~---~~~~~~~~~i~~~~~~~p~~~s~~~~~LI  380 (482)
                      ...+||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||..   .....+...+......+|..++.++.+||
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li  251 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLL  251 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHH
Confidence            88899999999999974   4689999999999999999999999974   34456677777888899999999999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCcc
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFE  439 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~  439 (482)
                      ++||++||.+||++    ++++++||||++++|+.+..+.+.|||+|.....++...|+
T Consensus       252 ~~lL~~dP~~R~s~----~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~~~~~~~~~~~  306 (384)
T 4fr4_A          252 KKLLEPNPDQRFSQ----LSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFE  306 (384)
T ss_dssp             HHHSCSSGGGSCCS----HHHHHTSGGGTTCCHHHHHTTCSCCCCCCSCCSSCCCCCCC
T ss_pred             HHHhcCCHhHhccc----HHHHHcChhhhcCCHHHHHhCCCCCCCCCCCCCCCCCCccC
Confidence            99999999999984    39999999999999999999999999999987665555554

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9.1e-59  Score=497.19  Aligned_cols=323  Identities=32%  Similarity=0.607  Sum_probs=279.9

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      ....++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++||||++++++|++...+
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            35668999999999999999999999999999999999987765556667788999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          226 YLVLDFINGGHLFFQLYHH----GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      |+||||++||+|..++...    ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+.
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999999998764    369999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCC-CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC----chHHHHHHHHhcccCCCccCChHH
Q 047009          302 ENTR-SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG----NRAKIQQKIVKDKLRLPAFLSSEA  376 (482)
Q Consensus       302 ~~~~-~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~----~~~~~~~~i~~~~~~~p~~~s~~~  376 (482)
                      .... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.    +...+.+.+......+|..++.++
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~  420 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS  420 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHH
Confidence            4433 34569999999999999999999999999999999999999999875    456788888888899999999999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCc-----ccccCccccccCCCCCCCC
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGK-----HCIANFEKKWTDMPLSDSP  451 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~-----~~~~~f~~~~~~~~~~~s~  451 (482)
                      ++||++||++||.+||++...++++|++||||++++|..+..+.+.|||+|.....     .+..+|+...        .
T Consensus       421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~d~~~f~~~~--------~  492 (543)
T 3c4z_A          421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTVK--------G  492 (543)
T ss_dssp             HHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCSSSCCSCC----CCCC-----------C
T ss_pred             HHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCccccccCCchhhhhccccC--------C
Confidence            99999999999999999865677999999999999999999999999999987532     2333443210        0


Q ss_pred             CCCCCCCCCCccCeeeecCCccccc
Q 047009          452 AATPKNNTNPFADFSYVRPAASFLQ  476 (482)
Q Consensus       452 ~~~~~~~~~~f~~f~~~~~~~~~~~  476 (482)
                      ......++..|.+|++..+..+|.+
T Consensus       493 ~~~~~~~~~~f~~f~~~~~~~~~~~  517 (543)
T 3c4z_A          493 VAFEKADTEFFQEFASGTCPIPWQE  517 (543)
T ss_dssp             CCCCHHHHHHHHHHCCEECHHHHHH
T ss_pred             CCCCcchhhHhhcCCCCCCChhHHH
Confidence            1111224578999999887776754

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.2e-58  Score=498.22  Aligned_cols=259  Identities=29%  Similarity=0.548  Sum_probs=240.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++++.||+|+||+||+|+++.+|+.||+|++.+...   ...+.+.+|+.+|+.++|||||+++++|++...+|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            5789999999999999999999999999999999987542   3456688999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC--CceeEcccCccccccCCCC
Q 047009          229 LDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD--GHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~--g~vKL~DFGla~~~~~~~~  305 (482)
                      ||||+||+|++++.. .+.+++..++.|++||+.||+|||++||+||||||+|||++.+  |++||+|||+|+.+.....
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            999999999998864 4679999999999999999999999999999999999999864  8999999999999887777


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLK  381 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~LI~  381 (482)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++...|....+.++    ..+|+++++||+
T Consensus       313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~  392 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR  392 (573)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHH
T ss_pred             eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            7788999999999999999999999999999999999999999999999999999998877665    358999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCCCChhh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK  415 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~  415 (482)
                      +||++||.+||++     .|+|+||||+..+|..
T Consensus       393 ~~L~~dp~~R~t~-----~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          393 KLLLADPNTRMTI-----HQALEHPWLTPGNAPG  421 (573)
T ss_dssp             TTSCSSGGGSCCH-----HHHHHSTTTSCCCCTT
T ss_pred             HHccCChhHCcCH-----HHHhcCcCcCCCCCCC
Confidence            9999999999998     9999999999988854

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.8e-58  Score=458.68  Aligned_cols=253  Identities=23%  Similarity=0.422  Sum_probs=223.2

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEc-----CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKK-----NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  221 (482)
                      +..++|.+.+.||+|+||+||+|++.     .++..||||+++...   ....+.+.+|+.+|++++|||||+++++|.+
T Consensus        10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~   86 (299)
T 4asz_A           10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE   86 (299)
T ss_dssp             CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            34478999999999999999999875     357899999997542   3455678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHHG-------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH  288 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~-------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~  288 (482)
                      .+.+|||||||+||+|.++|.+++             .+++..+..|+.||+.||+|||+++||||||||+||||+.+++
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence            999999999999999999997643             6899999999999999999999999999999999999999999


Q ss_pred             eeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc
Q 047009          289 VMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD  364 (482)
Q Consensus       289 vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~  364 (482)
                      +||+|||+|+......   .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+..+
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~  246 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG  246 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999998764332   2234579999999999999999999999999999999998 99999999999999998887


Q ss_pred             c-cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          365 K-LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       365 ~-~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      . +..|..+++++.+||.+||++||++||++     ++|.  +|++
T Consensus       247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~-----~~i~--~~L~  285 (299)
T 4asz_A          247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNI-----KGIH--TLLQ  285 (299)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHH--HHHH
T ss_pred             CCCCCCccchHHHHHHHHHHcCCChhHCcCH-----HHHH--HHHH
Confidence            4 57788999999999999999999999998     8884  4554

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.2e-57  Score=459.95  Aligned_cols=250  Identities=23%  Similarity=0.421  Sum_probs=217.6

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  221 (482)
                      +..++|.+.++||+|+||+||+|+++.     +++.||||+++...   ....+.+.+|+.+|++++|||||+++++|.+
T Consensus        38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~  114 (329)
T 4aoj_A           38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTE  114 (329)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            344789999999999999999999763     68899999997542   3455678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHH---------------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD  286 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~  286 (482)
                      .+.+|||||||++|+|.+++.++               +.+++.++..|+.||+.||+|||+++||||||||+||||+.+
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence            99999999999999999998764               358999999999999999999999999999999999999999


Q ss_pred             CceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHH
Q 047009          287 GHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIV  362 (482)
Q Consensus       287 g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~  362 (482)
                      +++||+|||+|+.+....   .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+.
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  274 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT  274 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999998764332   2345789999999999999999999999999999999999 999999999888888888


Q ss_pred             hc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          363 KD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       363 ~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ++ .+..|..+++++.+||.+||++||++||++     +||++
T Consensus       275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~-----~ei~~  312 (329)
T 4aoj_A          275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSI-----KDVHA  312 (329)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCH-----HHHHH
T ss_pred             cCCCCCCcccccHHHHHHHHHHcCcChhHCcCH-----HHHHH
Confidence            76 567888999999999999999999999998     88875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-57  Score=465.95  Aligned_cols=250  Identities=27%  Similarity=0.447  Sum_probs=209.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEc---CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKK---NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  225 (482)
                      ++|++++.||+|+||+||+|+++   .+++.||+|++.+..     ....+.+|+++|+.+ +|||||+++++|++.+++
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            67999999999999999999875   467899999987643     234577899999998 699999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC-CceeEcccCccccccCC-
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDEN-  303 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~-g~vKL~DFGla~~~~~~-  303 (482)
                      |+|||||+||+|.+++   +.+++..++.|+.||+.||+|||++|||||||||+|||++.+ |++||+|||+|+..... 
T Consensus        96 ~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           96 VIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            9999999999999988   358999999999999999999999999999999999999877 89999999999864322 


Q ss_pred             ----------------------------CCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCC-c
Q 047009          304 ----------------------------TRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGG-N  353 (482)
Q Consensus       304 ----------------------------~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~-~  353 (482)
                                                  ....+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||... +
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence                                        123456899999999999875 5899999999999999999999999654 3


Q ss_pred             hHHHHHHHHh--------------------------------------cc----------------cCCCccCChHHHHH
Q 047009          354 RAKIQQKIVK--------------------------------------DK----------------LRLPAFLSSEAHSL  379 (482)
Q Consensus       354 ~~~~~~~i~~--------------------------------------~~----------------~~~p~~~s~~~~~L  379 (482)
                      ..+....|.+                                      ..                ......+|++++||
T Consensus       253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL  332 (361)
T 4f9c_A          253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL  332 (361)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence            3333333321                                      00                01123478999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      |++||++||++|+|+     +|+|+||||++++
T Consensus       333 l~~lL~~dP~~R~ta-----~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          333 LDKLLDLNPASRITA-----EEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHTCSCTTTSCCH-----HHHHTSGGGTTC-
T ss_pred             HHHHCcCChhHCcCH-----HHHhcCcccCCCC
Confidence            999999999999999     9999999999875

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.9e-57  Score=454.50  Aligned_cols=252  Identities=21%  Similarity=0.349  Sum_probs=223.1

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEc-----CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKK-----NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  221 (482)
                      +..+++++++.||+|+||+||+|++.     .+++.||||+++...  .....+.+.+|+.+|++++|||||+++++|.+
T Consensus        23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            44578999999999999999999864     367899999997543  23345678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHH----------------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA  285 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~  285 (482)
                      .+.+|||||||++|+|.++|..+                ..+++..+..|+.||+.||+|||+++||||||||+||||+.
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence            99999999999999999999653                35899999999999999999999999999999999999999


Q ss_pred             CCceeEcccCccccccCC---CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHH
Q 047009          286 DGHVMLTDFGLAKQFDEN---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKI  361 (482)
Q Consensus       286 ~g~vKL~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i  361 (482)
                      ++++||+|||+|+.+...   ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++.+.+
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i  260 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI  260 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999999876432   23456789999999999999999999999999999999998 89999999999998888


Q ss_pred             Hhcc-cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          362 VKDK-LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       362 ~~~~-~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ..+. ...|..++.++.+||.+||+.||++||++     .||+++
T Consensus       261 ~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~-----~ei~~~  300 (308)
T 4gt4_A          261 RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRF-----KDIHSR  300 (308)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            8764 56788999999999999999999999998     888764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.1e-57  Score=484.92  Aligned_cols=285  Identities=39%  Similarity=0.676  Sum_probs=262.5

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++||||++++++|++.+.+|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            56688999999999999999999999999999999999876655566677889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      +||||++||+|..++...+.  +++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            99999999999999987544  9999999999999999999999999999999999999999999999999999877666


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC----chHHHHHHHHhcccCCCccCChHHHHHH
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG----NRAKIQQKIVKDKLRLPAFLSSEAHSLL  380 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~LI  380 (482)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.    ....+...+......+|..+++++++||
T Consensus       341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI  420 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC  420 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence            666789999999999999999999999999999999999999999875    3466777888888889999999999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCC
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAG  431 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~  431 (482)
                      ++||++||.+||++...+++||++||||++++|+.+..+.+.|||+|....
T Consensus       421 ~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~~~  471 (576)
T 2acx_A          421 SQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQA  471 (576)
T ss_dssp             HHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC
T ss_pred             HHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCccc
Confidence            999999999999875557799999999999999999999999999998654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-57  Score=451.32  Aligned_cols=250  Identities=24%  Similarity=0.314  Sum_probs=209.4

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      +.+..++|++.+.||+|+||+||+|++++   .||||+++.... ..+..+.+.+|+.+|++++|||||++++++.. +.
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~  105 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN  105 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence            34556889999999999999999998764   499999875432 34556778999999999999999999998754 56


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-
Q 047009          225 LYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-  302 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-  302 (482)
                      +|||||||+||+|.++|... +.+++..+..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+.... 
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            89999999999999999764 5799999999999999999999999999999999999999999999999999987643 


Q ss_pred             --CCCCcccccCCCCCchhhhcC---CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc------CCCcc
Q 047009          303 --NTRSNSMIGTVEYMAPEIVLG---KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL------RLPAF  371 (482)
Q Consensus       303 --~~~~~~~~gt~~y~APE~l~~---~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~------~~p~~  371 (482)
                        .......+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+.+.......+.....      .++..
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  265 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN  265 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence              233456799999999999975   3589999999999999999999999988766554444443322      24467


Q ss_pred             CChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       372 ~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +++++.+||.+||++||++||++     .||++
T Consensus       266 ~~~~l~~li~~cl~~dP~~RPs~-----~ei~~  293 (307)
T 3omv_A          266 CPKAMKRLVADCVKKVKEERPLF-----PQILS  293 (307)
T ss_dssp             SCHHHHHHHHHHTCSSSTTSCCH-----HHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCH-----HHHHH
Confidence            89999999999999999999998     77654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.9e-55  Score=440.99  Aligned_cols=261  Identities=33%  Similarity=0.590  Sum_probs=244.1

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ..+++|++++.||+|+||.||+|++..+|+.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            346889999999999999999999999999999999987654 3345567889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      +||||++||+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  170 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL  170 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred             EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence            99999999999999998899999999999999999999999999999999999999999999999999999987766667


Q ss_pred             cccccCCCCCchhhhcCCCCC-chhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhc
Q 047009          307 NSMIGTVEYMAPEIVLGKGHN-KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~-~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..++...+..+...+|..+++++.+||++||+
T Consensus       171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  250 (328)
T 3fe3_A          171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLV  250 (328)
T ss_dssp             GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCC
T ss_pred             ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCC
Confidence            788999999999999998875 7999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      .||.+||++     +|+++||||+....
T Consensus       251 ~dP~~R~t~-----~eil~h~~~~~~~~  273 (328)
T 3fe3_A          251 LNPIKRGTL-----EQIMKDRWINAGHE  273 (328)
T ss_dssp             SSTTTSCCH-----HHHTTCTTTTTTCT
T ss_pred             CChhHCcCH-----HHHhcCHhhcCCCc
Confidence            999999999     99999999987543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.2e-56  Score=450.08  Aligned_cols=252  Identities=24%  Similarity=0.418  Sum_probs=219.0

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCC-----eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCC-Cceeeeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTS-----EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH-PFVVQLKYSFQ  220 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~  220 (482)
                      +..++|++.+.||+|+||+||+|++..++     +.||||++....  .....+.+.+|+.+|.+++| ||||+++++|.
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            44578999999999999999999987643     689999997653  23345678899999999976 89999999986


Q ss_pred             c-CCeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 047009          221 T-KYRLYLVLDFINGGHLFFQLYHH----------------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL  283 (482)
Q Consensus       221 ~-~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl  283 (482)
                      . .+.+|||||||++|+|.++|...                ..+++..+..|+.||+.||+|||+++||||||||+|||+
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  218 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence            5 56789999999999999999753                348899999999999999999999999999999999999


Q ss_pred             ccCCceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchH-HHH
Q 047009          284 GADGHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRA-KIQ  358 (482)
Q Consensus       284 ~~~g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~-~~~  358 (482)
                      +.++++||+|||+|+.+....   .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.. .+.
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~  298 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  298 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred             CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999999764432   2345789999999999999999999999999999999998 99999886644 444


Q ss_pred             HHHHhc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          359 QKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       359 ~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ..+..+ .+..|..+++++.+||.+||++||++||++     .||++|
T Consensus       299 ~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~-----~eil~~  341 (353)
T 4ase_A          299 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-----SELVEH  341 (353)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCH-----HHHHHH
Confidence            555544 567888999999999999999999999998     899886

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.1e-54  Score=440.93  Aligned_cols=266  Identities=31%  Similarity=0.529  Sum_probs=244.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh---hHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK---NHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.+......   ...+.+.+|+.+|++++||||++++++|.+...+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            3679999999999999999999999999999999987653221   1346688999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC----ceeEcccCcccccc
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG----HVMLTDFGLAKQFD  301 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g----~vKL~DFGla~~~~  301 (482)
                      |+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++...
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999999998888999999999999999999999999999999999999998887    79999999999887


Q ss_pred             CCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHH
Q 047009          302 ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAH  377 (482)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  377 (482)
                      ........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..++...+......++    ..++.+++
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  250 (361)
T 2yab_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK  250 (361)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHH
Confidence            66666778999999999999999999999999999999999999999999999999999998887776    46899999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhc
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR  419 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~  419 (482)
                      +||++||.+||.+||++     .|+++||||++++|.....+
T Consensus       251 ~li~~~L~~dP~~R~t~-----~e~l~hp~~~~~~~~~~~~~  287 (361)
T 2yab_A          251 DFIRKLLVKETRKRLTI-----QEALRHPWITPVDTQQAMVR  287 (361)
T ss_dssp             HHHHHHSCSSTTTSCCH-----HHHHTSTTTSCSSHHHHHHH
T ss_pred             HHHHHHCCCChhHCcCH-----HHHhcCcCcCCCchhhhhhc
Confidence            99999999999999999     99999999999999876544

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-54  Score=438.11  Aligned_cols=292  Identities=49%  Similarity=0.881  Sum_probs=251.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEc---CCCeEEEEEEeechhhc-hhhHHHHHHHHHHHHHhC-CCCceeeeeeeeec
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKK---NTSEIYAMKVMRKDKIV-EKNHAEYMKAERDILTKI-DHPFVVQLKYSFQT  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  221 (482)
                      +.+++|++++.||+|+||.||+|++.   .+++.||||++++.... .....+.+.+|+.+|+.+ +||||+++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            45689999999999999999999984   57899999999764321 122334466799999999 69999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      ...+++||||+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999998753


Q ss_pred             C--CCCCcccccCCCCCchhhhcC--CCCCchhHHHHHhHHHHHHhhCCCCCCCC----chHHHHHHHHhcccCCCccCC
Q 047009          302 E--NTRSNSMIGTVEYMAPEIVLG--KGHNKAADWWSVGILLYEMLTGKPPFIGG----NRAKIQQKIVKDKLRLPAFLS  373 (482)
Q Consensus       302 ~--~~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwSlGvilyelltG~~PF~~~----~~~~~~~~i~~~~~~~p~~~s  373 (482)
                      .  .......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||...    ....+...+......+|..++
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  290 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccC
Confidence            2  223345689999999999986  35789999999999999999999999643    345566677777888899999


Q ss_pred             hHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCc
Q 047009          374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANF  438 (482)
Q Consensus       374 ~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f  438 (482)
                      ..+++||.+||.+||.+||++++.+++++++|+||+.++|+.+..+.+.+||.|.+....+.++|
T Consensus       291 ~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~~~d~~~~  355 (355)
T 1vzo_A          291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF  355 (355)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CCC---
T ss_pred             HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCccccccccccC
Confidence            99999999999999999997765677999999999999999999999999999998777766665

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.8e-54  Score=434.73  Aligned_cols=258  Identities=29%  Similarity=0.521  Sum_probs=237.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ..+++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...++
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   85 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV   85 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            34689999999999999999999999999999999998765544444567889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      +||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~  164 (336)
T 3h4j_B           86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL  164 (336)
T ss_dssp             EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred             EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence            999999 7899999988899999999999999999999999999999999999999999999999999999987776667


Q ss_pred             cccccCCCCCchhhhcCCCC-CchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhc
Q 047009          307 NSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~-~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+.+.+......+|..+++++++||++||+
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  244 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIV  244 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSC
T ss_pred             ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcC
Confidence            77899999999999998876 78999999999999999999999887777766667677778899999999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      .||.+||++     +|+++||||+.
T Consensus       245 ~dP~~Rpt~-----~eil~hp~~~~  264 (336)
T 3h4j_B          245 ADPMQRITI-----QEIRRDPWFNV  264 (336)
T ss_dssp             SSGGGSCCH-----HHHTTCHHHHT
T ss_pred             CChhHCcCH-----HHHHhChhhcc
Confidence            999999999     99999999975

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-52  Score=420.59  Aligned_cols=265  Identities=31%  Similarity=0.525  Sum_probs=241.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh---hHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK---NHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++.+......   ...+.+.+|+.+|++++||||++++++|.+...++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            569999999999999999999999999999999987543221   13567889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC----ceeEcccCccccccC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG----HVMLTDFGLAKQFDE  302 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g----~vKL~DFGla~~~~~  302 (482)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++....
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            9999999999999998888899999999999999999999999999999999999999888    899999999998766


Q ss_pred             CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHH
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHS  378 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  378 (482)
                      .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......++    ..++..+++
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (326)
T 2y0a_A          171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD  250 (326)
T ss_dssp             TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHH
Confidence            6566678899999999999999999999999999999999999999999988888888888776665    458999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhc
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR  419 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~  419 (482)
                      ||++||+.||.+||++     .|+++||||+..+|.....+
T Consensus       251 li~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~~~~~~~  286 (326)
T 2y0a_A          251 FIRRLLVKDPKKRMTI-----QDSLQHPWIKPKDTQQALSR  286 (326)
T ss_dssp             HHHHHSCSSGGGSCCH-----HHHHHSTTTSCCSHHHHHHH
T ss_pred             HHHHHccCChhhCCCH-----HHHhcCCCccCCcchhhhhh
Confidence            9999999999999999     99999999999998766444

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4e-52  Score=425.23  Aligned_cols=256  Identities=31%  Similarity=0.570  Sum_probs=236.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36799999999999999999999999999999999876542 34556788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC---ceeEcccCccccccCCCC
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG---HVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g---~vKL~DFGla~~~~~~~~  305 (482)
                      |||+.||+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.......
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence            99999999999998888899999999999999999999999999999999999998654   599999999998776666


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCc----cCChHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLK  381 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~LI~  381 (482)
                      ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+...+...+..+...+|.    .+++++++||.
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  266 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  266 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHH
T ss_pred             cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            66789999999999999999999999999999999999999999999999999999988777663    58999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      +||++||.+||++     .++++||||..
T Consensus       267 ~~L~~dP~~R~t~-----~e~l~hp~~~~  290 (362)
T 2bdw_A          267 SMLTVNPKKRITA-----DQALKVPWICN  290 (362)
T ss_dssp             HHSCSSGGGSCCH-----HHHTTSHHHHT
T ss_pred             HHcCCChhhCcCH-----HHHhcCcccCC
Confidence            9999999999999     99999999975

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-52  Score=442.18  Aligned_cols=259  Identities=31%  Similarity=0.549  Sum_probs=243.2

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ..+++|.+.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45689999999999999999999999999999999998876555555677899999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      +||||++||+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~  172 (476)
T 2y94_A           93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL  172 (476)
T ss_dssp             EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999999987766666


Q ss_pred             cccccCCCCCchhhhcCCCC-CchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhc
Q 047009          307 NSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~-~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+..++..+.+..|..+++++++||++||+
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~  252 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQ  252 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTC
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcC
Confidence            77899999999999998876 68999999999999999999999999999999999999989999999999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      .||.+||++     +||++||||+.
T Consensus       253 ~dP~~Rpt~-----~eil~hp~~~~  272 (476)
T 2y94_A          253 VDPMKRATI-----KDIREHEWFKQ  272 (476)
T ss_dssp             SSTTTSCCH-----HHHHTCHHHHT
T ss_pred             CCchhCcCH-----HHHHhCHHhhh
Confidence            999999999     99999999975

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6e-53  Score=428.18  Aligned_cols=281  Identities=30%  Similarity=0.507  Sum_probs=244.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  227 (482)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+....       ..+|+.++.++ +||||++++++|.+...+|+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            36799999999999999999999999999999999875421       24678888887 79999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC----CceeEcccCccccccCC
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD----GHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~----g~vKL~DFGla~~~~~~  303 (482)
                      ||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+..+    +.+||+|||+++.....
T Consensus        94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            99999999999999988899999999999999999999999999999999999998543    35999999999876433


Q ss_pred             -CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCC---CchHHHHHHHHhcccCCC----ccCChH
Q 047009          304 -TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIG---GNRAKIQQKIVKDKLRLP----AFLSSE  375 (482)
Q Consensus       304 -~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~---~~~~~~~~~i~~~~~~~p----~~~s~~  375 (482)
                       ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+   .+..++...+..+.+.++    ..++++
T Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  253 (342)
T 2qr7_A          174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT  253 (342)
T ss_dssp             TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHH
T ss_pred             CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHH
Confidence             345567899999999999988899999999999999999999999976   456778888888877665    468999


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCcccccc
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWT  443 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~  443 (482)
                      +++||++||..||++||++     .++++||||.  +|+.+..+++.+++.|........++|....+
T Consensus       254 ~~~li~~~L~~dP~~R~t~-----~~il~hp~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  314 (342)
T 2qr7_A          254 AKDLVSKMLHVDPHQRLTA-----ALVLRHPWIV--HWDQLPQYQLNRQDAPHLVKGAMAATYSALNR  314 (342)
T ss_dssp             HHHHHHHHTCSSTTTSCCH-----HHHTTSHHHH--TGGGSCCSCCCCCCCHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHCCCChhHCcCH-----HHHhcCCeec--CccccccccCCCccchhhhhhHHHHHHhhhcc
Confidence            9999999999999999998     9999999994  69899889999888886544334445554443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-52  Score=418.30  Aligned_cols=254  Identities=27%  Similarity=0.474  Sum_probs=234.7

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++....    .....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            478999999999999999999999999999999987542    3445678999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc--CCceeEcccCccccccCCCC
Q 047009          229 LDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA--DGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~--~g~vKL~DFGla~~~~~~~~  305 (482)
                      |||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.+.....
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            99999999999997654 6999999999999999999999999999999999999987  78999999999998876666


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCc----cCChHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLK  381 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~LI~  381 (482)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+......++.    .++.++++||.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  239 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD  239 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHH
Confidence            66788999999999999998999999999999999999999999999999999999988877763    68999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      +||..||.+||++     .|+++||||+..
T Consensus       240 ~~L~~dp~~Rpt~-----~e~l~hp~~~~~  264 (321)
T 1tki_A          240 RLLVKERKSRMTA-----SEALQHPWLKQK  264 (321)
T ss_dssp             TTSCSSGGGSCCH-----HHHHHSHHHHSC
T ss_pred             HHcCCChhHCcCH-----HHHhcChhhccC
Confidence            9999999999999     999999999863

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.1e-51  Score=431.15  Aligned_cols=256  Identities=30%  Similarity=0.564  Sum_probs=233.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3679999999999999999999999999999999987654 334456788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc---cCCceeEcccCccccccCC-C
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG---ADGHVMLTDFGLAKQFDEN-T  304 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~---~~g~vKL~DFGla~~~~~~-~  304 (482)
                      |||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..... .
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            99999999999999999999999999999999999999999999999999999998   4678999999999876543 3


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCc----cCChHHHHHH
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLL  380 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~LI  380 (482)
                      .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++.+.+..+...++.    .+++++++||
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  248 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI  248 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence            345678999999999999999999999999999999999999999999999999999998777663    6899999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      .+||+.||.+||++     .|+++||||+.
T Consensus       249 ~~~L~~dP~~Rpta-----~e~L~hp~~~~  273 (444)
T 3soa_A          249 NKMLTINPSKRITA-----AEALKHPWISH  273 (444)
T ss_dssp             HHHSCSSTTTSCCH-----HHHHHSCTTHH
T ss_pred             HHHcCCChhHCCCH-----HHHhcCccccC
Confidence            99999999999999     99999999964

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.4e-52  Score=417.00  Aligned_cols=243  Identities=25%  Similarity=0.342  Sum_probs=195.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC----eE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY----RL  225 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~  225 (482)
                      .+|.+.+.||+|+||+||+|++  +|+.||||+++....    .....+.|+..+.+++|||||++++++...+    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4689999999999999999988  478999999976431    2222345666777899999999999997653    68


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN--------GIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                      |||||||+||+|.+++.. ..++++.+..++.|++.||+|||++        +||||||||+||||+.+|++||+|||+|
T Consensus        77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999999976 4588999999999999999999987        9999999999999999999999999999


Q ss_pred             ccccCCC-----CCcccccCCCCCchhhhcCC------CCCchhHHHHHhHHHHHHhhCCCCCCCC--------------
Q 047009          298 KQFDENT-----RSNSMIGTVEYMAPEIVLGK------GHNKAADWWSVGILLYEMLTGKPPFIGG--------------  352 (482)
Q Consensus       298 ~~~~~~~-----~~~~~~gt~~y~APE~l~~~------~~~~~sDvwSlGvilyelltG~~PF~~~--------------  352 (482)
                      +......     .....+||+.|||||++.+.      .|+.++|||||||+||||+||..||...              
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            8765432     22356899999999999865      3678999999999999999997765321              


Q ss_pred             -chHHHHHHHHhcc--cCCCcc-----CChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          353 -NRAKIQQKIVKDK--LRLPAF-----LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       353 -~~~~~~~~i~~~~--~~~p~~-----~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                       ....+...+....  +.+|..     .+..+.+|+.+||+.||++|||+     .||++
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~ei~~  290 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-----LRIKK  290 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCH-----HHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCH-----HHHHH
Confidence             2234444454443  334433     23468899999999999999998     88875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.6e-51  Score=404.60  Aligned_cols=259  Identities=33%  Similarity=0.672  Sum_probs=239.6

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      ...+++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++++++||||+++++++.+.+.+
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            35568999999999999999999999999999999999876554444556788999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      |+||||+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++...... .
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~  168 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-R  168 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-C
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-c
Confidence            999999999999999998889999999999999999999999999999999999999999999999999999765432 3


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhc
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ....+||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+......+|..++.++++||.+||+
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  248 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLR  248 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSC
T ss_pred             cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhh
Confidence            34578999999999999999999999999999999999999999998888888889888889999999999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      .||.+||++     +++++||||+.
T Consensus       249 ~~p~~Rps~-----~~ll~h~~~~~  268 (284)
T 2vgo_A          249 YHPPQRLPL-----KGVMEHPWVKA  268 (284)
T ss_dssp             SSGGGSCCH-----HHHHTCHHHHH
T ss_pred             cCHhhCCCH-----HHHhhCHHHHh
Confidence            999999999     99999999974

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.4e-51  Score=411.25  Aligned_cols=265  Identities=31%  Similarity=0.529  Sum_probs=242.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh---hHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK---NHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++.+......   ...+.+.+|+.++++++||||+++++++.+...++
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            679999999999999999999999999999999987543221   13566889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC----ceeEcccCccccccC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG----HVMLTDFGLAKQFDE  302 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g----~vKL~DFGla~~~~~  302 (482)
                      +||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~  171 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence            9999999999999999888899999999999999999999999999999999999999988    799999999998776


Q ss_pred             CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHH
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHS  378 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  378 (482)
                      ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+......++    ..++..+++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  251 (321)
T 2a2a_A          172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKD  251 (321)
T ss_dssp             TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred             cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHH
Confidence            6666677899999999999999999999999999999999999999999988888888888776665    468999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhc
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR  419 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~  419 (482)
                      ||++||+.||++||++     +|+++||||.+++|+....+
T Consensus       252 li~~~l~~dp~~Rps~-----~e~l~hp~~~~~~~~~~~~~  287 (321)
T 2a2a_A          252 FIRKLLVKETRKRLTI-----QEALRHPWITPVDNQQAMVR  287 (321)
T ss_dssp             HHHTTSCSSTTTSCCH-----HHHHHSTTTSCSSHHHHHHH
T ss_pred             HHHHHcCCChhhCcCH-----HHHhcCccccCCCccccccc
Confidence            9999999999999999     99999999999999876544

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.6e-51  Score=408.82  Aligned_cols=254  Identities=30%  Similarity=0.504  Sum_probs=228.0

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||+||+|++..+++.||+|++.....   ...+.+.+|+.++++++||||++++++|...+.+|+|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            3689999999999999999999999999999999976542   3345678999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~  307 (482)
                      |||+.||+|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ....
T Consensus        96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence            9999999999988764 6899999999999999999999999999999999999999999999999999876543 3345


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc---ccCCCccCChHHHHHHHHhh
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~LI~~~L  384 (482)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...   ....|..++..+++||.+||
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  254 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHS
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHc
Confidence            678999999999999999999999999999999999999999988877666655543   33456789999999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          385 QKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      +.||.+||++     +|+++||||+..
T Consensus       255 ~~dp~~Rps~-----~ell~h~~~~~~  276 (297)
T 3fxz_A          255 EMDVEKRGSA-----KELLQHQFLKIA  276 (297)
T ss_dssp             CSSTTTSCCH-----HHHTTCGGGGGC
T ss_pred             cCChhHCcCH-----HHHhhChhhccc
Confidence            9999999999     999999999854

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.6e-51  Score=404.02  Aligned_cols=257  Identities=25%  Similarity=0.481  Sum_probs=220.6

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++++.||+|+||+||+|+++.+++.||+|++..... .......+.+|+.++++++||||+++++++.+...+++|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            4689999999999999999999999999999999986543 334456678999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~  307 (482)
                      |||++++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... ....
T Consensus        80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence            999987544444444678999999999999999999999999999999999999999999999999999876533 3345


Q ss_pred             ccccCCCCCchhhhcCCC-CCchhHHHHHhHHHHHHhhCCCC-CCCCchHHHHHHHHhccc-------------------
Q 047009          308 SMIGTVEYMAPEIVLGKG-HNKAADWWSVGILLYEMLTGKPP-FIGGNRAKIQQKIVKDKL-------------------  366 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~-~~~~sDvwSlGvilyelltG~~P-F~~~~~~~~~~~i~~~~~-------------------  366 (482)
                      ..+||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+....+.....                   
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence            568999999999998765 89999999999999999988777 556666666666544210                   


Q ss_pred             ----------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          367 ----------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       367 ----------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                                .....++.++++||++||+.||++||++     +|+++||||+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~  289 (292)
T 3o0g_A          240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-----EEALQHPYFSDF  289 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTC
T ss_pred             ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCH-----HHHhcCcccccC
Confidence                      1123478999999999999999999999     999999999974

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.2e-51  Score=402.61  Aligned_cols=258  Identities=32%  Similarity=0.647  Sum_probs=236.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ..+++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++++++||||+++++++.+....+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   85 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence            45689999999999999999999999999999999998776555555677889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      +||||+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ..
T Consensus        86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~~  164 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RR  164 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-cc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999998765433 33


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhcc
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~  386 (482)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+..+.+......+|..++.++++||.+||+.
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  244 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH  244 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCS
T ss_pred             cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhcc
Confidence            45689999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCCCC
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      ||.+||++     +|+++||||+.
T Consensus       245 ~p~~Rps~-----~e~l~h~~~~~  263 (279)
T 3fdn_A          245 NPSQRPML-----REVLEHPWITA  263 (279)
T ss_dssp             SGGGSCCH-----HHHHHCHHHHH
T ss_pred             ChhhCCCH-----HHHhhCccccC
Confidence            99999999     99999999975

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.1e-51  Score=409.35  Aligned_cols=262  Identities=30%  Similarity=0.502  Sum_probs=220.7

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      .....++|++++.||+|+||+||+|++.. |+.||+|++..... .......+.+|+.++++++||||+++++++.+...
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   93 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC   93 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence            34456899999999999999999999864 89999999976532 33345667899999999999999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          225 LYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      +++||||+++ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            9999999986 777777654 45999999999999999999999999999999999999999999999999999876533


Q ss_pred             -CCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC--------------
Q 047009          304 -TRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR--------------  367 (482)
Q Consensus       304 -~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~--------------  367 (482)
                       ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......              
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  252 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL  252 (311)
T ss_dssp             CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence             33445689999999999987 56899999999999999999999999887776666655431100              


Q ss_pred             ----------------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          368 ----------------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       368 ----------------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                                      +...+++++.+||++||++||++||++     +|+++||||++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~  310 (311)
T 3niz_A          253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA-----RDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCH-----HHHHTSGGGTTSCTT
T ss_pred             hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCH-----HHHhcCcccccCCcc
Confidence                            112467899999999999999999999     999999999998864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.6e-51  Score=399.16  Aligned_cols=262  Identities=30%  Similarity=0.549  Sum_probs=239.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++..... .....+.+.+|+.++++++||||+++++++......++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            4789999999999999999999999999999999987654 334556788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc---eeEcccCccccccCCCC
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH---VMLTDFGLAKQFDENTR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~---vKL~DFGla~~~~~~~~  305 (482)
                      |||+.|++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++........
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            999999999999988889999999999999999999999999999999999999987665   99999999988776666


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLK  381 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~LI~  381 (482)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+..+...+|    ..+++++.+||.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  243 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHH
Confidence            6678899999999999999999999999999999999999999999999999988888876665    368999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKL  416 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~  416 (482)
                      +||+.||.+||++     +|+++||||++..+...
T Consensus       244 ~~l~~dp~~Rps~-----~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          244 SMLTVNPKKRITA-----DQALKVPWICNRERVAS  273 (284)
T ss_dssp             HHSCSSTTTSCCH-----HHHTTSHHHHSCCCGGG
T ss_pred             HHcccChhhCCCH-----HHHhcCccccCChhHHh
Confidence            9999999999999     99999999988765443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.8e-51  Score=418.34  Aligned_cols=258  Identities=30%  Similarity=0.579  Sum_probs=227.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh--hHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK--NHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+......  ...+.+.+|+.+++.++||||++++++|.+.+.+|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            579999999999999999999999999999999986543221  135678899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc---eeEcccCccccc
Q 047009          228 VLDFINGGHLFFQLYHH----GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH---VMLTDFGLAKQF  300 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~---vKL~DFGla~~~  300 (482)
                      ||||++||+|...+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++..
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            99999999998777543    35899999999999999999999999999999999999987665   999999999887


Q ss_pred             cCCC-CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChH
Q 047009          301 DENT-RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSE  375 (482)
Q Consensus       301 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~  375 (482)
                      .... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+ ..+...+..+...++    ..++.+
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~  262 (351)
T 3c0i_A          184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISES  262 (351)
T ss_dssp             CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred             cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHH
Confidence            5443 2456789999999999999999999999999999999999999998754 566777777776655    468999


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      +++||++||++||.+||++     .++++||||+..++
T Consensus       263 ~~~li~~~L~~dP~~R~s~-----~e~l~hp~~~~~~~  295 (351)
T 3c0i_A          263 AKDLVRRMLMLDPAERITV-----YEALNHPWLKERDR  295 (351)
T ss_dssp             HHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHTHHH
T ss_pred             HHHHHHHHCCCChhHCcCH-----HHHhcChhhcCCcc
Confidence            9999999999999999999     99999999987543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.1e-51  Score=399.46  Aligned_cols=260  Identities=31%  Similarity=0.540  Sum_probs=230.9

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      .+..++|++.+.||+|+||.||+|+++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++......
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            35568999999999999999999999999999999999876554455567788999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      |+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            99999999999999998888999999999999999999999999999999999999999999999999999988766555


Q ss_pred             CcccccCCCCCchhhhcCCCC-CchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhh
Q 047009          306 SNSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLL  384 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~-~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L  384 (482)
                      ....+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+.....+.+......+|..++.++.+||.+||
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  246 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHML  246 (276)
T ss_dssp             ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHc
Confidence            566789999999999998776 6899999999999999999999999888888999988888889999999999999999


Q ss_pred             ccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          385 QKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       385 ~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      +.||.+||++     .++++||||+.
T Consensus       247 ~~~p~~Rps~-----~~~l~h~~~~~  267 (276)
T 2h6d_A          247 QVDPLKRATI-----KDIREHEWFKQ  267 (276)
T ss_dssp             CSSGGGSCCH-----HHHHHSHHHHT
T ss_pred             cCChhhCCCH-----HHHHhChhhcc
Confidence            9999999999     99999999975

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6e-51  Score=405.43  Aligned_cols=270  Identities=28%  Similarity=0.441  Sum_probs=220.7

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++++.||+|+||+||+|+++.+|+.||+|++.... ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            478999999999999999999999999999999987653 2334456678999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCCc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~  307 (482)
                      |||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            99999999999888888899999999999999999999999999999999999999999999999999987653 23345


Q ss_pred             ccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-------------------C
Q 047009          308 SMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-------------------R  367 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-------------------~  367 (482)
                      ..+||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.+...                   .
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            6689999999999987 6789999999999999999999999998877666555443210                   1


Q ss_pred             CC------------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCC
Q 047009          368 LP------------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPG  424 (482)
Q Consensus       368 ~p------------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~  424 (482)
                      .+            ..++.++.+||++||+.||.+||++     +|+++||||+++.+.....++.+.|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~~~~~~~~~~~  304 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC-----EQLLHHPYFENIREIEDLAKEHDKP  304 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCH-----HHHHTSGGGTTCC------------
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCH-----HHHhcChHHHhccCHHHHHHhhccH
Confidence            11            2478899999999999999999999     9999999999998876655555433

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.2e-51  Score=417.41  Aligned_cols=253  Identities=32%  Similarity=0.549  Sum_probs=214.2

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++.+...    ..+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            45789999999999999999999999999999999986542    22457789999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc--eeEcccCccccccCCCC
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH--VMLTDFGLAKQFDENTR  305 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~--vKL~DFGla~~~~~~~~  305 (482)
                      ||||+.||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.......
T Consensus        94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~  173 (361)
T 3uc3_A           94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  173 (361)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence            9999999999999988889999999999999999999999999999999999999987775  99999999986555555


Q ss_pred             CcccccCCCCCchhhhcCCCCCch-hHHHHHhHHHHHHhhCCCCCCCCch----HHHHHHHHhcccCCCc--cCChHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKA-ADWWSVGILLYEMLTGKPPFIGGNR----AKIQQKIVKDKLRLPA--FLSSEAHS  378 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~-sDvwSlGvilyelltG~~PF~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~  378 (482)
                      ....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.    ....+.+......+|.  .+++++++
T Consensus       174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  253 (361)
T 3uc3_A          174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH  253 (361)
T ss_dssp             -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHH
T ss_pred             CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHH
Confidence            567789999999999999888765 8999999999999999999987443    4556666666666665  58999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      ||++||++||.+||++     .|+++||||.
T Consensus       254 li~~~L~~dP~~Rps~-----~ell~hp~f~  279 (361)
T 3uc3_A          254 LISRIFVADPATRISI-----PEIKTHSWFL  279 (361)
T ss_dssp             HHHHHSCSCTTTSCCH-----HHHHTSHHHH
T ss_pred             HHHHHccCChhHCcCH-----HHHHhCcchh
Confidence            9999999999999999     9999999994

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.6e-51  Score=421.06  Aligned_cols=263  Identities=21%  Similarity=0.360  Sum_probs=223.6

Q ss_pred             cCCCCeEEEEEeccc--CceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          147 VGIEDFEVLKVVGQG--AFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G--~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ...++|++++.||+|  +||+||+|+++.+|+.||||++..... .....+.+.+|+.+++.++||||++++++|.+.+.
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            445889999999999  999999999999999999999987653 33556778899999999999999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          225 LYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      +|+||||+++|+|..++...  +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999999999876  6799999999999999999999999999999999999999999999999999865421


Q ss_pred             C--------CCCcccccCCCCCchhhhcC--CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc------
Q 047009          303 N--------TRSNSMIGTVEYMAPEIVLG--KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL------  366 (482)
Q Consensus       303 ~--------~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~------  366 (482)
                      .        ......+||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+.......+..+..      
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            1        22234589999999999988  6799999999999999999999999987665544443332211      


Q ss_pred             ----------------------------------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCc
Q 047009          367 ----------------------------------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHK  406 (482)
Q Consensus       367 ----------------------------------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp  406 (482)
                                                              .++..+++++++||++||+.||++||++     +|+++||
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-----~ell~hp  335 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA-----STLLNHS  335 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH-----HHHTTSG
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH-----HHHhcCH
Confidence                                                    1345688999999999999999999999     9999999


Q ss_pred             CCCCCChhh
Q 047009          407 WFKPINWKK  415 (482)
Q Consensus       407 ~f~~~~~~~  415 (482)
                      ||+.+.|..
T Consensus       336 ~f~~~~~~~  344 (389)
T 3gni_B          336 FFKQIKRRA  344 (389)
T ss_dssp             GGGGC---C
T ss_pred             HHHHHhhcc
Confidence            999987744

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.2e-50  Score=398.45  Aligned_cols=260  Identities=29%  Similarity=0.501  Sum_probs=240.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ...++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            34578999999999999999999999999999999998776555566778889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTR  305 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~  305 (482)
                      +||||+++++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence            9999999999999998888999999999999999999999999999999999999999999999999999987643 333


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhc
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+......+|..++..+.+||++||+
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  251 (294)
T 2rku_A          172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ  251 (294)
T ss_dssp             BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTC
T ss_pred             cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHcc
Confidence            45568999999999999999999999999999999999999999998888888888888888999999999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      .||++||++     +|+++||||...
T Consensus       252 ~~p~~Rps~-----~~ll~~~~~~~~  272 (294)
T 2rku_A          252 TDPTARPTI-----NELLNDEFFTSG  272 (294)
T ss_dssp             SSGGGSCCG-----GGGGGSHHHHTS
T ss_pred             cChhhCcCH-----HHHhhChheecC
Confidence            999999999     999999999753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5e-51  Score=420.01  Aligned_cols=273  Identities=30%  Similarity=0.470  Sum_probs=217.3

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecC--Ce
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTK--YR  224 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~~  224 (482)
                      ..++|++++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+|+.+. ||||+++++++...  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3578999999999999999999999999999999987543 23445566788999999997 99999999999754  37


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC--
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE--  302 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~--  302 (482)
                      +|+||||++ |+|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+..  
T Consensus        86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            999999998 588888765 5789999999999999999999999999999999999999999999999999987532  


Q ss_pred             --------------------CCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHH
Q 047009          303 --------------------NTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI  361 (482)
Q Consensus       303 --------------------~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i  361 (482)
                                          .......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.......|
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                112345689999999999987 67999999999999999999999999998887777766


Q ss_pred             HhcccCC------------------------------------------------CccCChHHHHHHHHhhccCcCCcCC
Q 047009          362 VKDKLRL------------------------------------------------PAFLSSEAHSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       362 ~~~~~~~------------------------------------------------p~~~s~~~~~LI~~~L~~dP~~R~s  393 (482)
                      ... +..                                                +..+++++.+||++||+.||.+||+
T Consensus       244 ~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t  322 (388)
T 3oz6_A          244 IGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS  322 (388)
T ss_dssp             HHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence            531 111                                                1257899999999999999999999


Q ss_pred             CCCCChHHHHhCcCCCCCC---hhhhhhccCCCCCcccc
Q 047009          394 AGPKGSEEIKSHKWFKPIN---WKKLEAREIQPGFCPEV  429 (482)
Q Consensus       394 ~~~~~~~eil~hp~f~~~~---~~~~~~~~~~p~~~p~~  429 (482)
                      +     +|+++||||+.+.   |+....+.+.+||.+..
T Consensus       323 ~-----~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (388)
T 3oz6_A          323 A-----NDALKHPFVSIFHNPNEEPNCDHIITIPINDNV  356 (388)
T ss_dssp             H-----HHHTTSTTTTTTCCGGGCCCCSSCCCCC-----
T ss_pred             H-----HHHhCCHHHHHhcCCccCCCCCCCCCCCccccc
Confidence            9     9999999987653   44444455556665543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.3e-51  Score=427.94  Aligned_cols=272  Identities=26%  Similarity=0.379  Sum_probs=212.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeee-----cCC
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQ-----TKY  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~  223 (482)
                      .++|++++.||+|+||+||+|+++.+++.||||++.+.. ......+.+.+|+.+|+.++||||++++++|.     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            478999999999999999999999999999999997643 23445667889999999999999999999984     346


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          224 RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      .+|+||||+. |+|..++...+.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            7999999985 689999988888999999999999999999999999999999999999999999999999999876422


Q ss_pred             C----------------------------CCcccccCCCCCchhhh-cCCCCCchhHHHHHhHHHHHHhh----------
Q 047009          304 T----------------------------RSNSMIGTVEYMAPEIV-LGKGHNKAADWWSVGILLYEMLT----------  344 (482)
Q Consensus       304 ~----------------------------~~~~~~gt~~y~APE~l-~~~~~~~~sDvwSlGvilyellt----------  344 (482)
                      .                            .....+||+.|+|||++ .+..|+.++||||||||+|||++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            1                            23456889999999987 46679999999999999999999          


Q ss_pred             -CCCCCCCCch--------------------HHHHHHHHhc-----------------------c--------cCCCccC
Q 047009          345 -GKPPFIGGNR--------------------AKIQQKIVKD-----------------------K--------LRLPAFL  372 (482)
Q Consensus       345 -G~~PF~~~~~--------------------~~~~~~i~~~-----------------------~--------~~~p~~~  372 (482)
                       |+++|.+.+.                    .+....|.+.                       .        ......+
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             7777766441                    1112222110                       0        0011346


Q ss_pred             ChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCcc
Q 047009          373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCP  427 (482)
Q Consensus       373 s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p  427 (482)
                      ++++.+||++||.+||++||++     +|+++||||++++|...+.....+...|
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~-----~e~L~Hp~f~~~~~~~~e~~~~~~~~~~  419 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITI-----NECLAHPFFKEVRIAEVETNATEKVRLP  419 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGTTTCCGGGCCCCSSCCCCS
T ss_pred             CHHHHHHHHHHhccCccccCCH-----HHHhcCHhhhhcCCCccCCCCCCCCCCC
Confidence            8999999999999999999998     9999999999999998876655554444

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.8e-51  Score=410.98  Aligned_cols=262  Identities=26%  Similarity=0.437  Sum_probs=218.1

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      ...+++|++++.||+|+||+||+|+++.+++.||||++..... .....+.+.+|+.++++++||||+++++++.+...+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            3456899999999999999999999999999999999976542 233445577899999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc-----cCCceeEcccCccccc
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG-----ADGHVMLTDFGLAKQF  300 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~-----~~g~vKL~DFGla~~~  300 (482)
                      |+||||++| +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||+++..
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            999999985 9999999988999999999999999999999999999999999999994     4556999999999876


Q ss_pred             cCC-CCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC-----------
Q 047009          301 DEN-TRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-----------  367 (482)
Q Consensus       301 ~~~-~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~-----------  367 (482)
                      ... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......           
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence            432 334556889999999999875 4899999999999999999999999988887777666542110           


Q ss_pred             -------C------------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          368 -------L------------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       368 -------~------------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                             +            +..++.++.+||.+||+.||.+||++     +|+++||||++++|+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA-----KNALEHPYFSHNDFD  328 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGSSSCSC
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH-----HHHhCCcccCCCCCC
Confidence                   0            11268999999999999999999999     999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-50  Score=418.20  Aligned_cols=257  Identities=30%  Similarity=0.540  Sum_probs=233.0

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++.....   .....+.+|+.+|+.++||||++++++|.+...+++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            4789999999999999999999999999999999976532   2345678999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc--CCceeEcccCccccccCCCC
Q 047009          229 LDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA--DGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~--~g~vKL~DFGla~~~~~~~~  305 (482)
                      |||+.||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+++.......
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            99999999999887654 6999999999999999999999999999999999999974  47899999999998766655


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLK  381 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~LI~  381 (482)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......++    ..+++++++||+
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  286 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK  286 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred             eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence            6667899999999999999999999999999999999999999999988888888888766554    458999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      +||++||.+||++     .|+++||||++..+
T Consensus       287 ~~L~~dP~~Rpt~-----~ell~hp~~~~~~~  313 (387)
T 1kob_A          287 NLLQKEPRKRLTV-----HDALEHPWLKGDHS  313 (387)
T ss_dssp             TTSCSSGGGSCCH-----HHHHTSTTTSSCCT
T ss_pred             HHcCCChhHCcCH-----HHHhhCccccCCcc
Confidence            9999999999999     99999999987543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.1e-50  Score=407.32  Aligned_cols=260  Identities=29%  Similarity=0.501  Sum_probs=241.2

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ...++|.+.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            34578999999999999999999999999999999998776555566778899999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTR  305 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~  305 (482)
                      +||||+.+++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  197 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  197 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence            9999999999999998888999999999999999999999999999999999999999999999999999987643 333


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhc
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ....+||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+......+|..++.++.+||++||+
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  277 (335)
T 2owb_A          198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ  277 (335)
T ss_dssp             BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTC
T ss_pred             ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcc
Confidence            45678999999999999999999999999999999999999999998888888888888889999999999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      .||++||++     +|+++|+||...
T Consensus       278 ~dp~~Rps~-----~ell~~~~~~~~  298 (335)
T 2owb_A          278 TDPTARPTI-----NELLNDEFFTSG  298 (335)
T ss_dssp             SSGGGSCCG-----GGGGGSHHHHTS
T ss_pred             CChhHCcCH-----HHHhcCccccCC
Confidence            999999999     999999999764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=412.24  Aligned_cols=255  Identities=34%  Similarity=0.564  Sum_probs=212.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++.+.||+|+||.||+|+++.+++.||||++.+..     ..+.+.+|+.+|++++||||++++++|.+...+++|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            367999999999999999999999999999999997643     234577899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc---CCceeEcccCccccccCCCC
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~---~g~vKL~DFGla~~~~~~~~  305 (482)
                      |||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.......
T Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  206 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL  206 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence            999999999999988888999999999999999999999999999999999999975   88999999999998766555


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHH-HHHHHHhcccCCC----ccCChHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAK-IQQKIVKDKLRLP----AFLSSEAHSLL  380 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~-~~~~i~~~~~~~p----~~~s~~~~~LI  380 (482)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... +...+......++    ..++.++++||
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  286 (349)
T 2w4o_A          207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV  286 (349)
T ss_dssp             ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred             cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHH
Confidence            567889999999999999999999999999999999999999997765544 6667776655443    46899999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      ++||+.||++||++     .|+++||||.+..+
T Consensus       287 ~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          287 RKLIVLDPKKRLTT-----FQALQHPWVTGKAA  314 (349)
T ss_dssp             HTTSCSSGGGSCCH-----HHHHHSTTTTSTTC
T ss_pred             HHHccCChhhCcCH-----HHHhcCcccCCCcc
Confidence            99999999999999     99999999987654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.1e-51  Score=407.62  Aligned_cols=260  Identities=29%  Similarity=0.485  Sum_probs=210.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++....  .....+.+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            478999999999999999999999999999999997654  222335577899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          229 LDFINGGHLFFQLYHH------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      |||++| +|..++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus        82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            999985 898887654      3589999999999999999999999999999999999999999999999999987653


Q ss_pred             C-CCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc---------------
Q 047009          303 N-TRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---------------  365 (482)
Q Consensus       303 ~-~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~---------------  365 (482)
                      . ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....               
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence            3 33455689999999999987 468999999999999999999999999988877776665420               


Q ss_pred             -------------------cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhh
Q 047009          366 -------------------LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKL  416 (482)
Q Consensus       366 -------------------~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~  416 (482)
                                         ...+..++.++++||.+||+.||++||++     +|+++||||+...|...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~~~~~~  305 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA-----KQALHHPWFAEYYHHAS  305 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH-----HHHTTSGGGGGGCC---
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH-----HHHhCChhhhcccchhh
Confidence                               01122578899999999999999999999     99999999998776543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3e-51  Score=433.83  Aligned_cols=259  Identities=33%  Similarity=0.599  Sum_probs=238.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.++++++||||++++++|.+.+.+|+|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            36799999999999999999999999999999999877655455667789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE---ccCCceeEcccCccccccCCCC
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl---~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      |||+.||+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+.....
T Consensus       105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  184 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK  184 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence            9999999999999988999999999999999999999999999999999999999   5678999999999998876666


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLK  381 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~LI~  381 (482)
                      ....+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..++...+.++.+.++    ..+++++++||+
T Consensus       185 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  263 (484)
T 3nyv_A          185 MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR  263 (484)
T ss_dssp             HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHH
T ss_pred             cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHH
Confidence            677889999999999987 599999999999999999999999999999999999998876654    458999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      +||++||.+||++     .|+++||||+...+
T Consensus       264 ~~L~~dp~~R~s~-----~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          264 KMLTYVPSMRISA-----RDALDHEWIQTYTK  290 (484)
T ss_dssp             HHTCSSGGGSCCH-----HHHHTSHHHHHHTC
T ss_pred             HHCCCChhHCcCH-----HHHhhChhhccccc
Confidence            9999999999999     99999999986554

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2e-50  Score=395.06  Aligned_cols=252  Identities=32%  Similarity=0.588  Sum_probs=234.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+|+++.++..||+|++.+...   ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            579999999999999999999999999999999987542   33566889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE---ccCCceeEcccCccccccCCCCC
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl---~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      ||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.........
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~  165 (277)
T 3f3z_A           86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM  165 (277)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence            999999999999888899999999999999999999999999999999999999   78899999999999987766666


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCc----cCChHHHHHHHH
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKG  382 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~LI~~  382 (482)
                      ....||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.+..+....+..+...+|.    .+++++.+||.+
T Consensus       166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (277)
T 3f3z_A          166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR  244 (277)
T ss_dssp             CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHH
T ss_pred             hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHH
Confidence            778899999999998765 899999999999999999999999999999999999988888775    689999999999


Q ss_pred             hhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          383 LLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       383 ~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      ||+.||.+||++     .++++||||+.
T Consensus       245 ~l~~dp~~R~s~-----~~~l~h~~~~~  267 (277)
T 3f3z_A          245 LLTKSPKQRITS-----LQALEHEWFEK  267 (277)
T ss_dssp             HTCSSTTTSCCH-----HHHTTSHHHHH
T ss_pred             HccCChhhCcCH-----HHHhcCHHHhc
Confidence            999999999999     99999999974

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.7e-50  Score=398.73  Aligned_cols=256  Identities=29%  Similarity=0.500  Sum_probs=216.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++++.||+|+||+||+|++ .+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+.+++|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            36899999999999999999998 5689999999976542 223345677899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCC
Q 047009          229 LDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~  306 (482)
                      |||+.+ +|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ...
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            999986 888888764 67999999999999999999999999999999999999999999999999999876432 233


Q ss_pred             cccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-------------------
Q 047009          307 NSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-------------------  366 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-------------------  366 (482)
                      ...+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.+...                   
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            456899999999999764 589999999999999999999999998887776666543100                   


Q ss_pred             ----------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          367 ----------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       367 ----------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                                .+...++.++.+||++||+.||++||++     +|+++||||++.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~n  288 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-----KQALEHAYFKENN  288 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGGC--
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCH-----HHHhcCcchhhcC
Confidence                      1123578999999999999999999999     9999999998753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.8e-51  Score=402.44  Aligned_cols=257  Identities=32%  Similarity=0.601  Sum_probs=222.2

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhch-----------------------hhHHHHHHHHHHH
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE-----------------------KNHAEYMKAERDI  203 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~-----------------------~~~~~~~~~E~~i  203 (482)
                      +.+++|++.+.||+|+||.||+|+++.+++.||||++.+.....                       ....+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            44689999999999999999999999999999999998754321                       1123567899999


Q ss_pred             HHhCCCCceeeeeeeeec--CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 047009          204 LTKIDHPFVVQLKYSFQT--KYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENI  281 (482)
Q Consensus       204 l~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NI  281 (482)
                      |++++||||+++++++.+  ...+|+||||+++++|..++ ..+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            999999999999999986  67899999999999997654 346799999999999999999999999999999999999


Q ss_pred             EEccCCceeEcccCccccccCCC-CCcccccCCCCCchhhhcCCC---CCchhHHHHHhHHHHHHhhCCCCCCCCchHHH
Q 047009          282 LLGADGHVMLTDFGLAKQFDENT-RSNSMIGTVEYMAPEIVLGKG---HNKAADWWSVGILLYEMLTGKPPFIGGNRAKI  357 (482)
Q Consensus       282 Ll~~~g~vKL~DFGla~~~~~~~-~~~~~~gt~~y~APE~l~~~~---~~~~sDvwSlGvilyelltG~~PF~~~~~~~~  357 (482)
                      |++.+|.+||+|||+++...... .....+||+.|+|||++.+..   ++.++|||||||++|+|++|+.||.+.+...+
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            99999999999999998765432 234568999999999998765   37899999999999999999999999888888


Q ss_pred             HHHHHhcccCCC--ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          358 QQKIVKDKLRLP--AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       358 ~~~i~~~~~~~p--~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      ...+......+|  ..+++++++||.+||+.||++||++     .|+++||||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~-----~e~l~hp~~~  297 (298)
T 2zv2_A          249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV-----PEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCH-----HHHTTCHHHH
T ss_pred             HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCH-----HHHhcCcccc
Confidence            888887776665  4689999999999999999999999     9999999985

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.9e-51  Score=398.16  Aligned_cols=260  Identities=31%  Similarity=0.566  Sum_probs=209.1

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      .+++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            45789999999999999999999999999999999987655444556778899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CC
Q 047009          228 VLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TR  305 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~  305 (482)
                      ||||+++++|..++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  168 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK  168 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence            99999999999998875 67999999999999999999999999999999999999999999999999999876432 23


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhc
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ....+||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+......+|..++.++++||.+||+
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  248 (278)
T 3cok_A          169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLR  248 (278)
T ss_dssp             -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSC
T ss_pred             ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHcc
Confidence            34568999999999999999999999999999999999999999888777777777667777888899999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      .||.+||++     +++++||||....
T Consensus       249 ~dp~~Rps~-----~~~l~h~~~~~~~  270 (278)
T 3cok_A          249 RNPADRLSL-----SSVLDHPFMSRNS  270 (278)
T ss_dssp             SSGGGSCCH-----HHHTTSTTTC---
T ss_pred             cCHhhCCCH-----HHHhcCccccCCC
Confidence            999999999     9999999998643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-50  Score=401.19  Aligned_cols=259  Identities=29%  Similarity=0.419  Sum_probs=218.9

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhch--hhHHHHHHHHHHHHHhC---CCCceeeeeeeeec
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE--KNHAEYMKAERDILTKI---DHPFVVQLKYSFQT  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~--~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~  221 (482)
                      ...++|++++.||+|+||+||+|+++.+++.||||++.......  ......+.+|+.+++++   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            45689999999999999999999999999999999997543211  11123455677776666   59999999999976


Q ss_pred             CC-----eEEEEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEccc
Q 047009          222 KY-----RLYLVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDF  294 (482)
Q Consensus       222 ~~-----~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DF  294 (482)
                      ..     .+++||||+.+ +|..++.....  +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            55     58999999974 99999887654  999999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC-------
Q 047009          295 GLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-------  367 (482)
Q Consensus       295 Gla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~-------  367 (482)
                      |+++...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......       
T Consensus       165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            9999877666677789999999999999999999999999999999999999999998888877777652110       


Q ss_pred             --------------------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          368 --------------------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       368 --------------------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                                          ....++.++.+||.+||+.||.+||++     .|+++||||+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~h~~~~~~  303 (308)
T 3g33_A          245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA-----FRALQHSYLHKD  303 (308)
T ss_dssp             SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSTTC---
T ss_pred             chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH-----HHHhcCccccCC
Confidence                                112478999999999999999999999     999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.1e-50  Score=407.86  Aligned_cols=257  Identities=30%  Similarity=0.481  Sum_probs=221.6

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            35899999999999999999999999999999999976542  2234567899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC---C
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---T  304 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~---~  304 (482)
                      ||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...   .
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999999875322   2


Q ss_pred             CCcccccCCCCCchhhhcCCCC-CchhHHHHHhHHHHHHhhCCCCCCCCchH-HHHHHHHhcccCC--CccCChHHHHHH
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRA-KIQQKIVKDKLRL--PAFLSSEAHSLL  380 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~-~~~sDvwSlGvilyelltG~~PF~~~~~~-~~~~~i~~~~~~~--p~~~s~~~~~LI  380 (482)
                      .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.. .............  ...++.++.+||
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence            3346789999999999988776 77999999999999999999999876553 2233333333222  256899999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      .+||+.||.+||++     +|+++||||+..
T Consensus       243 ~~~L~~dP~~R~t~-----~eil~h~~~~~~  268 (323)
T 3tki_A          243 HKILVENPSARITI-----PDIKKDRWYNKP  268 (323)
T ss_dssp             HHHSCSSTTTSCCH-----HHHTTCTTTTCC
T ss_pred             HHHccCChhhCcCH-----HHHhhChhhccc
Confidence            99999999999999     999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=8.2e-50  Score=394.51  Aligned_cols=265  Identities=32%  Similarity=0.512  Sum_probs=235.9

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhh------chhhHHHHHHHHHHHHHhCC-CCceeeeeeeee
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI------VEKNHAEYMKAERDILTKID-HPFVVQLKYSFQ  220 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~------~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~  220 (482)
                      ..++|++.+.||+|+||.||+|+++.+|+.||||++.....      ......+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            35899999999999999999999999999999999976431      11234566789999999995 999999999999


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF  300 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~  300 (482)
                      .....++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++...
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCcccccCCCCCchhhhc------CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----c
Q 047009          301 DENTRSNSMIGTVEYMAPEIVL------GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----A  370 (482)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~------~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~  370 (482)
                      .........+||+.|+|||++.      ...++.++||||||+++|+|++|+.||.+.+.......+..+...++    .
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  254 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccccc
Confidence            7666666788999999999985      45688999999999999999999999999888888888888766554    3


Q ss_pred             cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhh
Q 047009          371 FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLE  417 (482)
Q Consensus       371 ~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~  417 (482)
                      .++.++.+||.+||+.||.+||++     .++++||||+...++.+.
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~~~  296 (298)
T 1phk_A          255 DYSDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQQYVVEEVR  296 (298)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCH-----HHHTTSGGGCTTC-----
T ss_pred             ccCHHHHHHHHHHccCCcccCCCH-----HHHHhChHhhhccchhhc
Confidence            589999999999999999999999     999999999998887653

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7e-50  Score=417.93  Aligned_cols=264  Identities=27%  Similarity=0.436  Sum_probs=217.3

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC-----C
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK-----Y  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~  223 (482)
                      .++|++++.||+|+||.||+|+++.+++.||||++.+.. ......+.+.+|+.+|++++||||+++++++...     .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            478999999999999999999999999999999997643 2344566788999999999999999999999766     5


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          224 RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      .+|+||||+. |+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            7999999997 599999988888999999999999999999999999999999999999999999999999999876432


Q ss_pred             C-----------------------CCcccccCCCCCchhhh-cCCCCCchhHHHHHhHHHHHHhhC-----------CCC
Q 047009          304 T-----------------------RSNSMIGTVEYMAPEIV-LGKGHNKAADWWSVGILLYEMLTG-----------KPP  348 (482)
Q Consensus       304 ~-----------------------~~~~~~gt~~y~APE~l-~~~~~~~~sDvwSlGvilyelltG-----------~~P  348 (482)
                      .                       .....+||+.|+|||++ .+..|+.++|||||||++|||++|           +++
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            2                       23567899999999986 556799999999999999999984           444


Q ss_pred             CCCCch-----------------HHHHHHHHh------------------------cccCCC-------ccCChHHHHHH
Q 047009          349 FIGGNR-----------------AKIQQKIVK------------------------DKLRLP-------AFLSSEAHSLL  380 (482)
Q Consensus       349 F~~~~~-----------------~~~~~~i~~------------------------~~~~~p-------~~~s~~~~~LI  380 (482)
                      |.+.+.                 ......|..                        .....+       ..+++++.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence            444321                 111111111                        111111       34799999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhc
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR  419 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~  419 (482)
                      ++||+.||.+||++     +|+++||||++++|...+..
T Consensus       343 ~~mL~~dP~~R~ta-----~e~L~Hp~f~~~~~~~~e~~  376 (432)
T 3n9x_A          343 ESMLKFNPNKRITI-----DQALDHPYLKDVRKKKLENF  376 (432)
T ss_dssp             HHHSCSSTTTSCCH-----HHHHTCGGGTTTCCTTTC--
T ss_pred             HHHhcCCcccCCCH-----HHHhcChhhhhccCcccCcC
Confidence            99999999999998     99999999999999877653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2e-50  Score=426.10  Aligned_cols=253  Identities=26%  Similarity=0.444  Sum_probs=213.7

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC------
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK------  222 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  222 (482)
                      .++|++++.||+|+||+||+|+++.+++.||||++.+.. ......+.+.+|+.+|+.++||||++++++|...      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            578999999999999999999999999999999998753 2345566788999999999999999999999654      


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..+|+||||+.++ |...+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus       140 ~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          140 QDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             CEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             CeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            4679999999875 655553  3589999999999999999999999999999999999999999999999999998776


Q ss_pred             CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc----------------
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL----------------  366 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~----------------  366 (482)
                      .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....|.+...                
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~  296 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  296 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred             CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence            6666778999999999999999999999999999999999999999999888777776654211                


Q ss_pred             -----------CC----Ccc-----------CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          367 -----------RL----PAF-----------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       367 -----------~~----p~~-----------~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                                 .+    |..           .++++++||++||+.||++||++     +|+++||||+.
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-----~e~L~Hp~~~~  361 (464)
T 3ttj_A          297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-----DDALQHPYINV  361 (464)
T ss_dssp             HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH-----HHHHTSTTTGG
T ss_pred             HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCH-----HHHhcChhhhh
Confidence                       00    110           15679999999999999999999     99999999984

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.4e-50  Score=427.43  Aligned_cols=258  Identities=34%  Similarity=0.562  Sum_probs=232.6

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh----------hHHHHHHHHHHHHHhCCCCceeeeee
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK----------NHAEYMKAERDILTKIDHPFVVQLKY  217 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~----------~~~~~~~~E~~il~~l~hpnIv~l~~  217 (482)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++.+......          ...+.+.+|+.+|++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            34789999999999999999999999999999999987643321          33567889999999999999999999


Q ss_pred             eeecCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC---ceeEccc
Q 047009          218 SFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG---HVMLTDF  294 (482)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g---~vKL~DF  294 (482)
                      +|.+...+|+||||++||+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+||
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            9999999999999999999999998888999999999999999999999999999999999999999876   6999999


Q ss_pred             CccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----c
Q 047009          295 GLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----A  370 (482)
Q Consensus       295 Gla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~  370 (482)
                      |+++...........+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..++...+..+.+.++    .
T Consensus       194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (504)
T 3q5i_A          194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK  272 (504)
T ss_dssp             TTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred             CCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence            99998876666677899999999999875 599999999999999999999999999999999999999887766    5


Q ss_pred             cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          371 FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       371 ~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      .+++++++||++||++||.+||++     +|+++||||+..
T Consensus       273 ~~s~~~~~li~~~L~~dp~~R~t~-----~e~l~h~~~~~~  308 (504)
T 3q5i_A          273 NISDEAKELIKLMLTYDYNKRCTA-----EEALNSRWIKKY  308 (504)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHHT
T ss_pred             CCCHHHHHHHHHHcCCChhHCCCH-----HHHhcCHhhhhc
Confidence            689999999999999999999999     999999999753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.4e-50  Score=393.83  Aligned_cols=254  Identities=31%  Similarity=0.554  Sum_probs=221.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++.+...  ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            3689999999999999999999999999999999987642  23456788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE---ccCCceeEcccCcccccc
Q 047009          229 LDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl---~~~g~vKL~DFGla~~~~  301 (482)
                      |||+++|+|...+..    ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999999988854    3679999999999999999999999999999999999999   456889999999998876


Q ss_pred             CCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC---ccCChHHHH
Q 047009          302 ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP---AFLSSEAHS  378 (482)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~  378 (482)
                      ........+||+.|+|||++. ..++.++||||||+++|+|++|+.||.+.+..+....+......++   ..+++++.+
T Consensus       179 ~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (285)
T 3is5_A          179 SDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVD  257 (285)
T ss_dssp             --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHH
T ss_pred             CcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHH
Confidence            666666788999999999986 4689999999999999999999999999888888887776655443   347899999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      ||++||+.||++||++     .|+++||||+.
T Consensus       258 li~~~L~~dP~~Rps~-----~e~l~hp~f~~  284 (285)
T 3is5_A          258 LLKQMLTKDPERRPSA-----AQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHTCSCTTTSCCH-----HHHHTSGGGGC
T ss_pred             HHHHHccCChhhCcCH-----HHHhcCHHhhc
Confidence            9999999999999999     99999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.2e-50  Score=414.05  Aligned_cols=256  Identities=30%  Similarity=0.521  Sum_probs=226.9

Q ss_pred             EEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEec
Q 047009          153 EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFI  232 (482)
Q Consensus       153 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  232 (482)
                      ...+.||+|+||.||+|+++.+|+.||+|+++....   ...+.+.+|+.+|++++||||+++++++.+.+.+++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            336789999999999999999999999999987542   34566889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE--ccCCceeEcccCccccccCCCCCccc
Q 047009          233 NGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL--GADGHVMLTDFGLAKQFDENTRSNSM  309 (482)
Q Consensus       233 ~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl--~~~g~vKL~DFGla~~~~~~~~~~~~  309 (482)
                      +||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++...........
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~  248 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN  248 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence            999999888654 469999999999999999999999999999999999999  56789999999999988766666677


Q ss_pred             ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHHHHHHhhc
Q 047009          310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~LI~~~L~  385 (482)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......++    ..+++++++||.+||+
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~  328 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLI  328 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSC
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcC
Confidence            899999999999999999999999999999999999999999998888888888776655    3589999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCCChhhh
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKL  416 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~  416 (482)
                      +||.+||++     .|+++||||++..|...
T Consensus       329 ~dp~~Rps~-----~e~l~hp~~~~~~~~~~  354 (373)
T 2x4f_A          329 KEKSWRISA-----SEALKHPWLSDHKLHSR  354 (373)
T ss_dssp             SSGGGSCCH-----HHHHHSHHHHCHHHHHH
T ss_pred             CChhhCCCH-----HHHhcCcCcCCCchhhh
Confidence            999999999     99999999998876543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.5e-50  Score=427.31  Aligned_cols=257  Identities=32%  Similarity=0.612  Sum_probs=231.7

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||+||+|+++.+++.||||++.+..... .....+.+|+.+|++++||||+++++++.+...+|+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            367999999999999999999999999999999998755332 3456688999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc---cCCceeEcccCccccccCCCC
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG---ADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~---~~g~vKL~DFGla~~~~~~~~  305 (482)
                      |||+.||+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.......
T Consensus       100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  179 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence            99999999999998888999999999999999999999999999999999999995   456799999999998776666


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLK  381 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~LI~  381 (482)
                      ....+||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+.+..++...+..+...++    ..+++++++||+
T Consensus       180 ~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  258 (486)
T 3mwu_A          180 MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR  258 (486)
T ss_dssp             --CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHH
T ss_pred             cCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHH
Confidence            6778999999999999874 99999999999999999999999999999999999988876554    458999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      +||+.||.+||++     .++++||||+...
T Consensus       259 ~~L~~dp~~R~t~-----~~~l~hp~~~~~~  284 (486)
T 3mwu_A          259 KMLTFHPSLRITA-----TQCLEHPWIQKYS  284 (486)
T ss_dssp             HHTCSSTTTSCCH-----HHHHHCHHHHHTC
T ss_pred             HHcCCChhhCcCH-----HHHhcCHhhccCc
Confidence            9999999999999     9999999997643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-50  Score=406.17  Aligned_cols=267  Identities=29%  Similarity=0.478  Sum_probs=230.2

Q ss_pred             CCCCeEEE-EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeE
Q 047009          148 GIEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       148 ~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  225 (482)
                      ..+.|.+. +.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+++.+ .||||++++++|.+...+
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            34568887 899999999999999999999999999987543 223455678899999999 569999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc---CCceeEcccCccccc
Q 047009          226 YLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQF  300 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~---~g~vKL~DFGla~~~  300 (482)
                      |+||||+.||+|..++...  +.+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+++..
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~  184 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI  184 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence            9999999999999888553  67999999999999999999999999999999999999998   789999999999987


Q ss_pred             cCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHH
Q 047009          301 DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEA  376 (482)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~  376 (482)
                      .........+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+......++    ..++..+
T Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  264 (327)
T 3lm5_A          185 GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA  264 (327)
T ss_dssp             ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHH
Confidence            666666677899999999999999999999999999999999999999999988888888877655444    3589999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhcc
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEARE  420 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~  420 (482)
                      ++||.+||+.||.+||++     +++++||||+..+|+.+....
T Consensus       265 ~~li~~~L~~dP~~Rpt~-----~~ll~h~~~~~~~~~~~~~~~  303 (327)
T 3lm5_A          265 TDFIQSLLVKNPEKRPTA-----EICLSHSWLQQWDFENLFHPE  303 (327)
T ss_dssp             HHHHHHHSCSSGGGSCCH-----HHHTTCGGGCCCCTTCC----
T ss_pred             HHHHHHHcCCChhhCcCH-----HHHhCCHhhcccccccccCcc
Confidence            999999999999999999     999999999999998765443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.1e-50  Score=395.78  Aligned_cols=261  Identities=31%  Similarity=0.557  Sum_probs=231.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh---hHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK---NHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++........   ...+.+.+|+.++++++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            579999999999999999999999999999999987643221   13567889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC----ceeEcccCccccccC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG----HVMLTDFGLAKQFDE  302 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g----~vKL~DFGla~~~~~  302 (482)
                      +||||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||++.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999998888899999999999999999999999999999999999999887    899999999988766


Q ss_pred             CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHH
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHS  378 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  378 (482)
                      ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+......++    ..++..+.+
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD  244 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred             CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHH
Confidence            5555667899999999999999999999999999999999999999999888888888877766554    468999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhh
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK  415 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~  415 (482)
                      ||.+||+.||++||++     .++++||||+.+++..
T Consensus       245 li~~~l~~dp~~Rps~-----~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          245 FIRRLLVKDPKRRMTI-----AQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             HHHTTSCSSGGGSCCH-----HHHHHCHHHHHHHHCC
T ss_pred             HHHHHccCCHhHCcCH-----HHHHhCHHHHHHHHHh
Confidence            9999999999999998     9999999998765543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=8.2e-50  Score=405.93  Aligned_cols=259  Identities=29%  Similarity=0.420  Sum_probs=224.0

Q ss_pred             CCcccccccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-----CCcee
Q 047009          139 GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-----HPFVV  213 (482)
Q Consensus       139 ~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv  213 (482)
                      ..+...+....++|++++.||+|+||+||+|++..+++.||||++....    ........|+.+++.+.     ||||+
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            3344445566789999999999999999999999999999999997532    33455678999999986     99999


Q ss_pred             eeeeeeecCCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc------
Q 047009          214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA------  285 (482)
Q Consensus       214 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~------  285 (482)
                      ++++++...+.+|+||||+ +++|..++....  .+++..++.++.||+.||+|||++||+||||||+|||++.      
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence            9999999999999999999 889999988764  5999999999999999999999999999999999999975      


Q ss_pred             -------------------CCceeEcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCC
Q 047009          286 -------------------DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGK  346 (482)
Q Consensus       286 -------------------~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~  346 (482)
                                         ++.+||+|||+++....  .....+||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  256 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS  256 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence                               78999999999987543  334678999999999999999999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHhcccCCCc----------------------------------------------cCChHHHHHH
Q 047009          347 PPFIGGNRAKIQQKIVKDKLRLPA----------------------------------------------FLSSEAHSLL  380 (482)
Q Consensus       347 ~PF~~~~~~~~~~~i~~~~~~~p~----------------------------------------------~~s~~~~~LI  380 (482)
                      .||.+.+..+....+......+|.                                              ..++.+.+||
T Consensus       257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  336 (360)
T 3llt_A          257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL  336 (360)
T ss_dssp             CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred             CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence            999988877766666553332221                                              1237788999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      ++||+.||.+||++     +|+++||||+
T Consensus       337 ~~~L~~dP~~Rpta-----~elL~hp~f~  360 (360)
T 3llt_A          337 YSILQIDPTLRPSP-----AELLKHKFLE  360 (360)
T ss_dssp             HHHCCSSGGGSCCH-----HHHTTSGGGC
T ss_pred             HHHhcCChhhCCCH-----HHHhcCcccC
Confidence            99999999999999     9999999996

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=410.12  Aligned_cols=259  Identities=29%  Similarity=0.508  Sum_probs=228.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh-----hHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK-----NHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      .++|++++.||+|+||.||+|+++.+++.||||++.+......     .....+.+|+.+|++++||||++++++|.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            3689999999999999999999999999999999987643221     12334668999999999999999999999999


Q ss_pred             eEEEEEEecCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 RLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      .+++||||+.+| +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  182 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER  182 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence            999999999777 9999999888999999999999999999999999999999999999999999999999999998877


Q ss_pred             CCCCcccccCCCCCchhhhcCCCC-CchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHH
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~  381 (482)
                      .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....      ........|..++.++.+||.
T Consensus       183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~l~~li~  256 (335)
T 3dls_A          183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSKELMSLVS  256 (335)
T ss_dssp             TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCHHHHHHHH
T ss_pred             CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCHHHHHHHH
Confidence            666677889999999999998877 8899999999999999999999975322      233455667779999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCC------CChhhhhh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKP------INWKKLEA  418 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~------~~~~~~~~  418 (482)
                      +||+.||.+||++     +++++||||+.      .+|+.+..
T Consensus       257 ~~L~~dP~~Rps~-----~ell~hp~~~~~~~~~~~~~~~~~~  294 (335)
T 3dls_A          257 GLLQPVPERRTTL-----EKLVTDPWVTQPVNLADYTWEEVFR  294 (335)
T ss_dssp             HHTCSSGGGSCCH-----HHHHHCTTTTCCCCGGGCCHHHHC-
T ss_pred             HHccCChhhCcCH-----HHHhcCccccCCccccccCHHHHhh
Confidence            9999999999999     99999999965      45655543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.3e-50  Score=399.50  Aligned_cols=259  Identities=32%  Similarity=0.533  Sum_probs=219.2

Q ss_pred             CCCeEEE-EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEE
Q 047009          149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       149 ~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~  226 (482)
                      .+.|++. +.||+|+||+||+|+++.+++.||||++.+..   ....+.+.+|+.++.++ +||||+++++++.+.+.+|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            4679985 78999999999999999999999999997653   23355678899999985 7999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc---eeEcccCccccccCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH---VMLTDFGLAKQFDEN  303 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~---vKL~DFGla~~~~~~  303 (482)
                      +||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||+++.....
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999999999999998889999999999999999999999999999999999999998876   999999999865321


Q ss_pred             --------CCCcccccCCCCCchhhhcC-----CCCCchhHHHHHhHHHHHHhhCCCCCCCCc---------------hH
Q 047009          304 --------TRSNSMIGTVEYMAPEIVLG-----KGHNKAADWWSVGILLYEMLTGKPPFIGGN---------------RA  355 (482)
Q Consensus       304 --------~~~~~~~gt~~y~APE~l~~-----~~~~~~sDvwSlGvilyelltG~~PF~~~~---------------~~  355 (482)
                              ......+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.+               ..
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence                    12234579999999999975     558899999999999999999999997754               24


Q ss_pred             HHHHHHHhcccCCCc----cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhh
Q 047009          356 KIQQKIVKDKLRLPA----FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK  415 (482)
Q Consensus       356 ~~~~~i~~~~~~~p~----~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~  415 (482)
                      .+.+.+..+...+|.    .++.++++||++||+.||.+||++     .|+++||||++..+..
T Consensus       248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~e~l~hp~~~~~~~~~  306 (316)
T 2ac3_A          248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA-----AQVLQHPWVQGCAPEN  306 (316)
T ss_dssp             HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSTTCC------
T ss_pred             HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCH-----HHHhcChhhcCCCCcc
Confidence            466777777777773    589999999999999999999999     9999999999876643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.2e-50  Score=402.58  Aligned_cols=260  Identities=26%  Similarity=0.431  Sum_probs=223.9

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC--
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY--  223 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  223 (482)
                      ....++|++.+.||+|+||.||+|+++.+++.||||++.............+.+|+.++++++||||+++++++....  
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence            344588999999999999999999999999999999998765555566677889999999999999999999987654  


Q ss_pred             --eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          224 --RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       224 --~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                        ..|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  167 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred             CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence              349999999999999999988899999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC----CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCC
Q 047009          302 ENT----RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLS  373 (482)
Q Consensus       302 ~~~----~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s  373 (482)
                      ...    .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......+    ..++
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS  247 (311)
T ss_dssp             --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred             ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence            332    23446799999999999999999999999999999999999999999888777777666554433    4589


Q ss_pred             hHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       374 ~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      .++.+||.+||++||.+||++     .+++.|+|++.
T Consensus       248 ~~l~~li~~~l~~dP~~R~~~-----~~~l~~~l~~~  279 (311)
T 3ork_A          248 ADLDAVVLKALAKNPENRYQT-----AAEMRADLVRV  279 (311)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSS-----HHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCHhhChhh-----HHHHHHHHHHH
Confidence            999999999999999999998     89999999764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.5e-50  Score=403.72  Aligned_cols=251  Identities=32%  Similarity=0.597  Sum_probs=204.5

Q ss_pred             CCeEEE---EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCCeE
Q 047009          150 EDFEVL---KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       150 ~~y~i~---~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~  225 (482)
                      ++|++.   +.||+|+||.||+|+++.+++.||||++.+..      ...+.+|+.+++.+. ||||+++++++.+....
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~   81 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT   81 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence            456664   78999999999999999999999999997542      345678999999997 99999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC---ceeEcccCccccccC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG---HVMLTDFGLAKQFDE  302 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g---~vKL~DFGla~~~~~  302 (482)
                      |+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            99999999999999999999999999999999999999999999999999999999998776   899999999987543


Q ss_pred             -CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc-------hHHHHHHHHhcccCCCc----
Q 047009          303 -NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN-------RAKIQQKIVKDKLRLPA----  370 (482)
Q Consensus       303 -~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~-------~~~~~~~i~~~~~~~p~----  370 (482)
                       .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+       ..++...+..+.+.++.    
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (325)
T 3kn6_A          162 DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK  241 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHH
T ss_pred             CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccccc
Confidence             233456789999999999999999999999999999999999999997643       35677788877776663    


Q ss_pred             cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          371 FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       371 ~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      .+++++++||++||+.||.+||++     +|+++||||++.
T Consensus       242 ~~s~~~~~li~~~L~~dP~~Rpt~-----~ell~h~w~~~~  277 (325)
T 3kn6_A          242 NVSQEAKDLIQGLLTVDPNKRLKM-----SGLRYNEWLQDG  277 (325)
T ss_dssp             TSCHHHHHHHHHHHCCCTTTCCCT-----TTSTTCGGGCTT
T ss_pred             CCCHHHHHHHHHHCCCChhHCCCH-----HHHhcChhhccC
Confidence            589999999999999999999999     899999999863

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.6e-50  Score=425.56  Aligned_cols=256  Identities=33%  Similarity=0.593  Sum_probs=228.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++++.||+|+||+||+|+++.++..||+|++.+..... .....+.+|+.+|+.++||||++++++|.+...+|+||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999999999999999998765322 23456789999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC---CceeEcccCccccccCCCCC
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD---GHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~---g~vKL~DFGla~~~~~~~~~  306 (482)
                      ||+.||+|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+++........
T Consensus       116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~  195 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM  195 (494)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence            999999999999888899999999999999999999999999999999999999764   45999999999987766666


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHHHHHH
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLKG  382 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~LI~~  382 (482)
                      ...+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..++...+..+...++    ..+++++++||++
T Consensus       196 ~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  274 (494)
T 3lij_A          196 KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ  274 (494)
T ss_dssp             CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHH
T ss_pred             cccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHH
Confidence            77899999999999874 599999999999999999999999999999999999998877665    3589999999999


Q ss_pred             hhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          383 LLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       383 ~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      ||+.||.+||++     .++++||||+...
T Consensus       275 ~L~~dp~~R~s~-----~e~l~hp~~~~~~  299 (494)
T 3lij_A          275 MLQFDSQRRISA-----QQALEHPWIKEMC  299 (494)
T ss_dssp             HTCSSTTTSCCH-----HHHHTCHHHHHHH
T ss_pred             HCCCChhhCccH-----HHHhcCcccccCc
Confidence            999999999999     9999999998643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.9e-50  Score=415.95  Aligned_cols=250  Identities=30%  Similarity=0.546  Sum_probs=212.0

Q ss_pred             CCCCeEEE-EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHH-hCCCCceeeeeeeeec----
Q 047009          148 GIEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT-KIDHPFVVQLKYSFQT----  221 (482)
Q Consensus       148 ~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~----  221 (482)
                      .+++|.+. +.||+|+||+||+|+++.+|+.||||++...        ..+.+|+.++. ..+||||++++++|..    
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            34788887 7899999999999999999999999998643        23567888774 4589999999999875    


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc---CCceeEcccCc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGL  296 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~---~g~vKL~DFGl  296 (482)
                      ...+|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            677999999999999999998754  5999999999999999999999999999999999999998   78999999999


Q ss_pred             cccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchH----HHHHHHHhcccCCC---
Q 047009          297 AKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA----KIQQKIVKDKLRLP---  369 (482)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~----~~~~~i~~~~~~~p---  369 (482)
                      ++...........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..    .+...+..+.+.+|   
T Consensus       211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~  290 (400)
T 1nxk_A          211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  290 (400)
T ss_dssp             CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred             ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence            99876555566789999999999999999999999999999999999999999775532    25566777776665   


Q ss_pred             -ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          370 -AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       370 -~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                       ..++.++++||++||+.||.+||++     .|+++||||..
T Consensus       291 ~~~~s~~~~~li~~~L~~dP~~Rpt~-----~eil~hp~~~~  327 (400)
T 1nxk_A          291 WSEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIMQ  327 (400)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSHHHHT
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCH-----HHHhcCccccC
Confidence             4689999999999999999999998     99999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-50  Score=405.82  Aligned_cols=259  Identities=32%  Similarity=0.527  Sum_probs=225.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc--hhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV--EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++.+....  .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            6799999999999999999999999999999999876432  23456778899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 047009          228 VLDFINGGHLFFQLYH----------------------------------------HGLFREDLARIYAAEIVSAVSHLH  267 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~----------------------------------------~~~l~~~~~~~i~~qi~~aL~yLH  267 (482)
                      ||||++||+|.+++..                                        ...+++..++.++.||+.||+|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            9999999999988742                                        112467788899999999999999


Q ss_pred             HCCCcccCCCCCcEEEccCC--ceeEcccCccccccCCC-----CCcccccCCCCCchhhhcC--CCCCchhHHHHHhHH
Q 047009          268 ANGIMHRDLKPENILLGADG--HVMLTDFGLAKQFDENT-----RSNSMIGTVEYMAPEIVLG--KGHNKAADWWSVGIL  338 (482)
Q Consensus       268 ~~~IiHrDLKp~NILl~~~g--~vKL~DFGla~~~~~~~-----~~~~~~gt~~y~APE~l~~--~~~~~~sDvwSlGvi  338 (482)
                      ++||+||||||+|||++.++  .+||+|||+++.+....     ......||+.|+|||++.+  ..++.++|||||||+
T Consensus       186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i  265 (345)
T 3hko_A          186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL  265 (345)
T ss_dssp             HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred             HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence            99999999999999998777  89999999998753321     2346789999999999976  678999999999999


Q ss_pred             HHHHhhCCCCCCCCchHHHHHHHHhcccCCCc----cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          339 LYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       339 lyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      +|+|++|+.||.+.+..+....+......++.    .+++++++||.+||+.||.+||++     .++++||||+++.|
T Consensus       266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~~l~hp~~~~~~~  339 (345)
T 3hko_A          266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA-----MRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH-----HHHHHSHHHHTTSS
T ss_pred             HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCH-----HHHhcChhhccChH
Confidence            99999999999999988888888887665543    479999999999999999999999     99999999998765

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.9e-49  Score=404.22  Aligned_cols=256  Identities=31%  Similarity=0.545  Sum_probs=232.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhh-----chhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecC
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-----VEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTK  222 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~-----~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  222 (482)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++.....     ......+.+.+|+.+++++ +||||+++++++...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            3679999999999999999999999999999999976431     1123355678999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ...|+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+..
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            99999999999999999998888899999999999999999999999999999999999999999999999999998876


Q ss_pred             CCCCcccccCCCCCchhhhcC------CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccC
Q 047009          303 NTRSNSMIGTVEYMAPEIVLG------KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFL  372 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~------~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~  372 (482)
                      .......+||+.|+|||++.+      ..++.++|||||||++|+|++|+.||.+.+.......+..+...++    ..+
T Consensus       253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  332 (365)
T 2y7j_A          253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR  332 (365)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSS
T ss_pred             CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC
Confidence            666677899999999999863      3688999999999999999999999999888888888888776654    368


Q ss_pred             ChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       373 s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      +.++.+||++||+.||++||++     .++++||||+
T Consensus       333 ~~~~~~li~~~L~~dP~~Rps~-----~ell~hp~f~  364 (365)
T 2y7j_A          333 SSTVKDLISRLLQVDPEARLTA-----EQALQHPFFE  364 (365)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGC
T ss_pred             CHHHHHHHHHHcCCChhHCcCH-----HHHhcCcccC
Confidence            8999999999999999999999     9999999997

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.8e-50  Score=418.46  Aligned_cols=265  Identities=32%  Similarity=0.586  Sum_probs=220.0

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhch-----hhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE-----KNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      ..++|++.+.||+|+||+||+|.++.+++.||+|++.+.....     ......+.+|+.+|++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            3578999999999999999999999999999999998765321     1222347789999999999999999999865 


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC---ceeEcccCcccc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG---HVMLTDFGLAKQ  299 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g---~vKL~DFGla~~  299 (482)
                      ..+|+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++.
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            45789999999999999998888999999999999999999999999999999999999997654   599999999998


Q ss_pred             ccCCCCCcccccCCCCCchhhhcC---CCCCchhHHHHHhHHHHHHhhCCCCCCCCch-HHHHHHHHhcccCCC----cc
Q 047009          300 FDENTRSNSMIGTVEYMAPEIVLG---KGHNKAADWWSVGILLYEMLTGKPPFIGGNR-AKIQQKIVKDKLRLP----AF  371 (482)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~sDvwSlGvilyelltG~~PF~~~~~-~~~~~~i~~~~~~~p----~~  371 (482)
                      ..........+||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||.+... ..+...+..+...++    ..
T Consensus       292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  371 (419)
T 3i6u_A          292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  371 (419)
T ss_dssp             CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred             cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence            876666677899999999999864   6788999999999999999999999976543 345556666655544    35


Q ss_pred             CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhh
Q 047009          372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEA  418 (482)
Q Consensus       372 ~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~  418 (482)
                      ++.++.+||++||+.||.+||++     +|+++||||++.+|.....
T Consensus       372 ~~~~~~~li~~~L~~dP~~Rps~-----~e~l~hp~~~~~~~~~~~~  413 (419)
T 3i6u_A          372 VSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMKRKFQ  413 (419)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGCCHHHHHHHH
T ss_pred             cCHHHHHHHHHHccCChhHCcCH-----HHHhCCcccCChhHHHHHH
Confidence            89999999999999999999999     9999999999988866543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.6e-49  Score=406.74  Aligned_cols=269  Identities=26%  Similarity=0.456  Sum_probs=216.0

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC-----
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY-----  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  223 (482)
                      .++|++++.||+|+||.||+|++..+++.||||++.... ......+.+.+|+.+++.++||||+++++++....     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            578999999999999999999999999999999998653 23345566789999999999999999999997654     


Q ss_pred             -eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 -RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                       .+|+||||+.+ +|...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence             78999999985 6777774  4589999999999999999999999999999999999999999999999999988765


Q ss_pred             CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc----------------
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL----------------  366 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~----------------  366 (482)
                      .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.+...                
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  259 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  259 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred             ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence            5555677899999999999999999999999999999999999999999887777766654211                


Q ss_pred             ------CC--------------Cc------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhcc
Q 047009          367 ------RL--------------PA------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEARE  420 (482)
Q Consensus       367 ------~~--------------p~------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~  420 (482)
                            .+              |.      ..+.++++||++||+.||++||++     +|+++||||+.  |.......
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-----~e~l~hp~~~~--~~~~~~~~  332 (371)
T 2xrw_A          260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV-----DEALQHPYINV--WYDPSEAE  332 (371)
T ss_dssp             HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH-----HHHHHSHHHHT--TCCHHHHT
T ss_pred             HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH-----HHHhCCcchhh--hcCccccC
Confidence                  00              00      015689999999999999999999     99999999985  33333344


Q ss_pred             CCCCCccc
Q 047009          421 IQPGFCPE  428 (482)
Q Consensus       421 ~~p~~~p~  428 (482)
                      ..||+.|.
T Consensus       333 ~~~~~~~~  340 (371)
T 2xrw_A          333 APPPKIPD  340 (371)
T ss_dssp             CCCCCCCT
T ss_pred             CCCCCCCC
Confidence            45555554

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9.7e-50  Score=401.31  Aligned_cols=267  Identities=30%  Similarity=0.470  Sum_probs=226.1

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      .+++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+....|+
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence            45789999999999999999999999999999999876542 33445667899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCC
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRS  306 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~  306 (482)
                      ||||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ....
T Consensus       102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  181 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  181 (331)
T ss_dssp             EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcccc
Confidence            999999999988887778899999999999999999999999999999999999999999999999999987543 2334


Q ss_pred             cccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-------------------c
Q 047009          307 NSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-------------------L  366 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-------------------~  366 (482)
                      ...+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....                   .
T Consensus       182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (331)
T 4aaa_A          182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV  261 (331)
T ss_dssp             --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred             CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence            566899999999999876 78999999999999999999999999887766655544211                   1


Q ss_pred             CCC------------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhcc
Q 047009          367 RLP------------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEARE  420 (482)
Q Consensus       367 ~~p------------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~  420 (482)
                      .++            ..+++++.+||.+||+.||.+||++     .|+++||||+..+|.....++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~~~~~~~  322 (331)
T 4aaa_A          262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC-----AELLHHDFFQMDGFAERFSQE  322 (331)
T ss_dssp             CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCG-----GGGGGSHHHHGGGHHHHHHHH
T ss_pred             cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCH-----HHHhcCchhccCChhhhhhHH
Confidence            111            2478999999999999999999999     999999999988776654433

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-49  Score=398.44  Aligned_cols=254  Identities=27%  Similarity=0.454  Sum_probs=212.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC-----
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY-----  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  223 (482)
                      +++|++++.||+|+||.||+|+++.+|+.||||++....  .....+.+.+|+.+|++++||||++++++|.+..     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            467999999999999999999999999999999998653  2345567889999999999999999999985543     


Q ss_pred             ----------------------------------------------------eEEEEEEecCCCchHHHHHhcCC---CC
Q 047009          224 ----------------------------------------------------RLYLVLDFINGGHLFFQLYHHGL---FR  248 (482)
Q Consensus       224 ----------------------------------------------------~~~lV~E~~~gg~L~~~l~~~~~---l~  248 (482)
                                                                          .+++||||++||+|..++.....   .+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                38999999999999999987654   45


Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-------------CCcccccCCCC
Q 047009          249 EDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-------------RSNSMIGTVEY  315 (482)
Q Consensus       249 ~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-------------~~~~~~gt~~y  315 (482)
                      +..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......             .....+||+.|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            55688999999999999999999999999999999999999999999998865432             23446799999


Q ss_pred             CchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC-CCccCChHHHHHHHHhhccCcCCcCCC
Q 047009          316 MAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-LPAFLSSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       316 ~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                      +|||++.+..++.++|||||||++|+|++|..|+.  ........+...... .+...++++.+||.+||+.||.+||++
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  320 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--ERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA  320 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--HHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence            99999999999999999999999999999987752  222333333333221 123467889999999999999999999


Q ss_pred             CCCChHHHHhCcCCCCC
Q 047009          395 GPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       395 ~~~~~~eil~hp~f~~~  411 (482)
                           +|+++||||+++
T Consensus       321 -----~~~l~~~~f~~~  332 (332)
T 3qd2_B          321 -----TDIIENAIFENL  332 (332)
T ss_dssp             -----HHHHHSTTCCCC
T ss_pred             -----HHHhhchhhhcC
Confidence                 999999999874

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.1e-49  Score=390.70  Aligned_cols=258  Identities=25%  Similarity=0.437  Sum_probs=222.2

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      ....++|++++.||+|+||.||+|++..+++.||+|++...........+.+.+|+.++++++||||+++++++.+.+.+
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   86 (294)
T 4eqm_A            7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY   86 (294)
T ss_dssp             SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred             hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence            34457899999999999999999999999999999999766555556677889999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  304 (482)
                      |+||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            9999999999999999988999999999999999999999999999999999999999999999999999998765432 


Q ss_pred             -CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC-----CCccCChHHHH
Q 047009          305 -RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-----LPAFLSSEAHS  378 (482)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~  378 (482)
                       .....+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..............     .+..+++.+.+
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  246 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN  246 (294)
T ss_dssp             --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred             cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence             234568999999999999999999999999999999999999999988877666555554322     34568999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +|.+||++||.+||+.     .+.+.+.|.
T Consensus       247 li~~~l~~dp~~R~~~-----~~~l~~~l~  271 (294)
T 4eqm_A          247 VILRATEKDKANRYKT-----IQEMKDDLS  271 (294)
T ss_dssp             HHHHHSCSSGGGSCSS-----HHHHHHHHH
T ss_pred             HHHHHhcCCHhHcccc-----HHHHHHHHH
Confidence            9999999999999976     555555553

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.1e-49  Score=395.22  Aligned_cols=253  Identities=27%  Similarity=0.486  Sum_probs=226.1

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      .|+..+.||+|+||.||+|+++.+|+.||||++....   ....+.+.+|+.++++++||||+++++++......++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            4788889999999999999999999999999997653   2345567899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCccc
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSNSM  309 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~  309 (482)
                      |++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ......
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            9999999988754 56999999999999999999999999999999999999999999999999999876543 234567


Q ss_pred             ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc---CCCccCChHHHHHHHHhhcc
Q 047009          310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL---RLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~LI~~~L~~  386 (482)
                      +||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+.....   ..+..+++++++||.+||+.
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  281 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR  281 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCS
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccC
Confidence            899999999999999999999999999999999999999998888877777766533   23346899999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      ||++||++     .++++||||....
T Consensus       282 dp~~Rps~-----~ell~hp~~~~~~  302 (321)
T 2c30_A          282 DPQERATA-----QELLDHPFLLQTG  302 (321)
T ss_dssp             STTTSCCH-----HHHHTSGGGGGCC
T ss_pred             ChhhCcCH-----HHHhcChhhccCC
Confidence            99999999     9999999998654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.1e-49  Score=392.45  Aligned_cols=253  Identities=34%  Similarity=0.625  Sum_probs=228.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++.....   ...+.+.+|+.++++++||||+++++++.+...+|+||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            579999999999999999999999999999999986532   23355789999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE---ccCCceeEcccCccccccCCCCC
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl---~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      ||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++..... ..
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~  164 (304)
T 2jam_A           86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IM  164 (304)
T ss_dssp             CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TT
T ss_pred             EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-cc
Confidence            999999999999888899999999999999999999999999999999999999   78899999999999765432 33


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHHHHHH
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLKG  382 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~LI~~  382 (482)
                      ...+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+...+...+..+...++    ..++.++.+||.+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  244 (304)
T 2jam_A          165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH  244 (304)
T ss_dssp             HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHH
Confidence            456799999999999999999999999999999999999999999888888888888765543    4689999999999


Q ss_pred             hhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          383 LLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       383 ~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      ||+.||++||++     +++++||||.+.
T Consensus       245 ~l~~dp~~Rps~-----~~~l~h~~~~~~  268 (304)
T 2jam_A          245 LLEKDPNERYTC-----EKALSHPWIDGN  268 (304)
T ss_dssp             HHCSSTTTSCCH-----HHHHTSHHHHSS
T ss_pred             HcCCChhHCcCH-----HHHhcCccccCC
Confidence            999999999999     999999999763

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-49  Score=403.85  Aligned_cols=260  Identities=27%  Similarity=0.404  Sum_probs=220.8

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec------
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT------  221 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------  221 (482)
                      .+++|++++.||+|+||+||+|+++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++..      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            457899999999999999999999999999999998765432 2233456789999999999999999999976      


Q ss_pred             --CCeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccc
Q 047009          222 --KYRLYLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK  298 (482)
Q Consensus       222 --~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~  298 (482)
                        .+.+|+||||+.+ +|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence              4568999999986 66666654 3679999999999999999999999999999999999999999999999999998


Q ss_pred             cccC-----CCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCcc-
Q 047009          299 QFDE-----NTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF-  371 (482)
Q Consensus       299 ~~~~-----~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~-  371 (482)
                      .+..     .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......++.. 
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            7642     223355688999999999987 458999999999999999999999999988887777776532222211 


Q ss_pred             -------------------------------CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          372 -------------------------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       372 -------------------------------~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                                                     .++++.+||.+||+.||.+||++     +|+++||||....+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS-----DDALNHDFFWSDPMP  321 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGGSSSCC
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH-----HHHhCCCCcCCCCCc
Confidence                                           26789999999999999999999     999999999875543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=397.25  Aligned_cols=252  Identities=30%  Similarity=0.425  Sum_probs=209.1

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHh-CCCCceeeeeeeeecCCeEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK-IDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ..++|+++++||+|+||+||+|+++.+|+.||||++............ ...|+..+.+ .+||||++++++|.+.+.+|
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~-~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRAR-KLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHH-HHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHH-HHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            346799999999999999999999999999999998765433333333 3445555444 59999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          227 LVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      +||||+ +++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~  212 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA  212 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence            999999 56888777664 4699999999999999999999999999999999999999999999999999988766666


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc--CCCccCChHHHHHHHHh
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL--RLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~LI~~~  383 (482)
                      ....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+...   ...+..+..  .++..++.++.+||.+|
T Consensus       213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~  288 (311)
T 3p1a_A          213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMM  288 (311)
T ss_dssp             --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred             CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHH
Confidence            667789999999999987 699999999999999999999777654332   333333322  23456899999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      |+.||++||++     +|+++||||+.
T Consensus       289 L~~dP~~Rpt~-----~ell~hp~~~~  310 (311)
T 3p1a_A          289 LEPDPKLRATA-----EALLALPVLRQ  310 (311)
T ss_dssp             SCSSTTTSCCH-----HHHHTSGGGSC
T ss_pred             cCCChhhCcCH-----HHHHhCccccC
Confidence            99999999999     99999999975

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6e-50  Score=402.12  Aligned_cols=257  Identities=27%  Similarity=0.453  Sum_probs=214.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++++.||+|+||+||+|+++.+++.||+|++.....  ......+.+|+.++++++||||+++++++.+.+.+++|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            4789999999999999999999999999999999975432  11112345799999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCC
Q 047009          229 LDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~  306 (482)
                      |||+.| +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ...
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence            999985 888887765 45899999999999999999999999999999999999999999999999999875432 233


Q ss_pred             cccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-------------------
Q 047009          307 NSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-------------------  366 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-------------------  366 (482)
                      ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....                   
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            45688999999999987 5689999999999999999999999999888777776654211                   


Q ss_pred             C-----------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          367 R-----------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       367 ~-----------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      .           .+..+++++.+||++||+.||.+||++     +|+++||||.++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA-----EDAMKHPFFLSLGE  290 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHTTSGGGGGGCS
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCH-----HHHhcChhhhhccc
Confidence            0           112468899999999999999999999     99999999998654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-49  Score=404.26  Aligned_cols=257  Identities=29%  Similarity=0.428  Sum_probs=216.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC-----
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY-----  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  223 (482)
                      .++|++++.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++....     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            478999999999999999999999999999999996643 23345667889999999999999999999997653     


Q ss_pred             -eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 -RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                       .+|+||||+ +++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence             469999999 7899888865 6799999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc---------------
Q 047009          303 NTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL---------------  366 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~---------------  366 (482)
                        .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....|.+...               
T Consensus       181 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~  258 (367)
T 1cm8_A          181 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  258 (367)
T ss_dssp             --SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             --ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence              3455789999999999988 7899999999999999999999999999887776666654211               


Q ss_pred             ----------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhh
Q 047009          367 ----------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK  415 (482)
Q Consensus       367 ----------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~  415 (482)
                                      .+...+++++.+||.+||..||.+||++     +|+++||||+.+.+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~-----~e~l~hp~f~~~~~~~  318 (367)
T 1cm8_A          259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-----GEALAHPYFESLHDTE  318 (367)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGTTTC---
T ss_pred             HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCH-----HHHhcChHHHhhcCCc
Confidence                            1224578999999999999999999999     9999999999876543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.8e-49  Score=393.88  Aligned_cols=252  Identities=25%  Similarity=0.440  Sum_probs=216.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeec--CCeE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQT--KYRL  225 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~--~~~~  225 (482)
                      .++|++++.||+|+||+||+|++..+++.||+|++....      .+.+.+|+.++++++ ||||+++++++.+  ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            478999999999999999999999999999999987532      345789999999997 9999999999987  6778


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC-ceeEcccCccccccCCC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG-HVMLTDFGLAKQFDENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~  304 (482)
                      ++||||+.+++|..++.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus       109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            99999999999988774   389999999999999999999999999999999999999777 89999999999877666


Q ss_pred             CCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCc-hHHHHHH-------------HHhcccCC-
Q 047009          305 RSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGN-RAKIQQK-------------IVKDKLRL-  368 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~-~~~~~~~-------------i~~~~~~~-  368 (482)
                      .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+....             +......+ 
T Consensus       186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  265 (330)
T 3nsz_A          186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  265 (330)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence            6677889999999999987 678999999999999999999999995432 2222221             11111111 


Q ss_pred             -----------------------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          369 -----------------------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       369 -----------------------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                                             +..+++++++||++||+.||.+||++     +|+++||||+++.|+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA-----REAMEHPYFYTVVKD  329 (330)
T ss_dssp             THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCH-----HHHHTSGGGTTCC--
T ss_pred             cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCH-----HHHhcCccHhhhccC
Confidence                                   12379999999999999999999999     999999999998875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.1e-49  Score=402.45  Aligned_cols=263  Identities=26%  Similarity=0.492  Sum_probs=234.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhH--------------HHHHHHHHHHHHhCCCCce
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNH--------------AEYMKAERDILTKIDHPFV  212 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~--------------~~~~~~E~~il~~l~hpnI  212 (482)
                      ...++|++.+.||+|+||.||+|++  +++.||+|++..........              .+.+.+|+.++++++||||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            4468999999999999999999999  78999999998765432211              2678899999999999999


Q ss_pred             eeeeeeeecCCeEEEEEEecCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEE
Q 047009          213 VQLKYSFQTKYRLYLVLDFINGGHLFFQ------LYH--HGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILL  283 (482)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~~------l~~--~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl  283 (482)
                      +++++++.+.+.+|+||||+++|+|..+      +..  ...+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence            9999999999999999999999999887      655  5679999999999999999999999 999999999999999


Q ss_pred             ccCCceeEcccCccccccCCCCCcccccCCCCCchhhhcCC-CCCc-hhHHHHHhHHHHHHhhCCCCCCCCch-HHHHHH
Q 047009          284 GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGK-GHNK-AADWWSVGILLYEMLTGKPPFIGGNR-AKIQQK  360 (482)
Q Consensus       284 ~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~-~sDvwSlGvilyelltG~~PF~~~~~-~~~~~~  360 (482)
                      +.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|+.||...+. .++...
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  264 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN  264 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred             cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            99999999999999876443 44567899999999999987 6766 99999999999999999999988777 778888


Q ss_pred             HHhcccCCC-------------------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhh
Q 047009          361 IVKDKLRLP-------------------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLE  417 (482)
Q Consensus       361 i~~~~~~~p-------------------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~  417 (482)
                      +......+|                   ..++.++.+||.+||+.||.+||++     .|+++||||++.+|..+.
T Consensus       265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~-----~e~l~hp~f~~~~~~~~~  335 (348)
T 2pml_X          265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS-----EDALKHEWLADTNIEDLR  335 (348)
T ss_dssp             HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSGGGTTCCHHHHH
T ss_pred             HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCH-----HHHhcCccccCCCHHHHH
Confidence            888877777                   6689999999999999999999999     999999999999998764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4e-49  Score=390.86  Aligned_cols=259  Identities=29%  Similarity=0.518  Sum_probs=227.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhch-hhHHHHHHHHHHHHHhCCCCceeeeeeee--ecCCeE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE-KNHAEYMKAERDILTKIDHPFVVQLKYSF--QTKYRL  225 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~--~~~~~~  225 (482)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++.+..... ....+.+.+|+.++++++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999999999999999998765332 34567788999999999999999999998  455689


Q ss_pred             EEEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-
Q 047009          226 YLVLDFINGGHLFFQLYH--HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-  302 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-  302 (482)
                      |+||||+.++ |...+..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... 
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            9999999987 6666654  35699999999999999999999999999999999999999999999999999987643 


Q ss_pred             --CCCCcccccCCCCCchhhhcCCCC--CchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHH
Q 047009          303 --NTRSNSMIGTVEYMAPEIVLGKGH--NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHS  378 (482)
Q Consensus       303 --~~~~~~~~gt~~y~APE~l~~~~~--~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  378 (482)
                        ........||+.|+|||++.+...  +.++||||||+++|+|++|+.||.+.+.....+.+.+....++..++..+.+
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~  242 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD  242 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHH
T ss_pred             ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHH
Confidence              222345679999999999987543  7899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      ||++||+.||.+||++     +|+++||||+....
T Consensus       243 li~~~l~~dp~~Rps~-----~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          243 LLKGMLEYEPAKRFSI-----RQIRQHSWFRKKHP  272 (305)
T ss_dssp             HHHHHTCSSTTTSCCH-----HHHHHSHHHHSCCC
T ss_pred             HHHHHccCChhhCCCH-----HHHhcCcccccCCC
Confidence            9999999999999998     99999999987554

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.7e-49  Score=387.96  Aligned_cols=259  Identities=31%  Similarity=0.601  Sum_probs=233.3

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||.||+|+++.+++.||+|++.+.... ....+.+.+|+.++++++||||+++++++.....+++|
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            36799999999999999999999999999999999875432 33456688999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC---CceeEcccCccccccCCCC
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD---GHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~---g~vKL~DFGla~~~~~~~~  305 (482)
                      |||+.+++|...+...+.+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++........
T Consensus       100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~  179 (287)
T 2wei_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (287)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence            9999999999999888889999999999999999999999999999999999999764   4699999999988766655


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLK  381 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~LI~  381 (482)
                      .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.+...+...+..+...++    ..++.++.+||+
T Consensus       180 ~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  258 (287)
T 2wei_A          180 MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR  258 (287)
T ss_dssp             CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHH
T ss_pred             cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHH
Confidence            5667899999999999875 89999999999999999999999999998888888888766544    468999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                      +||+.||.+||++     .++++||||+..+++
T Consensus       259 ~~l~~dp~~Rps~-----~ell~hp~~~~~~~~  286 (287)
T 2wei_A          259 KMLTFHPSLRITA-----TQCLEHPWIQKYSSE  286 (287)
T ss_dssp             HHTCSSGGGSCCH-----HHHHHSHHHHHHCCC
T ss_pred             HHcccChhhCcCH-----HHHhcCHHHhccccC
Confidence            9999999999999     999999999876553

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.7e-49  Score=403.93  Aligned_cols=262  Identities=26%  Similarity=0.470  Sum_probs=226.3

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++++.||+|+||.||+|+++.+++.||+|++....  .....+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            44578999999999999999999999999999999998653  3345567889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      +||||++||+|..++...+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..... .
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~  186 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  186 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-c
Confidence            9999999999999999888999999999999999999999996 9999999999999999999999999999765332 2


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHH--------------------------
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ--------------------------  359 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~--------------------------  359 (482)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...+..                          
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (360)
T 3eqc_A          187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK  266 (360)
T ss_dssp             ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred             ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence            345689999999999999999999999999999999999999998766544322                          


Q ss_pred             ----------------HHHhcc-cCCC-ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhh
Q 047009          360 ----------------KIVKDK-LRLP-AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKL  416 (482)
Q Consensus       360 ----------------~i~~~~-~~~p-~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~  416 (482)
                                      .+.... ...+ ..++.++.+||++||+.||.+||++     +|+++||||+..+|+.+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~~~~~~  336 (360)
T 3eqc_A          267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL-----KQLMVHAFIKRSDAEEV  336 (360)
T ss_dssp             -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCH-----HHHHTSHHHHHHHHSCC
T ss_pred             cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCH-----HHHhhChHhhcchHhhh
Confidence                            222221 1222 3478999999999999999999999     99999999987666554

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.2e-49  Score=403.02  Aligned_cols=252  Identities=30%  Similarity=0.489  Sum_probs=217.0

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec------
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT------  221 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------  221 (482)
                      ..++|++++.||+|+||+||+|++..+|+.||||++..+..       ...+|+.+++.++||||++++++|..      
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34789999999999999999999999999999999876532       12369999999999999999999843      


Q ss_pred             --------------------------------CCeEEEEEEecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 047009          222 --------------------------------KYRLYLVLDFINGGHLFFQLY----HHGLFREDLARIYAAEIVSAVSH  265 (482)
Q Consensus       222 --------------------------------~~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~y  265 (482)
                                                      ...+++||||+++ +|...+.    ..+.+++..++.++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3458999999985 6655553    45779999999999999999999


Q ss_pred             HHHCCCcccCCCCCcEEEc-cCCceeEcccCccccccCCCCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHh
Q 047009          266 LHANGIMHRDLKPENILLG-ADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEML  343 (482)
Q Consensus       266 LH~~~IiHrDLKp~NILl~-~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyell  343 (482)
                      ||++||+||||||+|||++ .++.+||+|||+|+.+.........+||+.|+|||++.+. .++.++|||||||++|||+
T Consensus       157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  236 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI  236 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence            9999999999999999998 6899999999999987766666778899999999999875 4899999999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHHhc-----------------cc------------CCCccCChHHHHHHHHhhccCcCCcCCC
Q 047009          344 TGKPPFIGGNRAKIQQKIVKD-----------------KL------------RLPAFLSSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       344 tG~~PF~~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                      +|+.||.+.+..+....+.+.                 ..            .+|..++.++.+||.+||+.||.+||++
T Consensus       237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  316 (383)
T 3eb0_A          237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP  316 (383)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            999999998887777666541                 01            1345688999999999999999999999


Q ss_pred             CCCChHHHHhCcCCCCCC
Q 047009          395 GPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       395 ~~~~~~eil~hp~f~~~~  412 (482)
                           .|+++||||+.+.
T Consensus       317 -----~e~l~hp~f~~~~  329 (383)
T 3eb0_A          317 -----YEAMAHPFFDHLR  329 (383)
T ss_dssp             -----HHHHTSGGGHHHH
T ss_pred             -----HHHhcCHHHHHHH
Confidence                 9999999998754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.8e-48  Score=396.08  Aligned_cols=254  Identities=28%  Similarity=0.412  Sum_probs=224.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      +.|++++.||+|+||+||+|++..+++.||||++...........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45999999999999999999999999999999998665444555677889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcc
Q 047009          230 DFINGGHLFFQLY-HHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  308 (482)
                      ||+. |+|...+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....   ...
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~  209 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANS  209 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCC
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CCc
Confidence            9998 47776664 456799999999999999999999999999999999999999999999999999987643   345


Q ss_pred             cccCCCCCchhhhc---CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC--CCccCChHHHHHHHHh
Q 047009          309 MIGTVEYMAPEIVL---GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR--LPAFLSSEAHSLLKGL  383 (482)
Q Consensus       309 ~~gt~~y~APE~l~---~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~LI~~~  383 (482)
                      .+||+.|+|||++.   +..++.++|||||||++|||++|+.||.+.+.......+......  .+..++..+++||.+|
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  289 (348)
T 1u5q_A          210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  289 (348)
T ss_dssp             CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            68999999999985   567899999999999999999999999888877766666665432  2456899999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      |+.||++||++     +++++||||....
T Consensus       290 l~~dP~~Rps~-----~~ll~h~~~~~~~  313 (348)
T 1u5q_A          290 LQKIPQDRPTS-----EVLLKHRFVLRER  313 (348)
T ss_dssp             TCSSGGGSCCH-----HHHTTCHHHHSCC
T ss_pred             cccChhhCcCH-----HHHhhChhhhccC
Confidence            99999999999     9999999997644

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.2e-49  Score=395.79  Aligned_cols=261  Identities=34%  Similarity=0.620  Sum_probs=222.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc-----hhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-----EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ++|++.+.||+|+||.||+|+++.+++.||||++.+....     .......+.+|+.+|++++||||+++++++.... 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            6799999999999999999999999999999999765421     1223345788999999999999999999997765 


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc---eeEcccCcccccc
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH---VMLTDFGLAKQFD  301 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~---vKL~DFGla~~~~  301 (482)
                      +|+||||+++|+|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++...
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence            8999999999999999988889999999999999999999999999999999999999987665   9999999998876


Q ss_pred             CCCCCcccccCCCCCchhhhc---CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchH-HHHHHHHhcccCCC----ccCC
Q 047009          302 ENTRSNSMIGTVEYMAPEIVL---GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA-KIQQKIVKDKLRLP----AFLS  373 (482)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~-~~~~~i~~~~~~~p----~~~s  373 (482)
                      ........+||+.|+|||++.   ...++.++|||||||++|+|++|+.||...... .+...+..+...+.    ..++
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (322)
T 2ycf_A          169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS  248 (322)
T ss_dssp             CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSC
T ss_pred             cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcC
Confidence            544445678999999999974   567899999999999999999999999765432 44555655555443    4579


Q ss_pred             hHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhh
Q 047009          374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKL  416 (482)
Q Consensus       374 ~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~  416 (482)
                      .++.+||.+||+.||.+||++     .++++||||++.+|...
T Consensus       249 ~~~~~li~~~l~~dP~~Rps~-----~~~l~h~~~~~~~~~~~  286 (322)
T 2ycf_A          249 EKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMKRK  286 (322)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGCCHHHHHH
T ss_pred             HHHHHHHHHHcccCHhhCCCH-----HHHhhCcCcCCHHHHHH
Confidence            999999999999999999999     99999999999887543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.7e-49  Score=384.98  Aligned_cols=257  Identities=26%  Similarity=0.418  Sum_probs=204.3

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++++.||+|+||+||+|++..+|+.||+|++..... .....+.+.++...++.++||||+++++++.+.+..+
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            445889999999999999999999999999999999976532 2334444556666688899999999999999999999


Q ss_pred             EEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          227 LVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      +||||++| +|..++..    .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999985 77665543    56799999999999999999999998 99999999999999999999999999998876


Q ss_pred             CCCCCcccccCCCCCchhhh----cCCCCCchhHHHHHhHHHHHHhhCCCCCCCC-ch-HHHHHHHHhcccCCC-ccCCh
Q 047009          302 ENTRSNSMIGTVEYMAPEIV----LGKGHNKAADWWSVGILLYEMLTGKPPFIGG-NR-AKIQQKIVKDKLRLP-AFLSS  374 (482)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l----~~~~~~~~sDvwSlGvilyelltG~~PF~~~-~~-~~~~~~i~~~~~~~p-~~~s~  374 (482)
                      .........||+.|+|||++    .+..++.++||||||+++|+|++|+.||... .. ....+.+.......+ ..++.
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (290)
T 3fme_A          162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA  241 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCH
T ss_pred             ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCH
Confidence            66556667899999999996    5667899999999999999999999999752 33 333333443344443 46899


Q ss_pred             HHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          375 EAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       375 ~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      ++.+||.+||+.||++||++     .|+++||||+.
T Consensus       242 ~~~~li~~~l~~~p~~Rpt~-----~e~l~hp~f~~  272 (290)
T 3fme_A          242 EFVDFTSQCLKKNSKERPTY-----PELMQHPFFTL  272 (290)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH-----HHHTTSHHHHH
T ss_pred             HHHHHHHHHhhcChhhCcCH-----HHHHhCccccc
Confidence            99999999999999999999     99999999964

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-49  Score=397.20  Aligned_cols=260  Identities=28%  Similarity=0.438  Sum_probs=217.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh--hHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK--NHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++........  ...+.+.+|+.++++++||||++++++|.+...++
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            4789999999999999999999999999999999976432211  12245778999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CC
Q 047009          227 LVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NT  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~  304 (482)
                      +||||+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence            99999986 788777655 4689999999999999999999999999999999999999999999999999987643 33


Q ss_pred             CCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC-----C----------
Q 047009          305 RSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-----L----------  368 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~-----~----------  368 (482)
                      .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+......     +          
T Consensus       168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T 1ua2_A          168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  247 (346)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence            44567899999999999764 5899999999999999999999999998887777776653110     0          


Q ss_pred             -------------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          369 -------------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       369 -------------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                                   ...++.++++||++||+.||.+||++     .|+++||||.+..+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-----TQALKMKYFSNRPGP  301 (346)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH-----HHHHTSGGGTSSSCC
T ss_pred             cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCH-----HHHhcChhhhcCCCC
Confidence                         13467899999999999999999999     999999999986553

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.4e-48  Score=381.30  Aligned_cols=253  Identities=25%  Similarity=0.439  Sum_probs=220.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec----CCeE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT----KYRL  225 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~  225 (482)
                      ..|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.++++++||||++++++|..    ...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            458999999999999999999999999999999987654 33456778899999999999999999998865    4668


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEc-cCCceeEcccCccccccC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG--IMHRDLKPENILLG-ADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--IiHrDLKp~NILl~-~~g~vKL~DFGla~~~~~  302 (482)
                      ++||||+++|+|..++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.....
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            999999999999999998889999999999999999999999999  99999999999998 789999999999976443


Q ss_pred             CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch-HHHHHHHHhcc--cCCCccCChHHHHH
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR-AKIQQKIVKDK--LRLPAFLSSEAHSL  379 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~-~~~~~~i~~~~--~~~p~~~s~~~~~L  379 (482)
                       .......||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+... ......+..+.  ..++...++++.+|
T Consensus       185 -~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  262 (290)
T 1t4h_A          185 -SFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI  262 (290)
T ss_dssp             -TSBEESCSSCCCCCGGGGGTC-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred             -cccccccCCcCcCCHHHHhcc-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHH
Confidence             334567899999999998754 99999999999999999999999987444 44444454432  23455678999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      |.+||+.||.+||++     +|+++||||++
T Consensus       263 i~~~l~~dp~~Rps~-----~ell~h~~f~~  288 (290)
T 1t4h_A          263 IEGCIRQNKDERYSI-----KDLLNHAFFQE  288 (290)
T ss_dssp             HHHHSCSSGGGSCCH-----HHHHTSGGGC-
T ss_pred             HHHHccCChhhCCCH-----HHHhhCccccc
Confidence            999999999999999     99999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.5e-49  Score=405.35  Aligned_cols=255  Identities=29%  Similarity=0.445  Sum_probs=216.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC-----
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY-----  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  223 (482)
                      ..+|++.+.||+|+||+||+|++..+++ ||+|++.+....       ..+|+.+++.++||||++++++|...+     
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            3579999999999999999999988766 888887654321       236999999999999999999985433     


Q ss_pred             -eEEEEEEecCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc-cCCceeEcccCccc
Q 047009          224 -RLYLVLDFINGGHLFFQL---YHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG-ADGHVMLTDFGLAK  298 (482)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l---~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~-~~g~vKL~DFGla~  298 (482)
                       .+++||||++++.+....   .....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+
T Consensus       111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence             388999999876443322   2356799999999999999999999999999999999999999 79999999999999


Q ss_pred             cccCCCCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc------------
Q 047009          299 QFDENTRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK------------  365 (482)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~------------  365 (482)
                      ...........+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....+.+..            
T Consensus       191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  270 (394)
T 4e7w_A          191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN  270 (394)
T ss_dssp             ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            87666666778899999999999775 58999999999999999999999999988777666655420            


Q ss_pred             -----cC------------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhh
Q 047009          366 -----LR------------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKL  416 (482)
Q Consensus       366 -----~~------------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~  416 (482)
                           ..            ++..+++++.+||.+||++||.+||++     .|+++||||+.+.|...
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~~~  333 (394)
T 4e7w_A          271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA-----IEALCHPFFDELRTGEA  333 (394)
T ss_dssp             GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSGGGSTTTSSCC
T ss_pred             hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH-----HHHhcChhhhhhccccc
Confidence                 11            233478999999999999999999999     99999999999887543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.5e-48  Score=380.36  Aligned_cols=251  Identities=21%  Similarity=0.337  Sum_probs=215.3

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  227 (482)
                      .++|++++.||+|+||+||+|+++.+++.||+|++...... ......+.+|+.++..+ +||||+++++++.+.+.+++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            46899999999999999999999999999999999865432 23445677899999998 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC----------------
Q 047009          228 VLDFINGGHLFFQLYHH----GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG----------------  287 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g----------------  287 (482)
                      ||||++||+|.+++...    +.+++..++.++.||+.||.|||++||+||||||+|||++.+|                
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            99999999999998765    6799999999999999999999999999999999999998544                


Q ss_pred             ---ceeEcccCccccccCCCCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHh
Q 047009          288 ---HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK  363 (482)
Q Consensus       288 ---~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~  363 (482)
                         .+||+|||++......   ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+....   ....+..
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~  242 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQ  242 (289)
T ss_dssp             -CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHT
T ss_pred             CceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHc
Confidence               7999999999876543   335699999999999876 56789999999999999999998875443   2334444


Q ss_pred             c-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          364 D-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       364 ~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      + ...+|..++.++.+||.+||+.||.+||++     .++++||||.+.
T Consensus       243 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~  286 (289)
T 1x8b_A          243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSA-----MALVKHSVLLSA  286 (289)
T ss_dssp             TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCH-----HHHHTCTTC---
T ss_pred             CCCCCCCcccCHHHHHHHHHHhCCCcccCCCH-----HHHhhChHhhhh
Confidence            4 346778899999999999999999999999     999999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.3e-48  Score=395.63  Aligned_cols=253  Identities=28%  Similarity=0.425  Sum_probs=218.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC-----Ce
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK-----YR  224 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~  224 (482)
                      ++|++++.||+|+||.||+|++..+++.||||++....  .....+.+.+|+.+|++++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            68999999999999999999999999999999997533  234456788999999999999999999998654     46


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      +|+||||+.+ +|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            8999999985 88888765 569999999999999999999999999999999999999999999999999998764322


Q ss_pred             ----CCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-------------
Q 047009          305 ----RSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-------------  366 (482)
Q Consensus       305 ----~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-------------  366 (482)
                          .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....             
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence                2345689999999998765 4589999999999999999999999998887766666543110             


Q ss_pred             ------------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          367 ------------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       367 ------------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                                        .+...++.++.+||.+||+.||++||++     .|+++||||+..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~~~~~  320 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV-----EQALAHPYLEQY  320 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGTTT
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCcchhhc
Confidence                              0113578999999999999999999999     999999999976

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-48  Score=386.87  Aligned_cols=261  Identities=31%  Similarity=0.497  Sum_probs=224.7

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||.||+|+++.+++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            478999999999999999999999999999999987543   23456678899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCC
Q 047009          229 LDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~  306 (482)
                      |||+++++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR  174 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence            999999999988765 46799999999999999999999999999999999999999999999999999864321 1223


Q ss_pred             cccccCCCCCchhhh-----cCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc---CCCccCChHHHH
Q 047009          307 NSMIGTVEYMAPEIV-----LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL---RLPAFLSSEAHS  378 (482)
Q Consensus       307 ~~~~gt~~y~APE~l-----~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~  378 (482)
                      ....||+.|+|||++     .+..++.++||||||+++|+|++|+.||...+.......+.....   ..+..++.++.+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  254 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD  254 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHH
Confidence            456799999999998     467789999999999999999999999998888777777766543   235678999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhh
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLE  417 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~  417 (482)
                      ||.+||+.||.+||++     .++++||||+.+.|....
T Consensus       255 li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~~~  288 (302)
T 2j7t_A          255 FLKIALDKNPETRPSA-----AQLLEHPFVSSITSNKAL  288 (302)
T ss_dssp             HHHHHSCSCTTTSCCH-----HHHTTSTTTTTCCCCHHH
T ss_pred             HHHHHcccChhhCCCH-----HHHhcChHHhhhccchhH
Confidence            9999999999999999     999999999999886643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-48  Score=380.93  Aligned_cols=256  Identities=30%  Similarity=0.489  Sum_probs=223.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            4689999999999999999999999999999999976542  23456788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC---CC
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~---~~  305 (482)
                      |||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......   ..
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            999999999999887778999999999999999999999999999999999999999999999999999875422   22


Q ss_pred             CcccccCCCCCchhhhcCCCC-CchhHHHHHhHHHHHHhhCCCCCCCCchH-HHHHHHHhcccCC--CccCChHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRA-KIQQKIVKDKLRL--PAFLSSEAHSLLK  381 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~-~~~sDvwSlGvilyelltG~~PF~~~~~~-~~~~~i~~~~~~~--p~~~s~~~~~LI~  381 (482)
                      ....+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+.. .....+.......  ...++..+.+||.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence            456789999999999988775 77999999999999999999999876543 2333333332222  3468999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      +||+.||.+||++     +|+++||||+..
T Consensus       244 ~~l~~~p~~Rps~-----~~il~~~~~~~~  268 (276)
T 2yex_A          244 KILVENPSARITI-----PDIKKDRWYNKP  268 (276)
T ss_dssp             HHSCSSTTTSCCH-----HHHTTCTTTTCC
T ss_pred             HHCCCCchhCCCH-----HHHhcCccccCh
Confidence            9999999999998     999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-48  Score=406.19  Aligned_cols=253  Identities=31%  Similarity=0.509  Sum_probs=214.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec------CC
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT------KY  223 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~  223 (482)
                      .+|++++.||+|+||.||+|+++.+|+.||||++.++..       ...+|+.+|+.++||||++++++|..      ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            469999999999999999999999999999999876431       13469999999999999999998843      23


Q ss_pred             eEEEEEEecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC-CceeEcccCccc
Q 047009          224 RLYLVLDFINGGHLFFQLY----HHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAK  298 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~-g~vKL~DFGla~  298 (482)
                      .+++||||+++ +|...+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            47899999986 5554443    34679999999999999999999999999999999999999965 568999999999


Q ss_pred             cccCCCCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc-------------
Q 047009          299 QFDENTRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD-------------  364 (482)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~-------------  364 (482)
                      .+.........+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....+.+.             
T Consensus       206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            87666666678899999999999775 7999999999999999999999999988876666555441             


Q ss_pred             ----ccC------------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhh
Q 047009          365 ----KLR------------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK  415 (482)
Q Consensus       365 ----~~~------------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~  415 (482)
                          .+.            ++..+++++.+||++||++||.+||++     .|+++||||+.+.+..
T Consensus       286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP-----LEACAHSFFDELRDPN  347 (420)
T ss_dssp             SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGGGGGCTT
T ss_pred             hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH-----HHHhCCHhhccccccc
Confidence                112            234568999999999999999999999     9999999998776543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.6e-48  Score=381.65  Aligned_cols=256  Identities=29%  Similarity=0.523  Sum_probs=226.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeee--cCCeEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQ--TKYRLY  226 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~  226 (482)
                      .++|++++.||+|+||.||+|+++.+++.||+|++..... .....+.+.+|+.++++++||||+++++++.  ....+|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            4789999999999999999999999999999999987643 2345667889999999999999999999874  467899


Q ss_pred             EEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CcccCCCCCcEEEccCCceeEcccCcc
Q 047009          227 LVLDFINGGHLFFQLYHH----GLFREDLARIYAAEIVSAVSHLHANG-----IMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~-----IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                      +||||+++|+|.+++...    ..+++..++.++.||+.||+|||++|     |+||||||+|||++.++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            999999999999988754    34999999999999999999999999     999999999999999999999999999


Q ss_pred             ccccCCCC-CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CCCccCChH
Q 047009          298 KQFDENTR-SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSE  375 (482)
Q Consensus       298 ~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~  375 (482)
                      +....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+...+...+..+.. .+|..++.+
T Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (279)
T 2w5a_A          164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE  243 (279)
T ss_dssp             HHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             eeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHH
Confidence            87643322 2346799999999999999999999999999999999999999999888888888887765 567789999


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      +.+||.+||+.||.+||++     .||++|+|+.+
T Consensus       244 l~~li~~~l~~~p~~Rps~-----~~ll~~~~~~~  273 (279)
T 2w5a_A          244 LNEIITRMLNLKDYHRPSV-----EEILENPLILE  273 (279)
T ss_dssp             HHHHHHHHTCSSGGGSCCH-----HHHHTSTTCCG
T ss_pred             HHHHHHHHcCCCcccCCCH-----HHHHhChhhhh
Confidence            9999999999999999999     99999999975

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.5e-49  Score=391.83  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=218.3

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC--e
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY--R  224 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~  224 (482)
                      ..-++|++.+.||+|+||+||+|+++.+++.||||++.....  ....+.+.+|+.++++++||||+++++++....  .
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence            344789999999999999999999999999999999986543  233556778999999999999999999987655  7


Q ss_pred             EEEEEEecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE----ccCCceeEcccCcc
Q 047009          225 LYLVLDFINGGHLFFQLYHHGL---FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL----GADGHVMLTDFGLA  297 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl----~~~g~vKL~DFGla  297 (482)
                      .|+||||++||+|..++.....   +++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            8999999999999999976543   8999999999999999999999999999999999999    78888999999999


Q ss_pred             ccccCCCCCcccccCCCCCchhhhc--------CCCCCchhHHHHHhHHHHHHhhCCCCCCCC----chHHHHHHHHhcc
Q 047009          298 KQFDENTRSNSMIGTVEYMAPEIVL--------GKGHNKAADWWSVGILLYEMLTGKPPFIGG----NRAKIQQKIVKDK  365 (482)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~--------~~~~~~~sDvwSlGvilyelltG~~PF~~~----~~~~~~~~i~~~~  365 (482)
                      +...........+||+.|+|||++.        +..++.++|||||||++|||++|+.||...    ...+....+..+.
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            9887766667788999999999986        578899999999999999999999999642    3345555555543


Q ss_pred             c-------------------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcC
Q 047009          366 L-------------------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKW  407 (482)
Q Consensus       366 ~-------------------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~  407 (482)
                      +                         .++..++..+.+||++||+.||++||++     +|+++||=
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~-----~ell~h~~  305 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-----DQFFAETS  305 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH-----HHHHHHHH
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccH-----HHhhhccH
Confidence            2                         1223356788999999999999999999     99999863

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.3e-48  Score=392.55  Aligned_cols=270  Identities=23%  Similarity=0.366  Sum_probs=222.3

Q ss_pred             cccccCCCCeEEEEEecccCceEEEEEEEcCCC-eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCc------eeee
Q 047009          143 TVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTS-EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF------VVQL  215 (482)
Q Consensus       143 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn------Iv~l  215 (482)
                      ..+....++|++++.||+|+||+||+|+++.++ +.||+|+++...    ...+.+.+|+.++++++|++      ++.+
T Consensus        12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~   87 (355)
T 2eu9_A           12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLM   87 (355)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred             ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence            334455689999999999999999999998777 799999997542    34456778999999987655      8999


Q ss_pred             eeeeecCCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE----------
Q 047009          216 KYSFQTKYRLYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL----------  283 (482)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl----------  283 (482)
                      ++++...+.+|+||||+ +++|...+...  ..+++..++.++.||+.||.|||++||+||||||+|||+          
T Consensus        88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence            99999999999999999 55676666654  369999999999999999999999999999999999999          


Q ss_pred             ---------ccCCceeEcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch
Q 047009          284 ---------GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR  354 (482)
Q Consensus       284 ---------~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~  354 (482)
                               +.++.+||+|||+++....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                     6788999999999987543  33456899999999999999999999999999999999999999988777


Q ss_pred             HHHHHHHHhcccCCCc--------------------------------------------cCChHHHHHHHHhhccCcCC
Q 047009          355 AKIQQKIVKDKLRLPA--------------------------------------------FLSSEAHSLLKGLLQKEPGK  390 (482)
Q Consensus       355 ~~~~~~i~~~~~~~p~--------------------------------------------~~s~~~~~LI~~~L~~dP~~  390 (482)
                      .+....+.+....+|.                                            ..+.++.+||++||+.||.+
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            6655544432222221                                            12457899999999999999


Q ss_pred             cCCCCCCChHHHHhCcCCCCCChhhhhhccCCCC
Q 047009          391 RLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPG  424 (482)
Q Consensus       391 R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~  424 (482)
                      ||++     .|+++||||++++|+....+...+|
T Consensus       325 Rpt~-----~e~l~hp~f~~~~~~~~~~~~~~~p  353 (355)
T 2eu9_A          325 RITL-----AEALLHPFFAGLTPEERSFHTSRNP  353 (355)
T ss_dssp             SCCH-----HHHTTSGGGGGCCHHHHC-------
T ss_pred             CcCH-----HHHhcChhhcCCChhhccccccCCC
Confidence            9999     9999999999999987766555443

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.4e-48  Score=387.79  Aligned_cols=260  Identities=28%  Similarity=0.436  Sum_probs=222.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEc-CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC---CCCceeeeeeeee----
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKK-NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI---DHPFVVQLKYSFQ----  220 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~----  220 (482)
                      .++|++++.||+|+||.||+|++. .+|+.||+|++....... .....+.+|+.+++.+   +||||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            378999999999999999999995 678999999997653221 1122345677766665   8999999999987    


Q ss_pred             -cCCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          221 -TKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       221 -~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                       ....+++||||+. |+|..++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence             5678999999998 59999887753  4899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc------------
Q 047009          298 KQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK------------  365 (482)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~------------  365 (482)
                      +............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....            
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (326)
T 1blx_A          168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  247 (326)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             ccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccc
Confidence            87665445566789999999999999999999999999999999999999999988877777665420            


Q ss_pred             ---------------cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhh
Q 047009          366 ---------------LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK  415 (482)
Q Consensus       366 ---------------~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~  415 (482)
                                     ..++..++..+++||.+||+.||.+||++     .|+++||||+.+++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----YSALSHPYFQDLERCK  307 (326)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGTTCCCCC
T ss_pred             ccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCH-----HHHhcCccccccchhh
Confidence                           01234578999999999999999999999     9999999999887643

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.2e-48  Score=392.69  Aligned_cols=251  Identities=22%  Similarity=0.348  Sum_probs=214.5

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeE----EEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEI----YAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      ...++|++++.||+|+||+||+|++..+++.    ||+|++....  .......+.+|+.++++++||||+++++++. .
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            3457899999999999999999999988876    6666664332  1222334668999999999999999999886 4


Q ss_pred             CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      ...++||||+.+|+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++...
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            5688999999999999998775 579999999999999999999999999999999999999999999999999999864


Q ss_pred             CCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHH
Q 047009          302 ENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEA  376 (482)
Q Consensus       302 ~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (482)
                      ...   ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++...+... ....|..++.++
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV  246 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTT
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHH
Confidence            432   2345678889999999999999999999999999999999 99999998888887777765 456677889999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      .+||.+||+.||.+||++     .++++|
T Consensus       247 ~~li~~~l~~dp~~Rps~-----~el~~~  270 (325)
T 3kex_A          247 YMVMVKCWMIDENIRPTF-----KELANE  270 (325)
T ss_dssp             THHHHHHTCSCTTTSCCH-----HHHHHH
T ss_pred             HHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            999999999999999998     787764

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-48  Score=391.87  Aligned_cols=254  Identities=28%  Similarity=0.467  Sum_probs=214.6

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCC--CceeeeeeeeecCCeE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH--PFVVQLKYSFQTKYRL  225 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~  225 (482)
                      .-++|++++.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.+|++++|  |||+++++++.+...+
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            4467999999999999999999885 588999999986543 33455678899999999987  9999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  304 (482)
                      |+||| +.+|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...... 
T Consensus        85 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           85 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             EEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             EEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence            99999 56789999999999999999999999999999999999999999999999996 6899999999998764332 


Q ss_pred             --CCcccccCCCCCchhhhcC-----------CCCCchhHHHHHhHHHHHHhhCCCCCCCCch-HHHHHHHHh--cccCC
Q 047009          305 --RSNSMIGTVEYMAPEIVLG-----------KGHNKAADWWSVGILLYEMLTGKPPFIGGNR-AKIQQKIVK--DKLRL  368 (482)
Q Consensus       305 --~~~~~~gt~~y~APE~l~~-----------~~~~~~sDvwSlGvilyelltG~~PF~~~~~-~~~~~~i~~--~~~~~  368 (482)
                        .....+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||..... ......+..  ....+
T Consensus       163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T 3dbq_A          163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF  242 (343)
T ss_dssp             -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred             cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCC
Confidence              2346689999999999965           6789999999999999999999999976433 233334433  24467


Q ss_pred             CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          369 PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       369 p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      |...+.++.+||.+||+.||.+||++     .|+++||||+.
T Consensus       243 ~~~~~~~l~~li~~~L~~dp~~Rpt~-----~e~l~hp~~~~  279 (343)
T 3dbq_A          243 PDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQI  279 (343)
T ss_dssp             CCCSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHS
T ss_pred             cccCCHHHHHHHHHHcCCChhHCCCH-----HHHHhCccccc
Confidence            77888999999999999999999999     99999999974

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.1e-48  Score=385.52  Aligned_cols=250  Identities=25%  Similarity=0.413  Sum_probs=213.3

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++.+.||+|+||+||+|++  +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+...++
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            4457899999999999999999987  478899999976543 3344567889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          227 LVLDFINGGHLFFQLYHHGL---FREDLARIYAAEIVSAVSHLHANG--IMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~yLH~~~--IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      +||||+++|+|..++...+.   +++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++...
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            99999999999999987654   899999999999999999999999  9999999999999999999999999998654


Q ss_pred             CC-CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHh--cccCCCccCChHHHH
Q 047009          302 EN-TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK--DKLRLPAFLSSEAHS  378 (482)
Q Consensus       302 ~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~  378 (482)
                      .. ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..  ....+|..+++++.+
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  270 (309)
T 3p86_A          191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA  270 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred             ccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence            33 224457899999999999999999999999999999999999999999888877776643  356778889999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ||.+||+.||.+||++     +++++
T Consensus       271 li~~~l~~dP~~Rps~-----~~ll~  291 (309)
T 3p86_A          271 IIEGCWTNEPWKRPSF-----ATIMD  291 (309)
T ss_dssp             HHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHccCChhhCcCH-----HHHHH
Confidence            9999999999999998     88876

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.9e-48  Score=397.45  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=203.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC------
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK------  222 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  222 (482)
                      .++|++++.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++...      
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            378999999999999999999999999999999997643 2334556778999999999999999999998654      


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..+|+|||++ +++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            5689999999 6799887765 6799999999999999999999999999999999999999999999999999987543


Q ss_pred             CCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc----------------
Q 047009          303 NTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK----------------  365 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~----------------  365 (482)
                        .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....|.+..                
T Consensus       185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  262 (367)
T 2fst_X          185 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  262 (367)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred             --cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence              2345789999999999987 678999999999999999999999999988777666655411                


Q ss_pred             -------cCC--------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          366 -------LRL--------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       366 -------~~~--------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                             ...        ...+++++.+||++||+.||.+||++     +|+++||||+.....
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~-----~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-----AQALAHAYFAQYHDP  321 (367)
T ss_dssp             HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTTCCG
T ss_pred             HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCH-----HHHhcChhhhhccCC
Confidence                   001        12468899999999999999999999     999999999986553

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.9e-49  Score=387.70  Aligned_cols=265  Identities=29%  Similarity=0.466  Sum_probs=200.9

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      .+..++|++.+.||+|+||.||+|++..+++.||+|++.....  ....+.+.+|+.++++++||||+++++++...+..
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            3556899999999999999999999998999999999876532  23445678899999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          226 YLVLDFINGGHLFFQLYH--------HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                      ++||||++|++|.+++..        .+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999998864        456899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC------CCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc----
Q 047009          298 KQFDEN------TRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL----  366 (482)
Q Consensus       298 ~~~~~~------~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~----  366 (482)
                      ......      .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+.............    
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  248 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE  248 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence            865432      12345679999999999976 5689999999999999999999999988776655554444322    


Q ss_pred             ------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhh
Q 047009          367 ------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLE  417 (482)
Q Consensus       367 ------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~  417 (482)
                            .....++.++.+||.+||+.||.+||++     .++++||||+...++.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~~~  300 (303)
T 2vwi_A          249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA-----AELLRHKFFQKAKNKEFL  300 (303)
T ss_dssp             C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSTTC---------
T ss_pred             cccccchhhhhhhHHHHHHHHHHccCChhhCcCH-----HHHhhChhhhcCCCCccc
Confidence                  1224578999999999999999999999     999999999988776543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.5e-48  Score=393.59  Aligned_cols=257  Identities=30%  Similarity=0.429  Sum_probs=218.4

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE---
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL---  225 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~---  225 (482)
                      .++|.+.+.||+|+||.||+|+++.+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+..   
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            378999999999999999999999999999999997653 2334556788999999999999999999999877655   


Q ss_pred             ---EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          226 ---YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       226 ---~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                         |+||||+. ++|...+  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             eeEEEEEcccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence               99999998 5787766  34599999999999999999999999999999999999999999999999999987543


Q ss_pred             CCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc---------------
Q 047009          303 NTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL---------------  366 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~---------------  366 (482)
                        .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.+...               
T Consensus       197 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  274 (371)
T 4exu_A          197 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  274 (371)
T ss_dssp             -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred             --CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence              3445689999999999988 7899999999999999999999999998887776666644110               


Q ss_pred             ----------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhh
Q 047009          367 ----------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKL  416 (482)
Q Consensus       367 ----------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~  416 (482)
                                      .++..+++++.+||++||+.||.+||++     +|+++||||+.+.....
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~~~  335 (371)
T 4exu_A          275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA-----AQALTHPFFEPFRDPEE  335 (371)
T ss_dssp             HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCH-----HHHHTSGGGTTTCCGGG
T ss_pred             hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCH-----HHHhcCcccccCCCccc
Confidence                            0123468999999999999999999999     99999999998765443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.8e-50  Score=411.34  Aligned_cols=251  Identities=17%  Similarity=0.190  Sum_probs=209.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHH---HHHHhCCCCceeeee-------ee
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAER---DILTKIDHPFVVQLK-------YS  218 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~---~il~~l~hpnIv~l~-------~~  218 (482)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+   .+|++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            47899999999999999999999999999999999876555556677888999   455566899999998       55


Q ss_pred             eecCC-----------------eEEEEEEecCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCCccc
Q 047009          219 FQTKY-----------------RLYLVLDFINGGHLFFQLYHHGLFRE-------DLARIYAAEIVSAVSHLHANGIMHR  274 (482)
Q Consensus       219 ~~~~~-----------------~~~lV~E~~~gg~L~~~l~~~~~l~~-------~~~~~i~~qi~~aL~yLH~~~IiHr  274 (482)
                      +.+.+                 ..|+||||+ +|+|.+++...+.+++       ..+..++.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            55443                 288999999 6799999987665665       7778899999999999999999999


Q ss_pred             CCCCCcEEEccCCceeEcccCccccccCCCCCcccccCCCCCchhhhcCC-----------CCCchhHHHHHhHHHHHHh
Q 047009          275 DLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGK-----------GHNKAADWWSVGILLYEML  343 (482)
Q Consensus       275 DLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~~~~sDvwSlGvilyell  343 (482)
                      ||||+|||++.+|.+||+|||+++...  ......+| +.|+|||++.+.           .++.++|||||||++|||+
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell  307 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW  307 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence            999999999999999999999998643  34456778 999999999988           8999999999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          344 TGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       344 tG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      +|+.||.+.+.......+.    ..+..+++++.+||.+||+.||.+||++     .++++||||+.+.
T Consensus       308 tg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~f~~~~  367 (377)
T 3byv_A          308 CADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLP-----LQAMETPEYEQLR  367 (377)
T ss_dssp             HSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCH-----HHHHTSHHHHHHH
T ss_pred             HCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCH-----HHHhhChHHHHHH
Confidence            9999997765443333322    3346789999999999999999999999     9999999998653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.4e-48  Score=398.77  Aligned_cols=258  Identities=24%  Similarity=0.360  Sum_probs=214.2

Q ss_pred             cccccccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC--------CCce
Q 047009          141 SVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID--------HPFV  212 (482)
Q Consensus       141 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~--------hpnI  212 (482)
                      .+..+....++|++++.||+|+||+||+|++..+++.||||++....    ...+.+.+|+.+++.++        |+||
T Consensus        28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~i  103 (397)
T 1wak_A           28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMV  103 (397)
T ss_dssp             SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred             EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence            34445555689999999999999999999999999999999997542    34556788999999885        7889


Q ss_pred             eeeeeeee----cCCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEcc
Q 047009          213 VQLKYSFQ----TKYRLYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGA  285 (482)
Q Consensus       213 v~l~~~~~----~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl~~  285 (482)
                      ++++++|.    ....+|+||||+. ++|...+...  +.+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus       104 v~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~  182 (397)
T 1wak_A          104 VQLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV  182 (397)
T ss_dssp             CCEEEEEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC
T ss_pred             eeeecceeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec
Confidence            99999997    6678999999994 5666665544  5699999999999999999999998 9999999999999997


Q ss_pred             CC-------------------------------------------------ceeEcccCccccccCCCCCcccccCCCCC
Q 047009          286 DG-------------------------------------------------HVMLTDFGLAKQFDENTRSNSMIGTVEYM  316 (482)
Q Consensus       286 ~g-------------------------------------------------~vKL~DFGla~~~~~~~~~~~~~gt~~y~  316 (482)
                      ++                                                 .+||+|||+++.....  ....+||+.|+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~  260 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYR  260 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGC
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCccc
Confidence            76                                                 7999999999876433  44568999999


Q ss_pred             chhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch------HHHHHHHHhc--------------------------
Q 047009          317 APEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR------AKIQQKIVKD--------------------------  364 (482)
Q Consensus       317 APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~------~~~~~~i~~~--------------------------  364 (482)
                      |||++.+..++.++|||||||++|||++|+.||.+.+.      ......+...                          
T Consensus       261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  340 (397)
T 1wak_A          261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK  340 (397)
T ss_dssp             CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred             CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence            99999999999999999999999999999999976442      2222222211                          


Q ss_pred             ----------------ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          365 ----------------KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       365 ----------------~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                                      ...++...+.++.+||.+||+.||++||++     +|+++||||++
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~  397 (397)
T 1wak_A          341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA-----AECLRHPWLNS  397 (397)
T ss_dssp             SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCH-----HHHHTSGGGGC
T ss_pred             cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCH-----HHHhhCccccC
Confidence                            112233445778999999999999999999     99999999974

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6e-48  Score=384.33  Aligned_cols=261  Identities=30%  Similarity=0.479  Sum_probs=225.6

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++....     ..+.+.+|+.++++++||||+++++++.....+|+|
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            478999999999999999999999999999999997643     234578899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCC
Q 047009          229 LDFINGGHLFFQLY-HHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~  306 (482)
                      |||+++|+|.+++. ....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++...... ...
T Consensus       103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  182 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR  182 (314)
T ss_dssp             EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred             eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence            99999999999886 4567999999999999999999999999999999999999999999999999999876433 233


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc---cCCCccCChHHHHHHHHh
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~LI~~~  383 (482)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+....   ...+..++..+.+||.+|
T Consensus       183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  262 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQC  262 (314)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHH
T ss_pred             CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHH
Confidence            45689999999999999999999999999999999999999998877766555555442   234567899999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhc
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR  419 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~  419 (482)
                      |..||.+||++     .++++||||+...+......
T Consensus       263 l~~dp~~Rpt~-----~~ll~~~~~~~~~~~~~~~~  293 (314)
T 3com_A          263 LVKSPEQRATA-----TQLLQHPFVRSAKGVSILRD  293 (314)
T ss_dssp             TCSCTTTSCCH-----HHHTTSHHHHTCCCGGGGHH
T ss_pred             ccCChhhCcCH-----HHHHhCHHHhcCCcchHHHH
Confidence            99999999999     99999999998876655433

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6e-48  Score=403.09  Aligned_cols=252  Identities=28%  Similarity=0.447  Sum_probs=217.1

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC------CCCceeeeeeeeec
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI------DHPFVVQLKYSFQT  221 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~l~~~~~~  221 (482)
                      ...+|++++.||+|+||+||+|++..+++.||||++....    .....+.+|+.+++.+      +|+||+++++++..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            3468999999999999999999999999999999997643    3344566788888877      67899999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc--eeEcccCcc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH--VMLTDFGLA  297 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~--vKL~DFGla  297 (482)
                      ...+|+||||+. ++|..++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999999996 58888887654  4899999999999999999999999999999999999999987  999999999


Q ss_pred             ccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC----------
Q 047009          298 KQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR----------  367 (482)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~----------  367 (482)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+....-.          
T Consensus       250 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~  327 (429)
T 3kvw_A          250 CYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK  327 (429)
T ss_dssp             EETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred             eecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence            76543  345678999999999999999999999999999999999999999998877766665532000          


Q ss_pred             -------------------------------------------------CCccCChHHHHHHHHhhccCcCCcCCCCCCC
Q 047009          368 -------------------------------------------------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKG  398 (482)
Q Consensus       368 -------------------------------------------------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~  398 (482)
                                                                       ++...++++.+||++||+.||++||++    
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta----  403 (429)
T 3kvw_A          328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP----  403 (429)
T ss_dssp             THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH----
T ss_pred             hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH----
Confidence                                                             111237889999999999999999999    


Q ss_pred             hHHHHhCcCCCCC
Q 047009          399 SEEIKSHKWFKPI  411 (482)
Q Consensus       399 ~~eil~hp~f~~~  411 (482)
                       +|+++||||+..
T Consensus       404 -~e~L~Hpw~~~~  415 (429)
T 3kvw_A          404 -GQALRHPWLRRR  415 (429)
T ss_dssp             -HHHHTSTTTC--
T ss_pred             -HHHhCChhhccC
Confidence             999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.9e-48  Score=387.52  Aligned_cols=273  Identities=22%  Similarity=0.331  Sum_probs=205.2

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCe---EEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSE---IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      +..++|++.+.||+|+||.||+|+++.++.   .||+|++..... .....+.+.+|+.++++++||||+++++++....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            445789999999999999999999887765   899999976543 2344667889999999999999999999998776


Q ss_pred             eE------EEEEEecCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeE
Q 047009          224 RL------YLVLDFINGGHLFFQLYHHG------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVML  291 (482)
Q Consensus       224 ~~------~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL  291 (482)
                      ..      ++||||+.+|+|..++....      .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence            55      99999999999999886543      5899999999999999999999999999999999999999999999


Q ss_pred             cccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-cc
Q 047009          292 TDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KL  366 (482)
Q Consensus       292 ~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~  366 (482)
                      +|||+++.......   .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+..+ ..
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~  258 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL  258 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC
Confidence            99999987644322   223456788999999999999999999999999999999 99999998888888777765 45


Q ss_pred             CCCccCChHHHHHHHHhhccCcCCcCCCCC--CChHHHHhCcCCCCCChhhhhhcc
Q 047009          367 RLPAFLSSEAHSLLKGLLQKEPGKRLGAGP--KGSEEIKSHKWFKPINWKKLEARE  420 (482)
Q Consensus       367 ~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~--~~~~eil~hp~f~~~~~~~~~~~~  420 (482)
                      ..+..++.++.+||.+||+.||.+||++..  ...+++++|+|+....+..+..+.
T Consensus       259 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~~~  314 (323)
T 3qup_A          259 KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYINI  314 (323)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------------
T ss_pred             CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCCCC
Confidence            677889999999999999999999999310  112889999999987766554443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.9e-48  Score=397.70  Aligned_cols=255  Identities=27%  Similarity=0.461  Sum_probs=217.7

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC--CCceeeeeeeeecCCeEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID--HPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~  226 (482)
                      ..+|++++.||+|+||+||+|.+.. ++.||||++..... .....+.+.+|+.+|++++  ||||+++++++...+.+|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            4569999999999999999999876 89999999987643 3345667889999999996  599999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--  304 (482)
                      +||| +.+++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+....  
T Consensus       133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            9999 56889999999888999999999999999999999999999999999999995 6899999999998765432  


Q ss_pred             -CCcccccCCCCCchhhhcC-----------CCCCchhHHHHHhHHHHHHhhCCCCCCCCc-hHHHHHHHHhc--ccCCC
Q 047009          305 -RSNSMIGTVEYMAPEIVLG-----------KGHNKAADWWSVGILLYEMLTGKPPFIGGN-RAKIQQKIVKD--KLRLP  369 (482)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~-----------~~~~~~sDvwSlGvilyelltG~~PF~~~~-~~~~~~~i~~~--~~~~p  369 (482)
                       .....+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.... .......+...  ...+|
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  290 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP  290 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC
Confidence             2346789999999999976           468999999999999999999999997653 33444455543  34567


Q ss_pred             ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          370 AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       370 ~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      ...+.++++||.+||+.||.+||++     .|+++||||+...
T Consensus       291 ~~~~~~~~~li~~~L~~dP~~Rps~-----~ell~hp~~~~~~  328 (390)
T 2zmd_A          291 DIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQIQT  328 (390)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHSCC
T ss_pred             ccchHHHHHHHHHHcccChhhCCCH-----HHHhhCcCccccC
Confidence            7789999999999999999999999     9999999997543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.9e-48  Score=394.09  Aligned_cols=251  Identities=20%  Similarity=0.367  Sum_probs=221.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEc-------CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKK-------NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYS  218 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  218 (482)
                      ...++|++.+.||+|+||+||+|++.       .++..||+|+++...  .....+.+.+|+.+|+++ +||||++++++
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  155 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA  155 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            34578999999999999999999975       345689999997653  334566788999999999 89999999999


Q ss_pred             eecCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 047009          219 FQTKYRLYLVLDFINGGHLFFQLYHHG----------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENIL  282 (482)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NIL  282 (482)
                      |.+.+.+|+||||++||+|.+++...+                .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl  235 (370)
T 2psq_A          156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  235 (370)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence            999999999999999999999998753                4788999999999999999999999999999999999


Q ss_pred             EccCCceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHH
Q 047009          283 LGADGHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQ  358 (482)
Q Consensus       283 l~~~g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~  358 (482)
                      ++.+|.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++.
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~  315 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  315 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999999999999998764332   2334567889999999999999999999999999999999 99999998888888


Q ss_pred             HHHHhc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          359 QKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       359 ~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ..+..+ ....|..++.++.+||.+||+.||.+||++     .|+++
T Consensus       316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~  357 (370)
T 2psq_A          316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF-----KQLVE  357 (370)
T ss_dssp             HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            777765 456778899999999999999999999998     88876

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7.7e-48  Score=391.68  Aligned_cols=258  Identities=24%  Similarity=0.384  Sum_probs=210.0

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhh--------chhhHHHHHHHHHHHHHhCCCCceeeeeeee
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI--------VEKNHAEYMKAERDILTKIDHPFVVQLKYSF  219 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~--------~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  219 (482)
                      ..++|++.+.||+|+||.||+|.+.. |+.||||++.....        ......+.+.+|+.++++++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            35789999999999999999999866 89999999865432        1223346788999999999999999999998


Q ss_pred             e-----cCCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcc
Q 047009          220 Q-----TKYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTD  293 (482)
Q Consensus       220 ~-----~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~D  293 (482)
                      .     ....+|+||||+. |+|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence            4     3447899999998 4777777654 4699999999999999999999999999999999999999999999999


Q ss_pred             cCccccccCCCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc------
Q 047009          294 FGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL------  366 (482)
Q Consensus       294 FGla~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~------  366 (482)
                      ||+++...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....      
T Consensus       178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (362)
T 3pg1_A          178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED  257 (362)
T ss_dssp             TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence            999987666556667789999999999987 6799999999999999999999999999887777666643110      


Q ss_pred             --------------------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          367 --------------------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       367 --------------------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                                                ..+..+++.+.+||.+||+.||.+||++     .|+++||||+.+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~  324 (362)
T 3pg1_A          258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST-----EQALRHPYFESLF  324 (362)
T ss_dssp             HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGTTTC
T ss_pred             hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH-----HHHHcCchhhhcc
Confidence                                      0123468899999999999999999999     9999999999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.3e-48  Score=384.95  Aligned_cols=261  Identities=28%  Similarity=0.472  Sum_probs=220.0

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeec----
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQT----  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----  221 (482)
                      ...++|++++.||+|+||.||+|++..+++.||+|++....    ...+.+.+|+.+++++ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            34588999999999999999999999999999999997543    2335678899999998 89999999999976    


Q ss_pred             --CCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          222 --KYRLYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       222 --~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                        ...+|+||||+++|+|..++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence              56899999999999999998764  56899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC-CCCcccccCCCCCchhhhc-----CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC--CC
Q 047009          298 KQFDEN-TRSNSMIGTVEYMAPEIVL-----GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR--LP  369 (482)
Q Consensus       298 ~~~~~~-~~~~~~~gt~~y~APE~l~-----~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~--~p  369 (482)
                      ...... ......+||+.|+|||++.     +..++.++|||||||++|+|++|+.||.+.+.......+......  .+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 2x7f_A          177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS  256 (326)
T ss_dssp             C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred             eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCc
Confidence            876432 2334568999999999997     567899999999999999999999999888877766666654332  24


Q ss_pred             ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhh
Q 047009          370 AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKL  416 (482)
Q Consensus       370 ~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~  416 (482)
                      ..++..+++||.+||..||.+||++     .++++||||+...+...
T Consensus       257 ~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~hp~~~~~~~~~~  298 (326)
T 2x7f_A          257 KKWSKKFQSFIESCLVKNHSQRPAT-----EQLMKHPFIRDQPNERQ  298 (326)
T ss_dssp             SCSCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSHHHHCCTTHHH
T ss_pred             cccCHHHHHHHHHHhccChhhCCCH-----HHHhhChHHhhCccccc
Confidence            5689999999999999999999999     99999999998877554

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.6e-48  Score=386.86  Aligned_cols=254  Identities=28%  Similarity=0.455  Sum_probs=217.6

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEE-cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCC------ceeeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRK-KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP------FVVQLKYSF  219 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~-~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp------nIv~l~~~~  219 (482)
                      ...++|++++.||+|+||+||+|.+ +.+++.||+|+++...    ...+.+.+|+.+++.++|+      +|+++++++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            4457999999999999999999998 5688999999997542    3456678899999988765      499999999


Q ss_pred             ecCCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc------------
Q 047009          220 QTKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA------------  285 (482)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~------------  285 (482)
                      ...+.+|+||||+ +++|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.            
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            9999999999999 889999988765  6899999999999999999999999999999999999987            


Q ss_pred             -------CCceeEcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHH
Q 047009          286 -------DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ  358 (482)
Q Consensus       286 -------~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~  358 (482)
                             ++.+||+|||+++....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             cccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                   67899999999987543  334578999999999999999999999999999999999999999887776655


Q ss_pred             HHHHhcccCCC--------------------------------------------ccCChHHHHHHHHhhccCcCCcCCC
Q 047009          359 QKIVKDKLRLP--------------------------------------------AFLSSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       359 ~~i~~~~~~~p--------------------------------------------~~~s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                      ..+......+|                                            ...++++.+||.+||+.||.+||++
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  323 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL  323 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence            54433221111                                            1235678999999999999999999


Q ss_pred             CCCChHHHHhCcCCCCCC
Q 047009          395 GPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       395 ~~~~~~eil~hp~f~~~~  412 (482)
                           .|+++||||+.+.
T Consensus       324 -----~ell~hp~f~~~~  336 (339)
T 1z57_A          324 -----REALKHPFFDLLK  336 (339)
T ss_dssp             -----HHHTTSGGGGGGG
T ss_pred             -----HHHhcCHHHHHHh
Confidence                 9999999998653

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-47  Score=380.19  Aligned_cols=253  Identities=29%  Similarity=0.515  Sum_probs=227.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      +.|++++.||+|+||.||+|+++.+++.||+|++.....  ....+.+.+|+.++++++||||+++++++.+...+|+||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            569999999999999999999999999999999986542  234567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~  308 (482)
                      ||+++++|..++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++....... ....
T Consensus       100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred             EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence            99999999988854 679999999999999999999999999999999999999999999999999998765432 3345


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc-cCCCccCChHHHHHHHHhhccC
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLKGLLQKE  387 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~LI~~~L~~d  387 (482)
                      ..||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+.... ..++..++..+.+||.+||+.|
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  258 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE  258 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSS
T ss_pred             cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCC
Confidence            689999999999999999999999999999999999999999888777777666553 3566789999999999999999


Q ss_pred             cCCcCCCCCCChHHHHhCcCCCC
Q 047009          388 PGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       388 P~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      |.+||++     .++++||||..
T Consensus       259 p~~Rps~-----~~ll~~~~~~~  276 (303)
T 3a7i_A          259 PSFRPTA-----KELLKHKFILR  276 (303)
T ss_dssp             GGGSCCH-----HHHTTCHHHHH
T ss_pred             hhhCcCH-----HHHhhChhhhc
Confidence            9999999     99999999964

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=381.67  Aligned_cols=257  Identities=27%  Similarity=0.411  Sum_probs=214.3

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeee--------
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQ--------  220 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--------  220 (482)
                      .++|++++.||+|+||.||+|+++.+++.||+|++....   ....+.+.+|+.++++++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            478999999999999999999999999999999987542   345567889999999999999999998873        


Q ss_pred             ------cCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc-cCCceeEcc
Q 047009          221 ------TKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG-ADGHVMLTD  293 (482)
Q Consensus       221 ------~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~-~~g~vKL~D  293 (482)
                            ....+|+||||+. |+|..++. .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence                  4468899999998 58988875 46789999999999999999999999999999999999997 567999999


Q ss_pred             cCccccccCC----CCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC-
Q 047009          294 FGLAKQFDEN----TRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR-  367 (482)
Q Consensus       294 FGla~~~~~~----~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~-  367 (482)
                      ||+++.....    .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..+.+...... 
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999876422    22345678999999999876 67899999999999999999999999988877766666543211 


Q ss_pred             -----------------------------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhh
Q 047009          368 -----------------------------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK  415 (482)
Q Consensus       368 -----------------------------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~  415 (482)
                                                   ++..++.++++||++||+.||.+||++     +|+++||||+..+|..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA-----EEALSHPYMSIYSFPM  316 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCH-----HHHHTSHHHHTTCC--
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCH-----HHHhCCcccccccCcc
Confidence                                         124589999999999999999999999     9999999999888754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.3e-48  Score=394.72  Aligned_cols=258  Identities=29%  Similarity=0.419  Sum_probs=207.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe--
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR--  224 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--  224 (482)
                      ..+++|++.+.||+|+||.||+|+++.+|+.||||++......    .....+|+..+..++||||++++++|...+.  
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            4458899999999999999999999999999999998764321    2234567888889999999999999865433  


Q ss_pred             -----EEEEEEecCCCchH---HHHHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCCCcEEEcc-CCceeEcc
Q 047009          225 -----LYLVLDFINGGHLF---FQLYHHGLFREDLARIYAAEIVSAVSHLH--ANGIMHRDLKPENILLGA-DGHVMLTD  293 (482)
Q Consensus       225 -----~~lV~E~~~gg~L~---~~l~~~~~l~~~~~~~i~~qi~~aL~yLH--~~~IiHrDLKp~NILl~~-~g~vKL~D  293 (482)
                           +++||||+.++.+.   ..+.....+++..++.++.||+.||.|||  ++||+||||||+|||++. ++.+||+|
T Consensus        96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred             ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence                 88999999985332   22334567899999999999999999999  999999999999999997 89999999


Q ss_pred             cCccccccCCCCCcccccCCCCCchhhhcCCC-CCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc------
Q 047009          294 FGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG-HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL------  366 (482)
Q Consensus       294 FGla~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~------  366 (482)
                      ||+++...........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+.+...      
T Consensus       176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3e3p_A          176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV  255 (360)
T ss_dssp             CTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             CCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence            99999887666666788999999999997654 89999999999999999999999999888777776654210      


Q ss_pred             --------------------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          367 --------------------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       367 --------------------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                                                ..+...+.++.+||.+||+.||.+||++     .|+++||||+++.+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP-----YEALCHPYFDELHD  323 (360)
T ss_dssp             HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCH-----HHHTTSGGGGGGGC
T ss_pred             HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCH-----HHHhcCccccccCC
Confidence                                      1112256789999999999999999999     99999999998654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.1e-47  Score=386.62  Aligned_cols=259  Identities=25%  Similarity=0.404  Sum_probs=218.7

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC-----
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK-----  222 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----  222 (482)
                      ..++|++.+.||+|+||.||+|+++.+|+.||||++....  .......+.+|+.++++++||||+++++++...     
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            3478999999999999999999999999999999996532  234455677999999999999999999987654     


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ...|+||||+. |+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            67899999997 588888765 5799999999999999999999999999999999999999999999999999987643


Q ss_pred             CC-----------CCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc------
Q 047009          303 NT-----------RSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD------  364 (482)
Q Consensus       303 ~~-----------~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~------  364 (482)
                      ..           .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...      
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  244 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS  244 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence            21           1234578999999998865 77899999999999999999999999988766554444321      


Q ss_pred             ------------------ccC--------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhh
Q 047009          365 ------------------KLR--------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK  415 (482)
Q Consensus       365 ------------------~~~--------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~  415 (482)
                                        ...        .+..+++++.+||.+||+.||++||++     +|+++||||+...+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA-----KEALEHPYLQTYHDPN  316 (353)
T ss_dssp             TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTTCCTT
T ss_pred             hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH-----HHHhcCccccccCCcc
Confidence                              000        113578999999999999999999999     9999999999887644

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.5e-49  Score=404.95  Aligned_cols=260  Identities=17%  Similarity=0.208  Sum_probs=202.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC--CCCceeeeee-------ee
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI--DHPFVVQLKY-------SF  219 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l--~hpnIv~l~~-------~~  219 (482)
                      ..+|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+++.+  +||||++++.       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            34699999999999999999999999999999999987654556667788886555544  6999888653       33


Q ss_pred             ecC-----------------CeEEEEEEecCCCchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHCCCcccC
Q 047009          220 QTK-----------------YRLYLVLDFINGGHLFFQLYHH-GLFREDLA------RIYAAEIVSAVSHLHANGIMHRD  275 (482)
Q Consensus       220 ~~~-----------------~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~------~~i~~qi~~aL~yLH~~~IiHrD  275 (482)
                      ...                 ..+|+||||++ |+|.+++... ..+.+...      ..++.||+.||+|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            322                 34899999999 8999999764 33444444      56779999999999999999999


Q ss_pred             CCCCcEEEccCCceeEcccCccccccCCCCCcccccCCCCCchhhhcC--CCCCchhHHHHHhHHHHHHhhCCCCCCCCc
Q 047009          276 LKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG--KGHNKAADWWSVGILLYEMLTGKPPFIGGN  353 (482)
Q Consensus       276 LKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwSlGvilyelltG~~PF~~~~  353 (482)
                      |||+|||++.+|.+||+|||+++....  ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            999999999999999999999987643  2225567799999999988  789999999999999999999999997764


Q ss_pred             hHHH--HH-----HHHhcccCCC--ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhh
Q 047009          354 RAKI--QQ-----KIVKDKLRLP--AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKL  416 (482)
Q Consensus       354 ~~~~--~~-----~i~~~~~~~p--~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~  416 (482)
                      ....  ..     ......+.++  ..+++++++||.+||+.||++||++     .++++||||+.++|...
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~~~~~~  364 (371)
T 3q60_A          298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP-----LEAMETPEFLQLQNEIS  364 (371)
T ss_dssp             TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCH-----HHHTTSHHHHHHHHHHH
T ss_pred             cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCHHHHHHHHHHh
Confidence            3211  00     0111122233  4789999999999999999999999     99999999999887643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.7e-47  Score=384.79  Aligned_cols=262  Identities=23%  Similarity=0.312  Sum_probs=220.7

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  227 (482)
                      .++|++.+.||+|+||+||+|++..+++.||||++.....     .+.+.+|+.+++++ +||||+++++++......++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            3789999999999999999999999999999999876532     23467899999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc-----eeEcccCcccccc
Q 047009          228 VLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH-----VMLTDFGLAKQFD  301 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~-----vKL~DFGla~~~~  301 (482)
                      ||||+ +++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.     +||+|||+++.+.
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99999 89999998764 67999999999999999999999999999999999999999887     9999999998764


Q ss_pred             CCCC--------CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC---chHHHHHHHHhcccCCCc
Q 047009          302 ENTR--------SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG---NRAKIQQKIVKDKLRLPA  370 (482)
Q Consensus       302 ~~~~--------~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~---~~~~~~~~i~~~~~~~p~  370 (482)
                      ....        ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.   +..+..+.+.......+.
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  241 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI  241 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence            3322        24678999999999999999999999999999999999999999874   344555666554444332


Q ss_pred             -----cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh----------CcCCCCCChhhhhhccCCCCC
Q 047009          371 -----FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS----------HKWFKPINWKKLEAREIQPGF  425 (482)
Q Consensus       371 -----~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~----------hp~f~~~~~~~~~~~~~~p~~  425 (482)
                           .++ ++.+||..||+.||.+||++     ++|++          ..+...++|.   .+.+.+|+
T Consensus       242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~-----~~l~~~l~~~~~~~~~~~~~~~dw~---~~~~~~p~  302 (330)
T 2izr_A          242 EVLCENFP-EMATYLRYVRRLDFFEKPDY-----DYLRKLFTDLFDRKGYMFDYEYDWI---GKQLPTPV  302 (330)
T ss_dssp             HHHTTTCH-HHHHHHHHHHHCCTTCCCCH-----HHHHHHHHHHHHHTTCCCSCCCTTT---TSCCCCCC
T ss_pred             HHHhccCh-HHHHHHHHHHhCCCCCCCCH-----HHHHHHHHHHHHHcCCCCCCCccCC---CCCcCCCC
Confidence                 244 99999999999999999998     66654          3444567776   34445554

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=386.89  Aligned_cols=256  Identities=29%  Similarity=0.433  Sum_probs=216.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe----
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR----  224 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----  224 (482)
                      .++|.+.+.||+|+||.||+|+++.+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.....    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            378999999999999999999999999999999997643 233455678899999999999999999999987654    


Q ss_pred             --EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          225 --LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       225 --~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                        +|+||||+. |+|...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence              499999998 58876653  3589999999999999999999999999999999999999999999999999987543


Q ss_pred             CCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc----------------
Q 047009          303 NTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK----------------  365 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~----------------  365 (482)
                      .  ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.+..                
T Consensus       179 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  256 (353)
T 3coi_A          179 E--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  256 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred             C--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence            2  345689999999999987 678999999999999999999999999887766665554310                


Q ss_pred             ---------------cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhh
Q 047009          366 ---------------LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK  415 (482)
Q Consensus       366 ---------------~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~  415 (482)
                                     ...+..++.++++||.+||+.||.+||++     +++++||||+.+....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~f~~~~~~~  316 (353)
T 3coi_A          257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA-----AQALTHPFFEPFRDPE  316 (353)
T ss_dssp             HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCH-----HHHHTSGGGTTTCCGG
T ss_pred             HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCH-----HHHhcCcchhhccCcc
Confidence                           11234578999999999999999999999     9999999999876543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.7e-47  Score=375.91  Aligned_cols=258  Identities=29%  Similarity=0.515  Sum_probs=215.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec--------
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT--------  221 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--------  221 (482)
                      ++|++++.||+|+||.||+|++..+++.||||++...    ....+.+.+|+.++++++||||+++++++.+        
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            5799999999999999999999999999999999753    2345678899999999999999999998754        


Q ss_pred             -----CCeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccC
Q 047009          222 -----KYRLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFG  295 (482)
Q Consensus       222 -----~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFG  295 (482)
                           ...+|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence                 467899999999999999998654 57888999999999999999999999999999999999999999999999


Q ss_pred             ccccccCC---------------CCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCC-CchHHHH
Q 047009          296 LAKQFDEN---------------TRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQ  358 (482)
Q Consensus       296 la~~~~~~---------------~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~-~~~~~~~  358 (482)
                      +++.....               ......+||+.|+|||++.+. .++.++|||||||++|+|++   ||.. .+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~  238 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL  238 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence            99875421               223456799999999999875 68999999999999999998   5543 3444556


Q ss_pred             HHHHhcccCCCc----cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhc
Q 047009          359 QKIVKDKLRLPA----FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAR  419 (482)
Q Consensus       359 ~~i~~~~~~~p~----~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~  419 (482)
                      ..+......+|.    ..+..+++||++||+.||.+||++     .++++||||....++.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~~~~~  298 (303)
T 1zy4_A          239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA-----RTLLNSGWLPVKHQDEVIKE  298 (303)
T ss_dssp             HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCH-----HHHHHSSCSCCCCHHHHHHH
T ss_pred             HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCH-----HHHhCCCCcCCCChHHHHHH
Confidence            666655555543    456779999999999999999999     99999999999888766543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1e-47  Score=382.56  Aligned_cols=248  Identities=22%  Similarity=0.354  Sum_probs=214.2

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ...++|++.+.||+|+||+||+|+++.+++.||+|++...   .....+.+.+|+.++++++||||+++++++.+....+
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            4568999999999999999999999999999999998553   2345667889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          227 LVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      +||||++||+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999999987 46799999999999999999999999999999999999999999999999999987643222


Q ss_pred             C---------------cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHH-----HHHHHHhcc
Q 047009          306 S---------------NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAK-----IQQKIVKDK  365 (482)
Q Consensus       306 ~---------------~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~-----~~~~i~~~~  365 (482)
                      .               ...+||+.|+|||++.+..++.++||||||+++|+|++|..||.......     ......  .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--~  241 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--D  241 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--H
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--c
Confidence            1               25689999999999999999999999999999999999999986532211     011111  1


Q ss_pred             cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          366 LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       366 ~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ...|..+++++.+||.+||+.||.+||++     .++++
T Consensus       242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~l~~  275 (310)
T 3s95_A          242 RYCPPNCPPSFFPITVRCCDLDPEKRPSF-----VKLEH  275 (310)
T ss_dssp             HTCCTTCCTTHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             ccCCCCCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            23567789999999999999999999998     88876

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.9e-48  Score=393.18  Aligned_cols=257  Identities=21%  Similarity=0.314  Sum_probs=224.2

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEE-----cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRK-----KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  221 (482)
                      +..++|++++.||+|+||+||+|++     ..+++.||||++....  .......+.+|+.++++++||||+++++++.+
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            4457899999999999999999994     4577899999986532  23444567889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC---ceeE
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHHG-------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG---HVML  291 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g---~vKL  291 (482)
                      ....++||||++||+|..++...+       .+++..++.++.||+.||+|||++||+||||||+|||++.+|   .+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999999997653       489999999999999999999999999999999999999655   4999


Q ss_pred             cccCccccccC---CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc-c
Q 047009          292 TDFGLAKQFDE---NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-L  366 (482)
Q Consensus       292 ~DFGla~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~-~  366 (482)
                      +|||+++....   ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+. .
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~  305 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  305 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999986422   233445678999999999999999999999999999999998 999999999888888887764 5


Q ss_pred             CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          367 RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       367 ~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      ..+..++..+.+||.+||+.||.+||++     .+|++|.++..
T Consensus       306 ~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~eil~~l~~~~  344 (367)
T 3l9p_A          306 DPPKNCPGPVYRIMTQCWQHQPEDRPNF-----AIILERIEYCT  344 (367)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCCHhHCcCH-----HHHHHHHHHHh
Confidence            5677899999999999999999999999     99999887654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=384.03  Aligned_cols=251  Identities=21%  Similarity=0.360  Sum_probs=219.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCe---EEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSE---IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      +..++|++.+.||+|+||.||+|+++.+++   .||||+++...  .....+.+.+|+.++++++||||+++++++.+..
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            455789999999999999999999986554   59999997643  2344567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 RLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..|+||||++||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            999999999999999999755 5799999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC----CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHH
Q 047009          303 NTR----SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEA  376 (482)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (482)
                      ...    .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++...+..+ ....+..++.++
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  283 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHAL  283 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHH
Confidence            321    223456778999999999999999999999999999999 99999998888888887765 456677899999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||.+||..||.+||++     .+|++
T Consensus       284 ~~li~~~l~~dp~~Rps~-----~eil~  306 (325)
T 3kul_A          284 HQLMLDCWHKDRAQRPRF-----SQIVS  306 (325)
T ss_dssp             HHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHHccCChhhCcCH-----HHHHH
Confidence            999999999999999998     78775

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.9e-48  Score=387.49  Aligned_cols=262  Identities=29%  Similarity=0.454  Sum_probs=227.9

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh---hHHHHHHHHHHHHHhCC--CCceeeeeeeeecC
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK---NHAEYMKAERDILTKID--HPFVVQLKYSFQTK  222 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~---~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~  222 (482)
                      ..++|++.+.||+|+||.||+|+++.+++.||||++........   ...+.+.+|+.++++++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            45789999999999999999999999999999999987643221   12234567999999996  59999999999999


Q ss_pred             CeEEEEEEecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc-cCCceeEcccCccccc
Q 047009          223 YRLYLVLDFING-GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG-ADGHVMLTDFGLAKQF  300 (482)
Q Consensus       223 ~~~~lV~E~~~g-g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~-~~g~vKL~DFGla~~~  300 (482)
                      +..++|||++.+ ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~  200 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL  200 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence            999999999986 89999999888999999999999999999999999999999999999999 7899999999999876


Q ss_pred             cCCCCCcccccCCCCCchhhhcCCCC-CchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHH
Q 047009          301 DENTRSNSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSL  379 (482)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L  379 (482)
                      ... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...+      .+......++..++.++.+|
T Consensus       201 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~l  273 (320)
T 3a99_A          201 KDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHL  273 (320)
T ss_dssp             CSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHHHH
T ss_pred             ccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHHHHHH
Confidence            543 3345689999999999987766 688999999999999999999996532      34556677788899999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccC
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREI  421 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~  421 (482)
                      |.+||+.||.+||++     ++|++||||+++.+........
T Consensus       274 i~~~l~~dp~~Rps~-----~~ll~hp~~~~~~~~~~~~~~~  310 (320)
T 3a99_A          274 IRWCLALRPSDRPTF-----EEIQNHPWMQDVLLPQETAEIH  310 (320)
T ss_dssp             HHHHTCSSGGGSCCH-----HHHHTSGGGSSCCCHHHHHHHH
T ss_pred             HHHHccCChhhCcCH-----HHHhcCHhhcCccCcccccccc
Confidence            999999999999999     9999999999987765444333

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.2e-47  Score=371.05  Aligned_cols=249  Identities=22%  Similarity=0.404  Sum_probs=221.1

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++++.||+|+||.||+|++.. ++.||+|++.....    ..+.+.+|+.++++++||||+++++++.+....+
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             eChhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence            345789999999999999999999875 67799999986542    2345789999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-
Q 047009          227 LVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  304 (482)
                      +||||+++|+|..++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            999999999999998654 568999999999999999999999999999999999999999999999999998754321 


Q ss_pred             -CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHH
Q 047009          305 -RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~  381 (482)
                       ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+... ....|..++..+.+||.
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  241 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN  241 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHH
Confidence             2334567888999999999999999999999999999999 99999999988888888776 45567778999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      +||+.||.+||++     .++++|
T Consensus       242 ~~l~~~p~~Rps~-----~~ll~~  260 (269)
T 4hcu_A          242 HCWRERPEDRPAF-----SRLLRQ  260 (269)
T ss_dssp             HHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHccCCcccCcCH-----HHHHHH
Confidence            9999999999998     888864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-47  Score=384.10  Aligned_cols=251  Identities=21%  Similarity=0.367  Sum_probs=222.0

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  221 (482)
                      ...++|++++.||+|+||.||+|++..     +++.||+|+++...  .....+.+.+|+.++++++||||+++++++.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            445789999999999999999999974     45899999997653  23455678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHH------------------------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLK  277 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLK  277 (482)
                      .+.+|+||||+++|+|..++...                        ..+++..++.++.||+.||.|||++||+|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            99999999999999999999764                        568999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeEcccCccccccCC---CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCc
Q 047009          278 PENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGN  353 (482)
Q Consensus       278 p~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~  353 (482)
                      |+|||++.++.+||+|||+++.....   .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            99999999999999999999875332   22345678999999999999999999999999999999999 999999998


Q ss_pred             hHHHHHHHHhccc-CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          354 RAKIQQKIVKDKL-RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       354 ~~~~~~~i~~~~~-~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ..++...+..+.. .+|..++.++.+||++||+.||.+||++     .++++
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~~~  328 (343)
T 1luf_A          282 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF-----CSIHR  328 (343)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             hHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCH-----HHHHH
Confidence            8888888877654 5678899999999999999999999998     78875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.9e-47  Score=391.34  Aligned_cols=257  Identities=29%  Similarity=0.435  Sum_probs=216.7

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CC-----ceeeeeee
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HP-----FVVQLKYS  218 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp-----nIv~l~~~  218 (482)
                      +....++|++.+.||+|+||+||+|+++.+++.||||+++...    .....+..|+.+++.++ |+     +|++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            3445689999999999999999999999999999999997542    33455677888888875 44     49999999


Q ss_pred             eecCCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCCCcEEEc--cCCceeEc
Q 047009          219 FQTKYRLYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLH--ANGIMHRDLKPENILLG--ADGHVMLT  292 (482)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH--~~~IiHrDLKp~NILl~--~~g~vKL~  292 (482)
                      +...+.+|+||||+.+ +|.+++...  +.+++..++.++.||+.||.|||  ++||+||||||+|||++  .++.+||+
T Consensus       125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          125 FMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             EEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             eccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence            9999999999999975 999888765  45899999999999999999999  57999999999999995  47889999


Q ss_pred             ccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC---
Q 047009          293 DFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP---  369 (482)
Q Consensus       293 DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p---  369 (482)
                      |||+++....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.......|   
T Consensus       204 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          204 DFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             CCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9999987643  34567899999999999999999999999999999999999999999888777777665211100   


Q ss_pred             ---------------cc----------------------------------------------CChHHHHHHHHhhccCc
Q 047009          370 ---------------AF----------------------------------------------LSSEAHSLLKGLLQKEP  388 (482)
Q Consensus       370 ---------------~~----------------------------------------------~s~~~~~LI~~~L~~dP  388 (482)
                                     ..                                              .++++++||++||+.||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence                           00                                              01378999999999999


Q ss_pred             CCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          389 GKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       389 ~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      ++|||+     +|+++||||+...+
T Consensus       362 ~~Rpta-----~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          362 KTRIQP-----YYALQHSFFKKTAD  381 (382)
T ss_dssp             TTSCCH-----HHHTTSGGGCC---
T ss_pred             hhCCCH-----HHHhcCcccccCCC
Confidence            999999     99999999997654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2e-47  Score=387.70  Aligned_cols=253  Identities=25%  Similarity=0.412  Sum_probs=216.5

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEE-----EcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeee
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVR-----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSF  219 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  219 (482)
                      .+..++|++.+.||+|+||.||+|+     ...+++.||||+++...  .....+.+.+|+.++.++ +||||+++++++
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            3456889999999999999999999     45567999999997643  234456788999999999 789999999998


Q ss_pred             ecCC-eEEEEEEecCCCchHHHHHhcCC----------------------------------------------------
Q 047009          220 QTKY-RLYLVLDFINGGHLFFQLYHHGL----------------------------------------------------  246 (482)
Q Consensus       220 ~~~~-~~~lV~E~~~gg~L~~~l~~~~~----------------------------------------------------  246 (482)
                      ...+ .+++||||++||+|..++.....                                                    
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            7754 48999999999999999976543                                                    


Q ss_pred             --------------CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC---CCccc
Q 047009          247 --------------FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT---RSNSM  309 (482)
Q Consensus       247 --------------l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~  309 (482)
                                    +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   .....
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  255 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA  255 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence                          8899999999999999999999999999999999999999999999999998764332   23456


Q ss_pred             ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHH-HHHHhc-ccCCCccCChHHHHHHHHhhcc
Q 047009          310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQ-QKIVKD-KLRLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~-~~i~~~-~~~~p~~~s~~~~~LI~~~L~~  386 (482)
                      .||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.. ..+..+ ....|..+++++.+||.+||+.
T Consensus       256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  335 (359)
T 3vhe_A          256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  335 (359)
T ss_dssp             EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence            78999999999999999999999999999999998 99999887654443 333333 4567788999999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhC
Q 047009          387 EPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~h  405 (482)
                      ||.+||++     .|+++|
T Consensus       336 dP~~Rps~-----~ell~~  349 (359)
T 3vhe_A          336 EPSQRPTF-----SELVEH  349 (359)
T ss_dssp             SGGGSCCH-----HHHHHH
T ss_pred             ChhhCCCH-----HHHHHH
Confidence            99999998     888875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3e-47  Score=388.03  Aligned_cols=253  Identities=25%  Similarity=0.422  Sum_probs=211.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-----------CCceeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-----------HPFVVQL  215 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-----------hpnIv~l  215 (482)
                      ...++|++++.||+|+||+||+|+++.+++.||||++....    ...+.+.+|+.++++++           ||||+++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            34578999999999999999999999999999999997543    23455778999998886           8999999


Q ss_pred             eeeeecCC----eEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEcc---
Q 047009          216 KYSFQTKY----RLYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGA---  285 (482)
Q Consensus       216 ~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl~~---  285 (482)
                      ++++...+    .+++||||+ +++|..++...  +.+++..++.++.||+.||+|||++ ||+||||||+|||++.   
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99997654    789999999 88999988763  4599999999999999999999998 9999999999999954   


Q ss_pred             ---CCceeEcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch------HH
Q 047009          286 ---DGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR------AK  356 (482)
Q Consensus       286 ---~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~------~~  356 (482)
                         .+.+||+|||+++.....  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.      ..
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence               347999999999876543  3456899999999999999999999999999999999999999976542      11


Q ss_pred             HHHHH------------------------------------------HhcccCCCccCChHHHHHHHHhhccCcCCcCCC
Q 047009          357 IQQKI------------------------------------------VKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       357 ~~~~i------------------------------------------~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                      ....+                                          ......++..++.++.+||++||+.||.+||++
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            22222                                          122334555667899999999999999999999


Q ss_pred             CCCChHHHHhCcCCCCC
Q 047009          395 GPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       395 ~~~~~~eil~hp~f~~~  411 (482)
                           +|+++||||++.
T Consensus       329 -----~ell~hp~f~~~  340 (373)
T 1q8y_A          329 -----GGLVNHPWLKDT  340 (373)
T ss_dssp             -----HHHHTCGGGTTC
T ss_pred             -----HHHhhChhhhcc
Confidence                 999999999974

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3e-47  Score=380.56  Aligned_cols=264  Identities=22%  Similarity=0.317  Sum_probs=227.2

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEc-----CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeee
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKK-----NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQ  220 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  220 (482)
                      .+..++|++.+.||+|+||.||+|+++     .+++.||+|++....  .......+.+|+.++++++||||+++++++.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            345578999999999999999999887     357899999997543  2334556889999999999999999999999


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcee
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHH----------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVM  290 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vK  290 (482)
                      +....++||||+++|+|.+++...          ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence            999999999999999999988653          3568999999999999999999999999999999999999999999


Q ss_pred             EcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc-
Q 047009          291 LTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-  365 (482)
Q Consensus       291 L~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~-  365 (482)
                      |+|||+++......   ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+.......+..+. 
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  258 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  258 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence            99999998754322   2234567899999999999999999999999999999999 899999988888888777654 


Q ss_pred             cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC------cCCCCCChhhh
Q 047009          366 LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH------KWFKPINWKKL  416 (482)
Q Consensus       366 ~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h------p~f~~~~~~~~  416 (482)
                      ...+..++..+.+||.+||+.||.+||++     .|+++|      ++|+.++|...
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~e~l~~L~~~~~~~~~~~~~~~~  310 (322)
T 1p4o_A          259 LDKPDNCPDMLFELMRMCWQYNPKMRPSF-----LEIISSIKEEMEPGFREVSFYYS  310 (322)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHGGGSCTTHHHHCSTTS
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCH-----HHHHHHHHHhhccCCcccccccc
Confidence            35677899999999999999999999998     888875      55555554433

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=385.59  Aligned_cols=252  Identities=21%  Similarity=0.370  Sum_probs=223.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCC-------CeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNT-------SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYS  218 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  218 (482)
                      +..++|++.+.||+|+||.||+|++..+       +..||+|++....  .......+.+|+.+++++ +||||++++++
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            4457899999999999999999997543       3689999997653  334556788999999999 99999999999


Q ss_pred             eecCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 047009          219 FQTKYRLYLVLDFINGGHLFFQLYHHG----------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENIL  282 (482)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NIL  282 (482)
                      +...+.+++||||+.+|+|..++....                .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  223 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence            999999999999999999999998754                4899999999999999999999999999999999999


Q ss_pred             EccCCceeEcccCccccccCC---CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHH
Q 047009          283 LGADGHVMLTDFGLAKQFDEN---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQ  358 (482)
Q Consensus       283 l~~~g~vKL~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~  358 (482)
                      ++.++.+||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++.
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~  303 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  303 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999999876443   23344567889999999999999999999999999999999 99999999888888


Q ss_pred             HHHHhc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          359 QKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       359 ~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      +.+..+ ....|..+++++.+||++||+.||.+||++     .+++++
T Consensus       304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~  346 (382)
T 3tt0_A          304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-----KQLVED  346 (382)
T ss_dssp             HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            887766 456678899999999999999999999998     888873

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.5e-47  Score=376.68  Aligned_cols=252  Identities=23%  Similarity=0.359  Sum_probs=222.1

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEc-----CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKK-----NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  221 (482)
                      ...++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            34578999999999999999999983     456899999997543  33455678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHHGL------------------------FREDLARIYAAEIVSAVSHLHANGIMHRDLK  277 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~------------------------l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLK  277 (482)
                      .+.+++||||+++|+|.+++.....                        +++..++.++.||+.||.|||++||+|||||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence            9999999999999999999987543                        8899999999999999999999999999999


Q ss_pred             CCcEEEccCCceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCc
Q 047009          278 PENILLGADGHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGN  353 (482)
Q Consensus       278 p~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~  353 (482)
                      |+|||++.++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999998764332   2234567889999999999999999999999999999999 999999988


Q ss_pred             hHHHHHHHHhc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          354 RAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       354 ~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ...+...+..+ ....+..+++++.+||.+||+.||.+||++     .+++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~l~~~  305 (314)
T 2ivs_A          258 PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVF-----ADISKD  305 (314)
T ss_dssp             GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCH-----HHHHHH
Confidence            88887777665 346677899999999999999999999998     888764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=9.4e-47  Score=370.16  Aligned_cols=250  Identities=20%  Similarity=0.373  Sum_probs=218.5

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      .+..++|++++.||+|+||.||+|+++ ++..||+|++.....    ..+.+.+|+.++++++||||+++++++.+...+
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   94 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI   94 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence            355689999999999999999999887 477899999986543    234578899999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          226 YLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      ++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            999999999999999976 4679999999999999999999999999999999999999999999999999998754321


Q ss_pred             --CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHH
Q 047009          305 --RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLL  380 (482)
Q Consensus       305 --~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI  380 (482)
                        ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||...+.......+... ....|..+++.+.+||
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  254 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM  254 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHH
Confidence              2233456788999999999999999999999999999998 99999998888888888776 3455677899999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHhC
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      .+||+.||.+||++     +++++|
T Consensus       255 ~~~l~~~p~~Rps~-----~~ll~~  274 (283)
T 3gen_A          255 YSCWHEKADERPTF-----KILLSN  274 (283)
T ss_dssp             HHTTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHccCChhHCcCH-----HHHHHH
Confidence            99999999999998     888865

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-46  Score=374.47  Aligned_cols=248  Identities=27%  Similarity=0.420  Sum_probs=208.0

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ..+++|++.+.||+|+||.||+|+++.+++.||+|++...........+.+.+|+.++++++||||+++++++...+.+|
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            34589999999999999999999999999999999998765545555677899999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--  304 (482)
                      +||||++|++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence            999999999999999988899999999999999999999999999999999999999999999999999998764332  


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc---CCCccCChHHHHHHH
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL---RLPAFLSSEAHSLLK  381 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~LI~  381 (482)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+...+...+.....   ..+..++.++.+||.
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  270 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIA  270 (309)
T ss_dssp             ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHH
T ss_pred             cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHH
Confidence            23456799999999999999999999999999999999999999998877655555444322   345678999999999


Q ss_pred             HhhccCcCCcC-CC
Q 047009          382 GLLQKEPGKRL-GA  394 (482)
Q Consensus       382 ~~L~~dP~~R~-s~  394 (482)
                      +||+.||++|| ++
T Consensus       271 ~~l~~dP~~Rp~s~  284 (309)
T 2h34_A          271 RGMAKNPEDRYVTC  284 (309)
T ss_dssp             HHTCSSGGGSCSSH
T ss_pred             HhccCCHHHHHHhH
Confidence            99999999999 55

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.2e-47  Score=372.25  Aligned_cols=248  Identities=22%  Similarity=0.309  Sum_probs=214.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCC-------eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTS-------EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSF  219 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  219 (482)
                      +..++|++.+.||+|+||+||+|+++.++       ..||+|++.+..   ....+.+.+|+.++++++||||+++++++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            44578999999999999999999998877       479999997643   34456788999999999999999999999


Q ss_pred             ecCCeEEEEEEecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc--------ee
Q 047009          220 QTKYRLYLVLDFINGGHLFFQLYHHGL-FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH--------VM  290 (482)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~--------vK  290 (482)
                      .+.+..++||||+.||+|..++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.        +|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999999987654 999999999999999999999999999999999999999887        99


Q ss_pred             EcccCccccccCCCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC
Q 047009          291 LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP  369 (482)
Q Consensus       291 L~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p  369 (482)
                      |+|||++.....   .....||+.|+|||++.+ ..++.++|||||||++|+|++|..|+...........+......+|
T Consensus       162 l~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (289)
T 4fvq_A          162 LSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLP  238 (289)
T ss_dssp             ECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             eccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCC
Confidence            999999976532   234578999999999998 7799999999999999999995544444433444445555667778


Q ss_pred             ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          370 AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       370 ~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ...+.++.+||.+||+.||.+||++     .++++|
T Consensus       239 ~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~  269 (289)
T 4fvq_A          239 APKAAELANLINNCMDYEPDHRPSF-----RAIIRD  269 (289)
T ss_dssp             CCSSCTTHHHHHHHSCSSGGGSCCH-----HHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            8889999999999999999999998     888863

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.6e-47  Score=391.28  Aligned_cols=251  Identities=24%  Similarity=0.402  Sum_probs=220.9

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++.+.||+|+||.||+|+++.+++.||||+++...  .....+.+.+|+.+|++++||||+++++++...+.+|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence            45678999999999999999999999999999999987542  2334456788999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      +||||+++|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            9999999999999987654 589999999999999999999999999999999999999999999999999987543221


Q ss_pred             ---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHH
Q 047009          306 ---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLL  380 (482)
Q Consensus       306 ---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI  380 (482)
                         .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+ .+..|..++.++.+||
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  348 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM  348 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence               122345778999999999899999999999999999998 99999988887777776654 4567788999999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHh
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||+.||.+||++     ++|++
T Consensus       349 ~~cl~~dP~~Rps~-----~~i~~  367 (377)
T 3cbl_A          349 EQCWAYEPGQRPSF-----STIYQ  367 (377)
T ss_dssp             HHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHcCCCchhCcCH-----HHHHH
Confidence            99999999999998     78764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.1e-46  Score=367.67  Aligned_cols=247  Identities=21%  Similarity=0.307  Sum_probs=212.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  225 (482)
                      +..++|++.+.||+|+||.||+|++..+++.||+|++.....     .+.+.+|+.+++.+ +|+|++++++++......
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            345789999999999999999999999999999999875432     23467899999999 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc-----eeEcccCcccc
Q 047009          226 YLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH-----VMLTDFGLAKQ  299 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~-----vKL~DFGla~~  299 (482)
                      ++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++.
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999 999999998754 5999999999999999999999999999999999999988776     99999999987


Q ss_pred             ccCCC--------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC---chHHHHHHHHhcccC-
Q 047009          300 FDENT--------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG---NRAKIQQKIVKDKLR-  367 (482)
Q Consensus       300 ~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~---~~~~~~~~i~~~~~~-  367 (482)
                      .....        .....+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.   +.......+...... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            65432        235568999999999999999999999999999999999999999874   334444444443322 


Q ss_pred             ----CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          368 ----LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       368 ----~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                          +...+++++.+||.+||+.||.+||++     ++|++
T Consensus       241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~-----~~l~~  276 (298)
T 1csn_A          241 PLRELCAGFPEEFYKYMHYARNLAFDATPDY-----DYLQG  276 (298)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCH-----HHHHH
T ss_pred             cHHHHHhhCcHHHHHHHHHHhcCCcccCCCH-----HHHHH
Confidence                234689999999999999999999998     67654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.4e-47  Score=372.06  Aligned_cols=256  Identities=28%  Similarity=0.452  Sum_probs=215.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|.....||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   97 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF   97 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence            344555568999999999999999999999999997653   23456688999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc-CCceeEcccCccccccCC-
Q 047009          229 LDFINGGHLFFQLYHHG---LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA-DGHVMLTDFGLAKQFDEN-  303 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~-  303 (482)
                      |||+++++|..++....   .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..... 
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            99999999999987652   4678889999999999999999999999999999999998 899999999999876432 


Q ss_pred             CCCcccccCCCCCchhhhcCC--CCCchhHHHHHhHHHHHHhhCCCCCCCCchHH--HHH-HHHhcccCCCccCChHHHH
Q 047009          304 TRSNSMIGTVEYMAPEIVLGK--GHNKAADWWSVGILLYEMLTGKPPFIGGNRAK--IQQ-KIVKDKLRLPAFLSSEAHS  378 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwSlGvilyelltG~~PF~~~~~~~--~~~-~i~~~~~~~p~~~s~~~~~  378 (482)
                      .......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||.......  ... ........+|..++.++.+
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA  257 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence            223456899999999999764  38999999999999999999999996543322  122 2223355678889999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      ||.+||+.||++||++     .++++||||+...
T Consensus       258 li~~~l~~dp~~Rps~-----~~ll~~~~~~~~~  286 (295)
T 2clq_A          258 FILKCFEPDPDKRACA-----NDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHTTCSSTTTSCCH-----HHHHTSGGGCC--
T ss_pred             HHHHHccCChhhCCCH-----HHHhcChhhhhcc
Confidence            9999999999999999     9999999998654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.9e-46  Score=365.34  Aligned_cols=250  Identities=28%  Similarity=0.489  Sum_probs=206.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhch-hhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE-KNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      +..++|++.+.||+|+||.||+|++.  ++.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            45689999999999999999999985  7899999987653222 23346688999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCCCcEEEcc--------CCceeEccc
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG---IMHRDLKPENILLGA--------DGHVMLTDF  294 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---IiHrDLKp~NILl~~--------~g~vKL~DF  294 (482)
                      ++||||++|++|..++. .+.+++..++.++.||+.||.|||++|   |+||||||+|||++.        ++.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999988875 567999999999999999999999999   999999999999986        778999999


Q ss_pred             CccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc--cCCCccC
Q 047009          295 GLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK--LRLPAFL  372 (482)
Q Consensus       295 Gla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~~~  372 (482)
                      |+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+....  ...+..+
T Consensus       161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (271)
T 3dtc_A          161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC  239 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred             Cccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence            9998765433 335689999999999999999999999999999999999999999888777777766654  3556789


Q ss_pred             ChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       373 s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ++++.+||.+||+.||.+||++     .|+++|
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~-----~e~l~~  267 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSF-----TNILDQ  267 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CHHHHHHHHHHhcCCcccCcCH-----HHHHHH
Confidence            9999999999999999999998     888764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.3e-46  Score=366.31  Aligned_cols=249  Identities=24%  Similarity=0.382  Sum_probs=219.4

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++++.||+|+||.||+|+++. +..||+|++.....    ..+.+.+|+.++++++||||+++++++.+....+
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             echhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            345789999999999999999998874 67799999986543    2345788999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      +||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            9999999999999987754 499999999999999999999999999999999999999999999999999987644322


Q ss_pred             --CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc-cCCCccCChHHHHHHH
Q 047009          306 --SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLK  381 (482)
Q Consensus       306 --~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~LI~  381 (482)
                        .....||+.|+|||++.+..++.++||||||+++|+|++ |+.||...+.......+..+. ...|..+++.+.+||.
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  239 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMY  239 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHH
Confidence              233456778999999999899999999999999999999 999999888888877777664 4456778999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      +||+.||.+||++     .+++++
T Consensus       240 ~~l~~~p~~Rps~-----~~ll~~  258 (268)
T 3sxs_A          240 SCWHELPEKRPTF-----QQLLSS  258 (268)
T ss_dssp             HTTCSSGGGSCCH-----HHHHHH
T ss_pred             HHcCCChhhCcCH-----HHHHHH
Confidence            9999999999998     888864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-47  Score=393.68  Aligned_cols=254  Identities=29%  Similarity=0.469  Sum_probs=194.4

Q ss_pred             CeEE-EEEecccCceEEEEEEEc--CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeee--cCCeE
Q 047009          151 DFEV-LKVVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQ--TKYRL  225 (482)
Q Consensus       151 ~y~i-~~~LG~G~fg~Vy~a~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~  225 (482)
                      .|++ .++||+|+||+||+|+++  .+++.||||++.....     ...+.+|+.+|++++||||++++++|.  ....+
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            3555 357999999999999977  4688999999976532     234678999999999999999999994  57789


Q ss_pred             EEEEEecCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE----ccCCceeEc
Q 047009          226 YLVLDFINGGHLFFQLYHH---------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL----GADGHVMLT  292 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl----~~~g~vKL~  292 (482)
                      |+||||+.+ +|...+...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999999975 777666532         248999999999999999999999999999999999999    778999999


Q ss_pred             ccCccccccCC----CCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchH---------HHH
Q 047009          293 DFGLAKQFDEN----TRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRA---------KIQ  358 (482)
Q Consensus       293 DFGla~~~~~~----~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~---------~~~  358 (482)
                      |||+++.+...    ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..         +..
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            99999876432    233567899999999999884 5899999999999999999999999765432         333


Q ss_pred             HHHHhcccC--------------------------------------CCccCChHHHHHHHHhhccCcCCcCCCCCCChH
Q 047009          359 QKIVKDKLR--------------------------------------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSE  400 (482)
Q Consensus       359 ~~i~~~~~~--------------------------------------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~  400 (482)
                      ..+......                                      .....+..+.+||++||+.||.+||++     +
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta-----~  329 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS-----E  329 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH-----H
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH-----H
Confidence            333221000                                      001127889999999999999999999     9


Q ss_pred             HHHhCcCCCCCChhh
Q 047009          401 EIKSHKWFKPINWKK  415 (482)
Q Consensus       401 eil~hp~f~~~~~~~  415 (482)
                      |+++||||.+..|..
T Consensus       330 e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          330 QAMQDPYFLEDPLPT  344 (405)
T ss_dssp             HHHTSGGGTSSSCCC
T ss_pred             HHhcChhhccCCCCc
Confidence            999999999866543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-46  Score=369.63  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=208.0

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCC---CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNT---SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      +..++|++.+.||+|+||.||+|++..+   +..||+|++....  .....+.+.+|+.++++++||||+++++++. .+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   88 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   88 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence            4457899999999999999999998654   4679999987542  3345567889999999999999999999985 45


Q ss_pred             eEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 RLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..|+||||+++|+|..++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            7889999999999999997654 689999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC--CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHH
Q 047009          303 NTR--SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHS  378 (482)
Q Consensus       303 ~~~--~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (482)
                      ...  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+..+ ...++..+++++.+
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  248 (281)
T 1mp8_A          169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  248 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            332  234456789999999999999999999999999999996 99999988888777777665 45677889999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ||.+||+.||.+||++     .++++
T Consensus       249 li~~~l~~~p~~Rps~-----~~l~~  269 (281)
T 1mp8_A          249 LMTKCWAYDPSRRPRF-----TELKA  269 (281)
T ss_dssp             HHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHccCChhhCcCH-----HHHHH
Confidence            9999999999999998     78875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.8e-47  Score=380.17  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=221.8

Q ss_pred             cccccCCCCeEEEEEecccCceEEEEEEEcCCCeEE--EEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeee
Q 047009          143 TVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIY--AMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSF  219 (482)
Q Consensus       143 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v--AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  219 (482)
                      .......++|++.+.||+|+||.||+|+++.++..+  |+|.+....  .....+.+.+|+.+++++ +||||+++++++
T Consensus        18 ~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~   95 (327)
T 1fvr_A           18 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGAC   95 (327)
T ss_dssp             CSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             ccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence            344466789999999999999999999999888865  999987532  234455688999999999 999999999999


Q ss_pred             ecCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 047009          220 QTKYRLYLVLDFINGGHLFFQLYHHG----------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL  283 (482)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl  283 (482)
                      .+.+.+|+||||+++|+|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~  175 (327)
T 1fvr_A           96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV  175 (327)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE
Confidence            99999999999999999999997654                68999999999999999999999999999999999999


Q ss_pred             ccCCceeEcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHH
Q 047009          284 GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIV  362 (482)
Q Consensus       284 ~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~  362 (482)
                      +.++.+||+|||+++............+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++...+.
T Consensus       176 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~  255 (327)
T 1fvr_A          176 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  255 (327)
T ss_dssp             CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence            9999999999999986544444445567899999999999999999999999999999998 999999998888888777


Q ss_pred             hc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          363 KD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       363 ~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      .+ ....+..++.++.+||.+||+.||.+||++     ++++++
T Consensus       256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~~  294 (327)
T 1fvr_A          256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-----AQILVS  294 (327)
T ss_dssp             GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH-----HHHHHH
Confidence            65 455677889999999999999999999998     888874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=373.26  Aligned_cols=258  Identities=28%  Similarity=0.467  Sum_probs=201.6

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ..+++|++++.||+|+||.||+|+++.+|+.||||++..... .....+.+.++..+++.++||||+++++++.+.+.++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            456899999999999999999999999999999999986542 2233444555666788899999999999999999999


Q ss_pred             EEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          227 LVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      +||||+ ++.+...... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.......
T Consensus       101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999999 4455544433 56799999999999999999999995 99999999999999999999999999998776555


Q ss_pred             CCcccccCCCCCchhhhc-----CCCCCchhHHHHHhHHHHHHhhCCCCCCC-CchHHHHHHHHhccc-CCC--ccCChH
Q 047009          305 RSNSMIGTVEYMAPEIVL-----GKGHNKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKDKL-RLP--AFLSSE  375 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~-----~~~~~~~sDvwSlGvilyelltG~~PF~~-~~~~~~~~~i~~~~~-~~p--~~~s~~  375 (482)
                      ......||+.|+|||++.     +..++.++||||||+++|+|++|+.||.. .+..+....+..... .++  ..++.+
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (318)
T 2dyl_A          180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD  259 (318)
T ss_dssp             -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHH
T ss_pred             cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHH
Confidence            556678999999999994     56788999999999999999999999976 344555566655533 333  358999


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      +.+||.+||+.||.+||++     +++++||||+..
T Consensus       260 l~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~  290 (318)
T 2dyl_A          260 FQSFVKDCLTKDHRKRPKY-----NKLLEHSFIKRY  290 (318)
T ss_dssp             HHHHHHHHTCSCTTTSCCH-----HHHTTSHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCH-----HHHhhCHHHHhc
Confidence            9999999999999999999     999999999754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.7e-46  Score=368.95  Aligned_cols=249  Identities=26%  Similarity=0.401  Sum_probs=223.0

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++.+.||+|+||.||+|.++.+++.||+|++....    ...+.+.+|+.++++++||||+++++++.+...+|
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            45688999999999999999999999999999999997643    34566889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          227 LVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      +||||+.|++|..++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            999999999999999874  448999999999999999999999999999999999999999999999999998765433


Q ss_pred             C--CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHH
Q 047009          305 R--SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLL  380 (482)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI  380 (482)
                      .  .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.....+.+... ....|..+++.+.+||
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  245 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM  245 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence            2  234567889999999999999999999999999999999 99999988888777777665 4566788999999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHh
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ++||+.||.+||++     .++++
T Consensus       246 ~~~l~~dp~~Rps~-----~~~~~  264 (288)
T 3kfa_A          246 RACWQWNPSDRPSF-----AEIHQ  264 (288)
T ss_dssp             HHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHhCCChhhCcCH-----HHHHH
Confidence            99999999999998     78765

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.2e-46  Score=370.04  Aligned_cols=250  Identities=23%  Similarity=0.352  Sum_probs=208.4

Q ss_pred             cCCCCeEEEEEecccCceEEEEEE----EcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec-
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT-  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  221 (482)
                      +..++|++++.||+|+||+||+|+    +..+++.||+|++....   ....+.+.+|+.++++++||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            445789999999999999999999    56689999999987542   3455678899999999999999999999854 


Q ss_pred             -CCeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          222 -KYRLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       222 -~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                       ...+++||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence             456899999999999999997754 499999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCC----CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchH----------------HHHH
Q 047009          300 FDENT----RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA----------------KIQQ  359 (482)
Q Consensus       300 ~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~----------------~~~~  359 (482)
                      .....    ......||..|+|||++.+..++.++||||||+++|+|++|..||......                ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            64332    223445778899999999999999999999999999999999998643221                1222


Q ss_pred             HHHh-cccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          360 KIVK-DKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       360 ~i~~-~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+.. .....|..+++++.+||.+||+.||.+||++     .|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~el~~  284 (295)
T 3ugc_A          244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF-----RDLAL  284 (295)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHH
T ss_pred             HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCH-----HHHHH
Confidence            2222 2456678899999999999999999999998     78764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.7e-46  Score=377.49  Aligned_cols=251  Identities=24%  Similarity=0.374  Sum_probs=210.9

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEE----EEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIY----AMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v----AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      ...++|++++.||+|+||+||+|++..+++.+    |+|.+....  .....+.+.+|+.++++++||||+++++++.+.
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            34578999999999999999999998887765    666665332  233456688999999999999999999999876


Q ss_pred             CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      . .++|+||+.+|+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            5 78999999999999998774 579999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHH
Q 047009          302 ENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEA  376 (482)
Q Consensus       302 ~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (482)
                      ....   .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+...+...+..+ ....+..++.++
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  248 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence            4332   233456889999999999999999999999999999999 99999988887777776655 356677899999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      .+||.+||+.||.+||++     .+++++
T Consensus       249 ~~li~~~l~~~p~~Rps~-----~ell~~  272 (327)
T 3poz_A          249 YMIMVKCWMIDADSRPKF-----RELIIE  272 (327)
T ss_dssp             HHHHHHHTCSCGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHcCCChhhCCCH-----HHHHHH
Confidence            999999999999999998     888864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-47  Score=376.77  Aligned_cols=252  Identities=29%  Similarity=0.510  Sum_probs=213.7

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh---hHHHHHHHHHHHHHhC----CCCceeeeeeeeec
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK---NHAEYMKAERDILTKI----DHPFVVQLKYSFQT  221 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~---~~~~~~~~E~~il~~l----~hpnIv~l~~~~~~  221 (482)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++........   .....+.+|+.++.++    +||||+++++++..
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            4789999999999999999999999999999999976543221   1223355789999988    89999999999999


Q ss_pred             CCeEEEEEEe-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc-cCCceeEcccCcccc
Q 047009          222 KYRLYLVLDF-INGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG-ADGHVMLTDFGLAKQ  299 (482)
Q Consensus       222 ~~~~~lV~E~-~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~-~~g~vKL~DFGla~~  299 (482)
                      .+..++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+++.
T Consensus       110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~  189 (312)
T 2iwi_A          110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL  189 (312)
T ss_dssp             ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred             CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence            9999999999 78999999999888899999999999999999999999999999999999999 889999999999987


Q ss_pred             ccCCCCCcccccCCCCCchhhhcCCCCC-chhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHH
Q 047009          300 FDENTRSNSMIGTVEYMAPEIVLGKGHN-KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHS  378 (482)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  378 (482)
                      .... ......||+.|+|||++.+..+. .++||||||+++|+|++|+.||...      ..+......++..++.++.+
T Consensus       190 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~~~~~~~  262 (312)
T 2iwi_A          190 LHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDCCA  262 (312)
T ss_dssp             CCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCCTTSCHHHHH
T ss_pred             cccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCcccCCHHHHH
Confidence            6543 34466799999999999877664 5899999999999999999999653      23455677888899999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      ||.+||+.||++||++     +|+++||||+...
T Consensus       263 li~~~l~~~p~~Rps~-----~e~l~~~~~~~~~  291 (312)
T 2iwi_A          263 LIRRCLAPKPSSRPSL-----EEILLDPWMQTPA  291 (312)
T ss_dssp             HHHHHTCSSTTTSCCH-----HHHHHSTTTCC--
T ss_pred             HHHHHccCChhhCcCH-----HHHhcChhhcCch
Confidence            9999999999999999     9999999998753

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=378.36  Aligned_cols=252  Identities=24%  Similarity=0.390  Sum_probs=216.0

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEE-----cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRK-----KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQ  220 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  220 (482)
                      +..++|++.+.||+|+||.||+|++     ..++..||+|++....  .....+.+.+|+.+++++ +||||+++++++.
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4558899999999999999999997     3466789999997543  233456788999999999 9999999999999


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHHG-----------------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLK  277 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~-----------------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLK  277 (482)
                      ..+.+++||||+++|+|.+++....                       .+++..++.++.||+.||.|||++||+|||||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  199 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  199 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            9999999999999999999997653                       27899999999999999999999999999999


Q ss_pred             CCcEEEccCCceeEcccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCc
Q 047009          278 PENILLGADGHVMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGN  353 (482)
Q Consensus       278 p~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~  353 (482)
                      |+|||++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987644322   234567889999999999999999999999999999998 999998877


Q ss_pred             hHHHHHHHHhc--ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          354 RAKIQQKIVKD--KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       354 ~~~~~~~i~~~--~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      .......+...  ....|..+++++.+||.+||..||.+||++     .++++|
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~l~~~  328 (344)
T 1rjb_A          280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF-----PNLTSF  328 (344)
T ss_dssp             CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCH-----HHHHHH
Confidence            65555554444  345567789999999999999999999998     888875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.4e-46  Score=370.85  Aligned_cols=252  Identities=22%  Similarity=0.357  Sum_probs=218.2

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEE-----cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRK-----KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQ  220 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  220 (482)
                      ...++|++.+.||+|+||.||+|++     ..+++.||+|++....  .....+.+.+|+.+++++ +||||+++++++.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            4457899999999999999999985     4567899999997653  233456788999999999 9999999999999


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHHG------------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENIL  282 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~------------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NIL  282 (482)
                      ..+..++||||+++|+|.+++....                  .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil  177 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence            9999999999999999999997754                  4899999999999999999999999999999999999


Q ss_pred             EccCCceeEcccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHH
Q 047009          283 LGADGHVMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQ  358 (482)
Q Consensus       283 l~~~g~vKL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~  358 (482)
                      ++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+.....
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            99999999999999987654332   234567889999999999999999999999999999999 99999887655544


Q ss_pred             HHHHhc--ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          359 QKIVKD--KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       359 ~~i~~~--~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ..+...  ....+..++.++.+||.+||+.||.+||++     .+++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~~  301 (313)
T 1t46_A          258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF-----KQIVQL  301 (313)
T ss_dssp             HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCH-----HHHHHH
Confidence            444443  234467789999999999999999999998     888763

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.1e-46  Score=380.48  Aligned_cols=250  Identities=29%  Similarity=0.524  Sum_probs=185.6

Q ss_pred             CCCCeEEEE-EecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec----C
Q 047009          148 GIEDFEVLK-VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT----K  222 (482)
Q Consensus       148 ~~~~y~i~~-~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~  222 (482)
                      ..++|++.+ .||+|+||+||+|+++.+|+.||||++.....       ........++.++||||+++++++..    .
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   98 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHGK   98 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence            347899965 69999999999999999999999999975421       12223344677899999999999976    5


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc---CCceeEcccCcc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLA  297 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~---~g~vKL~DFGla  297 (482)
                      ..+++||||++||+|..++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            56899999999999999998764  6999999999999999999999999999999999999986   455999999999


Q ss_pred             ccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHH----HHHHHhcccCCC----
Q 047009          298 KQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKI----QQKIVKDKLRLP----  369 (482)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~----~~~i~~~~~~~p----  369 (482)
                      +..... .....+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+....    ...+......++    
T Consensus       179 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (336)
T 3fhr_A          179 KETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW  257 (336)
T ss_dssp             EEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred             eecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence            876532 34467899999999999999999999999999999999999999977655433    233333333333    


Q ss_pred             ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          370 AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       370 ~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      ..++.++++||.+||+.||.+||++     +|+++||||+.
T Consensus       258 ~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~  293 (336)
T 3fhr_A          258 SEVSEDAKQLIRLLLKTDPTERLTI-----TQFMNHPWINQ  293 (336)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHHSHHHHT
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCH-----HHHhcCccccc
Confidence            4689999999999999999999999     99999999975

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6e-47  Score=379.80  Aligned_cols=261  Identities=26%  Similarity=0.421  Sum_probs=194.5

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHH-HHHhCCCCceeeeeeeeecCCe
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERD-ILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ....++|++++.||+|+||.||+|.++.+|+.||||++.....  ......+..|+. +++.++||||+++++++...+.
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~   95 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD   95 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence            4566899999999999999999999999999999999976532  222333444555 7778899999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEccCCceeEcccCccc
Q 047009          225 LYLVLDFINGGHLFFQLYH-----HGLFREDLARIYAAEIVSAVSHLHAN-GIMHRDLKPENILLGADGHVMLTDFGLAK  298 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~-~IiHrDLKp~NILl~~~g~vKL~DFGla~  298 (482)
                      .++||||+.+ +|..++..     ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999999986 77666653     56799999999999999999999999 99999999999999999999999999998


Q ss_pred             cccCCCCCcccccCCCCCchhhh----cCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchH-HHHHHHHhcc-cCCC---
Q 047009          299 QFDENTRSNSMIGTVEYMAPEIV----LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA-KIQQKIVKDK-LRLP---  369 (482)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l----~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~-~~~~~i~~~~-~~~p---  369 (482)
                      ............||+.|+|||++    .+..++.++||||||+++|+|++|+.||.+.+.. +....+..+. ..++   
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE  254 (327)
T ss_dssp             C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCS
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcc
Confidence            87655555556899999999999    4667899999999999999999999999764421 2222222221 1222   


Q ss_pred             -ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          370 -AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       370 -~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                       ..++.++.+||.+||+.||.+||++     .++++||||...+++
T Consensus       255 ~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~hp~~~~~~~~  295 (327)
T 3aln_A          255 EREFSPSFINFVNLCLTKDESKRPKY-----KELLKHPFILMYEER  295 (327)
T ss_dssp             SCCCCHHHHHHHHHHTCSSGGGSCCH-----HHHTTSHHHHHHHHS
T ss_pred             cccCCHHHHHHHHHHhhCChhhCcCH-----HHHHhChHHHHhHhh
Confidence             3589999999999999999999999     999999999765443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.7e-46  Score=360.36  Aligned_cols=248  Identities=23%  Similarity=0.398  Sum_probs=219.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++.+.||+|+||.||+|.+. +++.||+|++.....    ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            34578999999999999999999987 467899999987542    2346789999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC--
Q 047009          227 LVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--  303 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~--  303 (482)
                      +||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....  
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            999999999999998765 56899999999999999999999999999999999999999999999999999875332  


Q ss_pred             CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHH
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~  381 (482)
                      .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+..+ ....|..++..+.+||.
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  239 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN  239 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence            12234567889999999999999999999999999999999 99999998888888888776 34556778999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +||+.||.+||++     .++++
T Consensus       240 ~~l~~~p~~Rps~-----~~ll~  257 (267)
T 3t9t_A          240 HCWRERPEDRPAF-----SRLLR  257 (267)
T ss_dssp             HHTCSSGGGSCCH-----HHHHH
T ss_pred             HHccCChhhCcCH-----HHHHH
Confidence            9999999999998     88876

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6e-46  Score=360.81  Aligned_cols=246  Identities=20%  Similarity=0.316  Sum_probs=216.4

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC--Ce
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK--YR  224 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~  224 (482)
                      +..++|++.+.||+|+||.||+|+++  ++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.  ..
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred             CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence            45688999999999999999999985  78899999987543 234456688999999999999999999999877  78


Q ss_pred             EEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEccCCceeEcccCccccc
Q 047009          225 LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANG--IMHRDLKPENILLGADGHVMLTDFGLAKQF  300 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~--IiHrDLKp~NILl~~~g~vKL~DFGla~~~  300 (482)
                      .++||||+++|+|.+++...+  .+++..++.++.||+.||.|||++|  |+||||||+|||++.+|.++|+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            899999999999999998765  4899999999999999999999999  999999999999999999999999887653


Q ss_pred             cCCCCCcccccCCCCCchhhhcCCCCCc---hhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc--ccCCCccCChH
Q 047009          301 DENTRSNSMIGTVEYMAPEIVLGKGHNK---AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD--KLRLPAFLSSE  375 (482)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~~~---~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~  375 (482)
                      .    .....||+.|+|||++.+..++.   ++||||||+++|+|++|+.||.+.+.......+...  ...+|..++++
T Consensus       164 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (271)
T 3kmu_A          164 Q----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH  239 (271)
T ss_dssp             S----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred             c----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence            2    23457899999999999865544   899999999999999999999988887777776655  44667889999


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +.+||.+||+.||.+||++     +++++
T Consensus       240 ~~~li~~~l~~~p~~Rps~-----~~il~  263 (271)
T 3kmu_A          240 VSKLMKICMNEDPAKRPKF-----DMIVP  263 (271)
T ss_dssp             HHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            9999999999999999998     78875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.8e-46  Score=369.87  Aligned_cols=258  Identities=28%  Similarity=0.458  Sum_probs=215.0

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC--CCceeeeeeeeecC
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID--HPFVVQLKYSFQTK  222 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~  222 (482)
                      ..+..++|++++.||+|+||.||+|++.. ++.||+|++..... .....+.+.+|+.++++++  ||||+++++++...
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            33455789999999999999999999864 88999999976543 3345667889999999997  59999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..+|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred             CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence            99999999 56789999999888999999999999999999999999999999999999996 58999999999987643


Q ss_pred             CC---CCcccccCCCCCchhhhcC-----------CCCCchhHHHHHhHHHHHHhhCCCCCCCCch-HHHHHHHHhc--c
Q 047009          303 NT---RSNSMIGTVEYMAPEIVLG-----------KGHNKAADWWSVGILLYEMLTGKPPFIGGNR-AKIQQKIVKD--K  365 (482)
Q Consensus       303 ~~---~~~~~~gt~~y~APE~l~~-----------~~~~~~sDvwSlGvilyelltG~~PF~~~~~-~~~~~~i~~~--~  365 (482)
                      ..   .....+||+.|+|||++.+           ..++.++||||||+++|+|++|+.||..... ......+...  .
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  258 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  258 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence            32   2245679999999999976           4788999999999999999999999976533 2333333333  3


Q ss_pred             cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          366 LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       366 ~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      ..+|...+.++.+||.+||+.||.+||++     .|+++||||+..
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~h~~~~~~  299 (313)
T 3cek_A          259 IEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQIQ  299 (313)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHCC
T ss_pred             cCCcccchHHHHHHHHHHccCCcccCcCH-----HHHhcCccccCC
Confidence            45677789999999999999999999999     999999999753

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.1e-46  Score=373.58  Aligned_cols=252  Identities=20%  Similarity=0.369  Sum_probs=220.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEc-------CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKK-------NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYS  218 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  218 (482)
                      +..++|++.+.||+|+||.||+|++.       .++..||+|++....  .....+.+.+|+.+++++ +||||++++++
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            44589999999999999999999986       356789999997653  234556788999999999 89999999999


Q ss_pred             eecCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 047009          219 FQTKYRLYLVLDFINGGHLFFQLYHHG----------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENIL  282 (482)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NIL  282 (482)
                      +...+.+|+||||+.+|+|..++....                .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  189 (334)
T ss_dssp             ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence            999999999999999999999997654                3889999999999999999999999999999999999


Q ss_pred             EccCCceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHH
Q 047009          283 LGADGHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQ  358 (482)
Q Consensus       283 l~~~g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~  358 (482)
                      ++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..++.
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            9999999999999998765432   2234467889999999999999999999999999999999 99999998888888


Q ss_pred             HHHHhc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          359 QKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       359 ~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ..+..+ ....+..++.++.+||.+||+.||.+||++     .+++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~~  312 (334)
T 2pvf_A          270 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF-----KQLVED  312 (334)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCH-----HHHHHH
Confidence            777765 356677899999999999999999999998     888763

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.3e-45  Score=362.88  Aligned_cols=250  Identities=23%  Similarity=0.371  Sum_probs=212.7

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhH----HHHHHHHHHHHHhCCCCceeeeeeeeec
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNH----AEYMKAERDILTKIDHPFVVQLKYSFQT  221 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~  221 (482)
                      ....++|++.+.||+|+||+||+|++..+++.||+|++..........    .+.+.+|+.++++++||||+++++++.+
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            355689999999999999999999999999999999997654322211    1568899999999999999999999977


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEccCCc-----eeEcc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANG--IMHRDLKPENILLGADGH-----VMLTD  293 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--IiHrDLKp~NILl~~~g~-----vKL~D  293 (482)
                      ..  ++||||+++|+|...+... ..+++..++.++.|++.||+|||++|  |+||||||+|||++.++.     +||+|
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            66  6999999999998887655 46999999999999999999999999  999999999999988886     99999


Q ss_pred             cCccccccCCCCCcccccCCCCCchhhhc--CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHH--HHHHHhc--ccC
Q 047009          294 FGLAKQFDENTRSNSMIGTVEYMAPEIVL--GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKI--QQKIVKD--KLR  367 (482)
Q Consensus       294 FGla~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~--~~~i~~~--~~~  367 (482)
                      ||+++....  ......||+.|+|||++.  ...++.++|||||||++|+|++|+.||...+....  ...+...  ...
T Consensus       173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 4f0f_A          173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT  250 (287)
T ss_dssp             CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred             CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence            999986433  345578999999999994  45678999999999999999999999987654433  3444433  345


Q ss_pred             CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          368 LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       368 ~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ++..+++++.+||.+||+.||.+||++     +++++
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~  282 (287)
T 4f0f_A          251 IPEDCPPRLRNVIELCWSGDPKKRPHF-----SYIVK  282 (287)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCcccCHHHHHHHHHHhcCChhhCcCH-----HHHHH
Confidence            677899999999999999999999998     88875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.9e-46  Score=381.22  Aligned_cols=272  Identities=17%  Similarity=0.173  Sum_probs=206.9

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCC-----CeEEEEEEeechhhchhhHH--------HHHHHHHHHHHhCCCCcee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNT-----SEIYAMKVMRKDKIVEKNHA--------EYMKAERDILTKIDHPFVV  213 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAiK~~~~~~~~~~~~~--------~~~~~E~~il~~l~hpnIv  213 (482)
                      ...++|++.+.||+|+||.||+|.++.+     ++.||||++...........        .....|+..+..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            4457899999999999999999999775     58899999876532111111        1233456677788999999


Q ss_pred             eeeeeeecC----CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc--cC
Q 047009          214 QLKYSFQTK----YRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG--AD  286 (482)
Q Consensus       214 ~l~~~~~~~----~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~--~~  286 (482)
                      ++++++...    ...|+||||+ |++|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999998764    5689999999 99999999876 6799999999999999999999999999999999999999  88


Q ss_pred             CceeEcccCccccccCCC--------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHH
Q 047009          287 GHVMLTDFGLAKQFDENT--------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ  358 (482)
Q Consensus       287 g~vKL~DFGla~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~  358 (482)
                      +.+||+|||+++.+....        .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            999999999998754321        124456999999999999999999999999999999999999999753322221


Q ss_pred             HHHHhc--ccC---------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh----------CcCCCCCChhhhh
Q 047009          359 QKIVKD--KLR---------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS----------HKWFKPINWKKLE  417 (482)
Q Consensus       359 ~~i~~~--~~~---------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~----------hp~f~~~~~~~~~  417 (482)
                      ......  ...         .+..++.++.+||..||..||.+||++     .+|++          .++-..++|....
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~-----~~l~~~l~~~~~~~~~~~~~~~dw~~~~  345 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLY-----ENLRDILLQGLKAIGSKDDGKLDLSVVE  345 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCH-----HHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCH-----HHHHHHHHHHHHHcCCCcCCccceEecc
Confidence            111110  000         125679999999999999999999998     66654          3445566666655


Q ss_pred             hccCCCC
Q 047009          418 AREIQPG  424 (482)
Q Consensus       418 ~~~~~p~  424 (482)
                      .....++
T Consensus       346 ~~~~~~~  352 (364)
T 3op5_A          346 NGGLKAK  352 (364)
T ss_dssp             -------
T ss_pred             CCccchh
Confidence            5444433

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.5e-46  Score=389.51  Aligned_cols=245  Identities=24%  Similarity=0.429  Sum_probs=215.5

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC-e
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY-R  224 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~  224 (482)
                      .+..++|++.+.||+|+||.||+|.++  |+.||||+++...     ..+.+.+|+.+|++++||||+++++++.... .
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            356789999999999999999999886  6799999997643     3456789999999999999999999976654 7


Q ss_pred             EEEEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          225 LYLVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      +|+||||+++|+|.+++...+.  +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999999987654  79999999999999999999999999999999999999999999999999986543


Q ss_pred             CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHH
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLL  380 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI  380 (482)
                      .  .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.++ .+..|..+++++.+||
T Consensus       342 ~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  419 (450)
T 1k9a_A          342 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM  419 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             c--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence            2  233467899999999999999999999999999999998 99999988887777777665 5667888999999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHh
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||+.||.+||++     .+|++
T Consensus       420 ~~cl~~dp~~Rpt~-----~~l~~  438 (450)
T 1k9a_A          420 KNCWHLDAATRPTF-----LQLRE  438 (450)
T ss_dssp             HHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHcCCChhHCcCH-----HHHHH
Confidence            99999999999998     77764

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.1e-45  Score=365.49  Aligned_cols=254  Identities=30%  Similarity=0.488  Sum_probs=207.4

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.++++++||||+++++++...+.+
T Consensus        28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            34567899999999999999999999999999999999875544556667788999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          226 YLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      ++||||+.+|+|..++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999988864    4568999999999999999999999999999999999999999999999999998764


Q ss_pred             CC-CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc--hHHHHHHHHhcccC-C-CccCChHH
Q 047009          302 EN-TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN--RAKIQQKIVKDKLR-L-PAFLSSEA  376 (482)
Q Consensus       302 ~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~--~~~~~~~i~~~~~~-~-p~~~s~~~  376 (482)
                      .. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..  .......+...... . +..++.++
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  267 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL  267 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred             CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence            33 22345679999999999999999999999999999999999999997643  33445555544332 2 25689999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||.+||+.||.+||++     .++++
T Consensus       268 ~~li~~~l~~dp~~Rps~-----~~il~  290 (310)
T 2wqm_A          268 RQLVNMCINPDPEKRPDV-----TYVYD  290 (310)
T ss_dssp             HHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHHcCCChhhCCCH-----HHHHH
Confidence            999999999999999998     88876

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-45  Score=364.88  Aligned_cols=249  Identities=20%  Similarity=0.339  Sum_probs=216.1

Q ss_pred             CCCeEEEE-EecccCceEEEEEEE--cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          149 IEDFEVLK-VVGQGAFGRVYQVRK--KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       149 ~~~y~i~~-~LG~G~fg~Vy~a~~--~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      .++|++.+ .||+|+||.||+|.+  +.+++.||+|++.... ......+.+.+|+.+++.++||||+++++++ ..+..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            46899998 999999999999954  5677999999997653 2334466788999999999999999999999 56678


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~  305 (482)
                      ++||||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  172 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999987644322


Q ss_pred             ----CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHH
Q 047009          306 ----SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSL  379 (482)
Q Consensus       306 ----~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L  379 (482)
                          .....||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..++...+..+ ...+|..++.++.+|
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  252 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL  252 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence                123456788999999999889999999999999999999 99999998888887777765 356778899999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHh
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      |.+||+.||.+||++     .++++
T Consensus       253 i~~~l~~dp~~Rps~-----~~l~~  272 (291)
T 1xbb_A          253 MNLCWTYDVENRPGF-----AAVEL  272 (291)
T ss_dssp             HHHHTCSSTTTSCCH-----HHHHH
T ss_pred             HHHHcCCChhhCcCH-----HHHHH
Confidence            999999999999998     77764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.8e-46  Score=382.49  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=208.3

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEc---CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKK---NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      +..++|++.+.||+|+||.||+|+++   .++..||||+++...  .....+.+.+|+.++++++||||+++++++....
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            34468999999999999999999987   457789999997643  2345567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 RLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      .+++||||+++|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            9999999999999999997764 699999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC----CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHH
Q 047009          303 NTR----SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEA  376 (482)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (482)
                      ...    .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++.+.+..+ ....+..++.++
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  279 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL  279 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHH
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence            321    122345778999999999999999999999999999998 99999988888888777665 345566789999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||.+||+.||.+||++     .+|++
T Consensus       280 ~~li~~cl~~dp~~RPs~-----~~i~~  302 (373)
T 2qol_A          280 YQLMLDCWQKDRNNRPKF-----EQIVS  302 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHHhCcChhhCcCH-----HHHHH
Confidence            999999999999999998     77765

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1e-45  Score=362.63  Aligned_cols=251  Identities=24%  Similarity=0.397  Sum_probs=215.2

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcC---CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKN---TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      +..++|++.+.||+|+||+||+|++..   ++..||+|++.+..  .....+.+.+|+.++++++||||+++++++.+. 
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   85 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-   85 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence            456889999999999999999998754   34579999998653  234556788999999999999999999998754 


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 RLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..|+||||+.+++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            568999999999999999765 4599999999999999999999999999999999999999999999999999987644


Q ss_pred             CC--CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHH
Q 047009          303 NT--RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHS  378 (482)
Q Consensus       303 ~~--~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (482)
                      ..  ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+.......+... ....+..+++.+.+
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  245 (281)
T 3cc6_A          166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT  245 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred             ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence            32  2234567889999999999999999999999999999998 99999887777777666654 45667789999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ||.+||..||.+||++     .+++++
T Consensus       246 li~~~l~~~p~~Rps~-----~ell~~  267 (281)
T 3cc6_A          246 LMTRCWDYDPSDRPRF-----TELVCS  267 (281)
T ss_dssp             HHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHccCCchhCcCH-----HHHHHH
Confidence            9999999999999998     888764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.8e-45  Score=362.42  Aligned_cols=257  Identities=20%  Similarity=0.302  Sum_probs=211.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeee-ecCCeEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSF-QTKYRLYL  227 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~~l  227 (482)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.....     ...+.+|+.+++.++|++++..+..+ ......++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            4789999999999999999999999999999998765432     22367899999999988776665544 67788999


Q ss_pred             EEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE---ccCCceeEcccCccccccCC
Q 047009          228 VLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl---~~~g~vKL~DFGla~~~~~~  303 (482)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            99999 8999998875 4679999999999999999999999999999999999999   78999999999999876543


Q ss_pred             C--------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch---HHHHHHHHhcccCCC---
Q 047009          304 T--------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR---AKIQQKIVKDKLRLP---  369 (482)
Q Consensus       304 ~--------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~---~~~~~~i~~~~~~~p---  369 (482)
                      .        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.   ......+.......|   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence            2        23456899999999999999999999999999999999999999976432   233444444433333   


Q ss_pred             --ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh----------CcCCCCCChhhh
Q 047009          370 --AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS----------HKWFKPINWKKL  416 (482)
Q Consensus       370 --~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~----------hp~f~~~~~~~~  416 (482)
                        ..+++++.+||.+||+.||.+||++     +++++          ..|-..++|+.+
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~l~~~l~~~~~~~~~~~~~~~dw~~~  295 (296)
T 4hgt_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDY-----SYLRQLFRNLFHRQGFSYDYVFDWNML  295 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCH-----HHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred             hhccCCHHHHHHHHHHHhcCCCCCCCH-----HHHHHHHHHHHHHhCCCccCccchhhc
Confidence              5689999999999999999999998     77765          445555666544

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.9e-46  Score=363.68  Aligned_cols=245  Identities=24%  Similarity=0.425  Sum_probs=215.3

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec-------
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT-------  221 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-------  221 (482)
                      .++|++++.||+|+||.||+|+++.+++.||+|++....       +.+.+|+.++++++||||+++++++..       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            367999999999999999999999999999999997643       235689999999999999999998854       


Q ss_pred             ---------CCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCcee
Q 047009          222 ---------KYRLYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVM  290 (482)
Q Consensus       222 ---------~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vK  290 (482)
                               ...+++||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence                     45689999999999999999754  5799999999999999999999999999999999999999999999


Q ss_pred             EcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCc
Q 047009          291 LTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA  370 (482)
Q Consensus       291 L~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~  370 (482)
                      |+|||+++............||+.|+|||++.+..++.++||||||+++|+|++|..||..  .......+...  .++.
T Consensus       163 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~~--~~~~  238 (284)
T 2a19_B          163 IGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRDG--IISD  238 (284)
T ss_dssp             ECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHTT--CCCT
T ss_pred             ECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhcc--cccc
Confidence            9999999987666556667899999999999999999999999999999999999998842  23333444333  3567


Q ss_pred             cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          371 FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       371 ~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      .++.++++||.+||+.||.+||++     .|+++|.+.-
T Consensus       239 ~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~~l~~~  272 (284)
T 2a19_B          239 IFDKKEKTLLQKLLSKKPEDRPNT-----SEILRTLTVW  272 (284)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCH-----HHHHHHHHHH
Confidence            789999999999999999999998     9999987653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-45  Score=369.73  Aligned_cols=252  Identities=23%  Similarity=0.341  Sum_probs=213.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCC----eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      +..++|++.+.||+|+||.||+|+++.++    ..||+|++....  .......+.+|+.++++++||||+++++++.+.
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            34578999999999999999999987653    469999997643  233455688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      ...++||||+++|+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            9999999999999999998765 679999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC----CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChH
Q 047009          302 ENTR----SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSE  375 (482)
Q Consensus       302 ~~~~----~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~  375 (482)
                      ....    .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++...+..+ ....+..++.+
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA  278 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHH
Confidence            3221    223356788999999999999999999999999999999 99999988888888877765 45567789999


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      +.+||.+||+.||.+||++     .+++++
T Consensus       279 l~~li~~~l~~~p~~Rps~-----~~l~~~  303 (333)
T 1mqb_A          279 IYQLMMQCWQQERARRPKF-----ADIVSI  303 (333)
T ss_dssp             HHHHHHHHTCSSTTTSCCH-----HHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            9999999999999999998     788753

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8.1e-46  Score=368.61  Aligned_cols=252  Identities=24%  Similarity=0.411  Sum_probs=216.2

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEE-----cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRK-----KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQ  220 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  220 (482)
                      ...++|++.+.||+|+||+||+|++     ..+++.||+|++....  .....+.+.+|+.++.++ +||||+++++++.
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  101 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT  101 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence            4457899999999999999999985     3567899999997653  233456688999999999 7899999999987


Q ss_pred             cCC-eEEEEEEecCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 047009          221 TKY-RLYLVLDFINGGHLFFQLYHHGL----------------FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL  283 (482)
Q Consensus       221 ~~~-~~~lV~E~~~gg~L~~~l~~~~~----------------l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl  283 (482)
                      ..+ .+++||||+++|+|..++.....                +++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~  181 (316)
T 2xir_A          102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  181 (316)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence            654 58999999999999999987654                8999999999999999999999999999999999999


Q ss_pred             ccCCceeEcccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHH-HH
Q 047009          284 GADGHVMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAK-IQ  358 (482)
Q Consensus       284 ~~~g~vKL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~-~~  358 (482)
                      +.++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+... ..
T Consensus       182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~  261 (316)
T 2xir_A          182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  261 (316)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence            9999999999999987643322   234568899999999999999999999999999999998 999998766433 33


Q ss_pred             HHHHhc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          359 QKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       359 ~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ..+..+ ....+..+++++.++|.+||+.||.+||++     .++++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~~  304 (316)
T 2xir_A          262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-----SELVEH  304 (316)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            444443 456678899999999999999999999998     898875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7e-46  Score=372.31  Aligned_cols=256  Identities=20%  Similarity=0.313  Sum_probs=218.4

Q ss_pred             cCCCCeEEEEEecccCceEEEEEE-----EcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVR-----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  221 (482)
                      +..++|++++.||+|+||.||+|+     ...+++.||+|++....  .......+.+|+.++++++||||+++++++..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            445789999999999999999999     55678899999996432  23445567889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC---CceeE
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHHG-------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD---GHVML  291 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~---g~vKL  291 (482)
                      ....|+||||++||+|..++....       .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999999998753       48899999999999999999999999999999999999954   46999


Q ss_pred             cccCccccccCC---CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-cc
Q 047009          292 TDFGLAKQFDEN---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KL  366 (482)
Q Consensus       292 ~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~  366 (482)
                      +|||+++.....   .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+..+ ..
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  264 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  264 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence            999999865332   22345678999999999999999999999999999999998 99999988888887777765 44


Q ss_pred             CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          367 RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       367 ~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      ..+..++..+.+||.+||+.||.+||++     .++++|.|+-
T Consensus       265 ~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~l~~~  302 (327)
T 2yfx_A          265 DPPKNCPGPVYRIMTQCWQHQPEDRPNF-----AIILERIEYC  302 (327)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCH-----HHHHHHHHHH
Confidence            5677899999999999999999999998     9999988764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-45  Score=370.73  Aligned_cols=252  Identities=23%  Similarity=0.366  Sum_probs=218.5

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCe-----EEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeee
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSE-----IYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSF  219 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  219 (482)
                      ....++|++.+.||+|+||.||+|.+..+++     .||+|++....  .....+.+.+|+.+++++ +||||+++++++
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            4556899999999999999999999987664     79999997653  234456788999999999 899999999999


Q ss_pred             ecCCeEEEEEEecCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc
Q 047009          220 QTKYRLYLVLDFINGGHLFFQLYHH--------------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA  285 (482)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~  285 (482)
                      ...+.+++||||+++|+|.+++...              ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN  199 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence            9999999999999999999988653              35799999999999999999999999999999999999999


Q ss_pred             CCceeEcccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHH
Q 047009          286 DGHVMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKI  361 (482)
Q Consensus       286 ~g~vKL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i  361 (482)
                      ++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  279 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL  279 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence            99999999999987643322   234567889999999999999999999999999999998 99999887665555555


Q ss_pred             Hhc--ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          362 VKD--KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       362 ~~~--~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ...  ....|..++..+.+||.+||+.||.+||++     .++++
T Consensus       280 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~  319 (333)
T 2i1m_A          280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF-----QQICS  319 (333)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCH-----HHHHH
Confidence            444  334567789999999999999999999998     88876

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=362.71  Aligned_cols=250  Identities=22%  Similarity=0.334  Sum_probs=218.5

Q ss_pred             CCCeEEEE-EecccCceEEEEEEEc--CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          149 IEDFEVLK-VVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       149 ~~~y~i~~-~LG~G~fg~Vy~a~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      .++|.+.+ .||+|+||.||+|.++  .++..||+|+++...  .....+.+.+|+.++++++||||+++++++. .+..
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   84 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEAL   84 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCc
Confidence            46788887 9999999999999864  467899999998642  3445667889999999999999999999994 5568


Q ss_pred             EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          226 YLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      ++||||+.+++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            9999999999999988654 569999999999999999999999999999999999999999999999999998764332


Q ss_pred             C----CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHH
Q 047009          305 R----SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHS  378 (482)
Q Consensus       305 ~----~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (482)
                      .    .....||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..++...+..+ ...+|..+++++.+
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  244 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA  244 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHH
Confidence            2    233456889999999998899999999999999999998 99999998888888777765 35678889999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCc
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHK  406 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp  406 (482)
                      ||.+||+.||.+||++     .++++|-
T Consensus       245 li~~~l~~~p~~Rps~-----~~l~~~l  267 (287)
T 1u59_A          245 LMSDCWIYKWEDRPDF-----LTVEQRM  267 (287)
T ss_dssp             HHHHTTCSSGGGSCCH-----HHHHHHH
T ss_pred             HHHHHcCCChhhCcCH-----HHHHHHH
Confidence            9999999999999998     8888753

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.4e-45  Score=364.91  Aligned_cols=251  Identities=24%  Similarity=0.356  Sum_probs=210.4

Q ss_pred             cCCCCeEEEEEecccCceEEEEEE----EcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      ...+.|++++.||+|+||.||+|+    +..+++.||+|++....  .....+.+.+|+.++++++||||+++++++...
T Consensus        18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            445679999999999999999999    56789999999997653  234456788999999999999999999999876


Q ss_pred             --CeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          223 --YRLYLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       223 --~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                        ..+++||||+++|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence              678999999999999999954 46799999999999999999999999999999999999999999999999999988


Q ss_pred             ccCCC----CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC---------------chHHHHHH
Q 047009          300 FDENT----RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG---------------NRAKIQQK  360 (482)
Q Consensus       300 ~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~---------------~~~~~~~~  360 (482)
                      .....    ......||..|+|||++.+..++.++||||||+++|+|++|..|+...               ........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            65443    234567888999999999999999999999999999999999986322               11222233


Q ss_pred             HHhc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          361 IVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       361 i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +..+ ....|..+++++.+||.+||+.||.+||++     .++++
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~  295 (302)
T 4e5w_A          256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSF-----QNLIE  295 (302)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCH-----HHHHH
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCH-----HHHHH
Confidence            3222 455677899999999999999999999998     78774

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-45  Score=366.76  Aligned_cols=253  Identities=22%  Similarity=0.328  Sum_probs=209.4

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcC---CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKN---TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      +..++|.+.+.||+|+||.||+|++..   ++..||+|++..... .....+.+.+|+.++++++||||+++++++....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            345789999999999999999998765   566899999976542 2344567889999999999999999999997654


Q ss_pred             -----eEEEEEEecCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEc
Q 047009          224 -----RLYLVLDFINGGHLFFQLYH------HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLT  292 (482)
Q Consensus       224 -----~~~lV~E~~~gg~L~~~l~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~  292 (482)
                           ..++||||+++|+|..++..      ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~  189 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA  189 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence                 35999999999999998843      3569999999999999999999999999999999999999999999999


Q ss_pred             ccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccC
Q 047009          293 DFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLR  367 (482)
Q Consensus       293 DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~  367 (482)
                      |||+++......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+..+ ...
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  269 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK  269 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC
Confidence            999998764332   2234567889999999999999999999999999999999 99999988888877777765 456


Q ss_pred             CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          368 LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       368 ~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      .+..++.++.+||.+||..||.+||++     .+++++
T Consensus       270 ~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~l~~~  302 (313)
T 3brb_A          270 QPEDCLDELYEIMYSCWRTDPLDRPTF-----SVLRLQ  302 (313)
T ss_dssp             CBTTCCHHHHHHHHHTTCSSGGGSCCH-----HHHHHH
T ss_pred             CCccccHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            678899999999999999999999998     888753

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7e-46  Score=394.39  Aligned_cols=250  Identities=25%  Similarity=0.392  Sum_probs=222.1

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      .+..++|++.+.||+|+||.||+|+++.++..||||+++...    ...+.+.+|+.+|++++||||+++++++.....+
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            345678999999999999999999999999999999997653    2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          226 YLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      |+||||+.+|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            9999999999999999864  45899999999999999999999999999999999999999999999999999876433


Q ss_pred             CC--CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHH
Q 047009          304 TR--SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSL  379 (482)
Q Consensus       304 ~~--~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L  379 (482)
                      ..  .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++.+.+..+ ....|..++.++.+|
T Consensus       372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  451 (495)
T 1opk_A          372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL  451 (495)
T ss_dssp             CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            22  223456789999999999999999999999999999999 99999998888777777655 456678899999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHh
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      |.+||+.||.+||++     .+|++
T Consensus       452 i~~cl~~dP~~RPs~-----~el~~  471 (495)
T 1opk_A          452 MRACWQWNPSDRPSF-----AEIHQ  471 (495)
T ss_dssp             HHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHcCcChhHCcCH-----HHHHH
Confidence            999999999999998     77765

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=386.89  Aligned_cols=251  Identities=27%  Similarity=0.437  Sum_probs=213.1

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC--e
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY--R  224 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~  224 (482)
                      ..-++|++.+.||+|+||+||+|+++.+|+.||||++.....  ....+.+.+|+.++++++||||+++++++....  .
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   83 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence            344789999999999999999999999999999999986543  233556778999999999999999999997655  7


Q ss_pred             EEEEEEecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE----ccCCceeEcccCcc
Q 047009          225 LYLVLDFINGGHLFFQLYHHGL---FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL----GADGHVMLTDFGLA  297 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl----~~~g~vKL~DFGla  297 (482)
                      .++||||++||+|..++.....   +++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            8999999999999999876433   9999999999999999999999999999999999999    77888999999999


Q ss_pred             ccccCCCCCcccccCCCCCchhhhcC--------CCCCchhHHHHHhHHHHHHhhCCCCCCC----CchHHHHHHHHhcc
Q 047009          298 KQFDENTRSNSMIGTVEYMAPEIVLG--------KGHNKAADWWSVGILLYEMLTGKPPFIG----GNRAKIQQKIVKDK  365 (482)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDvwSlGvilyelltG~~PF~~----~~~~~~~~~i~~~~  365 (482)
                      +...........+||+.|+|||++.+        ..++.++|||||||++|||++|+.||..    ....+....+..+.
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            98766666667889999999999875        5678899999999999999999999964    23345555565543


Q ss_pred             cC-------------------------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          366 LR-------------------------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       366 ~~-------------------------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ..                         ++..++..+.+||++||+.||++|+++     .++++
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~-----~e~l~  302 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-----DQFFA  302 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH-----HHHHH
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccH-----HHHHH
Confidence            21                         112356788999999999999999998     77654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.7e-45  Score=387.20  Aligned_cols=249  Identities=24%  Similarity=0.392  Sum_probs=218.1

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ..+..++|++.+.||+|+||+||+|+++. +..||||+++...    ...+.+.+|+.+|++++||||+++++++. ...
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~  256 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP  256 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence            34566889999999999999999999875 6789999998653    23566889999999999999999999986 567


Q ss_pred             EEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          225 LYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      +|+||||+.+|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            89999999999999999754  3688999999999999999999999999999999999999999999999999987643


Q ss_pred             CC--CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHH
Q 047009          303 NT--RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHS  378 (482)
Q Consensus       303 ~~--~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (482)
                      ..  ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+ ....|..+++++.+
T Consensus       337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  416 (454)
T 1qcf_A          337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN  416 (454)
T ss_dssp             HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred             CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            21  1233456789999999999999999999999999999999 99999998888888877765 45567789999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ||.+||+.||.+||++     ++|++
T Consensus       417 li~~cl~~dp~~RPt~-----~~i~~  437 (454)
T 1qcf_A          417 IMMRCWKNRPEERPTF-----EYIQS  437 (454)
T ss_dssp             HHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHccCChhHCcCH-----HHHHH
Confidence            9999999999999998     77764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=370.51  Aligned_cols=250  Identities=24%  Similarity=0.381  Sum_probs=210.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEE----EEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIY----AMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v----AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      +..++|++++.||+|+||+||+|++..+++.|    |+|.+....  .....+.+.+|+.++++++||||+++++++...
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            44588999999999999999999999888766    555544321  233456788999999999999999999999876


Q ss_pred             CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      . .++|+||+.+|+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            5 78999999999999998764 569999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHH
Q 047009          302 ENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEA  376 (482)
Q Consensus       302 ~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (482)
                      ....   .....||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+...+.+.+... ....+..++.++
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  248 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence            3322   233456788999999999999999999999999999999 99999998888877777665 356677899999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||++||+.||.+||++     .|+++
T Consensus       249 ~~li~~~l~~dp~~Rps~-----~ell~  271 (327)
T 3lzb_A          249 YMIMRKCWMIDADSRPKF-----RELII  271 (327)
T ss_dssp             HHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHHcCCChhHCcCH-----HHHHH
Confidence            999999999999999998     88886

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.7e-46  Score=371.49  Aligned_cols=246  Identities=23%  Similarity=0.323  Sum_probs=201.9

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC---
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY---  223 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---  223 (482)
                      +..++|++++.||+|+||+||+|++.  ++.||||++....    .......+|+.++++++||||+++++++....   
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD   94 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence            45688999999999999999999876  6899999997643    22334566899999999999999999997743   


Q ss_pred             -eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CCcccCCCCCcEEEccCCceeEc
Q 047009          224 -RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN----------GIMHRDLKPENILLGADGHVMLT  292 (482)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~----------~IiHrDLKp~NILl~~~g~vKL~  292 (482)
                       .+++||||+++|+|..++.. +.+++..++.++.||+.||.|||++          ||+||||||+|||++.++.+||+
T Consensus        95 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           95 VDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             ceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence             47999999999999999866 4589999999999999999999999          99999999999999999999999


Q ss_pred             ccCccccccCCC---CCcccccCCCCCchhhhcCC-----CCCchhHHHHHhHHHHHHhhCCCCCCCCc-----------
Q 047009          293 DFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGK-----GHNKAADWWSVGILLYEMLTGKPPFIGGN-----------  353 (482)
Q Consensus       293 DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~-----~~~~~sDvwSlGvilyelltG~~PF~~~~-----------  353 (482)
                      |||+++......   .....+||+.|+|||++.+.     .++.++|||||||++|||++|+.||.+..           
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            999998764332   23446899999999999873     45678899999999999999999997532           


Q ss_pred             -----hHHHHHHHHhccc--CCCcc-----CChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          354 -----RAKIQQKIVKDKL--RLPAF-----LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       354 -----~~~~~~~i~~~~~--~~p~~-----~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                           ...+...+.....  .++..     .+.++.+||.+||+.||.+||++     .++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~ell~  311 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA-----GCVGE  311 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence                 2223333332221  12221     23459999999999999999998     78775

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.1e-45  Score=359.52  Aligned_cols=245  Identities=20%  Similarity=0.298  Sum_probs=208.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeee-ecCCeEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSF-QTKYRLYL  227 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~~l  227 (482)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.....     .+.+.+|+.+++.++|++++..+..+ ......++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            4789999999999999999999999999999999876532     23477899999999988766655444 67788899


Q ss_pred             EEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE---ccCCceeEcccCccccccCC
Q 047009          228 VLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl---~~~g~vKL~DFGla~~~~~~  303 (482)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99999 8999999874 4579999999999999999999999999999999999999   58899999999999876543


Q ss_pred             CC--------CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc---hHHHHHHHHhcccCCC---
Q 047009          304 TR--------SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN---RAKIQQKIVKDKLRLP---  369 (482)
Q Consensus       304 ~~--------~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~---~~~~~~~i~~~~~~~p---  369 (482)
                      ..        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+   .......+.......+   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence            22        346689999999999999999999999999999999999999997632   3344455544444443   


Q ss_pred             --ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          370 --AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       370 --~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                        ..+++++.+||.+||+.||.+||++     .++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~l~~  273 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDY-----SYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCH-----HHHHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCCCH-----HHHHH
Confidence              6789999999999999999999998     67664

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=373.16  Aligned_cols=252  Identities=19%  Similarity=0.220  Sum_probs=203.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcC---CCeEEEEEEeechhhchhh--------HHHHHHHHHHHHHhCCCCceeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKN---TSEIYAMKVMRKDKIVEKN--------HAEYMKAERDILTKIDHPFVVQL  215 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~~~~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l  215 (482)
                      ...++|++.+.||+|+||.||+|+++.   ++..||+|++.........        ....+.+|+.+++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            345789999999999999999999987   7889999999865321111        11235578889999999999999


Q ss_pred             eeeeec----CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC--ce
Q 047009          216 KYSFQT----KYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG--HV  289 (482)
Q Consensus       216 ~~~~~~----~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g--~v  289 (482)
                      ++++..    ...+|+||||+ |++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  .+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            999987    78899999999 999999998888899999999999999999999999999999999999999888  99


Q ss_pred             eEcccCccccccCCC--------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC--chHHHHH
Q 047009          290 MLTDFGLAKQFDENT--------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG--NRAKIQQ  359 (482)
Q Consensus       290 KL~DFGla~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~--~~~~~~~  359 (482)
                      ||+|||+++.+....        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.  +......
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  272 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT  272 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence            999999998763221        124568999999999999999999999999999999999999999652  3222222


Q ss_pred             HHHhcccCCCc---------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          360 KIVKDKLRLPA---------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       360 ~i~~~~~~~p~---------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ........+|.         .++.++.+||.+||+.||++||++     ++|++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~l~~  321 (345)
T 2v62_A          273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNY-----QALKK  321 (345)
T ss_dssp             HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCH-----HHHHH
T ss_pred             HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCH-----HHHHH
Confidence            22222223332         688999999999999999999998     78775

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-46  Score=389.68  Aligned_cols=269  Identities=23%  Similarity=0.369  Sum_probs=208.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  225 (482)
                      ++..+|++.+.||+|+||+|+. ....+++.||||++.++...      .+.+|+.+|+.+ +|||||++++++.+...+
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~   93 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQ   93 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred             EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence            3446799999999999999764 44557899999999765421      245799999999 799999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc---CC--ceeEcccCcccc
Q 047009          226 YLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA---DG--HVMLTDFGLAKQ  299 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~---~g--~vKL~DFGla~~  299 (482)
                      |+||||+. |+|..++.... .+.+..+..++.||+.||.|||++||+||||||+|||++.   ++  .+||+|||+|+.
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            99999997 59998887654 4566667889999999999999999999999999999953   33  578999999988


Q ss_pred             ccCC----CCCcccccCCCCCchhhhc---CCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcccCC---
Q 047009          300 FDEN----TRSNSMIGTVEYMAPEIVL---GKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL---  368 (482)
Q Consensus       300 ~~~~----~~~~~~~gt~~y~APE~l~---~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~~~~---  368 (482)
                      ....    ......+||+.|+|||++.   +..++.++|||||||++|||++ |..||...........+.......   
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~  252 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP  252 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCT
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCc
Confidence            6533    2334578999999999998   4567889999999999999999 999996554443333222222111   


Q ss_pred             CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh---------hhhhccCCCCCccc
Q 047009          369 PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK---------KLEAREIQPGFCPE  428 (482)
Q Consensus       369 p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~---------~~~~~~~~p~~~p~  428 (482)
                      +...+..+++||.+||+.||.+||++     .++++||||.+++|.         .++.....+|+.+.
T Consensus       253 ~~~~~~~~~~li~~~L~~dP~~Rps~-----~evl~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
T 3p23_A          253 EKHEDVIARELIEKMIAMDPQKRPSA-----KHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQ  316 (432)
T ss_dssp             TCHHHHHHHHHHHHHSCSSGGGSCCH-----HHHHTSTTTCCHHHHHHHHHHHHHHCSCSCSSCHHHHH
T ss_pred             cccccHHHHHHHHHHHhCCHhhCCCH-----HHHHhCccccChHHHHHHHHHHHHHhhcccccchHHHH
Confidence            22345678999999999999999998     999999999999883         33444455555543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.2e-45  Score=360.35  Aligned_cols=250  Identities=25%  Similarity=0.371  Sum_probs=199.9

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ..+.-++|++.+.||+|+||+||+|++..   .||+|+++.... .....+.+.+|+.++++++||||+++++++ ....
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~   93 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ   93 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence            34556889999999999999999998654   499999976542 344566788999999999999999999855 5567


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-
Q 047009          225 LYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-  302 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-  302 (482)
                      .++||||+.+++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... 
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence            89999999999999988644 5699999999999999999999999999999999999999999999999999986542 


Q ss_pred             --CCCCcccccCCCCCchhhhc---CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHH-HHHHHHhcccC-----CCcc
Q 047009          303 --NTRSNSMIGTVEYMAPEIVL---GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAK-IQQKIVKDKLR-----LPAF  371 (482)
Q Consensus       303 --~~~~~~~~gt~~y~APE~l~---~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~-~~~~i~~~~~~-----~p~~  371 (482)
                        ........||+.|+|||++.   +..++.++||||||+++|+|++|+.||.+.+... +...+..+...     ++..
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN  253 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence              22334567999999999997   6678999999999999999999999998755444 44444443322     2346


Q ss_pred             CChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       372 ~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +++++.+||.+||+.||.+||++     .++++
T Consensus       254 ~~~~l~~li~~~l~~~p~~Rps~-----~ell~  281 (289)
T 3og7_A          254 CPKRMKRLMAECLKKKRDERPSF-----PRILA  281 (289)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCCCH-----HHHHH
Confidence            88999999999999999999998     78775

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.4e-45  Score=356.88  Aligned_cols=247  Identities=23%  Similarity=0.390  Sum_probs=215.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++++.||+|+||.||+|+++ ++..||+|++.....    ..+.+.+|+.++++++||||+++++++.. +..+
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   83 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence            34478999999999999999999976 467899999976532    24567899999999999999999998874 4688


Q ss_pred             EEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          227 LVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      +||||+++++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            9999999999999886543  68999999999999999999999999999999999999999999999999998765432


Q ss_pred             C--CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHH
Q 047009          305 R--SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLL  380 (482)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI  380 (482)
                      .  .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+..+.+..+ ....+..++.++.+||
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  243 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM  243 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHH
Confidence            2  234457889999999998889999999999999999999 99999998888888777665 3456778999999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHh
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||..||++||++     .++++
T Consensus       244 ~~~l~~~p~~Rps~-----~~l~~  262 (279)
T 1qpc_A          244 RLCWKERPEDRPTF-----DYLRS  262 (279)
T ss_dssp             HHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHhccChhhCCCH-----HHHHH
Confidence            99999999999998     77765

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.5e-45  Score=362.50  Aligned_cols=252  Identities=25%  Similarity=0.407  Sum_probs=209.1

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcC-CC--eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKN-TS--EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~--~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      +..++|++.+.||+|+||+||+|++.. ++  ..||+|+++..........+.+.+|+.++++++||||+++++++.+..
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   94 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence            445789999999999999999998653 33  369999998765445556778899999999999999999999998765


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 RLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                       .++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence             88999999999999988764 5699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC----CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc--cCCCccCChH
Q 047009          303 NTR----SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK--LRLPAFLSSE  375 (482)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~  375 (482)
                      ...    .....+|..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+....  ...+..++.+
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD  253 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHH
Confidence            322    234567889999999999989999999999999999999 999999998888888887654  3445679999


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +.++|.+||..||.+||++     .++++
T Consensus       254 l~~li~~~l~~~p~~Rps~-----~~l~~  277 (291)
T 1u46_A          254 IYNVMVQCWAHKPEDRPTF-----VALRD  277 (291)
T ss_dssp             HHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHHHccCCcccCcCH-----HHHHH
Confidence            9999999999999999998     88886

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3e-45  Score=358.80  Aligned_cols=244  Identities=25%  Similarity=0.430  Sum_probs=207.1

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec-CCeE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT-KYRL  225 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~  225 (482)
                      +..++|++.+.||+|+||+||+|+++  |+.||+|+++...     ..+.+.+|+.++++++||||+++++++.. .+.+
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence            44688999999999999999999875  7899999987542     34567899999999999999999998654 4578


Q ss_pred             EEEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          226 YLVLDFINGGHLFFQLYHHGL--FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      ++||||+++|+|.+++...+.  +++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999999999999876543  899999999999999999999999999999999999999999999999999865432


Q ss_pred             CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHH
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~  381 (482)
                        .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+..+ ....+..+++.+.++|+
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  248 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK  248 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence              234467899999999999999999999999999999998 99999988887777777665 45667889999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +||+.||.+||++     .++++
T Consensus       249 ~~l~~~p~~Rps~-----~~l~~  266 (278)
T 1byg_A          249 NCWHLDAAMRPSF-----LQLRE  266 (278)
T ss_dssp             HHTCSSGGGSCCH-----HHHHH
T ss_pred             HHhcCChhhCCCH-----HHHHH
Confidence            9999999999998     77764

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.8e-45  Score=367.97  Aligned_cols=249  Identities=24%  Similarity=0.383  Sum_probs=212.8

Q ss_pred             CCCCeEEEEEecccCceEEEEEE----EcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeee--c
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVR----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQ--T  221 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~  221 (482)
                      ..++|++++.||+|+||.||+|+    +..+++.||+|++....   ....+.+.+|+.++++++||||+++++++.  +
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            34789999999999999999999    46788999999997653   344566889999999999999999999886  5


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF  300 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~  300 (482)
                      ...+|+||||+++++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            56799999999999999999774 56999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCC----CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchH---------------HHHHHH
Q 047009          301 DENT----RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA---------------KIQQKI  361 (482)
Q Consensus       301 ~~~~----~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~---------------~~~~~i  361 (482)
                      ....    ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......               .+...+
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence            5433    223456888899999999999999999999999999999999999654332               222222


Q ss_pred             Hhc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          362 VKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       362 ~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ..+ ....+..+++++.+||.+||+.||.+||++     .++++
T Consensus       258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~  296 (327)
T 3lxl_A          258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSF-----SALGP  296 (327)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            222 345677899999999999999999999998     78754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7e-45  Score=385.19  Aligned_cols=268  Identities=22%  Similarity=0.318  Sum_probs=219.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCC-CceeeeeeeeecCCeEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH-PFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~l  227 (482)
                      .++|++++.||+|+||.||+|++..+++.||||++......     ..+.+|+.+++.++| ++|..+..++......+|
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence            47899999999999999999999999999999998765321     236789999999987 556666677778889999


Q ss_pred             EEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE---ccCCceeEcccCccccccCC
Q 047009          228 VLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl---~~~g~vKL~DFGla~~~~~~  303 (482)
                      ||||+ +++|.+++.. .+.+++..++.|+.||+.||.|||++|||||||||+||||   +.++.+||+|||+++.+...
T Consensus        81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99999 8999999875 4679999999999999999999999999999999999999   68899999999999876543


Q ss_pred             CC--------CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch---HHHHHHHHhccc-----C
Q 047009          304 TR--------SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR---AKIQQKIVKDKL-----R  367 (482)
Q Consensus       304 ~~--------~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~---~~~~~~i~~~~~-----~  367 (482)
                      ..        ....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+...   ...+..+.....     .
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA  239 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence            22        2367899999999999999999999999999999999999999977433   334444443322     2


Q ss_pred             CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHH----------hCcCCCCCChhhhhhccCCCCCcc
Q 047009          368 LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIK----------SHKWFKPINWKKLEAREIQPGFCP  427 (482)
Q Consensus       368 ~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil----------~hp~f~~~~~~~~~~~~~~p~~~p  427 (482)
                      ++..++.++.+||.+||+.||.+||++     .+|+          .++|+..++|..+..++.+++..|
T Consensus       240 l~~~~p~~l~~li~~cl~~dP~~RPs~-----~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~p  304 (483)
T 3sv0_A          240 LCRGYPTEFASYFHYCRSLRFDDKPDY-----SYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAP  304 (483)
T ss_dssp             HHTTSCHHHHHHHHHHHTCCTTCCCCH-----HHHHHHHHHHHHHTTCCCSSCCHHHHHTC---------
T ss_pred             HhcCCcHHHHHHHHHHhcCChhhCcCH-----HHHHHHHHHHHHHcCCCccCCcCchhhccccccccCCC
Confidence            235689999999999999999999998     5543          389999999999987776665544

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=356.34  Aligned_cols=247  Identities=21%  Similarity=0.325  Sum_probs=212.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCe---EEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE-E
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSE---IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL-Y  226 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~-~  226 (482)
                      .|++.+.||+|+||+||+|++..+++   .||+|++....  .....+.+.+|+.++++++||||+++++++.+.+.. +
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            47788999999999999999766544   79999987532  344567788999999999999999999999876655 9


Q ss_pred             EEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC--
Q 047009          227 LVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--  303 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~--  303 (482)
                      +||||+.+|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....  
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            99999999999999976 456899999999999999999999999999999999999999999999999999865322  


Q ss_pred             ---CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHH
Q 047009          304 ---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHS  378 (482)
Q Consensus       304 ---~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (482)
                         .......||+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+.......+... ....+..++.++.+
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  259 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ  259 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHH
Confidence               23345678899999999999999999999999999999999 56667777777777766665 34567789999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ||.+||+.||.+||++     +++++
T Consensus       260 li~~~l~~~p~~Rps~-----~~ll~  280 (298)
T 3pls_A          260 VMQQCWEADPAVRPTF-----RVLVG  280 (298)
T ss_dssp             HHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHccCChhhCcCH-----HHHHH
Confidence            9999999999999998     78775

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.8e-45  Score=364.52  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=207.4

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeee----c
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQ----T  221 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----~  221 (482)
                      .+..++|++.+.||+|+||.||+|+++.+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.    .
T Consensus        25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            345678999999999999999999999999999999987642   345567889999999999999999999986    3


Q ss_pred             CCeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                      ....++||||+.+|+|..++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            4578999999999999988876    467999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCC----------CcccccCCCCCchhhhcCCC---CCchhHHHHHhHHHHHHhhCCCCCCCCch--HHHHHHHH
Q 047009          298 KQFDENTR----------SNSMIGTVEYMAPEIVLGKG---HNKAADWWSVGILLYEMLTGKPPFIGGNR--AKIQQKIV  362 (482)
Q Consensus       298 ~~~~~~~~----------~~~~~gt~~y~APE~l~~~~---~~~~sDvwSlGvilyelltG~~PF~~~~~--~~~~~~i~  362 (482)
                      +.......          .....||+.|+|||++.+..   ++.++||||||+++|+|++|+.||.....  ......+.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  261 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ  261 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence            76432111          12346799999999998764   68899999999999999999999953211  11122222


Q ss_pred             h-cccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          363 K-DKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       363 ~-~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      . .....+..++.++.+||.+||+.||.+||++     .+++++
T Consensus       262 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~  300 (317)
T 2buj_A          262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHI-----PLLLSQ  300 (317)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             ccCCCCccccCCHHHHHHHHHHhhcChhhCCCH-----HHHHHH
Confidence            2 1223345689999999999999999999998     898874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.5e-44  Score=357.07  Aligned_cols=248  Identities=21%  Similarity=0.307  Sum_probs=211.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCC---CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeee-ecCCeE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNT---SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSF-QTKYRL  225 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~  225 (482)
                      .+|++.+.||+|+||.||+|++..+   +..||+|.+....  .....+.+.+|+.++++++||||+++++++ ...+..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            5699999999999999999997543   3468999987532  344566788999999999999999999985 566788


Q ss_pred             EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          226 YLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      ++||||+.+|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            9999999999999999764 458999999999999999999999999999999999999999999999999998754322


Q ss_pred             -----CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhccc-CCCccCChHHH
Q 047009          305 -----RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEAH  377 (482)
Q Consensus       305 -----~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~  377 (482)
                           ......||+.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..+....+..+.. ..|..++..+.
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  262 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY  262 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHH
Confidence                 2334567889999999999999999999999999999999 7788888777777777766543 45677899999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +||.+||+.||.+||++     .++++
T Consensus       263 ~li~~~l~~~p~~Rps~-----~ell~  284 (298)
T 3f66_A          263 EVMLKCWHPKAEMRPSF-----SELVS  284 (298)
T ss_dssp             HHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHcCCChhhCcCH-----HHHHH
Confidence            99999999999999998     78775

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.7e-45  Score=382.48  Aligned_cols=249  Identities=26%  Similarity=0.394  Sum_probs=213.4

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ..+..++|++.+.||+|+||.||+|.++. +..||||+++....    ..+.+.+|+.+|++++||||+++++++.. ..
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence            34556789999999999999999999986 46799999986542    23567899999999999999999999876 67


Q ss_pred             EEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          225 LYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      +|+||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            89999999999999999753  5689999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC--CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHH
Q 047009          303 NTR--SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHS  378 (482)
Q Consensus       303 ~~~--~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (482)
                      ...  .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+ ....|..++..+.+
T Consensus       333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  412 (452)
T 1fmk_A          333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  412 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            322  233456789999999999999999999999999999999 99999998888888877665 45667889999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ||.+||+.||++||++     ++|++
T Consensus       413 li~~cl~~dP~~Rpt~-----~~l~~  433 (452)
T 1fmk_A          413 LMCQCWRKEPEERPTF-----EYLQA  433 (452)
T ss_dssp             HHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHccCChhhCcCH-----HHHHH
Confidence            9999999999999998     78775

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.8e-46  Score=371.91  Aligned_cols=249  Identities=21%  Similarity=0.321  Sum_probs=209.0

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ..++|++.+.||+|+||.||+|+++ +++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            4578999999999999999999965 58899999987643   2445678899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          228 VLDFINGGHLFFQLYHHG----LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      ||||+++|+|..++....    .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999998886543    4899999999999999999999999999999999999999999999999999875322


Q ss_pred             ---CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHH-------HHHHhccc-------
Q 047009          304 ---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ-------QKIVKDKL-------  366 (482)
Q Consensus       304 ---~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~-------~~i~~~~~-------  366 (482)
                         .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+..       .....+.+       
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN  272 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred             cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence               2234567999999999999999999999999999999999999999765432211       11111111       


Q ss_pred             ---CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          367 ---RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       367 ---~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                         .++...+..+.++|.+||+.||++||++     .|+++|
T Consensus       273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~  309 (321)
T 2qkw_B          273 LADKIRPESLRKFGDTAVKCLALSSEDRPSM-----GDVLWK  309 (321)
T ss_dssp             CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             hccccCHHHHHHHHHHHHHHcCCCcccCcCH-----HHHHHH
Confidence               1223346788999999999999999998     888864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=8.8e-45  Score=363.71  Aligned_cols=248  Identities=26%  Similarity=0.408  Sum_probs=190.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeee------
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSF------  219 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~------  219 (482)
                      ....+|++.+.||+|+||.||+|+++.+++.||+|++....   ....+.+.+|+.+++++. ||||+++++++      
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~  101 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE  101 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence            34468999999999999999999999999999999986543   344556789999999995 99999999998      


Q ss_pred             --ecCCeEEEEEEecCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEccCCceeEc
Q 047009          220 --QTKYRLYLVLDFINGGHLFFQLYH---HGLFREDLARIYAAEIVSAVSHLHANG--IMHRDLKPENILLGADGHVMLT  292 (482)
Q Consensus       220 --~~~~~~~lV~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~--IiHrDLKp~NILl~~~g~vKL~  292 (482)
                        .....+++||||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+
T Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence              44556899999996 688887754   467999999999999999999999999  9999999999999999999999


Q ss_pred             ccCccccccCCCC-------------CcccccCCCCCchhhh---cCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHH
Q 047009          293 DFGLAKQFDENTR-------------SNSMIGTVEYMAPEIV---LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAK  356 (482)
Q Consensus       293 DFGla~~~~~~~~-------------~~~~~gt~~y~APE~l---~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~  356 (482)
                      |||+++.......             ....+||+.|+|||++   .+..++.++|||||||++|+|++|+.||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            9999987654322             1245799999999999   56778999999999999999999999997655443


Q ss_pred             HHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          357 IQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       357 ~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ......  ....+...+..+.+||++||+.||.+||++     .|+++|
T Consensus       261 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~e~l~~  302 (337)
T 3ll6_A          261 IVNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSI-----AEVVHQ  302 (337)
T ss_dssp             -----C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCH-----HHHHHH
T ss_pred             hhcCcc--cCCcccccchHHHHHHHHHccCChhhCcCH-----HHHHHH
Confidence            332211  223345678899999999999999999998     899886

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.9e-45  Score=358.99  Aligned_cols=244  Identities=28%  Similarity=0.434  Sum_probs=197.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHh--CCCCceeeeeeeeec---
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK--IDHPFVVQLKYSFQT---  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~---  221 (482)
                      ...++|++++.||+|+||+||+|++  +++.||||++....      ...+..|.+++..  ++||||+++++++..   
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~   76 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRH   76 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence            4457899999999999999999988  57899999987542      2334556677666  799999999988643   


Q ss_pred             -CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCcccCCCCCcEEEccCCceeEc
Q 047009          222 -KYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH--------ANGIMHRDLKPENILLGADGHVMLT  292 (482)
Q Consensus       222 -~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~IiHrDLKp~NILl~~~g~vKL~  292 (482)
                       ...+++||||+++|+|.+++. ...+++..+..++.||+.||+|||        ++||+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           77 SSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             TEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence             456899999999999999985 457899999999999999999999        9999999999999999999999999


Q ss_pred             ccCccccccCCCC-----CcccccCCCCCchhhhcCC------CCCchhHHHHHhHHHHHHhhC----------CCCCCC
Q 047009          293 DFGLAKQFDENTR-----SNSMIGTVEYMAPEIVLGK------GHNKAADWWSVGILLYEMLTG----------KPPFIG  351 (482)
Q Consensus       293 DFGla~~~~~~~~-----~~~~~gt~~y~APE~l~~~------~~~~~sDvwSlGvilyelltG----------~~PF~~  351 (482)
                      |||+++.......     ....+||+.|+|||++.+.      .++.++|||||||++|||++|          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            9999987543322     2345899999999999887      455799999999999999999          889865


Q ss_pred             Cch----HHHHHHHH-hc--ccCCCc-----cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          352 GNR----AKIQQKIV-KD--KLRLPA-----FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       352 ~~~----~~~~~~i~-~~--~~~~p~-----~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ...    ......+. ..  ...+|.     .++.++.+||.+||+.||.+||++     .++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~~i~~  295 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA-----LRIKK  295 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCH-----HHHHH
T ss_pred             cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCH-----HHHHH
Confidence            321    22222222 22  222332     245789999999999999999998     88875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=358.43  Aligned_cols=242  Identities=29%  Similarity=0.467  Sum_probs=200.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++.+.||+|+||+||+|++.  ++.||+|++...     ...+.+.+|+.++++++||||+++++++.+  ..+
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~   75 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC   75 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence            44578999999999999999999885  688999998643     345668899999999999999999999874  478


Q ss_pred             EEEEecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCCCcEEEccCCc-eeEcccCcccc
Q 047009          227 LVLDFINGGHLFFQLYHHG---LFREDLARIYAAEIVSAVSHLHA---NGIMHRDLKPENILLGADGH-VMLTDFGLAKQ  299 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~~IiHrDLKp~NILl~~~g~-vKL~DFGla~~  299 (482)
                      +||||++||+|.+++....   .+++..+..++.||+.||+|||+   +||+||||||+|||++.++. +||+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            9999999999999998765   37888999999999999999999   89999999999999999887 79999999986


Q ss_pred             ccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch--HHHHHHHHh-cccCCCccCChHH
Q 047009          300 FDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR--AKIQQKIVK-DKLRLPAFLSSEA  376 (482)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~--~~~~~~i~~-~~~~~p~~~s~~~  376 (482)
                      ....  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....  ......+.. .....+..++..+
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (307)
T 2eva_A          156 IQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI  233 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHH
T ss_pred             cccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHH
Confidence            5432  3345799999999999999999999999999999999999999975432  233333333 3445667899999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||.+||+.||.+||++     +++++
T Consensus       234 ~~li~~~l~~dp~~Rps~-----~ell~  256 (307)
T 2eva_A          234 ESLMTRCWSKDPSQRPSM-----EEIVK  256 (307)
T ss_dssp             HHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHHhcCChhhCcCH-----HHHHH
Confidence            999999999999999998     88876

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.7e-44  Score=394.56  Aligned_cols=247  Identities=21%  Similarity=0.349  Sum_probs=213.1

Q ss_pred             CeEEE-EEecccCceEEEEEEE--cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          151 DFEVL-KVVGQGAFGRVYQVRK--KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       151 ~y~i~-~~LG~G~fg~Vy~a~~--~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      .+.+. +.||+|+||.||+|.+  +.+++.||||+++... ......+.+.+|+.+|++++|||||++++++.. +.+++
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l  446 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML  446 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence            34443 4899999999999955  4567899999997653 233456678899999999999999999999975 45889


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC---
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT---  304 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~---  304 (482)
                      ||||+.+|+|..++...+.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+....   
T Consensus       447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999999999999988899999999999999999999999999999999999999999999999999998764332   


Q ss_pred             -CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHH
Q 047009          305 -RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~  381 (482)
                       ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++.+.+..+ ....|..++.++.+||.
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  606 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN  606 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence             1233456889999999999999999999999999999998 99999999988888888776 45678889999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +||+.||++||++     ++|++
T Consensus       607 ~cl~~dP~~RPs~-----~~l~~  624 (635)
T 4fl3_A          607 LCWTYDVENRPGF-----AAVEL  624 (635)
T ss_dssp             HHTCSSTTTSCCH-----HHHHH
T ss_pred             HHcCCCHhHCcCH-----HHHHH
Confidence            9999999999998     77764

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.8e-45  Score=380.47  Aligned_cols=247  Identities=30%  Similarity=0.413  Sum_probs=197.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +.|.+.+.||+|+||+||.+. ..+|+.||||++..+.      .+.+.+|+.+|+++ +||||+++++++.+...+|+|
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            456778999999999998754 4568999999987642      23467899999876 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC-------------Cc
Q 047009          229 LDFINGGHLFFQLYHHGLFR-------EDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD-------------GH  288 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~-------~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~-------------g~  288 (482)
                      |||+. |+|.+++...+...       +..++.++.||+.||+|||++||+||||||+|||++.+             ++
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence            99996 59999997765432       23456799999999999999999999999999999764             48


Q ss_pred             eeEcccCccccccCCC-----CCcccccCCCCCchhhhcC-------CCCCchhHHHHHhHHHHHHhh-CCCCCCCCchH
Q 047009          289 VMLTDFGLAKQFDENT-----RSNSMIGTVEYMAPEIVLG-------KGHNKAADWWSVGILLYEMLT-GKPPFIGGNRA  355 (482)
Q Consensus       289 vKL~DFGla~~~~~~~-----~~~~~~gt~~y~APE~l~~-------~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~  355 (482)
                      +||+|||+++......     .....+||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.+....
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            9999999999865432     2235689999999999976       678999999999999999999 99999765443


Q ss_pred             HHHHHHHhcccCCCc-------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          356 KIQQKIVKDKLRLPA-------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       356 ~~~~~i~~~~~~~p~-------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      .  ..+..+...++.       .++.++++||.+||+.||.+||++     .++++||||.+.
T Consensus       247 ~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~eil~hp~f~~~  302 (434)
T 2rio_A          247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA-----MKVLRHPLFWPK  302 (434)
T ss_dssp             H--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGSCH
T ss_pred             H--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCH-----HHHHhCCccCCc
Confidence            3  344454443332       245889999999999999999998     999999999764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=367.93  Aligned_cols=242  Identities=18%  Similarity=0.254  Sum_probs=202.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCC--------CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceee------
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNT--------SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQ------  214 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--------~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~------  214 (482)
                      .++|++.+.||+|+||.||+|+++.+        ++.||+|++.+.        +.+.+|+.++++++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            47899999999999999999999884        889999998764        24678999999999999988      


Q ss_pred             ---------eeeeeec-CCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 047009          215 ---------LKYSFQT-KYRLYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENIL  282 (482)
Q Consensus       215 ---------l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NIL  282 (482)
                               +++++.. ...+|+||||+ +++|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     4556654 77899999999 99999999876  78999999999999999999999999999999999999


Q ss_pred             EccCC--ceeEcccCccccccCCC--------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCC
Q 047009          283 LGADG--HVMLTDFGLAKQFDENT--------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGG  352 (482)
Q Consensus       283 l~~~g--~vKL~DFGla~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~  352 (482)
                      ++.++  .+||+|||+++.+....        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  99999999998754321        224458999999999999999999999999999999999999999765


Q ss_pred             c--hHHHHHHH---HhcccCCC------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          353 N--RAKIQQKI---VKDKLRLP------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       353 ~--~~~~~~~i---~~~~~~~p------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .  ...+....   ......++      ..++.++.+||.+||+.||++||++     ++|++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~l~~  329 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPY-----AMLRN  329 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCH-----HHHHH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCH-----HHHHH
Confidence            3  22232222   22222222      2468999999999999999999998     77765

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=391.68  Aligned_cols=248  Identities=22%  Similarity=0.334  Sum_probs=212.7

Q ss_pred             CCCCeEEEE-EecccCceEEEEEEEc--CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          148 GIEDFEVLK-VVGQGAFGRVYQVRKK--NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       148 ~~~~y~i~~-~LG~G~fg~Vy~a~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ..+++.+.+ .||+|+||.||+|.++  .++..||||+++...  .....+.+.+|+.+|++++|||||++++++.. +.
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence            345677777 8999999999999876  356789999997652  23455678899999999999999999999976 56


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          225 LYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      +++||||+.+|+|..++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            89999999999999998754 45999999999999999999999999999999999999999999999999999876433


Q ss_pred             CC----CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHH
Q 047009          304 TR----SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAH  377 (482)
Q Consensus       304 ~~----~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (482)
                      ..    .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++.+.+..+ .+.+|..+++++.
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  569 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY  569 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence            21    123345689999999999999999999999999999998 99999998888888888776 4567888999999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHH
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIK  403 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil  403 (482)
                      +||.+||+.||.+||++     .+|+
T Consensus       570 ~li~~cl~~dP~~RPs~-----~~l~  590 (613)
T 2ozo_A          570 ALMSDCWIYKWEDRPDF-----LTVE  590 (613)
T ss_dssp             HHHHHTTCSSTTTSCCH-----HHHH
T ss_pred             HHHHHHcCCChhHCcCH-----HHHH
Confidence            99999999999999998     6765

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-45  Score=372.20  Aligned_cols=248  Identities=22%  Similarity=0.318  Sum_probs=204.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCC---CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeee-ecCCeE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNT---SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSF-QTKYRL  225 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~  225 (482)
                      ..|++.+.||+|+||+||+|++..+   +..||+|.++..  ......+.+.+|+.++++++||||+++++++ ...+..
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            4588999999999999999987543   346899998653  2334567788999999999999999999986 456688


Q ss_pred             EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          226 YLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      ++||||+++|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999999765 458899999999999999999999999999999999999999999999999998754322


Q ss_pred             -----CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc-cCCCccCChHHH
Q 047009          305 -----RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAH  377 (482)
Q Consensus       305 -----~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~  377 (482)
                           ......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+..+. ...|..++..+.
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~  326 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY  326 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence                 1234567889999999999999999999999999999999 788998877766666666653 455778999999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ++|.+||+.||.+||++     .++++
T Consensus       327 ~li~~cl~~dp~~RPs~-----~ell~  348 (373)
T 3c1x_A          327 EVMLKCWHPKAEMRPSF-----SELVS  348 (373)
T ss_dssp             HHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHcCCChhhCcCH-----HHHHH
Confidence            99999999999999998     88875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.6e-45  Score=370.30  Aligned_cols=239  Identities=18%  Similarity=0.280  Sum_probs=198.7

Q ss_pred             ccCCCCeEEEEEecccCceEEEEE-----EEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC---CCceeeeee
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQV-----RKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID---HPFVVQLKY  217 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a-----~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~  217 (482)
                      ....++|++.+.||+|+||+||+|     .+..+++.||+|++....      ...+..|+.+++.++   |+||+++++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            345688999999999999999999     467789999999987543      234667888888886   999999999


Q ss_pred             eeecCCeEEEEEEecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc-------
Q 047009          218 SFQTKYRLYLVLDFINGGHLFFQLYH-----HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA-------  285 (482)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~-------  285 (482)
                      ++...+..|+||||++||+|.+++..     .+.+++..++.++.||+.||+|||++|||||||||+|||++.       
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence            99999999999999999999999974     456999999999999999999999999999999999999998       


Q ss_pred             ----CCceeEcccCcccccc---CCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHH
Q 047009          286 ----DGHVMLTDFGLAKQFD---ENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ  358 (482)
Q Consensus       286 ----~g~vKL~DFGla~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~  358 (482)
                          ++.+||+|||+|+.+.   ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.........
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  294 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK  294 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence                8999999999997643   333445678999999999999999999999999999999999999999654321100


Q ss_pred             HHHHhcccCCCccCChHHHHHHHHhhccCcCCcCCC
Q 047009          359 QKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       359 ~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                         ....+. ....++.+.+++..||+.+|.+|++.
T Consensus       295 ---~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~  326 (365)
T 3e7e_A          295 ---PEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPS  326 (365)
T ss_dssp             ---ECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCC
T ss_pred             ---echhcc-ccCcHHHHHHHHHHHcCCCCCCcchH
Confidence               001111 11246788999999999999999776

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.1e-44  Score=386.54  Aligned_cols=247  Identities=26%  Similarity=0.404  Sum_probs=216.8

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++.+.||+|+||.||+|+++. +..||||+++....    ..+.+.+|+.+|++++||||+++++++.. ..+|
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            445789999999999999999999986 46799999986542    23567899999999999999999999876 6789


Q ss_pred             EEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          227 LVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      |||||+.+|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            999999999999999753  568999999999999999999999999999999999999999999999999998764321


Q ss_pred             --CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHH
Q 047009          305 --RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLL  380 (482)
Q Consensus       305 --~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI  380 (482)
                        ......+|..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++.+.+..+ .+..|..++.++.+||
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  497 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM  497 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence              1233456789999999999999999999999999999999 99999998888888877665 4566788999999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHh
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||+.||++||++     ++|++
T Consensus       498 ~~cl~~dP~~RPt~-----~~l~~  516 (535)
T 2h8h_A          498 CQCWRKEPEERPTF-----EYLQA  516 (535)
T ss_dssp             HHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHcCCChhHCcCH-----HHHHH
Confidence            99999999999998     77775

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.6e-44  Score=359.89  Aligned_cols=246  Identities=28%  Similarity=0.378  Sum_probs=207.1

Q ss_pred             CeEEEEEecccCceEEEEEEE----cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec--CCe
Q 047009          151 DFEVLKVVGQGAFGRVYQVRK----KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT--KYR  224 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~----~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~  224 (482)
                      .|++++.||+|+||+||++.+    ..+++.||||++....  .....+.+.+|+.++++++||||+++++++.+  ...
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            359999999999999988764    4578999999998653  33456678899999999999999999999987  467


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      +++||||+++|+|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  188 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  188 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred             EEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence            89999999999999988664 48999999999999999999999999999999999999999999999999998875443


Q ss_pred             C----CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchH---------------HHHHHHHhc-
Q 047009          305 R----SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA---------------KIQQKIVKD-  364 (482)
Q Consensus       305 ~----~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~---------------~~~~~i~~~-  364 (482)
                      .    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......               .+...+... 
T Consensus       189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (318)
T 3lxp_A          189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE  268 (318)
T ss_dssp             SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred             cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence            2    33456888999999999999999999999999999999999999653221               122222222 


Q ss_pred             ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          365 KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       365 ~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ....+..++.++.+||++||+.||.+||++     .++++
T Consensus       269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~  303 (318)
T 3lxp_A          269 RLPRPDKCPAEVYHLMKNCWETEASFRPTF-----ENLIP  303 (318)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCCccccHHHHHHHHHHcCCCcccCcCH-----HHHHH
Confidence            445677899999999999999999999998     88874

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.8e-45  Score=366.27  Aligned_cols=259  Identities=22%  Similarity=0.293  Sum_probs=210.2

Q ss_pred             cccccccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeee
Q 047009          141 SVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQ  220 (482)
Q Consensus       141 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  220 (482)
                      +........++|++.+.||+|+||.||+|+++ +|+.||+|++......  .....+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             CTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             cHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            44445566789999999999999999999854 5889999999765422  12225788999999999999999999999


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCCCcEEEccCCceeEcc
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHHG----LFREDLARIYAAEIVSAVSHLHAN---GIMHRDLKPENILLGADGHVMLTD  293 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~IiHrDLKp~NILl~~~g~vKL~D  293 (482)
                      +....++||||+.+|+|..++....    .+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D  177 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD  177 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence            9999999999999999999997653    389999999999999999999999   999999999999999999999999


Q ss_pred             cCccccccCC--CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc-----hHHHHHHHH---h
Q 047009          294 FGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN-----RAKIQQKIV---K  363 (482)
Q Consensus       294 FGla~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~-----~~~~~~~i~---~  363 (482)
                      ||+++.....  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....     .......+.   .
T Consensus       178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 3uim_A          178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK  257 (326)
T ss_dssp             CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred             CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence            9999876432  22345569999999999999899999999999999999999999995211     111111111   1


Q ss_pred             c-c----------cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcC
Q 047009          364 D-K----------LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKW  407 (482)
Q Consensus       364 ~-~----------~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~  407 (482)
                      . .          ..++...+..+.+||.+||+.||.+||++     .++++|-.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~ell~~L~  307 (326)
T 3uim_A          258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM-----SEVVRMLE  307 (326)
T ss_dssp             SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCH-----HHHHHHHH
T ss_pred             chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCH-----HHHHHHhc
Confidence            0 0          01122234789999999999999999999     89987654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.8e-44  Score=354.09  Aligned_cols=229  Identities=32%  Similarity=0.591  Sum_probs=193.5

Q ss_pred             CCCCeEEE-EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHH-HhCCCCceeeeeeeeec----
Q 047009          148 GIEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL-TKIDHPFVVQLKYSFQT----  221 (482)
Q Consensus       148 ~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~----  221 (482)
                      .+++|.+. +.||+|+||.||+|.++.+++.||+|++....        ...+|+.++ +.++||||+++++++..    
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   86 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAG   86 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH--------HHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence            45789888 78999999999999999999999999986432        356788887 56699999999999977    


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc---CCceeEcccCc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGL  296 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~---~g~vKL~DFGl  296 (482)
                      ...+++||||++||+|..++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            778999999999999999998764  6999999999999999999999999999999999999998   78999999999


Q ss_pred             cccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHH----HHHhcccCCC---
Q 047009          297 AKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ----KIVKDKLRLP---  369 (482)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~----~i~~~~~~~p---  369 (482)
                      +....                     +..++.++|||||||++|+|++|+.||.+.+......    .+......++   
T Consensus       167 a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (299)
T 3m2w_A          167 AKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  225 (299)
T ss_dssp             CEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred             ccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence            87643                     2447889999999999999999999997765543322    2222333444   


Q ss_pred             -ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          370 -AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       370 -~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                       ..+++++++||.+||+.||.+||++     .|+++||||..
T Consensus       226 ~~~~~~~~~~li~~~l~~dP~~Rps~-----~e~l~hp~~~~  262 (299)
T 3m2w_A          226 WSEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIMQ  262 (299)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHT
T ss_pred             cccCCHHHHHHHHHHcccChhhCCCH-----HHHhcChhhcc
Confidence             4689999999999999999999998     99999999976

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=356.60  Aligned_cols=250  Identities=23%  Similarity=0.344  Sum_probs=210.2

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEE----cCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRK----KNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~----~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      ...++|++++.||+|+||.||+|++    ..+++.||+|++....   ....+.+.+|+.++++++||||+++++++...
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            3447799999999999999999994    5689999999997642   34556788999999999999999999988654


Q ss_pred             C--eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          223 Y--RLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       223 ~--~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      +  .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            4  789999999999999999876 4599999999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCC----CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchH----------------HHHH
Q 047009          300 FDENTR----SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA----------------KIQQ  359 (482)
Q Consensus       300 ~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~----------------~~~~  359 (482)
                      ......    .....+|..|+|||++.+..++.++||||||+++|+|++|..||......                .+.+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            654332    23346778899999999999999999999999999999999998542111                1122


Q ss_pred             HHHh-cccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          360 KIVK-DKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       360 ~i~~-~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+.. .....|..++.++.+||++||+.||.+||++     .++++
T Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~el~~  315 (326)
T 2w1i_A          275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF-----RDLAL  315 (326)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHH
T ss_pred             HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            2222 2445677899999999999999999999998     78774

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.7e-44  Score=358.43  Aligned_cols=247  Identities=21%  Similarity=0.383  Sum_probs=191.6

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeee-----e
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSF-----Q  220 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~  220 (482)
                      .+.+++|++++.||+|+||.||+|++  +++.||||++.....    .......|+..+..++||||+++++.+     .
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR----QNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch----hhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            35678999999999999999999977  578999999975431    111122344445568999999998744     3


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCcccCCCCCcEEEccCCceeE
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN---------GIMHRDLKPENILLGADGHVML  291 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------~IiHrDLKp~NILl~~~g~vKL  291 (482)
                      ....+++||||+++|+|..++.... .++..+..++.||+.||.|||++         ||+||||||+|||++.+|.+||
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             CCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence            3446899999999999999987654 58888999999999999999999         9999999999999999999999


Q ss_pred             cccCccccccCC---------CCCcccccCCCCCchhhhcC-------CCCCchhHHHHHhHHHHHHhhCCCCCCCCch-
Q 047009          292 TDFGLAKQFDEN---------TRSNSMIGTVEYMAPEIVLG-------KGHNKAADWWSVGILLYEMLTGKPPFIGGNR-  354 (482)
Q Consensus       292 ~DFGla~~~~~~---------~~~~~~~gt~~y~APE~l~~-------~~~~~~sDvwSlGvilyelltG~~PF~~~~~-  354 (482)
                      +|||+++.+...         ......+||+.|+|||++.+       ..++.++|||||||++|||++|..||..... 
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            999999876432         22235679999999999987       4566799999999999999999777643211 


Q ss_pred             ----------------HHHHHHHHhc---ccCCCcc------CChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          355 ----------------AKIQQKIVKD---KLRLPAF------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       355 ----------------~~~~~~i~~~---~~~~p~~------~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                                      ......+...   ...+|..      +++++.+||.+||+.||++||++     .|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~e~l~  311 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA-----QXAEE  311 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCH-----HHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcch-----HHHHH
Confidence                            1111122211   2334433      33479999999999999999998     78854

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3e-45  Score=398.55  Aligned_cols=272  Identities=26%  Similarity=0.407  Sum_probs=220.5

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec----
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT----  221 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----  221 (482)
                      ....++|++.+.||+|+||.||+|.++.+|+.||||++....  .....+.+.+|+.++++++||||+++++++..    
T Consensus        10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~   87 (676)
T 3qa8_A           10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL   87 (676)
T ss_dssp             -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred             CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence            344588999999999999999999999999999999987642  33456678899999999999999999998765    


Q ss_pred             --CCeEEEEEEecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCc---eeEcc
Q 047009          222 --KYRLYLVLDFINGGHLFFQLYHHG---LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGH---VMLTD  293 (482)
Q Consensus       222 --~~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~---vKL~D  293 (482)
                        .+..|+||||++||+|..++....   .+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence              677899999999999999998754   5899999999999999999999999999999999999998775   99999


Q ss_pred             cCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHH---------HHH---
Q 047009          294 FGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ---------QKI---  361 (482)
Q Consensus       294 FGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~---------~~i---  361 (482)
                      ||++............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......         ..+   
T Consensus       168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             cccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            99999887766667789999999999999999999999999999999999999999764322111         000   


Q ss_pred             --HhcccC----------CCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCc
Q 047009          362 --VKDKLR----------LPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFC  426 (482)
Q Consensus       362 --~~~~~~----------~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~  426 (482)
                        ..+...          ++..++..+.+||.+||..||.+||++     .++++||||+.  ++.+..+.+.+.|.
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa-----~elL~hp~F~~--l~~iL~~kil~~f~  317 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD-----PQNPNVGCFQA--LDSILSLKLLSVMN  317 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CC-----TTCCCCTTHHH--HHHHHCCCEEECCC
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCH-----HHHhcCHHHHH--HHHHHhcccccccc
Confidence              011111          122357889999999999999999999     89999999987  45665555544443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-44  Score=357.05  Aligned_cols=247  Identities=25%  Similarity=0.391  Sum_probs=198.3

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHh--CCCCceeeeeeeeecC
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK--IDHPFVVQLKYSFQTK  222 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~  222 (482)
                      .....++|++++.||+|+||.||+|+++  ++.||||++....      ......|.+++..  ++||||+++++++...
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            3344578999999999999999999886  7899999986542      1223445555554  4999999999999877


Q ss_pred             ----CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccCCCCCcEEEccCCcee
Q 047009          223 ----YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN--------GIMHRDLKPENILLGADGHVM  290 (482)
Q Consensus       223 ----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~IiHrDLKp~NILl~~~g~vK  290 (482)
                          ..+|+||||+++|+|..++.. ..+++..++.++.|++.||.|||++        ||+||||||+|||++.++.+|
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence                789999999999999999865 4689999999999999999999999        999999999999999999999


Q ss_pred             EcccCccccccCCCC-----CcccccCCCCCchhhhcCCCCCch------hHHHHHhHHHHHHhhC----------CCCC
Q 047009          291 LTDFGLAKQFDENTR-----SNSMIGTVEYMAPEIVLGKGHNKA------ADWWSVGILLYEMLTG----------KPPF  349 (482)
Q Consensus       291 L~DFGla~~~~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~------sDvwSlGvilyelltG----------~~PF  349 (482)
                      |+|||+++.+.....     ....+||+.|+|||++.+..++..      +|||||||++|||++|          +.||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            999999987643322     235689999999999988776654      9999999999999999          7777


Q ss_pred             CCCc-----hHHHHHHHHhc--ccCCCc-----cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          350 IGGN-----RAKIQQKIVKD--KLRLPA-----FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       350 ~~~~-----~~~~~~~i~~~--~~~~p~-----~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ....     .......+...  ...+|.     .++.++.+||.+||+.||.+||++     .++++|
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~  325 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA-----LRVKKT  325 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH-----HHHHHH
T ss_pred             hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH-----HHHHHH
Confidence            5432     12222222222  223333     356779999999999999999998     888864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.1e-44  Score=354.22  Aligned_cols=243  Identities=24%  Similarity=0.337  Sum_probs=202.4

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeechhh-chhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEec
Q 047009          154 VLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFI  232 (482)
Q Consensus       154 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  232 (482)
                      ..+.||+|+||.||+|.+  +++.||+|++..... ......+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  112 (307)
T 2nru_A           35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM  112 (307)
T ss_dssp             TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence            347899999999999986  478899999875432 23345677889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC---CC
Q 047009          233 NGGHLFFQLYH---HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT---RS  306 (482)
Q Consensus       233 ~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~---~~  306 (482)
                      ++|+|..++..   ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   ..
T Consensus       113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  192 (307)
T 2nru_A          113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT  192 (307)
T ss_dssp             TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred             CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence            99999998864   3468999999999999999999999999999999999999999999999999998764322   23


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHH----HHHHHHhccc-----------CCCcc
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAK----IQQKIVKDKL-----------RLPAF  371 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~----~~~~i~~~~~-----------~~p~~  371 (482)
                      ....||+.|+|||++.+. ++.++||||||+++|+|++|+.||...+...    +...+.....           ..+..
T Consensus       193 ~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (307)
T 2nru_A          193 SRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST  271 (307)
T ss_dssp             SSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHH
T ss_pred             cccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchH
Confidence            346799999999998764 8899999999999999999999997755432    2222222111           12334


Q ss_pred             CChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       372 ~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+..+.++|.+||+.||.+||++     .++++
T Consensus       272 ~~~~l~~li~~cl~~~p~~Rps~-----~~l~~  299 (307)
T 2nru_A          272 SVEAMYSVASQCLHEKKNKRPDI-----KKVQQ  299 (307)
T ss_dssp             HHHHHHHHHHHHTCSSTTTSCCH-----HHHHH
T ss_pred             HHHHHHHHHHHHcCCCcccCcCH-----HHHHH
Confidence            56789999999999999999998     88875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.7e-45  Score=368.65  Aligned_cols=244  Identities=18%  Similarity=0.258  Sum_probs=195.9

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc-----hhhHHHHHHHHHHHHHhCC---------C----
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-----EKNHAEYMKAERDILTKID---------H----  209 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~---------h----  209 (482)
                      ..++|++++.||+|+||+||+|++  +|+.||||++.+....     .....+.+.+|+.+|+.++         |    
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            347899999999999999999998  5799999999876421     2233466788999998886         4    


Q ss_pred             -------------Cceeeeeeeeec-------------CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 047009          210 -------------PFVVQLKYSFQT-------------KYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV  263 (482)
Q Consensus       210 -------------pnIv~l~~~~~~-------------~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL  263 (482)
                                   |||++++++|.+             ...+|+||||+++|++...+.+ +.+++..++.++.||+.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence                         555555555544             7889999999999987766644 6789999999999999999


Q ss_pred             HHHH-HCCCcccCCCCCcEEEccCC--------------------ceeEcccCccccccCCCCCcccccCCCCCchhhhc
Q 047009          264 SHLH-ANGIMHRDLKPENILLGADG--------------------HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL  322 (482)
Q Consensus       264 ~yLH-~~~IiHrDLKp~NILl~~~g--------------------~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~  322 (482)
                      +||| ++||+||||||+|||++.+|                    .+||+|||+|+.....    ..+||+.|+|||++.
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence            9999 99999999999999999987                    8999999999986532    458999999999999


Q ss_pred             CCCCCchhHHHHHhHH-HHHHhhCCCCCCCCch-HHHHHHHHhc-cc--C----CCccCChHHHHHHHHhhccCcCCcCC
Q 047009          323 GKGHNKAADWWSVGIL-LYEMLTGKPPFIGGNR-AKIQQKIVKD-KL--R----LPAFLSSEAHSLLKGLLQKEPGKRLG  393 (482)
Q Consensus       323 ~~~~~~~sDvwSlGvi-lyelltG~~PF~~~~~-~~~~~~i~~~-~~--~----~p~~~s~~~~~LI~~~L~~dP~~R~s  393 (482)
                      +.. +.++||||||++ .+++++|..||.+... ......+... ..  .    .+..+++++++||++||++|     +
T Consensus       251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s  324 (336)
T 2vuw_A          251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S  324 (336)
T ss_dssp             CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred             CCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence            876 899999998777 7889999999954221 2233333322 11  1    12247899999999999977     6


Q ss_pred             CCCCChHHHH-hCcCCC
Q 047009          394 AGPKGSEEIK-SHKWFK  409 (482)
Q Consensus       394 ~~~~~~~eil-~hp~f~  409 (482)
                      +     +|++ +||||+
T Consensus       325 a-----~e~l~~Hp~f~  336 (336)
T 2vuw_A          325 A-----TDLLCQHSLFK  336 (336)
T ss_dssp             H-----HHHHHHCGGGC
T ss_pred             H-----HHHHhcCCCcC
Confidence            6     9999 999995

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.4e-44  Score=356.89  Aligned_cols=249  Identities=23%  Similarity=0.321  Sum_probs=210.3

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      .+..++|++.+.||+|+||.||+|+++.   .||+|++..... .....+.+.+|+.++++++||||+++++++.+...+
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            3556899999999999999999999865   399999876532 222334467899999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC--
Q 047009          226 YLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE--  302 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~--  302 (482)
                      ++||||+.|++|..++...+ .+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++....  
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            99999999999999987754 689999999999999999999999999999999999998 78999999999876431  


Q ss_pred             ----CCCCcccccCCCCCchhhhcC---------CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCC-
Q 047009          303 ----NTRSNSMIGTVEYMAPEIVLG---------KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL-  368 (482)
Q Consensus       303 ----~~~~~~~~gt~~y~APE~l~~---------~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~-  368 (482)
                          ........||+.|+|||++.+         ..++.++||||||+++|+|++|+.||.+.+.......+..+.... 
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  263 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL  263 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence                223344579999999999975         457899999999999999999999999988888877776654322 


Q ss_pred             -CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          369 -PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       369 -p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                       +..++.++.+||.+||..||.+||++     .++++
T Consensus       264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~l~~  295 (319)
T 2y4i_B          264 SQIGMGKEISDILLFCWAFEQEERPTF-----TKLMD  295 (319)
T ss_dssp             CCSSCCTTHHHHHHHHHCSSTTTSCCH-----HHHHH
T ss_pred             CcCCCCHHHHHHHHHHhcCChhhCcCH-----HHHHH
Confidence             23588999999999999999999998     88875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.4e-43  Score=383.44  Aligned_cols=251  Identities=24%  Similarity=0.384  Sum_probs=216.5

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCC---CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNT---SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      .+..++|++.+.||+|+||+||+|.+..+   +..||+|++....  .....+.+.+|+.++++++||||+++++++. .
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            44567899999999999999999998653   4679999986532  2344567889999999999999999999985 4


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      +.+|+||||+++|+|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            56899999999999999997654 68999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC--CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHH
Q 047009          302 ENTR--SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAH  377 (482)
Q Consensus       302 ~~~~--~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (482)
                      ....  .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+ ...+|..+++.+.
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  622 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  622 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHH
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence            4332  233457789999999999999999999999999999997 99999998888888887765 4567888999999


Q ss_pred             HHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          378 SLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       378 ~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +||.+||..||.+||++     .+|++
T Consensus       623 ~li~~~l~~dP~~RPs~-----~el~~  644 (656)
T 2j0j_A          623 SLMTKCWAYDPSRRPRF-----TELKA  644 (656)
T ss_dssp             HHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHcCCChhHCcCH-----HHHHH
Confidence            99999999999999998     78775

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.2e-43  Score=352.49  Aligned_cols=247  Identities=25%  Similarity=0.358  Sum_probs=205.0

Q ss_pred             cccCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHh--CCCCceeeeeeeeecC
Q 047009          145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK--IDHPFVVQLKYSFQTK  222 (482)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~  222 (482)
                      .....++|++.+.||+|+||.||+|++  +|+.||||++....      ...+.+|.+++..  ++||||+++++++...
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            334457899999999999999999998  47899999986542      3446678888887  7999999999999877


Q ss_pred             C----eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCcccCCCCCcEEEccCCcee
Q 047009          223 Y----RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH--------ANGIMHRDLKPENILLGADGHVM  290 (482)
Q Consensus       223 ~----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~IiHrDLKp~NILl~~~g~vK  290 (482)
                      .    .+|+||||+++|+|..++.+ ..+++..++.++.||+.||.|||        ++||+||||||+|||++.++.+|
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence            6    89999999999999999975 46899999999999999999999        89999999999999999999999


Q ss_pred             EcccCccccccCCC-----CCcccccCCCCCchhhhcCCC------CCchhHHHHHhHHHHHHhhC----------CCCC
Q 047009          291 LTDFGLAKQFDENT-----RSNSMIGTVEYMAPEIVLGKG------HNKAADWWSVGILLYEMLTG----------KPPF  349 (482)
Q Consensus       291 L~DFGla~~~~~~~-----~~~~~~gt~~y~APE~l~~~~------~~~~sDvwSlGvilyelltG----------~~PF  349 (482)
                      |+|||+++......     .....+||+.|+|||++.+..      ++.++|||||||++|||++|          +.||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            99999998765443     234568999999999998763      33689999999999999999          8899


Q ss_pred             CCCc-----hHHHHHHHHhcc--cCCCc-----cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          350 IGGN-----RAKIQQKIVKDK--LRLPA-----FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       350 ~~~~-----~~~~~~~i~~~~--~~~p~-----~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ....     ...+...+....  ..+|.     .++..+.+||.+||+.||.+||++     .++++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~~i~~~  330 (342)
T 1b6c_B          268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-----LRIKKT  330 (342)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH-----HHHHHH
T ss_pred             cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCH-----HHHHHH
Confidence            6642     344444444432  23332     234578999999999999999998     888864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5e-44  Score=371.57  Aligned_cols=251  Identities=18%  Similarity=0.159  Sum_probs=200.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCC-Ccee--------------
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH-PFVV--------------  213 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv--------------  213 (482)
                      ..+|.+.+.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.+.| +|..              
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3568999999999999999999999999999999885443333445678899999999987 2211              


Q ss_pred             -ee------eeeeec-----CCeEEEEEEecCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 047009          214 -QL------KYSFQT-----KYRLYLVLDFINGGHLFFQLYH-------HGLFREDLARIYAAEIVSAVSHLHANGIMHR  274 (482)
Q Consensus       214 -~l------~~~~~~-----~~~~~lV~E~~~gg~L~~~l~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHr  274 (482)
                       .+      ..++..     ...++++|+++ +++|.+++..       .+.+++..+..++.||+.||+|||++|||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence             11      111111     22467777766 5788877741       2347788888999999999999999999999


Q ss_pred             CCCCCcEEEccCCceeEcccCccccccCCCCCcccccCCCCCchhhh----------cCCCCCchhHHHHHhHHHHHHhh
Q 047009          275 DLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIV----------LGKGHNKAADWWSVGILLYEMLT  344 (482)
Q Consensus       275 DLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l----------~~~~~~~~sDvwSlGvilyellt  344 (482)
                      ||||+|||++.+|.+||+|||+++.....  ....+| +.|+|||++          .+..++.++|||||||++|||++
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            99999999999999999999999875433  456788 999999999          56678899999999999999999


Q ss_pred             CCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          345 GKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       345 G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      |+.||.+.+.......+..    ....+++++++||.+||+.||++||++     .++++||||+.+.
T Consensus       313 g~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~~~l~~~~~~~~~  371 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLP-----LQAMETPEYEQLR  371 (413)
T ss_dssp             SSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCH-----HHHTTSHHHHHHH
T ss_pred             CCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCH-----HHHHhCHHHHHHH
Confidence            9999988776554444433    224578999999999999999999998     9999999998764

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7.5e-42  Score=337.90  Aligned_cols=224  Identities=16%  Similarity=0.158  Sum_probs=189.5

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++.+.||+|+||.||+|++..+++.||||++...........+.+.+|+.++.+++||||+++++++.+.+..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            34478999999999999999999999999999999998765544556677889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      +||||++|++|.+++.. +. ....+..++.||+.||+|||++||+||||||+|||++.+|.+||+++|           
T Consensus       108 lv~e~~~g~~L~~~l~~-~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT-SP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTT-CC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             EEEEecCCCCHHHHHhc-CC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            99999999999999854 33 555678899999999999999999999999999999999999998543           


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHH---HHHhccc----CCCccCChHHHHH
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ---KIVKDKL----RLPAFLSSEAHSL  379 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~---~i~~~~~----~~p~~~s~~~~~L  379 (482)
                              |++       .++.++|||||||++|||++|+.||.+.+......   +...+..    .++..+++++++|
T Consensus       175 --------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  239 (286)
T 3uqc_A          175 --------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV  239 (286)
T ss_dssp             --------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHH
T ss_pred             --------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHH
Confidence                    333       37899999999999999999999998765432111   1111211    1235689999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHh
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      |.+||++||++| ++     .|+++
T Consensus       240 i~~~l~~dP~~R-s~-----~el~~  258 (286)
T 3uqc_A          240 AARSVQGDGGIR-SA-----STLLN  258 (286)
T ss_dssp             HHHHHCTTSSCC-CH-----HHHHH
T ss_pred             HHHHcccCCccC-CH-----HHHHH
Confidence            999999999999 88     78875

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.5e-42  Score=380.63  Aligned_cols=244  Identities=25%  Similarity=0.337  Sum_probs=202.9

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcC-CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe-
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKN-TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR-  224 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-  224 (482)
                      ...++|++.+.||+|+||.||+|.++. +|+.||||++....  .......+.+|+.++++++||||+++++++...+. 
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            445899999999999999999999976 78999999987542  23445667899999999999999999999987665 


Q ss_pred             ----EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccc
Q 047009          225 ----LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF  300 (482)
Q Consensus       225 ----~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~  300 (482)
                          .||||||++|++|...+..  .+++..++.++.||+.||.|||++|||||||||+|||++.+ .+||+|||+++..
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence                7999999999999887654  79999999999999999999999999999999999999875 9999999999876


Q ss_pred             cCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHH
Q 047009          301 DENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLL  380 (482)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI  380 (482)
                      ...   ...+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.....+.      ........++.+.+||
T Consensus       232 ~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------~~~~~~~~~~~l~~li  301 (681)
T 2pzi_A          232 NSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------EDDPVLKTYDSYGRLL  301 (681)
T ss_dssp             TCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------TTCHHHHHCHHHHHHH
T ss_pred             ccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc------ccccccccCHHHHHHH
Confidence            543   556899999999999775 489999999999999999999998653221100      0000012467899999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      .+||++||.+||+.     .+.+.|+|+.-
T Consensus       302 ~~~l~~dP~~R~~~-----~~~l~~~l~~~  326 (681)
T 2pzi_A          302 RRAIDPDPRQRFTT-----AEEMSAQLTGV  326 (681)
T ss_dssp             HHHTCSSGGGSCSS-----HHHHHHHHHHH
T ss_pred             hhhccCChhhCCCH-----HHHHHHHHHHH
Confidence            99999999999998     88888888753

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=4.9e-36  Score=323.49  Aligned_cols=190  Identities=16%  Similarity=0.141  Sum_probs=141.8

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhc-------hhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecCCeEEE
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-------EKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~-------~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ...+.|++|.+..++..-.|+.||+|++.++...       .....+.+.+|+++|+++ .|+||+++++++++++.+||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            3456788888888888888999999999875321       233456689999999999 79999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCC
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRS  306 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~  306 (482)
                      ||||++|++|.+++.+.+.+++.   .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.... ....
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            99999999999999999888765   4789999999999999999999999999999999999999999988654 3445


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCC
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPF  349 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF  349 (482)
                      .+.+||+.|||||++.+. +..++|+||+|+++|+|.+|..+|
T Consensus       397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             HHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             cCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence            678999999999999875 677899999999999988775543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=4.7e-30  Score=275.23  Aligned_cols=186  Identities=18%  Similarity=0.171  Sum_probs=148.2

Q ss_pred             EEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc-----hhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          153 EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV-----EKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       153 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      ...+.||+|+||+||+|+.  .++.+|+|+.......     .....+.+.+|+.+|++++||||+++..++......||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            3457899999999999943  4678999987553322     12234568899999999999999966666667777899


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC--
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR--  305 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~--  305 (482)
                      ||||++|++|.+++..        +..++.||+.||.|||++||+||||||+|||++.  ++||+|||+++.......  
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            9999999999998865        5688999999999999999999999999999998  999999999998754321  


Q ss_pred             ------CcccccCCCCCchhhhcC--CCCCchhHHHHHhHHHHHHhhCCCCCC
Q 047009          306 ------SNSMIGTVEYMAPEIVLG--KGHNKAADWWSVGILLYEMLTGKPPFI  350 (482)
Q Consensus       306 ------~~~~~gt~~y~APE~l~~--~~~~~~sDvwSlGvilyelltG~~PF~  350 (482)
                            ....+||+.|||||++.+  ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                  236789999999999987  678889999999999999888877763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=7.8e-27  Score=230.08  Aligned_cols=148  Identities=18%  Similarity=0.187  Sum_probs=119.8

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh---------------hHHHHHHHHHHHHHhCCCCceeee
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK---------------NHAEYMKAERDILTKIDHPFVVQL  215 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~---------------~~~~~~~~E~~il~~l~hpnIv~l  215 (482)
                      .|.+.+.||+|+||.||+|++ .+|+.||+|+++.......               .....+.+|+.+|++++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            455669999999999999999 7899999999975432111               23556889999999999  5 666


Q ss_pred             eeeeecCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccC
Q 047009          216 KYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFG  295 (482)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFG  295 (482)
                      .+++.. +..|+||||++||+|.. +      .......++.||+.||.|||++||+||||||+|||++ +|.+||+|||
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence            665544 55699999999999976 3      2234567999999999999999999999999999999 9999999999


Q ss_pred             ccccccCCCCCcccccCCCCCchhhhcC
Q 047009          296 LAKQFDENTRSNSMIGTVEYMAPEIVLG  323 (482)
Q Consensus       296 la~~~~~~~~~~~~~gt~~y~APE~l~~  323 (482)
                      +|+.            +..++|||++.+
T Consensus       238 ~a~~------------~~~~~a~e~l~r  253 (282)
T 1zar_A          238 QSVE------------VGEEGWREILER  253 (282)
T ss_dssp             TCEE------------TTSTTHHHHHHH
T ss_pred             CCeE------------CCCCCHHHHHHH
Confidence            9864            456899998853

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=4.9e-22  Score=192.98  Aligned_cols=140  Identities=19%  Similarity=0.157  Sum_probs=108.7

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeE--EEEEEeechhhch---------------------hhHHHHHHHHHHHHHhCC
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEI--YAMKVMRKDKIVE---------------------KNHAEYMKAERDILTKID  208 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAiK~~~~~~~~~---------------------~~~~~~~~~E~~il~~l~  208 (482)
                      |++.+.||+|+||.||+|.+..+|+.  ||||+++......                     ......+.+|+.+|.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999999777888  9999976532110                     112246788999999998


Q ss_pred             CCce--eeeeeeeecCCeEEEEEEecCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCc
Q 047009          209 HPFV--VQLKYSFQTKYRLYLVLDFING-G----HLFFQLYHHGLFREDLARIYAAEIVSAVSHLH-ANGIMHRDLKPEN  280 (482)
Q Consensus       209 hpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~IiHrDLKp~N  280 (482)
                      |+++  ..++..    ...+|||||+.+ |    .|......   .++..+..++.||+.||.||| ++||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            8764  333322    356899999942 4    56554322   235577889999999999999 9999999999999


Q ss_pred             EEEccCCceeEcccCccccc
Q 047009          281 ILLGADGHVMLTDFGLAKQF  300 (482)
Q Consensus       281 ILl~~~g~vKL~DFGla~~~  300 (482)
                      ||++.  .++|+|||+|...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99988  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=3.5e-19  Score=181.74  Aligned_cols=140  Identities=14%  Similarity=0.186  Sum_probs=100.0

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc------------hhh-------HHHHHHHHHHHHHhCCCCce
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV------------EKN-------HAEYMKAERDILTKIDHPFV  212 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~------------~~~-------~~~~~~~E~~il~~l~hpnI  212 (482)
                      |++.+.||+|+||.||+|.+. +|+.||||+++.....            ...       ..-...+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999985 5899999998643211            000       01122346666666644433


Q ss_pred             eeeeeeeecCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC-----
Q 047009          213 VQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG-----  287 (482)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g-----  287 (482)
                      . ....+... ..+|||||++|+.|....      ....+..++.||+.+|.|||++|||||||||.|||++.+|     
T Consensus       176 ~-vp~p~~~~-~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 P-VPEPIAQS-RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             S-CCCEEEEE-TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             C-CCeeeecc-CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            2 11111111 236999999998885432      2234567889999999999999999999999999999887     


Q ss_pred             -----ceeEcccCccccc
Q 047009          288 -----HVMLTDFGLAKQF  300 (482)
Q Consensus       288 -----~vKL~DFGla~~~  300 (482)
                           .+.|+||+-+...
T Consensus       248 ~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TSEEEEEEECCCTTCEET
T ss_pred             cccccceEEEEeCCcccC
Confidence                 3889999987653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.42  E-value=9e-13  Score=127.04  Aligned_cols=141  Identities=15%  Similarity=0.113  Sum_probs=111.4

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCCeEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~l  227 (482)
                      ++.|++...+|.|+.+.||++...  +..+++|+......   .....+.+|+.+++.+. +..+.++++++.+.+..|+
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            357899999999999999998744  57899999875321   11234778999999884 6677788898888889999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA---------------------------------------  268 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~---------------------------------------  268 (482)
                      ||||++|.+|...+     .+......++.+++.+|..||+                                       
T Consensus        88 v~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           88 LMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            99999999987642     1223345678899999999999                                       


Q ss_pred             --------------------CCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          269 --------------------NGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       269 --------------------~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                                          ..++|+|++|.|||++.++.+.|+||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                3489999999999998765667999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.29  E-value=4.9e-12  Score=120.92  Aligned_cols=136  Identities=13%  Similarity=0.107  Sum_probs=100.3

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCc--eeeeeeeeecCCeEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF--VVQLKYSFQTKYRLY  226 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~  226 (482)
                      ..+|.+....+.|..+.||++.. .+|..|++|+.....      ...+.+|+.+++.+.+.+  +.++++++...+..+
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence            35566655555667799999864 456789999976531      134678899998885444  456888888888899


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG------------------------------------  270 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------------  270 (482)
                      +||||++|.+|.  .   ....   ...++.+++..|..||+..                                    
T Consensus        92 ~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           92 LLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             EEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999999998883  1   1111   2345677788888888643                                    


Q ss_pred             ----------------------CcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          271 ----------------------IMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       271 ----------------------IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                                            ++|+|++|.|||++.++.+.|+|||.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                  99999999999998776677999999754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.17  E-value=6.7e-11  Score=119.49  Aligned_cols=140  Identities=15%  Similarity=0.276  Sum_probs=104.4

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEee--chhhchhhHHHHHHHHHHHHHhCCC--CceeeeeeeeecC---CeEE
Q 047009          154 VLKVVGQGAFGRVYQVRKKNTSEIYAMKVMR--KDKIVEKNHAEYMKAERDILTKIDH--PFVVQLKYSFQTK---YRLY  226 (482)
Q Consensus       154 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~--~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~---~~~~  226 (482)
                      .++.|+.|.++.||++...  +..+++|+..  .....  .....+.+|..+++.+..  ..+.+++.++.+.   +..|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            3577999999999998764  3578889876  33211  123457789999999873  4577788887766   4588


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA--------------------------------------  268 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~--------------------------------------  268 (482)
                      +||||++|..+....  ...+++.....++.+++.+|..||+                                      
T Consensus       118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999999998774311  2346778888899999999999997                                      


Q ss_pred             --------------------CCCcccCCCCCcEEEccCCc--eeEcccCcccc
Q 047009          269 --------------------NGIMHRDLKPENILLGADGH--VMLTDFGLAKQ  299 (482)
Q Consensus       269 --------------------~~IiHrDLKp~NILl~~~g~--vKL~DFGla~~  299 (482)
                                          ..++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                35899999999999998764  68999999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.12  E-value=6.1e-11  Score=117.03  Aligned_cols=179  Identities=19%  Similarity=0.275  Sum_probs=120.9

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCc--eeeeeeeeecCC---eEEEEE
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPF--VVQLKYSFQTKY---RLYLVL  229 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpn--Iv~l~~~~~~~~---~~~lV~  229 (482)
                      +.++.|....||++.     ..+++|+....     .....+.+|..+|+.+. +..  +.+++.......   ..|+||
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            458999999999863     35889986533     23456889999998873 322  233444433332   358999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA-----------------------------------------  268 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~-----------------------------------------  268 (482)
                      ++++|..|.....  ..++.++...++.+++..|..||+                                         
T Consensus        96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9999998865332  346777778888899998888886                                         


Q ss_pred             -----------------CCCcccCCCCCcEEEcc--CCceeEcccCccccccCCCCCcccccCCCC---CchhhhcC---
Q 047009          269 -----------------NGIMHRDLKPENILLGA--DGHVMLTDFGLAKQFDENTRSNSMIGTVEY---MAPEIVLG---  323 (482)
Q Consensus       269 -----------------~~IiHrDLKp~NILl~~--~g~vKL~DFGla~~~~~~~~~~~~~gt~~y---~APE~l~~---  323 (482)
                                       ..++|+|++|.||+++.  .+.+.|+||+.+.......   .......+   ..|+....   
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhccccCHHHHHHHHH
Confidence                             13699999999999998  4568899999987642211   01111111   23332211   


Q ss_pred             --CCC---------CchhHHHHHhHHHHHHhhCCCCC
Q 047009          324 --KGH---------NKAADWWSVGILLYEMLTGKPPF  349 (482)
Q Consensus       324 --~~~---------~~~sDvwSlGvilyelltG~~PF  349 (482)
                        ...         ..-.+.|++|.++|.+.+|..+|
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence              001         12368999999999999998877

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.61  E-value=4.7e-07  Score=89.37  Aligned_cols=133  Identities=17%  Similarity=0.202  Sum_probs=92.4

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCC---ceeeeeeeee-cCCeEEEEEEe
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP---FVVQLKYSFQ-TKYRLYLVLDF  231 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~-~~~~~~lV~E~  231 (482)
                      +.++.|....||++     |..+++|+....     .....+.+|..+|+.+.+.   .+.+.+.+.. ..+..++||||
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            55789999999987     456889985322     2345688999999998652   2344555553 45567899999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------
Q 047009          232 INGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN------------------------------------------  269 (482)
Q Consensus       232 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~------------------------------------------  269 (482)
                      ++|..+.....  ..++......++.++...|..||+.                                          
T Consensus        95 i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           95 VQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             CCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             cCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            99988765321  2234455555555565555555542                                          


Q ss_pred             ------------------CCcccCCCCCcEEEcc---CCce-eEcccCccccc
Q 047009          270 ------------------GIMHRDLKPENILLGA---DGHV-MLTDFGLAKQF  300 (482)
Q Consensus       270 ------------------~IiHrDLKp~NILl~~---~g~v-KL~DFGla~~~  300 (482)
                                        .++|+|++|.|||++.   ++.+ .|+||+.+...
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                              3589999999999987   4554 89999988753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.55  E-value=1.3e-06  Score=83.84  Aligned_cols=132  Identities=17%  Similarity=0.158  Sum_probs=93.4

Q ss_pred             ecccCce-EEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCC-CceeeeeeeeecCCeEEEEEEecCCC
Q 047009          158 VGQGAFG-RVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH-PFVVQLKYSFQTKYRLYLVLDFINGG  235 (482)
Q Consensus       158 LG~G~fg-~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg  235 (482)
                      +..|..| .||+......+..+.+|+-...      ....+.+|..+|+.+.. --+.+++.++.+.+..++|||+++|.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            4445444 7998887777788999986543      24457789999988742 22556778888889999999999998


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------------
Q 047009          236 HLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN----------------------------------------------  269 (482)
Q Consensus       236 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~----------------------------------------------  269 (482)
                      ++.......    ......+..++...|.-||+.                                              
T Consensus       106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            876554321    122233455555555556531                                              


Q ss_pred             ------------CCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          270 ------------GIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       270 ------------~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                                  .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                        158999999999999877777999998864

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.36  E-value=7.7e-07  Score=90.81  Aligned_cols=79  Identities=15%  Similarity=0.216  Sum_probs=48.6

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhh-chh---hHHHHHHHHHHHHHhCCC--Ccee-eeeeeeecCCeEEE
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKI-VEK---NHAEYMKAERDILTKIDH--PFVV-QLKYSFQTKYRLYL  227 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~-~~~---~~~~~~~~E~~il~~l~h--pnIv-~l~~~~~~~~~~~l  227 (482)
                      .+.||.|..+.||++....+++.|++|....... ...   ...+.+..|.++|+.+..  +..+ +++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            4679999999999997666677899998653211 000   122345678888887742  3333 44433  3345679


Q ss_pred             EEEecCCC
Q 047009          228 VLDFINGG  235 (482)
Q Consensus       228 V~E~~~gg  235 (482)
                      |||+++|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.16  E-value=1.8e-05  Score=78.22  Aligned_cols=136  Identities=14%  Similarity=0.161  Sum_probs=78.0

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-----CCCceeeee-e--eeecCCeEE
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-----DHPFVVQLK-Y--SFQTKYRLY  226 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~-~--~~~~~~~~~  226 (482)
                      ++.|+.|..+.||++...+  ..+++|+.....       ..+..|..+++.|     ..|.++... +  +....+..+
T Consensus        37 ~~~l~gG~~n~~~~v~~~~--~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~  107 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDS--GAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF  107 (346)
T ss_dssp             EEECC----CEEEEEEETT--EEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred             eeeccccccCcEEEEEeCC--CCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence            3557777889999987643  358999987521       1223344444444     234444321 1  123466789


Q ss_pred             EEEEecCCCchH--------------HHHHhc-CCC--C-----------HH--------H-------------------
Q 047009          227 LVLDFINGGHLF--------------FQLYHH-GLF--R-----------ED--------L-------------------  251 (482)
Q Consensus       227 lV~E~~~gg~L~--------------~~l~~~-~~l--~-----------~~--------~-------------------  251 (482)
                      +||+|++|..+.              ..+... ..+  +           +.        .                   
T Consensus       108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  187 (346)
T 2q83_A          108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL  187 (346)
T ss_dssp             EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred             EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence            999999986431              111110 001  0           00        0                   


Q ss_pred             ----HHHHHHHHHHHHHHHHH-------------CCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          252 ----ARIYAAEIVSAVSHLHA-------------NGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       252 ----~~~i~~qi~~aL~yLH~-------------~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                          ...+..++..++.+|++             ..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence                11112234446666653             5799999999999998888999999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.01  E-value=1.5e-05  Score=79.66  Aligned_cols=85  Identities=11%  Similarity=0.128  Sum_probs=53.6

Q ss_pred             EEEEEe-cccCceEEEEEEEc---C---CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCC---CceeeeeeeeecC
Q 047009          153 EVLKVV-GQGAFGRVYQVRKK---N---TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH---PFVVQLKYSFQTK  222 (482)
Q Consensus       153 ~i~~~L-G~G~fg~Vy~a~~~---~---~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~~~~~~~  222 (482)
                      ...+.| +.|....+|++...   .   ++..+++|+..............+.+|..+++.+..   -.+.+++.++.+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345678 88999999988754   1   156788998654320000001235678888877732   2455666666554


Q ss_pred             ---CeEEEEEEecCCCch
Q 047009          223 ---YRLYLVLDFINGGHL  237 (482)
Q Consensus       223 ---~~~~lV~E~~~gg~L  237 (482)
                         +..++||||++|..+
T Consensus       103 ~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTTSSCEEEEECCCCBCC
T ss_pred             CccCCceEEEEecCCCCh
Confidence               356899999998654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.84  E-value=6.2e-05  Score=77.32  Aligned_cols=77  Identities=10%  Similarity=0.119  Sum_probs=47.6

Q ss_pred             HCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCccccc--CCCCCchhhhcCCC---CCchhHHHHHhHHHHHH
Q 047009          268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG--TVEYMAPEIVLGKG---HNKAADWWSVGILLYEM  342 (482)
Q Consensus       268 ~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~g--t~~y~APE~l~~~~---~~~~sDvwSlGvilyel  342 (482)
                      ...++|+|++|.|||++.++ ++|+||+.+..-..........+  ...|++|+......   -....++......+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            45799999999999998877 99999999876321111111111  13456666553211   11234455777777777


Q ss_pred             hhC
Q 047009          343 LTG  345 (482)
Q Consensus       343 ltG  345 (482)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.77  E-value=0.00024  Score=70.15  Aligned_cols=75  Identities=13%  Similarity=0.154  Sum_probs=58.0

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC---CCceeeeeeeeecCCeEEEEEEe
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID---HPFVVQLKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV~E~  231 (482)
                      .+.|+.|....+|++..  ++..+++|+....      ....+..|...|+.|.   ...+.+++.+....+..++||||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            46789999999999874  3567889987643      2455778988888873   35677778877777889999999


Q ss_pred             cCCCch
Q 047009          232 INGGHL  237 (482)
Q Consensus       232 ~~gg~L  237 (482)
                      ++|..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.55  E-value=0.00012  Score=71.47  Aligned_cols=132  Identities=14%  Similarity=0.081  Sum_probs=72.6

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCce-eeeeeeeecCCeEEEEEEec-
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV-VQLKYSFQTKYRLYLVLDFI-  232 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~-  232 (482)
                      ++.|+.|....+|++      ..|++|+.......    .....+|..+++.+..-.+ .++++.+.+  .-++|+||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecC
Confidence            577899999999998      34889987653110    0112457777766632222 345444432  346899999 


Q ss_pred             CCCchHHH------------------HHhcC-CCC-----HHHHHHHHH--------------HHHHHHHHHH----H--
Q 047009          233 NGGHLFFQ------------------LYHHG-LFR-----EDLARIYAA--------------EIVSAVSHLH----A--  268 (482)
Q Consensus       233 ~gg~L~~~------------------l~~~~-~l~-----~~~~~~i~~--------------qi~~aL~yLH----~--  268 (482)
                      +|..+...                  +...+ .+.     ...+..+..              .+...+..|.    .  
T Consensus        91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~  170 (301)
T 3dxq_A           91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP  170 (301)
T ss_dssp             TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence            66544210                  01111 010     111111111              1111122221    1  


Q ss_pred             --CCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          269 --NGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       269 --~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                        ..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence              13799999999999 5677899999998865

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.48  E-value=0.00019  Score=70.40  Aligned_cols=140  Identities=18%  Similarity=0.195  Sum_probs=78.3

Q ss_pred             EEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-----CCceeeee-e--eeecCCe
Q 047009          153 EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-----HPFVVQLK-Y--SFQTKYR  224 (482)
Q Consensus       153 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l~-~--~~~~~~~  224 (482)
                      .-++.|+.|....+|++...+ | .+++|+.....     ..+.+..|..++..+.     -|.++... +  +....+.
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~   97 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR   97 (322)
T ss_dssp             EEEEEECC---EEEEEEEESS-C-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred             eEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence            345678889999999987643 3 58899987531     1123455777766653     23333211 1  1123456


Q ss_pred             EEEEEEecCCCchH--------------HHHHhc-CCC--------CHHHHHH---------------HHHHHHHHHHHH
Q 047009          225 LYLVLDFINGGHLF--------------FQLYHH-GLF--------REDLARI---------------YAAEIVSAVSHL  266 (482)
Q Consensus       225 ~~lV~E~~~gg~L~--------------~~l~~~-~~l--------~~~~~~~---------------i~~qi~~aL~yL  266 (482)
                      .+++|+|++|..+.              ..+... ..+        ....-..               +...+...++.|
T Consensus        98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l  177 (322)
T 2ppq_A           98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL  177 (322)
T ss_dssp             EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred             EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence            78999999986431              111111 001        0000000               011244455666


Q ss_pred             HH-------CCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          267 HA-------NGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       267 H~-------~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      ++       .+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            53       3699999999999998876668999998754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.39  E-value=0.0016  Score=60.53  Aligned_cols=121  Identities=17%  Similarity=0.090  Sum_probs=82.2

Q ss_pred             chHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccccCC
Q 047009          236 HLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTV  313 (482)
Q Consensus       236 ~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~  313 (482)
                      +|.+.|.. ..+++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|+|..+|.|-+.+ +.+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            77887765 4689999999999999999877622 2222344557999999999998774 1111           1223


Q ss_pred             CCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhcc
Q 047009          314 EYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       314 ~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~  386 (482)
                      .+.+||... ...+.+.=|||||+++|.-+--..|=                 .-+..+|+.+.+||..|..-
T Consensus       102 ~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          102 PPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             -----CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred             CCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence            466888763 44578899999999999988633321                 22456899999999999865

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.37  E-value=0.00082  Score=66.06  Aligned_cols=136  Identities=15%  Similarity=0.145  Sum_probs=76.5

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCc--eeeeeee-----eecCCeEEEE
Q 047009          156 KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF--VVQLKYS-----FQTKYRLYLV  228 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~-----~~~~~~~~lV  228 (482)
                      ..|+ |....||++... +|+.+++|+......    ....+..|..++..+....  +.+++..     ....+..++|
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            3466 888899987653 356799999864321    1234556777777663211  3333332     1234567899


Q ss_pred             EEecCCCchH----H-------H---HHh---c-C-----CCCHHHH----HHH---------------HHHHHHHHHHH
Q 047009          229 LDFINGGHLF----F-------Q---LYH---H-G-----LFREDLA----RIY---------------AAEIVSAVSHL  266 (482)
Q Consensus       229 ~E~~~gg~L~----~-------~---l~~---~-~-----~l~~~~~----~~i---------------~~qi~~aL~yL  266 (482)
                      |+|++|..+.    .       .   +..   . .     .+.....    ..+               ...+-..++.+
T Consensus       106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l  185 (328)
T 1zyl_A          106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  185 (328)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence            9999985431    0       0   111   0 0     1111100    001               11111223333


Q ss_pred             H-------HCCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          267 H-------ANGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       267 H-------~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      .       ...++|+|+++.|||++ + .+.|+||+.+..
T Consensus       186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            2       23589999999999998 4 899999998754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.30  E-value=0.00038  Score=70.64  Aligned_cols=136  Identities=15%  Similarity=0.154  Sum_probs=80.5

Q ss_pred             EEecccCceEEEEEEEcC-------CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCCeEEE
Q 047009          156 KVVGQGAFGRVYQVRKKN-------TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~l  227 (482)
                      +.|..|-...+|++....       +++.|.+|+.....    .....+.+|..+++.|. +.-..++++.+.+.    +
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPEG----R  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----E
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----c
Confidence            457778888899987642       35789999863311    12344568888888774 22235566666542    8


Q ss_pred             EEEecCCCchH--------------HHH---HhcC-----CC--CHHHHHHHHHHHHH-------------------HHH
Q 047009          228 VLDFINGGHLF--------------FQL---YHHG-----LF--REDLARIYAAEIVS-------------------AVS  264 (482)
Q Consensus       228 V~E~~~gg~L~--------------~~l---~~~~-----~l--~~~~~~~i~~qi~~-------------------aL~  264 (482)
                      ||||++|..|.              ..|   ....     ..  -..++..+..++-.                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            99999986442              111   1110     11  13445555544422                   233


Q ss_pred             HHHH----C----CCcccCCCCCcEEEccC----CceeEcccCcccc
Q 047009          265 HLHA----N----GIMHRDLKPENILLGAD----GHVMLTDFGLAKQ  299 (482)
Q Consensus       265 yLH~----~----~IiHrDLKp~NILl~~~----g~vKL~DFGla~~  299 (482)
                      .|.+    .    .++|+|+.+.|||++.+    +.+.|+||..|..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3332    2    48999999999999887    7899999998854

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.28  E-value=0.0017  Score=62.83  Aligned_cols=79  Identities=14%  Similarity=0.084  Sum_probs=52.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCC---ceeeeeeeeecCCeEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP---FVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~~~~~~~l  227 (482)
                      ...-++.+|.|..+.||+++.. +|+.|.+|+......   .....+..|...|+.|.--   .+.+++...    .-++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence            3455788999999999999875 478899998654321   1223467899988887421   233344332    2368


Q ss_pred             EEEecCCCch
Q 047009          228 VLDFINGGHL  237 (482)
Q Consensus       228 V~E~~~gg~L  237 (482)
                      ||||+.++..
T Consensus        88 v~e~l~~~~~   97 (288)
T 3f7w_A           88 AMEWVDERPP   97 (288)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeecccCC
Confidence            9999987643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.27  E-value=0.0008  Score=69.37  Aligned_cols=73  Identities=14%  Similarity=0.151  Sum_probs=48.6

Q ss_pred             EEEecccCceEEEEEEEcC-------CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCce-eeeeeeeecCCeEE
Q 047009          155 LKVVGQGAFGRVYQVRKKN-------TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV-VQLKYSFQTKYRLY  226 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~  226 (482)
                      ++.|+.|....||++....       .+..|.+|+.....     ..+.+.+|..+++.+...++ .++++.+.+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            4678889999999998753       25689999984321     11234468888887743333 556666543    2


Q ss_pred             EEEEecCCCc
Q 047009          227 LVLDFINGGH  236 (482)
Q Consensus       227 lV~E~~~gg~  236 (482)
                      +|+||++|..
T Consensus       149 ~v~e~l~G~~  158 (429)
T 1nw1_A          149 RLEEYIPSRP  158 (429)
T ss_dssp             EEECCCCEEE
T ss_pred             EEEEEeCCcc
Confidence            8999998743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.18  E-value=0.0005  Score=69.08  Aligned_cols=74  Identities=14%  Similarity=0.139  Sum_probs=42.9

Q ss_pred             EEEecccCceEEEEEEEcC--------CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCc-eeeeeeeeecCCeE
Q 047009          155 LKVVGQGAFGRVYQVRKKN--------TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF-VVQLKYSFQTKYRL  225 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~  225 (482)
                      ++.|+.|....+|++...+        .+..|++|+......    .......|..+++.+...+ ..++++.+.  +  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~~--~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTFN--G--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEecC--C--
Confidence            4568888889999988653        136788998764321    1111356777777764323 335555442  2  


Q ss_pred             EEEEEecCCCc
Q 047009          226 YLVLDFINGGH  236 (482)
Q Consensus       226 ~lV~E~~~gg~  236 (482)
                      ++||||++|..
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            68999999854

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.17  E-value=0.00081  Score=66.43  Aligned_cols=32  Identities=31%  Similarity=0.348  Sum_probs=27.7

Q ss_pred             CCCcccCCCCCcEEEccC----CceeEcccCccccc
Q 047009          269 NGIMHRDLKPENILLGAD----GHVMLTDFGLAKQF  300 (482)
Q Consensus       269 ~~IiHrDLKp~NILl~~~----g~vKL~DFGla~~~  300 (482)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999875    67999999998753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.04  E-value=0.0041  Score=61.80  Aligned_cols=31  Identities=19%  Similarity=0.424  Sum_probs=27.8

Q ss_pred             CCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       269 ~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3599999999999999888999999988765

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.88  E-value=0.0042  Score=64.57  Aligned_cols=75  Identities=12%  Similarity=0.228  Sum_probs=48.7

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCce-eeeeeeeecCCeEEEEEEecC
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV-VQLKYSFQTKYRLYLVLDFIN  233 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~  233 (482)
                      ++.|+.|-...+|++...+.+..|++|+.....   .... ...+|..+++.|...++ .++++.+..    .+||||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeC
Confidence            467888999999999876555789999875421   0111 12578888888865444 456676632    25999998


Q ss_pred             CCch
Q 047009          234 GGHL  237 (482)
Q Consensus       234 gg~L  237 (482)
                      |..|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.92  E-value=0.013  Score=60.22  Aligned_cols=75  Identities=17%  Similarity=0.199  Sum_probs=46.8

Q ss_pred             EEEecccCceEEEEEEEcCC-------CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCCeEE
Q 047009          155 LKVVGQGAFGRVYQVRKKNT-------SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~  226 (482)
                      ++.|..|-...+|++.....       ++.|++|+.....    ...-...+|..+++.+. +.-..++++.+.  +  +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADFP--E--G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence            46677788899999887531       5779999865421    11111346777777774 222344555443  2  6


Q ss_pred             EEEEecCCCch
Q 047009          227 LVLDFINGGHL  237 (482)
Q Consensus       227 lV~E~~~gg~L  237 (482)
                      +||||++|..|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.79  E-value=0.11  Score=52.74  Aligned_cols=29  Identities=34%  Similarity=0.529  Sum_probs=24.9

Q ss_pred             CcccCCCCCcEEE------ccCCceeEcccCcccc
Q 047009          271 IMHRDLKPENILL------GADGHVMLTDFGLAKQ  299 (482)
Q Consensus       271 IiHrDLKp~NILl------~~~g~vKL~DFGla~~  299 (482)
                      ++|+|+.+.|||+      +.++.+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4467799999998864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.83  E-value=2.5  Score=38.88  Aligned_cols=138  Identities=16%  Similarity=0.172  Sum_probs=85.7

Q ss_pred             EEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHH
Q 047009          179 AMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAE  258 (482)
Q Consensus       179 AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~q  258 (482)
                      -++.+.+..+...+.     .|+.+| ...||+++.. .+-.+.+.+.+.++.-+.+.-+..+   ..++....++++.+
T Consensus        20 ~~~~~~ks~ik~~~~-----~el~LL-~~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~n   89 (215)
T 4ann_A           20 DMREIPKSSIKPEHF-----HLMYLL-EQHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLN   89 (215)
T ss_dssp             CEEEEEGGGSCGGGG-----GGGGGG-GSCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHH
T ss_pred             HHHHhcHhhccccCH-----HHHHHH-hccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHH
Confidence            356666665543322     222222 3368888765 4455666766666654433223333   23567777888888


Q ss_pred             HHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHH
Q 047009          259 IVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGIL  338 (482)
Q Consensus       259 i~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvi  338 (482)
                      |+....+++.  -+|--|.|+||+++.++.+++.--|+-..+.                |.     ..+...=+-.+=|+
T Consensus        90 i~~l~~~~~~--r~tf~L~P~NL~f~~~~~p~i~~RGik~~l~----------------P~-----~~~ee~fL~qyKAl  146 (215)
T 4ann_A           90 IKNLEEVNRT--RYTFVLAPDELFFTRDGLPIAKTRGLQNVVD----------------PL-----PVSEAEFLTRYKAL  146 (215)
T ss_dssp             GGGGGGGGGS--SEECCCSGGGEEECTTSCEEESCCEETTTBS----------------CC-----CCCHHHHHHHHHHH
T ss_pred             HHHHHHHhcC--ceEEEEecceEEEcCCCCEEEEEccCccCCC----------------CC-----CCCHHHHHHHHHHH
Confidence            8887755543  3788899999999999999998777643321                11     12222223347788


Q ss_pred             HHHHhhCCCCC
Q 047009          339 LYEMLTGKPPF  349 (482)
Q Consensus       339 lyelltG~~PF  349 (482)
                      +..+++++..|
T Consensus       147 iiall~~K~~F  157 (215)
T 4ann_A          147 VICAFNEKQSF  157 (215)
T ss_dssp             HHHHHCTTCCH
T ss_pred             HHHHHcCCCCH
Confidence            88999998887

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	482
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-107
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-104
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-100
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-100
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-97
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-97
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-94
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-88
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-87
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-84
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-84
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-84
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-83
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-83
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-83
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-82
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-82
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-81
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-80
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-78
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-77
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-73
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-73
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-71
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-69
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-69
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-68
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-68
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-67
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-67
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-66
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-66
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-65
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-64
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-64
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-63
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-63
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-63
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-62
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-62
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-62
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-62
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-61
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-61
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-60
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-58
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-57
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-57
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-57
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-56
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-48
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-44
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-20

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  319 bits (817), Expect = e-107
 Identities = 126/333 (37%), Positives = 203/333 (60%), Gaps = 11/333 (3%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           V + DF+ LK++G+G FG+V  VR+K T   YAMK++RK+ I+ K+   +   E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
             HPF+  LKY+FQT  RL  V+++ NGG LFF L    +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKG 325
           H+  +++RD+K EN++L  DGH+ +TDFGL K+   +     +  GT EY+APE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G+++YEM+ G+ PF   +  ++ + I+ +++R P  LS EA SLL GLL+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241

Query: 386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDM 445
           K+P +RLG GP  ++E+  H++F  INW+ +  +++ P F P+V  +     F+ ++T  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 301

Query: 446 PLSDSPAATP----------KNNTNPFADFSYV 468
            ++ +P              +     F DF Y+
Sbjct: 302 SITITPPDRYDSLGLLELDQREEQEMFEDFDYI 334

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  311 bits (798), Expect = e-104
 Identities = 123/324 (37%), Positives = 195/324 (60%), Gaps = 9/324 (2%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK-I 207
           IEDF + K++G+G+FG+V+    K T++ +A+K ++KD ++  +  E    E+ +L+   
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           +HPF+  +  +FQTK  L+ V++++NGG L + +     F    A  YAAEI+  +  LH
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQF-DENTRSNSMIGTVEYMAPEIVLGKGH 326
           + GI++RDLK +NILL  DGH+ + DFG+ K+    + ++N+  GT +Y+APEI+LG+ +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
           N + DWWS G+LLYEML G+ PF G +  ++   I  D    P +L  EA  LL  L  +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240

Query: 387 EPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMP 446
           EP KRLG       +I+ H  F+ INW++LE +EI P F P+V      +NF+K++ +  
Sbjct: 241 EPEKRLGV----RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEK 296

Query: 447 LSDSPAATPKNNT---NPFADFSY 467
              S A     N+   N F +FS+
Sbjct: 297 PRLSFADRALINSMDQNMFRNFSF 320

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  301 bits (772), Expect = e-100
 Identities = 119/318 (37%), Positives = 197/318 (61%), Gaps = 5/318 (1%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++DF++L+ +G G+FGRV+ +R ++    YAMKV++K+ +V     E+   ER +L+ + 
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HPF++++  +FQ   ++++++D+I GG LF  L     F   +A+ YAAE+  A+ +LH+
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             I++RDLKPENILL  +GH+ +TDFG AK   + T   ++ GT +Y+APE+V  K +NK
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVVSTKPYNK 180

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
           + DWWS GIL+YEML G  PF   N  K  +KI+  +LR P F + +   LL  L+ ++ 
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL 240

Query: 389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVA-GKHCIANFEKKWTDMPL 447
            +RLG    G+E++K+H WFK + W+KL +R I+  + P +  G+   + F+ K+ +  +
Sbjct: 241 SQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFD-KYPEEDI 299

Query: 448 SDSPAATPKNNTNPFADF 465
           +           + F DF
Sbjct: 300 NYGVQGEDPYA-DLFRDF 316

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  300 bits (770), Expect = e-100
 Identities = 108/275 (39%), Positives = 168/275 (61%), Gaps = 4/275 (1%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           EDF+  K++G+G+F  V   R+  TS  YA+K++ K  I+++N   Y+  ERD+++++DH
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   +   G F E   R Y AEIVSA+ +LH  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQF---DENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPENILL  D H+ +TDFG AK      +  R+NS +GT +Y++PE++  K  
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++Y+++ G PPF  GN   I QKI+K +   P     +A  L++ LL  
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247

Query: 387 EPGKRLGAG-PKGSEEIKSHKWFKPINWKKLEARE 420
           +  KRLG    +G   +K+H +F+ + W+ L  + 
Sbjct: 248 DATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  294 bits (754), Expect = 4e-97
 Identities = 125/343 (36%), Positives = 204/343 (59%), Gaps = 7/343 (2%)

Query: 124 TVKEIDESSIDENVK-GDSVTVCCVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKV 182
           +VKE    + ++ +K  ++ +     ++ F+ +K +G G+FGRV  V+ K +   YAMK+
Sbjct: 14  SVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI 73

Query: 183 MRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY 242
           + K K+V+    E+   E+ IL  ++ PF+V+L++SF+    LY+V++++ GG +F  L 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133

Query: 243 HHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE 302
             G F E  AR YAA+IV    +LH+  +++RDLKPEN+L+   G++ +TDFG AK+   
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-- 191

Query: 303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIV 362
             R+ ++ GT E +APEI+L KG+NKA DWW++G+L+YEM  G PPF      +I +KIV
Sbjct: 192 KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

Query: 363 KDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQ 422
             K+R P+  SS+   LL+ LLQ +  KR G    G  +IK+HKWF   +W  +  R+++
Sbjct: 252 SGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVE 311

Query: 423 PGFCPEVAGKHCIANFEKKWTDMPLSDSPAATPKNNTNPFADF 465
             F P+  G    +NF+  + +  +  S     +     F +F
Sbjct: 312 APFIPKFKGPGDTSNFD-DYEEEEIRVSI---NEKCGKEFTEF 350

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  294 bits (754), Expect = 6e-97
 Identities = 109/332 (32%), Positives = 182/332 (54%), Gaps = 19/332 (5%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAER---DILT 205
           + DF V +++G+G FG VY  RK +T ++YAMK + K +I  K        ER    +++
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             D PF+V + Y+F T  +L  +LD +NGG L + L  HG+F E   R YAAEI+  + H
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL-GK 324
           +H   +++RDLKP NILL   GHV ++D GLA  F    + ++ +GT  YMAPE++  G 
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGV 181

Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGN---RAKIQQKIVKDKLRLPAFLSSEAHSLLK 381
            ++ +ADW+S+G +L+++L G  PF       + +I +  +   + LP   S E  SLL+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241

Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHC-----IA 436
           GLLQ++  +RLG   +G++E+K   +F+ ++W+ +  ++  P   P     +      I 
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIG 301

Query: 437 NFEKKWTDMPLSDSPAATPKNNTNPFADFSYV 468
           +F+++ T              +   + +F   
Sbjct: 302 SFDEEDTKGIKLLDS------DQELYRNFPLT 327

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  283 bits (726), Expect = 4e-94
 Identities = 83/261 (31%), Positives = 148/261 (56%), Gaps = 6/261 (2%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +EDFE+ + +G+G FG VY  R+K +  I A+KV+ K ++ +      ++ E +I + + 
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           HP +++L   F    R+YL+L++   G ++ +L     F E     Y  E+ +A+S+ H+
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
             ++HRD+KPEN+LLG+ G + + DFG +     ++R  ++ GT++Y+ PE++ G+ H++
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDE 183

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP 388
             D WS+G+L YE L GKPPF      +  ++I + +   P F++  A  L+  LL+  P
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 243

Query: 389 GKRLGAGPKGSEEIKSHKWFK 409
            +R         E+  H W  
Sbjct: 244 SQRPML-----REVLEHPWIT 259

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  270 bits (690), Expect = 7e-88
 Identities = 142/296 (47%), Positives = 201/296 (67%), Gaps = 13/296 (4%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVEKNHA-EYMKAERD 202
           VGIE+FE+LKV+G GA+G+V+ VRK    +T ++YAMKV++K  IV+K    E+ + ER 
Sbjct: 21  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80

Query: 203 ILTKIDH-PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVS 261
           +L  I   PF+V L Y+FQT+ +L+L+LD+INGG LF  L     F E   +IY  EIV 
Sbjct: 81  VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD--ENTRSNSMIGTVEYMAPE 319
           A+ HLH  GI++RD+K ENILL ++GHV+LTDFGL+K+F   E  R+    GT+EYMAP+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 320 IVLGK--GHNKAADWWSVGILLYEMLTGKPPFIGGNR----AKIQQKIVKDKLRLPAFLS 373
           IV G   GH+KA DWWS+G+L+YE+LTG  PF         A+I ++I+K +   P  +S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260

Query: 374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEV 429
           + A  L++ LL K+P KRLG GP+ ++EIK H +F+ INW  L A+++   F P +
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVI 316

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  270 bits (691), Expect = 1e-87
 Identities = 80/316 (25%), Positives = 141/316 (44%), Gaps = 21/316 (6%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ +++ + +G GAFG V++V ++ T   +A K +      +K   E ++ E   ++ + 
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLR 81

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V L  +F+    + ++ +F++GG LF ++   H    ED A  Y  ++   + H+H
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 268 ANGIMHRDLKPENILLGAD--GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
            N  +H DLKPENI+        + L DFGL    D         GT E+ APE+  GK 
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 201

Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLK 381
                D WSVG+L Y +L+G  PF G N  +  + +      +     + +S +    ++
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261

Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKK 441
            LL  +P  R+        +   H W  P N    +  +I      ++       + + K
Sbjct: 262 KLLLADPNTRMTI-----HQALEHPWLTPGNAPGRD-SQIPSSRYTKI-----RDSIKTK 310

Query: 442 WTDMPLSDSPAATPKN 457
           +   P    P     N
Sbjct: 311 YDAWPEPLPPLGRISN 326

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  260 bits (666), Expect = 3e-84
 Identities = 66/313 (21%), Positives = 132/313 (42%), Gaps = 53/313 (16%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +DFE +  +G G  G V++V  K +  + A K++  +   +      +  E  +L + + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNS 63

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH-A 268
           P++V    +F +   + + ++ ++GG L   L   G   E +    +  ++  +++L   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNK 328
           + IMHRD+KP NIL+ + G + L DFG++ Q   ++ +NS +GT  YM+PE + G  ++ 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 182

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF----------------- 371
            +D WS+G+ L EM  G+ P    +  +++           A                  
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242

Query: 372 ---------------------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS 404
                                       S E    +   L K P +R        +++  
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL-----KQLMV 297

Query: 405 HKWFKPINWKKLE 417
           H + K  + ++++
Sbjct: 298 HAFIKRSDAEEVD 310

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  259 bits (662), Expect = 3e-84
 Identities = 85/277 (30%), Positives = 138/277 (49%), Gaps = 18/277 (6%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + +E++  +G GAFG+VY+ + K TS + A KV+       +   E    E DIL   DH
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDH 68

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLARIYAAEIVSAVSHLHA 268
           P +V+L  +F  +  L+++++F  GG +   +        E   ++   + + A+++LH 
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSNSMIGTVEYMAPEIVLG---- 323
           N I+HRDLK  NIL   DG + L DFG++ +      R +S IGT  +MAPE+V+     
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 324 -KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSL 379
            + ++  AD WS+GI L EM   +PP    N  ++  KI K +   L  P+  SS     
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248

Query: 380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKL 416
           LK  L+K    R         ++  H +    + K +
Sbjct: 249 LKKCLEKNVDARWTT-----SQLLQHPFVTVDSNKPI 280

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  258 bits (660), Expect = 4e-84
 Identities = 81/268 (30%), Positives = 140/268 (52%), Gaps = 14/268 (5%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +ED+++++ +G+GA+G V     + T E  A+K++   + V+    E +K E  I   ++
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLN 61

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           H  VV+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS---NSMIGTVEYMAPEIVLGKG 325
            GI HRD+KPEN+LL    ++ ++DFGLA  F  N R    N M GT+ Y+APE++  + 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 326 -HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---LRLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   + +  +    K+K   L     + S   +LL 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241

Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
            +L + P  R+        +IK  +W+ 
Sbjct: 242 KILVENPSARITI-----PDIKKDRWYN 264

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  259 bits (664), Expect = 1e-83
 Identities = 90/328 (27%), Positives = 153/328 (46%), Gaps = 29/328 (8%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
            + +++L+ +G GAFG V++  +K T  ++  K +     ++K     +K E  I+ ++ 
Sbjct: 28  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLH 84

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL-FREDLARIYAAEIVSAVSHLH 267
           HP ++ L  +F+ KY + L+L+F++GG LF ++        E     Y  +    + H+H
Sbjct: 85  HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144

Query: 268 ANGIMHRDLKPENILL--GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
            + I+H D+KPENI+        V + DFGLA + + +        T E+ APEIV  + 
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 204

Query: 326 HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLK 381
                D W++G+L Y +L+G  PF G +  +  Q + +          + +S EA   +K
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264

Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKK 441
            LLQKEP KRL        +   H W K  +   L +R       P           ++K
Sbjct: 265 NLLQKEPRKRLTV-----HDALEHPWLKG-DHSNLTSRI------PSSRYNKIRQKIKEK 312

Query: 442 WTDMPLSDSPAATPKNNTNPFADFSYVR 469
           + D P        P+      A+FS +R
Sbjct: 313 YADWP-------APQPAIGRIANFSSLR 333

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  255 bits (653), Expect = 5e-83
 Identities = 84/277 (30%), Positives = 131/277 (47%), Gaps = 22/277 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMK------AERDI 203
           E++E  +++G+G    V +   K T + YA+K++        +  E  +       E DI
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 204 LTKI-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
           L K+  HP ++QLK +++T    +LV D +  G LF  L       E   R     ++  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           +  LH   I+HRDLKPENILL  D ++ LTDFG + Q D   +   + GT  Y+APEI+ 
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182

Query: 323 G------KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFL 372
                   G+ K  D WS G+++Y +L G PPF    +  + + I+    +         
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242

Query: 373 SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           S     L+   L  +P KR  A     EE  +H +F+
Sbjct: 243 SDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQ 274

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  256 bits (654), Expect = 6e-83
 Identities = 79/264 (29%), Positives = 133/264 (50%), Gaps = 13/264 (4%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + +   + +GQGA G VY      T +  A++ M   +  +K   E +  E  ++ +  +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +V    S+     L++V++++ GG L   +       E        E + A+  LH+N
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTRSNSMIGTVEYMAPEIVLGKGHNK 328
            ++HRD+K +NILLG DG V LTDFG   Q   E ++ ++M+GT  +MAPE+V  K +  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQ 385
             D WS+GI+  EM+ G+PP++  N  +    I  +   +L+ P  LS+     L   L 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 386 KEPGKRLGAGPKGSEEIKSHKWFK 409
            +  KR  A     +E+  H++ K
Sbjct: 256 MDVEKRGSA-----KELLQHQFLK 274

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  256 bits (654), Expect = 1e-82
 Identities = 70/265 (26%), Positives = 116/265 (43%), Gaps = 13/265 (4%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + F  L+ +G G+FG VY  R    SE+ A+K M           + +  E   L K+ H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P  +Q +  +  ++  +LV+++  G        H    +E          +  +++LH++
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG---KGH 326
            ++HRD+K  NILL   G V L DFG A        +NS +GT  +MAPE++L      +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQY 191

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAFLSSEAHSLLKGLL 384
           +   D WS+GI   E+   KPP    N       I +++         S    + +   L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251

Query: 385 QKEPGKRLGAGPKGSEEIKSHKWFK 409
           QK P  R  +     E +  H++  
Sbjct: 252 QKIPQDRPTS-----EVLLKHRFVL 271

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  255 bits (651), Expect = 2e-82
 Identities = 81/287 (28%), Positives = 139/287 (48%), Gaps = 17/287 (5%)

Query: 149 IED-FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKA---ERDIL 204
           ++D ++  + +G G F  V + R+K+T   YA K ++K +          +    E  IL
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67

Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVS 264
            +I HP V+ L   ++ K  + L+L+ + GG LF  L       E+ A  +  +I++ V 
Sbjct: 68  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127

Query: 265 HLHANGIMHRDLKPENILLGADG----HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
           +LH+  I H DLKPENI+L         + + DFGLA + D      ++ GT E++APEI
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187

Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEA 376
           V  +     AD WS+G++ Y +L+G  PF+G  + +    +            +  S+ A
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 247

Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQP 423
              ++ LL K+P KR+       ++   H W KP + ++  +     
Sbjct: 248 KDFIRRLLVKDPKKRMTI-----QDSLQHPWIKPKDTQQALSSAWSH 289

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  253 bits (646), Expect = 2e-81
 Identities = 88/287 (30%), Positives = 149/287 (51%), Gaps = 17/287 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + ++   V+G GAF  V     K T ++ A+K + K  +  +     M+ E  +L KI H
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
           P +V L   +++   LYL++  ++GG LF ++   G + E  A     +++ AV +LH  
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 270 GIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           GI+HRDLKPEN+L      D  +M++DFGL+K  D  +  ++  GT  Y+APE++  K +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 186

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLKG 382
           +KA D WS+G++ Y +L G PPF   N AK+ ++I+K +    +     +S  A   ++ 
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEV 429
           L++K+P KR        E+   H W           + I      ++
Sbjct: 247 LMEKDPEKRFTC-----EQALQHPWIA---GDTALDKNIHQSVSEQI 285

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (637), Expect = 1e-80
 Identities = 74/271 (27%), Positives = 135/271 (49%), Gaps = 19/271 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           ED+EVL  +G G++GR  ++R+K+  +I   K +    + E    + + +E ++L ++ H
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKH 62

Query: 210 PFVVQLKYSF--QTKYRLYLVLDFINGGHLFFQLYHH----GLFREDLARIYAAEIVSAV 263
           P +V+       +T   LY+V+++  GG L   +           E+       ++  A+
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 264 SHLH-----ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSNSMIGTVEYMA 317
              H      + ++HRDLKP N+ L    +V L DFGLA+  + + + + + +GT  YM+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSEA 376
           PE +    +N+ +D WS+G LLYE+    PPF   ++ ++  KI + K  R+P   S E 
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 242

Query: 377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKW 407
           + ++  +L  +   R        EEI  +  
Sbjct: 243 NEIITRMLNLKDYHRPSV-----EEILENPL 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (623), Expect = 7e-78
 Identities = 69/280 (24%), Positives = 127/280 (45%), Gaps = 17/280 (6%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E + + + +G+G FG V++  + ++ + Y  K ++     +      +K E  IL    H
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL-FREDLARIYAAEIVSAVSHLHA 268
             ++ L  SF++   L ++ +FI+G  +F ++        E     Y  ++  A+  LH+
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 269 NGIMHRDLKPENILLGAD--GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGH 326
           + I H D++PENI+        + + +FG A+Q         +    EY APE+      
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 327 NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLKG 382
           + A D WS+G L+Y +L+G  PF+     +I + I+  +          +S EA   +  
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQ 422
           LL KE   R+ A      E   H W K    +++  + I+
Sbjct: 241 LLVKERKSRMTA-----SEALQHPWLKQ-KIERVSTKVIR 274

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (614), Expect = 4e-77
 Identities = 63/268 (23%), Positives = 128/268 (47%), Gaps = 18/268 (6%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
            +    +G+G+F  VY+     T+   A   ++  K+  K+  +  K E ++L  + HP 
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPN 69

Query: 212 VVQLKYSFQT----KYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           +V+   S+++    K  + LV + +  G L   L    + +  + R +  +I+  +  LH
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 268 ANG--IMHRDLKPENILL-GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGK 324
                I+HRDLK +NI + G  G V + D GLA      + + ++IGT E+MAPE+   K
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEEK 188

Query: 325 GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR---LPAFLSSEAHSLLK 381
            ++++ D ++ G+ + EM T + P+     A    + V   ++          E   +++
Sbjct: 189 -YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 247

Query: 382 GLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           G +++   +R        +++ +H +F+
Sbjct: 248 GCIRQNKDERYSI-----KDLLNHAFFQ 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  230 bits (588), Expect = 3e-73
 Identities = 68/257 (26%), Positives = 131/257 (50%), Gaps = 12/257 (4%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + +E+ +++G G    V+  R        A+KV+R D   + +     + E      ++H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 210 PFVVQLKYSFQTK----YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
           P +V +  + + +       Y+V+++++G  L   ++  G      A    A+   A++ 
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF----DENTRSNSMIGTVEYMAPEIV 321
            H NGI+HRD+KP NI++ A   V + DFG+A+      +  T++ ++IGT +Y++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 322 LGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF----LSSEAH 377
            G   +  +D +S+G +LYE+LTG+PPF G +   +  + V++    P+     LS++  
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246

Query: 378 SLLKGLLQKEPGKRLGA 394
           +++   L K P  R   
Sbjct: 247 AVVLKALAKNPENRYQT 263

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (586), Expect = 5e-73
 Identities = 79/279 (28%), Positives = 133/279 (47%), Gaps = 21/279 (7%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKN---HAEYMKAERDILTKI 207
            ++V  ++G G FG VY   + + +   A+K + KD+I +     +   +  E  +L K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 208 D--HPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQ-LYHHGLFREDLARIYAAEIVSAVS 264
                 V++L   F+      L+L+        F  +   G  +E+LAR +  +++ AV 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 265 HLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG 323
           H H  G++HRD+K ENIL+  + G + L DFG       +T      GT  Y  PE +  
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRY 183

Query: 324 -KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKG 382
            + H ++A  WS+GILLY+M+ G  PF          +I++ ++     +SSE   L++ 
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRW 237

Query: 383 LLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREI 421
            L   P  R        EEI++H W + +   + E  EI
Sbjct: 238 CLALRPSDRPTF-----EEIQNHPWMQDVLLPQ-ETAEI 270

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 9e-71
 Identities = 77/280 (27%), Positives = 140/280 (50%), Gaps = 32/280 (11%)

Query: 149 IEDFEVL-KVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI 207
           I+D++V  +V+G G  G+V Q+  K T E +A+K+++      +        E ++  + 
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA 61

Query: 208 -DHPFVVQLKYSFQTKYR----LYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIV 260
              P +V++   ++  Y     L +V++ ++GG LF ++   G   F E  A      I 
Sbjct: 62  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121

Query: 261 SAVSHLHANGIMHRDLKPENILL---GADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
            A+ +LH+  I HRD+KPEN+L      +  + LTDFG AK+   +    +   T  Y+A
Sbjct: 122 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 181

Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN----RAKIQQKIVKDKLRLP---- 369
           PE++  + ++K+ D WS+G+++Y +L G PPF   +       ++ +I   +   P    
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241

Query: 370 AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
           + +S E   L++ LL+ EP +R+        E  +H W  
Sbjct: 242 SEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIM 276

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (564), Expect = 1e-69
 Identities = 62/255 (24%), Positives = 108/255 (42%), Gaps = 18/255 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
               V + +G G+FG VY+ +        A+K++       +    +   E  +L K  H
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRH 63

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLARIYAAEIVSAVSHLHA 268
             ++     + T  +L +V  +  G  L+  L+     F        A +    + +LHA
Sbjct: 64  VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE---NTRSNSMIGTVEYMAPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA        + +   + G++ +MAPE++  + 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 326 HNK---AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF------LSSEA 376
            N     +D ++ GI+LYE++TG+ P+   N       +V      P             
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242

Query: 377 HSLLKGLLQKEPGKR 391
             L+   L+K+  +R
Sbjct: 243 KRLMAECLKKKRDER 257

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (560), Expect = 7e-69
 Identities = 76/289 (26%), Positives = 123/289 (42%), Gaps = 37/289 (12%)

Query: 153 EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHA--EYMKAERDILTKIDHP 210
           E L  +G+G F  VY+ R KNT++I A+K ++     E           E  +L ++ HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG 270
            ++ L  +F  K  + LV DF+          +  +      + Y    +  + +LH + 
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 271 IMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLG-KGHNK 328
           I+HRDLKP N+LL  +G + L DFGLAK F    R+ +  + T  Y APE++ G + +  
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180

Query: 329 AADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK-----------DKLRLPAF------ 371
             D W+VG +L E+L   P   G +      +I +           D   LP +      
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240

Query: 372 -----------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
                         +   L++GL    P  R+ A      +    K+F 
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-----TQALKMKYFS 284

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (555), Expect = 1e-68
 Identities = 64/267 (23%), Positives = 124/267 (46%), Gaps = 16/267 (5%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           + +++ ++L+ +G+G FG V     +      A+K ++ D   +        AE  ++T+
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQA-----FLAEASVMTQ 56

Query: 207 IDHPFVVQLK-YSFQTKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAV 263
           + H  +VQL     + K  LY+V +++  G L   L   G  +   D    ++ ++  A+
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG 323
            +L  N  +HRDL   N+L+  D    ++DFGL K+       ++    V++ APE +  
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE 174

Query: 324 KGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLK 381
           K  +  +D WS GILL+E+ + G+ P+       +  ++ K  K+  P       + ++K
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234

Query: 382 GLLQKEPGKRLGAGP--KGSEEIKSHK 406
                +   R       +  E IK+H+
Sbjct: 235 NCWHLDAAMRPSFLQLREQLEHIKTHE 261

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 8e-68
 Identities = 73/306 (23%), Positives = 125/306 (40%), Gaps = 41/306 (13%)

Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVR-KKNTSEIYAMKVMRKDKIVEKNHAEYMK--AERD 202
           C   + +E +  +G+GA+G+V++ R  KN     A+K +R     E      ++  A   
Sbjct: 3   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62

Query: 203 ILTKIDHPFVVQLKYSFQT-----KYRLYLVLDFINGGHL-FFQLYHHGLFREDLARIYA 256
            L   +HP VV+L           + +L LV + ++     +           +  +   
Sbjct: 63  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYM 316
            +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +       S++ T+ Y 
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 182

Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK------------- 363
           APE++L   +    D WSVG +  EM   KP F G +      KI+              
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 364 --------------DKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
                            +    +      LL   L   P KR+ A         SH +F+
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----YSALSHPYFQ 297

Query: 410 PINWKK 415
            +   K
Sbjct: 298 DLERCK 303

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 2e-67
 Identities = 66/258 (25%), Positives = 117/258 (45%), Gaps = 12/258 (4%)

Query: 145 CCVGIEDFEVLKVVGQGAFGRVYQVRKKNTS---EIYAMKVMRKDKIVEKNHAEYMKAER 201
           C +G +D  +L+ +G G+FG V +      S      A+K ++ D + +    +    E 
Sbjct: 3   CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62

Query: 202 DILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLARIYAAEIV 260
           + +  +DH  +++L Y       + +V +    G L  +L  H G F       YA ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 261 SAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEYM 316
             + +L +   +HRDL   N+LL     V + DFGL +   +N               + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKLRL--PAFLS 373
           APE +  +  + A+D W  G+ L+EM T G+ P+IG N ++I  KI K+  RL  P    
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241

Query: 374 SEAHSLLKGLLQKEPGKR 391
            + ++++      +P  R
Sbjct: 242 QDIYNVMVQCWAHKPEDR 259

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 5e-67
 Identities = 71/310 (22%), Positives = 119/310 (38%), Gaps = 52/310 (16%)

Query: 146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT 205
           C  +  +E L  +GQG FG V++ R + T +  A+K +  +   E      ++ E  IL 
Sbjct: 6   CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQ 64

Query: 206 KIDHPFVVQLKYSFQT--------KYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
            + H  VV L    +T        K  +YLV DF               F     +    
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRS-----NSMIGT 312
            +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F     S      + + T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 313 VEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP-- 369
           + Y  PE++LG + +    D W  G ++ EM T  P   G         I +    +   
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 370 ------------------------------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGS 399
                                               A  L+  LL  +P +R+ +     
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS----- 299

Query: 400 EEIKSHKWFK 409
           ++  +H +F 
Sbjct: 300 DDALNHDFFW 309

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (547), Expect = 3e-66
 Identities = 81/307 (26%), Positives = 138/307 (44%), Gaps = 52/307 (16%)

Query: 151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP 210
            +   KV+G G+FG VYQ +  ++ E+ A+K + +DK        +   E  I+ K+DH 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHC 73

Query: 211 FVVQLKYSFQT------KYRLYLVLDFINGGHLFFQLYH---HGLFREDLARIYAAEIVS 261
            +V+L+Y F +      +  L LVLD++         ++            ++Y  ++  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 262 AVSHLHANGIMHRDLKPENILLGADGHVM-LTDFGLAKQFDENTRSNSMIGTVEYMAPEI 320
           +++++H+ GI HRD+KP+N+LL  D  V+ L DFG AKQ      + S I +  Y APE+
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193

Query: 321 VLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK---------------- 363
           + G   +  + D WS G +L E+L G+P F G +      +I+K                
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 364 -DKLRLPAF------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP 410
             + + P                 EA +L   LL+  P  RL        E  +H +F  
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP-----LEACAHSFFDE 308

Query: 411 INWKKLE 417
           +    ++
Sbjct: 309 LRDPNVK 315

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 4e-66
 Identities = 80/296 (27%), Positives = 144/296 (48%), Gaps = 38/296 (12%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           +E+F+ ++ +G+G +G VY+ R K T E+ A+K +R D   E   +  ++ E  +L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFIN-GGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR-SNSMIGTVEYMAPEIVLGKGH 326
           ++ ++HRDLKP+N+L+  +G + L DFGLA+ F    R     + T+ Y APEI+LG  +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 327 N-KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK---------------------- 363
              A D WS+G +  EM+T +  F G +      +I +                      
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 364 -------DKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN 412
                  D  ++   L  +  SLL  +L  +P KR+ A     +   +H +F+ + 
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-----KAALAHPFFQDVT 290

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 1e-65
 Identities = 54/266 (20%), Positives = 117/266 (43%), Gaps = 12/266 (4%)

Query: 156 KVVGQGAFGRVYQV--RKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVV 213
           K +G G FG V +   + K   +  A+K+++ +   +    + + AE +++ ++D+P++V
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 71

Query: 214 QLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMH 273
           ++           LV++    G L   L  +   ++        ++   + +L  +  +H
Sbjct: 72  RM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130

Query: 274 RDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEYMAPEIVLGKGHNKA 329
           RDL   N+LL    +  ++DFGL+K    +             V++ APE +     +  
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190

Query: 330 ADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLKGLLQKE 387
           +D WS G+L++E  + G+ P+ G   +++   + K + +  PA    E + L+      +
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD 250

Query: 388 PGKRLGAGPKGSEEIKSHKWFKPINW 413
              R G      E    + ++  +N 
Sbjct: 251 VENRPGF--AAVELRLRNYYYDVVNE 274

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 9e-65
 Identities = 55/261 (21%), Positives = 119/261 (45%), Gaps = 15/261 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           +D   LK +G G FG V   + +   +  A+K++++  + E         E  ++  + H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDE----FIEEAKVMMNLSH 58

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHA 268
             +VQL      +  ++++ +++  G L   L      F+         ++  A+ +L +
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGH 326
              +HRDL   N L+   G V ++DFGL++    DE T S      V +  PE+++    
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 327 NKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLL 384
           +  +D W+ G+L++E+ + GK P+     ++  + I +  +L  P   S + ++++    
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238

Query: 385 QKEPGKRLGAGPKGSEEIKSH 405
            ++  +R        + + S+
Sbjct: 239 HEKADERPTF-----KILLSN 254

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  208 bits (529), Expect = 2e-64
 Identities = 72/291 (24%), Positives = 132/291 (45%), Gaps = 38/291 (13%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E +  L+ +G+G +G VY+ +     E +A+K +R +K  E   +  ++ E  IL ++ H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR-EISILKELKH 59

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
             +V+L     TK RL LV + ++           G      A+ +  ++++ +++ H  
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSNSMIGTVEYMAPEIVLGKG-HN 327
            ++HRDLKP+N+L+  +G + + DFGLA+ F     +    I T+ Y AP++++G   ++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 328 KAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVK------------------------ 363
              D WSVG +  EM+ G P F G + A    +I +                        
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 364 -----DKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
                        L      LL  +L+ +P +R+ A     ++   H +FK
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-----KQALEHAYFK 285

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 5e-64
 Identities = 67/292 (22%), Positives = 134/292 (45%), Gaps = 38/292 (13%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           + +E L+ +G+G +G V++ + + T EI A+K +R D   E   +  ++ E  +L ++ H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKH 60

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHAN 269
             +V+L     +  +L LV +F +     +    +G    ++ + +  +++  +   H+ 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 270 GIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSM-IGTVEYMAPEIVLGKG-HN 327
            ++HRDLKP+N+L+  +G + L +FGLA+ F    R  S  + T+ Y  P+++ G   ++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 328 KAADWWSVGILLYEMLTGK-PPFIGGNRAKIQQKIVK----------------------- 363
            + D WS G +  E+     P F G +     ++I +                       
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 364 ------DKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
                   + +   L++    LL+ LL+  P +R+ A     EE   H +F 
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-----EEALQHPYFS 287

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (525), Expect = 1e-63
 Identities = 59/257 (22%), Positives = 113/257 (43%), Gaps = 14/257 (5%)

Query: 147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSE---IYAMKVMRKDKIVEKNHAEYMKAERDI 203
           + I   ++ +V+G G FG V     K   +     A+K ++      +       +E  I
Sbjct: 23  IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASI 80

Query: 204 LTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSA 262
           + + DHP V+ L+        + ++ +F+  G L  F   + G F           I + 
Sbjct: 81  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN------TRSNSMIGTVEYM 316
           + +L     +HRDL   NIL+ ++    ++DFGL++  +++      T +      + + 
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 317 APEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSS 374
           APE +  +    A+D WS GI+++E+++ G+ P+       +   I +D +L  P    S
Sbjct: 201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS 260

Query: 375 EAHSLLKGLLQKEPGKR 391
             H L+    QK+   R
Sbjct: 261 ALHQLMLDCWQKDRNHR 277

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 3e-63
 Identities = 59/252 (23%), Positives = 111/252 (44%), Gaps = 13/252 (5%)

Query: 150 EDFEVLKVV-GQGAFGRVYQV--RKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK 206
           ++  +  +  G G FG V Q   R +      A+KV+++    EK   E M  E  I+ +
Sbjct: 8   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQ 65

Query: 207 IDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLY-HHGLFREDLARIYAAEIVSAVSH 265
           +D+P++V+L    Q    L LV++   GG L   L                 ++   + +
Sbjct: 66  LDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 124

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEYMAPEIV 321
           L     +HRDL   N+LL    +  ++DFGL+K    +    T  ++    +++ APE +
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184

Query: 322 LGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSL 379
             +  +  +D WS G+ ++E L+ G+ P+      ++   I + K +  P     E ++L
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 244

Query: 380 LKGLLQKEPGKR 391
           +      +   R
Sbjct: 245 MSDCWIYKWEDR 256

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 3e-63
 Identities = 60/262 (22%), Positives = 116/262 (44%), Gaps = 19/262 (7%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI- 207
             D +   V+G+G FG+V + R K         + R  +   K+       E ++L K+ 
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68

Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH----------------GLFREDL 251
            HP ++ L  + + +  LYL +++   G+L   L                          
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 252 ARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIG 311
              +AA++   + +L     +HRDL   NIL+G +    + DFGL++  +   +      
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 188

Query: 312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLP 369
            V +MA E +    +   +D WS G+LL+E+++ G  P+ G   A++ +K+ +  +L  P
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 248

Query: 370 AFLSSEAHSLLKGLLQKEPGKR 391
                E + L++   +++P +R
Sbjct: 249 LNCDDEVYDLMRQCWREKPYER 270

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 3e-63
 Identities = 57/247 (23%), Positives = 120/247 (48%), Gaps = 10/247 (4%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
            +   ++ +G G FG V+     N  +  A+K +R+  + E++       E +++ K+ H
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEED----FIEEAEVMMKLSH 59

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSAVSHLHA 268
           P +VQL      +  + LV +F+  G L  +     GLF  +       ++   +++L  
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119

Query: 269 NGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKGH 326
             ++HRDL   N L+G +  + ++DFG+ +    D+ T S      V++ +PE+     +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 327 NKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLL 384
           +  +D WS G+L++E+ + GK P+   + +++ + I    +L  P   S+  + ++    
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239

Query: 385 QKEPGKR 391
           ++ P  R
Sbjct: 240 KERPEDR 246

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 4e-63
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 19/268 (7%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E   +   +GQG FG V+      T+   A+K ++   +  +        E  ++ K+ H
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA----FLQEAQVMKKLRH 71

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLH 267
             +VQL Y+  ++  +Y+V ++++ G L   L        R       AA+I S ++++ 
Sbjct: 72  EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+G +    + DFGLA+  ++N  T        +++ APE  L   
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E+ T G+ P+ G    ++  ++ +  ++  P       H L+   
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250

Query: 384 LQKEPGKRLGAGPKGSEEIKS--HKWFK 409
            +KEP +R        E +++    +F 
Sbjct: 251 WRKEPEERPTF-----EYLQAFLEDYFT 273

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (519), Expect = 6e-63
 Identities = 68/279 (24%), Positives = 127/279 (45%), Gaps = 17/279 (6%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
            D  +   +G G +G VY+   K  S   A+K +++D +      E    E  ++ +I H
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 72

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLH 267
           P +VQL      +   Y++ +F+  G+L   L           +    A +I SA+ +L 
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQF--DENTRSNSMIGTVEYMAPEIVLGKG 325
               +HRDL   N L+G +  V + DFGL++    D  T        +++ APE +    
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192

Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
            +  +D W+ G+LL+E+ T G  P+ G + +++ + + KD ++  P     + + L++  
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 252

Query: 384 LQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQ 422
            Q  P  R         EI  H+ F+ +  +   + E++
Sbjct: 253 WQWNPSDRPSF-----AEI--HQAFETMFQESSISDEVE 284

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 1e-62
 Identities = 78/306 (25%), Positives = 128/306 (41%), Gaps = 48/306 (15%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
             +  L+ VG GA+G V       T    A+K + +    E       + E  +L  + H
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRH 76

Query: 210 PFVVQLKYSFQTK------YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAV 263
             V+ L   F            YLV+ F+  G    +L  H    ED  +    +++  +
Sbjct: 77  ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134

Query: 264 SHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG 323
            ++HA GI+HRDLKP N+ +  D  + + DFGLA+Q D        + T  Y APE++L 
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTRWYRAPEVILN 192

Query: 324 -KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAF----------- 371
              + +  D WSVG ++ EM+TGK  F G +     ++I+K     PA            
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

Query: 372 --------------------LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI 411
                                S  A +LL+ +L  +  +R+ A      E  +H +F+ +
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-----GEALAHPYFESL 307

Query: 412 NWKKLE 417
           +  + E
Sbjct: 308 HDTEDE 313

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 2e-62
 Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 7/249 (2%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRK--DKIVEKNHAEYMKAERDILTKI 207
            +F+ +KV+G GAFG VY+       E   + V  K   +       + +  E  ++  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 208 DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           D+P V +L     T     +      G  L +   H           +  +I   +++L 
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIGTVEYMAPEIVLGK 324
              ++HRDL   N+L+    HV +TDFGLAK          +      +++MA E +L +
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188

Query: 325 GHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLLKG 382
            +   +D WS G+ ++E++T G  P+ G   ++I   + K + L  P   + + + ++  
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 248

Query: 383 LLQKEPGKR 391
               +   R
Sbjct: 249 CWMIDADSR 257

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  204 bits (519), Expect = 2e-62
 Identities = 63/308 (20%), Positives = 122/308 (39%), Gaps = 57/308 (18%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI- 207
            +D+++++ +G+G +  V++      +E   +K+++  K       + +K E  IL  + 
Sbjct: 34  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLR 87

Query: 208 DHPFVVQLKYSFQ--TKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             P ++ L    +        LV + +N          +    +   R Y  EI+ A+ +
Sbjct: 88  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFK---QLYQTLTDYDIRFYMYEILKALDY 144

Query: 266 LHANGIMHRDLKPENILLGADG-HVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLG- 323
            H+ GIMHRD+KP N+++  +   + L D+GLA+ +      N  + +  +  PE+++  
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204

Query: 324 KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP-------------- 369
           + ++ + D WS+G +L  M+  K PF  G+    Q   +   L                 
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264

Query: 370 ------------------------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH 405
                                     +S EA   L  LL+ +   RL A      E   H
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA-----REAMEH 319

Query: 406 KWFKPINW 413
            +F  +  
Sbjct: 320 PYFYTVVK 327

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 3e-62
 Identities = 56/248 (22%), Positives = 119/248 (47%), Gaps = 12/248 (4%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E  ++++ +G G FG V+       ++  A+K +++  +          AE +++ ++ H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDA----FLAEANLMKQLQH 67

Query: 210 PFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARI--YAAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++   AA+I   ++ + 
Sbjct: 68  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--RSNSMIGTVEYMAPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N           +++ APE +    
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246

Query: 384 LQKEPGKR 391
            ++ P  R
Sbjct: 247 WKERPEDR 254

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 4e-62
 Identities = 60/291 (20%), Positives = 119/291 (40%), Gaps = 42/291 (14%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEI-----YAMKVMRKDKIVEKNHAEYMKAERDIL 204
           E+ E  KV+G GAFG+V        S+       A+K++++    + +  E + +E  ++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMM 94

Query: 205 TKI-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHH------------------- 244
           T++  H  +V L  +      +YL+ ++   G L   L                      
Sbjct: 95  TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 245 ----GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF 300
                +   +    +A ++   +  L     +HRDL   N+L+     V + DFGLA+  
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 301 DEN---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAK 356
             +       +    V++MAPE +    +   +D WS GILL+E+ + G  P+ G     
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 357 IQQKIVKDKLRL--PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH 405
              K++++  ++  P + + E + +++     +  KR          + S 
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF-----PNLTSF 320

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 1e-61
 Identities = 58/262 (22%), Positives = 121/262 (46%), Gaps = 12/262 (4%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSE-IYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           E  E+ + +G+G FG V+Q    +      A+ +         +  E    E   + + D
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 209 HPFVVQLKYSFQTKYRLYLVLDFINGGHLF-FQLYHHGLFREDLARIYAAEIVSAVSHLH 267
           HP +V+L     T+  ++++++    G L  F              +YA ++ +A+++L 
Sbjct: 67  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 268 ANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--TRSNSMIGTVEYMAPEIVLGKG 325
           +   +HRD+   N+L+ ++  V L DFGL++  +++   +++     +++MAPE +  + 
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185

Query: 326 HNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVK-DKLRLPAFLSSEAHSLLKGL 383
              A+D W  G+ ++E+L  G  PF G     +  +I   ++L +P       +SL+   
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKC 245

Query: 384 LQKEPGKRLGAGPKGSEEIKSH 405
              +P +R         E+K+ 
Sbjct: 246 WAYDPSRRPRF-----TELKAQ 262

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 5e-61
 Identities = 69/299 (23%), Positives = 118/299 (39%), Gaps = 50/299 (16%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF 211
           +  L  +G+GA+G V            A+K +   +   + + +    E  IL +  H  
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHEN 67

Query: 212 VVQLKYSFQTKY-----RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHL 266
           ++ +    +         +YLV   +      ++L        D    +  +I+  + ++
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADL--YKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 267 HANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEYMAPEIVL 322
           H+  ++HRDLKP N+LL     + + DFGLA+  D +          + T  Y APEI+L
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 323 -GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL--------------- 366
             KG+ K+ D WSVG +L EML+ +P F G +       I+                   
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245

Query: 367 ----------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
                           RL     S+A  LL  +L   P KR+       E+  +H + +
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV-----EQALAHPYLE 299

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  198 bits (504), Expect = 1e-60
 Identities = 52/295 (17%), Positives = 108/295 (36%), Gaps = 38/295 (12%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHP- 210
           + + + +G G+FG +Y        E  A+K+        +     +  E  I   +    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGV 63

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG 270
            +  +++         +V++ +         +    F      + A +++S + ++H+  
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 271 IMHRDLKPENIL---LGADGHVMLTDFGLAKQFDENT--------RSNSMIGTVEYMAPE 319
            +HRD+KP+N L         V + DFGLAK++ +           + ++ GT  Y +  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 320 IVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR--------LPAF 371
             LG   ++  D  S+G +L     G  P+ G   A  +QK  +   +        L   
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243

Query: 372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSE--EIKSHKWFK-------PINWKKLE 417
             SE  + L          +    P  S   ++  + + +         +W  L+
Sbjct: 244 YPSEFATYLNFCRSLRFDDK----PDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 294

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (487), Expect = 5e-58
 Identities = 53/276 (19%), Positives = 111/276 (40%), Gaps = 36/276 (13%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
            + E ++ +G+GAFGRV+Q R           + A+K+++++     +     + E  ++
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 70

Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL------------------ 246
            + D+P +V+L         + L+ +++  G L   L                       
Sbjct: 71  AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 247 ------FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQF 300
                          A ++ + +++L     +HRDL   N L+G +  V + DFGL++  
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 301 DEN---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAK 356
                     +    + +M PE +    +   +D W+ G++L+E+ + G  P+ G    +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 357 IQQKIVKDK-LRLPAFLSSEAHSLLKGLLQKEPGKR 391
           +   +     L  P     E ++L++    K P  R
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 286

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 1e-57
 Identities = 68/328 (20%), Positives = 125/328 (38%), Gaps = 59/328 (17%)

Query: 149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID 208
           ++ ++ LK +G GA G V            A+K + +     + HA+    E  ++  ++
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN 74

Query: 209 HPFVVQLKYSFQTK------YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSA 262
           H  ++ L   F  +        +YLV++ ++                +       +++  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCG 131

Query: 263 VSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +      + T  Y APE++L
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 323 GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP------------- 369
           G G+ +  D WSVG ++ EM+  K  F G +      K+++                   
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 370 -----------------------------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSE 400
                                           +S+A  LL  +L  +P KR+       +
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-----D 306

Query: 401 EIKSHKWFKPINWKKLEAREIQPGFCPE 428
           +   H +     W      E  P    +
Sbjct: 307 DALQHPYIN--VWYDPAEVEAPPPQIYD 332

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  190 bits (483), Expect = 2e-57
 Identities = 46/262 (17%), Positives = 99/262 (37%), Gaps = 27/262 (10%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH-P 210
           ++V + +G+G+FG +++      ++  A+K   +     +     ++ E      +    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-----LRDEYRTYKLLAGCT 61

Query: 211 FVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG 270
            +  + Y  Q      LV+D +              F      + A ++++ V  +H   
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 271 IMHRDLKPENILLGA-----DGHVMLTDFGLAKQFDE--------NTRSNSMIGTVEYMA 317
           +++RD+KP+N L+G         + + DFG+ K + +             ++ GT  YM+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 318 PEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR--------LP 369
               LG+  ++  D  ++G +    L G  P+ G   A  +QK  +   +        L 
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 370 AFLSSEAHSLLKGLLQKEPGKR 391
           A    E +  +           
Sbjct: 242 AGFPEEFYKYMHYARNLAFDAT 263

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 5e-57
 Identities = 57/272 (20%), Positives = 109/272 (40%), Gaps = 32/272 (11%)

Query: 150 EDFEVLKVVGQGAFGRVYQVR-----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
                 K +G GAFG+V +       K + +   A+K+++          E + +E  +L
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVL 80

Query: 205 TKI-DHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL----------------- 246
           + + +H  +V L  +        ++ ++   G L   L                      
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 247 -FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-- 303
               +    ++ ++   ++ L +   +HRDL   NILL       + DFGLA+    +  
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 304 -TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKI 361
                +    V++MAPE +    +   +D WS GI L+E+ + G  P+ G        K+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 362 VKDKLRL--PAFLSSEAHSLLKGLLQKEPGKR 391
           +K+  R+  P    +E + ++K     +P KR
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-56
 Identities = 72/296 (24%), Positives = 118/296 (39%), Gaps = 44/296 (14%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
           E ++ L  VG GA+G V       T    A+K + +       HA+    E  +L  + H
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKH 76

Query: 210 PFVVQLKYSFQTKYRL----YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             V+ L   F     L     + L     G     +       +D  +    +I+  + +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 266 LHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKG 325
           +H+  I+HRDLKP N+ +  D  + + DFGLA+  D+       + T  Y APEI+L   
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 194

Query: 326 H-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFL------------ 372
           H N+  D WSVG ++ E+LTG+  F G +     + I++      A L            
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254

Query: 373 -------------------SSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFK 409
                              +  A  LL+ +L  +  KR+ A      +  +H +F 
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-----AQALAHAYFA 305

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-56
 Identities = 54/253 (21%), Positives = 104/253 (41%), Gaps = 13/253 (5%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSE----IYAMKVMRKDKIVEKNHAEYMKAERDILT 205
                 KV+G G FG VY+   K +S       A+K ++      +        E  I+ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMG 64

Query: 206 KIDHPFVVQLKYSFQTKYRLYLVLDFINGG-HLFFQLYHHGLFREDLARIYAAEIVSAVS 264
           +  H  +++L+        + ++ +++  G    F     G F           I + + 
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 265 HLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN----TRSNSMIGTVEYMAPEI 320
           +L     +HRDL   NIL+ ++    ++DFGL++  +++      ++     + + APE 
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 321 VLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--PAFLSSEAHS 378
           +  +    A+D WS GI+++E++T               K + D  RL  P    S  + 
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244

Query: 379 LLKGLLQKEPGKR 391
           L+    Q+E  +R
Sbjct: 245 LMMQCWQQERARR 257

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-53
 Identities = 53/270 (19%), Positives = 117/270 (43%), Gaps = 29/270 (10%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSE-------IYAMKVMRKDKIVEKNHAEYMKAERD 202
           +   + K +G+GAFG+V         +         A+K+++ D   EK+ ++ +     
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEM 71

Query: 203 ILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGL---------------- 246
           +     H  ++ L  +      LY+++++ + G+L   L                     
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 247 FREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--- 303
                    A ++   + +L +   +HRDL   N+L+  D  + + DFGLA+        
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIV 362
            ++ +    V++MAPE +  + +   +D WS G+LL+E+ T G  P+ G    ++ + + 
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 363 KD-KLRLPAFLSSEAHSLLKGLLQKEPGKR 391
           +  ++  P+  ++E + +++      P +R
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 3e-53
 Identities = 61/278 (21%), Positives = 111/278 (39%), Gaps = 17/278 (6%)

Query: 128 IDESSIDENVKGDSVTVCCVGIEDFEV--LKVVGQGAFGRVYQVR---KKNTSEIYAMKV 182
           ID S+++  +   +V    +G     V   +V+G+G FG VY              A+K 
Sbjct: 4   IDLSALNPELV-QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62

Query: 183 MRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLK-YSFQTKYRLYLVLDFINGGHLF-FQ 240
           + +    +         E  I+    HP V+ L     +++    +VL ++  G L  F 
Sbjct: 63  LNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120

Query: 241 LYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAK-- 298
                         +  ++   +  L +   +HRDL   N +L     V + DFGLA+  
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180

Query: 299 ---QFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNR 354
              +FD           V++MA E +  +     +D WS G+LL+E++T G PP+   N 
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 240

Query: 355 AKIQQKIVKDK-LRLPAFLSSEAHSLLKGLLQKEPGKR 391
             I   +++ + L  P +     + ++      +   R
Sbjct: 241 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 278

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 8e-53
 Identities = 61/284 (21%), Positives = 117/284 (41%), Gaps = 34/284 (11%)

Query: 150 EDFEVLKVVGQGAFGRVYQVR-----KKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
           +  ++ K +G+GAFG+V +       K  T    A+K++++       H   M   + ++
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILI 71

Query: 205 TKIDHPFVVQLK-YSFQTKYRLYLVLDFINGGHLFFQLYHHG----------------LF 247
               H  VV L     +    L ++++F   G+L   L                      
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 248 REDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---T 304
             +    Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTG-KPPFIGGNRAKIQQKIVK 363
           R       +++MAPE +  + +   +D WS G+LL+E+ +    P+ G    +   + +K
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 364 D--KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH 405
           +  ++R P + + E +  +      EP +R         E+  H
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-----SELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (443), Expect = 2e-51
 Identities = 57/288 (19%), Positives = 112/288 (38%), Gaps = 31/288 (10%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 204
           E   + + +GQG+FG VY+   K           A+K + +              E  ++
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVM 77

Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDL----------ARI 254
            + +   VV+L           ++++ +  G L   L        +              
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 255 YAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TRSNSMIG 311
            A EI   +++L+AN  +HRDL   N ++  D  V + DFG+ +   E     +    + 
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 312 TVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTG-KPPFIGGNRAKIQQKIVKDKLR-LP 369
            V +M+PE +        +D WS G++L+E+ T  + P+ G +  ++ + +++  L   P
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257

Query: 370 AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSE-----EIKSHKWFKPIN 412
                    L++   Q  P  R    P   E     + +    F+ ++
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMR----PSFLEIISSIKEEMEPGFREVS 301

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 6e-48
 Identities = 62/290 (21%), Positives = 117/290 (40%), Gaps = 52/290 (17%)

Query: 150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH 209
               + + +G+G FG V++ + +   E  A+K+    +        + +AE      + H
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERS----WFREAEIYQTVMLRH 56

Query: 210 PFVVQLKYSFQ----TKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSH 265
             ++    +      T  +L+LV D+   G LF  L  + +  E + ++ A    S ++H
Sbjct: 57  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAH 115

Query: 266 LHA--------NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-----NTRSNSMIGT 312
           LH           I HRDLK +NIL+  +G   + D GLA + D      +   N  +GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 313 VEYMAPEIVLGKGH------NKAADWWSVGILLYEMLTGKPPFIGG-------------- 352
             YMAPE++    +       K AD +++G++ +E+                        
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 353 -NRAKIQQKIVKDKLR--LPAFLSS-----EAHSLLKGLLQKEPGKRLGA 394
            +  ++++ + + KLR  +P    S         +++         RL A
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  155 bits (393), Expect = 8e-44
 Identities = 56/323 (17%), Positives = 112/323 (34%), Gaps = 70/323 (21%)

Query: 152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDI-------L 204
           + +++ +G G F  V+  +    +   AMK++R DK+  +   + +K  + +        
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 205 TKIDHPFVVQLKYSFQTKYRLYLVLDFINGGH-----LFFQLYHHGLFREDLARIYAAEI 259
             +    +++L   F  K    + +  +            + Y H        +  + ++
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 260 VSAVSHLHAN-GIMHRDLKPENILLGADGHVM----LTDFGLAKQFDENTRSNSMIGTVE 314
           +  + ++H   GI+H D+KPEN+L+           +    L      +    + I T E
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 315 YMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ---------------- 358
           Y +PE++LG      AD WS   L++E++TG   F                         
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 359 --------------------------------QKIVKDKLRLPAFLSSEAHSLLKGLLQK 386
                                           + ++ +K +     + E    L  +LQ 
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314

Query: 387 EPGKRLGAGPKGSEEIKSHKWFK 409
           +P KR  A       + +H W K
Sbjct: 315 DPRKRADA-----GGLVNHPWLK 332

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.1 bits (215), Expect = 1e-20
 Identities = 28/204 (13%), Positives = 64/204 (31%), Gaps = 30/204 (14%)

Query: 153 EVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEY---------------M 197
            + K++G+G    V+    +       +K  +      K   E                 
Sbjct: 3   AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 198 KAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAA 257
           + E   L K+    V ++           ++++ I+   L+     +             
Sbjct: 62  RNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYRVRVENP-------DEVLD 110

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMIGTVEYMA 317
            I+  V+  +  GI+H DL   N+L+  +  + + DF  + +  E      +   V  + 
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNII 169

Query: 318 PEIVLGKGHNKAADWWSVGILLYE 341
                 + +    D  S    + +
Sbjct: 170 --TYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	482
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.48
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.06
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.95
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.23
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.06
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.28

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-72  Score=562.85  Aligned_cols=323  Identities=39%  Similarity=0.772  Sum_probs=293.6

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +++++|++++.||+|+||+||+|+++.+|+.||||++++......+..+.+.+|+.+|++++||||++++++|++.+.+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            46789999999999999999999999999999999999887666667788899999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc-CCCC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD-ENTR  305 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~-~~~~  305 (482)
                      +|||||+||+|..++.+.+.++++.++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+... ....
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999754 3455


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhc
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++.+.+..+.+.+|..+|+++++||++||+
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~  241 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK  241 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhcc
Confidence            66789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC----------C
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT----------P  455 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~----------~  455 (482)
                      +||.+|++....+++||++||||++++|+.+..+++.|||.|.+....+..+|+..++......++...          .
T Consensus       242 ~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (337)
T d1o6la_         242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQ  321 (337)
T ss_dssp             SSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC-----------------
T ss_pred             CCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhhhhhcCchhhhccCCCCCCccccccccccccc
Confidence            999999987666789999999999999999999999999999999888899999877665544333221          1


Q ss_pred             CCCCCCccCeeeec
Q 047009          456 KNNTNPFADFSYVR  469 (482)
Q Consensus       456 ~~~~~~f~~f~~~~  469 (482)
                      ...+..|.||+|+.
T Consensus       322 ~~~~~~f~~f~~v~  335 (337)
T d1o6la_         322 REEQEMFEDFDYIA  335 (337)
T ss_dssp             ---CCTTTTCCEEC
T ss_pred             hhhhhccCCCEeeC
Confidence            23568899999985

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-68  Score=535.63  Aligned_cols=315  Identities=39%  Similarity=0.726  Sum_probs=260.4

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHH-hCCCCceeeeeeeeecCCeEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILT-KIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      +++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+..|..++. .++|||||+++++|.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            478999999999999999999999999999999999876555555666677777765 6899999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCC
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRS  306 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~  306 (482)
                      |||||+||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ....
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999987643 3344


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhcc
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQK  386 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~  386 (482)
                      ...+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...+..++..+.+.+|..+|+++++||++||++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~  240 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR  240 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhccc
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCCCCC---CCCCCCCcc
Q 047009          387 EPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSPAAT---PKNNTNPFA  463 (482)
Q Consensus       387 dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~~~~---~~~~~~~f~  463 (482)
                      ||.+||++.    .++++||||++++|+.+..+++.||+.|.+....++++|+..+.......+....   ...+++.|.
T Consensus       241 dP~~R~s~~----~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~  316 (320)
T d1xjda_         241 EPEKRLGVR----GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFR  316 (320)
T ss_dssp             SGGGSBTTB----SCGGGSGGGTTCCHHHHHTTCSCC--------------------------------------CCTTT
T ss_pred             CCCCCcCHH----HHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccchhhcChHhhhCCccCCCCcccccCchhhcccC
Confidence            999999981    3899999999999999999999999999999888999999877654333332222   234678999


Q ss_pred             Ceee
Q 047009          464 DFSY  467 (482)
Q Consensus       464 ~f~~  467 (482)
                      ||+|
T Consensus       317 ~f~~  320 (320)
T d1xjda_         317 NFSF  320 (320)
T ss_dssp             TCCC
T ss_pred             cCcC
Confidence            9997

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-67  Score=528.64  Aligned_cols=291  Identities=39%  Similarity=0.771  Sum_probs=264.0

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            46789999999999999999999999999999999998766666667888999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCc
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN  307 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  307 (482)
                      |||||.||+|..++.....+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....  ...
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--~~~  159 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTY  159 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBC
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc--ccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998654  345


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccC
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE  387 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~d  387 (482)
                      +.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++.+++.++...+|..++++++++|++||++|
T Consensus       160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d  239 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD  239 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSC
T ss_pred             cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhC
Confidence            68999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCC-cccccCccc
Q 047009          388 PGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAG-KHCIANFEK  440 (482)
Q Consensus       388 P~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~-~~~~~~f~~  440 (482)
                      |.+|++....++++|++||||++++|+.+..+.++|||.|.+.. ..+.++|++
T Consensus       240 p~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~~~d~~~f~~  293 (316)
T d1fota_         240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDK  293 (316)
T ss_dssp             TTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC------------
T ss_pred             HHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCCCcchhhhcCC
Confidence            99998665556799999999999999999999999999997543 456778875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-66  Score=527.08  Aligned_cols=291  Identities=41%  Similarity=0.775  Sum_probs=272.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+...+++|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            57899999999999999999999999999999999887766666677889999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNS  308 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~  308 (482)
                      |||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..  ....
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--~~~~  197 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RTWT  197 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--CBCC
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--cccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998753  3456


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccCc
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKEP  388 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~dP  388 (482)
                      .+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+...+..+|..+.+.+|..+++++.+||++||++||
T Consensus       198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  277 (350)
T d1rdqe_         198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL  277 (350)
T ss_dssp             CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCT
T ss_pred             ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCH
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCcccc
Q 047009          389 GKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKK  441 (482)
Q Consensus       389 ~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~  441 (482)
                      .+|+.....+++||++||||++++|..+..++++|||+|......++++|+..
T Consensus       278 ~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~s~~~~~  330 (350)
T d1rdqe_         278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDY  330 (350)
T ss_dssp             TTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCCC
T ss_pred             HhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchhhhcCCC
Confidence            99974333455999999999999999999999999999999988899999753

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-66  Score=511.40  Aligned_cols=277  Identities=39%  Similarity=0.728  Sum_probs=250.6

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+......+..+.+.+|+.+|++++|||||+++++|.+.+.+|+|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            47899999999999999999999999999999999987766666777899999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC---CC
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~---~~  305 (482)
                      ||||+||+|..++...+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+...   ..
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~  166 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR  166 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999986432   23


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhc
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      ..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++.++|.+..+.+|..+++++++||++||+
T Consensus       167 ~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  246 (288)
T d1uu3a_         167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV  246 (288)
T ss_dssp             ---CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSC
T ss_pred             cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHcc
Confidence            45678999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCCcCCCCC-CChHHHHhCcCCCCCChhhhhhccCCCCCcc
Q 047009          386 KEPGKRLGAGP-KGSEEIKSHKWFKPINWKKLEAREIQPGFCP  427 (482)
Q Consensus       386 ~dP~~R~s~~~-~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p  427 (482)
                      +||++|||+.. ....+|++||||++++|+++..+  .||..|
T Consensus       247 ~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~--~pP~l~  287 (288)
T d1uu3a_         247 LDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ--TPPKLT  287 (288)
T ss_dssp             SSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS--CCCCCC
T ss_pred             CCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcC--CCCCCC
Confidence            99999999821 12234799999999999999755  355443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.1e-65  Score=518.10  Aligned_cols=321  Identities=33%  Similarity=0.640  Sum_probs=262.9

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHH---HHHHHhCCCCceeeeeeeeecCCe
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAE---RDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E---~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      ++++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|   +.+++.++|||||+++++|.+.+.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            57899999999999999999999999999999999987765444444444444   667777889999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      +|+|||||+||+|..++.+++.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+... 
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999987644 


Q ss_pred             CCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchH---HHHHHHHhcccCCCccCChHHHHHH
Q 047009          305 RSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRA---KIQQKIVKDKLRLPAFLSSEAHSLL  380 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~---~~~~~i~~~~~~~p~~~s~~~~~LI  380 (482)
                      .....+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.+..   .+...+......+|..+|+++++||
T Consensus       161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  240 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL  240 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHH
T ss_pred             cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHH
Confidence            3456789999999999974 67999999999999999999999999875443   3444555567778889999999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcccccCccccccCCCCCCCC-CCCCCCCC
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKHCIANFEKKWTDMPLSDSP-AATPKNNT  459 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~s~-~~~~~~~~  459 (482)
                      .+||++||++||+....+++||++||||++++|..+..++++||++|......+.+.|+....+.  .+.. ......++
T Consensus       241 ~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~~~~~~~~~d~~~~~~--~~~~~~~~~~~~~  318 (364)
T d1omwa3         241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDE--EDTKGIKLLDSDQ  318 (364)
T ss_dssp             HHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC----------------------CCCCSSSS
T ss_pred             HHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCCCCCcCCccccccCCh--hhccCCCCCChHH
Confidence            99999999999997656679999999999999999999999999999877666555554221111  1111 11122345


Q ss_pred             CCccCeeeecCC
Q 047009          460 NPFADFSYVRPA  471 (482)
Q Consensus       460 ~~f~~f~~~~~~  471 (482)
                      ..|.+|++..+.
T Consensus       319 ~~~~~~~~~~~~  330 (364)
T d1omwa3         319 ELYRNFPLTISE  330 (364)
T ss_dssp             GGGTTCCEECHH
T ss_pred             HHHhcCCccCch
Confidence            678888877543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-64  Score=490.27  Aligned_cols=257  Identities=32%  Similarity=0.654  Sum_probs=242.9

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEE
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  227 (482)
                      .+++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus         4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   83 (263)
T d2j4za1           4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   83 (263)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence            46899999999999999999999999999999999998776666667788999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCc
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN  307 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  307 (482)
                      |||||+||+|..++.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... ...
T Consensus        84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~  162 (263)
T d2j4za1          84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRT  162 (263)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCE
T ss_pred             EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-ccc
Confidence            9999999999999999899999999999999999999999999999999999999999999999999999876543 345


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHHHhhccC
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLKGLLQKE  387 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~~~L~~d  387 (482)
                      ..+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++.+++.+..+.+|..+|+++++||.+||++|
T Consensus       163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d  242 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN  242 (263)
T ss_dssp             ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCC
Confidence            67899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCcCCCCCCChHHHHhCcCCCC
Q 047009          388 PGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       388 P~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      |++|||+     +|+++||||..
T Consensus       243 p~~R~t~-----~eil~hp~~~~  260 (263)
T d2j4za1         243 PSQRPML-----REVLEHPWITA  260 (263)
T ss_dssp             GGGSCCH-----HHHHTCHHHHH
T ss_pred             HhHCcCH-----HHHHcCcCcCC
Confidence            9999998     99999999963

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-62  Score=481.25  Aligned_cols=268  Identities=30%  Similarity=0.511  Sum_probs=238.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh---hHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK---NHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+......   ...+.+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            569999999999999999999999999999999987654322   24567889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC----ceeEcccCccccccC
Q 047009          227 LVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG----HVMLTDFGLAKQFDE  302 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g----~vKL~DFGla~~~~~  302 (482)
                      ||||||+||+|..++..++.+++..++.++.||+.||+|||++||+||||||+|||++.+|    .+||+|||+|+....
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            9999999999999999889999999999999999999999999999999999999999877    599999999998877


Q ss_pred             CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHH
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHS  378 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  378 (482)
                      .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+......++    ..+|+++++
T Consensus       170 ~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  249 (293)
T d1jksa_         170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD  249 (293)
T ss_dssp             SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred             CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHH
Confidence            7777788999999999999999999999999999999999999999999999999999998877765    468999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCC
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQ  422 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~  422 (482)
                      ||++||++||++||++     +|+++||||++.+|+....+...
T Consensus       250 li~~~L~~dP~~R~s~-----~eil~hp~~~~~~~~~~l~~~~~  288 (293)
T d1jksa_         250 FIRRLLVKDPKKRMTI-----QDSLQHPWIKPKDTQQALSSAWS  288 (293)
T ss_dssp             HHHTTSCSSGGGSCCH-----HHHHHSTTTCC------------
T ss_pred             HHHHHccCChhHCcCH-----HHHhcCcccCCCChhHhhccCCC
Confidence            9999999999999998     99999999999999876555444

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-62  Score=477.42  Aligned_cols=255  Identities=30%  Similarity=0.489  Sum_probs=222.0

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+...  .+..+.+.+|+.+|++++|||||++++++.+.+.+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            5789999999999999999999999999999999987543  23345688999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC---CC
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN---TR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~---~~  305 (482)
                      ||||+||+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+...   ..
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999999976432   23


Q ss_pred             CcccccCCCCCchhhhcCCCC-CchhHHHHHhHHHHHHhhCCCCCCCCchHH-HHHHHHhcccCC--CccCChHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAK-IQQKIVKDKLRL--PAFLSSEAHSLLK  381 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~-~~~sDvwSlGvilyelltG~~PF~~~~~~~-~~~~i~~~~~~~--p~~~s~~~~~LI~  381 (482)
                      ....+||+.|||||++.+..+ +.++|||||||++|||++|+.||...+... ....+.......  +..+++++++||+
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  241 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence            456789999999999998876 578999999999999999999997755433 333333332222  2568999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      +||++||++||++     +|+++||||+.
T Consensus       242 ~~L~~dP~~R~t~-----~eil~hpwf~~  265 (271)
T d1nvra_         242 KILVENPSARITI-----PDIKKDRWYNK  265 (271)
T ss_dssp             HHSCSSTTTSCCH-----HHHTTCTTTTC
T ss_pred             HHcCCChhHCcCH-----HHHhcCHhhCc
Confidence            9999999999998     99999999974

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-61  Score=481.06  Aligned_cols=254  Identities=34%  Similarity=0.615  Sum_probs=216.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      +.|++++.||+|+||+||+|+++.+|+.||||++.+....  .....+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5699999999999999999999999999999999876543  23456789999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc---cCCceeEcccCccccccCCCCC
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG---ADGHVMLTDFGLAKQFDENTRS  306 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~---~~g~vKL~DFGla~~~~~~~~~  306 (482)
                      |||+||+|.+++..++.+++..++.|+.||+.||+|||++||+||||||+|||+.   .+|.+||+|||+|+........
T Consensus        87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~  166 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL  166 (307)
T ss_dssp             CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence            9999999999999999999999999999999999999999999999999999995   5789999999999988777777


Q ss_pred             cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHHHHHH
Q 047009          307 NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLKG  382 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~LI~~  382 (482)
                      .+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...+.+....++    ..+|+++++||++
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  246 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH  246 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence            788999999999999999999999999999999999999999999999999999998876554    4689999999999


Q ss_pred             hhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          383 LLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       383 ~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      ||++||++|||+     +|+++||||++
T Consensus       247 ~L~~dP~~R~s~-----~eil~hp~~~~  269 (307)
T d1a06a_         247 LMEKDPEKRFTC-----EQALQHPWIAG  269 (307)
T ss_dssp             HSCSSGGGSCCH-----HHHHHSTTTTS
T ss_pred             HccCCHhHCcCH-----HHHhcCHhhCC
Confidence            999999999998     99999999985

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-61  Score=476.88  Aligned_cols=252  Identities=31%  Similarity=0.509  Sum_probs=228.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+...   ...+.+.+|+.+|++++|||||+++++|.+.+.+|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            579999999999999999999999999999999986543   23466889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCCcc
Q 047009          230 DFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRSNS  308 (482)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~  308 (482)
                      |||+||+|..++.+ +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+.. ......
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            99999999987755 5699999999999999999999999999999999999999999999999999998754 344567


Q ss_pred             cccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc---ccCCCccCChHHHHHHHHhhc
Q 047009          309 MIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---KLRLPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~LI~~~L~  385 (482)
                      .+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+.......+...   .+..|..+++++++||++||+
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  255 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence            78999999999999999999999999999999999999999988877766666554   345567899999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      +||++||++     +|+++||||+.
T Consensus       256 ~dP~~R~s~-----~eil~Hp~~~~  275 (293)
T d1yhwa1         256 MDVEKRGSA-----KELLQHQFLKI  275 (293)
T ss_dssp             SSTTTSCCH-----HHHTTCGGGGG
T ss_pred             CChhHCcCH-----HHHhcCHhhCC
Confidence            999999998     99999999974

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-60  Score=482.82  Aligned_cols=259  Identities=29%  Similarity=0.548  Sum_probs=239.0

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+...   ...+.+.+|+.+|++++|||||+++++|.+.+.+|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            5799999999999999999999999999999999976542   3456788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc--CCceeEcccCccccccCCCC
Q 047009          229 LDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA--DGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~--~g~vKL~DFGla~~~~~~~~  305 (482)
                      ||||+||+|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+|||++.  +|.+||+|||+|+.+.....
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            999999999998854 467999999999999999999999999999999999999964  68899999999999877777


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLK  381 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~LI~  381 (482)
                      ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..++...|......++    ..+|+++++||+
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  261 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR  261 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHH
T ss_pred             cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            7788999999999999999999999999999999999999999999999999999998877665    358999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCCCChhh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKK  415 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~  415 (482)
                      +||++||++|||+     +|+++||||+..+|..
T Consensus       262 ~~L~~dP~~R~t~-----~eil~hp~~~~~~~~~  290 (350)
T d1koaa2         262 KLLLADPNTRMTI-----HQALEHPWLTPGNAPG  290 (350)
T ss_dssp             HHCCSSGGGSCCH-----HHHHHSTTTSCTTCCS
T ss_pred             HHccCChhHCcCH-----HHHhcCcccCCCCCCC
Confidence            9999999999998     9999999999887643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-60  Score=466.48  Aligned_cols=254  Identities=28%  Similarity=0.524  Sum_probs=219.6

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec--CCeEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT--KYRLY  226 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~  226 (482)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+.... ....+.+.+|+.+|++++|||||++++++.+  .+.+|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            37899999999999999999999999999999999876543 3456678899999999999999999999854  56789


Q ss_pred             EEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CcccCCCCCcEEEccCCceeEcccCcc
Q 047009          227 LVLDFINGGHLFFQLYH----HGLFREDLARIYAAEIVSAVSHLHANG-----IMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~-----IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                      +|||||+||+|.+++.+    ++.+++..++.++.||+.||.|||++|     ||||||||+|||++.+|.+||+|||+|
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            99999999999998854    467999999999999999999999976     999999999999999999999999999


Q ss_pred             ccccCC-CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc-CCCccCChH
Q 047009          298 KQFDEN-TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL-RLPAFLSSE  375 (482)
Q Consensus       298 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~  375 (482)
                      +.+... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++..++..+.. .+|..+|++
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  241 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE  241 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence            987543 334568999999999999999999999999999999999999999999999999999988765 567889999


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      +++||++||+.||++||++     +||++|||+
T Consensus       242 l~~li~~~L~~dp~~Rps~-----~ell~hp~i  269 (269)
T d2java1         242 LNEIITRMLNLKDYHRPSV-----EEILENPLI  269 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCH-----HHHHTSTTC
T ss_pred             HHHHHHHHcCCChhHCcCH-----HHHHhCCcC
Confidence            9999999999999999998     999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-60  Score=470.72  Aligned_cols=254  Identities=33%  Similarity=0.516  Sum_probs=228.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVL  229 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  229 (482)
                      +.|++++.||+|+||+||+|+++.+|+.||+|++.+..   ....+.+.+|+.+|++++|||||+++++|.+.+.+|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            46999999999999999999999999999999998653   234456789999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCc
Q 047009          230 DFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSN  307 (482)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~  307 (482)
                      |||+||+|..++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... ....
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~  168 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  168 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence            99999999998765 457999999999999999999999999999999999999999999999999999875322 2334


Q ss_pred             ccccCCCCCchhhhc-----CCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc---CCCccCChHHHHH
Q 047009          308 SMIGTVEYMAPEIVL-----GKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL---RLPAFLSSEAHSL  379 (482)
Q Consensus       308 ~~~gt~~y~APE~l~-----~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~L  379 (482)
                      +.+||+.|||||++.     +..|+.++|||||||++|||++|+.||.+.+..++..++.++..   ..|..+|+++++|
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l  248 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF  248 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence            678999999999984     45689999999999999999999999999988888888887743   4456799999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      |++||++||++|||+     +|+++||||+.-
T Consensus       249 i~~~L~~dp~~R~t~-----~ell~hp~~~~~  275 (288)
T d2jfla1         249 LKKCLEKNVDARWTT-----SQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHSCSSTTTSCCH-----HHHTTSGGGCCC
T ss_pred             HHHHccCChhHCcCH-----HHHhcCcccCCC
Confidence            999999999999998     999999999753

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-61  Score=482.62  Aligned_cols=260  Identities=27%  Similarity=0.473  Sum_probs=224.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||+||+|+++.+|+.||+|+++++.  .....+.+.+|+.+|++++|||||+++++|.+.+++|+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            478999999999999999999999999999999998653  234456788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~  307 (482)
                      |||++||+|..++.+++.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+.+... ...
T Consensus        83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~  161 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN  161 (322)
T ss_dssp             EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC-
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-ccc
Confidence            9999999999999999999999999999999999999997 59999999999999999999999999999976432 345


Q ss_pred             ccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHH----------------------------
Q 047009          308 SMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ----------------------------  359 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~----------------------------  359 (482)
                      +.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+......                            
T Consensus       162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (322)
T d1s9ja_         162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG  241 (322)
T ss_dssp             --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred             cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence            6799999999999999999999999999999999999999997765432211                            


Q ss_pred             --------------HHHhc-ccCCC-ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhh
Q 047009          360 --------------KIVKD-KLRLP-AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKL  416 (482)
Q Consensus       360 --------------~i~~~-~~~~p-~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~  416 (482)
                                    .+... ...+| ..+|.++++||.+||++||++|||+     +|+++||||+..+|+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta-----~e~L~Hpf~~~~~~~~~  309 (322)
T d1s9ja_         242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL-----KQLMVHAFIKRSDAEEV  309 (322)
T ss_dssp             ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHHHHHSCC
T ss_pred             cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCH-----HHHhhCHhhCcCCcccc
Confidence                          11111 11122 2368899999999999999999999     99999999987776544

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.1e-60  Score=478.39  Aligned_cols=255  Identities=31%  Similarity=0.546  Sum_probs=235.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||+||+|+++.+|+.||||++++...   ...+.+.+|+.+|++++|||||+++++|.+++.+|||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4689999999999999999999999999999999987542   3345678999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc--cCCceeEcccCccccccCCCC
Q 047009          229 LDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG--ADGHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~--~~g~vKL~DFGla~~~~~~~~  305 (482)
                      ||||+||+|.+.+...+ .+++..++.|+.||+.||+|||++|||||||||+||||+  .+|++||+|||+|+.+.....
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            99999999998876654 699999999999999999999999999999999999998  678999999999999887777


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCC----ccCChHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLP----AFLSSEAHSLLK  381 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~LI~  381 (482)
                      ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+......+|    ..+|+++++||+
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  264 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK  264 (352)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred             eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            7788999999999999999999999999999999999999999999999999999998877665    468999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                      +||++||.+||++     +|+++||||++.
T Consensus       265 ~~L~~dp~~R~s~-----~eil~Hp~~~~~  289 (352)
T d1koba_         265 NLLQKEPRKRLTV-----HDALEHPWLKGD  289 (352)
T ss_dssp             TTSCSSGGGSCCH-----HHHHTSTTTSSC
T ss_pred             HHccCChhHCcCH-----HHHhcCHhhCCC
Confidence            9999999999998     999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-59  Score=468.30  Aligned_cols=252  Identities=28%  Similarity=0.417  Sum_probs=230.2

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEE
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLD  230 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  230 (482)
                      .|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++|||||+++++|.+.+.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            49999999999999999999999999999999988766566667778999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCCCcccc
Q 047009          231 FINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTRSNSMI  310 (482)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~  310 (482)
                      ||.||+|..++..++.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....   ....+
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~~  172 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFV  172 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCccc
Confidence            999999988888888999999999999999999999999999999999999999999999999999987543   34578


Q ss_pred             cCCCCCchhhhcC---CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC--CCccCChHHHHHHHHhhc
Q 047009          311 GTVEYMAPEIVLG---KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR--LPAFLSSEAHSLLKGLLQ  385 (482)
Q Consensus       311 gt~~y~APE~l~~---~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~LI~~~L~  385 (482)
                      ||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+.+..+....+..+...  .+..+|+++++||.+||+
T Consensus       173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~  252 (309)
T d1u5ra_         173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ  252 (309)
T ss_dssp             SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTC
T ss_pred             cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCc
Confidence            9999999999975   45899999999999999999999999998888888887776543  234689999999999999


Q ss_pred             cCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          386 KEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       386 ~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      +||++|||+     +|+++||||..
T Consensus       253 ~dP~~Rpt~-----~ell~Hp~~~~  272 (309)
T d1u5ra_         253 KIPQDRPTS-----EVLLKHRFVLR  272 (309)
T ss_dssp             SSGGGSCCH-----HHHTTCHHHHS
T ss_pred             CChhHCcCH-----HHHHhCHHhcC
Confidence            999999999     99999999964

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-59  Score=455.90  Aligned_cols=250  Identities=24%  Similarity=0.442  Sum_probs=220.9

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec----CCeEEE
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT----KYRLYL  227 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~l  227 (482)
                      |++.++||+|+||+||+|+++.+++.||+|++...... ....+.+.+|+++|++++|||||+++++|.+    ...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            47888999999999999999999999999999876543 3456678899999999999999999999865    456899


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEc-cCCceeEcccCccccccCCC
Q 047009          228 VLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANG--IMHRDLKPENILLG-ADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--IiHrDLKp~NILl~-~~g~vKL~DFGla~~~~~~~  304 (482)
                      ||||++||+|..++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+|+... ..
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~-~~  168 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-AS  168 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-TT
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-CC
Confidence            9999999999999999899999999999999999999999998  99999999999996 57999999999998643 33


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCc-hHHHHHHHHhccc--CCCccCChHHHHHHH
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGN-RAKIQQKIVKDKL--RLPAFLSSEAHSLLK  381 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~-~~~~~~~i~~~~~--~~p~~~s~~~~~LI~  381 (482)
                      .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.. ...+.+.+..+..  .++..+++++++||.
T Consensus       169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  247 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE  247 (270)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred             ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHH
Confidence            4567899999999999976 49999999999999999999999997654 4556666665432  345668999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFK  409 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~  409 (482)
                      +||++||++|||+     +|+++||||+
T Consensus       248 ~~l~~dp~~R~s~-----~ell~Hp~fk  270 (270)
T d1t4ha_         248 GCIRQNKDERYSI-----KDLLNHAFFQ  270 (270)
T ss_dssp             HHSCSSGGGSCCH-----HHHHTSGGGC
T ss_pred             HHccCCHhHCcCH-----HHHhCCcccC
Confidence            9999999999998     9999999996

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.1e-59  Score=457.73  Aligned_cols=257  Identities=33%  Similarity=0.537  Sum_probs=235.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhch------hhHHHHHHHHHHHHHhCC-CCceeeeeeeeec
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVE------KNHAEYMKAERDILTKID-HPFVVQLKYSFQT  221 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~------~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  221 (482)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.....      +...+.+.+|+.+|++++ |||||+++++|.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            378999999999999999999999999999999998754322      233456789999999997 9999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      ++.+|||||||+||+|.+++..++.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCCcccccCCCCCchhhhcC------CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCc----c
Q 047009          302 ENTRSNSMIGTVEYMAPEIVLG------KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----F  371 (482)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~------~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----~  371 (482)
                      ........+||+.|+|||++.+      ..++.++||||+||++|||++|+.||.+.+.....+.+..+...++.    .
T Consensus       162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (277)
T d1phka_         162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD  241 (277)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred             CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            7666777899999999999863      45788999999999999999999999999999999999988765543    6


Q ss_pred             CChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          372 LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       372 ~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      +|+++++||++||++||++||++     +||++||||+.
T Consensus       242 ~s~~~~~li~~~L~~~p~~R~s~-----~eil~h~~~~~  275 (277)
T d1phka_         242 YSDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQQ  275 (277)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCH-----HHHTTSGGGCT
T ss_pred             CCHHHHHHHHHHccCChhHCcCH-----HHHHcCHHHHH
Confidence            89999999999999999999998     99999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-59  Score=468.11  Aligned_cols=287  Identities=48%  Similarity=0.880  Sum_probs=251.1

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEE---cCCCeEEEEEEeechhhch-hhHHHHHHHHHHHHHhCCC-Cceeeeeeeeec
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRK---KNTSEIYAMKVMRKDKIVE-KNHAEYMKAERDILTKIDH-PFVVQLKYSFQT  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~---~~~~~~vAiK~~~~~~~~~-~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~  221 (482)
                      +++++|++++.||+|+||+||+|++   +.+|+.||||++++..... ....+.+.+|+.+|++++| |||+++++++.+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            4568999999999999999999987   4578999999997654322 2334557789999999977 899999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      ...+++||||+.||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998764


Q ss_pred             C--CCCCcccccCCCCCchhhhcCC--CCCchhHHHHHhHHHHHHhhCCCCCCCCchHH----HHHHHHhcccCCCccCC
Q 047009          302 E--NTRSNSMIGTVEYMAPEIVLGK--GHNKAADWWSVGILLYEMLTGKPPFIGGNRAK----IQQKIVKDKLRLPAFLS  373 (482)
Q Consensus       302 ~--~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwSlGvilyelltG~~PF~~~~~~~----~~~~i~~~~~~~p~~~s  373 (482)
                      .  ........||+.|+|||.+.+.  .++.++|||||||+||+|++|+.||.+.+...    +........+.+|..++
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s  260 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  260 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence            3  3334567899999999999865  46889999999999999999999998765443    44444456677888999


Q ss_pred             hHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChhhhhhccCCCCCccccCCcc
Q 047009          374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWKKLEAREIQPGFCPEVAGKH  433 (482)
Q Consensus       374 ~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~~~~~  433 (482)
                      +++++||++||++||.+||+++..+++|+++||||++++|+.+..++++||++|.+.+..
T Consensus       261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~~~~  320 (322)
T d1vzoa_         261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDEL  320 (322)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-C
T ss_pred             HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCCCCC
Confidence            999999999999999999987656789999999999999999999999999999887654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-59  Score=466.21  Aligned_cols=253  Identities=27%  Similarity=0.477  Sum_probs=235.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||+||+|+++.+|+.||||++++..    .....+.+|+.+|++++|||||+++++|++.+.+|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            578999999999999999999999999999999998754    2334578999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC--CceeEcccCccccccCCCC
Q 047009          229 LDFINGGHLFFQLYHHG-LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD--GHVMLTDFGLAKQFDENTR  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~--g~vKL~DFGla~~~~~~~~  305 (482)
                      ||||+||+|..++..++ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++.......
T Consensus        80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            99999999999998765 79999999999999999999999999999999999999854  4799999999998877666


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCc----cCChHHHHHHH
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA----FLSSEAHSLLK  381 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~LI~  381 (482)
                      ....+||+.|+|||.+.+..|+.++|||||||++|+|++|+.||.+.+..++..+|.+..+.++.    .+|+++++||+
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  239 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD  239 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred             ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHH
Confidence            77789999999999999999999999999999999999999999999999999999999888774    68999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                      +||.+||++||++     +|+++||||+.
T Consensus       240 ~~L~~dp~~R~s~-----~eil~hp~~~~  263 (321)
T d1tkia_         240 RLLVKERKSRMTA-----SEALQHPWLKQ  263 (321)
T ss_dssp             TTSCSSGGGSCCH-----HHHHHSHHHHS
T ss_pred             HHccCChhHCcCH-----HHHhcCHhhcc
Confidence            9999999999998     99999999964

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-57  Score=450.91  Aligned_cols=254  Identities=28%  Similarity=0.431  Sum_probs=217.6

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchh--hHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEe
Q 047009          154 VLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEK--NHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDF  231 (482)
Q Consensus       154 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  231 (482)
                      .+++||+|+||+||+|+++.+|+.||||++++......  ...+.+.+|+.+|++++|||||+++++|.+++++|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            57899999999999999999999999999976543221  1234578999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCcccc
Q 047009          232 INGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSNSMI  310 (482)
Q Consensus       232 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~~  310 (482)
                      +.|+++.......+.+++..++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ......+
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            999888777766778999999999999999999999999999999999999999999999999999886543 3445678


Q ss_pred             cCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC--------------------C-
Q 047009          311 GTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR--------------------L-  368 (482)
Q Consensus       311 gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~--------------------~-  368 (482)
                      ||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+...+|.+....                    . 
T Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ua2a_         162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP  241 (299)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred             cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence            9999999999875 46899999999999999999999999998888887777642100                    0 


Q ss_pred             -------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          369 -------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       369 -------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                             ...+++++++||++||++||++|||+     +|+|+||||++..
T Consensus       242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa-----~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-----TQALKMKYFSNRP  287 (299)
T ss_dssp             CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH-----HHHHTSGGGTSSS
T ss_pred             CCChHHhcccCCHHHHHHHHHHccCChhhCcCH-----HHHhCCHhhCCCC
Confidence                   12468899999999999999999999     9999999998743

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=445.11  Aligned_cols=252  Identities=30%  Similarity=0.492  Sum_probs=223.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhh---HHHHHHHHHHHHHhCC--CCceeeeeeeeecCCe
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKN---HAEYMKAERDILTKID--HPFVVQLKYSFQTKYR  224 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~---~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~  224 (482)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+.......   ....+.+|+.+|++++  |||||+++++|.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            6899999999999999999999999999999999876543221   2233568999999986  8999999999999999


Q ss_pred             EEEEEEecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC-CceeEcccCccccccC
Q 047009          225 LYLVLDFING-GHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD-GHVMLTDFGLAKQFDE  302 (482)
Q Consensus       225 ~~lV~E~~~g-g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~-g~vKL~DFGla~~~~~  302 (482)
                      +|+||||+.+ +++..++.+++.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~  163 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  163 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence            9999999986 5788888888899999999999999999999999999999999999999854 7999999999987644


Q ss_pred             CCCCcccccCCCCCchhhhcCCCC-CchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCccCChHHHHHHH
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGH-NKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~LI~  381 (482)
                      . ...+.+||+.|||||++.+..+ +.++|||||||++|||++|+.||.+.      +.+.++...++..+|+++++||+
T Consensus       164 ~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~~~li~  236 (273)
T d1xwsa_         164 T-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIR  236 (273)
T ss_dssp             S-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHHHHHH
T ss_pred             c-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHHHHHHH
Confidence            3 3456789999999999987765 67799999999999999999999653      35677888899999999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                      +||++||++|||+     +|+++||||+++..
T Consensus       237 ~~L~~dp~~R~s~-----~eil~hp~~~~~~~  263 (273)
T d1xwsa_         237 WCLALRPSDRPTF-----EEIQNHPWMQDVLL  263 (273)
T ss_dssp             HHTCSSGGGSCCH-----HHHHTSGGGSSCCC
T ss_pred             HHccCCHhHCcCH-----HHHhcCHhhCCCCC
Confidence            9999999999998     99999999998654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-57  Score=446.04  Aligned_cols=260  Identities=27%  Similarity=0.424  Sum_probs=221.6

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCC-CeEEEEEEeechhhchhhHHHHHHHHHHHHHhC---CCCceeeeeeeee---
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNT-SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI---DHPFVVQLKYSFQ---  220 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~---  220 (482)
                      ..++|++++.||+|+||+||+|++..+ ++.||||+++...... .....+.+|+.+|+.|   +||||++++++|.   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            347899999999999999999999755 6789999997654322 2222345677776655   8999999999985   


Q ss_pred             --cCCeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          221 --TKYRLYLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       221 --~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                        ....++++|||+.++.+...... ...+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence              34578999999999877544433 456899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc------------
Q 047009          298 KQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK------------  365 (482)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~------------  365 (482)
                      +...........+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+....+.+..            
T Consensus       164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (305)
T d1blxa_         164 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  243 (305)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             hhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence            88766666778899999999999999999999999999999999999999999998888777765420            


Q ss_pred             ---------------cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCCh
Q 047009          366 ---------------LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINW  413 (482)
Q Consensus       366 ---------------~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~  413 (482)
                                     ..++..+++++++||++||++||++|||+     +|+++||||+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa-----~e~L~Hpff~~i~~  301 (305)
T d1blxa_         244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----YSALSHPYFQDLER  301 (305)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGTTCCC
T ss_pred             cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCH-----HHHhcChhhcCchh
Confidence                           11234578999999999999999999999     99999999999865

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=443.29  Aligned_cols=258  Identities=30%  Similarity=0.517  Sum_probs=219.4

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+.+|+++|++++|||||+++++|.+.+.+|+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            4799999999999999999999999999999999976542 223356688999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC-CCCC
Q 047009          229 LDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE-NTRS  306 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~~~  306 (482)
                      |||+.++.+...... .+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.... ....
T Consensus        80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred             EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence            999987655444333 45699999999999999999999999999999999999999999999999999988643 3345


Q ss_pred             cccccCCCCCchhhhcCCC-CCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccC------------------
Q 047009          307 NSMIGTVEYMAPEIVLGKG-HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLR------------------  367 (482)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~-~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~------------------  367 (482)
                      ...+||+.|+|||++.... ++.++|+|||||++|+|++|+.||.+.+..+...++.+....                  
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS  239 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence            5678999999999988766 478999999999999999999999998877776666542100                  


Q ss_pred             C-----------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCC
Q 047009          368 L-----------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPIN  412 (482)
Q Consensus       368 ~-----------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~  412 (482)
                      +           ...++.++++||++||++||++|||+     +||++||||++++
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~-----~ell~H~ff~~~~  290 (298)
T d1gz8a_         240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-----KAALAHPFFQDVT  290 (298)
T ss_dssp             SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGTTCC
T ss_pred             cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH-----HHHhCCHhhccCC
Confidence            0           01367899999999999999999999     9999999999874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-57  Score=457.47  Aligned_cols=249  Identities=31%  Similarity=0.545  Sum_probs=217.7

Q ss_pred             CCCeEEEE-EecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHh-CCCCceeeeeeeeec----C
Q 047009          149 IEDFEVLK-VVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTK-IDHPFVVQLKYSFQT----K  222 (482)
Q Consensus       149 ~~~y~i~~-~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~----~  222 (482)
                      +++|+++. .||+|+||+||+|+++.+++.||||++++..        .+.+|+.++.+ ++|||||+++++|++    .
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--------~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH--------HHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            57899885 5999999999999999999999999997532        35679988765 589999999999976    5


Q ss_pred             CeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc---CCceeEcccCcc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLA  297 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~---~g~vKL~DFGla  297 (482)
                      ..+|+|||||+||+|.+++.++  ..+++.+++.|+.||+.||+|||++||+||||||+|||++.   ++.+||+|||+|
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence            6799999999999999999875  36999999999999999999999999999999999999985   567999999999


Q ss_pred             ccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHH----HHHhcccCCCc---
Q 047009          298 KQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQ----KIVKDKLRLPA---  370 (482)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~----~i~~~~~~~p~---  370 (482)
                      +...........+||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+......    .+......+|.   
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~  241 (335)
T d2ozaa1         162 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW  241 (335)
T ss_dssp             EECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHH
T ss_pred             eeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccc
Confidence            98877777778899999999999999999999999999999999999999998766544433    34444555553   


Q ss_pred             -cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          371 -FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       371 -~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                       .+|+++++||++||++||++||++     .|+++||||..
T Consensus       242 ~~~s~~~~~li~~~L~~dP~~R~s~-----~eil~hp~~~~  277 (335)
T d2ozaa1         242 SEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIMQ  277 (335)
T ss_dssp             HHSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSHHHHT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCH-----HHHHcCHHhhC
Confidence             589999999999999999999998     99999999964

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.9e-56  Score=436.16  Aligned_cols=255  Identities=26%  Similarity=0.438  Sum_probs=219.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC----e
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY----R  224 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~  224 (482)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|++++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            367999999999999999999999999999999998876655666778999999999999999999999997654    4


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-
Q 047009          225 LYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-  303 (482)
                      +|+||||++||+|..++...+.+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||.++..... 
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            8999999999999999999999999999999999999999999999999999999999999999999999998765322 


Q ss_pred             ---CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCC----CccCChHH
Q 047009          304 ---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL----PAFLSSEA  376 (482)
Q Consensus       304 ---~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~----p~~~s~~~  376 (482)
                         ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+...++.......    ...+|+++
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  245 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL  245 (277)
T ss_dssp             -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHH
T ss_pred             ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence               23456789999999999999999999999999999999999999999999888888887775543    35689999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      ++||.+||++||.+||+.     .+.+.|+|.
T Consensus       246 ~~li~~~L~~dp~~R~~s-----a~~l~~~l~  272 (277)
T d1o6ya_         246 DAVVLKALAKNPENRYQT-----AAEMRADLV  272 (277)
T ss_dssp             HHHHHHHTCSSGGGSCSS-----HHHHHHHHH
T ss_pred             HHHHHHHccCCHhHCHhH-----HHHHHHHHH
Confidence            999999999999999955     344455554

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.8e-56  Score=435.82  Aligned_cols=249  Identities=25%  Similarity=0.374  Sum_probs=219.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++.+.||+|+||+||+|+++.+++.||||+++++.    ...+.+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            44578999999999999999999999999999999997653    23456889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          227 LVLDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      +|||||++|+|..++...  ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+......
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999999999998764  568999999999999999999999999999999999999999999999999999865433


Q ss_pred             C--CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCC-CCCCchHHHHHHHHhc-ccCCCccCChHHHHHH
Q 047009          305 R--SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPP-FIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLL  380 (482)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~P-F~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI  380 (482)
                      .  .....||+.|||||++.+..|+.++|||||||++|||++|..| |.+.+...+.+.+..+ .+.+|..+++++++||
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  249 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM  249 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHH
Confidence            2  2334689999999999999999999999999999999996555 5556666666666554 4677888999999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHh
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||+.||++||++     +||++
T Consensus       250 ~~cl~~dP~~Rps~-----~ei~~  268 (287)
T d1opja_         250 RACWQWNPSDRPSF-----AEIHQ  268 (287)
T ss_dssp             HHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHcCCCHhHCcCH-----HHHHH
Confidence            99999999999998     88865

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.9e-55  Score=433.00  Aligned_cols=255  Identities=28%  Similarity=0.489  Sum_probs=220.3

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++++.||+|+||+||+|+++ +|+.||||+++.... .....+.+.+|+.+|++++|||||+++++|.+.+..+++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            478999999999999999999986 679999999977643 334456788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-CCCc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-TRSN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~~~~  307 (482)
                      |||+.++.+.......+.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|...... ....
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            999999888877777888999999999999999999999999999999999999999999999999999886533 3345


Q ss_pred             ccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcc---------------------
Q 047009          308 SMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDK---------------------  365 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~---------------------  365 (482)
                      ...|++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+...++.+..                     
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            56799999999999765 56899999999999999999999999888777777665411                     


Q ss_pred             --------cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          366 --------LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       366 --------~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                              ..++..+++++++||++||++||++|||+     +|+++||||+.
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~-----~ell~Hp~f~~  286 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-----KQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGGC
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCc
Confidence                    01234578999999999999999999998     99999999974

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-55  Score=426.24  Aligned_cols=247  Identities=23%  Similarity=0.403  Sum_probs=210.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||+||+|++++ ++.||||++++...    ..+.+.+|+.++++++|||||++++++...+.+++|
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            4789999999999999999999874 67899999986542    234578999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--C
Q 047009          229 LDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--R  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--~  305 (482)
                      |||+++|+|.+++... ..++++.+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......  .
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            9999999999988665 568999999999999999999999999999999999999999999999999998765432  2


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHh
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~  383 (482)
                      .....||+.|||||++.+..|+.++|||||||++|||+| |++||...+..++.+.+..+ ....|..+++++.+||.+|
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c  238 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC  238 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHH
Confidence            334679999999999999999999999999999999999 67788888888888888776 4566788999999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      |+.||++||++     +||++|
T Consensus       239 l~~~p~~Rps~-----~~il~~  255 (263)
T d1sm2a_         239 WKERPEDRPAF-----SRLLRQ  255 (263)
T ss_dssp             TCSSGGGSCCH-----HHHHHH
T ss_pred             ccCCHhHCcCH-----HHHHHH
Confidence            99999999998     899875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-55  Score=433.79  Aligned_cols=249  Identities=24%  Similarity=0.383  Sum_probs=209.9

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCe---EEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSE---IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      .++|++.++||+|+||+||+|+++.+++   .||||.+....  .....+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            4679999999999999999999987664   68999886543  234556788999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          226 YLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      |+|||||+||+|..++... +.+++..+..++.||+.||+|||++|||||||||+||||+.++++||+|||+|+.+....
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999999988774 569999999999999999999999999999999999999999999999999998765432


Q ss_pred             CC------cccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHH
Q 047009          305 RS------NSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEA  376 (482)
Q Consensus       305 ~~------~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (482)
                      ..      ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+..+ .+..|..++.++
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l  262 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSAL  262 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHH
Confidence            21      22467899999999999999999999999999999998 89999999988888888765 456778899999


Q ss_pred             HHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          377 HSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       377 ~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .+||.+||+.||++||++     .||++
T Consensus       263 ~~li~~cl~~~P~~RPs~-----~ei~~  285 (299)
T d1jpaa_         263 HQLMLDCWQKDRNHRPKF-----GQIVN  285 (299)
T ss_dssp             HHHHHHHTCSSTTTSCCH-----HHHHH
T ss_pred             HHHHHHHcCCCHhHCcCH-----HHHHH
Confidence            999999999999999998     78765

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-55  Score=439.76  Aligned_cols=252  Identities=24%  Similarity=0.391  Sum_probs=217.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCe-----EEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSE-----IYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQ  220 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  220 (482)
                      +..++|++.+.||+|+||+||+|+++.+++     .||+|++....  .......+.+|+.+|.++ +|||||+++++|.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            344789999999999999999999876553     69999987543  233445678899999998 8999999999999


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHHG-----------------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLK  277 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~-----------------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLK  277 (482)
                      +.+.+|+|||||+||+|.+++..+.                       .+++..++.|+.||+.||+|||++||||||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK  191 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  191 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence            9999999999999999999997642                       48899999999999999999999999999999


Q ss_pred             CCcEEEccCCceeEcccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCc
Q 047009          278 PENILLGADGHVMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGN  353 (482)
Q Consensus       278 p~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~  353 (482)
                      |+|||++.++++||+|||+|+.......   ..+.+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987654332   235678999999999999999999999999999999998 899999877


Q ss_pred             hHHHHHHHHhc--ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          354 RAKIQQKIVKD--KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       354 ~~~~~~~i~~~--~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ......++...  .+..|..+++++++||.+||+.||++|||+     +||++|
T Consensus       272 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~-----~ei~~~  320 (325)
T d1rjba_         272 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF-----PNLTSF  320 (325)
T ss_dssp             CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            76666666655  445678899999999999999999999998     899875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=432.08  Aligned_cols=248  Identities=21%  Similarity=0.360  Sum_probs=215.3

Q ss_pred             EEecccCceEEEEEEEcC--CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEEEEecC
Q 047009          156 KVVGQGAFGRVYQVRKKN--TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLVLDFIN  233 (482)
Q Consensus       156 ~~LG~G~fg~Vy~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~  233 (482)
                      +.||+|+||+||+|.++.  +++.||||+++.+. ......+.+.+|+.+|++++|||||+++++|.++ ..+|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            579999999999998654  56789999997654 2344567789999999999999999999999764 5789999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCCC----Cccc
Q 047009          234 GGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENTR----SNSM  309 (482)
Q Consensus       234 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~----~~~~  309 (482)
                      +|+|..++.+...+++..+..|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.....    ....
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            999999999989999999999999999999999999999999999999999999999999999987644322    2345


Q ss_pred             ccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHhhccC
Q 047009          310 IGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGLLQKE  387 (482)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~L~~d  387 (482)
                      .||+.|||||++.+..++.++|||||||++|||++ |+.||.+.+..++...+.++ .+.+|..+++++++||.+||+.|
T Consensus       171 ~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~d  250 (277)
T d1xbba_         171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD  250 (277)
T ss_dssp             CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCC
Confidence            78999999999999999999999999999999998 99999999888888888775 56788899999999999999999


Q ss_pred             cCCcCCCCCCChHHH---HhCcCCCC
Q 047009          388 PGKRLGAGPKGSEEI---KSHKWFKP  410 (482)
Q Consensus       388 P~~R~s~~~~~~~ei---l~hp~f~~  410 (482)
                      |++||++     ++|   |+|+|+.-
T Consensus       251 p~~RPs~-----~~i~~~L~~~~~~~  271 (277)
T d1xbba_         251 VENRPGF-----AAVELRLRNYYYDV  271 (277)
T ss_dssp             TTTSCCH-----HHHHHHHHHHHHHH
T ss_pred             HhHCcCH-----HHHHHHhhCHHhhc
Confidence            9999998     676   56766543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-55  Score=423.15  Aligned_cols=247  Identities=21%  Similarity=0.377  Sum_probs=223.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++++.||+|+||+||+|+++ +++.||||++++...    ..+.+.+|+.++++++||||++++++|.+++.+++|
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            478999999999999999999986 678899999987643    234578999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--C
Q 047009          229 LDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--R  305 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--~  305 (482)
                      |||+++|+|..++.. ...+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++.+....  .
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            999999999888655 4678999999999999999999999999999999999999999999999999998765433  2


Q ss_pred             CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHHh
Q 047009          306 SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKGL  383 (482)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~~  383 (482)
                      .....||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..++.+++.++ .+..|..+++++++||++|
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c  237 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC  237 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHH
Confidence            334678999999999999999999999999999999998 89999999999999888876 5567888999999999999


Q ss_pred             hccCcCCcCCCCCCChHHHHhC
Q 047009          384 LQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       384 L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      |+.||++||++     ++|++|
T Consensus       238 l~~dP~~RPt~-----~eil~~  254 (258)
T d1k2pa_         238 WHEKADERPTF-----KILLSN  254 (258)
T ss_dssp             TCSSGGGSCCH-----HHHHHH
T ss_pred             ccCCHhHCcCH-----HHHHHH
Confidence            99999999998     899886

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-55  Score=429.07  Aligned_cols=254  Identities=22%  Similarity=0.343  Sum_probs=220.3

Q ss_pred             CCeEEEEE-ecccCceEEEEEEEcC--CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          150 EDFEVLKV-VGQGAFGRVYQVRKKN--TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       150 ~~y~i~~~-LG~G~fg~Vy~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      ++|.+.+. ||+|+||+||+|.++.  ++..||||++++..  .....+.+.+|+.+|++++|||||++++++.++ .+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~   84 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALM   84 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEE
Confidence            67888885 9999999999998764  45689999997643  344567788999999999999999999999764 588


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-
Q 047009          227 LVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-  304 (482)
                      +|||||+||+|..++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.... 
T Consensus        85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            999999999999987654 579999999999999999999999999999999999999999999999999999865432 


Q ss_pred             ---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHH
Q 047009          305 ---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSL  379 (482)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L  379 (482)
                         .....+||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...+.++ .+.+|..+++++.+|
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  244 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL  244 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence               2335678999999999999999999999999999999998 99999998888888888776 467888999999999


Q ss_pred             HHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          380 LKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       380 I~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      |.+||+.||++||++  ....+.|+|.|+
T Consensus       245 i~~cl~~~p~~RPs~--~~i~~~L~~~~~  271 (285)
T d1u59a_         245 MSDCWIYKWEDRPDF--LTVEQRMRACYY  271 (285)
T ss_dssp             HHHTTCSSGGGSCCH--HHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCH--HHHHHHHHHHHH
Confidence            999999999999998  222333667765

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-55  Score=426.93  Aligned_cols=250  Identities=22%  Similarity=0.393  Sum_probs=219.0

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      .++|++.+.||+|+||+||+|+++ +++.||||++++...    ..+.+.+|+.+|++++|||||++++++.+ +.+|+|
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence            478999999999999999999987 468899999976542    23568899999999999999999998755 567899


Q ss_pred             EEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC--
Q 047009          229 LDFINGGHLFFQLYHH--GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT--  304 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--  304 (482)
                      |||+++|+|.+++...  ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+....  
T Consensus        86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence            9999999998876543  358999999999999999999999999999999999999999999999999999875433  


Q ss_pred             CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHHH
Q 047009          305 RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLKG  382 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~~  382 (482)
                      ......||+.|||||++.+..|+.++|||||||++|||+| |++||...+..++.+.+..+ .+..|..+++++.+||.+
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  245 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL  245 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHH
Confidence            2345679999999999999999999999999999999999 56667777777888887765 456788899999999999


Q ss_pred             hhccCcCCcCCCCCCChHHHHh--CcCCC
Q 047009          383 LLQKEPGKRLGAGPKGSEEIKS--HKWFK  409 (482)
Q Consensus       383 ~L~~dP~~R~s~~~~~~~eil~--hp~f~  409 (482)
                      ||+.||++||++     ++|++  |+||.
T Consensus       246 cl~~~P~~Rpt~-----~ei~~~L~~~ft  269 (272)
T d1qpca_         246 CWKERPEDRPTF-----DYLRSVLEDFFT  269 (272)
T ss_dssp             HTCSSGGGSCCH-----HHHHHHHHHHHH
T ss_pred             HcCCCHhHCcCH-----HHHHHHhhhhhh
Confidence            999999999998     89987  67774

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-55  Score=427.95  Aligned_cols=249  Identities=24%  Similarity=0.325  Sum_probs=208.3

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++.+.||+|+||+||+|+++.   .||||+++.... .....+.+.+|+.+|++++|||||++++++. .+.++
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~   79 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA   79 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence            345789999999999999999998653   599999976543 3455677899999999999999999999865 45689


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC--
Q 047009          227 LVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--  303 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~--  303 (482)
                      +|||||+||+|.+++... +.+++..+..++.||+.||+|||++|||||||||+||||+.++++||+|||+|+.....  
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999999999764 56999999999999999999999999999999999999999999999999999876432  


Q ss_pred             -CCCcccccCCCCCchhhhcC---CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHH-HHHHhccc-----CCCccCC
Q 047009          304 -TRSNSMIGTVEYMAPEIVLG---KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQ-QKIVKDKL-----RLPAFLS  373 (482)
Q Consensus       304 -~~~~~~~gt~~y~APE~l~~---~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~-~~i~~~~~-----~~p~~~s  373 (482)
                       ......+||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+.+..... ..+.++..     .++..++
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  239 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP  239 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence             23456789999999999975   35899999999999999999999999886655444 44444321     2456789


Q ss_pred             hHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          374 SEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       374 ~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      +++++||.+||+.||++||++     +||+++
T Consensus       240 ~~l~~li~~cl~~dp~~RPt~-----~~il~~  266 (276)
T d1uwha_         240 KAMKRLMAECLKKKRDERPLF-----PQILAS  266 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCH-----HHHHHH
Confidence            999999999999999999998     899875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=431.28  Aligned_cols=257  Identities=27%  Similarity=0.409  Sum_probs=217.7

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec------
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT------  221 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------  221 (482)
                      .+++|+++++||+|+||+||+|+++.+|+.||||++.++.. .......+.+|+.+|++++||||+++++++..      
T Consensus         8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            46899999999999999999999999999999999977643 23345567889999999999999999998854      


Q ss_pred             --CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          222 --KYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       222 --~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                        .+.+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence              456899999999887776666667899999999999999999999999999999999999999999999999999987


Q ss_pred             ccCC-----CCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCCCc---
Q 047009          300 FDEN-----TRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRLPA---  370 (482)
Q Consensus       300 ~~~~-----~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~---  370 (482)
                      +...     ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.......+......++.   
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  246 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            5422     233456899999999999865 6899999999999999999999999988887777766553222111   


Q ss_pred             -----------------------------cCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCC
Q 047009          371 -----------------------------FLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKP  410 (482)
Q Consensus       371 -----------------------------~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~  410 (482)
                                                   ..++++++||.+||++||++|+|+     +|+++||||+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa-----~elL~Hpff~~  310 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS-----DDALNHDFFWS  310 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGSS
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH-----HHHHcChhhcc
Confidence                                         137788999999999999999999     99999999985

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.9e-54  Score=432.66  Aligned_cols=252  Identities=25%  Similarity=0.430  Sum_probs=215.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeec--CCeE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQT--KYRL  225 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~--~~~~  225 (482)
                      .++|+++++||+|+||+||+|+++.+|+.||||++++..      .+.+.+|+.+|++++ ||||++++++|..  ...+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            478999999999999999999999999999999987542      345788999999995 9999999999974  4569


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC-ceeEcccCccccccCCC
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG-HVMLTDFGLAKQFDENT  304 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~  304 (482)
                      ++|||||.+++|...   .+.+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+......
T Consensus       108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999999998754   35699999999999999999999999999999999999999765 59999999999887777


Q ss_pred             CCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchH-HHHHHHHh-------------ccc---
Q 047009          305 RSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRA-KIQQKIVK-------------DKL---  366 (482)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~-~~~~~i~~-------------~~~---  366 (482)
                      .....+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||...... .....+.+             ...   
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            77788999999999998875 5799999999999999999999999765432 22222211             000   


Q ss_pred             ---------------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          367 ---------------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       367 ---------------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                                           .....+++++++||++||++||++|||+     +|+|+||||+++.|+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-----~e~L~Hp~F~~v~~~  328 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA-----REAMEHPYFYTVVKD  328 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTSCCC
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCCCCCC
Confidence                                 0112378999999999999999999999     999999999999985

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=435.46  Aligned_cols=249  Identities=32%  Similarity=0.513  Sum_probs=215.0

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec------CCe
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT------KYR  224 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~  224 (482)
                      +|+.+++||+|+||+||+|+++.+|+.||||++.++..       ...+|+.+|++++||||++++++|..      ..+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            69999999999999999999999999999999976542       12479999999999999999999843      346


Q ss_pred             EEEEEEecCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCC-ceeEcccCccccc
Q 047009          225 LYLVLDFINGGHLFFQ---LYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADG-HVMLTDFGLAKQF  300 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~---l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g-~vKL~DFGla~~~  300 (482)
                      +|||||||+++.+...   ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            8999999987644333   23456799999999999999999999999999999999999999876 8999999999988


Q ss_pred             cCCCCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhc---------------
Q 047009          301 DENTRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKD---------------  364 (482)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~---------------  364 (482)
                      .......+.+||+.|+|||++.+ ..|+.++||||+||++|||++|+.||.+.+..+....+.+.               
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred             cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence            77777778899999999999876 57899999999999999999999999988877776666531               


Q ss_pred             --ccCC------------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          365 --KLRL------------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       365 --~~~~------------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                        ...+            ...+++++.+||++||++||++|||+     .|+++||||+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-----~e~L~Hp~f~~~  309 (350)
T d1q5ka_         254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP-----LEACAHSFFDEL  309 (350)
T ss_dssp             --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGGGG
T ss_pred             hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCH-----HHHhcCHhhccc
Confidence              1111            23478999999999999999999999     999999999865

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-53  Score=418.89  Aligned_cols=257  Identities=25%  Similarity=0.483  Sum_probs=224.8

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEEEE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +++|++++.||+|+||+||+|+++.+|+.||||+++.... .......+.+|+.+|+.++||||++++++|.+...+++|
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            4789999999999999999999999999999999987643 445677889999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC-CCc
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT-RSN  307 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~  307 (482)
                      ++++.|++|..++..++.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+...... ...
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            9999999999988888899999999999999999999999999999999999999999999999999999875433 334


Q ss_pred             ccccCCCCCchhhhcCCC-CCchhHHHHHhHHHHHHhhCCCCC-CCCchHHHHHHHHhcc--------------------
Q 047009          308 SMIGTVEYMAPEIVLGKG-HNKAADWWSVGILLYEMLTGKPPF-IGGNRAKIQQKIVKDK--------------------  365 (482)
Q Consensus       308 ~~~gt~~y~APE~l~~~~-~~~~sDvwSlGvilyelltG~~PF-~~~~~~~~~~~i~~~~--------------------  365 (482)
                      ...+++.|+|||++.+.. ++.++|||||||++|||++|+.|| .+.+..+...++....                    
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            556788999999998765 689999999999999999999985 4555555555554311                    


Q ss_pred             ---------cCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          366 ---------LRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       366 ---------~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                               ...+..+++++++||++||++||++|||+     +|+|+||||+++
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa-----~e~L~Hp~f~~~  289 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-----EEALQHPYFSDF  289 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHTTSGGGSSC
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCH-----HHHhcChhhcCC
Confidence                     11223468899999999999999999999     999999999863

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-54  Score=433.32  Aligned_cols=256  Identities=29%  Similarity=0.429  Sum_probs=214.2

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC-----
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY-----  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  223 (482)
                      .++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|++++|||||+++++|...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            3789999999999999999999999999999999986543 4455677889999999999999999999997654     


Q ss_pred             -eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 -RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                       .+|+||||+ +++|.... +++.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus        96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence             579999999 55665544 567899999999999999999999999999999999999999999999999999988643


Q ss_pred             CCCCcccccCCCCCchhhhcCC-CCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc---------------
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGK-GHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL---------------  366 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~---------------  366 (482)
                        .....+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+.....               
T Consensus       174 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (346)
T d1cm8a_         174 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  251 (346)
T ss_dssp             --SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             --ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence              34567899999999999874 568999999999999999999999998877666554443111               


Q ss_pred             ----------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCCChh
Q 047009          367 ----------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPINWK  414 (482)
Q Consensus       367 ----------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~~~~  414 (482)
                                      .....+++++++||++||..||++|||+     +|||+||||+.+.+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-----~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-----GEALAHPYFESLHDT  310 (346)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGTTTC--
T ss_pred             hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCH-----HHHhcChhhCcCCCc
Confidence                            1224578999999999999999999999     999999999987653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=420.32  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=215.2

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeEE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRLY  226 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  226 (482)
                      +..++|++.+.||+|+||+||+|+++++ +.||||+++....    ..+.+.+|+.+|++++|||||++++++.+ +.++
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~   87 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   87 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence            3457899999999999999999999875 5699999976542    23568899999999999999999999865 5678


Q ss_pred             EEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC
Q 047009          227 LVLDFINGGHLFFQLYH--HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT  304 (482)
Q Consensus       227 lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~  304 (482)
                      +||||+++|+|..++..  .+.+++.++..++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+......
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            99999999999887754  3579999999999999999999999999999999999999999999999999998764332


Q ss_pred             --CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhC-CCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHH
Q 047009          305 --RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTG-KPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLL  380 (482)
Q Consensus       305 --~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG-~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI  380 (482)
                        ......||+.|+|||++.+..++.++|||||||++|||++| ++||.+.+..++...+.++ ....+..+++++++||
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  247 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM  247 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHH
Confidence              33456799999999999999999999999999999999995 6666777777777777765 4567888999999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHh--CcCCCC
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKS--HKWFKP  410 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~--hp~f~~  410 (482)
                      .+||+.||++||++     ++|++  ++||..
T Consensus       248 ~~cl~~dP~~Rps~-----~~i~~~L~~~~~~  274 (285)
T d1fmka3         248 CQCWRKEPEERPTF-----EYLQAFLEDYFTS  274 (285)
T ss_dssp             HHHTCSSGGGSCCH-----HHHHHHHHTTTSC
T ss_pred             HHHcccCHhHCcCH-----HHHHHHHhhhhcC
Confidence            99999999999998     89887  788875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-53  Score=415.56  Aligned_cols=251  Identities=22%  Similarity=0.330  Sum_probs=210.7

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCC----eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTS----EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK  222 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  222 (482)
                      +..+.|++.++||+|+||+||+|.++.++    ..||||+++...  .......+.+|+.+|++++|||||++++++.+.
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            34578999999999999999999988765    479999997543  233455688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCcccccc
Q 047009          223 YRLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFD  301 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~  301 (482)
                      ..+++||||+.+|++...+... +.+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+.
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999999998877655 679999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC----CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhC-CCCCCCCchHHHHHHHHhc-ccCCCccCChH
Q 047009          302 ENT----RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTG-KPPFIGGNRAKIQQKIVKD-KLRLPAFLSSE  375 (482)
Q Consensus       302 ~~~----~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG-~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~  375 (482)
                      ...    ......||+.|||||++.+..++.++|||||||++|||++| .+||.+.+..++.+.+..+ ++..|..++.+
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  241 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA  241 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHH
Confidence            332    22345789999999999999999999999999999999995 5556666777777777665 45677889999


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +.+||.+||+.||++||++     .||++
T Consensus       242 l~~li~~cl~~~p~~RPt~-----~eil~  265 (283)
T d1mqba_         242 IYQLMMQCWQQERARRPKF-----ADIVS  265 (283)
T ss_dssp             HHHHHHHHTCSSTTTSCCH-----HHHHH
T ss_pred             HHHHHHHHCcCCHhHCcCH-----HHHHH
Confidence            9999999999999999998     88875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=416.90  Aligned_cols=249  Identities=23%  Similarity=0.383  Sum_probs=209.7

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCC---CeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCeE
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNT---SEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYRL  225 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  225 (482)
                      -++|++.+.||+|+||+||+|++..+   +..||||+++...  .....+.+.+|+.+|++++|||||++++++. .+.+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            36899999999999999999998754   3578899886432  3445667889999999999999999999996 4678


Q ss_pred             EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC-
Q 047009          226 YLVLDFINGGHLFFQLYH-HGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN-  303 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-  303 (482)
                      |+||||+++|+|..++.. .+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+... 
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            999999999999987665 457999999999999999999999999999999999999999999999999999876533 


Q ss_pred             -CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhcc-cCCCccCChHHHHHH
Q 047009          304 -TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDK-LRLPAFLSSEAHSLL  380 (482)
Q Consensus       304 -~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~LI  380 (482)
                       .......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..++...+..+. ..+|..+|+++++||
T Consensus       163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li  242 (273)
T d1mp8a_         163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM  242 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence             23345678999999999999999999999999999999998 899999999988888888764 578889999999999


Q ss_pred             HHhhccCcCCcCCCCCCChHHHHhC
Q 047009          381 KGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       381 ~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      .+||+.||++||++     .||++|
T Consensus       243 ~~cl~~dp~~Rps~-----~ei~~~  262 (273)
T d1mp8a_         243 TKCWAYDPSRRPRF-----TELKAQ  262 (273)
T ss_dssp             HHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHcCCCHhHCcCH-----HHHHHH
Confidence            99999999999998     899875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-53  Score=421.17  Aligned_cols=249  Identities=24%  Similarity=0.378  Sum_probs=213.5

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCe----EEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCCe
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSE----IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKYR  224 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  224 (482)
                      .++|+++++||+|+||+||+|++..+|+    .||+|.++...  .....+.+.+|+.+|++++|||||+++++|.++ .
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   84 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence            3689999999999999999999988876    47777775432  334456788999999999999999999999875 5


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          225 LYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      .++++||+.+|+|...+..+ ..+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.....
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            67889999999998877664 57999999999999999999999999999999999999999999999999999986543


Q ss_pred             CC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHH
Q 047009          304 TR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHS  378 (482)
Q Consensus       304 ~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (482)
                      ..   .....||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..++...+.++ ++..|..+++++.+
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~  244 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM  244 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence            32   234568999999999999999999999999999999998 89999998888888887775 46778889999999


Q ss_pred             HHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          379 LLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       379 LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      ||.+||+.||++||++     .||++|
T Consensus       245 li~~cl~~dP~~RPs~-----~eil~~  266 (317)
T d1xkka_         245 IMVKCWMIDADSRPKF-----RELIIE  266 (317)
T ss_dssp             HHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHhCCCChhhCcCH-----HHHHHH
Confidence            9999999999999998     899987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-53  Score=428.45  Aligned_cols=254  Identities=26%  Similarity=0.435  Sum_probs=207.6

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec------C
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT------K  222 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~  222 (482)
                      +++|+++++||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|++++|||||+++++|..      .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            4789999999999999999999999999999999987653 34556678899999999999999999999953      4


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      ..+|+||||+.++.+ ..+  ...+++..++.+++||+.||+|||++||+||||||+|||++.++.+|++|||+++....
T Consensus        95 ~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          95 QDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             CEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence            689999999987654 443  45789999999999999999999999999999999999999999999999999998877


Q ss_pred             CCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc----------------
Q 047009          303 NTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL----------------  366 (482)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~----------------  366 (482)
                      .......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+......++.....                
T Consensus       172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  251 (355)
T d2b1pa1         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred             ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence            7777788999999999999999999999999999999999999999998877666665543111                


Q ss_pred             ------CC---------C-----------ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          367 ------RL---------P-----------AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       367 ------~~---------p-----------~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                            ..         +           ...++++++||++||..||++|||+     +|+|+||||+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta-----~elL~Hpw~~~~  317 (355)
T d2b1pa1         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-----DDALQHPYINVW  317 (355)
T ss_dssp             HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH-----HHHHTSTTTGGG
T ss_pred             HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH-----HHHhcCcccCCC
Confidence                  00         0           1136789999999999999999999     999999999864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=422.53  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=221.1

Q ss_pred             ccCCCCeEEEEEecccCceEEEEEEEcCCCeE--EEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeecC
Q 047009          146 CVGIEDFEVLKVVGQGAFGRVYQVRKKNTSEI--YAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQTK  222 (482)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  222 (482)
                      .+..++|++.+.||+|+||+||+|+++.+|..  ||||.+....  ..+..+.+.+|+++|+++ +|||||+++++|.++
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            35568999999999999999999999988864  6677765432  334556688999999998 799999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccC
Q 047009          223 YRLYLVLDFINGGHLFFQLYHH----------------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGAD  286 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~  286 (482)
                      +.+|+||||++||+|.+++..+                ..+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence            9999999999999999998754                568999999999999999999999999999999999999999


Q ss_pred             CceeEcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhC-CCCCCCCchHHHHHHHHhc-
Q 047009          287 GHVMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTG-KPPFIGGNRAKIQQKIVKD-  364 (482)
Q Consensus       287 g~vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG-~~PF~~~~~~~~~~~i~~~-  364 (482)
                      +.+||+|||+|+............||..|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..++.+.+.++ 
T Consensus       164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~  243 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  243 (309)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence            99999999999887655555667899999999999999999999999999999999996 5689999999998888775 


Q ss_pred             ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          365 KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       365 ~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      .+..|..+++++++||.+||+.||++||++     +||++|
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~eil~~  279 (309)
T d1fvra_         244 RLEKPLNCDDEVYDLMRQCWREKPYERPSF-----AQILVS  279 (309)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            567788899999999999999999999999     999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=424.13  Aligned_cols=254  Identities=27%  Similarity=0.405  Sum_probs=211.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC----eE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY----RL  225 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~  225 (482)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+.+|+.+|++++||||+++++++....    ..
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            56999999999999999999999999999999997643  3445567889999999999999999999986543    23


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC--
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN--  303 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~--  303 (482)
                      +++++|+.||+|..++.. +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....  
T Consensus        86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            444556779999998865 46999999999999999999999999999999999999999999999999999875332  


Q ss_pred             --CCCcccccCCCCCchhhhcC-CCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhccc--------------
Q 047009          304 --TRSNSMIGTVEYMAPEIVLG-KGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKL--------------  366 (482)
Q Consensus       304 --~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~--------------  366 (482)
                        ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+..........              
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence              23456789999999999854 5678999999999999999999999988776655544432100              


Q ss_pred             -----------------CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          367 -----------------RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       367 -----------------~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                                       .....+++++++||.+||++||.+||++     +|+|+||||+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta-----~e~L~hpf~~~~  301 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV-----EQALAHPYLEQY  301 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGTTT
T ss_pred             hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCH-----HHHhcCHhhccC
Confidence                             0123468899999999999999999998     999999999854

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-53  Score=413.12  Aligned_cols=252  Identities=25%  Similarity=0.399  Sum_probs=209.6

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCC-C--eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNT-S--EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~--~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      +..+||++++.||+|+||+||+|+++.. +  ..||||++++......+..+.+.+|+.+|++++|||||++++++.+. 
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence            3457899999999999999999987543 2  47999999887665666677889999999999999999999999764 


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccC
Q 047009          224 RLYLVLDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~  302 (482)
                      .+++||||+++|++.+.+..+ +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            678999999999998876554 5799999999999999999999999999999999999999999999999999998754


Q ss_pred             CCC----CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhccc--CCCccCChH
Q 047009          303 NTR----SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKDKL--RLPAFLSSE  375 (482)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~~~--~~p~~~s~~  375 (482)
                      ...    .....||..|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+.+...  ..+..++++
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD  243 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence            332    234568889999999999999999999999999999998 8999999999999999887744  456789999


Q ss_pred             HHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          376 AHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       376 ~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +++||.+||+.||++||++     ++|++
T Consensus       244 l~~li~~cl~~dp~~RPt~-----~ei~~  267 (273)
T d1u46a_         244 IYNVMVQCWAHKPEDRPTF-----VALRD  267 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            9999999999999999998     78763

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=424.30  Aligned_cols=254  Identities=27%  Similarity=0.375  Sum_probs=216.1

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecC-----C
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTK-----Y  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~  223 (482)
                      .++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|++++|||||+++++|...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            3789999999999999999999999999999999987543 334556788999999999999999999998643     3


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          224 RLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      ..+++|+|+.||+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++....  
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~--  172 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--  172 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred             ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC--
Confidence            34666778889999988754 579999999999999999999999999999999999999999999999999997653  


Q ss_pred             CCCcccccCCCCCchhhhcCCC-CCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHHHhcccCC--------------
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKG-HNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKIVKDKLRL--------------  368 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i~~~~~~~--------------  368 (482)
                      ....+..||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+.+.....              
T Consensus       173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  252 (348)
T d2gfsa1         173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  252 (348)
T ss_dssp             GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred             cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence            3345678999999999987754 6899999999999999999999999988877777766532211              


Q ss_pred             -----------------CccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCCCCC
Q 047009          369 -----------------PAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWFKPI  411 (482)
Q Consensus       369 -----------------p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f~~~  411 (482)
                                       ...+++++++||++||+.||++|||+     +|+|+||||+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-----~elL~Hp~f~~~  307 (348)
T d2gfsa1         253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-----AQALAHAYFAQY  307 (348)
T ss_dssp             HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTT
T ss_pred             hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCH-----HHHhcCHhhCCC
Confidence                             12478999999999999999999999     999999999865

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-52  Score=414.41  Aligned_cols=249  Identities=21%  Similarity=0.362  Sum_probs=219.6

Q ss_pred             CCCeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC
Q 047009          149 IEDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY  223 (482)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  223 (482)
                      .++|++++.||+|+||+||+|++++     +++.||||+++...  ..+..+.+.+|+.+|++++||||+++++++.+..
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            4789999999999999999999864     56889999997643  3345667899999999999999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 047009          224 RLYLVLDFINGGHLFFQLYHHG------------------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPE  279 (482)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~------------------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~  279 (482)
                      ..++||||+++|+|.+++....                        .+++..+..|+.||+.||+|||+++||||||||+
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~  169 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  169 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence            9999999999999999986532                        3788899999999999999999999999999999


Q ss_pred             cEEEccCCceeEcccCccccccCC---CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhC-CCCCCCCchH
Q 047009          280 NILLGADGHVMLTDFGLAKQFDEN---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTG-KPPFIGGNRA  355 (482)
Q Consensus       280 NILl~~~g~vKL~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG-~~PF~~~~~~  355 (482)
                      ||||+.++++||+|||+|+.....   ....+.+||+.|+|||++.+..|+.++|||||||++|||++| .+||.+.+..
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            999999999999999999875332   233457899999999999999999999999999999999998 4789999999


Q ss_pred             HHHHHHHhccc-CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          356 KIQQKIVKDKL-RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       356 ~~~~~i~~~~~-~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ++...+.++.. ..|..+++++.+||.+||+.||++||++     .||++
T Consensus       250 e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~-----~ev~~  294 (301)
T d1lufa_         250 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF-----CSIHR  294 (301)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            99888887754 5678899999999999999999999998     88754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-53  Score=409.29  Aligned_cols=244  Identities=25%  Similarity=0.434  Sum_probs=210.1

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeee-cCCeE
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQ-TKYRL  225 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~  225 (482)
                      +..++|++++.||+|+||.||+|+++  |+.||||+++++.     ..+.+.+|+.++++++||||+++++++. +.+.+
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            45689999999999999999999985  6789999997643     3456889999999999999999999884 45678


Q ss_pred             EEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCC
Q 047009          226 YLVLDFINGGHLFFQLYHHG--LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDEN  303 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~  303 (482)
                      |+||||+++|+|.+++..++  .+++..++.++.||+.||.|||+++|+||||||+|||++.+|++||+|||+++.... 
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-  155 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-  155 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-
Confidence            99999999999999986643  589999999999999999999999999999999999999999999999999987643 


Q ss_pred             CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHHHHHHhc-ccCCCccCChHHHHHHH
Q 047009          304 TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQQKIVKD-KLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~  381 (482)
                       ......+|+.|+|||++.+..++.++|||||||++|||+| |++||...+..++...+.++ ++.+|..+++++++||+
T Consensus       156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  234 (262)
T d1byga_         156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK  234 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred             -CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence             2345678999999999999999999999999999999998 89999998888888888764 66788899999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHh
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +||..||.+||++     .+|++
T Consensus       235 ~cl~~dP~~Rps~-----~~l~~  252 (262)
T d1byga_         235 NCWHLDAAMRPSF-----LQLRE  252 (262)
T ss_dssp             HHTCSSGGGSCCH-----HHHHH
T ss_pred             HHcccCHhHCcCH-----HHHHH
Confidence            9999999999998     88876

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=412.22  Aligned_cols=251  Identities=24%  Similarity=0.404  Sum_probs=203.3

Q ss_pred             CCCCeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeeec
Q 047009          148 GIEDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQT  221 (482)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  221 (482)
                      ..++|++.+.||+|+||+||+|++..     +++.||||+++...  .....+.+.+|..++.++ +|+||+++++++..
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            34789999999999999999999765     44789999987543  223345566777777776 68999999988755


Q ss_pred             -CCeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 047009          222 -KYRLYLVLDFINGGHLFFQLYHH----------------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLG  284 (482)
Q Consensus       222 -~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~  284 (482)
                       ...+++|||||++|+|..++...                ..+++..++.|+.||+.||+|||++|||||||||+||||+
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  168 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence             45789999999999999998653                2488999999999999999999999999999999999999


Q ss_pred             cCCceeEcccCccccccCC---CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhC-CCCCCCCchHHHH-H
Q 047009          285 ADGHVMLTDFGLAKQFDEN---TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTG-KPPFIGGNRAKIQ-Q  359 (482)
Q Consensus       285 ~~g~vKL~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG-~~PF~~~~~~~~~-~  359 (482)
                      .+|++||+|||+|+.....   ......+||+.|||||++.+..++.++|||||||++|||++| .+||.+.+..+.. .
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~  248 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  248 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999999875432   234457899999999999999999999999999999999986 5688776654444 4


Q ss_pred             HHHhc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhC
Q 047009          360 KIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       360 ~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      .+..+ .+..|..+++++++||.+||+.||++||++     +||++|
T Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~eil~~  290 (299)
T d1ywna1         249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-----SELVEH  290 (299)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            44443 567788899999999999999999999998     899886

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-52  Score=409.55  Aligned_cols=251  Identities=21%  Similarity=0.373  Sum_probs=216.9

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcCCC-------eEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKNTS-------EIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYS  218 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  218 (482)
                      +..++|++++.||+|+||.||+|++..++       ..||||+++++.  .......+.+|..++.++ +|||||+++++
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            44589999999999999999999987654       479999997654  233455677888888887 89999999999


Q ss_pred             eecCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 047009          219 FQTKYRLYLVLDFINGGHLFFQLYHHG----------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENIL  282 (482)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NIL  282 (482)
                      |.+++.+++||||+++|+|..++....                .+++..++.++.||+.||+|||+++||||||||+|||
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  167 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence            999999999999999999999997543                4899999999999999999999999999999999999


Q ss_pred             EccCCceeEcccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHH
Q 047009          283 LGADGHVMLTDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQ  358 (482)
Q Consensus       283 l~~~g~vKL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~  358 (482)
                      ++.+|.+||+|||+++......   .....+||+.|+|||++.++.|+.++|||||||++|||++ |.+||.+.+...+.
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~  247 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  247 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence            9999999999999999765432   3445789999999999999999999999999999999998 79999998888888


Q ss_pred             HHHHhc-ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          359 QKIVKD-KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       359 ~~i~~~-~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      +.+..+ .+.+|..+++++++||.+||++||++||++     .||++
T Consensus       248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~-----~eil~  289 (299)
T d1fgka_         248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-----KQLVE  289 (299)
T ss_dssp             HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCH-----HHHHH
Confidence            887665 567788899999999999999999999998     88875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=408.85  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=221.1

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEcC-----CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKKN-----TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT  221 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  221 (482)
                      +..++|++.+.||+|+||+||+|.++.     ++..||||++++..  .......+.+|+.++++++|||||++++++..
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            345899999999999999999998863     35789999997643  33445668899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeE
Q 047009          222 KYRLYLVLDFINGGHLFFQLYHH----------GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVML  291 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL  291 (482)
                      ....++||||+++|+|..++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++||
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence            99999999999999999887543          24688899999999999999999999999999999999999999999


Q ss_pred             cccCccccccCCC---CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhC-CCCCCCCchHHHHHHHHhcc-c
Q 047009          292 TDFGLAKQFDENT---RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTG-KPPFIGGNRAKIQQKIVKDK-L  366 (482)
Q Consensus       292 ~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG-~~PF~~~~~~~~~~~i~~~~-~  366 (482)
                      +|||+|+.+....   .....+||+.|+|||.+.+..++.++|||||||++|||+|| ++||.+.+..+..+.+.++. +
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~  254 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL  254 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence            9999998764332   23445789999999999999999999999999999999998 68899999988888887754 4


Q ss_pred             CCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          367 RLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       367 ~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      ..|..+++.+.+||.+||+.||++||++     ++|++
T Consensus       255 ~~p~~~~~~l~~li~~cl~~~P~~RPs~-----~~il~  287 (308)
T d1p4oa_         255 DKPDNCPDMLFELMRMCWQYNPKMRPSF-----LEIIS  287 (308)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCcccchHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            5678899999999999999999999998     88886

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=402.61  Aligned_cols=251  Identities=22%  Similarity=0.358  Sum_probs=218.0

Q ss_pred             cCCCCeEEEEEecccCceEEEEEEEc-----CCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhC-CCCceeeeeeeee
Q 047009          147 VGIEDFEVLKVVGQGAFGRVYQVRKK-----NTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKI-DHPFVVQLKYSFQ  220 (482)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  220 (482)
                      +..++|++.+.||+|+||.||+|+++     .+++.||||++++..  .......+.+|+.+++++ +|||||++++++.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            34589999999999999999999864     466899999998654  234455688999999999 7999999999999


Q ss_pred             cCCeEEEEEEecCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 047009          221 TKYRLYLVLDFINGGHLFFQLYHHG------------------LFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENIL  282 (482)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~------------------~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NIL  282 (482)
                      +...+++|||||++|+|..++....                  .+++..+..|+.||+.||+|||++|||||||||+|||
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl  177 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence            9999999999999999999987643                  5889999999999999999999999999999999999


Q ss_pred             EccCCceeEcccCccccccCCCC---CcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhh-CCCCCCCCchHHHH
Q 047009          283 LGADGHVMLTDFGLAKQFDENTR---SNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLT-GKPPFIGGNRAKIQ  358 (482)
Q Consensus       283 l~~~g~vKL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyellt-G~~PF~~~~~~~~~  358 (482)
                      ++.++.+||+|||+++.......   ....+||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+..
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999998654322   245689999999999999999999999999999999998 77777777766655


Q ss_pred             HHHHhc--ccCCCccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          359 QKIVKD--KLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       359 ~~i~~~--~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .++...  .+..|..+++++.+||.+||+.||++||++     ++|++
T Consensus       258 ~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~-----~~il~  300 (311)
T d1t46a_         258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF-----KQIVQ  300 (311)
T ss_dssp             HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            555544  345567799999999999999999999998     88875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.2e-50  Score=394.66  Aligned_cols=252  Identities=20%  Similarity=0.287  Sum_probs=202.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCce-eeeeeeeecCCeEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFV-VQLKYSFQTKYRLYLV  228 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV  228 (482)
                      ++|++++.||+|+||+||+|+++.+|+.||||++..+..     .+.+..|+++++.++|+|+ +.+.+++.+....++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            469999999999999999999999999999999876532     1236789999999987765 5556666888899999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc---CCceeEcccCccccccCCC-
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA---DGHVMLTDFGLAKQFDENT-  304 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~---~g~vKL~DFGla~~~~~~~-  304 (482)
                      |||+.++.+.......+.+++..+..++.|++.||+|||++|||||||||+|||++.   +..+||+|||+|+.+.... 
T Consensus        82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            999966544444445678999999999999999999999999999999999999864   4579999999999865332 


Q ss_pred             -------CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchHHHHHHH---Hhccc-----CCC
Q 047009          305 -------RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRAKIQQKI---VKDKL-----RLP  369 (482)
Q Consensus       305 -------~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~~~~~~i---~~~~~-----~~p  369 (482)
                             .....+||+.|||||++.+..++.++|||||||++|||++|+.||...........+   .....     .++
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  241 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence                   234568999999999999999999999999999999999999999875544333222   12111     234


Q ss_pred             ccCChHHHHHHHHhhccCcCCcCCCCCCChHHHHhCcCC
Q 047009          370 AFLSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKSHKWF  408 (482)
Q Consensus       370 ~~~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~hp~f  408 (482)
                      ..+|+++.+||.+||+.||++||++  ....++++|+|.
T Consensus       242 ~~~p~~~~~li~~cl~~~p~~RP~~--~~i~~~l~~~~~  278 (299)
T d1ckia_         242 KGYPSEFATYLNFCRSLRFDDKPDY--SYLRQLFRNLFH  278 (299)
T ss_dssp             TTSCHHHHHHHHHHHHSCTTCCCCH--HHHHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCH--HHHHHHHHHHHH
Confidence            5689999999999999999999987  223456777664

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-49  Score=392.59  Aligned_cols=245  Identities=21%  Similarity=0.292  Sum_probs=205.8

Q ss_pred             EEEEecccCceEEEEEEEcCCC---eEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeec-CCeEEEEE
Q 047009          154 VLKVVGQGAFGRVYQVRKKNTS---EIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQT-KYRLYLVL  229 (482)
Q Consensus       154 i~~~LG~G~fg~Vy~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV~  229 (482)
                      ..++||+|+||+||+|++..++   ..||||++++.  ......+.+.+|+++|++++|||||++++++.. ++.+++||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            3578999999999999986643   46999998753  244556778999999999999999999998764 56899999


Q ss_pred             EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCccccccCCC----
Q 047009          230 DFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGLAKQFDENT----  304 (482)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~----  304 (482)
                      |||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||||++++.+||+|||+++......    
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999888754 457788899999999999999999999999999999999999999999999998764332    


Q ss_pred             -CCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCC-CchHHHHHHHHhc-ccCCCccCChHHHHHHH
Q 047009          305 -RSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIG-GNRAKIQQKIVKD-KLRLPAFLSSEAHSLLK  381 (482)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~-~~~~~~~~~i~~~-~~~~p~~~s~~~~~LI~  381 (482)
                       ......||+.|+|||++.+..++.++||||||+++|||++|..||.. .+..++...+..+ .+..|..+++++.+||.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence             22335789999999999999999999999999999999997676654 4445556666655 45677889999999999


Q ss_pred             HhhccCcCCcCCCCCCChHHHHhC
Q 047009          382 GLLQKEPGKRLGAGPKGSEEIKSH  405 (482)
Q Consensus       382 ~~L~~dP~~R~s~~~~~~~eil~h  405 (482)
                      +||++||++||++     .||++|
T Consensus       269 ~cl~~dP~~RPs~-----~ei~~~  287 (311)
T d1r0pa_         269 KCWHPKAEMRPSF-----SELVSR  287 (311)
T ss_dssp             HHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHcCCCHhHCcCH-----HHHHHH
Confidence            9999999999998     899976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.3e-47  Score=378.59  Aligned_cols=239  Identities=21%  Similarity=0.304  Sum_probs=203.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCC-CceeeeeeeeecCCeEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH-PFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV  228 (482)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.....     ...+.+|+++++.+.| +|++.+++++......++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            689999999999999999999999999999999876432     2236788999999976 8999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcc-----CCceeEcccCccccccC
Q 047009          229 LDFINGGHLFFQLYHH-GLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGA-----DGHVMLTDFGLAKQFDE  302 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~-----~g~vKL~DFGla~~~~~  302 (482)
                      |||+ +++|...+... ..+++..+..++.|++.||+|||++|||||||||+|||++.     ++.+||+|||+|+.+..
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9999 67888888665 46999999999999999999999999999999999999974     57899999999987643


Q ss_pred             C--------CCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCch---HHHHHHHHhccc-----
Q 047009          303 N--------TRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNR---AKIQQKIVKDKL-----  366 (482)
Q Consensus       303 ~--------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~---~~~~~~i~~~~~-----  366 (482)
                      .        ......+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+.   ......+.....     
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  238 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence            2        123457899999999999999999999999999999999999999976433   333333333222     


Q ss_pred             CCCccCChHHHHHHHHhhccCcCCcCCC
Q 047009          367 RLPAFLSSEAHSLLKGLLQKEPGKRLGA  394 (482)
Q Consensus       367 ~~p~~~s~~~~~LI~~~L~~dP~~R~s~  394 (482)
                      .++..+++++.+++..|+..+|++||+.
T Consensus       239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y  266 (293)
T d1csna_         239 ELCAGFPEEFYKYMHYARNLAFDATPDY  266 (293)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCH
T ss_pred             HhcCCCCHHHHHHHHHHhcCCcccCcCH
Confidence            2235688999999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-48  Score=381.80  Aligned_cols=243  Identities=25%  Similarity=0.345  Sum_probs=194.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCceeeeeeeeecCC----eE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFVVQLKYSFQTKY----RL  225 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~  225 (482)
                      .+|.+.+.||+|+||.||+|++  +|+.||||+++.+..    .....+.|+..+.+++|||||++++++.+.+    .+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            5789999999999999999987  478999999875431    2222334566667889999999999997654    68


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCCcccCCCCCcEEEccCCceeEcccCcc
Q 047009          226 YLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA--------NGIMHRDLKPENILLGADGHVMLTDFGLA  297 (482)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~--------~~IiHrDLKp~NILl~~~g~vKL~DFGla  297 (482)
                      |+|||||++|+|..++.+. .++++.+..++.|++.||+|||+        +|||||||||+||||+.+|++||+|||++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            9999999999999999765 58899999999999999999996        59999999999999999999999999999


Q ss_pred             ccccCCC-----CCcccccCCCCCchhhhcCCC------CCchhHHHHHhHHHHHHhhCCCCCCC---------------
Q 047009          298 KQFDENT-----RSNSMIGTVEYMAPEIVLGKG------HNKAADWWSVGILLYEMLTGKPPFIG---------------  351 (482)
Q Consensus       298 ~~~~~~~-----~~~~~~gt~~y~APE~l~~~~------~~~~sDvwSlGvilyelltG~~PF~~---------------  351 (482)
                      +......     .....+||+.|||||++.+..      ++.++|||||||+||||+||..||..               
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            8864432     234578999999999998753      57799999999999999999887732               


Q ss_pred             CchHHHHHHHHhccc--CCCcc-----CChHHHHHHHHhhccCcCCcCCCCCCChHHHHh
Q 047009          352 GNRAKIQQKIVKDKL--RLPAF-----LSSEAHSLLKGLLQKEPGKRLGAGPKGSEEIKS  404 (482)
Q Consensus       352 ~~~~~~~~~i~~~~~--~~p~~-----~s~~~~~LI~~~L~~dP~~R~s~~~~~~~eil~  404 (482)
                      .......+.+.....  .+|..     ....+.+|+.+||+.||++||++     .||++
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~ei~~  290 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-----LRIKK  290 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCH-----HHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCH-----HHHHH
Confidence            122334444443332  33332     22458899999999999999998     88875

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-46  Score=380.89  Aligned_cols=265  Identities=26%  Similarity=0.408  Sum_probs=205.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-----------CCceeeeeee
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-----------HPFVVQLKYS  218 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-----------hpnIv~l~~~  218 (482)
                      ++|+++++||+|+||+||+|+++.+|+.||||+++++..    ..+.+.+|+.+++.++           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            469999999999999999999999999999999987542    2345677888888775           5789999888


Q ss_pred             eec--CCeEEEEEEecCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEccCCc----
Q 047009          219 FQT--KYRLYLVLDFINGGHLFFQL---YHHGLFREDLARIYAAEIVSAVSHLHA-NGIMHRDLKPENILLGADGH----  288 (482)
Q Consensus       219 ~~~--~~~~~lV~E~~~gg~L~~~l---~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~IiHrDLKp~NILl~~~g~----  288 (482)
                      +..  ....+++|+++.++......   .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.    
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            754  45677777777665443332   234578999999999999999999998 89999999999999987764    


Q ss_pred             --eeEcccCccccccCCCCCcccccCCCCCchhhhcCCCCCchhHHHHHhHHHHHHhhCCCCCCCCchH------HHHHH
Q 047009          289 --VMLTDFGLAKQFDENTRSNSMIGTVEYMAPEIVLGKGHNKAADWWSVGILLYEMLTGKPPFIGGNRA------KIQQK  360 (482)
Q Consensus       289 --vKL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwSlGvilyelltG~~PF~~~~~~------~~~~~  360 (482)
                        +||+|||.+.....  .....+||+.|+|||++.+..|+.++|+||+||++++|++|+.||...+..      .....
T Consensus       169 ~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             ceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence              99999999987543  345678999999999999999999999999999999999999999654321      11111


Q ss_pred             HH------------------------------------------hcccCCCccCChHHHHHHHHhhccCcCCcCCCCCCC
Q 047009          361 IV------------------------------------------KDKLRLPAFLSSEAHSLLKGLLQKEPGKRLGAGPKG  398 (482)
Q Consensus       361 i~------------------------------------------~~~~~~p~~~s~~~~~LI~~~L~~dP~~R~s~~~~~  398 (482)
                      +.                                          .....++...++++++||.+||++||.+|||+    
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta----  322 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA----  322 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH----
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH----
Confidence            10                                          01112223356889999999999999999999    


Q ss_pred             hHHHHhCcCCCCCChhhhhhccCCCCCcccc
Q 047009          399 SEEIKSHKWFKPINWKKLEAREIQPGFCPEV  429 (482)
Q Consensus       399 ~~eil~hp~f~~~~~~~~~~~~~~p~~~p~~  429 (482)
                       +|+|+||||+++.+    ..+++.|..+..
T Consensus       323 -~e~L~Hp~f~~~~~----~~~~~~p~~~~~  348 (362)
T d1q8ya_         323 -GGLVNHPWLKDTLG----MEEIRVPDRELY  348 (362)
T ss_dssp             -HHHHTCGGGTTCTT----CTTCCCTTSCTT
T ss_pred             -HHHhcCcccCCCCC----cccCCCCCcccC
Confidence             99999999996542    334444544443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=7e-26  Score=207.93  Aligned_cols=168  Identities=16%  Similarity=0.171  Sum_probs=124.1

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhc---------------hhhHHHHHHHHHHHHHhCCCCceeeee
Q 047009          152 FEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIV---------------EKNHAEYMKAERDILTKIDHPFVVQLK  216 (482)
Q Consensus       152 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~---------------~~~~~~~~~~E~~il~~l~hpnIv~l~  216 (482)
                      +.+.+.||+|+||+||+|++. +|+.||||+++.....               .........+|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            457899999999999999986 5899999987642211               011223455788899999999998877


Q ss_pred             eeeecCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEccCCceeEcccCc
Q 047009          217 YSFQTKYRLYLVLDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLGADGHVMLTDFGL  296 (482)
Q Consensus       217 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IiHrDLKp~NILl~~~g~vKL~DFGl  296 (482)
                      ++..    .+++|||++++.+.       .+++..+..++.|++.||.|||++||+||||||+|||++++ .++|+|||+
T Consensus        81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            6532    26999999987653       24566678899999999999999999999999999999865 489999999


Q ss_pred             cccccCCCCCcccccCCCCCch------hhhcCCCCCchhHHHHHhHHHH
Q 047009          297 AKQFDENTRSNSMIGTVEYMAP------EIVLGKGHNKAADWWSVGILLY  340 (482)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~AP------E~l~~~~~~~~sDvwSlGvily  340 (482)
                      |+........       .|...      +. ..+.|+.++|+||+.--+.
T Consensus       149 a~~~~~~~~~-------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         149 SVEVGEEGWR-------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CEETTSTTHH-------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             cccCCCCCcH-------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence            9775432211       11111      11 2356888999999865443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.48  E-value=3.8e-07  Score=84.92  Aligned_cols=140  Identities=14%  Similarity=0.110  Sum_probs=90.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecCCeEEEE
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTKYRLYLV  228 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV  228 (482)
                      +.|++.+..+-++.+.||++.  .++..+.+|+.......   ....+.+|...+..+. +--+.+++.+....+..++|
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv   88 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence            567777766666668999875  34556788887654321   2223567888877663 32345667777888899999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 047009          229 LDFINGGHLFFQLYHHGLFREDLARIYAAEIVSAVSHLHA----------------------------------------  268 (482)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~----------------------------------------  268 (482)
                      |++++|..+......     ......++.++...|..||+                                        
T Consensus        89 ~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          89 MSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             EEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            999999877543211     11112223333333333332                                        


Q ss_pred             -------------C------CCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          269 -------------N------GIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       269 -------------~------~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                                   .      .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                         1      268999999999998776667999998754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.06  E-value=5.6e-06  Score=82.19  Aligned_cols=81  Identities=15%  Similarity=0.220  Sum_probs=48.1

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeechh-hch---hhHHHHHHHHHHHHHhCC-C--CceeeeeeeeecCCeEEE
Q 047009          155 LKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDK-IVE---KNHAEYMKAERDILTKID-H--PFVVQLKYSFQTKYRLYL  227 (482)
Q Consensus       155 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~-~~~---~~~~~~~~~E~~il~~l~-h--pnIv~l~~~~~~~~~~~l  227 (482)
                      .+.||.|....||++....+++.|++|.....- ...   ....++...|...|..+. +  ..+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            456899999999999887778889999754321 100   112234456777777662 2  334455443  3344578


Q ss_pred             EEEecCCCch
Q 047009          228 VLDFINGGHL  237 (482)
Q Consensus       228 V~E~~~gg~L  237 (482)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.95  E-value=1.7e-05  Score=72.80  Aligned_cols=136  Identities=15%  Similarity=0.120  Sum_probs=81.7

Q ss_pred             EecccC-ceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCC--CceeeeeeeeecCCeEEEEEEecC
Q 047009          157 VVGQGA-FGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDH--PFVVQLKYSFQTKYRLYLVLDFIN  233 (482)
Q Consensus       157 ~LG~G~-fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~  233 (482)
                      .+..|. .+.||++... ++..+.+|......      ...+..|...|+.+..  -.+.+++.+..+.+..++||++++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            344554 4689988754 46668889865442      1235677777776643  224566777788888999999998


Q ss_pred             CCchHH--------------HHHh-cC------CCCHHHHH-------HH---------------HHHHHHHHHHHHHC-
Q 047009          234 GGHLFF--------------QLYH-HG------LFREDLAR-------IY---------------AAEIVSAVSHLHAN-  269 (482)
Q Consensus       234 gg~L~~--------------~l~~-~~------~l~~~~~~-------~i---------------~~qi~~aL~yLH~~-  269 (482)
                      |.++..              .+.+ +.      .+......       .+               .......+..+... 
T Consensus        90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  169 (255)
T d1nd4a_          90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM  169 (255)
T ss_dssp             SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred             ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence            865521              1111 00      01000000       00               00112234444432 


Q ss_pred             ------CCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          270 ------GIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       270 ------~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                            .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                  279999999999998876678999998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.23  E-value=0.00056  Score=65.30  Aligned_cols=130  Identities=18%  Similarity=0.236  Sum_probs=74.8

Q ss_pred             ceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCCCCc-----eeee--eeeeecCCeEEEEEEecCCC
Q 047009          163 FGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPF-----VVQL--KYSFQTKYRLYLVLDFINGG  235 (482)
Q Consensus       163 fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-----Iv~l--~~~~~~~~~~~lV~E~~~gg  235 (482)
                      --.||+++.. +|..|++|+.+....    ..+.+..|...+..|....     .+..  -..+...+..+.+++++.|.
T Consensus        35 EN~vy~v~~~-dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQDE-DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECCT-TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEcC-CCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            4689998865 478899999876532    2344667888777764221     1221  12234566788999999874


Q ss_pred             chH--------------HHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH-----
Q 047009          236 HLF--------------FQLYH----------------------------HGLFREDLARIYAAEIVSAVSHLHA-----  268 (482)
Q Consensus       236 ~L~--------------~~l~~----------------------------~~~l~~~~~~~i~~qi~~aL~yLH~-----  268 (482)
                      .+.              ..+..                            ...++......+...+-..++.+..     
T Consensus       110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~  189 (325)
T d1zyla1         110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED  189 (325)
T ss_dssp             ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred             CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence            321              00100                            0011111111222223333344432     


Q ss_pred             --CCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          269 --NGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       269 --~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                        .++||+|+.+.|||++. | ..++||+.|..
T Consensus       190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             SCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             CCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence              36899999999999964 3 45899998864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.06  E-value=0.0011  Score=64.95  Aligned_cols=77  Identities=14%  Similarity=0.161  Sum_probs=51.1

Q ss_pred             CeEEEEEecccCceEEEEEEEcC-------CCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-CCceeeeeeeeecC
Q 047009          151 DFEVLKVVGQGAFGRVYQVRKKN-------TSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-HPFVVQLKYSFQTK  222 (482)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~  222 (482)
                      ++++ +.|+.|-.-.+|++....       .++.|.+++.-...     ......+|..+++.+. +.-..++++++.+ 
T Consensus        44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-  116 (395)
T d1nw1a_          44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG-  116 (395)
T ss_dssp             GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred             ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-----hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence            3444 678889999999998754       24567788765321     1223457888888874 4334467777754 


Q ss_pred             CeEEEEEEecCCCch
Q 047009          223 YRLYLVLDFINGGHL  237 (482)
Q Consensus       223 ~~~~lV~E~~~gg~L  237 (482)
                         .+|+||++|..|
T Consensus       117 ---g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ---GRLEEYIPSRPL  128 (395)
T ss_dssp             ---EEEECCCCEEEC
T ss_pred             ---ceEEEEeccccC
Confidence               589999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.28  E-value=0.018  Score=53.69  Aligned_cols=143  Identities=17%  Similarity=0.186  Sum_probs=75.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCeEEEEEEeechhhchhhHHHHHHHHHHHHHhCC-----CCceeeee---eeeec
Q 047009          150 EDFEVLKVVGQGAFGRVYQVRKKNTSEIYAMKVMRKDKIVEKNHAEYMKAERDILTKID-----HPFVVQLK---YSFQT  221 (482)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l~---~~~~~  221 (482)
                      +...-.+.|..|---+.|++...+ | .|++|+..+..  ..   +.+..|..++..|.     .|..+...   ....-
T Consensus        18 g~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~   90 (316)
T d2ppqa1          18 GSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   90 (316)
T ss_dssp             CCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             CCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CH---HHHHHHHHHHHhhhhccccccccceecCCCcceee
Confidence            444555667788888999987654 4 48999986532  11   23445666666553     23332221   11123


Q ss_pred             CCeEEEEEEecCCCchH--------------HHHHhc--C-------CCCHHH------------------HHHHHHHHH
Q 047009          222 KYRLYLVLDFINGGHLF--------------FQLYHH--G-------LFREDL------------------ARIYAAEIV  260 (482)
Q Consensus       222 ~~~~~lV~E~~~gg~L~--------------~~l~~~--~-------~l~~~~------------------~~~i~~qi~  260 (482)
                      ......++.++.|....              ..+...  .       ......                  ....+..+.
T Consensus        91 ~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  170 (316)
T d2ppqa1          91 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  170 (316)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             ecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHH
Confidence            45566777777664221              000000  0       000000                  111122222


Q ss_pred             HHHHHHHH----CCCcccCCCCCcEEEccCCceeEcccCcccc
Q 047009          261 SAVSHLHA----NGIMHRDLKPENILLGADGHVMLTDFGLAKQ  299 (482)
Q Consensus       261 ~aL~yLH~----~~IiHrDLKp~NILl~~~g~vKL~DFGla~~  299 (482)
                      ..+.-.+.    .|+||+|+.++||+++.++..-|.||+.|..
T Consensus       171 ~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         171 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            22222222    3799999999999999887778999998753